Citrus Sinensis ID: 003599

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------81
Protein Sequence
MIPIALLIILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGSFSAGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFRHNFTFGFANDWTFFALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQEKPICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKMKVPDFTEWTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRVANSDVDEKGKKDVFVSPLIKGMFALAICTLFLWRWIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPAFTERQGADDSESFKQIQQRILLMILLLHSQQAEIRRGSLW
Secondary Structure (PSIPRED)
cccHHHHHHHHHHHHHccccccccccccccccccccEEEEcccEEEEEEcccccccccEEEEEEcccccccEEEEEcccccccccccEEEEEccccEEEEcccccEEEEEccccccccccEEEEcccccEEEEEcccccEEEEEccccccccccccEEEEEEccccEEEEEEcccccccccccEEEEEEcccccEEEEEEccccEEEEccccccEEEccccccEEEEEEEEEEEEccccEEEEEEEEccEEEEEEEEcccccEEEEEEEcccccccccccccccccccccccccccccccccccHHHHccccccccEEEccccccccccccccccccccEEEcccccccccEEEcccccHHHHHHHHHHcccccEEEEcccccEEEEcccccEEEccccccccEEEEEEccccccccccccEEEccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccHHHHHHHHcccccccccccccccccEEEEcccccEEEEEEccccccccHHHHHHHHHHHHHcccccccEEEcccccccEEEEEEEEcccccccEEcccccccccccHHHHHHHHHHHHHHHHcccccccccEEEcccccccEEccccccccccccccEEEcccccccccccEEEEEcccccHHHHHccccccccccccccEEEEEEEEcccccccccccccHHHHHHHHHcccccccccccccccccccHHHHHHHHEEEEEcccccccccccHHHHHHHHccccccccccccccEEEcccccccccccccccEEEEEEEEEEEEEHHHHccccc
Secondary Structure Prediction (SSPRO)
ccHHHHHHHHHHHHHHHHHHHcccccccccccccccEEEccccEEEEEEEcccccccEEEEEEEEcccccEEEEEEEcccccccccEEEEEccccEEEEEEccccEEEEEccccccccccEEEEEccccEEEEEcccccEEEEEccccccccccccEccccccccccEEEEEcccccccccccEEEEEccccccEEEEEcccEEEEEccccccEEEEcccccccccEEEEEEEEEccccEEEEEEccccEEEEEEEEcccccEEEEEEccccccccHcccccccccccccccccccccccccccHHHHHccccccccEEccccEcccccccccccccccEEEEccccccccccEEEcccHHHHHHHHHHcccEEEEEEccccEEEEEEcccEEEHHHccccccEEEEEEccHHHcccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccEcHHHHHHHHccccHHcccccccccccEccccccccEEEEEEccccccccHHHHHHHHHHHHHHHHHHHHHHHccccccccEEEEEEEcccccccEEEcccHccccccHHHHHHHHHHHHHHHHHHHHccHcccccccccHHHEEEcccccEEEcccccccEcccccEEccccEEEEEcccccHHHHHHcEEcHHHHHHHHHHHHHHHHccccccccccccccHHHHHHHHHHccccHHHccHHHccccccHHHHHHHHHHHHHHHHccccccccHHHEEEEccccccccccccccEEEEEccccccccccccccccEEEEEEccccHHHHHccccc
Coil and Loop (DISEMBL)
MIPIALLIILLSCFCLDFAVAidssitssqlirdpdailsngsnfklgffnpadspyrymgiwydmpseKAVIWVANrdnplkdssgiitisedgnlvlvnGQKEVLWSSnvsnlvnnstsaqlldsgnlvlrdNINRAIVWEsfqeptdsflpgmhhgidqrtgkkvqltswkslsdpstgsfsaglihqnipeifvwnvsrpywrsgpwngqifigipelksvYLFRHnftfgfandwtFFALTAQGILEERIWIKWKDNWEVGFLNLRTecdvygkcgafgicnsqekpicsclegfepknaeewnrgnwtsgcirrsklqcerrnitgkvgkedgfsklnkmkvpdftewtspatedecreqclkncsciayafdggIGCMVWRSinlidiqrlpfggtdlYIRVansdvdekgkkdvfvsPLIKGMFALAICTLFLWRWIAKRKAEVIAKLSAtnvntvklqdlplfqfEELATAtnnfqlssklgqggfgpvywgrlkdgQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYmpnrsldallfdplkkERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNilldeelnpkisdfgmakifggnqdqadtgrvvgtfgymspeyamegrfseksdvFSFGVLLLEIVSgrkntsffeddLTILGYAWKLWNENKILAlvdpflsessfqLDMIIRCIHVGLLCVQElvkdrpnmSTVVSMLNSeirdlpypkepafterqgaddseSFKQIQQRILLMILLLHSQQAEIRRGSLW
Flexible Loop (DISEMBL)
MIPIALLIILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTsaqlldsgnLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGSFSAGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFRHNFTFGFANDWTFFALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQEKPICSCLEGFEPKnaeewnrgnwtsgcirrsklqcerrnitgkvgkedgfsklnkmkvpdfteWTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRvansdvdekgkKDVFVSPLIKGMFALAICTLFLWRWIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRkrfniiegisrgllylhRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFggnqdqadtgrVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSgrkntsffEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNseirdlpypkEPAFTerqgaddsESFKQIQQRILLMILLLHSqqaeirrgslw
Low Complexity Region (SEG)
MIPIALLIILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEvlwssnvsnlvnnsTSAQLLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGSFSAGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFRHNFTFGFANDWTFFALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQEKPICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKMKVPDFTEWTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRVANSDVDEKGKKDVFVSPLIKGMFALAICTLFLWRWIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPAFTERQGADDSESFKqiqqrillmilllhsqqAEIRRGSLW
Disordered region (IsUnstruct)
**PIALLIILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGI**********************SFSAGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFRHNFTFGFANDWTFFALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQEKPICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVG***GFSKLNKMKVPDFTEWTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRVANSDVDEKGKKDVFVSPLIKGMFALAICTLFLWRWIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS******************************QIQQRILLMILLLHS***********
Disordered Region (DISOPRED)
MIPIALLIILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNV**********QLLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGSFSAGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFRHNFTFGFANDWTFFALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQEKPICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQ**********GKEDGFSKLNKMKVPDFTEWTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRVA**********DVFVSPLIKGMFALAICTLFLWRWIAK*********************LPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPAF************************LLHSQQAEI*RGSLW
Disordered Region (DISEMBL)
MIPIALLIILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGSFSAGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFRHNFTFGFANDWTFFALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQEKPICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKMKVPDFTEWTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRVANSDVDEKGKKDVFVSPLIKGMFALAICTLFLWRWIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPAFT***********KQIQQRILLMILLLHSQQAEIRRGSLW
Disordered Region (DISPRO)
MIPIALLIILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGSFSAGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFRHNFTFGFANDWTFFALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQEKPICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNI****GKEDGFSKLNKMKVPDFTEWTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRVANSDVDEKGKKDVFVSPLIKGMFALAICTLFLWRWIAKRKAEV*************LQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPAFTERQG************RILLMILLLHSQQAEIRR**L*
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MIPIALLIILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGSFSAGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFRHNFTFGFANDWTFFALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQEKPICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKMKVPDFTEWTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRVANSDVDEKGKKDVFVSPLIKGMFALAICTLFLWRWIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPAFTERQGADDSESFKQIQQRILLMILLLHSQQAEIRRGSLW
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	808	2.2.26 [Sep-21-2011]
Q9SXB4	820	G-type lectin S-receptor-	no	no	0.944	0.930	0.531	0.0
Q9SXB8	842	G-type lectin S-receptor-	no	no	0.939	0.901	0.526	0.0
Q9SXB5	820	G-type lectin S-receptor-	no	no	0.940	0.926	0.510	0.0
Q9LPZ9	830	G-type lectin S-receptor-	no	no	0.952	0.927	0.506	0.0
Q9SY89	842	Putative G-type lectin S-	no	no	0.948	0.909	0.450	0.0
O81906	849	G-type lectin S-receptor-	no	no	0.948	0.902	0.457	0.0
O81905	850	Receptor-like serine/thre	no	no	0.903	0.858	0.449	0.0
O64783	814	G-type lectin S-receptor-	no	no	0.939	0.932	0.444	0.0
O64781	831	G-type lectin S-receptor-	no	no	0.948	0.921	0.433	0.0
O64770	804	G-type lectin S-receptor-	no	no	0.950	0.955	0.444	0.0

>sp|Q9SXB4|Y1130_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11300 OS=Arabidopsis thaliana GN=At1g11300 PE=2 SV=1

 Score =  837 bits (2162), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 426/801 (53%), Positives = 566/801 (70%), Gaps = 38/801 (4%)

Query: 6   LLIILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYD 65
           + I++LSCF L  ++A + +  S +L  D + I+S+   F+ GFF+P +S  RY GIWY+
Sbjct: 11  VCILVLSCFFLSVSLAQERAFFSGKL-NDSETIVSSFRTFRFGFFSPVNSTSRYAGIWYN 69

Query: 66  MPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVN-NSTSAQL 124
             S + VIWVAN+D P+ DSSG+I++S+DGNLV+ +GQ+ VLWS+NVS   + NST A+L
Sbjct: 70  SVSVQTVIWVANKDKPINDSSGVISVSQDGNLVVTDGQRRVLWSTNVSTQASANSTVAEL 129

Query: 125 LDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGK-KVQLTSWKSLSDPSTGS 183
           LDSGNLVL++  + A +WESF+ PTDS+LP M  G + R G   V +TSWKS SDPS GS
Sbjct: 130 LDSGNLVLKEASSDAYLWESFKYPTDSWLPNMLVGTNARIGGGNVTITSWKSPSDPSPGS 189

Query: 184 FSAGLIHQNIPEIFVWNVS---RPYWRSGPWNGQIFIGIPELKS-VYLFRH--------N 231
           ++A L+    PE+F+ N +      WRSGPWNGQ+F G+P++ + V+L+R         +
Sbjct: 190 YTAALVLAAYPELFIMNNNNNNSTVWRSGPWNGQMFNGLPDVYAGVFLYRFIVNDDTNGS 249

Query: 232 FTFGFANDWT--FFALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQ 289
            T  +AND T  +F +  +G +  R W + + NW VG     TECD Y +CG F  CN +
Sbjct: 250 VTMSYANDSTLRYFYMDYRGSVIRRDWSETRRNWTVGLQVPATECDNYRRCGEFATCNPR 309

Query: 290 EKPICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKMKVP 349
           + P+CSC+ GF P+N  EWN GNW+ GC RR  LQCER+N  G     DGF +L +MK+P
Sbjct: 310 KNPLCSCIRGFRPRNLIEWNNGNWSGGCTRRVPLQCERQNNNGSA---DGFLRLRRMKLP 366

Query: 350 DFTEWTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRV 409
           DF    S A+E EC   CL+ CSCIA A   G GCM+W   +L+D Q L   G DLYIR+
Sbjct: 367 DFAR-RSEASEPECLRTCLQTCSCIAAAHGLGYGCMIWNG-SLVDSQELSASGLDLYIRL 424

Query: 410 ANSDVDEKGKKDVFVSPLIKG-MFALAICTLFLWRWIAKRKA--------EVIAKLSA-T 459
           A+S++  K K+ + +  ++ G +F +A C L   R + K++A        ++  ++ A  
Sbjct: 425 AHSEIKTKDKRPILIGTILAGGIFVVAACVLLARRIVMKKRAKKKGRDAEQIFERVEALA 484

Query: 460 NVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASG 519
             N  KL++LPLF+F+ LA ATNNF L +KLGQGGFGPVY G+L++GQEIAVKRLS+ASG
Sbjct: 485 GGNKGKLKELPLFEFQVLAAATNNFSLRNKLGQGGFGPVYKGKLQEGQEIAVKRLSRASG 544

Query: 520 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD 579
           QGLEE +NEV+VISKLQHRNLV+LLGCC+ GEE+ML+YE+MP +SLD  LFD  + + LD
Sbjct: 545 QGLEELVNEVVVISKLQHRNLVKLLGCCIAGEERMLVYEFMPKKSLDYYLFDSRRAKLLD 604

Query: 580 WRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 639
           W+ RFNII GI RGLLYLHRDSRLRIIHRDLKASNILLDE L PKISDFG+A+IF GN+D
Sbjct: 605 WKTRFNIINGICRGLLYLHRDSRLRIIHRDLKASNILLDENLIPKISDFGLARIFPGNED 664

Query: 640 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYA 699
           +A+T RVVGT+GYM+PEYAM G FSEKSDVFS GV+LLEI+SGR+N+     + T+L Y 
Sbjct: 665 EANTRRVVGTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIISGRRNS-----NSTLLAYV 719

Query: 700 WKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIR 759
           W +WNE +I +LVDP + +  F+ + I +CIH+GLLCVQE   DRP++STV SML+SEI 
Sbjct: 720 WSIWNEGEINSLVDPEIFDLLFEKE-IHKCIHIGLLCVQEAANDRPSVSTVCSMLSSEIA 778

Query: 760 DLPYPKEPAFTERQGADDSES 780
           D+P PK+PAF  R    ++ES
Sbjct: 779 DIPEPKQPAFISRNNVPEAES 799

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3

 Score =  831 bits (2146), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 422/801 (52%), Positives = 561/801 (70%), Gaps = 42/801 (5%)

Query: 26  ITSSQLIRDPDA--ILSNGSNFKLGFFNPADSP--YRYMGIWYDMPSEKAVIWVANRDNP 81
           IT S  I+D ++  +L     F+ GFF P +S    RY+GIWY+    + V+WVAN+D+P
Sbjct: 33  ITFSSPIKDSESETLLCKSGIFRFGFFTPVNSTTRLRYVGIWYEKIPIQTVVWVANKDSP 92

Query: 82  LKDSSGIITISEDGNLVLVNGQKEVLWSSNVS-NLVNNSTSAQLLDSGNLVLRDNINRA- 139
           + D+SG+I+I +DGNL + +G+  ++WS+NVS  +  N+T  QL+DSGNL+L+DN N   
Sbjct: 93  INDTSGVISIYQDGNLAVTDGRNRLVWSTNVSVPVAPNATWVQLMDSGNLMLQDNRNNGE 152

Query: 140 IVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGSFSAGLIHQNIPEIFVW 199
           I+WESF+ P DSF+P M  G D RTG  ++LTSW S  DPSTG+++AG+     PE+ +W
Sbjct: 153 ILWESFKHPYDSFMPRMTLGTDGRTGGNLKLTSWTSHDDPSTGNYTAGIAPFTFPELLIW 212

Query: 200 NVSRPYWRSGPWNGQIFIGIPELKSVYLFRHNF----------TFGFAND--WTFFALTA 247
             + P WRSGPWNGQ+FIG+P + S+ LF   F          +  +AND     F L  
Sbjct: 213 KNNVPTWRSGPWNGQVFIGLPNMDSL-LFLDGFNLNSDNQGTISMSYANDSFMYHFNLDP 271

Query: 248 QGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQEKPICSCLEGFEPKNAEE 307
           +GI+ ++ W      W +G     T+CD YG+CG FG C++ E P C C++GF PKN  E
Sbjct: 272 EGIIYQKDWSTSMRTWRIGVKFPYTDCDAYGRCGRFGSCHAGENPPCKCVKGFVPKNNTE 331

Query: 308 WNRGNWTSGCIRRSKLQCER-RNITGKVG--KEDGFSKLNKMKVPDFTEWTSPATEDECR 364
           WN GNW++GC+R++ LQCER RN++   G  K DGF KL KMKVP   E  S A+E  C 
Sbjct: 332 WNGGNWSNGCMRKAPLQCERQRNVSNGGGGGKADGFLKLQKMKVPISAE-RSEASEQVCP 390

Query: 365 EQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRVANSDVDEKGKKDVFV 424
           + CL NCSC AYA+D GIGCM+W S +L+D+Q     G DL+IRVA+S++       V +
Sbjct: 391 KVCLDNCSCTAYAYDRGIGCMLW-SGDLVDMQSFLGSGIDLFIRVAHSELKTHSNLAVMI 449

Query: 425 S-PLIKGMFALAICTLFLWRWIAKRKA--------------EVIAKLSATNVNTVKLQDL 469
           + P+I  M   A+C L   R   KR A              E +   + +  N +KL++L
Sbjct: 450 AAPVIGVMLIAAVCVLLACRKYKKRPAPAKDRSAELMFKRMEALTSDNESASNQIKLKEL 509

Query: 470 PLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEV 529
           PLF+F+ LAT+T++F L +KLGQGGFGPVY G+L +GQEIAVKRLS+ SGQGLEE MNEV
Sbjct: 510 PLFEFQVLATSTDSFSLRNKLGQGGFGPVYKGKLPEGQEIAVKRLSRKSGQGLEELMNEV 569

Query: 530 MVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEG 589
           +VISKLQHRNLV+LLGCC+EGEE+ML+YEYMP +SLDA LFDP+K++ LDW+ RFNI+EG
Sbjct: 570 VVISKLQHRNLVKLLGCCIEGEERMLVYEYMPKKSLDAYLFDPMKQKILDWKTRFNIMEG 629

Query: 590 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 649
           I RGLLYLHRDSRL+IIHRDLKASNILLDE LNPKISDFG+A+IF  N+D+A+T RVVGT
Sbjct: 630 ICRGLLYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFRANEDEANTRRVVGT 689

Query: 650 FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFF--EDDLTILGYAWKLWNENK 707
           +GYMSPEYAMEG FSEKSDVFS GV+ LEI+SGR+N+S    E++L +L YAWKLWN+ +
Sbjct: 690 YGYMSPEYAMEGFFSEKSDVFSLGVIFLEIISGRRNSSSHKEENNLNLLAYAWKLWNDGE 749

Query: 708 ILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEP 767
             +L DP + +  F+ + I +C+H+GLLCVQE+  DRPN+S V+ ML +E   L  PK+P
Sbjct: 750 AASLADPAVFDKCFEKE-IEKCVHIGLLCVQEVANDRPNVSNVIWMLTTENMSLADPKQP 808

Query: 768 AFTERQGADDSESFKQIQQRI 788
           AF  R+GA ++ES  Q  Q++
Sbjct: 809 AFIVRRGASEAESSDQSSQKV 829

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SXB5|Y1135_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11305 OS=Arabidopsis thaliana GN=At1g11305 PE=2 SV=1

 Score =  795 bits (2054), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 407/798 (51%), Positives = 550/798 (68%), Gaps = 38/798 (4%)

Query: 8   IILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMP 67
           ++ LSCF L  ++A + ++ S  L  D + I+S+   F+ GFF+P +S  RY GIWY+  
Sbjct: 13  VLSLSCFFLSVSLAHERALFSGTL-NDSETIVSSFRTFRFGFFSPVNSTNRYAGIWYNSI 71

Query: 68  SEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVN-NSTSAQLLD 126
             + VIWVAN+D P+ DSSG+I+ISEDGNLV+ +GQ+ VLWS+NVS   + NST A+LL+
Sbjct: 72  PVQTVIWVANKDTPINDSSGVISISEDGNLVVTDGQRRVLWSTNVSTRASANSTVAELLE 131

Query: 127 SGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGK-KVQLTSWKSLSDPSTGSFS 185
           SGNLVL+D    A +WESF+ PTDS+LP M  G + RTG   + +TSW + SDPS GS++
Sbjct: 132 SGNLVLKDANTDAYLWESFKYPTDSWLPNMLVGTNARTGGGNITITSWTNPSDPSPGSYT 191

Query: 186 AGLIHQNIPEIFVWNVS---RPYWRSGPWNGQIFIGIPEL-KSVYLFRHNF--------T 233
           A L+    PE+F++N +      WRSGPWNG +F G+P++   ++L+R           T
Sbjct: 192 AALVLAPYPELFIFNNNDNNATVWRSGPWNGLMFNGLPDVYPGLFLYRFKVNDDTNGSAT 251

Query: 234 FGFANDWTF--FALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQEK 291
             +AND T     L  +G    R W + + NW +G     TECD+Y +CG +  CN ++ 
Sbjct: 252 MSYANDSTLRHLYLDYRGFAIRRDWSEARRNWTLGSQVPATECDIYSRCGQYTTCNPRKN 311

Query: 292 PICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKMKVPDF 351
           P CSC++GF P+N  EWN GNW+ GCIR+  LQCER+N     G  D F KL +MK+PDF
Sbjct: 312 PHCSCIKGFRPRNLIEWNNGNWSGGCIRKLPLQCERQN---NKGSADRFLKLQRMKMPDF 368

Query: 352 TEWTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRVAN 411
               S A+E EC   CL++CSCIA+A   G GCM+W   +L+D Q L   G DL IR+A+
Sbjct: 369 AR-RSEASEPECFMTCLQSCSCIAFAHGLGYGCMIWNR-SLVDSQVLSASGMDLSIRLAH 426

Query: 412 SDVDEKGKKDVFV-SPLIKGMFALAICTLFLWRWIAKRKA--------EVIAKLSA-TNV 461
           S+   + ++ + + + L  G+F +A C L   R + K++A        ++  ++ A    
Sbjct: 427 SEFKTQDRRPILIGTSLAGGIFVVATCVLLARRIVMKKRAKKKGTDAEQIFKRVEALAGG 486

Query: 462 NTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQG 521
           +  KL++LPLF+F+ LATAT+NF LS+KLGQGGFGPVY G L +GQEIAVKRLS+ASGQG
Sbjct: 487 SREKLKELPLFEFQVLATATDNFSLSNKLGQGGFGPVYKGMLLEGQEIAVKRLSQASGQG 546

Query: 522 LEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWR 581
           LEE + EV+VISKLQHRNLV+L GCC+ GEE+ML+YE+MP +SLD  +FDP + + LDW 
Sbjct: 547 LEELVTEVVVISKLQHRNLVKLFGCCIAGEERMLVYEFMPKKSLDFYIFDPREAKLLDWN 606

Query: 582 KRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA 641
            RF II GI RGLLYLHRDSRLRIIHRDLKASNILLDE L PKISDFG+A+IF GN+D+A
Sbjct: 607 TRFEIINGICRGLLYLHRDSRLRIIHRDLKASNILLDENLIPKISDFGLARIFPGNEDEA 666

Query: 642 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWK 701
           +T RVVGT+GYM+PEYAM G FSEKSDVFS GV+LLEI+SGR+N+       T+L + W 
Sbjct: 667 NTRRVVGTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIISGRRNS-----HSTLLAHVWS 721

Query: 702 LWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDL 761
           +WNE +I  +VDP + +  F+ + I +C+H+ LLCVQ+   DRP++STV  ML+SE+ D+
Sbjct: 722 IWNEGEINGMVDPEIFDQLFEKE-IRKCVHIALLCVQDAANDRPSVSTVCMMLSSEVADI 780

Query: 762 PYPKEPAFTERQGADDSE 779
           P PK+PAF  R    ++E
Sbjct: 781 PEPKQPAFMPRNVGLEAE 798

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LPZ9|SD113_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-13 OS=Arabidopsis thaliana GN=SD113 PE=1 SV=2

 Score =  768 bits (1984), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 410/809 (50%), Positives = 547/809 (67%), Gaps = 39/809 (4%)

Query: 13  CFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAV 72
           CF L   +A D  IT S   RD + ++SN S F+ GFF+P +S  RY GIW++    + V
Sbjct: 13  CFSLRLCLATDV-ITFSSEFRDSETVVSNHSTFRFGFFSPVNSTGRYAGIWFNNIPVQTV 71

Query: 73  IWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNV-SNLVNNSTSAQLLDSGNLV 131
           +WVAN ++P+ DSSG+++IS++GNLV+++G+ +V WS+NV   +  N+  A+LL++GNLV
Sbjct: 72  VWVANSNSPINDSSGMVSISKEGNLVVMDGRGQVHWSTNVLVPVAANTFYARLLNTGNLV 131

Query: 132 LRDNINRA--IVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGSFSAGLI 189
           L    N    I+WESF+ P + +LP M    D +TG+ ++L SWKS  DPS G +SAGLI
Sbjct: 132 LLGTTNTGDEILWESFEHPQNIYLPTMSLATDTKTGRSLKLRSWKSPFDPSPGRYSAGLI 191

Query: 190 HQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELK-SVYLF--------RHNFTFGFANDW 240
               PE+ VW      WRSGPWNGQ FIG+P +   + LF        R + +  +A + 
Sbjct: 192 PLPFPELVVWKDDLLMWRSGPWNGQYFIGLPNMDYRINLFELTLSSDNRGSVSMSYAGNT 251

Query: 241 TF--FALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGIC--NSQEKPICSC 296
               F L ++G + +R W      W+       T+CD Y  CG F  C  N    P C C
Sbjct: 252 LLYHFLLDSEGSVFQRDWNVAIQEWKTWLKVPSTKCDTYATCGQFASCRFNPGSTPPCMC 311

Query: 297 LEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKMKVPDFTEWTS 356
           + GF+P++  EWN GNWT GC+R++ LQCE R+      K DGF ++ KMKVP   +  S
Sbjct: 312 IRGFKPQSYAEWNNGNWTQGCVRKAPLQCESRDNNDGSRKSDGFVRVQKMKVPHNPQ-RS 370

Query: 357 PATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRVANSDVDE 416
            A E +C E CLKNCSC AY+FD GIGC++W S NL+D+Q     G   YIR+A+S+  +
Sbjct: 371 GANEQDCPESCLKNCSCTAYSFDRGIGCLLW-SGNLMDMQEFSGTGVVFYIRLADSEFKK 429

Query: 417 KGKKDVFVS-PLIKGMFALA-ICTLFLWRWIAKRKA---------EVIAKLSATNV---- 461
           +  + + ++  L+ G F  A    L LW+ IAK +          E +  LS+ +V    
Sbjct: 430 RTNRSIVITVTLLVGAFLFAGTVVLALWK-IAKHREKNRNTRLLNERMEALSSNDVGAIL 488

Query: 462 -NTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQ 520
            N  KL++LPLF+F+ LA ATNNF +++KLGQGGFG VY GRL++G +IAVKRLS+ SGQ
Sbjct: 489 VNQYKLKELPLFEFQVLAVATNNFSITNKLGQGGFGAVYKGRLQEGLDIAVKRLSRTSGQ 548

Query: 521 GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDW 580
           G+EEF+NEV+VISKLQHRNLVRLLG C+EGEE+ML+YE+MP   LDA LFDP+K+  LDW
Sbjct: 549 GVEEFVNEVVVISKLQHRNLVRLLGFCIEGEERMLVYEFMPENCLDAYLFDPVKQRLLDW 608

Query: 581 RKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ 640
           + RFNII+GI RGL+YLHRDSRL+IIHRDLKASNILLDE LNPKISDFG+A+IF GN+D+
Sbjct: 609 KTRFNIIDGICRGLMYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFQGNEDE 668

Query: 641 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFED--DLTILGY 698
             T RVVGT+GYM+PEYAM G FSEKSDVFS GV+LLEIVSGR+N+SF+ D  +  +  Y
Sbjct: 669 VSTVRVVGTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIVSGRRNSSFYNDGQNPNLSAY 728

Query: 699 AWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEI 758
           AWKLWN  + +ALVDP + E  F+ + I RC+HVGLLCVQ+   DRP+++TV+ ML+SE 
Sbjct: 729 AWKLWNTGEDIALVDPVIFEECFE-NEIRRCVHVGLLCVQDHANDRPSVATVIWMLSSEN 787

Query: 759 RDLPYPKEPAFTERQGADDSESFKQIQQR 787
            +LP PK+PAF  R+G  + ES  Q   R
Sbjct: 788 SNLPEPKQPAFIPRRGTSEVESSGQSDPR 816

Receptor-like serine/threonine-protein kinase that represses the disease resistance signaling pathway triggered in response to bacterial pathogen such as Pseudomonas syringae pv. tomato.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SY89|Y1661_ARATH Putative G-type lectin S-receptor-like serine/threonine-protein kinase At1g61610 OS=Arabidopsis thaliana GN=At1g61610 PE=2 SV=1

 Score =  700 bits (1806), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 372/825 (45%), Positives = 515/825 (62%), Gaps = 59/825 (7%)

Query: 2   IPIALLIILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMG 61
           + +   +++    C + + +  +S T +  IR+ D+++S   +F+LGFF P +S  RY+G
Sbjct: 8   LTLVTTLLIFHQLCSNVSCSTSNSFTRNHTIREGDSLISEDESFELGFFTPKNSTLRYVG 67

Query: 62  IWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTS 121
           IWY     + V+WVANR+ PL D  G + I++DGNLV+VNGQ E +WS+NV    NN T 
Sbjct: 68  IWYKNIEPQTVVWVANREKPLLDHKGALKIADDGNLVIVNGQNETIWSTNVEPESNN-TV 126

Query: 122 AQLLDSGNLVL-RDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPS 180
           A L  +G+LVL  D+  R   WESF  PTD+FLPGM   ++   G+      WKS SDPS
Sbjct: 127 AVLFKTGDLVLCSDSDRRKWYWESFNNPTDTFLPGMRVRVNPSLGENRAFIPWKSESDPS 186

Query: 181 TGSFSAGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFRHNFTFGF---- 236
            G +S G+      EI +W   +  WRSGPWN  IF GIP++    L   N+ +GF    
Sbjct: 187 PGKYSMGIDPVGALEIVIWEGEKRKWRSGPWNSAIFTGIPDM----LRFTNYIYGFKLSS 242

Query: 237 ----------------ANDWTFFALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKC 280
                           ++D+  F +   G+ E+  W K   NW +      TEC+ Y +C
Sbjct: 243 PPDRDGSVYFTYVASDSSDFLRFWIRPDGVEEQFRWNKDIRNWNLLQWKPSTECEKYNRC 302

Query: 281 GAFGICNSQEK---PICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKE 337
           G + +C+  ++     CSC++GFEP + ++WN  +++ GC RR  L C +  +    G+E
Sbjct: 303 GNYSVCDDSKEFDSGKCSCIDGFEPVHQDQWNNRDFSGGCQRRVPLNCNQSLV---AGQE 359

Query: 338 DGFSKLNKMKVPDFTEWTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQR 397
           DGF+ L  +KVPDF         + C++ C ++CSC AYA   GIGCM+W + +LID++ 
Sbjct: 360 DGFTVLKGIKVPDFGSVVLHNNSETCKDVCARDCSCKAYALVVGIGCMIW-TRDLIDMEH 418

Query: 398 LPFGGTDLYIRVANSDVDEKGKKD----VFVSPLIKGMFALAICTLFLWRWIAKRKAEVI 453
              GG  + IR+A S +   GK++    + V  +I G F L +C   LW++    KA + 
Sbjct: 419 FERGGNSINIRLAGSKLG-GGKENSTLWIIVFSVI-GAFLLGLCIWILWKFKKSLKAFLW 476

Query: 454 AK--LSATNV----------------NTVKLQDLPLFQFEELATATNNFQLSSKLGQGGF 495
            K  ++ +++                + V   DLP+F F+ +A+AT +F   +KLGQGGF
Sbjct: 477 KKKDITVSDIIENRDYSSSPIKVLVGDQVDTPDLPIFSFDSVASATGDFAEENKLGQGGF 536

Query: 496 GPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML 555
           G VY G   +G+EIAVKRLS  S QGLEEF NE+++I+KLQHRNLVRLLGCC+E  EKML
Sbjct: 537 GTVYKGNFSEGREIAVKRLSGKSKQGLEEFKNEILLIAKLQHRNLVRLLGCCIEDNEKML 596

Query: 556 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNI 615
           +YEYMPN+SLD  LFD  K+  LDWRKR+ +I GI+RGLLYLHRDSRL+IIHRDLKASNI
Sbjct: 597 LYEYMPNKSLDRFLFDESKQGSLDWRKRWEVIGGIARGLLYLHRDSRLKIIHRDLKASNI 656

Query: 616 LLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVL 675
           LLD E+NPKISDFGMA+IF   QD A+T RVVGT+GYM+PEYAMEG FSEKSDV+SFGVL
Sbjct: 657 LLDTEMNPKISDFGMARIFNYRQDHANTIRVVGTYGYMAPEYAMEGIFSEKSDVYSFGVL 716

Query: 676 LLEIVSGRKNTSFF-EDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGL 734
           +LEIVSGRKN SF   D  +++GYAW LW++ K   ++DP + ++   +   +RCIHVG+
Sbjct: 717 ILEIVSGRKNVSFRGTDHGSLIGYAWHLWSQGKTKEMIDPIVKDTR-DVTEAMRCIHVGM 775

Query: 735 LCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPAFTERQGADDSE 779
           LC Q+ V  RPNM +V+ ML S+   LP P++P F     + D E
Sbjct: 776 LCTQDSVIHRPNMGSVLLMLESQTSQLPPPRQPTFHSFLNSGDIE 820

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1

 Score =  698 bits (1802), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 386/843 (45%), Positives = 521/843 (61%), Gaps = 77/843 (9%)

Query: 7   LIILLSCFCLDFAVAIDSSITSSQLIRD---PDAILSNGSNFKLGFFNPADSPYRYMGIW 63
           L + L  F  + ++A ++ I   + +RD      ++S    F+LGFF+P  S +R++GIW
Sbjct: 11  LSLFLYFFLYESSMAANT-IRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHRFLGIW 69

Query: 64  YDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNV--SNLVNNSTS 121
           Y    +KAV+WVANR  P+ D SG++ IS DGNLVL++G+   +WSSN+  S   NN+  
Sbjct: 70  YGNIEDKAVVWVANRATPISDQSGVLMISNDGNLVLLDGKNITVWSSNIESSTTNNNNRV 129

Query: 122 AQLLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPST 181
             + D+GN VL +      +WESF  PTD+FLP M   ++ +TG      SW+S +DPS 
Sbjct: 130 VSIHDTGNFVLSETDTDRPIWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWRSETDPSP 189

Query: 182 GSFSAGLIHQNIPEIFVW--NVSRPYWRSGPWNGQIFIGIPELKSVYLFRHNFTFGFAND 239
           G++S G+     PEI +W  N +R  WRSG WN  IF GIP +  +  + + F      D
Sbjct: 190 GNYSLGVDPSGAPEIVLWEGNKTRK-WRSGQWNSAIFTGIPNMSLLTNYLYGFKLSSPPD 248

Query: 240 WT----------------FFALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAF 283
            T                 F +   G  EE  W +    W        +ECD Y +CG F
Sbjct: 249 ETGSVYFTYVPSDPSVLLRFKVLYNGTEEELRWNETLKKWTKFQSEPDSECDQYNRCGKF 308

Query: 284 GICNSQ-EKPICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSK 342
           GIC+ +    ICSC+ G+E     + + GNW+ GC RR+ L+CER    G    ED F  
Sbjct: 309 GICDMKGSNGICSCIHGYE-----QVSVGNWSRGCRRRTPLKCERNISVG----EDEFLT 359

Query: 343 LNKMKVPDFT--EWTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPF 400
           L  +K+PDF   E      ED CRE+CL+NCSC AY+  GGIGCM+W   +L+D+Q+   
Sbjct: 360 LKSVKLPDFEIPEHNLVDPED-CRERCLRNCSCNAYSLVGGIGCMIWNQ-DLVDLQQFEA 417

Query: 401 GGTDLYIRVANSDVDE--KGKKDVFVSPLIKGMFALAICTLFLWRWIAKRKAEVIAKLSA 458
           GG+ L+IR+A+S+V E  K K  V V+ L+ G+  + I  L LWR+  KRK +V      
Sbjct: 418 GGSSLHIRLADSEVGENRKTKIAVIVAVLV-GVILIGIFALLLWRF--KRKKDVSGAYCG 474

Query: 459 TNVNT-----------------------------VKLQDLPLFQFEELATATNNFQLSSK 489
            N +T                             V   +LP+F    +A ATN+F   ++
Sbjct: 475 KNTDTSVVVADLTKSKETTSAFSGSVDIMIEGKAVNTSELPVFSLNAIAIATNDFCKENE 534

Query: 490 LGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVE 549
           LG+GGFGPVY G L+DG+EIAVKRLS  SGQG++EF NE+++I+KLQHRNLVRLLGCC E
Sbjct: 535 LGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFE 594

Query: 550 GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRD 609
           GEEKML+YEYMPN+SLD  LFD  K+  +DW+ RF+IIEGI+RGLLYLHRDSRLRIIHRD
Sbjct: 595 GEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRD 654

Query: 610 LKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDV 669
           LK SN+LLD E+NPKISDFGMA+IFGGNQ++A+T RVVGT+GYMSPEYAMEG FS KSDV
Sbjct: 655 LKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDV 714

Query: 670 FSFGVLLLEIVSGRKNTSFFEDDL-TILGYAWKLWNENKILALVDPFLSESSFQLDMIIR 728
           +SFGVLLLEIVSG++NTS    +  +++GYAW L+   +   LVDP +  +  + +  +R
Sbjct: 715 YSFGVLLLEIVSGKRNTSLRSSEHGSLIGYAWYLYTHGRSEELVDPKIRVTCSKREA-LR 773

Query: 729 CIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPAF--TERQGADDSESFKQIQQ 786
           CIHV +LCVQ+   +RPNM++V+ ML S+   L  P++P F  T R   D + +    QQ
Sbjct: 774 CIHVAMLCVQDSAAERPNMASVLLMLESDTATLAAPRQPTFTSTRRNSIDVNFALDSSQQ 833

Query: 787 RIL 789
            I+
Sbjct: 834 YIV 836

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1

 Score =  669 bits (1726), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 359/798 (44%), Positives = 501/798 (62%), Gaps = 68/798 (8%)

Query: 25  SITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKD 84
           S + S  I   + I+S G+ F+LGFF P      Y+GIWY   S++  +WVANRD PL  
Sbjct: 33  SASESLTISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRTYVWVANRDTPLSS 92

Query: 85  SSGIITISEDGNLVLVNGQKEVLWSSNVSNL-VNNSTSAQLLDSGNLVLRDNINRA---I 140
           S G + IS D NLV+++     +WS+N++   V +   A+LLD+GN VLRD+ N A   +
Sbjct: 93  SIGTLKIS-DSNLVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGNFVLRDSKNSAPDGV 151

Query: 141 VWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGSFSAGLIHQNIPEIFVWN 200
           +W+SF  PTD+ LP M  G D +TG    + SWKS  DPS+G FS  L  +  PEIF+WN
Sbjct: 152 LWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETEGFPEIFLWN 211

Query: 201 VSRPYWRSGPWNGQIFIGIPELKSVYLFRHNFT-------FGF----ANDWTFFALTAQG 249
                +RSGPWNG  F G+PE++       NFT       + F    ++ ++  ++++ G
Sbjct: 212 RESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTTSKEEVTYSFRITKSDVYSRLSISSSG 271

Query: 250 ILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQEKPICSCLEGFEPKNAEEWN 309
           +L+   WI+   NW   +   + +CD Y +CG +G C+S   P+C+C++GF+P+N + W 
Sbjct: 272 LLQRFTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSNTSPVCNCIKGFKPRNPQVWG 331

Query: 310 RGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKMKVPDFTEWTSPATED------EC 363
             + + GC+R++ L C         G  DGF +L KMK+PD    T+ A+ D      EC
Sbjct: 332 LRDGSDGCVRKTLLSC---------GGGDGFVRLKKMKLPD----TTTASVDRGIGVKEC 378

Query: 364 REQCLKNCSCIAYAFD----GGIGCMVWRSINLIDIQRLPFGGTDLYIRVANSDVDEKGK 419
            ++CL++C+C A+A       G GC+ W    L DI+    GG DLY+R+A +D+++K  
Sbjct: 379 EQKCLRDCNCTAFANTDIRGSGSGCVTWTG-ELFDIRNYAKGGQDLYVRLAATDLEDKRN 437

Query: 420 KDVFV---SPLIKGMFALAICTLFLWRWIAKRKA-------------------EVI--AK 455
           +   +   S  +  +  L+    FLW+   KR                     EV+  ++
Sbjct: 438 RSAKIIGSSIGVSVLLLLSFIIFFLWKRKQKRSILIETPIVDHQLRSRDLLMNEVVISSR 497

Query: 456 LSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLS 515
              +  N     +LPL +FEE+A ATNNF  ++KLGQGGFG VY G+L DGQE+AVKRLS
Sbjct: 498 RHISRENNTDDLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLS 557

Query: 516 KASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKK 575
           K S QG +EF NEV +I++LQH NLVRLL CCV+  EKMLIYEY+ N SLD+ LFD  + 
Sbjct: 558 KTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRN 617

Query: 576 ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 635
            +L+W+ RF+II GI+RGLLYLH+DSR RIIHRDLKASNILLD+ + PKISDFGMA+IFG
Sbjct: 618 SKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFG 677

Query: 636 GNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFF--EDDL 693
            ++ +A+T +VVGT+GYMSPEYAM+G FS KSDVFSFGVLLLEI+S ++N  F+  + DL
Sbjct: 678 RDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDL 737

Query: 694 TILGYAWKLWNENKILALVDPFLSESS--FQLDMIIRCIHVGLLCVQELVKDRPNMSTVV 751
            +LG  W+ W E K L ++DP +++SS  F+   I+RCI +GLLCVQE  +DRP MS V+
Sbjct: 738 NLLGCVWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPTMSLVI 797

Query: 752 SMLNSEIRDLPYPKEPAF 769
            ML SE   +P PK P +
Sbjct: 798 LMLGSESTTIPQPKAPGY 815

Involved in the regulation of cellular expansion and differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O64783|Y1137_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61370 OS=Arabidopsis thaliana GN=At1g61370 PE=3 SV=2

 Score =  668 bits (1723), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 355/799 (44%), Positives = 503/799 (62%), Gaps = 40/799 (5%)

Query: 6   LLIILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYD 65
           LLII  SC     A+   S ++  Q +  P     NG+ ++LGFF+P +S  +Y+GIW+ 
Sbjct: 15  LLIIFPSCAFA--AITRASPLSIGQTLSSP-----NGT-YELGFFSPNNSRNQYVGIWFK 66

Query: 66  MPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLL 125
             + + V+WVANRD P+ +++  +TI+ +G+L+LV  ++ V+WS       +N   A+LL
Sbjct: 67  NITPRVVVWVANRDKPVTNNAANLTINSNGSLILVEREQNVVWSIG-ETFSSNELRAELL 125

Query: 126 DSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGSFS 185
           ++GNLVL D ++   +WESF+   D+ L       D    KK  L+SWK+ +DPS G F 
Sbjct: 126 ENGNLVLIDGVSERNLWESFEHLGDTMLLESSVMYDVPNNKKRVLSSWKNPTDPSPGEFV 185

Query: 186 AGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFRHNFTFGFA-------- 237
           A L  Q  P+ F+   SRPYWR GPW    F GIPE+   ++ + + +   A        
Sbjct: 186 AELTTQVPPQGFIMRGSRPYWRGGPWARVRFTGIPEMDGSHVSKFDISQDVAAGTGSLTY 245

Query: 238 ------NDWTFFALTAQGILEERIWIKWKDN--WEVGFLNLRTECDVYGKCGAFGICNSQ 289
                 ++ ++  LT+ G L+    I W +   W        + CDVY  CG FG+C   
Sbjct: 246 SLERRNSNLSYTTLTSAGSLK----IIWNNGSGWVTDLEAPVSSCDVYNTCGPFGLCIRS 301

Query: 290 EKPICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCE-RRNITGKVGKEDGFSKLNKMKV 348
             P C CL+GF PK+ EEWN+ NWT GC+RR+ L C+   + T +    D F  +  +K 
Sbjct: 302 NPPKCECLKGFVPKSDEEWNKRNWTGGCMRRTNLSCDVNSSATAQANNGDIFDIVANVKP 361

Query: 349 PDFTEWTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIR 408
           PDF E+ S   E++C+++CL NCSC A+++   IGC+VW    L+D+ +   GG  L IR
Sbjct: 362 PDFYEYLSLINEEDCQQRCLGNCSCTAFSYIEQIGCLVWNR-ELVDVMQFVAGGETLSIR 420

Query: 409 VANSDVDEKGKKDVFVSPL--IKGMFALAICTLFLWRWIAKRKAEVIAKLSATN---VNT 463
           +A+S++    +  + V+ +  I     L   + + WR+ AK+       L  +       
Sbjct: 421 LASSELAGSNRVKIIVASIVSISVFMILVFASYWYWRYKAKQNDSNPIPLETSQDAWREQ 480

Query: 464 VKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLE 523
           +K QD+  F  + + T TNNF + +KLGQGGFGPVY G L+DG+EIA+KRLS  SGQGLE
Sbjct: 481 LKPQDVNFFDMQTILTITNNFSMENKLGQGGFGPVYKGNLQDGKEIAIKRLSSTSGQGLE 540

Query: 524 EFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKR 583
           EFMNE+++ISKLQHRNLVRLLGCC+EGEEK+LIYE+M N+SL+  +FD  KK  LDW KR
Sbjct: 541 EFMNEIILISKLQHRNLVRLLGCCIEGEEKLLIYEFMANKSLNTFIFDSTKKLELDWPKR 600

Query: 584 FNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 643
           F II+GI+ GLLYLHRDS LR++HRD+K SNILLDEE+NPKISDFG+A++F G Q QA+T
Sbjct: 601 FEIIQGIACGLLYLHRDSCLRVVHRDMKVSNILLDEEMNPKISDFGLARMFQGTQHQANT 660

Query: 644 GRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFF--EDDLTILGYAWK 701
            RVVGT GYMSPEYA  G FSEKSD+++FGVLLLEI++G++ +SF   E+  T+L +AW 
Sbjct: 661 RRVVGTLGYMSPEYAWTGMFSEKSDIYAFGVLLLEIITGKRISSFTIGEEGKTLLEFAWD 720

Query: 702 LWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDL 761
            W E+    L+D  +S S  + + + RC+ +GLLC+Q+   DRPN++ V+SML + + DL
Sbjct: 721 SWCESGGSDLLDQDISSSGSESE-VARCVQIGLLCIQQQAGDRPNIAQVMSMLTTTM-DL 778

Query: 762 PYPKEPAFTERQGADDSES 780
           P PK+P F  +    DSES
Sbjct: 779 PKPKQPVFAMQVQESDSES 797

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O64781|Y1639_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61390 OS=Arabidopsis thaliana GN=At1g61390 PE=2 SV=1

 Score =  667 bits (1722), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 349/805 (43%), Positives = 507/805 (62%), Gaps = 39/805 (4%)

Query: 1   MIPIALLIILLSCFCLDFA-VAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRY 59
           M+  A L++L+      +A +   S ++  Q +  PD +      ++LGFF+P +S  +Y
Sbjct: 24  MVIFACLLLLIIFPTFGYADINTSSPLSIGQTLSSPDGV------YELGFFSPNNSRKQY 77

Query: 60  MGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNS 119
           +GIW+   + + V+WVANRD P+  ++  +TIS +G+L+L++G ++V+WS+  +   +N 
Sbjct: 78  VGIWFKNIAPQVVVWVANRDKPVTKTAANLTISSNGSLILLDGTQDVIWSTGEA-FTSNK 136

Query: 120 TSAQLLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDP 179
             A+LLD+GNLV+ D+++   +W+SF+   ++ LP      D   GK   LTSW+S SDP
Sbjct: 137 CHAELLDTGNLVVIDDVSGKTLWKSFENLGNTMLPQSSVMYDIPRGKNRVLTSWRSNSDP 196

Query: 180 STGSFSAGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLF----------- 228
           S G F+     Q  P+  +   S PYWRSGPW    F GIP + + Y+            
Sbjct: 197 SPGEFTLEFTPQVPPQGLIRRGSSPYWRSGPWAKTRFSGIPGIDASYVSPFTVLQDVAKG 256

Query: 229 RHNFTFGFANDW--TFFALTAQGILEERIWIKWKD--NWEVGFLNLRTECDVYGKCGAFG 284
             +F++    ++  ++  LT++G ++    I W D  +W++ F    + CD+Y  CG FG
Sbjct: 257 TASFSYSMLRNYKLSYVTLTSEGKMK----ILWNDGKSWKLHFEAPTSSCDLYRACGPFG 312

Query: 285 ICNSQEKPICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKE-DGFSKL 343
           +C     P C CL+GF PK+ +EW +GNWTSGC+RR++L C   + T   GKE D F  +
Sbjct: 313 LCVRSRNPKCICLKGFVPKSDDEWKKGNWTSGCVRRTQLSCHTNSSTKTQGKETDSFYHM 372

Query: 344 NKMKVPDFTEWTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGT 403
            ++K PD  +       ++C + CL NCSC A+A+  GIGC+VW    L+D  +    G 
Sbjct: 373 TRVKTPDLYQLAGFLNAEQCYQDCLGNCSCTAFAYISGIGCLVWNR-ELVDTVQFLSDGE 431

Query: 404 DLYIRVANSDVDEKGKKDVFVSPLIK-GMFALAICTLFL-WRWIAKRKAEVIAKLSATN- 460
            L +R+A+S++    +  + +   +   +F + +   +  WR+  K+       + ++  
Sbjct: 432 SLSLRLASSELAGSNRTKIILGTTVSLSIFVILVFAAYKSWRYRTKQNEPNPMFIHSSQD 491

Query: 461 --VNTVKLQDLP---LFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLS 515
                ++ QD+    LF    + TATNNF  S+KLGQGGFGPVY G+L DG+EIAVKRLS
Sbjct: 492 AWAKDMEPQDVSGVNLFDMHTIRTATNNFSSSNKLGQGGFGPVYKGKLVDGKEIAVKRLS 551

Query: 516 KASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKK 575
            +SGQG +EFMNE+ +ISKLQH+NLVRLLGCC++GEEK+LIYEY+ N+SLD  LFD   K
Sbjct: 552 SSSGQGTDEFMNEIRLISKLQHKNLVRLLGCCIKGEEKLLIYEYLVNKSLDVFLFDSTLK 611

Query: 576 ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 635
             +DW+KRFNII+G++RGLLYLHRDSRLR+IHRDLK SNILLDE++ PKISDFG+A++  
Sbjct: 612 FEIDWQKRFNIIQGVARGLLYLHRDSRLRVIHRDLKVSNILLDEKMIPKISDFGLARMSQ 671

Query: 636 GNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTI 695
           G Q Q +T RVVGT GYM+PEYA  G FSEKSD++SFGVLLLEI+ G K + F E+  T+
Sbjct: 672 GTQYQDNTRRVVGTLGYMAPEYAWTGVFSEKSDIYSFGVLLLEIIIGEKISRFSEEGKTL 731

Query: 696 LGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN 755
           L YAW+ W E K + L+D  L++SS   + + RC+ +GLLCVQ    DRPN   ++SML 
Sbjct: 732 LAYAWESWCETKGVDLLDQALADSSHPAE-VGRCVQIGLLCVQHQPADRPNTLELMSMLT 790

Query: 756 SEIRDLPYPKEPAFTERQGADDSES 780
           + I +LP PK+P FT     DDS S
Sbjct: 791 T-ISELPSPKQPTFTVHSRDDDSTS 814

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O64770|Y1649_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61490 OS=Arabidopsis thaliana GN=At1g61490 PE=3 SV=1

 Score =  662 bits (1708), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 353/794 (44%), Positives = 495/794 (62%), Gaps = 26/794 (3%)

Query: 8   IILLSCFCLDFAVAIDSS---ITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWY 64
           I+  +C  L F V +  S   IT+   +     + S+   ++LGFF+P +S   Y+GIW+
Sbjct: 6   IVFFACLLL-FTVLLRFSYAGITTESPLSVEQTLSSSNGIYELGFFSPNNSQNLYVGIWF 64

Query: 65  DMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQL 124
                + V+WVANR+ P  D+S  + IS +G+L+L NG+  V+WS    N  +N + A+L
Sbjct: 65  KGIIPRVVVWVANRETPTTDTSANLAISSNGSLLLFNGKHGVVWSIG-ENFASNGSRAEL 123

Query: 125 LDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGSF 184
            D+GNLV+ DN +   +WESF+   D+ LP      +  TG+K  LTSWK+ +DPS G F
Sbjct: 124 TDNGNLVVIDNASGRTLWESFEHFGDTMLPFSSLMYNLATGEKRVLTSWKTDTDPSPGVF 183

Query: 185 SAGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFRHNFTFGFANDWTFFA 244
              +  Q   ++ +   S  Y+R+GPW    F GIP +   Y    +     AN   FF 
Sbjct: 184 VGQITPQVPSQVLIMRGSTRYYRTGPWAKTRFTGIPLMDDTYASPFSLQQD-ANGSGFFT 242

Query: 245 LTAQGILEERIWI-------KWKDN---WEVGFLNLRTECDVYGKCGAFGICNSQEKPIC 294
              +     RI I       +++ N   WE+ ++     CD+YG CG FG+C       C
Sbjct: 243 YFDRSFKLSRIIISSEGSMKRFRHNGTDWELSYMAPANSCDIYGVCGPFGLCIVSVPLKC 302

Query: 295 SCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKMKVPDFTEW 354
            CL+GF P + EEW RGNWT GC R ++L C+  N TGK    + F  +  +K+PDF E+
Sbjct: 303 KCLKGFVPHSTEEWKRGNWTGGCARLTELHCQG-NSTGK--DVNIFHPVTNVKLPDFYEY 359

Query: 355 TSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRVANSDV 414
            S    +EC + CL NCSC+A+A+  GIGC++W   NL+D  +   GG  L IR+A+S++
Sbjct: 360 ESSVDAEECHQSCLHNCSCLAFAYIHGIGCLIWNQ-NLMDAVQFSAGGEILSIRLAHSEL 418

Query: 415 DEKGKKDVFVSPLIK-GMFALAICTLF-LWRWIAKRKAEVIAKLSATNVNTVKLQDLPLF 472
               +  + V+  +   +F +     F  WR+  K KA  +      ++ + ++  L  F
Sbjct: 419 GGNKRNKIIVASTVSLSLFVILTSAAFGFWRYRVKHKAYTLKDAWRNDLKSKEVPGLEFF 478

Query: 473 QFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVI 532
           +   + TATNNF LS+KLGQGGFG VY G+L+DG+EIAVK+LS +SGQG EEFMNE+++I
Sbjct: 479 EMNTIQTATNNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKQLSSSSGQGKEEFMNEIVLI 538

Query: 533 SKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 592
           SKLQHRNLVR+LGCC+EGEEK+LIYE+M N+SLD  +FD  KK  +DW KRF+I++GI+R
Sbjct: 539 SKLQHRNLVRVLGCCIEGEEKLLIYEFMLNKSLDTFVFDARKKLEVDWPKRFDIVQGIAR 598

Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 652
           GLLYLHRDSRL++IHRDLK SNILLDE++NPKISDFG+A+++ G Q Q  T RVVGT GY
Sbjct: 599 GLLYLHRDSRLKVIHRDLKVSNILLDEKMNPKISDFGLARMYEGTQCQDKTRRVVGTLGY 658

Query: 653 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNT--SFFEDDLTILGYAWKLWNENKILA 710
           MSPEYA  G FSEKSD++SFGVLLLEI+ G K +  S+ E+  T+L YAW+ W E K + 
Sbjct: 659 MSPEYAWTGVFSEKSDIYSFGVLLLEIIIGEKISRFSYGEEGKTLLAYAWESWGETKGID 718

Query: 711 LVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPAFT 770
           L+D  L++S   L+ + RC+ +GLLCVQ    DRPN   +++ML +   DLP PK+P F 
Sbjct: 719 LLDQDLADSCRPLE-VGRCVQIGLLCVQHQPADRPNTLELLAMLTT-TSDLPSPKQPTFV 776

Query: 771 ERQGADDSESFKQI 784
                D+S   K +
Sbjct: 777 VHSRDDESSLSKDL 790

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	808
224114125	832	predicted protein [Populus trichocarpa]	0.959	0.931	0.603	0.0
359496521	844	PREDICTED: G-type lectin S-receptor-like	0.950	0.909	0.611	0.0
224114137	827	predicted protein [Populus trichocarpa]	0.956	0.934	0.592	0.0
224078778	831	predicted protein [Populus trichocarpa]	0.965	0.938	0.594	0.0
147840284	827	hypothetical protein VITISV_016155 [Viti	0.933	0.911	0.595	0.0
224112032	824	predicted protein [Populus trichocarpa]	0.948	0.929	0.589	0.0
224114141	824	predicted protein [Populus trichocarpa]	0.948	0.929	0.587	0.0
359496519	854	PREDICTED: G-type lectin S-receptor-like	0.945	0.894	0.600	0.0
296084622	817	unnamed protein product [Vitis vinifera]	0.949	0.938	0.608	0.0
359496538	887	PREDICTED: G-type lectin S-receptor-like	0.929	0.846	0.608	0.0

>gi|224114125|ref|XP_002316674.1| predicted protein [Populus trichocarpa] gi|222859739|gb|EEE97286.1| predicted protein [Populus trichocarpa]

 Score =  984 bits (2545), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 493/817 (60%), Positives = 607/817 (74%), Gaps = 42/817 (5%)

Query: 4   IALLIILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIW 63
           I  L ++L CFCL+F  +ID+ I+ SQ IRDP+ I+S G  F+LGFF+P +S  RY+ IW
Sbjct: 9   IIALHLILYCFCLEFGASIDT-ISLSQFIRDPETIVSAGKKFELGFFSPVNSTNRYVAIW 67

Query: 64  YDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQ 123
           Y   S    +WVANR+ PL DSSGI+TISEDGNLV++NGQKE LWSSNVS  +N+S  AQ
Sbjct: 68  YSNISITTPVWVANRNKPLNDSSGIMTISEDGNLVVLNGQKETLWSSNVSTGMNDS-RAQ 126

Query: 124 LLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGS 183
           L+D GNLVL  + N   +W+SFQEP+D+++P M    + RTGKK  LTSWKS SDPS GS
Sbjct: 127 LMDDGNLVLGGSENGNSLWQSFQEPSDTYIPKMRLTANPRTGKKTPLTSWKSPSDPSIGS 186

Query: 184 FSAGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFRHNF----------T 233
           FS G+   +IPE+ +WN SRP WR+GPWNGQ+FIG+PE+ SVYL   N           +
Sbjct: 187 FSLGIDPSSIPEVVLWNDSRPIWRTGPWNGQVFIGVPEMNSVYLDGFNLADDGNGGFTLS 246

Query: 234 FGFAND--WTFFALTAQGILEERIWI-----KWKDNWEVGFLNLRTECDVYGKCGAFGIC 286
            GFA++   T F L+++G   +  W       W+  WE    +++ ECDVYGKCG+F  C
Sbjct: 247 VGFADESYITNFVLSSEGKFGQVFWDDMNEGSWRYQWE----SVQDECDVYGKCGSFASC 302

Query: 287 NSQEKPICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKM 346
           +++  PICSCL+GFEPKNA+EWN  NWT GC+RR  ++CER    G++GKEDGFSKL ++
Sbjct: 303 DAKNTPICSCLKGFEPKNADEWNSRNWTHGCVRRKAMRCERIQNGGELGKEDGFSKLERV 362

Query: 347 KVPDFTEWTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLY 406
           KVP F EW+S  TE +CR+ C  NCSCIAYA+  GI CM+W+  NL DI++   GG DLY
Sbjct: 363 KVPGFAEWSSSITEQKCRDDCWNNCSCIAYAYYTGIYCMLWKG-NLTDIKKFSSGGADLY 421

Query: 407 IRVANSDVDEK--GKKDVFVSPLIKGMFALAICTLFLWRWI-----------AKRKAEVI 453
           IR+A +++D K    K +    ++ G  A+AIC  + WRWI            KRK  ++
Sbjct: 422 IRLAYTELDNKKINMKVIISLTVVVGAIAIAICVFYSWRWIERKRTSKKVLLPKRKHPIL 481

Query: 454 --AKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAV 511
               +   N+N VKLQ+LPLF  + L  AT+NF  ++KLGQGGFGPVY G+  DGQEIA+
Sbjct: 482 LDENVIQDNLNHVKLQELPLFSLQMLIVATDNFNTANKLGQGGFGPVYKGKFPDGQEIAL 541

Query: 512 KRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD 571
           KRLS+ASGQG EEFM EV+VISKLQH NLVRLLGCCVEGEEKML+YEYMPNRSLDA LFD
Sbjct: 542 KRLSRASGQGQEEFMTEVVVISKLQHMNLVRLLGCCVEGEEKMLVYEYMPNRSLDAFLFD 601

Query: 572 PLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 631
           P +K+ LDW+KRFNI+EGI RGLLYLHRDSRLRIIHRDLKASNILLD+ELNPKISDFGMA
Sbjct: 602 PSRKQLLDWKKRFNIVEGICRGLLYLHRDSRLRIIHRDLKASNILLDQELNPKISDFGMA 661

Query: 632 KIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFF-- 689
           +IFG N+DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEI+SGRKNTSF+  
Sbjct: 662 RIFGRNEDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIISGRKNTSFYGN 721

Query: 690 EDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMST 749
           E+ L++LGYAWKLWNE  I ALVDP +S  SF  + I RC+HVGLLCVQE  KDRP + T
Sbjct: 722 EEALSLLGYAWKLWNEGNIAALVDPGISYPSFH-EEIFRCVHVGLLCVQEFAKDRPAIFT 780

Query: 750 VVSMLNSEIRDLPYPKEPAFTERQGADDSESFKQIQQ 786
           V+SMLNSEI DLP PK+PAF+ER+   D+ S +  Q+
Sbjct: 781 VISMLNSEIVDLPTPKQPAFSERRSELDTASLQHDQR 817

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359496521|ref|XP_002262970.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330-like [Vitis vinifera]

 Score =  982 bits (2539), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 504/824 (61%), Positives = 616/824 (74%), Gaps = 56/824 (6%)

Query: 4   IALLIILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIW 63
           +  L++LLS  C  F  AID+ +TS++ I DP+ ++SNGS FKLGFF+ ADS  RY+GIW
Sbjct: 9   VIALLLLLSVICFGFCTAIDT-MTSTRFIEDPETLVSNGSAFKLGFFSLADSTNRYVGIW 67

Query: 64  YDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQ 123
           Y  PS   VIWVANRD PL DSSGI+TISEDGNL+++NGQKE++WSSNVSN   NS SAQ
Sbjct: 68  YSTPSLSTVIWVANRDKPLNDSSGIVTISEDGNLLVMNGQKEIVWSSNVSNASANS-SAQ 126

Query: 124 LLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGS 183
           LLDSGNLVL+DN + +I WES Q P+ S LP M    D  TG+KV LTSWKS SDPS GS
Sbjct: 127 LLDSGNLVLQDN-SGSITWESIQHPSHSLLPNMKISTDTNTGEKVVLTSWKSPSDPSIGS 185

Query: 184 FSAGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFRHNF----------- 232
           FS G+   NIP+IF+WN S PYWRSGPW+ QIFIGIP++ SVY  R  F           
Sbjct: 186 FSLGMNPLNIPQIFIWNGSHPYWRSGPWSSQIFIGIPDMDSVY--RSGFQVVDDKEGTVY 243

Query: 233 -TFGFAND--WTFFALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQ 289
            TF  AN   + ++ LT+QG L +      K+ W V + + ++ECDVYG CGAFGICNS 
Sbjct: 244 ATFTEANSSIFLYYVLTSQGSLVQTDREYGKEEWGVTWRSNKSECDVYGTCGAFGICNSG 303

Query: 290 EKPICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKMKVP 349
             PICSCL G+EPK  EEW+RGNWTSGC+R++ LQCER N +G+ GK DGF +L  +KVP
Sbjct: 304 TSPICSCLRGYEPKYTEEWSRGNWTSGCVRKTTLQCERTNSSGQQGKIDGFFRLTTVKVP 363

Query: 350 DFTEWTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRV 409
           D+ +W S A EDECRE+CLKNCSCIAY++  GIGCM+W S +LID+Q+    G DLYIR+
Sbjct: 364 DYADW-SLAHEDECREECLKNCSCIAYSYYSGIGCMLW-SGSLIDLQKFTKRGADLYIRL 421

Query: 410 ANSDVDEKGKKDVFV---SPLIKGMFALAICTLFLWRWIAKRKAEVIAK----------- 455
           A+S++  K K+D+ V     ++ G  A+AICT FLWRWI ++  +  +K           
Sbjct: 422 AHSELG-KNKRDMKVIISVTIVIGTIAIAICTYFLWRWIGRQAVKEKSKEILPSDRGHAY 480

Query: 456 ------LSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEI 509
                 +   NVN VKL++LPL  FE+LA ATNNF  ++KLGQGGFGPVY G L  GQ+I
Sbjct: 481 QNYDMNMLGDNVNRVKLEELPLLDFEKLAAATNNFHEANKLGQGGFGPVYRGNLPGGQKI 540

Query: 510 AVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLG-C----------CVEGEEKMLIYE 558
           AVKRLS+AS QG EEFMNE++VISK+QHRNLVRLLG C          C+EG+EK+LIYE
Sbjct: 541 AVKRLSRASAQGQEEFMNEMIVISKIQHRNLVRLLGFCIEGDVRLLGFCIEGDEKLLIYE 600

Query: 559 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD 618
           YMPN+SLDA LFDPLK+E LDWR+RF+IIEGI RGLLYLHRDSRL+IIHRDLKASNILLD
Sbjct: 601 YMPNKSLDAFLFDPLKRESLDWRRRFSIIEGIGRGLLYLHRDSRLKIIHRDLKASNILLD 660

Query: 619 EELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLE 678
           E+LN KISDFGMA+IFG NQDQA+T RVVGT+GYMSPEYAM G+FSEKSDVFSFGVLLLE
Sbjct: 661 EDLNAKISDFGMARIFGSNQDQANTMRVVGTYGYMSPEYAMGGQFSEKSDVFSFGVLLLE 720

Query: 679 IVSGRKNTSFFEDD--LTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLC 736
           IVSGR+NTSF  DD  +++LGYAW LW ++ I  L+D  ++E+ FQ + I RCIHVGLLC
Sbjct: 721 IVSGRRNTSFQYDDQHMSLLGYAWTLWCQHNIQELIDETIAEACFQ-EEISRCIHVGLLC 779

Query: 737 VQELVKDRPNMSTVVSMLNSEIRDLPYPKEPAFTERQGADDSES 780
           VQE  KDRP++STV+SML+SEI  LP PK+P F E+Q A D+ES
Sbjct: 780 VQESAKDRPSISTVLSMLSSEIAHLPSPKQPPFLEKQTAIDTES 823

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224114137|ref|XP_002316677.1| predicted protein [Populus trichocarpa] gi|222859742|gb|EEE97289.1| predicted protein [Populus trichocarpa]

 Score =  967 bits (2499), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 482/813 (59%), Positives = 599/813 (73%), Gaps = 40/813 (4%)

Query: 4   IALLIILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIW 63
           IA L+IL  CFC +F  ++D+ ITSSQ I+DP+ I+S G+ FKLGFF+P +S  RY  IW
Sbjct: 10  IAFLLILY-CFCWEFGASVDT-ITSSQYIKDPEDIVSAGNKFKLGFFSPVNSTNRYAAIW 67

Query: 64  YDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQ 123
           Y   S    +WVANR+ PL DSSGI+TISEDGNLV++NGQKE+LWSSNVS  +N+S  AQ
Sbjct: 68  YSNISITTPVWVANRNMPLNDSSGIMTISEDGNLVVLNGQKEILWSSNVSTGMNDS-RAQ 126

Query: 124 LLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGS 183
           L+D GNLVL  + N   +W+SFQEP+D+++P M    + RTGKK  L SW S+SDPS GS
Sbjct: 127 LMDDGNLVLGGSENGNSLWQSFQEPSDTYMPKMRLTANSRTGKKTLLKSWTSVSDPSIGS 186

Query: 184 FSAGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFRHN----------FT 233
            S G+    IP+ ++WN SRP WR+GPWNGQ+FIGIPE+ SVYL   N           +
Sbjct: 187 ISGGIDPSRIPQFYIWNGSRPIWRTGPWNGQVFIGIPEMVSVYLDGFNIADEGNGTFTLS 246

Query: 234 FGFANDWTF--FALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQEK 291
            GFAN+     + L+++G   + +W   + +W   +   + ECDVYGKCG+FG CN ++ 
Sbjct: 247 VGFANESLISNYILSSEGKFGKVLWDDTEGSWRYEWKFPKDECDVYGKCGSFGSCNPKDS 306

Query: 292 PICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKMKVPDF 351
           PICSCL+GFEPKNA+EWN GNWT+GC+RR +LQCER    G+VGKEDGF KL +MKVPDF
Sbjct: 307 PICSCLKGFEPKNADEWNNGNWTNGCVRRRELQCERTQNGGQVGKEDGFLKLERMKVPDF 366

Query: 352 TEWTSPATEDECREQCLK-NCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRVA 410
           +EW S  +E  C+ +CL  NCSCIAY++  G GCM+WR  NL D+++ P    DLYIR+A
Sbjct: 367 SEWLSSTSEHTCKNECLNINCSCIAYSYYPGFGCMLWRG-NLTDLKKFPIKAADLYIRLA 425

Query: 411 NSDVDEK--GKKDVFVSPLIKGMFALAICTLFLWRWIAKRKAEVIAKLSA---------- 458
           +S++D K    K +    ++ G  A+AIC  + WR I +++      LS           
Sbjct: 426 DSELDNKKINLKVIISLTVVVGAIAIAICVFYSWRRIDRKRKSKKVFLSKRKVGYPILSD 485

Query: 459 -----TNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKR 513
                 N+N VKLQ+LPLF  + L  AT+NF  ++KLGQGGFGPVY G L DGQEIAVKR
Sbjct: 486 ENMIQDNLNHVKLQELPLFSLQTLIAATDNFNTANKLGQGGFGPVYKGNLSDGQEIAVKR 545

Query: 514 LSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL 573
           LS++SGQGLEEFMNEV+VISKLQHRNLVR+LGCCVEGEEKMLIYEYMPN+SLDA LFD L
Sbjct: 546 LSRSSGQGLEEFMNEVVVISKLQHRNLVRILGCCVEGEEKMLIYEYMPNKSLDAFLFDSL 605

Query: 574 KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 633
           +K+ LDW+ RF I+EGI RGLLYLHRDSRLRIIHRDLKASNILLD+ELNPKISDFGMA+I
Sbjct: 606 RKQLLDWKNRFKIVEGICRGLLYLHRDSRLRIIHRDLKASNILLDQELNPKISDFGMARI 665

Query: 634 FGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDL 693
           FG ++DQA+T RVVGT+GYMSPEYAMEGRFSEKSDVFSFGVLLLE +SGRKNT++F    
Sbjct: 666 FGNHEDQANTRRVVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLETISGRKNTTYF---- 721

Query: 694 TILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM 753
            +   AWKLWNE  I ALVDP +S  SF  + I RC+HVGLLCVQE  KDRP + TV+SM
Sbjct: 722 -LTSQAWKLWNEGNIAALVDPGISYPSFH-EEIFRCVHVGLLCVQEFAKDRPAIFTVISM 779

Query: 754 LNSEIRDLPYPKEPAFTERQGADDSESFKQIQQ 786
           LNSEI DLP PK+PAF+ER+   D++S +  Q+
Sbjct: 780 LNSEIADLPTPKQPAFSERRSELDTKSLQHDQR 812

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224078778|ref|XP_002305625.1| predicted protein [Populus trichocarpa] gi|222848589|gb|EEE86136.1| predicted protein [Populus trichocarpa]

 Score =  953 bits (2463), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 485/816 (59%), Positives = 602/816 (73%), Gaps = 36/816 (4%)

Query: 2   IPIALLIILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMG 61
           I +ALL+ L S FC++   AID+ ITS+Q ++DP+AI+SNG+ + LGFF+P +S  RY+G
Sbjct: 8   ISVALLL-LTSSFCVEIITAIDT-ITSTQFLKDPEAIVSNGNIYTLGFFSPVNSTDRYVG 65

Query: 62  IWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTS 121
           IW++       IWVANR+NPL DSSGI+ IS+DG LV++NGQ+E+LWS+NVSN V+NS S
Sbjct: 66  IWFNEVPVVTAIWVANRNNPLNDSSGILAISKDGALVVLNGQQEILWSTNVSNFVSNS-S 124

Query: 122 AQLLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPST 181
           AQL D+GNLVLRDN N  I+WESFQ P+D+F   M    ++RTG K  +TSWKS +DPS 
Sbjct: 125 AQLSDTGNLVLRDNNNEEIMWESFQYPSDTFFSNMKLSANKRTGGKTLITSWKSATDPSI 184

Query: 182 GSFSAGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFRHN---------- 231
           GSFSAGL H +IPEIF+W  + PY+RSGPWN  +FIG+P + S  +   N          
Sbjct: 185 GSFSAGLNHLDIPEIFIWKDNYPYFRSGPWNRLVFIGVPYMNSAAVDGLNLVDDGEGTID 244

Query: 232 FTFGFAND--WTFFALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQ 289
            TF +AN    + F LT+QG LE+  W    ++  V +     +C+ YG+CG FG CN+Q
Sbjct: 245 LTFSYANQSIMSSFVLTSQGQLEQTRWEHGMEDRIVLWSVPMFDCEFYGRCGLFGSCNAQ 304

Query: 290 EKPICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCER-RNITGKVGKEDGFSKLNKMKV 348
             PICSCL GFEP N EEW  GNWT GCIRR  LQCER ++ +   GK D F KL  MKV
Sbjct: 305 ASPICSCLRGFEPNNPEEWYVGNWTGGCIRRKSLQCERVKSESEAAGKNDVFLKLGNMKV 364

Query: 349 PDFTEWTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIR 408
           PD  +W S  TE EC+++CL NCSCIAYA+D GIGCM W   +LID+Q  P GG DLYIR
Sbjct: 365 PDLAQW-SRLTEIECKDKCLTNCSCIAYAYDSGIGCMSWIG-DLIDVQEFPTGGADLYIR 422

Query: 409 VANSDVDEKGKKD--VFVSPLIKGMFALAICTLFLWRWIAKRKAEVIAK----------- 455
           +A S++D   +K   V VS +I  + +  IC L  WR+++K + E +             
Sbjct: 423 MAYSELDGNHRKKVIVIVSAVIGTITSAMICALLTWRFMSKHRGEKLHSDTNEKHPSFLD 482

Query: 456 --LSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKR 513
             ++  +++ VKLQ+LPLF  E L  AT+ F LS+KLGQGGFGPVY G+L DG+EIAVKR
Sbjct: 483 RDMAGDSMDHVKLQELPLFSLESLTAATDGFDLSNKLGQGGFGPVYKGKLSDGKEIAVKR 542

Query: 514 LSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL 573
           LS+ASGQGL+EFMNEV VISKLQHRNLVRLLGCCVEGEEK+L+YEYMPN+SLDA L+DPL
Sbjct: 543 LSRASGQGLKEFMNEVEVISKLQHRNLVRLLGCCVEGEEKLLVYEYMPNKSLDAFLYDPL 602

Query: 574 KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 633
           +K+ LDW+KRFNIIEGI RGLLYLHRDSRLRIIHRDLKASNILLD EL PKISDFG A+I
Sbjct: 603 RKQLLDWKKRFNIIEGICRGLLYLHRDSRLRIIHRDLKASNILLDPELKPKISDFGAARI 662

Query: 634 FGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFF--ED 691
           FGG++DQA+T RVVGT+GY+SPEYAMEGRFSEKSDV+SFGVLLLEIVSGR+NTSF+  E 
Sbjct: 663 FGGDEDQANTIRVVGTYGYISPEYAMEGRFSEKSDVYSFGVLLLEIVSGRRNTSFYGNEQ 722

Query: 692 DLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVV 751
            L++LG+AWKLWNE  I ALVDP +S+ S Q++ I RCIHVGLLCVQE  +DRP  STVV
Sbjct: 723 ALSLLGFAWKLWNEGNISALVDPAISDPSSQVE-IFRCIHVGLLCVQEFPEDRPTASTVV 781

Query: 752 SMLNSEIRDLPYPKEPAFTERQGADDSESFKQIQQR 787
           SMLNSEI  L  PK+P F ER+   + E   Q +++
Sbjct: 782 SMLNSEISYLATPKQPPFAERKYHFNEERPHQNEEK 817

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147840284|emb|CAN63987.1| hypothetical protein VITISV_016155 [Vitis vinifera]

 Score =  948 bits (2451), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 485/815 (59%), Positives = 590/815 (72%), Gaps = 61/815 (7%)

Query: 12  SCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKA 71
           S  C  F  A D+ ITS+Q I+DP+ ++SNGS FK+GFF+P +S  RY GIWY+  S   
Sbjct: 17  SGLCFQFCTATDT-ITSTQFIKDPETMVSNGSLFKMGFFSPGNSTKRYFGIWYNSTSLFT 75

Query: 72  VIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLV 131
           VIW+ANR+NPL DSSGI+ +SEDGNL+++N QKE+ WSSNVSN   NS  AQLLDSGNLV
Sbjct: 76  VIWIANRENPLNDSSGIVMVSEDGNLLVLNDQKEIFWSSNVSNAALNS-RAQLLDSGNLV 134

Query: 132 LRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGSFSAGLIHQ 191
           L+D  +  I W+SFQ P+ +FL  M    + +TG+K  LTSWKS SDPS GSFS G+   
Sbjct: 135 LQDKNSGRITWQSFQHPSHAFLQKMELSENMKTGEKQGLTSWKSPSDPSVGSFSTGIDPS 194

Query: 192 NIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFR----------HNFTFGFANDWT 241
           +IPEIFVWN SRP+WRSGPWNGQ  IG+P++  +  F             F   +A+   
Sbjct: 195 DIPEIFVWNGSRPFWRSGPWNGQTLIGVPDMNYLNGFHIVNDKEGNVSVTFEHAYASILW 254

Query: 242 FFALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQEKPICSCLEGFE 301
           ++ L+ QG + E        NWE+ + + +TECDVYGKCGAFGICN++  PICSCL G+E
Sbjct: 255 YYVLSPQGTIVEIYSDDGMKNWEITWQSRKTECDVYGKCGAFGICNAKNSPICSCLRGYE 314

Query: 302 PKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKMKVPDFTEWTSPATED 361
           P+N EEW+RGNWT GC+R++  QCE+ N + + G+ DGF +L  +KVPDF EW S A ED
Sbjct: 315 PRNIEEWSRGNWTGGCVRKTPFQCEKINGSMEEGEADGFIRLTTVKVPDFAEW-SLALED 373

Query: 362 ECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRVANSDVDEKGKKD 421
           +C+E CLKNCSCIAYA+  GIGCM W S NL D+Q+    G DLYIRV  S++       
Sbjct: 374 DCKEFCLKNCSCIAYAYYTGIGCMSW-SRNLTDVQKFSSNGADLYIRVPYSEL------- 425

Query: 422 VFVSPLIKGMFALAICTLFLWRWI--------------AKRKAEVIAKLSATNV-----N 462
                   G   +A+   F  RWI              +  + +V   +S  N+     N
Sbjct: 426 --------GTIFVAVFIYFSRRWITKRRAKNKKRKEMLSSDRGDVHLNVSDANILGDRMN 477

Query: 463 TVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVY----------WGRLKDGQEIAVK 512
            VKL++LPL  F +L TATNNF  ++KLGQGGFG VY           GRL +GQEIAVK
Sbjct: 478 QVKLEELPLVDFGKLVTATNNFDEANKLGQGGFGSVYRVMLAHLELHGGRLPEGQEIAVK 537

Query: 513 RLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDP 572
           RLS+AS QGLEEFMNEV+VISKLQHRNLVRLLGCC+EG+EKMLIYEYMP +SLDALLFDP
Sbjct: 538 RLSRASAQGLEEFMNEVVVISKLQHRNLVRLLGCCIEGDEKMLIYEYMPKKSLDALLFDP 597

Query: 573 LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 632
           L++E LDW+KRF+IIEGI RGLLYLHRDSRLRIIHRDLKASNILLD  LNPKISDFGMA+
Sbjct: 598 LRQETLDWKKRFSIIEGIGRGLLYLHRDSRLRIIHRDLKASNILLDXNLNPKISDFGMAR 657

Query: 633 IFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDD 692
           IFGGNQDQA+T RVVGT+GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR+N SF+ D+
Sbjct: 658 IFGGNQDQANTIRVVGTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRRNNSFYHDE 717

Query: 693 --LTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTV 750
             L++LGYAWKLWNE+ I  L+D  +SE+ F  D I+RCIHVGLLCVQEL KDRP++STV
Sbjct: 718 QSLSLLGYAWKLWNEHNIETLIDGSISEACFP-DEILRCIHVGLLCVQELAKDRPSISTV 776

Query: 751 VSMLNSEIRDLPYPKEPAFTERQGADDSESFKQIQ 785
           VSM+ SEI  LP PK+PAFTERQ + D+ES  Q Q
Sbjct: 777 VSMICSEIAXLPTPKKPAFTERQISKDTESXGQSQ 811

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224112032|ref|XP_002332843.1| predicted protein [Populus trichocarpa] gi|222833304|gb|EEE71781.1| predicted protein [Populus trichocarpa]

 Score =  946 bits (2445), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 473/803 (58%), Positives = 590/803 (73%), Gaps = 37/803 (4%)

Query: 4   IALLIILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIW 63
           +A L +LL CFC     A+D+ ITSSQ I+DP+A++S G+ FKLGFF+P +S  RY+GIW
Sbjct: 1   MAALRLLLCCFCWQLGAAVDT-ITSSQYIKDPEAVVSAGNKFKLGFFSPGNSTNRYVGIW 59

Query: 64  YDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQ 123
           Y   S    +W+ANR+ PL DSSGI+TISEDGN+V+++G+KE+LWSSNVSN V+NS SAQ
Sbjct: 60  YSNISVTTPVWIANRNKPLNDSSGIMTISEDGNIVVLDGRKEILWSSNVSNGVSNS-SAQ 118

Query: 124 LLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGS 183
           L D GN++LR       +W+SFQEP+D+F+  M    ++RTGKK Q+TSWKS SDPS GS
Sbjct: 119 LTDDGNVILRGGEIGNSLWQSFQEPSDTFMLKMRLTANRRTGKKTQITSWKSPSDPSVGS 178

Query: 184 FSAGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFRHNF----------T 233
           FS+G+   +IPE+FVWN SRP+WRSGPWNGQ FIGIPE+ SVYL  +N           +
Sbjct: 179 FSSGIEPSSIPEVFVWNDSRPFWRSGPWNGQAFIGIPEMNSVYLNGYNLVQDGDGTFSLS 238

Query: 234 FGFAND--WTFFALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQEK 291
            G AN+   T FAL+ +G   E  W    + WE        +CD+YGKCG FG CN+Q  
Sbjct: 239 VGLANESYITNFALSYEGRFGEMYWDSANERWEHKKQYPGDDCDIYGKCGPFGFCNTQNS 298

Query: 292 PICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKMKVPDF 351
            IC CL+GFEPKN++EWNR NWT+GC+RR +L+CER    G+V KED F KL+K+KVPDF
Sbjct: 299 LICRCLKGFEPKNSDEWNRRNWTNGCVRRRELKCERTQSDGQVPKEDEFLKLDKVKVPDF 358

Query: 352 TEWTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRVAN 411
           +EW+S A+E  C+++CL NCSCIAY++  GIGCM+WR   L DI++   GG +LY+R+A+
Sbjct: 359 SEWSSSASEQNCKDECLNNCSCIAYSYHTGIGCMLWRG-KLTDIRKFSSGGANLYVRLAD 417

Query: 412 SDVDE-KGKKDVFVSPLIKGMFALAICTLFLWRWIAK-----RKAEVI------------ 453
            +  + +  K V    ++ G   +A+   F WR +AK     R++E I            
Sbjct: 418 LEFGKNRDMKAVICITVVTGAIIVAVGAFFWWRRMAKYRERKRESERILSSRRKKGYPIF 477

Query: 454 --AKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAV 511
               L   ++N VK Q+LPLF+ + L  AT+ F  ++KLG+GGFGPVY G L DGQEIAV
Sbjct: 478 FNGNLIQESMNQVKFQELPLFKLQMLIAATDYFDAANKLGEGGFGPVYRGNLPDGQEIAV 537

Query: 512 KRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD 571
           KRLS+ASGQG EEFMNEV+VIS+LQHRNLVRLLGCCVEG+EKML+YEYMPN+SLDA LFD
Sbjct: 538 KRLSRASGQGQEEFMNEVVVISELQHRNLVRLLGCCVEGDEKMLVYEYMPNKSLDASLFD 597

Query: 572 PLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 631
           P++KE LDW+KRFNI++GI RGLLYLHRDSRLRIIHRDLK SNILLD+ELNPKISDFGMA
Sbjct: 598 PVRKEVLDWKKRFNIVDGICRGLLYLHRDSRLRIIHRDLKPSNILLDQELNPKISDFGMA 657

Query: 632 KIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSF--F 689
           +IFGGN+D   T RVVGT+GYMSPEYAM GRFSEKSDVFSFGVLLLEIVSGR++T     
Sbjct: 658 RIFGGNEDHVKTRRVVGTYGYMSPEYAMHGRFSEKSDVFSFGVLLLEIVSGRRSTKIDGN 717

Query: 690 EDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMST 749
           E  L +L +AWKLWNE    ALVDP L+   +    I RCIHVGLLCVQE  KDRP +ST
Sbjct: 718 EQGLNLLEFAWKLWNEGNAPALVDPALTLDQYSKVEIFRCIHVGLLCVQEFAKDRPAIST 777

Query: 750 VVSMLNSEIRDLPYPKEPAFTER 772
           ++SMLNSEI DLP P  PA+TER
Sbjct: 778 IISMLNSEIVDLPLPNNPAYTER 800

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224114141|ref|XP_002316678.1| predicted protein [Populus trichocarpa] gi|222859743|gb|EEE97290.1| predicted protein [Populus trichocarpa]

 Score =  945 bits (2443), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 472/803 (58%), Positives = 590/803 (73%), Gaps = 37/803 (4%)

Query: 4   IALLIILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIW 63
           +A L +LL CFC     A+D+ ITSSQ I+DP+A++S G+ FKLGFF+P +S  RY+GIW
Sbjct: 1   MAALRLLLCCFCWQLGAAVDT-ITSSQYIKDPEAVVSAGNKFKLGFFSPGNSTNRYVGIW 59

Query: 64  YDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQ 123
           Y   S    +W+ANR+ PL DSSGI+TISEDGN+V+++G+KE+LWSSNVSN V+NS SAQ
Sbjct: 60  YSNISVTTPVWIANRNKPLNDSSGIMTISEDGNIVVLDGRKEILWSSNVSNGVSNS-SAQ 118

Query: 124 LLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGS 183
           L D GN++LR       +W+SFQEP+D+F+  M    ++RTGKK Q+TSWKS SDPS GS
Sbjct: 119 LTDDGNVILRGGEIGNSLWQSFQEPSDTFMLKMRLTANRRTGKKTQITSWKSPSDPSVGS 178

Query: 184 FSAGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFRHNF----------T 233
           FS+G+   +IPE+FVWN SRP+WRSGPWNGQ FIGIPE+ SVYL  +N           +
Sbjct: 179 FSSGIEPSSIPEVFVWNDSRPFWRSGPWNGQAFIGIPEMNSVYLNGYNLVQDGDGTFSLS 238

Query: 234 FGFAND--WTFFALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQEK 291
            G AN+   T FAL+ +G   E  W    + WE        +CD+YGKCG FG CN+Q  
Sbjct: 239 VGLANESYITNFALSYEGRFGEMYWDSANERWEHKKQYPGDDCDIYGKCGPFGFCNTQNS 298

Query: 292 PICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKMKVPDF 351
            IC CL+GFEPKN++EWNR NWT+GC+RR +L+CER    G+V KED F KL+K+KVPDF
Sbjct: 299 LICRCLKGFEPKNSDEWNRRNWTNGCVRRRELKCERTQSDGQVPKEDEFLKLDKVKVPDF 358

Query: 352 TEWTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRVAN 411
           +EW+S A+E  C+++CL NCSCIAY++  GIGCM+WR   L DI++   GG +LY+R+A+
Sbjct: 359 SEWSSSASEQNCKDECLNNCSCIAYSYHTGIGCMLWRG-KLTDIRKFSSGGANLYVRLAD 417

Query: 412 SDVDE-KGKKDVFVSPLIKGMFALAICTLFLWRWIAK-----RKAEVI------------ 453
            +  + +  K V    ++ G   +A+   F WR +AK     R++E I            
Sbjct: 418 LEFGKNRDMKAVICITVVTGAIIVAVGAFFWWRRMAKYRERKRESERILSSRRKKGYPIF 477

Query: 454 --AKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAV 511
               L   ++N VK Q+LPLF+ + L  AT+ F  ++KLG+GGFGPVY G L DGQEIAV
Sbjct: 478 FNGNLIQESMNQVKFQELPLFKLQMLIAATDYFDAANKLGEGGFGPVYRGNLPDGQEIAV 537

Query: 512 KRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD 571
           KRLS+ASGQG EEFMNEV+VIS+LQH+NLVRLLGCCVEG+EKML+YEYMPN+SLDA LFD
Sbjct: 538 KRLSRASGQGQEEFMNEVVVISELQHKNLVRLLGCCVEGDEKMLVYEYMPNKSLDASLFD 597

Query: 572 PLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 631
           P++KE LDW+KRFNI++GI RGLLYLHRDSRLRIIHRDLK SNILLD+ELNPKISDFGMA
Sbjct: 598 PVRKEVLDWKKRFNIVDGICRGLLYLHRDSRLRIIHRDLKPSNILLDQELNPKISDFGMA 657

Query: 632 KIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSF--F 689
           +IFGGN+D   T RVVGT+GYMSPEYAM GRFSEKSDVFSFGVLLLEIVSGR++T     
Sbjct: 658 RIFGGNEDHVKTRRVVGTYGYMSPEYAMHGRFSEKSDVFSFGVLLLEIVSGRRSTKIDGN 717

Query: 690 EDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMST 749
           E  L +L +AWKLWNE    ALVDP L+   +    I RCIHVGLLCVQE  KDRP +ST
Sbjct: 718 EQGLNLLEFAWKLWNEGNAPALVDPALTLDQYSKVEIFRCIHVGLLCVQEFAKDRPAIST 777

Query: 750 VVSMLNSEIRDLPYPKEPAFTER 772
           ++SMLNSEI DLP P  PA+TER
Sbjct: 778 IISMLNSEIVDLPLPNNPAYTER 800

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359496519|ref|XP_002263029.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330-like [Vitis vinifera]

 Score =  943 bits (2438), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 497/828 (60%), Positives = 599/828 (72%), Gaps = 64/828 (7%)

Query: 4   IALLIILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIW 63
           +  L++LLS  C  F  AID+ +TS++ I DP+ ++S+GS FKLGFF+ ADS  RY+GIW
Sbjct: 9   VIALLLLLSVICFGFCTAIDT-MTSTRFIEDPETLVSDGSAFKLGFFSLADSTNRYVGIW 67

Query: 64  YDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQ 123
           Y  PS   +IWVANRD PL DSSG++TISEDGNL+++NGQKE+ WS+NVSN   NS SAQ
Sbjct: 68  YSTPSLSTIIWVANRDKPLNDSSGLVTISEDGNLLVMNGQKEIFWSTNVSNAAANS-SAQ 126

Query: 124 LLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGS 183
           LLDSGNLVLRDN  R I WES Q P+ SFLP M    D  +G+KV LTSWKS SDPS GS
Sbjct: 127 LLDSGNLVLRDNSGR-ITWESIQHPSHSFLPKMKISADTDSGEKVVLTSWKSPSDPSIGS 185

Query: 184 FSAGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFIG-----IPELKSVYLFRHNF------ 232
           FS G+   NIP+ FVWN S PYWRSGPWNGQIFIG     +P++ SV+L    F      
Sbjct: 186 FSLGMNPLNIPQAFVWNGSHPYWRSGPWNGQIFIGQIYIGVPKMNSVFLNGFGFQVVDDK 245

Query: 233 ------TFGFAND--WTFFALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFG 284
                 TF  AN   + ++ LT QG + E      K+ WEV + +  +ECDVYG CGAFG
Sbjct: 246 AGTVYETFTLANSSIFLYYVLTPQGTVVETYREDGKEEWEVTWRSNNSECDVYGTCGAFG 305

Query: 285 ICNSQEKPICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLN 344
           ICNS   PICSCL G+EPK  EEW+RGNWTSGC+R++ LQCER N +G+ GK DGF +L 
Sbjct: 306 ICNSGNSPICSCLRGYEPKYIEEWSRGNWTSGCVRKTPLQCERTNSSGQQGKLDGFFRLT 365

Query: 345 KMKVPDFTEWTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTD 404
            +KVPDF +W S A EDECREQCLKNCSC+AY++  GIGCM W S NLID+ +   GG D
Sbjct: 366 TVKVPDFADW-SLALEDECREQCLKNCSCMAYSYYSGIGCMSW-SGNLIDLGKFTQGGAD 423

Query: 405 LYIRVANSDVD-----------------EKGKKDVFVSPLIKGMFALAICTLFLWRWIAK 447
           LYIR+ANS+++                 ++  K +    ++ G  A+ I T F WRW  K
Sbjct: 424 LYIRLANSELEWNMRTPKLIKHLMATYKKRDMKAIISVTIVIGTIAIGIYTYFSWRWRRK 483

Query: 448 RKAEVIAK---LS--------------ATNVNTVKLQDLPLFQFEELATATNNFQLSSKL 490
           +  +  +K   LS                N N  KL++LPL   E+L TATNNF  ++KL
Sbjct: 484 QTVKDKSKEILLSDRGDAYQIYDMNRLGDNANQFKLEELPLLALEKLETATNNFHEANKL 543

Query: 491 GQGGFGPVY---WGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC 547
           GQGGFGPVY    G+L  GQEIAVKRLS+AS QGLEEF NEV+VISK+QHRNLVRLLG C
Sbjct: 544 GQGGFGPVYRVMLGKLPGGQEIAVKRLSRASAQGLEEFGNEVVVISKIQHRNLVRLLGYC 603

Query: 548 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 607
           +EG+EK+LIYEYMPN+SLD+ LFDPLK++ LDWR+RFNIIEGI RGLLYLHRDSR RIIH
Sbjct: 604 IEGDEKLLIYEYMPNKSLDSFLFDPLKRDFLDWRRRFNIIEGIGRGLLYLHRDSRFRIIH 663

Query: 608 RDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKS 667
           RDLKASNILLDE+L  KISDFG+A+I GGNQDQA+T RVVGT+GYMSPEYAMEGRFSEKS
Sbjct: 664 RDLKASNILLDEDLTAKISDFGIARIVGGNQDQANTMRVVGTYGYMSPEYAMEGRFSEKS 723

Query: 668 DVFSFGVLLLEIVSGRKNTSFFEDD--LTILGYAWKLWNENKILALVDPFLSESSFQLDM 725
           DVFSFGVLLLEIVSGR+NTSF  DD  +++LGYAW LW E+ I  L+D  ++E  FQ + 
Sbjct: 724 DVFSFGVLLLEIVSGRRNTSFQYDDQYMSLLGYAWTLWCEHNIEELIDEIIAEEGFQ-EE 782

Query: 726 IIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPAFTERQ 773
           I RCIHVGLL VQEL KDRP++STVVSML+SEI  LP PK+P F E+Q
Sbjct: 783 ISRCIHVGLLAVQELAKDRPSISTVVSMLSSEIAHLPPPKQPPFLEKQ 830

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|296084622|emb|CBI25710.3| unnamed protein product [Vitis vinifera]

 Score =  943 bits (2437), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 483/794 (60%), Positives = 597/794 (75%), Gaps = 27/794 (3%)

Query: 9   ILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPS 68
           +LL+CF   F  +   +ITS+  I+DP+ I+S+G  FKLGFF+   S  RY+GIWY+  S
Sbjct: 11  LLLTCFWFVFGCSAIDTITSTHFIKDPETIVSSGRVFKLGFFSLDGSSNRYVGIWYNTTS 70

Query: 69  EKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSG 128
              +IWVAN+D PL DSSG++TISEDGN+ ++NG+KE+LWSSNVSN    ++SAQL DSG
Sbjct: 71  LLTIIWVANKDRPLNDSSGVLTISEDGNIQVLNGRKEILWSSNVSNPAAVNSSAQLQDSG 130

Query: 129 NLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGSFSAGL 188
           NLVLRD  N   VWES Q P+ SF+P M    + RT  +  LTSWKS SDPS GSF+AG+
Sbjct: 131 NLVLRDK-NGVSVWESLQNPSHSFVPQMKISTNTRTRVRKVLTSWKSSSDPSMGSFTAGV 189

Query: 189 IHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFRHNF----------TFGFAN 238
              NIP++F+WN SRPYWRSGPW+GQI  G+ ++K + L   N           TF    
Sbjct: 190 EPLNIPQVFIWNGSRPYWRSGPWDGQILTGV-DVKWITLDGLNIVDDKEGTVYVTFAHPE 248

Query: 239 DWTFFA--LTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQEKPICSC 296
              F+A  LT +GIL E    K  ++WE  +     EC++YGKCG FG CNS++ PICSC
Sbjct: 249 SGFFYAYVLTPEGILVETSRDKRNEDWERVWTTKENECEIYGKCGPFGHCNSRDSPICSC 308

Query: 297 LEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKMKVPDFTEWTS 356
           L+G+EPK+ +EWNRGNWT GC+R++ LQCER     +  K DGF KL  MKVPDF E  S
Sbjct: 309 LKGYEPKHTQEWNRGNWTGGCVRKTPLQCERTKNGSEEAKVDGFLKLTNMKVPDFAE-QS 367

Query: 357 PATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRVANSDVDE 416
            A ED+CR+QCL+NCSCIAY++  GIGCM W S +LIDIQ+L   G +L+IRVA+S++ +
Sbjct: 368 YALEDDCRQQCLRNCSCIAYSYYTGIGCMWW-SGDLIDIQKLSSTGANLFIRVAHSELKQ 426

Query: 417 KGKKDV---FVSPLIKGMFALAICTLFLWRWIAKRKAEV-IAKLS-----ATNVNTVKLQ 467
             K+D     +  +I G  A+A+CT FL RWIA+++  + I K S        VN VKL+
Sbjct: 427 DRKRDARVIVIVTVIIGTIAIALCTYFLRRWIARQRGNLLIGKFSDPSVPGDGVNQVKLE 486

Query: 468 DLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMN 527
           +LPL  F +LATATNNF  ++KLGQGGFGPVY G+L +GQ+IAVKRLS+AS QGLEEFMN
Sbjct: 487 ELPLIDFNKLATATNNFHEANKLGQGGFGPVYRGKLAEGQDIAVKRLSRASTQGLEEFMN 546

Query: 528 EVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNII 587
           EV+VISKLQHRNLVRL+GCC+EG+EKMLIYE+MPN+SLDA LFDP+K++ LDWR RF II
Sbjct: 547 EVVVISKLQHRNLVRLIGCCIEGDEKMLIYEFMPNKSLDASLFDPVKRQILDWRTRFKII 606

Query: 588 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVV 647
           EGI RGLLYLHRDSRLRIIHRDLKASNILLDE+LNPKISDFGMA+IFG NQDQA+T RVV
Sbjct: 607 EGIGRGLLYLHRDSRLRIIHRDLKASNILLDEDLNPKISDFGMARIFGSNQDQANTKRVV 666

Query: 648 GTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFF-EDDLTILGYAWKLWNEN 706
           GT+GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKN+SF+ E+  T+LGYAWKLW E+
Sbjct: 667 GTYGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNSSFYHEEYFTLLGYAWKLWKED 726

Query: 707 KILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKE 766
            +  L+D  + E+ FQ + I+RCIHVGLLCVQEL KDRP++STVV M+ SEI  LP PK+
Sbjct: 727 NMKTLIDGSILEACFQ-EEILRCIHVGLLCVQELAKDRPSVSTVVGMICSEIAHLPPPKQ 785

Query: 767 PAFTERQGADDSES 780
           PAFTE +   D ES
Sbjct: 786 PAFTEMRSGIDIES 799

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359496538|ref|XP_002270222.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330-like [Vitis vinifera]

 Score =  930 bits (2404), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 479/787 (60%), Positives = 592/787 (75%), Gaps = 36/787 (4%)

Query: 25  SITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKD 84
           +ITS+  I+DP+ I+S+G  FKLGFF+   S  RY+GIWY+  S   +IWVAN+D PL D
Sbjct: 88  TITSTHFIKDPETIVSSGRVFKLGFFSLDGSSNRYVGIWYNTTSLLTIIWVANKDRPLND 147

Query: 85  SSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWES 144
           SSG++TISEDGN+ ++NG+KE+LWSSNVSN    ++SAQL DSGNLVLRD  N   VWES
Sbjct: 148 SSGVLTISEDGNIQVLNGRKEILWSSNVSNPAAVNSSAQLQDSGNLVLRDK-NGVSVWES 206

Query: 145 FQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGSFSAGLIHQNIPEIFVWNVSRP 204
            Q P+ SF+P M    + RT  +  LTSWKS SDPS GSF+AG+   NIP++F+WN SRP
Sbjct: 207 LQNPSHSFVPQMKISTNTRTRVRKVLTSWKSSSDPSMGSFTAGVEPLNIPQVFIWNGSRP 266

Query: 205 YWRSGPWNGQIFIGIPELKSVYLFRHNF----------TFGFANDWTFFA--LTAQGILE 252
           YWRSGPW+GQI  G+ ++K + L   N           TF       F+A  LT +GIL 
Sbjct: 267 YWRSGPWDGQILTGV-DVKWITLDGLNIVDDKEGTVYVTFAHPESGFFYAYVLTPEGILV 325

Query: 253 ERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQEKPICSCLEGFEPKNAEEWNRGN 312
           E    K  ++WE  +     EC++YGKCG FG CNS++ PICSCL+G+EPK+ +EWNRGN
Sbjct: 326 ETSRDKRNEDWERVWTTKENECEIYGKCGPFGHCNSRDSPICSCLKGYEPKHTQEWNRGN 385

Query: 313 WTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKMKVPDFTEWTSPATEDECREQCLKNCS 372
           WT GC+R++ LQCER     +  K DGF KL  MKVPDF E  S A ED+CR+QCL+NCS
Sbjct: 386 WTGGCVRKTPLQCERTKNGSEEAKVDGFLKLTNMKVPDFAE-QSYALEDDCRQQCLRNCS 444

Query: 373 CIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRVANSDVDEKGKKDV---FVSPLIK 429
           CIAY++  GIGCM W S +LIDIQ+L   G +L+IRVA+S++ +  K+D     +  +I 
Sbjct: 445 CIAYSYYTGIGCMWW-SGDLIDIQKLSSTGANLFIRVAHSELKQDRKRDARVIVIVTVII 503

Query: 430 GMFALAICTLFLWRWIAKRKAEV--IAKLSATN-------------VNTVKLQDLPLFQF 474
           G  A+A+CT FL RWIA+++A+   I +L + N             VN VKL++LPL  F
Sbjct: 504 GTIAIALCTYFLRRWIARQRAKKGKIEELLSFNRGKFSDPSVPGDGVNQVKLEELPLIDF 563

Query: 475 EELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISK 534
            +LATATNNF  ++KLGQGGFGPVY G+L +GQ+IAVKRLS+AS QGLEEFMNEV+VISK
Sbjct: 564 NKLATATNNFHEANKLGQGGFGPVYRGKLAEGQDIAVKRLSRASTQGLEEFMNEVVVISK 623

Query: 535 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 594
           LQHRNLVRL+GCC+EG+EKMLIYE+MPN+SLDA LFDP+K++ LDWR RF IIEGI RGL
Sbjct: 624 LQHRNLVRLIGCCIEGDEKMLIYEFMPNKSLDASLFDPVKRQILDWRTRFKIIEGIGRGL 683

Query: 595 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 654
           LYLHRDSRLRIIHRDLKASNILLDE+LNPKISDFGMA+IFG NQDQA+T RVVGT+GYMS
Sbjct: 684 LYLHRDSRLRIIHRDLKASNILLDEDLNPKISDFGMARIFGSNQDQANTKRVVGTYGYMS 743

Query: 655 PEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFF-EDDLTILGYAWKLWNENKILALVD 713
           PEYAMEGRFSEKSDVFSFGVLLLEIVSGRKN+SF+ E+  T+LGYAWKLW E+ +  L+D
Sbjct: 744 PEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNSSFYHEEYFTLLGYAWKLWKEDNMKTLID 803

Query: 714 PFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPAFTERQ 773
             + E+ FQ + I+RCIHVGLLCVQEL KDRP++STVV M+ SEI  LP PK+PAFTE +
Sbjct: 804 GSILEACFQ-EEILRCIHVGLLCVQELAKDRPSVSTVVGMICSEIAHLPPPKQPAFTEMR 862

Query: 774 GADDSES 780
              D ES
Sbjct: 863 SGIDIES 869

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	808
TAIR|locus:2141181	850	RK3 "receptor kinase 3" [Arabi	0.402	0.382	0.606	1.1e-176
TAIR|locus:2018546	843	RK1 "receptor kinase 1" [Arabi	0.373	0.358	0.638	1.7e-174
TAIR|locus:2141176	849	B120 [Arabidopsis thaliana (ta	0.387	0.368	0.620	9.6e-174
TAIR|locus:2018506	847	RK2 "receptor kinase 2" [Arabi	0.381	0.363	0.623	1.6e-173
TAIR|locus:2197664	804	AT1G61490 [Arabidopsis thalian	0.946	0.951	0.445	2.1e-173
TAIR|locus:2131684	783	AT4G27290 [Arabidopsis thalian	0.376	0.388	0.584	6.7e-173
TAIR|locus:2200888	804	AT1G61500 [Arabidopsis thalian	0.933	0.937	0.450	3e-172
TAIR|locus:2200908	842	AT1G61610 [Arabidopsis thalian	0.389	0.374	0.621	5.4e-171
TAIR|locus:2197744	807	AT1G61420 [Arabidopsis thalian	0.940	0.941	0.437	1.9e-170
TAIR|locus:2197729	805	SD1-29 "S-domain-1 29" [Arabid	0.928	0.931	0.443	3.1e-170

TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1000 (357.1 bits), Expect = 1.1e-176, Sum P(2) = 1.1e-176
 Identities = 202/333 (60%), Positives = 252/333 (75%)

Query:   456 LSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLS 515
             +S  N NT  L+ LPL +FEE+A ATNNF  ++KLGQGGFG VY G+L DGQE+AVKRLS
Sbjct:   500 ISREN-NTDDLE-LPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLS 557

Query:   516 KASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKK 575
             K S QG +EF NEV +I++LQH NLVRLL CCV+  EKMLIYEY+ N SLD+ LFD  + 
Sbjct:   558 KTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRN 617

Query:   576 ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 635
              +L+W+ RF+II GI+RGLLYLH+DSR RIIHRDLKASNILLD+ + PKISDFGMA+IFG
Sbjct:   618 SKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFG 677

Query:   636 GNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDD--L 693
              ++ +A+T +VVGT+GYMSPEYAM+G FS KSDVFSFGVLLLEI+S ++N  F+  D  L
Sbjct:   678 RDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDL 737

Query:   694 TILGYAWKLWNENKILALVDPFLSESS--FQLDMIIRCIHVGLLCVQELVKDRPNMSTVV 751
              +LG  W+ W E K L ++DP +++SS  F+   I+RCI +GLLCVQE  +DRP MS V+
Sbjct:   738 NLLGCVWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPTMSLVI 797

Query:   752 SMLNSEIRDLPYPKEPAFT-ERQGAD-DSESFK 782
              ML SE   +P PK P +  ER   D DS S K
Sbjct:   798 LMLGSESTTIPQPKAPGYCLERSLLDTDSSSSK 830

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0005773 "vacuole" evidence=IDA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0009506 "plasmodesma" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=RCA

TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1002 (357.8 bits), Expect = 1.7e-174, Sum P(2) = 1.7e-174
 Identities = 196/307 (63%), Positives = 236/307 (76%)

Query:   468 DLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMN 527
             +LPL + E LATATNNF   +KLGQGGFG VY GRL DG+EIAVKRLSK S QG +EFMN
Sbjct:   503 ELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKMSSQGTDEFMN 562

Query:   528 EVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNII 587
             EV +I+KLQH NLVRLLGCCV+  EKMLIYEY+ N SLD+ LFD  +   L+W+KRF+II
Sbjct:   563 EVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDII 622

Query:   588 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVV 647
              GI+RGLLYLH+DSR RIIHRDLKASN+LLD+ + PKISDFGMA+IFG  + +A+T RVV
Sbjct:   623 NGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVV 682

Query:   648 GTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFED--DLTILGYAWKLWNE 705
             GT+GYMSPEYAM+G FS KSDVFSFGVLLLEI+SG++N  F+    DL +LG+ W+ W E
Sbjct:   683 GTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKE 742

Query:   706 NKILALVDPFLSES---SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLP 762
                L +VDP   +S    F    I+RCI +GLLCVQE  +DRP MS+V+ ML SE   +P
Sbjct:   743 GNELEIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAIP 802

Query:   763 YPKEPAF 769
              PK P F
Sbjct:   803 QPKRPGF 809

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0009875 "pollen-pistil interaction" evidence=TAS

GO:0016020 "membrane" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=ISS

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)]

 Score = 1020 (364.1 bits), Expect = 9.6e-174, Sum P(2) = 9.6e-174
 Identities = 196/316 (62%), Positives = 250/316 (79%)

Query:   464 VKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLE 523
             V   +LP+F    +A ATN+F   ++LG+GGFGPVY G L+DG+EIAVKRLS  SGQG++
Sbjct:   509 VNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVD 568

Query:   524 EFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKR 583
             EF NE+++I+KLQHRNLVRLLGCC EGEEKML+YEYMPN+SLD  LFD  K+  +DW+ R
Sbjct:   569 EFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLR 628

Query:   584 FNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 643
             F+IIEGI+RGLLYLHRDSRLRIIHRDLK SN+LLD E+NPKISDFGMA+IFGGNQ++A+T
Sbjct:   629 FSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANT 688

Query:   644 GRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDL-TILGYAWKL 702
              RVVGT+GYMSPEYAMEG FS KSDV+SFGVLLLEIVSG++NTS    +  +++GYAW L
Sbjct:   689 VRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEHGSLIGYAWYL 748

Query:   703 WNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLP 762
             +   +   LVDP +  +  + + + RCIHV +LCVQ+   +RPNM++V+ ML S+   L 
Sbjct:   749 YTHGRSEELVDPKIRVTCSKREAL-RCIHVAMLCVQDSAAERPNMASVLLMLESDTATLA 807

Query:   763 YPKEPAFTE-RQGADD 777
              P++P FT  R+ + D
Sbjct:   808 APRQPTFTSTRRNSID 823

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0006979 "response to oxidative stress" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 995 (355.3 bits), Expect = 1.6e-173, Sum P(2) = 1.6e-173
 Identities = 195/313 (62%), Positives = 237/313 (75%)

Query:   462 NTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQG 521
             N     +LPL +++ LA ATNNF   +KLGQGGFG VY G L DG+EIAVKRLSK S QG
Sbjct:   501 NKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMSSQG 560

Query:   522 LEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWR 581
              +EFMNEV +I+KLQH NLVRLLGCCV+  EKMLIYEY+ N SLD+ LFD  +   L+W+
Sbjct:   561 TDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQ 620

Query:   582 KRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA 641
             KRF+II GI+RGLLYLH+DSR RIIHRDLKASN+LLD+ + PKISDFGMA+IFG  + +A
Sbjct:   621 KRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEA 680

Query:   642 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFED--DLTILGYA 699
             +T RVVGT+GYMSPEYAM+G FS KSDVFSFGVLLLEI+SG++N  F+    DL +LG+ 
Sbjct:   681 NTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFV 740

Query:   700 WKLWNENKILALVDPFLSE---SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS 756
             W+ W E K L +VDP   +   S F    I+RCI +GLLCVQE  +DRP MS+V+ ML S
Sbjct:   741 WRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGS 800

Query:   757 EIRDLPYPKEPAF 769
             E   +P PK P F
Sbjct:   801 ETTAIPQPKRPGF 813

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0034613 "cellular protein localization" evidence=IGI

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

TAIR|locus:2197664 AT1G61490 [Arabidopsis thaliana (taxid:3702)]

 Score = 1685 (598.2 bits), Expect = 2.1e-173, P = 2.1e-173
 Identities = 353/793 (44%), Positives = 489/793 (61%)

Query:     8 IILLSCFCLDFAVAIDSS---ITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWY 64
             I+  +C  L F V +  S   IT+   +     + S+   ++LGFF+P +S   Y+GIW+
Sbjct:     6 IVFFACLLL-FTVLLRFSYAGITTESPLSVEQTLSSSNGIYELGFFSPNNSQNLYVGIWF 64

Query:    65 DMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEXXXXXXXXXXXXXXTSAQL 124
                  + V+WVANR+ P  D+S  + IS +G+L+L NG K               + A+L
Sbjct:    65 KGIIPRVVVWVANRETPTTDTSANLAISSNGSLLLFNG-KHGVVWSIGENFASNGSRAEL 123

Query:   125 LDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGSF 184
              D+GNLV+ DN +   +WESF+   D+ LP      +  TG+K  LTSWK+ +DPS G F
Sbjct:   124 TDNGNLVVIDNASGRTLWESFEHFGDTMLPFSSLMYNLATGEKRVLTSWKTDTDPSPGVF 183

Query:   185 SAGLIHQNIP-EIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFRHNFTFGFANDWTFF 243
               G I   +P ++ +   S  Y+R+GPW    F GIP +   Y    +     AN   FF
Sbjct:   184 -VGQITPQVPSQVLIMRGSTRYYRTGPWAKTRFTGIPLMDDTYASPFSLQQD-ANGSGFF 241

Query:   244 ALTAQGILEERIWI-------KWKDN---WEVGFLNLRTECDVYGKCGAFGICNSQEKPI 293
                 +     RI I       +++ N   WE+ ++     CD+YG CG FG+C       
Sbjct:   242 TYFDRSFKLSRIIISSEGSMKRFRHNGTDWELSYMAPANSCDIYGVCGPFGLCIVSVPLK 301

Query:   294 CSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKMKVPDFTE 353
             C CL+GF P + EEW RGNWT GC R ++L C+  N TGK    + F  +  +K+PDF E
Sbjct:   302 CKCLKGFVPHSTEEWKRGNWTGGCARLTELHCQG-NSTGK--DVNIFHPVTNVKLPDFYE 358

Query:   354 WTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRVANSD 413
             + S    +EC + CL NCSC+A+A+  GIGC++W   NL+D  +   GG  L IR+A+S+
Sbjct:   359 YESSVDAEECHQSCLHNCSCLAFAYIHGIGCLIWNQ-NLMDAVQFSAGGEILSIRLAHSE 417

Query:   414 VD-EKGKKDVFVSPLIKGMFALAICTLF-LWRWIAKRKAEVIAKLSATNVNTVKLQDLPL 471
             +   K  K +  S +   +F +     F  WR+  K KA  +      ++ + ++  L  
Sbjct:   418 LGGNKRNKIIVASTVSLSLFVILTSAAFGFWRYRVKHKAYTLKDAWRNDLKSKEVPGLEF 477

Query:   472 FQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMV 531
             F+   + TATNNF LS+KLGQGGFG VY G+L+DG+EIAVK+LS +SGQG EEFMNE+++
Sbjct:   478 FEMNTIQTATNNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKQLSSSSGQGKEEFMNEIVL 537

Query:   532 ISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGIS 591
             ISKLQHRNLVR+LGCC+EGEEK+LIYE+M N+SLD  +FD  KK  +DW KRF+I++GI+
Sbjct:   538 ISKLQHRNLVRVLGCCIEGEEKLLIYEFMLNKSLDTFVFDARKKLEVDWPKRFDIVQGIA 597

Query:   592 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFG 651
             RGLLYLHRDSRL++IHRDLK SNILLDE++NPKISDFG+A+++ G Q Q  T RVVGT G
Sbjct:   598 RGLLYLHRDSRLKVIHRDLKVSNILLDEKMNPKISDFGLARMYEGTQCQDKTRRVVGTLG 657

Query:   652 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNT--SFFEDDLTILGYAWKLWNENKIL 709
             YMSPEYA  G FSEKSD++SFGVLLLEI+ G K +  S+ E+  T+L YAW+ W E K +
Sbjct:   658 YMSPEYAWTGVFSEKSDIYSFGVLLLEIIIGEKISRFSYGEEGKTLLAYAWESWGETKGI 717

Query:   710 ALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPAF 769
              L+D  L++S   L+ + RC+ +GLLCVQ    DRPN   +++ML +   DLP PK+P F
Sbjct:   718 DLLDQDLADSCRPLE-VGRCVQIGLLCVQHQPADRPNTLELLAMLTTT-SDLPSPKQPTF 775

Query:   770 TERQGADDSESFK 782
                   D+S   K
Sbjct:   776 VVHSRDDESSLSK 788

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)]

 Score = 940 (336.0 bits), Expect = 6.7e-173, Sum P(2) = 6.7e-173
 Identities = 180/308 (58%), Positives = 238/308 (77%)

Query:   468 DLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMN 527
             +LP    + ++ AT+ F   +KLGQGGFGPVY G L  GQE+AVKRLS+ S QG+EEF N
Sbjct:   449 ELPFLDLDTVSEATSGFSAGNKLGQGGFGPVYKGTLACGQEVAVKRLSRTSRQGVEEFKN 508

Query:   528 EVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNII 587
             E+ +I+KLQHRNLV++LG CV+ EE+MLIYEY PN+SLD+ +FD  ++  LDW KR  II
Sbjct:   509 EIKLIAKLQHRNLVKILGYCVDEEERMLIYEYQPNKSLDSFIFDKERRRELDWPKRVEII 568

Query:   588 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVV 647
             +GI+RG+LYLH DSRLRIIHRDLKASN+LLD ++N KISDFG+A+  GG++ +A+T RVV
Sbjct:   569 KGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKISDFGLARTLGGDETEANTTRVV 628

Query:   648 GTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDD--LTILGYAWKLWNE 705
             GT+GYMSPEY ++G FS KSDVFSFGVL+LEIVSGR+N  F  ++  L +LG+AW+ + E
Sbjct:   629 GTYGYMSPEYQIDGYFSLKSDVFSFGVLVLEIVSGRRNRGFRNEEHKLNLLGHAWRQFLE 688

Query:   706 NKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPK 765
             +K   ++D  ++ES   +  ++R IH+GLLCVQ+  KDRPNMS VV ML+SE+  L  P+
Sbjct:   689 DKAYEIIDEAVNESCTDISEVLRVIHIGLLCVQQDPKDRPNMSVVVLMLSSEMLLLD-PR 747

Query:   766 EPAF-TER 772
             +P F  ER
Sbjct:   748 QPGFFNER 755

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0048765 "root hair cell differentiation" evidence=RCA

TAIR|locus:2200888 AT1G61500 [Arabidopsis thaliana (taxid:3702)]

 Score = 1674 (594.3 bits), Expect = 3.0e-172, P = 3.0e-172
 Identities = 358/795 (45%), Positives = 494/795 (62%)

Query:    10 LLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSN-FKLGFFNPADSPYRYMGIWYDMPS 68
             L + F         S++ +++        LS+ +  ++LGFF+P ++  +Y+GIW+    
Sbjct:    10 LFTMFLFTLLSGSSSAVITTESPLSMGQTLSSANEVYELGFFSPNNTQDQYVGIWFKDTI 69

Query:    69 EKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEXXXXXXXXXXXXXXTSAQLLDSG 128
              + V+WVANR+ P+ DS+  + IS  G+L+L+NG K                 A+L DSG
Sbjct:    70 PRVVVWVANREKPVTDSTAYLAISSSGSLLLLNG-KHGTVWSSGVTFSSSGCRAELSDSG 128

Query:   129 NLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGSFSAGL 188
             NL + DN++   +W+SF    D+ L       +  T +K  LTSWKS +DPS G F  G 
Sbjct:   129 NLKVIDNVSERALWQSFDHLGDTLLHTSSLTYNLATAEKRVLTSWKSYTDPSPGDF-LGQ 187

Query:   189 IHQNIP-EIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYL--FR-HNFTFG------FAN 238
             I   +P + FV   S PYWRSGPW    F GIP +   Y   F  H    G      F  
Sbjct:   188 ITPQVPSQGFVMRGSTPYWRSGPWAKTRFTGIPFMDESYTGPFTLHQDVNGSGYLTYFQR 247

Query:   239 DWTF--FALTAQGILEERIWIKWKDN---WEVGFLNLRTECDVYGKCGAFGICNSQEKPI 293
             D+      LT++G ++      ++DN   WE+ +   +  CD YG CG FG+C     P+
Sbjct:   248 DYKLSRITLTSEGSIK-----MFRDNGMGWELYYEAPKKLCDFYGACGPFGLCVMSPSPM 302

Query:   294 CSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKMKVPDFTE 353
             C C  GF PK+ EEW RGNWT GC+R ++L C   N TG+    D F ++  +K PDF E
Sbjct:   303 CKCFRGFVPKSVEEWKRGNWTGGCVRHTELDC-LGNSTGE--DADDFHQIANIKPPDFYE 359

Query:   354 WTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRVANSD 413
             + S    +EC ++C+ NCSC+A+A+  GIGC+VW   +L+D  +    G  L IR+A S+
Sbjct:   360 FASSVNAEECHQRCVHNCSCLAFAYIKGIGCLVWNQ-DLMDAVQFSATGELLSIRLARSE 418

Query:   414 VD-EKGKKDVFVSPLIKGMFALAICTLF-LWRWIAKRKAEVIAKLSATN-VNTVKLQDLP 470
             +D  K KK +  S +   +F +   T F +WR     + E IA +S     N +K QD+P
Sbjct:   419 LDGNKRKKTIVASIVSLTLFMILGFTAFGVWRC----RVEHIAHISKDAWKNDLKPQDVP 474

Query:   471 LFQFEELAT---ATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMN 527
                F ++ T   ATNNF LS+KLGQGGFG VY G+L+DG+EIAVKRLS +SGQG EEFMN
Sbjct:   475 GLDFFDMHTIQNATNNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKRLSSSSGQGKEEFMN 534

Query:   528 EVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNII 587
             E+++ISKLQHRNLVR+LGCC+E EEK+LIYE+M N+SLD  LFD  K+  +DW KRF+II
Sbjct:   535 EIVLISKLQHRNLVRVLGCCIEEEEKLLIYEFMVNKSLDTFLFDSRKRLEIDWPKRFDII 594

Query:   588 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVV 647
             +GI+RGLLYLH DSRLR+IHRDLK SNILLDE++NPKISDFG+A+++ G + Q +T RVV
Sbjct:   595 QGIARGLLYLHHDSRLRVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNTRRVV 654

Query:   648 GTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNT--SFFEDDLTILGYAWKLWNE 705
             GT GYMSPEYA  G FSEKSD++SFGVL+LEI+SG K +  S+  +  T++ YAW+ W+E
Sbjct:   655 GTLGYMSPEYAWTGMFSEKSDIYSFGVLMLEIISGEKISRFSYGVEGKTLIAYAWESWSE 714

Query:   706 NKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPK 765
              + + L+D  L++S   L+ + RCI +GLLCVQ    DRPN   +++ML +   DLP PK
Sbjct:   715 YRGIDLLDQDLADSCHPLE-VGRCIQIGLLCVQHQPADRPNTLELLAMLTTT-SDLPSPK 772

Query:   766 EPAFTERQGADDSES 780
             +P F      D+S S
Sbjct:   773 QPTFAFHTRDDESLS 787

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)]

 Score = 1026 (366.2 bits), Expect = 5.4e-171, Sum P(2) = 5.4e-171
 Identities = 197/317 (62%), Positives = 244/317 (76%)

Query:   464 VKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLE 523
             V   DLP+F F+ +A+AT +F   +KLGQGGFG VY G   +G+EIAVKRLS  S QGLE
Sbjct:   505 VDTPDLPIFSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGREIAVKRLSGKSKQGLE 564

Query:   524 EFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKR 583
             EF NE+++I+KLQHRNLVRLLGCC+E  EKML+YEYMPN+SLD  LFD  K+  LDWRKR
Sbjct:   565 EFKNEILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDESKQGSLDWRKR 624

Query:   584 FNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 643
             + +I GI+RGLLYLHRDSRL+IIHRDLKASNILLD E+NPKISDFGMA+IF   QD A+T
Sbjct:   625 WEVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARIFNYRQDHANT 684

Query:   644 GRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDL-TILGYAWKL 702
              RVVGT+GYM+PEYAMEG FSEKSDV+SFGVL+LEIVSGRKN SF   D  +++GYAW L
Sbjct:   685 IRVVGTYGYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVSFRGTDHGSLIGYAWHL 744

Query:   703 WNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLP 762
             W++ K   ++DP + ++   +   +RCIHVG+LC Q+ V  RPNM +V+ ML S+   LP
Sbjct:   745 WSQGKTKEMIDPIVKDTR-DVTEAMRCIHVGMLCTQDSVIHRPNMGSVLLMLESQTSQLP 803

Query:   763 YPKEPAFTERQGADDSE 779
              P++P F     + D E
Sbjct:   804 PPRQPTFHSFLNSGDIE 820

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0009693 "ethylene biosynthetic process" evidence=RCA

TAIR|locus:2197744 AT1G61420 [Arabidopsis thaliana (taxid:3702)]

 Score = 1657 (588.4 bits), Expect = 1.9e-170, P = 1.9e-170
 Identities = 346/791 (43%), Positives = 488/791 (61%)

Query:     9 ILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPS 68
             +LLS F   F  +  + IT    +     + S+   ++LGFFN  +S  +Y+GIW+    
Sbjct:    12 LLLSSF---FISSSSAGITKESPLPIGQTLSSSNGFYELGFFNFNNSQNQYVGIWFKGII 68

Query:    69 EKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEXXXXXXXXXXXXXXTSAQLLDSG 128
              + V+WVANR+ P+ DS+  + IS +G+L+L NG K               + A+L D+G
Sbjct:    69 PRVVVWVANREKPVTDSTANLAISNNGSLLLFNG-KHGVAWSSGEALVSNGSRAELSDTG 127

Query:   129 NLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGSFSAGL 188
             NL++ DN +   +W+SF    D+ LP      +  TG+K  L+SWKS +DPS G F   +
Sbjct:   128 NLIVIDNFSGRTLWQSFDHLGDTMLPSSTLKYNLATGEKQVLSSWKSYTDPSVGDFVLQI 187

Query:   189 IHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLF----------RHNFTFGFAN 238
               Q   ++ V   S PY+RSGPW    F GIP +   +              + T+   N
Sbjct:   188 TPQVPTQVLVTKGSTPYYRSGPWAKTRFTGIPLMDDTFTGPVSVQQDTNGSGSLTYLNRN 247

Query:   239 D-WTFFALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQEKPICSCL 297
             D      LT++G  +E  W    D W + F+     CD YG CG FG+C     P C+C 
Sbjct:   248 DRLQRTMLTSKGT-QELSWHNGTD-WVLNFVAPEHSCDYYGVCGPFGLCVKSVPPKCTCF 305

Query:   298 EGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKMKVPDFTEWTSP 357
             +GF PK  EEW RGNWT GC+RR++L C+  N TGK      F  + ++K PDF E+ S 
Sbjct:   306 KGFVPKLIEEWKRGNWTGGCVRRTELYCQG-NSTGKYANV--FHPVARIKPPDFYEFASF 362

Query:   358 ATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRVANSDVD-E 416
                +EC++ CL NCSC+A+A+  GIGC++W   +L+D  +   GG  L IR+A S++   
Sbjct:   363 VNVEECQKSCLHNCSCLAFAYIDGIGCLMWNQ-DLMDAVQFSEGGELLSIRLARSELGGN 421

Query:   417 KGKKDVFVSPLIKGMFALAICTLF-LWRWIAKRKAEVIAKLSATNV-NTVKLQDLP---L 471
             K KK +  S +   +  +     F  WR+  K  A++    S  +  N +K QD+P    
Sbjct:   422 KRKKAITASIVSLSLVVIIAFVAFCFWRYRVKHNADITTDASQVSWRNDLKPQDVPGLDF 481

Query:   472 FQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMV 531
             F    + TATNNF +S+KLGQGGFGPVY G+L+DG+EIAVKRLS +SGQG EEFMNE+++
Sbjct:   482 FDMHTIQTATNNFSISNKLGQGGFGPVYKGKLQDGKEIAVKRLSSSSGQGKEEFMNEIVL 541

Query:   532 ISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGIS 591
             ISKLQH+NLVR+LGCC+EGEEK+LIYE+M N SLD  LFD  K+  +DW KR +II+GI+
Sbjct:   542 ISKLQHKNLVRILGCCIEGEEKLLIYEFMLNNSLDTFLFDSRKRLEIDWPKRLDIIQGIA 601

Query:   592 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFG 651
             RG+ YLHRDS L++IHRDLK SNILLDE++NPKISDFG+A+++ G + Q +T RVVGT G
Sbjct:   602 RGIHYLHRDSHLKVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNTRRVVGTLG 661

Query:   652 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNT--SFFEDDLTILGYAWKLWNENKIL 709
             YM+PEYA  G FSEKSD++SFGVL+LEI+SG K +  S+ +++ T++ YAW+ W +   +
Sbjct:   662 YMAPEYAWTGMFSEKSDIYSFGVLMLEIISGEKISRFSYGKEEKTLIAYAWESWCDTGGI 721

Query:   710 ALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPAF 769
              L+D  +++S   L+ + RC+ +GLLCVQ    DRPN   ++SML +   DLP P++P F
Sbjct:   722 DLLDKDVADSCRPLE-VERCVQIGLLCVQHQPADRPNTLELLSMLTTT-SDLPPPEQPTF 779

Query:   770 TERQGADDSES 780
                +  D S S
Sbjct:   780 VVHRRDDKSSS 790

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

TAIR|locus:2197729 SD1-29 "S-domain-1 29" [Arabidopsis thaliana (taxid:3702)]

 Score = 1655 (587.6 bits), Expect = 3.1e-170, P = 3.1e-170
 Identities = 350/790 (44%), Positives = 491/790 (62%)

Query:     1 MIPIALLIILLSCFCLDFAVAIDSSITSSQL-IRDPDAILSNGSNFKLGFFNPADSPYRY 59
             M+  A L++L+      +A AI+   TSS L IR    + S G  ++LGFF+P ++  +Y
Sbjct:     3 MVLFACLLLLIIFPTCGYA-AIN---TSSPLSIRQ--TLSSPGGFYELGFFSPNNTQNQY 56

Query:    60 MGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEXXXXXXXXXXXXXX 119
             +GIW+     + V+WVANRD P+  S+  +TIS +G+L+L++G K+              
Sbjct:    57 VGIWFKKIVPRVVVWVANRDTPVTSSAANLTISSNGSLILLDG-KQDVIWSTGKAFTSNK 115

Query:   120 TSAQLLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDP 179
               A+LLD+GN V+ D+++   +W+SF+   ++ LP      D   GKK  LT+WKS SDP
Sbjct:   116 CHAELLDTGNFVVIDDVSGNKLWQSFEHLGNTMLPQSSLMYDTSNGKKRVLTTWKSNSDP 175

Query:   180 STGSFSAGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYL--FR-------- 229
             S G FS  +  Q   +  +   S PYWR GPW    F GI  + + Y+  F         
Sbjct:   176 SPGEFSLEITPQIPTQGLIRRGSVPYWRCGPWAKTRFSGISGIDASYVSPFSVVQDTAAG 235

Query:   230 -HNFTFGFANDW--TFFALTAQGILEERIWIKWKD--NWEVGFLNLRTECDVYGKCGAFG 284
               +F++    ++  ++  LT +G ++    I W D  NW++        CD+YG+CG +G
Sbjct:   236 TGSFSYSTLRNYNLSYVTLTPEGKMK----ILWDDGNNWKLHLSLPENPCDLYGRCGPYG 291

Query:   285 ICNSQEKPICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKE-DGFSKL 343
             +C   + P C CL+GF PK+ EEW +GNWTSGC+RR+KL C+ ++     GK+ D F ++
Sbjct:   292 LCVRSDPPKCECLKGFVPKSDEEWGKGNWTSGCVRRTKLSCQAKSSMKTQGKDTDIFYRM 351

Query:   344 NKMKVPDFTEWTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGT 403
               +K PD  ++ S    ++C + CL NCSC A+A+  GIGC+VW    L D  +    G 
Sbjct:   352 TDVKTPDLHQFASFLNAEQCYQGCLGNCSCTAFAYISGIGCLVWNG-ELADTVQFLSSGE 410

Query:   404 DLYIRVANSDVDEKGKKDVFVSPLIK-GMFALAI-CTLFLWRWIAKRKAEVIAKLSATNV 461
              L+IR+A+S++    ++ + V   +   +F + +   + LWR+ AK+           +V
Sbjct:   411 FLFIRLASSELAGSSRRKIIVGTTVSLSIFLILVFAAIMLWRYRAKQNDAWKNGFERQDV 470

Query:   462 NTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQG 521
             + V       F+   + TATNNF  S+KLGQGGFGPVY G+L DG+EI VKRL+ +SGQG
Sbjct:   471 SGVNF-----FEMHTIRTATNNFSPSNKLGQGGFGPVYKGKLVDGKEIGVKRLASSSGQG 525

Query:   522 LEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWR 581
              EEFMNE+ +ISKLQHRNLVRLLG C++GEEK+LIYE+M N+SLD  +FDP  K  LDW 
Sbjct:   526 TEEFMNEITLISKLQHRNLVRLLGYCIDGEEKLLIYEFMVNKSLDIFIFDPCLKFELDWP 585

Query:   582 KRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA 641
             KRFNII+GI+RGLLYLHRDSRLR+IHRDLK SNILLD+ +NPKISDFG+A++F G Q Q 
Sbjct:   586 KRFNIIQGIARGLLYLHRDSRLRVIHRDLKVSNILLDDRMNPKISDFGLARMFQGTQYQD 645

Query:   642 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLT--ILGYA 699
             +T RVVGT GYMSPEYA  G FSEKSD++SFGVL+LEI+SG++ + F   D +  +L Y 
Sbjct:   646 NTRRVVGTLGYMSPEYAWAGLFSEKSDIYSFGVLMLEIISGKRISRFIYGDESKGLLAYT 705

Query:   700 WKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIR 759
             W  W E     L+D  L+++  Q   + RC+ +GLLCVQ    DRPN   V+SML S   
Sbjct:   706 WDSWCETGGSNLLDRDLTDTC-QAFEVARCVQIGLLCVQHEAVDRPNTLQVLSMLTSAT- 763

Query:   760 DLPYPKEPAF 769
             DLP PK+P F
Sbjct:   764 DLPVPKQPIF 773

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0046777 "protein autophosphorylation" evidence=RCA;IDA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.946
3rd Layer	2.7.11	0.963

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: fgenesh4_pg.C_LG_XI000360 hypothetical protein (832 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	808
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	6e-56
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	6e-56
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	5e-52
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	8e-52
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	4e-51
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-48
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	4e-46
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	5e-44
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-37
pfam01453	109	pfam01453, B_lectin, D-mannose binding lectin	5e-37
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-35
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-35
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-34
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	5e-33
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-32
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	6e-32
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	6e-32
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-31
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-31
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-31
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-31
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-31
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-31
cd00028	116	cd00028, B_lectin, Bulb-type mannose-specific lect	3e-31
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	5e-31
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	8e-31
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-30
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-30
pfam00954	110	pfam00954, S_locus_glycop, S-locus glycoprotein fa	1e-29
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-29
smart00108	114	smart00108, B_lectin, Bulb-type mannose-specific l	3e-29
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-29
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	5e-29
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-28
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-28
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	5e-28
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	8e-28
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-27
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-27
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	4e-27
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-26
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-26
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-26
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-26
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-26
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	9e-26
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	9e-26
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-25
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-25
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-25
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-25
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-25
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-24
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-24
cd01098	84	cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain	1e-24
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-24
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-24
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-24
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-24
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	5e-24
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	6e-24
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	7e-24
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	8e-24
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	8e-24
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-23
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-23
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-23
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-23
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-23
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-23
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-23
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-23
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-23
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-23
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	5e-23
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	8e-23
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-22
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-22
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-22
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-22
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-22
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	5e-22
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	6e-22
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	9e-22
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-21
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-21
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-21
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-21
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-21
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-21
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	4e-21
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-21
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	6e-21
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	7e-21
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	9e-21
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	9e-21
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-20
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-20
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-20
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-20
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-20
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-20
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-20
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-20
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-20
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-20
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-20
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	4e-20
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	5e-20
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-20
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-19
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-19
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-19
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-19
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-19
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-19
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-19
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	4e-19
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	4e-19
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	5e-19
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	5e-19
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	6e-19
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	6e-19
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	7e-19
pfam08276	66	pfam08276, PAN_2, PAN-like domain	7e-19
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	7e-19
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	8e-19
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	8e-19
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-18
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-18
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-18
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-18
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-18
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-18
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-18
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-18
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-18
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	5e-18
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	6e-18
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	7e-18
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	7e-18
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	9e-18
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-17
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-17
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-17
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-17
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-17
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	7e-17
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	7e-17
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	7e-17
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	8e-17
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	8e-17
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	9e-17
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	9e-17
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	9e-17
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-16
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-16
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-16
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-16
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-16
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-16
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-16
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-16
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-16
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-16
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	3e-16
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	4e-16
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	4e-16
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	5e-16
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	5e-16
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	5e-16
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	8e-16
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	8e-16
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-15
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-15
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-15
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-15
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-15
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	4e-15
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	4e-15
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	6e-15
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	8e-15
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	8e-15
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	8e-15
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	9e-15
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	9e-15
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-14
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-14
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-14
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-14
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-14
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-14
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-14
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-14
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-14
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-14
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	5e-14
smart00473	78	smart00473, PAN_AP, divergent subfamily of APPLE d	6e-14
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-13
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-13
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-13
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-13
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-13
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-13
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-13
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-13
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-13
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	5e-13
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	5e-13
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	6e-13
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	7e-13
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	8e-13
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	8e-13
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	9e-13
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	9e-13
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-12
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-12
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-12
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-12
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-12
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-12
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-12
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-12
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-12
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-12
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	4e-12
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-12
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	4e-12
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	4e-12
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	4e-12
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	5e-12
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	5e-12
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	6e-12
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	6e-12
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	8e-12
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	9e-12
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	9e-12
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	9e-12
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-11
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-11
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-11
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-11
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-11
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-11
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-11
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-11
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-11
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	4e-11
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	7e-11
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	7e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	7e-11
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	8e-11
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	8e-11
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-10
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-10
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-10
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-10
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-10
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-10
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-10
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-10
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	3e-10
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-10
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	4e-10
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	4e-10
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-10
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	7e-10
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	7e-10
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-09
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-09
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-09
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	3e-09
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-09
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-09
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	5e-09
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	5e-09
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-08
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-08
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-08
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-08
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-08
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-08
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	4e-08
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	4e-08
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	4e-08
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	6e-08
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	7e-08
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	8e-08
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	8e-08
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-07
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-07
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	4e-07
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	8e-07
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	8e-07
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-06
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-06
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	4e-06
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	9e-06
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-05
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	1e-05
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	1e-05
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	6e-05
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	6e-05
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-04
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	3e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	4e-04
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	4e-04
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	6e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	8e-04
COG1718	268	COG1718, RIO1, Serine/threonine protein kinase inv	8e-04
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	9e-04
cd00129	80	cd00129, PAN_APPLE, PAN/APPLE-like domain; present	0.001
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	0.004
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	0.004

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  192 bits (491), Expect = 6e-56
 Identities = 97/284 (34%), Positives = 141/284 (49%), Gaps = 42/284 (14%)

Query: 485 QLSSKLGQGGFGPVYWGRLKD-----GQEIAVKRLSK-ASGQGLEEFMNEVMVISKLQHR 538
            L  KLG+G FG VY G+LK        E+AVK L + AS Q +EEF+ E  ++ KL H 
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           N+V+LLG C E E   ++ EYM    L + L     + +L      +    I+RG+ YL 
Sbjct: 62  NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRK--NRPKLSLSDLLSFALQIARGMEYLE 119

Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAK-IFGGNQDQADTGRVVGTFGYMSPEY 657
                  IHRDL A N L+ E L  KISDFG+++ ++  +  +   G++     +M+PE 
Sbjct: 120 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL--PIRWMAPES 174

Query: 658 AMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILG---YAWKLWNENKILALVDP 714
             EG+F+ KSDV+SFGVLL EI +              LG   Y      E  +L  +  
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEIFT--------------LGEQPYPGMSNEE--VLEYL-- 216

Query: 715 FLSESSFQLDMIIRC----IHVGLLCVQELVKDRPNMSTVVSML 754
              ++ ++L     C      + L C  E  +DRP  S +V +L
Sbjct: 217 ---KNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  192 bits (490), Expect = 6e-56
 Identities = 83/203 (40%), Positives = 115/203 (56%), Gaps = 13/203 (6%)

Query: 486 LSSKLGQGGFGPVYWGRLKDG-----QEIAVKRLSK-ASGQGLEEFMNEVMVISKLQHRN 539
           L  KLG+G FG VY G LK        E+AVK L + AS Q +EEF+ E  ++ KL H N
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62

Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 599
           +V+LLG C E E  M++ EYMP   L   L    + + L      +    I+RG+ YL  
Sbjct: 63  IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKN-RPKELSLSDLLSFALQIARGMEYLE- 120

Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAK-IFGGNQDQADTGRVVGTFGYMSPEYA 658
                 IHRDL A N L+ E L  KISDFG+++ ++  +  +   G++     +M+PE  
Sbjct: 121 --SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPESL 176

Query: 659 MEGRFSEKSDVFSFGVLLLEIVS 681
            EG+F+ KSDV+SFGVLL EI +
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFT 199

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  181 bits (463), Expect = 5e-52
 Identities = 80/206 (38%), Positives = 114/206 (55%), Gaps = 13/206 (6%)

Query: 484 FQLSSKLGQGGFGPVYWGRLKD-----GQEIAVKRL-SKASGQGLEEFMNEVMVISKLQH 537
            +L  KLG+G FG VY G LK        ++AVK L   AS +  EEF+ E  ++ KL H
Sbjct: 1   LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60

Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 597
            N+VRLLG C +GE   ++ EYMP   L   L      E+L  +    +   I++G+ YL
Sbjct: 61  PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRK--HGEKLTLKDLLQMALQIAKGMEYL 118

Query: 598 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK-IFGGNQDQADTGRVVGTFGYMSPE 656
                   +HRDL A N L+ E L  KISDFG+++ I+  +  +   G  +    +M+PE
Sbjct: 119 E---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIK-WMAPE 174

Query: 657 YAMEGRFSEKSDVFSFGVLLLEIVSG 682
              +G+F+ KSDV+SFGVLL EI + 
Sbjct: 175 SLKDGKFTSKSDVWSFGVLLWEIFTL 200

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  181 bits (461), Expect = 8e-52
 Identities = 80/205 (39%), Positives = 115/205 (56%), Gaps = 16/205 (7%)

Query: 489 KLGQGGFGPVYWGRLKDGQ----EIAVKRLSK-ASGQGLEEFMNEVMVISKLQHRNLVRL 543
           KLG+G FG VY G+LK       E+AVK L + AS +  ++F+ E  V+ KL H N+VRL
Sbjct: 2   KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61

Query: 544 LGCCVEGEEKMLIYEYMPNRSLDALL------FDPLKKERLDWRKRFNIIEGISRGLLYL 597
           LG C E E   L+ EYM    L   L      F   +K  L  +   +    I++G+ YL
Sbjct: 62  LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121

Query: 598 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK-IFGGNQDQADTGRVVGTFGYMSPE 656
                 + +HRDL A N L+ E+L  KISDFG+++ ++  +  +  TG  +    +M+PE
Sbjct: 122 A---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAPE 177

Query: 657 YAMEGRFSEKSDVFSFGVLLLEIVS 681
              +G F+ KSDV+SFGVLL EI +
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFT 202

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  177 bits (452), Expect = 4e-51
 Identities = 77/194 (39%), Positives = 111/194 (57%), Gaps = 11/194 (5%)

Query: 490 LGQGGFGPVYWGR-LKDGQEIAVKRLSK-ASGQGLEEFMNEVMVISKLQHRNLVRLLGCC 547
           LG+GGFG VY  R  K G+++A+K + K  S   LEE + E+ ++ KL H N+V+L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 548 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 607
            +     L+ EY    SL  LL +   + +L   +   I+  I  GL YLH      IIH
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKE--NEGKLSEDEILRILLQILEGLEYLH---SNGIIH 115

Query: 608 RDLKASNILLDE-ELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE-YAMEGRFSE 665
           RDLK  NILLD      K++DFG++K+   ++    T  +VGT  YM+PE    +G +SE
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSE 173

Query: 666 KSDVFSFGVLLLEI 679
           KSD++S GV+L E+
Sbjct: 174 KSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  170 bits (434), Expect = 4e-48
 Identities = 75/204 (36%), Positives = 105/204 (51%), Gaps = 12/204 (5%)

Query: 484 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSK--ASGQGLEEFMNEVMVISKLQHRNL 540
           ++L  KLG G FG VY  + K  G+ +AVK L K     +  +    E+ ++ +L H N+
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 541 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 600
           VRL+    + +   L+ EY     L   L    +   L   +   I   I RGL YLH  
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLHS- 116

Query: 601 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
               IIHRDLK  NILLDE    KI+DFG+AK    +     T   VGT  YM+PE  + 
Sbjct: 117 --NGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT--FVGTPWYMAPEVLLG 172

Query: 661 GR-FSEKSDVFSFGVLLLEIVSGR 683
           G  +  K DV+S GV+L E+++G+
Sbjct: 173 GNGYGPKVDVWSLGVILYELLTGK 196

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  165 bits (420), Expect = 4e-46
 Identities = 78/252 (30%), Positives = 127/252 (50%), Gaps = 18/252 (7%)

Query: 484 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEE-FMNEVMVISKLQHRNLV 541
           +++  KLG+G FG VY  R K  G+ +A+K + K   +   E  + E+ ++ KL+H N+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 542 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD-WRKRFNIIEGISRGLLYLHRD 600
           RL     + ++  L+ EY     L  LL    K+ RL     RF  +  I   L YLH  
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLL---KKRGRLSEDEARF-YLRQILSALEYLHS- 115

Query: 601 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
               I+HRDLK  NILLDE+ + K++DFG+A+     + +  T   VGT  YM+PE  + 
Sbjct: 116 --KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGE-KLTT--FVGTPEYMAPEVLLG 170

Query: 661 GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS 720
             + +  D++S GV+L E+++G+     F  D  +L    K+          +  +S  +
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGK---PPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEA 227

Query: 721 FQLDMIIRCIHV 732
              D+I + +  
Sbjct: 228 --KDLIRKLLVK 237

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  159 bits (405), Expect = 5e-44
 Identities = 73/210 (34%), Positives = 114/210 (54%), Gaps = 19/210 (9%)

Query: 483 NFQLSSKLGQGGFGPVYWGRLKD-GQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRN 539
            +     LG+G FG VY    KD G+ +AVK   LS  S + LE    E+ ++S LQH N
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60

Query: 540 LVRLLGCCVEGEEKML-IY-EYMPNRSLDALL--FDPLKKERLDWRKRF--NIIEGISRG 593
           +VR  G   + E+  L I+ EY+   SL +LL  F  L +  +   +++   I+EG++  
Sbjct: 61  IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVI---RKYTRQILEGLA-- 115

Query: 594 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 653
             YLH      I+HRD+K +NIL+D +   K++DFG AK  G  +    TG V GT  +M
Sbjct: 116 --YLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWM 170

Query: 654 SPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           +PE      +   +D++S G  ++E+ +G+
Sbjct: 171 APEVIRGEEYGRAADIWSLGCTVIEMATGK 200

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  141 bits (357), Expect = 1e-37
 Identities = 62/207 (29%), Positives = 108/207 (52%), Gaps = 21/207 (10%)

Query: 484 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 542
           F++  K+G+GGFG VY  R  + G+E+A+K +   S +  E+ +NE+ ++ K +H N+V+
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 543 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN------IIEGISRGLLY 596
             G  ++ +E  ++ E+    SL  LL            +         + + + +GL Y
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSLKDLL--------KSTNQTLTESQIAYVCKELLKGLEY 113

Query: 597 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 656
           LH      IIHRD+KA+NILL  +   K+ DFG++       D      +VGT  +M+PE
Sbjct: 114 LHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGTPYWMAPE 167

Query: 657 YAMEGRFSEKSDVFSFGVLLLEIVSGR 683
                 +  K+D++S G+  +E+  G+
Sbjct: 168 VINGKPYDYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin

 Score =  133 bits (338), Expect = 5e-37
 Identities = 54/113 (47%), Positives = 68/113 (60%), Gaps = 5/113 (4%)

Query: 69  EKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSG 128
            + V+WVANR NPL DSS  + +  DGNLVL +G   V+WSSN S   +    A L D G
Sbjct: 1   NQTVVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSG-CVAVLQDDG 59

Query: 129 NLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRT-GKKVQLTSWKSLSDPS 180
           NLVL DN +  ++W+SF  PTD+ LPG          G   +LTSWKS +DPS
Sbjct: 60  NLVLYDN-SGKVLWQSFDHPTDTLLPGQ--KDGNVVIGGSRRLTSWKSNTDPS 109

These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  134 bits (340), Expect = 2e-35
 Identities = 69/207 (33%), Positives = 112/207 (54%), Gaps = 17/207 (8%)

Query: 483 NFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLS--KASGQGLEEFMNEVMVISKLQHRN 539
           N+QL   +G+G FG VY G  L+ G  +A+K++S  K   + L+  M E+ ++  L+H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALL--FDPLKKERLDWRKRFNIIEGISRGLLYL 597
           +V+ +G     +   +I EY  N SL  ++  F P   E L     + +++G    L YL
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFP-ESLVAVYVYQVLQG----LAYL 115

Query: 598 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE- 656
           H      +IHRD+KA+NIL  ++   K++DFG+A           +  VVGT  +M+PE 
Sbjct: 116 HEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYWMAPEV 170

Query: 657 YAMEGRFSEKSDVFSFGVLLLEIVSGR 683
             M G  S  SD++S G  ++E+++G 
Sbjct: 171 IEMSGA-STASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  134 bits (340), Expect = 2e-35
 Identities = 68/198 (34%), Positives = 105/198 (53%), Gaps = 6/198 (3%)

Query: 484 FQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRL 543
           F L  KLG G FG V+ G  K+   +A+K L        ++F  EV  + +L+H++L+ L
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 544 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 603
              C  GE   +I E M   SL A L  P  +  L      ++   ++ G+ YL      
Sbjct: 68  FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQV-LPVASLIDMACQVAEGMAYLEEQ--- 123

Query: 604 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRF 663
             IHRDL A NIL+ E+L  K++DFG+A++   +   +   ++   + + +PE A  G F
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTF 181

Query: 664 SEKSDVFSFGVLLLEIVS 681
           S KSDV+SFG+LL E+ +
Sbjct: 182 STKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  132 bits (334), Expect = 2e-34
 Identities = 81/206 (39%), Positives = 111/206 (53%), Gaps = 13/206 (6%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 541
            + +L  KLG G FG V+ G      ++AVK L K      E F+ E  ++ KL+H  LV
Sbjct: 6   ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLV 64

Query: 542 RLLGCCVEGEEKMLIYEYMPNRSL-DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 600
           +L   C E E   ++ EYM   SL D L     KK RL   +  ++   I+ G+ YL   
Sbjct: 65  QLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLP--QLVDMAAQIAEGMAYLES- 121

Query: 601 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMSPEYA 658
                IHRDL A NIL+ E L  KI+DFG+A++   ++  A  G     F   + +PE A
Sbjct: 122 --RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREG---AKFPIKWTAPEAA 176

Query: 659 MEGRFSEKSDVFSFGVLLLEIVS-GR 683
             GRF+ KSDV+SFG+LL EIV+ GR
Sbjct: 177 NYGRFTIKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  127 bits (322), Expect = 5e-33
 Identities = 77/210 (36%), Positives = 111/210 (52%), Gaps = 26/210 (12%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 541
              +L + +G+G FG V  G  + GQ++AVK L K      + F+ E  V++ L+H NLV
Sbjct: 6   KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCL-KDDSTAAQAFLAEASVMTTLRHPNLV 63

Query: 542 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLK-KER----LDWRKRFNIIEGISRGLLY 596
           +LLG  ++G    ++ EYM   SL     D L+ + R    L  +  F +   +  G+ Y
Sbjct: 64  QLLGVVLQGNPLYIVTEYMAKGSL----VDYLRSRGRAVITLAQQLGFAL--DVCEGMEY 117

Query: 597 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMS 654
           L        +HRDL A N+L+ E+L  K+SDFG+AK     QD        G     + +
Sbjct: 118 LEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-------SGKLPVKWTA 167

Query: 655 PEYAMEGRFSEKSDVFSFGVLLLEIVS-GR 683
           PE   E +FS KSDV+SFG+LL EI S GR
Sbjct: 168 PEALREKKFSTKSDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  127 bits (321), Expect = 1e-32
 Identities = 71/216 (32%), Positives = 110/216 (50%), Gaps = 17/216 (7%)

Query: 483 NFQLSSKLGQGGFGPVYWGRL-----KDGQEIAVKRLSKASG-QGLEEFMNEVMVISKLQ 536
           + +   +LG+G FG V   R        G+++AVK L+ +   Q   +F  E+ ++  L 
Sbjct: 5   HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLD 64

Query: 537 HRNLVRLLGCCVE--GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 594
           H N+V+  G C +  G    LI EY+P+ SL   L     +++++ ++       I +G+
Sbjct: 65  HENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGM 122

Query: 595 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD--QADTGRVVGTFGY 652
            YL      R IHRDL A NIL++ E   KISDFG+AK+   ++D            F Y
Sbjct: 123 DYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY 179

Query: 653 MSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTS 687
            +PE     +FS  SDV+SFGV L E+ + G  + S
Sbjct: 180 -APECLRTSKFSSASDVWSFGVTLYELFTYGDPSQS 214

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  125 bits (315), Expect = 6e-32
 Identities = 71/228 (31%), Positives = 109/228 (47%), Gaps = 37/228 (16%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRL-SKASGQGLEEFMNEVMVISKLQHRN 539
           ++ +    LGQG  G VY  R K  G+  A+K++      +  ++ + E+  +   +   
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60

Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN--IIEGISR----G 593
           +V+  G   +  E  ++ EYM   SL  LL    KK       +    ++  I+R    G
Sbjct: 61  VVKCYGAFYKEGEISIVLEYMDGGSLADLL----KK-----VGKIPEPVLAYIARQILKG 111

Query: 594 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 653
           L YLH      IIHRD+K SN+L++ +   KI+DFG++K+     DQ +T   VGT  YM
Sbjct: 112 LDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT--FVGTVTYM 167

Query: 654 SPEYAMEGRF-----SEKSDVFSFGVLLLEIVSGR------KNTSFFE 690
           SPE     R      S  +D++S G+ LLE   G+         SFFE
Sbjct: 168 SPE-----RIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFE 210

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  125 bits (316), Expect = 6e-32
 Identities = 75/224 (33%), Positives = 110/224 (49%), Gaps = 33/224 (14%)

Query: 483 NFQLSSKLGQGGFGPVYWGRL------KDGQEIAVKRLSK-ASGQGLEEFMNEVMVISKL 535
             +   +LG+G FG VY G L           +A+K L + A  +  +EF  E  ++S L
Sbjct: 6   AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL 65

Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLF-------------DPLKKERLDWRK 582
           QH N+V LLG C + +   +++EY+ +  L   L              D   K  LD   
Sbjct: 66  QHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSD 125

Query: 583 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK-IFGGNQDQA 641
             +I   I+ G+ YL   S    +HRDL A N L+ E L  KISDFG+++ I+      A
Sbjct: 126 FLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIY-----SA 177

Query: 642 DTGRVVGT----FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           D  RV         +M PE  + G+F+ +SD++SFGV+L EI S
Sbjct: 178 DYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  123 bits (312), Expect = 1e-31
 Identities = 66/205 (32%), Positives = 104/205 (50%), Gaps = 19/205 (9%)

Query: 489 KLGQGGFGPVYWGR-LKDGQEIAVKR--LSKASGQGLEEFMNEVMVISKLQHRNLVRLLG 545
           ++G+G FG VY  R   DG+   +K   LS  S +  E+ +NEV ++ KL H N+++   
Sbjct: 7   QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66

Query: 546 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF---NIIE---GISRGLLYLHR 599
              E  +  ++ EY     L   +     K++    K F    I++    +   L YLH 
Sbjct: 67  SFEEKGKLCIVMEYADGGDLSQKI-----KKQKKEGKPFPEEQILDWFVQLCLALKYLH- 120

Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 659
            SR +I+HRD+K  NI L      K+ DFG++K+     D A T  VVGT  Y+SPE   
Sbjct: 121 -SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYYLSPELCQ 176

Query: 660 EGRFSEKSDVFSFGVLLLEIVSGRK 684
              ++ KSD++S G +L E+ + + 
Sbjct: 177 NKPYNYKSDIWSLGCVLYELCTLKH 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  123 bits (311), Expect = 1e-31
 Identities = 78/206 (37%), Positives = 111/206 (53%), Gaps = 14/206 (6%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 541
              +L  KLG G FG V+ G      ++A+K L + S    E F+ E  ++ +LQH  LV
Sbjct: 6   ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLV 64

Query: 542 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKE---RLDWRKRFNIIEGISRGLLYLH 598
           RL    V  E   +I EYM N SL     D LK     +L   K  ++   I+ G+ ++ 
Sbjct: 65  RLYAV-VTQEPIYIITEYMENGSL----VDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE 119

Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 658
           R +    IHRDL+A+NIL+ E L  KI+DFG+A++   N+  A  G       + +PE  
Sbjct: 120 RKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKF-PIKWTAPEAI 175

Query: 659 MEGRFSEKSDVFSFGVLLLEIVS-GR 683
             G F+ KSDV+SFG+LL EIV+ GR
Sbjct: 176 NYGTFTIKSDVWSFGILLTEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  124 bits (313), Expect = 2e-31
 Identities = 63/204 (30%), Positives = 112/204 (54%), Gaps = 17/204 (8%)

Query: 490 LGQGGFGPVY---WGRLKDGQEI--AVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRL 543
           LG G FG VY   W    +  +I  A+K L + +  +  +E ++E  V++ + H ++VRL
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 544 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 603
           LG C+   +  LI + MP   L   + +   K+ +  +   N    I++G+ YL      
Sbjct: 75  LGICL-SSQVQLITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYL---EEK 128

Query: 604 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYMSPEYAMEG 661
           R++HRDL A N+L+    + KI+DFG+AK+   ++ +  A+ G+V     +M+ E  +  
Sbjct: 129 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKV--PIKWMALESILHR 186

Query: 662 RFSEKSDVFSFGVLLLEIVS-GRK 684
            ++ KSDV+S+GV + E+++ G K
Sbjct: 187 IYTHKSDVWSYGVTVWELMTFGAK 210

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  127 bits (318), Expect = 2e-31
 Identities = 70/213 (32%), Positives = 109/213 (51%), Gaps = 17/213 (7%)

Query: 483 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQH-R 538
           ++++  KLG+G FG VY    +D + +A+K L+K      + +E F+ E+ +++ L H  
Sbjct: 1   SYRILRKLGEGSFGEVY--LARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           N+V+L     +     L+ EY+   SL+ LL    +K  L   +   I+  I   L YLH
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 599 RDSRLRIIHRDLKASNILLDEELN-PKISDFGMAKIFGGNQ----DQADTGRVVGTFGYM 653
                 IIHRD+K  NILLD +    K+ DFG+AK+           A     VGT GYM
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175

Query: 654 SPEYAM---EGRFSEKSDVFSFGVLLLEIVSGR 683
           +PE  +       S  SD++S G+ L E+++G 
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGL 208

Length = 384

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  123 bits (311), Expect = 2e-31
 Identities = 75/210 (35%), Positives = 111/210 (52%), Gaps = 20/210 (9%)

Query: 490 LGQGGFGPVYWGRLKD-GQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLG 545
           LG+G FG V   R KD G+  A+K L K      + +E  + E  ++S++ H  +V+L  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59

Query: 546 CCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGLLYLHRDSR 602
              + EEK+ L+ EY P   L    F  L KE    + R RF   E I   L YLH    
Sbjct: 60  YAFQTEEKLYLVLEYAPGGEL----FSHLSKEGRFSEERARFYAAE-IVLALEYLHS--- 111

Query: 603 LRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGR 662
           L II+RDLK  NILLD + + K++DFG+AK       + +T    GT  Y++PE  +   
Sbjct: 112 LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLLGKG 169

Query: 663 FSEKSDVFSFGVLLLEIVSGRKNTSFFEDD 692
           + +  D +S GVLL E+++G+    F+ +D
Sbjct: 170 YGKAVDWWSLGVLLYEMLTGK--PPFYAED 197

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  123 bits (310), Expect = 2e-31
 Identities = 70/207 (33%), Positives = 114/207 (55%), Gaps = 15/207 (7%)

Query: 483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKR--LSKASGQGLEEFMNEVMVISKLQHRN 539
           +F++ +K+G+G FG V+    K D +  A+K+  LSK + +  EE ++E  V++KL    
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKK---ERLDWRKRFNIIEGISRGLLY 596
           ++R     ++  +  ++ EY  N  L  LL     +   E   WR        I  GL +
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWR----FFIQILLGLAH 116

Query: 597 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 656
           LH     +I+HRD+K+ N+ LD   N KI D G+AK+   N + A+T  +VGT  Y+SPE
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPE 171

Query: 657 YAMEGRFSEKSDVFSFGVLLLEIVSGR 683
              +  ++EKSDV++ GV+L E  +G+
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGK 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin

 Score =  117 bits (296), Expect = 3e-31
 Identities = 50/120 (41%), Positives = 67/120 (55%), Gaps = 4/120 (3%)

Query: 29  SQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGI 88
           S  +     ++S+GS F+LGFF        Y  I Y   S + V+WVANRDNP   SS  
Sbjct: 1   SNPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYK-GSSRTVVWVANRDNP-SGSSCT 58

Query: 89  ITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQEP 148
           +T+  DGNLV+ +G   V+WSSN + +  N     LLD GNLVL D+    + W+SF  P
Sbjct: 59  LTLQSDGNLVIYDGSGTVVWSSNTTRVNGN-YVLVLLDDGNLVLYDSDGNFL-WQSFDYP 116

The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  122 bits (308), Expect = 5e-31
 Identities = 65/215 (30%), Positives = 104/215 (48%), Gaps = 31/215 (14%)

Query: 490 LGQGGFGPVYWGR---LKDGQE---IAVKRLSKASGQGLEE-FMNEVMVISKLQHRNLVR 542
           LG+G FG V+ G    L+   +   +AVK L + +     + F  E  +++  QH N+V+
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 543 LLGCCVEGEEKMLIYEYMPNRSLDALL-----------FDPLKKERLDWRKRFNIIEGIS 591
             G C EG+  ++++EYM +  L+  L                   L   +   I   I+
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 592 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK-IFGGNQDQADTGRVVGT- 649
            G++YL   +    +HRDL   N L+  +L  KI DFGM++ ++       D  RV G  
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVY-----TTDYYRVGGHT 184

Query: 650 ---FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
                +M PE  M  +F+ +SDV+SFGV+L EI +
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  121 bits (306), Expect = 8e-31
 Identities = 70/206 (33%), Positives = 107/206 (51%), Gaps = 13/206 (6%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 541
            + QL  KLG G FG V+ G   +   +AVK L K      ++F+ E  ++ KL+H  L+
Sbjct: 6   TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLI 64

Query: 542 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE---GISRGLLYLH 598
           +L   C   E   ++ E M   SL     + L+       K   +I+    ++ G+ YL 
Sbjct: 65  QLYAVCTLEEPIYIVTELMKYGSL----LEYLQGGAGRALKLPQLIDMAAQVASGMAYLE 120

Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 658
             +    IHRDL A N+L+ E    K++DFG+A++   +  +A  G       + +PE A
Sbjct: 121 AQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKF-PIKWTAPEAA 176

Query: 659 MEGRFSEKSDVFSFGVLLLEIVS-GR 683
           +  RFS KSDV+SFG+LL EIV+ GR
Sbjct: 177 LYNRFSIKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  120 bits (304), Expect = 1e-30
 Identities = 96/293 (32%), Positives = 135/293 (46%), Gaps = 57/293 (19%)

Query: 490 LGQGGFGPVYWG--RLKDGQEI--AVKRLSK-ASGQGLEEFMNEVMVISKLQHRNLVRLL 544
           LG G FG V  G   +K G+E+  AVK L +     G +EF+ E  V+++L H  +VRL+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 545 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE---GISRGLLYLHRDS 601
           G C +GE  ML+ E  P   L  LL   LKK R       ++ E    ++ G+ YL    
Sbjct: 63  GVC-KGEPLMLVMELAP---LGPLL-KYLKKRRE--IPVSDLKELAHQVAMGMAYLESK- 114

Query: 602 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD--QADTGRVVGTF--GYMSPEY 657
               +HRDL A N+LL      KISDFGM++  G   D  +A T    G +   + +PE 
Sbjct: 115 --HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA---GRWPLKWYAPEC 169

Query: 658 AMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENK---ILALVDP 714
              G+FS KSDV+S+GV L E  S                Y  K + E K   ++A++  
Sbjct: 170 INYGKFSSKSDVWSYGVTLWEAFS----------------YGAKPYGEMKGAEVIAML-- 211

Query: 715 FLSESSFQLDMIIRC----IHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPY 763
              ES  +L     C      + L C +   +DRP  S + S      R  P 
Sbjct: 212 ---ESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTF----RRDPE 257

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  120 bits (302), Expect = 2e-30
 Identities = 70/195 (35%), Positives = 103/195 (52%), Gaps = 6/195 (3%)

Query: 489 KLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNLVRLLGCC 547
           K+G+G FG VY G LK   E+AVK         L  +F+ E  ++ +  H N+V+L+G C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 548 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 607
           V+ +   ++ E +P  SL  L F   KK RL  +K   +    + G+ YL  +S+   IH
Sbjct: 62  VQKQPIYIVMELVPGGSL--LTFLRKKKNRLTVKKLLQMSLDAAAGMEYL--ESK-NCIH 116

Query: 608 RDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKS 667
           RDL A N L+ E    KISDFGM++   G       G       + +PE    GR++ +S
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSES 176

Query: 668 DVFSFGVLLLEIVSG 682
           DV+S+G+LL E  S 
Sbjct: 177 DVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family

 Score =  113 bits (284), Expect = 1e-29
 Identities = 42/114 (36%), Positives = 61/114 (53%), Gaps = 19/114 (16%)

Query: 206 WRSGPWNGQIFIGIPELKSVYLFRHNF---------TFGFANDWTF--FALTAQGILEER 254
           WRSGPWNG  F GIPE++ +  + +NF         T+   N+  +    L+++G LE  
Sbjct: 1   WRSGPWNGIRFSGIPEMQKLSYYVYNFTENNEEVYYTYRMTNNSIYSRLTLSSEGSLERF 60

Query: 255 IWIK----WKDNWEVGFLNLRTECDVYGKCGAFGICNSQEKPICSCLEGFEPKN 304
            WI     W   W       + +CDVYG+CG +G C+    P C+C++GF PKN
Sbjct: 61  TWIPNSQDWNLFWSAP----KDQCDVYGRCGPYGYCDVNTSPKCNCIKGFVPKN 110

In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  118 bits (298), Expect = 2e-29
 Identities = 58/205 (28%), Positives = 109/205 (53%), Gaps = 18/205 (8%)

Query: 482 NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 540
            N +   K+G+G  G VY       G+E+A+K++ +   Q  E  +NE++++   +H N+
Sbjct: 22  KNLE---KIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPNI 77

Query: 541 VRLLGCCVEGEEKMLIYEYMPNRSLDALL---FDPLKKERLDWRKRFNIIEGISRGLLYL 597
           V      + G+E  ++ EYM   SL  ++   F  + + ++ +     +   + +GL YL
Sbjct: 78  VDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAY-----VCREVLQGLEYL 132

Query: 598 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEY 657
           H      +IHRD+K+ NILL ++ + K++DFG A      + + ++  VVGT  +M+PE 
Sbjct: 133 HS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPEV 187

Query: 658 AMEGRFSEKSDVFSFGVLLLEIVSG 682
                +  K D++S G++ +E+  G
Sbjct: 188 IKRKDYGPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin

 Score =  112 bits (281), Expect = 3e-29
 Identities = 48/117 (41%), Positives = 66/117 (56%), Gaps = 5/117 (4%)

Query: 29  SQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGI 88
           S  +     ++S  S F+LGFF        Y  I Y   S + V+WVANRDNP+ DS   
Sbjct: 1   SNTLSSGQTLVSGNSLFELGFFTLIMQ-NDYNLILYK-SSSRTVVWVANRDNPVSDS-CT 57

Query: 89  ITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESF 145
           +T+  DGNLVL +G   V+WSSN +   N +    LLD GNLV+ D+ +   +W+SF
Sbjct: 58  LTLQSDGNLVLYDGDGRVVWSSNTTG-ANGNYVLVLLDDGNLVIYDS-DGNFLWQSF 112

Length = 114

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  116 bits (294), Expect = 3e-29
 Identities = 58/201 (28%), Positives = 107/201 (53%), Gaps = 10/201 (4%)

Query: 484 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 542
           F +  KLG+G +G VY    K+ GQ +A+K +     + L+E + E+ ++ +     +V+
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVK 62

Query: 543 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSR 602
             G   +  +  ++ EY    S+  ++   +  + L   +   I+    +GL YLH    
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGSVSDIM--KITNKTLTEEEIAAILYQTLKGLEYLHS--- 117

Query: 603 LRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGR 662
            + IHRD+KA NILL+EE   K++DFG++        + +T  V+GT  +M+PE   E  
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAPEVIQEIG 175

Query: 663 FSEKSDVFSFGVLLLEIVSGR 683
           ++ K+D++S G+  +E+  G+
Sbjct: 176 YNNKADIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  117 bits (294), Expect = 5e-29
 Identities = 75/204 (36%), Positives = 110/204 (53%), Gaps = 17/204 (8%)

Query: 488 SKLGQGGFGPVYWGR---LKD--GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 542
            +LG+G FG V   R   L+D  G+ +AVK+L  ++ + L +F  E+ ++  LQH N+V+
Sbjct: 10  QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69

Query: 543 LLGCCVE-GEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 600
             G C   G   + L+ EY+P  SL   L     +ERLD RK       I +G+ YL   
Sbjct: 70  YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQK--HRERLDHRKLLLYASQICKGMEYL--- 124

Query: 601 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG---TFGYMSPEY 657
              R +HRDL   NIL++ E   KI DFG+ K+   +++     R  G    F Y +PE 
Sbjct: 125 GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYY-KVREPGESPIFWY-APES 182

Query: 658 AMEGRFSEKSDVFSFGVLLLEIVS 681
             E +FS  SDV+SFGV+L E+ +
Sbjct: 183 LTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  115 bits (291), Expect = 1e-28
 Identities = 70/214 (32%), Positives = 102/214 (47%), Gaps = 19/214 (8%)

Query: 483 NFQLSSKLGQGGFGPVYWG----RLKDGQEIAVK---RLSKASGQGLEEFMNEVMVISKL 535
           +  L   LG G FG VY G    R  D  E+ V         S Q   +F+ E +++SK 
Sbjct: 7   SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF 66

Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD----PLKKERLDWRKRFNIIEGIS 591
            H+N+VRL+G   E   + ++ E M    L + L +    P +   L  +        ++
Sbjct: 67  NHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126

Query: 592 RGLLYLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMAKIFGGNQDQADTGRVV 647
           +G  YL  +     IHRD+ A N LL  +  P    KI+DFGMA+           GR +
Sbjct: 127 KGCKYLEEN---HFIHRDIAARNCLLTCK-GPGRVAKIADFGMARDIYRASYYRKGGRAM 182

Query: 648 GTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
               +M PE  ++G F+ K+DV+SFGVLL EI S
Sbjct: 183 LPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  114 bits (288), Expect = 1e-28
 Identities = 66/197 (33%), Positives = 101/197 (51%), Gaps = 11/197 (5%)

Query: 490 LGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVE 549
           LG G FG V+ G+ +   ++A+K + + +    ++F+ E  V+ KL H NLV+L G C +
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70

Query: 550 GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRD 609
                ++ EYM N  L   L +   K   +W    ++   +   + YL  +     IHRD
Sbjct: 71  QRPIFIVTEYMANGCLLNYLRERKGKLGTEW--LLDMCSDVCEAMEYLESNG---FIHRD 125

Query: 610 LKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMSPEYAMEGRFSEKS 667
           L A N L+ E+   K+SDFG+A+    +Q  +  G     F   +  PE     RFS KS
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQG---TKFPVKWAPPEVFDYSRFSSKS 182

Query: 668 DVFSFGVLLLEIVSGRK 684
           DV+SFGVL+ E+ S  K
Sbjct: 183 DVWSFGVLMWEVFSEGK 199

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  113 bits (285), Expect = 5e-28
 Identities = 65/199 (32%), Positives = 109/199 (54%), Gaps = 14/199 (7%)

Query: 490 LGQGGFGPVYWGRLK--DGQEI--AVKRL-SKASGQGLEEFMNEVMVISKLQHRNLVRLL 544
           +G G FG V  GRLK    +EI  A+K L + +S +   +F+ E  ++ +  H N++RL 
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71

Query: 545 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 604
           G   +    M+I EYM N SLD  L +     +    +   ++ GI+ G+ YL   S + 
Sbjct: 72  GVVTKSRPVMIITEYMENGSLDKFLRE--NDGKFTVGQLVGMLRGIASGMKYL---SEMN 126

Query: 605 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT--GRVVGTFGYMSPEYAMEGR 662
            +HRDL A NIL++  L  K+SDFG+++    ++    T  G++     + +PE     +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKI--PIRWTAPEAIAYRK 184

Query: 663 FSEKSDVFSFGVLLLEIVS 681
           F+  SDV+SFG+++ E++S
Sbjct: 185 FTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  112 bits (282), Expect = 8e-28
 Identities = 73/203 (35%), Positives = 109/203 (53%), Gaps = 12/203 (5%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 541
            + +L  KLG G FG V+ G   +  ++AVK L K     ++ F+ E  ++  LQH  LV
Sbjct: 6   ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLV 64

Query: 542 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKE---RLDWRKRFNIIEGISRGLLYLH 598
           RL     + E   +I EYM   SL     D LK +   ++   K  +    I+ G+ Y+ 
Sbjct: 65  RLYAVVTKEEPIYIITEYMAKGSL----LDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE 120

Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 658
           R +    IHRDL+A+N+L+ E L  KI+DFG+A++   N+  A  G       + +PE  
Sbjct: 121 RKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAI 176

Query: 659 MEGRFSEKSDVFSFGVLLLEIVS 681
             G F+ KSDV+SFG+LL EIV+
Sbjct: 177 NFGSFTIKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  112 bits (283), Expect = 1e-27
 Identities = 64/202 (31%), Positives = 105/202 (51%), Gaps = 13/202 (6%)

Query: 484 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVKR--LSKASGQGLEEFMNEVMVISKLQHRNL 540
           F L   +G+G FG VY    K   Q +A+K   L +A  + +E+   E+  +S+ +   +
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE-IEDIQQEIQFLSQCRSPYI 61

Query: 541 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 600
            +  G  ++G +  +I EY    S      D LK  +LD      I+  +  GL YLH +
Sbjct: 62  TKYYGSFLKGSKLWIIMEYCGGGSC----LDLLKPGKLDETYIAFILREVLLGLEYLHEE 117

Query: 601 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
                IHRD+KA+NILL EE + K++DFG++        + +T   VGT  +M+PE   +
Sbjct: 118 ---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT--FVGTPFWMAPEVIKQ 172

Query: 661 GRFSEKSDVFSFGVLLLEIVSG 682
             + EK+D++S G+  +E+  G
Sbjct: 173 SGYDEKADIWSLGITAIELAKG 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  112 bits (283), Expect = 2e-27
 Identities = 62/210 (29%), Positives = 111/210 (52%), Gaps = 21/210 (10%)

Query: 484 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEF----MNEVMVISKLQHR 538
           ++  +++G+G +G VY  R  K G+ +A+K++   + +  E F    + E+ ++ KL+H 
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEK--EGFPITAIREIKLLQKLRHP 58

Query: 539 NLVRLLGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRF--NIIEGISRGL 594
           N+VRL        +    +++EYM +  L  LL  P  K      K +   ++EG+    
Sbjct: 59  NIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQ--- 114

Query: 595 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 654
            YLH +    I+HRD+K SNIL++ +   K++DFG+A+ +        T RV+ T  Y  
Sbjct: 115 -YLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRP 169

Query: 655 PEYAM-EGRFSEKSDVFSFGVLLLEIVSGR 683
           PE  +   R+  + D++S G +L E+  G+
Sbjct: 170 PELLLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  111 bits (278), Expect = 4e-27
 Identities = 72/210 (34%), Positives = 111/210 (52%), Gaps = 22/210 (10%)

Query: 490 LGQGGFGPVYWGRLKD-------GQEIAVKRLSK-ASGQGLEEFMNEVMVISKLQHRNLV 541
           LG G FG VY G   D          +AVK L K A+ Q  +EF+ E  ++S   H N+V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 542 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER-----LDWRKRFNIIEGISRGLLY 596
           +LLG C+  E + +I E M    L + L D  + ER     L  ++  +I   +++G +Y
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDA-RVERFGPPLLTLKELLDICLDVAKGCVY 121

Query: 597 LHRDSRLRIIHRDLKASNILLDEELNP-----KISDFGMAKIFGGNQDQADTGRVVGTFG 651
           L    ++  IHRDL A N L+ E+        KI DFG+A+    +      G  +    
Sbjct: 122 LE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR 178

Query: 652 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           +M+PE  ++G+F+ +SDV+SFGVL+ EI++
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  108 bits (272), Expect = 2e-26
 Identities = 74/205 (36%), Positives = 111/205 (54%), Gaps = 8/205 (3%)

Query: 480 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 539
              + QL  KLG G FG V+ G      ++AVK L K      E F+ E  ++ KL+H  
Sbjct: 4   PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDK 62

Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 599
           LV+L     E E   ++ EYM   SL   L D  +   L      ++   ++ G+ Y+ R
Sbjct: 63  LVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIER 120

Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 659
              +  IHRDL+++NIL+ + L  KI+DFG+A++   N+  A  G       + +PE A+
Sbjct: 121 ---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKF-PIKWTAPEAAL 176

Query: 660 EGRFSEKSDVFSFGVLLLEIVS-GR 683
            GRF+ KSDV+SFG+LL E+V+ GR
Sbjct: 177 YGRFTIKSDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  108 bits (273), Expect = 2e-26
 Identities = 64/209 (30%), Positives = 103/209 (49%), Gaps = 12/209 (5%)

Query: 484 FQLSSKLGQGGFGPVY-WGRLKDGQEIAVKRLS--KASGQGLEEFMNEVMVISKLQHRNL 540
           +++   +G+G FG V    R  DG+ +  K +     + +  ++ ++EV ++ +L+H N+
Sbjct: 2   YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61

Query: 541 VRLLGCCVEGEEKMLIYEYMPNRSLDAL--LFDPLKKER--LDWRKRFNIIEGISRGLLY 596
           VR     ++      +Y  M       L  L    KKER  ++    + I+  +   L  
Sbjct: 62  VRYYDRIID-RSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYE 120

Query: 597 LHR--DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 654
            H   D    ++HRDLK +NI LD   N K+ DFG+AKI G +   A T   VGT  YMS
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGTPYYMS 178

Query: 655 PEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           PE      + EKSD++S G L+ E+ +  
Sbjct: 179 PEQLNHMSYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  108 bits (272), Expect = 2e-26
 Identities = 76/205 (37%), Positives = 112/205 (54%), Gaps = 14/205 (6%)

Query: 483 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 542
           + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+ KL+H  LV+
Sbjct: 7   SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQ 65

Query: 543 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER---LDWRKRFNIIEGISRGLLYLHR 599
           L     E E   ++ EYM   SL     D LK E    L   +  ++   I+ G+ Y+ R
Sbjct: 66  LYAVVSE-EPIYIVTEYMSKGSL----LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 120

Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 659
              +  +HRDL+A+NIL+ E L  K++DFG+A++   N+  A  G       + +PE A+
Sbjct: 121 ---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAAL 176

Query: 660 EGRFSEKSDVFSFGVLLLEIVS-GR 683
            GRF+ KSDV+SFG+LL E+ + GR
Sbjct: 177 YGRFTIKSDVWSFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  108 bits (273), Expect = 3e-26
 Identities = 65/220 (29%), Positives = 106/220 (48%), Gaps = 29/220 (13%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKD------GQEIAVKRLSK-ASGQGLEEFMNEVMVISK 534
               L  +LGQG FG VY G  K          +A+K +++ AS +   EF+NE  V+ +
Sbjct: 6   EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKE 65

Query: 535 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL------------FDPLKKERLDWRK 582
               ++VRLLG    G+  +++ E M    L + L              P   ++     
Sbjct: 66  FNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKF---- 121

Query: 583 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK-IFGGNQDQA 641
              +   I+ G+ YL      + +HRDL A N ++ E+L  KI DFGM + I+  +  + 
Sbjct: 122 -IQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRK 177

Query: 642 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
               ++    +M+PE   +G F+ KSDV+SFGV+L E+ +
Sbjct: 178 GGKGLL-PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  107 bits (269), Expect = 4e-26
 Identities = 66/213 (30%), Positives = 105/213 (49%), Gaps = 14/213 (6%)

Query: 486 LSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLG 545
           L  ++G G FG V+ G   + +++A+K + + +    E+F+ E  V+ KL H  LV+L G
Sbjct: 8   LVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYG 66

Query: 546 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 605
            C E     L++E+M +  L   L    ++ +        +   +  G+ YL   +   +
Sbjct: 67  VCTERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---V 121

Query: 606 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSE 665
           IHRDL A N L+ E    K+SDFGM +    +Q  + TG       + SPE     ++S 
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKF-PVKWSSPEVFSFSKYSS 180

Query: 666 KSDVFSFGVLLLEIVS-------GRKNTSFFED 691
           KSDV+SFGVL+ E+ S        R N+   E 
Sbjct: 181 KSDVWSFGVLMWEVFSEGKTPYENRSNSEVVET 213

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  107 bits (268), Expect = 9e-26
 Identities = 67/197 (34%), Positives = 103/197 (52%), Gaps = 7/197 (3%)

Query: 486 LSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLL 544
           +  KLG G +G VY G  K     +AVK L K     +EEF+ E  V+ +++H NLV+LL
Sbjct: 10  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 68

Query: 545 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 604
           G C       +I E+M   +L   L +   ++ ++      +   IS  + YL + +   
Sbjct: 69  GVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKKN--- 124

Query: 605 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFS 664
            IHRDL A N L+ E    K++DFG++++  G+   A  G       + +PE     +FS
Sbjct: 125 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFS 183

Query: 665 EKSDVFSFGVLLLEIVS 681
            KSDV++FGVLL EI +
Sbjct: 184 IKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  107 bits (269), Expect = 9e-26
 Identities = 64/207 (30%), Positives = 100/207 (48%), Gaps = 12/207 (5%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLE-EFMNEVMVISKLQHRN 539
                 S+LG+G  G V   RLK+   I A+K ++      L+ + + E+ +    +   
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 540 LVRLLGCCVEGEEKML--IYEYMPNRSLDALLFDPLKKE-RLDWRKRFNIIEGISRGLLY 596
           +V+  G  ++     +    EY    SLD++     K+  R+  +    I E + +GL Y
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120

Query: 597 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 656
           LH  SR +IIHRD+K SNILL  +   K+ DFG++     +      G   GT  YM+PE
Sbjct: 121 LH--SR-KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA----GTFTGTSFYMAPE 173

Query: 657 YAMEGRFSEKSDVFSFGVLLLEIVSGR 683
                 +S  SDV+S G+ LLE+   R
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  107 bits (269), Expect = 1e-25
 Identities = 65/226 (28%), Positives = 107/226 (47%), Gaps = 31/226 (13%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEF-MNEVMVISKL-Q 536
           ++F+    +G+G F  V   + K   +E A+K L K     +   ++   E  V+++L  
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 537 HRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
           H  +++L     + EE +  + EY PN  L   +    K   LD +        I   L 
Sbjct: 61  HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTRFYAAEILLALE 116

Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN---------------QDQ 640
           YLH      IIHRDLK  NILLD++++ KI+DFG AK+   N               Q +
Sbjct: 117 YLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173

Query: 641 ADTGR---VVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
            +  R    VGT  Y+SPE   E    + SD+++ G ++ ++++G+
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  106 bits (267), Expect = 1e-25
 Identities = 67/204 (32%), Positives = 103/204 (50%), Gaps = 21/204 (10%)

Query: 490 LGQGGFGPVYWGRLKDGQ-EIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV 548
           LG+G +G VY  R    Q  IA+K + +   + ++    E+ + S L+HRN+V+ LG   
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75

Query: 549 EGEEKMLIYEYMPNRSLDALL---FDPLKKERLDWRKRFNII---EGISRGLLYLHRDSR 602
           E     +  E +P  SL ALL   + PLK           II   + I  GL YLH    
Sbjct: 76  ENGFFKIFMEQVPGGSLSALLRSKWGPLKD------NEQTIIFYTKQILEGLKYLH---D 126

Query: 603 LRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 661
            +I+HRD+K  N+L++      KISDFG +K   G     +T    GT  YM+PE   +G
Sbjct: 127 NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET--FTGTLQYMAPEVIDKG 184

Query: 662 R--FSEKSDVFSFGVLLLEIVSGR 683
              +   +D++S G  ++E+ +G+
Sbjct: 185 PRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score =  106 bits (265), Expect = 1e-25
 Identities = 73/202 (36%), Positives = 112/202 (55%), Gaps = 13/202 (6%)

Query: 483 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 542
           + +L  KLGQG FG V+ G      ++A+K L K      E F+ E  ++ KL+H  LV 
Sbjct: 7   SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVP 65

Query: 543 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKK---ERLDWRKRFNIIEGISRGLLYLHR 599
           L     E E   ++ E+M   SL     D LK+   + L   +  ++   I+ G+ Y+ R
Sbjct: 66  LYAVVSE-EPIYIVTEFMGKGSL----LDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER 120

Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 659
              +  IHRDL+A+NIL+ + L  KI+DFG+A++   N+  A  G       + +PE A+
Sbjct: 121 ---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF-PIKWTAPEAAL 176

Query: 660 EGRFSEKSDVFSFGVLLLEIVS 681
            GRF+ KSDV+SFG+LL E+V+
Sbjct: 177 YGRFTIKSDVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  106 bits (266), Expect = 2e-25
 Identities = 68/214 (31%), Positives = 109/214 (50%), Gaps = 21/214 (9%)

Query: 486 LSSKLGQGGFGPVYWGRL------KDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 539
           L  +LG+G FG V+          +D   +AVK L +AS    ++F  E  +++ LQH++
Sbjct: 9   LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQH 68

Query: 540 LVRLLGCCVEGEEKMLIYEYMP----NRSL-----DALLFDPLKKE---RLDWRKRFNII 587
           +VR  G C EG   ++++EYM     NR L     DA +    +     +L   +   I 
Sbjct: 69  IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128

Query: 588 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVV 647
             I+ G++YL   + L  +HRDL   N L+ + L  KI DFGM++           GR +
Sbjct: 129 SQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185

Query: 648 GTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
               +M PE  +  +F+ +SD++SFGV+L EI +
Sbjct: 186 LPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score =  106 bits (265), Expect = 2e-25
 Identities = 84/291 (28%), Positives = 146/291 (50%), Gaps = 57/291 (19%)

Query: 490 LGQGGFGPVYWGRLK--DGQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLL 544
           +G G FG V  GRLK    +EI V   +  +G   +   +F++E  ++ +  H N++ L 
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 545 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRK---RFNIIE------GISRGLL 595
           G   + +  M++ EYM N SLDA L           RK   +F +I+      GI+ G+ 
Sbjct: 72  GVVTKSKPVMIVTEYMENGSLDAFL-----------RKHDGQFTVIQLVGMLRGIASGMK 120

Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT---GRVVGTFGY 652
           YL   S +  +HRDL A NIL++  L  K+SDFG++++   + + A T   G++     +
Sbjct: 121 YL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRW 175

Query: 653 MSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILAL 711
            +PE     +F+  SDV+S+G+++ E++S G +               W++ N++ I A+
Sbjct: 176 TAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY-------------WEMSNQDVIKAI 222

Query: 712 VDPFLSESSFQLDMIIRC---IHVGLL-CVQELVKDRPNMSTVVSMLNSEI 758
                 E  ++L   + C   +H  +L C Q+   +RP    +VS+L+  I
Sbjct: 223 ------EEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score =  103 bits (259), Expect = 1e-24
 Identities = 75/212 (35%), Positives = 111/212 (52%), Gaps = 22/212 (10%)

Query: 478 ATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRL-SKASGQGLEEFMNEVMVISKLQ 536
           A      +L   +G+G FG V  G  + G ++AVK + + A+ Q    F+ E  V+++L+
Sbjct: 2   ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLR 57

Query: 537 HRNLVRLLGCCVEGEEKMLIY-EYMPNRSLDALLFDPLK---KERLDWRKRFNIIEGISR 592
           H NLV+LLG  VE +  + I  EYM   SL     D L+   +  L           +  
Sbjct: 58  HSNLVQLLGVIVEEKGGLYIVTEYMAKGSL----VDYLRSRGRSVLGGDCLLKFSLDVCE 113

Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 652
            + YL  ++    +HRDL A N+L+ E+   K+SDFG+ K     Q   DTG++     +
Sbjct: 114 AMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKL--PVKW 165

Query: 653 MSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GR 683
            +PE   E +FS KSDV+SFG+LL EI S GR
Sbjct: 166 TAPEALREKKFSTKSDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score =  104 bits (261), Expect = 1e-24
 Identities = 66/216 (30%), Positives = 109/216 (50%), Gaps = 19/216 (8%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRL------KDGQEIAVKRLSKASGQGLEEFMNEVMVISKL 535
           +N  L  +LG+G FG V+          +D   +AVK L  AS    ++F  E  +++ L
Sbjct: 5   HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 64

Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLD----------ALLFDPLKKERLDWRKRFN 585
           QH ++V+  G CVEG+  ++++EYM +  L+           L+ +  +   L   +  +
Sbjct: 65  QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124

Query: 586 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 645
           I + I+ G++YL   +    +HRDL   N L+ E L  KI DFGM++           G 
Sbjct: 125 IAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGH 181

Query: 646 VVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
            +    +M PE  M  +F+ +SDV+S GV+L EI +
Sbjct: 182 TMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins

 Score = 97.9 bits (244), Expect = 1e-24
 Identities = 36/90 (40%), Positives = 50/90 (55%), Gaps = 8/90 (8%)

Query: 322 KLQCERRNITGKVGKEDGFSKLNKMKVPDFTEWTSPATEDECREQCLKNCSCIAYAFD-G 380
            L C         G  DGF KL  +K+PD     +  + +ECRE CL NCSC AYA++ G
Sbjct: 2   PLNCGGD------GSTDGFLKLPDVKLPDNASAITAISLEECREACLSNCSCTAYAYNNG 55

Query: 381 GIGCMVWRSINLIDIQRLPFGGTDLYIRVA 410
             GC++W    L +++ L  GG  LY+R+A
Sbjct: 56  SGGCLLWNG-LLNNLRSLSSGGGTLYLRLA 84

PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  103 bits (259), Expect = 2e-24
 Identities = 68/222 (30%), Positives = 111/222 (50%), Gaps = 18/222 (8%)

Query: 485 QLSSKLGQGGFGPVYWG-RLKDGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRNLV 541
           Q  +K+G G FG VY    L  G+ +AVK  R+     + ++E  +E+ V+  L+H NLV
Sbjct: 3   QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV 62

Query: 542 RLLGCCVEGEEKMLIY-EYMPNRSLDALL-FDPLKKERLDWRKRFNIIEGISRGLLYLHR 599
           +  G  V   EK+ I+ EY    +L+ LL    +  E +       ++EG++    YLH 
Sbjct: 63  KYYGVEVH-REKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLA----YLHS 117

Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG--RVVGTFGYMSPEY 657
                I+HRD+K +NI LD     K+ DFG A     N          + GT  YM+PE 
Sbjct: 118 H---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV 174

Query: 658 AMEGRFSEK---SDVFSFGVLLLEIVSGRKNTSFFEDDLTIL 696
              G+       +D++S G ++LE+ +G++  S  +++  I+
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIM 216

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  102 bits (257), Expect = 2e-24
 Identities = 68/214 (31%), Positives = 112/214 (52%), Gaps = 32/214 (14%)

Query: 490 LGQGGFGPVYWG-RLKDGQEIAVKR--LSKASGQG-------LEEFMNEVMVISKLQHRN 539
           +G G FG VY G     G+ +AVK+  L   S          L+    E+ ++ +LQH N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLF------DPLKKERLDWRKRFNIIEGISRG 593
           +V+ LG  ++ +   +  EY+P  S+ ALL       + L +         N +  I +G
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR---------NFVRQILKG 118

Query: 594 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR----VVGT 649
           L YLH  +R  IIHRD+K +NIL+D +   KISDFG++K    N     T      + G+
Sbjct: 119 LNYLH--NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGS 175

Query: 650 FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
             +M+PE   +  ++ K+D++S G L++E+++G+
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  102 bits (256), Expect = 3e-24
 Identities = 66/210 (31%), Positives = 103/210 (49%), Gaps = 20/210 (9%)

Query: 490 LGQGGFGPVYWG-RLKDGQEIAVKRLS-----KASGQGLEEFMNEVMVISKLQHRNLVRL 543
           LG G FG VY G  L DG   AVK +S     +   + +++   E+ ++SKLQH N+V+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 544 LGCCVEGEEKMLIYEYMPNRSLDALL--FDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
           LG   E +   +  E +P  SL  LL  +    +  +           I  GL YLH   
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIR-----LYTRQILLGLEYLHDR- 121

Query: 602 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM-E 660
               +HRD+K +NIL+D     K++DFGMAK      + +      G+  +M+PE    +
Sbjct: 122 --NTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSPYWMAPEVIAQQ 176

Query: 661 GRFSEKSDVFSFGVLLLEIVSGRKNTSFFE 690
           G +   +D++S G  +LE+ +G+   S  E
Sbjct: 177 GGYGLAADIWSLGCTVLEMATGKPPWSQLE 206

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score =  103 bits (258), Expect = 3e-24
 Identities = 66/227 (29%), Positives = 108/227 (47%), Gaps = 31/227 (13%)

Query: 482 NNFQLSSKLGQGGFGPVYWGR---LKDGQE---IAVKRLSK-ASGQGLEEFMNEVMVISK 534
           NN +    +GQG FG V+  R   L   +    +AVK L + AS     +F  E  ++++
Sbjct: 5   NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64

Query: 535 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD-------------------PLKK 575
             H N+V+LLG C  G+   L++EYM    L+  L                      L  
Sbjct: 65  FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124

Query: 576 ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA-KIF 634
             L   ++  I + ++ G+ YL   S  + +HRDL   N L+ E +  KI+DFG++  I+
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181

Query: 635 GGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
             +  +A     +    +M PE     R++ +SDV+++GV+L EI S
Sbjct: 182 SADYYKASENDAI-PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score =  102 bits (254), Expect = 5e-24
 Identities = 72/205 (35%), Positives = 108/205 (52%), Gaps = 14/205 (6%)

Query: 483 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 542
           + +L  KLG G FG V+        ++AVK + K     +E F+ E  V+  LQH  LV+
Sbjct: 7   SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVK 65

Query: 543 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKE---RLDWRKRFNIIEGISRGLLYLHR 599
           L    V  E   +I E+M   SL     D LK +   +    K  +    I+ G+ ++ +
Sbjct: 66  L-HAVVTKEPIYIITEFMAKGSL----LDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 120

Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 659
            +    IHRDL+A+NIL+   L  KI+DFG+A++   N+  A  G       + +PE   
Sbjct: 121 RN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAIN 176

Query: 660 EGRFSEKSDVFSFGVLLLEIVS-GR 683
            G F+ KSDV+SFG+LL+EIV+ GR
Sbjct: 177 FGSFTIKSDVWSFGILLMEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score =  102 bits (256), Expect = 6e-24
 Identities = 70/223 (31%), Positives = 102/223 (45%), Gaps = 37/223 (16%)

Query: 489 KLGQGGFGPVYWGR--------LKDGQE---------IAVKRLSK-ASGQGLEEFMNEVM 530
           KLG+G FG V+            K   E         +AVK L   AS    E+F+ EV 
Sbjct: 12  KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71

Query: 531 VISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL--------FDPLKKERLDWRK 582
           ++S+L   N+ RLLG C       +I EYM N  L+  L              + L +  
Sbjct: 72  ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131

Query: 583 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD 642
              +   I+ G+ YL     L  +HRDL   N L+ +    KI+DFGM++    N   +D
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR----NLYSSD 184

Query: 643 ----TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
                GR      +M+ E  + G+F+ KSDV++FGV L EI++
Sbjct: 185 YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  101 bits (252), Expect = 7e-24
 Identities = 69/206 (33%), Positives = 106/206 (51%), Gaps = 28/206 (13%)

Query: 486 LSSKLGQGGFGPVYWGRLKDGQEIAVKRLS-KASGQGLEEFMNEVMVISKLQHRNLVRLL 544
           L   +G+G FG V  G    GQ++AVK +    + Q    F+ E  V++KL H+NLVRLL
Sbjct: 10  LGEIIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLL 65

Query: 545 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE------GISRGLLYLH 598
           G  +      ++ E M   +L   L       R   R   ++I+       ++ G+ YL 
Sbjct: 66  GVILH-NGLYIVMELMSKGNLVNFL-------RTRGRALVSVIQLLQFSLDVAEGMEYLE 117

Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 658
                +++HRDL A NIL+ E+   K+SDFG+A++        D  ++     + +PE  
Sbjct: 118 SK---KLVHRDLAARNILVSEDGVAKVSDFGLARV---GSMGVDNSKL--PVKWTAPEAL 169

Query: 659 MEGRFSEKSDVFSFGVLLLEIVS-GR 683
              +FS KSDV+S+GVLL E+ S GR
Sbjct: 170 KHKKFSSKSDVWSYGVLLWEVFSYGR 195

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  101 bits (254), Expect = 8e-24
 Identities = 73/204 (35%), Positives = 100/204 (49%), Gaps = 22/204 (10%)

Query: 490 LGQGGFGPVYWGRLK-----DGQEIAVKRLSKASGQGLEE-FMNEVMVISKLQHRNLVRL 543
           LG+G FG V            G+ +AVK L +  GQ     +  E+ ++  L H N+V+ 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 544 LGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
            GCC E   K   LI EY+P  SL     D L K +L+  +     + I  G+ YLH   
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSL----RDYLPKHKLNLAQLLLFAQQICEGMAYLHSQ- 126

Query: 602 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD----QADTGRVVGTFGYMSPEY 657
               IHRDL A N+LLD +   KI DFG+AK      +    + D    V  F Y + E 
Sbjct: 127 --HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV--FWY-AVEC 181

Query: 658 AMEGRFSEKSDVFSFGVLLLEIVS 681
             E +FS  SDV+SFGV L E+++
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score =  102 bits (255), Expect = 8e-24
 Identities = 80/296 (27%), Positives = 129/296 (43%), Gaps = 38/296 (12%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQE---------------IAVKRL-SKASGQGLEEF 525
              +L  KLG+G FG V+    +   E               +AVK L +  +     +F
Sbjct: 5   QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDF 64

Query: 526 MNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 585
           + E+ ++S+L++ N++RLLG CV  +   +I EYM N  L+  L    ++E        N
Sbjct: 65  LKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLS---QREIESTFTHAN 121

Query: 586 IIEGISRG-LLYLHRD--------SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 636
            I  +S   LLY+           + L  +HRDL   N L+      KI+DFGM++    
Sbjct: 122 NIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYS 181

Query: 637 NQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNT--SFFEDDLT 694
                  GR V    +M+ E  + G+F+  SDV++FGV L E+ +  K    S   D+  
Sbjct: 182 GDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241

Query: 695 ILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTV 750
           I        N+ + + L    L  S     +++RC           +KDRP  + +
Sbjct: 242 IENTGEFFRNQGRQIYLSQTPLCPSPV-FKLMMRCW-------SRDIKDRPTFNKI 289

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score =  100 bits (251), Expect = 1e-23
 Identities = 60/193 (31%), Positives = 104/193 (53%), Gaps = 7/193 (3%)

Query: 489 KLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV 548
           +LG G FG V+ G+ +   ++A+K +++ +    E+F+ E  V+ KL H  LV+L G C 
Sbjct: 11  ELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69

Query: 549 EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHR 608
           + +   ++ E+M N  L  L +   ++ +L      ++ + +  G+ YL R+S    IHR
Sbjct: 70  QQKPLYIVTEFMENGCL--LNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124

Query: 609 DLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSD 668
           DL A N L+      K+SDFGM +    ++  + +G       +  PE     ++S KSD
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKF-PVKWSPPEVFNFSKYSSKSD 183

Query: 669 VFSFGVLLLEIVS 681
           V+SFGVL+ E+ +
Sbjct: 184 VWSFGVLMWEVFT 196

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  100 bits (252), Expect = 1e-23
 Identities = 63/208 (30%), Positives = 107/208 (51%), Gaps = 10/208 (4%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKR--LSKASGQGLEEFMNEVMVISKLQHR 538
           ++++L   +G G    VY        E +A+KR  L K     ++E   EV  +S+  H 
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEK-CQTSVDELRKEVQAMSQCNHP 59

Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           N+V+     V G+E  L+  Y+   SL  ++     +  LD      +++ + +GL YLH
Sbjct: 60  NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119

Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGM-AKIFGGNQDQADTGR-VVGTFGYMSPE 656
            + +   IHRD+KA NILL E+ + KI+DFG+ A +  G        +  VGT  +M+PE
Sbjct: 120 SNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE 176

Query: 657 YAMEGR-FSEKSDVFSFGVLLLEIVSGR 683
              +   +  K+D++SFG+  +E+ +G 
Sbjct: 177 VMEQVHGYDFKADIWSFGITAIELATGA 204

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score =  100 bits (250), Expect = 1e-23
 Identities = 65/195 (33%), Positives = 102/195 (52%), Gaps = 11/195 (5%)

Query: 489 KLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV 548
           +LG G FG V +G+ +   ++A+K + + S    +EF+ E  V+ KL H  LV+L G C 
Sbjct: 11  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69

Query: 549 EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHR 608
           +     ++ EYM N  L   L +  K  R    +   + + +  G+ YL      + IHR
Sbjct: 70  KQRPIYIVTEYMSNGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESK---QFIHR 124

Query: 609 DLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMSPEYAMEGRFSEK 666
           DL A N L+D++   K+SDFG+++      D   T  V   F   +  PE  +  +FS K
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYV---LDDEYTSSVGSKFPVRWSPPEVLLYSKFSSK 181

Query: 667 SDVFSFGVLLLEIVS 681
           SDV++FGVL+ E+ S
Sbjct: 182 SDVWAFGVLMWEVYS 196

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  100 bits (251), Expect = 2e-23
 Identities = 64/216 (29%), Positives = 111/216 (51%), Gaps = 26/216 (12%)

Query: 483 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLS----KASGQG--LEEFMNEVMVISKL 535
            +    +LG G F   Y  R +K G  +AVK+++     +S Q   +E    E+ ++++L
Sbjct: 1   EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60

Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL--FDPLKKERLDWRKRFNIIEGISRG 593
            H +++R+LG   E     L  E+M   S+  LL  +   K+  +      N  E + RG
Sbjct: 61  NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-----INYTEQLLRG 115

Query: 594 LLYLHRDSRLRIIHRDLKASNILLDEE-LNPKISDFGMA-----KIFGGNQDQADTGRVV 647
           L YLH +   +IIHRD+K +N+L+D      +I+DFG A     K  G  + Q   G+++
Sbjct: 116 LSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQ---GQLL 169

Query: 648 GTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           GT  +M+PE     ++    DV+S G +++E+ + +
Sbjct: 170 GTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  100 bits (250), Expect = 2e-23
 Identities = 67/209 (32%), Positives = 104/209 (49%), Gaps = 17/209 (8%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKR-----LSKASGQGLEEFMNEVMVISKL 535
            N++    LGQG FG VY     D G+E+AVK+      S  + + +     E+ ++  L
Sbjct: 2   TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61

Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSL-DAL-LFDPLKKERLDWRKRFNIIEGISRG 593
           QH  +V+  GC  + E   +  EYMP  S+ D L  +  L  E +  +    I+EG+   
Sbjct: 62  QHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALT-ETVTRKYTRQILEGVE-- 118

Query: 594 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR-VVGTFGY 652
             YLH +    I+HRD+K +NIL D   N K+ DFG +K            + V GT  +
Sbjct: 119 --YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYW 173

Query: 653 MSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           MSPE      +  K+DV+S G  ++E+++
Sbjct: 174 MSPEVISGEGYGRKADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score =  100 bits (251), Expect = 2e-23
 Identities = 67/222 (30%), Positives = 108/222 (48%), Gaps = 22/222 (9%)

Query: 486 LSSKLGQGGFGPVYWGR------LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 539
           L  +LG+G FG V+          KD   +AVK L   +    ++F  E  +++ LQH +
Sbjct: 9   LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68

Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSL---------DALLF---DPLK-KERLDWRKRFNI 586
           +V+  G C +G+  ++++EYM +  L         DA++     P + K  L   +  +I
Sbjct: 69  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128

Query: 587 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV 646
              I+ G++YL   +    +HRDL   N L+   L  KI DFGM++           G  
Sbjct: 129 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185

Query: 647 VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSF 688
           +    +M PE  M  +F+ +SDV+SFGV+L EI +  K   F
Sbjct: 186 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF 227

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 99.7 bits (248), Expect = 2e-23
 Identities = 68/200 (34%), Positives = 105/200 (52%), Gaps = 21/200 (10%)

Query: 490 LGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLE-EFMNEVMVISKLQHRNLVRLLGCCV 548
           LG+G FG V+ G LKD   +AVK   +   Q L+ +F++E  ++ +  H N+V+L+G C 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 549 EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHR 608
           + +   ++ E +P    D L F   KK+ L  ++        + G+ YL   +    IHR
Sbjct: 63  QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117

Query: 609 DLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFG-------YMSPEYAMEG 661
           DL A N L+ E    KISDFGM++       Q D G +  + G       + +PE    G
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR-------QEDDG-IYSSSGLKQIPIKWTAPEALNYG 169

Query: 662 RFSEKSDVFSFGVLLLEIVS 681
           R+S +SDV+S+G+LL E  S
Sbjct: 170 RYSSESDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score =  100 bits (250), Expect = 3e-23
 Identities = 75/230 (32%), Positives = 116/230 (50%), Gaps = 33/230 (14%)

Query: 476 ELATATNNFQLSSKLGQGGFGPVYWGRL------KDGQEIAVKRLS-KASGQGLEEFMNE 528
           E+  +T  F    +LG+  FG VY G L      +  Q +A+K L  KA G   EEF +E
Sbjct: 1   EINLSTVRFM--EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58

Query: 529 VMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLF-------------DPLKK 575
            M+ S+LQH N+V LLG   + +   +I+ Y  +  L   L              D   K
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118

Query: 576 ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 635
             L+     +I+  I+ G+ +L   S   ++H+DL   N+L+ ++LN KISD G+ +   
Sbjct: 119 STLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFR--- 172

Query: 636 GNQDQADTGRVVGT----FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
                AD  +++G       +MSPE  M G+FS  SD++S+GV+L E+ S
Sbjct: 173 -EVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 99.8 bits (249), Expect = 3e-23
 Identities = 70/209 (33%), Positives = 108/209 (51%), Gaps = 19/209 (9%)

Query: 483 NFQLSSKLGQGGFGPVYW-GRLKDGQEIAVKR--LSKASGQGLEEFMNEVMVISKLQHRN 539
           +F++  KLG+G +G VY   RL D Q  A+K   L   S +  E+ +NE+ +++ + H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL-----DWRKRFNIIEGISRGL 594
           ++      ++G +  ++ EY P   L   +    KK +L      WR    I   + RGL
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR----IFIQLLRGL 116

Query: 595 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 654
             LH     +I+HRDLK++NILL      KI D G++K+   N   A T   +GT  YM+
Sbjct: 117 QALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--MAKT--QIGTPHYMA 169

Query: 655 PEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           PE      +S KSD++S G LL E+ +  
Sbjct: 170 PEVWKGRPYSYKSDIWSLGCLLYEMATFA 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 99.0 bits (247), Expect = 4e-23
 Identities = 67/204 (32%), Positives = 93/204 (45%), Gaps = 21/204 (10%)

Query: 489 KLGQGGFGPVYWGRLKDGQ----EIAVKRLSKASGQG-LEEFMNEVMVISKLQHRNLVRL 543
           KLG G FG V  G           +AVK L        +++F+ E  ++  L H NL+RL
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 544 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDW---RKRFNIIEGISRGLLYLHRD 600
            G  V     M++ E  P  SL     D L+K+ L         +    I+ G+ YL   
Sbjct: 62  YGV-VLTHPLMMVTELAPLGSL----LDRLRKDALGHFLISTLCDYAVQIANGMRYLESK 116

Query: 601 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD---QADTGRVVGTFGYMSPEY 657
              R IHRDL A NILL  +   KI DFG+ +    N+D     +  +V   F + +PE 
Sbjct: 117 ---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPES 171

Query: 658 AMEGRFSEKSDVFSFGVLLLEIVS 681
                FS  SDV+ FGV L E+ +
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 99.5 bits (248), Expect = 5e-23
 Identities = 69/212 (32%), Positives = 105/212 (49%), Gaps = 17/212 (8%)

Query: 483 NFQLSSKLGQGGFGPVYWGRLKDGQE------IAVKRLSKASGQGLE-EFMNEVMVISKL 535
           N Q  + LG+G FG V+  + K  +E      + VK L K   + L+ EF  E+ +  KL
Sbjct: 6   NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65

Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL------FDPLKKERLDWRKRFNIIEG 589
            H+N+VRLLG C E E   +I EY     L   L       + LK   L  +++  +   
Sbjct: 66  SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125

Query: 590 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 649
           I+ G+ +L   S  R +HRDL A N L+  +   K+S   ++K    N +       +  
Sbjct: 126 IALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVY-NSEYYKLRNALIP 181

Query: 650 FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
             +++PE   E  FS KSDV+SFGVL+ E+ +
Sbjct: 182 LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 98.4 bits (245), Expect = 8e-23
 Identities = 64/197 (32%), Positives = 102/197 (51%), Gaps = 13/197 (6%)

Query: 490 LGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEE---FMNEVMVISKLQHRNLVRLLGC 546
           +G+G FG V+  R K  Q++ + +         +E     NE  V+  L H N++     
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67

Query: 547 CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRII 606
            +E +  M++ EY P  +L     + ++K          I+    + LL LH      I+
Sbjct: 68  FLEDKALMIVMEYAPGGTL----AEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLIL 123

Query: 607 HRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGR-FS 664
           HRDLK  NILLD+     KI DFG++KI   ++ +A T  VVGT  Y+SPE   EG+ ++
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILS-SKSKAYT--VVGTPCYISPELC-EGKPYN 179

Query: 665 EKSDVFSFGVLLLEIVS 681
           +KSD+++ G +L E+ S
Sbjct: 180 QKSDIWALGCVLYELAS 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 97.9 bits (244), Expect = 1e-22
 Identities = 59/205 (28%), Positives = 105/205 (51%), Gaps = 23/205 (11%)

Query: 490 LGQGGFG-PVYWGRLKDGQEIAVKR--LSKASGQGLEEFMNEVMVISKLQHRNLVRLLGC 546
           LG+G FG    + R +D   +  K   L++ S +   + +NE++++S LQH N++     
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67

Query: 547 CVEGEEKMLIYEYMPNRSL-------DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 599
            ++    ++  EY    +L          LF+   +E + W      +  I   + Y+H+
Sbjct: 68  FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFE---EEMVLW-----YLFQIVSAVSYIHK 119

Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 659
                I+HRD+K  NI L +    K+ DFG++KI G     A+T  VVGT  YMSPE   
Sbjct: 120 AG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPELCQ 174

Query: 660 EGRFSEKSDVFSFGVLLLEIVSGRK 684
             +++ KSD+++ G +L E+++ ++
Sbjct: 175 GVKYNFKSDIWALGCVLYELLTLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 97.8 bits (244), Expect = 1e-22
 Identities = 62/206 (30%), Positives = 97/206 (47%), Gaps = 26/206 (12%)

Query: 488 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLE-EFMNEVMVISKLQHRNLVRLLG 545
            +LG G  G V     +  G+ +AVK +     + ++ + + E+ ++ K     +V   G
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66

Query: 546 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 605
                 +  +  EYM   SLD +L     + R+  R    I   + +GL YLH     +I
Sbjct: 67  AFYNNGDISICMEYMDGGSLDKIL--KEVQGRIPERILGKIAVAVLKGLTYLHEK--HKI 122

Query: 606 IHRDLKASNILLDEELNPKISDFG--------MAKIFGGNQDQADTGRVVGTFGYMSPEY 657
           IHRD+K SNIL++     K+ DFG        +AK F            VGT  YM+PE 
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF------------VGTSSYMAPER 170

Query: 658 AMEGRFSEKSDVFSFGVLLLEIVSGR 683
                +S KSD++S G+ L+E+ +GR
Sbjct: 171 IQGNDYSVKSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 98.0 bits (244), Expect = 1e-22
 Identities = 65/215 (30%), Positives = 108/215 (50%), Gaps = 22/215 (10%)

Query: 484 FQLSSKLGQGGFGPVYWGRLK--DG--QEIAVK--RLSKASGQGLEEFMNEVMVISKLQH 537
            +L   LG+G FG V  G+L   DG   ++AVK  +L   +   +EEF++E   +    H
Sbjct: 1   LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60

Query: 538 RNLVRLLGCCVEGEEK------MLIYEYMPNRSLDALLFDP---LKKERLDWRKRFNIIE 588
            N+++L+G C E          M+I  +M +  L + L         E+L  +     + 
Sbjct: 61  PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120

Query: 589 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA-KIFGGNQDQADTGRVV 647
            I+ G+ YL   S    IHRDL A N +L E++   ++DFG++ KI+ G  D    GR+ 
Sbjct: 121 DIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSG--DYYRQGRIA 175

Query: 648 GT-FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
                +++ E   +  ++ KSDV++FGV + EI +
Sbjct: 176 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 97.6 bits (243), Expect = 2e-22
 Identities = 61/199 (30%), Positives = 98/199 (49%), Gaps = 13/199 (6%)

Query: 490 LGQGGFGPVYWGRLKD-GQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLG 545
           LG+GGFG V   ++K  G+  A K+L K      +G +  +NE  ++ K+  R +V L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59

Query: 546 CCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 604
              E ++ + L+   M    L   +++  +    + R  F   + I  GL +LH+    R
Sbjct: 60  YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQ-IICGLEHLHQ---RR 115

Query: 605 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFS 664
           I++RDLK  N+LLD+  N +ISD G+A      +         GT GYM+PE      + 
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVEL---KGGKKIKGRAGTPGYMAPEVLQGEVYD 172

Query: 665 EKSDVFSFGVLLLEIVSGR 683
              D F+ G  L E+++GR
Sbjct: 173 FSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 97.2 bits (242), Expect = 2e-22
 Identities = 77/281 (27%), Positives = 135/281 (48%), Gaps = 35/281 (12%)

Query: 490 LGQGGFGPVYWGRLK----DGQEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLL 544
           +G G FG V  GRLK        +A+K L    + +   +F++E  ++ +  H N++ L 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 545 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 604
           G   +    M+I E+M N +LD+ L       +    +   ++ GI+ G+ YL   S + 
Sbjct: 72  GVVTKSRPVMIITEFMENGALDSFL--RQNDGQFTVIQLVGMLRGIAAGMKYL---SEMN 126

Query: 605 IIHRDLKASNILLDEELNPKISDFGMAKIFGGN-QDQADTGRVVGTFG--YMSPEYAMEG 661
            +HRDL A NIL++  L  K+SDFG+++    +  D   T  + G     + +PE     
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186

Query: 662 RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSF 721
           +F+  SDV+S+G+++ E++      S+ E         W + N++ I A+      E  +
Sbjct: 187 KFTSASDVWSYGIVMWEVM------SYGERPY------WDMSNQDVINAI------EQDY 228

Query: 722 QLDMIIRC---IHVGLL-CVQELVKDRPNMSTVVSMLNSEI 758
           +L   + C   +H  +L C Q+    RP    +VS L+  I
Sbjct: 229 RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 96.7 bits (241), Expect = 5e-22
 Identities = 64/211 (30%), Positives = 111/211 (52%), Gaps = 17/211 (8%)

Query: 481 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 539
            + +++  +LG G FG VY  + K+ G   A K +   S + LE+FM E+ ++S+ +H N
Sbjct: 4   NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63

Query: 540 LVRLLGCCV-EGEEKMLIYEYMPNRSLDALLFDPLKKER-LDWRKRFNIIEGISRGLLYL 597
           +V L      E +  +LI E+    +LD+++   L+ ER L   +   +   +   L +L
Sbjct: 64  IVGLYEAYFYENKLWILI-EFCDGGALDSIM---LELERGLTEPQIRYVCRQMLEALNFL 119

Query: 598 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEY 657
           H     ++IHRDLKA NILL  + + K++DFG++        + DT   +GT  +M+PE 
Sbjct: 120 HSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEV 174

Query: 658 AMEGRFSE-----KSDVFSFGVLLLEIVSGR 683
                F +     K+D++S G+ L+E+    
Sbjct: 175 VACETFKDNPYDYKADIWSLGITLIELAQME 205

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 96.0 bits (239), Expect = 6e-22
 Identities = 79/290 (27%), Positives = 137/290 (47%), Gaps = 41/290 (14%)

Query: 483 NFQLSSKLGQGGFGPVYWGRLKDG-------QEIAVKRLS-----KASGQGLEEFMNEVM 530
            + +   LG G FG VY  R K+        +EI V   +     +   + + + ++EV 
Sbjct: 1   EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60

Query: 531 VISK-LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLK--KERLDWRKRFNII 587
           +I + L+H N+VR     +E +   ++ + +    L    F+ LK  K+R    + +NI 
Sbjct: 61  IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPL-GEHFNSLKEKKQRFTEERIWNIF 119

Query: 588 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVV 647
             +   L YLH++ R  I+HRDL  +NI+L E+    I+DFG+AK     Q ++    VV
Sbjct: 120 VQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVV 174

Query: 648 GTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENK 707
           GT  Y  PE      + EK+DV++FG +L ++ +      F+  ++  L  A K+     
Sbjct: 175 GTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT--LQPPFYSTNM--LSLATKIVE--- 227

Query: 708 ILALVDPFLSESSFQ---LDMIIRCIHVGLLCVQELVKDRPNMSTVVSML 754
             A+ +P L E  +     D+I  C+           + RP++  V +M+
Sbjct: 228 --AVYEP-LPEGMYSEDVTDVITSCLTPD-------AEARPDIIQVSAMI 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 95.4 bits (237), Expect = 9e-22
 Identities = 62/200 (31%), Positives = 111/200 (55%), Gaps = 15/200 (7%)

Query: 490 LGQGGFGPVYWGRLK-DGQE---IAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLL 544
           +G G FG V+ G LK  G++   +A+K L    + +  ++F++E  ++ +  H N++RL 
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72

Query: 545 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 604
           G   + +  M+I EYM N +LD  L D          +   ++ GI+ G+ YL   S + 
Sbjct: 73  GVVTKFKPAMIITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYL---SDMN 127

Query: 605 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT---GRVVGTFGYMSPEYAMEG 661
            +HRDL A NIL++  L  K+SDFG++++   + +   T   G++     + +PE     
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI--PIRWTAPEAIAYR 185

Query: 662 RFSEKSDVFSFGVLLLEIVS 681
           +F+  SDV+SFG+++ E++S
Sbjct: 186 KFTSASDVWSFGIVMWEVMS 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 94.7 bits (235), Expect = 2e-21
 Identities = 69/216 (31%), Positives = 110/216 (50%), Gaps = 17/216 (7%)

Query: 480 ATNNFQLSSKLGQGGFGPVYWG----RLKDGQE--IAVKRLSK-ASGQGLEEFMNEVMVI 532
           A     +S +LGQG FG VY G     +KD  E  +A+K +++ AS +   EF+NE  V+
Sbjct: 4   AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63

Query: 533 SKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD-------WRKRFN 585
            +    ++VRLLG   +G+  ++I E M    L + L     +   +        +K   
Sbjct: 64  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQ 123

Query: 586 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 645
           +   I+ G+ YL+ +   + +HRDL A N ++ E+   KI DFGM +           G+
Sbjct: 124 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 180

Query: 646 VVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
            +    +MSPE   +G F+  SDV+SFGV+L EI +
Sbjct: 181 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 95.5 bits (237), Expect = 2e-21
 Identities = 65/198 (32%), Positives = 105/198 (53%), Gaps = 19/198 (9%)

Query: 489 KLGQGGFGPVYWGR-LKDGQEIAVKRLS---KASGQGLEEFMNEVMVISKLQHRNLVRLL 544
           ++G G FG VY+ R +++ + +A+K++S   K S +  ++ + EV  + KL+H N ++  
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81

Query: 545 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 604
           GC +      L+ EY    + D L    + K+ L   +   +  G  +GL YLH  +   
Sbjct: 82  GCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHSHN--- 135

Query: 605 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM---EG 661
           +IHRD+KA NILL E    K+ DFG A I       A     VGT  +M+PE  +   EG
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVILAMDEG 189

Query: 662 RFSEKSDVFSFGVLLLEI 679
           ++  K DV+S G+  +E+
Sbjct: 190 QYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 95.1 bits (236), Expect = 2e-21
 Identities = 64/200 (32%), Positives = 118/200 (59%), Gaps = 16/200 (8%)

Query: 490 LGQGGFGPVYWG-RLKDGQEI----AVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRL 543
           LG G FG VY G  + +G+ +    A+K L++ +G +   EFM+E ++++ + H +LVRL
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 544 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 603
           LG C+    + L+ + MP+  L  L +    K+ +  +   N    I++G++YL      
Sbjct: 75  LGVCLSPTIQ-LVTQLMPHGCL--LDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER--- 128

Query: 604 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYMSPEYAMEG 661
           R++HRDL A N+L+    + KI+DFG+A++  G++ +  AD G++     +M+ E     
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM--PIKWMALECIHYR 186

Query: 662 RFSEKSDVFSFGVLLLEIVS 681
           +F+ +SDV+S+GV + E+++
Sbjct: 187 KFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 95.0 bits (236), Expect = 2e-21
 Identities = 69/228 (30%), Positives = 113/228 (49%), Gaps = 39/228 (17%)

Query: 489 KLGQGGFGPVYWGRLKDGQE-----------------IAVKRL-SKASGQGLEEFMNEVM 530
           KLG+G FG V+   + + Q+                 +AVK L   A+     +F+ EV 
Sbjct: 12  KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71

Query: 531 VISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER------------- 577
           ++S+L+  N++RLLG CV+ +   +I EYM N  L+  L      ++             
Sbjct: 72  ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131

Query: 578 ---LDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK-I 633
              + +    ++   I+ G+ YL   S L  +HRDL   N L+ E L  KI+DFGM++ +
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188

Query: 634 FGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           + G+  +   GR V    +M+ E  + G+F+  SDV++FGV L EI+ 
Sbjct: 189 YAGDYYRIQ-GRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 94.9 bits (236), Expect = 3e-21
 Identities = 69/203 (33%), Positives = 107/203 (52%), Gaps = 19/203 (9%)

Query: 484 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLS---KASGQGLEEFMNEVMVISKLQHRN 539
           F    ++G G FG VY+ R ++  + +A+K++S   K S +  ++ + EV  + +L+H N
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 599
            +   GC +      L+ EY    + D L  +  KK  L   +   I  G  +GL YLH 
Sbjct: 77  TIEYKGCYLREHTAWLVMEYCLGSASDIL--EVHKKP-LQEVEIAAICHGALQGLAYLHS 133

Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE--Y 657
             R   IHRD+KA NILL E    K++DFG A +       A++   VGT  +M+PE   
Sbjct: 134 HER---IHRDIKAGNILLTEPGTVKLADFGSASL----VSPANS--FVGTPYWMAPEVIL 184

Query: 658 AM-EGRFSEKSDVFSFGVLLLEI 679
           AM EG++  K DV+S G+  +E+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 93.8 bits (233), Expect = 3e-21
 Identities = 62/206 (30%), Positives = 111/206 (53%), Gaps = 20/206 (9%)

Query: 490 LGQGGFGPVYWGRLKDGQEIAVKRLS------KASGQGLEEFMNEVMVISKLQHRNLVRL 543
           LG+G +G VY G    GQ IAVK++        A+ +  E+   EV ++  L+H N+V+ 
Sbjct: 8   LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67

Query: 544 LGCCVEGEEKMLIYEYMPNRSLDALL--FDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
           LG C++     +  E++P  S+ ++L  F PL  E +  +    I++G++    YLH + 
Sbjct: 68  LGTCLDDNTISIFMEFVPGGSISSILNRFGPL-PEPVFCKYTKQILDGVA----YLHNNC 122

Query: 602 RLRIIHRDLKASNILLDEELNPKISDFGMAK---IFGGNQDQADTGRVV-GTFGYMSPEY 657
              ++HRD+K +N++L      K+ DFG A+     G +   ++  + + GT  +M+PE 
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179

Query: 658 AMEGRFSEKSDVFSFGVLLLEIVSGR 683
             E  +  KSD++S G  + E+ +G+
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 94.2 bits (234), Expect = 4e-21
 Identities = 60/199 (30%), Positives = 104/199 (52%), Gaps = 18/199 (9%)

Query: 489 KLGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC 547
           K+GQG  G VY    +  GQE+A+K+++       E  +NE++V+ + +H N+V  L   
Sbjct: 26  KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85

Query: 548 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL----YLHRDSRL 603
           + G+E  ++ EY+   SL  ++ +    E          I  + R  L    +LH +   
Sbjct: 86  LVGDELWVVMEYLAGGSLTDVVTETCMDE--------GQIAAVCRECLQALEFLHSN--- 134

Query: 604 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRF 663
           ++IHRD+K+ NILL  + + K++DFG        Q +  T  +VGT  +M+PE      +
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAY 192

Query: 664 SEKSDVFSFGVLLLEIVSG 682
             K D++S G++ +E+V G
Sbjct: 193 GPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 93.2 bits (231), Expect = 4e-21
 Identities = 64/195 (32%), Positives = 103/195 (52%), Gaps = 7/195 (3%)

Query: 489 KLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLE-EFMNEVMVISKLQHRNLVRLLGC 546
           ++G+G FG V+ GRL+ D   +AVK   +     L+ +F+ E  ++ +  H N+VRL+G 
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61

Query: 547 CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRII 606
           C + +   ++ E +  +  D L F   +  RL  ++   ++E  + G+ YL        I
Sbjct: 62  CTQKQPIYIVMELV--QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116

Query: 607 HRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEK 666
           HRDL A N L+ E+   KISDFGM++        +  G       + +PE    GR+S +
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE 176

Query: 667 SDVFSFGVLLLEIVS 681
           SDV+SFG+LL E  S
Sbjct: 177 SDVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 93.3 bits (232), Expect = 6e-21
 Identities = 59/205 (28%), Positives = 108/205 (52%), Gaps = 15/205 (7%)

Query: 484 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQG-LEEFMNEVMVISKLQH---R 538
           +Q    +G+G +G VY G+ +  G+ +A+K ++  +    + +   EV ++S+L+     
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62

Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           N+ +  G  ++G    +I EY    S+  L+    K   +  +    II  +   L Y+H
Sbjct: 63  NITKYYGSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIAEKYISVIIREVLVALKYIH 118

Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 658
           +     +IHRD+KA+NIL+    N K+ DFG+A +   N  +  T   VGT  +M+PE  
Sbjct: 119 KVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST--FVGTPYWMAPEVI 173

Query: 659 MEGR-FSEKSDVFSFGVLLLEIVSG 682
            EG+ +  K+D++S G+ + E+ +G
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATG 198

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 93.6 bits (232), Expect = 7e-21
 Identities = 61/196 (31%), Positives = 107/196 (54%), Gaps = 12/196 (6%)

Query: 489 KLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC 547
           K+G+G  G V   R K  G+++AVK +     Q  E   NEV+++   QH+N+V +    
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87

Query: 548 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 607
           + GEE  ++ E++   +L     D + + RL+  +   + E + + L YLH      +IH
Sbjct: 88  LVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIH 140

Query: 608 RDLKASNILLDEELNPKISDFGM-AKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEK 666
           RD+K+ +ILL  +   K+SDFG  A+I   ++D      +VGT  +M+PE      +  +
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQI---SKDVPKRKSLVGTPYWMAPEVISRTPYGTE 197

Query: 667 SDVFSFGVLLLEIVSG 682
            D++S G++++E+V G
Sbjct: 198 VDIWSLGIMVIEMVDG 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 92.8 bits (230), Expect = 9e-21
 Identities = 66/203 (32%), Positives = 110/203 (54%), Gaps = 15/203 (7%)

Query: 484 FQLSSKLGQGGFGPVYWG---RLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 540
           F    ++G+G FG VY G   R K+   I +  L +A  + +E+   E+ V+S+     +
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYI 64

Query: 541 VRLLGCCVEGEEKMLIYEYMPNRS-LDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 599
            R  G  ++G +  +I EY+   S LD L   PL++  +       I+  I +GL YLH 
Sbjct: 65  TRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIA-----TILREILKGLDYLHS 119

Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 659
           +   R IHRD+KA+N+LL E+ + K++DFG+A      Q + +T   VGT  +M+PE   
Sbjct: 120 E---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIK 174

Query: 660 EGRFSEKSDVFSFGVLLLEIVSG 682
           +  +  K+D++S G+  +E+  G
Sbjct: 175 QSAYDFKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 92.8 bits (230), Expect = 9e-21
 Identities = 68/214 (31%), Positives = 106/214 (49%), Gaps = 25/214 (11%)

Query: 489 KLGQGGFGPVYWGRL-----KDGQEIAVKRLSK-ASGQGLEEFMNEVMVISKLQHRNLVR 542
           +LG+  FG +Y G L        Q +A+K L    + Q   EF  E  ++++L H N+V 
Sbjct: 12  ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71

Query: 543 LLGCCVEGEEKMLIYEYMPNRSLDALLF--------------DPLKKERLDWRKRFNIIE 588
           LLG   + +   +++EY+    L   L               D   K  LD     +I  
Sbjct: 72  LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131

Query: 589 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK-IFGGNQDQADTGRVV 647
            I+ G+ YL   S    +H+DL A NIL+ E+L+ KISD G+++ I+  +  +     ++
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188

Query: 648 GTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
               +M PE  M G+FS  SD++SFGV+L EI S
Sbjct: 189 -PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 92.8 bits (231), Expect = 1e-20
 Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 16/206 (7%)

Query: 484 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN--EVMVISKLQHRNL 540
           +Q   K+G+G +G VY  R    G+ +A+K++               E+ ++ +L H N+
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60

Query: 541 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER--LDWRKRFNIIEGISRGLLYLH 598
           ++LL       +  L++E+M     D  L+  +K  +  L      + +  + +GL + H
Sbjct: 61  IKLLDVFRHKGDLYLVFEFM-----DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH 115

Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 658
                 I+HRDLK  N+L++ E   K++DFG+A+ FG       T  VV T  Y +PE  
Sbjct: 116 SH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR-PYTHYVV-TRWYRAPELL 170

Query: 659 MEGRF-SEKSDVFSFGVLLLEIVSGR 683
           +  +  S   D++S G +  E++S R
Sbjct: 171 LGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 93.0 bits (231), Expect = 1e-20
 Identities = 79/295 (26%), Positives = 134/295 (45%), Gaps = 41/295 (13%)

Query: 489 KLGQGGFGPVYWGRLKDGQE-----------------IAVKRL-SKASGQGLEEFMNEVM 530
           KLG+G FG V+    +  ++                 +AVK L   A+     +F+ E+ 
Sbjct: 12  KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71

Query: 531 VISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLF------DPLKKER--LDWRK 582
           ++S+L+  N++RLL  C+  +   +I EYM N  L+  L          K +   + +  
Sbjct: 72  IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131

Query: 583 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK-IFGGNQDQA 641
              +   I+ G+ YL   S L  +HRDL   N L+ +    KI+DFGM++ ++ G+  + 
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188

Query: 642 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSF--FEDDLTILGYA 699
             GR V    +MS E  + G+F+  SDV++FGV L EI++  K   +    D+  I    
Sbjct: 189 Q-GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTG 247

Query: 700 WKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML 754
               ++ + + L  P L   S    M        L C +   K+RP+   + + L
Sbjct: 248 EFFRDQGRQVYLPKPALCPDSLYKLM--------LSCWRRNAKERPSFQEIHATL 294

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 92.5 bits (231), Expect = 1e-20
 Identities = 60/203 (29%), Positives = 103/203 (50%), Gaps = 20/203 (9%)

Query: 489 KLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEF----MNEVMVISKLQHRNLVRL 543
           KLG+G +G VY  R  K G+ +A+K++        E      + E+ ++ +L+H N+V+L
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKI--RLDNEEEGIPSTALREISLLKELKHPNIVKL 63

Query: 544 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKR--FNIIEGISRGLLYLHRDS 601
           L       +  L++EY  +  L   L         +  K   + ++    RGL Y H   
Sbjct: 64  LDVIHTERKLYLVFEYC-DMDLKKYLDKRPGPLSPNLIKSIMYQLL----RGLAYCHSH- 117

Query: 602 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 661
             RI+HRDLK  NIL++ +   K++DFG+A+ F G   +  T  VV T  Y +PE  +  
Sbjct: 118 --RILHRDLKPQNILINRDGVLKLADFGLARAF-GIPLRTYTHEVV-TLWYRAPEILLGS 173

Query: 662 RFSEKS-DVFSFGVLLLEIVSGR 683
           +    + D++S G +  E+++G+
Sbjct: 174 KHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 92.3 bits (230), Expect = 1e-20
 Identities = 62/207 (29%), Positives = 113/207 (54%), Gaps = 19/207 (9%)

Query: 484 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLS-KASGQGLEEFM-NEVMVISKLQ---H 537
           ++  +++G+G +G VY  R L  G+ +A+K++    S +G+      E+ ++ +L+   H
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60

Query: 538 RNLVRLLGCC----VEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 592
            N+VRLL  C     + E K+ L++E++ ++ L   L     K  L      +++  + R
Sbjct: 61  PNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYL-SKCPKPGLPPETIKDLMRQLLR 118

Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 652
           G+ +LH     RI+HRDLK  NIL+  +   KI+DFG+A+I+    + A T  VV T  Y
Sbjct: 119 GVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS--FEMALTSVVV-TLWY 172

Query: 653 MSPEYAMEGRFSEKSDVFSFGVLLLEI 679
            +PE  ++  ++   D++S G +  E+
Sbjct: 173 RAPEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 92.1 bits (229), Expect = 1e-20
 Identities = 60/208 (28%), Positives = 107/208 (51%), Gaps = 18/208 (8%)

Query: 481 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRL-------SKASGQGLEEFMNEVMVI 532
             NF++  K+G+G F  VY    L DG+ +A+K++       +KA     ++ + E+ ++
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKAR----QDCLKEIDLL 56

Query: 533 SKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL-DWRKRFNIIEGIS 591
            +L H N+++ L   +E  E  ++ E      L  ++    K++RL   R  +     + 
Sbjct: 57  KQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC 116

Query: 592 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFG 651
             L ++H  S+ RI+HRD+K +N+ +      K+ D G+ + F      A +  +VGT  
Sbjct: 117 SALEHMH--SK-RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPY 171

Query: 652 YMSPEYAMEGRFSEKSDVFSFGVLLLEI 679
           YMSPE   E  ++ KSD++S G LL E+
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 91.8 bits (228), Expect = 2e-20
 Identities = 68/232 (29%), Positives = 114/232 (49%), Gaps = 25/232 (10%)

Query: 490 LGQGGFGPVYWG-RLKDGQEIAVKRLS---------KASGQGLEEFMN-EVMVISKLQHR 538
           +G+G +G VY    +  G+ +AVK++           +  + + + +  E+  +  L H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 539 NLVRLLGCCVEGEEKMLIY-EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 597
           N+V+ LG     EE + I+ EY+P  S+ + L    + E     + F   E +  GL YL
Sbjct: 69  NIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEE-QLVRFFT--EQVLEGLAYL 124

Query: 598 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEY 657
           H      I+HRDLKA N+L+D +   KISDFG++K      D      + G+  +M+PE 
Sbjct: 125 HSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181

Query: 658 AMEGR--FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENK 707
                  +S K D++S G ++LE+ +GR+  S    D   +   +KL N+  
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWS----DEEAIAAMFKLGNKRS 229

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 91.9 bits (228), Expect = 2e-20
 Identities = 67/206 (32%), Positives = 106/206 (51%), Gaps = 24/206 (11%)

Query: 490 LGQGGFGPVYWGRL-----KDGQEIAVKRLSKASGQG-LEEFMNEVMVISKLQHRNLVRL 543
           LG+G FG V   R        G+++AVK L   SG   + +   E+ ++  L H N+V+ 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 544 LGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
            G C E       LI E++P+ SL   L  P  K +++ +++      I +G+ YL   S
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYL--GS 127

Query: 602 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ------DQADTGRVVGTFGYMSP 655
           R + +HRDL A N+L++ E   KI DFG+ K    ++      D  D+      F Y +P
Sbjct: 128 R-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDS----PVFWY-AP 181

Query: 656 EYAMEGRFSEKSDVFSFGVLLLEIVS 681
           E  ++ +F   SDV+SFGV L E+++
Sbjct: 182 ECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 92.7 bits (230), Expect = 2e-20
 Identities = 62/200 (31%), Positives = 113/200 (56%), Gaps = 16/200 (8%)

Query: 490 LGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRL 543
           LG G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ + + ++ RL
Sbjct: 15  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74

Query: 544 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 603
           LG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ YL      
Sbjct: 75  LGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER--- 128

Query: 604 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD--QADTGRVVGTFGYMSPEYAMEG 661
           R++HRDL A N+L+    + KI+DFG+AK+ G ++    A+ G+V     +M+ E  +  
Sbjct: 129 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKV--PIKWMALESILHR 186

Query: 662 RFSEKSDVFSFGVLLLEIVS 681
            ++ +SDV+S+GV + E+++
Sbjct: 187 IYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 92.1 bits (228), Expect = 2e-20
 Identities = 57/195 (29%), Positives = 106/195 (54%), Gaps = 10/195 (5%)

Query: 489 KLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC 547
           K+GQG  G V+    +  GQE+A+K+++       E  +NE++V+ +L++ N+V  L   
Sbjct: 26  KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85

Query: 548 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 607
           + G+E  ++ EY+   SL     D + +  +D  +   +     + L +LH +   ++IH
Sbjct: 86  LVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRECLQALEFLHAN---QVIH 138

Query: 608 RDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKS 667
           RD+K+ N+LL  + + K++DFG        Q +  T  +VGT  +M+PE      +  K 
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKV 196

Query: 668 DVFSFGVLLLEIVSG 682
           D++S G++ +E+V G
Sbjct: 197 DIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 92.2 bits (229), Expect = 3e-20
 Identities = 68/209 (32%), Positives = 99/209 (47%), Gaps = 14/209 (6%)

Query: 482 NNFQLSSKLGQGGFGPVY----WGRLKDGQ--EIAVKRL-SKASGQGLEEFMNEVMVISK 534
           NN      LG G FG V     +G  K     ++AVK L   A     E  M+E+ ++S 
Sbjct: 35  NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94

Query: 535 L-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER-LDWRKRFNIIEGISR 592
           L  H N+V LLG C  G   ++I EY      D L F   K+E  L      +    +++
Sbjct: 95  LGNHENIVNLLGACTIGGPILVITEYC--CYGDLLNFLRRKRESFLTLEDLLSFSYQVAK 152

Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 652
           G+ +L   +    IHRDL A N+LL      KI DFG+A+    + +    G       +
Sbjct: 153 GMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKW 209

Query: 653 MSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           M+PE      ++ +SDV+S+G+LL EI S
Sbjct: 210 MAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 92.1 bits (228), Expect = 3e-20
 Identities = 63/198 (31%), Positives = 104/198 (52%), Gaps = 19/198 (9%)

Query: 489 KLGQGGFGPVYWGR-LKDGQEIAVKRLS---KASGQGLEEFMNEVMVISKLQHRNLVRLL 544
           ++G G FG VY+ R ++  + +A+K++S   K S +  ++ + EV  + +++H N +   
Sbjct: 32  EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYK 91

Query: 545 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 604
           GC +      L+ EY    + D L    + K+ L   +   I  G  +GL YLH  +   
Sbjct: 92  GCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHSHN--- 145

Query: 605 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM---EG 661
           +IHRD+KA NILL E    K++DFG A I       +     VGT  +M+PE  +   EG
Sbjct: 146 MIHRDIKAGNILLTEPGQVKLADFGSASI------ASPANSFVGTPYWMAPEVILAMDEG 199

Query: 662 RFSEKSDVFSFGVLLLEI 679
           ++  K DV+S G+  +E+
Sbjct: 200 QYDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 91.6 bits (228), Expect = 4e-20
 Identities = 64/234 (27%), Positives = 114/234 (48%), Gaps = 43/234 (18%)

Query: 479 TATNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEF----MNEVMVIS 533
           +   ++++  KLG+G FG VY  R +K G+ +A+K++   + +  + F    + E+ ++ 
Sbjct: 5   SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK--DGFPITALREIKILK 62

Query: 534 KLQHRNLVRLLGCCVE-----GEEKMLIYEYMP--NRSLDALLFDPLKKERLDWRKRF-- 584
           KL+H N+V L+   VE       ++  +Y   P  +  L  LL +P          +   
Sbjct: 63  KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENP--------SVKLTE 114

Query: 585 ----NIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF------ 634
                 +  +  G+ YLH +    I+HRD+KA+NIL+D +   KI+DFG+A+ +      
Sbjct: 115 SQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPN 171

Query: 635 ----GGNQDQADTGRVVGTFGYMSPEYAM-EGRFSEKSDVFSFGVLLLEIVSGR 683
               GG   +  T  VV T  Y  PE  + E R++   D++  G +  E+ + R
Sbjct: 172 PKGGGGGGTRKYTNLVV-TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 90.0 bits (223), Expect = 5e-20
 Identities = 64/203 (31%), Positives = 107/203 (52%), Gaps = 14/203 (6%)

Query: 489 KLGQGGFGPVYWG--RLKDGQ-EIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNLVRLL 544
           +LG G FG V  G  +++  Q ++A+K L   + + + +E M E  ++ +L +  +VR++
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 545 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 604
           G C E E  ML+ E      L+  L    KK+ +       ++  +S G+ YL   +   
Sbjct: 62  GVC-EAEALMLVMEMASGGPLNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN--- 115

Query: 605 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMSPEYAMEGR 662
            +HRDL A N+LL  +   KISDFG++K  G + D     R  G +   + +PE     +
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGAD-DSYYKARSAGKWPLKWYAPECINFRK 174

Query: 663 FSEKSDVFSFGVLLLEIVS-GRK 684
           FS +SDV+S+G+ + E  S G+K
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQK 197

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 90.8 bits (225), Expect = 6e-20
 Identities = 66/229 (28%), Positives = 109/229 (47%), Gaps = 35/229 (15%)

Query: 483 NFQLSSKLGQGGFGPVYWG---RLKDG---QEIAVKRLSKASGQG-LEEFMNEVMVISKL 535
           N  L   LG+G FG V      RLK       +AVK L + +    L + ++E  ++ ++
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60

Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLK--------------------- 574
            H ++++L G C +    +LI EY    SL + L +  K                     
Sbjct: 61  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120

Query: 575 KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 634
           +  L      +    ISRG+ YL   + ++++HRDL A N+L+ E    KISDFG+++  
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177

Query: 635 GGNQDQADTGRVVGTF--GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
              ++ +   R  G     +M+ E   +  ++ +SDV+SFGVLL EIV+
Sbjct: 178 --YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 89.7 bits (222), Expect = 1e-19
 Identities = 66/212 (31%), Positives = 111/212 (52%), Gaps = 21/212 (9%)

Query: 486 LSSKLGQGGFGPVYWGRLKDGQEI---AVKRLSKA--SGQGLEEFMNEVMVISKLQHRNL 540
           L   LG+G FG V  G+L     I   AVK +  A  +   +E+F++E + + +  H N+
Sbjct: 3   LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNV 62

Query: 541 VRLLGCCVEGEEK------MLIYEYMPNRSLDA-LLFDPL--KKERLDWRKRFNIIEGIS 591
           +RL+G C++  E       ++I  +M +  L + LL+  L    + L  +     +  I+
Sbjct: 63  MRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIA 122

Query: 592 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA-KIFGGNQDQADTGRVVGT- 649
            G+ YL   S    IHRDL A N +L+E +N  ++DFG++ KI+ G  D    GR+    
Sbjct: 123 SGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNG--DYYRQGRIAKMP 177

Query: 650 FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
             +++ E   +  ++ KSDV+SFGV + EI +
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTMWEIAT 209

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 89.6 bits (222), Expect = 1e-19
 Identities = 64/207 (30%), Positives = 105/207 (50%), Gaps = 17/207 (8%)

Query: 489 KLGQGGFGPVYWGRLKD---GQ---EIAVKRLSK-ASGQGLEEFMNEVMVISKLQHRNLV 541
           +LGQG FG VY G  +D   G+    +AVK +++ AS +   EF+NE  V+      ++V
Sbjct: 13  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72

Query: 542 RLLGCCVEGEEKMLIYEYMPN-------RSLDALLFDPLKKERLDWRKRFNIIEGISRGL 594
           RLLG   +G+  +++ E M +       RSL     +   +     ++   +   I+ G+
Sbjct: 73  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132

Query: 595 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 654
            YL+     + +HRDL A N ++  +   KI DFGM +           G+ +    +M+
Sbjct: 133 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189

Query: 655 PEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           PE   +G F+  SD++SFGV+L EI S
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 89.8 bits (223), Expect = 2e-19
 Identities = 66/207 (31%), Positives = 104/207 (50%), Gaps = 19/207 (9%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEE---FMNEVMVISKLQH 537
            +FQ+ +++GQGG+G V+  + KD  EI A+KR+ K+    L E    + E  +++  + 
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60

Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDP--LKKERLDWRKRFNIIEGISRGLL 595
             LV+LL    + E   L  EY+P      LL +   L ++      RF + E     + 
Sbjct: 61  EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDH----ARFYMAEMFE-AVD 115

Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 655
            LH    L  IHRDLK  N L+D   + K++DFG++K   G    A++  VVG+  YM+P
Sbjct: 116 ALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSK---GIVTYANS--VVGSPDYMAP 167

Query: 656 EYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           E      +    D +S G +L E + G
Sbjct: 168 EVLRGKGYDFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 88.2 bits (218), Expect = 2e-19
 Identities = 71/225 (31%), Positives = 112/225 (49%), Gaps = 31/225 (13%)

Query: 483 NFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRL-----SKASGQGLEEFMNEVMVISKLQ 536
           N++L   LGQG FG VY     D G+E+AVK++     S  + + +     E+ ++  L 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 537 HRNLVRLLGCCVEGEEKML--IYEYMPNRSLDALLFDPLKK-----ERLDWRKRFNIIEG 589
           H  +V+  GC  +  E+ L    E+MP  S+     D LK      E +  +    I+EG
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGGSIK----DQLKSYGALTENVTRKYTRQILEG 118

Query: 590 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG----R 645
           +S    YLH +    I+HRD+K +NIL D   N K+ DFG +K     Q    +G     
Sbjct: 119 VS----YLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRL---QTICLSGTGMKS 168

Query: 646 VVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFE 690
           V GT  +MSPE      +  K+D++S G  ++E+++ +   + FE
Sbjct: 169 VTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE 213

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 88.9 bits (221), Expect = 3e-19
 Identities = 56/212 (26%), Positives = 105/212 (49%), Gaps = 25/212 (11%)

Query: 483 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKR--LSKASGQGLEEFMNEVMVISKLQHRN 539
            +++  ++G+G  G V+  +  + G+ +A+K+  L +  G    + + E+  +   QH  
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60

Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD---PLKKERLDWRKRFNIIEGISRGLL- 595
           +V+LL     G   +L+ EYMP   L  +L D   PL +           ++   R LL 
Sbjct: 61  VVKLLDVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEA---------QVKSYMRMLLK 110

Query: 596 ---YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 652
              Y+H      I+HRDLK +N+L+  +   KI+DFG+A++F   + +  + + V T  Y
Sbjct: 111 GVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWY 166

Query: 653 MSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 683
            +PE     R +    D+++ G +  E+++G 
Sbjct: 167 RAPELLYGARKYDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 89.3 bits (221), Expect = 3e-19
 Identities = 63/198 (31%), Positives = 101/198 (51%), Gaps = 19/198 (9%)

Query: 489 KLGQGGFGPVYWGRLKDGQEI-AVKRLS---KASGQGLEEFMNEVMVISKLQHRNLVRLL 544
           ++G G FG VY+       E+ AVK++S   K + +  ++ + EV  + +L+H N +   
Sbjct: 28  EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87

Query: 545 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 604
           GC ++     L+ EY    + D L    + K+ L   +   I  G  +GL YLH  +   
Sbjct: 88  GCYLKEHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHSHN--- 141

Query: 605 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM---EG 661
           +IHRD+KA NILL E    K++DFG A         +     VGT  +M+PE  +   EG
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSASK------SSPANSFVGTPYWMAPEVILAMDEG 195

Query: 662 RFSEKSDVFSFGVLLLEI 679
           ++  K DV+S G+  +E+
Sbjct: 196 QYDGKVDVWSLGITCIEL 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 88.6 bits (219), Expect = 3e-19
 Identities = 58/195 (29%), Positives = 105/195 (53%), Gaps = 10/195 (5%)

Query: 489 KLGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC 547
           K+GQG  G VY    +  GQE+A+K+++       E  +NE++V+ + ++ N+V  L   
Sbjct: 26  KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85

Query: 548 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 607
           + G+E  ++ EY+   SL     D + +  +D  +   +     + L +LH +   ++IH
Sbjct: 86  LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALDFLHSN---QVIH 138

Query: 608 RDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKS 667
           RD+K+ NILL  + + K++DFG        Q +  T  +VGT  +M+PE      +  K 
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKV 196

Query: 668 DVFSFGVLLLEIVSG 682
           D++S G++ +E+V G
Sbjct: 197 DIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 87.8 bits (218), Expect = 4e-19
 Identities = 65/212 (30%), Positives = 101/212 (47%), Gaps = 25/212 (11%)

Query: 483 NFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKA---SGQGLEEFMNEVMVISKLQHR 538
           +F+L   +G+G FG V   + +D +++ A+K ++K        +   +NE  ++ +L H 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----FDPLKKERLD-WRKRFNIIEGISR 592
            LV L     + EE M    Y+    +D LL     +   +K +    + +F I E I  
Sbjct: 61  FLVNLWYS-FQDEENM----YL---VVDLLLGGDLRYHLSQKVKFSEEQVKFWICE-IVL 111

Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 652
            L YLH      IIHRD+K  NILLDE+ +  I+DF +A           T    GT GY
Sbjct: 112 ALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKV---TPDTLTTSTSGTPGY 165

Query: 653 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRK 684
           M+PE      +S   D +S GV   E + G++
Sbjct: 166 MAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 87.7 bits (218), Expect = 4e-19
 Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 30/210 (14%)

Query: 490 LGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQG---LEEFMNEVMVISKLQHRNLVRLLG 545
           + +G +G V+  + K  G   A+K + KA       +++ + E  ++S+ Q   +V+L  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59

Query: 546 CCVEGEEKM-LIYEYMPNRSLDALL-----FDPLKKERLDWRKRFNIIEGISRGLLYLHR 599
              +G++ + L+ EY+P   L +LL      D       D  +    I  I   L YLH 
Sbjct: 60  YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDE------DVAR--IYIAEIVLALEYLHS 111

Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ-------ADTGRVVGTFGY 652
                IIHRDLK  NIL+D   + K++DFG++K  G  + Q        +  R+VGT  Y
Sbjct: 112 ---NGIIHRDLKPDNILIDSNGHLKLTDFGLSK-VGLVRRQINLNDDEKEDKRIVGTPDY 167

Query: 653 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           ++PE  +    S+  D +S G +L E + G
Sbjct: 168 IAPEVILGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 87.9 bits (218), Expect = 5e-19
 Identities = 56/198 (28%), Positives = 102/198 (51%), Gaps = 16/198 (8%)

Query: 489 KLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC 547
           K+G+G  G V     K  G+++AVK++     Q  E   NEV+++   QH N+V +    
Sbjct: 26  KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY 85

Query: 548 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 607
           + G+E  ++ E++   +L     D +   R++  +   +   + + L +LH      +IH
Sbjct: 86  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLAVLKALSFLHAQ---GVIH 138

Query: 608 RDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR---VVGTFGYMSPEYAMEGRFS 664
           RD+K+ +ILL  +   K+SDFG    F   Q   +  R   +VGT  +M+PE      + 
Sbjct: 139 RDIKSDSILLTSDGRVKLSDFG----FCA-QVSKEVPRRKSLVGTPYWMAPEVISRLPYG 193

Query: 665 EKSDVFSFGVLLLEIVSG 682
            + D++S G++++E+V G
Sbjct: 194 TEVDIWSLGIMVIEMVDG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 87.7 bits (217), Expect = 5e-19
 Identities = 63/200 (31%), Positives = 105/200 (52%), Gaps = 16/200 (8%)

Query: 490 LGQGGFGPVYWG-RLKDGQEI----AVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRL 543
           LG G FG V+ G  + +G  I    A+K +   SG Q  +E  + ++ +  L H  +VRL
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74

Query: 544 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER--LDWRKRFNIIEGISRGLLYLHRDS 601
           LG C  G    L+ +  P  SL     D +++ R  LD ++  N    I++G+ YL    
Sbjct: 75  LGIC-PGASLQLVTQLSPLGSL----LDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH- 128

Query: 602 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 661
             R++HR+L A NILL  +   +I+DFG+A +   +  +           +M+ E  + G
Sbjct: 129 --RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG 186

Query: 662 RFSEKSDVFSFGVLLLEIVS 681
           R++ +SDV+S+GV + E++S
Sbjct: 187 RYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 87.0 bits (215), Expect = 6e-19
 Identities = 71/222 (31%), Positives = 112/222 (50%), Gaps = 25/222 (11%)

Query: 483 NFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRL-----SKASGQGLEEFMNEVMVISKLQ 536
           N++L   LG+G FG VY     D G+E+AVK++     S+ + + +     E+ ++  L+
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 537 HRNLVRLLGCCVEGEEKML--IYEYMPNRSLDALLFDPLK-----KERLDWRKRFNIIEG 589
           H  +V+  GC  + EEK L    EYMP  S+     D LK      E +  R    I++G
Sbjct: 63  HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIK----DQLKAYGALTENVTRRYTRQILQG 118

Query: 590 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK-IFGGNQDQADTGRVVG 648
           +S    YLH +    I+HRD+K +NIL D   N K+ DFG +K I            V G
Sbjct: 119 VS----YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTG 171

Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFE 690
           T  +MSPE      +  K+DV+S    ++E+++ +   + +E
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE 213

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 87.1 bits (216), Expect = 6e-19
 Identities = 62/200 (31%), Positives = 106/200 (53%), Gaps = 13/200 (6%)

Query: 490 LGQGGFGPVYWGRL--KDGQEI--AVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRLL 544
           +G+G FG VY G L   DGQ+I  AVK L++ +  + +E+F+ E +++    H N++ LL
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 545 GCCVEGE-EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 603
           G C+  E   +++  YM +  L   +        +     F +   +++G+ YL   +  
Sbjct: 63  GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGL--QVAKGMEYL---ASK 117

Query: 604 RIIHRDLKASNILLDEELNPKISDFGMAK-IFGGNQDQADTGRVVG-TFGYMSPEYAMEG 661
           + +HRDL A N +LDE    K++DFG+A+ I+                  +M+ E     
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ 177

Query: 662 RFSEKSDVFSFGVLLLEIVS 681
           +F+ KSDV+SFGVLL E+++
Sbjct: 178 KFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 87.4 bits (216), Expect = 7e-19
 Identities = 61/208 (29%), Positives = 110/208 (52%), Gaps = 15/208 (7%)

Query: 484 FQLSSKLGQGGFGPVYWG---RLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 540
           F    ++G+G FG V+ G   R +    I +  L +A  + +E+   E+ V+S+     +
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYV 64

Query: 541 VRLLGCCVEGEEKMLIYEYMPNRS-LDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 599
            +  G  ++G +  +I EY+   S LD L   P  + ++       +++ I +GL YLH 
Sbjct: 65  TKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIA-----TMLKEILKGLDYLHS 119

Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 659
           + +   IHRD+KA+N+LL E+ + K++DFG+A      Q + +T   VGT  +M+PE   
Sbjct: 120 EKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQ 174

Query: 660 EGRFSEKSDVFSFGVLLLEIVSGRKNTS 687
           +  +  K+D++S G+  +E+  G    S
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPPNS 202

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain

 Score = 80.8 bits (200), Expect = 7e-19
 Identities = 28/66 (42%), Positives = 37/66 (56%), Gaps = 6/66 (9%)

Query: 335 GKEDGFSKLNKMKVPDFTEWT--SPATEDECREQCLKNCSCIAYAFD---GGIGCMVWRS 389
           G  DGF +L  MK+PD T           EC ++CL NCSC AYA+    GG GC++W  
Sbjct: 2   GGGDGFLRLPNMKLPDTTAAIVDRSIGLKECEQRCLSNCSCTAYAYADIRGGSGCLIWTG 61

Query: 390 INLIDI 395
             L+D+
Sbjct: 62  -ELVDM 66

Length = 66

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 87.6 bits (218), Expect = 7e-19
 Identities = 69/214 (32%), Positives = 104/214 (48%), Gaps = 33/214 (15%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKA----SGQGLEEFMNEVMVISKLQ 536
           ++F+    LG G FG V   R K   +  A+K LSKA      Q +E  +NE  ++  ++
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIR 59

Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR---- 592
           H  LV L G   +     L+ EY+P   L    F  L+K       RF   E ++R    
Sbjct: 60  HPFLVNLYGSFQDDSNLYLVMEYVPGGEL----FSHLRKSG-----RFP--EPVARFYAA 108

Query: 593 ----GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 648
                L YLH    L I++RDLK  N+LLD +   KI+DFG AK   G      T  + G
Sbjct: 109 QVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----TYTLCG 160

Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           T  Y++PE  +   + +  D ++ G+L+ E+++G
Sbjct: 161 TPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 87.5 bits (216), Expect = 8e-19
 Identities = 57/196 (29%), Positives = 108/196 (55%), Gaps = 12/196 (6%)

Query: 489 KLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC 547
           K+GQG  G VY    +  GQE+A+++++       E  +NE++V+ + ++ N+V  L   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86

Query: 548 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 607
           + G+E  ++ EY+   SL     D + +  +D  +   +     + L +LH +   ++IH
Sbjct: 87  LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 139

Query: 608 RDLKASNILLDEELNPKISDFGM-AKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEK 666
           RD+K+ NILL  + + K++DFG  A+I     +Q+    +VGT  +M+PE      +  K
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196

Query: 667 SDVFSFGVLLLEIVSG 682
            D++S G++ +E++ G
Sbjct: 197 VDIWSLGIMAIEMIEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 87.1 bits (216), Expect = 8e-19
 Identities = 61/218 (27%), Positives = 109/218 (50%), Gaps = 31/218 (14%)

Query: 484 FQLSSKLGQGGFGPVYWGRLKDG-----QEIAVKRLSK-ASGQGLEEFMNEVMVISKLQH 537
             LS  L +G FG +++G L D      +E+ VK +   AS   +   + E  ++  L H
Sbjct: 8   VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSH 67

Query: 538 RNLVRLLGCCVEGEEK-MLIYEYMPNRSLDALLFDP-----LKKERLDWRKRFNIIEGIS 591
           +N++ +L  C+E  E   ++Y YM   +L   L           + L  ++  ++   I+
Sbjct: 68  QNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIA 127

Query: 592 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK-IF-------GGNQDQADT 643
            G+ YLH+     +IH+D+ A N ++DEEL  KI+D  +++ +F       G N+++   
Sbjct: 128 CGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRP-- 182

Query: 644 GRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
                   +M+ E  +   +S  SDV+SFGVLL E+++
Sbjct: 183 ------VKWMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 86.6 bits (215), Expect = 1e-18
 Identities = 55/206 (26%), Positives = 100/206 (48%), Gaps = 25/206 (12%)

Query: 484 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 542
           ++L  ++G G +G VY  R +  G+ +A+K +    G   E    E+ ++ + +H N+V 
Sbjct: 5   YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64

Query: 543 LLGCCVEGEEKMLIYEYMPNRSLDAL---LFDPLKKERLDWRKRFNIIEGISR----GLL 595
             G  +  ++  ++ EY    SL  +      PL + +         I  + R    GL 
Sbjct: 65  YFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQ---------IAYVCRETLKGLA 115

Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 655
           YLH       IHRD+K +NILL E+ + K++DFG++        +  +   +GT  +M+P
Sbjct: 116 YLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS--FIGTPYWMAP 170

Query: 656 EYA---MEGRFSEKSDVFSFGVLLLE 678
           E A    +G +  K D+++ G+  +E
Sbjct: 171 EVAAVERKGGYDGKCDIWALGITAIE 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 87.0 bits (215), Expect = 1e-18
 Identities = 62/206 (30%), Positives = 111/206 (53%), Gaps = 21/206 (10%)

Query: 484 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 542
           +++  +LG G FG VY  + K+ G   A K +   S + LE++M E+ +++   H  +V+
Sbjct: 14  WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVK 73

Query: 543 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL----YLH 598
           LLG      +  ++ E+ P  ++DA++ +      LD       I+ I R +L    YLH
Sbjct: 74  LLGAFYWDGKLWIMIEFCPGGAVDAIMLE------LDRGLTEPQIQVICRQMLEALQYLH 127

Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 658
               ++IIHRDLKA N+LL  + + K++DFG++        + D+   +GT  +M+PE  
Sbjct: 128 S---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS--FIGTPYWMAPEVV 182

Query: 659 M-----EGRFSEKSDVFSFGVLLLEI 679
           M     +  +  K+D++S G+ L+E+
Sbjct: 183 MCETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 86.1 bits (213), Expect = 1e-18
 Identities = 77/285 (27%), Positives = 133/285 (46%), Gaps = 47/285 (16%)

Query: 490 LGQGGFGPVYWGRLK--DGQE--IAVKRL-SKASGQGLEEFMNEVMVISKLQHRNLVRLL 544
           LG G FG +  G LK    +E  +A+  L +  S +    F+ E + + +  H N+VRL 
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72

Query: 545 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKE-RLDWRKRFNIIEGISRGLLYLHRDSRL 603
           G    G   M++ EYM N +LD+ L    K E +L   +   ++ G++ G+ YL   S +
Sbjct: 73  GVITRGNTMMIVTEYMSNGALDSFL---RKHEGQLVAGQLMGMLPGLASGMKYL---SEM 126

Query: 604 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFG------YMSPEY 657
             +H+ L A  +L++ +L  KIS F         +D+++   +  T        + +PE 
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFRR-----LQEDKSEA--IYTTMSGKSPVLWAAPEA 179

Query: 658 AMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS 717
                FS  SDV+SFG+++ E++      S+ E         W +  ++ I A+      
Sbjct: 180 IQYHHFSSASDVWSFGIVMWEVM------SYGERPY------WDMSGQDVIKAV------ 221

Query: 718 ESSFQLDMIIRC---IHVGLL-CVQELVKDRPNMSTVVSMLNSEI 758
           E  F+L     C   +H  +L C Q+   +RP  S + S+L+  +
Sbjct: 222 EDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKMV 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 85.8 bits (212), Expect = 2e-18
 Identities = 68/203 (33%), Positives = 98/203 (48%), Gaps = 17/203 (8%)

Query: 486 LSSKLGQGGFGPVYW---------GRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ 536
           L  +LG+G FG VY           RLK  +EI V  L+        +   E  ++SKL 
Sbjct: 4   LQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNE---TVQANQEAQLLSKLD 60

Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 596
           H  +V+     +E +   +I EY   R LD  L +     +     +  + E   + LL 
Sbjct: 61  HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQ--VCEWFIQLLLG 118

Query: 597 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 656
           +H   + RI+HRDLKA NI L   L  KI DFG++++  G+ D A T    GT  YMSPE
Sbjct: 119 VHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGTPYYMSPE 175

Query: 657 YAMEGRFSEKSDVFSFGVLLLEI 679
                 +  KSD++S G +L E+
Sbjct: 176 ALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 85.9 bits (212), Expect = 2e-18
 Identities = 80/265 (30%), Positives = 121/265 (45%), Gaps = 35/265 (13%)

Query: 483 NFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRL-----SKASGQGLEEFMNEVMVISKLQ 536
           N++    LGQG FG VY     D G+E+A K++     S  + + +     E+ ++  LQ
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62

Query: 537 HRNLVRLLGCCVEGEEKML--IYEYMPNRSLDALLFDPLK-----KERLDWRKRFNIIEG 589
           H  +V+  GC  +  EK L    EYMP  S+     D LK      E +  +    I+EG
Sbjct: 63  HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVK----DQLKAYGALTESVTRKYTRQILEG 118

Query: 590 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG--RVV 647
           +S    YLH +    I+HRD+K +NIL D   N K+ DFG +K        + TG   V 
Sbjct: 119 MS----YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL-QTICMSGTGIRSVT 170

Query: 648 GTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENK 707
           GT  +MSPE      +  K+DV+S G  ++E+++ +   + +E    I   A +  N   
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNP-- 228

Query: 708 ILALVDPFLSESSFQLDMIIRCIHV 732
                    S  S      + CI V
Sbjct: 229 ------QLPSHISEHARDFLGCIFV 247

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 85.8 bits (212), Expect = 2e-18
 Identities = 60/229 (26%), Positives = 111/229 (48%), Gaps = 20/229 (8%)

Query: 483 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLS---KASGQGLEEFMNEVMVISKLQHR 538
           NFQ+  K+G+G F  VY    L D + +A+K++        +  ++ + E+ ++ +L H 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD-----WRKRFNIIEGISRG 593
           N+++ L   +E  E  ++ E      L  ++    K++RL      W+    +   +   
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE-- 120

Query: 594 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 653
               H  SR R++HRD+K +N+ +      K+ D G+ + F      A +  +VGT  YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173

Query: 654 SPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKL 702
           SPE   E  ++ KSD++S G LL E+ +    + F+ D + +     K+
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAA--LQSPFYGDKMNLFSLCQKI 220

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 86.6 bits (214), Expect = 2e-18
 Identities = 73/225 (32%), Positives = 112/225 (49%), Gaps = 38/225 (16%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRL-KDG--QEIAVKRLSK-ASGQGLEEFMNEVMVISKL-Q 536
           N+ +    +G+G FG V   R+ KDG   + A+KR+ + AS     +F  E+ V+ KL  
Sbjct: 7   NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66

Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER-----------------LD 579
           H N++ LLG C       L  EY P+ +L     D L+K R                 L 
Sbjct: 67  HPNIINLLGACEHRGYLYLAIEYAPHGNL----LDFLRKSRVLETDPAFAIANSTASTLS 122

Query: 580 WRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 639
            ++  +    ++RG+ YL   S+ + IHRDL A NIL+ E    KI+DFG+++     Q+
Sbjct: 123 SQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQE 175

Query: 640 ---QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
              +   GR+     +M+ E      ++  SDV+S+GVLL EIVS
Sbjct: 176 VYVKKTMGRL--PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 86.0 bits (213), Expect = 2e-18
 Identities = 59/188 (31%), Positives = 87/188 (46%), Gaps = 33/188 (17%)

Query: 558 EYMPNRSLDALL--FDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNI 615
           E+M   SLD +     P+  E L       I   +  GL YL+  +  RI+HRD+K SNI
Sbjct: 83  EFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYLY--NVHRIMHRDIKPSNI 135

Query: 616 LLDEELNPKISDFGMAKIFGGN--QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFG 673
           L++     K+ DFG++    G      ADT   VGT  YMSPE    G+++ KSDV+S G
Sbjct: 136 LVNSRGQIKLCDFGVS----GELINSIADT--FVGTSTYMSPERIQGGKYTVKSDVWSLG 189

Query: 674 VLLLEIVSGRKNTSFFEDD-------LTILGYAWKLWNENKILALVDPFLSESSFQ---L 723
           + ++E+  G+   +F   D       + IL    ++  E        P L  S F     
Sbjct: 190 ISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP------PRLPSSDFPEDLR 243

Query: 724 DMIIRCIH 731
           D +  C+ 
Sbjct: 244 DFVDACLL 251

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 85.5 bits (211), Expect = 3e-18
 Identities = 63/202 (31%), Positives = 113/202 (55%), Gaps = 20/202 (9%)

Query: 490 LGQGGFGPVYWG-RLKDGQEI----AVKRLSK-ASGQGLEEFMNEVMVISKLQHRNLVRL 543
           LG G FG VY G  + DG+ +    A+K L +  S +  +E ++E  V++ +    + RL
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74

Query: 544 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLK--KERLDWRKRFNIIEGISRGLLYLHRDS 601
           LG C+    + L+ + MP       L D ++  K+R+  +   N    I++G+ YL    
Sbjct: 75  LGICLTSTVQ-LVTQLMPY----GCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE-- 127

Query: 602 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYMSPEYAM 659
            +R++HRDL A N+L+    + KI+DFG+A++   ++ +  AD G+V     +M+ E  +
Sbjct: 128 -VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV--PIKWMALESIL 184

Query: 660 EGRFSEKSDVFSFGVLLLEIVS 681
             RF+ +SDV+S+GV + E+++
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 85.2 bits (211), Expect = 5e-18
 Identities = 64/206 (31%), Positives = 107/206 (51%), Gaps = 24/206 (11%)

Query: 489 KLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEE------FMNEVMVISKLQHRNLV 541
           K+G+G +G VY GR  K GQ +A+K++   S    EE       + E+ ++ +LQH N+V
Sbjct: 7   KIGEGTYGVVYKGRNKKTGQIVAMKKIRLES----EEEGVPSTAIREISLLKELQHPNIV 62

Query: 542 RLLGCCVEGEEKMLIYEYMP---NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
            L    ++     LI+E++     + LD+L         L     + I++GI    L+ H
Sbjct: 63  CLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGI----LFCH 118

Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 658
                R++HRDLK  N+L+D +   K++DFG+A+ F G   +  T  VV T  Y +PE  
Sbjct: 119 SR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHEVV-TLWYRAPEVL 173

Query: 659 MEG-RFSEKSDVFSFGVLLLEIVSGR 683
           +   R+S   D++S G +  E+ + +
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 85.5 bits (212), Expect = 6e-18
 Identities = 75/212 (35%), Positives = 105/212 (49%), Gaps = 24/212 (11%)

Query: 490 LGQGGFGPVYWGRLKDGQEI-AVKRLSK---ASGQGLEEFMNEVMVISKL-QHRNLVRLL 544
           LG+G FG V    LK   E+ AVK L K        +E  M E  V++   +H  L +L 
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62

Query: 545 GCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDW-RKRFNIIEGISRGLLYLHRDSR 602
             C + ++++  + EY+    L   +F   +  R D  R RF   E I  GL +LH    
Sbjct: 63  -SCFQTKDRLFFVMEYVNGGDL---MFHIQRSGRFDEPRARFYAAE-IVLGLQFLHERG- 116

Query: 603 LRIIHRDLKASNILLDEELNPKISDFGMAK--IFGGNQDQADTGRVVGTFGYMSPEYAME 660
             II+RDLK  N+LLD E + KI+DFGM K  I GG      T    GT  Y++PE    
Sbjct: 117 --IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT----TSTFCGTPDYIAPEILSY 170

Query: 661 GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDD 692
             +    D ++ GVLL E+++G+   S FE D
Sbjct: 171 QPYGPAVDWWALGVLLYEMLAGQ---SPFEGD 199

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 85.3 bits (211), Expect = 7e-18
 Identities = 68/198 (34%), Positives = 96/198 (48%), Gaps = 13/198 (6%)

Query: 490 LGQGGFGPVYWGRLK-DGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQHRNLVRLLG 545
           LG+G FG V   RLK  G+  AVK L K        +E  M E  ++S  ++   +  L 
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 546 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDW-RKRFNIIEGISRGLLYLHRDSRLR 604
           CC +  +++       N     L+F   K  R D  R RF   E  S  L++LH      
Sbjct: 63  CCFQTPDRLFFVMEFVNGG--DLMFHIQKSRRFDEARARFYAAEITS-ALMFLHDKG--- 116

Query: 605 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFS 664
           II+RDLK  N+LLD E + K++DFGM K   G  +   T    GT  Y++PE   E  + 
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEILQEMLYG 174

Query: 665 EKSDVFSFGVLLLEIVSG 682
              D ++ GVLL E++ G
Sbjct: 175 PSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 83.9 bits (207), Expect = 7e-18
 Identities = 65/201 (32%), Positives = 103/201 (51%), Gaps = 17/201 (8%)

Query: 489 KLGQGGFGPV---YWGRLKDGQEIAVKRLSKASGQGL--EEFMNEVMVISKLQHRNLVRL 543
           +LG G FG V    +   K  + +AVK L   +      +E + E  V+ +L +  +VR+
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 544 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 603
           +G C E E  ML+ E      L+  L    K + +  +    ++  +S G+ YL   +  
Sbjct: 62  IGIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN-- 115

Query: 604 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD--QADT-GRVVGTFGYMSPEYAME 660
             +HRDL A N+LL  +   KISDFG++K  G +++  +A T G+      + +PE    
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK--WPVKWYAPECMNY 172

Query: 661 GRFSEKSDVFSFGVLLLEIVS 681
            +FS KSDV+SFGVL+ E  S
Sbjct: 173 YKFSSKSDVWSFGVLMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 84.0 bits (207), Expect = 9e-18
 Identities = 61/203 (30%), Positives = 105/203 (51%), Gaps = 15/203 (7%)

Query: 484 FQLSSKLGQGGFGPVYWG---RLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 540
           F    K+G+G FG V+ G   R +    I +  L +A  + +E+   E+ V+S+     +
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYV 64

Query: 541 VRLLGCCVEGEEKMLIYEYMPNRS-LDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 599
            +  G  ++  +  +I EY+   S LD L   PL + ++       I+  I +GL YLH 
Sbjct: 65  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA-----TILREILKGLDYLHS 119

Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 659
           + +   IHRD+KA+N+LL E    K++DFG+A      Q + +    VGT  +M+PE   
Sbjct: 120 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN--TFVGTPFWMAPEVIK 174

Query: 660 EGRFSEKSDVFSFGVLLLEIVSG 682
           +  +  K+D++S G+  +E+  G
Sbjct: 175 QSAYDSKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 83.6 bits (207), Expect = 2e-17
 Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 24/213 (11%)

Query: 490 LGQGGFGPVYWGRLKD------GQEIAVKRL-SKASGQGLEEFMNEVMVISKL-QHRNLV 541
           LG+G FG V                +AVK L   A+ + L + ++E+ ++  + +H+N++
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79

Query: 542 RLLGCCVEGEEKMLIYEYM-------------PNRSLDALLFDPLKKERLDWRKRFNIIE 588
            LLG C +     ++ EY              P     +       +E L  +   +   
Sbjct: 80  NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139

Query: 589 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 648
            ++RG+ +L   S+ + IHRDL A N+L+ E+   KI+DFG+A+          T     
Sbjct: 140 QVARGMEFL--ASK-KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRL 196

Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
              +M+PE   +  ++ +SDV+SFGVLL EI +
Sbjct: 197 PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 84.2 bits (208), Expect = 2e-17
 Identities = 70/228 (30%), Positives = 118/228 (51%), Gaps = 36/228 (15%)

Query: 482 NNFQLSSKLGQGGFGPVY----WGRLKDGQE----IAVKRLS-KASGQGLEEFMNEVMVI 532
           +   L   LG+G FG V     +G  K   +    +AVK L   A+ + L + ++E+ ++
Sbjct: 12  DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71

Query: 533 SKL-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----------FDPLK--KERL 578
             + +H+N++ LLG C +     +I EY    +L   L           FD  K  +E+L
Sbjct: 72  KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131

Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
            ++   +    ++RG+ YL  +SR R IHRDL A N+L+ E+   KI+DFG+A+   G  
Sbjct: 132 SFKDLVSCAYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLAR---GVH 185

Query: 639 D-----QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           D     +   GR+     +M+PE   +  ++ +SDV+SFG+L+ EI +
Sbjct: 186 DIDYYKKTSNGRL--PVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 83.4 bits (207), Expect = 2e-17
 Identities = 61/219 (27%), Positives = 111/219 (50%), Gaps = 20/219 (9%)

Query: 488 SKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN-----EVMVISKLQHRNLV 541
            KLG+G +  VY  R  + G+ +A+K++     +  ++ +N     E+ ++ +L+H N++
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 542 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
            LL          L++E+M    L+ ++ D  K   L      + +    RGL YLH + 
Sbjct: 66  GLLDVFGHKSNINLVFEFMET-DLEKVIKD--KSIVLTPADIKSYMLMTLRGLEYLHSNW 122

Query: 602 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 661
              I+HRDLK +N+L+  +   K++DFG+A+ F G+ ++  T +VV T  Y +PE     
Sbjct: 123 ---ILHRDLKPNNLLIASDGVLKLADFGLARSF-GSPNRKMTHQVV-TRWYRAPELLFGA 177

Query: 662 R-FSEKSDVFSFGVLLLEIVSGRKNTSFF--EDDLTILG 697
           R +    D++S G +  E++       F   + D+  LG
Sbjct: 178 RHYGVGVDMWSVGCIFAELLLRV---PFLPGDSDIDQLG 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 82.7 bits (205), Expect = 2e-17
 Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 19/209 (9%)

Query: 490 LGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEE-FMNEVMVISKLQHRNLVRLLG 545
           LG GGFG V   ++K   +  A+K + K      G +E   +E  ++ +  H  +V+L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 546 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGLLYLHRDSRL 603
              + +   ++ EY     L    +  L+   L  ++  RF  I  +     YLH     
Sbjct: 61  TFKDKKYIYMLMEYCLGGEL----WTILRDRGLFDEYTARF-YIACVVLAFEYLHN---R 112

Query: 604 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRF 663
            II+RDLK  N+LLD     K+ DFG AK     Q    T    GT  Y++PE  +   +
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGY 169

Query: 664 SEKSDVFSFGVLLLEIVSGRKNTSFFEDD 692
               D +S G+LL E+++GR    F EDD
Sbjct: 170 DFSVDYWSLGILLYELLTGR--PPFGEDD 196

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 84.2 bits (208), Expect = 2e-17
 Identities = 58/217 (26%), Positives = 99/217 (45%), Gaps = 16/217 (7%)

Query: 478 ATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQH 537
             A+  + +   L  G  G V+    K GQ   V  + K  GQ     + E M++  + H
Sbjct: 62  VVASLGYTVIKTLTPGSEGRVFVAT-KPGQPDPV--VLKI-GQKGTTLI-EAMLLQNVNH 116

Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 597
            +++R+    V G    ++   +P+ S D   +   +   L   +   I + I  GL YL
Sbjct: 117 PSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYL 173

Query: 598 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEY 657
           H     RIIHRD+K  NI +++     I D G A+ F      A  G + GT    +PE 
Sbjct: 174 HA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQ-FPVV-APAFLG-LAGTVETNAPEV 227

Query: 658 AMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLT 694
               +++ K+D++S G++L E+++     + FED  +
Sbjct: 228 LARDKYNSKADIWSAGIVLFEMLAYPS--TIFEDPPS 262

Length = 357

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 81.6 bits (202), Expect = 7e-17
 Identities = 61/207 (29%), Positives = 110/207 (53%), Gaps = 17/207 (8%)

Query: 484 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLS-KASGQGL-EEFMNEVMVISKLQHRNL 540
           +Q   K+G+G +G VY  R    G+ +A+K++  +   +G+    + E+ ++ +L H N+
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNI 60

Query: 541 VRLLGCCVEGEEKMLIYEYMP---NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 597
           VRLL       +  L++E++     + +D+     L    +   K +  +  + +G+ Y 
Sbjct: 61  VRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLI---KSY--LYQLLQGIAYC 115

Query: 598 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEY 657
           H  S  R++HRDLK  N+L+D E   K++DFG+A+ FG    +  T  VV T  Y +PE 
Sbjct: 116 H--SH-RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV-RTYTHEVV-TLWYRAPEI 170

Query: 658 AMEGR-FSEKSDVFSFGVLLLEIVSGR 683
            +  R +S   D++S G +  E+V+ R
Sbjct: 171 LLGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 81.3 bits (201), Expect = 7e-17
 Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 20/205 (9%)

Query: 486 LSSKLGQGGFGPVYWGRLKDGQ----EIAVKRLSK-ASGQGLEEFMNEVMVISKLQHRNL 540
           L   +G+G FG VY G     +     +AVK      S    E+F+ E  ++ +  H ++
Sbjct: 10  LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHI 69

Query: 541 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 600
           V+L+G   E     ++ E  P   L + L   + K  LD          +S  L YL   
Sbjct: 70  VKLIGVITE-NPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES- 125

Query: 601 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ----ADTGRVVGTFGYMSPE 656
              R +HRD+ A N+L+      K+ DFG+++     +D+    A  G++     +M+PE
Sbjct: 126 --KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL---EDESYYKASKGKL--PIKWMAPE 178

Query: 657 YAMEGRFSEKSDVFSFGVLLLEIVS 681
                RF+  SDV+ FGV + EI+ 
Sbjct: 179 SINFRRFTSASDVWMFGVCMWEILM 203

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 81.6 bits (201), Expect = 7e-17
 Identities = 54/196 (27%), Positives = 103/196 (52%), Gaps = 12/196 (6%)

Query: 489 KLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC 547
           K+G+G  G V    +K  G+ +AVK++     Q  E   NEV+++   QH N+V +    
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86

Query: 548 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 607
           + G+E  ++ E++   +L     D +   R++  +   +   + + L  LH      +IH
Sbjct: 87  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIH 139

Query: 608 RDLKASNILLDEELNPKISDFGM-AKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEK 666
           RD+K+ +ILL  +   K+SDFG  A++   +++      +VGT  +M+PE      +  +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKSLVGTPYWMAPELISRLPYGPE 196

Query: 667 SDVFSFGVLLLEIVSG 682
            D++S G++++E+V G
Sbjct: 197 VDIWSLGIMVIEMVDG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 80.8 bits (199), Expect = 8e-17
 Identities = 59/210 (28%), Positives = 105/210 (50%), Gaps = 24/210 (11%)

Query: 483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKR--LSKASGQGLEEFMNEVMVISKLQHRN 539
            +++  K+G+G FG +Y  + K D +   +K   L+K   +  E    EV++++K++H N
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSL-------DALLFDPLKKERLDWRKRFNIIEGISR 592
           +V       E     ++ EY     L         +LF   + + L W  +      IS 
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFS--EDQILSWFVQ------ISL 112

Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEE-LNPKISDFGMAKIFGGNQDQADTGRVVGTFG 651
           GL ++H     +I+HRD+K+ NI L +  +  K+ DFG+A+    + + A T   VGT  
Sbjct: 113 GLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT--CVGTPY 167

Query: 652 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           Y+SPE      ++ K+D++S G +L E+ +
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCT 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 81.4 bits (201), Expect = 8e-17
 Identities = 65/213 (30%), Positives = 113/213 (53%), Gaps = 27/213 (12%)

Query: 483 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRN 539
           NFQ   K+G+G +G VY  R    G+ +A+K  RL   +       + E+ ++ +L H N
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 540 LVRLLGCCVEGEEKM-LIYEYMPN---RSLDAL----LFDPLKKERLDWRKRFNIIEGIS 591
           +V+LL   +  E K+ L++E++     + +DA     +  PL K  L     F +++G++
Sbjct: 61  IVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYL-----FQLLQGLA 114

Query: 592 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFG 651
               + H     R++HRDLK  N+L++ E   K++DFG+A+ FG    +  T  VV T  
Sbjct: 115 ----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVV-TLW 165

Query: 652 YMSPEYAMEGRF-SEKSDVFSFGVLLLEIVSGR 683
           Y +PE  +  ++ S   D++S G +  E+V+ R
Sbjct: 166 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 81.2 bits (200), Expect = 9e-17
 Identities = 63/200 (31%), Positives = 101/200 (50%), Gaps = 15/200 (7%)

Query: 490 LGQGGFGPV------YWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRL 543
           LG+GGFG V        G++   +++  KR+ K  G+ +   +NE  ++ K+  R +V L
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNSRFVVSL 65

Query: 544 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 603
                  +   L+   M    L   ++   +    + R  F   E I  GL  LH++   
Sbjct: 66  AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAE-ICCGLEDLHQE--- 121

Query: 604 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRF 663
           RI++RDLK  NILLD+  + +ISD G+A      + Q   GR VGT GYM+PE     R+
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGR-VGTVGYMAPEVVKNERY 178

Query: 664 SEKSDVFSFGVLLLEIVSGR 683
           +   D ++ G LL E+++G+
Sbjct: 179 TFSPDWWALGCLLYEMIAGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 81.6 bits (201), Expect = 9e-17
 Identities = 67/243 (27%), Positives = 121/243 (49%), Gaps = 37/243 (15%)

Query: 465 KLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWG--------RLKDGQEIAVKRLS- 515
           +L + P ++F     + +   L   LG+G FG V           + K+   +AVK L  
Sbjct: 3   ELPEDPRWEF-----SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKD 57

Query: 516 KASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL----- 569
            A+ + L + ++E+ ++  + +H+N++ LLG C +     +I EY    +L   L     
Sbjct: 58  DATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRP 117

Query: 570 ------FD--PLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL 621
                 +D   +  E++ ++   +    ++RG+ YL   +  + IHRDL A N+L+ E  
Sbjct: 118 PGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENN 174

Query: 622 NPKISDFGMAKIFGGNQD---QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLE 678
             KI+DFG+A+    N D   +   GR+     +M+PE   +  ++ +SDV+SFGVL+ E
Sbjct: 175 VMKIADFGLARDV-NNIDYYKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLMWE 231

Query: 679 IVS 681
           I +
Sbjct: 232 IFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 81.2 bits (200), Expect = 9e-17
 Identities = 54/196 (27%), Positives = 103/196 (52%), Gaps = 12/196 (6%)

Query: 489 KLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC 547
           K+G+G  G V     K  G+++AVK++     Q  E   NEV+++    H N+V +    
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88

Query: 548 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 607
           + G+E  ++ E++   +L     D +   R++  +   +   + R L YLH      +IH
Sbjct: 89  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 141

Query: 608 RDLKASNILLDEELNPKISDFGM-AKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEK 666
           RD+K+ +ILL  +   K+SDFG  A++   +++      +VGT  +M+PE      +  +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQV---SKEVPKRKSLVGTPYWMAPEVISRLPYGTE 198

Query: 667 SDVFSFGVLLLEIVSG 682
            D++S G++++E++ G
Sbjct: 199 VDIWSLGIMVIEMIDG 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 80.8 bits (199), Expect = 1e-16
 Identities = 66/280 (23%), Positives = 126/280 (45%), Gaps = 30/280 (10%)

Query: 483 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLS---KASGQGLEEFMNEVMVISKLQHR 538
           NF++  K+G+G F  VY    L DG  +A+K++        +   + + E+ ++ +L H 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALL--FDPLKK---ERLDWRKRFNIIEGISRG 593
           N+++     +E  E  ++ E      L  ++  F   K+   E+  W+    +   +   
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE-- 120

Query: 594 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 653
               H  SR R++HRD+K +N+ +      K+ D G+ + F      A +  +VGT  YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173

Query: 654 SPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVD 713
           SPE   E  ++ KSD++S G LL E+ +    + F+ D + +     K+   +      D
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAA--LQSPFYGDKMNLYSLCKKIEQCDYPPLPSD 231

Query: 714 PFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM 753
            +  E    ++M          C+    + RP+++ V  +
Sbjct: 232 HYSEELRQLVNM----------CINPDPEKRPDITYVYDV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 80.8 bits (200), Expect = 1e-16
 Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 25/213 (11%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN----EVMVISKLQ 536
           N +++   +G+G +G V   R K  G+ +A+K+  K S +  E+       EV V+ +L+
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKF-KES-EDDEDVKKTALREVKVLRQLR 58

Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----FDPLKKERLDWRKRFNIIEGIS 591
           H N+V L           L++EY+    L+ L        P       W+    +++ I+
Sbjct: 59  HENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQ----LLQAIA 114

Query: 592 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFG 651
               Y H      IIHRD+K  NIL+ E    K+ DFG A+          T  V  T  
Sbjct: 115 ----YCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRW 166

Query: 652 YMSPEYAM-EGRFSEKSDVFSFGVLLLEIVSGR 683
           Y +PE  + +  + +  DV++ G ++ E++ G 
Sbjct: 167 YRAPELLVGDTNYGKPVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 81.8 bits (202), Expect = 1e-16
 Identities = 49/163 (30%), Positives = 80/163 (49%), Gaps = 21/163 (12%)

Query: 528 EVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF--N 585
           E+ ++  + H N+V+         E  ++ E+M   SL+               ++F  +
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEG---------THIADEQFLAD 172

Query: 586 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 645
           +   I  G+ YLHR     I+HRD+K SN+L++   N KI+DFG+++I     D  ++  
Sbjct: 173 VARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS- 228

Query: 646 VVGTFGYMSPEYA----MEGRFSEKS-DVFSFGVLLLEIVSGR 683
            VGT  YMSPE        G +   + D++S GV +LE   GR
Sbjct: 229 -VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 80.6 bits (199), Expect = 2e-16
 Identities = 70/208 (33%), Positives = 111/208 (53%), Gaps = 28/208 (13%)

Query: 489 KLGQGGFGPVYWGRLKDGQE-IAVK--RLSKASGQGLEEFMNEVMVISKLQHRNLVRLLG 545
           K+G+G +G VY  R +   E IA+K  RL +         + E+ ++ ++QH N+VRL  
Sbjct: 9   KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68

Query: 546 CCVEGEEKM-LIYEYMPNRSLDALLFDPLKKE---RLDWRKRFNIIEG----ISRGLLYL 597
             V  E+++ L++EY+    LD      LKK      D+ K   +I+     I RG+ Y 
Sbjct: 69  V-VHSEKRLYLVFEYL---DLD------LKKHMDSSPDFAKNPRLIKTYLYQILRGIAYC 118

Query: 598 HRDSRLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 656
           H  S  R++HRDLK  N+L+D   N  K++DFG+A+ F G   +  T  VV T  Y +PE
Sbjct: 119 H--SH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFTHEVV-TLWYRAPE 173

Query: 657 YAMEGR-FSEKSDVFSFGVLLLEIVSGR 683
             +  R +S   D++S G +  E+V+ +
Sbjct: 174 ILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 80.3 bits (199), Expect = 2e-16
 Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 20/208 (9%)

Query: 484 FQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEEFMN--EVMVISKLQ-HRN 539
           +++  +LG G FG VY  R K+  E+ A+K++ K      EE MN  EV  + KL  H N
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKM-KKKFYSWEECMNLREVKSLRKLNEHPN 59

Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER---LDWRKRFNIIEGISRGLLY 596
           +V+L     E +E   ++EYM     +  L+  +K  +          +II  I +GL +
Sbjct: 60  IVKLKEVFRENDELYFVFEYM-----EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114

Query: 597 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 656
           +H+       HRDLK  N+L+      KI+DFG+A+     + +      V T  Y +PE
Sbjct: 115 IHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAR---EIRSRPPYTDYVSTRWYRAPE 168

Query: 657 YAMEGRF-SEKSDVFSFGVLLLEIVSGR 683
             +     S   D+++ G ++ E+ + R
Sbjct: 169 ILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 80.0 bits (198), Expect = 2e-16
 Identities = 64/226 (28%), Positives = 101/226 (44%), Gaps = 32/226 (14%)

Query: 477 LATATNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKL 535
           L   T  F+L   +G+G +G VY  R  K GQ +A+K +        EE   E  ++ K 
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIM-DIIEDEEEEIKEEYNILRKY 59

Query: 536 -QHRNLVRLLGC------CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN--- 585
             H N+    G           ++  L+ E     S+  L+    KK +   R +     
Sbjct: 60  SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGK---RLKEEWIA 116

Query: 586 -IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG 644
            I+    RGL YLH +   ++IHRD+K  NILL +    K+ DFG++      Q  +  G
Sbjct: 117 YILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA-----QLDSTLG 168

Query: 645 R---VVGTFGYMSPE-----YAMEGRFSEKSDVFSFGVLLLEIVSG 682
           R    +GT  +M+PE        +  +  +SDV+S G+  +E+  G
Sbjct: 169 RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 80.8 bits (200), Expect = 3e-16
 Identities = 65/251 (25%), Positives = 106/251 (42%), Gaps = 51/251 (20%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKA----SGQGLEEFMNE--VMVISK 534
           ++F++   +G+G FG V+  R KD  ++ A+K L K+      Q       E  ++  + 
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH-VRAERDILADAD 59

Query: 535 LQHRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLD--WRKRFNIIEGIS 591
                +V+L     + EE + L+ EYMP   L  LL   ++K+        RF I E + 
Sbjct: 60  --SPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLL---IRKDVFPEET-ARFYIAELV- 111

Query: 592 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF-----------GGNQDQ 640
              L L    +L  IHRD+K  NIL+D + + K++DFG+ K               +   
Sbjct: 112 ---LALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLL 168

Query: 641 ADTGR----------------VVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRK 684
                                 VGT  Y++PE      +  + D +S GV+L E++ G  
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGF- 227

Query: 685 NTSFFEDDLTI 695
              F+ D L  
Sbjct: 228 -PPFYSDTLQE 237

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 80.4 bits (199), Expect = 3e-16
 Identities = 60/221 (27%), Positives = 108/221 (48%), Gaps = 34/221 (15%)

Query: 484 FQLSSKLGQGGFGPVYWGRLK---DGQEIAVKRL--SKASGQGLEE-FMNEVMVISKLQH 537
           +++   +G+G +G VY  + K   DG+E A+K+    K    G+ +    E+ ++ +L+H
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61

Query: 538 RNLVRLLGCCVEGEEKM--LIYEYMP---------NRSLDALLFDPLKKERLDWRKRFNI 586
            N+V L+   +E  +K   L+++Y           +R    +   P   + L W+     
Sbjct: 62  ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ----- 116

Query: 587 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMAKIFGGN-QDQA 641
              I  G+ YLH +    ++HRDLK +NIL+  E       KI D G+A++F    +  A
Sbjct: 117 ---ILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLA 170

Query: 642 DTGRVVGTFGYMSPEYAMEGRFSEKS-DVFSFGVLLLEIVS 681
           D   VV T  Y +PE  +  R   K+ D+++ G +  E+++
Sbjct: 171 DLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 80.3 bits (198), Expect = 3e-16
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 19/202 (9%)

Query: 490 LGQGGFGPVYWGRLKDGQEI-AVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLG 545
           LG+G FG V    LK   E+ A+K L K        ++  M E  +++       +  L 
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62

Query: 546 CCVEGEEKML-IYEYMPNRSLDALLFDPLKKERLDW-RKRFNIIEGISRGLLYLHRDSRL 603
           CC + ++++  + EY+    L   +F   +  + D  R RF   E ++  L++LHR    
Sbjct: 63  CCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAE-VTLALMFLHRHG-- 116

Query: 604 RIIHRDLKASNILLDEELNPKISDFGMAK--IFGGNQDQADTGRVVGTFGYMSPEYAMEG 661
            +I+RDLK  NILLD E + K++DFGM K  I  G      T    GT  Y++PE   E 
Sbjct: 117 -VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT----TTTFCGTPDYIAPEILQEL 171

Query: 662 RFSEKSDVFSFGVLLLEIVSGR 683
            +    D ++ GVL+ E+++G+
Sbjct: 172 EYGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 80.4 bits (198), Expect = 3e-16
 Identities = 66/222 (29%), Positives = 112/222 (50%), Gaps = 32/222 (14%)

Query: 486 LSSKLGQGGFGPVYWG--------RLKDGQEIAVKRLSK-ASGQGLEEFMNEVMVISKL- 535
           L   LG+G FG V           +      +AVK L   A+ + L + ++E+ ++  + 
Sbjct: 16  LGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIG 75

Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----------FDPLK--KERLDWRK 582
           +H+N++ LLG C +     ++ EY    +L   L           FD  K  +E+L ++ 
Sbjct: 76  KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135

Query: 583 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD--- 639
             +    ++RG+ YL   +  + IHRDL A N+L+ E+   KI+DFG+A+    N D   
Sbjct: 136 LVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDV-HNIDYYK 191

Query: 640 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           +   GR+     +M+PE   +  ++ +SDV+SFGVLL EI +
Sbjct: 192 KTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 79.3 bits (195), Expect = 3e-16
 Identities = 59/203 (29%), Positives = 108/203 (53%), Gaps = 15/203 (7%)

Query: 484 FQLSSKLGQGGFGPVYWGRLKDGQEIAV-KRLSKASGQGLEEFMNEVMVISKLQHRNLVR 542
           +++  +LG G FG VY  + K+   +A  K +   S + LE++M E+ +++   H N+V+
Sbjct: 7   WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 66

Query: 543 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNII-EGISRGLLYLHRDS 601
           LL          ++ E+    ++DA++   L+ ER     +  ++ +     L YLH + 
Sbjct: 67  LLDAFYYENNLWILIEFCAGGAVDAVM---LELERPLTEPQIRVVCKQTLEALNYLHEN- 122

Query: 602 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM-- 659
             +IIHRDLKA NIL   + + K++DFG++        + D+   +GT  +M+PE  M  
Sbjct: 123 --KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCE 178

Query: 660 ---EGRFSEKSDVFSFGVLLLEI 679
              +  +  K+DV+S G+ L+E+
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 79.8 bits (197), Expect = 4e-16
 Identities = 71/201 (35%), Positives = 102/201 (50%), Gaps = 17/201 (8%)

Query: 490 LGQGGFGPVYWGRLKDGQEI-AVKRLSK---ASGQGLEEFMNEVMVIS-KLQHRNLVRLL 544
           LG+G FG V    LK   E  A+K L K        +E  M E  V++   +H  L  L 
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62

Query: 545 GCCVEGEEKML-IYEYMPNRSLDALLFDPLKKERLD-WRKRFNIIEGISRGLLYLHRDSR 602
            C  + +E +  + EY+    L   +F      R D  R RF   E I  GL +LH+   
Sbjct: 63  -CTFQTKEHLFFVMEYLNGGDL---MFHIQSSGRFDEARARFYAAEIIC-GLQFLHKKG- 116

Query: 603 LRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGR 662
             II+RDLK  N+LLD++ + KI+DFGM K     + +A T    GT  Y++PE     +
Sbjct: 117 --IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST--FCGTPDYIAPEILKGQK 172

Query: 663 FSEKSDVFSFGVLLLEIVSGR 683
           ++E  D +SFGVLL E++ G+
Sbjct: 173 YNESVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 79.3 bits (195), Expect = 4e-16
 Identities = 69/216 (31%), Positives = 105/216 (48%), Gaps = 36/216 (16%)

Query: 490 LGQGGFGPVYWGRLK-DGQEI--AVKRLSK-ASGQGLEEFMNEVMVISKL-QHRNLVRLL 544
           +G+G FG V    +K DG ++  A+K L + AS     +F  E+ V+ KL  H N++ LL
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69

Query: 545 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER-----------------LDWRKRFNII 587
           G C       +  EY P  +L     D L+K R                 L  ++     
Sbjct: 70  GACENRGYLYIAIEYAPYGNL----LDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125

Query: 588 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVV 647
             ++ G+ YL   S  + IHRDL A N+L+ E L  KI+DFG+++      ++    + +
Sbjct: 126 SDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR-----GEEVYVKKTM 177

Query: 648 GTFG--YMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           G     +M+ E      ++ KSDV+SFGVLL EIVS
Sbjct: 178 GRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 79.0 bits (194), Expect = 5e-16
 Identities = 70/216 (32%), Positives = 107/216 (49%), Gaps = 36/216 (16%)

Query: 490 LGQGGFGPVYWGRLK-DGQEI--AVKRLSK-ASGQGLEEFMNEVMVISKL-QHRNLVRLL 544
           +G+G FG V   R+K DG  +  A+KR+ + AS     +F  E+ V+ KL  H N++ LL
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 545 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER-----------------LDWRKRFNII 587
           G C       L  EY P+ +L     D L+K R                 L  ++  +  
Sbjct: 63  GACEHRGYLYLAIEYAPHGNL----LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118

Query: 588 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVV 647
             ++RG+ YL   S+ + IHRDL A NIL+ E    KI+DFG+++       +    + +
Sbjct: 119 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTM 170

Query: 648 GTFG--YMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           G     +M+ E      ++  SDV+S+GVLL EIVS
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 79.1 bits (195), Expect = 5e-16
 Identities = 65/215 (30%), Positives = 111/215 (51%), Gaps = 31/215 (14%)

Query: 483 NFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGL-EEFMNEVMVISKLQHRNL 540
           NF+   KLG+G +  VY GR +   EI A+K +   + +G     + E+ ++ +L+H N+
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60

Query: 541 VRLLGCCVEGEEK-MLIYEYMPNRSLDALLFDPLKK------ER--LDWRKRFNIIEGIS 591
           VRL    +  E K ML++EYM            LKK       R  LD     +    + 
Sbjct: 61  VRLHDV-IHTENKLMLVFEYMDK---------DLKKYMDTHGVRGALDPNTVKSFTYQLL 110

Query: 592 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG--GNQDQADTGRVVGT 649
           +G+ + H +   R++HRDLK  N+L+++    K++DFG+A+ FG   N    +    V T
Sbjct: 111 KGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNE----VVT 163

Query: 650 FGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 683
             Y +P+  +  R +S   D++S G ++ E+++GR
Sbjct: 164 LWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 78.8 bits (194), Expect = 5e-16
 Identities = 67/218 (30%), Positives = 109/218 (50%), Gaps = 28/218 (12%)

Query: 484 FQLSSKLGQGGFGPVYWGRLK----DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQ 536
           F L   LG+G FG V   +LK      Q++AVK L KA   S   +EEF+ E   + +  
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEFD 59

Query: 537 HRNLVRLLGCCVEGEEK------MLIYEYMPNRSLDA-LLFDPLKKE--RLDWRKRFNII 587
           H N+++L+G  +    K      M+I  +M +  L   LL   + +E   L  +     +
Sbjct: 60  HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119

Query: 588 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA-KIFGGN---QDQADT 643
             I+ G+ YL   S    IHRDL A N +L+E +   ++DFG++ KI+ G+   Q  A  
Sbjct: 120 IDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASK 176

Query: 644 GRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
             V     +++ E   +  ++  SDV++FGV + EI++
Sbjct: 177 LPV----KWLALESLADNVYTTHSDVWAFGVTMWEIMT 210

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 79.0 bits (195), Expect = 8e-16
 Identities = 57/190 (30%), Positives = 97/190 (51%), Gaps = 23/190 (12%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEEF----MNEVMVISKLQ 536
           + ++  +K+GQG FG V+  R K  ++I A+K++        E F    + E+ ++  L+
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKV--LMENEKEGFPITALREIKILQLLK 69

Query: 537 HRNLVRLLGCC-----VEGEEKMLIYEYMP--NRSLDALLFDPLKKERLDWRKRFNIIEG 589
           H N+V L+  C          K   Y         L  LL +   K  L   K+  +++ 
Sbjct: 70  HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKK--VMKM 127

Query: 590 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD---TGRV 646
           +  GL Y+HR+   +I+HRD+KA+NIL+ ++   K++DFG+A+ F  +++      T RV
Sbjct: 128 LLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRV 184

Query: 647 VGTFGYMSPE 656
           V T  Y  PE
Sbjct: 185 V-TLWYRPPE 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 78.3 bits (193), Expect = 8e-16
 Identities = 65/213 (30%), Positives = 103/213 (48%), Gaps = 22/213 (10%)

Query: 483 NFQLSSKLGQGGFGPVYW----GRLKDGQEIAVKRLSKAS----GQGLEEFMNEVMVISK 534
           NF+L   LG G +G V+     G    G+  A+K L KA+     +  E    E  V+  
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 535 LQHRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDW-RKRFNIIEGISR 592
           ++    +  L    + + K+ LI +Y+    L   L+   ++E       R  I E I  
Sbjct: 61  VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLY---QREHFTESEVRVYIAE-IVL 116

Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF-GGNQDQADTGRVVGTFG 651
            L +LH+   L II+RD+K  NILLD E +  ++DFG++K F    +++A +    GT  
Sbjct: 117 ALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS--FCGTIE 171

Query: 652 YMSPEYAM--EGRFSEKSDVFSFGVLLLEIVSG 682
           YM+PE      G   +  D +S GVL  E+++G
Sbjct: 172 YMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 78.3 bits (193), Expect = 1e-15
 Identities = 61/218 (27%), Positives = 114/218 (52%), Gaps = 29/218 (13%)

Query: 484 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEF----MNEVMVISKLQHR 538
           F +  ++G+G +G VY  R KD G+ +A+K++   + +  E F    + E+ ++ +L HR
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKILRQLNHR 66

Query: 539 NLVRLLGCCVEGEEKM----------LIYEYMPNRSLDALLFDPLKKERLDWRKRFN--I 586
           N+V L     + ++ +          L++EYM     D  L   L+   + + +      
Sbjct: 67  NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLESGLVHFSEDHIKSF 121

Query: 587 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV 646
           ++ +  GL Y H+ + L   HRD+K SNILL+ +   K++DFG+A+++   + +  T +V
Sbjct: 122 MKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKV 178

Query: 647 VGTFGYMSPEYAM-EGRFSEKSDVFSFGVLLLEIVSGR 683
           + T  Y  PE  + E R+    DV+S G +L E+ + +
Sbjct: 179 I-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 77.6 bits (191), Expect = 1e-15
 Identities = 65/207 (31%), Positives = 104/207 (50%), Gaps = 17/207 (8%)

Query: 484 FQLSSKLGQGGFGPV------YWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQH 537
           F+    LG+GGFG V        G++   +++  KR+ K  G+ +   +NE  ++ K+  
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNS 59

Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 597
           R +V L       +   L+   M    L   +++       + R  F   E I+ GL  L
Sbjct: 60  RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAE-ITCGLEDL 118

Query: 598 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMA-KIFGGNQDQADTGRVVGTFGYMSPE 656
           HR+   RI++RDLK  NILLD+  + +ISD G+A +I  G   +   GR VGT GYM+PE
Sbjct: 119 HRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG---ETIRGR-VGTVGYMAPE 171

Query: 657 YAMEGRFSEKSDVFSFGVLLLEIVSGR 683
                R++   D +  G L+ E++ G+
Sbjct: 172 VVKNERYTFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 78.1 bits (192), Expect = 1e-15
 Identities = 66/221 (29%), Positives = 115/221 (52%), Gaps = 30/221 (13%)

Query: 486 LSSKLGQGGFGPVYW----GRLKDG----QEIAVKRL-SKASGQGLEEFMNEVMVISKL- 535
           L   LG+G FG V      G  K+      ++AVK L S A+ + L + ++E+ ++  + 
Sbjct: 22  LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 81

Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----------FDP--LKKERLDWRK 582
           +H+N++ LLG C +     +I EY    +L   L           ++P  + +E+L ++ 
Sbjct: 82  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141

Query: 583 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG--GNQDQ 640
             +    ++RG+ YL   +  + IHRDL A N+L+ E+   KI+DFG+A+         +
Sbjct: 142 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 198

Query: 641 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
              GR+     +M+PE   +  ++ +SDV+SFGVLL EI +
Sbjct: 199 TTNGRL--PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 77.5 bits (191), Expect = 2e-15
 Identities = 68/202 (33%), Positives = 108/202 (53%), Gaps = 20/202 (9%)

Query: 490 LGQGGFGPVYWGRLK----DGQEIAVKRLSKASGQGLEEF--MNEVMVISKLQHRNLVRL 543
           LGQG FG V+  R       GQ  A+K L KA+ +  +      E  +++++ H  +V+L
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63

Query: 544 LGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGLLYLHRD 600
                + E K+ LI +++  R  D  LF  L KE +  +   +F + E ++  L +LH  
Sbjct: 64  -HYAFQTEGKLYLILDFL--RGGD--LFTRLSKEVMFTEEDVKFYLAE-LALALDHLHS- 116

Query: 601 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
             L II+RDLK  NILLDEE + K++DFG++K       +       GT  YM+PE    
Sbjct: 117 --LGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNR 172

Query: 661 GRFSEKSDVFSFGVLLLEIVSG 682
              ++ +D +SFGVL+ E+++G
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 80.3 bits (198), Expect = 2e-15
 Identities = 73/300 (24%), Positives = 140/300 (46%), Gaps = 25/300 (8%)

Query: 468 DLPLFQFEELATATNNFQLSSK-----LGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQG 521
           +L  F  +   + T N  LSS      + +G  G  Y G+ +K+G +  VK ++  +   
Sbjct: 671 ELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP 730

Query: 522 LEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWR 581
             E  +    + KLQH N+V+L+G C   +   LI+EY+  ++L  +L        L W 
Sbjct: 731 SSEIAD----MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL------RNLSWE 780

Query: 582 KRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA 641
           +R  I  GI++ L +LH      ++  +L    I++D +  P +    +  +        
Sbjct: 781 RRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC-----T 834

Query: 642 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSF-FEDDLTILGYAW 700
           DT   + +  Y++PE       +EKSD++ FG++L+E+++G+      F    +I+ +A 
Sbjct: 835 DTKCFISS-AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWAR 893

Query: 701 KLWNENKILALVDPFLS-ESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIR 759
             +++  +   +DP +  + S   + I+  +++ L C       RP  + V+  L S  R
Sbjct: 894 YCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953

Length = 968

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 76.6 bits (188), Expect = 4e-15
 Identities = 60/212 (28%), Positives = 113/212 (53%), Gaps = 20/212 (9%)

Query: 484 FQLSSKLGQGGFGPVYWGR-LKDGQE-IAVKRLS-KASGQGLE-EFMNEVMVISKLQ--- 536
           ++  +++G+G +G V+  R LK+G   +A+KR+  +   +G+    + EV V+  L+   
Sbjct: 3   YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 62

Query: 537 HRNLVRLLGCCV----EGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGIS 591
           H N+VRL   C     + E K+ L++E++ ++ L   L D + +  +      +++  + 
Sbjct: 63  HPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLL 120

Query: 592 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFG 651
           RGL +LH     R++HRDLK  NIL+      K++DFG+A+I+     Q     VV T  
Sbjct: 121 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLW 174

Query: 652 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           Y +PE  ++  ++   D++S G +  E+   +
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 76.2 bits (187), Expect = 4e-15
 Identities = 59/203 (29%), Positives = 105/203 (51%), Gaps = 19/203 (9%)

Query: 488 SKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQ-GLE-EFMNEVMVISKLQ---HRNLV 541
           +++G G +G VY  R    G  +A+K +   + + GL    + EV ++ +L+   H N+V
Sbjct: 6   AEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIV 65

Query: 542 RLLGCC----VEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 596
           RL+  C     + E K+ L++E++ ++ L   L D +    L      +++    RGL +
Sbjct: 66  RLMDVCATSRTDRETKVTLVFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLRGLDF 123

Query: 597 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 656
           LH +    I+HRDLK  NIL+      K++DFG+A+I+     Q     VV T  Y +PE
Sbjct: 124 LHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYSC---QMALTPVVVTLWYRAPE 177

Query: 657 YAMEGRFSEKSDVFSFGVLLLEI 679
             ++  ++   D++S G +  E+
Sbjct: 178 VLLQSTYATPVDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 76.2 bits (187), Expect = 6e-15
 Identities = 68/202 (33%), Positives = 98/202 (48%), Gaps = 19/202 (9%)

Query: 490 LGQGGFGPVYWGRLK-DGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQHRNLVRLLG 545
           LG+G FG V+   LK   Q  A+K L K        +E  M E  V+S       +  L 
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62

Query: 546 CCVEGEEKML-IYEYMPNRSLDALLFDPLKKERLDW-RKRFNIIEGISRGLLYLHRDSRL 603
           C  + +E +  + EY+    L   +F      + D  R  F   E I  GL +LH     
Sbjct: 63  CTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAE-IICGLQFLHSKG-- 116

Query: 604 RIIHRDLKASNILLDEELNPKISDFGMAK--IFGGNQDQADTGRVVGTFGYMSPEYAMEG 661
            I++RDLK  NILLD + + KI+DFGM K  + G     A T    GT  Y++PE  +  
Sbjct: 117 -IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG----DAKTCTFCGTPDYIAPEILLGQ 171

Query: 662 RFSEKSDVFSFGVLLLEIVSGR 683
           +++   D +SFGVLL E++ G+
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 74.9 bits (184), Expect = 8e-15
 Identities = 58/206 (28%), Positives = 101/206 (49%), Gaps = 27/206 (13%)

Query: 488 SKLGQGGFGPVYWGRLK-DGQEIAVKRL--SKASGQGLEEFMNEVMVISKLQHRNLVRLL 544
            K+G+G FG     + K DG++  +K +  SK S +  EE   EV V+S ++H N+V+  
Sbjct: 6   KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65

Query: 545 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER---------LDWRKRFNIIEGISRGLL 595
               E     ++ +Y     L    +  +  +R         LDW  +      I   L 
Sbjct: 66  ESFEENGNLYIVMDYCEGGDL----YKKINAQRGVLFPEDQILDWFVQ------ICLALK 115

Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 655
           ++H     +I+HRD+K+ NI L ++   K+ DFG+A++     + A T   +GT  Y+SP
Sbjct: 116 HVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART--CIGTPYYLSP 170

Query: 656 EYAMEGRFSEKSDVFSFGVLLLEIVS 681
           E      ++ KSD+++ G +L E+ +
Sbjct: 171 EICENRPYNNKSDIWALGCVLYEMCT 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 75.1 bits (184), Expect = 8e-15
 Identities = 57/205 (27%), Positives = 104/205 (50%), Gaps = 18/205 (8%)

Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 540
           ++++L  ++G G +G VY  R L  G+  AVK +    G        E+ ++ + +H N+
Sbjct: 9   HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNI 68

Query: 541 VRLLGCCVEGEEKMLIYEYMPNRSLDAL--LFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           V   G  +  E+  +  EY    SL  +  +  PL + ++ +  R  +     +GL YLH
Sbjct: 69  VAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLH 123

Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGM-AKIFGGNQDQADTGRVVGTFGYMSPEY 657
              ++   HRD+K +NILL +  + K++DFG+ AKI       A     +GT  +M+PE 
Sbjct: 124 SKGKM---HRDIKGANILLTDNGDVKLADFGVAAKI---TATIAKRKSFIGTPYWMAPEV 177

Query: 658 AM---EGRFSEKSDVFSFGVLLLEI 679
           A     G +++  D+++ G+  +E+
Sbjct: 178 AAVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 75.1 bits (184), Expect = 8e-15
 Identities = 63/216 (29%), Positives = 107/216 (49%), Gaps = 28/216 (12%)

Query: 484 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLV 541
           F+L   +G G +G VY GR +K GQ  A+K +   +G   EE   E+ ++ K   HRN+ 
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTGDEEEEIKQEINMLKKYSHHRNIA 66

Query: 542 RLLGCCVE------GEEKMLIYEYMPNRSLDALLFDP----LKKERLDWRKRFNIIEGIS 591
              G  ++       ++  L+ E+    S+  L+ +     LK+E + +     I   I 
Sbjct: 67  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY-----ICREIL 121

Query: 592 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFG 651
           RGL +LH+    ++IHRD+K  N+LL E    K+ DFG++        + +T   +GT  
Sbjct: 122 RGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPY 176

Query: 652 YMSPEYAM-----EGRFSEKSDVFSFGVLLLEIVSG 682
           +M+PE        +  +  KSD++S G+  +E+  G
Sbjct: 177 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 75.9 bits (187), Expect = 9e-15
 Identities = 62/206 (30%), Positives = 93/206 (45%), Gaps = 16/206 (7%)

Query: 484 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKA---SGQGLEEFMNE---VMVISKLQ 536
           F+  + LG+G FG V     K  G+  A+K L K    +   +E  M E       +  +
Sbjct: 1   FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60

Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 596
           H  LV L  C    +    + EY     L   +   +  E    R  F     +  GL Y
Sbjct: 61  HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP---RAVFYAAC-VVLGLQY 116

Query: 597 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 656
           LH +   +I++RDLK  N+LLD E   KI+DFG+ K   G  D+  T    GT  +++PE
Sbjct: 117 LHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR--TSTFCGTPEFLAPE 171

Query: 657 YAMEGRFSEKSDVFSFGVLLLEIVSG 682
              E  ++   D +  GVL+ E++ G
Sbjct: 172 VLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 75.1 bits (185), Expect = 9e-15
 Identities = 66/205 (32%), Positives = 98/205 (47%), Gaps = 20/205 (9%)

Query: 490 LGQGGFGPVYWGRLKD-GQEIAVKRL-SKASGQGLEEFMNEVMVISKLQH-RNLVRLLGC 546
           +G+G FG V     K  G  +AVKR+ S    +  +  + ++ V+ +      +V+  G 
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71

Query: 547 CV-EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGIS----RGLLYLHRDS 601
              EG+  + + E M + SLD   F     E L       I+  I+    + L YL  + 
Sbjct: 72  LFREGDCWICM-ELM-DISLD--KFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE- 126

Query: 602 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE-YAME 660
            L+IIHRD+K SNILLD   N K+ DFG   I G   D     R  G   YM+PE     
Sbjct: 127 -LKIIHRDVKPSNILLDRNGNIKLCDFG---ISGQLVDSIAKTRDAGCRPYMAPERIDPS 182

Query: 661 GR--FSEKSDVFSFGVLLLEIVSGR 683
            R  +  +SDV+S G+ L E+ +G+
Sbjct: 183 ARDGYDVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 75.8 bits (186), Expect = 1e-14
 Identities = 73/211 (34%), Positives = 106/211 (50%), Gaps = 21/211 (9%)

Query: 490 LGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLG 545
           LG+G FG V    LK  G+  AVK L K        +E  M E  V++       +  L 
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62

Query: 546 CCVEGEEKML-IYEYMPNRSLDALLFDPLKKERLD-WRKRFNIIEGISRGLLYLHRDSRL 603
           C  + +E +  + E++    L   +F    K R D +R  F   E I  GL +LH     
Sbjct: 63  CTFQTKEHLFFVMEFLNGGDL---MFHIQDKGRFDLYRATFYAAE-IVCGLQFLHSKG-- 116

Query: 604 RIIHRDLKASNILLDEELNPKISDFGMAK--IFGGNQDQADTGRVVGTFGYMSPEYAMEG 661
            II+RDLK  N++LD + + KI+DFGM K  +FG N  +A T    GT  Y++PE     
Sbjct: 117 -IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--RAST--FCGTPDYIAPEILQGL 171

Query: 662 RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDD 692
           +++   D +SFGVLL E++ G+  + F  DD
Sbjct: 172 KYTFSVDWWSFGVLLYEMLIGQ--SPFHGDD 200

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 74.9 bits (184), Expect = 1e-14
 Identities = 64/201 (31%), Positives = 101/201 (50%), Gaps = 14/201 (6%)

Query: 490 LGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLG 545
           LG+GGFG V   +++  G+  A K+L+K      +G E  M E  +++K+  R +V L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 546 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDW---RKRFNIIEGISRGLLYLHRDSR 602
                 +  L+   M    L   +++ + +E   +   R  F   + IS GL +LH+   
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYN-VDEENPGFPEPRACFYTAQIIS-GLEHLHQR-- 116

Query: 603 LRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGR 662
            RII+RDLK  N+LLD + N +ISD G+A      Q +  T    GT G+M+PE      
Sbjct: 117 -RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPELLQGEE 173

Query: 663 FSEKSDVFSFGVLLLEIVSGR 683
           +    D F+ GV L E+++ R
Sbjct: 174 YDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 75.0 bits (185), Expect = 1e-14
 Identities = 53/213 (24%), Positives = 101/213 (47%), Gaps = 34/213 (15%)

Query: 484 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN--EVMVISKLQ-HRN 539
           +++  K+G+G F  V   +  K G+  A+K + K   + LE+  N  E+  + +L  H N
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPN 59

Query: 540 LVRLLGCCVEGEEK----------MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEG 589
           ++RL+    + +            M +YE +  R           K  L  ++  + +  
Sbjct: 60  ILRLIEVLFDRKTGRLALVFELMDMNLYELIKGR-----------KRPLPEKRVKSYMYQ 108

Query: 590 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 649
           + + L ++HR+    I HRD+K  NIL+ +++  K++DFG  +  G       T   + T
Sbjct: 109 LLKSLDHMHRNG---IFHRDIKPENILIKDDI-LKLADFGSCR--GIYSKPPYT-EYIST 161

Query: 650 FGYMSPEYAM-EGRFSEKSDVFSFGVLLLEIVS 681
             Y +PE  + +G +  K D+++ G +  EI+S
Sbjct: 162 RWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 74.7 bits (184), Expect = 1e-14
 Identities = 54/206 (26%), Positives = 104/206 (50%), Gaps = 14/206 (6%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEE--FMNEVMVISKLQHR 538
             ++    +G+G +G V   + K+ GQ +A+K+  ++    + +   M E+ ++ +L+H 
Sbjct: 1   EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60

Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           NLV L+      +   L++E++ +  LD L   P   +    RK    +  I RG+ + H
Sbjct: 61  NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRK---YLFQILRGIEFCH 117

Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAK-IFGGNQDQADTGRVVGTFGYMSPEY 657
             +   IIHRD+K  NIL+ +    K+ DFG A+ +    +   D    V T  Y +PE 
Sbjct: 118 SHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD---YVATRWYRAPEL 171

Query: 658 AM-EGRFSEKSDVFSFGVLLLEIVSG 682
            + + ++    D+++ G L+ E+++G
Sbjct: 172 LVGDTKYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 74.8 bits (184), Expect = 2e-14
 Identities = 51/138 (36%), Positives = 70/138 (50%), Gaps = 33/138 (23%)

Query: 558 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGIS----RGLLYLHRDSRLRIIHRDLKAS 613
           E+M   SLD +L    KK     R   NI+  IS    RGL YL R+ + +I+HRD+K S
Sbjct: 79  EHMDGGSLDQVL----KKAG---RIPENILGKISIAVLRGLTYL-RE-KHKIMHRDVKPS 129

Query: 614 NILLDEELNPKISDFG--------MAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSE 665
           NIL++     K+ DFG        MA  F            VGT  YMSPE      ++ 
Sbjct: 130 NILVNSRGEIKLCDFGVSGQLIDSMANSF------------VGTRSYMSPERLQGTHYTV 177

Query: 666 KSDVFSFGVLLLEIVSGR 683
           +SD++S G+ L+E+  GR
Sbjct: 178 QSDIWSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 75.2 bits (185), Expect = 2e-14
 Identities = 62/208 (29%), Positives = 104/208 (50%), Gaps = 18/208 (8%)

Query: 481 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK--ASGQGLEEFMNEVMVISKLQH 537
           TN +     +G G FG V   R    GQ +A+K++ K  ++    +    E+ ++  L+H
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68

Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD-PLKKERLDWRKRFNIIEGISRGLLY 596
            N++ L    +   E +     +    L  LL   PL+K+ + +      +  I RGL Y
Sbjct: 69  ENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQY-----FLYQILRGLKY 123

Query: 597 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 656
           +H      ++HRDLK SNIL++E  + KI DFG+A+I    QD   TG  V T  Y +PE
Sbjct: 124 VHSAG---VVHRDLKPSNILINENCDLKICDFGLARI----QDPQMTG-YVSTRYYRAPE 175

Query: 657 YAME-GRFSEKSDVFSFGVLLLEIVSGR 683
             +   ++  + D++S G +  E++ G+
Sbjct: 176 IMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 74.7 bits (183), Expect = 2e-14
 Identities = 71/226 (31%), Positives = 108/226 (47%), Gaps = 21/226 (9%)

Query: 471 LFQFEELATATNNFQLSSKLGQGGFGPVY-WGRLKDGQEIAVKRLSKASGQGLEEFMNEV 529
           +   E L   T+ +++   +G+G +G VY     KDG   AVK L   S    EE   E 
Sbjct: 11  MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEY 69

Query: 530 MVISKL-QHRNLVRLLGC------CVEGEEKMLIYEYMPNRSLDALLFDPLKK-ERLDWR 581
            ++  L  H N+V+  G        V G+   L+ E     S+  L+   L   +RLD  
Sbjct: 70  NILQSLPNHPNVVKFYGMFYKADKLVGGQ-LWLVLELCNGGSVTELVKGLLICGQRLDEA 128

Query: 582 KRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA 641
               I+ G   GL +LH +   RIIHRD+K +NILL  E   K+ DFG++      + + 
Sbjct: 129 MISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR 185

Query: 642 DTGRVVGTFGYMSPEY-AMEGR----FSEKSDVFSFGVLLLEIVSG 682
           +T   VGT  +M+PE  A E +    +  + DV+S G+  +E+  G
Sbjct: 186 NTS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 74.2 bits (182), Expect = 2e-14
 Identities = 62/201 (30%), Positives = 99/201 (49%), Gaps = 17/201 (8%)

Query: 490 LGQGGFGPV------YWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRL 543
           LG+GGFG V        G++   + +  KR+ K  G+ +   +NE  ++ K+  + +V L
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA--LNEKQILEKVNSQFVVNL 65

Query: 544 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 603
                  +   L+   M    L   +++       + R  F   E I  GL  LHR++  
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAE-ILCGLEDLHREN-- 122

Query: 604 RIIHRDLKASNILLDEELNPKISDFGMA-KIFGGNQDQADTGRVVGTFGYMSPEYAMEGR 662
             ++RDLK  NILLD+  + +ISD G+A KI  G   +   GR VGT GYM+PE     R
Sbjct: 123 -TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIR---GR-VGTVGYMAPEVLNNQR 177

Query: 663 FSEKSDVFSFGVLLLEIVSGR 683
           ++   D +  G L+ E++ G+
Sbjct: 178 YTLSPDYWGLGCLIYEMIEGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 73.9 bits (181), Expect = 2e-14
 Identities = 51/203 (25%), Positives = 103/203 (50%), Gaps = 16/203 (7%)

Query: 483 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 541
           +F+L  ++G G +G VY  R +  G+  A+K +    G+       E++++   +H N+V
Sbjct: 10  DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69

Query: 542 RLLGCCVEGEEKMLIYEYMPNRSLDAL--LFDPLKKERLDWRKRFNIIEGISRGLLYLHR 599
              G  +  ++  +  E+    SL  +  +  PL + ++ +  R  +     +GL YLH 
Sbjct: 70  AYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHS 124

Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 659
             +   +HRD+K +NILL +  + K++DFG++         A     +GT  +M+PE A 
Sbjct: 125 KGK---MHRDIKGANILLTDNGHVKLADFGVSAQITAT--IAKRKSFIGTPYWMAPEVAA 179

Query: 660 ---EGRFSEKSDVFSFGVLLLEI 679
              +G +++  D+++ G+  +E+
Sbjct: 180 VERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 74.3 bits (183), Expect = 3e-14
 Identities = 58/210 (27%), Positives = 101/210 (48%), Gaps = 35/210 (16%)

Query: 490 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN---------EVMVISKLQHRN 539
           +G G +G V        G+++A+K+LS         F +         E+ ++  + H N
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLS-------RPFQSAIHAKRTYRELRLLKHMDHEN 75

Query: 540 LVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL-DWRKRFNIIEGISRGLLYL 597
           ++ LL             + Y+    + A L + +K ++L D   +F ++  I RGL Y+
Sbjct: 76  VIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQF-LVYQILRGLKYI 134

Query: 598 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD---TGRVVGTFGYMS 654
           H      IIHRDLK SNI ++E+   KI DFG+A+         D   TG V  T  Y +
Sbjct: 135 HS---AGIIHRDLKPSNIAVNEDCELKILDFGLAR-------HTDDEMTGYVA-TRWYRA 183

Query: 655 PEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
           PE  +    +++  D++S G ++ E+++G+
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 72.3 bits (177), Expect = 5e-14
 Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 16/215 (7%)

Query: 490 LGQGGFGPVYWGRLK-DGQEIAVKRLS--KASGQGLEEFMNEVMVISKLQHRNLVRLLGC 546
           +G+G +G V   R + DG++  +K+L+   AS +  +    E  ++S+L+H N+V     
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 547 CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE---GISRGLLYLHRDSRL 603
             EGE+ +L Y  M        L+  LK+++        ++E    I+  L YLH     
Sbjct: 68  W-EGEDGLL-YIVM-GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK--- 121

Query: 604 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRF 663
            I+HRDLK  N+ L      K+ D G+A++     D A T  ++GT  YMSPE      +
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYYMSPELFSNKPY 179

Query: 664 SEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGY 698
           + KSDV++ G  + E+ + +   +F   D+  L Y
Sbjct: 180 NYKSDVWALGCCVYEMATLKH--AFNAKDMNSLVY 212

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains

 Score = 67.2 bits (164), Expect = 6e-14
 Identities = 28/76 (36%), Positives = 45/76 (59%), Gaps = 3/76 (3%)

Query: 337 EDGFSKLNKMKVPDFTE-WTSPATEDECREQCLK-NCSCIAYAFD-GGIGCMVWRSINLI 393
           +D F +L   K+P F+    S A+ +EC  +CL  NCSC ++ ++ G  GC++W   +L 
Sbjct: 3   DDCFVRLPNTKLPGFSRIVISVASLEECASKCLNSNCSCRSFTYNNGTKGCLLWSESSLG 62

Query: 394 DIQRLPFGGTDLYIRV 409
           D +  P GG DLY ++
Sbjct: 63  DARLFPSGGVDLYEKI 78

Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 71.9 bits (176), Expect = 1e-13
 Identities = 59/201 (29%), Positives = 101/201 (50%), Gaps = 17/201 (8%)

Query: 490 LGQGGFGPVYWGRLKD-GQEIAVK-----RLSKASGQGLEEFMNEVMVISKLQHRNLVRL 543
           LG+GGFG V   ++K+ G+  A K     RL K SG+ +     E++   K+    +V L
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEIL--EKVNSPFIVNL 58

Query: 544 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 603
                      L+   M    L   +++ + +  L+  +  +    I+ G+L+LH    +
Sbjct: 59  AYAFESKTHLCLVMSLMNGGDLKYHIYN-VGERGLEMERVIHYSAQITCGILHLHS---M 114

Query: 604 RIIHRDLKASNILLDEELNPKISDFGMA-KIFGGNQDQADTGRVVGTFGYMSPEYAMEGR 662
            I++RD+K  N+LLD++ N ++SD G+A ++  G        +  GT GYM+PE   E  
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT----ITQRAGTNGYMAPEILKEEP 170

Query: 663 FSEKSDVFSFGVLLLEIVSGR 683
           +S   D F+ G  + E+V+GR
Sbjct: 171 YSYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 73.0 bits (180), Expect = 1e-13
 Identities = 65/220 (29%), Positives = 111/220 (50%), Gaps = 38/220 (17%)

Query: 484 FQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEEFMN---------EVMVIS 533
           +++  KLG+G +G V+    +  +E+ A+K++  A       F N         E+M + 
Sbjct: 9   YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDA-------FRNATDAQRTFREIMFLQ 61

Query: 534 KL-QHRNLVRLLGCCVEGEEKM----LIYEYMPNRSLDALLFDPLKKERL-DWRKRFNII 587
           +L  H N+V+LL   V   E      L++EYM     +  L   ++   L D  KR+ I+
Sbjct: 62  ELGDHPNIVKLLN--VIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRY-IM 113

Query: 588 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF---GGNQDQADTG 644
             + + L Y+H  S   +IHRDLK SNILL+ +   K++DFG+A+       N +     
Sbjct: 114 YQLLKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLT 170

Query: 645 RVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGR 683
             V T  Y +PE  +   R+++  D++S G +L E++ G+
Sbjct: 171 DYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 71.8 bits (176), Expect = 1e-13
 Identities = 57/206 (27%), Positives = 92/206 (44%), Gaps = 20/206 (9%)

Query: 489 KLGQGGFGPVYWGRLKDGQEIA---VKRL-SKASGQGLEEFMNEVMVISKLQHRNLVRLL 544
           ++G G FG V  G    G   A   VK L + A+      F+ EV    +L H N+++ L
Sbjct: 2   EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61

Query: 545 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF--NIIEGISRGLLYLHRDSR 602
           G C+E    +L+ E+ P   L   L           +K     +   ++ GLL+LH   +
Sbjct: 62  GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---Q 118

Query: 603 LRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG-RVVGTFGYMSPEYAMEG 661
              IH DL   N  L  +L+ KI D+G+A +    +D   T         +++PE  +E 
Sbjct: 119 ADFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPE-LVEI 176

Query: 662 RFS--------EKSDVFSFGVLLLEI 679
           R          +KS+++S GV + E+
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 72.6 bits (179), Expect = 1e-13
 Identities = 58/220 (26%), Positives = 106/220 (48%), Gaps = 37/220 (16%)

Query: 484 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN---------EVMVIS 533
           ++L   +G G +G V      + G+++A+K++S         F +         E+ ++ 
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNV-------FDDLIDAKRILREIKLLR 54

Query: 534 KLQHRNLVRLLGCCV-EGEEKM----LIYEYMPNRSLDALLFD--PLKKERLDWRKRFNI 586
            L+H N++ LL        E      ++ E M    L  ++    PL  + + +      
Sbjct: 55  HLRHENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQY-----F 108

Query: 587 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD--TG 644
           +  I RGL YLH  +   +IHRDLK SNIL++   + KI DFG+A+    ++D+    T 
Sbjct: 109 LYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTE 165

Query: 645 RVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGR 683
            VV T  Y +PE  +   R+++  D++S G +  E+++ +
Sbjct: 166 YVV-TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 72.0 bits (177), Expect = 1e-13
 Identities = 61/210 (29%), Positives = 107/210 (50%), Gaps = 20/210 (9%)

Query: 483 NFQLSSKLGQGGFGPVYWGRLKDGQEI-AVK--RLSKASGQGLEEFMNEVMVISKLQHRN 539
            F+  +++G+G +G VY  R     EI A+K  R+           + E+ ++  L+H N
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67

Query: 540 LVRLLGCCV--EGEEKMLIYEYMPNRSLDALLFD---PLKKERLDWRKRFNIIEGISRGL 594
           +V L    V    +   L+ EY   + L +LL +   P  + ++       ++  + RGL
Sbjct: 68  IVELKEVVVGKHLDSIFLVMEYC-EQDLASLLDNMPTPFSESQVK-----CLMLQLLRGL 121

Query: 595 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 654
            YLH +    IIHRDLK SN+LL ++   KI+DFG+A+ + G   +  T +VV T  Y +
Sbjct: 122 QYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMTPKVV-TLWYRA 176

Query: 655 PEYAMEGRFSEKS-DVFSFGVLLLEIVSGR 683
           PE  +       + D+++ G +L E+++ +
Sbjct: 177 PELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 71.2 bits (174), Expect = 2e-13
 Identities = 60/202 (29%), Positives = 103/202 (50%), Gaps = 19/202 (9%)

Query: 490 LGQGGFGPV------YWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRL 543
           LG+GGFG V        G++   +++  KR+ K  G+ +   +NE  ++ K+  R +V L
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNSRFVVSL 65

Query: 544 LGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSR 602
                E ++ + L+   M    L   +++ +     D ++       +  GL  L R+  
Sbjct: 66  -AYAYETKDALCLVLTIMNGGDLKFHIYN-MGNPGFDEQRAIFYAAELCCGLEDLQRE-- 121

Query: 603 LRIIHRDLKASNILLDEELNPKISDFGMA-KIFGGNQDQADTGRVVGTFGYMSPEYAMEG 661
            RI++RDLK  NILLD+  + +ISD G+A +I  G   +   GR VGT GYM+PE     
Sbjct: 122 -RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG---ETVRGR-VGTVGYMAPEVINNE 176

Query: 662 RFSEKSDVFSFGVLLLEIVSGR 683
           +++   D +  G L+ E++ G+
Sbjct: 177 KYTFSPDWWGLGCLIYEMIQGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 71.8 bits (176), Expect = 2e-13
 Identities = 76/264 (28%), Positives = 108/264 (40%), Gaps = 70/264 (26%)

Query: 485 QLSSKLGQGGFGPVYW------GRLKDGQEIAVKRLSK-ASGQGLEEFMNEVMVISKL-Q 536
           +L   LG+G FG V         +    + +AVK L + A+    +  M E+ ++  +  
Sbjct: 10  KLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGH 69

Query: 537 HRNLVRLLGCCVE-GEEKMLIYEYMPNRSLDALL------FDP---------------LK 574
           H N+V LLG C + G   M+I EY    +L   L      F P                K
Sbjct: 70  HLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGK 129

Query: 575 KERLDWR--------------KRFNIIEGIS-----------------------RGLLYL 597
           K+RLD                K  + +E                          RG+ +L
Sbjct: 130 KQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL 189

Query: 598 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEY 657
              SR + IHRDL A NILL E    KI DFG+A+    + D    G       +M+PE 
Sbjct: 190 --ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPES 246

Query: 658 AMEGRFSEKSDVFSFGVLLLEIVS 681
             +  ++ +SDV+SFGVLL EI S
Sbjct: 247 IFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 71.1 bits (175), Expect = 3e-13
 Identities = 61/213 (28%), Positives = 105/213 (49%), Gaps = 26/213 (12%)

Query: 483 NFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRL---SKASGQGLEEF----MNEVMVISK 534
            ++  +++ +G +G VY  R K   EI A+K+L    +  G     F    + E+ ++ K
Sbjct: 6   EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG-----FPITSLREINILLK 60

Query: 535 LQHRNLVRLLGCCVEGEEKMLIY---EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGIS 591
           LQH N+V +    V G     IY   EY+ +  L +L+     K+     +   ++  + 
Sbjct: 61  LQHPNIVTVKEVVV-GSNLDKIYMVMEYVEH-DLKSLMET--MKQPFLQSEVKCLMLQLL 116

Query: 592 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFG 651
            G+ +LH +    I+HRDLK SN+LL+     KI DFG+A+ +G       T  VV T  
Sbjct: 117 SGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY-TQLVV-TLW 171

Query: 652 YMSPEYAM-EGRFSEKSDVFSFGVLLLEIVSGR 683
           Y +PE  +    +S   D++S G +  E+++ +
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 73.7 bits (181), Expect = 3e-13
 Identities = 59/229 (25%), Positives = 104/229 (45%), Gaps = 37/229 (16%)

Query: 484 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK-ASGQGL--EEFMNEVMVISKLQHRN 539
           + +   +G+GG G VY        + +A+K++ +  S   L  + F+ E  + + L H  
Sbjct: 4   YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPG 63

Query: 540 LVRLLGCCVEGEEKMLIYEYMP---NRSLDALL-----FDPLKK---ERLDWRKRFNIIE 588
           +V +   C +G+    +Y  MP     +L +LL      + L K   E+       +I  
Sbjct: 64  IVPVYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120

Query: 589 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD-QADT---- 643
            I   + Y+H  S+  ++HRDLK  NILL       I D+G A      ++   D     
Sbjct: 121 KICATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDE 177

Query: 644 -----------GRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
                      G++VGT  YM+PE  +    SE +D+++ GV+L ++++
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 70.8 bits (173), Expect = 5e-13
 Identities = 66/200 (33%), Positives = 99/200 (49%), Gaps = 17/200 (8%)

Query: 490 LGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEE---FMNEVMVISK-LQHRNLVRLL 544
           +G+G FG V   + K DG   AVK L K +    +E    M E  V+ K L+H  LV L 
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 545 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER--LDWRKRFNIIEGISRGLLYLHRDSR 602
                 E+   + +Y+    L    F  L++ER  L+ R RF   E ++  + YLH    
Sbjct: 63  YSFQTAEKLYFVLDYVNGGEL----FFHLQRERCFLEPRARFYAAE-VASAIGYLHS--- 114

Query: 603 LRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGR 662
           L II+RDLK  NILLD + +  ++DFG+ K   G + +  T    GT  Y++PE   +  
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKEP 172

Query: 663 FSEKSDVFSFGVLLLEIVSG 682
           +    D +  G +L E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 70.8 bits (174), Expect = 5e-13
 Identities = 61/214 (28%), Positives = 106/214 (49%), Gaps = 25/214 (11%)

Query: 483 NFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNL 540
            +Q  S +G+G +G V        G ++A+K++S    Q   +  + E+ ++ + +H N+
Sbjct: 6   RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENI 65

Query: 541 VRLLGC-CVEGEEKM----LIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRG 593
           + +L        E      ++ E M        L+  +K + L  D  + F  +  I RG
Sbjct: 66  IGILDIIRPPSFESFNDVYIVQELMETD-----LYKLIKTQHLSNDHIQYF--LYQILRG 118

Query: 594 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV---VGTF 650
           L Y+H  +   ++HRDLK SN+LL+   + KI DFG+A+I     D   TG +   V T 
Sbjct: 119 LKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH--TGFLTEYVATR 173

Query: 651 GYMSPEYAMEGRFSEKS-DVFSFGVLLLEIVSGR 683
            Y +PE  +  +   K+ D++S G +L E++S R
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 70.6 bits (173), Expect = 6e-13
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 17/208 (8%)

Query: 483 NFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSK---ASGQGLEEFMNEVMVISKLQHR 538
           +F     LG+G FG V     K   E+ A+K L K        +E  M E  V++     
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60

Query: 539 NLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 597
             +  L  C +  +++  + EY+    L   ++   +  +            I+ GL +L
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGKFKEPHAVFYAAEIAIGLFFL 117

Query: 598 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK--IFGGNQDQADTGRVVGTFGYMSP 655
           H      II+RDLK  N++LD E + KI+DFGM K  IFGG      T    GT  Y++P
Sbjct: 118 HSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG----KTTRTFCGTPDYIAP 170

Query: 656 EYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           E      + +  D ++FGVLL E+++G+
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 70.2 bits (172), Expect = 7e-13
 Identities = 65/200 (32%), Positives = 98/200 (49%), Gaps = 17/200 (8%)

Query: 490 LGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEE---FMNEVMVISK-LQHRNLVRLL 544
           +G+G FG V   + K DG+  AVK L K +    +E    M E  V+ K ++H  LV L 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 545 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER--LDWRKRFNIIEGISRGLLYLHRDSR 602
                 ++   + +Y+    L    F  L++ER   + R RF   E I+  L YLH    
Sbjct: 63  YSFQTADKLYFVLDYVNGGEL----FFHLQRERSFPEPRARFYAAE-IASALGYLHS--- 114

Query: 603 LRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGR 662
           L II+RDLK  NILLD + +  ++DFG+ K   G +    T    GT  Y++PE   +  
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEVLRKQP 172

Query: 663 FSEKSDVFSFGVLLLEIVSG 682
           +    D +  G +L E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 70.2 bits (172), Expect = 8e-13
 Identities = 66/287 (22%), Positives = 122/287 (42%), Gaps = 60/287 (20%)

Query: 485 QLSSKLGQGGFGPVYWGR-LKDGQEIAVKR--LSKASGQGLEEFMN------------EV 529
           Q  + LG+G +G V        G+ +A+K+  + + S    ++               E+
Sbjct: 12  QKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLREL 71

Query: 530 MVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPN---RSLDA--LLFDPLKKERLDWRKRF 584
            ++++++H N++ L+   VEG+   L+ + M +   + +D    L +   K         
Sbjct: 72  KIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVK--------- 122

Query: 585 NIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD-- 642
            I+  I  GL  LH+      +HRDL  +NI ++ +   KI+DFG+A+ +G         
Sbjct: 123 CILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLS 179

Query: 643 -----------TGRVVGTFGYMSPEYAM-EGRFSEKSDVFSFGVLLLEIVSGRKNTSFF- 689
                      T +VV T  Y +PE  M   ++    D++S G +  E+++G+     F 
Sbjct: 180 KDETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK---PLFP 235

Query: 690 -EDDLTILGYAWKL--------WNENKILALVDPFLSESSFQLDMII 727
            E+++  LG  ++L        W + K L L   F       L  I 
Sbjct: 236 GENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIF 282

Length = 335

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 69.8 bits (171), Expect = 8e-13
 Identities = 64/205 (31%), Positives = 100/205 (48%), Gaps = 24/205 (11%)

Query: 490 LGQGGFGPVYWGRLKDGQE----IAVKRLSKA----SGQGLEEFMNEVMVISKLQHRNLV 541
           LG+GG+G V+  R   G +     A+K L KA    + +       E  ++  ++H  +V
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63

Query: 542 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER--LDWRKRFNIIEGISRGLLYLHR 599
            L+     G +  LI EY+    L    F  L++E   ++    F + E IS  L +LH+
Sbjct: 64  DLIYAFQTGGKLYLILEYLSGGEL----FMHLEREGIFMEDTACFYLSE-ISLALEHLHQ 118

Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAK--IFGGNQDQADTGRVVGTFGYMSPEY 657
                II+RDLK  NILLD + + K++DFG+ K  I  G      T    GT  YM+PE 
Sbjct: 119 ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG----TVTHTFCGTIEYMAPEI 171

Query: 658 AMEGRFSEKSDVFSFGVLLLEIVSG 682
            M     +  D +S G L+ ++++G
Sbjct: 172 LMRSGHGKAVDWWSLGALMYDMLTG 196

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 69.2 bits (169), Expect = 9e-13
 Identities = 49/157 (31%), Positives = 74/157 (47%), Gaps = 25/157 (15%)

Query: 489 KLGQGGFGPVYWGRLKDG---QEIAVKRL-SKASGQGLEEFMNEVMVISKLQHRNLVRLL 544
           ++G G FG V  G +  G    ++ VK L   AS Q   +F+ E      LQH NL++ L
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 545 GCCVEGEEKMLIYEYMP----------NRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 594
           G C E    +L+ E+ P           R  + +  DP   +R+           I+ GL
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACE--------IALGL 113

Query: 595 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 631
           L+LH+++    IH DL   N LL  +L  KI D+G++
Sbjct: 114 LHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLS 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 69.3 bits (169), Expect = 9e-13
 Identities = 60/216 (27%), Positives = 105/216 (48%), Gaps = 28/216 (12%)

Query: 484 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLV 541
           F+L   +G G +G VY GR +K GQ  A+K +     +  EE   E+ ++ K   HRN+ 
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLKKYSHHRNIA 76

Query: 542 RLLGCCVE------GEEKMLIYEYMPNRSLDALLF----DPLKKERLDWRKRFNIIEGIS 591
              G  ++       ++  L+ E+    S+  L+     + LK++ + +     I   I 
Sbjct: 77  TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY-----ICREIL 131

Query: 592 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFG 651
           RGL +LH     ++IHRD+K  N+LL E    K+ DFG++        + +T   +GT  
Sbjct: 132 RGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPY 186

Query: 652 YMSPEYAM-----EGRFSEKSDVFSFGVLLLEIVSG 682
           +M+PE        +  +  +SD++S G+  +E+  G
Sbjct: 187 WMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 68.9 bits (169), Expect = 1e-12
 Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 35/219 (15%)

Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVM---VISKLQH 537
           N+ +   ++G G  G VY  R  K G  +AVK++ +   +  EE    +M   V+ K  H
Sbjct: 15  NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLK-SH 71

Query: 538 R--NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKK-------ERLDWRKRFNIIE 588
               +V+  G  +   +  +  E M      +   D L K       E +  +    I+ 
Sbjct: 72  DCPYIVKCYGYFITDSDVFICMELM------STCLDKLLKRIQGPIPEDILGKMTVAIV- 124

Query: 589 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 648
              + L YL    +  +IHRD+K SNILLD   N K+ DFG   I G   D     R  G
Sbjct: 125 ---KALHYL--KEKHGVIHRDVKPSNILLDASGNVKLCDFG---ISGRLVDSKAKTRSAG 176

Query: 649 TFGYMSPEY----AMEGRFSEKSDVFSFGVLLLEIVSGR 683
              YM+PE         ++  ++DV+S G+ L+E+ +G+
Sbjct: 177 CAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 68.3 bits (167), Expect = 1e-12
 Identities = 50/198 (25%), Positives = 93/198 (46%), Gaps = 21/198 (10%)

Query: 492 QGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMN----EVMVISKLQHRNLVRLLGC 546
           +G FG VY  + +  G   A+K L K+      +  N      +++ + +   + +L   
Sbjct: 6   KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65

Query: 547 CVEGEEKMLIYEYMPNRSLDALL--FDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 604
               +   L+ EY+      +L+     L     DW K++  I  +  G+  LH+     
Sbjct: 66  FQSKDYLYLVMEYLNGGDCASLIKTLGGLP---EDWAKQY--IAEVVLGVEDLHQRG--- 117

Query: 605 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFS 664
           IIHRD+K  N+L+D+  + K++DFG+++    N+      + VGT  Y++PE  +     
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK------KFVGTPDYLAPETILGVGDD 171

Query: 665 EKSDVFSFGVLLLEIVSG 682
           + SD +S G ++ E + G
Sbjct: 172 KMSDWWSLGCVIFEFLFG 189

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 68.9 bits (168), Expect = 2e-12
 Identities = 55/207 (26%), Positives = 103/207 (49%), Gaps = 17/207 (8%)

Query: 489 KLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLE-EFMNEVMVISKLQHRNLVRLLGCC 547
           K+G+G +G VY  + KDG++     L +  G G+      E+ ++ +L+H N++ L    
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67

Query: 548 VEGEEKM--LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY-----LHRD 600
           +   ++   L+++Y  +     + F    K     +K   +  G+ + LLY     +H  
Sbjct: 68  LSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILDGIHYL 124

Query: 601 SRLRIIHRDLKASNILL----DEELNPKISDFGMAKIFGGN-QDQADTGRVVGTFGYMSP 655
               ++HRDLK +NIL+     E    KI+D G A++F    +  AD   VV TF Y +P
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184

Query: 656 EYAMEGR-FSEKSDVFSFGVLLLEIVS 681
           E  +  R +++  D+++ G +  E+++
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 68.9 bits (168), Expect = 2e-12
 Identities = 58/204 (28%), Positives = 97/204 (47%), Gaps = 11/204 (5%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGL--EEFMNEVMVISKLQHRN 539
           ++F+  S+LG G  G V   + K    I  ++L     +     + + E+ V+ +     
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 599
           +V   G      E  +  E+M   SLD +L +    +R+       +   + RGL YL  
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLRE 121

Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 659
             + +I+HRD+K SNIL++     K+ DFG++    G    +     VGT  YMSPE   
Sbjct: 122 --KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 175

Query: 660 EGRFSEKSDVFSFGVLLLEIVSGR 683
              +S +SD++S G+ L+E+  GR
Sbjct: 176 GTHYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 67.8 bits (166), Expect = 3e-12
 Identities = 62/222 (27%), Positives = 96/222 (43%), Gaps = 38/222 (17%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 540
           ++ ++  +LG+G +G V   R    G  +AVKR+ +A+            V S+ Q R L
Sbjct: 1   DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRI-RAT------------VNSQEQKRLL 47

Query: 541 VRL-----LGCCVE---------GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNI 586
           + L        C            E  + I   + + SLD        K           
Sbjct: 48  MDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGK 107

Query: 587 IE-GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 645
           I   I + L YLH  S+L +IHRD+K SN+L++     K+ DFG   I G   D      
Sbjct: 108 IAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFG---ISGYLVDSVAKTI 162

Query: 646 VVGTFGYMSPEY---AMEGR-FSEKSDVFSFGVLLLEIVSGR 683
             G   YM+PE     +  + +  KSDV+S G+ ++E+ +GR
Sbjct: 163 DAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 68.5 bits (167), Expect = 3e-12
 Identities = 63/206 (30%), Positives = 106/206 (51%), Gaps = 15/206 (7%)

Query: 484 FQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSK--ASGQGLEEFMNEVMVISKLQHRNL 540
           +Q  S +G G +G V      K G  +AVK+LS+   S    +    E+ ++  ++H N+
Sbjct: 19  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 78

Query: 541 VRLLGCCVEGEE-KMLIYEYMPNRSLDALLFDPLKKERL-DWRKRFNIIEGISRGLLYLH 598
           + LL         +     Y+    + A L + +K ++L D   +F +I  I RGL Y+H
Sbjct: 79  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH 137

Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 658
                 IIHRDLK SN+ ++E+   KI DFG+A+    + D   TG  V T  Y +PE  
Sbjct: 138 SAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTG-YVATRWYRAPEIM 189

Query: 659 MEG-RFSEKSDVFSFGVLLLEIVSGR 683
           +    +++  D++S G ++ E+++GR
Sbjct: 190 LNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 68.2 bits (166), Expect = 3e-12
 Identities = 54/207 (26%), Positives = 102/207 (49%), Gaps = 17/207 (8%)

Query: 489 KLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLE-EFMNEVMVISKLQHRNLVRLLGCC 547
           K+G+G +G VY  + KDG++     L +  G G+      E+ ++ +L+H N++ L    
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67

Query: 548 VEGEEKM--LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY-----LHRD 600
           +   ++   L+++Y  +     + F    K     +K   +   + + LLY     +H  
Sbjct: 68  LSHSDRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPMQLPRSMVKSLLYQILDGIHYL 124

Query: 601 SRLRIIHRDLKASNILL----DEELNPKISDFGMAKIFGGN-QDQADTGRVVGTFGYMSP 655
               ++HRDLK +NIL+     E    KI+D G A++F    +  AD   VV TF Y +P
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184

Query: 656 EYAMEGR-FSEKSDVFSFGVLLLEIVS 681
           E  +  R +++  D+++ G +  E+++
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 68.1 bits (166), Expect = 3e-12
 Identities = 60/213 (28%), Positives = 104/213 (48%), Gaps = 13/213 (6%)

Query: 489 KLGQGGFGPVYWGRLKDGQE-IAVKRLSKASGQGLE-EFMNEVMVISKLQHRNLVRLLGC 546
           KLG+G +  V+ GR K  +  +A+K +     +G     + EV ++  L+H N+V L   
Sbjct: 13  KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 547 CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRII 606
               +   L++EY+ ++ L   + D      +   K F  +  I RGL Y HR    +++
Sbjct: 73  VHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIF--LYQILRGLAYCHRR---KVL 126

Query: 607 HRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM-EGRFSE 665
           HRDLK  N+L++E    K++DFG+A+    +         V T  Y  P+  +    +S 
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVLLGSSEYST 184

Query: 666 KSDVFSFGVLLLEIVSGRK--NTSFFEDDLTIL 696
           + D++  G +  E+ SGR     S  ED+L ++
Sbjct: 185 QIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 67.5 bits (165), Expect = 3e-12
 Identities = 62/223 (27%), Positives = 106/223 (47%), Gaps = 33/223 (14%)

Query: 483 NFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLSKA---SGQGLEEFMNEVMVISKLQHR 538
           + +    +G G FG V+  R +  +   A+K ++       +  +   NE  V+ ++ H 
Sbjct: 2   DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61

Query: 539 NLVRLLGCCVEGEEKML--IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEG------I 590
            ++RL     E +++ L  + EY+P   L    F  L+        RF+   G      I
Sbjct: 62  FIIRLF--WTEHDQRFLYMLMEYVPGGEL----FSYLRN-----SGRFSNSTGLFYASEI 110

Query: 591 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF 650
              L YLH      I++RDLK  NILLD+E + K++DFG AK     +D+  T  + GT 
Sbjct: 111 VCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKL---RDR--TWTLCGTP 162

Query: 651 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDL 693
            Y++PE       ++  D ++ G+L+ E++ G     FF+D+ 
Sbjct: 163 EYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYP--PFFDDNP 203

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 67.5 bits (165), Expect = 4e-12
 Identities = 52/198 (26%), Positives = 102/198 (51%), Gaps = 12/198 (6%)

Query: 489 KLGQGGFGPVYWGRLKDGQEI-AVKRLS-KASGQGLEEF-MNEVMVISKLQHRNLVRLLG 545
           K+G+G +G V+  + ++  EI A+KR+      +G+    + E+ ++ +L+H+N+VRL  
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66

Query: 546 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 605
                ++  L++EY  ++ L    FD    + +D     + +  + +GL + H      +
Sbjct: 67  VLHSDKKLTLVFEYC-DQDLKKY-FDSCNGD-IDPEIVKSFMFQLLKGLAFCHSH---NV 120

Query: 606 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSE 665
           +HRDLK  N+L+++    K++DFG+A+ FG       +  VV T  Y  P+     +   
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY-SAEVV-TLWYRPPDVLFGAKLYS 178

Query: 666 KS-DVFSFGVLLLEIVSG 682
            S D++S G +  E+ + 
Sbjct: 179 TSIDMWSAGCIFAELANA 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 67.9 bits (166), Expect = 4e-12
 Identities = 61/200 (30%), Positives = 93/200 (46%), Gaps = 16/200 (8%)

Query: 490 LGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEEF---MNEVMVISKLQHRNLVRLLG 545
           LG+G FG V   R K   +  A+K L K      +E    + E  V+   +H  L  L  
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62

Query: 546 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGLLYLHRDSRL 603
                +    + EY     L    F  L +ER+  + R RF   E +S  L YLH     
Sbjct: 63  SFQTHDRLCFVMEYANGGEL----FFHLSRERVFSEDRARFYGAEIVS-ALGYLHSCD-- 115

Query: 604 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRF 663
            +++RDLK  N++LD++ + KI+DFG+ K   G  D A      GT  Y++PE   +  +
Sbjct: 116 -VVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDY 172

Query: 664 SEKSDVFSFGVLLLEIVSGR 683
               D +  GV++ E++ GR
Sbjct: 173 GRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 68.3 bits (167), Expect = 4e-12
 Identities = 54/216 (25%), Positives = 106/216 (49%), Gaps = 34/216 (15%)

Query: 490 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRL----- 543
           LG G  G V+     D  + +AVK++     Q ++  + E+ +I +L H N+V++     
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 544 ---------LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISR 592
                    +G   E     ++ EYM     +  L + L++  L  +  + F  +  + R
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLSEEHARLF--MYQLLR 125

Query: 593 GLLYLHRDSRLRIIHRDLKASNILLD-EELNPKISDFGMAKIFGGNQDQADTGRV---VG 648
           GL Y+H  +   ++HRDLK +N+ ++ E+L  KI DFG+A+I   +   +  G +   + 
Sbjct: 126 GLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIV--DPHYSHKGYLSEGLV 180

Query: 649 TFGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 683
           T  Y SP   +    +++  D+++ G +  E+++G+
Sbjct: 181 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 69.9 bits (171), Expect = 4e-12
 Identities = 50/195 (25%), Positives = 88/195 (45%), Gaps = 28/195 (14%)

Query: 506 GQEIAVKRLSKASGQGLEE---FMNEVMVISKLQHRNLVRLLGCCVEGEEKML-IYEYMP 561
           G E+A+K L   + +   +   F  E  + ++L H N+V LL         +  ++EY+P
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 562 NRSLDALL-----FDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNIL 616
            R+L  +L         +  RL        +  +   L   H      I+HRDLK  NI+
Sbjct: 63  GRTLREVLAADGALPAGETGRL--------MLQVLDALACAHNQG---IVHRDLKPQNIM 111

Query: 617 L---DEELNPKISDFGMAKIFGGNQDQAD-----TGRVVGTFGYMSPEYAMEGRFSEKSD 668
           +       + K+ DFG+  +  G +D        T  V+GT  Y +PE       +  SD
Sbjct: 112 VSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSD 171

Query: 669 VFSFGVLLLEIVSGR 683
           ++++G++ LE ++G+
Sbjct: 172 LYAWGLIFLECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 67.3 bits (164), Expect = 4e-12
 Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 38/211 (18%)

Query: 490 LGQGGFGPVYWGRLKD-GQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLG 545
           +G+GGFG VY  R  D G+  A+K L K      QG    +NE +++S +          
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS--------- 52

Query: 546 CCVEGEEKMLIYEYMPNRSLDALLF--DPLKKERLDWR-----------KRFNIIEGISR 592
               G+   ++       + D L F  D +    L +             RF   E I  
Sbjct: 53  ---TGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATE-IIL 108

Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 652
           GL ++H  +R  +++RDLK +NILLDE  + +ISD G+A  F   +  A     VGT GY
Sbjct: 109 GLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGY 161

Query: 653 MSPEYAMEGR-FSEKSDVFSFGVLLLEIVSG 682
           M+PE   +G  +   +D FS G +L +++ G
Sbjct: 162 MAPEVLQKGTAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 67.8 bits (165), Expect = 4e-12
 Identities = 65/209 (31%), Positives = 99/209 (47%), Gaps = 18/209 (8%)

Query: 490 LGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEF---MNEVMVISKLQHRNLVRLLG 545
           LG+G FG V   R K  G+  A+K L K      +E    + E  V+   +H  L  L  
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62

Query: 546 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGLLYLHRDSRL 603
                +    + EY+    L    F  L +ER+  + R RF   E +S  L YLH     
Sbjct: 63  SFQTKDRLCFVMEYVNGGEL----FFHLSRERVFSEDRTRFYGAEIVS-ALDYLHSG--- 114

Query: 604 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRF 663
           +I++RDLK  N++LD++ + KI+DFG+ K   G  D A      GT  Y++PE   +  +
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDNDY 172

Query: 664 SEKSDVFSFGVLLLEIVSGRKNTSFFEDD 692
               D +  GV++ E++ GR    F+  D
Sbjct: 173 GRAVDWWGLGVVMYEMMCGR--LPFYNQD 199

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 67.0 bits (164), Expect = 5e-12
 Identities = 56/205 (27%), Positives = 103/205 (50%), Gaps = 24/205 (11%)

Query: 488 SKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEE-------FMNEVMVISKLQHRN 539
           SK+G+G +G V+  R ++ GQ +A+K+  ++     E+        + E+ ++ +L+H N
Sbjct: 7   SKIGEGSYGVVFKCRNRETGQIVAIKKFVES-----EDDPVIKKIALREIRMLKQLKHPN 61

Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 599
           LV L+       +  L++EY  +  L+ L  +P        +K   II    + + + H+
Sbjct: 62  LVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKK---IIWQTLQAVNFCHK 118

Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF-GGNQDQADTGRVVGTFGYMSPEYA 658
                 IHRD+K  NIL+ ++   K+ DFG A+I  G   D  D    V T  Y +PE  
Sbjct: 119 ---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD---YVATRWYRAPELL 172

Query: 659 M-EGRFSEKSDVFSFGVLLLEIVSG 682
           + + ++    DV++ G +  E+++G
Sbjct: 173 VGDTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 67.7 bits (165), Expect = 5e-12
 Identities = 55/201 (27%), Positives = 98/201 (48%), Gaps = 17/201 (8%)

Query: 490 LGQGGFGPV-YWGRLKDGQEIAVKRLSKASGQGL--EEFMNEVMVISKLQHRNLVRLLGC 546
           +G G +G V      + G ++A+K+L +     L  +    E+ ++  ++H N++ LL  
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82

Query: 547 CVEGE---EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 603
                        Y  MP    D  L   +K E+L   +   ++  + +GL Y+H     
Sbjct: 83  FTPDLSLDRFHDFYLVMPFMGTD--LGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAG-- 138

Query: 604 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG-R 662
            IIHRDLK  N+ ++E+   KI DFG+A+      D   TG VV T  Y +PE  +    
Sbjct: 139 -IIHRDLKPGNLAVNEDCELKILDFGLAR----QTDSEMTGYVV-TRWYRAPEVILNWMH 192

Query: 663 FSEKSDVFSFGVLLLEIVSGR 683
           +++  D++S G ++ E+++G+
Sbjct: 193 YTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 67.6 bits (165), Expect = 6e-12
 Identities = 58/203 (28%), Positives = 106/203 (52%), Gaps = 22/203 (10%)

Query: 490 LGQGGFGPVYWG-RLKDGQEIAVKRLSK--ASGQGLEEFMNEVMVISKLQHRNLVRLLG- 545
           +G G +G V      + G+++A+K+LS+   S    +    E+ ++  +QH N++ LL  
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82

Query: 546 --CCVEGEEKMLIYEYMP--NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
               V G+E    Y  MP     L  ++  PL ++++ +     ++  +  GL Y+H   
Sbjct: 83  FTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQY-----LVYQMLCGLKYIHSAG 137

Query: 602 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 661
              IIHRDLK  N+ ++E+   KI DFG+A+    + D   TG VV T  Y +PE  +  
Sbjct: 138 ---IIHRDLKPGNLAVNEDCELKILDFGLAR----HADAEMTGYVV-TRWYRAPEVILNW 189

Query: 662 -RFSEKSDVFSFGVLLLEIVSGR 683
             +++  D++S G ++ E+++G+
Sbjct: 190 MHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 67.3 bits (164), Expect = 6e-12
 Identities = 61/199 (30%), Positives = 102/199 (51%), Gaps = 16/199 (8%)

Query: 490 LGQGGFGPVYWGRLKDGQEI-AVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLG 545
           +G+G FG V   R +D Q I A+K + KA   S   +   + E  V++++    +V L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 546 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKE-RLD-WRKRFNIIEGISRGLLYLHRDSRL 603
                E+  L+  ++    L    F  L++E R D  R RF   E +   L  LH+    
Sbjct: 61  SFQSPEKLYLVLAFINGGEL----FHHLQREGRFDLSRARFYTAE-LLCALENLHK---F 112

Query: 604 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRF 663
            +I+RDLK  NILLD + +  + DFG+ K+   + D+ +T    GT  Y++PE  +   +
Sbjct: 113 NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT--FCGTPEYLAPELLLGHGY 170

Query: 664 SEKSDVFSFGVLLLEIVSG 682
           ++  D ++ GVLL E+++G
Sbjct: 171 TKAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 66.6 bits (162), Expect = 8e-12
 Identities = 60/211 (28%), Positives = 101/211 (47%), Gaps = 18/211 (8%)

Query: 483 NFQLSSKLGQGGFGPVYWGRLKDGQE----IAVKRLSKAS----GQGLEEFMNEVMVISK 534
           NF+L   LG G +G V+  R   G +     A+K L KA+     +  E    E  V+  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 535 LQHRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRG 593
           ++    +  L    + + K+ LI +Y+    L   L    ++ER   ++       I   
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHL---SQRERFKEQEVQIYSGEIVLA 117

Query: 594 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 653
           L +LH+   L II+RD+K  NILLD   +  ++DFG++K F  ++ +       GT  YM
Sbjct: 118 LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-FCGTIEYM 173

Query: 654 SPEYAM--EGRFSEKSDVFSFGVLLLEIVSG 682
           +P+     +G   +  D +S GVL+ E+++G
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 66.9 bits (163), Expect = 9e-12
 Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 13/206 (6%)

Query: 483 NFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSK---ASGQGLEEFMNEVMVISKLQHR 538
           +F     LG+G FG V     K   E+ A+K L K        +E  M E  V++     
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60

Query: 539 NLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 597
             +  L  C +  +++  + EY+   +   L++   +  +    +       IS GL +L
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYV---NGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFL 117

Query: 598 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEY 657
           HR     II+RDLK  N++LD E + KI+DFGM K      D   T    GT  Y++PE 
Sbjct: 118 HRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAPEI 172

Query: 658 AMEGRFSEKSDVFSFGVLLLEIVSGR 683
                + +  D +++GVLL E+++G+
Sbjct: 173 IAYQPYGKSVDWWAYGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 66.1 bits (161), Expect = 9e-12
 Identities = 64/201 (31%), Positives = 99/201 (49%), Gaps = 18/201 (8%)

Query: 490 LGQGGFGPVYWGRLKD-GQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRN--LVRL 543
           +G+GGFG VY  R  D G+  A+K L K      QG    +NE +++S +   +   +  
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 544 LGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSR 602
           +       +K+  I + M    L   L         +   RF   E I  GL ++H  +R
Sbjct: 62  MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAE--MRFYAAE-IILGLEHMH--NR 116

Query: 603 LRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG- 661
             +++RDLK +NILLDE  + +ISD G+A  F   +  A     VGT GYM+PE   +G 
Sbjct: 117 F-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQKGV 171

Query: 662 RFSEKSDVFSFGVLLLEIVSG 682
            +   +D FS G +L +++ G
Sbjct: 172 AYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 67.8 bits (165), Expect = 9e-12
 Identities = 54/180 (30%), Positives = 92/180 (51%), Gaps = 25/180 (13%)

Query: 511 VKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE---YMPNRSLDA 567
           VK  S+A+ Q LE   NE++ + +L H N++++        E++L  E   YM  +  D 
Sbjct: 200 VKAGSRAAIQ-LE---NEILALGRLNHENILKI--------EEILRSEANTYMITQKYDF 247

Query: 568 LLFDPLKKERLDWRKR------FNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL 621
            L+  +  E  DW+ R        I++ +   + Y+H     ++IHRD+K  NI L+ + 
Sbjct: 248 DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDG 304

Query: 622 NPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
              + DFG A  F   ++  D G V GT    SPE      + E +D++S G++LL+++S
Sbjct: 305 KIVLGDFGTAMPFEKEREAFDYGWV-GTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 67.1 bits (164), Expect = 1e-11
 Identities = 68/232 (29%), Positives = 108/232 (46%), Gaps = 24/232 (10%)

Query: 473 QFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEE---FMNE 528
           +  +L     +F +   +G+G FG V   R K  +++ A+K LSK       +   F  E
Sbjct: 34  KITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEE 93

Query: 529 VMVISKLQHRNLVRLLGCCVEGEEKML--IYEYMPNRSLDALLFDPLKKERLDWRKRFNI 586
             +++      +V+L       ++K L  + EYMP   L  L+ +    E   W  RF  
Sbjct: 94  RDIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE--KW-ARFYT 148

Query: 587 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN-QDQADTGR 645
            E +   L  +H    +  IHRD+K  N+LLD+  + K++DFG       N   + DT  
Sbjct: 149 AE-VVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA- 203

Query: 646 VVGTFGYMSPEYAM----EGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDL 693
            VGT  Y+SPE       +G +  + D +S GV L E++ G  +T F+ D L
Sbjct: 204 -VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG--DTPFYADSL 252

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 66.6 bits (162), Expect = 1e-11
 Identities = 47/121 (38%), Positives = 63/121 (52%), Gaps = 8/121 (6%)

Query: 561 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE 620
           P +  D L   PL  E L     F +    +RG+ +L   SR + IHRDL A NILL E 
Sbjct: 159 PPQETDDLWKSPLTMEDLICYS-FQV----ARGMEFLA--SR-KCIHRDLAARNILLSEN 210

Query: 621 LNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIV 680
              KI DFG+A+    + D    G       +M+PE   +  ++ +SDV+SFGVLL EI 
Sbjct: 211 NVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIF 270

Query: 681 S 681
           S
Sbjct: 271 S 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 66.2 bits (161), Expect = 1e-11
 Identities = 63/209 (30%), Positives = 108/209 (51%), Gaps = 21/209 (10%)

Query: 484 FQLSSKLGQGGFGPV---YWGRLKDGQEIAVKRLSKASGQGL---EEFMNEVMVISKLQH 537
           +Q  + +G G +G V   Y  RL+  Q++AVK+LS+   Q L        E+ ++  ++H
Sbjct: 17  YQNLTPVGSGAYGSVCSAYDTRLR--QKVAVKKLSRPF-QSLIHARRTYRELRLLKHMKH 73

Query: 538 RNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL-DWRKRFNIIEGISRGLL 595
            N++ LL             E Y+    + A L + +K ++L D   +F +I  + RGL 
Sbjct: 74  ENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQF-LIYQLLRGLK 132

Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 655
           Y+H      IIHRDLK SN+ ++E+   +I DFG+A+      D   TG  V T  Y +P
Sbjct: 133 YIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR----QADDEMTG-YVATRWYRAP 184

Query: 656 EYAMEG-RFSEKSDVFSFGVLLLEIVSGR 683
           E  +    +++  D++S G ++ E++ G+
Sbjct: 185 EIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 66.2 bits (161), Expect = 1e-11
 Identities = 58/204 (28%), Positives = 97/204 (47%), Gaps = 11/204 (5%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGL--EEFMNEVMVISKLQHRN 539
           ++F+  S+LG G  G V+    K    I  ++L     +     + + E+ V+ +     
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 599
           +V   G      E  +  E+M   SLD +L    K  R+  +    +   + +GL YL  
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLRE 121

Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 659
             + +I+HRD+K SNIL++     K+ DFG++    G    +     VGT  YMSPE   
Sbjct: 122 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 175

Query: 660 EGRFSEKSDVFSFGVLLLEIVSGR 683
              +S +SD++S G+ L+E+  GR
Sbjct: 176 GTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 66.6 bits (162), Expect = 2e-11
 Identities = 66/230 (28%), Positives = 109/230 (47%), Gaps = 20/230 (8%)

Query: 473 QFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKAS--GQGLEEFMNEV 529
           +  +L     ++ +   +G+G FG V   R K  Q++ A+K LSK     +    F  E 
Sbjct: 34  KIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEE 93

Query: 530 MVISKLQHRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE 588
             I    +   V  L C  + ++ + ++ EYMP   L  L+ +    E+  W K +    
Sbjct: 94  RDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK--WAKFYT--- 148

Query: 589 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA-KIFGGNQDQADTGRVV 647
             +  +L L     + +IHRD+K  N+LLD+  + K++DFG   K+      + DT   V
Sbjct: 149 --AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA--V 204

Query: 648 GTFGYMSPEY----AMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDL 693
           GT  Y+SPE       +G +  + D +S GV L E++ G  +T F+ D L
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG--DTPFYADSL 252

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 60/222 (27%), Positives = 106/222 (47%), Gaps = 19/222 (8%)

Query: 474 FEELATATNNFQLSSKLGQGGFGPVY-WGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVI 532
           F+     ++ +++   +G+G +G V+     K+G + AVK L        EE   E  ++
Sbjct: 10  FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNIL 68

Query: 533 SKLQ-HRNLVRLLGC-----CVEGEEKMLIYEYMPNRSLDALLFDPLKK-ERLDWRKRFN 585
             L  H N+V+  G         G++  L+ E     S+  L+   LK+ ER++      
Sbjct: 69  KALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY 128

Query: 586 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 645
           I+     GL +LH +   + IHRD+K +NILL  E   K+ DFG++      + + +T  
Sbjct: 129 ILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS- 184

Query: 646 VVGTFGYMSPEY-----AMEGRFSEKSDVFSFGVLLLEIVSG 682
            VGT  +M+PE       ++  +  + DV+S G+  +E+  G
Sbjct: 185 -VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 56/198 (28%), Positives = 96/198 (48%), Gaps = 11/198 (5%)

Query: 489 KLGQGGFGPVYWGRLKDGQE-IAVKRLSKASGQGLE-EFMNEVMVISKLQHRNLVRLLGC 546
           KLG+G +  VY GR K     +A+K +     +G     + EV ++  L+H N+V L   
Sbjct: 13  KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 547 CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRII 606
               +   L++EY+ ++ L   L D      +   K F  +  + RGL Y HR    +++
Sbjct: 73  IHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLF--LFQLLRGLNYCHRR---KVL 126

Query: 607 HRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM-EGRFSE 665
           HRDLK  N+L++E    K++DFG+A+    +         V T  Y  P+  +    +S 
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYSNEVVTLWYRPPDILLGSTDYST 184

Query: 666 KSDVFSFGVLLLEIVSGR 683
           + D++  G +  E+ +GR
Sbjct: 185 QIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 64.5 bits (157), Expect = 3e-11
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 18/205 (8%)

Query: 489 KLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRNLVRLLG 545
           +LG+G +G VY    +  G  +A+K  RL     +   + + E+ ++ K     +V   G
Sbjct: 8   ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK-FNQIIMELDILHKAVSPYIVDFYG 66

Query: 546 C-CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 604
              +EG   M + EYM   SLD L    +  E +       I   + +GL +L  +    
Sbjct: 67  AFFIEGAVYMCM-EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HN 123

Query: 605 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEY----AME 660
           IIHRD+K +N+L++     K+ DFG++    GN   +     +G   YM+PE        
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVS----GNLVASLAKTNIGCQSYMAPERIKSGGPN 179

Query: 661 GR--FSEKSDVFSFGVLLLEIVSGR 683
               ++ +SDV+S G+ +LE+  GR
Sbjct: 180 QNPTYTVQSDVWSLGLSILEMALGR 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 65.0 bits (158), Expect = 4e-11
 Identities = 65/212 (30%), Positives = 101/212 (47%), Gaps = 38/212 (17%)

Query: 490 LGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV 548
           +G+G FG VY  R KD + I A+K LSK      +E + +  V   +  RN+   L   +
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSK------KEIVAKKEVAHTIGERNI---LVRTL 51

Query: 549 EGE---------------EKMLIYEYMPNRSLDALLFDPLKKE-RL-DWRKRFNIIEGIS 591
             E               +  L+ +YM    L    F  L+KE R  + R +F I E + 
Sbjct: 52  LDESPFIVGLKFSFQTDSDLYLVTDYMSGGEL----FWHLQKEGRFSEDRAKFYIAELV- 106

Query: 592 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFG 651
             L +LH+     I++RDLK  NILLD   +  + DFG++K      D   T    GT  
Sbjct: 107 LALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTE 161

Query: 652 YMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSG 682
           Y++PE  ++ + +++  D +S GVL+ E+  G
Sbjct: 162 YLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 64.6 bits (157), Expect = 4e-11
 Identities = 63/209 (30%), Positives = 97/209 (46%), Gaps = 18/209 (8%)

Query: 490 LGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEF---MNEVMVISKLQHRNLVRLLG 545
           LG+G FG V   R K  G+  A+K L K      +E    + E  V+   +H  L  L  
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62

Query: 546 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGLLYLHRDSRL 603
                +    + EY     L    F  L +ER+  + R RF   E +S  L YLH     
Sbjct: 63  AFQTHDRLCFVMEYANGGEL----FFHLSRERVFTEERARFYGAEIVS-ALEYLHSRD-- 115

Query: 604 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRF 663
            +++RD+K  N++LD++ + KI+DFG+ K   G  D A      GT  Y++PE   +  +
Sbjct: 116 -VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDY 172

Query: 664 SEKSDVFSFGVLLLEIVSGRKNTSFFEDD 692
               D +  GV++ E++ GR    F+  D
Sbjct: 173 GRAVDWWGLGVVMYEMMCGR--LPFYNQD 199

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 64.3 bits (156), Expect = 7e-11
 Identities = 66/216 (30%), Positives = 105/216 (48%), Gaps = 22/216 (10%)

Query: 490 LGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEE---FMNEVMVISK-LQHRNLVRLL 544
           +G+G FG V   R K  ++  AVK L K +    +E    M+E  V+ K ++H  LV L 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 545 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER--LDWRKRFNIIEGISRGLLYLHRDSR 602
                 ++   + +Y+    L    F  L++ER  L+ R RF   E I+  L YLH    
Sbjct: 63  FSFQTADKLYFVLDYINGGEL----FYHLQRERCFLEPRARFYAAE-IASALGYLHS--- 114

Query: 603 LRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGR 662
           L I++RDLK  NILLD + +  ++DFG+ K     +    T    GT  Y++PE   +  
Sbjct: 115 LNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQP 172

Query: 663 FSEKSDVFSFGVLLLEIVSG-----RKNTSFFEDDL 693
           +    D +  G +L E++ G      +NT+   D++
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI 208

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 64.3 bits (156), Expect = 7e-11
 Identities = 64/209 (30%), Positives = 99/209 (47%), Gaps = 17/209 (8%)

Query: 490 LGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEF---MNEVMVISKLQHRNLVRLLG 545
           LG+G FG V   + K  G+  A+K L K      +E    + E  V+   +H  L  L  
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62

Query: 546 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGLLYLHRDSRL 603
                +    + EY     L    F  L +ER+  + R RF   E +S  L YLH  S  
Sbjct: 63  SFQTHDRLCFVMEYANGGEL----FFHLSRERVFSEDRARFYGAEIVS-ALDYLH--SEK 115

Query: 604 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRF 663
            +++RDLK  N++LD++ + KI+DFG+ K   G +D A      GT  Y++PE   +  +
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDY 173

Query: 664 SEKSDVFSFGVLLLEIVSGRKNTSFFEDD 692
               D +  GV++ E++ GR    F+  D
Sbjct: 174 GRAVDWWGLGVVMYEMMCGR--LPFYNQD 200

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 65.3 bits (159), Expect = 7e-11
 Identities = 35/92 (38%), Positives = 55/92 (59%), Gaps = 2/92 (2%)

Query: 594 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV-VGTFGY 652
           LL +H      +IHRD+K++NILL      K+ DFG +K++       D GR   GT  Y
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYA-ATVSDDVGRTFCGTPYY 211

Query: 653 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRK 684
           ++PE      +S+K+D+FS GVLL E+++ ++
Sbjct: 212 VAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243

Length = 496

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 63.9 bits (155), Expect = 8e-11
 Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 15/200 (7%)

Query: 490 LGQGGFGPVYWGRLKDGQEIAVKRLSKAS----GQGLEEFMNEVMVISKLQHRNLVRLLG 545
           +G+G +  V   RLK  + I   ++ K       + ++    E  V  +  +   +  L 
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 546 CCVEGEEKML-IYEYMPNRSLDALLFDPLKKERL-DWRKRFNIIEGISRGLLYLHRDSRL 603
            C + E ++  + EY+    L   +F   ++ +L +   RF   E IS  L YLH     
Sbjct: 63  SCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAE-ISLALNYLHERG-- 116

Query: 604 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRF 663
            II+RDLK  N+LLD E + K++D+GM K   G +    T    GT  Y++PE      +
Sbjct: 117 -IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDY 173

Query: 664 SEKSDVFSFGVLLLEIVSGR 683
               D ++ GVL+ E+++GR
Sbjct: 174 GFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 63.8 bits (155), Expect = 8e-11
 Identities = 63/212 (29%), Positives = 107/212 (50%), Gaps = 21/212 (9%)

Query: 483 NFQLSSKLGQGGFGPVYWGRLKDGQE----IAVKRLSKAS----GQGLEEFMNEVMVISK 534
           NF+L   LG G +G V+  R   G +     A+K L KA+     + +E    E  V+  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 535 LQHRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLF--DPLKKERLDWRKRFNIIEGIS 591
           ++    +  L    + E K+ LI +Y+    +   L+  D   ++ +    RF   E I 
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEV----RFYSGE-II 115

Query: 592 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFG 651
             L +LH+   L I++RD+K  NILLD E +  ++DFG++K F  ++++  T    GT  
Sbjct: 116 LALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEF-LSEEKERTYSFCGTIE 171

Query: 652 YMSPEYAM-EGRFSEKSDVFSFGVLLLEIVSG 682
           YM+PE    +G   +  D +S G+L+ E+++G
Sbjct: 172 YMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 68/271 (25%), Positives = 126/271 (46%), Gaps = 35/271 (12%)

Query: 490 LGQGGFGPVYWGRLKDG-QEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGC 546
           +G+G FG     +  +  Q+ A+K  RL K+S   +E+   E ++++K++H N+V     
Sbjct: 8   VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS-SAVEDSRKEAVLLAKMKHPNIVAFKES 66

Query: 547 CVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 605
             E +  + ++ EY         L   +K +R        I++   +  L +      R+
Sbjct: 67  -FEADGHLYIVMEYCD----GGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRV 121

Query: 606 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSE 665
           +HRD+K+ NI L +    K+ DFG A++       A T   VGT  Y+ PE      ++ 
Sbjct: 122 LHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEIWENMPYNN 179

Query: 666 KSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILAL----VDPFLSESSF 721
           KSD++S G +L E+ + +     F+ +      +WK    N IL +      P  S  S+
Sbjct: 180 KSDIWSLGCILYELCTLKHP---FQAN------SWK----NLILKVCQGSYKPLPSHYSY 226

Query: 722 QLDMIIRCIHVGLLCVQELVKDRPNMSTVVS 752
           +L  +I+ +       +   + RP+ +T++S
Sbjct: 227 ELRSLIKQM------FKRNPRSRPSATTILS 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 63.6 bits (155), Expect = 1e-10
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 37/219 (16%)

Query: 484 FQLSSKLGQGGFGPVYWGRL--KDGQEIAVKRLSKASGQGLEEFMN---------EVMVI 532
            +    +G G FG V W     +DG+ +A+K++          F N         E+ ++
Sbjct: 2   VEPDRPIGYGAFG-VVWSVTDPRDGKRVALKKMPNV-------FQNLVSCKRVFRELKML 53

Query: 533 SKLQHRNLVRLLGCCVEG-----EEKMLIYEYMPNRSLDALLFDPLKKERL--DWRKRFN 585
              +H N++  L           EE  ++ E M    L  ++  P   + L  D  K F 
Sbjct: 54  CFFKHDNVLSALDILQPPHIDPFEEIYVVTELM-QSDLHKIIVSP---QPLSSDHVKVF- 108

Query: 586 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 645
            +  I RGL YLH      I+HRD+K  N+L++     KI DFG+A++   ++ +  T  
Sbjct: 109 -LYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQE 164

Query: 646 VVGTFGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 683
           VV  + Y +PE  M  R ++   D++S G +  E++  R
Sbjct: 165 VVTQY-YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 63.5 bits (155), Expect = 1e-10
 Identities = 33/100 (33%), Positives = 55/100 (55%), Gaps = 11/100 (11%)

Query: 590 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV--- 646
           + RGL Y+H  +   +IHRDLK SN+L++E+   +I DFGMA+  G +    +       
Sbjct: 116 LLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR--GLSSSPTEHKYFMTE 170

Query: 647 -VGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRK 684
            V T  Y +PE  +    ++   D++S G +  E++ GR+
Sbjct: 171 YVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRR 209

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 53/205 (25%), Positives = 101/205 (49%), Gaps = 10/205 (4%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRL--SKASGQGLEEFMNEVMVISKLQHR 538
           N F++   +G+G +G V   R K+ +EI A+K+   S+ + +  E  + E+ ++  L+  
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           N+V L        +  L++EY+    L+  L + +       + R  I + I + + + H
Sbjct: 61  NIVELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIYQLI-KAIHWCH 117

Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 658
           ++    I+HRD+K  N+L+      K+ DFG A+      + A+    V T  Y SPE  
Sbjct: 118 KND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN-ANYTEYVATRWYRSPELL 173

Query: 659 MEGRFSEKSDVFSFGVLLLEIVSGR 683
           +   + +  D++S G +L E+  G+
Sbjct: 174 LGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 63.5 bits (154), Expect = 1e-10
 Identities = 38/92 (41%), Positives = 54/92 (58%), Gaps = 3/92 (3%)

Query: 590 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 649
           +++G+ +L   SR + IHRDL A NILL E    KI DFG+A+    + D    G     
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244

Query: 650 FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
             +M+PE   +  ++ +SDV+SFGVLL EI S
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 63.1 bits (153), Expect = 2e-10
 Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 13/206 (6%)

Query: 483 NFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSK---ASGQGLEEFMNEVMVISKLQHR 538
           +F     LG+G FG V     K   E+ A+K L K        +E  M E  V++     
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60

Query: 539 NLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 597
             +  L  C +  +++  + EY+    L   ++   +  R            I+ GL +L
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYQIQQVGRFKEPHAVFYAAEIAIGLFFL 117

Query: 598 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEY 657
           H      II+RDLK  N++LD E + KI+DFGM K      D   T    GT  Y++PE 
Sbjct: 118 HSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDYIAPEI 172

Query: 658 AMEGRFSEKSDVFSFGVLLLEIVSGR 683
                + +  D ++FGVLL E+++G+
Sbjct: 173 IAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 62.9 bits (153), Expect = 2e-10
 Identities = 66/254 (25%), Positives = 100/254 (39%), Gaps = 44/254 (17%)

Query: 484 FQLSSKLGQGGFGPVY----WGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 539
           + + S L  G  G V+     G  +  +++ VK ++     G      E+ ++  + HR 
Sbjct: 94  YNILSSLTPGSEGEVFVCTKHGD-EQRKKVIVKAVTGGKTPG-----REIDILKTISHRA 147

Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLYLH 598
           ++ L+        K  +   MP    D  LF  + +   L   +   I   +   L YLH
Sbjct: 148 IINLIHAY---RWKSTVCMVMPKYKCD--LFTYVDRSGPLPLEQAITIQRRLLEALAYLH 202

Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 658
                 IIHRD+K  NI LDE  N  + DFG A     + D        GT    SPE  
Sbjct: 203 GRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELL 259

Query: 659 MEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSE 718
               +  K+D++S G++L E+    KN + F               + K           
Sbjct: 260 ALDPYCAKTDIWSAGLVLFEMSV--KNVTLFG-------------KQVK----------S 294

Query: 719 SSFQLDMIIRCIHV 732
           SS QL  IIRC+ V
Sbjct: 295 SSSQLRSIIRCMQV 308

Length = 392

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 62.4 bits (151), Expect = 2e-10
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 15/209 (7%)

Query: 490 LGQGGFGPVYWGRLKDGQEIAVKRLSKAS----GQGLEEFMNEVMVISKLQHRNLVRLLG 545
           +G+G +  V   RLK   +I   ++ K       + ++    E  V  +      +  L 
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62

Query: 546 CCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERL-DWRKRFNIIEGISRGLLYLHRDSRL 603
            C +   ++ L+ EY+    L   +F   ++ +L +   RF   E I   L +LH     
Sbjct: 63  SCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAE-ICIALNFLHERG-- 116

Query: 604 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRF 663
            II+RDLK  N+LLD + + K++D+GM K   G  D   T    GT  Y++PE      +
Sbjct: 117 -IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST--FCGTPNYIAPEILRGEEY 173

Query: 664 SEKSDVFSFGVLLLEIVSGRKNTSFFEDD 692
               D ++ GVL+ E+++GR       D+
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIITDN 202

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 62.3 bits (151), Expect = 3e-10
 Identities = 63/201 (31%), Positives = 99/201 (49%), Gaps = 19/201 (9%)

Query: 490 LGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISK-LQHRNLVRLL 544
           +G+G FG V   + K DG+  AVK L K    + +  +  M E  V+ K ++H  LV L 
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 545 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGLLYLHRDSR 602
                 E+   + +++    L    F  L++ER   + R RF   E I+  L YLH    
Sbjct: 63  YSFQTTEKLYFVLDFVNGGEL----FFHLQRERSFPEPRARFYAAE-IASALGYLHS--- 114

Query: 603 LRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV-VGTFGYMSPEYAMEG 661
           + I++RDLK  NILLD + +  ++DFG+ K       Q+DT     GT  Y++PE   + 
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCK---EGIAQSDTTTTFCGTPEYLAPEVIRKQ 171

Query: 662 RFSEKSDVFSFGVLLLEIVSG 682
            +    D +  G +L E++ G
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 61.4 bits (149), Expect = 3e-10
 Identities = 59/203 (29%), Positives = 93/203 (45%), Gaps = 16/203 (7%)

Query: 483 NFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGLE-EFMNEVMVISKLQHRNL 540
           + Q    LG G  G VY    L   + +AVK +       L+ + M+E+ ++ K     +
Sbjct: 2   DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYI 61

Query: 541 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 600
           +   G         +  E+M   SLD     P   E +  R    I   + +GL YL   
Sbjct: 62  IGFYGAFFVENRISICTEFMDGGSLDVYRKIP---EHVLGR----IAVAVVKGLTYLWS- 113

Query: 601 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
             L+I+HRD+K SN+L++     K+ DFG++     +   A T   VGT  YM+PE    
Sbjct: 114 --LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--AKT--YVGTNAYMAPERISG 167

Query: 661 GRFSEKSDVFSFGVLLLEIVSGR 683
            ++   SDV+S G+  +E+  GR
Sbjct: 168 EQYGIHSDVWSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 61.1 bits (148), Expect = 4e-10
 Identities = 55/199 (27%), Positives = 96/199 (48%), Gaps = 13/199 (6%)

Query: 489 KLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLE-EFMNEVMVISKLQHRNLVRLLGC 546
           KLG+G +  VY G  + +GQ +A+K +S  + +G+    + E  ++  L+H N+V L   
Sbjct: 12  KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71

Query: 547 CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRK-RFNIIEGISRGLLYLHRDSRLRI 605
               E    ++EYM       ++  P      + R   F ++    RGL Y+H      I
Sbjct: 72  IHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLL----RGLAYIHGQ---HI 124

Query: 606 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG-RFS 664
           +HRDLK  N+L+      K++DFG+A+       Q  +  VV T  Y  P+  +    +S
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLARA-KSIPSQTYSSEVV-TLWYRPPDVLLGATDYS 182

Query: 665 EKSDVFSFGVLLLEIVSGR 683
              D++  G + +E++ G+
Sbjct: 183 SALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 61.8 bits (150), Expect = 4e-10
 Identities = 62/220 (28%), Positives = 105/220 (47%), Gaps = 31/220 (14%)

Query: 483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHR 538
           +F++   LG G FG V   + K  G+  A+K L K      + ++    E  ++ +L H 
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78

Query: 539 NLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRF--NIIEGISRGLL 595
            +V ++ C  + E ++  + E++    +   LF  L+K       RF  ++ +     L+
Sbjct: 79  FIVNMM-CSFQDENRVYFLLEFV----VGGELFTHLRKA-----GRFPNDVAKFYHAELV 128

Query: 596 ----YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFG 651
               YLH      II+RDLK  N+LLD + + K++DFG AK     +    T  + GT  
Sbjct: 129 LAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPE 180

Query: 652 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFED 691
           Y++PE        +  D ++ GVLL E ++G     FF+D
Sbjct: 181 YLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYP--PFFDD 218

Length = 329

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 61.2 bits (148), Expect = 5e-10
 Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 25/205 (12%)

Query: 489 KLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLE-EFMNEVMVISKLQHRNLVRLLGC 546
           KLG+G +  V+ GR K     +A+K +     +G     + EV ++  L+H N+V L   
Sbjct: 12  KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71

Query: 547 CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGIS-------RGLLYLHR 599
                   L++EY     LD+ L     K+ LD       +  +        RGL Y H+
Sbjct: 72  IHTERCLTLVFEY-----LDSDL-----KQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK 121

Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 659
               +I+HRDLK  N+L++E+   K++DFG+A+    +         V T  Y  P+  +
Sbjct: 122 R---KILHRDLKPQNLLINEKGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVLL 176

Query: 660 -EGRFSEKSDVFSFGVLLLEIVSGR 683
               +S   D++  G +L E+ +GR
Sbjct: 177 GSTEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 61.1 bits (148), Expect = 7e-10
 Identities = 53/208 (25%), Positives = 95/208 (45%), Gaps = 22/208 (10%)

Query: 483 NFQLSSKLGQGGFGPVYWGRLKDGQ--EIAVKRLSKAS---GQGLEEFMNEVMVISKLQH 537
           +F     LG G FG V     K+     +A+KR  K+     + ++   +E  +++ + H
Sbjct: 31  DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH 90

Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGI---SRGL 594
              V L G   +     L+ E++    +    F  L++      KRF    G    ++ +
Sbjct: 91  PFCVNLYGSFKDESYLYLVLEFV----IGGEFFTFLRRN-----KRFPNDVGCFYAAQIV 141

Query: 595 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 654
           L       L I++RDLK  N+LLD++   K++DFG AK+         T  + GT  Y++
Sbjct: 142 LIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV-----DTRTYTLCGTPEYIA 196

Query: 655 PEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           PE  +     + +D ++ G+ + EI+ G
Sbjct: 197 PEILLNVGHGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 61.0 bits (148), Expect = 7e-10
 Identities = 57/200 (28%), Positives = 94/200 (47%), Gaps = 15/200 (7%)

Query: 490 LGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEEF---MNEVMVISKLQHRNLVRLLG 545
           +G+G +  V    LK  + I A+K + K      E+      E  V     +   +  L 
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62

Query: 546 CCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERL-DWRKRFNIIEGISRGLLYLHRDSRL 603
            C + E ++  + E++    L   +F   ++ +L +   RF   E IS  L +LH     
Sbjct: 63  SCFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYSAE-ISLALNFLHERG-- 116

Query: 604 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRF 663
            II+RDLK  N+LLD E + K++D+GM K   G +    T    GT  Y++PE      +
Sbjct: 117 -IIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPEILRGEDY 173

Query: 664 SEKSDVFSFGVLLLEIVSGR 683
               D ++ GVL+ E+++GR
Sbjct: 174 GFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 60.8 bits (147), Expect = 1e-09
 Identities = 52/185 (28%), Positives = 93/185 (50%), Gaps = 20/185 (10%)

Query: 506 GQEIAVKRLSK--ASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV------EGEEKMLIY 557
           G  +AVK+LS+   +    +    E++++  + H+N++ LL          E ++  L+ 
Sbjct: 46  GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105

Query: 558 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
           E M + +L  ++   L  ER+ +     ++  +  G+ +LH      IIHRDLK SNI++
Sbjct: 106 ELM-DANLCQVIHMELDHERMSY-----LLYQMLCGIKHLHSAG---IIHRDLKPSNIVV 156

Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
             +   KI DFG+A+    N     T  VV  + Y +PE  +   + E  D++S G ++ 
Sbjct: 157 KSDCTLKILDFGLARTACTNFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMG 213

Query: 678 EIVSG 682
           E+V G
Sbjct: 214 ELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 61.7 bits (149), Expect = 1e-09
 Identities = 69/248 (27%), Positives = 112/248 (45%), Gaps = 48/248 (19%)

Query: 473 QFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEE-----FMN 527
           ++++  +  N +++  K+G G FG V+  + K  QE    +    S +GL+E      + 
Sbjct: 4   KYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWK--AISYRGLKEREKSQLVI 61

Query: 528 EVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNII 587
           EV V+ +L+H+N+VR +   +    + L   Y+     DA     L +      K F  I
Sbjct: 62  EVNVMRELKHKNIVRYIDRFLNKANQKL---YILMEFCDA---GDLSRNIQKCYKMFGKI 115

Query: 588 E-----GISRGLL----YLHR----DSRLRIIHRDLKASNILLD-------------EEL 621
           E      I+R LL    Y H      +  R++HRDLK  NI L                L
Sbjct: 116 EEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNL 175

Query: 622 N----PKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME--GRFSEKSDVFSFGVL 675
           N     KI DFG++K  G    ++     VGT  Y SPE  +     + +KSD+++ G +
Sbjct: 176 NGRPIAKIGDFGLSKNIG---IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCI 232

Query: 676 LLEIVSGR 683
           + E+ SG+
Sbjct: 233 IYELCSGK 240

Length = 1021

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 60.4 bits (146), Expect = 2e-09
 Identities = 70/250 (28%), Positives = 115/250 (46%), Gaps = 22/250 (8%)

Query: 473 QFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEE---FMNE 528
           +  +L     ++++   +G+G FG V   R K  +++ A+K LSK       +   F  E
Sbjct: 34  KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 93

Query: 529 VMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE 588
             +++      +V+L     +     ++ EYMP   L  L+ +    E+  W  RF   E
Sbjct: 94  RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK--W-ARFYTAE 150

Query: 589 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA-KIFGGNQDQADTGRVV 647
            +    L L     +  IHRD+K  N+LLD+  + K++DFG   K+      + DT   V
Sbjct: 151 VV----LALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA--V 204

Query: 648 GTFGYMSPEY----AMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLW 703
           GT  Y+SPE       +G +  + D +S GV L E++ G  +T F+ D L  +G   K+ 
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG--DTPFYADSL--VGTYSKIM 260

Query: 704 NENKILALVD 713
           N    L   D
Sbjct: 261 NHKNSLTFPD 270

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 58.3 bits (141), Expect = 3e-09
 Identities = 61/238 (25%), Positives = 102/238 (42%), Gaps = 38/238 (15%)

Query: 490 LGQGGFGPVYWG---RLKDGQ-----EIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 541
           LGQG F  ++ G    + D       E+ +K L K+     E F     ++S+L H++LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 542 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
              G CV G+E +++ EY+   SLD  L        + W+    + + ++  L +L    
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK--LEVAKQLAWALHFLEDKG 120

Query: 602 RLRIIHRDLKASNILLDEEL-----NP---KISDFGMAKIFGGNQDQADTGRVVGTFGYM 653
              + H ++ A N+LL  E      NP   K+SD G++      +       ++    ++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKE------ILLERIPWV 171

Query: 654 SPEYAMEGR-FSEKSDVFSFGVLLLEIVSG----------RKNTSFFEDDLTILGYAW 700
            PE     +  S  +D +SFG  L EI SG          +K   F+ED   +    W
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLPAPKW 229

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 59.3 bits (144), Expect = 3e-09
 Identities = 55/193 (28%), Positives = 93/193 (48%), Gaps = 34/193 (17%)

Query: 506 GQEIAVKRLSKASGQGLEEFMN---------EVMVISKLQHRNLVRLLGCCV------EG 550
           GQ +A+K+LS+        F N         E++++  + H+N++ LL          E 
Sbjct: 41  GQNVAIKKLSRP-------FQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93

Query: 551 EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDL 610
           ++  L+ E M     DA L   ++ + LD  +   ++  +  G+ +LH      IIHRDL
Sbjct: 94  QDVYLVMELM-----DANLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSAG---IIHRDL 144

Query: 611 KASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVF 670
           K SNI++  +   KI DFG+A+  G       T  VV T  Y +PE  +   + E  D++
Sbjct: 145 KPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVV-TRYYRAPEVILGMGYKENVDIW 201

Query: 671 SFGVLLLEIVSGR 683
           S G ++ E++ G 
Sbjct: 202 SVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 58.9 bits (143), Expect = 3e-09
 Identities = 52/224 (23%), Positives = 93/224 (41%), Gaps = 46/224 (20%)

Query: 486 LSSKLGQG--GFGPVYWGRLKD-GQEIAVKR--LSKASGQGLEEFMNEVMVISKLQHRNL 540
           L + +G+       V+  + K     +AVK+  L   S + L+    E++   +LQH N+
Sbjct: 2   LLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNI 61

Query: 541 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF----------NIIEGI 590
           +  +   +   E  ++   M   S + LL           +  F           I++ +
Sbjct: 62  LPYVTSFIVDSELYVVSPLMAYGSCEDLL-----------KTHFPEGLPELAIAFILKDV 110

Query: 591 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDF-GMAKIFGGNQDQADTGRVVGT 649
              L Y+H       IHR +KAS+ILL  +    +S       +    + Q    RVV  
Sbjct: 111 LNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ----RVVHD 163

Query: 650 FG--------YMSPEY---AMEGRFSEKSDVFSFGVLLLEIVSG 682
           F         ++SPE     ++G ++EKSD++S G+   E+ +G
Sbjct: 164 FPKSSVKNLPWLSPEVLQQNLQG-YNEKSDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 58.3 bits (141), Expect = 5e-09
 Identities = 60/223 (26%), Positives = 103/223 (46%), Gaps = 24/223 (10%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEE---FMNEVMVISKLQH 537
            +F + S +G+G FG V   R K   +I A+K + K+     E    F  E  ++S    
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL---FDPLKKERLDWRKRFNIIEGISRGL 594
             + +L     + +   L+ EY P   L +LL    D   ++      +F + E +    
Sbjct: 61  PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMA----QFYLAELV---- 112

Query: 595 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 654
           L +H   ++  +HRD+K  N+L+D   + K++DFG A     N+   ++   VGT  Y++
Sbjct: 113 LAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK-MVNSKLPVGTPDYIA 171

Query: 655 PEY--AMEG----RFSEKSDVFSFGVLLLEIVSGRKNTSFFED 691
           PE    M G     +  + D +S GV+  E++ GR  + F E 
Sbjct: 172 PEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR--SPFHEG 212

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 58.2 bits (140), Expect = 5e-09
 Identities = 54/205 (26%), Positives = 98/205 (47%), Gaps = 13/205 (6%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHR 538
           ++++   KLG+G +  VY G+ K +G+ +A+K  RL +  G      + E  ++  L+H 
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTA-IREASLLKGLKHA 63

Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           N+V L       E   L++EY+       +   P      +  K F  +  + RGL Y+H
Sbjct: 64  NIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHP-GGLHPENVKLF--LFQLLRGLSYIH 120

Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 658
           +     I+HRDLK  N+L+ +    K++DFG+A+    +         V T  Y  P+  
Sbjct: 121 QRY---ILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRPPDVL 175

Query: 659 M-EGRFSEKSDVFSFGVLLLEIVSG 682
           +    +S   D++  G + +E++ G
Sbjct: 176 LGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 57.5 bits (139), Expect = 1e-08
 Identities = 71/271 (26%), Positives = 124/271 (45%), Gaps = 32/271 (11%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEE---FMNEVMVISKLQH 537
           ++F++   +G+G FG V   ++K+  ++ A+K L+K       E   F  E  V+     
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60

Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL--FDPLKKERLDWRKRFNIIEGISRGLL 595
           R +  L     +     L+ +Y     L  LL  F+    E +    RF + E +    L
Sbjct: 61  RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDM---ARFYLAEMV----L 113

Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA-KIFGGNQDQADTGRVVGTFGYMS 654
            +    +L  +HRD+K  N+LLD+  + +++DFG   ++      Q++    VGT  Y+S
Sbjct: 114 AIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVA--VGTPDYIS 171

Query: 655 PEY--AME---GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKI- 708
           PE   AME   GR+  + D +S GV + E++ G   T F+ + L +  Y   + ++    
Sbjct: 172 PEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE--TPFYAESL-VETYGKIMNHKEHFQ 228

Query: 709 LALVDPFLSESSFQLDMIIRCIHVGLLCVQE 739
                  +SE +   D+I R     L+C  E
Sbjct: 229 FPPDVTDVSEEA--KDLIRR-----LICSPE 252

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 56.9 bits (137), Expect = 1e-08
 Identities = 66/230 (28%), Positives = 107/230 (46%), Gaps = 35/230 (15%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEEFMNEVMVISKLQHRNL 540
           ++F++   +G+G FG V   ++K  + I A+K L+K       E +         + RN+
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKW------EMLKRAETACFREERNV 54

Query: 541 --------VRLLGCCVEGEEKM-LIYEYMPNRSLDALL--FDPLKKERLDWRKRFNIIEG 589
                   +  L    + E  + L+ +Y     L  LL  F+    E +    RF I E 
Sbjct: 55  LVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDM---ARFYIAEM 111

Query: 590 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV-VG 648
           +    L +H   +L  +HRD+K  N+LLD   + +++DFG       NQD      V VG
Sbjct: 112 V----LAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFG--SCLKMNQDGTVQSSVAVG 165

Query: 649 TFGYMSPEY--AME---GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDL 693
           T  Y+SPE   AME   G++  + D +S GV + E++ G   T F+ + L
Sbjct: 166 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE--TPFYAESL 213

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 57.2 bits (138), Expect = 2e-08
 Identities = 30/76 (39%), Positives = 42/76 (55%)

Query: 606 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSE 665
           IHRDL A NILL      KI DFG+A+    + +    G       +M+PE      ++ 
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTF 295

Query: 666 KSDVFSFGVLLLEIVS 681
           +SDV+S+G+LL EI S
Sbjct: 296 ESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 57.0 bits (137), Expect = 2e-08
 Identities = 37/125 (29%), Positives = 61/125 (48%), Gaps = 4/125 (3%)

Query: 557 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNIL 616
           Y+   +  +  LL D    E L      +    ++RG+ +L   +    +HRDL A N+L
Sbjct: 214 YKGSNDSEVKNLLSDDGS-EGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVL 269

Query: 617 LDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLL 676
           L +    KI DFG+A+    + +    G       +M+PE   +  ++  SDV+S+G+LL
Sbjct: 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILL 329

Query: 677 LEIVS 681
            EI S
Sbjct: 330 WEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 56.9 bits (137), Expect = 2e-08
 Identities = 45/173 (26%), Positives = 75/173 (43%), Gaps = 26/173 (15%)

Query: 528 EVMVISKLQHRNLVRLLG--------CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD 579
           E  ++  + H ++++L G        C +    K  +Y Y+  +   A+  D L  ER  
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKRNIAIC-DILAIER-- 189

Query: 580 WRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 639
                     + R + YLH +   RIIHRD+KA NI ++   +  + DFG A  F  + +
Sbjct: 190 ---------SVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDIN 236

Query: 640 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDD 692
                   GT    +PE      +    D++S G++L E+ +     S FE D
Sbjct: 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHD--SLFEKD 287

Length = 391

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 55.5 bits (134), Expect = 3e-08
 Identities = 46/158 (29%), Positives = 78/158 (49%), Gaps = 32/158 (20%)

Query: 489 KLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLE-EFMNEVMVISKLQHRNLVRLLGC 546
           KLG+G +  VY GR K  GQ +A+K +     +G     + E  ++  L+H N+V  L  
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIV-TLHD 70

Query: 547 CVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKR-----------FNIIEGISRGL 594
            +  ++ + L++EY+ +  L         K+ +D               F ++    RGL
Sbjct: 71  IIHTKKTLTLVFEYL-DTDL---------KQYMDDCGGGLSMHNVRLFLFQLL----RGL 116

Query: 595 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 632
            Y H+    R++HRDLK  N+L+ E    K++DFG+A+
Sbjct: 117 AYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 55.6 bits (134), Expect = 3e-08
 Identities = 59/237 (24%), Positives = 106/237 (44%), Gaps = 49/237 (20%)

Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKR-LSKASGQGL-EEFMNEVMVISKLQHR 538
           + ++   K+G+G +G VY  R    G+ +A+K+   +   +G+    + E+ ++  L   
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60

Query: 539 N-LVRLLGCCVEGEEK-------MLIYEYM--------------PNRSLDALLFDPLKKE 576
             +VRLL   VE  E+        L++EY+              P R L A         
Sbjct: 61  IYIVRLL--DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTI------ 112

Query: 577 RLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP-KISDFGMAKIFG 635
                K F  +  + +G+ + H+     ++HRDLK  N+L+D++    KI+D G+ + F 
Sbjct: 113 -----KSF--MYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF- 161

Query: 636 GNQDQADTGRVVGTFGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGRKNTSFFED 691
               ++ T  +V T  Y +PE  +    +S   D++S G +  E+   RK   F  D
Sbjct: 162 SIPVKSYTHEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS--RKQPLFPGD 215

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 55.9 bits (135), Expect = 4e-08
 Identities = 54/216 (25%), Positives = 103/216 (47%), Gaps = 24/216 (11%)

Query: 483 NFQLSSKLGQGGFGPVYWGRLK---DGQEIAVKRLSKASGQGL--EEFMNEVMVISKLQ- 536
            ++L  +LGQG +G V   R     + + +A+K+++    + +  +  + E+ ++   + 
Sbjct: 1   RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG 60

Query: 537 HRNLVRLLGCCV---EGEEKMLIYEYMPNRSLDALLFD--PLKKERLDWRKRFNIIEGIS 591
           H+N+  L    +       ++ +YE +    L  ++    PL        + F  I  I 
Sbjct: 61  HKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHF---QSF--IYQIL 115

Query: 592 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD---TGRVVG 648
            GL Y+H  +   ++HRDLK  N+L++ +   KI DFG+A+ F  N  +     T   V 
Sbjct: 116 CGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTE-YVA 171

Query: 649 TFGYMSPEYAMEGRFSEKS-DVFSFGVLLLEIVSGR 683
           T  Y +PE  +  +   K+ DV+S G +L E++  +
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 54.8 bits (132), Expect = 4e-08
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 39/216 (18%)

Query: 490 LGQGGFGPVYWGRLKD---------GQEIAVKR-LSKASGQGLEEFMNEVMVISKLQHRN 539
           LGQG F  +Y G L+          GQE++V   +  +  +    F     ++S+L H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER----LDWRKRFNIIEGISRGLL 595
           LV+L G CV  E  M + EY+    LD      L +E+    L W  + ++ + ++  L 
Sbjct: 63  LVKLYGVCVRDENIM-VEEYVKFGPLDVF----LHREKNNVSLHW--KLDVAKQLASALH 115

Query: 596 YLHRDSRLRIIHRDLKASNILL-----DEELNP--KISDFGMAKIFGGNQDQADTGRVVG 648
           YL      +++H ++   NIL+     +E   P  K+SD G+       +++      V 
Sbjct: 116 YLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREER------VE 166

Query: 649 TFGYMSPEYAMEGRFSEKS--DVFSFGVLLLEIVSG 682
              +++PE    G+ S     D +SFG  LLEI S 
Sbjct: 167 RIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSN 202

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 55.9 bits (134), Expect = 4e-08
 Identities = 51/182 (28%), Positives = 92/182 (50%), Gaps = 20/182 (10%)

Query: 507 QEIAVKRLSK--ASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV------EGEEKMLIYE 558
           + +A+K+LS+   +    +    E++++  + H+N++ LL          E ++  L+ E
Sbjct: 43  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVME 102

Query: 559 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD 618
            M     DA L   ++ E LD  +   ++  +  G+ +LH      IIHRDLK SNI++ 
Sbjct: 103 LM-----DANLCQVIQME-LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVK 153

Query: 619 EELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLE 678
            +   KI DFG+A+  G +     T  VV  + Y +PE  +   + E  D++S G ++ E
Sbjct: 154 SDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGE 210

Query: 679 IV 680
           +V
Sbjct: 211 MV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 55.8 bits (134), Expect = 6e-08
 Identities = 44/161 (27%), Positives = 77/161 (47%), Gaps = 14/161 (8%)

Query: 527 NEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNI 586
           +E+  ++   H  +V+        ++ +LI EY     L+  +     K+RL     F  
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI-----KQRLKEHLPFQE 168

Query: 587 IEGISRGLLY------LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ 640
            E    GLL+      L      +++HRDLK++NI L      K+ DFG +K +  +   
Sbjct: 169 YEV---GLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225

Query: 641 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
                  GT  Y++PE     R+S+K+D++S GV+L E+++
Sbjct: 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266

Length = 478

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 55.1 bits (132), Expect = 7e-08
 Identities = 51/182 (28%), Positives = 92/182 (50%), Gaps = 14/182 (7%)

Query: 507 QEIAVKRLSK--ASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG---EEKMLIYEYMP 561
           + +A+K+LS+   +    +    E++++  + H+N++ LL         EE   +Y  M 
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVM- 108

Query: 562 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL 621
              +DA L   ++ E LD  +   ++  +  G+ +LH      IIHRDLK SNI++  + 
Sbjct: 109 -ELMDANLCQVIQME-LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDC 163

Query: 622 NPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
             KI DFG+A+  G +     T  VV  + Y +PE  +   + E  D++S G ++ E++ 
Sbjct: 164 TLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIK 220

Query: 682 GR 683
           G 
Sbjct: 221 GG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 54.7 bits (132), Expect = 8e-08
 Identities = 36/94 (38%), Positives = 53/94 (56%), Gaps = 7/94 (7%)

Query: 592 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFG 651
           RGL Y+H  +   ++HRDLK SN+LL+   + KI DFG+A+      D   T  VV T  
Sbjct: 119 RGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM-TEYVV-TRW 173

Query: 652 YMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRK 684
           Y +PE  +    ++   DV+S G +  E++ GRK
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 55.7 bits (134), Expect = 8e-08
 Identities = 50/165 (30%), Positives = 77/165 (46%), Gaps = 32/165 (19%)

Query: 484 FQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEEFMNEVMVISKLQHRN--- 539
           F +   + +G FG VY GR K+  ++ AVK + KA      + +N+ MV      R+   
Sbjct: 6   FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKA------DMINKNMVHQVQAERDALA 59

Query: 540 ------LVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----FDPLKKERLDWRKRFNIIE 588
                 +V L           L+ EY+    + +LL     FD    E +       I E
Sbjct: 60  LSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFD----EEM---AVKYISE 112

Query: 589 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 633
            ++  L YLHR     IIHRDLK  N+L+  E + K++DFG++K+
Sbjct: 113 -VALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 54.3 bits (131), Expect = 1e-07
 Identities = 61/244 (25%), Positives = 108/244 (44%), Gaps = 52/244 (21%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKAS----GQGLEEFMNEVMVISKLQ 536
           ++F+    +G+G FG V   + KD   I A+K+L K+      Q +     E  ++++  
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQ-VAHVRAERDILAEAD 59

Query: 537 HRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERL-DWRKRFNIIEGISRGL 594
           +  +V+L     + E  + LI EY+P   +  LL   +KK+   +   RF I E I    
Sbjct: 60  NPWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLL---MKKDTFTEEETRFYIAETI---- 111

Query: 595 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA------------- 641
           L +    +L  IHRD+K  N+LLD + + K+SDFG+      +                 
Sbjct: 112 LAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNF 171

Query: 642 --------DTGR---------------VVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLE 678
                    + R                VGT  Y++PE  ++  ++++ D +S GV++ E
Sbjct: 172 LDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYE 231

Query: 679 IVSG 682
           ++ G
Sbjct: 232 MLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 53.5 bits (128), Expect = 2e-07
 Identities = 61/223 (27%), Positives = 105/223 (47%), Gaps = 23/223 (10%)

Query: 483 NFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEE---FMNEVMVISKLQHR 538
           +F++   +G+G FG V   +LK+  ++ A+K L+K       E   F  E  V+    ++
Sbjct: 2   DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61

Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALL--FDPLKKERLDWRKRFNIIEGISRGLLY 596
            +  L     +     L+ +Y     L  LL  F+    E +    RF + E +    + 
Sbjct: 62  WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDM---ARFYLAEMV----IA 114

Query: 597 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA-KIFGGNQDQADTGRVVGTFGYMSP 655
           +    +L  +HRD+K  NIL+D   + +++DFG   K+      Q+     VGT  Y+SP
Sbjct: 115 IDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA--VGTPDYISP 172

Query: 656 EY--AME---GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDL 693
           E   AME   G++  + D +S GV + E++ G   T F+ + L
Sbjct: 173 EILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE--TPFYAESL 213

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 53.9 bits (129), Expect = 2e-07
 Identities = 28/76 (36%), Positives = 42/76 (55%)

Query: 606 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSE 665
           +HRDL A N+L+ E    KI DFG+A+    + +    G       +M+PE      ++ 
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTT 320

Query: 666 KSDVFSFGVLLLEIVS 681
            SDV+SFG+LL EI +
Sbjct: 321 LSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 53.3 bits (128), Expect = 3e-07
 Identities = 29/80 (36%), Positives = 46/80 (57%)

Query: 606 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSE 665
           IHRD+ A N+LL +    KI DFG+A+    + +    G       +M+PE   +  ++ 
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTV 293

Query: 666 KSDVFSFGVLLLEIVSGRKN 685
           +SDV+S+G+LL EI S  K+
Sbjct: 294 QSDVWSYGILLWEIFSLGKS 313

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 52.2 bits (126), Expect = 3e-07
 Identities = 65/232 (28%), Positives = 108/232 (46%), Gaps = 33/232 (14%)

Query: 475 EELATATNNFQLSSKLG--QGGFGPVYWGRLKDGQEIAVKRLSKASG-QGLEEFMNEVMV 531
            EL     N ++  KL    G FG V   + K  Q++ V+++ KA     +E  ++++M 
Sbjct: 7   SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQLMK 66

Query: 532 ISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKE-RLDWRKRFNIIEGI 590
                + N ++L       +  +LI +Y+     D  LFD LKKE +L   +   II  +
Sbjct: 67  ----DNPNFIKLYYSVTTLKGHVLIMDYIK----DGDLFDLLKKEGKLSEAEVKKIIRQL 118

Query: 591 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNP-KISDFGMAKIFG--GNQDQADTGRVV 647
              L  LH+     IIH D+K  N+L D   +   + D+G+ KI G     D        
Sbjct: 119 VEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD-------- 167

Query: 648 GTFGYMSPEYAMEGRFSEKS-DVFSFGVLLLEIVSGR---KNTSFFEDDLTI 695
           GT  Y SPE  ++G   + S D ++ GVL  E+++G+   K     +++L +
Sbjct: 168 GTLDYFSPE-KIKGHNYDVSFDWWAVGVLTYELLTGKHPFKE--DEDEELDL 216

Length = 267

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 51.8 bits (124), Expect = 4e-07
 Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 29/210 (13%)

Query: 489 KLGQGGFGPVYWGRLKDGQEIA---VKRL-SKASGQGLEEFMNEVMVISKLQHRNLVRLL 544
           ++G G FG V    +     +A   VK L + AS +   EF+ +      LQH N+++ L
Sbjct: 2   EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61

Query: 545 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR-------GLLYL 597
           G CVE    +L++EY     L + L       +  W +R + +  + R       G+ ++
Sbjct: 62  GQCVEAIPYLLVFEYCELGDLKSYL------SQEQWHRRNSQLLLLQRMACEIAAGVTHM 115

Query: 598 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT-GRVVGTFGYMSPE 656
           H   +   +H DL   N  L  +L  K+ D+G+       +D  +T         +++PE
Sbjct: 116 H---KHNFLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDYIETEDDKCVPLRWLAPE 171

Query: 657 YAME--GRF-----SEKSDVFSFGVLLLEI 679
              E  G       ++ S+V++ GV L E+
Sbjct: 172 LVGEFHGGLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 52.0 bits (124), Expect = 8e-07
 Identities = 61/240 (25%), Positives = 107/240 (44%), Gaps = 47/240 (19%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN---EVMVISKLQH 537
           ++F+    +G+G FG V   + KD G   A+K L KA     E+  +   E  ++ +   
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL-DWRKRFNIIEGISRGLLY 596
             +V++     +     LI E++P   +  LL   +KK+ L +   +F I E +    L 
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLL---MKKDTLSEEATQFYIAETV----LA 113

Query: 597 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGM-------------------------- 630
           +    +L  IHRD+K  N+LLD + + K+SDFG+                          
Sbjct: 114 IDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSF 173

Query: 631 --------AKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
                   A+ +  N+ Q      VGT  Y++PE  M+  +++  D +S GV++ E++ G
Sbjct: 174 QNMNSKRKAETWKKNRRQLAYS-TVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 52.0 bits (124), Expect = 8e-07
 Identities = 56/230 (24%), Positives = 101/230 (43%), Gaps = 51/230 (22%)

Query: 479 TATNNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLSKASGQGLEEFMN-EVMVISKLQ 536
           +   +++L + +G G FG VY     D  E +A+K++ +       ++ N E++++  L 
Sbjct: 63  SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLN 117

Query: 537 HRNLVRLLGC----CVEGEEKML----IYEYMP-------------NRSLDALLFDPLKK 575
           H N++ L       C +  EK +    + E++P             N +L   L      
Sbjct: 118 HINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSY 177

Query: 576 ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP-KISDFGMAK-I 633
           +             + R L Y+H  S+  I HRDLK  N+L+D   +  K+ DFG AK +
Sbjct: 178 Q-------------LCRALAYIH--SKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL 221

Query: 634 FGGNQDQADTGRVVGTFGYMSPEYAM-EGRFSEKSDVFSFGVLLLEIVSG 682
             G   Q     +   F Y +PE  +    ++   D++S G ++ E++ G
Sbjct: 222 LAG---QRSVSYICSRF-YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 51.2 bits (122), Expect = 1e-06
 Identities = 60/238 (25%), Positives = 107/238 (44%), Gaps = 45/238 (18%)

Query: 483 NFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN---EVMVISKLQHR 538
           +F+    +G+G FG V   + KD G   A+K L KA     E+  +   E  ++ +    
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61

Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL-DWRKRFNIIEGISRGLLYL 597
            +V++     +     LI E++P   +  LL   +KK+ L +   +F I E +    L +
Sbjct: 62  WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLL---MKKDTLTEEETQFYIAETV----LAI 114

Query: 598 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG---------------------- 635
               +L  IHRD+K  N+LLD + + K+SDFG+                           
Sbjct: 115 DSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQ 174

Query: 636 --GNQDQADTGR---------VVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
              ++ +A+T +          VGT  Y++PE  M+  +++  D +S GV++ E++ G
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 50.2 bits (120), Expect = 2e-06
 Identities = 68/294 (23%), Positives = 123/294 (41%), Gaps = 60/294 (20%)

Query: 484 FQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKAS---GQGLEEFMNEVMVISKLQHRN 539
           F     +G G FG V   R  D   + A+K L KA             E  ++++  +  
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62

Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD-PLKKERLDWRKRFNIIEGISRGLLYLH 598
           +V+L     + +    + +Y+P   + +LL    + +E L    RF I E ++  +  +H
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL---ARFYIAE-LTCAIESVH 118

Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGM---------AKIFGGN----QDQ----- 640
           +   +  IHRD+K  NIL+D + + K++DFG+         +K +       QD      
Sbjct: 119 K---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSE 175

Query: 641 --ADTGR---------------------VVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
             ++  R                     +VGT  Y++PE  +   +++  D +S GV+L 
Sbjct: 176 EWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235

Query: 678 EIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQ-LDMIIRCI 730
           E++ G+     F  D T      K+ N    L +  P  ++ S +  D+I+R  
Sbjct: 236 EMLVGQPP---FLAD-TPAETQLKVINWETTLHI--PSQAKLSREASDLILRLC 283

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 49.8 bits (119), Expect = 3e-06
 Identities = 31/86 (36%), Positives = 44/86 (51%), Gaps = 8/86 (9%)

Query: 482 NNFQLSSKLGQGGFGPVY------WGRLKDGQEIAVKRL-SKASGQGLEEFMNEVMVISK 534
           +N Q    LG G FG V        G+  +   +AVK L + A     E  M+E+ ++S 
Sbjct: 38  DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSH 97

Query: 535 L-QHRNLVRLLGCCVEGEEKMLIYEY 559
           L QH+N+V LLG C  G   ++I EY
Sbjct: 98  LGQHKNIVNLLGACTHGGPVLVITEY 123

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 49.4 bits (118), Expect = 4e-06
 Identities = 29/95 (30%), Positives = 49/95 (51%), Gaps = 6/95 (6%)

Query: 592 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI-FGGNQDQADTGRVVGTF 650
           R L Y+H  +   + HRDLK  NIL + +   KI DFG+A++ F            V T 
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170

Query: 651 GYMSPEY--AMEGRFSEKSDVFSFGVLLLEIVSGR 683
            Y +PE   +   +++   D++S G +  E+++G+
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 48.0 bits (114), Expect = 9e-06
 Identities = 58/229 (25%), Positives = 100/229 (43%), Gaps = 52/229 (22%)

Query: 488 SKLGQGGFGPVYWGRLK-----------------------DGQEIAV--KRLSKASGQGL 522
           + LGQG    +Y GRL+                       +G+E+ V  K L  +     
Sbjct: 1   AHLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIA 60

Query: 523 EEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL---- 578
             F     ++S++ H +L  + G CV G E +++ E++ +  LD      L+KE+     
Sbjct: 61  LAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVC----LRKEKGRVPV 116

Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNIL-----LDEELNP--KISDFGMA 631
            W  +  + + ++  L YL   +   ++H ++ A NIL     L E  +P  K+SD G++
Sbjct: 117 AW--KITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS 171

Query: 632 KIFGGNQDQADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEI 679
             F     +    R+     +++PE    G   S  +D +SFG  LLEI
Sbjct: 172 --FTALSREERVERI----PWIAPECVPGGNSLSTAADKWSFGTTLLEI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 47.9 bits (114), Expect = 1e-05
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 35/224 (15%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDG-QEIAVKRLSKASGQGLEEFMNEVMV---ISKLQH 537
            +F+    +  G +G VY  R K+  Q  A+K+++K +   L   + +V V   I     
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQN-LILRNQIQQVFVERDILTFAE 59

Query: 538 RNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFD----PLKKERLDWRKRFNIIEGISR 592
              V  + C  E +  + ++ EY+       LL +    P+   R+ + +    +E    
Sbjct: 60  NPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALE---- 115

Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI---------FGGNQDQADT 643
              YLH      I+HRDLK  N+L+    + K++DFG++KI         + G+ ++ DT
Sbjct: 116 ---YLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEK-DT 168

Query: 644 -----GRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
                 +V GT  Y++PE  +   + +  D ++ G++L E + G
Sbjct: 169 REFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 47.2 bits (112), Expect = 1e-05
 Identities = 53/211 (25%), Positives = 90/211 (42%), Gaps = 32/211 (15%)

Query: 490 LGQGGFGPVYWGRLKD---------GQEIAVKRLSKASGQGLEE----FMNEVMVISKLQ 536
           LG+G    +Y G L             E  +K + K       +    F     ++ ++ 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 596
           H+++V L G CV   E +++ E++    LD  LF   K + L    +F + + ++  L Y
Sbjct: 63  HKHIVLLYGVCVRDVENIMVEEFVEFGPLD--LFMHRKSDVLTTPWKFKVAKQLASALSY 120

Query: 597 LHRDSRLRIIHRDLKASNILL-----DEELNP--KISDFGMAKIFGGNQDQADTGRVVGT 649
           L  D  L  +H ++   NILL     D E  P  K+SD G+       Q+  +       
Sbjct: 121 L-EDKDL--VHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVE------R 171

Query: 650 FGYMSPEYAMEGR-FSEKSDVFSFGVLLLEI 679
             +++PE   + +  S  +D +SFG  L EI
Sbjct: 172 IPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 56/221 (25%), Positives = 98/221 (44%), Gaps = 36/221 (16%)

Query: 485 QLSSKLGQG--GFGPVYWGR-LKDGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRN 539
           +L  ++G+G      VY  R    G  + V+   L   + + L+   NEV++    +H N
Sbjct: 1   ELQVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPN 60

Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALL--FDPLKKERLDWRKRFNIIEGISRGLLYL 597
           ++        G    +I  +M   S ++LL  + P   E +      NI+ G  RGL YL
Sbjct: 61  IMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFP---EGMSEALIGNILFGALRGLNYL 117

Query: 598 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ-----DQADTGRVVGTF-- 650
           H++     IHR++KAS+IL+  +        G+  + G +            +VV  F  
Sbjct: 118 HQNG---YIHRNIKASHILISGD--------GLVSLSGLSHLYSLVRNGQKAKVVYDFPQ 166

Query: 651 ------GYMSPEYAMEGR--FSEKSDVFSFGVLLLEIVSGR 683
                  ++SPE   +    ++ KSD++S G+   E+ +GR
Sbjct: 167 FSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 45.4 bits (108), Expect = 6e-05
 Identities = 62/242 (25%), Positives = 93/242 (38%), Gaps = 47/242 (19%)

Query: 484 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQG---LEEFMNEVMVISKLQHRN 539
           F+    LG+G  G V+  RLK  G+  A+K L K        ++  + E  +++ L H  
Sbjct: 3   FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPF 62

Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWR-----KRFNIIEGISRGL 594
           L  L           L+ +Y P   L  LL     + +          RF   E +   L
Sbjct: 63  LPTLYASFQTETYLCLVMDYCPGGELFRLL-----QRQPGKCLSEEVARFYAAE-VLLAL 116

Query: 595 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK-------------IFGGNQDQ- 640
            YLH    L I++RDLK  NILL E  +  +SDF ++K               G  +   
Sbjct: 117 EYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSV 173

Query: 641 -------------ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTS 687
                          +   VGT  Y++PE           D ++ G+LL E++ G   T 
Sbjct: 174 NSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT--TP 231

Query: 688 FF 689
           F 
Sbjct: 232 FK 233

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 45.1 bits (107), Expect = 6e-05
 Identities = 38/180 (21%), Positives = 83/180 (46%), Gaps = 20/180 (11%)

Query: 512 KRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKM----LIYEYMPNRSLDA 567
           K+  K     ++   NE+  + ++   N++++ G  ++  + +    LI EY        
Sbjct: 52  KKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC----TRG 107

Query: 568 LLFDPLKKER-LDWRKRFNIIEGISRGLLYLHR-DSRLRIIHRDLKASNILLDEELNPKI 625
            L + L KE+ L ++ + ++     +GL  L++  ++    +++L + + L+ E    KI
Sbjct: 108 YLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNK---PYKNLTSVSFLVTENYKLKI 164

Query: 626 SDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME--GRFSEKSDVFSFGVLLLEIVSGR 683
              G+ KI       +   + V    Y S +   +    ++ K D++S GV+L EI +G+
Sbjct: 165 ICHGLEKIL-----SSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGK 219

Length = 283

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 44.1 bits (104), Expect = 2e-04
 Identities = 60/252 (23%), Positives = 104/252 (41%), Gaps = 59/252 (23%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQH 537
            +F     +G+G FG V   + KD G+  A+K L K+       L     E  V+++   
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60

Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL--FDPLKKERLDWRKRFNIIEGISRGLL 595
             +V L     + +   LI E++P   L  +L  +D   ++      RF + E +    L
Sbjct: 61  PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV----TRFYMAECV----L 112

Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA-------------KIFGG------ 636
            +    +L  IHRD+K  NIL+D   + K+SDFG++             K+  G      
Sbjct: 113 AIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNR 172

Query: 637 -----------------NQDQADTGR---------VVGTFGYMSPEYAMEGRFSEKSDVF 670
                            ++DQ  T +          VGT  Y++PE  ++  + ++ D +
Sbjct: 173 IDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWW 232

Query: 671 SFGVLLLEIVSG 682
           S G ++ E + G
Sbjct: 233 SLGAIMFECLIG 244

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 43.6 bits (103), Expect = 3e-04
 Identities = 57/212 (26%), Positives = 87/212 (41%), Gaps = 50/212 (23%)

Query: 483 NFQLSSKLGQGGFGPVYWG-----RLKDGQEIAVKRLSKASGQG-LEEFMNEVM------ 530
           +F L  KLG+G FG VY       + K   +  +K   KA+  G +E +MNE +      
Sbjct: 133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLK---KATEYGAVEIWMNERVRRACPN 189

Query: 531 VISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD---PLKKERLDWRK----- 582
             +   +  L  +     + +E  L++ Y    +L  L+     P   E     K     
Sbjct: 190 SCADFVYGFLEPVSS--KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLP 247

Query: 583 ----RFN-IIEGISRGLLY----LHRDSRLRIIHRDLKASNILLDEELNP-KISDFGMAK 632
               R N II+ I R +L+    LH      I+HRD+K  NI+  E     KI D G A 
Sbjct: 248 KGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGAA- 303

Query: 633 IFGGNQDQADTGRVVGTFGYMSPEYAMEGRFS 664
                   AD  RV     Y+  E+ ++ R++
Sbjct: 304 --------ADL-RV--GINYIPKEFLLDPRYA 324

Length = 566

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 43.3 bits (102), Expect = 4e-04
 Identities = 26/96 (27%), Positives = 47/96 (48%), Gaps = 7/96 (7%)

Query: 587 IEGISRGLL----YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD 642
           +  ++R LL    Y+H +    IIHRD+K  N+L++   +  + DFG A    G+     
Sbjct: 262 VTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318

Query: 643 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLE 678
              + GT    +PE      ++   D++S G+++ E
Sbjct: 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 43.4 bits (102), Expect = 4e-04
 Identities = 58/240 (24%), Positives = 99/240 (41%), Gaps = 50/240 (20%)

Query: 475 EELATATNNFQLSSKLGQGGFGPVY--WGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVI 532
           E++  +T  F++ S LG+G FG V   W R K  +  AVK +     + + ++  +  + 
Sbjct: 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDR-KRKEYCAVKIV-----RNVPKYTRDAKI- 174

Query: 533 SKLQHRNLVRLLGCCVEGEEK---MLIYEYMPNRSLDALLFDPLKKE-RLDW-------- 580
            ++Q    VR      +  ++   M I  Y  N +    +  P      LDW        
Sbjct: 175 -EIQFMEKVRQ----ADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFS 229

Query: 581 -RKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL---DEELNP------------- 623
            R    II      L Y H  + L ++H DLK  NIL+   D  ++P             
Sbjct: 230 HRHLAQIIFQTGVALDYFH--TELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRV 287

Query: 624 KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           +I D G     G   ++     +V T  Y SPE  +   +   +D++S G ++ E+ +G+
Sbjct: 288 RICDLG-----GCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342

Length = 467

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 42.7 bits (100), Expect = 6e-04
 Identities = 54/244 (22%), Positives = 101/244 (41%), Gaps = 57/244 (23%)

Query: 490 LGQGGFGPVYWGRLKDGQEI-AVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLG 545
           LG G FG V      D   + A+K L K    +   +     E  ++++  +  +V+L  
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68

Query: 546 CCVEGEEKMLIYEYMPNRSLDALLFD-PLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 604
              + +    + +Y+P   + +LL    +  E L    RF I E ++  +  +H+   + 
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVL---ARFYIAE-LTLAIESVHK---MG 121

Query: 605 IIHRDLKASNILLDEELNPKISDFGMAKIF----------GGNQDQADTGR--------- 645
            IHRD+K  NIL+D + + K++DFG+   F           G+  + D+           
Sbjct: 122 FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVS 181

Query: 646 --------------------------VVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEI 679
                                     +VGT  Y++PE  +   +++  D +S GV+L E+
Sbjct: 182 NCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM 241

Query: 680 VSGR 683
           + G+
Sbjct: 242 LVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 42.2 bits (99), Expect = 8e-04
 Identities = 31/86 (36%), Positives = 39/86 (45%), Gaps = 8/86 (9%)

Query: 482 NNFQLSSKLGQGGFGPVY----WGRLKD--GQEIAVKRL-SKASGQGLEEFMNEVMVISK 534
           N       LG G FG V     +G  K      +AVK L   A     E  M+E+ V+S 
Sbjct: 35  NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 94

Query: 535 L-QHRNLVRLLGCCVEGEEKMLIYEY 559
           L  H N+V LLG C  G   ++I EY
Sbjct: 95  LGNHINIVNLLGACTVGGPTLVITEY 120

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|224632 COG1718, RIO1, Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

 Score = 41.9 bits (99), Expect = 8e-04
 Identities = 37/157 (23%), Positives = 57/157 (36%), Gaps = 30/157 (19%)

Query: 498 VYWGRLKDGQEIAVK--RLSKASGQGLEE-------FMNEVMVISKLQH-------RNLV 541
           VY     DG+ +AVK  R S +  + +         F N      KL         RNL 
Sbjct: 64  VYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLK 123

Query: 542 RLLGCCV------EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN-IIEGISRGL 594
           R     V           +L+ E++ +  L A     +  E  +    +  ++E + R  
Sbjct: 124 RAYEAGVRVPEPIAFRNNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRR-- 181

Query: 595 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 631
           LY        ++H DL   NIL+ +   P I D   A
Sbjct: 182 LY----KEAGLVHGDLSEYNILVHDG-EPYIIDVSQA 213

Length = 268

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 41.9 bits (98), Expect = 9e-04
 Identities = 58/244 (23%), Positives = 102/244 (41%), Gaps = 57/244 (23%)

Query: 490 LGQGGFGPVYWGRLKDGQEI-AVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLG 545
           LG G FG V   R  D + + A+K L K        +     E  ++++  +  +VRL  
Sbjct: 9   LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68

Query: 546 CCVEGEEKMLIYEYMPNRSLDALLFD-PLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 604
              + +    + +Y+P   + +LL    +  E L    RF I E ++  +  +H+   + 
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDL---ARFYIAE-LTCAVESVHK---MG 121

Query: 605 IIHRDLKASNILLDEELNPKISDFGMAKIF----------GGN---QDQAD--------- 642
            IHRD+K  NIL+D + + K++DFG+   F           G+   QD  D         
Sbjct: 122 FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPA 181

Query: 643 -----------------------TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEI 679
                                     +VGT  Y++PE  +   +++  D +S GV+L E+
Sbjct: 182 NCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 241

Query: 680 VSGR 683
           + G+
Sbjct: 242 LVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|238074 cd00129, PAN_APPLE, PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins

 Score = 38.4 bits (89), Expect = 0.001
 Identities = 23/80 (28%), Positives = 29/80 (36%), Gaps = 7/80 (8%)

Query: 337 EDGFSKLNKMKVPDFT---EWTSPATEDECREQCLKN---CSCIAYAFDGGIGCMVWRSI 390
            D F K     +       + T   T DEC  +C KN    SC A+ F       +W   
Sbjct: 1   VDEFCKSAGTTLIKIALKIKTTKANTADECANRCEKNGLPFSCKAFVFAKARKQCLWFPF 60

Query: 391 NLIDIQRLPFG-GTDLYIRV 409
           N +   R  F  G DLY   
Sbjct: 61  NSMSGVRKEFSHGFDLYENK 80

Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. Length = 80

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 39.2 bits (92), Expect = 0.004
 Identities = 24/113 (21%), Positives = 43/113 (38%), Gaps = 26/113 (23%)

Query: 527 NEVMVISKLQHRNLVRLLGCC------VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDW 580
            E  +++K       R  G        V+ +  +++ EY+    L   L           
Sbjct: 48  REARILAKA------REAGVPVPIVYDVDPDNGLIVMEYIEGELLKDAL----------E 91

Query: 581 RKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 633
             R +++  + R +  LH+     I+H DL  SNI+L         DFG+ + 
Sbjct: 92  EARPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGG-RIYFIDFGLGEF 140

Length = 204

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 40.1 bits (93), Expect = 0.004
 Identities = 20/52 (38%), Positives = 33/52 (63%), Gaps = 1/52 (1%)

Query: 581 RKRFNIIEGISRGLLY-LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 631
           ++  N+I+G+ R +L  L +  R+ I+HRD+K  N+L+  +   KI DFG A
Sbjct: 305 KRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356

Length = 507

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	808
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.98
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.98
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.98
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.98
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.98
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.98
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.98
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.98
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.98
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.98
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.98
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.98
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.98
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.98
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.98
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.98
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.98
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.98
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.97
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.97
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.97
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.97
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.97
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.97
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.97
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.96
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.96
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.96
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.96
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.96
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.96
PF01453	114	B_lectin: D-mannose binding lectin; InterPro: IPR0	99.96
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.95
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.95
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.95
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.95
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.95
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.95
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.95
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.94
cd00028	116	B_lectin Bulb-type mannose-specific lectin. The do	99.94
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.94
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.93
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.93
KOG1152	772	consensus Signal transduction serine/threonine kin	99.93
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.93
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.93
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.93
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.92
smart00108	114	B_lectin Bulb-type mannose-specific lectin.	99.92
PF00954	110	S_locus_glycop: S-locus glycoprotein family; Inter	99.92
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.92
PLN00181	793	protein SPA1-RELATED; Provisional	99.9
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.89
PRK09188	365	serine/threonine protein kinase; Provisional	99.88
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.87
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.86
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.84
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.83
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.82
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.82
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.82
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.81
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.8
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.79
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.78
PRK12274	218	serine/threonine protein kinase; Provisional	99.76
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.74
PRK10345	210	hypothetical protein; Provisional	99.73
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.7
smart00090	237	RIO RIO-like kinase.	99.69
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.69
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.69
PRK14879	211	serine/threonine protein kinase; Provisional	99.68
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.65
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.65
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.63
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.62
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.58
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.58
PF08276	66	PAN_2: PAN-like domain; InterPro: IPR013227 PAN do	99.54
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.54
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.53
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.48
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.46
cd00129	80	PAN_APPLE PAN/APPLE-like domain; present in N-term	99.44
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.32
cd01098	84	PAN_AP_plant Plant PAN/APPLE-like domain; present	99.29
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.29
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.26
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.24
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.14
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.1
KOG1243	690	consensus Protein kinase [General function predict	99.05
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.02
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.0
KOG3087	229	consensus Serine/threonine protein kinase [General	98.99
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.87
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.76
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.75
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.75
COG4248	637	Uncharacterized protein with protein kinase and he	98.73
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.68
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.54
PRK09902	216	hypothetical protein; Provisional	98.52
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.5
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.43
smart00473	78	PAN_AP divergent subfamily of APPLE domains. Apple	98.39
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.39
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.36
smart00108	114	B_lectin Bulb-type mannose-specific lectin.	98.3
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.23
cd00028	116	B_lectin Bulb-type mannose-specific lectin. The do	98.21
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.2
PF01636	239	APH: Phosphotransferase enzyme family This family	98.11
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.08
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.04
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.03
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.89
PLN02876	822	acyl-CoA dehydrogenase	97.82
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.8
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.78
PRK10593	297	hypothetical protein; Provisional	97.77
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.71
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.64
PF01453	114	B_lectin: D-mannose binding lectin; InterPro: IPR0	97.63
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.58
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.53
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.52
PRK05231	319	homoserine kinase; Provisional	97.43
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.35
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.11
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.09
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.89
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.77
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	96.74
PLN02236	344	choline kinase	96.69
cd01100	73	APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d	96.45
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.36
PLN02756	418	S-methyl-5-thioribose kinase	96.29
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.26
KOG2270	520	consensus Serine/threonine protein kinase involved	96.18
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.04
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	95.93
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	95.69

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-54  Score=468.47  Aligned_cols=287  Identities=47%  Similarity=0.804  Sum_probs=254.8

Q ss_pred             CCCCcCHHHHHHHhcCCcccCcccccCceeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEE
Q 003599          468 DLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC  547 (808)
Q Consensus       468 ~l~~f~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~  547 (808)
                      ....|++.++..||++|...+.||+|+||.||+|.+.+++.||||++.....+..++|.+|+.++.+++|||+|+++|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            56679999999999999999999999999999999999999999988765443156699999999999999999999999


Q ss_pred             EeCC-eeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeee
Q 003599          548 VEGE-EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKIS  626 (808)
Q Consensus       548 ~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~  626 (808)
                      .+++ +++||||||++|+|+++|+..... .++|.+|++||.++|+||+|||....++|+||||||+|||||+++++||+
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            9999 599999999999999999875443 89999999999999999999999998899999999999999999999999


Q ss_pred             ccccceecCCCCCcccccce-eccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCC--Cchhhhhhhhhhh
Q 003599          627 DFGMAKIFGGNQDQADTGRV-VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFE--DDLTILGYAWKLW  703 (808)
Q Consensus       627 DFGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~--~~~~~~~~~~~~~  703 (808)
                      |||+|+.........  ... .||.+|+|||++..+..+.|+|||||||+|+||+||+++.+...  ....+..|++..+
T Consensus       220 DFGLa~~~~~~~~~~--~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~  297 (361)
T KOG1187|consen  220 DFGLAKLGPEGDTSV--STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL  297 (361)
T ss_pred             CccCcccCCccccce--eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence            999997543211111  112 79999999999999999999999999999999999999887543  4556899999999


Q ss_pred             ccccchhccCCcccCCcccH-HHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003599          704 NENKILALVDPFLSESSFQL-DMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  757 (808)
Q Consensus       704 ~~~~~~~~~d~~l~~~~~~~-~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~  757 (808)
                      .++.+.+++|+.+....... +++.++..++.+|++.+|++||+|.||+++|+.+
T Consensus       298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~  352 (361)
T KOG1187|consen  298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI  352 (361)
T ss_pred             HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence            99999999999997443554 7899999999999999999999999999999665

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-45  Score=393.66  Aligned_cols=259  Identities=31%  Similarity=0.491  Sum_probs=212.6

Q ss_pred             CcccCcccccCceeEEEEEecCCcEEEEEEeccccc--ccHHHHHHHHHHHHhccCCceeeEeeEEEeCC-eeEEEEEec
Q 003599          484 FQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASG--QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE-EKMLIYEYM  560 (808)
Q Consensus       484 ~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~E~~  560 (808)
                      ..+.+.||+|+||+||+|.++....||||++.....  ...++|.+|+.+|.+++|||||+++|+|.+.. ..++|||||
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~  122 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM  122 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence            344567999999999999999555599999976432  22669999999999999999999999999888 799999999


Q ss_pred             CCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCC-CeeeeccccceecCCCCC
Q 003599          561 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL-NPKISDFGMAKIFGGNQD  639 (808)
Q Consensus       561 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~-~~kl~DFGla~~~~~~~~  639 (808)
                      ++|+|.++++.. ....+++..+++|+.+||+||.|||++++  ||||||||+||||+.++ ++||+|||+++...... 
T Consensus       123 ~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-  198 (362)
T KOG0192|consen  123 PGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-  198 (362)
T ss_pred             CCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence            999999999864 46789999999999999999999999874  99999999999999997 99999999998764322 


Q ss_pred             cccccceeccCCccChhhhc--cCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCccc
Q 003599          640 QADTGRVVGTFGYMSPEYAM--EGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS  717 (808)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~--~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  717 (808)
                       .......||+.|||||++.  ...|+.|+|||||||+||||+||+.||...... ...   ......+.     .    
T Consensus       199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~-~~~---~~v~~~~~-----R----  264 (362)
T KOG0192|consen  199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV-QVA---SAVVVGGL-----R----  264 (362)
T ss_pred             -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH-HHH---HHHHhcCC-----C----
Confidence             2222268999999999999  568999999999999999999999999765542 111   11111111     1    


Q ss_pred             CCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhcccCC
Q 003599          718 ESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDL  761 (808)
Q Consensus       718 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~~~~  761 (808)
                       ...+......+..++.+||+.||++||++.+|+.+|+.+....
T Consensus       265 -p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~  307 (362)
T KOG0192|consen  265 -PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI  307 (362)
T ss_pred             -CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence             1123335678889999999999999999999999998765433

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-44  Score=365.50  Aligned_cols=250  Identities=30%  Similarity=0.395  Sum_probs=207.2

Q ss_pred             CcccCcccccCceeEEEEEec-CCcEEEEEEeccc-ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCC-eeEEEEEec
Q 003599          484 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE-EKMLIYEYM  560 (808)
Q Consensus       484 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~E~~  560 (808)
                      .+..+.||+|..|+|||++++ +++.+|+|++... .+...+++.+|++++++.+||+||+++|.|.... ...|+||||
T Consensus        81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM  160 (364)
T KOG0581|consen   81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM  160 (364)
T ss_pred             hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence            344689999999999999987 5888999999544 3445678999999999999999999999999988 599999999


Q ss_pred             CCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHh-cCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCC
Q 003599          561 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR-DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  639 (808)
Q Consensus       561 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  639 (808)
                      ++|||+.++..   .+++++...-+|+.++++||.|||+ .+   ||||||||+||||+..|++||||||.++.+.+.  
T Consensus       161 DgGSLd~~~k~---~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--  232 (364)
T KOG0581|consen  161 DGGSLDDILKR---VGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--  232 (364)
T ss_pred             CCCCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence            99999999853   3679999999999999999999996 54   999999999999999999999999999977544  


Q ss_pred             cccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCC-CchhhhhhhhhhhccccchhccCCcccC
Q 003599          640 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFE-DDLTILGYAWKLWNENKILALVDPFLSE  718 (808)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~d~~l~~  718 (808)
                        .....+||..|||||.+.+..|+.++||||||+.++|+.+|+.|+.... ...........+..+      ..|.+..
T Consensus       233 --~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~------ppP~lP~  304 (364)
T KOG0581|consen  233 --IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDE------PPPRLPE  304 (364)
T ss_pred             --hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcC------CCCCCCc
Confidence              3344789999999999999999999999999999999999999987642 122222222222211      1122222


Q ss_pred             CcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          719 SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       719 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                      .    ....++..++-.||++||.+||+++|+++.
T Consensus       305 ~----~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  305 G----EFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             c----cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            1    356789999999999999999999998764

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-44  Score=384.59  Aligned_cols=254  Identities=33%  Similarity=0.522  Sum_probs=215.4

Q ss_pred             CCcccCcccccCceeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEecCC
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPN  562 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  562 (808)
                      .+.+.+.||+|-||+||.|.++....||+|.++.. ....+.|.+|+.+|++|+|+|||+++|+|..+...+||||||+.
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~  285 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK  285 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence            35567899999999999999998889999999654 45568899999999999999999999999999999999999999


Q ss_pred             CCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCccc
Q 003599          563 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD  642 (808)
Q Consensus       563 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  642 (808)
                      |+|.++|.. ..+..+...+.+.++.|||+||+||++++   +|||||.++||||+++..+||+||||||....+.....
T Consensus       286 GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~  361 (468)
T KOG0197|consen  286 GSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTAS  361 (468)
T ss_pred             CcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceeec
Confidence            999999976 35678999999999999999999999998   99999999999999999999999999996554444333


Q ss_pred             ccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCcc
Q 003599          643 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSF  721 (808)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  721 (808)
                      .+ ..-+..|.|||.+..++++.|+|||||||+||||+| |+.|++.......              .+.++..-.-. .
T Consensus       362 ~~-~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev--------------~~~le~GyRlp-~  425 (468)
T KOG0197|consen  362 EG-GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV--------------LELLERGYRLP-R  425 (468)
T ss_pred             CC-CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHH--------------HHHHhccCcCC-C
Confidence            22 345789999999999999999999999999999999 7777664443221              12222222212 4


Q ss_pred             cHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003599          722 QLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  757 (808)
Q Consensus       722 ~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~  757 (808)
                      +..++.++.+|+..||+.+|++|||++.+...|+.+
T Consensus       426 P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~  461 (468)
T KOG0197|consen  426 PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF  461 (468)
T ss_pred             CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence            556778899999999999999999999999999876

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=9e-43  Score=360.18  Aligned_cols=202  Identities=31%  Similarity=0.556  Sum_probs=181.4

Q ss_pred             hcCCcccCcccccCceeEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEE
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  557 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  557 (808)
                      ..+|.+.++||+|+|++||+|+++ ++.+||||.+.+.  .....+....|+.+|+.++|||||++++++..++..+|||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            467889999999999999999986 5899999999765  4556677889999999999999999999999999999999


Q ss_pred             EecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCC------CCeeeeccccc
Q 003599          558 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE------LNPKISDFGMA  631 (808)
Q Consensus       558 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~------~~~kl~DFGla  631 (808)
                      |||.+|+|..|++.   .+.+++.....++.|||.||++||+++   ||||||||+||||+..      -.+||+|||+|
T Consensus        89 EyC~gGDLs~yi~~---~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA  162 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRR---RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA  162 (429)
T ss_pred             EeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence            99999999999964   458999999999999999999999999   9999999999999765      45899999999


Q ss_pred             eecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCC
Q 003599          632 KIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFED  691 (808)
Q Consensus       632 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~  691 (808)
                      |.+..   .......+|++.|||||+++..+|+.|+|+||+|+||||+++|+.||.....
T Consensus       163 R~L~~---~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~  219 (429)
T KOG0595|consen  163 RFLQP---GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP  219 (429)
T ss_pred             hhCCc---hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence            98753   2333457899999999999999999999999999999999999999975443

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-42  Score=375.92  Aligned_cols=248  Identities=26%  Similarity=0.394  Sum_probs=212.8

Q ss_pred             cCCcccCcccccCceeEEEEEe-cCCcEEEEEEeccc---ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRL-KDGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  557 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  557 (808)
                      ..|...+.||+|||+.||.++. ..|+.||+|++.+.   .....+...+|+++.++|+|||||+++++|++.+..|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            4688899999999999999998 78999999999763   3455678899999999999999999999999999999999


Q ss_pred             EecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCC
Q 003599          558 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  637 (808)
Q Consensus       558 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  637 (808)
                      |+|++++|.+++.   .++.+++.++..++.||+.||.|||+.+   |+|||||..|+||++++++||+|||||..+..+
T Consensus        98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence            9999999999985   4678999999999999999999999998   999999999999999999999999999988755


Q ss_pred             CCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCccc
Q 003599          638 QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS  717 (808)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  717 (808)
                      .+...  ..+|||.|.|||++.....+..+||||+||++|-|+.|++||+...-....    ..+.    ..+       
T Consensus       172 ~Erk~--TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety----~~Ik----~~~-------  234 (592)
T KOG0575|consen  172 GERKK--TLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETY----NKIK----LNE-------  234 (592)
T ss_pred             ccccc--eecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHH----HHHH----hcC-------
Confidence            44433  379999999999999999999999999999999999999999743211111    1111    001       


Q ss_pred             CCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          718 ESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       718 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                       -.++.....+..+||.++|+.+|.+|||+++|+..
T Consensus       235 -Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  235 -YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             -cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence             11333456677899999999999999999999864

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=6.4e-43  Score=392.37  Aligned_cols=262  Identities=30%  Similarity=0.479  Sum_probs=221.2

Q ss_pred             cCCcccCcccccCceeEEEEEec------CCcEEEEEEecccccc-cHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASGQ-GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKM  554 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  554 (808)
                      .+....+.||+|.||.||+|+..      +.+.||||.++..... ..++|.+|+++|+.++|||||+++|.|.+++..+
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~  565 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC  565 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence            44566789999999999999843      3567999999887655 7889999999999999999999999999999999


Q ss_pred             EEEEecCCCCchhhccCCC-------C----CCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCe
Q 003599          555 LIYEYMPNRSLDALLFDPL-------K----KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP  623 (808)
Q Consensus       555 lV~E~~~~gsL~~~l~~~~-------~----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~  623 (808)
                      +|+|||..|+|.+||....       .    ..+|+..+.+.||.|||.||+||-++.   +|||||..+|+||.++..|
T Consensus       566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~V  642 (774)
T KOG1026|consen  566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVV  642 (774)
T ss_pred             EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEE
Confidence            9999999999999996421       1    234899999999999999999999888   9999999999999999999


Q ss_pred             eeeccccceecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhh
Q 003599          624 KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKL  702 (808)
Q Consensus       624 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~  702 (808)
                      ||+|||++|...............-+.+|||||.++.++||.++|||||||+|||++| |+.|+...++++.+     ..
T Consensus       643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI-----e~  717 (774)
T KOG1026|consen  643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI-----EC  717 (774)
T ss_pred             EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH-----HH
Confidence            9999999997765554444434556889999999999999999999999999999999 88888765544322     12


Q ss_pred             hccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhcccCC
Q 003599          703 WNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDL  761 (808)
Q Consensus       703 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~~~~  761 (808)
                      ..++++          -+.+.+++.++..|+..||+.+|++||+++||-..|+...+..
T Consensus       718 i~~g~l----------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s  766 (774)
T KOG1026|consen  718 IRAGQL----------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS  766 (774)
T ss_pred             HHcCCc----------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence            223322          1256677889999999999999999999999999998864443

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.3e-42  Score=355.02  Aligned_cols=251  Identities=24%  Similarity=0.335  Sum_probs=203.4

Q ss_pred             hcCCcccCcccccCceeEEEEEec-CCcEEEEEEecccccc-------cHHHHHHHHHHHHhccCCceeeEeeEEEeCCe
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQ-------GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEE  552 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  552 (808)
                      .+.|.+.+.||+|+||.|-+|..+ +|+.||||++++....       ......+|+++|++|+|||||+++++++..+.
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence            356888999999999999999865 7999999999864211       12334699999999999999999999999999


Q ss_pred             eEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCC---CCeeeeccc
Q 003599          553 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE---LNPKISDFG  629 (808)
Q Consensus       553 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~---~~~kl~DFG  629 (808)
                      .|+||||++||.|.+++..   .+.+.+..-..++.|++.|+.|||++|   |+||||||+|||+..+   -.+||+|||
T Consensus       251 ~YmVlE~v~GGeLfd~vv~---nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFG  324 (475)
T KOG0615|consen  251 SYMVLEYVEGGELFDKVVA---NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFG  324 (475)
T ss_pred             eEEEEEEecCccHHHHHHh---ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccc
Confidence            9999999999999998854   456777777889999999999999999   9999999999999765   779999999


Q ss_pred             cceecCCCCCcccccceeccCCccChhhhccCCC---CccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccc
Q 003599          630 MAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRF---SEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNEN  706 (808)
Q Consensus       630 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~  706 (808)
                      +|+..+.   .......+||+.|.|||++....+   ..+.|+||+||+||-+++|.+||+....+..+.+..    ..+
T Consensus       325 lAK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI----~~G  397 (475)
T KOG0615|consen  325 LAKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQI----LKG  397 (475)
T ss_pred             hhhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHH----hcC
Confidence            9998752   233445799999999999976643   347899999999999999999997544333222111    111


Q ss_pred             cchhccCCcccC-CcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          707 KILALVDPFLSE-SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       707 ~~~~~~d~~l~~-~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                              +... .....+..++.+++|.+||..||++|||+.|+++
T Consensus       398 --------~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  398 --------RYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             --------cccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence                    1111 1233456788999999999999999999999875

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-43  Score=347.31  Aligned_cols=259  Identities=24%  Similarity=0.391  Sum_probs=210.7

Q ss_pred             cCCcccCcccccCceeEEEEE-ecCCcEEEEEEeccc--ccccHHHHHHHHHHHHhccCCceeeEee-EEEeCCe-eEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLG-CCVEGEE-KMLI  556 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g-~~~~~~~-~~lV  556 (808)
                      .+|+++++||+|.||+||++. +.+|..||.|.+.-.  .....+....|+.+|++|+|||||++++ .+.++.+ ..||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            458889999999999999997 458999999998632  3445678899999999999999999999 4555555 7899


Q ss_pred             EEecCCCCchhhccCC-CCCCcCChhhHHHHHHHHHHHHHHhHhcCC-CcEEeCCCCCCceEeCCCCCeeeeccccceec
Q 003599          557 YEYMPNRSLDALLFDP-LKKERLDWRKRFNIIEGISRGLLYLHRDSR-LRIIHRDLKASNILLDEELNPKISDFGMAKIF  634 (808)
Q Consensus       557 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~-~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~  634 (808)
                      ||++.+|+|...+... ..++.+++..+++++.|+++||..+|..-+ ..|+||||||.||+|+.+|.+||+|||+++.+
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            9999999999998653 345679999999999999999999998421 23999999999999999999999999999998


Q ss_pred             CCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCC
Q 003599          635 GGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDP  714 (808)
Q Consensus       635 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  714 (808)
                      .......  ...+|||.||+||.+.+.+|+.|+||||+||++|||..-+.||...    ++.+...++ ..+..      
T Consensus       179 ~s~~tfA--~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~----n~~~L~~KI-~qgd~------  245 (375)
T KOG0591|consen  179 SSKTTFA--HSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD----NLLSLCKKI-EQGDY------  245 (375)
T ss_pred             cchhHHH--HhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc----cHHHHHHHH-HcCCC------
Confidence            6654433  2378999999999999999999999999999999999999998643    333322221 12211      


Q ss_pred             cccCCccc-HHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003599          715 FLSESSFQ-LDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  757 (808)
Q Consensus       715 ~l~~~~~~-~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~  757 (808)
                          .+.+ ......+..|+..|+..||+.||+...++..+...
T Consensus       246 ----~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~  285 (375)
T KOG0591|consen  246 ----PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSE  285 (375)
T ss_pred             ----CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHH
Confidence                1122 45678889999999999999999976666666553

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-42  Score=378.44  Aligned_cols=269  Identities=28%  Similarity=0.465  Sum_probs=223.3

Q ss_pred             cCHHHHHHHhc---------CCcccCcccccCceeEEEEEecC----CcEEEEEEecccc-cccHHHHHHHHHHHHhccC
Q 003599          472 FQFEELATATN---------NFQLSSKLGQGGFGPVYWGRLKD----GQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQH  537 (808)
Q Consensus       472 f~~~~l~~~~~---------~~~~~~~lG~G~~g~Vy~~~~~~----~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H  537 (808)
                      ++|++-..+..         ...|.++||.|.||+||+|+++-    ...||||.++... +....+|+.|+.||.++.|
T Consensus       610 ~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdH  689 (996)
T KOG0196|consen  610 HTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDH  689 (996)
T ss_pred             ccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCC
Confidence            55665444433         35677899999999999999862    4569999998753 4467799999999999999


Q ss_pred             CceeeEeeEEEeCCeeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEe
Q 003599          538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL  617 (808)
Q Consensus       538 ~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl  617 (808)
                      |||++|.|........+||.|||++|+|+.||..  +.+.+++.++..++++||.||.||.+.+   +|||||.++||||
T Consensus       690 PNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~--~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILV  764 (996)
T KOG0196|consen  690 PNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILV  764 (996)
T ss_pred             CcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhh--cCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheee
Confidence            9999999999999999999999999999999976  4577999999999999999999999988   9999999999999


Q ss_pred             CCCCCeeeeccccceecCCCCCcccc-cceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhh
Q 003599          618 DEELNPKISDFGMAKIFGGNQDQADT-GRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTI  695 (808)
Q Consensus       618 ~~~~~~kl~DFGla~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~  695 (808)
                      +.+..+|++|||++|.+.++.+...+ ..-.-+.+|.|||.+...+++.++|||||||++||.++ |.+|+=..++.   
T Consensus       765 NsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ---  841 (996)
T KOG0196|consen  765 NSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---  841 (996)
T ss_pred             ccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH---
Confidence            99999999999999988665532222 11233678999999999999999999999999999887 88886332222   


Q ss_pred             hhhhhhhhccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhcccC
Q 003599          696 LGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRD  760 (808)
Q Consensus       696 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~~~  760 (808)
                                 .+...++....- +.+.+++..|.+|++.|||+|-.+||.+.||+.+|+++++.
T Consensus       842 -----------dVIkaIe~gyRL-PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn  894 (996)
T KOG0196|consen  842 -----------DVIKAIEQGYRL-PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN  894 (996)
T ss_pred             -----------HHHHHHHhccCC-CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence                       222233333322 26678899999999999999999999999999999998654

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-41  Score=345.32  Aligned_cols=242  Identities=26%  Similarity=0.332  Sum_probs=202.6

Q ss_pred             hcCCcccCcccccCceeEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEE
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI  556 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  556 (808)
                      .++|+++++||+|+||.||.++.+ .++.+|+|++++..   ....+..++|..+|.+++||.||+++..+.+.+.+|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            468999999999999999999866 58899999998752   34567889999999999999999999999999999999


Q ss_pred             EEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCC
Q 003599          557 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  636 (808)
Q Consensus       557 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  636 (808)
                      +||+.||.|..+|.   +.+.+++....-++.+|+.||.|||+.+   ||||||||+|||||++|.++|+|||+++....
T Consensus       104 ld~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~  177 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK  177 (357)
T ss_pred             EeccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence            99999999999995   3567999989999999999999999999   99999999999999999999999999996533


Q ss_pred             CCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcc
Q 003599          637 NQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL  716 (808)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  716 (808)
                      ..  ..+..++||+.|||||++....++..+|.||||+++|||++|.+||...+...    +.......         .+
T Consensus       178 ~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~----~~~~I~~~---------k~  242 (357)
T KOG0598|consen  178 DG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK----MYDKILKG---------KL  242 (357)
T ss_pred             CC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH----HHHHHhcC---------cC
Confidence            32  33444899999999999999999999999999999999999999996533221    11111111         11


Q ss_pred             cCCcccHHHHHHHHHHHHhcccCCcCCCC
Q 003599          717 SESSFQLDMIIRCIHVGLLCVQELVKDRP  745 (808)
Q Consensus       717 ~~~~~~~~~~~~l~~li~~cl~~~P~~RP  745 (808)
                      ..  .+.-...+..+++...++.||++|-
T Consensus       243 ~~--~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  243 PL--PPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             CC--CCccCCHHHHHHHHHHhccCHHHhc
Confidence            11  1222445678899999999999996

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=358.27  Aligned_cols=269  Identities=29%  Similarity=0.474  Sum_probs=217.2

Q ss_pred             HHHHHHhcCCcccCcccccCceeEEEEEecCCcEEEEEEeccc--ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCe
Q 003599          475 EELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEE  552 (808)
Q Consensus       475 ~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  552 (808)
                      +++....+.+.+.+.||+|.||+||+|++.  ..||||++...  .++..+.|++|+..+++-+|.||+-+.|+|.....
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~  462 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL  462 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence            445555567788899999999999999987  36999999764  34567899999999999999999999999998777


Q ss_pred             eEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccce
Q 003599          553 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK  632 (808)
Q Consensus       553 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~  632 (808)
                       .||..+|+|.+|..+|+.  .+..++..+.+.|+.|||+||.|||.++   |||||||..||+|.+++.|||+||||+.
T Consensus       463 -AIiTqwCeGsSLY~hlHv--~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLat  536 (678)
T KOG0193|consen  463 -AIITQWCEGSSLYTHLHV--QETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLAT  536 (678)
T ss_pred             -eeeehhccCchhhhhccc--hhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccccee
Confidence             999999999999999986  3467999999999999999999999999   9999999999999999999999999998


Q ss_pred             ecCCCCCcccccceeccCCccChhhhcc---CCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccch
Q 003599          633 IFGGNQDQADTGRVVGTFGYMSPEYAME---GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKIL  709 (808)
Q Consensus       633 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  709 (808)
                      .-..-.-........|...|||||+++.   .+|+..+||||||+++|||+||..|+.....++.+.       .-++-.
T Consensus       537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIif-------mVGrG~  609 (678)
T KOG0193|consen  537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIF-------MVGRGY  609 (678)
T ss_pred             eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEE-------Eecccc
Confidence            6433222222223457889999999964   468999999999999999999999987322222221       112222


Q ss_pred             hccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhcccCCC
Q 003599          710 ALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLP  762 (808)
Q Consensus       710 ~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~~~~~  762 (808)
                      -..|...    ...+...++.+|...||..++++||.+.+|+.+|+.++..+|
T Consensus       610 l~pd~s~----~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~p  658 (678)
T KOG0193|consen  610 LMPDLSK----IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLP  658 (678)
T ss_pred             cCccchh----hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhccc
Confidence            2223222    223456788899999999999999999999999988765443

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=6.6e-40  Score=359.32  Aligned_cols=262  Identities=28%  Similarity=0.409  Sum_probs=206.3

Q ss_pred             hcCCcccCcccccCceeEEEEEe------cCCcEEEEEEecccc-cccHHHHHHHHHHHHhc-cCCceeeEeeEEEeCC-
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRL------KDGQEIAVKRLSKAS-GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGE-  551 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~-  551 (808)
                      .++|++.++||+|+||.||+|..      .++..||||++.... ....+.+.+|+.++.++ +||||+++++++...+ 
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            46799999999999999999974      235689999987543 23356789999999999 8999999999887644 


Q ss_pred             eeEEEEEecCCCCchhhccCCCC---------------------------------------------------------
Q 003599          552 EKMLIYEYMPNRSLDALLFDPLK---------------------------------------------------------  574 (808)
Q Consensus       552 ~~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------  574 (808)
                      ..++||||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            57899999999999998864211                                                         


Q ss_pred             --CCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCcccccceeccCCc
Q 003599          575 --KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY  652 (808)
Q Consensus       575 --~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y  652 (808)
                        ...+++.++..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++...............++..|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence              134788889999999999999999988   999999999999999999999999999865433222222334567889


Q ss_pred             cChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCcccHHHHHHHHH
Q 003599          653 MSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIH  731 (808)
Q Consensus       653 ~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~  731 (808)
                      +|||.+.+..++.++||||||+++|||++ |+.||...........    ...++..     ..     .+......+.+
T Consensus       243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~----~~~~~~~-----~~-----~~~~~~~~l~~  308 (338)
T cd05102         243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQ----RLKDGTR-----MR-----APENATPEIYR  308 (338)
T ss_pred             cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHH----HHhcCCC-----CC-----CCCCCCHHHHH
Confidence            99999999899999999999999999997 9999865433222111    1111110     00     11223456889


Q ss_pred             HHHhcccCCcCCCCCHHHHHHHHhhccc
Q 003599          732 VGLLCVQELVKDRPNMSTVVSMLNSEIR  759 (808)
Q Consensus       732 li~~cl~~~P~~RPs~~ev~~~L~~~~~  759 (808)
                      ++.+|++.+|++||++.+|+++|+.++.
T Consensus       309 li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         309 IMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            9999999999999999999999988743

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=3e-40  Score=327.61  Aligned_cols=262  Identities=20%  Similarity=0.297  Sum_probs=205.7

Q ss_pred             cCCcccCcccccCceeEEEEEecC-CcEEEEEEeccccc--ccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASG--QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  558 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  558 (808)
                      +.|+.+.++|+|+||+||+++.++ |+.||||++....+  ...+-.++|+++|++++|+|+|.++..|.......||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            457788999999999999999874 99999999976433  234567899999999999999999999999999999999


Q ss_pred             ecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCC
Q 003599          559 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  638 (808)
Q Consensus       559 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  638 (808)
                      |++..-|+++-.   ....++...+.+++.|+++|+.|+|+++   ++||||||+||||+.++.+||||||+||.+....
T Consensus        82 ~~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg  155 (396)
T KOG0593|consen   82 YCDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPG  155 (396)
T ss_pred             ecchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence            999877766543   2345788889999999999999999998   9999999999999999999999999999886322


Q ss_pred             CcccccceeccCCccChhhhcc-CCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhh----------hhc-cc
Q 003599          639 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWK----------LWN-EN  706 (808)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~----------~~~-~~  706 (808)
                        ......+.|..|.|||.+.+ .+|....|||++||++.||++|.+.|+..++-..+......          .+. ++
T Consensus       156 --d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~  233 (396)
T KOG0593|consen  156 --DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP  233 (396)
T ss_pred             --chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence              22233678999999999876 78999999999999999999999988876654333211110          111 11


Q ss_pred             c-----chhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          707 K-----ILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       707 ~-----~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      .     +.+.-++.-.+. .-.....-+++++..|++.||++|++-+|++.
T Consensus       234 ~F~Gv~lP~~~~~epLe~-k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  234 FFHGVRLPEPEHPEPLER-KYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             ceeeeecCCCCCccchhh-hcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            1     111111111111 11223457889999999999999999999864

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-39  Score=340.16  Aligned_cols=257  Identities=28%  Similarity=0.404  Sum_probs=204.5

Q ss_pred             cCCcccCcccccCceeEEEEEecC-CcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCC--eeEEEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE--EKMLIYE  558 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~E  558 (808)
                      .++...+.||+|+||+||++...+ |...|||..........+.+.+|+.+|.+++|||||+++|......  ...++||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            457778999999999999999764 8999999987654333677899999999999999999999855444  6889999


Q ss_pred             ecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCC-CCCeeeeccccceecCCC
Q 003599          559 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE-ELNPKISDFGMAKIFGGN  637 (808)
Q Consensus       559 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~-~~~~kl~DFGla~~~~~~  637 (808)
                      |+++|+|.+++.+..  ..+++..+.++++||++||+|||+++   |+||||||+||||+. ++.+||+|||+++.....
T Consensus        97 y~~~GsL~~~~~~~g--~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~  171 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYG--GKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK  171 (313)
T ss_pred             ccCCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence            999999999996532  27999999999999999999999998   999999999999999 799999999999876531


Q ss_pred             C-CcccccceeccCCccChhhhccCC-CCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCc
Q 003599          638 Q-DQADTGRVVGTFGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPF  715 (808)
Q Consensus       638 ~-~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  715 (808)
                      . .........||+.|||||++..+. ...++|||||||++.||+||++|+....+.   ..+........     ..| 
T Consensus       172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~---~~~~~~ig~~~-----~~P-  242 (313)
T KOG0198|consen  172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEE---AEALLLIGRED-----SLP-  242 (313)
T ss_pred             cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcch---HHHHHHHhccC-----CCC-
Confidence            1 112233478999999999998643 345999999999999999999998753111   11111111111     111 


Q ss_pred             ccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhh
Q 003599          716 LSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS  756 (808)
Q Consensus       716 l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~  756 (808)
                          ..+.....+..+++.+|++.+|++|||++++++..--
T Consensus       243 ----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~  279 (313)
T KOG0198|consen  243 ----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL  279 (313)
T ss_pred             ----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence                1334456678899999999999999999999987633

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-38  Score=335.61  Aligned_cols=282  Identities=22%  Similarity=0.337  Sum_probs=215.6

Q ss_pred             hcCCcccCcccccCceeEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHHhccCCceeeEeeEEEeC--CeeEE
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG--EEKML  555 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l  555 (808)
                      .+.|+.+++||+|.||.||+|+.. +|+.||+|+++...  +....-..+|+.+|++|+||||+++.+...+.  ...||
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            356777899999999999999854 69999999998654  33455667999999999999999999998876  68999


Q ss_pred             EEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecC
Q 003599          556 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG  635 (808)
Q Consensus       556 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~  635 (808)
                      |+|||++ +|.-++..  ..-.++..++.-++.||+.||+|+|..+   |+|||||.+|||||.+|.+||+|||||+++.
T Consensus       196 VFeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~  269 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT  269 (560)
T ss_pred             EEecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence            9999977 78777754  3457999999999999999999999999   9999999999999999999999999999887


Q ss_pred             CCCCcccccceeccCCccChhhhccC-CCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhh-------hhcccc
Q 003599          636 GNQDQADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWK-------LWNENK  707 (808)
Q Consensus       636 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~-------~~~~~~  707 (808)
                      .......+. .+-|..|.|||++.+. .|+.+.|+||.||||.||++|++.+....+-..+......       .|...+
T Consensus       270 ~~~~~~~T~-rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k  348 (560)
T KOG0600|consen  270 PSGSAPYTS-RVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK  348 (560)
T ss_pred             CCCCccccc-ceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence            665554444 5679999999999865 6999999999999999999999988776654333322111       111000


Q ss_pred             ch--hccCCccc-----CCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhcccCCCCCCCCCcccC
Q 003599          708 IL--ALVDPFLS-----ESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPAFTER  772 (808)
Q Consensus       708 ~~--~~~d~~l~-----~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~~~~~~p~~p~~~~~  772 (808)
                      +.  ..+.+.-.     .+ .-.......++|+..+|..||.+|.|+.++++.=  -+...+.|..|...+.
T Consensus       349 LP~~~~~kp~~~y~r~l~E-~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~se--yF~t~p~~~~p~~Lp~  417 (560)
T KOG0600|consen  349 LPHATIFKPQQPYKRRLRE-TFKDFPASALDLLEKLLSLDPDKRGTASSALQSE--YFTTEPLPCDPSSLPK  417 (560)
T ss_pred             CCcccccCCCCcccchHHH-HhccCCHHHHHHHHHHhccCccccccHHHHhcCc--ccccCCCCCCcccCCC
Confidence            00  01111100     00 0112245678899999999999999999987642  2234555666666655

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-39  Score=341.38  Aligned_cols=264  Identities=27%  Similarity=0.439  Sum_probs=219.8

Q ss_pred             cCCcccCcccccCceeEEEEEecCCcEEEEEEecccccc-cHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEec
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQ-GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  560 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  560 (808)
                      ....+.++||+|-||+|.++....+..||||+++..... ...+|.+|+++|.+++||||++++|.|..++..++|+|||
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm  617 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM  617 (807)
T ss_pred             hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence            456778999999999999999998899999999876544 4589999999999999999999999999999999999999


Q ss_pred             CCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCc
Q 003599          561 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  640 (808)
Q Consensus       561 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  640 (808)
                      ++|+|.+|+..... +.+.-....+|+.|||.||+||.+.+   +|||||.++|+|++.++++||+|||++|.+......
T Consensus       618 EnGDLnqFl~ahea-pt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy  693 (807)
T KOG1094|consen  618 ENGDLNQFLSAHEL-PTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY  693 (807)
T ss_pred             hcCcHHHHHHhccC-cccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCce
Confidence            99999999976422 22566677889999999999999988   999999999999999999999999999987766666


Q ss_pred             ccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh--CCCCCCCCCCchhhhhhhhhhhccccchhccCCcccC
Q 003599          641 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS--GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSE  718 (808)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt--G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  718 (808)
                      ...++.+-+.+|||||.+..++++.++|||+||+++||+++  ..+|++...+++... -+..++..+.....+      
T Consensus       694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vve-n~~~~~~~~~~~~~l------  766 (807)
T KOG1094|consen  694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVE-NAGEFFRDQGRQVVL------  766 (807)
T ss_pred             eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHH-hhhhhcCCCCcceec------
Confidence            66667778899999999999999999999999999999876  567776555443322 222233322221111      


Q ss_pred             CcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003599          719 SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  757 (808)
Q Consensus       719 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~  757 (808)
                       ..+.-++..+.++++.|+..|-++||++++|...|++.
T Consensus       767 -~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  767 -SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             -cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence             13334556788999999999999999999999999764

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.3e-39  Score=343.94  Aligned_cols=278  Identities=24%  Similarity=0.363  Sum_probs=227.7

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  558 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  558 (808)
                      ++|.+.+.||+|.||.||||+-+ +.+.||+|.+.+..  +.+.+.+.+|++++++++|||||.+++.|+...+.++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            57889999999999999999876 57899999998753  3456778999999999999999999999999999999999


Q ss_pred             ecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCC
Q 003599          559 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  638 (808)
Q Consensus       559 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  638 (808)
                      |+.+ +|..+|.   ..+.+++..+..|+.++..||.|||+..   |+|||+||.|||++.++.+|++|||+||.+... 
T Consensus        82 ~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-  153 (808)
T KOG0597|consen   82 YAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-  153 (808)
T ss_pred             hhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccC-
Confidence            9977 9999995   4567999999999999999999999998   999999999999999999999999999987543 


Q ss_pred             CcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccC
Q 003599          639 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSE  718 (808)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  718 (808)
                       ......+.||+.|||||...+.+|+..+|.||+|||+||+.+|++||...    .+.+....+..+.        .   
T Consensus       154 -t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~----si~~Lv~~I~~d~--------v---  217 (808)
T KOG0597|consen  154 -TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR----SITQLVKSILKDP--------V---  217 (808)
T ss_pred             -ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH----HHHHHHHHHhcCC--------C---
Confidence             33344578999999999999999999999999999999999999998532    1222222222221        1   


Q ss_pred             CcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH--HHhhcccCCCCCCCCCcccCCCCCCchhHHHH
Q 003599          719 SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS--MLNSEIRDLPYPKEPAFTERQGADDSESFKQI  784 (808)
Q Consensus       719 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~--~L~~~~~~~~~p~~p~~~~~~~~~~~~~~~~~  784 (808)
                       ..+......+..+....+++||.+|.+..+++.  ..++.+.....|..|+...-......+.+++.
T Consensus       218 -~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~~~a~~spftn~~Ppe~kek  284 (808)
T KOG0597|consen  218 -KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAELPAQVAFDSPFTNNTPPEYKEK  284 (808)
T ss_pred             -CCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhcccccccccCccccCCChHHHHh
Confidence             133356678889999999999999999999875  34555566666777766555555554444443

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-39  Score=342.42  Aligned_cols=253  Identities=30%  Similarity=0.395  Sum_probs=210.7

Q ss_pred             HhcCCcccCcccccCceeEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHHhc-cCCceeeEeeEEEeCCeeE
Q 003599          480 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKM  554 (808)
Q Consensus       480 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~  554 (808)
                      ...+|.+.+.||+|+|++|++|+.. .++.+|||++.+.   .....+-...|-..|.+| .||.|++|+-.|.++..+|
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY  150 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY  150 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence            3467889999999999999999865 5899999999764   233345567899999999 8999999999999999999


Q ss_pred             EEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceec
Q 003599          555 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF  634 (808)
Q Consensus       555 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~  634 (808)
                      +|+||+++|+|.++|.   +.+.+++.....++.+|+.||+|||+.|   ||||||||+|||||++|++||+|||.|+.+
T Consensus       151 FvLe~A~nGdll~~i~---K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l  224 (604)
T KOG0592|consen  151 FVLEYAPNGDLLDLIK---KYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKIL  224 (604)
T ss_pred             EEEEecCCCcHHHHHH---HhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccC
Confidence            9999999999999995   4578999999999999999999999999   999999999999999999999999999988


Q ss_pred             CCCCCc---------ccc--cceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhh
Q 003599          635 GGNQDQ---------ADT--GRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLW  703 (808)
Q Consensus       635 ~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~  703 (808)
                      ......         ...  ..++||..|.+||++.++..+..+|+|+||||||+|+.|++||....+-..+.       
T Consensus       225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFq-------  297 (604)
T KOG0592|consen  225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQ-------  297 (604)
T ss_pred             ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHH-------
Confidence            643222         112  34899999999999999999999999999999999999999997544322111       


Q ss_pred             ccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHH
Q 003599          704 NENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML  754 (808)
Q Consensus       704 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L  754 (808)
                         ++.+ ++-.     ++....+...+|+.+.|..||.+|++.++|-+..
T Consensus       298 ---kI~~-l~y~-----fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp  339 (604)
T KOG0592|consen  298 ---KIQA-LDYE-----FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP  339 (604)
T ss_pred             ---HHHH-hccc-----CCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence               1111 1111     3333446778899999999999999999998765

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.3e-38  Score=341.81  Aligned_cols=264  Identities=27%  Similarity=0.434  Sum_probs=203.4

Q ss_pred             cCCcccCcccccCceeEEEEEecC-----------------CcEEEEEEecccc-cccHHHHHHHHHHHHhccCCceeeE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLKD-----------------GQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRL  543 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l  543 (808)
                      ++|++.++||+|+||.||++.+++                 +..||+|.+.... .....+|.+|+.++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            578889999999999999997542                 3469999987643 3345679999999999999999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCchhhccCCC----------------CCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEe
Q 003599          544 LGCCVEGEEKMLIYEYMPNRSLDALLFDPL----------------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH  607 (808)
Q Consensus       544 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH  607 (808)
                      ++++.+.+..++||||+++|+|.+++....                ....+++..+.+++.||+.||.|||+.+   |+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence            999999999999999999999999885421                1134788899999999999999999988   999


Q ss_pred             CCCCCCceEeCCCCCeeeeccccceecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCC--CC
Q 003599          608 RDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR--KN  685 (808)
Q Consensus       608 ~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~--~p  685 (808)
                      |||||+|||++.++.+||+|||+++.+.............++..|+|||.+..+.++.++||||||+++|||+++.  .|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            9999999999999999999999998664333222233345678999999999889999999999999999999854  45


Q ss_pred             CCCCCCchhhhhhhhhhhccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhh
Q 003599          686 TSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS  756 (808)
Q Consensus       686 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~  756 (808)
                      +...... ...................       ..+......+.+++.+|++.+|++||++.+|++.|++
T Consensus       242 ~~~~~~~-~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         242 YGELTDE-QVIENAGEFFRDQGRQVYL-------FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCcCCHH-HHHHHHHHHhhhccccccc-------cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            5433222 2221111111111000000       0111234578899999999999999999999998853

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-39  Score=375.18  Aligned_cols=260  Identities=32%  Similarity=0.495  Sum_probs=215.9

Q ss_pred             CCcccCcccccCceeEEEEEecC--Cc----EEEEEEeccc-ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEE
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLKD--GQ----EIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML  555 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~~--~~----~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  555 (808)
                      +.++...||+|.||.||.|...+  +.    .||||.+.+. +.+...+|++|..+|++++|||||+++|.|.+....+|
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i  772 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI  772 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence            45567889999999999998653  33    4999999875 45667899999999999999999999999999999999


Q ss_pred             EEEecCCCCchhhccCCC----CCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccc
Q 003599          556 IYEYMPNRSLDALLFDPL----KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA  631 (808)
Q Consensus       556 V~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla  631 (808)
                      ++|||++|+|..||.+.+    ....++..+.+.++.+||+|+.||++++   +|||||.++|+||++...+||+|||+|
T Consensus       773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGlA  849 (1025)
T KOG1095|consen  773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGLA  849 (1025)
T ss_pred             EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccchh
Confidence            999999999999998642    2456899999999999999999999998   999999999999999999999999999


Q ss_pred             eecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhccccchh
Q 003599          632 KIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILA  710 (808)
Q Consensus       632 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  710 (808)
                      |.+.+...........-+..|||||.+.++.++.|+|||||||+|||++| |..|++...+.+.+..+    ...+    
T Consensus       850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~----~~gg----  921 (1025)
T KOG1095|consen  850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDV----LEGG----  921 (1025)
T ss_pred             HhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHH----HhCC----
Confidence            96655444444443445679999999999999999999999999999999 67777654443322211    1111    


Q ss_pred             ccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhcccC
Q 003599          711 LVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRD  760 (808)
Q Consensus       711 ~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~~~  760 (808)
                          ++.   .+..+++.+.+|+.+||+.+|++||++..|++.+..+...
T Consensus       922 ----RL~---~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~  964 (1025)
T KOG1095|consen  922 ----RLD---PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA  964 (1025)
T ss_pred             ----ccC---CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence                221   4455677889999999999999999999999999887544

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-39  Score=352.96  Aligned_cols=260  Identities=32%  Similarity=0.419  Sum_probs=208.8

Q ss_pred             cCCcccCcccccCceeEEEEEecC--C--cE-EEEEEecc---cccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCee
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLKD--G--QE-IAVKRLSK---ASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEK  553 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~~--~--~~-vAvK~l~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  553 (808)
                      ++..+.++||+|+||.||+|+++.  +  .. ||||..+.   .......+|++|+++|++++|||||+++|++......
T Consensus       157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl  236 (474)
T KOG0194|consen  157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL  236 (474)
T ss_pred             cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence            455556899999999999998763  2  23 89999874   3466788999999999999999999999999999999


Q ss_pred             EEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeecccccee
Q 003599          554 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI  633 (808)
Q Consensus       554 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  633 (808)
                      ++|||+|+||+|+++|...  ...++..++++++.++|+||+|||+++   ++||||.++|+|++.++.+||+|||+++.
T Consensus       237 ~ivmEl~~gGsL~~~L~k~--~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~  311 (474)
T KOG0194|consen  237 MLVMELCNGGSLDDYLKKN--KKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRA  311 (474)
T ss_pred             EEEEEecCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccC
Confidence            9999999999999999653  336999999999999999999999998   99999999999999999999999999885


Q ss_pred             cCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhccccchhcc
Q 003599          634 FGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALV  712 (808)
Q Consensus       634 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  712 (808)
                      -.  ..........-+..|+|||.+..+.++.++|||||||++||+++ |..|+......+... .   ...++-     
T Consensus       312 ~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~-k---I~~~~~-----  380 (474)
T KOG0194|consen  312 GS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKA-K---IVKNGY-----  380 (474)
T ss_pred             Cc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHH-H---HHhcCc-----
Confidence            42  11111111245789999999999999999999999999999999 788876544321111 1   101110     


Q ss_pred             CCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhcccCCC
Q 003599          713 DPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLP  762 (808)
Q Consensus       713 d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~~~~~  762 (808)
                        +.   ..+...+.++..++.+|+..+|++||+|.+|.+.|+.+.....
T Consensus       381 --r~---~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  381 --RM---PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             --cC---CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence              01   1222446677788889999999999999999999988744433

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-38  Score=330.64  Aligned_cols=263  Identities=24%  Similarity=0.356  Sum_probs=208.3

Q ss_pred             hcCCcccCcccccCceeEEEEEe-cCCcEEEEEEeccccc-ccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEE
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRL-KDGQEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  558 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  558 (808)
                      .+.|++.++||.|.-++||+|+. ..+..||||++.-... ...+.+.+|+..|+.++||||++++..|..+..+++||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            46799999999999999999985 4679999999975433 336889999999999999999999999999999999999


Q ss_pred             ecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCC
Q 003599          559 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  638 (808)
Q Consensus       559 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  638 (808)
                      ||.+||+.+++...... .+++..+..|++++++||.|||+++   .||||||+.||||+.+|.+||+|||.+..+....
T Consensus       105 fMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG  180 (516)
T ss_pred             hhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence            99999999999765433 4899999999999999999999999   9999999999999999999999999877664433


Q ss_pred             Cccc--ccceeccCCccChhhhcc--CCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCC
Q 003599          639 DQAD--TGRVVGTFGYMSPEYAME--GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDP  714 (808)
Q Consensus       639 ~~~~--~~~~~gt~~y~aPE~~~~--~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  714 (808)
                      ....  .....||+.|||||+++.  ..|+.|+||||||++..||.+|..||..+..-.-+..    .+... .....-.
T Consensus       181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~----tLqn~-pp~~~t~  255 (516)
T KOG0582|consen  181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLL----TLQND-PPTLLTS  255 (516)
T ss_pred             ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHH----HhcCC-CCCcccc
Confidence            2211  144689999999999654  3589999999999999999999999976543222211    11111 1000000


Q ss_pred             cccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          715 FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       715 ~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                      .+.. .........+.+++..||+.||.+|||++++++.
T Consensus       256 ~~~~-d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  256 GLDK-DEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             cCCh-HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence            1111 1222334578899999999999999999998763

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.6e-38  Score=351.20  Aligned_cols=260  Identities=27%  Similarity=0.384  Sum_probs=205.9

Q ss_pred             hcCCcccCcccccCceeEEEEEe------cCCcEEEEEEecccc-cccHHHHHHHHHHHHhc-cCCceeeEeeEEEeCCe
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRL------KDGQEIAVKRLSKAS-GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEE  552 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~  552 (808)
                      .++|++.+.||+|+||.||+|+.      ..+..||||+++... ....+.+.+|+.++..+ +||||+++++++.+++.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            45788999999999999999963      235689999986532 33456788999999999 89999999999999999


Q ss_pred             eEEEEEecCCCCchhhccCCC-----------------------------------------------------------
Q 003599          553 KMLIYEYMPNRSLDALLFDPL-----------------------------------------------------------  573 (808)
Q Consensus       553 ~~lV~E~~~~gsL~~~l~~~~-----------------------------------------------------------  573 (808)
                      .++||||+++|+|.+++....                                                           
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            999999999999999885421                                                           


Q ss_pred             -------------CCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCc
Q 003599          574 -------------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  640 (808)
Q Consensus       574 -------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  640 (808)
                                   ....+++..+.+++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                         0124788899999999999999999988   999999999999999999999999999876443322


Q ss_pred             ccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCC
Q 003599          641 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSES  719 (808)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  719 (808)
                      .......++..|+|||.+.+..++.++||||||+++|||++ |..|+............    ...+..  ..       
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~----~~~~~~--~~-------  337 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKM----IKEGYR--ML-------  337 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHH----HHhCcc--CC-------
Confidence            22222345678999999999999999999999999999998 77787644332222221    111110  00       


Q ss_pred             cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003599          720 SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  757 (808)
Q Consensus       720 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~  757 (808)
                       .+.....++.+++.+|++.||++||++.+|+++|++.
T Consensus       338 -~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         338 -SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             -CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence             1111235788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=7e-38  Score=334.28  Aligned_cols=244  Identities=20%  Similarity=0.319  Sum_probs=198.2

Q ss_pred             CcccccCceeEEEEEecCCcEEEEEEeccccccc---HHHHHHHHHHHHhccCCceeeEeeEEEe----CCeeEEEEEec
Q 003599          488 SKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQG---LEEFMNEVMVISKLQHRNLVRLLGCCVE----GEEKMLIYEYM  560 (808)
Q Consensus       488 ~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~E~~  560 (808)
                      ..||+|++|.||+|+.. |+.||||+++......   .+.|.+|+.+|++++||||++++|++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEEC-CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            57999999999999984 8899999997653333   5778899999999999999999999877    34678999999


Q ss_pred             CCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhc-CCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCC
Q 003599          561 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD-SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  639 (808)
Q Consensus       561 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  639 (808)
                      ++|+|.+++..   ...+++....+++.+++.||.|||+. +   ++||||||+|||+++++.+||+|||+++...... 
T Consensus       105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-  177 (283)
T PHA02988        105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-  177 (283)
T ss_pred             CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence            99999999954   34689999999999999999999985 5   7899999999999999999999999998653321 


Q ss_pred             cccccceeccCCccChhhhcc--CCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCccc
Q 003599          640 QADTGRVVGTFGYMSPEYAME--GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS  717 (808)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  717 (808)
                          ....|+..|+|||.+.+  ..++.++|||||||++|||++|+.||....... ....   ....+     ..+.  
T Consensus       178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~-~~~~---i~~~~-----~~~~--  242 (283)
T PHA02988        178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE-IYDL---IINKN-----NSLK--  242 (283)
T ss_pred             ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH-HHHH---HHhcC-----CCCC--
Confidence                12357899999999976  679999999999999999999999987543221 1111   11000     0011  


Q ss_pred             CCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003599          718 ESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  757 (808)
Q Consensus       718 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~  757 (808)
                         .+......+.+++.+||+.||++|||+++|++.|+..
T Consensus       243 ---~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~  279 (283)
T PHA02988        243 ---LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY  279 (283)
T ss_pred             ---CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence               2223456788999999999999999999999999764

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=5e-38  Score=307.17  Aligned_cols=281  Identities=22%  Similarity=0.340  Sum_probs=217.0

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  558 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  558 (808)
                      .+|...++||+|.||.||+|++. .|+.||||+++...  ........+|++.|+.++|+||+.+++.+-..+..-||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            46777899999999999999864 69999999997542  2223567899999999999999999999999999999999


Q ss_pred             ecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCC
Q 003599          559 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  638 (808)
Q Consensus       559 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  638 (808)
                      ||+. +|+..+.+  +...++..++..++.++++|++|||.+.   |+||||||.|+|++++|.+||+|||+++.+....
T Consensus        82 fm~t-dLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   82 FMPT-DLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             eccc-cHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence            9964 89998865  4567999999999999999999999998   9999999999999999999999999999987554


Q ss_pred             CcccccceeccCCccChhhhccC-CCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhc---ccc---chhc
Q 003599          639 DQADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN---ENK---ILAL  711 (808)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~---~~~---~~~~  711 (808)
                      .....  .+-|..|.|||.+.+. .|+...|+||.|||+.||+-|.+-++..++-+.+..... .+.   ++.   +..+
T Consensus       156 ~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~-~LGTP~~~~WP~~~~l  232 (318)
T KOG0659|consen  156 RIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFR-ALGTPTPDQWPEMTSL  232 (318)
T ss_pred             ccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHH-HcCCCCcccCcccccc
Confidence            43332  2679999999999875 589999999999999999999877765554322221111 111   010   1111


Q ss_pred             ---------cCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhcccCCCCCCCCCcccCCCC
Q 003599          712 ---------VDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPAFTERQGA  775 (808)
Q Consensus       712 ---------~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~~~~~~p~~p~~~~~~~~  775 (808)
                               ..+.+. . .-.......++++..++..||.+|++++|.+++=-  +...|.|..|...+....
T Consensus       233 pdY~~~~~~P~~~~~-~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~y--f~~~P~pt~~~~lp~p~~  301 (318)
T KOG0659|consen  233 PDYVKIQQFPKPPLN-N-LFPAASSDALDLLSKMLTYNPKKRITASQALKHPY--FKSLPLPTPPSKLPIPST  301 (318)
T ss_pred             ccHHHHhcCCCCccc-c-ccccccHHHHHHHHhhhccCchhcccHHHHhcchh--hhcCCCCCChhhCcCCcc
Confidence                     111111 1 12223456689999999999999999999988652  245666666666655544

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.5e-37  Score=384.94  Aligned_cols=263  Identities=24%  Similarity=0.458  Sum_probs=214.6

Q ss_pred             HhcCCcccCcccccCceeEEEEEe-cCCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEE
Q 003599          480 ATNNFQLSSKLGQGGFGPVYWGRL-KDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  558 (808)
Q Consensus       480 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  558 (808)
                      ....+...+.||+|+||.||+|+. .++..||||++......    ..+|++.+++++|||||+++|+|.+.+..++|||
T Consensus       688 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E  763 (968)
T PLN00113        688 ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE  763 (968)
T ss_pred             HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence            345677788999999999999997 47899999998653322    2356889999999999999999999999999999


Q ss_pred             ecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCC
Q 003599          559 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  638 (808)
Q Consensus       559 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  638 (808)
                      |+++|+|.++++      .++|.++.+|+.|+|+||+|||..+..+|+||||||+||+++.++.+++. ||........ 
T Consensus       764 y~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-  835 (968)
T PLN00113        764 YIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-  835 (968)
T ss_pred             CCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-
Confidence            999999999984      38999999999999999999997655679999999999999999988876 6655432211 


Q ss_pred             CcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCC-CchhhhhhhhhhhccccchhccCCccc
Q 003599          639 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFE-DDLTILGYAWKLWNENKILALVDPFLS  717 (808)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~d~~l~  717 (808)
                           ....+|..|+|||++.+..++.++|||||||++|||+||+.|+.... .......|+............+|+.+.
T Consensus       836 -----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  910 (968)
T PLN00113        836 -----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIR  910 (968)
T ss_pred             -----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCcccc
Confidence                 12367899999999999999999999999999999999999985432 233455555555545555666777664


Q ss_pred             CC-cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhccc
Q 003599          718 ES-SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIR  759 (808)
Q Consensus       718 ~~-~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~~  759 (808)
                      .. ....+...++.+++.+|++.+|++||+|+||+++|+++.+
T Consensus       911 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        911 GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             CCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            32 2445677889999999999999999999999999988744

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-38  Score=340.79  Aligned_cols=250  Identities=28%  Similarity=0.427  Sum_probs=210.5

Q ss_pred             cCCcccCcccccCceeEEEEEe-cCCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEec
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRL-KDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  560 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  560 (808)
                      ..|...++||+|+.|.||.++. ..++.||||++........+-.++|+.+|+..+|+|||+++..+..+++.++|||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            3566678999999999999974 468899999997766666677899999999999999999999999999999999999


Q ss_pred             CCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCc
Q 003599          561 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  640 (808)
Q Consensus       561 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  640 (808)
                      ++|+|.+.+.    ...+++.++..|++++++||+|||.++   |+|||||.+|||++.+|.+||+|||++..+......
T Consensus       353 ~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K  425 (550)
T KOG0578|consen  353 EGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK  425 (550)
T ss_pred             CCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccCc
Confidence            9999999884    446999999999999999999999999   999999999999999999999999999987665543


Q ss_pred             ccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCc
Q 003599          641 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS  720 (808)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  720 (808)
                      .  ...+||+.|||||+.....|.+|.||||||++++||+-|.+||-....   +. ..+.+..++      .|.+.   
T Consensus       426 R--~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P---lr-AlyLIa~ng------~P~lk---  490 (550)
T KOG0578|consen  426 R--STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP---LR-ALYLIATNG------TPKLK---  490 (550)
T ss_pred             c--ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh---HH-HHHHHhhcC------CCCcC---
Confidence            3  347999999999999999999999999999999999999999753111   11 111111111      12222   


Q ss_pred             ccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          721 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       721 ~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                      ........+.++..+||+.|+++||++.|+++.
T Consensus       491 ~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  491 NPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             CccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence            344566788999999999999999999998863

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-39  Score=340.65  Aligned_cols=265  Identities=25%  Similarity=0.349  Sum_probs=208.8

Q ss_pred             HhcCCcccCcccccCceeEEEEEec-CCcEEEEEEecccccccHHH--HHHHHHHHHhcc-CCceeeEeeEEEeCC-eeE
Q 003599          480 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEE--FMNEVMVISKLQ-HRNLVRLLGCCVEGE-EKM  554 (808)
Q Consensus       480 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~--~~~E~~~l~~l~-H~niv~l~g~~~~~~-~~~  554 (808)
                      ..++|.++++||.|.||.||+|+.. ++..||||++++.... .++  =++|+..|++|+ ||||+++...+.+.+ .++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            3468999999999999999999855 6889999999765332 333  368999999998 999999999999888 899


Q ss_pred             EEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceec
Q 003599          555 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF  634 (808)
Q Consensus       555 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~  634 (808)
                      +|||||+ .+|.+++.++  +..+++..+..|+.||++||+|+|.+|   +.|||+||+|||+..+..+||+|||+||.+
T Consensus        87 fVfE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev  160 (538)
T KOG0661|consen   87 FVFEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV  160 (538)
T ss_pred             eeHHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence            9999995 4999998764  678999999999999999999999999   999999999999999999999999999977


Q ss_pred             CCCCCcccccceeccCCccChhhh-ccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhh-------hhccc
Q 003599          635 GGNQDQADTGRVVGTFGYMSPEYA-MEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWK-------LWNEN  706 (808)
Q Consensus       635 ~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~-------~~~~~  706 (808)
                      .....   ....+.|..|.|||++ +.+.|+.+.|+|++|||++|+.+-++.|+..++-+.+.....-       .+.++
T Consensus       161 ~SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg  237 (538)
T KOG0661|consen  161 RSKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG  237 (538)
T ss_pred             ccCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence            54332   3346789999999987 4677999999999999999999999988876654333222111       11110


Q ss_pred             -cchhccC---CcccCC---cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHH
Q 003599          707 -KILALVD---PFLSES---SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML  754 (808)
Q Consensus       707 -~~~~~~d---~~l~~~---~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L  754 (808)
                       .+...+.   |.....   ..-.....++++++.+|+..||++|||++|.+++=
T Consensus       238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p  292 (538)
T KOG0661|consen  238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP  292 (538)
T ss_pred             HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence             0011111   111110   01122567899999999999999999999998764

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3.7e-38  Score=349.65  Aligned_cols=261  Identities=26%  Similarity=0.394  Sum_probs=205.8

Q ss_pred             hcCCcccCcccccCceeEEEEEec------CCcEEEEEEecccc-cccHHHHHHHHHHHHhc-cCCceeeEeeEEEeCCe
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEE  552 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~  552 (808)
                      .++|++.+.||+|+||.||+++..      ++..||||++.... ....+.+.+|+.+++.+ +|+||+++++++.....
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            457899999999999999998742      24579999997543 33456788999999999 89999999999999999


Q ss_pred             eEEEEEecCCCCchhhccCCC-----------------------------------------------------------
Q 003599          553 KMLIYEYMPNRSLDALLFDPL-----------------------------------------------------------  573 (808)
Q Consensus       553 ~~lV~E~~~~gsL~~~l~~~~-----------------------------------------------------------  573 (808)
                      .++||||+++|+|.+++....                                                           
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            999999999999999885321                                                           


Q ss_pred             --------CCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCcccccc
Q 003599          574 --------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR  645 (808)
Q Consensus       574 --------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~  645 (808)
                              ...++++.++.+++.||++||+|||+.+   |+||||||+|||+++++.+||+|||+++.............
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                    1124788889999999999999999988   99999999999999999999999999986543322222222


Q ss_pred             eeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCcccHH
Q 003599          646 VVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLD  724 (808)
Q Consensus       646 ~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  724 (808)
                      ..++..|+|||.+....++.++||||||+++|||++ |+.||.............    ..+     ..+.     .+..
T Consensus       274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~----~~~-----~~~~-----~~~~  339 (374)
T cd05106         274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV----KRG-----YQMS-----RPDF  339 (374)
T ss_pred             CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHH----Hcc-----cCcc-----CCCC
Confidence            345678999999998899999999999999999997 999986543322211111    111     0000     1111


Q ss_pred             HHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhcc
Q 003599          725 MIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEI  758 (808)
Q Consensus       725 ~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~  758 (808)
                      ...++.+++.+|++.+|++||++.+|+++|++++
T Consensus       340 ~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         340 APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            2457889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-39  Score=340.50  Aligned_cols=238  Identities=28%  Similarity=0.446  Sum_probs=199.4

Q ss_pred             cCcccccCceeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEecCCCCch
Q 003599          487 SSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLD  566 (808)
Q Consensus       487 ~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~  566 (808)
                      ++=||+|+.|.||+|+++ ++.||||+++...+       .+++-|++|+||||+.+.|+|......+||||||..|-|.
T Consensus       129 LeWlGSGaQGAVF~Grl~-netVAVKKV~elkE-------TdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~  200 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH-NETVAVKKVRELKE-------TDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY  200 (904)
T ss_pred             hhhhccCcccceeeeecc-CceehhHHHhhhhh-------hhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence            568999999999999998 68999999854332       4788899999999999999999999999999999999999


Q ss_pred             hhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCcccccce
Q 003599          567 ALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV  646 (808)
Q Consensus       567 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~  646 (808)
                      +.|.   .+..+.......+..+||.||.|||.+.   |||||||.-||||..+..+||+|||.++.....   ...-.+
T Consensus       201 ~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSF  271 (904)
T KOG4721|consen  201 EVLK---AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSF  271 (904)
T ss_pred             HHHh---ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhh
Confidence            9995   3457888888999999999999999998   999999999999999999999999999865432   222237


Q ss_pred             eccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccc-cchhccCCcccCCcccHHH
Q 003599          647 VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNEN-KILALVDPFLSESSFQLDM  725 (808)
Q Consensus       647 ~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~d~~l~~~~~~~~~  725 (808)
                      .||..|||||++.+.+.++|.||||||||||||+||..|+...+....+       |.-+ +...        -+.+..+
T Consensus       272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII-------wGVGsNsL~--------LpvPstc  336 (904)
T KOG4721|consen  272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII-------WGVGSNSLH--------LPVPSTC  336 (904)
T ss_pred             hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE-------EeccCCccc--------ccCcccC
Confidence            8999999999999999999999999999999999999998643322111       1111 1111        1244455


Q ss_pred             HHHHHHHHHhcccCCcCCCCCHHHHHHHHhh
Q 003599          726 IIRCIHVGLLCVQELVKDRPNMSTVVSMLNS  756 (808)
Q Consensus       726 ~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~  756 (808)
                      +.-+.-|+++||+..|.+||++++|+..|+-
T Consensus       337 P~GfklL~Kqcw~sKpRNRPSFrqil~HldI  367 (904)
T KOG4721|consen  337 PDGFKLLLKQCWNSKPRNRPSFRQILLHLDI  367 (904)
T ss_pred             chHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence            6677889999999999999999999999954

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-37  Score=338.17  Aligned_cols=248  Identities=24%  Similarity=0.360  Sum_probs=204.4

Q ss_pred             HhcCCcccCcccccCceeEEEEEec-CCcEEEEEEeccc----cc-ccHHHHHHHHHHHHhcc-CCceeeEeeEEEeCCe
Q 003599          480 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA----SG-QGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEE  552 (808)
Q Consensus       480 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~----~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~  552 (808)
                      ..++|.+.+.||+|+||.|+.|... ++..||+|.+.+.    .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            4568999999999999999999764 6899999977653    12 23456678999999998 9999999999999999


Q ss_pred             eEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCC-CCeeeeccccc
Q 003599          553 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE-LNPKISDFGMA  631 (808)
Q Consensus       553 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~-~~~kl~DFGla  631 (808)
                      .++||||+.+|+|.+++.+   .+++.+.+..+++.|++.|++|+|+.+   |+||||||+|||++.+ +++||+|||++
T Consensus        95 ~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             EEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            9999999999999999954   567888999999999999999999998   9999999999999999 99999999999


Q ss_pred             eecCCCCCcccccceeccCCccChhhhccCC-CC-ccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccch
Q 003599          632 KIFGGNQDQADTGRVVGTFGYMSPEYAMEGR-FS-EKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKIL  709 (808)
Q Consensus       632 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  709 (808)
                      ....  .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||.....    ......+.. +   
T Consensus       169 ~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~----~~l~~ki~~-~---  238 (370)
T KOG0583|consen  169 AISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV----PNLYRKIRK-G---  238 (370)
T ss_pred             cccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH----HHHHHHHhc-C---
Confidence            9774  1122233468999999999999877 75 789999999999999999999975221    111111110 0   


Q ss_pred             hccCCcccCCcccHHH-HHHHHHHHHhcccCCcCCCCCHHHHH
Q 003599          710 ALVDPFLSESSFQLDM-IIRCIHVGLLCVQELVKDRPNMSTVV  751 (808)
Q Consensus       710 ~~~d~~l~~~~~~~~~-~~~l~~li~~cl~~~P~~RPs~~ev~  751 (808)
                           ..   .++... ..++..++.+|+..+|.+|+++.+|+
T Consensus       239 -----~~---~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  239 -----EF---KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             -----Cc---cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence                 00   122222 56788999999999999999999998

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3e-37  Score=329.93  Aligned_cols=252  Identities=23%  Similarity=0.333  Sum_probs=201.7

Q ss_pred             CCcccCcccccCceeEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEE
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  558 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  558 (808)
                      .|+..+.||+|+||.||++... +++.||+|.+....   ......+.+|+.++++++|+||+++++++.+++..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            3677899999999999999875 68999999986532   2334567899999999999999999999999999999999


Q ss_pred             ecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCC
Q 003599          559 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  638 (808)
Q Consensus       559 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  638 (808)
                      |+++|+|..++... ....+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++......
T Consensus        81 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05631          81 IMNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE  156 (285)
T ss_pred             ecCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence            99999998887542 2346899999999999999999999988   9999999999999999999999999998753222


Q ss_pred             CcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccC
Q 003599          639 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSE  718 (808)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  718 (808)
                      .   .....||..|+|||.+.+..++.++|||||||++|||++|+.||.............. ...        ....  
T Consensus       157 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~-~~~--------~~~~--  222 (285)
T cd05631         157 T---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDR-RVK--------EDQE--  222 (285)
T ss_pred             e---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHH-Hhh--------cccc--
Confidence            1   1234689999999999999999999999999999999999999875433211111100 000        0000  


Q ss_pred             CcccHHHHHHHHHHHHhcccCCcCCCCC-----HHHHHHH
Q 003599          719 SSFQLDMIIRCIHVGLLCVQELVKDRPN-----MSTVVSM  753 (808)
Q Consensus       719 ~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~ev~~~  753 (808)
                       ..+......+.+|+.+||+.||++||+     ++++++.
T Consensus       223 -~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         223 -EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             -cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence             122234457889999999999999997     7887763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.8e-37  Score=330.93  Aligned_cols=257  Identities=30%  Similarity=0.498  Sum_probs=207.1

Q ss_pred             cCCcccCcccccCceeEEEEEecC------CcEEEEEEecccc-cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLKD------GQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKM  554 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  554 (808)
                      ++|++.+.||+|+||.||+|....      ...||+|.+.... ......|.+|+.++++++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            468889999999999999998643      2579999986543 234567899999999999999999999999999999


Q ss_pred             EEEEecCCCCchhhccCCCC-------------CCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCC
Q 003599          555 LIYEYMPNRSLDALLFDPLK-------------KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL  621 (808)
Q Consensus       555 lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~  621 (808)
                      ++|||+++++|.+++.....             ...+++.+++.++.|++.||.|||+.+   ++|+||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence            99999999999999864211             145888999999999999999999998   99999999999999999


Q ss_pred             CeeeeccccceecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhh
Q 003599          622 NPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAW  700 (808)
Q Consensus       622 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~  700 (808)
                      .+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..|+....... ...   
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~-~~~---  237 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE-VIE---  237 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH-HHH---
Confidence            999999999986643332222333456889999999998899999999999999999998 988876433221 111   


Q ss_pred             hhhccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhh
Q 003599          701 KLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS  756 (808)
Q Consensus       701 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~  756 (808)
                       ....+.         .. ..+...+.++.+|+.+|++.+|++||++++|++.|++
T Consensus       238 -~i~~~~---------~~-~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         238 -MIRSRQ---------LL-PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             -HHHcCC---------cC-CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence             111111         00 1223456788999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=3.2e-37  Score=325.01  Aligned_cols=255  Identities=30%  Similarity=0.466  Sum_probs=207.6

Q ss_pred             hcCCcccCcccccCceeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEec
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  560 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  560 (808)
                      .++|++.++||+|+||.||+|...++..||+|.+... ....+.+.+|+.++++++|+||+++++.+...+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            3578999999999999999999888889999998653 234678999999999999999999999999999999999999


Q ss_pred             CCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCc
Q 003599          561 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  640 (808)
Q Consensus       561 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  640 (808)
                      ++++|.+++... ....+++.++..++.|+++||+|||+.+   ++||||||+||+++.++.++|+|||+++........
T Consensus        84 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05072          84 AKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT  159 (261)
T ss_pred             CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence            999999998653 3456888999999999999999999987   999999999999999999999999999876432221


Q ss_pred             ccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCC
Q 003599          641 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSES  719 (808)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  719 (808)
                      . .....++..|+|||.+....++.++||||||+++|||+| |+.|+........... .    ....    ..+     
T Consensus       160 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~-~----~~~~----~~~-----  224 (261)
T cd05072         160 A-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSA-L----QRGY----RMP-----  224 (261)
T ss_pred             c-cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHH-H----HcCC----CCC-----
Confidence            1 122345678999999988889999999999999999998 8888864332221111 1    0110    001     


Q ss_pred             cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhh
Q 003599          720 SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS  756 (808)
Q Consensus       720 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~  756 (808)
                       ........+.+++.+|++.+|++||++++|.++|++
T Consensus       225 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         225 -RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             -CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence             111234568899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=3e-37  Score=344.01  Aligned_cols=261  Identities=26%  Similarity=0.374  Sum_probs=207.1

Q ss_pred             hcCCcccCcccccCceeEEEEEec------CCcEEEEEEecccc-cccHHHHHHHHHHHHhcc-CCceeeEeeEEEeCCe
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEE  552 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~  552 (808)
                      .++|.+.++||+|+||.||+|+..      .+..||||++.... ....+.|.+|+.+++++. ||||+++++++.+...
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            468899999999999999999853      13469999997543 234567999999999996 9999999999999999


Q ss_pred             eEEEEEecCCCCchhhccCCCC----------------------------------------------------------
Q 003599          553 KMLIYEYMPNRSLDALLFDPLK----------------------------------------------------------  574 (808)
Q Consensus       553 ~~lV~E~~~~gsL~~~l~~~~~----------------------------------------------------------  574 (808)
                      .++||||+++|+|.+++.....                                                          
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            9999999999999988754210                                                          


Q ss_pred             -----------------------------------CCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCC
Q 003599          575 -----------------------------------KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE  619 (808)
Q Consensus       575 -----------------------------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~  619 (808)
                                                         ...+++.++.+++.||++||+|||+.+   |+||||||+|||++.
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence                                               124778888999999999999999988   999999999999999


Q ss_pred             CCCeeeeccccceecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhh
Q 003599          620 ELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGY  698 (808)
Q Consensus       620 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~  698 (808)
                      ++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+........... 
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~-  351 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN-  351 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH-
Confidence            99999999999987643332222233456788999999998899999999999999999997 8888764332221111 


Q ss_pred             hhhhhccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhcc
Q 003599          699 AWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEI  758 (808)
Q Consensus       699 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~  758 (808)
                         ....+.     ..     ..+......+.+++.+|++.+|++||++.+|+++|++++
T Consensus       352 ---~~~~~~-----~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         352 ---KIKSGY-----RM-----AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             ---HHhcCC-----CC-----CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence               111110     00     012234567889999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.9e-37  Score=327.89  Aligned_cols=255  Identities=25%  Similarity=0.376  Sum_probs=204.0

Q ss_pred             cCCcccCcccccCceeEEEEEec----CCcEEEEEEecccc-cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK----DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI  556 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  556 (808)
                      ++|++.+.||+|+||.||+|.++    .+..||+|.++... ....+.|.+|+.++++++||||+++++++..++..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            46888999999999999999764    35689999987643 23346789999999999999999999999999999999


Q ss_pred             EEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCC
Q 003599          557 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  636 (808)
Q Consensus       557 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  636 (808)
                      |||+++|+|.+++..  ....+++.+++.++.|++.||+|||+.+   ++||||||+|||++.++.+|++|||.+.....
T Consensus        85 ~e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~  159 (266)
T cd05064          85 TEYMSNGALDSFLRK--HEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS  159 (266)
T ss_pred             EEeCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence            999999999999864  2347899999999999999999999988   99999999999999999999999998765322


Q ss_pred             CCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhccccchhccCCc
Q 003599          637 NQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPF  715 (808)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  715 (808)
                      .. ........++..|+|||.+....++.++||||||+++||+++ |+.|+....... ...    ...++..     . 
T Consensus       160 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~-~~~----~~~~~~~-----~-  227 (266)
T cd05064         160 EA-IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD-VIK----AVEDGFR-----L-  227 (266)
T ss_pred             cc-hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-HHH----HHHCCCC-----C-
Confidence            11 111112345678999999999999999999999999999775 999886433221 111    1111100     0 


Q ss_pred             ccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003599          716 LSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  757 (808)
Q Consensus       716 l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~  757 (808)
                          +.+......+.+++.+|++.+|++||++++|++.|+++
T Consensus       228 ----~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         228 ----PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             ----CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                12223456788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1e-37  Score=328.58  Aligned_cols=250  Identities=34%  Similarity=0.569  Sum_probs=195.7

Q ss_pred             ccCcccccCceeEEEEEec-----CCcEEEEEEecccc-cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEe
Q 003599          486 LSSKLGQGGFGPVYWGRLK-----DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       486 ~~~~lG~G~~g~Vy~~~~~-----~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  559 (808)
                      +.+.||.|.||.||+|.+.     .+..|+||.++... ....+.|.+|++.+++++||||++++|++...+..++||||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4578999999999999987     35789999996533 33478999999999999999999999999988889999999


Q ss_pred             cCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCC
Q 003599          560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  639 (808)
Q Consensus       560 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  639 (808)
                      +++|+|.++|... ....+++.++.+|+.||++||+|||+.+   ++|+||+++||++++++.+||+|||+++.......
T Consensus        83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence            9999999999763 3467999999999999999999999988   99999999999999999999999999987633222


Q ss_pred             cccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhccccchhccCCcccC
Q 003599          640 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSE  718 (808)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  718 (808)
                      ............|+|||.+....++.++||||||+++|||++ |+.|+..... ......   . .++....        
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~-~~~~~~---~-~~~~~~~--------  225 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN-EEIIEK---L-KQGQRLP--------  225 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH-HHHHHH---H-HTTEETT--------
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccc---c-cccccce--------
Confidence            222233457789999999999999999999999999999999 6777654422 221111   1 1111111        


Q ss_pred             CcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHH
Q 003599          719 SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML  754 (808)
Q Consensus       719 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L  754 (808)
                        .+......+.+++.+||+.+|++||++++|++.|
T Consensus       226 --~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  226 --IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             --SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             --eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence              2222356688999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=4.9e-37  Score=322.67  Aligned_cols=252  Identities=26%  Similarity=0.420  Sum_probs=203.2

Q ss_pred             cCCcccCcccccCceeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEecC
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMP  561 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  561 (808)
                      ++|++.+.||+|+||.||+++.+++..+|+|.+... ....+.|.+|+.++++++||||+++++++.+....++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            458888999999999999999988889999988643 3345789999999999999999999999999999999999999


Q ss_pred             CCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCcc
Q 003599          562 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA  641 (808)
Q Consensus       562 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  641 (808)
                      +|+|.+++...  ...+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||+++.........
T Consensus        83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05114          83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS  157 (256)
T ss_pred             CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence            99999988642  246889999999999999999999988   9999999999999999999999999998653322211


Q ss_pred             cccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCc
Q 003599          642 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS  720 (808)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  720 (808)
                       .....++..|+|||.+....++.++||||||+++|||++ |+.|+........ ...   .. .+..  ...       
T Consensus       158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~-~~~---i~-~~~~--~~~-------  222 (256)
T cd05114         158 -SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV-VEM---IS-RGFR--LYR-------  222 (256)
T ss_pred             -cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-HHH---HH-CCCC--CCC-------
Confidence             112235678999999988889999999999999999999 8888754332211 111   11 1100  001       


Q ss_pred             ccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHh
Q 003599          721 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN  755 (808)
Q Consensus       721 ~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~  755 (808)
                       +.....++.+++.+|++.+|++||+++++++.|.
T Consensus       223 -~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         223 -PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             -CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence             1112356889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=5e-37  Score=324.54  Aligned_cols=256  Identities=29%  Similarity=0.466  Sum_probs=206.5

Q ss_pred             cCCcccCcccccCceeEEEEEecC----CcEEEEEEecccc-cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLKD----GQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI  556 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  556 (808)
                      ++|++.+.||+|+||.||+|.+..    ...||||.++... .....+|.+|+.++++++||||+++++++...+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            578899999999999999998752    4579999987543 33456789999999999999999999999999999999


Q ss_pred             EEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCC
Q 003599          557 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  636 (808)
Q Consensus       557 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  636 (808)
                      |||+++++|.+++..  ....+++.++.+++.|++.|++|||+.+   |+|+||||+||++++++.++|+|||+++....
T Consensus        84 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  158 (266)
T cd05033          84 TEYMENGSLDKFLRE--NDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED  158 (266)
T ss_pred             EEcCCCCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence            999999999999864  2347899999999999999999999988   99999999999999999999999999997752


Q ss_pred             CCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhccccchhccCCc
Q 003599          637 NQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPF  715 (808)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  715 (808)
                      ...........++..|+|||.+....++.++||||||+++|||++ |..|+....... ...    ....+.    ..+ 
T Consensus       159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~-~~~----~~~~~~----~~~-  228 (266)
T cd05033         159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD-VIK----AVEDGY----RLP-  228 (266)
T ss_pred             cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH-HHH----HHHcCC----CCC-
Confidence            222222222345678999999998899999999999999999998 888875332221 111    111110    000 


Q ss_pred             ccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003599          716 LSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  757 (808)
Q Consensus       716 l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~  757 (808)
                           .+......+.+++.+|++.+|++||++++|+++|+++
T Consensus       229 -----~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         229 -----PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             -----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                 1123346788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=4.4e-37  Score=327.36  Aligned_cols=256  Identities=27%  Similarity=0.475  Sum_probs=206.8

Q ss_pred             cCCcccCcccccCceeEEEEEecC------CcEEEEEEecccccc-cHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLKD------GQEIAVKRLSKASGQ-GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKM  554 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  554 (808)
                      ++|.+.+.||+|+||.||+|+..+      +..||||.++..... ..+.|.+|++++++++|+||+++++++..+...+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            468888999999999999998643      478999999765444 4678999999999999999999999999999999


Q ss_pred             EEEEecCCCCchhhccCCC-----------CCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCe
Q 003599          555 LIYEYMPNRSLDALLFDPL-----------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP  623 (808)
Q Consensus       555 lV~E~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~  623 (808)
                      +||||+++++|.+++....           ....+++.++..++.|++.|+.|||+.+   ++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence            9999999999999986421           2345889999999999999999999998   9999999999999999999


Q ss_pred             eeeccccceecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhh
Q 003599          624 KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKL  702 (808)
Q Consensus       624 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~  702 (808)
                      ||+|||+++...............++..|+|||.+....++.++||||||+++|||++ |+.|+....... .....   
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~-~~~~~---  237 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE-VIECI---  237 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-HHHHH---
Confidence            9999999986543322222223346788999999999999999999999999999999 998875433221 11111   


Q ss_pred             hccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHh
Q 003599          703 WNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN  755 (808)
Q Consensus       703 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~  755 (808)
                       ..+....          .+......+.+++.+||+.+|++||++.||++.|+
T Consensus       238 -~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         238 -TQGRLLQ----------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             -HcCCcCC----------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence             1111000          11223467889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-37  Score=307.30  Aligned_cols=236  Identities=29%  Similarity=0.358  Sum_probs=200.5

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  557 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  557 (808)
                      ++|++.+.||.|+||.|.+++.+ +|..+|+|++.+..   -...++..+|..+|+.+.||.++++++.+.+.+..+|||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            56888999999999999999976 58899999998653   334567789999999999999999999999999999999


Q ss_pred             EecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCC
Q 003599          558 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  637 (808)
Q Consensus       558 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  637 (808)
                      ||++||-|..+|+   +.+++++....-++.||+.||+|||+.+   |++|||||+|||||.+|.+||+|||.|+.....
T Consensus       124 eyv~GGElFS~Lr---k~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r  197 (355)
T KOG0616|consen  124 EYVPGGELFSYLR---KSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR  197 (355)
T ss_pred             eccCCccHHHHHH---hcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence            9999999999995   4568999999999999999999999998   999999999999999999999999999976432


Q ss_pred             CCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCccc
Q 003599          638 QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS  717 (808)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  717 (808)
                           +-..+||+.|+|||.+....+..++|.|+|||++|||+.|.+||.....-    +...+         ++...+ 
T Consensus       198 -----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~----~iY~K---------I~~~~v-  258 (355)
T KOG0616|consen  198 -----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI----QIYEK---------ILEGKV-  258 (355)
T ss_pred             -----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH----HHHHH---------HHhCcc-
Confidence                 44579999999999999999999999999999999999999998654331    11111         111111 


Q ss_pred             CCcccHHHHHHHHHHHHhcccCCcCCC
Q 003599          718 ESSFQLDMIIRCIHVGLLCVQELVKDR  744 (808)
Q Consensus       718 ~~~~~~~~~~~l~~li~~cl~~~P~~R  744 (808)
                        .++......+.+|+...++.|-.+|
T Consensus       259 --~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  259 --KFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             --cCCcccCHHHHHHHHHHHhhhhHhh
Confidence              1444445567788889999999888

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=9.5e-37  Score=333.20  Aligned_cols=264  Identities=24%  Similarity=0.311  Sum_probs=204.1

Q ss_pred             hcCCcccCcccccCceeEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEE
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  558 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  558 (808)
                      .++|++.+.||+|+||.||+++.. ++..+|+|.+.... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            368999999999999999999976 57889999987542 3345679999999999999999999999999999999999


Q ss_pred             ecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCC
Q 003599          559 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  638 (808)
Q Consensus       559 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  638 (808)
                      |+++++|.+++..   ...+++..+..++.|++.||.|||+.+  +|+||||||+|||++.++.+||+|||+++......
T Consensus        84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  158 (331)
T cd06649          84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  158 (331)
T ss_pred             cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence            9999999999854   346889999999999999999999853  39999999999999999999999999998653221


Q ss_pred             CcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhh-hhc--ccc--------
Q 003599          639 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWK-LWN--ENK--------  707 (808)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~-~~~--~~~--------  707 (808)
                          .....|+..|+|||.+.+..++.++||||||+++|||++|+.|+....... +...... ...  ++.        
T Consensus       159 ----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  233 (331)
T cd06649         159 ----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE-LEAIFGRPVVDGEEGEPHSISPRP  233 (331)
T ss_pred             ----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHhcccccccccCCccccCccc
Confidence                223468999999999998899999999999999999999999986433211 1100000 000  000        


Q ss_pred             -------------------chhccCCcc---cCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHH
Q 003599          708 -------------------ILALVDPFL---SESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML  754 (808)
Q Consensus       708 -------------------~~~~~d~~l---~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L  754 (808)
                                         ..+..+-..   ...........++.+++.+||+.||++||++++|++.-
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~  302 (331)
T cd06649         234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT  302 (331)
T ss_pred             ccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence                               000000000   00000112345789999999999999999999998754

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=6.2e-37  Score=350.69  Aligned_cols=261  Identities=21%  Similarity=0.280  Sum_probs=207.4

Q ss_pred             HHHHHHhcCCcccCcccccCceeEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCC
Q 003599          475 EELATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE  551 (808)
Q Consensus       475 ~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~  551 (808)
                      .+.....++|++.+.||+|+||+||+++.. +++.||||++...  .......+.+|+..+..++|+||++++..+...+
T Consensus        25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~  104 (496)
T PTZ00283         25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD  104 (496)
T ss_pred             ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence            344455679999999999999999999864 6899999998653  2344567889999999999999999988775432


Q ss_pred             --------eeEEEEEecCCCCchhhccCCC-CCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCC
Q 003599          552 --------EKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELN  622 (808)
Q Consensus       552 --------~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~  622 (808)
                              ..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.
T Consensus       105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~  181 (496)
T PTZ00283        105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGL  181 (496)
T ss_pred             ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCC
Confidence                    3579999999999999986532 2356889999999999999999999988   999999999999999999


Q ss_pred             eeeeccccceecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhh
Q 003599          623 PKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKL  702 (808)
Q Consensus       623 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~  702 (808)
                      +||+|||+++.+.............||+.|+|||.+.+..++.++||||||+++|||++|+.||.......    .....
T Consensus       182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~----~~~~~  257 (496)
T PTZ00283        182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE----VMHKT  257 (496)
T ss_pred             EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH----HHHHH
Confidence            99999999987654333333334679999999999999999999999999999999999999986432111    11111


Q ss_pred             hccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          703 WNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       703 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                      . .+.    .++      .+.....++.+++.+||+.+|++||++.++++.
T Consensus       258 ~-~~~----~~~------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        258 L-AGR----YDP------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             h-cCC----CCC------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            1 110    111      222344678899999999999999999999864

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=4.4e-37  Score=336.35  Aligned_cols=262  Identities=30%  Similarity=0.423  Sum_probs=205.5

Q ss_pred             hcCCcccCcccccCceeEEEEEec------CCcEEEEEEecccc-cccHHHHHHHHHHHHhc-cCCceeeEeeEEEe-CC
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVE-GE  551 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~-~~  551 (808)
                      .++|++.+.||+|+||.||+|...      .++.||+|+++... ....+.+.+|+.++.++ +|+||++++++|.. +.
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            357999999999999999999642      24789999987543 23346788899999999 89999999998864 45


Q ss_pred             eeEEEEEecCCCCchhhccCCCC---------------------------------------------------------
Q 003599          552 EKMLIYEYMPNRSLDALLFDPLK---------------------------------------------------------  574 (808)
Q Consensus       552 ~~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------  574 (808)
                      ..+++|||+++++|.+++.....                                                         
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            67899999999999988853211                                                         


Q ss_pred             -CCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCcccccceeccCCcc
Q 003599          575 -KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM  653 (808)
Q Consensus       575 -~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~  653 (808)
                       ...+++..+.+++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+.............++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence             136889999999999999999999988   9999999999999999999999999998764333222233345678899


Q ss_pred             ChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCcccHHHHHHHHHH
Q 003599          654 SPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHV  732 (808)
Q Consensus       654 aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l  732 (808)
                      |||++.+..++.++|||||||++|||++ |+.|+........+..    ....+..     +.     .+.....++.++
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~----~~~~~~~-----~~-----~~~~~~~~~~~l  308 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCR----RLKEGTR-----MR-----APEYATPEIYSI  308 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHH----HHhccCC-----CC-----CCccCCHHHHHH
Confidence            9999999999999999999999999998 9888864332221111    1111110     00     112234578899


Q ss_pred             HHhcccCCcCCCCCHHHHHHHHhhccc
Q 003599          733 GLLCVQELVKDRPNMSTVVSMLNSEIR  759 (808)
Q Consensus       733 i~~cl~~~P~~RPs~~ev~~~L~~~~~  759 (808)
                      +.+|++.+|++||++.+|+++|+.+++
T Consensus       309 ~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         309 MLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            999999999999999999999988743

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=7e-37  Score=327.21  Aligned_cols=264  Identities=20%  Similarity=0.289  Sum_probs=202.8

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  558 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  558 (808)
                      ++|++.+.||+|+||.||+++.+ +++.||+|++....  ....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            46899999999999999999986 57889999987532  3345678899999999999999999999999999999999


Q ss_pred             ecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCC
Q 003599          559 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  638 (808)
Q Consensus       559 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  638 (808)
                      |++++.+..+..   ....+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++......
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  154 (287)
T cd07848          81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS  154 (287)
T ss_pred             cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence            999987765542   2346889999999999999999999988   9999999999999999999999999998764322


Q ss_pred             CcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhh-----------hhcccc
Q 003599          639 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWK-----------LWNENK  707 (808)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~-----------~~~~~~  707 (808)
                      . .......|++.|+|||.+.+..++.++|||||||++|||++|+.||...............           ......
T Consensus       155 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07848         155 N-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR  233 (287)
T ss_pred             c-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence            1 1122356899999999999888999999999999999999999998754432221111000           000000


Q ss_pred             chhccCCcccCC-----cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          708 ILALVDPFLSES-----SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       708 ~~~~~d~~l~~~-----~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      ......+.....     .........+.+++.+|++.||++|||++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000101111000     011123456899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-38  Score=327.26  Aligned_cols=249  Identities=26%  Similarity=0.386  Sum_probs=208.3

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEeccc-ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEe
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  559 (808)
                      ..|+..+.||+|.||.||+|.+. .++.||+|++.-. .....++..+|+.+|.+++|+||.+++|.+..+....++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            45777799999999999999875 5889999998754 455678899999999999999999999999999999999999


Q ss_pred             cCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCC
Q 003599          560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  639 (808)
Q Consensus       560 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  639 (808)
                      +.+|++.+.|..   ...+++.++.-|++++..|+.|||.++   .+|||||+.|||+.++|.+||+|||.+-.+.....
T Consensus        93 ~~gGsv~~lL~~---~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~  166 (467)
T KOG0201|consen   93 CGGGSVLDLLKS---GNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK  166 (467)
T ss_pred             hcCcchhhhhcc---CCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence            999999999842   334588888889999999999999998   99999999999999999999999999987765444


Q ss_pred             cccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCC
Q 003599          640 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSES  719 (808)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  719 (808)
                      ..  ..++||+.|||||++....|+.|+||||||++.+||++|.+|+.....-..+.          -+.+-..|.+.+ 
T Consensus       167 rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf----------lIpk~~PP~L~~-  233 (467)
T KOG0201|consen  167 RR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF----------LIPKSAPPRLDG-  233 (467)
T ss_pred             cc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE----------eccCCCCCcccc-
Confidence            43  45899999999999998899999999999999999999999986544311111          111122233332 


Q ss_pred             cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          720 SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       720 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                          .....+.+++..||.++|+.||++.++++.
T Consensus       234 ----~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  234 ----DFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             ----ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence                344568889999999999999999998763

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-37  Score=334.51  Aligned_cols=253  Identities=24%  Similarity=0.328  Sum_probs=204.5

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  557 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  557 (808)
                      ++|++.+.||+|+||.||+|+.. +++.||||++....   ....+.+.+|+.++.+++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36889999999999999999976 58899999997542   234567889999999999999999999999999999999


Q ss_pred             EecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCC
Q 003599          558 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  637 (808)
Q Consensus       558 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  637 (808)
                      ||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.... 
T Consensus        81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-  153 (333)
T cd05600          81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-  153 (333)
T ss_pred             eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence            99999999999853   346889999999999999999999998   99999999999999999999999999986532 


Q ss_pred             CCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCccc
Q 003599          638 QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS  717 (808)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  717 (808)
                          ......||+.|+|||.+.+..++.++|||||||++|||++|+.||............    ......  ...+...
T Consensus       154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i----~~~~~~--~~~~~~~  223 (333)
T cd05600         154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENL----KYWKET--LQRPVYD  223 (333)
T ss_pred             ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHH----Hhcccc--ccCCCCC
Confidence                222357899999999999889999999999999999999999998654322211110    000000  0001110


Q ss_pred             CCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          718 ESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       718 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                      .  .......++.+++.+|++.+|.+||+++++++.
T Consensus       224 ~--~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         224 D--PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             c--cccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            0  011235677889999999999999999999875

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=5.1e-37  Score=326.57  Aligned_cols=259  Identities=29%  Similarity=0.445  Sum_probs=203.8

Q ss_pred             HhcCCcccCcccccCceeEEEEEec------CCcEEEEEEecccc-cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCe
Q 003599          480 ATNNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEE  552 (808)
Q Consensus       480 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  552 (808)
                      ..++|++.+.||+|+||.||+|...      .+..||+|++.... .....+|.+|+.++++++||||+++++++.++..
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4578999999999999999998753      25679999986432 2345678999999999999999999999999999


Q ss_pred             eEEEEEecCCCCchhhccCCCC-------CCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeee
Q 003599          553 KMLIYEYMPNRSLDALLFDPLK-------KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKI  625 (808)
Q Consensus       553 ~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl  625 (808)
                      .++||||+++++|.+++.....       ...+++..+..++.|+++||+|||+.+   ++|+||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence            9999999999999999864221       234678889999999999999999987   999999999999999999999


Q ss_pred             eccccceecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhc
Q 003599          626 SDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWN  704 (808)
Q Consensus       626 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~  704 (808)
                      +|||+++...............++..|+|||.+....++.++||||||+++|||++ |..|+....... ...    ...
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~-~~~----~~~  235 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ-VLR----FVM  235 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-HHH----HHH
Confidence            99999986543322222222345778999999998889999999999999999999 677775432221 111    111


Q ss_pred             cccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhh
Q 003599          705 ENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS  756 (808)
Q Consensus       705 ~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~  756 (808)
                      ++....          .+......+.+++.+|++.+|++||++.|++++|++
T Consensus       236 ~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         236 EGGLLD----------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             cCCcCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            111100          112234578899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-37  Score=320.74  Aligned_cols=268  Identities=27%  Similarity=0.381  Sum_probs=208.9

Q ss_pred             cCCcccCcccccCceeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHHh--ccCCceeeEeeEEEeCC----eeEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISK--LQHRNLVRLLGCCVEGE----EKML  555 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~~----~~~l  555 (808)
                      ...++.+.||+|+||.||||++. ++.||||++..   +..+.|.+|-++.+.  ++|+||++++++-..+.    +..|
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL  285 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL  285 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence            34566789999999999999998 59999999964   456788899888875  48999999999977655    7899


Q ss_pred             EEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhc------CCCcEEeCCCCCCceEeCCCCCeeeeccc
Q 003599          556 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD------SRLRIIHRDLKASNILLDEELNPKISDFG  629 (808)
Q Consensus       556 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~------~~~~ivH~Dikp~NILl~~~~~~kl~DFG  629 (808)
                      |+||.+.|+|.++|    +...++|....+|+.-+++||+|||..      .+++|+|||||++||||.++++..|+|||
T Consensus       286 Vt~fh~kGsL~dyL----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG  361 (534)
T KOG3653|consen  286 VTEFHPKGSLCDYL----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG  361 (534)
T ss_pred             EeeeccCCcHHHHH----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence            99999999999999    455799999999999999999999975      35789999999999999999999999999


Q ss_pred             cceecCCCCCcccccceeccCCccChhhhccCC-C-----CccccEEehhHHHHHHHhCCCCCCCCC-Cc----------
Q 003599          630 MAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGR-F-----SEKSDVFSFGVLLLEIVSGRKNTSFFE-DD----------  692 (808)
Q Consensus       630 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~-----s~k~DvwSlGvil~elltG~~p~~~~~-~~----------  692 (808)
                      +|..+........+...+||.+|||||++.+.- +     -.+.||||+|.|||||++.-.-..... ++          
T Consensus       362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG  441 (534)
T KOG3653|consen  362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG  441 (534)
T ss_pred             eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence            999998777766666689999999999986432 2     236899999999999999764332100 00          


Q ss_pred             -hhhhhhhhhhhccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhcccCC
Q 003599          693 -LTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDL  761 (808)
Q Consensus       693 -~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~~~~  761 (808)
                       ..-++..+..+    +.+...|.+.........+.-+.+.+..||..||+-|.|+.=|-+++.++....
T Consensus       442 ~hPt~e~mq~~V----V~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~  507 (534)
T KOG3653|consen  442 NHPTLEEMQELV----VRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW  507 (534)
T ss_pred             CCCCHHHHHHHH----HhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence             00001111111    122222333222222245677889999999999999999999999998874433

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.9e-37  Score=325.20  Aligned_cols=256  Identities=29%  Similarity=0.452  Sum_probs=211.4

Q ss_pred             HhcCCcccCcccccCceeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEe
Q 003599          480 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       480 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  559 (808)
                      ...+|++.++||+|+||.||+|...++..+|+|.+..........+.+|+.+++.++|+||+++++++......++||||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            34578899999999999999999988999999999876665677899999999999999999999999999999999999


Q ss_pred             cCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCC
Q 003599          560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  639 (808)
Q Consensus       560 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  639 (808)
                      +++++|.+++... ....+++.++.+++.||+.||.|||+.+   ++|+||||+||++++++.+||+|||++........
T Consensus        84 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          84 MEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             cccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence            9999999999753 3456899999999999999999999988   99999999999999999999999999986643221


Q ss_pred             cccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhccccchhccCCcccC
Q 003599          640 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSE  718 (808)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  718 (808)
                      ..  ....++..|+|||.+....++.++||||||+++|+|++ |+.|+.......... ...    .+         .. 
T Consensus       160 ~~--~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~-~~~----~~---------~~-  222 (261)
T cd05148         160 LS--SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYD-QIT----AG---------YR-  222 (261)
T ss_pred             cc--cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHH-HHH----hC---------Cc-
Confidence            11  12345678999999988889999999999999999998 788886433221111 110    00         00 


Q ss_pred             CcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhh
Q 003599          719 SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS  756 (808)
Q Consensus       719 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~  756 (808)
                      .+.+......+.+++.+|++.+|++||+++++++.|+.
T Consensus       223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         223 MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence            01222344678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.7e-37  Score=322.15  Aligned_cols=255  Identities=29%  Similarity=0.426  Sum_probs=206.8

Q ss_pred             hcCCcccCcccccCceeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEec
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  560 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  560 (808)
                      .++|++.+.||+|++|.||+|...+++.||+|.++... ...+++.+|+.++++++||||+++++++...+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            35688899999999999999998878899999986543 34678999999999999999999999999999999999999


Q ss_pred             CCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCc
Q 003599          561 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  640 (808)
Q Consensus       561 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  640 (808)
                      ++++|.+++.... ...+++..+.+++.|++.|+.|||+.+   ++||||||+||++++++.+||+|||+++........
T Consensus        84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05068          84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE  159 (261)
T ss_pred             cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence            9999999986532 346899999999999999999999988   999999999999999999999999999876532211


Q ss_pred             ccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCC
Q 003599          641 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSES  719 (808)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  719 (808)
                      . ......+..|+|||.+....++.++||||||+++|||++ |+.|+..........     ......     ..     
T Consensus       160 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-----~~~~~~-----~~-----  223 (261)
T cd05068         160 A-REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQ-----QVDQGY-----RM-----  223 (261)
T ss_pred             c-cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH-----HHHcCC-----CC-----
Confidence            1 111223467999999998899999999999999999999 888875432221111     110100     00     


Q ss_pred             cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhh
Q 003599          720 SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS  756 (808)
Q Consensus       720 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~  756 (808)
                      ..+......+.+++.+|++.+|++||++.+|++.|+.
T Consensus       224 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         224 PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            0122334678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=5.7e-37  Score=333.80  Aligned_cols=241  Identities=23%  Similarity=0.272  Sum_probs=196.4

Q ss_pred             CcccccCceeEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEecCCC
Q 003599          488 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNR  563 (808)
Q Consensus       488 ~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  563 (808)
                      +.||+|+||.||+++.. +++.||+|++.+..   ......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999875 68899999987532   334567889999999999999999999999999999999999999


Q ss_pred             CchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCcccc
Q 003599          564 SLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT  643 (808)
Q Consensus       564 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  643 (808)
                      +|.+++..   ...+++.++..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~  152 (323)
T cd05571          81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATM  152 (323)
T ss_pred             cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccc
Confidence            99988853   356899999999999999999999998   9999999999999999999999999987532211  122


Q ss_pred             cceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCcccH
Q 003599          644 GRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQL  723 (808)
Q Consensus       644 ~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  723 (808)
                      ....||+.|+|||.+.+..++.++|||||||++|||++|+.||..........    .... +      +.     .++.
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~----~~~~-~------~~-----~~p~  216 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE----LILM-E------EI-----RFPR  216 (323)
T ss_pred             cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHH----HHHc-C------CC-----CCCC
Confidence            33579999999999999999999999999999999999999985432211110    0100 0      00     1222


Q ss_pred             HHHHHHHHHHHhcccCCcCCCC-----CHHHHHH
Q 003599          724 DMIIRCIHVGLLCVQELVKDRP-----NMSTVVS  752 (808)
Q Consensus       724 ~~~~~l~~li~~cl~~~P~~RP-----s~~ev~~  752 (808)
                      ....++.+++.+||+.||++||     ++.++++
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            3456788999999999999999     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-38  Score=302.25  Aligned_cols=265  Identities=24%  Similarity=0.282  Sum_probs=212.8

Q ss_pred             HhcCCcccCcccccCceeEEEEE-ecCCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCC-----ee
Q 003599          480 ATNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE-----EK  553 (808)
Q Consensus       480 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~  553 (808)
                      ..++|++.++||+|||+-||.++ ..++..+|+|++.....++.+..++|++..++++|||+++++++...+.     ..
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            34689999999999999999998 5578899999998777788899999999999999999999999876543     48


Q ss_pred             EEEEEecCCCCchhhccCCC-CCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccce
Q 003599          554 MLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK  632 (808)
Q Consensus       554 ~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~  632 (808)
                      +|+++|...|+|.+.+.... ++..+++.+.+.|+.+|++||++||... ++++||||||.|||+.+.+.++|.|||.+.
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~  177 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT  177 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence            99999999999999987643 3447999999999999999999999987 479999999999999999999999999988


Q ss_pred             ecCCCCCcc-------cccceeccCCccChhhhc---cCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhh
Q 003599          633 IFGGNQDQA-------DTGRVVGTFGYMSPEYAM---EGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKL  702 (808)
Q Consensus       633 ~~~~~~~~~-------~~~~~~gt~~y~aPE~~~---~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~  702 (808)
                      ...-.....       .-.....|..|.|||.+.   +...++++|||||||+||+|+.|..||+..-+...-+      
T Consensus       178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSl------  251 (302)
T KOG2345|consen  178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSL------  251 (302)
T ss_pred             ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeE------
Confidence            653221111       111235799999999885   4457899999999999999999999986422111101      


Q ss_pred             hccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003599          703 WNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  757 (808)
Q Consensus       703 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~  757 (808)
                           ...+..+.+... ......+.+.+++.+|++.||.+||+..+++..++.+
T Consensus       252 -----aLAv~n~q~s~P-~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  252 -----ALAVQNAQISIP-NSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             -----EEeeeccccccC-CCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence                 111222222212 1122567889999999999999999999999999876

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=7e-37  Score=327.53  Aligned_cols=260  Identities=29%  Similarity=0.476  Sum_probs=208.4

Q ss_pred             cCCcccCcccccCceeEEEEEec------CCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML  555 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  555 (808)
                      ++|.+.+.||+|+||.||++...      ++..+|+|.+........+.+.+|+.++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            57888999999999999999742      345689999876665667789999999999999999999999999999999


Q ss_pred             EEEecCCCCchhhccCCC----------CCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeee
Q 003599          556 IYEYMPNRSLDALLFDPL----------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKI  625 (808)
Q Consensus       556 V~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl  625 (808)
                      ||||+++++|.+++....          ....+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence            999999999999886421          2235899999999999999999999988   999999999999999999999


Q ss_pred             eccccceecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhc
Q 003599          626 SDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWN  704 (808)
Q Consensus       626 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~  704 (808)
                      +|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+..........     ...
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~-----~i~  236 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE-----CIT  236 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-----HHH
Confidence            99999986543322222222345778999999998889999999999999999999 888875433221111     111


Q ss_pred             cccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhccc
Q 003599          705 ENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIR  759 (808)
Q Consensus       705 ~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~~  759 (808)
                      .+....          .+......+.+++.+|++.+|.+||++++|++.|+++..
T Consensus       237 ~~~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~  281 (288)
T cd05093         237 QGRVLQ----------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK  281 (288)
T ss_pred             cCCcCC----------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            111100          111123568899999999999999999999999988743

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=7.4e-37  Score=327.86  Aligned_cols=260  Identities=27%  Similarity=0.460  Sum_probs=209.1

Q ss_pred             cCCcccCcccccCceeEEEEEec------CCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML  555 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  555 (808)
                      .+|.+.+.||+|+||.||+++..      ++..+++|.+........+.+.+|+.++++++|+||+++++++..++..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            45788899999999999999743      356699999876655556789999999999999999999999999999999


Q ss_pred             EEEecCCCCchhhccCCC-------------CCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCC
Q 003599          556 IYEYMPNRSLDALLFDPL-------------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELN  622 (808)
Q Consensus       556 V~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~  622 (808)
                      ||||+++++|.+++....             ....+++..+++++.||+.||+|||+.+   |+||||||+||+++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence            999999999999986421             1245899999999999999999999998   999999999999999999


Q ss_pred             eeeeccccceecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhh
Q 003599          623 PKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWK  701 (808)
Q Consensus       623 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~  701 (808)
                      ++|+|||+++...............++..|+|||.+.+..++.++||||||+++|||+| |+.|+....... ..    .
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-~~----~  236 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-VI----E  236 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-HH----H
Confidence            99999999986543322222223456788999999998899999999999999999999 888875433221 11    1


Q ss_pred             hhccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhccc
Q 003599          702 LWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIR  759 (808)
Q Consensus       702 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~~  759 (808)
                      ....+....          .....+..+.+++.+|++.+|++||++++|+++|+++..
T Consensus       237 ~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         237 CITQGRVLE----------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             HHhCCCCCC----------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence            111111111          111234578899999999999999999999999998743

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=7.9e-37  Score=331.68  Aligned_cols=257  Identities=26%  Similarity=0.437  Sum_probs=203.3

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCc----EEEEEEecccc-cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQ----EIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML  555 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  555 (808)
                      .+|++.+.||+|+||.||+|++. ++.    .||+|.++... ....+++.+|+.+++.++||||++++|++... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            46899999999999999999864 333    48999987543 34467899999999999999999999999764 5779


Q ss_pred             EEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecC
Q 003599          556 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG  635 (808)
Q Consensus       556 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~  635 (808)
                      |+||+++|+|.+++..  ....+++..+++++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        86 v~e~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          86 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             eeecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence            9999999999999865  2346889999999999999999999988   9999999999999999999999999999765


Q ss_pred             CCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhccccchhccCC
Q 003599          636 GNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDP  714 (808)
Q Consensus       636 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  714 (808)
                      ............++..|+|||.+....++.++||||||+++|||++ |+.|+....... ...    ....+.       
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-~~~----~~~~~~-------  228 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISS----ILEKGE-------  228 (316)
T ss_pred             CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-HHH----HHhCCC-------
Confidence            4333222222334678999999999999999999999999999998 888876432211 111    111110       


Q ss_pred             cccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhccc
Q 003599          715 FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIR  759 (808)
Q Consensus       715 ~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~~  759 (808)
                      ...   .+.....++..++.+|++.+|++||++.+|+..|..+..
T Consensus       229 ~~~---~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~  270 (316)
T cd05108         229 RLP---QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  270 (316)
T ss_pred             CCC---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence            000   111223567889999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=6.7e-37  Score=334.07  Aligned_cols=245  Identities=24%  Similarity=0.283  Sum_probs=200.3

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  557 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  557 (808)
                      ++|++.+.||+|+||.||+|+.+ +++.||+|++....   ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            57899999999999999999976 58899999986532   234567889999999999999999999999999999999


Q ss_pred             EecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCC
Q 003599          558 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  637 (808)
Q Consensus       558 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  637 (808)
                      ||+++|+|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            99999999999854   346888889999999999999999998   999999999999999999999999999865322


Q ss_pred             CCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCccc
Q 003599          638 QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS  717 (808)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  717 (808)
                      .     ....||+.|+|||.+.+..++.++|||||||++|||++|+.||.........     ....++.        +.
T Consensus       172 ~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-----~~i~~~~--------~~  233 (329)
T PTZ00263        172 T-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIY-----EKILAGR--------LK  233 (329)
T ss_pred             c-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHH-----HHHhcCC--------cC
Confidence            1     2256899999999999988999999999999999999999998543211110     1111111        10


Q ss_pred             CCcccHHHHHHHHHHHHhcccCCcCCCCC-----HHHHHHH
Q 003599          718 ESSFQLDMIIRCIHVGLLCVQELVKDRPN-----MSTVVSM  753 (808)
Q Consensus       718 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~ev~~~  753 (808)
                         .+.....++.+++.+||+.||.+||+     ++++++.
T Consensus       234 ---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        234 ---FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             ---CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence               11112356789999999999999996     6777643

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1e-36  Score=325.29  Aligned_cols=257  Identities=30%  Similarity=0.465  Sum_probs=203.4

Q ss_pred             cCCcccCcccccCceeEEEEEe-----cCCcEEEEEEecccc-cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRL-----KDGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML  555 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  555 (808)
                      ++|++.++||+|+||.||+|..     ..+..||+|.+.... .+....|.+|+.++++++||||+++++++..+...++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4578889999999999999985     246789999987533 3345678999999999999999999999999999999


Q ss_pred             EEEecCCCCchhhccCCC--------------CCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCC
Q 003599          556 IYEYMPNRSLDALLFDPL--------------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL  621 (808)
Q Consensus       556 V~E~~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~  621 (808)
                      ||||+++++|.+++....              ....+++.+.+.++.|++.||+|||+.+   ++||||||+|||+++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence            999999999999885321              1235788899999999999999999988   99999999999999999


Q ss_pred             CeeeeccccceecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhh
Q 003599          622 NPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAW  700 (808)
Q Consensus       622 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~  700 (808)
                      .+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+..... ......  
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-~~~~~~--  238 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-QEVIEM--  238 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-HHHHHH--
Confidence            999999999986643322222233446778999999988889999999999999999999 8888753322 111111  


Q ss_pred             hhhccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhh
Q 003599          701 KLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS  756 (808)
Q Consensus       701 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~  756 (808)
                        ........          .+.....++.+++.+|++.+|++||++.+|.++|..
T Consensus       239 --~~~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         239 --VRKRQLLP----------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             --HHcCCcCC----------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence              11111100          112234578889999999999999999999998853

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-36  Score=329.98  Aligned_cols=237  Identities=24%  Similarity=0.279  Sum_probs=192.1

Q ss_pred             ccccCceeEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEecCCCCc
Q 003599          490 LGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSL  565 (808)
Q Consensus       490 lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  565 (808)
                      ||+|+||.||+++.. +++.||+|++.+.   .......+.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999876 5789999998653   234456788999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCcccccc
Q 003599          566 DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR  645 (808)
Q Consensus       566 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~  645 (808)
                      .+++..   ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++......  .....
T Consensus        81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~  152 (312)
T cd05585          81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT  152 (312)
T ss_pred             HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence            999854   346899999999999999999999988   9999999999999999999999999998543222  12233


Q ss_pred             eeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCcccHHH
Q 003599          646 VVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDM  725 (808)
Q Consensus       646 ~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  725 (808)
                      ..||+.|+|||.+.+..++.++|||||||++|||++|+.||.......    ........         ..   .++...
T Consensus       153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~----~~~~~~~~---------~~---~~~~~~  216 (312)
T cd05585         153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE----MYRKILQE---------PL---RFPDGF  216 (312)
T ss_pred             ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH----HHHHHHcC---------CC---CCCCcC
Confidence            578999999999999999999999999999999999999986432211    11111110         00   122233


Q ss_pred             HHHHHHHHHhcccCCcCCCCCHHHH
Q 003599          726 IIRCIHVGLLCVQELVKDRPNMSTV  750 (808)
Q Consensus       726 ~~~l~~li~~cl~~~P~~RPs~~ev  750 (808)
                      ..++.+++.+||+.||++||+...+
T Consensus       217 ~~~~~~li~~~L~~dp~~R~~~~~~  241 (312)
T cd05585         217 DRDAKDLLIGLLSRDPTRRLGYNGA  241 (312)
T ss_pred             CHHHHHHHHHHcCCCHHHcCCCCCH
Confidence            4567899999999999999864333

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-37  Score=330.23  Aligned_cols=245  Identities=24%  Similarity=0.283  Sum_probs=200.5

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  557 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  557 (808)
                      ++|++.+.||+|+||.||+++.. +++.||+|++....   ....+.+.+|+.++++++||||+++++++.++...++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            46888999999999999999976 68899999986432   234567889999999999999999999999999999999


Q ss_pred             EecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCC
Q 003599          558 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  637 (808)
Q Consensus       558 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  637 (808)
                      ||+++|+|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  154 (291)
T cd05612          81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR  154 (291)
T ss_pred             eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence            99999999999853   346889999999999999999999998   999999999999999999999999999865321


Q ss_pred             CCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCccc
Q 003599          638 QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS  717 (808)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  717 (808)
                           .....|++.|+|||.+.+..++.++||||||+++|||++|+.|+.........    .... .+.        . 
T Consensus       155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~----~~i~-~~~--------~-  215 (291)
T cd05612         155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIY----EKIL-AGK--------L-  215 (291)
T ss_pred             -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHH-hCC--------c-
Confidence                 12246899999999999888999999999999999999999998643321111    1010 110        0 


Q ss_pred             CCcccHHHHHHHHHHHHhcccCCcCCCCC-----HHHHHHH
Q 003599          718 ESSFQLDMIIRCIHVGLLCVQELVKDRPN-----MSTVVSM  753 (808)
Q Consensus       718 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~ev~~~  753 (808)
                        .++......+.+++.+|++.||.+||+     ++++++.
T Consensus       216 --~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         216 --EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             --CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence              012222456789999999999999995     7887755

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=8.8e-37  Score=349.15  Aligned_cols=252  Identities=19%  Similarity=0.231  Sum_probs=203.8

Q ss_pred             CCcccCcccccCceeEEEEEec-C-CcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEec
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLK-D-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  560 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~-~-~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  560 (808)
                      .|.+.+.||+|++|.||+|... + ++.||+|.+..........+.+|+.+|+.++||||+++++++..++..+|||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            4889999999999999999754 3 6788999876555555567888999999999999999999999999999999999


Q ss_pred             CCCCchhhccCC-CCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCC
Q 003599          561 PNRSLDALLFDP-LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  639 (808)
Q Consensus       561 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  639 (808)
                      ++|+|.+++... .....+++.++..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++.+.....
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            999999988642 23446889999999999999999999988   99999999999999999999999999987654332


Q ss_pred             cccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCC
Q 003599          640 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSES  719 (808)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  719 (808)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.|+.........    .... .+.    .++     
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~----~~~~-~~~----~~~-----  290 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIM----QQVL-YGK----YDP-----  290 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHH-hCC----CCC-----
Confidence            22233456999999999999999999999999999999999999998643221111    1110 010    000     


Q ss_pred             cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          720 SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       720 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                       .+......+.+++.+||+.+|++||++++++.
T Consensus       291 -~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        291 -FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             -CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence             11223456889999999999999999999865

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.2e-36  Score=321.03  Aligned_cols=255  Identities=28%  Similarity=0.420  Sum_probs=205.7

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEec
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  560 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  560 (808)
                      .+|.+.++||+|+||.||+|..+ .++.||+|.+... ....+++.+|++++++++|+||+++++++..+...++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            45788899999999999999876 4788999998653 334678999999999999999999999999999999999999


Q ss_pred             CCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCc
Q 003599          561 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  640 (808)
Q Consensus       561 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  640 (808)
                      ++++|.+++... ....+++..++.++.|+++||+|||+.+   ++||||||+||++++++.+||+|||+++........
T Consensus        85 ~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~  160 (263)
T cd05052          85 TYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  160 (263)
T ss_pred             CCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence            999999998643 3346899999999999999999999988   999999999999999999999999999876432211


Q ss_pred             ccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCC
Q 003599          641 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSES  719 (808)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  719 (808)
                       ......++..|+|||.+.+..++.++||||||+++|||++ |..|++...... ..    .....+     ..+.    
T Consensus       161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-~~----~~~~~~-----~~~~----  225 (263)
T cd05052         161 -AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VY----ELLEKG-----YRME----  225 (263)
T ss_pred             -ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-HH----HHHHCC-----CCCC----
Confidence             1111234668999999998899999999999999999998 888875432211 11    111110     0011    


Q ss_pred             cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003599          720 SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  757 (808)
Q Consensus       720 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~  757 (808)
                       .+.....++.+++.+|++.+|++||++.+++++|+.+
T Consensus       226 -~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         226 -RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             -CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence             2222346788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=9.2e-37  Score=325.42  Aligned_cols=254  Identities=24%  Similarity=0.322  Sum_probs=204.2

Q ss_pred             HhcCCcccCcccccCceeEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEE
Q 003599          480 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML  555 (808)
Q Consensus       480 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  555 (808)
                      ..++|+++++||+|+||.||+++-+ .|..+|+|++++.   .....+..+.|-.+|....+|.||+++..|.+.+.+||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            4578999999999999999999866 5899999999875   34567788999999999999999999999999999999


Q ss_pred             EEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecC
Q 003599          556 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG  635 (808)
Q Consensus       556 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~  635 (808)
                      ||||++||++..+|.   +.+.|++.....++.+++.||..||+.|   +|||||||+|+|||..|++||+||||+.-+.
T Consensus       219 iMEylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~  292 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD  292 (550)
T ss_pred             EEEecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence            999999999999995   5678999999999999999999999999   9999999999999999999999999996432


Q ss_pred             CC---------------------CCcc------c------------------ccceeccCCccChhhhccCCCCccccEE
Q 003599          636 GN---------------------QDQA------D------------------TGRVVGTFGYMSPEYAMEGRFSEKSDVF  670 (808)
Q Consensus       636 ~~---------------------~~~~------~------------------~~~~~gt~~y~aPE~~~~~~~s~k~Dvw  670 (808)
                      ..                     ....      .                  ....+|||.|+|||++.+..|+..+|.|
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW  372 (550)
T KOG0605|consen  293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW  372 (550)
T ss_pred             hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence            10                     0000      0                  0024699999999999999999999999


Q ss_pred             ehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCC---H
Q 003599          671 SFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPN---M  747 (808)
Q Consensus       671 SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs---~  747 (808)
                      |||||+|||+.|.+||...........    +..........        .......+..++|.+|+. ||++|-.   +
T Consensus       373 SLG~ImyEmLvGyPPF~s~tp~~T~rk----I~nwr~~l~fP--------~~~~~s~eA~DLI~rll~-d~~~RLG~~G~  439 (550)
T KOG0605|consen  373 SLGCIMYEMLVGYPPFCSETPQETYRK----IVNWRETLKFP--------EEVDLSDEAKDLITRLLC-DPENRLGSKGA  439 (550)
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHH----HHHHhhhccCC--------CcCcccHHHHHHHHHHhc-CHHHhcCcccH
Confidence            999999999999999976554432211    11111101110        111223677889999998 9999985   5


Q ss_pred             HHHHH
Q 003599          748 STVVS  752 (808)
Q Consensus       748 ~ev~~  752 (808)
                      +||-+
T Consensus       440 ~EIK~  444 (550)
T KOG0605|consen  440 EEIKK  444 (550)
T ss_pred             HHHhc
Confidence            55443

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.3e-36  Score=318.55  Aligned_cols=248  Identities=28%  Similarity=0.414  Sum_probs=197.2

Q ss_pred             CcccccCceeEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEecCCCCc
Q 003599          488 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSL  565 (808)
Q Consensus       488 ~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  565 (808)
                      ++||+|+||.||+|+.. +++.||+|.+.... ......|.+|++++++++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            47999999999999875 68899999876543 33456799999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCcccccc
Q 003599          566 DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR  645 (808)
Q Consensus       566 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~  645 (808)
                      .+++..  ....+++.++..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.............
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  155 (252)
T cd05084          81 LTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM  155 (252)
T ss_pred             HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence            999854  2346889999999999999999999988   99999999999999999999999999876432211111111


Q ss_pred             eeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCcccHH
Q 003599          646 VVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLD  724 (808)
Q Consensus       646 ~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  724 (808)
                      ...+..|+|||.+..+.++.++||||||+++|||++ |..|+........ ..             .+...... ..+..
T Consensus       156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~-~~-------------~~~~~~~~-~~~~~  220 (252)
T cd05084         156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT-RE-------------AIEQGVRL-PCPEL  220 (252)
T ss_pred             CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH-HH-------------HHHcCCCC-CCccc
Confidence            123457999999998899999999999999999998 7777753322111 10             00000000 12223


Q ss_pred             HHHHHHHHHHhcccCCcCCCCCHHHHHHHHh
Q 003599          725 MIIRCIHVGLLCVQELVKDRPNMSTVVSMLN  755 (808)
Q Consensus       725 ~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~  755 (808)
                      ....+.+++.+|++.+|++||++.+|.++|+
T Consensus       221 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         221 CPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            3567889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.4e-36  Score=319.48  Aligned_cols=252  Identities=27%  Similarity=0.473  Sum_probs=203.5

Q ss_pred             cCCcccCcccccCceeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEecC
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMP  561 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  561 (808)
                      ++|++.+.||+|+||.||+|+..++..+|+|.+... ....++|.+|+.++++++||||+++++++.+....++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            457888999999999999999887778999998643 2345789999999999999999999999999989999999999


Q ss_pred             CCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCcc
Q 003599          562 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA  641 (808)
Q Consensus       562 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  641 (808)
                      +++|.+++...  ...+++..+++++.||+.||+|||+.+   ++|+||||+||+++.++.+||+|||+++........ 
T Consensus        83 ~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-  156 (256)
T cd05113          83 NGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-  156 (256)
T ss_pred             CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee-
Confidence            99999998642  236899999999999999999999988   999999999999999999999999999865433211 


Q ss_pred             cccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCc
Q 003599          642 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS  720 (808)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  720 (808)
                      ......++..|+|||.+....++.++||||||+++|||++ |+.|+........ ..   .. ..+..     +.     
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~-~~---~~-~~~~~-----~~-----  221 (256)
T cd05113         157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET-VE---KV-SQGLR-----LY-----  221 (256)
T ss_pred             ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH-HH---HH-hcCCC-----CC-----
Confidence            1112345678999999988889999999999999999999 8888764332211 11   01 11100     00     


Q ss_pred             ccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHh
Q 003599          721 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN  755 (808)
Q Consensus       721 ~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~  755 (808)
                      ........+.+++.+||+.+|++||++.+|++.|+
T Consensus       222 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         222 RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            11112467889999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.6e-36  Score=325.36  Aligned_cols=261  Identities=26%  Similarity=0.416  Sum_probs=207.3

Q ss_pred             HhcCCcccCcccccCceeEEEEEecC------CcEEEEEEeccc-ccccHHHHHHHHHHHHhc-cCCceeeEeeEEEeCC
Q 003599          480 ATNNFQLSSKLGQGGFGPVYWGRLKD------GQEIAVKRLSKA-SGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGE  551 (808)
Q Consensus       480 ~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~  551 (808)
                      ..++|++.+.||+|+||.||++...+      ...+|+|.+... ......++.+|+.++.++ +|+||+++++++..++
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   89 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG   89 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence            34678899999999999999998642      367999998754 233456788999999999 8999999999999999


Q ss_pred             eeEEEEEecCCCCchhhccCC-------------CCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeC
Q 003599          552 EKMLIYEYMPNRSLDALLFDP-------------LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD  618 (808)
Q Consensus       552 ~~~lV~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~  618 (808)
                      ..++||||+++|+|..++...             .....+++..+++++.|++.||+|||+.+   |+||||||+||+++
T Consensus        90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~  166 (293)
T cd05053          90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT  166 (293)
T ss_pred             CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence            999999999999999998542             22456899999999999999999999988   99999999999999


Q ss_pred             CCCCeeeeccccceecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhh
Q 003599          619 EELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILG  697 (808)
Q Consensus       619 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~  697 (808)
                      .++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..|+........ . 
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-~-  244 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL-F-  244 (293)
T ss_pred             CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH-H-
Confidence            999999999999987643322222222345678999999988899999999999999999998 8888754322111 1 


Q ss_pred             hhhhhhccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhcc
Q 003599          698 YAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEI  758 (808)
Q Consensus       698 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~  758 (808)
                         .....+..   .       ..+......+.+++.+|++.+|++|||+.+|++.|+.++
T Consensus       245 ---~~~~~~~~---~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         245 ---KLLKEGYR---M-------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             ---HHHHcCCc---C-------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence               11111100   0       012233457889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2e-37  Score=317.03  Aligned_cols=248  Identities=23%  Similarity=0.370  Sum_probs=209.4

Q ss_pred             hcCCcccCcccccCceeEEEEEe-cCCcEEEEEEecccc---cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEE
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRL-KDGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI  556 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  556 (808)
                      ..+|++.+.||+|.||.|-+|.. ..|+.||||.+++..   .++.-.+.+|+++|..|+||||+.++..|+..+...||
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            35788999999999999999986 679999999998753   44555678999999999999999999999999999999


Q ss_pred             EEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCC
Q 003599          557 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  636 (808)
Q Consensus       557 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  636 (808)
                      |||..+|.|.+|+.   ..+.|++.+...+++||..|+.|+|++.   ++|||||.+|||||.|+++||+|||++-.+..
T Consensus       132 MEYaS~GeLYDYiS---er~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~  205 (668)
T KOG0611|consen  132 MEYASGGELYDYIS---ERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD  205 (668)
T ss_pred             EEecCCccHHHHHH---HhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence            99999999999995   4678999999999999999999999998   99999999999999999999999999987643


Q ss_pred             CCCcccccceeccCCccChhhhccCCC-CccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCc
Q 003599          637 NQDQADTGRVVGTFGYMSPEYAMEGRF-SEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPF  715 (808)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  715 (808)
                      .   .....++|++-|.+||++.+.+| .+..|-|||||+||-|+.|..||+..+...-+.+.     ..|..       
T Consensus       206 ~---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQI-----s~GaY-------  270 (668)
T KOG0611|consen  206 K---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQI-----SRGAY-------  270 (668)
T ss_pred             c---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHh-----hcccc-------
Confidence            2   22334799999999999999888 67899999999999999999999865543222111     11111       


Q ss_pred             ccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHH
Q 003599          716 LSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML  754 (808)
Q Consensus       716 l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L  754 (808)
                           +..+.+....-||.+||..||++|-|+.+|....
T Consensus       271 -----rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  271 -----REPETPSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             -----cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence                 1122234456789999999999999999998875

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.3e-36  Score=322.02  Aligned_cols=256  Identities=26%  Similarity=0.415  Sum_probs=201.0

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCc----EEEEEEecccc-cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQ----EIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML  555 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  555 (808)
                      ++|++.+.||+|+||.||+|.+. +++    .+++|.+.... .....++..|+..+++++||||+++++++. +...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence            46788899999999999999864 344    47888875432 233467788999999999999999999875 456788


Q ss_pred             EEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecC
Q 003599          556 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG  635 (808)
Q Consensus       556 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~  635 (808)
                      ++||+++|+|.+++..  ....+++..+..++.||+.||+|||+.+   ++||||||+|||+++++.+||+|||+++...
T Consensus        86 i~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          86 VTQLSPLGSLLDHVRQ--HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             EEEeCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            9999999999999964  3456899999999999999999999988   9999999999999999999999999998764


Q ss_pred             CCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhccccchhccCC
Q 003599          636 GNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDP  714 (808)
Q Consensus       636 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  714 (808)
                      ............++..|+|||.+..+.++.++||||||+++|||++ |+.|+...... ....    ....+...  ..+
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-~~~~----~~~~~~~~--~~~  233 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH-EVPD----LLEKGERL--AQP  233 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-HHHH----HHHCCCcC--CCC
Confidence            4332222333457789999999998999999999999999999998 88887543221 1111    11111100  011


Q ss_pred             cccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhcc
Q 003599          715 FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEI  758 (808)
Q Consensus       715 ~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~  758 (808)
                      .        .....+..++.+|+..+|++||++.|+++.|..+.
T Consensus       234 ~--------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~  269 (279)
T cd05111         234 Q--------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA  269 (279)
T ss_pred             C--------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            1        12345678899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.9e-36  Score=326.75  Aligned_cols=264  Identities=22%  Similarity=0.324  Sum_probs=199.1

Q ss_pred             hcCCcccCcccccCceeEEEEEec-CCcEEEEEEeccccc-ccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEE
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  558 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  558 (808)
                      .++|++.++||+|+||.||+|+.. +++.||||++..... .....+.+|+.++++++||||+++++++.+....++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            468999999999999999999976 688999999875432 234567899999999999999999999999999999999


Q ss_pred             ecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCC
Q 003599          559 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  638 (808)
Q Consensus       559 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  638 (808)
                      |+. ++|.+++..  ....++...+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  157 (303)
T cd07869          84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS  157 (303)
T ss_pred             CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence            995 677777753  3356888999999999999999999998   9999999999999999999999999997543221


Q ss_pred             CcccccceeccCCccChhhhcc-CCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhcccc---c---hh-
Q 003599          639 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENK---I---LA-  710 (808)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~---~~-  710 (808)
                        .......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||....+................   .   .. 
T Consensus       158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (303)
T cd07869         158 --HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL  235 (303)
T ss_pred             --ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhc
Confidence              11223467899999998865 45788999999999999999999999754432222111111110000   0   00 


Q ss_pred             -ccCCc-ccC-Cccc-------HHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          711 -LVDPF-LSE-SSFQ-------LDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       711 -~~d~~-l~~-~~~~-------~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                       ..++. ... .+..       ......+.+++.+|++.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence             00000 000 0000       011245778999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-36  Score=323.69  Aligned_cols=263  Identities=27%  Similarity=0.428  Sum_probs=201.6

Q ss_pred             cCCcccCcccccCceeEEEEEecC---------------CcEEEEEEeccc-ccccHHHHHHHHHHHHhccCCceeeEee
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLKD---------------GQEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLG  545 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~~---------------~~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g  545 (808)
                      ++|++.++||+|+||.||+++..+               ...||+|.++.. .....+.|.+|++++++++|+||+++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            578999999999999999987542               235899998754 2334567999999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCchhhccCCC---------CCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceE
Q 003599          546 CCVEGEEKMLIYEYMPNRSLDALLFDPL---------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNIL  616 (808)
Q Consensus       546 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NIL  616 (808)
                      ++......++||||+++++|.+++....         ....+++..+++++.|++.||+|||+.+   ++|+||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence            9999999999999999999999885421         1124788899999999999999999988   999999999999


Q ss_pred             eCCCCCeeeeccccceecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhC--CCCCCCCCCchh
Q 003599          617 LDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG--RKNTSFFEDDLT  694 (808)
Q Consensus       617 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG--~~p~~~~~~~~~  694 (808)
                      +++++.+||+|||+++...............++..|+|||.+..+.++.++||||||+++|||+++  ..|+........
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~  241 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV  241 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence            999999999999999865433222222223457789999999988999999999999999999984  445543332221


Q ss_pred             hhhhhhhhhccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHh
Q 003599          695 ILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN  755 (808)
Q Consensus       695 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~  755 (808)
                      ... ...............       .+......+.+++.+|++.+|++||++++|++.|+
T Consensus       242 ~~~-~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         242 IEN-TGEFFRNQGRQIYLS-------QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HHH-HHHhhhhccccccCC-------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            111 111111110000000       11123457899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2e-36  Score=330.02  Aligned_cols=242  Identities=23%  Similarity=0.276  Sum_probs=196.7

Q ss_pred             CcccccCceeEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEecCCC
Q 003599          488 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNR  563 (808)
Q Consensus       488 ~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  563 (808)
                      +.||+|+||.||+++.. +++.||+|++.+.   .......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999875 6899999999754   2334567889999999999999999999999999999999999999


Q ss_pred             CchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCcccc
Q 003599          564 SLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT  643 (808)
Q Consensus       564 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  643 (808)
                      +|..++..   ...+++.++..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~  152 (328)
T cd05593          81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATM  152 (328)
T ss_pred             CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccc
Confidence            99888853   346899999999999999999999988   9999999999999999999999999987542221  122


Q ss_pred             cceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCcccH
Q 003599          644 GRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQL  723 (808)
Q Consensus       644 ~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  723 (808)
                      ....||+.|+|||.+.+..++.++|||||||++|||++|+.||..........    .... .      +.     .++.
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~----~~~~-~------~~-----~~p~  216 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE----LILM-E------DI-----KFPR  216 (328)
T ss_pred             ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHH----Hhcc-C------Cc-----cCCC
Confidence            23568999999999998899999999999999999999999986433211110    0100 0      00     1222


Q ss_pred             HHHHHHHHHHHhcccCCcCCCC-----CHHHHHHH
Q 003599          724 DMIIRCIHVGLLCVQELVKDRP-----NMSTVVSM  753 (808)
Q Consensus       724 ~~~~~l~~li~~cl~~~P~~RP-----s~~ev~~~  753 (808)
                      ....++.+++.+|++.||++||     ++.++++.
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            2345678999999999999997     88988764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3.2e-36  Score=322.46  Aligned_cols=263  Identities=22%  Similarity=0.306  Sum_probs=200.0

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEe
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  559 (808)
                      ++|++.++||+|+||.||+|+.+ +++.||+|.++... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            56899999999999999999876 68899999986543 23345788999999999999999999999999999999999


Q ss_pred             cCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCC
Q 003599          560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  639 (808)
Q Consensus       560 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  639 (808)
                      +++ +|.+++..  ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus        85 ~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~  158 (288)
T cd07871          85 LDS-DLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK  158 (288)
T ss_pred             CCc-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence            975 89888754  2345788999999999999999999988   99999999999999999999999999986532221


Q ss_pred             cccccceeccCCccChhhhcc-CCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhh-------hc----ccc
Q 003599          640 QADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKL-------WN----ENK  707 (808)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~-------~~----~~~  707 (808)
                        ......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||........+.......       +.    ...
T Consensus       159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07871         159 --TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE  236 (288)
T ss_pred             --cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence              1223467999999998865 568999999999999999999999986544322221111100       00    000


Q ss_pred             chhccCCcccCCc---ccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          708 ILALVDPFLSESS---FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       708 ~~~~~d~~l~~~~---~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      ......+......   .......++.+++.+|++.||.+|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            0111111110000   00112356789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.5e-36  Score=318.96  Aligned_cols=256  Identities=26%  Similarity=0.432  Sum_probs=202.3

Q ss_pred             CcccCcccccCceeEEEEEecC----CcEEEEEEecccc--cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCe-----
Q 003599          484 FQLSSKLGQGGFGPVYWGRLKD----GQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEE-----  552 (808)
Q Consensus       484 ~~~~~~lG~G~~g~Vy~~~~~~----~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-----  552 (808)
                      |++.+.||+|+||.||+|....    +..||+|+++...  ....+.+.+|++.++.++||||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5678999999999999998652    3679999987532  3345688999999999999999999999876554     


Q ss_pred             -eEEEEEecCCCCchhhccCCC---CCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeecc
Q 003599          553 -KMLIYEYMPNRSLDALLFDPL---KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDF  628 (808)
Q Consensus       553 -~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DF  628 (808)
                       .++||||+++++|..++....   ....+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence             789999999999999885432   2346899999999999999999999988   999999999999999999999999


Q ss_pred             ccceecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhcccc
Q 003599          629 GMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENK  707 (808)
Q Consensus       629 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  707 (808)
                      |+++...............++..|+|||.+....++.++||||||+++|||++ |..|+....... .....    ..+.
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~-~~~~~----~~~~  232 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE-IYDYL----RHGN  232 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHH----HcCC
Confidence            99987644332222222345678999999988889999999999999999999 778775433221 11111    1111


Q ss_pred             chhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003599          708 ILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  757 (808)
Q Consensus       708 ~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~  757 (808)
                      .     ..     .+.....++.+++.+|++.||++||++.+|++.|+++
T Consensus       233 ~-----~~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         233 R-----LK-----QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             C-----CC-----CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            0     00     1223456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=318.18  Aligned_cols=254  Identities=25%  Similarity=0.331  Sum_probs=201.3

Q ss_pred             HhcCCcccCcccccCceeEEEEEec-CCcEEEEEEecccc--------------cccHHHHHHHHHHHHhccCCceeeEe
Q 003599          480 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--------------GQGLEEFMNEVMVISKLQHRNLVRLL  544 (808)
Q Consensus       480 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~--------------~~~~~~~~~E~~~l~~l~H~niv~l~  544 (808)
                      ..++|++.+.||+|.||.|-+|+.. +++.||||++.+..              ....+...+|+.+|++++|||||+++
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li  174 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI  174 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence            3478999999999999999999865 68999999997531              11246889999999999999999999


Q ss_pred             eEEEe--CCeeEEEEEecCCCCchhhccCCCCCCc-CChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCC
Q 003599          545 GCCVE--GEEKMLIYEYMPNRSLDALLFDPLKKER-LDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL  621 (808)
Q Consensus       545 g~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~  621 (808)
                      .+..+  .+..|||+|||..|.+...-    ...+ ++..+..++++++..||+|||.++   |+||||||+|+||+++|
T Consensus       175 EvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g  247 (576)
T KOG0585|consen  175 EVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDG  247 (576)
T ss_pred             EeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCC
Confidence            99875  46789999999999885443    2333 999999999999999999999999   99999999999999999


Q ss_pred             CeeeeccccceecCCC---CCcccccceeccCCccChhhhccCC----CCccccEEehhHHHHHHHhCCCCCCCCCCchh
Q 003599          622 NPKISDFGMAKIFGGN---QDQADTGRVVGTFGYMSPEYAMEGR----FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLT  694 (808)
Q Consensus       622 ~~kl~DFGla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~----~s~k~DvwSlGvil~elltG~~p~~~~~~~~~  694 (808)
                      ++||+|||.+..+...   ..........||+.|+|||...++.    .+.+.||||+||+||-|+-|+.||-...    
T Consensus       248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~----  323 (576)
T KOG0585|consen  248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF----  323 (576)
T ss_pred             cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch----
Confidence            9999999999866222   1112233468999999999987743    3568899999999999999999984211    


Q ss_pred             hhhhhhhhhccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHH
Q 003599          695 ILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML  754 (808)
Q Consensus       695 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L  754 (808)
                      ......         .++...+.-. ...++-+.+.+|++++|++||++|.+..+|....
T Consensus       324 ~~~l~~---------KIvn~pL~fP-~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp  373 (576)
T KOG0585|consen  324 ELELFD---------KIVNDPLEFP-ENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP  373 (576)
T ss_pred             HHHHHH---------HHhcCcccCC-CcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence            111111         1222222222 2235667889999999999999999999987765

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.5e-36  Score=332.24  Aligned_cols=245  Identities=24%  Similarity=0.331  Sum_probs=200.5

Q ss_pred             cCCcccCcccccCceeEEEEEecC--CcEEEEEEeccc---ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLKD--GQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI  556 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~~--~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  556 (808)
                      ++|++.+.||+|+||.||+|+.+.  +..||+|++...   .....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            579999999999999999998653  368999998653   233456788999999999999999999999999999999


Q ss_pred             EEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCC
Q 003599          557 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  636 (808)
Q Consensus       557 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  636 (808)
                      |||+++|+|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       110 ~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~  183 (340)
T PTZ00426        110 LEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT  183 (340)
T ss_pred             EeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence            999999999999854   346889999999999999999999998   99999999999999999999999999986532


Q ss_pred             CCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcc
Q 003599          637 NQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL  716 (808)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  716 (808)
                      .     .....||+.|+|||.+.+..++.++|||||||++|||++|+.||........    ..... .+.        .
T Consensus       184 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~----~~~i~-~~~--------~  245 (340)
T PTZ00426        184 R-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI----YQKIL-EGI--------I  245 (340)
T ss_pred             C-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH----HHHHh-cCC--------C
Confidence            2     1235789999999999988899999999999999999999999864332111    11111 110        0


Q ss_pred             cCCcccHHHHHHHHHHHHhcccCCcCCCC-----CHHHHHHH
Q 003599          717 SESSFQLDMIIRCIHVGLLCVQELVKDRP-----NMSTVVSM  753 (808)
Q Consensus       717 ~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~ev~~~  753 (808)
                         .++......+.+++.+|++.+|++|+     +++++++.
T Consensus       246 ---~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        246 ---YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             ---CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence               01122234577899999999999995     89888765

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2.3e-36  Score=323.85  Aligned_cols=258  Identities=26%  Similarity=0.408  Sum_probs=204.4

Q ss_pred             CCcccCcccccCceeEEEEEec------CCcEEEEEEecccc-cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEE
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML  555 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  555 (808)
                      +|++.+.||+|+||.||+|...      ....+|+|.+.... ....+.+.+|+.+++.++||||+++++.+..++..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4778899999999999999853      23568999886543 2345678999999999999999999999999999999


Q ss_pred             EEEecCCCCchhhccCCC---------------------CCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCc
Q 003599          556 IYEYMPNRSLDALLFDPL---------------------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASN  614 (808)
Q Consensus       556 V~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~N  614 (808)
                      ||||+.+++|.+++....                     ....+++..++.++.|++.||.|||+.+   ++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence            999999999999875321                     1235889999999999999999999988   9999999999


Q ss_pred             eEeCCCCCeeeeccccceecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCch
Q 003599          615 ILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDL  693 (808)
Q Consensus       615 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~  693 (808)
                      ||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... 
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-  236 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE-  236 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence            9999999999999999986543322222222345778999999988889999999999999999999 88887543221 


Q ss_pred             hhhhhhhhhhccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhcc
Q 003599          694 TILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEI  758 (808)
Q Consensus       694 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~  758 (808)
                      .+..    ....+         ... ..+.....++.+++.+|++.+|++||++.+|++.|++++
T Consensus       237 ~~~~----~~~~~---------~~~-~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~  287 (290)
T cd05045         237 RLFN----LLKTG---------YRM-ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM  287 (290)
T ss_pred             HHHH----HHhCC---------CCC-CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence            1111    11111         000 012223457889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.5e-36  Score=330.40  Aligned_cols=241  Identities=23%  Similarity=0.275  Sum_probs=195.4

Q ss_pred             CcccccCceeEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEecCCC
Q 003599          488 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNR  563 (808)
Q Consensus       488 ~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  563 (808)
                      +.||+|+||.||+++.. +|+.||+|+++..   .......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999875 6899999998754   2334567788999999999999999999999999999999999999


Q ss_pred             CchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCcccc
Q 003599          564 SLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT  643 (808)
Q Consensus       564 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  643 (808)
                      +|..++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~  152 (323)
T cd05595          81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATM  152 (323)
T ss_pred             cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccc
Confidence            99888843   346899999999999999999999988   9999999999999999999999999987532221  112


Q ss_pred             cceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCcccH
Q 003599          644 GRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQL  723 (808)
Q Consensus       644 ~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  723 (808)
                      ....||+.|+|||.+.+..++.++|||||||++|||++|+.||...........    ....       +..     .+.
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~----~~~~-------~~~-----~p~  216 (323)
T cd05595         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL----ILME-------EIR-----FPR  216 (323)
T ss_pred             ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHH----HhcC-------CCC-----CCC
Confidence            235689999999999999999999999999999999999999864332211111    0000       000     122


Q ss_pred             HHHHHHHHHHHhcccCCcCCCC-----CHHHHHH
Q 003599          724 DMIIRCIHVGLLCVQELVKDRP-----NMSTVVS  752 (808)
Q Consensus       724 ~~~~~l~~li~~cl~~~P~~RP-----s~~ev~~  752 (808)
                      ....++.+++.+|++.||++||     ++.++++
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            2345678999999999999998     7888765

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.2e-36  Score=321.50  Aligned_cols=266  Identities=27%  Similarity=0.402  Sum_probs=203.3

Q ss_pred             CcccCcccccCceeEEEEEe-----cCCcEEEEEEecccc-cccHHHHHHHHHHHHhccCCceeeEeeEEEeC--CeeEE
Q 003599          484 FQLSSKLGQGGFGPVYWGRL-----KDGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG--EEKML  555 (808)
Q Consensus       484 ~~~~~~lG~G~~g~Vy~~~~-----~~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l  555 (808)
                      |++.+.||+|+||+||++..     .++..||+|.++... ....+.|.+|++++++++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            37889999999999988653     357889999987543 23457889999999999999999999998754  35789


Q ss_pred             EEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecC
Q 003599          556 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG  635 (808)
Q Consensus       556 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~  635 (808)
                      ||||+++++|.+++..    ..+++.++..++.|+++||.|||+.+   |+||||||+|||+++++.+||+|||+++...
T Consensus        86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence            9999999999999843    35899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCCccc-ccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCch-hhhhhhhhhhccccchhccC
Q 003599          636 GNQDQAD-TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDL-TILGYAWKLWNENKILALVD  713 (808)
Q Consensus       636 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~d  713 (808)
                      ....... .....++..|+|||.+....++.++||||||+++|||++|+.|+....... ................+.++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd05080         159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE  238 (283)
T ss_pred             CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence            3222111 111235667999999988889999999999999999999998875432211 11111100011111122222


Q ss_pred             CcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003599          714 PFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  757 (808)
Q Consensus       714 ~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~  757 (808)
                      ..... +.+.....++.+++.+|++.+|++||++++|+++|+.+
T Consensus       239 ~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         239 RGMRL-PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             cCCCC-CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence            22111 12333456889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=4.2e-36  Score=321.67  Aligned_cols=263  Identities=23%  Similarity=0.323  Sum_probs=196.1

Q ss_pred             cCCcccCcccccCceeEEEEEec--CCcEEEEEEecccc--cccHHHHHHHHHHHHhc---cCCceeeEeeEEEe-----
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK--DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKL---QHRNLVRLLGCCVE-----  549 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~-----  549 (808)
                      ++|++.+.||+|+||.||+|+..  +++.||+|+++...  ......+.+|+.+++++   +||||+++++++..     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36889999999999999999863  46889999986532  22345667788777766   69999999999852     


Q ss_pred             CCeeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccc
Q 003599          550 GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFG  629 (808)
Q Consensus       550 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFG  629 (808)
                      ....++||||+. ++|.+++... ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence            456889999996 6898888643 2345889999999999999999999998   9999999999999999999999999


Q ss_pred             cceecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhh--cccc
Q 003599          630 MAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLW--NENK  707 (808)
Q Consensus       630 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~--~~~~  707 (808)
                      +++.....   .......||+.|+|||.+....++.++||||||+++|||++|+.||....+...+........  ....
T Consensus       156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~  232 (290)
T cd07862         156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED  232 (290)
T ss_pred             ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhh
Confidence            99875432   122335689999999999888999999999999999999999999875443222211111000  0000


Q ss_pred             ch-------hccCCcccC--CcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          708 IL-------ALVDPFLSE--SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       708 ~~-------~~~d~~l~~--~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      ..       ....+....  .....+....+.+++.+|++.+|++|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            00       000000000  0011123456789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.5e-36  Score=323.92  Aligned_cols=256  Identities=29%  Similarity=0.463  Sum_probs=203.2

Q ss_pred             CCcccCcccccCceeEEEEEec------CCcEEEEEEecccccc-cHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEE
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASGQ-GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML  555 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  555 (808)
                      +|++.++||+|+||.||+|...      .++.||+|+++..... ..+.|.+|+.++.+++||||+++++++......++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            4777899999999999999864      2578999999754332 34678899999999999999999999999999999


Q ss_pred             EEEecCCCCchhhccCC-------------CCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCC
Q 003599          556 IYEYMPNRSLDALLFDP-------------LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELN  622 (808)
Q Consensus       556 V~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~  622 (808)
                      ++||+++++|.+++...             .....+++..+.+++.|++.||.|||+.+   |+||||||+||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence            99999999999998421             11235888889999999999999999988   999999999999999999


Q ss_pred             eeeeccccceecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhh
Q 003599          623 PKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWK  701 (808)
Q Consensus       623 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~  701 (808)
                      +||+|||+++...............+++.|+|||.+..+.++.++||||||+++|||++ |..|+...... ....    
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-~~~~----  237 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ-DVIE----  237 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH-HHHH----
Confidence            99999999886643332222233456789999999988889999999999999999998 77776543222 1111    


Q ss_pred             hhccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhh
Q 003599          702 LWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS  756 (808)
Q Consensus       702 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~  756 (808)
                      ....+...          ..+.+....+.+++.+|++.+|++||++.+|++.|+.
T Consensus       238 ~i~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         238 MIRNRQVL----------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHcCCcC----------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            11111110          1222345678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=4e-36  Score=316.54  Aligned_cols=253  Identities=32%  Similarity=0.497  Sum_probs=203.6

Q ss_pred             cCCcccCcccccCceeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEecC
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMP  561 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  561 (808)
                      ++|++.++||+|+||.||+|...++..+|+|.++.... ..+.|.+|+.++++++|+|++++++++. ....+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS   83 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence            56888999999999999999988888999999875432 4567999999999999999999999875 456889999999


Q ss_pred             CCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCcc
Q 003599          562 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA  641 (808)
Q Consensus       562 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  641 (808)
                      +++|.+++... ....+++.++.+++.+++.||+|||+.+   ++||||||+||++++++.++|+|||+++.........
T Consensus        84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05070          84 KGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             CCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence            99999998653 2345899999999999999999999988   9999999999999999999999999998764322111


Q ss_pred             cccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCc
Q 003599          642 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS  720 (808)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  720 (808)
                       .....++..|+|||.+....++.++||||||+++|||++ |+.|+....... ....   .. .+         .. .+
T Consensus       160 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-~~~~---~~-~~---------~~-~~  223 (260)
T cd05070         160 -RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE-VLEQ---VE-RG---------YR-MP  223 (260)
T ss_pred             -ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH-HHHH---HH-cC---------CC-CC
Confidence             111235678999999988889999999999999999999 888875432211 1111   10 00         00 01


Q ss_pred             ccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhh
Q 003599          721 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS  756 (808)
Q Consensus       721 ~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~  756 (808)
                      .+......+.+++.+|++.+|++|||+.++.+.|++
T Consensus       224 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         224 CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            222345678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=7e-36  Score=320.89  Aligned_cols=264  Identities=27%  Similarity=0.434  Sum_probs=205.7

Q ss_pred             hcCCcccCcccccCceeEEEEEecC-----------------CcEEEEEEecccc-cccHHHHHHHHHHHHhccCCceee
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLKD-----------------GQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVR  542 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~  542 (808)
                      ..+|++.++||+|+||.||+++..+                 +..||+|.+.... ....+.+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            3578999999999999999987642                 2468999987643 335678899999999999999999


Q ss_pred             EeeEEEeCCeeEEEEEecCCCCchhhccCCC--------CCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCc
Q 003599          543 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPL--------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASN  614 (808)
Q Consensus       543 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~N  614 (808)
                      +++++..+...++||||+++++|.+++....        ....+++..++.++.|++.||+|||+.+   ++|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence            9999999999999999999999999986532        1236899999999999999999999988   9999999999


Q ss_pred             eEeCCCCCeeeeccccceecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh--CCCCCCCCCCc
Q 003599          615 ILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS--GRKNTSFFEDD  692 (808)
Q Consensus       615 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt--G~~p~~~~~~~  692 (808)
                      |+++.++.++|+|||+++...............++..|+|||.+....++.++||||||+++|||++  |..|+......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ  240 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence            9999999999999999986543322222333456788999999988889999999999999999998  55565433222


Q ss_pred             hhhhhhhhhhhccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHh
Q 003599          693 LTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN  755 (808)
Q Consensus       693 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~  755 (808)
                      . ........+..........       .+.....++.+++.+|++.+|++||++.+|++.|+
T Consensus       241 ~-~~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         241 Q-VIENAGHFFRDDGRQIYLP-------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             H-HHHHHHhccccccccccCC-------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            2 1111111111111100000       11223467899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-36  Score=317.18  Aligned_cols=250  Identities=29%  Similarity=0.457  Sum_probs=202.1

Q ss_pred             CCcccCcccccCceeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEecCC
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPN  562 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  562 (808)
                      +|++.+.||+|+||.||+++.+++..+|+|.+.... .....|.+|+.++++++||||+++++++...+..++||||+++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN   83 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence            578889999999999999998877889999986432 3456789999999999999999999999999999999999999


Q ss_pred             CCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCccc
Q 003599          563 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD  642 (808)
Q Consensus       563 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  642 (808)
                      ++|.+++...  ...+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++......... 
T Consensus        84 ~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~-  157 (256)
T cd05059          84 GCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS-  157 (256)
T ss_pred             CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc-
Confidence            9999998642  346899999999999999999999998   9999999999999999999999999998654322111 


Q ss_pred             ccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCcc
Q 003599          643 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSF  721 (808)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  721 (808)
                      .....++..|+|||.+....++.++||||||+++|||++ |+.|+....+.....    .. ..+     ....     .
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~----~~-~~~-----~~~~-----~  222 (256)
T cd05059         158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVE----SV-SAG-----YRLY-----R  222 (256)
T ss_pred             cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHH----HH-HcC-----CcCC-----C
Confidence            111223457999999998899999999999999999999 788876443222111    01 000     0000     1


Q ss_pred             cHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHH
Q 003599          722 QLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML  754 (808)
Q Consensus       722 ~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L  754 (808)
                      +.....++.+++.+|++.+|++||++.+|+++|
T Consensus       223 ~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         223 PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            122456788999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.6e-37  Score=296.37  Aligned_cols=249  Identities=27%  Similarity=0.372  Sum_probs=208.6

Q ss_pred             hcCCcccCcccccCceeEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEE
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI  556 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  556 (808)
                      .++|++.+.||+|-||.||.|+.+ ++-.||+|++.+.   ..+...++.+|+++-+.|+||||+++++++.+....||+
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            367899999999999999999976 5778999998764   234467889999999999999999999999999999999


Q ss_pred             EEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCC
Q 003599          557 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  636 (808)
Q Consensus       557 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  636 (808)
                      +||.++|.|...|.+. ...++++.....++.|+|.|+.|+|..+   |+||||||+|+|++..+.+||+|||-+.... 
T Consensus       101 lEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP-  175 (281)
T ss_pred             EEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence            9999999999999753 4557888999999999999999999988   9999999999999999999999999987532 


Q ss_pred             CCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcc
Q 003599          637 NQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL  716 (808)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  716 (808)
                         .......+||..|.|||...+...+.+.|+|++|++.||++.|.+||+....+.......        -.+..    
T Consensus       176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~--------k~~~~----  240 (281)
T KOG0580|consen  176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIR--------KVDLK----  240 (281)
T ss_pred             ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHH--------Hcccc----
Confidence               222334789999999999999999999999999999999999999997544322211110        01111    


Q ss_pred             cCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          717 SESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       717 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                          ++........+++..|+..+|.+|.+..||+..
T Consensus       241 ----~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  241 ----FPSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             ----CCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence                223445677899999999999999999998764

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-37  Score=330.59  Aligned_cols=263  Identities=27%  Similarity=0.403  Sum_probs=217.3

Q ss_pred             HHHHHhcCCcccCcccccCceeEEEEEecC-CcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeE
Q 003599          476 ELATATNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKM  554 (808)
Q Consensus       476 ~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  554 (808)
                      +++-...+....++||-|-||.||.|.++. .-.||||.++.. ....++|+.|+.+|+.|+|||+|+++|.|..+..+|
T Consensus       261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY  339 (1157)
T KOG4278|consen  261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY  339 (1157)
T ss_pred             hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence            333334456677899999999999999874 567999999654 456899999999999999999999999999999999


Q ss_pred             EEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceec
Q 003599          555 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF  634 (808)
Q Consensus       555 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~  634 (808)
                      ||.|||..|+|.+||.+. ++..++.-..+.++.||+.||+||..++   +|||||.++|+|+.++..+|++||||+|++
T Consensus       340 IiTEfM~yGNLLdYLRec-nr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlM  415 (1157)
T KOG4278|consen  340 IITEFMCYGNLLDYLREC-NRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLM  415 (1157)
T ss_pred             EEEecccCccHHHHHHHh-chhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhh
Confidence            999999999999999764 5566788888999999999999999988   999999999999999999999999999998


Q ss_pred             CCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhccccchhccC
Q 003599          635 GGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVD  713 (808)
Q Consensus       635 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  713 (808)
                      ..+...... ...-...|.|||-+....++.|+|||+|||+||||.| |-.|++..+-.     .++         ++++
T Consensus       416 tgDTYTAHA-GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS-----qVY---------~LLE  480 (1157)
T KOG4278|consen  416 TGDTYTAHA-GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----QVY---------GLLE  480 (1157)
T ss_pred             cCCceeccc-CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH-----HHH---------HHHh
Confidence            766543322 2345789999999999999999999999999999998 66666533211     122         2222


Q ss_pred             CcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhccc
Q 003599          714 PFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIR  759 (808)
Q Consensus       714 ~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~~  759 (808)
                      ....-. .+..++..+.+|+++||+.+|.+||++.|+-+.++.++.
T Consensus       481 kgyRM~-~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~  525 (1157)
T KOG4278|consen  481 KGYRMD-GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS  525 (1157)
T ss_pred             cccccc-CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence            222222 344567789999999999999999999999999977644

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=4.6e-36  Score=327.99  Aligned_cols=200  Identities=29%  Similarity=0.387  Sum_probs=174.1

Q ss_pred             hcCCcccCcccccCceeEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEE
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  558 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  558 (808)
                      .++|++.++||+|+||.||++... ++..+|+|.+.... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            368999999999999999999876 57889999886542 3345678999999999999999999999999999999999


Q ss_pred             ecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCC
Q 003599          559 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  638 (808)
Q Consensus       559 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  638 (808)
                      |+++++|.+++..   ...+++..+..++.+++.||.|||+.+  +|+|+||||+|||++.++.+||+|||++.......
T Consensus        84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~  158 (333)
T cd06650          84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  158 (333)
T ss_pred             cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence            9999999999853   346888999999999999999999753  39999999999999999999999999987553221


Q ss_pred             CcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCC
Q 003599          639 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFF  689 (808)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~  689 (808)
                          .....|+..|+|||.+.+..++.++|||||||++|||++|+.|+...
T Consensus       159 ----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         159 ----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             ----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence                12246899999999999888999999999999999999999998643

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=4.1e-36  Score=331.20  Aligned_cols=248  Identities=25%  Similarity=0.325  Sum_probs=193.5

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEeccccc-ccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEe
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  559 (808)
                      ++|+..++||+|+||.||+++.. +++.||||++..... ...+.+.+|++++++++|+||+++++++.+.+..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            34566789999999999999875 689999999865432 3356789999999999999999999999999999999999


Q ss_pred             cCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCC
Q 003599          560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  639 (808)
Q Consensus       560 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  639 (808)
                      +++++|....       ..++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++.+.....
T Consensus       154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~  223 (353)
T PLN00034        154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD  223 (353)
T ss_pred             CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence            9999996533       3456778899999999999999998   99999999999999999999999999987643221


Q ss_pred             cccccceeccCCccChhhhcc-----CCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCC
Q 003599          640 QADTGRVVGTFGYMSPEYAME-----GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDP  714 (808)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  714 (808)
                        ......||..|+|||.+..     ...+.++|||||||++|||++|+.||........ ..........      ..+
T Consensus       224 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~~------~~~  294 (353)
T PLN00034        224 --PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDW-ASLMCAICMS------QPP  294 (353)
T ss_pred             --cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH-HHHHHHHhcc------CCC
Confidence              1223578999999998743     2245689999999999999999999873222111 1000000000      000


Q ss_pred             cccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          715 FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       715 ~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                      .     .......++.+++.+||+.||++||++.||++.
T Consensus       295 ~-----~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        295 E-----APATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             C-----CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0     122334578899999999999999999999875

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-36  Score=329.73  Aligned_cols=248  Identities=25%  Similarity=0.329  Sum_probs=208.0

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  557 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  557 (808)
                      .-|++.+-||+|+-|.|-.|+.. .|+.+|||++.+.   .......+.+|+.+|+.|.|||++++++.+++..+.|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            45788899999999999999875 6999999999765   2233456778999999999999999999999999999999


Q ss_pred             EecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCC
Q 003599          558 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  637 (808)
Q Consensus       558 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  637 (808)
                      ||+++|-|.+++.   .++++.+.+..+++.||+.|+.|+|..+   |+||||||+|+|||..+++||+|||+|..--  
T Consensus        92 Eyv~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~--  163 (786)
T KOG0588|consen   92 EYVPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEV--  163 (786)
T ss_pred             EecCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeeccc--
Confidence            9999999999984   5678999999999999999999999998   9999999999999999999999999997532  


Q ss_pred             CCcccccceeccCCccChhhhccCCC-CccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcc
Q 003599          638 QDQADTGRVVGTFGYMSPEYAMEGRF-SEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL  716 (808)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  716 (808)
                       ........+|.+.|+|||++++.+| ..++||||.|||||.|+||+.||+.    +++..... .+..|. .       
T Consensus       164 -~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD----dNir~LLl-KV~~G~-f-------  229 (786)
T KOG0588|consen  164 -PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD----DNIRVLLL-KVQRGV-F-------  229 (786)
T ss_pred             -CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC----ccHHHHHH-HHHcCc-c-------
Confidence             2223334689999999999999998 6789999999999999999999972    22222211 111111 1       


Q ss_pred             cCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHH
Q 003599          717 SESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML  754 (808)
Q Consensus       717 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L  754 (808)
                         ..+.....++++|+.+|+..||++|.|++||++.-
T Consensus       230 ---~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP  264 (786)
T KOG0588|consen  230 ---EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP  264 (786)
T ss_pred             ---cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence               13344567788999999999999999999999864

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=3.4e-36  Score=320.88  Aligned_cols=256  Identities=28%  Similarity=0.428  Sum_probs=204.5

Q ss_pred             cCCcccCcccccCceeEEEEEec------CCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML  555 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  555 (808)
                      .+|...++||+|+||.||++...      ++..+|+|.+........+.|.+|++++++++|+||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            45777899999999999999642      356799999877666667889999999999999999999999999999999


Q ss_pred             EEEecCCCCchhhccCCCC------------CCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCe
Q 003599          556 IYEYMPNRSLDALLFDPLK------------KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP  623 (808)
Q Consensus       556 V~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~  623 (808)
                      ||||+++++|.+++.....            ...+++..++.++.|++.|++|||+.+   ++||||||+|||+++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence            9999999999999864321            135889999999999999999999988   9999999999999999999


Q ss_pred             eeeccccceecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhh
Q 003599          624 KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKL  702 (808)
Q Consensus       624 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~  702 (808)
                      ||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.|+.........    .. 
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~----~~-  236 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI----EC-  236 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHH----HH-
Confidence            9999999986543322222222345788999999998899999999999999999998 88887533221111    00 


Q ss_pred             hccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHh
Q 003599          703 WNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN  755 (808)
Q Consensus       703 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~  755 (808)
                      ...+..     ..     .+......+.+++.+|++.+|++||++.+|++.|+
T Consensus       237 ~~~~~~-----~~-----~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         237 ITQGRE-----LE-----RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             HHcCcc-----CC-----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            001100     00     11123456789999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=3e-36  Score=320.70  Aligned_cols=257  Identities=29%  Similarity=0.462  Sum_probs=202.8

Q ss_pred             hcCCcccCcccccCceeEEEEEecC------CcEEEEEEecccc-cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCee
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLKD------GQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEK  553 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  553 (808)
                      .++|++.+.||+|++|.||+|.+.+      +..||+|.+.... ......|.+|+.++++++|+||+++++++.+....
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            4678999999999999999998753      5678999886543 33456799999999999999999999999999999


Q ss_pred             EEEEEecCCCCchhhccCCCC----CCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCC---Ceeee
Q 003599          554 MLIYEYMPNRSLDALLFDPLK----KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL---NPKIS  626 (808)
Q Consensus       554 ~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~---~~kl~  626 (808)
                      ++||||+++++|.+++.....    ...+++..+++++.||+.||+|||+.+   ++||||||+||+++.++   .+||+
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence            999999999999999865321    235899999999999999999999998   99999999999998754   59999


Q ss_pred             ccccceecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhcc
Q 003599          627 DFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNE  705 (808)
Q Consensus       627 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  705 (808)
                      |||+++................+..|+|||.+.+..++.++|||||||++|||++ |+.||+...... ....   ....
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~-~~~~---~~~~  237 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE-VMEF---VTGG  237 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHH---HHcC
Confidence            9999987633222111222234568999999999999999999999999999997 888876433221 1111   1111


Q ss_pred             ccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHh
Q 003599          706 NKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN  755 (808)
Q Consensus       706 ~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~  755 (808)
                      ..           ...+.....++.+++.+|++.+|++||++.+|++.|+
T Consensus       238 ~~-----------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         238 GR-----------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             Cc-----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            00           0012223467889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=3.6e-36  Score=320.50  Aligned_cols=261  Identities=26%  Similarity=0.408  Sum_probs=208.0

Q ss_pred             hcCCcccCcccccCceeEEEEEecC-----CcEEEEEEecccc-cccHHHHHHHHHHHHhccCCceeeEeeEEEe-CCee
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLKD-----GQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVE-GEEK  553 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~  553 (808)
                      .++|++.+.||+|+||.||+|...+     +..|++|++.... ....+.+.+|+.++++++|+||+++++++.+ +...
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            4678999999999999999999765     6889999987542 3346778899999999999999999999876 4678


Q ss_pred             EEEEEecCCCCchhhccCCCCC-----CcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeecc
Q 003599          554 MLIYEYMPNRSLDALLFDPLKK-----ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDF  628 (808)
Q Consensus       554 ~lV~E~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DF  628 (808)
                      ++++||+++++|.+++......     ..+++.++..++.|++.||+|||+.+   ++|+||||+||++++++.+||+||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence            9999999999999998653222     56899999999999999999999988   999999999999999999999999


Q ss_pred             ccceecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhcccc
Q 003599          629 GMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENK  707 (808)
Q Consensus       629 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  707 (808)
                      |+++.+.............++..|+|||.+....++.++||||||+++||+++ |+.|+..... ......    ...+.
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~~~~~~----~~~~~  236 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP-FEMAAY----LKDGY  236 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH-HHHHHH----HHcCC
Confidence            99986643332222222346778999999988889999999999999999999 9988854321 111111    11110


Q ss_pred             chhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhccc
Q 003599          708 ILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIR  759 (808)
Q Consensus       708 ~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~~  759 (808)
                             .+.   .......++.+++.+|++.+|++||++.+|++.|+.+.+
T Consensus       237 -------~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         237 -------RLA---QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             -------CCC---CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                   000   111234578899999999999999999999999988643

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=4.8e-36  Score=327.90  Aligned_cols=252  Identities=26%  Similarity=0.328  Sum_probs=198.5

Q ss_pred             CCcccCcccccCceeEEEEEec----CCcEEEEEEecccc----cccHHHHHHHHHHHHhc-cCCceeeEeeEEEeCCee
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLK----DGQEIAVKRLSKAS----GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEK  553 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~----~~~~vAvK~l~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~  553 (808)
                      +|++.+.||+|+||.||+++..    +++.||+|++.+..    ....+.+.+|+.++.++ +|+||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4788999999999999998753    57899999986532    23346688899999999 599999999999999999


Q ss_pred             EEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeecccccee
Q 003599          554 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI  633 (808)
Q Consensus       554 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  633 (808)
                      ++||||+++|+|.+++..   ...+++.++..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            999999999999998853   346889999999999999999999988   99999999999999999999999999986


Q ss_pred             cCCCCCcccccceeccCCccChhhhccC-CCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhcc
Q 003599          634 FGGNQDQADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALV  712 (808)
Q Consensus       634 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  712 (808)
                      ....... ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||..................       .
T Consensus       155 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-------~  226 (332)
T cd05614         155 FLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK-------C  226 (332)
T ss_pred             ccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc-------C
Confidence            5332222 22235789999999998765 4788999999999999999999998643322111111111110       1


Q ss_pred             CCcccCCcccHHHHHHHHHHHHhcccCCcCCCC-----CHHHHHHH
Q 003599          713 DPFLSESSFQLDMIIRCIHVGLLCVQELVKDRP-----NMSTVVSM  753 (808)
Q Consensus       713 d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~ev~~~  753 (808)
                      ++.     .+......+.+++.+|++.||++||     +++++++.
T Consensus       227 ~~~-----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         227 DPP-----FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             CCC-----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence            111     1222345678899999999999999     67777653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.1e-35  Score=319.62  Aligned_cols=263  Identities=27%  Similarity=0.421  Sum_probs=202.4

Q ss_pred             cCCcccCcccccCceeEEEEEec-----------------CCcEEEEEEecccc-cccHHHHHHHHHHHHhccCCceeeE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-----------------DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRL  543 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-----------------~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l  543 (808)
                      ++|++.++||+|+||.||++...                 ++..||+|.++... ....++|.+|+.++++++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            56899999999999999998532                 23468999987543 3345789999999999999999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCchhhccCCCC--------CCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCce
Q 003599          544 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLK--------KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNI  615 (808)
Q Consensus       544 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NI  615 (808)
                      ++++..++..++||||+++++|.+++.....        ...+++.++.+++.|++.||+|||+.+   ++|+||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence            9999999999999999999999999865221        134778899999999999999999998   99999999999


Q ss_pred             EeCCCCCeeeeccccceecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh--CCCCCCCCCCch
Q 003599          616 LLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS--GRKNTSFFEDDL  693 (808)
Q Consensus       616 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt--G~~p~~~~~~~~  693 (808)
                      |++.++.++|+|||+++.+.............++..|+|||....+.++.++||||||+++|||++  |..|+.......
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            999999999999999986543322222222345678999999888889999999999999999998  556665433222


Q ss_pred             hhhhhhhhhhccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHh
Q 003599          694 TILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN  755 (808)
Q Consensus       694 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~  755 (808)
                      ..... ............+ +      .+......+.+++.+|++.+|++||++.+|++.|+
T Consensus       242 ~~~~~-~~~~~~~~~~~~~-~------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         242 VIENT-GEFFRDQGRQVYL-P------KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             HHHHH-HHHHhhccccccC-C------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            11111 1111111000000 0      11123467889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=4.7e-36  Score=334.22  Aligned_cols=262  Identities=26%  Similarity=0.395  Sum_probs=205.9

Q ss_pred             HhcCCcccCcccccCceeEEEEEec------CCcEEEEEEecccc-cccHHHHHHHHHHHHhcc-CCceeeEeeEEEeCC
Q 003599          480 ATNNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGE  551 (808)
Q Consensus       480 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~  551 (808)
                      ..++|.+.++||+|+||.||+|++.      .+..||||+++... ....+.+++|+++|.++. ||||+++++++....
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~  114 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG  114 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence            3456888899999999999999864      34689999997643 233457899999999997 999999999999999


Q ss_pred             eeEEEEEecCCCCchhhccCCC----------------------------------------------------------
Q 003599          552 EKMLIYEYMPNRSLDALLFDPL----------------------------------------------------------  573 (808)
Q Consensus       552 ~~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------  573 (808)
                      ..++||||+++|+|.++++...                                                          
T Consensus       115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (401)
T cd05107         115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD  194 (401)
T ss_pred             CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence            9999999999999999986421                                                          


Q ss_pred             -------------------------------------CCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceE
Q 003599          574 -------------------------------------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNIL  616 (808)
Q Consensus       574 -------------------------------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NIL  616 (808)
                                                           ....+++..+.+++.||+.||+|||+.+   ++||||||+|||
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiL  271 (401)
T cd05107         195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVL  271 (401)
T ss_pred             chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEE
Confidence                                                 1124677888999999999999999887   999999999999


Q ss_pred             eCCCCCeeeeccccceecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhh
Q 003599          617 LDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTI  695 (808)
Q Consensus       617 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~  695 (808)
                      +++++.+||+|||+++...............++..|+|||.+....++.++||||||+++|||++ |+.|+.........
T Consensus       272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~  351 (401)
T cd05107         272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF  351 (401)
T ss_pred             EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH
Confidence            99999999999999986533222222223456789999999998889999999999999999998 88887643322211


Q ss_pred             hhhhhhhhccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhcc
Q 003599          696 LGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEI  758 (808)
Q Consensus       696 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~  758 (808)
                      ...    ...+.       ..   ..+.....++.+++.+|++.+|.+||++++|++.|++++
T Consensus       352 ~~~----~~~~~-------~~---~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         352 YNA----IKRGY-------RM---AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             HHH----HHcCC-------CC---CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            111    11110       00   011223467889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=6.4e-36  Score=315.49  Aligned_cols=254  Identities=29%  Similarity=0.448  Sum_probs=204.0

Q ss_pred             cCCcccCcccccCceeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEecC
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMP  561 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  561 (808)
                      ++|++.++||+|+||.||+|+..+...||+|+++... ...+.|.+|+.++++++||||+++++.+. ....++||||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS   83 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence            5699999999999999999998777789999987532 34568999999999999999999999875 456789999999


Q ss_pred             CCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCcc
Q 003599          562 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA  641 (808)
Q Consensus       562 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  641 (808)
                      +|+|.+++... ....+++..+..++.|+++||+|||+.+   ++|+||||+||++++++.++|+|||.++.+...... 
T Consensus        84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-  158 (262)
T cd05071          84 KGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-  158 (262)
T ss_pred             CCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc-
Confidence            99999999643 2346789999999999999999999988   999999999999999999999999999866433221 


Q ss_pred             cccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCc
Q 003599          642 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS  720 (808)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  720 (808)
                      ......++..|+|||......++.++||||||+++|||++ |+.|+.........    .... .+     ..     ..
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~----~~~~-~~-----~~-----~~  223 (262)
T cd05071         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL----DQVE-RG-----YR-----MP  223 (262)
T ss_pred             cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHH----HHHh-cC-----CC-----CC
Confidence            1112346778999999988899999999999999999999 77777543222111    0000 00     00     01


Q ss_pred             ccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003599          721 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  757 (808)
Q Consensus       721 ~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~  757 (808)
                      ...+....+.+++.+|++.+|++||++.+++++|+..
T Consensus       224 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         224 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            2234456788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-36  Score=331.92  Aligned_cols=253  Identities=25%  Similarity=0.315  Sum_probs=204.2

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  557 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  557 (808)
                      ++|++.+.||+|+||.||+|+.. +++.||||++....   ......+.+|+.++..++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46889999999999999999976 68999999987532   244567889999999999999999999999999999999


Q ss_pred             EecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCC
Q 003599          558 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  637 (808)
Q Consensus       558 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  637 (808)
                      ||+++++|.+++...   ..+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            999999999998642   57899999999999999999999988   999999999999999999999999999866433


Q ss_pred             C---------------------------CcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCC
Q 003599          638 Q---------------------------DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFE  690 (808)
Q Consensus       638 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~  690 (808)
                      .                           .........||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  234 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT  234 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence            2                           0011223568999999999999999999999999999999999999986544


Q ss_pred             CchhhhhhhhhhhccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCC-HHHHHHH
Q 003599          691 DDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPN-MSTVVSM  753 (808)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-~~ev~~~  753 (808)
                      ......    ......       ..+... .......++.+++.+|++ +|++||+ ++++++.
T Consensus       235 ~~~~~~----~i~~~~-------~~~~~p-~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         235 LQETYN----KIINWK-------ESLRFP-PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             HHHHHH----HHhccC-------CcccCC-CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            221111    111000       000000 111135677889999997 9999999 9999875

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=4.6e-36  Score=318.06  Aligned_cols=256  Identities=27%  Similarity=0.438  Sum_probs=198.8

Q ss_pred             CcccCcccccCceeEEEEEecCC-c--EEEEEEeccc--ccccHHHHHHHHHHHHhccCCceeeEeeEEEeC------Ce
Q 003599          484 FQLSSKLGQGGFGPVYWGRLKDG-Q--EIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG------EE  552 (808)
Q Consensus       484 ~~~~~~lG~G~~g~Vy~~~~~~~-~--~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~  552 (808)
                      |.+.+.||+|+||.||+|++.+. .  .+|+|.++..  .....+.+.+|+.++++++|+||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            34678999999999999997643 2  5899988653  234467889999999999999999999987532      24


Q ss_pred             eEEEEEecCCCCchhhccCC---CCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccc
Q 003599          553 KMLIYEYMPNRSLDALLFDP---LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFG  629 (808)
Q Consensus       553 ~~lV~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFG  629 (808)
                      .++||||+++|+|.+++...   .....+++.....++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence            68999999999999887421   12345889999999999999999999987   9999999999999999999999999


Q ss_pred             cceecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhccccc
Q 003599          630 MAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKI  708 (808)
Q Consensus       630 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~  708 (808)
                      +++...............+++.|+|||.+....++.++||||||+++|||++ |+.|+...... ...    .....+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-~~~----~~~~~~~~  232 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS-EIY----DYLRQGNR  232 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH-HHH----HHHHcCCC
Confidence            9987643322111222346778999999998899999999999999999999 77887543221 111    11111111


Q ss_pred             hhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003599          709 LALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  757 (808)
Q Consensus       709 ~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~  757 (808)
                      ..          ........+.+++.+|++.+|++||++.+|++.|+++
T Consensus       233 ~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         233 LK----------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            00          1112345688999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=5.1e-36  Score=326.27  Aligned_cols=241  Identities=27%  Similarity=0.323  Sum_probs=194.2

Q ss_pred             CcccccCceeEEEEEe----cCCcEEEEEEecccc----cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEe
Q 003599          488 SKLGQGGFGPVYWGRL----KDGQEIAVKRLSKAS----GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       488 ~~lG~G~~g~Vy~~~~----~~~~~vAvK~l~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  559 (808)
                      +.||+|+||.||+++.    ..++.||||.+....    ......+.+|+.+|++++||||+++++.+..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6899999999999985    357899999987532    23345678899999999999999999999999999999999


Q ss_pred             cCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCC
Q 003599          560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  639 (808)
Q Consensus       560 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  639 (808)
                      +++++|.+++..   ...+.+..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (323)
T cd05584          82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT  155 (323)
T ss_pred             CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence            999999998853   346788888899999999999999988   99999999999999999999999999875432221


Q ss_pred             cccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCC
Q 003599          640 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSES  719 (808)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  719 (808)
                        ......||+.|+|||.+....++.++||||||+++|||++|+.||..........    ...         ....   
T Consensus       156 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~----~~~---------~~~~---  217 (323)
T cd05584         156 --VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTID----KIL---------KGKL---  217 (323)
T ss_pred             --cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHH----HHH---------cCCC---
Confidence              1223568999999999998889999999999999999999999986433221111    111         1111   


Q ss_pred             cccHHHHHHHHHHHHhcccCCcCCCC-----CHHHHHH
Q 003599          720 SFQLDMIIRCIHVGLLCVQELVKDRP-----NMSTVVS  752 (808)
Q Consensus       720 ~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~ev~~  752 (808)
                      ..+......+.+++.+|++.+|++||     +++++++
T Consensus       218 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         218 NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            01222345678999999999999999     7888766

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=4.1e-36  Score=327.25  Aligned_cols=244  Identities=25%  Similarity=0.358  Sum_probs=194.1

Q ss_pred             CcccCcccccCceeEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHH---HhccCCceeeEeeEEEeCCeeEEE
Q 003599          484 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVI---SKLQHRNLVRLLGCCVEGEEKMLI  556 (808)
Q Consensus       484 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~~l---~~l~H~niv~l~g~~~~~~~~~lV  556 (808)
                      |++.+.||+|+||.||++... +++.||||++++..   ....+.+.+|++++   ++++||||+++++++...+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            567899999999999999875 58999999997532   23345677776665   466799999999999999999999


Q ss_pred             EEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCC
Q 003599          557 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  636 (808)
Q Consensus       557 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  636 (808)
                      |||+++++|..++.    ...+++.++..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++....
T Consensus        81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence            99999999988874    346899999999999999999999988   99999999999999999999999999875322


Q ss_pred             CCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcc
Q 003599          637 NQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL  716 (808)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  716 (808)
                      ..  .......|++.|+|||.+.+..++.++|||||||++|||++|+.||...........    .. .+.      .. 
T Consensus       154 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~----i~-~~~------~~-  219 (324)
T cd05589         154 FG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDS----IV-NDE------VR-  219 (324)
T ss_pred             CC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHH----HH-hCC------CC-
Confidence            21  122335789999999999998999999999999999999999999864332211111    10 000      00 


Q ss_pred             cCCcccHHHHHHHHHHHHhcccCCcCCCC-----CHHHHHH
Q 003599          717 SESSFQLDMIIRCIHVGLLCVQELVKDRP-----NMSTVVS  752 (808)
Q Consensus       717 ~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~ev~~  752 (808)
                          .+......+.+++.+||+.||.+||     ++.++++
T Consensus       220 ----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         220 ----YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             ----CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence                1122345678899999999999999     4666655

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.7e-36  Score=318.87  Aligned_cols=257  Identities=28%  Similarity=0.443  Sum_probs=205.7

Q ss_pred             hcCCcccCcccccCceeEEEEEecC------CcEEEEEEecccc-cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCee
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLKD------GQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEK  553 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  553 (808)
                      .++|++.+.||+|+||.||+|....      +..||+|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            3578899999999999999998652      3689999986543 23456789999999999999999999999999999


Q ss_pred             EEEEEecCCCCchhhccCCC-------CCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeee
Q 003599          554 MLIYEYMPNRSLDALLFDPL-------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKIS  626 (808)
Q Consensus       554 ~lV~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~  626 (808)
                      ++||||+++++|.+++....       ....+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence            99999999999999986432       1234788999999999999999999988   9999999999999999999999


Q ss_pred             ccccceecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhcc
Q 003599          627 DFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNE  705 (808)
Q Consensus       627 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  705 (808)
                      |||+++...............++..|+|||.+..+.++.++||||||+++|||++ |+.|+....... ....    ...
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-~~~~----~~~  236 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE-VLKF----VID  236 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH-HHHH----Hhc
Confidence            9999986643322222233456789999999988889999999999999999998 888875433221 1111    111


Q ss_pred             ccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHh
Q 003599          706 NKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN  755 (808)
Q Consensus       706 ~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~  755 (808)
                      +....          .+.....++.+++.+|++.+|++|||+.++++.|+
T Consensus       237 ~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         237 GGHLD----------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             CCCCC----------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            11111          11223567889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=9.1e-36  Score=317.58  Aligned_cols=247  Identities=25%  Similarity=0.330  Sum_probs=196.8

Q ss_pred             ccccCceeEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEecCCCCc
Q 003599          490 LGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSL  565 (808)
Q Consensus       490 lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  565 (808)
                      ||+|+||+||++... +++.||+|++....   ....+.+..|++++++++|+||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            799999999999875 68899999987532   22346778899999999999999999999999999999999999999


Q ss_pred             hhhccCCC-CCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCccccc
Q 003599          566 DALLFDPL-KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG  644 (808)
Q Consensus       566 ~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  644 (808)
                      ..++.... ....+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||+++........  ..
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--cc
Confidence            98875422 3456899999999999999999999988   999999999999999999999999999865433221  22


Q ss_pred             ceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCcccHH
Q 003599          645 RVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLD  724 (808)
Q Consensus       645 ~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  724 (808)
                      ...||+.|+|||.+.+..++.++||||||+++|||++|+.||...............         ......   ..+..
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~---------~~~~~~---~~~~~  223 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR---------ILNDSV---TYPDK  223 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHh---------hcccCC---CCccc
Confidence            356899999999999999999999999999999999999998654322111111100         011111   12233


Q ss_pred             HHHHHHHHHHhcccCCcCCCC-----CHHHHHHH
Q 003599          725 MIIRCIHVGLLCVQELVKDRP-----NMSTVVSM  753 (808)
Q Consensus       725 ~~~~l~~li~~cl~~~P~~RP-----s~~ev~~~  753 (808)
                      ....+.+++.+|++.+|++||     +++++++.
T Consensus       224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            456788999999999999999     66777653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.2e-36  Score=302.80  Aligned_cols=280  Identities=23%  Similarity=0.308  Sum_probs=208.7

Q ss_pred             hcCCcccCcccccCceeEEEEEec-CCcEEEEEEecccccc--cHHHHHHHHHHHHhccCCceeeEeeEEEe--CCeeEE
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQ--GLEEFMNEVMVISKLQHRNLVRLLGCCVE--GEEKML  555 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~l  555 (808)
                      .++|+.+++|++|.||.||+|+++ +++.||+|+++.....  ---.-++|+.+|.+++|||||.+-.....  -+..|+
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            356888999999999999999986 5889999999754321  12235799999999999999999888763  356899


Q ss_pred             EEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecC
Q 003599          556 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG  635 (808)
Q Consensus       556 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~  635 (808)
                      |||||+. +|...+..  -.+++...++.-+..|+++|++|||.+.   |+||||||+|+|+...|.+||+|||+||.++
T Consensus       155 VMe~~Eh-DLksl~d~--m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  155 VMEYVEH-DLKSLMET--MKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG  228 (419)
T ss_pred             eHHHHHh-hHHHHHHh--ccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence            9999976 88888865  2367999999999999999999999998   9999999999999999999999999999886


Q ss_pred             CCCCcccccceeccCCccChhhhccCC-CCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhc--cccc----
Q 003599          636 GNQDQADTGRVVGTFGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN--ENKI----  708 (808)
Q Consensus       636 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~--~~~~----  708 (808)
                      .....  ....+-|..|.|||.+.+.+ |+.+.|+||+|||+.||+++++.|+..++-..+..... .+.  .+.+    
T Consensus       229 sp~k~--~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~-llGtPte~iwpg~  305 (419)
T KOG0663|consen  229 SPLKP--YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFK-LLGTPSEAIWPGY  305 (419)
T ss_pred             CCccc--CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHH-HhCCCccccCCCc
Confidence            54322  23367799999999998764 89999999999999999999998876654322221111 110  0000    


Q ss_pred             --hhccC-Cccc-------CCcccHH-HHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhcccCCCCCCCCCccc
Q 003599          709 --LALVD-PFLS-------ESSFQLD-MIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPAFTE  771 (808)
Q Consensus       709 --~~~~d-~~l~-------~~~~~~~-~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~~~~~~p~~p~~~~  771 (808)
                        ..... -...       ...+... ..+.-.++....+.+||++|-|++|-++.  +-+.+.|.|..|...+
T Consensus       306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h--~~F~e~P~p~~P~~~P  377 (419)
T KOG0663|consen  306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH--EYFRETPLPIDPSMFP  377 (419)
T ss_pred             cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc--cccccCCCCCChhhcC
Confidence              00000 0000       0011111 33566788889999999999999997764  2345666665555433

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=6.4e-36  Score=327.63  Aligned_cols=262  Identities=19%  Similarity=0.300  Sum_probs=196.1

Q ss_pred             CCcccCcccccCceeEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCC-----eeE
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE-----EKM  554 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~  554 (808)
                      +|++.++||+|+||.||+|+.. +++.||||++...  .......+.+|+.++++++||||+++++++....     ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4788899999999999999865 6899999998643  2234467889999999999999999999886432     479


Q ss_pred             EEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceec
Q 003599          555 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF  634 (808)
Q Consensus       555 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~  634 (808)
                      +||||+. ++|.+++..   ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          81 VVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             EEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            9999995 688888743   346899999999999999999999998   999999999999999999999999999865


Q ss_pred             CCCCCc-ccccceeccCCccChhhhcc--CCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhh---------
Q 003599          635 GGNQDQ-ADTGRVVGTFGYMSPEYAME--GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKL---------  702 (808)
Q Consensus       635 ~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~---------  702 (808)
                      ...... .......||+.|+|||.+..  ..++.++|||||||++|||++|+.||........+ ......         
T Consensus       154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~  232 (338)
T cd07859         154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL-DLITDLLGTPSPETI  232 (338)
T ss_pred             ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHH-HHHHHHhCCCCHHHH
Confidence            322211 11223568999999999865  67899999999999999999999998654321111 000000         


Q ss_pred             --hccccchhcc---CCcccCCccc---HHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          703 --WNENKILALV---DPFLSESSFQ---LDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       703 --~~~~~~~~~~---d~~l~~~~~~---~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                        .........+   .+..... ..   ......+.+++.+|++.+|++||+++|+++.
T Consensus       233 ~~i~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         233 SRVRNEKARRYLSSMRKKQPVP-FSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HHhhhhhHHHHHHhhcccCCCc-hHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence              0000000000   0000000 00   0123467899999999999999999999864

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=8.6e-36  Score=315.07  Aligned_cols=259  Identities=22%  Similarity=0.363  Sum_probs=207.4

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  557 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  557 (808)
                      ++|++.+.||+|+||.||+|+.. +++.||||.+...   .......+.+|++++++++||||+++++++.+.+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57899999999999999999875 6899999987542   2233457889999999999999999999999999999999


Q ss_pred             EecCCCCchhhccCCC-CCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCC
Q 003599          558 EYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  636 (808)
Q Consensus       558 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  636 (808)
                      ||+++++|.+++.... ....++...+..++.|+++||+|||+.+   ++|+||||+||+++.++.++|+|||+++....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            9999999998885422 2345788999999999999999999988   99999999999999999999999999987643


Q ss_pred             CCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcc
Q 003599          637 NQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL  716 (808)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  716 (808)
                      ...  ......++..|+|||.+.+..++.++|+||||+++|||++|+.|+......  ........ ..     ...+..
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~--~~~~~~~~-~~-----~~~~~~  228 (267)
T cd08228         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LFSLCQKI-EQ-----CDYPPL  228 (267)
T ss_pred             hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc--HHHHHHHH-hc-----CCCCCC
Confidence            221  112246788999999998888999999999999999999999997532211  11111111 00     001111


Q ss_pred             cCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003599          717 SESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  757 (808)
Q Consensus       717 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~  757 (808)
                          ........+.+++.+|++.+|++||++.+|++.++++
T Consensus       229 ----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         229 ----PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             ----ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence                1223456788999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8e-36  Score=332.23  Aligned_cols=257  Identities=17%  Similarity=0.205  Sum_probs=195.4

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEec
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  560 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  560 (808)
                      .+|++.++||+|+||.||++... .++.||+|...      .+.+.+|++++++++||||+++++++......++|+|++
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~  165 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY  165 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence            57999999999999999999875 58899999753      245789999999999999999999999999999999999


Q ss_pred             CCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCc
Q 003599          561 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  640 (808)
Q Consensus       561 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  640 (808)
                      . ++|..++..   ...+++.+++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++....... 
T Consensus       166 ~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~-  237 (391)
T PHA03212        166 K-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA-  237 (391)
T ss_pred             C-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccc-
Confidence            5 688887743   346889999999999999999999988   99999999999999999999999999975432211 


Q ss_pred             ccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCC------chhhhhhhhhhhcc---------
Q 003599          641 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFED------DLTILGYAWKLWNE---------  705 (808)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~------~~~~~~~~~~~~~~---------  705 (808)
                      .......||+.|+|||++....++.++|||||||++|||++|+.|+.....      ..............         
T Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~  317 (391)
T PHA03212        238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA  317 (391)
T ss_pred             cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence            112235799999999999988999999999999999999999987532211      00000000000000         


Q ss_pred             -ccchhcc---------CCcccCC-cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          706 -NKILALV---------DPFLSES-SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       706 -~~~~~~~---------d~~l~~~-~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                       .......         .+..... ........++.+++.+||+.||++|||++|+++
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence             0000000         0000000 001134567889999999999999999999986

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-35  Score=317.98  Aligned_cols=252  Identities=25%  Similarity=0.328  Sum_probs=202.0

Q ss_pred             CCcccCcccccCceeEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEE
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  558 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  558 (808)
                      +|++.+.||+|+||.||++... +++.||+|++....   ......+.+|+.++++++||||+++++.+..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4778899999999999999875 68899999986532   2234567889999999999999999999999999999999


Q ss_pred             ecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCC
Q 003599          559 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  638 (808)
Q Consensus       559 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  638 (808)
                      |+++|+|.+++... ....+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||+++......
T Consensus        81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence            99999999888642 3346899999999999999999999998   9999999999999999999999999998753322


Q ss_pred             CcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccC
Q 003599          639 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSE  718 (808)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  718 (808)
                      .   .....|+..|+|||.+.+..++.++||||+|+++|||++|+.||.............          ..+....  
T Consensus       157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~----------~~~~~~~--  221 (285)
T cd05605         157 T---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVE----------RRVKEDQ--  221 (285)
T ss_pred             c---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHH----------HHhhhcc--
Confidence            1   122468999999999998889999999999999999999999987533221111110          0010000  


Q ss_pred             CcccHHHHHHHHHHHHhcccCCcCCCC-----CHHHHHHH
Q 003599          719 SSFQLDMIIRCIHVGLLCVQELVKDRP-----NMSTVVSM  753 (808)
Q Consensus       719 ~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~ev~~~  753 (808)
                      ...+......+.+++.+|++.||++||     +++++++.
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            012233456788999999999999999     78888654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=8.9e-36  Score=313.86  Aligned_cols=254  Identities=32%  Similarity=0.478  Sum_probs=204.9

Q ss_pred             hcCCcccCcccccCceeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEec
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  560 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  560 (808)
                      .++|++.++||+|+||.||+|..++++.||+|.+.... ...+.|.+|+.++++++|+||+++++++. .+..+++|||+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            35788999999999999999999889999999987543 34578999999999999999999999864 55689999999


Q ss_pred             CCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCc
Q 003599          561 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  640 (808)
Q Consensus       561 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  640 (808)
                      ++++|.+++... ....+++.++..++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||+++........
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05067          83 ENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence            999999988653 3456899999999999999999999988   999999999999999999999999999876432211


Q ss_pred             ccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCC
Q 003599          641 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSES  719 (808)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  719 (808)
                       ......++..|+|||.+....++.++||||||+++|||++ |+.|+....... ....    ...+     ....    
T Consensus       159 -~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~----~~~~-----~~~~----  223 (260)
T cd05067         159 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE-VIQN----LERG-----YRMP----  223 (260)
T ss_pred             -cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH-HHHH----HHcC-----CCCC----
Confidence             1112345678999999988889999999999999999999 998886433221 1111    1111     0000    


Q ss_pred             cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhh
Q 003599          720 SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS  756 (808)
Q Consensus       720 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~  756 (808)
                       .......++.+++.+|++.+|++||+++++++.|+.
T Consensus       224 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         224 -RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             -CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence             111234578999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=6.9e-36  Score=322.13  Aligned_cols=259  Identities=27%  Similarity=0.388  Sum_probs=206.2

Q ss_pred             hcCCcccCcccccCceeEEEEEec------CCcEEEEEEecccc-cccHHHHHHHHHHHHhc-cCCceeeEeeEEEeCCe
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEE  552 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~  552 (808)
                      .++|.+.+.||+|+||.||++...      .+..||||.++... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  113 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP  113 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence            367999999999999999999742      34579999987543 33456789999999999 79999999999999999


Q ss_pred             eEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccce
Q 003599          553 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK  632 (808)
Q Consensus       553 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~  632 (808)
                      .++||||+++|+|.+++... ....+++.++..++.|++.||+|||+.+   |+|+||||+|||++.++.++|+|||+++
T Consensus       114 ~~lv~e~~~~~~L~~~i~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~  189 (302)
T cd05055         114 ILVITEYCCYGDLLNFLRRK-RESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR  189 (302)
T ss_pred             eEEEEEcCCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence            99999999999999998642 2234899999999999999999999988   9999999999999999999999999998


Q ss_pred             ecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhccccchhc
Q 003599          633 IFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILAL  711 (808)
Q Consensus       633 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  711 (808)
                      ...............++..|+|||.+....++.++||||||+++|||++ |+.|+............    ...+.    
T Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~----~~~~~----  261 (302)
T cd05055         190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKL----IKEGY----  261 (302)
T ss_pred             cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHH----HHcCC----
Confidence            6543322222222346788999999999899999999999999999998 88887543322211111    11110    


Q ss_pred             cCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003599          712 VDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  757 (808)
Q Consensus       712 ~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~  757 (808)
                       ...     .+.....++.+++.+|++.+|++||++.+|++.|++.
T Consensus       262 -~~~-----~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         262 -RMA-----QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             -cCC-----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence             000     1112345788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=3.2e-36  Score=329.04  Aligned_cols=253  Identities=23%  Similarity=0.295  Sum_probs=201.1

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  557 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  557 (808)
                      ++|++.+.||+|+||.||+++.. +++.||+|+++...   ....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46889999999999999999875 68899999997542   234567889999999999999999999999999999999


Q ss_pred             EecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCC
Q 003599          558 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  637 (808)
Q Consensus       558 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  637 (808)
                      ||+++|+|.+++...  ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            999999999998642  356899999999999999999999998   999999999999999999999999999876433


Q ss_pred             CCcccccceeccCCccChhhhc------cCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhc
Q 003599          638 QDQADTGRVVGTFGYMSPEYAM------EGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILAL  711 (808)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~------~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  711 (808)
                      ... ......||+.|+|||.+.      ...++.++|||||||++|||++|+.||..........    ...........
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~----~i~~~~~~~~~  230 (330)
T cd05601         156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYN----NIMNFQRFLKF  230 (330)
T ss_pred             Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHH----HHHcCCCccCC
Confidence            222 222346899999999986      4567899999999999999999999986433222111    11111110000


Q ss_pred             cCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          712 VDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       712 ~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                      .        ........+.+++..|++ +|++||++.++++.
T Consensus       231 ~--------~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         231 P--------EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             C--------CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence            0        111234567788889998 99999999998753

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.7e-36  Score=325.06  Aligned_cols=251  Identities=25%  Similarity=0.347  Sum_probs=211.1

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCe-eEEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEE-KMLIY  557 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-~~lV~  557 (808)
                      ++|..++++|+|+||.++..+.+ ++..+++|++.-.  .....+...+|+.++++++|||||.+.+.+++++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            57888999999999999988765 5778999988643  33445577899999999999999999999999888 89999


Q ss_pred             EecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCC
Q 003599          558 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  637 (808)
Q Consensus       558 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  637 (808)
                      +|++||+|.+.+... +...+++.++.+++.|++.|+.|||++.   |+|||||+.||+++.+..+||.|||+|+.+...
T Consensus        84 ~Y~eGg~l~~~i~~~-k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQ-KGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             eecCCCCHHHHHHHH-hhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            999999999998663 3567999999999999999999999877   999999999999999999999999999988655


Q ss_pred             CCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCccc
Q 003599          638 QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS  717 (808)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  717 (808)
                      ...  .....||+.||.||.+.+.+|..|+|||||||++|||++-+++|...+-...    ..+..          ... 
T Consensus       160 ~~~--a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L----i~ki~----------~~~-  222 (426)
T KOG0589|consen  160 DSL--ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL----ILKIN----------RGL-  222 (426)
T ss_pred             hhh--hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH----HHHHh----------hcc-
Confidence            422  3347899999999999999999999999999999999999999865432211    11111          011 


Q ss_pred             CCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          718 ESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       718 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                      -.+.+.....++..++..|++.+|+.||++.+++.+
T Consensus       223 ~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  223 YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            112455567788999999999999999999999876

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=9.9e-36  Score=306.03  Aligned_cols=266  Identities=23%  Similarity=0.312  Sum_probs=202.9

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEecccccc--cHHHHHHHHHHHHhccCCc-eeeEeeEEEeCC------
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQ--GLEEFMNEVMVISKLQHRN-LVRLLGCCVEGE------  551 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~------  551 (808)
                      ..|..+++||+|+||+||+|+.+ +|+.||+|+++-...+  ......+|+.+|++++|+| |+++++++...+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            44666788999999999999865 6899999999765442  3345689999999999999 999999998877      


Q ss_pred             eeEEEEEecCCCCchhhccCCCCC-CcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeecccc
Q 003599          552 EKMLIYEYMPNRSLDALLFDPLKK-ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGM  630 (808)
Q Consensus       552 ~~~lV~E~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGl  630 (808)
                      ..++|+||++ .+|..++...... ..++...+..++.||++||+|||+++   |+||||||+||||+++|.+||+|||+
T Consensus        91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence            7889999995 4899998664322 35666889999999999999999998   99999999999999999999999999


Q ss_pred             ceecCCCCCcccccceeccCCccChhhhccC-CCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhh-------h
Q 003599          631 AKIFGGNQDQADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWK-------L  702 (808)
Q Consensus       631 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~-------~  702 (808)
                      |+...-...  .....++|..|.|||++.+. .|+...||||+|||+.||++++..|+...+...+......       .
T Consensus       167 Ara~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~  244 (323)
T KOG0594|consen  167 ARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD  244 (323)
T ss_pred             HHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence            997642222  23346789999999999877 6899999999999999999999888776653333221111       1


Q ss_pred             hccccchhccCCcccCC----cccHHH---HHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          703 WNENKILALVDPFLSES----SFQLDM---IIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       703 ~~~~~~~~~~d~~l~~~----~~~~~~---~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                      |.......-.++.....    ......   .....+++.+|++.+|++|.|++..+++
T Consensus       245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            11111111111111111    011111   1367899999999999999999999886

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.3e-35  Score=330.63  Aligned_cols=253  Identities=22%  Similarity=0.307  Sum_probs=196.4

Q ss_pred             CCcccCcccccCceeEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEE
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  558 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  558 (808)
                      .|++.+.||+|+||+||+|+.. +++.||||++.+..   ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5788999999999999999865 57899999997532   3345678999999999999999999999999999999999


Q ss_pred             ecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCC
Q 003599          559 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  638 (808)
Q Consensus       559 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  638 (808)
                      |+++|+|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++.+....
T Consensus        82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence            9999999999854   346888888999999999999999988   9999999999999999999999999986432100


Q ss_pred             Cc---------------------------------------------ccccceeccCCccChhhhccCCCCccccEEehh
Q 003599          639 DQ---------------------------------------------ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFG  673 (808)
Q Consensus       639 ~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlG  673 (808)
                      ..                                             .......||+.|+|||.+.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG  235 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence            00                                             001124699999999999988899999999999


Q ss_pred             HHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCcccHHHHHHHHHHHHh--cccCCcCCCCCHHHHH
Q 003599          674 VLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLL--CVQELVKDRPNMSTVV  751 (808)
Q Consensus       674 vil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~--cl~~~P~~RPs~~ev~  751 (808)
                      |++|||++|+.||...........    ........     ...   .......++.+++.+  |+..+|..||++++++
T Consensus       236 ~il~elltG~~Pf~~~~~~~~~~~----i~~~~~~~-----~~~---~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l  303 (381)
T cd05626         236 VILFEMLVGQPPFLAPTPTETQLK----VINWENTL-----HIP---PQVKLSPEAVDLITKLCCSAEERLGRNGADDIK  303 (381)
T ss_pred             hHHHHHHhCCCCCcCCCHHHHHHH----HHcccccc-----CCC---CCCCCCHHHHHHHHHHccCcccccCCCCHHHHh
Confidence            999999999999865433221111    10000000     000   011123455667765  5666777799999998


Q ss_pred             HH
Q 003599          752 SM  753 (808)
Q Consensus       752 ~~  753 (808)
                      +.
T Consensus       304 ~h  305 (381)
T cd05626         304 AH  305 (381)
T ss_pred             cC
Confidence            74

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=5.4e-36  Score=328.90  Aligned_cols=262  Identities=28%  Similarity=0.379  Sum_probs=203.2

Q ss_pred             hcCCcccCcccccCceeEEEEEe------cCCcEEEEEEecccc-cccHHHHHHHHHHHHhc-cCCceeeEeeEEEeC-C
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRL------KDGQEIAVKRLSKAS-GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEG-E  551 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~-~  551 (808)
                      .++|++.+.||+|+||.||+|..      .+++.||||+++... ......+.+|+.++.++ +||||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            35799999999999999999973      347889999997543 23456788999999999 789999999988654 4


Q ss_pred             eeEEEEEecCCCCchhhccCCCC---------------------------------------------------------
Q 003599          552 EKMLIYEYMPNRSLDALLFDPLK---------------------------------------------------------  574 (808)
Q Consensus       552 ~~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------  574 (808)
                      ..++||||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            67899999999999998853210                                                         


Q ss_pred             -------CCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCccccccee
Q 003599          575 -------KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVV  647 (808)
Q Consensus       575 -------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  647 (808)
                             ...+++.++.+++.||++||+|||+.+   |+||||||+|||+++++.+||+|||+++...............
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                   124688888999999999999999988   9999999999999999999999999998654332222222234


Q ss_pred             ccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCcccHHHH
Q 003599          648 GTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMI  726 (808)
Q Consensus       648 gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  726 (808)
                      ++..|+|||.+....++.++||||||+++|||++ |..|+...........    ...++...     .     .+....
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~----~~~~~~~~-----~-----~~~~~~  308 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR----RLKEGTRM-----R-----APDYTT  308 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHH----HHhccCCC-----C-----CCCCCC
Confidence            5678999999988889999999999999999997 8888764332221111    11111100     0     011123


Q ss_pred             HHHHHHHHhcccCCcCCCCCHHHHHHHHhhccc
Q 003599          727 IRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIR  759 (808)
Q Consensus       727 ~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~~  759 (808)
                      .++.+++..|++.+|++||++.+|++.|+.+++
T Consensus       309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            467899999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=4.8e-36  Score=326.87  Aligned_cols=242  Identities=22%  Similarity=0.262  Sum_probs=195.2

Q ss_pred             CcccccCceeEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEecCCC
Q 003599          488 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNR  563 (808)
Q Consensus       488 ~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  563 (808)
                      +.||+|+||.||+++.. +++.||+|.+...   .......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999865 6889999999753   2334567788999999999999999999999999999999999999


Q ss_pred             CchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHh-cCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCccc
Q 003599          564 SLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR-DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD  642 (808)
Q Consensus       564 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  642 (808)
                      +|..++..   ...+++.++..++.||+.||+|||+ .+   |+||||||+|||++.++.+||+|||+++.......  .
T Consensus        81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~  152 (325)
T cd05594          81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--T  152 (325)
T ss_pred             cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--c
Confidence            99988853   3468999999999999999999997 56   99999999999999999999999999875432211  1


Q ss_pred             ccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCccc
Q 003599          643 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQ  722 (808)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  722 (808)
                      .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..........    ... ..      ...     ++
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~----~i~-~~------~~~-----~p  216 (325)
T cd05594         153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE----LIL-ME------EIR-----FP  216 (325)
T ss_pred             cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHH----HHh-cC------CCC-----CC
Confidence            223568999999999999999999999999999999999999986433221110    000 00      000     11


Q ss_pred             HHHHHHHHHHHHhcccCCcCCCC-----CHHHHHHH
Q 003599          723 LDMIIRCIHVGLLCVQELVKDRP-----NMSTVVSM  753 (808)
Q Consensus       723 ~~~~~~l~~li~~cl~~~P~~RP-----s~~ev~~~  753 (808)
                      .....++.+++.+|++.||++|+     ++.++++.
T Consensus       217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            22345678899999999999996     89998754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=8.5e-36  Score=325.29  Aligned_cols=241  Identities=25%  Similarity=0.336  Sum_probs=191.0

Q ss_pred             CcccccCceeEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHHhc-cCCceeeEeeEEEeCCeeEEEEEecCC
Q 003599          488 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEYMPN  562 (808)
Q Consensus       488 ~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~  562 (808)
                      +.||+|+||.||+++.. +++.||+|++.+.   .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            47999999999999976 5789999998754   223445678899988877 899999999999999999999999999


Q ss_pred             CCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCccc
Q 003599          563 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD  642 (808)
Q Consensus       563 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  642 (808)
                      |+|..++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~  152 (329)
T cd05618          81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DT  152 (329)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cc
Confidence            999888743   346899999999999999999999998   9999999999999999999999999987532211  12


Q ss_pred             ccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCc----hhhhhhhhhhhccccchhccCCcccC
Q 003599          643 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDD----LTILGYAWKLWNENKILALVDPFLSE  718 (808)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~d~~l~~  718 (808)
                      .....||..|+|||.+.+..++.++||||||+++|||++|+.||......    .....+........        ..  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~--------~~--  222 (329)
T cd05618         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--------QI--  222 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC--------CC--
Confidence            22357899999999999999999999999999999999999998632211    11111111111111        00  


Q ss_pred             CcccHHHHHHHHHHHHhcccCCcCCCCCH
Q 003599          719 SSFQLDMIIRCIHVGLLCVQELVKDRPNM  747 (808)
Q Consensus       719 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~  747 (808)
                       ..+......+.+++.+||+.||++||+.
T Consensus       223 -~~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         223 -RIPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             -CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence             1222334567899999999999999983

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=9.2e-36  Score=318.03  Aligned_cols=268  Identities=27%  Similarity=0.429  Sum_probs=202.8

Q ss_pred             cCCcccCcccccCceeEEEEEec-----CCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEe--CCeeE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-----DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVE--GEEKM  554 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~  554 (808)
                      .+|++.+.||+|+||.||++..+     ++..||+|++........+.|.+|++++++++||||+++++++..  ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            47888999999999999999742     578999999977666667789999999999999999999998754  34678


Q ss_pred             EEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceec
Q 003599          555 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF  634 (808)
Q Consensus       555 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~  634 (808)
                      +||||+++++|.+++..  ....+++..+..++.|+++||+|||+.+   ++||||||+||++++++.+||+|||+++..
T Consensus        84 lv~e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          84 LVMEYLPYGSLRDYLQK--HRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             EEEEecCCCCHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            99999999999999854  2346899999999999999999999988   999999999999999999999999999876


Q ss_pred             CCCCCccc-ccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhc-c---ccch
Q 003599          635 GGNQDQAD-TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN-E---NKIL  709 (808)
Q Consensus       635 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~-~---~~~~  709 (808)
                      ........ .....++..|+|||.+.+..++.++||||||+++|||++|..+.......  .......... .   ..+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE--FMRMMGNDKQGQMIVYHLI  236 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh--hhhhcccccccccchHHHH
Confidence            43322111 11122345699999998888999999999999999999987664321110  0000000000 0   0000


Q ss_pred             hccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003599          710 ALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  757 (808)
Q Consensus       710 ~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~  757 (808)
                      +.+..... .+.......++.+++.+|++.+|++|||+.+|++.|+.+
T Consensus       237 ~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         237 ELLKNNGR-LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHhcCCc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            11111110 011223456788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=8e-36  Score=315.59  Aligned_cols=256  Identities=27%  Similarity=0.476  Sum_probs=204.6

Q ss_pred             cCCcccCcccccCceeEEEEEecC-C---cEEEEEEecccc-cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLKD-G---QEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI  556 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~~-~---~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  556 (808)
                      ++|+..+.||+|+||.||+|++.. +   ..+|+|.+.... ....+.+.+|++++++++|+||+++++++...+..++|
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            467888999999999999998752 3   379999986542 33457799999999999999999999999999999999


Q ss_pred             EEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCC
Q 003599          557 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  636 (808)
Q Consensus       557 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  636 (808)
                      |||+++++|.+++..  +...+++.++..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||+++....
T Consensus        85 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  159 (268)
T cd05063          85 TEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLED  159 (268)
T ss_pred             EEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence            999999999999854  3356899999999999999999999988   99999999999999999999999999986643


Q ss_pred             CCCcccc-cceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhccccchhccCC
Q 003599          637 NQDQADT-GRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDP  714 (808)
Q Consensus       637 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  714 (808)
                      ....... .....+..|+|||.+....++.++||||||+++|||++ |+.|+....... ..   ... ..+.    .  
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~-~~---~~i-~~~~----~--  228 (268)
T cd05063         160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE-VM---KAI-NDGF----R--  228 (268)
T ss_pred             ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HH---HHH-hcCC----C--
Confidence            2221111 11223457999999988889999999999999999998 999985433221 11   111 1110    0  


Q ss_pred             cccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003599          715 FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  757 (808)
Q Consensus       715 ~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~  757 (808)
                          .+...+....+.+++.+|++.+|++||++.+|++.|+++
T Consensus       229 ----~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         229 ----LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             ----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                011223346788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=5.4e-36  Score=323.25  Aligned_cols=260  Identities=25%  Similarity=0.415  Sum_probs=206.5

Q ss_pred             hcCCcccCcccccCceeEEEEEec--------CCcEEEEEEecccc-cccHHHHHHHHHHHHhc-cCCceeeEeeEEEeC
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLK--------DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEG  550 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~  550 (808)
                      .++|.+.+.||+|+||.||+++..        ++..||+|.+.... ....+++.+|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            467889999999999999999741        24579999986542 34467889999999999 899999999999999


Q ss_pred             CeeEEEEEecCCCCchhhccCCC-------------CCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEe
Q 003599          551 EEKMLIYEYMPNRSLDALLFDPL-------------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL  617 (808)
Q Consensus       551 ~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl  617 (808)
                      ...++||||+++|+|.+++....             ....+++.++..++.||++||.|||+.+   ++||||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence            99999999999999999986531             1245788899999999999999999988   9999999999999


Q ss_pred             CCCCCeeeeccccceecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhh
Q 003599          618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTIL  696 (808)
Q Consensus       618 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~  696 (808)
                      +.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+....... ..
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~  249 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-LF  249 (304)
T ss_pred             cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH-HH
Confidence            9999999999999987644332222222345678999999988889999999999999999998 677764332111 11


Q ss_pred             hhhhhhhccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhcc
Q 003599          697 GYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEI  758 (808)
Q Consensus       697 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~  758 (808)
                         . ....+...          ..+......+.+++.+|++.+|++||++.+|++.|++++
T Consensus       250 ---~-~~~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~  297 (304)
T cd05101         250 ---K-LLKEGHRM----------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL  297 (304)
T ss_pred             ---H-HHHcCCcC----------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence               1 11111100          011234567888999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.7e-35  Score=311.72  Aligned_cols=253  Identities=30%  Similarity=0.464  Sum_probs=202.8

Q ss_pred             cCCcccCcccccCceeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEecC
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMP  561 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  561 (808)
                      ++|.+.++||+|++|.||++...++..+|+|.+.... ...+.+.+|+.++++++|+|++++++++. ....++||||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            4688899999999999999998877789999886433 34577899999999999999999999875 456889999999


Q ss_pred             CCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCcc
Q 003599          562 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA  641 (808)
Q Consensus       562 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  641 (808)
                      +++|.+++... ....+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||+++........ 
T Consensus        84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-  158 (260)
T cd05069          84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-  158 (260)
T ss_pred             CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc-
Confidence            99999999653 3345889999999999999999999988   999999999999999999999999999876432211 


Q ss_pred             cccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCc
Q 003599          642 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS  720 (808)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  720 (808)
                      ......++..|+|||......++.++||||||+++|||++ |+.|+....+... ...   . ..+     ..+     .
T Consensus       159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-~~~---~-~~~-----~~~-----~  223 (260)
T cd05069         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV-LEQ---V-ERG-----YRM-----P  223 (260)
T ss_pred             ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHH---H-HcC-----CCC-----C
Confidence            1112345678999999988889999999999999999999 8888764322211 111   0 000     000     1


Q ss_pred             ccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhh
Q 003599          721 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS  756 (808)
Q Consensus       721 ~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~  756 (808)
                      .+......+.+++.+|++.+|++||++++|++.|++
T Consensus       224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            222345678899999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1e-35  Score=323.62  Aligned_cols=242  Identities=24%  Similarity=0.352  Sum_probs=194.9

Q ss_pred             CcccccCceeEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHHhc-cCCceeeEeeEEEeCCeeEEEEEecCC
Q 003599          488 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEYMPN  562 (808)
Q Consensus       488 ~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~  562 (808)
                      +.||+|+||.||+|+.. +++.||||++.+.   .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            47999999999999876 4789999998754   233456678899999876 799999999999999999999999999


Q ss_pred             CCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCccc
Q 003599          563 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD  642 (808)
Q Consensus       563 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  642 (808)
                      |+|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.......  .
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~  152 (321)
T cd05591          81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--T  152 (321)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc--c
Confidence            999988853   346889999999999999999999998   99999999999999999999999999885432221  1


Q ss_pred             ccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCccc
Q 003599          643 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQ  722 (808)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  722 (808)
                      .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..........    ......    ..        .+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~----~i~~~~----~~--------~p  216 (321)
T cd05591         153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFE----SILHDD----VL--------YP  216 (321)
T ss_pred             ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHH----HHHcCC----CC--------CC
Confidence            223568999999999998899999999999999999999999987543222111    111110    00        11


Q ss_pred             HHHHHHHHHHHHhcccCCcCCCC-------CHHHHHHH
Q 003599          723 LDMIIRCIHVGLLCVQELVKDRP-------NMSTVVSM  753 (808)
Q Consensus       723 ~~~~~~l~~li~~cl~~~P~~RP-------s~~ev~~~  753 (808)
                      .....++.+++.+|++.+|++||       +++++++.
T Consensus       217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            11235678899999999999999       77777654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-36  Score=330.73  Aligned_cols=253  Identities=23%  Similarity=0.320  Sum_probs=199.1

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  557 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  557 (808)
                      ++|++.+.||+|+||.||+++.. +++.||||++....   ......+.+|+.++..++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            46889999999999999999976 58899999997532   234566889999999999999999999999999999999


Q ss_pred             EecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCC
Q 003599          558 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  637 (808)
Q Consensus       558 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  637 (808)
                      ||+++|+|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  154 (364)
T cd05599          81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS  154 (364)
T ss_pred             CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence            99999999999854   346899999999999999999999998   999999999999999999999999998765321


Q ss_pred             CCcc------------------------------------cccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh
Q 003599          638 QDQA------------------------------------DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS  681 (808)
Q Consensus       638 ~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt  681 (808)
                      ....                                    ......||+.|+|||++....++.++|||||||++|||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~  234 (364)
T cd05599         155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV  234 (364)
T ss_pred             ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence            1100                                    0012358999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCC---HHHHHHH
Q 003599          682 GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPN---MSTVVSM  753 (808)
Q Consensus       682 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs---~~ev~~~  753 (808)
                      |+.||..........    ...........  +      ........+.+++.+|+. +|.+|++   +.++++.
T Consensus       235 G~~Pf~~~~~~~~~~----~i~~~~~~~~~--~------~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         235 GYPPFCSDNPQETYR----KIINWKETLQF--P------DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             CCCCCCCCCHHHHHH----HHHcCCCccCC--C------CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            999986433221111    11100000000  0      001123456778888886 8999998   8888763

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-36  Score=327.87  Aligned_cols=244  Identities=27%  Similarity=0.383  Sum_probs=207.7

Q ss_pred             HHhcCCcccCcccccCceeEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHHhc-cCCceeeEeeEEEeCCee
Q 003599          479 TATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEK  553 (808)
Q Consensus       479 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~  553 (808)
                      ...++|.+.++||+|.||.|+++..+ +++.+|||.+++.   ..++.+..+.|.+++... +||.++.++.++...++.
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l  444 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL  444 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence            34578999999999999999999987 5789999999875   466788899999999888 599999999999999999


Q ss_pred             EEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeecccccee
Q 003599          554 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI  633 (808)
Q Consensus       554 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  633 (808)
                      +.||||+.||++..+.    +.+.+++....-++..|+.||.|||+++   |||||||.+|||||.+|.+||+|||+++.
T Consensus       445 ~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe  517 (694)
T KOG0694|consen  445 FFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKE  517 (694)
T ss_pred             EEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccc
Confidence            9999999999955444    4467999999999999999999999999   99999999999999999999999999995


Q ss_pred             cCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccC
Q 003599          634 FGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVD  713 (808)
Q Consensus       634 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  713 (808)
                      -..  ....+..++||+.|||||++.+..|+.+.|.|||||+||||+.|..||+..+++...-..    ..+        
T Consensus       518 ~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI----~~d--------  583 (694)
T KOG0694|consen  518 GMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSI----VND--------  583 (694)
T ss_pred             cCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH----hcC--------
Confidence            432  233566689999999999999999999999999999999999999999865544322111    111        


Q ss_pred             CcccCCcccHHHHHHHHHHHHhcccCCcCCCCCH
Q 003599          714 PFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNM  747 (808)
Q Consensus       714 ~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~  747 (808)
                          +..++.-...+.+.|+.+.+..+|++|..+
T Consensus       584 ----~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  584 ----EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             ----CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence                112555567788999999999999999976

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=8.1e-36  Score=319.29  Aligned_cols=260  Identities=27%  Similarity=0.432  Sum_probs=203.7

Q ss_pred             HhcCCcccCcccccCceeEEEEEec------CCcEEEEEEecccc-cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCe
Q 003599          480 ATNNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEE  552 (808)
Q Consensus       480 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  552 (808)
                      ..++|++.++||+|+||.||+|..+      .+..||+|.+.... ......+.+|+.++++++||||+++++++.+...
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4578999999999999999999754      24579999886443 2234568899999999999999999999999999


Q ss_pred             eEEEEEecCCCCchhhccCCC-------CCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeee
Q 003599          553 KMLIYEYMPNRSLDALLFDPL-------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKI  625 (808)
Q Consensus       553 ~~lV~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl  625 (808)
                      .++||||+++|+|.+++....       ....+++..+.+++.|++.||.|||+.+   |+||||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence            999999999999999996421       1234567788899999999999999988   999999999999999999999


Q ss_pred             eccccceecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhc
Q 003599          626 SDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWN  704 (808)
Q Consensus       626 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~  704 (808)
                      +|||+++...............++..|+|||.+.++.++.++||||||+++|||++ |+.|+.....+. ...    ...
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~-~~~----~~~  235 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ-VLK----FVM  235 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHH----HHH
Confidence            99999986543222222222345678999999998899999999999999999999 677765322211 111    111


Q ss_pred             cccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003599          705 ENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  757 (808)
Q Consensus       705 ~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~  757 (808)
                      .+...     .     .+......+.+++.+|++.+|++||++.++++.|++.
T Consensus       236 ~~~~~-----~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         236 DGGYL-----D-----QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             cCCCC-----C-----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence            11000     0     1122346789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.7e-35  Score=310.63  Aligned_cols=250  Identities=27%  Similarity=0.415  Sum_probs=204.6

Q ss_pred             CCcccCcccccCceeEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEe
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  559 (808)
                      +|++.+.||+|++|.||++..+ +++.|++|.+...  .....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4778899999999999999876 5889999998643  334567889999999999999999999999999999999999


Q ss_pred             cCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCC
Q 003599          560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  639 (808)
Q Consensus       560 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  639 (808)
                      +++++|.+++... ....+++..+.+++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||+++.......
T Consensus        81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence            9999999998653 2457899999999999999999999987   99999999999999999999999999987643322


Q ss_pred             cccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCC
Q 003599          640 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSES  719 (808)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  719 (808)
                      .  .....|+..|+|||++.+..++.++|+||||+++|||++|+.|+........ .   .... .+.    .      .
T Consensus       157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~---~~~~-~~~----~------~  219 (256)
T cd08529         157 F--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL-I---LKII-RGV----F------P  219 (256)
T ss_pred             h--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH-H---HHHH-cCC----C------C
Confidence            1  1224678999999999999999999999999999999999999864432111 1   0000 000    0      0


Q ss_pred             cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          720 SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       720 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                      .........+.+++.+|++.+|++||++.++++.
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         220 PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            1222345678999999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=5.6e-36  Score=323.64  Aligned_cols=261  Identities=26%  Similarity=0.404  Sum_probs=205.1

Q ss_pred             hcCCcccCcccccCceeEEEEEec--------CCcEEEEEEecccc-cccHHHHHHHHHHHHhc-cCCceeeEeeEEEeC
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLK--------DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEG  550 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~  550 (808)
                      .++|.+.+.||+|+||.||+++..        +...+|+|.+.... .....++.+|+.+++++ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            367999999999999999999753        23569999987542 33456788999999999 799999999999999


Q ss_pred             CeeEEEEEecCCCCchhhccCCCC-------------CCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEe
Q 003599          551 EEKMLIYEYMPNRSLDALLFDPLK-------------KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL  617 (808)
Q Consensus       551 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl  617 (808)
                      +..++||||+++|+|.+++.....             ...+++.++++++.|++.||+|||+.+   ++||||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence            999999999999999999965321             235889999999999999999999987   9999999999999


Q ss_pred             CCCCCeeeeccccceecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhh
Q 003599          618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTIL  696 (808)
Q Consensus       618 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~  696 (808)
                      +.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... ....
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~-~~~~  252 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-EELF  252 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH-HHHH
Confidence            9999999999999886532221111112234568999999988889999999999999999998 7777753221 1111


Q ss_pred             hhhhhhhccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhccc
Q 003599          697 GYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIR  759 (808)
Q Consensus       697 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~~  759 (808)
                      .    ....+...          ..+.....++.+++.+|++.+|++||+|.+|++.|+.++.
T Consensus       253 ~----~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~  301 (307)
T cd05098         253 K----LLKEGHRM----------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA  301 (307)
T ss_pred             H----HHHcCCCC----------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence            1    11111000          0122334678889999999999999999999999988743

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=6.5e-36  Score=321.52  Aligned_cols=259  Identities=26%  Similarity=0.368  Sum_probs=202.5

Q ss_pred             cCCcccCcccccCceeEEEEEecC-C--cEEEEEEeccc-ccccHHHHHHHHHHHHhc-cCCceeeEeeEEEeCCeeEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLKD-G--QEIAVKRLSKA-SGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLI  556 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~~-~--~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV  556 (808)
                      ++|++.+.||+|+||.||+|..++ +  ..+++|.++.. .....+.|.+|+.++.++ +||||+++++++.+....++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            578899999999999999998764 3  34788888643 334456789999999999 799999999999999999999


Q ss_pred             EEecCCCCchhhccCCC-------------CCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCe
Q 003599          557 YEYMPNRSLDALLFDPL-------------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP  623 (808)
Q Consensus       557 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~  623 (808)
                      |||+++++|.+++....             ....+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence            99999999999986421             1135888999999999999999999988   9999999999999999999


Q ss_pred             eeeccccceecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhh
Q 003599          624 KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKL  702 (808)
Q Consensus       624 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~  702 (808)
                      ||+|||++......   ........+..|+|||.+....++.++||||||+++|||++ |+.||....... ...    .
T Consensus       159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~-~~~----~  230 (297)
T cd05089         159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-LYE----K  230 (297)
T ss_pred             EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-HHH----H
Confidence            99999998642211   11111223567999999988889999999999999999998 988885432211 110    0


Q ss_pred             hccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhcccCC
Q 003599          703 WNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDL  761 (808)
Q Consensus       703 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~~~~  761 (808)
                      ...+     ..+.     .+......+.+++.+|++.+|.+||++++|++.|+.+.+..
T Consensus       231 ~~~~-----~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         231 LPQG-----YRME-----KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             HhcC-----CCCC-----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            1010     0000     11223456889999999999999999999999998875443

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=3.1e-35  Score=310.57  Aligned_cols=259  Identities=23%  Similarity=0.363  Sum_probs=208.7

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  557 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  557 (808)
                      ++|++.+.||+|+||.||+|... +++.||+|.++..   .....+.+.+|++++++++|+|++++++++...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57899999999999999999987 7899999988642   2234678899999999999999999999999999999999


Q ss_pred             EecCCCCchhhccCCC-CCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCC
Q 003599          558 EYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  636 (808)
Q Consensus       558 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  636 (808)
                      ||+++++|.+++.... ....+++.++..++.++++||.|||+.+   ++||||+|+||+++.++.++|+|||+++....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            9999999999886432 2456899999999999999999999988   99999999999999999999999999886543


Q ss_pred             CCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcc
Q 003599          637 NQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL  716 (808)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  716 (808)
                      ....  .....++..|+|||.+.+..++.++||||||+++|||++|+.|+......  ...... ....+..     +..
T Consensus       159 ~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~-~~~~~~~-----~~~  228 (267)
T cd08224         159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCK-KIEKCDY-----PPL  228 (267)
T ss_pred             CCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc--HHHHHh-hhhcCCC-----CCC
Confidence            2211  12246888999999998888999999999999999999999987533211  111111 0111100     000


Q ss_pred             cCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003599          717 SESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  757 (808)
Q Consensus       717 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~  757 (808)
                          ........+.+++.+|++.+|++||++.+|+++|+++
T Consensus       229 ----~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         229 ----PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             ----ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence                1113455788999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.8e-36  Score=310.50  Aligned_cols=260  Identities=23%  Similarity=0.329  Sum_probs=200.0

Q ss_pred             CCcccCcccccCceeEEEEEecC-CcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCe-----eEEE
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEE-----KMLI  556 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-----~~lV  556 (808)
                      .|...+++|.|+||.||+|.+.+ ++.||||+.....+    .--+|+.+|+++.|||||+++-++.....     ..+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            46667899999999999999764 68999999865432    12369999999999999999998874332     3589


Q ss_pred             EEecCCCCchhhccCC-CCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCC-CCeeeeccccceec
Q 003599          557 YEYMPNRSLDALLFDP-LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE-LNPKISDFGMAKIF  634 (808)
Q Consensus       557 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~-~~~kl~DFGla~~~  634 (808)
                      ||||+. +|.+.+... ..+..++...+.-+..||.+||+|||+.+   |+||||||.|+|+|.+ |.+||||||.|+.+
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            999986 888877531 23457888888889999999999999987   9999999999999976 99999999999988


Q ss_pred             CCCCCcccccceeccCCccChhhhccC-CCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhc--c------
Q 003599          635 GGNQDQADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN--E------  705 (808)
Q Consensus       635 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~--~------  705 (808)
                      ...+...   ....|..|.|||.+.+. .|+.+.||||.|||+.||+-|++.|+..+....+.......-.  .      
T Consensus       177 ~~~epni---SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m  253 (364)
T KOG0658|consen  177 VKGEPNI---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM  253 (364)
T ss_pred             ccCCCce---eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence            6554432   25679999999998865 6999999999999999999999998876554444433222110  0      


Q ss_pred             -ccchhccCCcccCCc----ccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          706 -NKILALVDPFLSESS----FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       706 -~~~~~~~d~~l~~~~----~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                       ....+...|.+....    +......+.++++.++++++|.+|.++.|++..
T Consensus       254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence             111122223332222    333456788999999999999999999998764

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=7.1e-36  Score=331.04  Aligned_cols=253  Identities=23%  Similarity=0.279  Sum_probs=200.4

Q ss_pred             hcCCcccCcccccCceeEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEE
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI  556 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  556 (808)
                      .++|++.+.||+|+||.||+++.. +++.||+|++.+.   .....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv  121 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV  121 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence            467999999999999999999876 5889999998643   223445678999999999999999999999999999999


Q ss_pred             EEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCC
Q 003599          557 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  636 (808)
Q Consensus       557 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  636 (808)
                      |||+++|+|.+++..    ..++...+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       122 ~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~  194 (370)
T cd05596         122 MEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA  194 (370)
T ss_pred             EcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence            999999999998843    35788888899999999999999988   99999999999999999999999999987643


Q ss_pred             CCCcccccceeccCCccChhhhccC----CCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhcc
Q 003599          637 NQDQADTGRVVGTFGYMSPEYAMEG----RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALV  712 (808)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  712 (808)
                      ... .......||+.|+|||.+...    .++.++|||||||++|||++|+.||.........    ..........   
T Consensus       195 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~----~~i~~~~~~~---  266 (370)
T cd05596         195 NGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY----SKIMDHKNSL---  266 (370)
T ss_pred             CCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHH----HHHHcCCCcC---
Confidence            221 112235799999999998653    4788999999999999999999998643322111    1111110000   


Q ss_pred             CCcccCCcccHHHHHHHHHHHHhcccCCcCC--CCCHHHHHHH
Q 003599          713 DPFLSESSFQLDMIIRCIHVGLLCVQELVKD--RPNMSTVVSM  753 (808)
Q Consensus       713 d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~--RPs~~ev~~~  753 (808)
                        ...   .......++.+++.+||+.+|++  ||+++++++.
T Consensus       267 --~~~---~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         267 --TFP---DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             --CCC---CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence              000   11123467788999999999988  9999999764

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.1e-35  Score=324.51  Aligned_cols=246  Identities=24%  Similarity=0.312  Sum_probs=194.8

Q ss_pred             CcccccCceeEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHHhc-cCCceeeEeeEEEeCCeeEEEEEecCC
Q 003599          488 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEYMPN  562 (808)
Q Consensus       488 ~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~  562 (808)
                      +.||+|+||.||+++.. +++.||||++++..   ....+.+..|..++.++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999876 58899999997532   23446688999999998 799999999999999999999999999


Q ss_pred             CCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCccc
Q 003599          563 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD  642 (808)
Q Consensus       563 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  642 (808)
                      |+|..++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~  152 (329)
T cd05588          81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DT  152 (329)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC--Cc
Confidence            999888843   357999999999999999999999998   9999999999999999999999999987432211  12


Q ss_pred             ccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCc----hhhhhhhhhhhccccchhccCCcccC
Q 003599          643 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDD----LTILGYAWKLWNENKILALVDPFLSE  718 (808)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~d~~l~~  718 (808)
                      .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......    .....+........        ... 
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--------~~~-  223 (329)
T cd05588         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK--------QIR-  223 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC--------CCC-
Confidence            22357899999999999999999999999999999999999998643211    11111111111111        110 


Q ss_pred             CcccHHHHHHHHHHHHhcccCCcCCCCC------HHHHHH
Q 003599          719 SSFQLDMIIRCIHVGLLCVQELVKDRPN------MSTVVS  752 (808)
Q Consensus       719 ~~~~~~~~~~l~~li~~cl~~~P~~RPs------~~ev~~  752 (808)
                        .+.....++.+++.+|++.||++||+      ++++++
T Consensus       224 --~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         224 --IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             --CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence              11223456789999999999999997      667654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.6e-35  Score=309.90  Aligned_cols=247  Identities=28%  Similarity=0.401  Sum_probs=198.8

Q ss_pred             CcccccCceeEEEEEecCCcEEEEEEeccccc-ccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEecCCCCch
Q 003599          488 SKLGQGGFGPVYWGRLKDGQEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLD  566 (808)
Q Consensus       488 ~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~  566 (808)
                      ++||+|+||.||+|...+++.+|+|.++.... .....|.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            47999999999999988899999999876543 33457889999999999999999999999999999999999999999


Q ss_pred             hhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCcccccce
Q 003599          567 ALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV  646 (808)
Q Consensus       567 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~  646 (808)
                      +++..  ....+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++........ .....
T Consensus        81 ~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~  154 (250)
T cd05085          81 SFLRK--KKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLK  154 (250)
T ss_pred             HHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCC
Confidence            98854  2346889999999999999999999988   999999999999999999999999999754322211 11122


Q ss_pred             eccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCcccHHH
Q 003599          647 VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDM  725 (808)
Q Consensus       647 ~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  725 (808)
                      .++..|+|||.+..+.++.++||||||+++||+++ |..|+..........     ....+     ...     ..+...
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~-----~~~~~-----~~~-----~~~~~~  219 (250)
T cd05085         155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQARE-----QVEKG-----YRM-----SCPQKC  219 (250)
T ss_pred             CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH-----HHHcC-----CCC-----CCCCCC
Confidence            34678999999998899999999999999999998 888876432221110     01010     000     012224


Q ss_pred             HHHHHHHHHhcccCCcCCCCCHHHHHHHHh
Q 003599          726 IIRCIHVGLLCVQELVKDRPNMSTVVSMLN  755 (808)
Q Consensus       726 ~~~l~~li~~cl~~~P~~RPs~~ev~~~L~  755 (808)
                      ...+.+++.+|++.+|++||++.++++.|.
T Consensus       220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         220 PDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            567889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.1e-35  Score=316.75  Aligned_cols=255  Identities=25%  Similarity=0.415  Sum_probs=201.5

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCc----EEEEEEecccc-cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQ----EIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML  555 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  555 (808)
                      ++|++.++||+|+||+||+|+.. +++    .||+|.++... ....+++.+|+.+++.++|+||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l   85 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL   85 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence            56888999999999999999854 344    48999987543 3345678899999999999999999999875 45789


Q ss_pred             EEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecC
Q 003599          556 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG  635 (808)
Q Consensus       556 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~  635 (808)
                      +|||+++|+|.+++..  ....+++..++.++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++...
T Consensus        86 ~~~~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          86 VTQLMPYGCLLDYVRE--NKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             EEEcCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecc
Confidence            9999999999999864  2356899999999999999999999988   9999999999999999999999999998764


Q ss_pred             CCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhccccchhccCC
Q 003599          636 GNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDP  714 (808)
Q Consensus       636 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  714 (808)
                      ............++..|+|||...+..++.++||||||+++|||++ |..|+...... .+....    ..+...     
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~~~----~~~~~~-----  230 (279)
T cd05109         161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR-EIPDLL----EKGERL-----  230 (279)
T ss_pred             cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHH----HCCCcC-----
Confidence            3322211222235678999999998899999999999999999998 88887533221 111111    111000     


Q ss_pred             cccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003599          715 FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  757 (808)
Q Consensus       715 ~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~  757 (808)
                           ..+.....++.+++.+|++.||++||++.++++.|+.+
T Consensus       231 -----~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~  268 (279)
T cd05109         231 -----PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM  268 (279)
T ss_pred             -----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence                 01112345678999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.1e-36  Score=326.37  Aligned_cols=238  Identities=26%  Similarity=0.290  Sum_probs=192.4

Q ss_pred             CcccccCceeEEEEEe----cCCcEEEEEEecccc--cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEecC
Q 003599          488 SKLGQGGFGPVYWGRL----KDGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMP  561 (808)
Q Consensus       488 ~~lG~G~~g~Vy~~~~----~~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  561 (808)
                      +.||+|+||.||+++.    .+++.||+|++....  ......+.+|++++++++||||+++++++.+....++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            6899999999999875    357899999997542  2234567789999999999999999999999999999999999


Q ss_pred             CCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCcc
Q 003599          562 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA  641 (808)
Q Consensus       562 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  641 (808)
                      +|+|.+++..   ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.......  
T Consensus        82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--  153 (318)
T cd05582          82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--  153 (318)
T ss_pred             CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--
Confidence            9999998853   346899999999999999999999998   99999999999999999999999999986533211  


Q ss_pred             cccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCcc
Q 003599          642 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSF  721 (808)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  721 (808)
                      ......|++.|+|||.+....++.++||||||+++|||++|+.|+..........    ... ..        ..   ..
T Consensus       154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~----~i~-~~--------~~---~~  217 (318)
T cd05582         154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMT----MIL-KA--------KL---GM  217 (318)
T ss_pred             ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHH----HHH-cC--------CC---CC
Confidence            1223568999999999998889999999999999999999999986433221111    111 00        00   01


Q ss_pred             cHHHHHHHHHHHHhcccCCcCCCCCHHH
Q 003599          722 QLDMIIRCIHVGLLCVQELVKDRPNMST  749 (808)
Q Consensus       722 ~~~~~~~l~~li~~cl~~~P~~RPs~~e  749 (808)
                      +......+.+++.+||+.||++||++.+
T Consensus       218 p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         218 PQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            2223456788999999999999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.1e-35  Score=312.51  Aligned_cols=247  Identities=28%  Similarity=0.430  Sum_probs=196.0

Q ss_pred             CcccccCceeEEEEEec---CCcEEEEEEecccc--cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEecCC
Q 003599          488 SKLGQGGFGPVYWGRLK---DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPN  562 (808)
Q Consensus       488 ~~lG~G~~g~Vy~~~~~---~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  562 (808)
                      ++||+|+||.||+|.++   ++..+|+|+++...  ....+++.+|+.++++++||||+++++++. .+..++||||+++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~   79 (257)
T cd05116           1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL   79 (257)
T ss_pred             CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence            36999999999999753   57889999986443  234568899999999999999999999875 4567899999999


Q ss_pred             CCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCccc
Q 003599          563 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD  642 (808)
Q Consensus       563 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  642 (808)
                      ++|.+++..   ...+++..+.+++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++..........
T Consensus        80 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~  153 (257)
T cd05116          80 GPLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK  153 (257)
T ss_pred             CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence            999999853   346889999999999999999999988   99999999999999999999999999987643322111


Q ss_pred             -ccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCc
Q 003599          643 -TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS  720 (808)
Q Consensus       643 -~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  720 (808)
                       .....++..|+|||.+....++.++||||||+++|||++ |+.|+...... .....    ...+...          .
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~~----i~~~~~~----------~  218 (257)
T cd05116         154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN-EVTQM----IESGERM----------E  218 (257)
T ss_pred             ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHH----HHCCCCC----------C
Confidence             111234578999999988889999999999999999998 89888643322 11111    1111100          0


Q ss_pred             ccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhh
Q 003599          721 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS  756 (808)
Q Consensus       721 ~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~  756 (808)
                      .+.....++.+++.+|++.+|++||++.+|+++|++
T Consensus       219 ~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         219 CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence            122344678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.1e-35  Score=314.78  Aligned_cols=256  Identities=26%  Similarity=0.473  Sum_probs=202.7

Q ss_pred             cCCcccCcccccCceeEEEEEecC-C---cEEEEEEeccc-ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLKD-G---QEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI  556 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~~-~---~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  556 (808)
                      ..|++.+.||+|+||.||+|.... +   ..||||.+... .....++|..|+.++++++||||+++++++.++...++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            357788999999999999998753 3   36999998754 334467899999999999999999999999999999999


Q ss_pred             EEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCC
Q 003599          557 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  636 (808)
Q Consensus       557 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  636 (808)
                      |||+++++|.+++..  ....+++.++..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||+++....
T Consensus        84 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          84 TEFMENGALDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             EecCCCCcHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence            999999999999864  2456899999999999999999999988   99999999999999999999999999886543


Q ss_pred             CCCcccc-cce--eccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhccccchhcc
Q 003599          637 NQDQADT-GRV--VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALV  712 (808)
Q Consensus       637 ~~~~~~~-~~~--~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  712 (808)
                      ....... ...  ..+..|+|||.+....++.++||||||+++|||++ |..|+...... ......    ...     .
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~-~~~~~i----~~~-----~  228 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-DVINAI----EQD-----Y  228 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH-HHHHHH----HcC-----C
Confidence            2221111 111  12457999999998899999999999999999887 98887543221 111111    000     0


Q ss_pred             CCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003599          713 DPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  757 (808)
Q Consensus       713 d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~  757 (808)
                        .+   +.+.+.+..+.+++.+|++.+|.+||++.+|+++|++.
T Consensus       229 --~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         229 --RL---PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             --cC---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence              00   01223345678999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1e-35  Score=324.19  Aligned_cols=241  Identities=25%  Similarity=0.333  Sum_probs=194.1

Q ss_pred             CCcccCcccccCceeEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHHhccC-CceeeEeeEEEeCCeeEEEE
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQH-RNLVRLLGCCVEGEEKMLIY  557 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~  557 (808)
                      +|++.+.||+|+||.||+|+.. +++.||||++.+.   .....+.+..|++++..++| ++|+++++++.+.+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4788999999999999999876 4788999998753   23455678899999999976 56888999999999999999


Q ss_pred             EecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCC
Q 003599          558 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  637 (808)
Q Consensus       558 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  637 (808)
                      ||+++|+|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05587          81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG  154 (324)
T ss_pred             cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence            99999999988853   346889999999999999999999988   999999999999999999999999998753221


Q ss_pred             CCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCccc
Q 003599          638 QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS  717 (808)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  717 (808)
                      .  .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..........    ... ...      ..  
T Consensus       155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~----~i~-~~~------~~--  219 (324)
T cd05587         155 G--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ----SIM-EHN------VS--  219 (324)
T ss_pred             C--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHH----HHH-cCC------CC--
Confidence            1  12223568999999999999999999999999999999999999986433221111    111 000      00  


Q ss_pred             CCcccHHHHHHHHHHHHhcccCCcCCCCCH
Q 003599          718 ESSFQLDMIIRCIHVGLLCVQELVKDRPNM  747 (808)
Q Consensus       718 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~  747 (808)
                         .+.....++.+++.+|++.+|.+||+.
T Consensus       220 ---~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         220 ---YPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             ---CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence               122234567899999999999999976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.8e-35  Score=312.63  Aligned_cols=259  Identities=22%  Similarity=0.357  Sum_probs=207.7

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  557 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  557 (808)
                      ++|++.+.||+|+||.||++... +++.+|||.+...   .....+++.+|+.++++++|+||+++++++.+++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            46888899999999999999964 7899999987653   2234468889999999999999999999999999999999


Q ss_pred             EecCCCCchhhccCC-CCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCC
Q 003599          558 EYMPNRSLDALLFDP-LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  636 (808)
Q Consensus       558 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  636 (808)
                      ||+++++|.+++... .....+++..+..++.||++||.|||+.+   ++|+||||+||+++.++.++|+|||+++....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            999999999988532 23456899999999999999999999988   99999999999999999999999999886543


Q ss_pred             CCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcc
Q 003599          637 NQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL  716 (808)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  716 (808)
                      ....  .....++..|+|||.+.+..++.++|+||||+++|||++|..|+.....+  ......      .+.....+..
T Consensus       159 ~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~------~~~~~~~~~~  228 (267)
T cd08229         159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCK------KIEQCDYPPL  228 (267)
T ss_pred             CCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch--HHHHhh------hhhcCCCCCC
Confidence            2221  12246889999999998888999999999999999999999997532211  111111      0111111111


Q ss_pred             cCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003599          717 SESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  757 (808)
Q Consensus       717 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~  757 (808)
                          ........+.+++.+|++.+|++||||.+|++++.+.
T Consensus       229 ----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         229 ----PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             ----CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence                1123456788999999999999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.5e-35  Score=322.69  Aligned_cols=241  Identities=26%  Similarity=0.347  Sum_probs=194.4

Q ss_pred             CCcccCcccccCceeEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHHhc-cCCceeeEeeEEEeCCeeEEEE
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIY  557 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~  557 (808)
                      +|.+.+.||+|+||.||+|+.. +++.||||.+.+..   ....+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4788899999999999999876 57899999987542   23345677888888887 5899999999999999999999


Q ss_pred             EecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCC
Q 003599          558 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  637 (808)
Q Consensus       558 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  637 (808)
                      ||+++|+|..++..   ...+++.++..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~  154 (323)
T cd05616          81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD  154 (323)
T ss_pred             cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence            99999999988853   346889999999999999999999988   999999999999999999999999999754321


Q ss_pred             CCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCccc
Q 003599          638 QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS  717 (808)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  717 (808)
                      .  .......||+.|+|||.+....++.++|||||||++|||++|+.||..........    ... ..        .. 
T Consensus       155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~----~i~-~~--------~~-  218 (323)
T cd05616         155 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ----SIM-EH--------NV-  218 (323)
T ss_pred             C--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHH----HHH-hC--------CC-
Confidence            1  12223568999999999999999999999999999999999999986543221111    111 10        00 


Q ss_pred             CCcccHHHHHHHHHHHHhcccCCcCCCCCH
Q 003599          718 ESSFQLDMIIRCIHVGLLCVQELVKDRPNM  747 (808)
Q Consensus       718 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~  747 (808)
                        .++.....++.+++.+|++.+|.+|++.
T Consensus       219 --~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         219 --AYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             --CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence              1222345677899999999999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-36  Score=309.99  Aligned_cols=273  Identities=23%  Similarity=0.317  Sum_probs=214.7

Q ss_pred             HHHHHHHhcCCcccCcccccCceeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHHh--ccCCceeeEeeEEEeCC
Q 003599          474 FEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISK--LQHRNLVRLLGCCVEGE  551 (808)
Q Consensus       474 ~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~~  551 (808)
                      +-..........+.+.||+|.||+||+|+++ |+.||||++..   .+++.+.+|.++.+.  |+|+||+.+++.-..+.
T Consensus       203 lLVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~  278 (513)
T KOG2052|consen  203 LLVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDN  278 (513)
T ss_pred             hHhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCC
Confidence            3445566678889999999999999999999 89999999964   345778889888886  49999999998866443


Q ss_pred             ----eeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhc-----CCCcEEeCCCCCCceEeCCCCC
Q 003599          552 ----EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD-----SRLRIIHRDLKASNILLDEELN  622 (808)
Q Consensus       552 ----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-----~~~~ivH~Dikp~NILl~~~~~  622 (808)
                          +++||.+|.++|||.+||    ++..++....++++.-+|.||++||.+     +++.|.|||||+.||||.+++.
T Consensus       279 gs~TQLwLvTdYHe~GSL~DyL----~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~  354 (513)
T KOG2052|consen  279 GSWTQLWLVTDYHEHGSLYDYL----NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT  354 (513)
T ss_pred             CceEEEEEeeecccCCcHHHHH----hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCc
Confidence                678999999999999999    446799999999999999999999964     7888999999999999999999


Q ss_pred             eeeeccccceecCCCCCc--ccccceeccCCccChhhhccCC----C--CccccEEehhHHHHHHHhC----------CC
Q 003599          623 PKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYMSPEYAMEGR----F--SEKSDVFSFGVLLLEIVSG----------RK  684 (808)
Q Consensus       623 ~kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~----~--s~k~DvwSlGvil~elltG----------~~  684 (808)
                      ..|+|+|||.......+.  ......+||.+|||||++...-    +  -..+||||||+|+||+...          +.
T Consensus       355 C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~  434 (513)
T KOG2052|consen  355 CCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQL  434 (513)
T ss_pred             EEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcC
Confidence            999999999987654332  2234468999999999985432    2  2358999999999999763          23


Q ss_pred             CCCCCCCchhhhhhhhhhhccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhcc
Q 003599          685 NTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEI  758 (808)
Q Consensus       685 p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~  758 (808)
                      ||....+...-.+...+.+-.+++    .|.+.....+.+.+..+.+++..||..+|.-|-|+-.|-+.|.++.
T Consensus       435 Pyyd~Vp~DPs~eeMrkVVCv~~~----RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~  504 (513)
T KOG2052|consen  435 PYYDVVPSDPSFEEMRKVVCVQKL----RPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS  504 (513)
T ss_pred             CcccCCCCCCCHHHHhcceeeccc----CCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence            443322222222222222223333    3444444466788999999999999999999999999999998874

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-35  Score=310.98  Aligned_cols=255  Identities=31%  Similarity=0.473  Sum_probs=207.1

Q ss_pred             hcCCcccCcccccCceeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEec
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  560 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  560 (808)
                      .++|++.++||+|+||.||+|..++++.||||.+.... ...+++.+|+.++++++|+||+++++++......++||||+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            46799999999999999999998888899999987533 34678999999999999999999999999989999999999


Q ss_pred             CCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCc
Q 003599          561 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  640 (808)
Q Consensus       561 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  640 (808)
                      ++++|.+++... ....+++.++..++.+++.|+.|||+.+   ++|+||||+||++++++.+||+|||+++.+......
T Consensus        84 ~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~  159 (261)
T cd05034          84 SKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT  159 (261)
T ss_pred             CCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence            999999999653 2346899999999999999999999998   999999999999999999999999999876432111


Q ss_pred             ccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCC
Q 003599          641 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSES  719 (808)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  719 (808)
                       ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+............    .. +     ...     
T Consensus       160 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~----~~-~-----~~~-----  223 (261)
T cd05034         160 -AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV----ER-G-----YRM-----  223 (261)
T ss_pred             -hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----Hc-C-----CCC-----
Confidence             1112234678999999998889999999999999999999 88887543322111110    00 0     000     


Q ss_pred             cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhh
Q 003599          720 SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS  756 (808)
Q Consensus       720 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~  756 (808)
                      ..+.....++.+++.+|++.+|++||+++++++.|+.
T Consensus       224 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         224 PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            0112224678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.2e-35  Score=313.96  Aligned_cols=254  Identities=22%  Similarity=0.369  Sum_probs=202.0

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEec
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  560 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  560 (808)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++..........+.+|+.++++++||||+++++.+..++..++||||+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            57999999999999999999974 68899999987655555667889999999999999999999999999999999999


Q ss_pred             CCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCc
Q 003599          561 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  640 (808)
Q Consensus       561 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  640 (808)
                      ++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++....... 
T Consensus        89 ~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-  161 (267)
T cd06646          89 GGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-  161 (267)
T ss_pred             CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc-
Confidence            99999998853   346889999999999999999999987   99999999999999999999999999986642221 


Q ss_pred             ccccceeccCCccChhhhc---cCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCccc
Q 003599          641 ADTGRVVGTFGYMSPEYAM---EGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS  717 (808)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~---~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  717 (808)
                       ......|+..|+|||.+.   ...++.++||||||+++|||++|+.|+............     ....   ...+...
T Consensus       162 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~-----~~~~---~~~~~~~  232 (267)
T cd06646         162 -KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM-----SKSN---FQPPKLK  232 (267)
T ss_pred             -ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee-----ecCC---CCCCCCc
Confidence             112246889999999874   445788999999999999999999987532211111100     0000   0011111


Q ss_pred             CCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHH
Q 003599          718 ESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML  754 (808)
Q Consensus       718 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L  754 (808)
                         ........+.+++.+|++.+|++||++++|++.|
T Consensus       233 ---~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         233 ---DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             ---cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence               1112346788999999999999999999998753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.8e-35  Score=327.42  Aligned_cols=254  Identities=22%  Similarity=0.271  Sum_probs=198.7

Q ss_pred             HhcCCcccCcccccCceeEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEE
Q 003599          480 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML  555 (808)
Q Consensus       480 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  555 (808)
                      ..++|++.+.||+|+||.||+++.. +++.+|+|.+.+.   .....+.+.+|+.+++.++||||+++++++.++...++
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM  120 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            3468999999999999999999976 5789999998642   22334568899999999999999999999999999999


Q ss_pred             EEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecC
Q 003599          556 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG  635 (808)
Q Consensus       556 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~  635 (808)
                      ||||+++|+|.+++..    ..++...+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++...
T Consensus       121 v~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~  193 (370)
T cd05621         121 VMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecc
Confidence            9999999999998843    35788899999999999999999988   9999999999999999999999999998764


Q ss_pred             CCCCcccccceeccCCccChhhhccC----CCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhc
Q 003599          636 GNQDQADTGRVVGTFGYMSPEYAMEG----RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILAL  711 (808)
Q Consensus       636 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  711 (808)
                      .... .......||+.|+|||.+...    .++.++|||||||++|||++|+.||.........    ........... 
T Consensus       194 ~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~----~~i~~~~~~~~-  267 (370)
T cd05621         194 ETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTY----SKIMDHKNSLN-  267 (370)
T ss_pred             cCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHH----HHHHhCCcccC-
Confidence            3221 122235799999999998654    3788999999999999999999998643322111    11111100000 


Q ss_pred             cCCcccCCcccHHHHHHHHHHHHhcccCCcCC--CCCHHHHHHH
Q 003599          712 VDPFLSESSFQLDMIIRCIHVGLLCVQELVKD--RPNMSTVVSM  753 (808)
Q Consensus       712 ~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~--RPs~~ev~~~  753 (808)
                          ..   ........+.+++..|++.++.+  ||++.++++.
T Consensus       268 ----~p---~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         268 ----FP---EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             ----CC---CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence                00   11223456678888888765544  8899998876

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.1e-35  Score=323.29  Aligned_cols=236  Identities=28%  Similarity=0.369  Sum_probs=191.3

Q ss_pred             CcccccCceeEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHHhc-cCCceeeEeeEEEeCCeeEEEEEecCC
Q 003599          488 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEYMPN  562 (808)
Q Consensus       488 ~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~  562 (808)
                      +.||+|+||.||+++.+ +++.||||++.+.   .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999976 5789999998753   234456778899999877 699999999999999999999999999


Q ss_pred             CCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCccc
Q 003599          563 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD  642 (808)
Q Consensus       563 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  642 (808)
                      |+|..++..   ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~  152 (320)
T cd05590          81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KT  152 (320)
T ss_pred             chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cc
Confidence            999988853   346889999999999999999999988   9999999999999999999999999987542221  12


Q ss_pred             ccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCccc
Q 003599          643 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQ  722 (808)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  722 (808)
                      .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.........    .... .+..   .        .+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~----~~i~-~~~~---~--------~~  216 (320)
T cd05590         153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLF----EAIL-NDEV---V--------YP  216 (320)
T ss_pred             ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHH----HHHh-cCCC---C--------CC
Confidence            22356899999999999889999999999999999999999998654322111    1111 1100   0        11


Q ss_pred             HHHHHHHHHHHHhcccCCcCCCCCH
Q 003599          723 LDMIIRCIHVGLLCVQELVKDRPNM  747 (808)
Q Consensus       723 ~~~~~~l~~li~~cl~~~P~~RPs~  747 (808)
                      .....++.+++.+|++.||++||++
T Consensus       217 ~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         217 TWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCCCHHHHHHHHHHcccCHHHCCCC
Confidence            1234567889999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.4e-35  Score=317.28  Aligned_cols=258  Identities=26%  Similarity=0.470  Sum_probs=204.1

Q ss_pred             hcCCcccCcccccCceeEEEEEec------CCcEEEEEEecccc-cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCee
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEK  553 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  553 (808)
                      .++|++.+.||+|+||.||++...      ++..||+|.+.... ....++|.+|+.++++++||||+++++++.++...
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            467899999999999999999864      46789999987543 33456799999999999999999999999999999


Q ss_pred             EEEEEecCCCCchhhccCCC-------------------CCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCc
Q 003599          554 MLIYEYMPNRSLDALLFDPL-------------------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASN  614 (808)
Q Consensus       554 ~lV~E~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~N  614 (808)
                      ++||||+++++|.+++....                   ....+++.+++.++.|++.||+|||+.+   ++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence            99999999999999986321                   1234788899999999999999999988   9999999999


Q ss_pred             eEeCCCCCeeeeccccceecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCch
Q 003599          615 ILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDL  693 (808)
Q Consensus       615 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~  693 (808)
                      |+++.++.++|+|||+++................+..|+|||.+....++.++||||||+++|||++ |..|+.......
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~  240 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE  240 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999986543322211222345678999999988899999999999999999998 777764322111


Q ss_pred             hhhhhhhhhhccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhh
Q 003599          694 TILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS  756 (808)
Q Consensus       694 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~  756 (808)
                       ..    .....+....          .+.....++.+++.+|++.+|++||++.||++.|++
T Consensus       241 -~~----~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         241 -VI----YYVRDGNVLS----------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             -HH----HHHhcCCCCC----------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence             11    1111111110          112234678899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-36  Score=338.31  Aligned_cols=257  Identities=25%  Similarity=0.300  Sum_probs=210.5

Q ss_pred             hcCCcccCcccccCceeEEEEEecCC-cEEEEEEecccccccHHHHHHHHHHHHhcc-CCceeeEeeEE-Ee------CC
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLKDG-QEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HRNLVRLLGCC-VE------GE  551 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~~~-~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~-~~------~~  551 (808)
                      ..++++.+.|.+|||+.||.|.+..+ ..+|+|++-...+...+...+|+++|++|+ |+|||.+++.. ..      .-
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~  115 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW  115 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence            35678889999999999999998766 999999998888888999999999999997 99999999932 21      23


Q ss_pred             eeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccc
Q 003599          552 EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA  631 (808)
Q Consensus       552 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla  631 (808)
                      +.+|.||||.+|.|-+++..+... .|++.++++|+.++++|+++||... +||||||||-+||||..+++.||||||.+
T Consensus       116 EvllLmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSa  193 (738)
T KOG1989|consen  116 EVLLLMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSA  193 (738)
T ss_pred             EEEeehhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccccc
Confidence            678999999999999999765444 4999999999999999999999875 78999999999999999999999999998


Q ss_pred             eecCCCCCccc-------ccceeccCCccChhhh---ccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhh
Q 003599          632 KIFGGNQDQAD-------TGRVVGTFGYMSPEYA---MEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWK  701 (808)
Q Consensus       632 ~~~~~~~~~~~-------~~~~~gt~~y~aPE~~---~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~  701 (808)
                      ...........       .-...-|+-|.|||.+   .+..+++|+|||+|||+||-|+....||+....          
T Consensus       194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----------  263 (738)
T KOG1989|consen  194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----------  263 (738)
T ss_pred             ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----------
Confidence            75432221110       0012358999999986   467899999999999999999999999964321          


Q ss_pred             hhccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003599          702 LWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  757 (808)
Q Consensus       702 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~  757 (808)
                             ..+++...... -......++.+||..||+.||.+||++-+|+..+..+
T Consensus       264 -------laIlng~Y~~P-~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l  311 (738)
T KOG1989|consen  264 -------LAILNGNYSFP-PFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL  311 (738)
T ss_pred             -------eeEEeccccCC-CCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence                   22233333222 2246788999999999999999999999999998776

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.8e-35  Score=320.96  Aligned_cols=240  Identities=28%  Similarity=0.367  Sum_probs=191.1

Q ss_pred             CcccccCceeEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHHhc-cCCceeeEeeEEEeCCeeEEEEEecCC
Q 003599          488 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEYMPN  562 (808)
Q Consensus       488 ~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~  562 (808)
                      +.||+|+||.||+|+.. +++.||+|+++...   ....+.+..|..++..+ +||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999876 57889999987532   23445666777777754 899999999999999999999999999


Q ss_pred             CCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCccc
Q 003599          563 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD  642 (808)
Q Consensus       563 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  642 (808)
                      |+|..++..   ...++...+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~  152 (316)
T cd05592          81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK  152 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence            999988853   346889999999999999999999988   9999999999999999999999999998643222  22


Q ss_pred             ccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCccc
Q 003599          643 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQ  722 (808)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  722 (808)
                      .....||+.|+|||.+.+..++.++|||||||++|||++|+.||..........    .....       .+.     .+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~----~i~~~-------~~~-----~~  216 (316)
T cd05592         153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFD----SILND-------RPH-----FP  216 (316)
T ss_pred             cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHH----HHHcC-------CCC-----CC
Confidence            233578999999999998899999999999999999999999986543221111    11100       011     12


Q ss_pred             HHHHHHHHHHHHhcccCCcCCCCCHH-HHH
Q 003599          723 LDMIIRCIHVGLLCVQELVKDRPNMS-TVV  751 (808)
Q Consensus       723 ~~~~~~l~~li~~cl~~~P~~RPs~~-ev~  751 (808)
                      .....++.+++.+|++.+|++||++. ++.
T Consensus       217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         217 RWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            22345677899999999999999875 453

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-35  Score=329.23  Aligned_cols=253  Identities=23%  Similarity=0.304  Sum_probs=196.6

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  557 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  557 (808)
                      ++|++.++||+|+||.||+++.. +++.||||++.+.   .....+.+.+|++++++++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            46889999999999999999865 6889999998653   2334567889999999999999999999999999999999


Q ss_pred             EecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCC
Q 003599          558 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  637 (808)
Q Consensus       558 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  637 (808)
                      ||+++|+|.+++..   ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  154 (377)
T cd05629          81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ  154 (377)
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence            99999999999853   356888899999999999999999998   999999999999999999999999999643211


Q ss_pred             CCc-----------c----------------------------------cccceeccCCccChhhhccCCCCccccEEeh
Q 003599          638 QDQ-----------A----------------------------------DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSF  672 (808)
Q Consensus       638 ~~~-----------~----------------------------------~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSl  672 (808)
                      ...           .                                  ......||+.|+|||.+.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  234 (377)
T cd05629         155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL  234 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence            000           0                                  0012468999999999998899999999999


Q ss_pred             hHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCC---CCHHH
Q 003599          673 GVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDR---PNMST  749 (808)
Q Consensus       673 Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~R---Ps~~e  749 (808)
                      ||++|||++|+.||..........    ............        .......++.+++.+|++ +|.+|   |++.+
T Consensus       235 Gvil~elltG~~Pf~~~~~~~~~~----~i~~~~~~~~~p--------~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~  301 (377)
T cd05629         235 GAIMFECLIGWPPFCSENSHETYR----KIINWRETLYFP--------DDIHLSVEAEDLIRRLIT-NAENRLGRGGAHE  301 (377)
T ss_pred             chhhhhhhcCCCCCCCCCHHHHHH----HHHccCCccCCC--------CCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHH
Confidence            999999999999986433211111    111100000000        001123467788889997 66665   59999


Q ss_pred             HHHH
Q 003599          750 VVSM  753 (808)
Q Consensus       750 v~~~  753 (808)
                      +++.
T Consensus       302 ~l~h  305 (377)
T cd05629         302 IKSH  305 (377)
T ss_pred             HhcC
Confidence            8875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-35  Score=308.36  Aligned_cols=248  Identities=30%  Similarity=0.426  Sum_probs=199.7

Q ss_pred             CcccccCceeEEEEEecCCcEEEEEEecccccc-cHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEecCCCCch
Q 003599          488 SKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQ-GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLD  566 (808)
Q Consensus       488 ~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~  566 (808)
                      ++||+|+||.||++.+.+++.||+|.+...... ..+.+.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            479999999999999877999999998765433 5678999999999999999999999999999999999999999999


Q ss_pred             hhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCcccccce
Q 003599          567 ALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV  646 (808)
Q Consensus       567 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~  646 (808)
                      +++...  ...+++..+..++.+++.||.|||+++   ++||||||+||+++.++.+||+|||+++..............
T Consensus        81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            998542  346788999999999999999999988   999999999999999999999999999865422211111122


Q ss_pred             eccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCcccHHH
Q 003599          647 VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDM  725 (808)
Q Consensus       647 ~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  725 (808)
                      .++..|+|||.+.++.++.++||||||+++|||+| |..|+..........     ..         .... ....+...
T Consensus       156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~-----~~---------~~~~-~~~~~~~~  220 (251)
T cd05041         156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRE-----RI---------ESGY-RMPAPQLC  220 (251)
T ss_pred             cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHH-----HH---------hcCC-CCCCCccC
Confidence            34667999999988899999999999999999999 777775433221111     00         0000 00122234


Q ss_pred             HHHHHHHHHhcccCCcCCCCCHHHHHHHHh
Q 003599          726 IIRCIHVGLLCVQELVKDRPNMSTVVSMLN  755 (808)
Q Consensus       726 ~~~l~~li~~cl~~~P~~RPs~~ev~~~L~  755 (808)
                      ..++.+++.+|++.+|++||++.||++.|+
T Consensus       221 ~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         221 PEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            567899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.2e-35  Score=329.07  Aligned_cols=251  Identities=22%  Similarity=0.290  Sum_probs=193.2

Q ss_pred             CCcccCcccccCceeEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEE
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  558 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  558 (808)
                      .|++.++||+|+||.||+|+.. +++.||+|++.+..   ....+.+.+|+.++++++||||+++++.+.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5888999999999999999875 57899999987532   2345678899999999999999999999999999999999


Q ss_pred             ecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCC
Q 003599          559 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  638 (808)
Q Consensus       559 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  638 (808)
                      |+++|+|.+++..   ...+++.....++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+....
T Consensus        82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence            9999999998854   346788888999999999999999998   9999999999999999999999999975331100


Q ss_pred             C---------------------------------------------cccccceeccCCccChhhhccCCCCccccEEehh
Q 003599          639 D---------------------------------------------QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFG  673 (808)
Q Consensus       639 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlG  673 (808)
                      .                                             ........||+.|+|||.+.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  235 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence            0                                             0001124689999999999998999999999999


Q ss_pred             HHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCC---HHHH
Q 003599          674 VLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPN---MSTV  750 (808)
Q Consensus       674 vil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs---~~ev  750 (808)
                      |++|||++|+.||...........    .....       ..+... .......++.+++.+++ .+|++|++   ++++
T Consensus       236 vil~elltG~~Pf~~~~~~~~~~~----i~~~~-------~~~~~p-~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei  302 (382)
T cd05625         236 VILYEMLVGQPPFLAQTPLETQMK----VINWQ-------TSLHIP-PQAKLSPEASDLIIKLC-RGPEDRLGKNGADEI  302 (382)
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHH----HHccC-------CCcCCC-CcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHH
Confidence            999999999999865432211111    00000       000000 01112344556666655 49999997   7776


Q ss_pred             HH
Q 003599          751 VS  752 (808)
Q Consensus       751 ~~  752 (808)
                      ++
T Consensus       303 ~~  304 (382)
T cd05625         303 KA  304 (382)
T ss_pred             hc
Confidence            65

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.6e-35  Score=316.68  Aligned_cols=250  Identities=24%  Similarity=0.374  Sum_probs=204.5

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEec
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  560 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  560 (808)
                      .+|++.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++|+||+++++.+..+...++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            57889999999999999999864 68899999987665556678999999999999999999999999999999999999


Q ss_pred             CCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCc
Q 003599          561 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  640 (808)
Q Consensus       561 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  640 (808)
                      ++++|.+++..    ..+++.++..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++........
T Consensus       100 ~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~  172 (296)
T cd06654         100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  172 (296)
T ss_pred             CCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence            99999999843    35889999999999999999999988   999999999999999999999999998865332211


Q ss_pred             ccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCc
Q 003599          641 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS  720 (808)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  720 (808)
                        .....+++.|+|||.+....++.++||||||+++|||++|+.||...........    ....+      .+.+.   
T Consensus       173 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~----~~~~~------~~~~~---  237 (296)
T cd06654         173 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL----IATNG------TPELQ---  237 (296)
T ss_pred             --cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHH----HhcCC------CCCCC---
Confidence              1224688999999999888899999999999999999999999864332111111    00000      00110   


Q ss_pred             ccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          721 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       721 ~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                      .+......+.+++.+|++.+|++||++.+|++.
T Consensus       238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             CccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            122344667889999999999999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=4.3e-35  Score=310.35  Aligned_cols=254  Identities=27%  Similarity=0.390  Sum_probs=193.6

Q ss_pred             CcccccCceeEEEEEecC---CcEEEEEEecccc-cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEecCCC
Q 003599          488 SKLGQGGFGPVYWGRLKD---GQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNR  563 (808)
Q Consensus       488 ~~lG~G~~g~Vy~~~~~~---~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  563 (808)
                      +.||+|+||.||+|...+   +..+|+|.++... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            469999999999998653   4579999987543 233457889999999999999999999999999999999999999


Q ss_pred             CchhhccCCC--CCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCcc
Q 003599          564 SLDALLFDPL--KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA  641 (808)
Q Consensus       564 sL~~~l~~~~--~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  641 (808)
                      +|.+++....  .....++..+.+++.|+++||+|||+.+   ++|+||||+||+++.++.+||+|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999986432  1234667788899999999999999988   9999999999999999999999999997543322222


Q ss_pred             cccceeccCCccChhhhccC-------CCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhccccchhccC
Q 003599          642 DTGRVVGTFGYMSPEYAMEG-------RFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVD  713 (808)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~~~-------~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  713 (808)
                      ......++..|+|||.+...       .++.++||||||+++|||++ |+.|+.......... ..   . .+......+
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~-~~---~-~~~~~~~~~  232 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT-YT---V-REQQLKLPK  232 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH-HH---h-hcccCCCCC
Confidence            22234577889999988532       35789999999999999997 999986544332211 10   1 111122222


Q ss_pred             CcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHh
Q 003599          714 PFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN  755 (808)
Q Consensus       714 ~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~  755 (808)
                      +.+..     .....+.+++..|+ .+|++||++++|++.|+
T Consensus       233 ~~~~~-----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         233 PRLKL-----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CccCC-----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            22221     12345677888898 58999999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.5e-35  Score=319.59  Aligned_cols=258  Identities=29%  Similarity=0.434  Sum_probs=201.5

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCc--EEEEEEeccc-ccccHHHHHHHHHHHHhc-cCCceeeEeeEEEeCCeeEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQ--EIAVKRLSKA-SGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLI  556 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~--~vAvK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV  556 (808)
                      ++|++.+.||+|+||.||+|.++ ++.  .+|+|.+... .....+.+.+|++++.++ +|+||+++++++.+++..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            56888999999999999999875 343  4688877643 233456788999999999 899999999999999999999


Q ss_pred             EEecCCCCchhhccCCC-------------CCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCe
Q 003599          557 YEYMPNRSLDALLFDPL-------------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP  623 (808)
Q Consensus       557 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~  623 (808)
                      |||+++++|.+++....             ....+++.+++.++.|+++||+|||+.+   ++||||||+|||++.++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence            99999999999986421             1235889999999999999999999988   9999999999999999999


Q ss_pred             eeeccccceecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhh
Q 003599          624 KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKL  702 (808)
Q Consensus       624 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~  702 (808)
                      ||+|||+++.....   .......++..|+|||.+....++.++||||||+++|||+| |..|+....... ....   .
T Consensus       164 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-~~~~---~  236 (303)
T cd05088         164 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-LYEK---L  236 (303)
T ss_pred             EeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH-HHHH---H
Confidence            99999998632111   11111234668999999988889999999999999999998 888875332211 1110   0


Q ss_pred             hccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhcccC
Q 003599          703 WNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRD  760 (808)
Q Consensus       703 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~~~  760 (808)
                       ..+     .  ...   .+......+.+++.+|++.+|++||++++++++|+.++..
T Consensus       237 -~~~-----~--~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~  283 (303)
T cd05088         237 -PQG-----Y--RLE---KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  283 (303)
T ss_pred             -hcC-----C--cCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence             000     0  000   1112345678999999999999999999999999876443

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=4.7e-35  Score=307.67  Aligned_cols=250  Identities=35%  Similarity=0.501  Sum_probs=204.3

Q ss_pred             CcccccCceeEEEEEecC----CcEEEEEEecccccc-cHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEecCC
Q 003599          488 SKLGQGGFGPVYWGRLKD----GQEIAVKRLSKASGQ-GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPN  562 (808)
Q Consensus       488 ~~lG~G~~g~Vy~~~~~~----~~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  562 (808)
                      +.||+|+||.||++....    +..||+|.++..... ..+.+.+|++.+++++|+||+++++++..+...++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            479999999999998764    788999999765433 367899999999999999999999999999999999999999


Q ss_pred             CCchhhccCCCC------CCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCC
Q 003599          563 RSLDALLFDPLK------KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  636 (808)
Q Consensus       563 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  636 (808)
                      ++|.+++.....      ...+++.++..++.|+++||+|||+.+   ++|+||||+||+++.++.+||+|||.++....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence            999999975321      367999999999999999999999988   99999999999999999999999999987754


Q ss_pred             CCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhccccchhccCCc
Q 003599          637 NQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPF  715 (808)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  715 (808)
                      ...........++..|+|||.+....++.++||||||+++|||++ |+.|+....... ...    ....+.       .
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-~~~----~~~~~~-------~  225 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-VLE----YLRKGY-------R  225 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH-HHH----HHHcCC-------C
Confidence            432222333567889999999988889999999999999999999 588886543211 111    111110       0


Q ss_pred             ccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHh
Q 003599          716 LSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN  755 (808)
Q Consensus       716 l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~  755 (808)
                      .   ..+.....++.+++.+|++.+|++||++.++++.|+
T Consensus       226 ~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         226 L---PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             C---CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            0   122233567889999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-35  Score=310.49  Aligned_cols=249  Identities=31%  Similarity=0.459  Sum_probs=204.6

Q ss_pred             cCCcccCcccccCceeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEecC
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMP  561 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  561 (808)
                      ++|++.+.||+|+||.||++... ++.||+|.+..... ..+++.+|+.++++++|+||+++++++.+....++||||++
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   83 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA   83 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence            57888999999999999999876 78999999976544 56789999999999999999999999999999999999999


Q ss_pred             CCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCcc
Q 003599          562 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA  641 (808)
Q Consensus       562 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  641 (808)
                      +++|.+++... ....+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||.++.......  
T Consensus        84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--  157 (256)
T cd05039          84 KGSLVDYLRSR-GRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--  157 (256)
T ss_pred             CCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence            99999998643 2236899999999999999999999998   99999999999999999999999999986632211  


Q ss_pred             cccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCc
Q 003599          642 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS  720 (808)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  720 (808)
                         ....+..|+|||.+..+.++.++||||||+++|||++ |+.|+...... .+....    ..+.     ...     
T Consensus       158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-~~~~~~----~~~~-----~~~-----  219 (256)
T cd05039         158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-DVVPHV----EKGY-----RME-----  219 (256)
T ss_pred             ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH-HHHHHH----hcCC-----CCC-----
Confidence               1234678999999988889999999999999999998 88887543221 111111    0100     000     


Q ss_pred             ccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhh
Q 003599          721 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS  756 (808)
Q Consensus       721 ~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~  756 (808)
                      .+...+..+.+++.+|+..+|++||++++++++|++
T Consensus       220 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         220 APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            112234678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-35  Score=303.25  Aligned_cols=267  Identities=22%  Similarity=0.339  Sum_probs=204.1

Q ss_pred             HhcCCcccCcccccCceeEEEEEec-CCcEEEEEEecc--cccccHHHHHHHHHHHHhccCCceeeEeeEEEe-----CC
Q 003599          480 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSK--ASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVE-----GE  551 (808)
Q Consensus       480 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-----~~  551 (808)
                      ....|...+.||+|+||.|..+..+ +|+.||||++..  ......++..+|+++|++++|+||+.+++.+..     -.
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            3456666799999999999999876 689999999974  345567888999999999999999999998865     35


Q ss_pred             eeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccc
Q 003599          552 EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA  631 (808)
Q Consensus       552 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla  631 (808)
                      ..|+|+|+| ..+|...+..   .+.++..+..-++.||++||.|+|+.+   |+||||||+|+|++.+-.+||+|||+|
T Consensus       100 DvYiV~elM-etDL~~iik~---~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLA  172 (359)
T KOG0660|consen  100 DVYLVFELM-ETDLHQIIKS---QQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLA  172 (359)
T ss_pred             eeEEehhHH-hhHHHHHHHc---CccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccce
Confidence            679999999 6688888843   344999999999999999999999998   999999999999999999999999999


Q ss_pred             eecCCCCCcccccceeccCCccChhhhc-cCCCCccccEEehhHHHHHHHhCCCCCCCCCCc--hhhhhhhh--------
Q 003599          632 KIFGGNQDQADTGRVVGTFGYMSPEYAM-EGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDD--LTILGYAW--------  700 (808)
Q Consensus       632 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~--~~~~~~~~--------  700 (808)
                      |...........+..+.|..|.|||++. ...|+.+.||||.|||+.||++|++.|+..+.-  ..++....        
T Consensus       173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l  252 (359)
T KOG0660|consen  173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL  252 (359)
T ss_pred             eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence            9886542233334567899999999875 457999999999999999999999988765421  11111000        


Q ss_pred             hhhccccchhccCCcccCC--ccc---HHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          701 KLWNENKILALVDPFLSES--SFQ---LDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       701 ~~~~~~~~~~~~d~~l~~~--~~~---~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                      ...........+...-...  ++.   .......+++..+||..||.+|+|++|.++.
T Consensus       253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            0111111111111111111  111   1233567889999999999999999998764

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.3e-35  Score=312.03  Aligned_cols=256  Identities=28%  Similarity=0.472  Sum_probs=204.1

Q ss_pred             cCCcccCcccccCceeEEEEEec----CCcEEEEEEecccc-cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK----DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI  556 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  556 (808)
                      .+|++.+.||+|+||.||+|+..    .+..+|+|.++... ....+.|.+|+.++++++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            56888999999999999999864    23479999986543 33456889999999999999999999999999999999


Q ss_pred             EEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCC
Q 003599          557 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  636 (808)
Q Consensus       557 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  636 (808)
                      |||+++++|.+++..  ....+++.++..++.|++.||+|||+.+   ++||||||+|||++.++.++|+|||+++....
T Consensus        84 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          84 TEYMENGSLDAFLRK--HDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             EEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            999999999999864  2346899999999999999999999988   99999999999999999999999999987643


Q ss_pred             CCCccc-ccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhccccchhccCC
Q 003599          637 NQDQAD-TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDP  714 (808)
Q Consensus       637 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  714 (808)
                      ...... .....++..|+|||.+.+..++.++||||||+++||+++ |+.|+........ ....    .++     .. 
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~-~~~~----~~~-----~~-  227 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV-IKAI----EEG-----YR-  227 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH-HHHH----hCC-----Cc-
Confidence            322111 111223568999999998889999999999999999887 9988754332211 1111    111     00 


Q ss_pred             cccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003599          715 FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  757 (808)
Q Consensus       715 ~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~  757 (808)
                       .   +.....+..+.+++.+|++.+|.+||+|.+|++.|+++
T Consensus       228 -~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         228 -L---PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             -C---CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence             0   01122345778999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2e-35  Score=310.37  Aligned_cols=249  Identities=29%  Similarity=0.412  Sum_probs=200.0

Q ss_pred             CcccccCceeEEEEEecC--C--cEEEEEEeccccc-ccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEecCC
Q 003599          488 SKLGQGGFGPVYWGRLKD--G--QEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPN  562 (808)
Q Consensus       488 ~~lG~G~~g~Vy~~~~~~--~--~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  562 (808)
                      ++||+|++|.||+|.+.+  +  ..||||.+..... ...+.|.+|+.++++++||||+++++.+.. ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            478999999999998753  2  3699999987655 567789999999999999999999999988 889999999999


Q ss_pred             CCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCc-c
Q 003599          563 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ-A  641 (808)
Q Consensus       563 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~-~  641 (808)
                      ++|.+++.+... ..+++..+..++.|+++||+|||+.+   ++|+||||+||+++.++.+||+|||+++.+...... .
T Consensus        80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            999999865322 56899999999999999999999988   999999999999999999999999999876442221 1


Q ss_pred             cccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCc
Q 003599          642 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS  720 (808)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  720 (808)
                      ......++..|+|||.+....++.++||||||+++|||++ |+.|+..........    ......       ...   .
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~----~~~~~~-------~~~---~  221 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILK----KIDKEG-------ERL---E  221 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHH----HHHhcC-------CcC---C
Confidence            1122456789999999998899999999999999999999 999875432221111    111000       000   0


Q ss_pred             ccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHh
Q 003599          721 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN  755 (808)
Q Consensus       721 ~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~  755 (808)
                      .+...+..+.+++.+|++.+|++||++.+|++.|.
T Consensus       222 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         222 RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            11223467889999999999999999999999884

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3.3e-35  Score=309.20  Aligned_cols=248  Identities=27%  Similarity=0.432  Sum_probs=195.1

Q ss_pred             cccccCceeEEEEEec---CCcEEEEEEecccc-cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEecCCCC
Q 003599          489 KLGQGGFGPVYWGRLK---DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRS  564 (808)
Q Consensus       489 ~lG~G~~g~Vy~~~~~---~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  564 (808)
                      .||+|+||.||+|.+.   .+..||+|.+.... ....+.|.+|+.++++++||||+++++++. ....++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            4899999999999764   35579999987553 233567999999999999999999999875 457899999999999


Q ss_pred             chhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCccc-c
Q 003599          565 LDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD-T  643 (808)
Q Consensus       565 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~-~  643 (808)
                      |.+++..  ....+++..+++++.|+++||+|||+.+   ++||||||+||+++.++.+||+|||+++.......... .
T Consensus        81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  155 (257)
T cd05115          81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR  155 (257)
T ss_pred             HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence            9999864  2456899999999999999999999988   99999999999999999999999999986543322111 1


Q ss_pred             cceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCccc
Q 003599          644 GRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQ  722 (808)
Q Consensus       644 ~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  722 (808)
                      ....++..|+|||.+....++.++||||||+++||+++ |+.|+....... ...    ....+..          ...+
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~----~~~~~~~----------~~~~  220 (257)
T cd05115         156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE-VMS----FIEQGKR----------LDCP  220 (257)
T ss_pred             CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH-HHH----HHHCCCC----------CCCC
Confidence            11233578999999988889999999999999999996 998886433221 111    1111110          0122


Q ss_pred             HHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003599          723 LDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  757 (808)
Q Consensus       723 ~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~  757 (808)
                      .....++.+++.+|++.+|++||++.+|.+.|+..
T Consensus       221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            23456788899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.5e-35  Score=319.61  Aligned_cols=260  Identities=25%  Similarity=0.422  Sum_probs=204.5

Q ss_pred             cCCcccCcccccCceeEEEEEec--------CCcEEEEEEecccc-cccHHHHHHHHHHHHhc-cCCceeeEeeEEEeCC
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK--------DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGE  551 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~  551 (808)
                      ++|.+.++||+|+||.||+++..        ....+|+|.++... .....++.+|+.+++++ +||||+++++++....
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            57888999999999999999742        24579999987542 34466789999999999 6999999999999999


Q ss_pred             eeEEEEEecCCCCchhhccCCC-------------CCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeC
Q 003599          552 EKMLIYEYMPNRSLDALLFDPL-------------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD  618 (808)
Q Consensus       552 ~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~  618 (808)
                      ..++||||+++|+|.+++....             ....+++.++.+++.|++.||.|||+.+   ++||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~  168 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT  168 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence            9999999999999999986532             1245889999999999999999999988   99999999999999


Q ss_pred             CCCCeeeeccccceecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhh
Q 003599          619 EELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILG  697 (808)
Q Consensus       619 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~  697 (808)
                      +++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... ....
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~-~~~~  247 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE-ELFK  247 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH-HHHH
Confidence            999999999999986543222111112234567999999998889999999999999999999 78887543221 1111


Q ss_pred             hhhhhhccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhccc
Q 003599          698 YAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIR  759 (808)
Q Consensus       698 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~~  759 (808)
                          ....+...+          .+.....++.+++.+|++.+|++||++.++++.|+++..
T Consensus       248 ----~~~~~~~~~----------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         248 ----LLREGHRMD----------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             ----HHHcCCCCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence                111111000          112234577889999999999999999999999988743

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3.6e-35  Score=324.92  Aligned_cols=202  Identities=26%  Similarity=0.370  Sum_probs=174.8

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  557 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  557 (808)
                      ++|++.+.||+|+||+||+++.. +++.||||++++..   ......+.+|+.++.+++|+||+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            46889999999999999999875 58899999997532   233467888999999999999999999999999999999


Q ss_pred             EecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCC
Q 003599          558 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  637 (808)
Q Consensus       558 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  637 (808)
                      ||+++|+|.+++..   ...+++.++..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~  154 (363)
T cd05628          81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA  154 (363)
T ss_pred             cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence            99999999999853   457899999999999999999999988   999999999999999999999999998754321


Q ss_pred             CCc---------------------------------ccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCC
Q 003599          638 QDQ---------------------------------ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRK  684 (808)
Q Consensus       638 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~  684 (808)
                      ...                                 .......||+.|+|||.+.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~  234 (363)
T cd05628         155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (363)
T ss_pred             ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence            100                                 00112479999999999999999999999999999999999999


Q ss_pred             CCCCC
Q 003599          685 NTSFF  689 (808)
Q Consensus       685 p~~~~  689 (808)
                      ||...
T Consensus       235 Pf~~~  239 (363)
T cd05628         235 PFCSE  239 (363)
T ss_pred             CCCCC
Confidence            98643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=4.7e-35  Score=311.61  Aligned_cols=247  Identities=24%  Similarity=0.326  Sum_probs=194.7

Q ss_pred             ccccCceeEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEecCCCCc
Q 003599          490 LGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSL  565 (808)
Q Consensus       490 lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  565 (808)
                      ||+|+||.||+++.+ +|+.||+|++....   ....+.+..|++++++++||||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            799999999999875 58999999986432   12334566799999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCcccccc
Q 003599          566 DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR  645 (808)
Q Consensus       566 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~  645 (808)
                      ..++... ....+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.++|+|||++........   ...
T Consensus        81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~  153 (277)
T cd05607          81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQ  153 (277)
T ss_pred             HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---eec
Confidence            9888543 3345889999999999999999999988   99999999999999999999999999986643221   122


Q ss_pred             eeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCcccHHH
Q 003599          646 VVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDM  725 (808)
Q Consensus       646 ~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  725 (808)
                      ..|+..|+|||.+.+..++.++|||||||++|||++|+.|+.................         ......  .....
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~---------~~~~~~--~~~~~  222 (277)
T cd05607         154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTL---------EDEVKF--EHQNF  222 (277)
T ss_pred             cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhh---------cccccc--ccccC
Confidence            4689999999999988899999999999999999999999865433221111111111         111100  00123


Q ss_pred             HHHHHHHHHhcccCCcCCCCCHHHHHHHH
Q 003599          726 IIRCIHVGLLCVQELVKDRPNMSTVVSML  754 (808)
Q Consensus       726 ~~~l~~li~~cl~~~P~~RPs~~ev~~~L  754 (808)
                      ..++.+++.+||+.||++||+++|+++.+
T Consensus       223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         223 TEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             CHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence            45678999999999999999998776444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=4.6e-35  Score=312.37  Aligned_cols=252  Identities=25%  Similarity=0.379  Sum_probs=201.5

Q ss_pred             CCcccCcccccCceeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEecC
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMP  561 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  561 (808)
                      .|++.+.||+|+||.||+|... .+..+|+|.+........+.+.+|+++++.++||||+++++++..+...++||||++
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~   85 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   85 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence            3677899999999999999976 477889999876655667789999999999999999999999999999999999999


Q ss_pred             CCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCcc
Q 003599          562 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA  641 (808)
Q Consensus       562 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  641 (808)
                      +++|..++..  ....+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||+++.......  
T Consensus        86 ~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--  158 (282)
T cd06643          86 GGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--  158 (282)
T ss_pred             CCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccccc--
Confidence            9999988754  2346899999999999999999999988   99999999999999999999999999876532211  


Q ss_pred             cccceeccCCccChhhhc-----cCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcc
Q 003599          642 DTGRVVGTFGYMSPEYAM-----EGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL  716 (808)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~-----~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  716 (808)
                      ......++..|+|||.+.     ...++.++|||||||++|||++|+.|+.............    ..      ..+.+
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~----~~------~~~~~  228 (282)
T cd06643         159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIA----KS------EPPTL  228 (282)
T ss_pred             ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHh----hc------CCCCC
Confidence            122346899999999874     3457889999999999999999999986443222111110    00      00111


Q ss_pred             cCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHH
Q 003599          717 SESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML  754 (808)
Q Consensus       717 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L  754 (808)
                      .   .+.....++.+++.+|++.+|.+||++.++++.-
T Consensus       229 ~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  263 (282)
T cd06643         229 A---QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP  263 (282)
T ss_pred             C---CccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence            1   1122345788999999999999999999987543

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.6e-35  Score=329.57  Aligned_cols=253  Identities=23%  Similarity=0.298  Sum_probs=196.0

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  557 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  557 (808)
                      .+|++.+.||+|+||.||+++.. +++.||||++.+..   ....+.+.+|+++|++++|+||+++++.+.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36889999999999999999875 58899999986532   234567889999999999999999999999999999999


Q ss_pred             EecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCC
Q 003599          558 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  637 (808)
Q Consensus       558 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  637 (808)
                      ||+++|+|.+++..   ...++......++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~  154 (376)
T cd05598          81 DYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (376)
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence            99999999999854   346788888899999999999999988   999999999999999999999999997533110


Q ss_pred             CC-----------------------------------------cccccceeccCCccChhhhccCCCCccccEEehhHHH
Q 003599          638 QD-----------------------------------------QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLL  676 (808)
Q Consensus       638 ~~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil  676 (808)
                      ..                                         ........||+.|+|||.+.+..++.++|||||||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil  234 (376)
T cd05598         155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL  234 (376)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence            00                                         0001124699999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCC---CHHHHHHH
Q 003599          677 LEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRP---NMSTVVSM  753 (808)
Q Consensus       677 ~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RP---s~~ev~~~  753 (808)
                      |||++|+.||...........    .......  ...+      .......++.+++.+|+ .+|.+|+   ++.++++.
T Consensus       235 yell~G~~Pf~~~~~~~~~~~----i~~~~~~--~~~~------~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         235 YEMLVGQPPFLADTPAETQLK----VINWETT--LHIP------SQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             eehhhCCCCCCCCCHHHHHHH----HhccCcc--ccCC------CCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            999999999875443221111    0000000  0000      01112344566676765 4999999   88888765

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.4e-35  Score=313.80  Aligned_cols=260  Identities=25%  Similarity=0.401  Sum_probs=201.6

Q ss_pred             CCcccCcccccCceeEEEEEe-----cCCcEEEEEEecccc-cccHHHHHHHHHHHHhccCCceeeEeeEEEeC--CeeE
Q 003599          483 NFQLSSKLGQGGFGPVYWGRL-----KDGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG--EEKM  554 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~  554 (808)
                      .|++.+.||+|+||.||+++.     .++..||+|.++... ....+.+.+|+.++++++||||+++++++...  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            468889999999999999974     357889999987543 33456799999999999999999999998875  5678


Q ss_pred             EEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceec
Q 003599          555 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF  634 (808)
Q Consensus       555 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~  634 (808)
                      +||||+++++|.+++...  ...+++.++..++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||+++..
T Consensus        85 lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAI  159 (284)
T ss_pred             EEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccccc
Confidence            999999999999998542  346899999999999999999999988   999999999999999999999999999876


Q ss_pred             CCCCCc-ccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCc----------hhhhhhhhhhh
Q 003599          635 GGNQDQ-ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDD----------LTILGYAWKLW  703 (808)
Q Consensus       635 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~----------~~~~~~~~~~~  703 (808)
                      ...... .......++..|+|||.+.+..++.++||||||+++|||++++.|.......          ...........
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05079         160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL  239 (284)
T ss_pred             ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH
Confidence            433221 1122245677899999998888999999999999999999987654211100          00000000000


Q ss_pred             ccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003599          704 NENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  757 (808)
Q Consensus       704 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~  757 (808)
                      .++.         . .+.......++.+++.+|++.+|++||++++|++.|+.+
T Consensus       240 ~~~~---------~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         240 EEGK---------R-LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HcCc---------c-CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            0000         0 001122456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.3e-35  Score=320.46  Aligned_cols=242  Identities=27%  Similarity=0.330  Sum_probs=195.3

Q ss_pred             CcccccCceeEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHHhc-cCCceeeEeeEEEeCCeeEEEEEecCC
Q 003599          488 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEYMPN  562 (808)
Q Consensus       488 ~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~  562 (808)
                      +.||+|+||.||+++.. +++.||||++++..   ....+.+..|.++++.+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999876 47899999997542   33456778899999888 799999999999999999999999999


Q ss_pred             CCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCccc
Q 003599          563 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD  642 (808)
Q Consensus       563 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  642 (808)
                      |+|..++..   ...+++.++..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++......  ..
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~  152 (318)
T cd05570          81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VT  152 (318)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cc
Confidence            999988853   346899999999999999999999988   9999999999999999999999999987532211  12


Q ss_pred             ccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCccc
Q 003599          643 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQ  722 (808)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  722 (808)
                      .....|++.|+|||.+.+..++.++|||||||++|||++|+.||..........    ... ...      ..     .+
T Consensus       153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~----~i~-~~~------~~-----~~  216 (318)
T cd05570         153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQ----SIL-EDE------VR-----YP  216 (318)
T ss_pred             ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHH----HHH-cCC------CC-----CC
Confidence            223568999999999999999999999999999999999999986433221111    111 000      00     11


Q ss_pred             HHHHHHHHHHHHhcccCCcCCCCCH-----HHHHHH
Q 003599          723 LDMIIRCIHVGLLCVQELVKDRPNM-----STVVSM  753 (808)
Q Consensus       723 ~~~~~~l~~li~~cl~~~P~~RPs~-----~ev~~~  753 (808)
                      ......+.+++.+||+.||++||++     .++++.
T Consensus       217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence            2234567899999999999999999     777653

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-35  Score=309.32  Aligned_cols=252  Identities=28%  Similarity=0.405  Sum_probs=201.8

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEecccc-----cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-----GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML  555 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  555 (808)
                      ++|.+.+.||+|++|.||++... +++.||+|.+....     ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            57889999999999999999865 58999999886432     1234578899999999999999999999999999999


Q ss_pred             EEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecC
Q 003599          556 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG  635 (808)
Q Consensus       556 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~  635 (808)
                      |+||+++++|.+++..   ...+++..+.+++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||+++...
T Consensus        82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            9999999999998853   346888999999999999999999998   9999999999999999999999999998654


Q ss_pred             CCCCccc-ccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCC
Q 003599          636 GNQDQAD-TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDP  714 (808)
Q Consensus       636 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  714 (808)
                      ....... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+...........    .....     ..+
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~-----~~~  226 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFK----IATQP-----TNP  226 (263)
T ss_pred             ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHH----HhccC-----CCC
Confidence            3221111 1224578899999999988899999999999999999999999754322111111    00000     000


Q ss_pred             cccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          715 FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       715 ~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                           ..+......+.+++.+|++.+|++||++.++++.
T Consensus       227 -----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         227 -----QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             -----CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence                 1222344567889999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.2e-35  Score=314.74  Aligned_cols=270  Identities=27%  Similarity=0.440  Sum_probs=205.7

Q ss_pred             cCCcccCcccccCceeEEEEEec-----CCcEEEEEEecccccc-cHHHHHHHHHHHHhccCCceeeEeeEEEe--CCee
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-----DGQEIAVKRLSKASGQ-GLEEFMNEVMVISKLQHRNLVRLLGCCVE--GEEK  553 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~  553 (808)
                      +.|++.+.||+|+||.||+++..     .+..+|||.+...... ..+.|.+|++++++++|+||+++++++..  +...
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            45777899999999999999854     3678999999765443 46789999999999999999999999887  5678


Q ss_pred             EEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeecccccee
Q 003599          554 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI  633 (808)
Q Consensus       554 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  633 (808)
                      ++||||+++++|.+++...  ...+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++..
T Consensus        84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            9999999999999999642  336999999999999999999999988   99999999999999999999999999987


Q ss_pred             cCCCCCc-ccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCch-hhhhhhhhhhccccchhc
Q 003599          634 FGGNQDQ-ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDL-TILGYAWKLWNENKILAL  711 (808)
Q Consensus       634 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~  711 (808)
                      ....... .......++..|+|||.+....++.++||||||+++|||++|+.|+....... ..............+.+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL  238 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence            6532221 11112344567999999988899999999999999999999998865322111 000000000000001111


Q ss_pred             cCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003599          712 VDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  757 (808)
Q Consensus       712 ~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~  757 (808)
                      +...... ..+.....++.+++.+|++.+|++||+|.+|+++|+++
T Consensus       239 ~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         239 LKEGERL-PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHcCCcC-CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            1111110 11223346788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=4.9e-35  Score=308.30  Aligned_cols=254  Identities=28%  Similarity=0.463  Sum_probs=204.4

Q ss_pred             hcCCcccCcccccCceeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEec
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  560 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  560 (808)
                      .++|++.++||+|+||.||++...++..+|+|.+... ....+.|.+|+.++++++|+||+++++.+.+ ...+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            3578899999999999999999888888999988643 2345789999999999999999999999887 7789999999


Q ss_pred             CCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCc
Q 003599          561 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  640 (808)
Q Consensus       561 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  640 (808)
                      ++++|.+++... ....+++.++..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++........
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  158 (260)
T cd05073          83 AKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT  158 (260)
T ss_pred             CCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence            999999998653 3456888999999999999999999987   999999999999999999999999999865432211


Q ss_pred             ccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCC
Q 003599          641 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSES  719 (808)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  719 (808)
                       ......++..|+|||.+....++.++|+||||+++||+++ |+.|+....... ...    ....+...    +     
T Consensus       159 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-~~~----~~~~~~~~----~-----  223 (260)
T cd05073         159 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-VIR----ALERGYRM----P-----  223 (260)
T ss_pred             -cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH-HHH----HHhCCCCC----C-----
Confidence             1112345678999999988889999999999999999999 888876432211 111    01111000    0     


Q ss_pred             cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhh
Q 003599          720 SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS  756 (808)
Q Consensus       720 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~  756 (808)
                       ........+.+++.+|++.+|++||++.+|.++|+.
T Consensus       224 -~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         224 -RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             -CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence             112234578899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=4.2e-35  Score=312.23  Aligned_cols=248  Identities=24%  Similarity=0.344  Sum_probs=197.9

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEeccc-ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEe
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  559 (808)
                      ++|++.+.||+|+||.||+|... +++.||+|.+... .....+++.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            35788899999999999999864 6889999998654 233456789999999999999999999999999999999999


Q ss_pred             cCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCC
Q 003599          560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  639 (808)
Q Consensus       560 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  639 (808)
                      +++++|..+.       .+++..+..++.|++.||.|||+.+   |+|+||||+|||++.++.++|+|||++....... 
T Consensus        81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-  149 (279)
T cd06619          81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-  149 (279)
T ss_pred             CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence            9999996543       4678888899999999999999988   9999999999999999999999999998653321 


Q ss_pred             cccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhh---hhhhhhhccccchhccCCcc
Q 003599          640 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTIL---GYAWKLWNENKILALVDPFL  716 (808)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~d~~l  716 (808)
                         .....|+..|+|||.+.+..++.++||||||+++|||++|+.|+..........   ....... .     ...+.+
T Consensus       150 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~-----~~~~~~  220 (279)
T cd06619         150 ---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV-D-----EDPPVL  220 (279)
T ss_pred             ---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHh-c-----cCCCCC
Confidence               223568999999999998889999999999999999999999986433211110   0000000 0     001111


Q ss_pred             cCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          717 SESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       717 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                      ..    .....++.+++.+|++.+|++||+++++++.
T Consensus       221 ~~----~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         221 PV----GQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             CC----CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            11    1233567899999999999999999998874

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.3e-35  Score=318.73  Aligned_cols=241  Identities=27%  Similarity=0.363  Sum_probs=192.3

Q ss_pred             CcccccCceeEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHHhc-cCCceeeEeeEEEeCCeeEEEEEecCC
Q 003599          488 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEYMPN  562 (808)
Q Consensus       488 ~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~  562 (808)
                      +.||+|+||.||+|+.. +++.||||+++...   ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            47999999999999976 47899999987542   33456677788888765 899999999999999999999999999


Q ss_pred             CCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCccc
Q 003599          563 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD  642 (808)
Q Consensus       563 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  642 (808)
                      |+|.+++..   ...+++.++..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~  152 (316)
T cd05619          81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AK  152 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cc
Confidence            999998853   346889999999999999999999988   9999999999999999999999999987532211  12


Q ss_pred             ccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCccc
Q 003599          643 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQ  722 (808)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  722 (808)
                      .....||..|+|||.+.+..++.++|||||||++|||++|+.||....... ....    ...      ..+.     .+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~-~~~~----i~~------~~~~-----~~  216 (316)
T cd05619         153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE-LFQS----IRM------DNPC-----YP  216 (316)
T ss_pred             eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH-HHHH----HHh------CCCC-----CC
Confidence            223568999999999998899999999999999999999999986433221 1110    000      0111     11


Q ss_pred             HHHHHHHHHHHHhcccCCcCCCCCHH-HHHH
Q 003599          723 LDMIIRCIHVGLLCVQELVKDRPNMS-TVVS  752 (808)
Q Consensus       723 ~~~~~~l~~li~~cl~~~P~~RPs~~-ev~~  752 (808)
                      .....++.+++.+|++.+|++||++. ++.+
T Consensus       217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         217 RWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            12335678899999999999999997 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-36  Score=322.14  Aligned_cols=244  Identities=29%  Similarity=0.454  Sum_probs=205.0

Q ss_pred             cccccCceeEEEEEecC-CcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEecCCCCchh
Q 003599          489 KLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDA  567 (808)
Q Consensus       489 ~lG~G~~g~Vy~~~~~~-~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~  567 (808)
                      +||+|.||+||.|++.+ ...+|||.+.....+..+-+.+|+.+.++++|.|||+++|.+.+++..-|.||.++||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            69999999999999875 45699999988777788889999999999999999999999999999999999999999999


Q ss_pred             hccCCCCCCcC--ChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeC-CCCCeeeeccccceecCCCCCccccc
Q 003599          568 LLFDPLKKERL--DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD-EELNPKISDFGMAKIFGGNQDQADTG  644 (808)
Q Consensus       568 ~l~~~~~~~~l--~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~  644 (808)
                      +|..  +-+++  ++...--+.+||++||.|||++.   |||||||-.||||+ -.|.+||+|||-++.+..-.  ..+.
T Consensus       662 LLrs--kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~TE  734 (1226)
T KOG4279|consen  662 LLRS--KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PCTE  734 (1226)
T ss_pred             HHHh--ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCC--cccc
Confidence            9975  33445  77788888999999999999998   99999999999996 57899999999998774332  2344


Q ss_pred             ceeccCCccChhhhccCC--CCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCccc
Q 003599          645 RVVGTFGYMSPEYAMEGR--FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQ  722 (808)
Q Consensus       645 ~~~gt~~y~aPE~~~~~~--~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  722 (808)
                      .+.||.-|||||++..++  |..++|||||||++.||.||++||-.....+..      ++.-|.  -..     ..+.+
T Consensus       735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA------MFkVGm--yKv-----HP~iP  801 (1226)
T KOG4279|consen  735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA------MFKVGM--YKV-----HPPIP  801 (1226)
T ss_pred             ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh------hhhhcc--eec-----CCCCc
Confidence            578999999999998775  789999999999999999999998654443221      111110  011     12366


Q ss_pred             HHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          723 LDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       723 ~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      .+..+++..++++|+.++|.+||+++++++
T Consensus       802 eelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            778899999999999999999999999876

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=7.7e-35  Score=323.49  Aligned_cols=262  Identities=20%  Similarity=0.281  Sum_probs=198.1

Q ss_pred             CCcccCcccccCceeEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCC-----eeE
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE-----EKM  554 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~  554 (808)
                      +|++.++||+|+||.||++... +++.||||++...  .....+++.+|+++++.++|+||+++++++....     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4778899999999999999874 6899999998653  2234567889999999999999999999998776     789


Q ss_pred             EEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceec
Q 003599          555 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF  634 (808)
Q Consensus       555 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~  634 (808)
                      +||||+. ++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~l~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          81 VVTELMQ-SDLHKIIVS---PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             EEeeccc-cCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence            9999996 577777643   456899999999999999999999998   999999999999999999999999999865


Q ss_pred             CCCCCcccccceeccCCccChhhhccC-CCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccc-----
Q 003599          635 GGNQDQADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKI-----  708 (808)
Q Consensus       635 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~-----  708 (808)
                      ...... ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||........+.. ..........     
T Consensus       154 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~-i~~~~g~~~~~~~~~  231 (372)
T cd07853         154 EPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDL-ITDLLGTPSLEAMRS  231 (372)
T ss_pred             ccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHH-HHHHcCCCCHHHHHH
Confidence            432221 12224678999999998764 478999999999999999999999865443221111 1000000000     


Q ss_pred             -----hhccCCcccCC-------cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          709 -----LALVDPFLSES-------SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       709 -----~~~~d~~l~~~-------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                           ...+.......       ........++.+++.+|++.||++|||++|+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence                 00000000000       0111234678899999999999999999999874

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.8e-35  Score=319.38  Aligned_cols=240  Identities=27%  Similarity=0.345  Sum_probs=191.6

Q ss_pred             CcccccCceeEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHHhc-cCCceeeEeeEEEeCCeeEEEEEecCC
Q 003599          488 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEYMPN  562 (808)
Q Consensus       488 ~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~  562 (808)
                      +.||+|+||.||+|+.+ +++.||+|.++...   ....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            47999999999999976 58899999997542   23456677888888765 899999999999999999999999999


Q ss_pred             CCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCccc
Q 003599          563 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD  642 (808)
Q Consensus       563 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  642 (808)
                      |+|..++..   ...+++.++..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~  152 (316)
T cd05620          81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NR  152 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cc
Confidence            999988853   346889999999999999999999998   9999999999999999999999999987532111  11


Q ss_pred             ccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCccc
Q 003599          643 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQ  722 (808)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  722 (808)
                      .....||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ....    ....      .+.     .+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~-~~~~----~~~~------~~~-----~~  216 (316)
T cd05620         153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE-LFES----IRVD------TPH-----YP  216 (316)
T ss_pred             eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-HHHH----HHhC------CCC-----CC
Confidence            223568999999999999999999999999999999999999986433221 1110    0000      111     11


Q ss_pred             HHHHHHHHHHHHhcccCCcCCCCCHH-HHH
Q 003599          723 LDMIIRCIHVGLLCVQELVKDRPNMS-TVV  751 (808)
Q Consensus       723 ~~~~~~l~~li~~cl~~~P~~RPs~~-ev~  751 (808)
                      .....++.+++.+|++.||++||++. ++.
T Consensus       217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         217 RWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            12345678899999999999999984 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=5e-35  Score=307.38  Aligned_cols=248  Identities=29%  Similarity=0.407  Sum_probs=199.1

Q ss_pred             cCCcccCcccccCceeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEE-eCCeeEEEEEec
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV-EGEEKMLIYEYM  560 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~-~~~~~~lV~E~~  560 (808)
                      ++|++.+.||+|+||.||++... +..||+|.++..  ...+.|.+|+.++++++|+|++++++++. ++...++||||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            46888999999999999999876 788999998643  23568999999999999999999999765 456789999999


Q ss_pred             CCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCc
Q 003599          561 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  640 (808)
Q Consensus       561 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  640 (808)
                      ++++|.+++... ....+++..+.+++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++......  
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  156 (256)
T cd05082          83 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  156 (256)
T ss_pred             CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence            999999998653 2345889999999999999999999988   9999999999999999999999999988653222  


Q ss_pred             ccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCC
Q 003599          641 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSES  719 (808)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  719 (808)
                         ....++..|+|||.+....++.++||||||+++|||++ |+.|+....... ..   ... ..+     ..+.    
T Consensus       157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~-~~---~~~-~~~-----~~~~----  219 (256)
T cd05082         157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-VV---PRV-EKG-----YKMD----  219 (256)
T ss_pred             ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH-HH---HHH-hcC-----CCCC----
Confidence               12334678999999988889999999999999999998 888875322111 11   100 000     0001    


Q ss_pred             cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhh
Q 003599          720 SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS  756 (808)
Q Consensus       720 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~  756 (808)
                       ........+.+++.+|++.+|++||++.++++.|+.
T Consensus       220 -~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         220 -APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             -CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence             112335678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.9e-35  Score=321.81  Aligned_cols=237  Identities=24%  Similarity=0.293  Sum_probs=188.4

Q ss_pred             CcccccCceeEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHH-HHHhccCCceeeEeeEEEeCCeeEEEEEecCC
Q 003599          488 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVM-VISKLQHRNLVRLLGCCVEGEEKMLIYEYMPN  562 (808)
Q Consensus       488 ~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  562 (808)
                      +.||+|+||+||+|+.. +++.||+|++.+..   ....+++..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            47999999999999976 68999999987532   223345555555 56789999999999999999999999999999


Q ss_pred             CCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCccc
Q 003599          563 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD  642 (808)
Q Consensus       563 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  642 (808)
                      |+|..++..   ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~  152 (323)
T cd05575          81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KT  152 (323)
T ss_pred             CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cc
Confidence            999998853   346888999999999999999999998   9999999999999999999999999987532221  12


Q ss_pred             ccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCccc
Q 003599          643 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQ  722 (808)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  722 (808)
                      .....||+.|+|||.+.+..++.++|||||||++|||++|+.||........    ......         ....   ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~----~~~i~~---------~~~~---~~  216 (323)
T cd05575         153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM----YDNILN---------KPLR---LK  216 (323)
T ss_pred             cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHH----HHHHHc---------CCCC---CC
Confidence            2235689999999999999999999999999999999999999864322111    111110         0000   11


Q ss_pred             HHHHHHHHHHHHhcccCCcCCCCCHH
Q 003599          723 LDMIIRCIHVGLLCVQELVKDRPNMS  748 (808)
Q Consensus       723 ~~~~~~l~~li~~cl~~~P~~RPs~~  748 (808)
                      ......+.+++.+|++.+|++||++.
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         217 PNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            12345688999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=4.3e-35  Score=343.95  Aligned_cols=263  Identities=21%  Similarity=0.322  Sum_probs=206.0

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  557 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  557 (808)
                      ++|++.++||+|+||.||+|... .++.||+|+++...   ....++|.+|++++++++||||+++++++.+++..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57899999999999999999876 58899999987542   223567999999999999999999999999999999999


Q ss_pred             EecCCCCchhhccCCC--------CCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccc
Q 003599          558 EYMPNRSLDALLFDPL--------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFG  629 (808)
Q Consensus       558 E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFG  629 (808)
                      ||+++++|.+++....        ....+++..+++++.||++||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence            9999999999885321        1234667788999999999999999988   9999999999999999999999999


Q ss_pred             cceecCCCCC----------------cccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCch
Q 003599          630 MAKIFGGNQD----------------QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDL  693 (808)
Q Consensus       630 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~  693 (808)
                      +++.......                ........||+.|+|||.+.+..++.++|||||||++|||+||+.|+.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9987621110                001122469999999999999999999999999999999999999986422111


Q ss_pred             hhhhhhhhhhccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCC-CHHHHHHHHhhcccC
Q 003599          694 TILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRP-NMSTVVSMLNSEIRD  760 (808)
Q Consensus       694 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RP-s~~ev~~~L~~~~~~  760 (808)
                      ...        ...   ..++....  ...+.+..+.+++.+|++.||++|| +++++.+.|+..+..
T Consensus       239 i~~--------~~~---i~~P~~~~--p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~  293 (932)
T PRK13184        239 ISY--------RDV---ILSPIEVA--PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG  293 (932)
T ss_pred             hhh--------hhh---ccChhhcc--ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence            000        000   01110000  0113345678899999999999996 788888888776543

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=4.5e-35  Score=310.10  Aligned_cols=254  Identities=24%  Similarity=0.356  Sum_probs=190.3

Q ss_pred             CcccccCceeEEEEEecC---CcEEEEEEecccc-cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEecCCC
Q 003599          488 SKLGQGGFGPVYWGRLKD---GQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNR  563 (808)
Q Consensus       488 ~~lG~G~~g~Vy~~~~~~---~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  563 (808)
                      ++||+|+||.||+|...+   ...+|+|.+.... ......|.+|+.+++.++|+||+++++.+.+....++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            369999999999997543   4568888876543 233567889999999999999999999999999999999999999


Q ss_pred             CchhhccCCCC--CCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCcc
Q 003599          564 SLDALLFDPLK--KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA  641 (808)
Q Consensus       564 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  641 (808)
                      +|.+++.....  ....++.....++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            99999865322  234567788899999999999999988   9999999999999999999999999987543222111


Q ss_pred             cccceeccCCccChhhhcc-------CCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhccccchhccC
Q 003599          642 DTGRVVGTFGYMSPEYAME-------GRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVD  713 (808)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~~-------~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  713 (808)
                      ......++..|+|||++..       ..++.++||||||+++|||++ |..|+....+...+..    .... ......+
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~----~~~~-~~~~~~~  232 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQ----VVRE-QDIKLPK  232 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHH----Hhhc-cCccCCC
Confidence            1222345778999998743       356889999999999999999 6777754432221111    1111 1112222


Q ss_pred             CcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHh
Q 003599          714 PFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN  755 (808)
Q Consensus       714 ~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~  755 (808)
                      +.+     .......+.+++..|+ .+|++||++++|+++|.
T Consensus       233 ~~~-----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         233 PQL-----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             Ccc-----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            222     2223455667777887 59999999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=5.5e-35  Score=308.41  Aligned_cols=240  Identities=22%  Similarity=0.336  Sum_probs=189.1

Q ss_pred             CcccccCceeEEEEEecC-------------CcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeE
Q 003599          488 SKLGQGGFGPVYWGRLKD-------------GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKM  554 (808)
Q Consensus       488 ~~lG~G~~g~Vy~~~~~~-------------~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  554 (808)
                      +.||+|+||.||+|+...             ...||+|.+..........|.+|+.+++.++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            478999999999998532             2358999887655555678899999999999999999999999999999


Q ss_pred             EEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCC-------eeeec
Q 003599          555 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELN-------PKISD  627 (808)
Q Consensus       555 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~-------~kl~D  627 (808)
                      +||||+++++|+.++..  ....+++..+.+++.||++||+|||+.+   |+||||||+|||++.++.       ++++|
T Consensus        81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            99999999999988854  3356899999999999999999999988   999999999999987664       89999


Q ss_pred             cccceecCCCCCcccccceeccCCccChhhhc-cCCCCccccEEehhHHHHHHH-hCCCCCCCCCCchhhhhhhhhhhcc
Q 003599          628 FGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM-EGRFSEKSDVFSFGVLLLEIV-SGRKNTSFFEDDLTILGYAWKLWNE  705 (808)
Q Consensus       628 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~k~DvwSlGvil~ell-tG~~p~~~~~~~~~~~~~~~~~~~~  705 (808)
                      ||++......      ....++..|+|||.+. ...++.++||||||+++|||+ +|+.|+....... ..    ... .
T Consensus       156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~----~~~-~  223 (262)
T cd05077         156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-KE----RFY-E  223 (262)
T ss_pred             CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH-HH----HHH-h
Confidence            9998754321      1245788999999886 456899999999999999998 5777664322111 00    000 0


Q ss_pred             ccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHh
Q 003599          706 NKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN  755 (808)
Q Consensus       706 ~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~  755 (808)
                      +..      ..     ......++.+++.+|++.+|++||++.+|++.|+
T Consensus       224 ~~~------~~-----~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         224 GQC------ML-----VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             cCc------cC-----CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            000      00     0112356789999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=5.2e-35  Score=308.18  Aligned_cols=251  Identities=27%  Similarity=0.419  Sum_probs=193.2

Q ss_pred             CcccccCceeEEEEEec----CCcEEEEEEeccc-ccccHHHHHHHHHHHHhccCCceeeEeeEEE-eCCeeEEEEEecC
Q 003599          488 SKLGQGGFGPVYWGRLK----DGQEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCCV-EGEEKMLIYEYMP  561 (808)
Q Consensus       488 ~~lG~G~~g~Vy~~~~~----~~~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~-~~~~~~lV~E~~~  561 (808)
                      +.||+|+||.||+|.+.    ++..||+|++... .....+.+.+|+.+++.++||||+++++++. .+...++||||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            47899999999999864    2457999998543 2344678899999999999999999999876 4556789999999


Q ss_pred             CCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCc-
Q 003599          562 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ-  640 (808)
Q Consensus       562 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~-  640 (808)
                      +++|.+++...  ...+++..+..++.|+++||+|||+.+   ++||||||+|||+++++.+||+|||+++........ 
T Consensus        81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence            99999998642  334677888999999999999999987   999999999999999999999999999865322111 


Q ss_pred             -ccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCC-CCCCCCCchhhhhhhhhhhccccchhccCCcccC
Q 003599          641 -ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRK-NTSFFEDDLTILGYAWKLWNENKILALVDPFLSE  718 (808)
Q Consensus       641 -~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  718 (808)
                       .......++..|+|||.+....++.++||||||+++|||++|+. |+... +.......   .. .+.     .+.   
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~-~~~~~~~~---~~-~~~-----~~~---  222 (262)
T cd05058         156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-DSFDITVY---LL-QGR-----RLL---  222 (262)
T ss_pred             ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHH---Hh-cCC-----CCC---
Confidence             11112345778999999988889999999999999999999654 44322 22121111   11 110     000   


Q ss_pred             CcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhcc
Q 003599          719 SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEI  758 (808)
Q Consensus       719 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~  758 (808)
                        .+...+..+.+++.+|++.+|++||++.+|++.|+++.
T Consensus       223 --~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         223 --QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             --CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence              11122457889999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.4e-34  Score=319.76  Aligned_cols=262  Identities=22%  Similarity=0.241  Sum_probs=196.5

Q ss_pred             HhcCCcccCcccccCceeEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCC-----
Q 003599          480 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE-----  551 (808)
Q Consensus       480 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----  551 (808)
                      ..++|++.+.||+|+||.||+++.. .+..||||++...  .......+.+|+.+++.++||||+++++++....     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            4578999999999999999999875 5889999998653  2334567889999999999999999999986543     


Q ss_pred             -eeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeecccc
Q 003599          552 -EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGM  630 (808)
Q Consensus       552 -~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGl  630 (808)
                       ..++||||+++ +|...+.     ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~  169 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  169 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence             46899999975 5655553     24788888999999999999999998   99999999999999999999999999


Q ss_pred             ceecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhh---------
Q 003599          631 AKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWK---------  701 (808)
Q Consensus       631 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~---------  701 (808)
                      ++......   ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...+...........         
T Consensus       170 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  246 (359)
T cd07876         170 ARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM  246 (359)
T ss_pred             ccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence            97543221   122356899999999999999999999999999999999999998754322111100000         


Q ss_pred             ---------hhccc------cchhccCCcccC--CcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          702 ---------LWNEN------KILALVDPFLSE--SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       702 ---------~~~~~------~~~~~~d~~l~~--~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                               .....      ...+........  .........++.+++.+|++.||++|||+.|+++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence                     00000      000000000000  00111124567899999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=3.7e-35  Score=311.14  Aligned_cols=253  Identities=26%  Similarity=0.399  Sum_probs=199.5

Q ss_pred             HHhcCCcccCcccccCceeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHHhc-cCCceeeEeeEEEeC------
Q 003599          479 TATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEG------  550 (808)
Q Consensus       479 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~------  550 (808)
                      .+++.|++.+.||+|+||.||+|... +++.||+|++... ......+.+|+.++.++ +|+||+++++++...      
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            35678899999999999999999875 5788999998654 34456788999999999 799999999998753      


Q ss_pred             CeeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeecccc
Q 003599          551 EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGM  630 (808)
Q Consensus       551 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGl  630 (808)
                      ...++||||+++++|.+++... ....+++..+..++.|++.||+|||+.+   |+|+||||+||++++++.++|+|||+
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~  157 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV  157 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence            4578999999999999998652 3346889999999999999999999988   99999999999999999999999999


Q ss_pred             ceecCCCCCcccccceeccCCccChhhhc-----cCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhcc
Q 003599          631 AKIFGGNQDQADTGRVVGTFGYMSPEYAM-----EGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNE  705 (808)
Q Consensus       631 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~  705 (808)
                      ++.......  ......|+..|+|||++.     ...++.++||||||+++|||++|+.|+..........    .... 
T Consensus       158 ~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~----~~~~-  230 (272)
T cd06637         158 SAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF----LIPR-  230 (272)
T ss_pred             ceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH----HHhc-
Confidence            986533221  122356899999999986     3457889999999999999999999985433211111    0000 


Q ss_pred             ccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          706 NKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       706 ~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                           ...+...    .......+.+++.+|++.+|.+||++.+|++
T Consensus       231 -----~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         231 -----NPAPRLK----SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             -----CCCCCCC----CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence                 0011111    1123356789999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=5.7e-35  Score=309.61  Aligned_cols=250  Identities=29%  Similarity=0.428  Sum_probs=195.3

Q ss_pred             CcccccCceeEEEEEecC-Cc--EEEEEEecccc-cccHHHHHHHHHHHHhc-cCCceeeEeeEEEeCCeeEEEEEecCC
Q 003599          488 SKLGQGGFGPVYWGRLKD-GQ--EIAVKRLSKAS-GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEYMPN  562 (808)
Q Consensus       488 ~~lG~G~~g~Vy~~~~~~-~~--~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~  562 (808)
                      +.||+|+||.||+|++++ +.  .+|+|.+.... ....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            469999999999999764 33  47888886532 34456889999999999 899999999999999999999999999


Q ss_pred             CCchhhccCCC-------------CCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccc
Q 003599          563 RSLDALLFDPL-------------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFG  629 (808)
Q Consensus       563 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFG  629 (808)
                      |+|.+++....             ....+++.++..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence            99999986421             1235789999999999999999999987   9999999999999999999999999


Q ss_pred             cceecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhccccc
Q 003599          630 MAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKI  708 (808)
Q Consensus       630 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~  708 (808)
                      +++.....   ........+..|+|||++....++.++||||||+++|||++ |..||....... ...   .. ..+. 
T Consensus       158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-~~~---~~-~~~~-  228 (270)
T cd05047         158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-LYE---KL-PQGY-  228 (270)
T ss_pred             Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH-HHH---HH-hCCC-
Confidence            98632111   11111233567999999988889999999999999999997 888875322111 111   01 0000 


Q ss_pred             hhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhcc
Q 003599          709 LALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEI  758 (808)
Q Consensus       709 ~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~  758 (808)
                            ...   ........+.+++.+|++.+|.+||++.++++.|++++
T Consensus       229 ------~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         229 ------RLE---KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             ------CCC---CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence                  000   11123456789999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-36  Score=325.25  Aligned_cols=252  Identities=29%  Similarity=0.408  Sum_probs=210.6

Q ss_pred             CCcccCcccccCceeEEEEEec--CCc--EEEEEEecccccc-cHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEE
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLK--DGQ--EIAVKRLSKASGQ-GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  557 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~--~~~--~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  557 (808)
                      ...+.++||+|.||.|++|.+.  +|+  .||||.++..... ...+|++|+.+|.+|+|||++++||...+ ....+|+
T Consensus       111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~  189 (1039)
T KOG0199|consen  111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF  189 (1039)
T ss_pred             HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence            3455689999999999999876  343  5899999876443 67899999999999999999999999887 7788999


Q ss_pred             EecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCC
Q 003599          558 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  637 (808)
Q Consensus       558 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  637 (808)
                      |.++.|+|.+.|++ .....+-......++.|||.||.||..+.   +|||||..+||||.....+||+||||.|.++..
T Consensus       190 ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~n  265 (1039)
T KOG0199|consen  190 ELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGEN  265 (1039)
T ss_pred             hhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCC
Confidence            99999999999987 46677888999999999999999999988   999999999999999999999999999988765


Q ss_pred             CCcc-cccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhccccchhccCCc
Q 003599          638 QDQA-DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPF  715 (808)
Q Consensus       638 ~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  715 (808)
                      .... ......-...|+|||.+...+|+.++|||+|||+||||+| |..|+.....              -.+.+.+|..
T Consensus       266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g--------------~qIL~~iD~~  331 (1039)
T KOG0199|consen  266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG--------------IQILKNIDAG  331 (1039)
T ss_pred             CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH--------------HHHHHhcccc
Confidence            4432 2333445788999999999999999999999999999999 5566643322              2344455532


Q ss_pred             ccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHH
Q 003599          716 LSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML  754 (808)
Q Consensus       716 l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L  754 (808)
                      -. -+.+..+.+++.++++.||..+|++||++..|++.+
T Consensus       332 er-LpRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  332 ER-LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             cc-CCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            22 235667889999999999999999999999998544

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=7.2e-35  Score=308.39  Aligned_cols=257  Identities=25%  Similarity=0.385  Sum_probs=201.1

Q ss_pred             HHHhcCCcccCcccccCceeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEE
Q 003599          478 ATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI  556 (808)
Q Consensus       478 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  556 (808)
                      +.+++++.....||+|+||.||+|+.. ++..||+|.+........+.+.+|+.++++++|+||+++++++..++..++|
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   83 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF   83 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence            344566666689999999999999865 5788999998776666677899999999999999999999999999999999


Q ss_pred             EEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCC-CCCeeeeccccceecC
Q 003599          557 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE-ELNPKISDFGMAKIFG  635 (808)
Q Consensus       557 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~-~~~~kl~DFGla~~~~  635 (808)
                      +||+++++|.+++.........++..+..++.||++||+|||+.+   |+||||||+||+++. ++.++|+|||++....
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~  160 (268)
T cd06624          84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA  160 (268)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence            999999999999865322112278888899999999999999988   999999999999976 6799999999998654


Q ss_pred             CCCCcccccceeccCCccChhhhccCC--CCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccC
Q 003599          636 GNQDQADTGRVVGTFGYMSPEYAMEGR--FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVD  713 (808)
Q Consensus       636 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  713 (808)
                      ....  ......|+..|+|||.+....  ++.++||||||+++|||++|+.|+.......... +.....       ...
T Consensus       161 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~-~~~~~~-------~~~  230 (268)
T cd06624         161 GINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM-FKVGMF-------KIH  230 (268)
T ss_pred             cCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH-hhhhhh-------ccC
Confidence            3221  112245789999999986644  7889999999999999999999985432211110 000000       001


Q ss_pred             CcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          714 PFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       714 ~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      +.     .+.....++.+++.+|++.+|++||++.+|++
T Consensus       231 ~~-----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         231 PE-----IPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             CC-----CCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            11     22234567889999999999999999999876

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=7.7e-35  Score=322.74  Aligned_cols=258  Identities=22%  Similarity=0.255  Sum_probs=200.4

Q ss_pred             HHHHhcCCcccCcccccCceeEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCe
Q 003599          477 LATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEE  552 (808)
Q Consensus       477 l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  552 (808)
                      +....++|++.+.||+|+||.||+++.+ +++.+|+|++.+.   .....+.+.+|+.+++.++||||+++++.+.++..
T Consensus        38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (371)
T cd05622          38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY  117 (371)
T ss_pred             cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence            3444578999999999999999999976 5789999998642   22334567899999999999999999999999999


Q ss_pred             eEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccce
Q 003599          553 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK  632 (808)
Q Consensus       553 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~  632 (808)
                      .++||||+++|+|.+++..    ..++...+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       118 ~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~  190 (371)
T cd05622         118 LYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM  190 (371)
T ss_pred             EEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence            9999999999999998843    35788888999999999999999998   9999999999999999999999999998


Q ss_pred             ecCCCCCcccccceeccCCccChhhhccC----CCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccc
Q 003599          633 IFGGNQDQADTGRVVGTFGYMSPEYAMEG----RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKI  708 (808)
Q Consensus       633 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  708 (808)
                      ....... .......||+.|+|||.+...    .++.++|||||||++|||++|+.||.......    ...........
T Consensus       191 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~----~~~~i~~~~~~  265 (371)
T cd05622         191 KMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG----TYSKIMNHKNS  265 (371)
T ss_pred             EcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH----HHHHHHcCCCc
Confidence            7643221 122235799999999998653    37889999999999999999999986432211    11111111110


Q ss_pred             hhccCCcccCCcccHHHHHHHHHHHHhcccCCcCC--CCCHHHHHHHH
Q 003599          709 LALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKD--RPNMSTVVSML  754 (808)
Q Consensus       709 ~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~--RPs~~ev~~~L  754 (808)
                      ....        ........+.+++.+|++.++.+  ||+++++++..
T Consensus       266 ~~~~--------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         266 LTFP--------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             ccCC--------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence            1111        11234456778899999854443  78999988854

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=5.1e-35  Score=307.18  Aligned_cols=252  Identities=29%  Similarity=0.489  Sum_probs=202.5

Q ss_pred             cCCcccCcccccCceeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEecC
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMP  561 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  561 (808)
                      .+|++.+.||+|+||.||++...++..+|+|.+... ......|.+|++++++++|||++++++++......++||||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            467888999999999999999877889999988643 2345689999999999999999999999999999999999999


Q ss_pred             CCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCcc
Q 003599          562 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA  641 (808)
Q Consensus       562 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  641 (808)
                      +++|.+++..  ....+++..+..++.+++.|++|||+.+   ++|+||||+||+++.++.+||+|||+++.........
T Consensus        83 ~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~  157 (256)
T cd05112          83 HGCLSDYLRA--QRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS  157 (256)
T ss_pred             CCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence            9999999864  2346889999999999999999999988   9999999999999999999999999998654322111


Q ss_pred             cccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCc
Q 003599          642 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS  720 (808)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  720 (808)
                       .....++..|+|||.+..+.++.++||||||+++|||++ |+.|+....... ..   ... ..+  .....+..    
T Consensus       158 -~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-~~---~~~-~~~--~~~~~~~~----  225 (256)
T cd05112         158 -STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE-VV---ETI-NAG--FRLYKPRL----  225 (256)
T ss_pred             -cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH-HH---HHH-hCC--CCCCCCCC----
Confidence             111235678999999988889999999999999999998 888875432211 11   111 110  01111111    


Q ss_pred             ccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHh
Q 003599          721 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN  755 (808)
Q Consensus       721 ~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~  755 (808)
                          ....+.+++.+|++.+|++||++.+|+++|.
T Consensus       226 ----~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         226 ----ASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             ----CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence                2357889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=4.6e-35  Score=320.41  Aligned_cols=259  Identities=26%  Similarity=0.414  Sum_probs=204.3

Q ss_pred             cCCcccCcccccCceeEEEEEec--------CCcEEEEEEecccc-cccHHHHHHHHHHHHhc-cCCceeeEeeEEEeCC
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK--------DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGE  551 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~  551 (808)
                      .+|++.+.||+|+||.||++...        .+..||+|.+.... ....+++.+|+.+++++ +||||+++++++..+.
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            46889999999999999999742        12368999887542 33467899999999999 8999999999999999


Q ss_pred             eeEEEEEecCCCCchhhccCCC-------------CCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeC
Q 003599          552 EKMLIYEYMPNRSLDALLFDPL-------------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD  618 (808)
Q Consensus       552 ~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~  618 (808)
                      ..+++|||+++|+|.+++....             ....+++.++..++.|++.||+|||+.+   ++||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence            9999999999999999986421             2345888999999999999999999988   99999999999999


Q ss_pred             CCCCeeeeccccceecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhh
Q 003599          619 EELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILG  697 (808)
Q Consensus       619 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~  697 (808)
                      .++.+||+|||+++...............++..|+|||.+....++.++||||||+++|||++ |+.|+....... .. 
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-~~-  246 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-LF-  246 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH-HH-
Confidence            999999999999986643322222222334567999999999899999999999999999998 777775332111 11 


Q ss_pred             hhhhhhccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhcc
Q 003599          698 YAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEI  758 (808)
Q Consensus       698 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~  758 (808)
                        ... ..+...+          .+.....++.+++.+|++.+|++||++.++++.|+++.
T Consensus       247 --~~~-~~~~~~~----------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~  294 (334)
T cd05100         247 --KLL-KEGHRMD----------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL  294 (334)
T ss_pred             --HHH-HcCCCCC----------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence              111 1110000          11223457889999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=6.9e-35  Score=306.07  Aligned_cols=250  Identities=20%  Similarity=0.289  Sum_probs=202.3

Q ss_pred             CCcccCcccccCceeEEEEEec-CCcEEEEEEeccc-ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEec
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  560 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  560 (808)
                      +|++.++||+|+||.||+++.. +++.+|+|.++.. .....+.+.+|+.++++++|+||+++++.+..++..++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4788899999999999999876 5889999998643 2345677889999999999999999999999999999999999


Q ss_pred             CCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCc
Q 003599          561 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  640 (808)
Q Consensus       561 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  640 (808)
                      ++++|.+++... ....++......++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||+++........
T Consensus        81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  156 (255)
T cd08219          81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY  156 (255)
T ss_pred             CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence            999999888542 3446789999999999999999999988   999999999999999999999999999866432211


Q ss_pred             ccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCc
Q 003599          641 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS  720 (808)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  720 (808)
                        .....|+..|+|||.+....++.++|+||||+++|+|++|+.|+........    .... ..+...          .
T Consensus       157 --~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~----~~~~-~~~~~~----------~  219 (255)
T cd08219         157 --ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL----ILKV-CQGSYK----------P  219 (255)
T ss_pred             --cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH----HHHH-hcCCCC----------C
Confidence              1235688999999999888899999999999999999999999864221111    1111 111110          0


Q ss_pred             ccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          721 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       721 ~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                      .+......+.+++.+|++.+|++||++.+|++.
T Consensus       220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            112234567899999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4e-35  Score=311.63  Aligned_cols=239  Identities=24%  Similarity=0.344  Sum_probs=188.5

Q ss_pred             cccccCceeEEEEEecC-------------------------CcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeE
Q 003599          489 KLGQGGFGPVYWGRLKD-------------------------GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRL  543 (808)
Q Consensus       489 ~lG~G~~g~Vy~~~~~~-------------------------~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l  543 (808)
                      +||+|+||.||+|.+..                         ...||+|.+.........+|.+|+.++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999997421                         23589999876555556789999999999999999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCC--
Q 003599          544 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL--  621 (808)
Q Consensus       544 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~--  621 (808)
                      ++++.+....++||||+++|+|+.++..  ....+++..+.+++.||++||+|||+.+   |+||||||+|||++..+  
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence            9999999999999999999999998854  3456889999999999999999999987   99999999999997654  


Q ss_pred             -----CeeeeccccceecCCCCCcccccceeccCCccChhhhcc-CCCCccccEEehhHHHHHHH-hCCCCCCCCCCchh
Q 003599          622 -----NPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIV-SGRKNTSFFEDDLT  694 (808)
Q Consensus       622 -----~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvil~ell-tG~~p~~~~~~~~~  694 (808)
                           .+|++|||++.......      ...++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+........
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~~------~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~  230 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSRE------ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK  230 (274)
T ss_pred             cCccceeeecCCcccccccccc------ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence                 37999999886442211      1346788999998865 56899999999999999995 68888764332211


Q ss_pred             hhhhhhhhhccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHh
Q 003599          695 ILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN  755 (808)
Q Consensus       695 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~  755 (808)
                       ...    ...       ...+     +.....++.+++.+|++.+|++||++.+|++.|.
T Consensus       231 -~~~----~~~-------~~~~-----~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         231 -ERF----YEK-------KHRL-----PEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             -HHH----HHh-------ccCC-----CCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence             110    000       0001     1111246788999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=6.2e-35  Score=308.62  Aligned_cols=252  Identities=22%  Similarity=0.394  Sum_probs=200.9

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEec
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  560 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  560 (808)
                      ++|++.+.||+|+||.||+|+.. +++.||+|.++.........+.+|+.+++.++||||+++++.+..++..++||||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            57888899999999999999865 58899999987655555567889999999999999999999999999999999999


Q ss_pred             CCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCc
Q 003599          561 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  640 (808)
Q Consensus       561 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  640 (808)
                      ++++|.+++..   .+.+++.++..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.......  
T Consensus        89 ~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--  160 (267)
T cd06645          89 GGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI--  160 (267)
T ss_pred             CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc--
Confidence            99999998853   346899999999999999999999998   9999999999999999999999999987654322  


Q ss_pred             ccccceeccCCccChhhhc---cCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCccc
Q 003599          641 ADTGRVVGTFGYMSPEYAM---EGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS  717 (808)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~---~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  717 (808)
                      .......|+..|+|||.+.   ...++.++|||||||++|||++|+.|+.............     ...   ...+...
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~-----~~~---~~~~~~~  232 (267)
T cd06645         161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMT-----KSN---FQPPKLK  232 (267)
T ss_pred             cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhh-----ccC---CCCCccc
Confidence            1122356899999999874   4568899999999999999999999875333221111110     000   0011110


Q ss_pred             CCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          718 ESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       718 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      .   .......+.+++.+|++.+|++||++++|++
T Consensus       233 ~---~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         233 D---KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             c---cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            0   0112346788999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.9e-35  Score=309.34  Aligned_cols=252  Identities=29%  Similarity=0.455  Sum_probs=199.6

Q ss_pred             CcccCcccccCceeEEEEEecC-CcEEEEEEecccccccH--HHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEec
Q 003599          484 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGL--EEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  560 (808)
Q Consensus       484 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vAvK~l~~~~~~~~--~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  560 (808)
                      |++.+.||+|+||+||+++... ++.+|+|.+........  ....+|+.++++++||||+++++++.+....++|||++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            5678999999999999999874 66899999976543322  23456999999999999999999999999999999999


Q ss_pred             CCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCc
Q 003599          561 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  640 (808)
Q Consensus       561 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  640 (808)
                      ++++|.+++.   ....+++.++..++.|+++||++||+.+   ++|+||||+||++++++.++|+|||.+.....  ..
T Consensus        81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~  152 (260)
T PF00069_consen   81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NN  152 (260)
T ss_dssp             TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTS--TT
T ss_pred             cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc--cc
Confidence            9999999996   3567899999999999999999999998   99999999999999999999999999986521  12


Q ss_pred             ccccceeccCCccChhhhc-cCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCC
Q 003599          641 ADTGRVVGTFGYMSPEYAM-EGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSES  719 (808)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~-~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  719 (808)
                      .......++..|+|||.+. ....+.++||||+|+++|+|++|+.|+.......... ........    .......   
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~-~~~~~~~~----~~~~~~~---  224 (260)
T PF00069_consen  153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLE-IIEKILKR----PLPSSSQ---  224 (260)
T ss_dssp             SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHH-HHHHHHHT----HHHHHTT---
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhh-hhhhcccc----ccccccc---
Confidence            2333457899999999998 7889999999999999999999999987541111111 01000000    0000000   


Q ss_pred             cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          720 SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       720 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                       ........+.+++.+||+.+|++||++.++++
T Consensus       225 -~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  225 -QSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             -SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             -ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             00111278899999999999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-35  Score=327.36  Aligned_cols=258  Identities=26%  Similarity=0.404  Sum_probs=214.6

Q ss_pred             CcccCcccccCceeEEEEEec-C----CcEEEEEEeccc-ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEE
Q 003599          484 FQLSSKLGQGGFGPVYWGRLK-D----GQEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  557 (808)
Q Consensus       484 ~~~~~~lG~G~~g~Vy~~~~~-~----~~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  557 (808)
                      ....++||+|+||+||+|.+- +    +-+||+|++... ..+...++++|+.+|.+++|||+++++|+|.... ..||+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            344679999999999999753 3    346999998764 4556789999999999999999999999998766 88999


Q ss_pred             EecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCC
Q 003599          558 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  637 (808)
Q Consensus       558 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  637 (808)
                      +||+.|+|.+|++.  ++..+..+..+.|..|||+||.|||.+.   ++||||.++||||.+-..+||.|||+++....+
T Consensus       777 q~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             HhcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            99999999999976  5677889999999999999999999887   999999999999999999999999999998877


Q ss_pred             CCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhccccchhccCCcc
Q 003599          638 QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL  716 (808)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  716 (808)
                      ..+.......-.+.|||-|.+....++.++|||||||++||++| |.+|+.....+              .+.++++...
T Consensus       852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~--------------eI~dlle~ge  917 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE--------------EIPDLLEKGE  917 (1177)
T ss_pred             cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH--------------HhhHHHhccc
Confidence            66655555566789999999999999999999999999999999 78887543321              1222222222


Q ss_pred             cCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhcccCCC
Q 003599          717 SESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLP  762 (808)
Q Consensus       717 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~~~~~  762 (808)
                      + -+.+.....++..++.+||..|++.||+++++.....+..++.+
T Consensus       918 R-LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpq  962 (1177)
T KOG1025|consen  918 R-LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQ  962 (1177)
T ss_pred             c-CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcc
Confidence            1 12455667888999999999999999999999999987755433

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=9e-35  Score=311.82  Aligned_cols=251  Identities=25%  Similarity=0.391  Sum_probs=202.1

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEec
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  560 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  560 (808)
                      +.|++.++||+|+||.||+|+.. +++.+|+|.+........+.+.+|+.++++++|+||+++++.+..+...++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            56889999999999999999976 48899999998766666788999999999999999999999999999999999999


Q ss_pred             CCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCc
Q 003599          561 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  640 (808)
Q Consensus       561 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  640 (808)
                      ++++|..++.+  ....+++..+..++.|+++||+|||+.+   ++||||||+||+++.++.+||+|||+++......  
T Consensus        92 ~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--  164 (292)
T cd06644          92 PGGAVDAIMLE--LDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--  164 (292)
T ss_pred             CCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc--
Confidence            99999888754  2346899999999999999999999987   9999999999999999999999999987543221  


Q ss_pred             ccccceeccCCccChhhhc-----cCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCc
Q 003599          641 ADTGRVVGTFGYMSPEYAM-----EGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPF  715 (808)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  715 (808)
                      .......++..|+|||.+.     ...++.++||||||+++|||++|+.|+............    . .     ...+.
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~----~-~-----~~~~~  234 (292)
T cd06644         165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI----A-K-----SEPPT  234 (292)
T ss_pred             cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHH----h-c-----CCCcc
Confidence            1122346788999999884     345688999999999999999999988543322111111    0 0     00111


Q ss_pred             ccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          716 LSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       716 l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      ..   .+.....++.+++.+|++.+|++||++++|++
T Consensus       235 ~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         235 LS---QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             CC---CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            11   11223456788999999999999999999876

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=8.7e-35  Score=305.14  Aligned_cols=250  Identities=26%  Similarity=0.405  Sum_probs=204.9

Q ss_pred             hcCCcccCcccccCceeEEEEEecC-CcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEe
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  559 (808)
                      .++|++.+.||+|+||.||+|...+ ++.+|+|.+.....  .+++.+|++++++++|+||+++++++.+....++++||
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            3678999999999999999999875 78999999865432  68899999999999999999999999999999999999


Q ss_pred             cCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCC
Q 003599          560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  639 (808)
Q Consensus       560 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  639 (808)
                      +++++|.+++..  ....+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.+||+|||++........
T Consensus        80 ~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (256)
T cd06612          80 CGAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA  154 (256)
T ss_pred             CCCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence            999999999854  3457899999999999999999999988   99999999999999999999999999986643221


Q ss_pred             cccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCC
Q 003599          640 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSES  719 (808)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  719 (808)
                        ......++..|+|||.+.+..++.++||||||+++|||++|+.|+............          .....+.+   
T Consensus       155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~----------~~~~~~~~---  219 (256)
T cd06612         155 --KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI----------PNKPPPTL---  219 (256)
T ss_pred             --ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh----------ccCCCCCC---
Confidence              122245788999999998888999999999999999999999998643322111100          00000111   


Q ss_pred             cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          720 SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       720 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      ..+.....++.+++.+|++.+|++||++++|++
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            122234467889999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.2e-35  Score=305.56  Aligned_cols=248  Identities=31%  Similarity=0.470  Sum_probs=197.3

Q ss_pred             CcccccCceeEEEEEecC----CcEEEEEEeccccc-ccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEecCC
Q 003599          488 SKLGQGGFGPVYWGRLKD----GQEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPN  562 (808)
Q Consensus       488 ~~lG~G~~g~Vy~~~~~~----~~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  562 (808)
                      ++||+|+||.||+|+...    +..+|+|.+..... ...+++.+|+.+++++.|+||+++++++. ++..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            479999999999997542    26899999876543 34568999999999999999999999875 5568999999999


Q ss_pred             CCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCccc
Q 003599          563 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD  642 (808)
Q Consensus       563 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  642 (808)
                      ++|.+++...   ..+++..+..++.|++.||+|||..+   ++|+||||+|||++.++.+||+|||+++..........
T Consensus        80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          80 GPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             CcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence            9999999642   36899999999999999999999988   99999999999999999999999999987643332211


Q ss_pred             -ccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCc
Q 003599          643 -TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS  720 (808)
Q Consensus       643 -~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  720 (808)
                       .....++..|+|||.+....++.++||||||+++|||++ |+.|+...... ......    ......          .
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~-~~~~~~----~~~~~~----------~  218 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA-EVIAML----ESGERL----------P  218 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH-HHHHHH----HcCCcC----------C
Confidence             111234568999999998899999999999999999998 88888643321 221111    111100          0


Q ss_pred             ccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003599          721 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  757 (808)
Q Consensus       721 ~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~  757 (808)
                      .+......+.+++.+|++.+|++||++.+|++.|++.
T Consensus       219 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         219 RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence            1122345788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=4.9e-35  Score=318.48  Aligned_cols=241  Identities=26%  Similarity=0.359  Sum_probs=193.3

Q ss_pred             CCcccCcccccCceeEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHHhcc-CCceeeEeeEEEeCCeeEEEE
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEKMLIY  557 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~  557 (808)
                      +|++.+.||+|+||.||+++.. +++.||+|++.+.   .....+.+..|..++..+. |++|+++++++.+.+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            3677899999999999999875 5889999998753   2334567888999998885 577888999999999999999


Q ss_pred             EecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCC
Q 003599          558 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  637 (808)
Q Consensus       558 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  637 (808)
                      ||+++|+|..++..   ...+++.++..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~  154 (323)
T cd05615          81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD  154 (323)
T ss_pred             cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence            99999999998853   356899999999999999999999988   999999999999999999999999998754222


Q ss_pred             CCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCccc
Q 003599          638 QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS  717 (808)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  717 (808)
                      .  .......||+.|+|||.+.+..++.++||||||+++|||++|+.|+..........    ... ..        .. 
T Consensus       155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~----~i~-~~--------~~-  218 (323)
T cd05615         155 G--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQ----SIM-EH--------NV-  218 (323)
T ss_pred             C--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHH----HHH-hC--------CC-
Confidence            1  11223568999999999998899999999999999999999999986543221111    111 00        00 


Q ss_pred             CCcccHHHHHHHHHHHHhcccCCcCCCCCH
Q 003599          718 ESSFQLDMIIRCIHVGLLCVQELVKDRPNM  747 (808)
Q Consensus       718 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~  747 (808)
                        ..+.....++.+++.+|++.+|.+|++.
T Consensus       219 --~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         219 --SYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             --CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence              0122234567889999999999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.7e-35  Score=310.62  Aligned_cols=257  Identities=26%  Similarity=0.420  Sum_probs=203.8

Q ss_pred             cCCcccCcccccCceeEEEEEecC-Cc----EEEEEEecccc-cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLKD-GQ----EIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML  555 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~----~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  555 (808)
                      .+|++.+.||+|+||.||+|..++ +.    .+|+|.+.... .....++.+|+.++++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            568888999999999999998653 32    58999887654 3345788999999999999999999999987 78899


Q ss_pred             EEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecC
Q 003599          556 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG  635 (808)
Q Consensus       556 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~  635 (808)
                      ||||+++|+|.+++..  ....+++..+++++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||+++...
T Consensus        86 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          86 ITQLMPLGCLLDYVRN--HKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             EEecCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence            9999999999999865  2345899999999999999999999987   9999999999999999999999999998765


Q ss_pred             CCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhccccchhccCC
Q 003599          636 GNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDP  714 (808)
Q Consensus       636 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  714 (808)
                      ............++..|+|||.+....++.++||||||+++||+++ |+.|+....... ....    ...+..      
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~----~~~~~~------  229 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE-IPDL----LEKGER------  229 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH-HHHH----HhCCCC------
Confidence            3322222112234568999999988889999999999999999999 999886433211 1111    111100      


Q ss_pred             cccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhccc
Q 003599          715 FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIR  759 (808)
Q Consensus       715 ~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~~  759 (808)
                       .   +.+......+.+++.+|+..+|++||++.++++.|+.+.+
T Consensus       230 -~---~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         230 -L---PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             -C---CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence             0   0111223467889999999999999999999999988743

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1e-34  Score=310.36  Aligned_cols=251  Identities=24%  Similarity=0.332  Sum_probs=199.3

Q ss_pred             CcccCcccccCceeEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEe
Q 003599          484 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       484 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  559 (808)
                      |+..+.||+|+||+||++... +++.||+|.+....   ....+.+.+|++++++++|+||+++.+.+..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            667789999999999999875 68899999986532   22345678899999999999999999999999999999999


Q ss_pred             cCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCC
Q 003599          560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  639 (808)
Q Consensus       560 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  639 (808)
                      +++++|.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||+++.......
T Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05632          82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES  157 (285)
T ss_pred             ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence            9999999888643 2346999999999999999999999988   99999999999999999999999999976532211


Q ss_pred             cccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCC
Q 003599          640 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSES  719 (808)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  719 (808)
                         .....|+..|+|||.+.+..++.++|+||||+++|||++|+.||....+......... .....     . ..    
T Consensus       158 ---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~-~~~~~-----~-~~----  223 (285)
T cd05632         158 ---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDR-RVLET-----E-EV----  223 (285)
T ss_pred             ---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH-hhhcc-----c-cc----
Confidence               1224689999999999988999999999999999999999999865432221111111 11000     0 00    


Q ss_pred             cccHHHHHHHHHHHHhcccCCcCCCCC-----HHHHHHH
Q 003599          720 SFQLDMIIRCIHVGLLCVQELVKDRPN-----MSTVVSM  753 (808)
Q Consensus       720 ~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~ev~~~  753 (808)
                       ........+.+++..|++.+|++||+     +.++++.
T Consensus       224 -~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         224 -YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             -cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence             12223456788999999999999999     5666553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.9e-35  Score=320.68  Aligned_cols=242  Identities=22%  Similarity=0.253  Sum_probs=190.2

Q ss_pred             CcccccCceeEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHH-HHHhccCCceeeEeeEEEeCCeeEEEEEecCC
Q 003599          488 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVM-VISKLQHRNLVRLLGCCVEGEEKMLIYEYMPN  562 (808)
Q Consensus       488 ~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  562 (808)
                      +.||+|+||.||+++.. +|+.||+|++.+..   ......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            47999999999999865 68999999986532   233445566655 46778999999999999999999999999999


Q ss_pred             CCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCccc
Q 003599          563 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD  642 (808)
Q Consensus       563 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  642 (808)
                      |+|..++..   ...+++.++..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~  152 (325)
T cd05604          81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DT  152 (325)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CC
Confidence            999888853   456899999999999999999999988   9999999999999999999999999987532211  12


Q ss_pred             ccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCccc
Q 003599          643 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQ  722 (808)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  722 (808)
                      .....||+.|+|||.+.+..++.++|||||||++|||++|+.||........    ...... .        .+.   ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~----~~~~~~-~--------~~~---~~  216 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM----YDNILH-K--------PLV---LR  216 (325)
T ss_pred             cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH----HHHHHc-C--------Ccc---CC
Confidence            2235689999999999999999999999999999999999999864332111    111111 0        000   11


Q ss_pred             HHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          723 LDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       723 ~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                      ......+.+++.+|++.+|.+||++.+.++.
T Consensus       217 ~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~  247 (325)
T cd05604         217 PGASLTAWSILEELLEKDRQRRLGAKEDFLE  247 (325)
T ss_pred             CCCCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence            1234567789999999999999988644433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=4.6e-35  Score=309.90  Aligned_cols=251  Identities=30%  Similarity=0.489  Sum_probs=198.9

Q ss_pred             CcccccCceeEEEEEecC-------CcEEEEEEecccc-cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEe
Q 003599          488 SKLGQGGFGPVYWGRLKD-------GQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       488 ~~lG~G~~g~Vy~~~~~~-------~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  559 (808)
                      +.||+|+||.||+|+..+       ++.+|+|.+.... ......+.+|+.++++++||||+++++++......++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            469999999999998653       2579999886543 24467899999999999999999999999999999999999


Q ss_pred             cCCCCchhhccCCC----CCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCC-----Ceeeecccc
Q 003599          560 MPNRSLDALLFDPL----KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL-----NPKISDFGM  630 (808)
Q Consensus       560 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~-----~~kl~DFGl  630 (808)
                      +++++|.+++....    ....+++.+++.++.|++.||.|||+.+   ++|+||||+||+++.+.     .++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999999986422    2235788999999999999999999987   99999999999999877     899999999


Q ss_pred             ceecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhccccch
Q 003599          631 AKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKIL  709 (808)
Q Consensus       631 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  709 (808)
                      ++...............++..|+|||.+.++.++.++||||||+++|||++ |+.|+...... .....   . ..+.  
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~-~~~~~---~-~~~~--  230 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ-EVLQH---V-TAGG--  230 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH-HHHHH---H-hcCC--
Confidence            986543322222223345788999999999999999999999999999998 88887643221 11111   1 1100  


Q ss_pred             hccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhh
Q 003599          710 ALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS  756 (808)
Q Consensus       710 ~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~  756 (808)
                           ..   .........+.+++.+|++.+|.+||++++|++.|++
T Consensus       231 -----~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         231 -----RL---QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             -----cc---CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence                 00   0222345678899999999999999999999999863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.3e-34  Score=309.72  Aligned_cols=262  Identities=22%  Similarity=0.310  Sum_probs=194.5

Q ss_pred             CCcccCcccccCceeEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHHhc---cCCceeeEeeEEEe-----CC
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKL---QHRNLVRLLGCCVE-----GE  551 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~-----~~  551 (808)
                      +|++.+.||+|+||.||+|+.. +++.||+|.++...  ......+.+|+.+++++   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4788899999999999999876 58899999987532  22234566777777665   69999999998864     34


Q ss_pred             eeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccc
Q 003599          552 EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA  631 (808)
Q Consensus       552 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla  631 (808)
                      ..++||||+++ +|.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence            57899999974 888887542 2345899999999999999999999998   999999999999999999999999999


Q ss_pred             eecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhh--ccccch
Q 003599          632 KIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLW--NENKIL  709 (808)
Q Consensus       632 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~--~~~~~~  709 (808)
                      +.......   .....||..|+|||.+.+..++.++|||||||++|||++|++||........+........  ......
T Consensus       156 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07863         156 RIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  232 (288)
T ss_pred             ccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCc
Confidence            86643221   2234678999999999988999999999999999999999998865433222211111000  000000


Q ss_pred             -------hccCCcccCC--cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          710 -------ALVDPFLSES--SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       710 -------~~~d~~l~~~--~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                             ....+.....  ....+....+.+++.+|++.||++|||+.|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                   0000000000  011223466789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.3e-35  Score=327.73  Aligned_cols=261  Identities=17%  Similarity=0.225  Sum_probs=196.1

Q ss_pred             hcCCcccCcccccCceeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEe
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  559 (808)
                      ..+|.+.+.||+|+||.||++... .++.||||...      ...+.+|+++|++++|+||+++++++..+...++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            457999999999999999999876 47889999642      23467899999999999999999999999999999999


Q ss_pred             cCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCC
Q 003599          560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  639 (808)
Q Consensus       560 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  639 (808)
                      +. ++|.+++..  ....+++.+++.|+.||++||.|||+.+   |+||||||+||||+.++.+||+|||+++.......
T Consensus       242 ~~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        242 YR-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS  315 (461)
T ss_pred             cC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence            95 688888754  2346999999999999999999999998   99999999999999999999999999987643322


Q ss_pred             cccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCc---hhhhhhhhhhhccccch--hc---
Q 003599          640 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDD---LTILGYAWKLWNENKIL--AL---  711 (808)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~---~~~~~~~~~~~~~~~~~--~~---  711 (808)
                      ........||..|+|||++.+..++.++|||||||+||||++|..++-.....   .................  +.   
T Consensus       316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~  395 (461)
T PHA03211        316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH  395 (461)
T ss_pred             cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence            22222356999999999999999999999999999999999988654221110   00000011111110000  00   


Q ss_pred             ----------------cCCcccCCccc--HHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          712 ----------------VDPFLSESSFQ--LDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       712 ----------------~d~~l~~~~~~--~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                                      ..+........  ......+.+|+.+||+.||++|||+.|+++.
T Consensus       396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence                            00000000000  0122367889999999999999999999874

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-34  Score=305.02  Aligned_cols=253  Identities=23%  Similarity=0.369  Sum_probs=206.2

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEec
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  560 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  560 (808)
                      ++|++.+.||+|+||.||++... +++.+|+|.+........+.+.+|+.++++++||||+++++++..+...+++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            57889999999999999999875 57889999998765556788999999999999999999999999999999999999


Q ss_pred             CCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCc
Q 003599          561 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  640 (808)
Q Consensus       561 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  640 (808)
                      ++++|.+++..  ....++..++..++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|||++........ 
T Consensus        83 ~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-  156 (262)
T cd06613          83 GGGSLQDIYQV--TRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-  156 (262)
T ss_pred             CCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh-
Confidence            99999998854  2356889999999999999999999988   99999999999999999999999999886543221 


Q ss_pred             ccccceeccCCccChhhhccC---CCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCccc
Q 003599          641 ADTGRVVGTFGYMSPEYAMEG---RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS  717 (808)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~---~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  717 (808)
                       ......++..|+|||.+...   .++.++||||||+++|||++|+.|+..............     .   ....+.+.
T Consensus       157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~-----~---~~~~~~~~  227 (262)
T cd06613         157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISK-----S---NFPPPKLK  227 (262)
T ss_pred             -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----c---cCCCcccc
Confidence             11224678899999998776   789999999999999999999999865432222111100     0   00111111


Q ss_pred             CCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          718 ESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       718 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                         .......++.+++.+|++.+|.+||++++|+.
T Consensus       228 ---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         228 ---DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             ---chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence               22334567899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.1e-34  Score=312.03  Aligned_cols=250  Identities=24%  Similarity=0.372  Sum_probs=204.2

Q ss_pred             hcCCcccCcccccCceeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEe
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  559 (808)
                      ..+|++.+.||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++|+||+++++++..++..++||||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            367999999999999999999864 6899999999765555567789999999999999999999999999999999999


Q ss_pred             cCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCC
Q 003599          560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  639 (808)
Q Consensus       560 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  639 (808)
                      +++++|.+++.+    ..+++.++..++.|++.||.|||+.+   ++||||||+|||++.++.++|+|||++........
T Consensus        98 ~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~  170 (297)
T cd06656          98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (297)
T ss_pred             cCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence            999999999843    45788999999999999999999988   99999999999999999999999999986543322


Q ss_pred             cccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCC
Q 003599          640 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSES  719 (808)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  719 (808)
                      .  .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||...........    ....+      .+.+.  
T Consensus       171 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~----~~~~~------~~~~~--  236 (297)
T cd06656         171 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL----IATNG------TPELQ--  236 (297)
T ss_pred             C--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee----eccCC------CCCCC--
Confidence            1  1224678899999999988899999999999999999999999854332111110    00000      00000  


Q ss_pred             cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          720 SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       720 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                       .+......+.+++.+|++.+|++||++++|++
T Consensus       237 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         237 -NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             -CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             12233456788999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.3e-34  Score=313.08  Aligned_cols=263  Identities=24%  Similarity=0.321  Sum_probs=200.7

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEeccc-ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEe
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  559 (808)
                      ++|++.+.||+|+||.||+++.. ++..+|+|.+... ......++.+|++++.+++||||+++++++.+++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            46889999999999999999876 5788999988654 233446788999999999999999999999999999999999


Q ss_pred             cCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCC
Q 003599          560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  639 (808)
Q Consensus       560 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  639 (808)
                      +++++|.+++..   ...+++..+..++.|+++||.|||+..  +++|+||||+|||++.++.+||+|||+++...... 
T Consensus        81 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  154 (308)
T cd06615          81 MDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  154 (308)
T ss_pred             cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc-
Confidence            999999999854   356889999999999999999999742  39999999999999999999999999987543221 


Q ss_pred             cccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhcccc------------
Q 003599          640 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENK------------  707 (808)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~------------  707 (808)
                         .....++..|+|||.+.+..++.++||||||+++|||++|+.|+...... ..............            
T Consensus       155 ---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (308)
T cd06615         155 ---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK-ELEAMFGRPVSEGEAKESHRPVSGHP  230 (308)
T ss_pred             ---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh-hHHHhhcCccccccccCCcccccCCC
Confidence               12346889999999998888999999999999999999999998643311 11100000000000            


Q ss_pred             --------chhccCCcccCC--cc-cHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHH
Q 003599          708 --------ILALVDPFLSES--SF-QLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML  754 (808)
Q Consensus       708 --------~~~~~d~~l~~~--~~-~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L  754 (808)
                              ..+..+......  .. ......++.+++.+|++.+|++||++++|++..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~  288 (308)
T cd06615         231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP  288 (308)
T ss_pred             CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence                    000000000000  00 001345688999999999999999999998764

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.5e-34  Score=315.26  Aligned_cols=241  Identities=25%  Similarity=0.343  Sum_probs=191.6

Q ss_pred             CcccccCceeEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHHhc-cCCceeeEeeEEEeCCeeEEEEEecCC
Q 003599          488 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEYMPN  562 (808)
Q Consensus       488 ~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~  562 (808)
                      +.||+|+||.||+++.. +++.||+|++++..   ....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            47999999999999876 57899999997642   23456688999999988 699999999999999999999999999


Q ss_pred             CCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCccc
Q 003599          563 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD  642 (808)
Q Consensus       563 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  642 (808)
                      |+|..++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~  152 (327)
T cd05617          81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DT  152 (327)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Cc
Confidence            999888743   346899999999999999999999998   9999999999999999999999999987532211  11


Q ss_pred             ccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCch--hhhhhhhhhhccccchhccCCcccCCc
Q 003599          643 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDL--TILGYAWKLWNENKILALVDPFLSESS  720 (808)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~d~~l~~~~  720 (808)
                      .....||+.|+|||.+.+..++.++||||||+++|||++|+.||....+..  .............        ..   .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------~~---~  221 (327)
T cd05617         153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK--------PI---R  221 (327)
T ss_pred             eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC--------CC---C
Confidence            223578999999999999999999999999999999999999996433211  1111111111110        00   0


Q ss_pred             ccHHHHHHHHHHHHhcccCCcCCCCCH
Q 003599          721 FQLDMIIRCIHVGLLCVQELVKDRPNM  747 (808)
Q Consensus       721 ~~~~~~~~l~~li~~cl~~~P~~RPs~  747 (808)
                      .+......+.+++.+||+.||++||++
T Consensus       222 ~p~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         222 IPRFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence            222234567899999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=5.2e-35  Score=318.67  Aligned_cols=242  Identities=23%  Similarity=0.257  Sum_probs=189.2

Q ss_pred             CcccccCceeEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHH-HHHhccCCceeeEeeEEEeCCeeEEEEEecCC
Q 003599          488 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVM-VISKLQHRNLVRLLGCCVEGEEKMLIYEYMPN  562 (808)
Q Consensus       488 ~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  562 (808)
                      +.||+|+||.||+++.. +++.||+|++.+..   ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            47999999999999876 57889999987532   222344455544 56788999999999999999999999999999


Q ss_pred             CCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCccc
Q 003599          563 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD  642 (808)
Q Consensus       563 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  642 (808)
                      ++|.+++..   ...+.......++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~  152 (325)
T cd05602          81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GT  152 (325)
T ss_pred             CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CC
Confidence            999998853   345778888889999999999999998   9999999999999999999999999997542221  12


Q ss_pred             ccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCccc
Q 003599          643 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQ  722 (808)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  722 (808)
                      .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.........    .....         ....   ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~----~~i~~---------~~~~---~~  216 (325)
T cd05602         153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY----DNILN---------KPLQ---LK  216 (325)
T ss_pred             cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHH----HHHHh---------CCcC---CC
Confidence            23357999999999999999999999999999999999999998643322111    11110         0000   11


Q ss_pred             HHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          723 LDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       723 ~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                      .+....+.+++.+|++.+|.+||++.+.+..
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~  247 (325)
T cd05602         217 PNITNSARHLLEGLLQKDRTKRLGAKDDFME  247 (325)
T ss_pred             CCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence            2234567889999999999999988754433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=7.3e-35  Score=315.22  Aligned_cols=263  Identities=23%  Similarity=0.308  Sum_probs=199.1

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEe
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  559 (808)
                      ++|.+.++||+|+||.||+|+.+ +++.||+|.++... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            56889999999999999999876 57889999987543 23345678999999999999999999999999999999999


Q ss_pred             cCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCC
Q 003599          560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  639 (808)
Q Consensus       560 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  639 (808)
                      +++ +|.+++..  ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus        86 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  159 (309)
T cd07872          86 LDK-DLKQYMDD--CGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK  159 (309)
T ss_pred             CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence            975 78777754  2345888999999999999999999988   99999999999999999999999999986433221


Q ss_pred             cccccceeccCCccChhhhcc-CCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhh----------hccc-c
Q 003599          640 QADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKL----------WNEN-K  707 (808)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~----------~~~~-~  707 (808)
                        ......++..|+|||.+.+ ..++.++||||||+++|||+||+.||................          .... .
T Consensus       160 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07872         160 --TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE  237 (309)
T ss_pred             --ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence              1122467899999998865 457899999999999999999999987544322221111100          0000 0


Q ss_pred             chhccCCcccCC---cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          708 ILALVDPFLSES---SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       708 ~~~~~d~~l~~~---~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      ....-.+.....   ........++.+++.+|++.||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            000000000000   001123456789999999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=8.3e-35  Score=312.76  Aligned_cols=249  Identities=24%  Similarity=0.385  Sum_probs=203.6

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEec
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  560 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  560 (808)
                      .+|++.+.||.|++|.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            46899999999999999999864 68999999987655555678899999999999999999999999999999999999


Q ss_pred             CCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCc
Q 003599          561 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  640 (808)
Q Consensus       561 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  640 (808)
                      ++++|.+++..    ..+++.++..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||+++........
T Consensus        99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~  171 (296)
T cd06655          99 AGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK  171 (296)
T ss_pred             CCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence            99999998843    35899999999999999999999998   999999999999999999999999998865433221


Q ss_pred             ccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCc
Q 003599          641 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS  720 (808)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  720 (808)
                        .....++..|+|||.+.+..++.++||||||+++|||++|+.||............    .. ..     .+.+.   
T Consensus       172 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~----~~-~~-----~~~~~---  236 (296)
T cd06655         172 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI----AT-NG-----TPELQ---  236 (296)
T ss_pred             --CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----Hh-cC-----CcccC---
Confidence              12246888999999999888999999999999999999999998654332211110    00 00     00010   


Q ss_pred             ccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          721 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       721 ~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      .+......+.+++.+|++.+|++||++.+|+.
T Consensus       237 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         237 NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             CcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            11223456788999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1e-34  Score=309.94  Aligned_cols=263  Identities=24%  Similarity=0.325  Sum_probs=199.3

Q ss_pred             CCcccCcccccCceeEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEe
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  559 (808)
                      +|++.+.||+|++|.||+|+.. +++.||+|+++...  ....+.+.+|+.++++++||||+++++++.++...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4788899999999999999875 68899999986532  22346788999999999999999999999999999999999


Q ss_pred             cCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCC
Q 003599          560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  639 (808)
Q Consensus       560 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  639 (808)
                      ++ ++|.+++........+++..+..++.||++||+|||+.+   ++|+||||+||+++.++.+||+|||+++.......
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR  156 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence            97 688888865444467899999999999999999999988   99999999999999999999999999986543221


Q ss_pred             cccccceeccCCccChhhhccC-CCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhh-------hcc----cc
Q 003599          640 QADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKL-------WNE----NK  707 (808)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~-------~~~----~~  707 (808)
                        ......+++.|+|||.+.+. .++.++||||||+++|||+||+.|+................       +..    ..
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
T cd07861         157 --VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD  234 (285)
T ss_pred             --cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence              11223568899999988654 47889999999999999999999886433221111110000       000    00


Q ss_pred             chhccCCcccCC---cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          708 ILALVDPFLSES---SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       708 ~~~~~d~~l~~~---~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      .....+. ....   ........++.+++.+|++.||++|||+++|++
T Consensus       235 ~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         235 YKNTFPK-WKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HHhhccc-cCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            0000000 0000   001113456789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-34  Score=315.45  Aligned_cols=255  Identities=23%  Similarity=0.277  Sum_probs=195.4

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  557 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  557 (808)
                      ++|++.+.||+|+||.||+++.. +++.||+|++.+.   .....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            46889999999999999999976 5889999998652   2234566889999999999999999999999999999999


Q ss_pred             EecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCC
Q 003599          558 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  637 (808)
Q Consensus       558 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  637 (808)
                      ||+++|+|.+++..  ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            99999999999854  2346889999999999999999999998   999999999999999999999999999765432


Q ss_pred             CCcccccceeccCCccChhhhcc-----CCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhcc
Q 003599          638 QDQADTGRVVGTFGYMSPEYAME-----GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALV  712 (808)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  712 (808)
                      ... ......||+.|+|||.+..     ..++.++|||||||++|||++|+.||.........    ............ 
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~----~~i~~~~~~~~~-  229 (331)
T cd05597         156 GTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY----GKIMNHKEHFQF-  229 (331)
T ss_pred             CCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHH----HHHHcCCCcccC-
Confidence            221 1222468999999999863     45788999999999999999999998643221111    111111110111 


Q ss_pred             CCcccCCcccHHHHHHHHHHHHhcccC--CcCCCCCHHHHHHH
Q 003599          713 DPFLSESSFQLDMIIRCIHVGLLCVQE--LVKDRPNMSTVVSM  753 (808)
Q Consensus       713 d~~l~~~~~~~~~~~~l~~li~~cl~~--~P~~RPs~~ev~~~  753 (808)
                      .+      ........+.+++.+|+..  ++..||+++++++.
T Consensus       230 ~~------~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         230 PP------DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             CC------ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            00      1111334566677776654  44448899888776

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.6e-34  Score=305.38  Aligned_cols=249  Identities=28%  Similarity=0.457  Sum_probs=200.5

Q ss_pred             CCcccCcccccCceeEEEEEec-CCcEEEEEEecccccc---------cHHHHHHHHHHHHhccCCceeeEeeEEEeCCe
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQ---------GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEE  552 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~~---------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  552 (808)
                      +|.+.+.||+|++|.||+|... +++.+|+|.+......         ..+.+.+|+.++++++||||+++++++.+...
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            4777899999999999999875 5789999988653221         23568899999999999999999999999999


Q ss_pred             eEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccce
Q 003599          553 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK  632 (808)
Q Consensus       553 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~  632 (808)
                      .++||||+++++|.+++..   ...+++..+..++.|++.||+|||+.+   ++||||+|+||++++++.++|+|||+++
T Consensus        81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence            9999999999999999953   346888999999999999999999988   9999999999999999999999999998


Q ss_pred             ecCCCCCcc----cccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccc
Q 003599          633 IFGGNQDQA----DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKI  708 (808)
Q Consensus       633 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  708 (808)
                      .........    ......|+..|+|||.+....++.++||||||+++|||++|+.|+...........          +
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~----------~  224 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFK----------I  224 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHH----------H
Confidence            764221111    11124578899999999988899999999999999999999999864332211110          0


Q ss_pred             hhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          709 LALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       709 ~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      .....+.     .+......+.+++.+|++.+|.+||++.+|++
T Consensus       225 ~~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         225 GENASPE-----IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             hccCCCc-----CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            0011111     22234567889999999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2e-34  Score=319.25  Aligned_cols=262  Identities=21%  Similarity=0.232  Sum_probs=196.9

Q ss_pred             HhcCCcccCcccccCceeEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHHhccCCceeeEeeEEEeC------
Q 003599          480 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG------  550 (808)
Q Consensus       480 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------  550 (808)
                      ..++|++.+.||+|+||.||++... .++.||||++...  .....+.+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            3578999999999999999999865 5889999998753  233456788999999999999999999987543      


Q ss_pred             CeeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeecccc
Q 003599          551 EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGM  630 (808)
Q Consensus       551 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGl  630 (808)
                      ...++||||+++ +|..++..     .+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~  172 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  172 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence            357999999965 67666632     4788889999999999999999988   99999999999999999999999999


Q ss_pred             ceecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhh---------
Q 003599          631 AKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWK---------  701 (808)
Q Consensus       631 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~---------  701 (808)
                      ++......   ......||..|+|||.+.+..++.++|||||||++|||++|+.||...............         
T Consensus       173 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  249 (364)
T cd07875         173 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM  249 (364)
T ss_pred             ccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            98653321   122346899999999999999999999999999999999999998654322111111000         


Q ss_pred             ---------hhccc-cc----hhccCCcccC---CcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          702 ---------LWNEN-KI----LALVDPFLSE---SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       702 ---------~~~~~-~~----~~~~d~~l~~---~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                               ...+. ..    .+.+.+....   .........++.+++.+|++.||.+|||+.++++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                     00000 00    0000000000   00111123567899999999999999999999875

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=4e-35  Score=331.72  Aligned_cols=262  Identities=20%  Similarity=0.258  Sum_probs=192.5

Q ss_pred             hcCCcccCcccccCceeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeC--------C
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG--------E  551 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--------~  551 (808)
                      ..+|++.++||+|+||.||+|... .++.||||++....    ....+|+.+|++++||||+++++++...        .
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            457999999999999999999875 58899999885432    2345799999999999999999886432        2


Q ss_pred             eeEEEEEecCCCCchhhccC-CCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCC-Ceeeeccc
Q 003599          552 EKMLIYEYMPNRSLDALLFD-PLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL-NPKISDFG  629 (808)
Q Consensus       552 ~~~lV~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~-~~kl~DFG  629 (808)
                      ..++||||+++ +|.+++.. ......+++..+..++.||++||+|||+.+   |+||||||+||||+.++ .+||+|||
T Consensus       141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence            35689999975 66666542 123457899999999999999999999998   99999999999999664 79999999


Q ss_pred             cceecCCCCCcccccceeccCCccChhhhccC-CCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhcc--c
Q 003599          630 MAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNE--N  706 (808)
Q Consensus       630 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~--~  706 (808)
                      +++.+.....   .....||+.|+|||.+.+. .++.++|||||||++|||++|++||........+.......-..  +
T Consensus       217 la~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~  293 (440)
T PTZ00036        217 SAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED  293 (440)
T ss_pred             cchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            9986643221   1224689999999998654 68999999999999999999999987544332222211110000  0


Q ss_pred             -------cchhccCCcccCC----cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          707 -------KILALVDPFLSES----SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       707 -------~~~~~~d~~l~~~----~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                             ...+..-+.....    .++.....++.+++.+||+.+|.+|||+.|+++.
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence                   0000000000000    0111234678899999999999999999998754

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=5.5e-35  Score=315.27  Aligned_cols=256  Identities=27%  Similarity=0.470  Sum_probs=200.5

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCc----EEEEEEeccccc-ccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQ----EIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML  555 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  555 (808)
                      ++|+..+.||+|+||.||+|.+. ++.    .||+|.+..... ....++.+|+.++++++||||+++++++... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            56788899999999999999864 343    578898865432 3345788999999999999999999998754 5679


Q ss_pred             EEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecC
Q 003599          556 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG  635 (808)
Q Consensus       556 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~  635 (808)
                      ++||+++|+|.+++..  ....+++..+..++.|++.||+|||+.+   |+|+||||+||++++++.+||+|||+++...
T Consensus        86 v~e~~~~g~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~  160 (303)
T cd05110          86 VTQLMPHGCLLDYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE  160 (303)
T ss_pred             eehhcCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence            9999999999999864  2346889999999999999999999988   9999999999999999999999999998765


Q ss_pred             CCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhccccchhccCC
Q 003599          636 GNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDP  714 (808)
Q Consensus       636 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  714 (808)
                      ............++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... .......    ..+..      
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~-~~~~~~~----~~~~~------  229 (303)
T cd05110         161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT-REIPDLL----EKGER------  229 (303)
T ss_pred             CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHH----HCCCC------
Confidence            4332222222345778999999988889999999999999999998 8888753221 1111111    11100      


Q ss_pred             cccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhcc
Q 003599          715 FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEI  758 (808)
Q Consensus       715 ~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~  758 (808)
                       ..   ........+..++..|+..+|++||+++++++.|+.+.
T Consensus       230 -~~---~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~  269 (303)
T cd05110         230 -LP---QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA  269 (303)
T ss_pred             -CC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence             00   11112356788999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.1e-34  Score=307.48  Aligned_cols=255  Identities=24%  Similarity=0.351  Sum_probs=202.8

Q ss_pred             cCCcccCcccccCceeEEEEEecC----CcEEEEEEecccc-cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLKD----GQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI  556 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  556 (808)
                      ++|.+.++||+|+||.||+|...+    ...||||...... ....+.+.+|+.++++++||||+++++++.+ ...++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            468888999999999999998653    3468999887554 4456789999999999999999999999875 557899


Q ss_pred             EEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCC
Q 003599          557 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  636 (808)
Q Consensus       557 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  636 (808)
                      |||+++++|.+++...  ...+++..+..++.+++.||+|||+.+   ++|+||||+||+++.++.+||+|||+++....
T Consensus        85 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          85 MELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             EEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence            9999999999999642  345899999999999999999999988   99999999999999999999999999987644


Q ss_pred             CCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhccccchhccCCc
Q 003599          637 NQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPF  715 (808)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  715 (808)
                      ..... .....++..|+|||.+....++.++||||||+++||+++ |+.||.......... .   . ..+...     .
T Consensus       160 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~-~---~-~~~~~~-----~  228 (270)
T cd05056         160 ESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIG-R---I-ENGERL-----P  228 (270)
T ss_pred             cccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH-H---H-HcCCcC-----C
Confidence            32211 112234568999999988889999999999999999986 999986443221111 1   1 111000     0


Q ss_pred             ccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhcc
Q 003599          716 LSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEI  758 (808)
Q Consensus       716 l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~  758 (808)
                           .+......+.+++.+|+..+|++||++.++++.|+++.
T Consensus       229 -----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~  266 (270)
T cd05056         229 -----MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL  266 (270)
T ss_pred             -----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                 11223457888999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.5e-34  Score=309.08  Aligned_cols=253  Identities=23%  Similarity=0.359  Sum_probs=201.2

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEeccc-ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEe
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  559 (808)
                      ++|++.+.||+|+||.||+++.. ++..||+|.++.. .....+.+.+|+.++++++|+||+++++.+...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            36888999999999999999976 6899999988654 233457889999999999999999999999999999999999


Q ss_pred             cCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhc-CCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCC
Q 003599          560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD-SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  638 (808)
Q Consensus       560 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  638 (808)
                      +++++|..++........+++..+..++.|++.||.|||+. +   |+|+||||+||+++.++.+||+|||+++......
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  157 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL  157 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence            99999999886543345789999999999999999999974 5   9999999999999999999999999987653221


Q ss_pred             CcccccceeccCCccChhhhccCC------CCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhcc
Q 003599          639 DQADTGRVVGTFGYMSPEYAMEGR------FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALV  712 (808)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~------~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  712 (808)
                          .....++..|+|||.+....      ++.++||||||+++|||++|+.||......... ....         ...
T Consensus       158 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~~~~---------~~~  223 (286)
T cd06622         158 ----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF-AQLS---------AIV  223 (286)
T ss_pred             ----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHH-HHHH---------HHh
Confidence                12245788999999985443      478999999999999999999998643221111 1000         011


Q ss_pred             CCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          713 DPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       713 d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                      +...  ...+.+...++.+++.+|++.+|++||++++++..
T Consensus       224 ~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         224 DGDP--PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             hcCC--CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence            1000  01223355678899999999999999999998863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.3e-34  Score=307.64  Aligned_cols=256  Identities=30%  Similarity=0.416  Sum_probs=203.1

Q ss_pred             cCCcccCcccccCceeEEEEEec------CCcEEEEEEecccccc-cHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASGQ-GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKM  554 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  554 (808)
                      ++|++.+.||+|+||.||+|+.+      +.+.||+|.+...... ..+.+.+|++++++++|+||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            56888999999999999999864      2467999988654433 4578999999999999999999999999999999


Q ss_pred             EEEEecCCCCchhhccCCCCC------CcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeecc
Q 003599          555 LIYEYMPNRSLDALLFDPLKK------ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDF  628 (808)
Q Consensus       555 lV~E~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DF  628 (808)
                      +||||+++++|.+++......      ..+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.++|+||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence            999999999999998653321      26899999999999999999999998   999999999999999999999999


Q ss_pred             ccceecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhcccc
Q 003599          629 GMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENK  707 (808)
Q Consensus       629 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  707 (808)
                      |+++...... ........++..|+|||.+.+...+.++||||||+++|||++ |..|+....+.....     ....+.
T Consensus       162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~-----~~~~~~  235 (275)
T cd05046         162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLN-----RLQAGK  235 (275)
T ss_pred             ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHH-----HHHcCC
Confidence            9987543222 112223456788999999988888999999999999999999 677775332221111     111111


Q ss_pred             chhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHh
Q 003599          708 ILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN  755 (808)
Q Consensus       708 ~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~  755 (808)
                      .. ..        ........+.+++.+|++.+|++||++.+++++|.
T Consensus       236 ~~-~~--------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         236 LE-LP--------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             cC-CC--------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            10 00        11123457889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-34  Score=306.43  Aligned_cols=248  Identities=28%  Similarity=0.418  Sum_probs=203.0

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEe
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  559 (808)
                      ++|++.+.||.|++|.||+|+.. +++.||+|.+.... ......+.+|+.++++++|+||+++++++.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            36888899999999999999976 58899999986543 34456788999999999999999999999999999999999


Q ss_pred             cCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCC
Q 003599          560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  639 (808)
Q Consensus       560 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  639 (808)
                      +++++|.+++..    ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||+++.......
T Consensus        81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  153 (274)
T cd06609          81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS  153 (274)
T ss_pred             eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence            999999999853    27899999999999999999999988   99999999999999999999999999987754321


Q ss_pred             cccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCC
Q 003599          640 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSES  719 (808)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  719 (808)
                        ......++..|+|||.+.+..++.++||||||+++|||++|+.|+..........     ...     ....+.+...
T Consensus       154 --~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~-----~~~-----~~~~~~~~~~  221 (274)
T cd06609         154 --KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLF-----LIP-----KNNPPSLEGN  221 (274)
T ss_pred             --ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHH-----Hhh-----hcCCCCCccc
Confidence              1223467889999999998889999999999999999999999986433211110     000     0111111111


Q ss_pred             cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          720 SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       720 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                          .....+.+++.+|++.+|++||+++++++
T Consensus       222 ----~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         222 ----KFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             ----ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence                13456788999999999999999999977

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=6.9e-35  Score=317.19  Aligned_cols=237  Identities=23%  Similarity=0.270  Sum_probs=187.2

Q ss_pred             CcccccCceeEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHH-HHHhccCCceeeEeeEEEeCCeeEEEEEecCC
Q 003599          488 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVM-VISKLQHRNLVRLLGCCVEGEEKMLIYEYMPN  562 (808)
Q Consensus       488 ~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  562 (808)
                      +.||+|+||.||+|+.. +++.||+|++.+..   ......+.+|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999976 58899999986532   223345555554 67889999999999999999999999999999


Q ss_pred             CCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCccc
Q 003599          563 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD  642 (808)
Q Consensus       563 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  642 (808)
                      ++|..++..   ...++...+..++.||++||.|||+.+   |+||||||+||+|+.++.+||+|||+++......  ..
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~  152 (321)
T cd05603          81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ET  152 (321)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cc
Confidence            999888743   346888889999999999999999988   9999999999999999999999999987532211  12


Q ss_pred             ccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCccc
Q 003599          643 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQ  722 (808)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  722 (808)
                      .....||+.|+|||.+.+..++.++|||||||++|||++|+.||...+...    ......         ...+   ..+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~~~i~---------~~~~---~~~  216 (321)
T cd05603         153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ----MYDNIL---------HKPL---QLP  216 (321)
T ss_pred             cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH----HHHHHh---------cCCC---CCC
Confidence            233568999999999998889999999999999999999999986432111    111111         0001   012


Q ss_pred             HHHHHHHHHHHHhcccCCcCCCCCHH
Q 003599          723 LDMIIRCIHVGLLCVQELVKDRPNMS  748 (808)
Q Consensus       723 ~~~~~~l~~li~~cl~~~P~~RPs~~  748 (808)
                      ......+.+++.+|++.+|.+||++.
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         217 GGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            22345678999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-34  Score=309.31  Aligned_cols=253  Identities=25%  Similarity=0.382  Sum_probs=203.9

Q ss_pred             hcCCcccCcccccCceeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEe
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  559 (808)
                      .++|++.+.||+|+||.||++... ++..+|+|.+........+.|.+|++++++++||||+++++.+..+...++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            467999999999999999999875 5889999998766666677899999999999999999999999999999999999


Q ss_pred             cCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCC
Q 003599          560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  639 (808)
Q Consensus       560 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  639 (808)
                      +++++|.+++..  ....+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||++........
T Consensus        84 ~~~~~L~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (280)
T cd06611          84 CDGGALDSIMLE--LERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ  158 (280)
T ss_pred             cCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence            999999999854  2346899999999999999999999998   99999999999999999999999999876532221


Q ss_pred             cccccceeccCCccChhhhc-----cCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCC
Q 003599          640 QADTGRVVGTFGYMSPEYAM-----EGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDP  714 (808)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  714 (808)
                        ......++..|+|||.+.     ...++.++||||||+++|||++|+.|+............     ..+     ..+
T Consensus       159 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~-----~~~-----~~~  226 (280)
T cd06611         159 --KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKI-----LKS-----EPP  226 (280)
T ss_pred             --ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHH-----hcC-----CCC
Confidence              122356899999999875     344678999999999999999999998643322211111     000     011


Q ss_pred             cccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          715 FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       715 ~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                      .+.   .+.....++.+++.+|++.+|.+||++.+|++.
T Consensus       227 ~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         227 TLD---QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             CcC---CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            111   112234567889999999999999999999764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.1e-34  Score=307.91  Aligned_cols=250  Identities=26%  Similarity=0.355  Sum_probs=199.0

Q ss_pred             CcccCcccccCceeEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEe
Q 003599          484 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       484 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  559 (808)
                      |+..+.||+|+||.||++... +++.||||.+....   ....+.+.+|+.++++++|+|++++++.+.+.+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            667789999999999999876 58899999986532   22235678899999999999999999999999999999999


Q ss_pred             cCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCC
Q 003599          560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  639 (808)
Q Consensus       560 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  639 (808)
                      +++++|.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||++........
T Consensus        82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05630          82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT  157 (285)
T ss_pred             cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence            9999999988542 2345889999999999999999999987   99999999999999999999999999976533221


Q ss_pred             cccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCC
Q 003599          640 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSES  719 (808)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  719 (808)
                         .....|+..|+|||.+.+..++.++||||||+++|||++|+.||........... .......      ....    
T Consensus       158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~-~~~~~~~------~~~~----  223 (285)
T cd05630         158 ---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE-VERLVKE------VQEE----  223 (285)
T ss_pred             ---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHH-HHhhhhh------hhhh----
Confidence               1224689999999999998999999999999999999999999864332211110 0000000      0000    


Q ss_pred             cccHHHHHHHHHHHHhcccCCcCCCCC-----HHHHHH
Q 003599          720 SFQLDMIIRCIHVGLLCVQELVKDRPN-----MSTVVS  752 (808)
Q Consensus       720 ~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~ev~~  752 (808)
                       ........+.+++.+|++.||++||+     ++|+++
T Consensus       224 -~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         224 -YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             -cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence             11223456789999999999999999     788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.8e-35  Score=324.98  Aligned_cols=259  Identities=20%  Similarity=0.247  Sum_probs=198.3

Q ss_pred             cCCcccCcccccCceeEEEEEec---CCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK---DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  558 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~---~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  558 (808)
                      .+|.+.+.||+|+||.||++...   .+..||+|.+...     ..+.+|+++|++++||||+++++++......++|||
T Consensus        92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e  166 (392)
T PHA03207         92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP  166 (392)
T ss_pred             CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence            57999999999999999999754   3578999988543     345689999999999999999999999999999999


Q ss_pred             ecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCC
Q 003599          559 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  638 (808)
Q Consensus       559 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  638 (808)
                      ++. ++|.+++.   ....+++.+++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus       167 ~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~  239 (392)
T PHA03207        167 KYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP  239 (392)
T ss_pred             hcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence            995 68888873   3457999999999999999999999998   9999999999999999999999999998765443


Q ss_pred             CcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCch---hhhhhhhhhhcccc--------
Q 003599          639 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDL---TILGYAWKLWNENK--------  707 (808)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~---~~~~~~~~~~~~~~--------  707 (808)
                      .........||+.|+|||++....++.++|||||||++|||++|+.||.......   .+..... ......        
T Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~-~~~~~~~~~~~~~~  318 (392)
T PHA03207        240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIR-CMQVHPLEFPQNGS  318 (392)
T ss_pred             ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHH-HhccCccccCCccc
Confidence            3333334579999999999999999999999999999999999999985433211   1111000 000000        


Q ss_pred             --chh---ccCCcccCC-cc-----cHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          708 --ILA---LVDPFLSES-SF-----QLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       708 --~~~---~~d~~l~~~-~~-----~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                        +..   ......... ..     ......++.+++.+|++.+|++||++.+++..
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence              000   000000000 00     01123467789999999999999999999875

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.4e-34  Score=302.11  Aligned_cols=251  Identities=24%  Similarity=0.347  Sum_probs=204.2

Q ss_pred             CCcccCcccccCceeEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEe
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  559 (808)
                      +|+..+.||+|+||.||.++.. +++.+++|++...  .....+++.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            5788999999999999998865 5889999987643  344567789999999999999999999999999999999999


Q ss_pred             cCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCC
Q 003599          560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  639 (808)
Q Consensus       560 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  639 (808)
                      +++++|.+++... ....+++.++..++.|+++||.|||+.+   ++|+||+|+||++++++.+||+|||+++.......
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          81 ANGGTLYDKIVRQ-KGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             cCCCcHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence            9999999998653 2456899999999999999999999988   99999999999999999999999999987643332


Q ss_pred             cccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCC
Q 003599          640 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSES  719 (808)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  719 (808)
                        ......+++.|+|||.+.+..++.++||||||+++|||++|+.|+.........    .... .+...    +     
T Consensus       157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~----~~~~-~~~~~----~-----  220 (256)
T cd08221         157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLV----VKIV-QGNYT----P-----  220 (256)
T ss_pred             --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHH----HHHH-cCCCC----C-----
Confidence              122346899999999998888899999999999999999999988643221111    1111 11110    0     


Q ss_pred             cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHH
Q 003599          720 SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML  754 (808)
Q Consensus       720 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L  754 (808)
                       .......++.+++.+|++.+|++||+++++++.+
T Consensus       221 -~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         221 -VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             -CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence             1122345688999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.2e-34  Score=314.58  Aligned_cols=255  Identities=21%  Similarity=0.250  Sum_probs=197.0

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  557 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  557 (808)
                      ++|++.+.||+|+||.||+++.. +++.||+|.+.+.   .....+.+.+|..++..++|+||+++++++.+.+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47899999999999999999976 5788999998652   2233456888999999999999999999999999999999


Q ss_pred             EecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCC
Q 003599          558 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  637 (808)
Q Consensus       558 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  637 (808)
                      ||+++|+|.+++..  ....+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 Ey~~gg~L~~~l~~--~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          81 DYYVGGDLLTLLSK--FEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             eCCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            99999999999964  2346888999999999999999999988   999999999999999999999999999866433


Q ss_pred             CCcccccceeccCCccChhhhcc-----CCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhcc
Q 003599          638 QDQADTGRVVGTFGYMSPEYAME-----GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALV  712 (808)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  712 (808)
                      ... ......||+.|+|||.+..     +.++.++||||||+++|||++|+.||.........    ........... +
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~----~~i~~~~~~~~-~  229 (331)
T cd05624         156 GTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY----GKIMNHEERFQ-F  229 (331)
T ss_pred             Cce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHH----HHHHcCCCccc-C
Confidence            221 1223568999999999865     46788999999999999999999998643321111    11111110000 0


Q ss_pred             CCcccCCcccHHHHHHHHHHHHhcccCCcCC--CCCHHHHHHH
Q 003599          713 DPFLSESSFQLDMIIRCIHVGLLCVQELVKD--RPNMSTVVSM  753 (808)
Q Consensus       713 d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~--RPs~~ev~~~  753 (808)
                      .+      ...+...++.+++.+|++.++++  |++++++++.
T Consensus       230 p~------~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         230 PS------HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             CC------ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            11      11123456778888888865544  4678887754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=3.8e-34  Score=302.14  Aligned_cols=258  Identities=26%  Similarity=0.405  Sum_probs=206.8

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEe
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  559 (808)
                      ++|++.+.||.|+||+||+|... ++..+|+|++.... ....+.+.+|+..++.++|+||+++++.+..++..++|||+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            46889999999999999999865 57889999986542 33567899999999999999999999999999999999999


Q ss_pred             cCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCC
Q 003599          560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  639 (808)
Q Consensus       560 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  639 (808)
                      +++++|.+++........+++.....++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++..+.....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            999999999965433457899999999999999999999988   99999999999999999999999999987654322


Q ss_pred             cc--cccceeccCCccChhhhccC-CCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcc
Q 003599          640 QA--DTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL  716 (808)
Q Consensus       640 ~~--~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  716 (808)
                      ..  ......|+..|+|||.+... .++.++|+||||+++|||++|+.|+.............    ..      ..+.+
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~----~~------~~~~~  227 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTL----QN------DPPSL  227 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHh----cC------CCCCc
Confidence            21  22234688999999998877 78999999999999999999999986443322111111    00      01111


Q ss_pred             cCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          717 SESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       717 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      ............+.+++.+|++.+|++||++++|++
T Consensus       228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         228 ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            111011234567889999999999999999999876

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=7e-35  Score=310.14  Aligned_cols=247  Identities=26%  Similarity=0.398  Sum_probs=200.5

Q ss_pred             CCcccCcccccCceeEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEec
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  560 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  560 (808)
                      .|+..+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++..+...++||||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            4667789999999999999865 57889999986443 334567899999999999999999999999999999999999


Q ss_pred             CCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCc
Q 003599          561 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  640 (808)
Q Consensus       561 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  640 (808)
                      ++++|.+++.    ...+++..+..++.|+++|+.|||+.+   ++|+||+|+||++++++.++|+|||+++....... 
T Consensus        85 ~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-  156 (277)
T cd06642          85 GGGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-  156 (277)
T ss_pred             CCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence            9999999884    346889999999999999999999988   99999999999999999999999999986543221 


Q ss_pred             ccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCc
Q 003599          641 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS  720 (808)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  720 (808)
                       ......++..|+|||.+.+..++.++||||||+++|||++|+.|+..........     ....     ...+.     
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-----~~~~-----~~~~~-----  220 (277)
T cd06642         157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF-----LIPK-----NSPPT-----  220 (277)
T ss_pred             -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh-----hhhc-----CCCCC-----
Confidence             1122457889999999998889999999999999999999999875332211110     0000     00111     


Q ss_pred             ccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          721 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       721 ~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                      ........+.+++.+|++.+|++||+|.+|++.
T Consensus       221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         221 LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             CCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            122345678899999999999999999999984

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.7e-34  Score=301.67  Aligned_cols=250  Identities=23%  Similarity=0.353  Sum_probs=200.7

Q ss_pred             CCcccCcccccCceeEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHHhccCCceeeEeeEEEe-CCeeEEEEE
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVE-GEEKMLIYE  558 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~E  558 (808)
                      +|++.+.||+|++|.||+++.+ +++.||+|++...  .....+.+.+|++++++++|+|++++++.+.. +...++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4788999999999999999876 4788999998643  23345678899999999999999999998764 446789999


Q ss_pred             ecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCC
Q 003599          559 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  638 (808)
Q Consensus       559 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  638 (808)
                      |+++++|.+++... ....+++.++..++.+++.|++|||+.+   ++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            99999999998653 2346899999999999999999999998   9999999999999999999999999998764332


Q ss_pred             CcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccC
Q 003599          639 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSE  718 (808)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  718 (808)
                      .  ......+++.|+|||.+.+..++.++||||||++++||++|+.|+........    ..... .+..     +    
T Consensus       157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~----~~~~~-~~~~-----~----  220 (257)
T cd08223         157 D--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL----VYRII-EGKL-----P----  220 (257)
T ss_pred             C--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH----HHHHH-hcCC-----C----
Confidence            2  12234688999999999999999999999999999999999998764321111    11111 1110     0    


Q ss_pred             CcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          719 SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       719 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                       ..+......+.+++.+|++.+|++||++.++++.
T Consensus       221 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         221 -PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             -CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence             1222345678899999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=5.3e-35  Score=307.69  Aligned_cols=240  Identities=25%  Similarity=0.401  Sum_probs=190.1

Q ss_pred             CcccccCceeEEEEEecC--------CcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEe
Q 003599          488 SKLGQGGFGPVYWGRLKD--------GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       488 ~~lG~G~~g~Vy~~~~~~--------~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  559 (808)
                      +.||+|+||.||+|....        ...||+|.+........+.+.+|+.++++++||||+++++++..+...++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            479999999999998642        234888888665555567899999999999999999999999999999999999


Q ss_pred             cCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCC--------eeeeccccc
Q 003599          560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELN--------PKISDFGMA  631 (808)
Q Consensus       560 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~--------~kl~DFGla  631 (808)
                      +++|+|.+++...  ...+++..+++++.||+.||+|||+.+   |+||||||+||+++.++.        ++++|||++
T Consensus        81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence            9999999998652  336889999999999999999999988   999999999999987765        599999988


Q ss_pred             eecCCCCCcccccceeccCCccChhhhccC-CCCccccEEehhHHHHHHHhCC-CCCCCCCCchhhhhhhhhhhccccch
Q 003599          632 KIFGGNQDQADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGR-KNTSFFEDDLTILGYAWKLWNENKIL  709 (808)
Q Consensus       632 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvil~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~  709 (808)
                      ......      ....++..|+|||.+.+. .++.++||||||+++|||++|. .|+...... .....    ....   
T Consensus       156 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~-~~~~~----~~~~---  221 (258)
T cd05078         156 ITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ-KKLQF----YEDR---  221 (258)
T ss_pred             cccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH-HHHHH----HHcc---
Confidence            754321      224578899999999764 4789999999999999999995 444322211 11110    0000   


Q ss_pred             hccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHh
Q 003599          710 ALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN  755 (808)
Q Consensus       710 ~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~  755 (808)
                          ..     .+.....++.+++.+|++.+|++||++++|++.|+
T Consensus       222 ----~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         222 ----HQ-----LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ----cc-----CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                00     11112356789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.4e-34  Score=317.47  Aligned_cols=262  Identities=22%  Similarity=0.237  Sum_probs=197.0

Q ss_pred             HhcCCcccCcccccCceeEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHHhccCCceeeEeeEEEeC------
Q 003599          480 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG------  550 (808)
Q Consensus       480 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------  550 (808)
                      ..++|++.+.||+|+||.||++... .++.||||++....  ....+.+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            4578999999999999999999865 58899999987542  23456788999999999999999999988643      


Q ss_pred             CeeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeecccc
Q 003599          551 EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGM  630 (808)
Q Consensus       551 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGl  630 (808)
                      ...++||||+++ +|.+.+.     ..+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~  165 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence            346899999965 5666553     24788889999999999999999988   99999999999999999999999999


Q ss_pred             ceecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhh--------
Q 003599          631 AKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKL--------  702 (808)
Q Consensus       631 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~--------  702 (808)
                      ++......   ......||..|+|||.+.+..++.++|||||||++|||++|+.||................        
T Consensus       166 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (355)
T cd07874         166 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM  242 (355)
T ss_pred             cccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            98653221   1223568999999999998899999999999999999999999986433211111100000        


Q ss_pred             ----------hcc-ccchhccCCc------cc-CCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          703 ----------WNE-NKILALVDPF------LS-ESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       703 ----------~~~-~~~~~~~d~~------l~-~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                                ... ........+.      .. ..........++.+++.+|++.||++|||+.|+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                      000 0000000000      00 000111234567899999999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-35  Score=315.39  Aligned_cols=256  Identities=26%  Similarity=0.404  Sum_probs=212.3

Q ss_pred             cCCcccCcccccCceeEEEEEecC---C--cEEEEEEeccc-ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLKD---G--QEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML  555 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~~---~--~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  555 (808)
                      +...+.++||.|-||.||+|...+   |  -.||||..+.. ..+..+.|+.|+.+|++++||||++++|.|.+ ...+|
T Consensus       389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi  467 (974)
T KOG4257|consen  389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI  467 (974)
T ss_pred             hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence            344556789999999999998542   2  34899999873 45568899999999999999999999999976 46789


Q ss_pred             EEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecC
Q 003599          556 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG  635 (808)
Q Consensus       556 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~  635 (808)
                      |||.++-|.|..||+.  +...++......++.||..||+|||+..   +|||||..+|||+....-+||+|||++|.+.
T Consensus       468 vmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e  542 (974)
T KOG4257|consen  468 VMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLE  542 (974)
T ss_pred             EEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhcc
Confidence            9999999999999976  4567899999999999999999999988   9999999999999999999999999999987


Q ss_pred             CCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhccccchhccCC
Q 003599          636 GNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDP  714 (808)
Q Consensus       636 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  714 (808)
                      .+.....+ ...-+..|||||.+.-.+++.++|||-|||.+||+++ |.+||....+...+              ..++.
T Consensus       543 d~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI--------------~~iEn  607 (974)
T KOG4257|consen  543 DDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI--------------GHIEN  607 (974)
T ss_pred             ccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE--------------EEecC
Confidence            65544333 3456789999999999999999999999999999987 88998654433221              11111


Q ss_pred             cccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhccc
Q 003599          715 FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIR  759 (808)
Q Consensus       715 ~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~~  759 (808)
                      .- +.+.+..++..+..|+.+||.++|.+||.+.++...|..+.+
T Consensus       608 Ge-RlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  608 GE-RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             CC-CCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            11 123666778899999999999999999999999988866543

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=3.5e-34  Score=304.76  Aligned_cols=248  Identities=25%  Similarity=0.390  Sum_probs=203.4

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEe
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  559 (808)
                      ..|+..++||+|+||.||+|... .++.||+|.+.... ....+.+.+|+.++++++||||+++++++.++...++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            35777899999999999999875 58899999986542 34567889999999999999999999999999999999999


Q ss_pred             cCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCC
Q 003599          560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  639 (808)
Q Consensus       560 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  639 (808)
                      +++++|.+++..    ..+++.++..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06640          84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence            999999998843    46888999999999999999999987   99999999999999999999999999987643221


Q ss_pred             cccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCC
Q 003599          640 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSES  719 (808)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  719 (808)
                        ......++..|+|||.+.+..++.++|+||||+++|||++|+.|+..........              .+.... ..
T Consensus       157 --~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~--------------~~~~~~-~~  219 (277)
T cd06640         157 --KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF--------------LIPKNN-PP  219 (277)
T ss_pred             --ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh--------------hhhcCC-CC
Confidence              1222457889999999988889999999999999999999999876432211110              000000 01


Q ss_pred             cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          720 SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       720 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                      .........+.+++.+|++.+|++||+++++++.
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            1333456788999999999999999999999775

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2e-34  Score=318.71  Aligned_cols=253  Identities=24%  Similarity=0.321  Sum_probs=195.7

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  557 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  557 (808)
                      ++|++.+.||+|+||.||+++.. +++.||+|+++..   .....+.+.+|+.++.+++|+||+++++.+.+.+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888999999999999999876 5889999998753   2334567888999999999999999999999999999999


Q ss_pred             EecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCC
Q 003599          558 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  637 (808)
Q Consensus       558 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  637 (808)
                      ||+++|+|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~  154 (360)
T cd05627          81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA  154 (360)
T ss_pred             eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence            99999999999853   356889999999999999999999998   999999999999999999999999998754321


Q ss_pred             CCc---------------------------------ccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCC
Q 003599          638 QDQ---------------------------------ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRK  684 (808)
Q Consensus       638 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~  684 (808)
                      ...                                 .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~  234 (360)
T cd05627         155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (360)
T ss_pred             cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence            100                                 00112469999999999999999999999999999999999999


Q ss_pred             CCCCCCCchhhhhhhhhhhccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCC---HHHHHHH
Q 003599          685 NTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPN---MSTVVSM  753 (808)
Q Consensus       685 p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs---~~ev~~~  753 (808)
                      ||..........    ......... .+.+.       .....++.+++.+++. +|++|++   ++++++.
T Consensus       235 Pf~~~~~~~~~~----~i~~~~~~~-~~p~~-------~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         235 PFCSETPQETYR----KVMNWKETL-VFPPE-------VPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH  293 (360)
T ss_pred             CCCCCCHHHHHH----HHHcCCCce-ecCCC-------CCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence            986443221111    111000000 01111       0123456677777664 9999995   5555543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=3e-34  Score=306.38  Aligned_cols=263  Identities=24%  Similarity=0.345  Sum_probs=201.1

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  558 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  558 (808)
                      ++|++.+.||+|++|.||+|+.+ +++.||+|++....  ....+.+.+|+.++++++|+||+++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46888999999999999999986 58999999986532  2234668899999999999999999999999999999999


Q ss_pred             ecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCC
Q 003599          559 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  638 (808)
Q Consensus       559 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  638 (808)
                      |+++++|..++..   ...+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07847          81 YCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG  154 (286)
T ss_pred             ccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence            9999998887643   346899999999999999999999988   9999999999999999999999999998764432


Q ss_pred             CcccccceeccCCccChhhhcc-CCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhh----------hcccc
Q 003599          639 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKL----------WNENK  707 (808)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~----------~~~~~  707 (808)
                      .  ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||................          +....
T Consensus       155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07847         155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ  232 (286)
T ss_pred             c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence            1  1222457889999999875 457899999999999999999999987544322211111000          00000


Q ss_pred             c-h--hccCCcccCC--cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          708 I-L--ALVDPFLSES--SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       708 ~-~--~~~d~~l~~~--~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      . .  ...++.....  .........+.+++.+|++.+|++||++.|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            0 0  0000000000  000123467889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.5e-34  Score=308.70  Aligned_cols=254  Identities=26%  Similarity=0.353  Sum_probs=203.4

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEe
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  559 (808)
                      ++|++.+.||+|+||+||++... +++.||+|++.... ....+.+.+|+++++.++||||+++++++......++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            56888899999999999999875 58899999876543 33467899999999999999999999999999999999999


Q ss_pred             cCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCC
Q 003599          560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  639 (808)
Q Consensus       560 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  639 (808)
                      +++++|.+++..   .+.+++..+..++.+++.||.|||+..  +++|+||||+||++++++.++|+|||++....... 
T Consensus        85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-  158 (284)
T cd06620          85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-  158 (284)
T ss_pred             CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence            999999988743   346899999999999999999999742  39999999999999999999999999987542211 


Q ss_pred             cccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchh-------hhhhhhhhhccccchhcc
Q 003599          640 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLT-------ILGYAWKLWNENKILALV  712 (808)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~~~  712 (808)
                         .....|+..|+|||.+.+..++.++||||||+++|||++|+.|+........       ..........+      .
T Consensus       159 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------~  229 (284)
T cd06620         159 ---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE------P  229 (284)
T ss_pred             ---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc------c
Confidence               1235689999999999888899999999999999999999999875432110       11111111100      0


Q ss_pred             CCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHH
Q 003599          713 DPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML  754 (808)
Q Consensus       713 d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L  754 (808)
                      .+.+.    ..+....+.+++.+|++.+|++||+++||+++.
T Consensus       230 ~~~~~----~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         230 PPRLP----SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             CCCCC----chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            11111    112456788999999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.1e-34  Score=304.21  Aligned_cols=251  Identities=25%  Similarity=0.408  Sum_probs=200.5

Q ss_pred             CCcccCcccccCceeEEEEEecCCcEEEEEEecccc------cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEE
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKAS------GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI  556 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  556 (808)
                      +|++.+.||+|+||.||+|...+++.+|+|.+....      ....+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            477889999999999999998889999999886432      12345688999999999999999999999999999999


Q ss_pred             EEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCC
Q 003599          557 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  636 (808)
Q Consensus       557 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  636 (808)
                      |||+++++|.+++.+   ...+++..+..++.|++.||+|||+.+   |+|+||+|+||++++++.++|+|||+++....
T Consensus        81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            999999999999853   246788999999999999999999988   99999999999999999999999999886532


Q ss_pred             CC----CcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhcc
Q 003599          637 NQ----DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALV  712 (808)
Q Consensus       637 ~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  712 (808)
                      ..    .........|+..|+|||.+.+..++.++||||||+++|||++|+.|+...........    ....    ...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~----~~~~----~~~  226 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFY----IGAH----RGL  226 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHH----hhhc----cCC
Confidence            11    11111224588999999999988899999999999999999999999864332111110    0000    000


Q ss_pred             CCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          713 DPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       713 d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      .+.     .+.....++.+++.+|++.+|++||++.++++
T Consensus       227 ~~~-----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         227 MPR-----LPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             CCC-----CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            111     12234567789999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.8e-34  Score=301.56  Aligned_cols=249  Identities=22%  Similarity=0.360  Sum_probs=201.8

Q ss_pred             CCcccCcccccCceeEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEe
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  559 (808)
                      +|++.+.||+|+||.||+++.. +++.||+|++...  .....+++.+|+.++++++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            4788999999999999999865 6889999998643  233456889999999999999999999999999999999999


Q ss_pred             cCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCC
Q 003599          560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  639 (808)
Q Consensus       560 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  639 (808)
                      +++++|.+++... ....+++.++.+++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence            9999999988642 2335788999999999999999999988   99999999999999999999999999986543221


Q ss_pred             cccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCC
Q 003599          640 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSES  719 (808)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  719 (808)
                      .  .....|+..|+|||.+.+..++.++|+||||++++||++|+.|+........    ..... .+..     +     
T Consensus       157 ~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~----~~~~~-~~~~-----~-----  219 (256)
T cd08218         157 L--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL----VLKII-RGSY-----P-----  219 (256)
T ss_pred             h--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH----HHHHh-cCCC-----C-----
Confidence            1  1224578899999999888899999999999999999999998754322111    11111 0100     0     


Q ss_pred             cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          720 SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       720 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      ..+.....++.+++.+|++.+|++||+|.+|++
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            012233557889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=2.5e-34  Score=304.35  Aligned_cols=253  Identities=27%  Similarity=0.425  Sum_probs=200.5

Q ss_pred             CCcccCcccccCceeEEEEEecC--CcEEEEEEeccc----------ccccHHHHHHHHHHHHh-ccCCceeeEeeEEEe
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLKD--GQEIAVKRLSKA----------SGQGLEEFMNEVMVISK-LQHRNLVRLLGCCVE  549 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~~--~~~vAvK~l~~~----------~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~  549 (808)
                      +|++.+.||+|+||.||+|....  ++.+|+|.+...          ......++.+|+.++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47888999999999999999765  688999987532          22234567789988875 799999999999999


Q ss_pred             CCeeEEEEEecCCCCchhhccCC-CCCCcCChhhHHHHHHHHHHHHHHhHh-cCCCcEEeCCCCCCceEeCCCCCeeeec
Q 003599          550 GEEKMLIYEYMPNRSLDALLFDP-LKKERLDWRKRFNIIEGISRGLLYLHR-DSRLRIIHRDLKASNILLDEELNPKISD  627 (808)
Q Consensus       550 ~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~ivH~Dikp~NILl~~~~~~kl~D  627 (808)
                      ++..++||||+++++|.+++... .....+++..+++++.|++.||.|||+ .+   ++|+||+|+||+++.++.+||+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence            99999999999999999887431 234568999999999999999999996 44   99999999999999999999999


Q ss_pred             cccceecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhcccc
Q 003599          628 FGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENK  707 (808)
Q Consensus       628 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  707 (808)
                      ||++.......   ......|+..|+|||.+.+..++.++||||||+++|||++|+.|+........    .... .++.
T Consensus       158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~----~~~~-~~~~  229 (269)
T cd08528         158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL----ATKI-VEAV  229 (269)
T ss_pred             ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH----HHHH-hhcc
Confidence            99998754332   22235688999999999988899999999999999999999998753221111    1100 1111


Q ss_pred             chhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHh
Q 003599          708 ILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN  755 (808)
Q Consensus       708 ~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~  755 (808)
                      .    .+. .    .......+.+++.+|++.||++||++.||.+++.
T Consensus       230 ~----~~~-~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         230 Y----EPL-P----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             C----CcC-C----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            1    010 0    1122456888999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.5e-34  Score=302.28  Aligned_cols=238  Identities=24%  Similarity=0.410  Sum_probs=189.3

Q ss_pred             CcccccCceeEEEEEecCCc-----------EEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEE
Q 003599          488 SKLGQGGFGPVYWGRLKDGQ-----------EIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI  556 (808)
Q Consensus       488 ~~lG~G~~g~Vy~~~~~~~~-----------~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  556 (808)
                      +.||+|+||.||+|.+.+..           .|++|.+...... ...|.+|+.++++++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            47999999999999986433           5788877654333 6889999999999999999999999988 778999


Q ss_pred             EEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCC-------Ceeeeccc
Q 003599          557 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL-------NPKISDFG  629 (808)
Q Consensus       557 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~-------~~kl~DFG  629 (808)
                      |||+++|+|.+++...  ...+++..++.++.||+.||+|||+.+   |+||||||+|||++.++       .+||+|||
T Consensus        79 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          79 EEYVKFGPLDVFLHRE--KNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EEcCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence            9999999999998652  236889999999999999999999988   99999999999999888       79999999


Q ss_pred             cceecCCCCCcccccceeccCCccChhhhccC--CCCccccEEehhHHHHHHHhC-CCCCCCCCCchhhhhhhhhhhccc
Q 003599          630 MAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG--RFSEKSDVFSFGVLLLEIVSG-RKNTSFFEDDLTILGYAWKLWNEN  706 (808)
Q Consensus       630 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~k~DvwSlGvil~elltG-~~p~~~~~~~~~~~~~~~~~~~~~  706 (808)
                      +++....      .....++..|+|||.+...  .++.++||||||+++|||++| ..|+.......... .    ....
T Consensus       154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~-~----~~~~  222 (259)
T cd05037         154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER-F----YQDQ  222 (259)
T ss_pred             ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH-H----HhcC
Confidence            9986533      1123567789999998776  789999999999999999995 55654332111110 0    0000


Q ss_pred             cchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHh
Q 003599          707 KILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN  755 (808)
Q Consensus       707 ~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~  755 (808)
                      .       ...     ......+.+++.+|++.+|.+||++.+|++.|+
T Consensus       223 ~-------~~~-----~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         223 H-------RLP-----MPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             C-------CCC-----CCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            0       000     001167889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.8e-34  Score=304.06  Aligned_cols=254  Identities=22%  Similarity=0.340  Sum_probs=189.8

Q ss_pred             CcccccCceeEEEEEecCC---cEEEEEEecccc-cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEecCCC
Q 003599          488 SKLGQGGFGPVYWGRLKDG---QEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNR  563 (808)
Q Consensus       488 ~~lG~G~~g~Vy~~~~~~~---~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  563 (808)
                      ++||+|+||.||+|+..++   ..+++|.+.... ....+.|.+|+.+++.++||||+++++.+......++||||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            4699999999999975433   346677765433 345678999999999999999999999999999999999999999


Q ss_pred             CchhhccCCCC-CCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCccc
Q 003599          564 SLDALLFDPLK-KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD  642 (808)
Q Consensus       564 sL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  642 (808)
                      +|.+++..... ....++..+..++.||++||+|||+.+   ++||||||+|||++.++.+||+|||++...........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            99999865321 234667778899999999999999987   99999999999999999999999999864322211112


Q ss_pred             ccceeccCCccChhhhcc-------CCCCccccEEehhHHHHHHHhC-CCCCCCCCCchhhhhhhhhhhccccchhccCC
Q 003599          643 TGRVVGTFGYMSPEYAME-------GRFSEKSDVFSFGVLLLEIVSG-RKNTSFFEDDLTILGYAWKLWNENKILALVDP  714 (808)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~-------~~~s~k~DvwSlGvil~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  714 (808)
                      .....++..|+|||++..       ..++.++||||||+++|||+++ ..|+....+.....    ... .+......++
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~----~~~-~~~~~~~~~~  232 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLN----HVI-KDQQVKLFKP  232 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHH----HHH-hhcccccCCC
Confidence            223467889999998743       2457899999999999999975 55664333221111    111 1122233344


Q ss_pred             cccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHh
Q 003599          715 FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN  755 (808)
Q Consensus       715 ~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~  755 (808)
                      .+...     ...++.+++..|+ .+|++||++++|++.|.
T Consensus       233 ~~~~~-----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         233 QLELP-----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             ccCCC-----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            43322     2345677888898 57999999999999884

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.6e-34  Score=308.76  Aligned_cols=261  Identities=25%  Similarity=0.355  Sum_probs=202.4

Q ss_pred             HHHHHHHhcCCcccCcccccCceeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHHhc-cCCceeeEeeEEE---
Q 003599          474 FEELATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCV---  548 (808)
Q Consensus       474 ~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~---  548 (808)
                      +..+..+.++|++.+.||+|+||.||+++.. .++.+|+|.+.... ....++.+|+.+++++ +||||+++++++.   
T Consensus        10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   88 (286)
T cd06638          10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD   88 (286)
T ss_pred             eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence            4455567789999999999999999999875 57899999886432 2346788999999999 6999999999884   


Q ss_pred             --eCCeeEEEEEecCCCCchhhccCCC-CCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeee
Q 003599          549 --EGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKI  625 (808)
Q Consensus       549 --~~~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl  625 (808)
                        .+...++||||+++++|.+++.... ....+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.+||
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl  165 (286)
T cd06638          89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKL  165 (286)
T ss_pred             cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEE
Confidence              3456899999999999998875322 3356888999999999999999999987   999999999999999999999


Q ss_pred             eccccceecCCCCCcccccceeccCCccChhhhcc-----CCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhh
Q 003599          626 SDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME-----GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAW  700 (808)
Q Consensus       626 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~  700 (808)
                      +|||+++.......  ......|+..|+|||.+..     ..++.++||||||+++|||++|+.|+............  
T Consensus       166 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~--  241 (286)
T cd06638         166 VDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKI--  241 (286)
T ss_pred             ccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhc--
Confidence            99999986543221  1222468999999998753     44788999999999999999999998643322211110  


Q ss_pred             hhhccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          701 KLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       701 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                         ...     ..+.+.   .+......+.+++.+|++.+|++||++.||++.
T Consensus       242 ---~~~-----~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         242 ---PRN-----PPPTLH---QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             ---ccc-----CCCccc---CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence               000     011110   111123468899999999999999999999875

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=3.9e-34  Score=312.70  Aligned_cols=255  Identities=21%  Similarity=0.251  Sum_probs=195.5

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  557 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  557 (808)
                      ++|++.++||+|+||.||+++.+ .++.+|+|.+.+.   .....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            46889999999999999999976 4778999998642   2233456888999999999999999999999999999999


Q ss_pred             EecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCC
Q 003599          558 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  637 (808)
Q Consensus       558 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  637 (808)
                      ||+++|+|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 ey~~~g~L~~~l~~--~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             eccCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            99999999999964  2346888999999999999999999988   999999999999999999999999999765332


Q ss_pred             CCcccccceeccCCccChhhhc-----cCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhcc
Q 003599          638 QDQADTGRVVGTFGYMSPEYAM-----EGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALV  712 (808)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  712 (808)
                      .. .......||+.|+|||++.     ...++.++|||||||++|||++|+.||...+.....    ...........  
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~----~~i~~~~~~~~--  228 (332)
T cd05623         156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY----GKIMNHKERFQ--  228 (332)
T ss_pred             Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHH----HHHhCCCcccc--
Confidence            21 1222356899999999986     346789999999999999999999998643321111    11111110000  


Q ss_pred             CCcccCCcccHHHHHHHHHHHHhcccCCcC--CCCCHHHHHHH
Q 003599          713 DPFLSESSFQLDMIIRCIHVGLLCVQELVK--DRPNMSTVVSM  753 (808)
Q Consensus       713 d~~l~~~~~~~~~~~~l~~li~~cl~~~P~--~RPs~~ev~~~  753 (808)
                         .  .........++.+++.+|+..++.  .||+++++++.
T Consensus       229 ---~--p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         229 ---F--PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             ---C--CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence               0  001112345667778787755444  46889998776

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=3e-34  Score=313.03  Aligned_cols=258  Identities=20%  Similarity=0.289  Sum_probs=194.4

Q ss_pred             ccCccccc--CceeEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEec
Q 003599          486 LSSKLGQG--GFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  560 (808)
Q Consensus       486 ~~~~lG~G--~~g~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  560 (808)
                      +.++||+|  +|++||+++.+ +|+.||+|++....  ....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            46789999  78899999875 68999999987542  233456778999999999999999999999999999999999


Q ss_pred             CCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCc
Q 003599          561 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  640 (808)
Q Consensus       561 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  640 (808)
                      ++|+|.+++... ....+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.++++||+...........
T Consensus        82 ~~~~l~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~  157 (327)
T cd08227          82 AYGSAKDLICTH-FMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR  157 (327)
T ss_pred             CCCcHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence            999999998542 2335899999999999999999999988   999999999999999999999999865543211110


Q ss_pred             c-----cccceeccCCccChhhhcc--CCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhcc-
Q 003599          641 A-----DTGRVVGTFGYMSPEYAME--GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALV-  712 (808)
Q Consensus       641 ~-----~~~~~~gt~~y~aPE~~~~--~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-  712 (808)
                      .     ......++..|+|||.+..  ..++.++|||||||++|||++|+.||..............     +.....+ 
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~-----~~~~~~~~  232 (327)
T cd08227         158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN-----GTVPCLLD  232 (327)
T ss_pred             ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhc-----CCcccccc
Confidence            0     0112346778999999875  4588999999999999999999999864332221111000     0000000 


Q ss_pred             ------------------CCccc----------------CCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          713 ------------------DPFLS----------------ESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       713 ------------------d~~l~----------------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                                        +....                ...........+.+++.+|++.||++|||++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         233 TTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             ccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence                              00000                00012223457889999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.4e-34  Score=305.10  Aligned_cols=256  Identities=26%  Similarity=0.408  Sum_probs=199.0

Q ss_pred             CcccCcccccCceeEEEEEec----CCcEEEEEEeccc--ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCC------
Q 003599          484 FQLSSKLGQGGFGPVYWGRLK----DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE------  551 (808)
Q Consensus       484 ~~~~~~lG~G~~g~Vy~~~~~----~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------  551 (808)
                      |.+.+.||+|+||.||+|.+.    .++.||||.+...  .....+++.+|+.++++++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567789999999999999864    3688999998654  2334677899999999999999999999886543      


Q ss_pred             eeEEEEEecCCCCchhhccCCC---CCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeecc
Q 003599          552 EKMLIYEYMPNRSLDALLFDPL---KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDF  628 (808)
Q Consensus       552 ~~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DF  628 (808)
                      ..++++||+++|+|..++....   +...+++..+.+++.|++.||+|||+.+   |+||||||+||+++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence            2478899999999998875321   2235788899999999999999999988   999999999999999999999999


Q ss_pred             ccceecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhcccc
Q 003599          629 GMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENK  707 (808)
Q Consensus       629 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  707 (808)
                      |+++...............++..|++||.+....++.++||||||+++|||++ |+.|+..... .....+..    ...
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~-~~~~~~~~----~~~  232 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-SEIYNYLI----KGN  232 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH-HHHHHHHH----cCC
Confidence            99987643322222222345678999999988889999999999999999999 7787753322 11111110    100


Q ss_pred             chhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003599          708 ILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  757 (808)
Q Consensus       708 ~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~  757 (808)
                             .+.   .+......+.+++.+|++.+|++||++.+|++.|+++
T Consensus       233 -------~~~---~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         233 -------RLK---QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             -------cCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                   000   1122345788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=6.3e-34  Score=300.92  Aligned_cols=250  Identities=26%  Similarity=0.403  Sum_probs=194.5

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEecccc-----cccHHHHHHHHHHHHhccCCceeeEeeEEEe--CCee
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-----GQGLEEFMNEVMVISKLQHRNLVRLLGCCVE--GEEK  553 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~  553 (808)
                      .+|+..+.||+|+||.||+|... .+..||+|++....     ....+.+.+|+.++++++||||+++++++.+  +...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            46888999999999999999875 58899999886432     1234568899999999999999999998875  3567


Q ss_pred             EEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeecccccee
Q 003599          554 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI  633 (808)
Q Consensus       554 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  633 (808)
                      ++++||+++++|.+++..   ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.
T Consensus        82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            899999999999999853   345889999999999999999999887   99999999999999999999999999986


Q ss_pred             cCCCCCc-ccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhcc
Q 003599          634 FGGNQDQ-ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALV  712 (808)
Q Consensus       634 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  712 (808)
                      ....... .......++..|+|||.+.+..++.++||||||+++|||++|+.|+...........    ....     ..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~----~~~~-----~~  226 (266)
T cd06651         156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFK----IATQ-----PT  226 (266)
T ss_pred             cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHH----HhcC-----CC
Confidence            5322111 111224578999999999988899999999999999999999999864322211110    0000     00


Q ss_pred             CCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          713 DPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       713 d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      .+.     .+......+..++ .|+..+|++||+++||++
T Consensus       227 ~~~-----~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         227 NPQ-----LPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             CCC-----CchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            111     2222334455555 788899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.8e-34  Score=300.48  Aligned_cols=247  Identities=28%  Similarity=0.397  Sum_probs=200.6

Q ss_pred             CCcccCcccccCceeEEEEEec-CCcEEEEEEecccc-----cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEE
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-----GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI  556 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  556 (808)
                      +|+..+.||+|++|.||+|... +++.|++|.+....     .+..+.+.+|+.++++++|+||+++++++..+...++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4677889999999999999986 78999999886533     23457789999999999999999999999999999999


Q ss_pred             EEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCC
Q 003599          557 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  636 (808)
Q Consensus       557 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  636 (808)
                      |||+++++|.+++..   ...+++..+..++.|+++||+|||+.+   ++|+||+|+||+++.++.+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            999999999999854   345889999999999999999999988   99999999999999999999999999886543


Q ss_pred             CCCcccccceeccCCccChhhhccCC-CCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCc
Q 003599          637 NQDQADTGRVVGTFGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPF  715 (808)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  715 (808)
                      ..   ......++..|+|||.+.... ++.++|+||||+++|||++|+.|+...........    .......       
T Consensus       155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~----~~~~~~~-------  220 (258)
T cd06632         155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFK----IGRSKEL-------  220 (258)
T ss_pred             cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHH----HHhcccC-------
Confidence            32   122346789999999987766 89999999999999999999999865432111111    0000000       


Q ss_pred             ccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          716 LSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       716 l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                         ...+......+.+++.+|++.+|++||+++++++
T Consensus       221 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         221 ---PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             ---CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence               0122223466788999999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.1e-34  Score=311.77  Aligned_cols=262  Identities=21%  Similarity=0.291  Sum_probs=195.8

Q ss_pred             HHhcCCcccCcccccCceeEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHHhccCCceeeEeeEEEeC-----
Q 003599          479 TATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG-----  550 (808)
Q Consensus       479 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----  550 (808)
                      ...++|++.+.||+|+||.||+|... +++.||||++....  ....+.+.+|+.++++++||||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            34578999999999999999999865 67899999986532  23346678999999999999999999987543     


Q ss_pred             -CeeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccc
Q 003599          551 -EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFG  629 (808)
Q Consensus       551 -~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFG  629 (808)
                       ...++++|++ +++|.+++.    ...+++..+..++.||++||.|||+.+   |+||||||+|||+++++.+||+|||
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg  163 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG  163 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence             3468999988 788988773    346899999999999999999999998   9999999999999999999999999


Q ss_pred             cceecCCCCCcccccceeccCCccChhhhcc-CCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhh------
Q 003599          630 MAKIFGGNQDQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKL------  702 (808)
Q Consensus       630 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~------  702 (808)
                      +++.....     .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||........+.......      
T Consensus       164 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  238 (343)
T cd07878         164 LARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPE  238 (343)
T ss_pred             cceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            99865322     122468999999999876 568999999999999999999999986433221111110000      


Q ss_pred             ----hccccchhccC--CcccCCc---ccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          703 ----WNENKILALVD--PFLSESS---FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       703 ----~~~~~~~~~~d--~~l~~~~---~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                          .........+.  +......   ........+.+++.+|++.||++|||++|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         239 VLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                00000000000  0000000   000112346789999999999999999999864

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=3e-34  Score=309.24  Aligned_cols=262  Identities=21%  Similarity=0.310  Sum_probs=198.6

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEe
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  559 (808)
                      ++|++.++||+|+||.||+|+.+ +++.||+|.+.... ......+.+|+.++++++||||+++++++......++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            57899999999999999999876 57899999986543 23345678999999999999999999999999999999999


Q ss_pred             cCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCC
Q 003599          560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  639 (808)
Q Consensus       560 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  639 (808)
                      ++ ++|.+++...  ...+++..+..++.||++||+|||+.+   |+|+||||+||++++++.+||+|||+++.......
T Consensus        86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  159 (301)
T cd07873          86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  159 (301)
T ss_pred             cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence            97 5888887542  346888999999999999999999988   99999999999999999999999999976432221


Q ss_pred             cccccceeccCCccChhhhccC-CCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhh------------ccc
Q 003599          640 QADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLW------------NEN  706 (808)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~------------~~~  706 (808)
                        ......+++.|+|||.+.+. .++.++||||||+++|||++|+.||...+....... .....            ...
T Consensus       160 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  236 (301)
T cd07873         160 --TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHF-IFRILGTPTEETWPGILSNE  236 (301)
T ss_pred             --cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHHcCCCChhhchhhhccc
Confidence              11224568899999988654 478899999999999999999999875432211110 00000            000


Q ss_pred             cchhccCCcccCC---cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          707 KILALVDPFLSES---SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       707 ~~~~~~d~~l~~~---~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      .....-.+.....   .........+.+++.+|++.||.+|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            0000000110000   001123446789999999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.8e-34  Score=301.35  Aligned_cols=247  Identities=28%  Similarity=0.418  Sum_probs=197.8

Q ss_pred             cCCcccCcccccCceeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEecC
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMP  561 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  561 (808)
                      ++|++.+.||+|+||.||++.. .++.||+|.++...  ..+.+.+|+.++++++|||++++++++... ..++||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            4688899999999999999975 47889999986532  346889999999999999999999998754 4799999999


Q ss_pred             CCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCcc
Q 003599          562 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA  641 (808)
Q Consensus       562 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  641 (808)
                      +++|.+++... ....+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++......   
T Consensus        82 ~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---  154 (254)
T cd05083          82 KGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---  154 (254)
T ss_pred             CCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence            99999998653 2346889999999999999999999987   9999999999999999999999999997643211   


Q ss_pred             cccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCc
Q 003599          642 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS  720 (808)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  720 (808)
                        .....+..|+|||.+.++.++.++|+||||+++|||++ |+.|+....... ..   . ....+.   ..+       
T Consensus       155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-~~---~-~~~~~~---~~~-------  217 (254)
T cd05083         155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-VK---E-CVEKGY---RME-------  217 (254)
T ss_pred             --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH-HH---H-HHhCCC---CCC-------
Confidence              11234578999999988899999999999999999998 888875433211 11   1 111110   000       


Q ss_pred             ccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhh
Q 003599          721 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS  756 (808)
Q Consensus       721 ~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~  756 (808)
                      ........+.+++.+|++.+|++||++++|++.|++
T Consensus       218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            112234677899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.2e-34  Score=297.96  Aligned_cols=253  Identities=23%  Similarity=0.273  Sum_probs=209.7

Q ss_pred             cCCcccCcccccCceeEEEEEecC-CcEEEEEEecccc---cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  557 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  557 (808)
                      ++|++++.||.|.-|+||++++++ +...|+|++.+..   .....+...|.+||+.++||.++.+++.++.+...+++|
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            457778999999999999999885 5889999998753   344566778999999999999999999999999999999


Q ss_pred             EecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCC
Q 003599          558 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  637 (808)
Q Consensus       558 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  637 (808)
                      |||+||+|...++. +..+.+++..+.-++.+++-||+|||..|   ||.|||||+||||.++|.+.|+||.|+......
T Consensus       157 eyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             ecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            99999999998876 35678999999999999999999999998   999999999999999999999999998754110


Q ss_pred             --------------------------------CCc----------------------ccccceeccCCccChhhhccCCC
Q 003599          638 --------------------------------QDQ----------------------ADTGRVVGTFGYMSPEYAMEGRF  663 (808)
Q Consensus       638 --------------------------------~~~----------------------~~~~~~~gt~~y~aPE~~~~~~~  663 (808)
                                                      ...                      ......+||-.|+|||++.+...
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                            000                      11123579999999999999999


Q ss_pred             CccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCC
Q 003599          664 SEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKD  743 (808)
Q Consensus       664 s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~  743 (808)
                      +.+.|.|.|||+||||+.|+.||........+...+.             ..+.-. ...+....+.+||.+.|.+||.+
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~-------------~~l~Fp-~~~~vs~~akDLIr~LLvKdP~k  378 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG-------------QPLKFP-EEPEVSSAAKDLIRKLLVKDPSK  378 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc-------------CCCcCC-CCCcchhHHHHHHHHHhccChhh
Confidence            9999999999999999999999988777666543321             111111 22245677889999999999999


Q ss_pred             CCC----HHHHHH
Q 003599          744 RPN----MSTVVS  752 (808)
Q Consensus       744 RPs----~~ev~~  752 (808)
                      |-.    +.||-+
T Consensus       379 Rlg~~rGA~eIK~  391 (459)
T KOG0610|consen  379 RLGSKRGAAEIKR  391 (459)
T ss_pred             hhccccchHHhhc
Confidence            998    777754

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.3e-34  Score=302.35  Aligned_cols=255  Identities=27%  Similarity=0.398  Sum_probs=199.6

Q ss_pred             CCcccCcccccCceeEEEEEec-CCcEEEEEEeccccc----------ccHHHHHHHHHHHHhccCCceeeEeeEEEeCC
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG----------QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE  551 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~----------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~  551 (808)
                      +|.+.+.||+|+||.||+|... +++.||+|.++....          ...+.+.+|+.++++++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4777899999999999999865 588999998753211          12356788999999999999999999999999


Q ss_pred             eeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccc
Q 003599          552 EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA  631 (808)
Q Consensus       552 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla  631 (808)
                      ..++||||+++++|.+++...   ..+++..+..++.||+.||.|||+.+   ++||||+|+||+++.++.++|+|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence            999999999999999998542   56889999999999999999999987   999999999999999999999999999


Q ss_pred             eecCCCCCcccccceeccCCccChhhhccCC--CCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccch
Q 003599          632 KIFGGNQDQADTGRVVGTFGYMSPEYAMEGR--FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKIL  709 (808)
Q Consensus       632 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  709 (808)
                      +...............++..|+|||.+....  ++.++|+||||+++||+++|+.|+..........    ... .....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~----~~~-~~~~~  230 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMF----KLG-NKRSA  230 (272)
T ss_pred             ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHH----Hhh-ccccC
Confidence            8654322222222346889999999987654  7899999999999999999999985322211111    111 01111


Q ss_pred             hccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          710 ALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       710 ~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                      ..+...     ...+....+.+++.+|++.+|++||++++|++.
T Consensus       231 ~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         231 PPIPPD-----VSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             CcCCcc-----ccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            111111     112345678899999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-34  Score=310.04  Aligned_cols=252  Identities=25%  Similarity=0.335  Sum_probs=211.1

Q ss_pred             HhcCCcccCcccccCceeEEEEEecC-CcEEEEEEecccccc---cHHHHHHHHHHHHhcc-CCceeeEeeEEEeCCeeE
Q 003599          480 ATNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQ---GLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEKM  554 (808)
Q Consensus       480 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vAvK~l~~~~~~---~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~  554 (808)
                      ....|++.+.||+|.||.||+++.+. |+.+|+|.+.+....   ..+.+.+|+.+|+++. |||||.+.+.+++....+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            44679999999999999999999875 999999999875432   4568899999999998 999999999999999999


Q ss_pred             EEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCC----CCeeeecccc
Q 003599          555 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE----LNPKISDFGM  630 (808)
Q Consensus       555 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~----~~~kl~DFGl  630 (808)
                      +|||++.||.|.+.+...    .+++.....++.|++.++.|||+.+   |+||||||+|+|+...    +.+|++|||+
T Consensus       113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            999999999999998654    3999999999999999999999988   9999999999999643    5799999999


Q ss_pred             ceecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchh
Q 003599          631 AKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILA  710 (808)
Q Consensus       631 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  710 (808)
                      +.....   .......+||+.|+|||.+....++..+||||+|+++|.|++|..||....+........     .+..  
T Consensus       186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~-----~~~~--  255 (382)
T KOG0032|consen  186 AKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAIL-----RGDF--  255 (382)
T ss_pred             ceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHH-----cCCC--
Confidence            998765   233445789999999999999999999999999999999999999997655444333111     1111  


Q ss_pred             ccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          711 LVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       711 ~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                          ....+ .-........+++..++..||.+|+++.++++.
T Consensus       256 ----~f~~~-~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  256 ----DFTSE-PWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             ----CCCCC-CccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence                11112 222346777899999999999999999999984

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.5e-34  Score=308.42  Aligned_cols=248  Identities=23%  Similarity=0.355  Sum_probs=200.2

Q ss_pred             CcccCcccccCceeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEecCC
Q 003599          484 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPN  562 (808)
Q Consensus       484 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  562 (808)
                      |.....||+|+||.||++... ++..||||++........+.+.+|+.++++++|+||+++++.+..++..++||||+++
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~  103 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG  103 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence            344468999999999999875 5889999998765555667889999999999999999999999999999999999999


Q ss_pred             CCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCccc
Q 003599          563 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD  642 (808)
Q Consensus       563 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  642 (808)
                      ++|.+++.    ...+++.++..++.||+.||+|||+.+   |+||||||+||++++++.++|+|||++........  .
T Consensus       104 ~~L~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~  174 (292)
T cd06658         104 GALTDIVT----HTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--K  174 (292)
T ss_pred             CcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--c
Confidence            99999883    345889999999999999999999988   99999999999999999999999999876533221  1


Q ss_pred             ccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCccc
Q 003599          643 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQ  722 (808)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  722 (808)
                      .....|+..|+|||.+....++.++||||||+++|||++|+.|+...........          +...+.+.+..   .
T Consensus       175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~----------~~~~~~~~~~~---~  241 (292)
T cd06658         175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR----------IRDNLPPRVKD---S  241 (292)
T ss_pred             CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----------HHhcCCCcccc---c
Confidence            2235689999999999888899999999999999999999999864322111110          01111111111   1


Q ss_pred             HHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          723 LDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       723 ~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                      ......+.+++.+|++.+|++||+++++++.
T Consensus       242 ~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         242 HKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            1234467789999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=6.8e-34  Score=308.75  Aligned_cols=197  Identities=26%  Similarity=0.444  Sum_probs=160.3

Q ss_pred             cCcccccCceeEEEEEec---CCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEe--CCeeEEEEEecC
Q 003599          487 SSKLGQGGFGPVYWGRLK---DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVE--GEEKMLIYEYMP  561 (808)
Q Consensus       487 ~~~lG~G~~g~Vy~~~~~---~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~E~~~  561 (808)
                      .++||+|+||+||+|+..   +++.||+|.+....  ....+.+|+.++++++||||+++++.+..  +...++||||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999865   46789999986532  23567899999999999999999998864  456789999986


Q ss_pred             CCCchhhccCC------CCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEe----CCCCCeeeeccccc
Q 003599          562 NRSLDALLFDP------LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL----DEELNPKISDFGMA  631 (808)
Q Consensus       562 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl----~~~~~~kl~DFGla  631 (808)
                       ++|.+++...      .....+++..+..++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence             4777766421      12235888999999999999999999998   9999999999999    45678999999999


Q ss_pred             eecCCCCC-cccccceeccCCccChhhhccC-CCCccccEEehhHHHHHHHhCCCCCCCC
Q 003599          632 KIFGGNQD-QADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFF  689 (808)
Q Consensus       632 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvil~elltG~~p~~~~  689 (808)
                      +....... ........||+.|+|||.+.+. .++.++||||+||++|||++|++||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            87643321 1222345789999999998764 5899999999999999999999998643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=4.3e-34  Score=306.39  Aligned_cols=262  Identities=28%  Similarity=0.376  Sum_probs=204.2

Q ss_pred             cCHHHHHHHhcCCcccCcccccCceeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHHhc-cCCceeeEeeEEEe
Q 003599          472 FQFEELATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVE  549 (808)
Q Consensus       472 f~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~  549 (808)
                      +...++..++++|++.+.||+|+||.||++... +++.+|+|.+.... ...+.+.+|+.+++++ +|||++++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            444566667889999999999999999999875 68899999986432 2346778899999999 89999999999875


Q ss_pred             C-----CeeEEEEEecCCCCchhhccCCC-CCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCe
Q 003599          550 G-----EEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP  623 (808)
Q Consensus       550 ~-----~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~  623 (808)
                      .     ...++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence            4     35799999999999999885422 3456899999999999999999999987   9999999999999999999


Q ss_pred             eeeccccceecCCCCCcccccceeccCCccChhhhccC-----CCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhh
Q 003599          624 KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG-----RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGY  698 (808)
Q Consensus       624 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~  698 (808)
                      ||+|||+++........  .....|+..|+|||.+...     .++.++||||||+++|||++|+.|+........+...
T Consensus       168 kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~  245 (291)
T cd06639         168 KLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI  245 (291)
T ss_pred             EEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHH
Confidence            99999998865432211  1224678999999987543     3688999999999999999999998643322222111


Q ss_pred             hhhhhccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          699 AWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       699 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      .     ...     .+.+.   ...+....+.+++.+|++.+|++||++.++++
T Consensus       246 ~-----~~~-----~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         246 P-----RNP-----PPTLL---HPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             h-----cCC-----CCCCC---cccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            0     000     01111   11223456889999999999999999999876

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=8.4e-34  Score=305.14  Aligned_cols=262  Identities=21%  Similarity=0.276  Sum_probs=199.3

Q ss_pred             CCcccCcccccCceeEEEEEec-CCcEEEEEEecccccc-----cHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEE
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQ-----GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI  556 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  556 (808)
                      +|++.+.||+|++|.||+|... +++.||||+++.....     ....+..|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4778899999999999999975 6899999999754322     345677899999999999999999999999999999


Q ss_pred             EEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCC
Q 003599          557 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  636 (808)
Q Consensus       557 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  636 (808)
                      |||+ +++|.+++...  ...+++..+..++.||++||.|||+.+   ++|+||||+||+++.++.++|+|||+++....
T Consensus        81 ~e~~-~~~L~~~i~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDK--SIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 99999998642  236999999999999999999999998   99999999999999999999999999987643


Q ss_pred             CCCcccccceeccCCccChhhhcc-CCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhcc---------c
Q 003599          637 NQDQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNE---------N  706 (808)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~---------~  706 (808)
                      ....  .....++..|+|||.+.+ ..++.++||||||+++|||++|..++....+...+... ......         .
T Consensus       155 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  231 (298)
T cd07841         155 PNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKI-FEALGTPTEENWPGVT  231 (298)
T ss_pred             CCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHH-HHHcCCCchhhhhhcc
Confidence            3211  122356788999998864 45789999999999999999997776543322111111 000000         0


Q ss_pred             cchhccCCcccCC----cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          707 KILALVDPFLSES----SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       707 ~~~~~~d~~l~~~----~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                      .............    ........++.+++.+|++.+|++||++.||++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            0000000000000    0112235678899999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=5.6e-34  Score=299.11  Aligned_cols=251  Identities=36%  Similarity=0.552  Sum_probs=200.5

Q ss_pred             CcccCcccccCceeEEEEEecC-----CcEEEEEEecccccc-cHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEE
Q 003599          484 FQLSSKLGQGGFGPVYWGRLKD-----GQEIAVKRLSKASGQ-GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  557 (808)
Q Consensus       484 ~~~~~~lG~G~~g~Vy~~~~~~-----~~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  557 (808)
                      +++.+.||+|+||.||+++..+     +..||+|.+...... ..+.+.+|+..+.+++|+||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3567899999999999998764     378999999765433 5678999999999999999999999999999999999


Q ss_pred             EecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCC
Q 003599          558 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  637 (808)
Q Consensus       558 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  637 (808)
                      ||+++++|.+++.... ...+++.++..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||+++.....
T Consensus        81 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       81 EYMEGGDLLDYLRKNR-PKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             eccCCCCHHHHHHhhh-hccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence            9999999999986421 122899999999999999999999998   999999999999999999999999999876543


Q ss_pred             CCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhhhccccchhccCCcc
Q 003599          638 QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL  716 (808)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  716 (808)
                      ...... ...++..|+|||.+....++.++||||||++++||++ |+.|+..... ......   . ..+...     . 
T Consensus       157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~-~~~~~~---~-~~~~~~-----~-  224 (258)
T smart00219      157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN-EEVLEY---L-KKGYRL-----P-  224 (258)
T ss_pred             cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHH---H-hcCCCC-----C-
Confidence            222211 2336789999999988889999999999999999998 6777653221 111111   1 011100     0 


Q ss_pred             cCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHH
Q 003599          717 SESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML  754 (808)
Q Consensus       717 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L  754 (808)
                          .......++.+++.+|+..+|++|||+.++++.|
T Consensus       225 ----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      225 ----KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             ----CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                1112456788899999999999999999998864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-34  Score=314.01  Aligned_cols=240  Identities=23%  Similarity=0.263  Sum_probs=186.2

Q ss_pred             ccccCceeEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHHhc---cCCceeeEeeEEEeCCeeEEEEEecCC
Q 003599          490 LGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKL---QHRNLVRLLGCCVEGEEKMLIYEYMPN  562 (808)
Q Consensus       490 lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~~~lV~E~~~~  562 (808)
                      ||+|+||+||+|+.. +++.||||++.+..   ......+..|..++.+.   +||||+++++.+.+....++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999876 58999999986532   22334556677777765   699999999999999999999999999


Q ss_pred             CCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCccc
Q 003599          563 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD  642 (808)
Q Consensus       563 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  642 (808)
                      |+|..++..   ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.......  .
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~  152 (330)
T cd05586          81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--T  152 (330)
T ss_pred             ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--C
Confidence            999988853   456899999999999999999999998   99999999999999999999999999875432221  1


Q ss_pred             ccceeccCCccChhhhccC-CCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCcc
Q 003599          643 TGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSF  721 (808)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  721 (808)
                      .....||..|+|||.+.+. .++.++|||||||++|||++|+.||........    .. ....+.      ..+...  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~----~~-~i~~~~------~~~~~~--  219 (330)
T cd05586         153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM----YR-NIAFGK------VRFPKN--  219 (330)
T ss_pred             ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH----HH-HHHcCC------CCCCCc--
Confidence            2235689999999998765 478999999999999999999999854322111    11 111110      011111  


Q ss_pred             cHHHHHHHHHHHHhcccCCcCCCCC----HHHHHH
Q 003599          722 QLDMIIRCIHVGLLCVQELVKDRPN----MSTVVS  752 (808)
Q Consensus       722 ~~~~~~~l~~li~~cl~~~P~~RPs----~~ev~~  752 (808)
                        .....+.+++.+||+.+|++||+    +.++++
T Consensus       220 --~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         220 --VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             --cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence              12356778999999999999994    555554

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=3.4e-34  Score=308.19  Aligned_cols=246  Identities=24%  Similarity=0.371  Sum_probs=199.0

Q ss_pred             ccCcccccCceeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEecCCCC
Q 003599          486 LSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRS  564 (808)
Q Consensus       486 ~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  564 (808)
                      ....||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||+++++
T Consensus        25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~  104 (297)
T cd06659          25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA  104 (297)
T ss_pred             hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence            3458999999999999875 689999999876555556788999999999999999999999999999999999999999


Q ss_pred             chhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCccccc
Q 003599          565 LDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG  644 (808)
Q Consensus       565 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  644 (808)
                      |..++.    ...+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++.......  ...
T Consensus       105 L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~  175 (297)
T cd06659         105 LTDIVS----QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRK  175 (297)
T ss_pred             HHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--ccc
Confidence            998873    346889999999999999999999988   99999999999999999999999999875533221  122


Q ss_pred             ceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCcccHH
Q 003599          645 RVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLD  724 (808)
Q Consensus       645 ~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  724 (808)
                      ...|+..|+|||.+.+..++.++||||||+++|||++|+.|+...........     ....     ..+...   ....
T Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~-----~~~~-----~~~~~~---~~~~  242 (297)
T cd06659         176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR-----LRDS-----PPPKLK---NAHK  242 (297)
T ss_pred             ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-----Hhcc-----CCCCcc---ccCC
Confidence            35689999999999988899999999999999999999999864332211110     0000     000000   1112


Q ss_pred             HHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          725 MIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       725 ~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                      ....+.+++.+|++.+|++||++++|++.
T Consensus       243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         243 ISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             CCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            23467889999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=3e-34  Score=328.01  Aligned_cols=263  Identities=18%  Similarity=0.203  Sum_probs=192.6

Q ss_pred             HHHHHhcCCcccCcccccCceeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHHhccC------CceeeEeeEEE
Q 003599          476 ELATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQH------RNLVRLLGCCV  548 (808)
Q Consensus       476 ~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H------~niv~l~g~~~  548 (808)
                      ++...+++|++.++||+|+||+||+|... .++.||||+++... ...+.+..|+.++++++|      .+++++++++.
T Consensus       123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            34445688999999999999999999875 57889999986432 234456678888777754      45889999887


Q ss_pred             eC-CeeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhc-CCCcEEeCCCCCCceEeCCCC-----
Q 003599          549 EG-EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD-SRLRIIHRDLKASNILLDEEL-----  621 (808)
Q Consensus       549 ~~-~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~ivH~Dikp~NILl~~~~-----  621 (808)
                      .. ...++|||++ +++|.+++..   ...+++.++..|+.||+.||+|||++ +   |+||||||+|||++.++     
T Consensus       202 ~~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~  274 (467)
T PTZ00284        202 NETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDP  274 (467)
T ss_pred             cCCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccc
Confidence            54 4678999988 7788888753   35789999999999999999999974 6   99999999999998765     


Q ss_pred             -----------CeeeeccccceecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCC
Q 003599          622 -----------NPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFE  690 (808)
Q Consensus       622 -----------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~  690 (808)
                                 .+||+|||++....     .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       275 ~~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~  349 (467)
T PTZ00284        275 VTNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD  349 (467)
T ss_pred             ccccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence                       49999999876321     11223578999999999999999999999999999999999999997544


Q ss_pred             Cchhhhhhhhhhhc-----------cccchhcc------CCccc--------CC-c-ccHHHHHHHHHHHHhcccCCcCC
Q 003599          691 DDLTILGYAWKLWN-----------ENKILALV------DPFLS--------ES-S-FQLDMIIRCIHVGLLCVQELVKD  743 (808)
Q Consensus       691 ~~~~~~~~~~~~~~-----------~~~~~~~~------d~~l~--------~~-~-~~~~~~~~l~~li~~cl~~~P~~  743 (808)
                      ....+.. ......           .....++.      ++...        .. . ........+++|+.+||+.||++
T Consensus       350 ~~~~~~~-i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~  428 (467)
T PTZ00284        350 NLEHLHL-MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQK  428 (467)
T ss_pred             hHHHHHH-HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhh
Confidence            3221111 000000           00000000      00000        00 0 00011345779999999999999


Q ss_pred             CCCHHHHHH
Q 003599          744 RPNMSTVVS  752 (808)
Q Consensus       744 RPs~~ev~~  752 (808)
                      |||++|+++
T Consensus       429 R~ta~e~L~  437 (467)
T PTZ00284        429 RLNARQMTT  437 (467)
T ss_pred             CCCHHHHhc
Confidence            999999987

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.7e-34  Score=313.90  Aligned_cols=192  Identities=23%  Similarity=0.357  Sum_probs=164.7

Q ss_pred             HhcCCcccCcccccCceeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEE
Q 003599          480 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  558 (808)
Q Consensus       480 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  558 (808)
                      ...+|++.+.||+|+||.||+|+.. .++.||+|.....      ....|+.++++++||||+++++++..+...++|||
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            3457999999999999999999976 4678999975432      23569999999999999999999999999999999


Q ss_pred             ecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCC
Q 003599          559 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  638 (808)
Q Consensus       559 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  638 (808)
                      ++. ++|.+++..  ....+++.++..|+.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus       138 ~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  211 (357)
T PHA03209        138 HYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP  211 (357)
T ss_pred             ccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence            995 688888754  3456899999999999999999999998   9999999999999999999999999997532211


Q ss_pred             CcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCC
Q 003599          639 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNT  686 (808)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~  686 (808)
                         ......||..|+|||.+.+..++.++|||||||++|||+++..++
T Consensus       212 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        212 ---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             ---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence               122356899999999999999999999999999999999976554

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=5.9e-34  Score=303.79  Aligned_cols=259  Identities=25%  Similarity=0.390  Sum_probs=202.6

Q ss_pred             CHHHHHHHhcCCcccCcccccCceeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHHhc-cCCceeeEeeEEEe-
Q 003599          473 QFEELATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVE-  549 (808)
Q Consensus       473 ~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~-  549 (808)
                      ++.++..+.+.|++.+.||+|+||.||+|+.. +++.+|+|.+.... ....++..|+.++.++ +|+||+++++++.. 
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            44555566789999999999999999999975 58899999885543 3446788999999998 79999999999863 


Q ss_pred             -----CCeeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCee
Q 003599          550 -----GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPK  624 (808)
Q Consensus       550 -----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~k  624 (808)
                           ....+++|||+++|+|.+++... ....+++..+..++.||+.||.|||+.+   |+|+||||+||++++++.++
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~  161 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK  161 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence                 45779999999999999988643 2345788888999999999999999988   99999999999999999999


Q ss_pred             eeccccceecCCCCCcccccceeccCCccChhhhc-----cCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhh
Q 003599          625 ISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM-----EGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYA  699 (808)
Q Consensus       625 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~  699 (808)
                      |+|||+++.......  ......|+..|+|||.+.     ...++.++||||||+++|||++|+.|+...........  
T Consensus       162 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~--  237 (282)
T cd06636         162 LVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL--  237 (282)
T ss_pred             EeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh--
Confidence            999999876532211  122356889999999875     34578899999999999999999999854332111110  


Q ss_pred             hhhhccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          700 WKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       700 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                              +.....+.+.    .......+.+++.+||+.+|.+||++.||++
T Consensus       238 --------~~~~~~~~~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         238 --------IPRNPPPKLK----SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             --------HhhCCCCCCc----ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence                    0011111111    1123457889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-35  Score=311.07  Aligned_cols=245  Identities=29%  Similarity=0.462  Sum_probs=200.6

Q ss_pred             CCcccCcccccCceeEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEE
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  558 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  558 (808)
                      .|.-++.||.|+||.||.+++. +.+.||||++.-..   .+.+++++.|++.|++++|||++.+.|++..+...+||||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            3556689999999999999875 57889999997544   3456788999999999999999999999999999999999


Q ss_pred             ecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCC
Q 003599          559 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  638 (808)
Q Consensus       559 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  638 (808)
                      ||- |+-.+++.-  .++++.+.++..|..+.+.||+|||+.+   .||||||+.||||.+.|.|||+|||.|.+..+..
T Consensus       107 YCl-GSAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn  180 (948)
T KOG0577|consen  107 YCL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN  180 (948)
T ss_pred             HHh-ccHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCchh
Confidence            994 576666643  4567889999999999999999999998   9999999999999999999999999998764432


Q ss_pred             CcccccceeccCCccChhhhc---cCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCc
Q 003599          639 DQADTGRVVGTFGYMSPEYAM---EGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPF  715 (808)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  715 (808)
                            .++|||.|||||++.   .+.|+-|.|||||||+-.||...++|.-..    +.....+.+..+      -.|.
T Consensus       181 ------sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM----NAMSALYHIAQN------esPt  244 (948)
T KOG0577|consen  181 ------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM----NAMSALYHIAQN------ESPT  244 (948)
T ss_pred             ------cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc----hHHHHHHHHHhc------CCCC
Confidence                  378999999999974   578999999999999999999999885321    111112222111      1233


Q ss_pred             ccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          716 LSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       716 l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                      +.    ..+-...+.+++..||++-|.+|||.+++++.
T Consensus       245 Lq----s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  245 LQ----SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             CC----CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence            32    34567788999999999999999999988764

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=3.3e-34  Score=305.93  Aligned_cols=262  Identities=20%  Similarity=0.303  Sum_probs=196.2

Q ss_pred             CCcccCcccccCceeEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEe
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  559 (808)
                      +|++.+.||+|+||.||+|+.. +|+.||+|++....  ......+.+|+.++++++||||+++++++.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4788899999999999999976 68899999986532  22345678899999999999999999999999999999999


Q ss_pred             cCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCC
Q 003599          560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  639 (808)
Q Consensus       560 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  639 (808)
                      ++ ++|.+++..  ....+++..+..++.||++||.|||+.+   ++||||||+||+++.++.+||+|||+++.......
T Consensus        81 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  154 (284)
T cd07839          81 CD-QDLKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR  154 (284)
T ss_pred             CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence            97 578777653  2356899999999999999999999988   99999999999999999999999999986543221


Q ss_pred             cccccceeccCCccChhhhccCC-CCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccc------cchhcc
Q 003599          640 QADTGRVVGTFGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNEN------KILALV  712 (808)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~------~~~~~~  712 (808)
                        ......++..|+|||.+.+.. ++.++||||||+++|||+||+.|+....+...............      .+....
T Consensus       155 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07839         155 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP  232 (284)
T ss_pred             --CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcc
Confidence              112245788999999987654 68999999999999999999988643222111111100000000      000000


Q ss_pred             CC----cccCC----cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          713 DP----FLSES----SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       713 d~----~l~~~----~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      +.    .....    ........++.+++.+|++.||.+|||++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            00    00000    011123467789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-34  Score=305.96  Aligned_cols=264  Identities=22%  Similarity=0.320  Sum_probs=202.6

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  558 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  558 (808)
                      ++|++.+.||+|++|.||+|..+ +++.||+|+++..  .....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36888999999999999999876 5789999988653  23345788999999999999999999999999999999999


Q ss_pred             ecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCC
Q 003599          559 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  638 (808)
Q Consensus       559 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  638 (808)
                      |++++.+..++.   +...+++.++..++.||+.||.|||+.+   ++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence            999877776653   2345899999999999999999999988   9999999999999999999999999998765433


Q ss_pred             CcccccceeccCCccChhhhccC-CCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhh----------h-ccc
Q 003599          639 DQADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKL----------W-NEN  706 (808)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~----------~-~~~  706 (808)
                      .. ......++..|+|||.+... .++.++||||||+++|||++|+.|+........+.......          + ...
T Consensus       155 ~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07833         155 AS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP  233 (288)
T ss_pred             cc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence            21 22235678899999999887 78999999999999999999999886443221111100000          0 000


Q ss_pred             c-----chhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          707 K-----ILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       707 ~-----~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      .     ..+..++.......+.....++.+++.+|++.+|++||++++|++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            0     000000000000112223678899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2.5e-34  Score=307.09  Aligned_cols=263  Identities=23%  Similarity=0.347  Sum_probs=199.9

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEeccccc--ccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG--QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  558 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  558 (808)
                      ++|++.++||+|+||.||+|..+ .++.||+|++.....  ...+.+.+|++++++++||||+++++++..+...++|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46888999999999999999986 588999998865322  235678899999999999999999999999999999999


Q ss_pred             ecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCC
Q 003599          559 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  638 (808)
Q Consensus       559 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  638 (808)
                      |+++++|..+...   ...+++.++..++.||++||+|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07846          81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  154 (286)
T ss_pred             cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence            9999999887643   335899999999999999999999988   9999999999999999999999999998764332


Q ss_pred             CcccccceeccCCccChhhhcc-CCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhh---h-------hhcccc
Q 003599          639 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAW---K-------LWNENK  707 (808)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~---~-------~~~~~~  707 (808)
                      .  ......++..|+|||.+.+ ..++.++||||||+++|||++|++|+..............   .       ......
T Consensus       155 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07846         155 E--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP  232 (286)
T ss_pred             c--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence            2  1222457899999999875 4478899999999999999999988864332111111000   0       000000


Q ss_pred             -chhccCCcccCC----cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          708 -ILALVDPFLSES----SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       708 -~~~~~d~~l~~~----~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                       ......+.....    .........+.+++.+|++.+|++||++.+|++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence             000000111000    001123567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1e-33  Score=298.98  Aligned_cols=250  Identities=27%  Similarity=0.388  Sum_probs=196.3

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEecccc-----cccHHHHHHHHHHHHhccCCceeeEeeEEEeC--Cee
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-----GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG--EEK  553 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~  553 (808)
                      ++|++.+.||+|+||.||+|... ++..||||.+....     ....+.+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            47889999999999999999875 58899999875321     12346788999999999999999999988763  457


Q ss_pred             EEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeecccccee
Q 003599          554 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI  633 (808)
Q Consensus       554 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  633 (808)
                      ++||||+++++|.+++..   ...+++....+++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence            899999999999998853   245788889999999999999999988   99999999999999999999999999986


Q ss_pred             cCCCCCc-ccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhcc
Q 003599          634 FGGNQDQ-ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALV  712 (808)
Q Consensus       634 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  712 (808)
                      ....... .......++..|+|||.+.+..++.++||||||+++|||++|+.|+...........    ...        
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~----~~~--------  223 (265)
T cd06652         156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFK----IAT--------  223 (265)
T ss_pred             cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHH----Hhc--------
Confidence            5322111 112224588999999999888899999999999999999999999864322211110    000        


Q ss_pred             CCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          713 DPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       713 d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      .+.  ....+......+.+++.+|+. +|++||++++|++
T Consensus       224 ~~~--~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         224 QPT--NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             CCC--CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            000  011233445677788888885 8999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=6.9e-34  Score=304.75  Aligned_cols=265  Identities=23%  Similarity=0.325  Sum_probs=197.5

Q ss_pred             HhcCCcccCcccccCceeEEEEEec-CCcEEEEEEeccccc-ccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEE
Q 003599          480 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  557 (808)
Q Consensus       480 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  557 (808)
                      ++++|.+.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.++++++|+||+++++++..+...++||
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            4578999999999999999999865 688999999865432 33456789999999999999999999999999999999


Q ss_pred             EecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCC
Q 003599          558 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  637 (808)
Q Consensus       558 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  637 (808)
                      ||+. ++|.+++..  ....+.+.++..++.|++.||+|||+.+   |+|+||||+||+++.++.+||+|||+++.....
T Consensus        83 e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  156 (291)
T cd07870          83 EYMH-TDLAQYMIQ--HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP  156 (291)
T ss_pred             eccc-CCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence            9996 677766643  2345788888999999999999999988   999999999999999999999999999764322


Q ss_pred             CCcccccceeccCCccChhhhccC-CCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccc---------c
Q 003599          638 QDQADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNEN---------K  707 (808)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~---------~  707 (808)
                      ..  ......++..|+|||.+.+. .++.++||||||+++|||++|+.||....+........+......         .
T Consensus       157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07870         157 SQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK  234 (291)
T ss_pred             CC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhh
Confidence            11  11224578899999998754 478899999999999999999999875443222111111111000         0


Q ss_pred             c----hhccC---C-cccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          708 I----LALVD---P-FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       708 ~----~~~~d---~-~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      .    .+...   + .+............+.+++.+|++.+|++|||++|++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            0    00000   0 00000000012356778999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=6.2e-34  Score=303.97  Aligned_cols=263  Identities=21%  Similarity=0.329  Sum_probs=201.4

Q ss_pred             CCcccCcccccCceeEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEe
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  559 (808)
                      +|++.+.||+|++|.||+|+.. +++.||+|++....  ....+.+.+|+.++++++||||+++++++..+...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4788899999999999999975 68999999987643  33457899999999999999999999999999999999999


Q ss_pred             cCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCC
Q 003599          560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  639 (808)
Q Consensus       560 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  639 (808)
                      + +++|.+++...  ...+++.++..++.||++||+|||+.+   ++|+||||+||+++.++.++|+|||++........
T Consensus        81 ~-~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          81 M-PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             c-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence            9 99999988643  256899999999999999999999988   99999999999999999999999999987643322


Q ss_pred             cccccceeccCCccChhhhccC-CCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccc------------
Q 003599          640 QADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNEN------------  706 (808)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~------------  706 (808)
                       .......++..|+|||.+.+. .++.++||||+|+++|||++|++++....+..... .........            
T Consensus       155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07832         155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLA-IVFRTLGTPNEETWPGLTSLP  232 (286)
T ss_pred             -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHH-HHHHHcCCCChHHHhhccCcc
Confidence             112234688999999988654 46899999999999999999977765433221111 111100000            


Q ss_pred             cchhccCCcccC---CcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          707 KILALVDPFLSE---SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       707 ~~~~~~d~~l~~---~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                      .......+....   .....+....+.+++.+|++.+|++||+++++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            000000000000   00111234788999999999999999999999863

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.7e-34  Score=338.42  Aligned_cols=256  Identities=23%  Similarity=0.350  Sum_probs=198.6

Q ss_pred             HHhcCCcccCcccccCceeEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHHhccCCceeeEeeEEEe--CCee
Q 003599          479 TATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVE--GEEK  553 (808)
Q Consensus       479 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~  553 (808)
                      ...++|.+.++||+|+||+||+++.. .+..||+|.+...  .......|..|+.++++|+|||||++++++..  ....
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l   89 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL   89 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence            34578999999999999999999876 4778999988643  23345778999999999999999999998864  3568


Q ss_pred             EEEEEecCCCCchhhccCCC-CCCcCChhhHHHHHHHHHHHHHHhHhcCC----CcEEeCCCCCCceEeCC---------
Q 003599          554 MLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLYLHRDSR----LRIIHRDLKASNILLDE---------  619 (808)
Q Consensus       554 ~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~----~~ivH~Dikp~NILl~~---------  619 (808)
                      +|||||+++|+|.++|.... ....+++..++.|+.||+.||.|||+.+.    .+|+||||||+||||+.         
T Consensus        90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~  169 (1021)
T PTZ00266         90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT  169 (1021)
T ss_pred             EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence            89999999999999986422 23569999999999999999999998542    34999999999999964         


Q ss_pred             --------CCCeeeeccccceecCCCCCcccccceeccCCccChhhhcc--CCCCccccEEehhHHHHHHHhCCCCCCCC
Q 003599          620 --------ELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME--GRFSEKSDVFSFGVLLLEIVSGRKNTSFF  689 (808)
Q Consensus       620 --------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DvwSlGvil~elltG~~p~~~~  689 (808)
                              ...+||+|||+++.+.....   .....||+.|+|||++..  ..++.++||||||||||||++|+.||...
T Consensus       170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        170 AQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA  246 (1021)
T ss_pred             ccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence                    23489999999986543221   223468999999999854  45889999999999999999999998643


Q ss_pred             CCchhhhhhhhhhhccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          690 EDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       690 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      .....+...    ....       +.+...    ....++.+|+..||+.+|.+||++.|++.
T Consensus       247 ~~~~qli~~----lk~~-------p~lpi~----~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        247 NNFSQLISE----LKRG-------PDLPIK----GKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             CcHHHHHHH----HhcC-------CCCCcC----CCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            322222111    1110       111111    12356889999999999999999999984

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.4e-33  Score=297.24  Aligned_cols=250  Identities=28%  Similarity=0.392  Sum_probs=206.5

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEeccccc-ccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEe
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  559 (808)
                      ++|++.+.||+|++|.||+++.. +++.||||++..... ...+.+.+|+..+.+++|+||+++++++......++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            36888999999999999999987 489999999876543 4567899999999999999999999999999999999999


Q ss_pred             cCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHh-cCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCC
Q 003599          560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR-DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  638 (808)
Q Consensus       560 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  638 (808)
                      +++++|.+++...   ..++...+..++.|+++|++|||+ .+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~  154 (264)
T cd06623          81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL  154 (264)
T ss_pred             cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence            9999999999542   578999999999999999999999 87   9999999999999999999999999998764333


Q ss_pred             CcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCC--chhhhhhhhhhhccccchhccCCcc
Q 003599          639 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFED--DLTILGYAWKLWNENKILALVDPFL  716 (808)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~l  716 (808)
                      ...  ....++..|+|||.+....++.++|+||||+++|||++|+.|+.....  .......   ...      ...+. 
T Consensus       155 ~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~---~~~------~~~~~-  222 (264)
T cd06623         155 DQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA---ICD------GPPPS-  222 (264)
T ss_pred             Ccc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHH---Hhc------CCCCC-
Confidence            221  234678999999999988899999999999999999999999865432  1111111   110      00011 


Q ss_pred             cCCcccHH-HHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          717 SESSFQLD-MIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       717 ~~~~~~~~-~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                          .+.. ....+.+++.+|++.+|++||++.++++.
T Consensus       223 ----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         223 ----LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             ----CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                1222 45678899999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=9.9e-34  Score=303.97  Aligned_cols=250  Identities=25%  Similarity=0.382  Sum_probs=204.0

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEec
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  560 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  560 (808)
                      ++|.+.+.||+|+||.||++... +++.||+|.+........+.+.+|+.++++++||||+++++.+...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            67899999999999999999864 67899999987655555678899999999999999999999999999999999999


Q ss_pred             CCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCc
Q 003599          561 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  640 (808)
Q Consensus       561 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  640 (808)
                      ++++|.+++.+    ..+++.++..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.........
T Consensus        99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~  171 (293)
T cd06647          99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  171 (293)
T ss_pred             CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence            99999999843    35788999999999999999999998   999999999999999999999999998765433221


Q ss_pred             ccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCc
Q 003599          641 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS  720 (808)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  720 (808)
                        .....+++.|+|||.+....++.++||||||+++||+++|+.||...........    ....+      .+..   .
T Consensus       172 --~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~----~~~~~------~~~~---~  236 (293)
T cd06647         172 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL----IATNG------TPEL---Q  236 (293)
T ss_pred             --cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee----hhcCC------CCCC---C
Confidence              1224688899999999888899999999999999999999999864332211110    00000      0001   0


Q ss_pred             ccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          721 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       721 ~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                      ........+.+++.+|++.+|++||++.+++.+
T Consensus       237 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            122334568889999999999999999999876

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.1e-33  Score=296.83  Aligned_cols=248  Identities=26%  Similarity=0.383  Sum_probs=200.4

Q ss_pred             CCcccCcccccCceeEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEe
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  559 (808)
                      +|++.+.||+|+||.||++... +++.+|+|.+...  .....+.+.+|++++++++||||+++++.+..++..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            4788899999999999999875 6889999998653  234467889999999999999999999999999999999999


Q ss_pred             cCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCC-CCeeeeccccceecCCCC
Q 003599          560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE-LNPKISDFGMAKIFGGNQ  638 (808)
Q Consensus       560 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~-~~~kl~DFGla~~~~~~~  638 (808)
                      +++++|.+++... ....+++..+.+++.++++||.|||+.+   ++|+||+|+||+++++ +.+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            9999999999652 2345899999999999999999999988   9999999999999855 458999999998764332


Q ss_pred             CcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccC
Q 003599          639 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSE  718 (808)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  718 (808)
                      .   .....++..|+|||.+....++.++||||||+++|+|++|+.|+..........    .... +...         
T Consensus       157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~----~~~~-~~~~---------  219 (256)
T cd08220         157 K---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVL----KIMS-GTFA---------  219 (256)
T ss_pred             c---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHH----HHHh-cCCC---------
Confidence            1   122467899999999988889999999999999999999999986433221111    1110 0000         


Q ss_pred             CcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          719 SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       719 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                       .........+.+++.+|++.+|++||+++|+++
T Consensus       220 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         220 -PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             -CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence             011223456889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.7e-33  Score=301.14  Aligned_cols=259  Identities=25%  Similarity=0.304  Sum_probs=200.6

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEeccccc-ccHHHHHHHHHHHHhccCCceeeEeeEEEeC--CeeEEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRLLGCCVEG--EEKMLIY  557 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~  557 (808)
                      ++|...++||.|++|.||++... +++.+|+|.+..... .....+.+|++++++++||||+++++++.+.  ...++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            46788899999999999999985 578899999875432 3457799999999999999999999998653  4679999


Q ss_pred             EecCCCCchhhccCC-CCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCC
Q 003599          558 EYMPNRSLDALLFDP-LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  636 (808)
Q Consensus       558 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  636 (808)
                      ||+++++|.+++... .....++...+..++.||+.||+|||+.+   ++|+||+|+||++++++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            999999999887532 13456888999999999999999999988   99999999999999999999999999875432


Q ss_pred             CCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCc-hhhhhhhhhhhccccchhccCCc
Q 003599          637 NQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDD-LTILGYAWKLWNENKILALVDPF  715 (808)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~  715 (808)
                      ...    ....++..|+|||.+.+..++.++||||||+++|||++|+.|+...... ........ .........+ ...
T Consensus       158 ~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~  231 (287)
T cd06621         158 SLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLS-YIVNMPNPEL-KDE  231 (287)
T ss_pred             ccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHH-HHhcCCchhh-ccC
Confidence            211    1245788999999999889999999999999999999999998754221 01111111 1111011111 101


Q ss_pred             ccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          716 LSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       716 l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      ..   ........+.+++.+|++.+|++|||+.||++
T Consensus       232 ~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         232 PG---NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             CC---CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            00   11123567889999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-33  Score=303.39  Aligned_cols=263  Identities=24%  Similarity=0.339  Sum_probs=197.1

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEeccccc-ccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEe
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  559 (808)
                      ++|++.+.||+|++|.||+|..+ +++.||+|.+..... .....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            67889999999999999999976 688999999865432 2335677899999999999999999999999999999999


Q ss_pred             cCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCC
Q 003599          560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  639 (808)
Q Consensus       560 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  639 (808)
                      +.+ +|.+++...  ...+++.....++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||+++.......
T Consensus        85 ~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          85 LDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             CCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence            985 898888642  346889999999999999999999988   99999999999999999999999999875432111


Q ss_pred             cccccceeccCCccChhhhcc-CCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccc--cch-h-----
Q 003599          640 QADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNEN--KIL-A-----  710 (808)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~--~~~-~-----  710 (808)
                        ......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+....................  ... .     
T Consensus       159 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07844         159 --TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP  236 (291)
T ss_pred             --cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence              1112346889999998865 4578999999999999999999999864432211111111111000  000 0     


Q ss_pred             -c-------cC-CcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          711 -L-------VD-PFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       711 -~-------~d-~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                       .       .. ..+............+.+++.+|++.+|++||++.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence             0       00 000000000111256789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8e-34  Score=300.89  Aligned_cols=255  Identities=26%  Similarity=0.390  Sum_probs=201.9

Q ss_pred             HHhcCCcccCcccccCceeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHHhc-cCCceeeEeeEEEeCC-----
Q 003599          479 TATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGE-----  551 (808)
Q Consensus       479 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~-----  551 (808)
                      .++++|++.+.||+|++|.||+|..+ +++.+++|.+..... ..+.+.+|+.+++++ +|+||+++++++....     
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            35688999999999999999999975 578899999865433 457899999999999 7999999999997644     


Q ss_pred             -eeEEEEEecCCCCchhhccCCC-CCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccc
Q 003599          552 -EKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFG  629 (808)
Q Consensus       552 -~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFG  629 (808)
                       ..++||||+++++|.+++.... ....+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.+||+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence             4899999999999999886422 2457899999999999999999999988   9999999999999999999999999


Q ss_pred             cceecCCCCCcccccceeccCCccChhhhcc-----CCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhc
Q 003599          630 MAKIFGGNQDQADTGRVVGTFGYMSPEYAME-----GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN  704 (808)
Q Consensus       630 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~  704 (808)
                      ++.........  .....|+..|+|||.+..     ..++.++||||||+++|||++|+.|+............    . 
T Consensus       159 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~----~-  231 (275)
T cd06608         159 VSAQLDSTLGR--RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKI----P-  231 (275)
T ss_pred             cceecccchhh--hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHh----h-
Confidence            98865432221  222468899999998753     34678999999999999999999998643222211110    0 


Q ss_pred             cccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          705 ENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       705 ~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                           ....+.+.   .......++.+++.+|+..||++|||+.+|++
T Consensus       232 -----~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         232 -----RNPPPTLK---SPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             -----ccCCCCCC---chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence                 00111111   12234567889999999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-35  Score=293.87  Aligned_cols=249  Identities=24%  Similarity=0.391  Sum_probs=207.6

Q ss_pred             CCcccCcccccCceeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEecC
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMP  561 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  561 (808)
                      -|.++++||+|+||.||++..+ +|+.||||.+..  ..+.+++..|+.+|++...|++|+++|.+.....+++|||||-
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG  111 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG  111 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence            3677899999999999999876 599999999864  3467899999999999999999999999999999999999999


Q ss_pred             CCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCcc
Q 003599          562 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA  641 (808)
Q Consensus       562 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  641 (808)
                      .|+..+.+..  +++++++.++..+++..++||+|||...   -+|||||+.||||+.+|.+||+|||.+-.+.....  
T Consensus       112 AGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA--  184 (502)
T KOG0574|consen  112 AGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA--  184 (502)
T ss_pred             CCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHH--
Confidence            9999999864  5678999999999999999999999987   89999999999999999999999999976543322  


Q ss_pred             cccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCcc
Q 003599          642 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSF  721 (808)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  721 (808)
                      ....+.||+-|||||++..-.|..++||||||++..||..|++|+.....-..+.          .+.....|...   .
T Consensus       185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF----------MIPT~PPPTF~---K  251 (502)
T KOG0574|consen  185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF----------MIPTKPPPTFK---K  251 (502)
T ss_pred             hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE----------eccCCCCCCCC---C
Confidence            2234789999999999999999999999999999999999999985322111000          01111122222   3


Q ss_pred             cHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          722 QLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       722 ~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                      +..-..++-+++++||-+.|++|-|+.++++.
T Consensus       252 PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  252 PEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            34556788899999999999999999887764

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.5e-33  Score=299.84  Aligned_cols=247  Identities=26%  Similarity=0.401  Sum_probs=200.3

Q ss_pred             CCcccCcccccCceeEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEec
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  560 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  560 (808)
                      -|++.++||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.++++++||||+++++++..+...++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            4677889999999999999865 68899999876432 334567889999999999999999999999999999999999


Q ss_pred             CCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCc
Q 003599          561 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  640 (808)
Q Consensus       561 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  640 (808)
                      ++++|.+++.    ...+++..+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++........ 
T Consensus        85 ~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-  156 (277)
T cd06641          85 GGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-  156 (277)
T ss_pred             CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence            9999999884    346889999999999999999999988   99999999999999999999999999886543221 


Q ss_pred             ccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCc
Q 003599          641 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS  720 (808)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  720 (808)
                       ......++..|+|||.+.+..++.++|+||||+++|||++|+.|+..........     ......     .+.     
T Consensus       157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-----~~~~~~-----~~~-----  220 (277)
T cd06641         157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLF-----LIPKNN-----PPT-----  220 (277)
T ss_pred             -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHH-----HHhcCC-----CCC-----
Confidence             1122457889999999988889999999999999999999999885432211110     000000     011     


Q ss_pred             ccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          721 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       721 ~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                      ........+.+++.+|++.+|.+||++.++++.
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         221 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            122334667889999999999999999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=7.1e-34  Score=299.97  Aligned_cols=253  Identities=27%  Similarity=0.382  Sum_probs=203.1

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEe
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  559 (808)
                      ++|++.+.||+|++|.||++..+ +++.+|+|.+.... ....+++.+|++++++++||||+++++.+......++|+||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            35778899999999999999986 58899999987653 34557789999999999999999999999999999999999


Q ss_pred             cCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHh-cCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCC
Q 003599          560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR-DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  638 (808)
Q Consensus       560 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  638 (808)
                      +++++|.+++...  ...++...+.+++.|+++||+|||+ .+   ++|+||||+||++++++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~  155 (265)
T cd06605          81 MDGGSLDKILKEV--QGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL  155 (265)
T ss_pred             cCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence            9999999998643  2578889999999999999999999 76   9999999999999999999999999987553221


Q ss_pred             CcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCC-chhhhhhhhhhhccccchhccCCccc
Q 003599          639 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFED-DLTILGYAWKLWNENKILALVDPFLS  717 (808)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~l~  717 (808)
                      ..    ...++..|+|||.+.+..++.++||||||+++|+|++|+.|+..... ..............      ..+.+.
T Consensus       156 ~~----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------~~~~~~  225 (265)
T cd06605         156 AK----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE------PPPRLP  225 (265)
T ss_pred             hh----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcC------CCCCCC
Confidence            11    15678899999999988999999999999999999999999864321 11111111111100      011111


Q ss_pred             CCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          718 ESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       718 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                          ......++.+++.+|+..+|++||++.+++..
T Consensus       226 ----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         226 ----SGKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             ----hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence                11145678899999999999999999998753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=9.2e-34  Score=306.03  Aligned_cols=256  Identities=19%  Similarity=0.251  Sum_probs=201.1

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  557 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  557 (808)
                      ++|++.+.||+|+||.||++... .++.||+|.+....   ....+.+.+|+.+++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            46888999999999999999876 47899999987543   234567889999999999999999999999999999999


Q ss_pred             EecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCC
Q 003599          558 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  637 (808)
Q Consensus       558 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  637 (808)
                      ||+++++|.+++..   ...+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||+++.....
T Consensus        81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~  154 (305)
T cd05609          81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS  154 (305)
T ss_pred             ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence            99999999999854   346889999999999999999999988   999999999999999999999999998742111


Q ss_pred             CCc-------------ccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhc
Q 003599          638 QDQ-------------ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN  704 (808)
Q Consensus       638 ~~~-------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~  704 (808)
                      ...             .......++..|+|||.+....++.++|+||||+++|||++|+.|+....... ..   .....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~-~~---~~~~~  230 (305)
T cd05609         155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-LF---GQVIS  230 (305)
T ss_pred             ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HH---HHHHh
Confidence            000             01112357889999999988889999999999999999999999985332211 11   11110


Q ss_pred             cccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhh
Q 003599          705 ENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS  756 (808)
Q Consensus       705 ~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~  756 (808)
                       +   ....+..     .......+.+++.+|++.+|++||++.++.+.|+.
T Consensus       231 -~---~~~~~~~-----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         231 -D---DIEWPEG-----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             -c---ccCCCCc-----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence             0   0011111     01234567899999999999999998777777755

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.1e-33  Score=296.15  Aligned_cols=252  Identities=29%  Similarity=0.447  Sum_probs=202.0

Q ss_pred             CCcccCcccccCceeEEEEEec-CCcEEEEEEeccccc--ccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEe
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG--QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  559 (808)
                      +|++.+.||+|+||.||+|... +++.||+|.+.....  ...+.+.+|+.++++++|+||+++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            4788899999999999999865 688999999876543  3677899999999999999999999999999999999999


Q ss_pred             cCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCC
Q 003599          560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  639 (808)
Q Consensus       560 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  639 (808)
                      +++++|.+++..   ...+++..+..++.++++||.|||+.+   ++|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~  154 (264)
T cd06626          81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT  154 (264)
T ss_pred             CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence            999999999854   345888999999999999999999988   99999999999999999999999999987644322


Q ss_pred             ccc--ccceeccCCccChhhhccCC---CCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCC
Q 003599          640 QAD--TGRVVGTFGYMSPEYAMEGR---FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDP  714 (808)
Q Consensus       640 ~~~--~~~~~gt~~y~aPE~~~~~~---~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  714 (808)
                      ...  .....++..|+|||.+....   ++.++||||||+++|||++|+.||..........   .....      ...+
T Consensus       155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~---~~~~~------~~~~  225 (264)
T cd06626         155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIM---FHVGA------GHKP  225 (264)
T ss_pred             cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHH---HHHhc------CCCC
Confidence            211  11245788999999998766   8899999999999999999999986443221111   00000      0011


Q ss_pred             cccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          715 FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       715 ~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      .+.   ........+.+++.+|++.+|.+||++.+++.
T Consensus       226 ~~~---~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         226 PIP---DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CCC---cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            111   11122456778999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.2e-33  Score=297.59  Aligned_cols=254  Identities=26%  Similarity=0.387  Sum_probs=201.5

Q ss_pred             CCcccCcccccCceeEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHHhccCCceeeEeeEEEe--CCeeEEEE
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVE--GEEKMLIY  557 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~  557 (808)
                      +|++.+.||+|+||.||++... +++.+|+|.+...  .....+.+.+|+.++++++|+||+++++++..  +...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4788899999999999999865 6789999998643  23345678899999999999999999998764  45678999


Q ss_pred             EecCCCCchhhccCC-CCCCcCChhhHHHHHHHHHHHHHHhHhcC--CCcEEeCCCCCCceEeCCCCCeeeeccccceec
Q 003599          558 EYMPNRSLDALLFDP-LKKERLDWRKRFNIIEGISRGLLYLHRDS--RLRIIHRDLKASNILLDEELNPKISDFGMAKIF  634 (808)
Q Consensus       558 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~--~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~  634 (808)
                      ||+++++|.+++... .....+++..++.++.||++||.|||..+  ..+++|+||||+||++++++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999998643 22457899999999999999999999332  234999999999999999999999999999876


Q ss_pred             CCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCC
Q 003599          635 GGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDP  714 (808)
Q Consensus       635 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  714 (808)
                      ......  .....++..|+|||.+....++.++|+||||+++|+|++|+.|+..... .....    ....+.     .+
T Consensus       161 ~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~----~~~~~~-----~~  228 (265)
T cd08217         161 GHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ-LQLAS----KIKEGK-----FR  228 (265)
T ss_pred             cCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH-HHHHH----HHhcCC-----CC
Confidence            443321  1224689999999999988899999999999999999999999865431 11111    111111     01


Q ss_pred             cccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          715 FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       715 ~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                           ..+......+.+++.+|++.+|++||++.+|+++
T Consensus       229 -----~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         229 -----RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             -----CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                 1223345678899999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.9e-33  Score=297.20  Aligned_cols=253  Identities=26%  Similarity=0.443  Sum_probs=200.9

Q ss_pred             CCcccCcccccCceeEEEEEe-cCCcEEEEEEeccccc------ccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEE
Q 003599          483 NFQLSSKLGQGGFGPVYWGRL-KDGQEIAVKRLSKASG------QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML  555 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  555 (808)
                      +|+..+.||+|++|.||+++. .+++.||+|.+.....      ...+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477889999999999999986 4688999999865321      135678999999999999999999999999999999


Q ss_pred             EEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCC-Ceeeeccccceec
Q 003599          556 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL-NPKISDFGMAKIF  634 (808)
Q Consensus       556 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~-~~kl~DFGla~~~  634 (808)
                      ||||+++++|.+++.+   ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++ .+||+|||++...
T Consensus        81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            9999999999999853   346889999999999999999999998   99999999999998776 5999999999876


Q ss_pred             CCCCCc--ccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhcc
Q 003599          635 GGNQDQ--ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALV  712 (808)
Q Consensus       635 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  712 (808)
                      ......  .......++..|+|||.+....++.++||||+|+++|||++|+.|+.......... ...         ...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~---------~~~  224 (268)
T cd06630         155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA-LIF---------KIA  224 (268)
T ss_pred             ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHH-HHH---------HHh
Confidence            433111  11223467899999999988889999999999999999999999985332211110 000         000


Q ss_pred             CCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          713 DPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       713 d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      ... .....+.....++.+++.+|++.+|++||++.++++
T Consensus       225 ~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         225 SAT-TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             ccC-CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            000 011133345577889999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.1e-34  Score=305.31  Aligned_cols=252  Identities=26%  Similarity=0.365  Sum_probs=203.0

Q ss_pred             hcCCcccCcccccCceeEEEEEecCCcEEEEEEecc--cccccHHHHHHHHHHHHhcc-CCceeeEeeEEEeCCeeEEEE
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSK--ASGQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEKMLIY  557 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~--~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~  557 (808)
                      ...|+++++||+||.+.||++...+.+.+|+|++..  ...+....|.+|+..|.+|+ |.+||++++|-..++.+|+||
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            356999999999999999999999889999998754  35567889999999999995 999999999999999999999


Q ss_pred             EecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCC
Q 003599          558 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  637 (808)
Q Consensus       558 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  637 (808)
                      ||= ..+|..+|... ......| .+..+..|++.|+.++|+++   |||.||||.|+|+-. |.+||+|||+|..+..+
T Consensus       440 E~G-d~DL~kiL~k~-~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~D  512 (677)
T KOG0596|consen  440 ECG-DIDLNKILKKK-KSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPD  512 (677)
T ss_pred             ecc-cccHHHHHHhc-cCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCcc
Confidence            986 55899999653 2223334 67789999999999999998   999999999999965 68999999999988777


Q ss_pred             CCcccccceeccCCccChhhhccC-----------CCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccc
Q 003599          638 QDQADTGRVVGTFGYMSPEYAMEG-----------RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNEN  706 (808)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~  706 (808)
                      .........+||+.||+||.+...           +++.++||||||||||+|+.|+.||..+...     +       .
T Consensus       513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~-----~-------a  580 (677)
T KOG0596|consen  513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ-----I-------A  580 (677)
T ss_pred             ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH-----H-------H
Confidence            666555567899999999998543           2668999999999999999999998532211     1       1


Q ss_pred             cchhccCCcccCC--cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          707 KILALVDPFLSES--SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       707 ~~~~~~d~~l~~~--~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                      ++..+.||.-.-+  ..+.  -.+++++++.||+.||++||+..++++.
T Consensus       581 Kl~aI~~P~~~Iefp~~~~--~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  581 KLHAITDPNHEIEFPDIPE--NDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             HHHhhcCCCccccccCCCC--chHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence            2334445532111  1111  1238999999999999999999998864

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.5e-33  Score=304.19  Aligned_cols=196  Identities=27%  Similarity=0.449  Sum_probs=159.3

Q ss_pred             CcccccCceeEEEEEec---CCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEe--CCeeEEEEEecCC
Q 003599          488 SKLGQGGFGPVYWGRLK---DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVE--GEEKMLIYEYMPN  562 (808)
Q Consensus       488 ~~lG~G~~g~Vy~~~~~---~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~E~~~~  562 (808)
                      .+||+|+||.||+|+..   ++..||+|.+....  ....+.+|+.++++++||||+++++++..  +...++||||+.+
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence            58999999999999865   35789999986532  23567899999999999999999999854  4567899999875


Q ss_pred             CCchhhccCC------CCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEe----CCCCCeeeeccccce
Q 003599          563 RSLDALLFDP------LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL----DEELNPKISDFGMAK  632 (808)
Q Consensus       563 gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl----~~~~~~kl~DFGla~  632 (808)
                       +|.+++...      .....+++..+..++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+|||+++
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence             666665321      12235888899999999999999999988   9999999999999    567789999999998


Q ss_pred             ecCCCCCc-ccccceeccCCccChhhhccC-CCCccccEEehhHHHHHHHhCCCCCCCC
Q 003599          633 IFGGNQDQ-ADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFF  689 (808)
Q Consensus       633 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvil~elltG~~p~~~~  689 (808)
                      ........ .......||+.|+|||.+.+. .++.++||||||+++|||+||+.||...
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            76433221 222335789999999998764 5789999999999999999999998643

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-33  Score=304.99  Aligned_cols=253  Identities=23%  Similarity=0.258  Sum_probs=202.6

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEeccccc---ccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  557 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  557 (808)
                      ++|++.+.||+|++|.||++... +++.||+|.+.....   ...+.+.+|++++++++|+||+++++.+.++...++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36888999999999999999876 489999999876432   24567889999999999999999999999999999999


Q ss_pred             EecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCC
Q 003599          558 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  637 (808)
Q Consensus       558 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  637 (808)
                      ||+.+++|.+++... ....+++..+..++.|+++||+|||+.+   ++|+||||+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            999999999988642 3457899999999999999999999988   999999999999999999999999998765321


Q ss_pred             CCc---------------------------ccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCC
Q 003599          638 QDQ---------------------------ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFE  690 (808)
Q Consensus       638 ~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~  690 (808)
                      ...                           .......|+..|+|||.+.+..++.++||||||+++|||++|+.|+....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            110                           01112467889999999998889999999999999999999999986443


Q ss_pred             CchhhhhhhhhhhccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCC----HHHHHH
Q 003599          691 DDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPN----MSTVVS  752 (808)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs----~~ev~~  752 (808)
                      .......    .         .+....-. ........+.+++.+|++.+|++||+    +++++.
T Consensus       237 ~~~~~~~----~---------~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         237 RDETFSN----I---------LKKEVTFP-GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             hHHHHHH----H---------hcCCccCC-CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            3222111    1         11111000 11124578899999999999999999    666655

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2.7e-33  Score=298.70  Aligned_cols=251  Identities=24%  Similarity=0.352  Sum_probs=193.8

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHH-HHhccCCceeeEeeEEEeCCeeEEEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMV-ISKLQHRNLVRLLGCCVEGEEKMLIYE  558 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lV~E  558 (808)
                      ++|++.+.||+|+||.||+++.. +|+.||+|+++... ......+..|+.. ++.++||||+++++++..+...++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            46888999999999999999976 58999999987542 2334556667665 566789999999999999999999999


Q ss_pred             ecCCCCchhhccCC-CCCCcCChhhHHHHHHHHHHHHHHhHhc-CCCcEEeCCCCCCceEeCCCCCeeeeccccceecCC
Q 003599          559 YMPNRSLDALLFDP-LKKERLDWRKRFNIIEGISRGLLYLHRD-SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  636 (808)
Q Consensus       559 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  636 (808)
                      |++ |+|.+++... .....+++..+.+++.||+.||+|||++ +   ++||||||+||+++.++.+||+|||+++....
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            996 6888777542 2335789999999999999999999986 5   99999999999999999999999999986532


Q ss_pred             CCCcccccceeccCCccChhhhcc----CCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhcc
Q 003599          637 NQDQADTGRVVGTFGYMSPEYAME----GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALV  712 (808)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  712 (808)
                      ..   ......++..|+|||.+..    ..++.++|+||||+++|||++|+.|+..........   ....      ...
T Consensus       157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~---~~~~------~~~  224 (283)
T cd06617         157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQL---KQVV------EEP  224 (283)
T ss_pred             cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHH---HHHH------hcC
Confidence            21   1122457889999998854    446889999999999999999999985432221111   0000      011


Q ss_pred             CCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          713 DPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       713 d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      .+.+..    .....++.+++.+|++.+|++||++++|++
T Consensus       225 ~~~~~~----~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         225 SPQLPA----EKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             CCCCCc----cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            111111    123456889999999999999999999976

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=9.8e-34  Score=302.32  Aligned_cols=263  Identities=22%  Similarity=0.322  Sum_probs=198.0

Q ss_pred             CCcccCcccccCceeEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEe
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  559 (808)
                      +|++.+.||+|++|.||+|+.. +++.||||++....  ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4788899999999999999875 68899999886432  22346788999999999999999999999999999999999


Q ss_pred             cCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCC
Q 003599          560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  639 (808)
Q Consensus       560 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  639 (808)
                      +. ++|.+++... ....+++..+..++.|+++||+|||+.+   ++|+||+|+||+++.++.+||+|||+++.......
T Consensus        81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~  155 (284)
T cd07860          81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  155 (284)
T ss_pred             cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence            96 6888887543 3456899999999999999999999988   99999999999999999999999999886543221


Q ss_pred             cccccceeccCCccChhhhccCC-CCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhcc-ccc----hhcc-
Q 003599          640 QADTGRVVGTFGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNE-NKI----LALV-  712 (808)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~-~~~----~~~~-  712 (808)
                        ......++..|+|||.+.+.. ++.++||||||+++|||+||+.|+....+...........-.. ...    .... 
T Consensus       156 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07860         156 --TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD  233 (284)
T ss_pred             --ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHH
Confidence              112235688999999887654 5889999999999999999999986544322222111100000 000    0000 


Q ss_pred             ----CCcccCC---cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          713 ----DPFLSES---SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       713 ----d~~l~~~---~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                          -+.....   ........++.+++.+|++.||++||+++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence                0000000   001112356778999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=3.4e-33  Score=298.64  Aligned_cols=255  Identities=24%  Similarity=0.393  Sum_probs=206.0

Q ss_pred             HHhcCCcccCcccccCceeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEE
Q 003599          479 TATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  557 (808)
Q Consensus       479 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  557 (808)
                      ..++.|++.+.||+|++|.||++..+ +++.+|+|++..... ..+.+.+|++++++++|+|++++++.+......++|+
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            34567888899999999999999987 688999999976544 5678899999999999999999999999999999999


Q ss_pred             EecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCC
Q 003599          558 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  637 (808)
Q Consensus       558 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  637 (808)
                      ||+++++|.+++....  ..+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++......
T Consensus        95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  169 (286)
T cd06614          95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE  169 (286)
T ss_pred             eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence            9999999999996532  47999999999999999999999987   999999999999999999999999998755332


Q ss_pred             CCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCccc
Q 003599          638 QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS  717 (808)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  717 (808)
                      ..  ......++..|+|||.+.+..++.++||||||+++|||++|+.|+............    . ....     +...
T Consensus       170 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~----~-~~~~-----~~~~  237 (286)
T cd06614         170 KS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLI----T-TKGI-----PPLK  237 (286)
T ss_pred             hh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----H-hcCC-----CCCc
Confidence            21  112245788999999998888999999999999999999999997643322111110    0 0000     0000


Q ss_pred             CCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHH
Q 003599          718 ESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML  754 (808)
Q Consensus       718 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L  754 (808)
                         ........+.+++.+|++.+|.+||++.+|++.-
T Consensus       238 ---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  271 (286)
T cd06614         238 ---NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHP  271 (286)
T ss_pred             ---chhhCCHHHHHHHHHHhccChhhCcCHHHHhhCh
Confidence               1112346788999999999999999999998643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-33  Score=297.48  Aligned_cols=247  Identities=27%  Similarity=0.445  Sum_probs=199.3

Q ss_pred             CCcccCcccccCceeEEEEEec-CCcEEEEEEeccc-ccccHHHHHHHHHHHHhcc---CCceeeEeeEEEeCCeeEEEE
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA-SGQGLEEFMNEVMVISKLQ---HRNLVRLLGCCVEGEEKMLIY  557 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~  557 (808)
                      .|++.+.||+|+||.||+|... +++.||+|.+... .....+++.+|+.++++++   |||++++++++..+...++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            4777899999999999999964 6899999998654 3345677889999999997   999999999999999999999


Q ss_pred             EecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCC
Q 003599          558 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  637 (808)
Q Consensus       558 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  637 (808)
                      ||+++++|.+++..    ..+++.....++.|+++||.|||+.+   ++|+||+|+||+++.++.++|+|||++......
T Consensus        82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            99999999998843    36899999999999999999999988   999999999999999999999999999876543


Q ss_pred             CCcccccceeccCCccChhhhccC-CCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcc
Q 003599          638 QDQADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL  716 (808)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  716 (808)
                      ...  .....|+..|+|||.+..+ .++.++||||||+++|||++|+.|+..........     .     +.....+.+
T Consensus       155 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~-----~-----~~~~~~~~~  222 (277)
T cd06917         155 SSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM-----L-----IPKSKPPRL  222 (277)
T ss_pred             ccc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh-----c-----cccCCCCCC
Confidence            321  2224688999999998754 46899999999999999999999986432211100     0     000011111


Q ss_pred             cCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          717 SESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       717 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      ...    ....++.+++.+|++.+|++||++.++++
T Consensus       223 ~~~----~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         223 EDN----GYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             Ccc----cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            111    13457889999999999999999999976

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.9e-33  Score=301.22  Aligned_cols=244  Identities=28%  Similarity=0.363  Sum_probs=199.6

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  557 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  557 (808)
                      ++|++.+.||+|+||.||++... +++.+|+|.+....   ....+.+.+|++++++++||||+++++++.++...++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46889999999999999999876 58999999986532   234567889999999999999999999999999999999


Q ss_pred             EecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCC
Q 003599          558 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  637 (808)
Q Consensus       558 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  637 (808)
                      ||+++++|.+++..   ...++...+..++.|+++||.|||+.+   ++|+||+|+||+++.++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          81 EYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            99999999999854   357899999999999999999999988   999999999999999999999999999875433


Q ss_pred             CCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCccc
Q 003599          638 QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS  717 (808)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  717 (808)
                           .....+++.|+|||.+.+...+.++||||||+++|||++|+.|+..........    ... .+.      ..  
T Consensus       155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~-~~~------~~--  216 (290)
T cd05580         155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYE----KIL-EGK------VR--  216 (290)
T ss_pred             -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHh-cCC------cc--
Confidence                 223468899999999988888999999999999999999999986433111100    000 110      01  


Q ss_pred             CCcccHHHHHHHHHHHHhcccCCcCCCC-----CHHHHHH
Q 003599          718 ESSFQLDMIIRCIHVGLLCVQELVKDRP-----NMSTVVS  752 (808)
Q Consensus       718 ~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~ev~~  752 (808)
                         .+......+.+++.+|++.+|.+||     +++++++
T Consensus       217 ---~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         217 ---FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             ---CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence               1222346778999999999999999     6666653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-33  Score=295.84  Aligned_cols=248  Identities=24%  Similarity=0.346  Sum_probs=210.4

Q ss_pred             cCCcccCcccccCceeEEEEEe-cCCcEEEEEEeccccc--ccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRL-KDGQEIAVKRLSKASG--QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  558 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  558 (808)
                      .-|.+.+-||+|.|..|-+|+. -.|..||||++.+..-  ....++++|++.|+.++|||||++|.+......+|||+|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            4578889999999999999975 3799999999987543  345678999999999999999999999999999999999


Q ss_pred             ecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeC-CCCCeeeeccccceecCCC
Q 003599          559 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD-EELNPKISDFGMAKIFGGN  637 (808)
Q Consensus       559 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~-~~~~~kl~DFGla~~~~~~  637 (808)
                      .-.+|+|.+|+..  ....+.+....+++.||..||.|+|+..   +|||||||+||.+- +-|-+||.|||++-.+.+.
T Consensus        98 LGD~GDl~DyImK--He~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG  172 (864)
T KOG4717|consen   98 LGDGGDLFDYIMK--HEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG  172 (864)
T ss_pred             ecCCchHHHHHHh--hhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence            9999999999976  3456888999999999999999999998   99999999999874 5688999999999877554


Q ss_pred             CCcccccceeccCCccChhhhccCCCC-ccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcc
Q 003599          638 QDQADTGRVVGTFGYMSPEYAMEGRFS-EKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL  716 (808)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  716 (808)
                      +.   ....+|+..|-|||++.+..|. ++.||||||||||.|++|+.||....+...+.             .++|-..
T Consensus       173 ~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT-------------mImDCKY  236 (864)
T KOG4717|consen  173 KK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT-------------MIMDCKY  236 (864)
T ss_pred             ch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh-------------hhhcccc
Confidence            33   2346899999999999998885 67899999999999999999997655544432             2222222


Q ss_pred             cCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          717 SESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       717 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                         ..+.....+|.+||..||..||.+|.+.++|+..
T Consensus       237 ---tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  237 ---TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             ---cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence               2566788999999999999999999999999763

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=5.8e-33  Score=289.76  Aligned_cols=249  Identities=29%  Similarity=0.467  Sum_probs=204.5

Q ss_pred             CCcccCcccccCceeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEecC
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMP  561 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  561 (808)
                      .|++.+.||+|++|.||++... +++.+++|++........+.+.+|++.+++++|+|++++++++......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            3677899999999999999986 688999999977655567889999999999999999999999999999999999999


Q ss_pred             CCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCcc
Q 003599          562 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA  641 (808)
Q Consensus       562 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  641 (808)
                      +++|.+++...  ...+++..+..++.|+++||.|||..+   ++|+||+|+||++++++.++|+|||.+........  
T Consensus        81 ~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  153 (253)
T cd05122          81 GGSLKDLLKST--NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--  153 (253)
T ss_pred             CCcHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence            99999988542  257899999999999999999999987   99999999999999999999999999986644321  


Q ss_pred             cccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCcc
Q 003599          642 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSF  721 (808)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  721 (808)
                       .....++..|+|||.+....++.++||||||+++|+|++|+.|+...+.........     ..     .-+.+.   .
T Consensus       154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-----~~-----~~~~~~---~  219 (253)
T cd05122         154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIA-----TN-----GPPGLR---N  219 (253)
T ss_pred             -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH-----hc-----CCCCcC---c
Confidence             233568899999999988889999999999999999999999986443221111100     00     000110   1


Q ss_pred             cHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          722 QLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       722 ~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      ......++.+++.+|++.+|++||++.++++
T Consensus       220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1112467889999999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.4e-33  Score=307.70  Aligned_cols=197  Identities=26%  Similarity=0.355  Sum_probs=170.3

Q ss_pred             CCcccCcccccCceeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHHhcc-C-----CceeeEeeEEEeCCeeEE
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-H-----RNLVRLLGCCVEGEEKML  555 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-H-----~niv~l~g~~~~~~~~~l  555 (808)
                      +|.+.+.||+|+||.|.++.+. .++.||||+++.. ..-..+-..|+.+|..|+ |     -|+|++++++...++.+|
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            7899999999999999999876 5899999999643 344566778999999997 4     379999999999999999


Q ss_pred             EEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCC--CCeeeecccccee
Q 003599          556 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE--LNPKISDFGMAKI  633 (808)
Q Consensus       556 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~--~~~kl~DFGla~~  633 (808)
                      |+|.+ ..+|.++|... +...++...+..++.||+.||.+||+.+   |||+||||+||||.+.  ..+||+|||.+..
T Consensus       266 VfELL-~~NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~  340 (586)
T KOG0667|consen  266 VFELL-STNLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF  340 (586)
T ss_pred             eehhh-hhhHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence            99999 45999999764 4456999999999999999999999988   9999999999999654  3699999999986


Q ss_pred             cCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCC
Q 003599          634 FGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFE  690 (808)
Q Consensus       634 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~  690 (808)
                      ......     ...-+..|.|||++.+.+|+.+.|+||||||+.||++|.+.|+..+
T Consensus       341 ~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n  392 (586)
T KOG0667|consen  341 ESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN  392 (586)
T ss_pred             cCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence            532221     3566889999999999999999999999999999999987776544

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.6e-33  Score=295.78  Aligned_cols=249  Identities=23%  Similarity=0.389  Sum_probs=200.0

Q ss_pred             CCcccCcccccCceeEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEe
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  559 (808)
                      +|++.+.||+|+||.||++..+ ++..+|+|.+...  .....+.+.+|+.++++++|+||+++++.+..+...++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4788899999999999999976 5889999998653  223456788999999999999999999999999999999999


Q ss_pred             cCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCC-CeeeeccccceecCCCC
Q 003599          560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL-NPKISDFGMAKIFGGNQ  638 (808)
Q Consensus       560 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~-~~kl~DFGla~~~~~~~  638 (808)
                      +++++|.+++... ....+++..+..++.|+++||.|||+.+   ++|+||||+||++++++ .+||+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            9999999988653 2345799999999999999999999988   99999999999999885 46999999998764332


Q ss_pred             CcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccC
Q 003599          639 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSE  718 (808)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  718 (808)
                      ...  ....|++.|+|||.+....++.++|+||||+++|||++|+.|+........    ..... .+.    ..+    
T Consensus       157 ~~~--~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----~~~~~-~~~----~~~----  221 (257)
T cd08225         157 ELA--YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQL----VLKIC-QGY----FAP----  221 (257)
T ss_pred             ccc--cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH----HHHHh-ccc----CCC----
Confidence            211  224588999999999888899999999999999999999999854322111    11111 111    110    


Q ss_pred             CcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          719 SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       719 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                        ........+.+++.+|++.+|++||++.+|++
T Consensus       222 --~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         222 --ISPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             --CCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence              11123456889999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.2e-34  Score=278.90  Aligned_cols=253  Identities=25%  Similarity=0.339  Sum_probs=200.9

Q ss_pred             HHhcCCcccCcccccCceeEEEEEec-CCcEEEEEEecccc----cc----cHHHHHHHHHHHHhc-cCCceeeEeeEEE
Q 003599          479 TATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS----GQ----GLEEFMNEVMVISKL-QHRNLVRLLGCCV  548 (808)
Q Consensus       479 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~----~~----~~~~~~~E~~~l~~l-~H~niv~l~g~~~  548 (808)
                      ..-++|.-.+.||+|..++|-+...+ .|...|+|++....    .+    -.+.-.+|+.+|+++ -||+|+++.++++
T Consensus        14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye   93 (411)
T KOG0599|consen   14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE   93 (411)
T ss_pred             hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence            33456788899999999999988765 57889999886421    11    234456799999998 5999999999999


Q ss_pred             eCCeeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeecc
Q 003599          549 EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDF  628 (808)
Q Consensus       549 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DF  628 (808)
                      .....++|+|.|+.|.|.++|..   .-.+++.+..+|++|+.+|++|||..+   ||||||||+|||++++.++||+||
T Consensus        94 s~sF~FlVFdl~prGELFDyLts---~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDF  167 (411)
T KOG0599|consen   94 SDAFVFLVFDLMPRGELFDYLTS---KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDF  167 (411)
T ss_pred             CcchhhhhhhhcccchHHHHhhh---heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecc
Confidence            99999999999999999999953   456899999999999999999999998   999999999999999999999999


Q ss_pred             ccceecCCCCCcccccceeccCCccChhhhcc------CCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhh
Q 003599          629 GMAKIFGGNQDQADTGRVVGTFGYMSPEYAME------GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKL  702 (808)
Q Consensus       629 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~  702 (808)
                      |.+..+.+...   ....+||++|+|||.+..      ..|+...|+|+.|||+|-|+.|.+||-..  . .+. +. .+
T Consensus       168 GFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR--k-Qml-ML-R~  239 (411)
T KOG0599|consen  168 GFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR--K-QML-ML-RM  239 (411)
T ss_pred             ceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH--H-HHH-HH-HH
Confidence            99998755433   334789999999998842      34788999999999999999999997311  0 000 00 01


Q ss_pred             hccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          703 WNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       703 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      ..+|+. +.-.      +.-.+...+..+|+.+||+.||.+|.|++|.++
T Consensus       240 ImeGky-qF~s------peWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  240 IMEGKY-QFRS------PEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             HHhccc-ccCC------cchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            111111 1111      122355677889999999999999999999875

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=3.6e-33  Score=298.34  Aligned_cols=247  Identities=23%  Similarity=0.352  Sum_probs=199.3

Q ss_pred             CcccCcccccCceeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEecCC
Q 003599          484 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPN  562 (808)
Q Consensus       484 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  562 (808)
                      |...+.||+|++|.||++... +++.+|+|++........+.+.+|+.++++++||||+++++++..++..++|+||+++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~  100 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG  100 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence            444579999999999999864 6889999998655545567789999999999999999999999999999999999999


Q ss_pred             CCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCccc
Q 003599          563 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD  642 (808)
Q Consensus       563 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  642 (808)
                      ++|.+++..    ..+++.++..++.|++.||+|||+.+   ++||||+|+||+++.++.++|+|||++.........  
T Consensus       101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~--  171 (285)
T cd06648         101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR--  171 (285)
T ss_pred             CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCcc--
Confidence            999999854    46889999999999999999999988   999999999999999999999999988755432211  


Q ss_pred             ccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCccc
Q 003599          643 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQ  722 (808)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  722 (808)
                      .....|+..|+|||.+.+..++.++||||||+++|||++|+.|+........    ... ...     ...+.+..   .
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~----~~~-~~~-----~~~~~~~~---~  238 (285)
T cd06648         172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA----MKR-IRD-----NLPPKLKN---L  238 (285)
T ss_pred             cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH----HHH-HHh-----cCCCCCcc---c
Confidence            1224688999999999888899999999999999999999999753221111    110 111     11111111   1


Q ss_pred             HHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          723 LDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       723 ~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      ......+.+++.+|++.+|++||++.++++
T Consensus       239 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         239 HKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             ccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            123457889999999999999999999886

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=3.7e-33  Score=299.39  Aligned_cols=262  Identities=21%  Similarity=0.286  Sum_probs=198.3

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHHhccCCceeeEeeEEEeC--CeeEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG--EEKMLI  556 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV  556 (808)
                      ++|++.+.||+|+||.||+|..+ +++.+|+|.++...  ......+.+|+.++++++||||+++++++...  ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            57888999999999999999986 58899999986432  22334678899999999999999999999877  889999


Q ss_pred             EEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCC
Q 003599          557 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  636 (808)
Q Consensus       557 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  636 (808)
                      |||+. ++|.+++...  ...+++.++..++.||+.||+|||+.+   ++|+||||+||+++.++.+||+|||+++....
T Consensus        85 ~e~~~-~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          85 MEYVE-HDLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             ehhcC-cCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            99997 4898887542  336899999999999999999999988   99999999999999999999999999987644


Q ss_pred             CCCcccccceeccCCccChhhhccCC-CCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhh----------hhh--
Q 003599          637 NQDQADTGRVVGTFGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAW----------KLW--  703 (808)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~----------~~~--  703 (808)
                      ...  ......++..|+|||.+.+.. ++.++|+||||+++|||++|+.|+..............          ..+  
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
T cd07843         159 PLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE  236 (293)
T ss_pred             Ccc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence            321  122245788999999987654 68999999999999999999999865433211111000          000  


Q ss_pred             ----ccccchhccCCcccCCcccHH-HHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          704 ----NENKILALVDPFLSESSFQLD-MIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       704 ----~~~~~~~~~d~~l~~~~~~~~-~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                          ............+. ..++.. ....+.+++.+|++.+|++||++.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         237 LPGAKKKTFTKYPYNQLR-KKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             cchhcccccccccchhhh-ccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence                00000000000110 111111 3556788999999999999999999875

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=8.2e-33  Score=289.86  Aligned_cols=251  Identities=28%  Similarity=0.440  Sum_probs=205.5

Q ss_pred             CCcccCcccccCceeEEEEEec-CCcEEEEEEeccccc--ccHHHHHHHHHHHHhccCCceeeEeeEEEeC--CeeEEEE
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG--QGLEEFMNEVMVISKLQHRNLVRLLGCCVEG--EEKMLIY  557 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~  557 (808)
                      +|+..+.||+|++|.||+|... +++.|++|++.....  ...+.+.+|+.++++++|+||+++++.+...  ...++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4777899999999999999987 688999999876542  4567899999999999999999999999988  8899999


Q ss_pred             EecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCC
Q 003599          558 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  637 (808)
Q Consensus       558 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  637 (808)
                      ||+++++|.+++...   ..+++..+..++.|+++||+|||+.+   ++|+||+|+||+++.++.++|+|||.+......
T Consensus        81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          81 EYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            999999999998642   37899999999999999999999987   999999999999999999999999999877544


Q ss_pred             CCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCccc
Q 003599          638 QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS  717 (808)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  717 (808)
                      ..........++..|+|||.+.....+.++||||||+++++|++|+.|+....+...   .........         ..
T Consensus       155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~---------~~  222 (260)
T cd06606         155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA---ALYKIGSSG---------EP  222 (260)
T ss_pred             cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH---HHHhccccC---------CC
Confidence            321112235688999999999888899999999999999999999999875442111   111111000         00


Q ss_pred             CCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          718 ESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       718 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                       ...+......+.+++.+|++.+|++||++.++++
T Consensus       223 -~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         223 -PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             -cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence             0122233567889999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-33  Score=305.85  Aligned_cols=269  Identities=21%  Similarity=0.304  Sum_probs=199.6

Q ss_pred             hcCCcccCcccccCceeEEEEEec-CCcEEEEEEeccc-ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCC-----ee
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE-----EK  553 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~  553 (808)
                      .++|++.++||+|+||.||+|+.. +++.||+|++... .......+.+|+.++++++|+||+++++++....     ..
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            468999999999999999999865 6899999998643 2334567889999999999999999999876543     57


Q ss_pred             EEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeecccccee
Q 003599          554 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI  633 (808)
Q Consensus       554 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  633 (808)
                      ++|+||+.+ +|..++.    ...+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||+++.
T Consensus        84 ~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~  155 (336)
T cd07849          84 YIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI  155 (336)
T ss_pred             EEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence            999999964 7777763    346899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCCcc-cccceeccCCccChhhhcc-CCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhcc---ccc
Q 003599          634 FGGNQDQA-DTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNE---NKI  708 (808)
Q Consensus       634 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~---~~~  708 (808)
                      ........ ......|+..|+|||.+.+ ..++.++||||||+++|||++|+.|+.......... ........   +..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~-~~~~~~~~~~~~~~  234 (336)
T cd07849         156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLN-LILGVLGTPSQEDL  234 (336)
T ss_pred             ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHHcCCCCHHHH
Confidence            54322211 1123468899999998754 468899999999999999999999986432111111 00000100   000


Q ss_pred             hhccCCc-------------ccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH--Hhhcc
Q 003599          709 LALVDPF-------------LSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM--LNSEI  758 (808)
Q Consensus       709 ~~~~d~~-------------l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~--L~~~~  758 (808)
                      ....+..             ............++.+++.+|++.+|++||++.++++.  ++...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~  299 (336)
T cd07849         235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH  299 (336)
T ss_pred             HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence            0000000             00000001234568899999999999999999999887  55543

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-33  Score=303.18  Aligned_cols=265  Identities=21%  Similarity=0.317  Sum_probs=196.9

Q ss_pred             CCcccCcccccCceeEEEEEecC---CcEEEEEEecccc---cccHHHHHHHHHHHHhccCCceeeEeeEEEeC--CeeE
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLKD---GQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG--EEKM  554 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~~---~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~  554 (808)
                      +|++.++||+|+||.||+|....   ++.||+|.+....   ....+.+.+|+.++++++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            47888999999999999999754   7899999997633   34456788999999999999999999999988  7899


Q ss_pred             EEEEecCCCCchhhccCCC--CCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCC----CCCeeeecc
Q 003599          555 LIYEYMPNRSLDALLFDPL--KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE----ELNPKISDF  628 (808)
Q Consensus       555 lV~E~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~----~~~~kl~DF  628 (808)
                      +||||+++ +|.+++....  ....++...+..++.||+.||.|||+.+   |+||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 6666554321  2236888999999999999999999988   999999999999999    999999999


Q ss_pred             ccceecCCCCC-cccccceeccCCccChhhhccC-CCCccccEEehhHHHHHHHhCCCCCCCCCCchh---------hhh
Q 003599          629 GMAKIFGGNQD-QADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLT---------ILG  697 (808)
Q Consensus       629 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~---------~~~  697 (808)
                      |+++....... ........++..|+|||.+.+. .++.++||||||+++|||++|+.|+........         +..
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99987643322 1122234678999999988764 578999999999999999999999865433220         000


Q ss_pred             hhhhhhcc------------ccchhccCC----cccCCc----ccH--HHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          698 YAWKLWNE------------NKILALVDP----FLSESS----FQL--DMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       698 ~~~~~~~~------------~~~~~~~d~----~l~~~~----~~~--~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      .. ..+..            .......+.    ......    ...  ....++.+++.+|++.+|++|||+.|+++
T Consensus       237 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         237 IF-EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HH-HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            00 00000            000000000    000000    000  23356889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=5.1e-33  Score=300.50  Aligned_cols=246  Identities=28%  Similarity=0.449  Sum_probs=195.7

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  557 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  557 (808)
                      ..|.+.+.||+|+||.||+|+.. +++.||+|++....   ....+++.+|++++++++||||+++++++.+.+..++||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            45888899999999999999875 68999999986432   233457889999999999999999999999999999999


Q ss_pred             EecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCC
Q 003599          558 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  637 (808)
Q Consensus       558 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  637 (808)
                      ||+. |+|.+++..  ....+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++......
T Consensus        95 e~~~-g~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~  168 (307)
T cd06607          95 EYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA  168 (307)
T ss_pred             HhhC-CCHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence            9997 577666643  2346899999999999999999999988   999999999999999999999999998764322


Q ss_pred             CCcccccceeccCCccChhhhc---cCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCC
Q 003599          638 QDQADTGRVVGTFGYMSPEYAM---EGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDP  714 (808)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  714 (808)
                            ....++..|+|||.+.   ...++.++||||||+++|||++|+.|+..........    .....      ..+
T Consensus       169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~----~~~~~------~~~  232 (307)
T cd06607         169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY----HIAQN------DSP  232 (307)
T ss_pred             ------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHH----HHhcC------CCC
Confidence                  1245788999999874   4568899999999999999999999875332211110    00000      001


Q ss_pred             cccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          715 FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       715 ~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                      .+    ........+.+++.+|++.+|++||++.+|+..
T Consensus       233 ~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         233 TL----SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             CC----CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            11    112245678999999999999999999999875

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-33  Score=298.66  Aligned_cols=262  Identities=24%  Similarity=0.342  Sum_probs=197.4

Q ss_pred             CcccCcccccCceeEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEec
Q 003599          484 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  560 (808)
Q Consensus       484 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  560 (808)
                      |++.+.||+|++|.||+|... +|..||+|++....  ....+.+.+|++++++++|||++++++++.+++..++||||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            567889999999999999875 68999999986542  223467889999999999999999999999999999999999


Q ss_pred             CCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCc
Q 003599          561 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  640 (808)
Q Consensus       561 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  640 (808)
                      + ++|.+++... ....+++..+.+++.|+++||+|||+.+   ++||||+|+||+++.++.++|+|||+++........
T Consensus        81 ~-~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~  155 (283)
T cd07835          81 D-LDLKKYMDSS-PLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT  155 (283)
T ss_pred             C-cCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence            5 6899888543 2246899999999999999999999987   999999999999999999999999999765322111


Q ss_pred             ccccceeccCCccChhhhccC-CCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccc-----cchhccC-
Q 003599          641 ADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNEN-----KILALVD-  713 (808)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~-----~~~~~~d-  713 (808)
                        .....++..|+|||.+.+. .++.++||||||+++|||++|+.||....+...+...........     ......+ 
T Consensus       156 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07835         156 --YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY  233 (283)
T ss_pred             --cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh
Confidence              1123568899999987654 468899999999999999999999865443222211111000000     0000000 


Q ss_pred             ----CcccC---CcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          714 ----PFLSE---SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       714 ----~~l~~---~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                          +....   ..........+.+++.+|++.+|++||+++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                00000   0011123357889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=5.2e-33  Score=296.60  Aligned_cols=264  Identities=23%  Similarity=0.349  Sum_probs=200.0

Q ss_pred             CCcccCcccccCceeEEEEEec-CCcEEEEEEeccccc-ccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEec
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  560 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  560 (808)
                      +|++.++||+|++|.||+|+.. +++.||||+++.... ...+.+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4788999999999999999986 588999999876432 33567789999999999999999999999999999999999


Q ss_pred             CCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCc
Q 003599          561 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  640 (808)
Q Consensus       561 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  640 (808)
                      ++ +|.+++........+++..+.+++.|++.||.|||+.+   ++||||||+||++++++.++|+|||+++....... 
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-  155 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-  155 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence            85 88888765444457899999999999999999999988   99999999999999999999999999976533221 


Q ss_pred             ccccceeccCCccChhhhccC-CCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhh--ccccch-----hcc
Q 003599          641 ADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLW--NENKIL-----ALV  712 (808)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~--~~~~~~-----~~~  712 (808)
                       ......++..|+|||.+.+. .++.++||||||+++|||++|+.|+.................  .+....     ...
T Consensus       156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07836         156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY  234 (284)
T ss_pred             -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence             11223568899999988654 468899999999999999999999865443222111110000  000000     000


Q ss_pred             CCcccC------CcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          713 DPFLSE------SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       713 d~~l~~------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      ......      ..........+.+++.+|++.+|++||++.+|++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            000000      0011123456789999999999999999999875

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.2e-33  Score=305.25  Aligned_cols=267  Identities=20%  Similarity=0.306  Sum_probs=200.0

Q ss_pred             hcCCcccCcccccCceeEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHHhccCCceeeEeeEEEeC-----Ce
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG-----EE  552 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~  552 (808)
                      .++|.+.+.||+|+||+||+++.. +++.||||.+...  .......+.+|+.++++++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            457999999999999999999865 6899999998653  233456778899999999999999999987654     34


Q ss_pred             eEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccce
Q 003599          553 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK  632 (808)
Q Consensus       553 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~  632 (808)
                      .++||||+. ++|.+++..   ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++
T Consensus        84 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  156 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR  156 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence            799999996 688888743   356899999999999999999999988   9999999999999999999999999998


Q ss_pred             ecCCCCCcccccceeccCCccChhhhcc-CCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhh--------
Q 003599          633 IFGGNQDQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLW--------  703 (808)
Q Consensus       633 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~--------  703 (808)
                      .......  ......++..|+|||.+.. ..++.++||||||+++|||++|+.||...+.... ........        
T Consensus       157 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~  233 (337)
T cd07858         157 TTSEKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQ-LKLITELLGSPSEEDL  233 (337)
T ss_pred             ccCCCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHH-HHHHHHHhCCCChHHh
Confidence            6543221  1122467889999998865 4689999999999999999999999864321111 10000000        


Q ss_pred             ---ccccchhccCC--cccC---CcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH--Hhhc
Q 003599          704 ---NENKILALVDP--FLSE---SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM--LNSE  757 (808)
Q Consensus       704 ---~~~~~~~~~d~--~l~~---~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~--L~~~  757 (808)
                         ........++.  ....   .........++.+++.+|++.+|++||+++++++.  +...
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         234 GFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             hhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence               00000000000  0000   00112345678899999999999999999999877  5544

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-35  Score=281.41  Aligned_cols=251  Identities=24%  Similarity=0.320  Sum_probs=198.2

Q ss_pred             hcCCcccCcccccCceeEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEE
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  557 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  557 (808)
                      ++.|++-+.||+|.|+.||+.... .|+.+|+|++...  ...+.+++.+|+++-+.|+||||+++.....+....+||+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            467888899999999999998654 6888898877532  3346788999999999999999999999999999999999


Q ss_pred             EecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCC---CCCeeeeccccceec
Q 003599          558 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE---ELNPKISDFGMAKIF  634 (808)
Q Consensus       558 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~---~~~~kl~DFGla~~~  634 (808)
                      |+|.|++|..-+-   .+..+++...-..++||++||.|.|.++   |||||+||+|++|..   .--+||+|||+|..+
T Consensus        90 e~m~G~dl~~eIV---~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   90 DLVTGGELFEDIV---AREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             ecccchHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            9999999966553   2345777778889999999999999998   999999999999953   345899999999987


Q ss_pred             CCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCC
Q 003599          635 GGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDP  714 (808)
Q Consensus       635 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  714 (808)
                      ..   ........|||+|||||++...+|+..+|||+-|||||-|+.|..||...+... +.+    ....+. .++..+
T Consensus       164 ~~---g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r-lye----~I~~g~-yd~~~~  234 (355)
T KOG0033|consen  164 ND---GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-LYE----QIKAGA-YDYPSP  234 (355)
T ss_pred             CC---ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH-HHH----HHhccc-cCCCCc
Confidence            62   222334689999999999999999999999999999999999999986422211 111    111110 011111


Q ss_pred             cccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          715 FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       715 ~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                            .-....++..+|+.+||..||++|.|+.|.+.
T Consensus       235 ------~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  235 ------EWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             ------ccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence                  11234566778999999999999999988654

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=6.1e-33  Score=297.90  Aligned_cols=265  Identities=20%  Similarity=0.277  Sum_probs=196.3

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHHhc-cCCceeeEeeEEEeCCe-----
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEE-----  552 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~-----  552 (808)
                      ++|++.+.||+|+||.||+|... +++.||+|.+....  ......+.+|+.+++++ +||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46888999999999999999975 68999999876542  22346788999999999 46999999999887665     


Q ss_pred             eEEEEEecCCCCchhhccCCCC--CCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCC-CCCeeeeccc
Q 003599          553 KMLIYEYMPNRSLDALLFDPLK--KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE-ELNPKISDFG  629 (808)
Q Consensus       553 ~~lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~-~~~~kl~DFG  629 (808)
                      .++||||+++ +|.+++.....  ...+++..+..++.||++||.|||+.+   |+||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence            7999999985 78888754322  346899999999999999999999988   999999999999998 8999999999


Q ss_pred             cceecCCCCCcccccceeccCCccChhhhcc-CCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhcc-cc
Q 003599          630 MAKIFGGNQDQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNE-NK  707 (808)
Q Consensus       630 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~-~~  707 (808)
                      +++........  .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.|+....+.............. ..
T Consensus       157 ~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (295)
T cd07837         157 LGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ  234 (295)
T ss_pred             cceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            99865332111  112356888999998865 457899999999999999999999886543322221111100000 00


Q ss_pred             ----chhccC----CcccCC---cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          708 ----ILALVD----PFLSES---SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       708 ----~~~~~d----~~l~~~---~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                          .....+    +.....   ........++.+++.+|++.+|++||++++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence                000000    000000   011124567889999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-33  Score=296.78  Aligned_cols=261  Identities=24%  Similarity=0.366  Sum_probs=198.3

Q ss_pred             CcccCcccccCceeEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHHhccCCceeeEeeEEEeC--CeeEEEEE
Q 003599          484 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG--EEKMLIYE  558 (808)
Q Consensus       484 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~E  558 (808)
                      |++.++||+|++|.||+|+.. +++.+|+|++....  ....+.+.+|++++++++|+|++++++++...  ...++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            567889999999999999876 48899999997653  33456788999999999999999999999988  88999999


Q ss_pred             ecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCC
Q 003599          559 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  638 (808)
Q Consensus       559 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  638 (808)
                      |+++ +|.+++...  ...+++..++.++.||++||+|||+.+   ++|+||||+||++++++.+||+|||++.......
T Consensus        81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence            9975 888887542  247899999999999999999999988   9999999999999999999999999998765433


Q ss_pred             CcccccceeccCCccChhhhcc-CCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhcc---c---cchh-
Q 003599          639 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNE---N---KILA-  710 (808)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~---~---~~~~-  710 (808)
                      .. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+............ ......   .   .... 
T Consensus       155 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  232 (287)
T cd07840         155 SA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKI-FELCGSPTDENWPGVSKL  232 (287)
T ss_pred             cc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-HHHhCCCchhhccccccc
Confidence            21 1122356788999998764 45789999999999999999999998654432211111 100000   0   0000 


Q ss_pred             ----ccCCccc-----CCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          711 ----LVDPFLS-----ESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       711 ----~~d~~l~-----~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                          ...+...     .......+...+.+++.+|++.+|++||+++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                0000000     00011112567899999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=3.2e-33  Score=293.91  Aligned_cols=247  Identities=25%  Similarity=0.299  Sum_probs=201.3

Q ss_pred             CCcccCcccccCceeEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEE
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  558 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  558 (808)
                      +|++.+.||.|+||.||+++.. +++.||+|.+.+..   ....+.+.+|++++++++||||+++++++.++...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4788899999999999999976 58899999987542   2346789999999999999999999999999999999999


Q ss_pred             ecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCC
Q 003599          559 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  638 (808)
Q Consensus       559 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  638 (808)
                      |+.+++|.+++..   ...+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  154 (258)
T cd05578          81 LLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT  154 (258)
T ss_pred             CCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence            9999999999854   247889999999999999999999988   9999999999999999999999999988654332


Q ss_pred             CcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccC
Q 003599          639 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSE  718 (808)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  718 (808)
                         ......|+..|+|||.+....++.++|+||||+++|+|++|+.|+...... ...... .....           ..
T Consensus       155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~-~~~~~-----------~~  218 (258)
T cd05578         155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-IRDQIR-AKQET-----------AD  218 (258)
T ss_pred             ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc-HHHHHH-HHhcc-----------cc
Confidence               122346788999999998888999999999999999999999998754431 011110 00000           00


Q ss_pred             CcccHHHHHHHHHHHHhcccCCcCCCCCH--HHHH
Q 003599          719 SSFQLDMIIRCIHVGLLCVQELVKDRPNM--STVV  751 (808)
Q Consensus       719 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~--~ev~  751 (808)
                      ...+......+.+++.+|++.+|.+||++  +|++
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            11223345788899999999999999999  5543

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=4.6e-33  Score=297.87  Aligned_cols=254  Identities=25%  Similarity=0.348  Sum_probs=194.9

Q ss_pred             CCcccCcccccCceeEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHHhcc-CCceeeEeeEEEeCCeeEEEEEe
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~  559 (808)
                      +|...++||+|+||.||++... +++.||+|.+.... ......+.+|+.++.++. |+||+++++++......+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4566789999999999999875 58999999987543 234567889999999996 99999999999999999999999


Q ss_pred             cCCCCchhhccC--CCCCCcCChhhHHHHHHHHHHHHHHhHhc-CCCcEEeCCCCCCceEeCCCCCeeeeccccceecCC
Q 003599          560 MPNRSLDALLFD--PLKKERLDWRKRFNIIEGISRGLLYLHRD-SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  636 (808)
Q Consensus       560 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  636 (808)
                      +.. +|.++...  ......+++..+.+++.+++.||+|||+. +   ++||||||+||+++.++.+||+|||+++....
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            864 55443321  11235689999999999999999999975 5   99999999999999999999999999976533


Q ss_pred             CCCcccccceeccCCccChhhhccC---CCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccC
Q 003599          637 NQDQADTGRVVGTFGYMSPEYAMEG---RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVD  713 (808)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  713 (808)
                      ....   ....|+..|+|||.+...   .++.++||||||+++|||++|+.|+.....   .........      ....
T Consensus       161 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~~~------~~~~  228 (288)
T cd06616         161 SIAK---TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS---VFDQLTQVV------KGDP  228 (288)
T ss_pred             CCcc---ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch---HHHHHhhhc------CCCC
Confidence            2211   223578999999998766   689999999999999999999999864331   111111110      0011


Q ss_pred             CcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          714 PFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       714 ~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                      +.+... .......++.+++.+|++.+|++||++++|++.
T Consensus       229 ~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         229 PILSNS-EEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CcCCCc-CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            112111 222345678999999999999999999998774

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.2e-32  Score=293.37  Aligned_cols=258  Identities=20%  Similarity=0.281  Sum_probs=193.6

Q ss_pred             CcccCcccccCceeEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHHhcc-CCceeeEeeEEEeC--CeeEEEEE
Q 003599          484 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEG--EEKMLIYE  558 (808)
Q Consensus       484 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lV~E  558 (808)
                      |++.++||+|+||.||+|+.. +++.||+|+++... ........+|+.++.++. |+|++++++++.+.  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            567889999999999999865 68899999987542 223345567999999985 99999999999987  88999999


Q ss_pred             ecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCC
Q 003599          559 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  638 (808)
Q Consensus       559 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  638 (808)
                      |++ ++|.+++..  ....+++.++..++.|++.||+|||+.+   ++||||||+||+++. +.+||+|||+++......
T Consensus        81 ~~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          81 LMD-MNLYELIKG--RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             cCC-ccHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence            997 577777754  2346899999999999999999999988   999999999999999 999999999998664332


Q ss_pred             CcccccceeccCCccChhhhcc-CCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhh-----------ccc
Q 003599          639 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLW-----------NEN  706 (808)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~-----------~~~  706 (808)
                      ..   ....++..|+|||.+.. ..++.++|||||||++|||++|+.|+...+..... .......           ...
T Consensus       154 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  229 (282)
T cd07831         154 PY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQI-AKIHDVLGTPDAEVLKKFRKS  229 (282)
T ss_pred             Cc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHH-HHHHHHcCCCCHHHHHhhccc
Confidence            21   12457889999997654 55788999999999999999999998654322111 1111000           000


Q ss_pred             cchhccCCcccCC---cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          707 KILALVDPFLSES---SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       707 ~~~~~~d~~l~~~---~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      .......+.....   .........+.+++.+|++.+|++||+++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            0000000000000   011234678899999999999999999999876

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.3e-32  Score=303.37  Aligned_cols=262  Identities=22%  Similarity=0.251  Sum_probs=197.6

Q ss_pred             HhcCCcccCcccccCceeEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHHhccCCceeeEeeEEEeC------
Q 003599          480 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG------  550 (808)
Q Consensus       480 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------  550 (808)
                      ..++|++.+.||+|+||.||++... +++.||+|++...  .....+.+.+|+.++++++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            4578999999999999999999875 6899999998643  233446778899999999999999999988643      


Q ss_pred             CeeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeecccc
Q 003599          551 EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGM  630 (808)
Q Consensus       551 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGl  630 (808)
                      ...++||||+. ++|.+.+..     .++...+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~  164 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  164 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence            35699999996 478777742     2788899999999999999999988   99999999999999999999999999


Q ss_pred             ceecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhh----------
Q 003599          631 AKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAW----------  700 (808)
Q Consensus       631 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~----------  700 (808)
                      ++.......   .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+..........          
T Consensus       165 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
T cd07850         165 ARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM  241 (353)
T ss_pred             ceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            987543221   2224678999999999999999999999999999999999999864432111100000          


Q ss_pred             --------hhhccc------cchhccCCcccCC---cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          701 --------KLWNEN------KILALVDPFLSES---SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       701 --------~~~~~~------~~~~~~d~~l~~~---~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                              ......      ...+.....+...   .........+.+++.+|++.||++||++.|+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                    000000      0001111000000   0011235667899999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.6e-34  Score=308.85  Aligned_cols=246  Identities=26%  Similarity=0.402  Sum_probs=196.4

Q ss_pred             cccCcccccCceeEEEEEec-CCcEEEEEEec--c--cccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCe--eEEEE
Q 003599          485 QLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLS--K--ASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEE--KMLIY  557 (808)
Q Consensus       485 ~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~--~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~--~~lV~  557 (808)
                      +..++||+|+|-+||+|.+. +|-.||---++  +  ..+...++|..|+.+|+.|+||||++++.++.+...  ..+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            44579999999999999876 46667632221  1  244567899999999999999999999999987766  67899


Q ss_pred             EecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeC-CCCCeeeeccccceecCC
Q 003599          558 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD-EELNPKISDFGMAKIFGG  636 (808)
Q Consensus       558 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~-~~~~~kl~DFGla~~~~~  636 (808)
                      |.|..|+|..|+.   +.++++...+..|++||++||.|||.+. +||+|||||-.||+|+ ..|.|||+|+|||.....
T Consensus       123 EL~TSGtLr~Y~k---k~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~  198 (632)
T KOG0584|consen  123 ELFTSGTLREYRK---KHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK  198 (632)
T ss_pred             ecccCCcHHHHHH---HhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence            9999999999995   3457888899999999999999999986 7899999999999997 458999999999998743


Q ss_pred             CCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcc
Q 003599          637 NQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL  716 (808)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  716 (808)
                      ...    ..+.|||.|||||.+. ..|....||||||+.++||+|+..|+........+    ++.+..|.     .|.-
T Consensus       199 s~a----ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQI----YKKV~SGi-----KP~s  264 (632)
T KOG0584|consen  199 SHA----KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQI----YKKVTSGI-----KPAA  264 (632)
T ss_pred             ccc----ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHH----HHHHHcCC-----CHHH
Confidence            332    2278999999999886 78999999999999999999999998765554332    22222221     1111


Q ss_pred             cCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          717 SESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       717 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                          +..-...++.++|.+|+.. .++|||+.|++..
T Consensus       265 ----l~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  265 ----LSKVKDPEVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             ----hhccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence                1112234677899999999 9999999999863

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1e-32  Score=296.13  Aligned_cols=264  Identities=21%  Similarity=0.297  Sum_probs=195.6

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  558 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  558 (808)
                      ++|++.+.||+|++|.||+|+.+ +++.||+|++....  ....+.+.+|++++++++||||+++++++..+...++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46889999999999999999976 68899999986542  2334678899999999999999999999999999999999


Q ss_pred             ecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCC-CCCeeeeccccceecCCC
Q 003599          559 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE-ELNPKISDFGMAKIFGGN  637 (808)
Q Consensus       559 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~-~~~~kl~DFGla~~~~~~  637 (808)
                      |++ ++|.+++... ....+++.....++.||+.||+|||+.+   ++|+||+|+||+++. ++.+||+|||+++.....
T Consensus        82 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         82 YLD-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             ccc-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence            996 5787776432 2234677888899999999999999987   999999999999985 567999999999865432


Q ss_pred             CCcccccceeccCCccChhhhccC-CCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhcc--cc------c
Q 003599          638 QDQADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNE--NK------I  708 (808)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~--~~------~  708 (808)
                      ...  .....+++.|+|||.+.+. .++.++||||||+++|||+||+.|+...................  ..      +
T Consensus       157 ~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (294)
T PLN00009        157 VRT--FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL  234 (294)
T ss_pred             ccc--cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccc
Confidence            211  1224578899999988664 57899999999999999999999986543322211111000000  00      0


Q ss_pred             hhcc--CCcccCC---cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          709 LALV--DPFLSES---SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       709 ~~~~--d~~l~~~---~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      ....  .+.....   ........++.+++.+|++.+|++||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0000  0000000   011123456789999999999999999999986

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.3e-32  Score=290.06  Aligned_cols=242  Identities=25%  Similarity=0.326  Sum_probs=194.5

Q ss_pred             ccccCceeEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEecCCCCc
Q 003599          490 LGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSL  565 (808)
Q Consensus       490 lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  565 (808)
                      ||+|++|.||+++.. .++.+|+|++....   ....+.+.+|+.++++++||||+++++.+.++...++||||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            799999999999986 48899999987532   23456789999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCcccccc
Q 003599          566 DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR  645 (808)
Q Consensus       566 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~  645 (808)
                      .+++..   ...+++..+..++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||+++......   ....
T Consensus        81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~  151 (262)
T cd05572          81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT  151 (262)
T ss_pred             HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence            999854   345889999999999999999999988   9999999999999999999999999998764332   1222


Q ss_pred             eeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCcccHHH
Q 003599          646 VVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDM  725 (808)
Q Consensus       646 ~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  725 (808)
                      ..++..|+|||.+....++.++|+||||+++|||++|+.|+....++.  ........         +.. .....+...
T Consensus       152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~---------~~~-~~~~~~~~~  219 (262)
T cd05572         152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP--MEIYNDIL---------KGN-GKLEFPNYI  219 (262)
T ss_pred             ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH--HHHHHHHh---------ccC-CCCCCCccc
Confidence            467889999999988889999999999999999999999986544211  11111111         000 001122223


Q ss_pred             HHHHHHHHHhcccCCcCCCCC-----HHHHHH
Q 003599          726 IIRCIHVGLLCVQELVKDRPN-----MSTVVS  752 (808)
Q Consensus       726 ~~~l~~li~~cl~~~P~~RPs-----~~ev~~  752 (808)
                      ..++.+++.+|++.+|++||+     ++|+++
T Consensus       220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            567899999999999999999     555554

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2e-33  Score=308.57  Aligned_cols=269  Identities=25%  Similarity=0.376  Sum_probs=207.5

Q ss_pred             CCcccCcccccCceeEEEEEec-CCcEEEEEEeccc-ccccHHHHHHHHHHHHhccCCceeeEeeEEEeC------CeeE
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG------EEKM  554 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~  554 (808)
                      .+...+.||+|+||.||+|+.+ .|+.||||.++.. .....+...+|+++|++++|+|||++++.-++.      ....
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            3556789999999999999965 6999999999874 344567888999999999999999999986543      3578


Q ss_pred             EEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeC--CCC--Ceeeecccc
Q 003599          555 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD--EEL--NPKISDFGM  630 (808)
Q Consensus       555 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~--~~~--~~kl~DFGl  630 (808)
                      +|||||.+|||...|.++.+...|++.+.+.++.++..||.|||+++   |+||||||.||++-  ++|  ..||+|||.
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            99999999999999999888889999999999999999999999988   99999999999994  333  379999999


Q ss_pred             ceecCCCCCcccccceeccCCccChhhhcc-CCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccc--c
Q 003599          631 AKIFGGNQDQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNEN--K  707 (808)
Q Consensus       631 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~--~  707 (808)
                      ||-+..+.   .....+||..|++||.+.. +.|+...|.|||||++||.+||..||.............+......  .
T Consensus       171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~  247 (732)
T KOG4250|consen  171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG  247 (732)
T ss_pred             cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence            99876544   3344789999999999984 8899999999999999999999999977665433222222222110  0


Q ss_pred             chhccCCccc-----------CCcccHHHHHHHHHHHHhcccCCcCCCC--CHHHHHHHHhhc
Q 003599          708 ILALVDPFLS-----------ESSFQLDMIIRCIHVGLLCVQELVKDRP--NMSTVVSMLNSE  757 (808)
Q Consensus       708 ~~~~~d~~l~-----------~~~~~~~~~~~l~~li~~cl~~~P~~RP--s~~ev~~~L~~~  757 (808)
                      +.-...+...           ..........++-.....++..+|++|-  ...+....+..+
T Consensus       248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI  310 (732)
T KOG4250|consen  248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI  310 (732)
T ss_pred             eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence            1111111110           0113334456666677777888888888  666666655554

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.7e-32  Score=297.78  Aligned_cols=249  Identities=28%  Similarity=0.440  Sum_probs=196.9

Q ss_pred             CCcccCcccccCceeEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEE
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  558 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  558 (808)
                      .|...+.||+|+||.||+++.. ++..||+|++....   ....+.+.+|++++++++|||++++++++.++...++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            3667789999999999999865 68899999986432   2334578899999999999999999999999999999999


Q ss_pred             ecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCC
Q 003599          559 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  638 (808)
Q Consensus       559 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  638 (808)
                      |+. |+|.+++..  ....+++.++..++.|++.||.|||+.+   ++||||+|+||+++.++.+||+|||++...... 
T Consensus       106 ~~~-g~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-  178 (317)
T cd06635         106 YCL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA-  178 (317)
T ss_pred             CCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence            997 477776643  2446899999999999999999999988   999999999999999999999999998754321 


Q ss_pred             CcccccceeccCCccChhhhc---cCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCc
Q 003599          639 DQADTGRVVGTFGYMSPEYAM---EGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPF  715 (808)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  715 (808)
                           ....|+..|+|||.+.   .+.++.++||||||+++|||++|+.|+............    ...+      .+.
T Consensus       179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~----~~~~------~~~  243 (317)
T cd06635         179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI----AQNE------SPT  243 (317)
T ss_pred             -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH----Hhcc------CCC
Confidence                 1246788999999873   456889999999999999999999987543221111111    0000      011


Q ss_pred             ccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003599          716 LSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  757 (808)
Q Consensus       716 l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~  757 (808)
                      .    ........+.+++.+|++.+|.+||++.+|++.+-..
T Consensus       244 ~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~  281 (317)
T cd06635         244 L----QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL  281 (317)
T ss_pred             C----CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence            1    1112345688999999999999999999999876443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-32  Score=287.69  Aligned_cols=247  Identities=27%  Similarity=0.420  Sum_probs=202.8

Q ss_pred             CCcccCcccccCceeEEEEEec-CCcEEEEEEeccccc--ccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEe
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG--QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  559 (808)
                      +|++.+.||+|++|.||+++.. +++.||+|.+.....  ...+.+.+|++++++++|+|++++++++.++...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4778899999999999999876 578999999976543  4567899999999999999999999999999999999999


Q ss_pred             cCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCC
Q 003599          560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  639 (808)
Q Consensus       560 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  639 (808)
                      +++++|.+++...   ..+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (254)
T cd06627          81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK  154 (254)
T ss_pred             CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence            9999999998542   57899999999999999999999988   99999999999999999999999999987654322


Q ss_pred             cccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCC
Q 003599          640 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSES  719 (808)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  719 (808)
                      .  .....++..|+|||......++.++||||||+++|+|++|+.|+...........    .. ..     ..+     
T Consensus       155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~----~~-~~-----~~~-----  217 (254)
T cd06627         155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFR----IV-QD-----DHP-----  217 (254)
T ss_pred             c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHH----Hh-cc-----CCC-----
Confidence            1  1234678999999999888889999999999999999999998864332111111    00 00     001     


Q ss_pred             cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          720 SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       720 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      ..+......+.+++.+|++.+|++||++.+++.
T Consensus       218 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         218 PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            122233567889999999999999999999875

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2e-32  Score=299.91  Aligned_cols=266  Identities=22%  Similarity=0.333  Sum_probs=198.8

Q ss_pred             HhcCCcccCcccccCceeEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHHhc-cCCceeeEeeEEEeC--Cee
Q 003599          480 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEG--EEK  553 (808)
Q Consensus       480 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~--~~~  553 (808)
                      ..++|++.+.||+|+||.||+|... +++.+|+|++...  .......+.+|+.+++++ +||||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            4578999999999999999999976 5789999988643  233456678899999999 999999999998643  467


Q ss_pred             EEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeecccccee
Q 003599          554 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI  633 (808)
Q Consensus       554 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  633 (808)
                      ++||||++ ++|..++..    ..+++..+..++.||+.||+|||+.+   |+|+||||+||+++.++.+||+|||+++.
T Consensus        85 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          85 YLVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             EEEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            99999997 589888743    26889999999999999999999988   99999999999999999999999999987


Q ss_pred             cCCCCCc---ccccceeccCCccChhhhcc-CCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhh-------
Q 003599          634 FGGNQDQ---ADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKL-------  702 (808)
Q Consensus       634 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~-------  702 (808)
                      .......   .......|+..|+|||.+.. ..++.++||||||+++|||++|+.|+................       
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED  236 (337)
T ss_pred             cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            6433221   12223568999999998754 457889999999999999999999986543222111100000       


Q ss_pred             ---hccccchhccCCcccCC-----cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          703 ---WNENKILALVDPFLSES-----SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       703 ---~~~~~~~~~~d~~l~~~-----~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                         +.......+++......     ........++.+++.+|++.+|++||++.++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence               00000000111000000     0111135678899999999999999999999875

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.1e-32  Score=297.88  Aligned_cols=265  Identities=23%  Similarity=0.348  Sum_probs=193.9

Q ss_pred             hcCCcccCcccccCceeEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHHhccCCceeeEeeEEEeCC------
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE------  551 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------  551 (808)
                      .++|++.++||+|+||.||+|+.. +++.||||++....  ......+.+|+.++++++||||+++++++....      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            457999999999999999999876 58899999886432  223345678999999999999999999987654      


Q ss_pred             --eeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccc
Q 003599          552 --EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFG  629 (808)
Q Consensus       552 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFG  629 (808)
                        ..++||||+.+ +|.+++..  ....+++.++..++.||+.||.|||+.+   ++|+||||+||+++.++.+||+|||
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg  164 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG  164 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence              34999999964 78777743  2346899999999999999999999988   9999999999999999999999999


Q ss_pred             cceecCCCCCc--ccccceeccCCccChhhhccCC-CCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhc--
Q 003599          630 MAKIFGGNQDQ--ADTGRVVGTFGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN--  704 (808)
Q Consensus       630 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~--  704 (808)
                      ++.........  .......++..|+|||.+.+.. ++.++||||||+++|||++|+.|+........ .........  
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~-~~~~~~~~~~~  243 (310)
T cd07865         165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQ-LTLISQLCGSI  243 (310)
T ss_pred             CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCC
Confidence            99866432221  1112245788999999886644 68899999999999999999988864432211 111111100  


Q ss_pred             -cc-----cchhccCC-cccCC---cc-----cHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          705 -EN-----KILALVDP-FLSES---SF-----QLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       705 -~~-----~~~~~~d~-~l~~~---~~-----~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                       ..     ...+..+. .....   ..     .......+.+++.+|++.+|++||+++++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence             00     00000000 00000   00     0001245678999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.6e-32  Score=297.02  Aligned_cols=279  Identities=23%  Similarity=0.320  Sum_probs=203.5

Q ss_pred             hcCCcccCcccccCceeEEEEEec-CCcEEEEEEeccccc--ccHHHHHHHHHHHHhccCCceeeEeeEEEeC--CeeEE
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG--QGLEEFMNEVMVISKLQHRNLVRLLGCCVEG--EEKML  555 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l  555 (808)
                      .++|++.+.||+|+||.||+|... +|+.||+|+++....  .....+.+|+.++++++|+||+++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            467999999999999999999976 589999999864322  2234567899999999999999999998755  46899


Q ss_pred             EEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecC
Q 003599          556 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG  635 (808)
Q Consensus       556 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~  635 (808)
                      ||||+.+ +|.+++...  ...+++.++..++.||++||+|||+.+   ++||||||+||++++++.+||+|||+++...
T Consensus        86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG  159 (309)
T ss_pred             EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence            9999964 788877542  356899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCCcccccceeccCCccChhhhcc-CCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhcc--ccchhcc
Q 003599          636 GNQDQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNE--NKILALV  712 (808)
Q Consensus       636 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~  712 (808)
                      .....  .....++..|+|||.+.+ ..++.++||||||+++|||++|+.|+...+....+..... ....  ......+
T Consensus       160 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~-~~~~~~~~~~~~~  236 (309)
T cd07845         160 LPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQ-LLGTPNESIWPGF  236 (309)
T ss_pred             CccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH-hcCCCChhhchhh
Confidence            33211  112345788999999865 4578999999999999999999999875443222211111 0000  0000000


Q ss_pred             -------CCcccCCc---c---cHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhcccCCCCCCCCCcc
Q 003599          713 -------DPFLSESS---F---QLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPAFT  770 (808)
Q Consensus       713 -------d~~l~~~~---~---~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~~~~~~p~~p~~~  770 (808)
                             ...+....   .   .......+.+++.+|++.||++||+++++++.-  -++..+.|..|...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~--~f~~~~~~~~~~~~  305 (309)
T cd07845         237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESS--YFKEKPLPCEPEMM  305 (309)
T ss_pred             hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcCh--hhccCCCCCCCCcC
Confidence                   00000000   0   011245677899999999999999999998743  33445555444443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=3e-32  Score=290.36  Aligned_cols=242  Identities=26%  Similarity=0.285  Sum_probs=187.3

Q ss_pred             cccccCceeEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHHh---ccCCceeeEeeEEEeCCeeEEEEEecC
Q 003599          489 KLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISK---LQHRNLVRLLGCCVEGEEKMLIYEYMP  561 (808)
Q Consensus       489 ~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~---l~H~niv~l~g~~~~~~~~~lV~E~~~  561 (808)
                      .||+|+||.||++... +++.+|+|.+.+..   ......+.+|..+++.   .+||||+.+++.+..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999875 58899999886532   1222344555544443   479999999999999999999999999


Q ss_pred             CCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCcc
Q 003599          562 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA  641 (808)
Q Consensus       562 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  641 (808)
                      +++|.+++..   ...+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.++|+|||++.......   
T Consensus        81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---  151 (279)
T cd05633          81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---  151 (279)
T ss_pred             CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence            9999988853   346999999999999999999999998   9999999999999999999999999987553221   


Q ss_pred             cccceeccCCccChhhhcc-CCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCc
Q 003599          642 DTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS  720 (808)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  720 (808)
                       .....|+..|+|||.+.. ..++.++||||||+++|||++|+.||..........  .....      ......     
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~--~~~~~------~~~~~~-----  217 (279)
T cd05633         152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--IDRMT------LTVNVE-----  217 (279)
T ss_pred             -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH--HHHHh------hcCCcC-----
Confidence             122468999999998864 457899999999999999999999986433211110  00000      001111     


Q ss_pred             ccHHHHHHHHHHHHhcccCCcCCCC-----CHHHHHHH
Q 003599          721 FQLDMIIRCIHVGLLCVQELVKDRP-----NMSTVVSM  753 (808)
Q Consensus       721 ~~~~~~~~l~~li~~cl~~~P~~RP-----s~~ev~~~  753 (808)
                      .+.....++.+++.+|++.||++||     +++++++.
T Consensus       218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            2223456788999999999999999     59998875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.7e-32  Score=294.51  Aligned_cols=259  Identities=16%  Similarity=0.199  Sum_probs=185.2

Q ss_pred             cCCcccCcccccCceeEEEEEecC----CcEEEEEEeccccccc-----------HHHHHHHHHHHHhccCCceeeEeeE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLKD----GQEIAVKRLSKASGQG-----------LEEFMNEVMVISKLQHRNLVRLLGC  546 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vAvK~l~~~~~~~-----------~~~~~~E~~~l~~l~H~niv~l~g~  546 (808)
                      ++|++.++||+|+||.||+|...+    +..+|+|.........           ......+...+..++|+|+++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            679999999999999999998764    3456666543222111           0112234445666789999999997


Q ss_pred             EEeCC----eeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCC
Q 003599          547 CVEGE----EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELN  622 (808)
Q Consensus       547 ~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~  622 (808)
                      +....    ..++++|++.. ++.+.+..   ....++..+..|+.|+++||+|||+.+   |+||||||+|||++.++.
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~  164 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLVE-NTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNR  164 (294)
T ss_pred             eeEecCCceEEEEEEehhcc-CHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCc
Confidence            76543    34677777643 55555432   223567888899999999999999988   999999999999999999


Q ss_pred             eeeeccccceecCCCCCc-----ccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhh
Q 003599          623 PKISDFGMAKIFGGNQDQ-----ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILG  697 (808)
Q Consensus       623 ~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~  697 (808)
                      ++|+|||+++.+......     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...........
T Consensus       165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~  244 (294)
T PHA02882        165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH  244 (294)
T ss_pred             EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence            999999999876432211     111224699999999999999999999999999999999999999976543333221


Q ss_pred             hhhhhhccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHh
Q 003599          698 YAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN  755 (808)
Q Consensus       698 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~  755 (808)
                      .....+    +..+..+.+.-    .....++.+++..|++.+|++||++.+|++.++
T Consensus       245 ~~~~~~----~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        245 AAKCDF----IKRLHEGKIKI----KNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HhHHHH----HHHhhhhhhcc----CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            111100    01111111111    112467889999999999999999999998763

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-34  Score=307.13  Aligned_cols=251  Identities=24%  Similarity=0.370  Sum_probs=205.8

Q ss_pred             cCCcccCcccccCceeEEEEEecCC-cEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEec
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLKDG-QEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  560 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~~~-~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  560 (808)
                      +.|.|+..||-|+||.||+|..++. -..|.|++...+....++|+-|+++|+...||+||++++.|...+.++++.|||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            4577788999999999999998753 445778887778888999999999999999999999999999999999999999


Q ss_pred             CCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCc
Q 003599          561 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  640 (808)
Q Consensus       561 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  640 (808)
                      .||-.+..+..  -...|+..++.-++.|++.||.|||++.   |||||||+.|||+.-+|.++|+|||.+.....  ..
T Consensus       112 ~GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~  184 (1187)
T KOG0579|consen  112 GGGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TR  184 (1187)
T ss_pred             CCchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh--HH
Confidence            99999998865  3457999999999999999999999998   99999999999999999999999998764322  12


Q ss_pred             ccccceeccCCccChhhhc-----cCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCc
Q 003599          641 ADTGRVVGTFGYMSPEYAM-----EGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPF  715 (808)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  715 (808)
                      .....+.||+.|||||+.+     +.+|+.++||||||++|.||..+.+|......-..++..+          ..-.|.
T Consensus       185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKia----------KSePPT  254 (1187)
T KOG0579|consen  185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA----------KSEPPT  254 (1187)
T ss_pred             hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHh----------hcCCCc
Confidence            2233478999999999874     5679999999999999999999999875433222222111          111233


Q ss_pred             ccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          716 LSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       716 l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      +.   .+..-...+.++...||..||..||++.++++
T Consensus       255 Ll---qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  255 LL---QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             cc---CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            33   22334567888999999999999999999875

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.4e-33  Score=324.32  Aligned_cols=255  Identities=27%  Similarity=0.405  Sum_probs=191.0

Q ss_pred             HHhcCCcccCcccccCceeEEEEEec-CCcEEEEEEeccc-ccccHHHHHHHHHHHHhccCCceeeEeeEEEe-------
Q 003599          479 TATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVE-------  549 (808)
Q Consensus       479 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-------  549 (808)
                      .-..+|+.++.||+||||.||+++.+ ||+.+|||++... .........+|+..|++|+|||||+++..+.+       
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            34567888999999999999999988 8999999999765 33445678899999999999999999833211       


Q ss_pred             --------------------------------------------------------------------------------
Q 003599          550 --------------------------------------------------------------------------------  549 (808)
Q Consensus       550 --------------------------------------------------------------------------------  549 (808)
                                                                                                      
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ------------------------C--------CeeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHh
Q 003599          550 ------------------------G--------EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL  597 (808)
Q Consensus       550 ------------------------~--------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yL  597 (808)
                                              .        ...||-||||+..+|..++.+.....  .-...++++++|++||+|+
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYI  713 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYI  713 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHH
Confidence                                    0        12467788888888877775422111  3567789999999999999


Q ss_pred             HhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecC---C-------------CCCcccccceeccCCccChhhhccC
Q 003599          598 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG---G-------------NQDQADTGRVVGTFGYMSPEYAMEG  661 (808)
Q Consensus       598 H~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~---~-------------~~~~~~~~~~~gt~~y~aPE~~~~~  661 (808)
                      |+.+   ||||||||.||+|+++..|||+|||+|....   .             ..........+||.-|+|||++.+.
T Consensus       714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~  790 (1351)
T KOG1035|consen  714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT  790 (1351)
T ss_pred             HhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence            9998   9999999999999999999999999999721   0             0111123346899999999998655


Q ss_pred             ---CCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCcccHHHHHHHHHHHHhccc
Q 003599          662 ---RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQ  738 (808)
Q Consensus       662 ---~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~  738 (808)
                         +|+.|+|+|||||||+||+.   ||....+....+.    .++.+.+..-       ..+..+....=.+++.++++
T Consensus       791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~----~LR~g~iP~~-------~~f~~~~~~~e~slI~~Ll~  856 (1351)
T KOG1035|consen  791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILT----NLRKGSIPEP-------ADFFDPEHPEEASLIRWLLS  856 (1351)
T ss_pred             ccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHH----hcccCCCCCC-------cccccccchHHHHHHHHHhc
Confidence               49999999999999999994   5544333322221    1222222211       11333444555789999999


Q ss_pred             CCcCCCCCHHHHHH
Q 003599          739 ELVKDRPNMSTVVS  752 (808)
Q Consensus       739 ~~P~~RPs~~ev~~  752 (808)
                      .||.+|||+.|++.
T Consensus       857 hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  857 HDPSKRPTATELLN  870 (1351)
T ss_pred             CCCccCCCHHHHhh
Confidence            99999999999875

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.8e-32  Score=291.62  Aligned_cols=244  Identities=25%  Similarity=0.343  Sum_probs=192.5

Q ss_pred             ccccCceeEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEecCCCCc
Q 003599          490 LGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSL  565 (808)
Q Consensus       490 lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  565 (808)
                      ||+|+||+||++... +++.+|+|.+....   ....+.+.+|++++++++||||+++++.+...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            699999999999865 58899999986532   23355678899999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCcccccc
Q 003599          566 DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR  645 (808)
Q Consensus       566 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~  645 (808)
                      .+++... ....+++.++..++.|+++||.|||+.+   ++||||+|+||++++++.++|+|||+++......   ....
T Consensus        81 ~~~l~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~  153 (277)
T cd05577          81 KYHIYNV-GEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKG  153 (277)
T ss_pred             HHHHHHc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---cccc
Confidence            9998653 2246899999999999999999999998   9999999999999999999999999987653321   1122


Q ss_pred             eeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCcccHHH
Q 003599          646 VVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDM  725 (808)
Q Consensus       646 ~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  725 (808)
                      ..++..|+|||.+.+..++.++||||||+++|+|++|+.|+.............     .. ...  .+    ...+...
T Consensus       154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-----~~-~~~--~~----~~~~~~~  221 (277)
T cd05577         154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK-----RR-TLE--MA----VEYPDKF  221 (277)
T ss_pred             ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH-----hc-ccc--cc----ccCCccC
Confidence            457889999999988889999999999999999999999986443211111000     00 000  00    0122223


Q ss_pred             HHHHHHHHHhcccCCcCCCC-----CHHHHHH
Q 003599          726 IIRCIHVGLLCVQELVKDRP-----NMSTVVS  752 (808)
Q Consensus       726 ~~~l~~li~~cl~~~P~~RP-----s~~ev~~  752 (808)
                      ...+.+++.+||+.+|++||     ++.++++
T Consensus       222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             CHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            55778999999999999999     6666654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.2e-32  Score=295.23  Aligned_cols=244  Identities=23%  Similarity=0.335  Sum_probs=196.9

Q ss_pred             cCcccccCceeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEecCCCCc
Q 003599          487 SSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSL  565 (808)
Q Consensus       487 ~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  565 (808)
                      ..+||+|+||.||++..+ +++.||||++........+.+.+|+.++++++|+||+++++.+..++..++||||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            368999999999999875 6889999998655555567789999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCcccccc
Q 003599          566 DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR  645 (808)
Q Consensus       566 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~  645 (808)
                      .+++..    ..+++.....++.|++.|++|||+.+   ++|+||+|+||++++++.++|+|||++........  ....
T Consensus       105 ~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~  175 (292)
T cd06657         105 TDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKS  175 (292)
T ss_pred             HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--cccc
Confidence            988732    35889999999999999999999988   99999999999999999999999999876543221  1223


Q ss_pred             eeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCcccHHH
Q 003599          646 VVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDM  725 (808)
Q Consensus       646 ~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  725 (808)
                      ..|+..|+|||.+....++.++|+||||+++|||++|+.|+......... ....         ....+.+..   ....
T Consensus       176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~-~~~~---------~~~~~~~~~---~~~~  242 (292)
T cd06657         176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM-KMIR---------DNLPPKLKN---LHKV  242 (292)
T ss_pred             cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHH---------hhCCcccCC---cccC
Confidence            46889999999998888999999999999999999999997643221111 1100         011111110   1122


Q ss_pred             HHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          726 IIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       726 ~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      ...+.+++.+|++.+|.+||++.++++
T Consensus       243 ~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         243 SPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             CHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            346778999999999999999999887

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=9.7e-33  Score=289.48  Aligned_cols=248  Identities=27%  Similarity=0.375  Sum_probs=202.8

Q ss_pred             CCcccCcccccCceeEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEe
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  559 (808)
                      +|++.++||+|+||.||+++.. +++.+|+|++...  ......++.+|++++++++|+||+++++++.+....++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4788899999999999999765 6789999998753  233456788999999999999999999999999999999999


Q ss_pred             cCCCCchhhccCCC-CCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCC
Q 003599          560 MPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  638 (808)
Q Consensus       560 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  638 (808)
                      +++++|.+++.+.. ....+++..+..++.|+++||+|||+.+   ++|+||+|+||++++++.+||+|||+++......
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~  157 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM  157 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence            99999999885422 2356899999999999999999999988   9999999999999999999999999998765431


Q ss_pred             CcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccC
Q 003599          639 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSE  718 (808)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  718 (808)
                          .....++..|+|||.+.+..++.++|+||||+++|||++|+.|+...+... ..   . ....+..          
T Consensus       158 ----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~-~~---~-~~~~~~~----------  218 (256)
T cd08530         158 ----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD-LR---Y-KVQRGKY----------  218 (256)
T ss_pred             ----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HH---H-HHhcCCC----------
Confidence                112457889999999999889999999999999999999999986443211 11   0 0011110          


Q ss_pred             CcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          719 SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       719 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      ...+.....++.+++.+|++.+|++||++.++++
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            0122345567899999999999999999999876

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-32  Score=289.12  Aligned_cols=261  Identities=22%  Similarity=0.319  Sum_probs=196.0

Q ss_pred             CcccCcccccCceeEEEEEecC-CcEEEEEEeccccc--ccHHHHHHHHHHHHhc---cCCceeeEeeEEEeCCe-----
Q 003599          484 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASG--QGLEEFMNEVMVISKL---QHRNLVRLLGCCVEGEE-----  552 (808)
Q Consensus       484 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~-----  552 (808)
                      |++.+.||+|+||.||+|+.+. ++.||+|++.....  .....+.+|+.+++++   +|+||+++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            5678899999999999999874 89999999874322  2234566788877766   59999999999988776     


Q ss_pred             eEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccce
Q 003599          553 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK  632 (808)
Q Consensus       553 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~  632 (808)
                      .+++|||+.+ +|.+++... ....+++..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.+||+|||+++
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~-~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKC-PKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             eEEEehhccc-CHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence            8999999974 788887542 2236899999999999999999999988   9999999999999999999999999998


Q ss_pred             ecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccc----
Q 003599          633 IFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKI----  708 (808)
Q Consensus       633 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~----  708 (808)
                      ........   ....++..|+|||.+....++.++|+||||+++|||++|+.|+....+.................    
T Consensus       156 ~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07838         156 IYSFEMAL---TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR  232 (287)
T ss_pred             eccCCccc---ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCC
Confidence            76433221   12357889999999998899999999999999999999998886544332222111100000000    


Q ss_pred             -----hhccCCcccC--CcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          709 -----LALVDPFLSE--SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       709 -----~~~~d~~l~~--~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                           ..........  .....+....+.+++.+|++.+|++||+++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence                 0000000000  0011234567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=2.4e-32  Score=286.32  Aligned_cols=250  Identities=24%  Similarity=0.379  Sum_probs=204.5

Q ss_pred             CCcccCcccccCceeEEEEEec-CCcEEEEEEeccccc--ccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEe
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG--QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  559 (808)
                      +|++.+.||+|+||.||++... +++.+|+|++.....  ...+.+.+|++++++++|+|++++++.+..+...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4788899999999999999976 588999999875432  4567789999999999999999999999999999999999


Q ss_pred             cCCCCchhhccCCC-CCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCC
Q 003599          560 MPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  638 (808)
Q Consensus       560 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  638 (808)
                      +++++|.+++.... ....+++.++..++.+++.||.|||+.+   ++|+||+|+||++++++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999886532 2467999999999999999999999998   9999999999999999999999999998764432


Q ss_pred             CcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccC
Q 003599          639 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSE  718 (808)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  718 (808)
                      .  ......|++.|+|||......++.++|+||+|+++++|++|+.|+........    ..... ....    . .   
T Consensus       158 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~----~~~~~-~~~~----~-~---  222 (258)
T cd08215         158 D--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLEL----ALKIL-KGQY----P-P---  222 (258)
T ss_pred             c--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHH----HHHHh-cCCC----C-C---
Confidence            1  22234688899999999888899999999999999999999999854332111    11111 1100    0 0   


Q ss_pred             CcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          719 SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       719 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                        .+......+.+++.+|+..+|++||++.++++
T Consensus       223 --~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         223 --IPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             --CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence              11233467889999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.2e-32  Score=290.14  Aligned_cols=247  Identities=26%  Similarity=0.368  Sum_probs=197.4

Q ss_pred             ccccCceeEEEEEecC-CcEEEEEEeccccc---ccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEecCCCCc
Q 003599          490 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSL  565 (808)
Q Consensus       490 lG~G~~g~Vy~~~~~~-~~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  565 (808)
                      ||+|+||.||+++..+ ++.+|+|.+.....   ...+.+.+|++++++++||||+++++.+..+...++||||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999874 89999999865432   4567789999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCC------
Q 003599          566 DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD------  639 (808)
Q Consensus       566 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~------  639 (808)
                      .+++...   ..+++..+.+++.|+++||+|||+.+   ++|+||+|+||++++++.++|+|||++........      
T Consensus        81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence            9998542   36899999999999999999999988   99999999999999999999999999886533211      


Q ss_pred             cccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCC
Q 003599          640 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSES  719 (808)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  719 (808)
                      ........++..|+|||.......+.++||||||+++|||++|+.|+..........    .. ..+.    ..  ..  
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~----~~-~~~~----~~--~~--  221 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQ----NI-LNGK----IE--WP--  221 (265)
T ss_pred             cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH----HH-hcCC----cC--CC--
Confidence            112223467889999999988889999999999999999999999986433221111    00 0000    00  00  


Q ss_pred             cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhh
Q 003599          720 SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS  756 (808)
Q Consensus       720 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~  756 (808)
                       ........+.+++.+|++.+|++||++.++.+.|+.
T Consensus       222 -~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~  257 (265)
T cd05579         222 -EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH  257 (265)
T ss_pred             -ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence             001125678899999999999999999777776643

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.8e-32  Score=293.27  Aligned_cols=256  Identities=27%  Similarity=0.335  Sum_probs=200.4

Q ss_pred             CCcccCcccccCceeEEEEEec----CCcEEEEEEecccc----cccHHHHHHHHHHHHhc-cCCceeeEeeEEEeCCee
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLK----DGQEIAVKRLSKAS----GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEK  553 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~----~~~~vAvK~l~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~  553 (808)
                      +|++.+.||+|++|.||+++..    ++..||||.+++..    ....+.+.+|+.++.++ +||||+++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4778899999999999998743    57889999986532    22346788999999999 599999999999999999


Q ss_pred             EEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeecccccee
Q 003599          554 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI  633 (808)
Q Consensus       554 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  633 (808)
                      ++||||+++++|.+++..   ...+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.++|+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence            999999999999998853   346889999999999999999999987   99999999999999999999999999886


Q ss_pred             cCCCCCcccccceeccCCccChhhhccCC--CCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhc
Q 003599          634 FGGNQDQADTGRVVGTFGYMSPEYAMEGR--FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILAL  711 (808)
Q Consensus       634 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  711 (808)
                      ....... ......|+..|+|||.+.+..  .+.++||||||+++|||++|+.|+...................      
T Consensus       155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~------  227 (288)
T cd05583         155 FLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS------  227 (288)
T ss_pred             ccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc------
Confidence            5433221 112245789999999987665  7889999999999999999999985432211111111111100      


Q ss_pred             cCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003599          712 VDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  757 (808)
Q Consensus       712 ~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~  757 (808)
                       .+.     .+......+.+++.+|++.+|++|||+.++.+.|+-.
T Consensus       228 -~~~-----~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~  267 (288)
T cd05583         228 -KPP-----FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP  267 (288)
T ss_pred             -CCC-----CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence             011     1122335678899999999999999999988877553

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.7e-32  Score=300.03  Aligned_cols=266  Identities=18%  Similarity=0.290  Sum_probs=200.2

Q ss_pred             hcCCcccCcccccCceeEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHHhccCCceeeEeeEEEe----CCee
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVE----GEEK  553 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~  553 (808)
                      .++|++.+.||+|+||.||+|... +++.||+|++....  ....+.+.+|+.++++++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            378999999999999999999865 58999999987542  2345678889999999999999999998763    3467


Q ss_pred             EEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeecccccee
Q 003599          554 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI  633 (808)
Q Consensus       554 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  633 (808)
                      ++||||+. ++|.+++..   ...+++..+..++.||++||+|||+.+   |+||||||+||++++++.+||+|||+++.
T Consensus        84 ~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~  156 (334)
T cd07855          84 YVVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG  156 (334)
T ss_pred             EEEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence            99999995 689888853   345899999999999999999999988   99999999999999999999999999986


Q ss_pred             cCCCCCcc--cccceeccCCccChhhhcc-CCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhh--------
Q 003599          634 FGGNQDQA--DTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKL--------  702 (808)
Q Consensus       634 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~--------  702 (808)
                      ........  ......++..|+|||.+.. ..++.++||||||+++|||++|+.||........+. .....        
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~-~~~~~~g~~~~~~  235 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLK-LILSVLGSPSEEV  235 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHH-HHHHHhCCChhHh
Confidence            64332211  1123468899999999865 458899999999999999999999986433211110 00000        


Q ss_pred             ---hccccchhccCCcccCCcc-----cHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHH
Q 003599          703 ---WNENKILALVDPFLSESSF-----QLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML  754 (808)
Q Consensus       703 ---~~~~~~~~~~d~~l~~~~~-----~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L  754 (808)
                         ...+.+.+..+..-.....     ......++.+++.+|++.+|++||++++++..-
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~  295 (334)
T cd07855         236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP  295 (334)
T ss_pred             hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence               0001111111100000001     122357789999999999999999999988743

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-32  Score=287.02  Aligned_cols=250  Identities=26%  Similarity=0.386  Sum_probs=196.8

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEeccc-----ccccHHHHHHHHHHHHhccCCceeeEeeEEEeC--Cee
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA-----SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG--EEK  553 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~  553 (808)
                      .+|++.+.||+|+||.||+|... ++..||+|.+...     .......+.+|+.++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            47889999999999999999875 5889999987532     223456788999999999999999999998764  457


Q ss_pred             EEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeecccccee
Q 003599          554 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI  633 (808)
Q Consensus       554 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  633 (808)
                      ++|+||+++++|.+++..   ...+++....+++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence            899999999999998853   245788899999999999999999988   99999999999999999999999999986


Q ss_pred             cCCCCC-cccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhcc
Q 003599          634 FGGNQD-QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALV  712 (808)
Q Consensus       634 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  712 (808)
                      ...... ........++..|+|||.+.+..++.++|+||||+++|||++|+.|+............    ....     .
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----~~~~-----~  226 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKI----ATQP-----T  226 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHH----HcCC-----C
Confidence            532111 11112345889999999998888999999999999999999999998643222111110    0000     0


Q ss_pred             CCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          713 DPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       713 d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      .+     ..+......+.+++.+|++ +|.+||+..++++
T Consensus       227 ~~-----~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         227 KP-----MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             CC-----CCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            01     1233445678899999999 5799999998765

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.4e-33  Score=300.06  Aligned_cols=247  Identities=25%  Similarity=0.365  Sum_probs=204.8

Q ss_pred             hcCCcccCcccccCceeEEEEEec-CCcEEEEEEeccccc--ccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEE
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG--QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  557 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  557 (808)
                      ...|.+...||+|.|+.|.+|+.. .+..||||.+.+..-  ...+.+.+|+++|..++|||||+++.+.+....+++||
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            467899999999999999999865 689999999987532  33466899999999999999999999999999999999


Q ss_pred             EecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCC
Q 003599          558 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  637 (808)
Q Consensus       558 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  637 (808)
                      ||+.+|.+.+++..   .++........++.|+.+|++|||+++   |+|||||++||||+.+.++||+|||++..+...
T Consensus       135 eya~~ge~~~yl~~---~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~  208 (596)
T KOG0586|consen  135 EYASGGELFDYLVK---HGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYG  208 (596)
T ss_pred             EeccCchhHHHHHh---cccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeeccc
Confidence            99999999999964   455666888899999999999999999   999999999999999999999999999987532


Q ss_pred             CCcccccceeccCCccChhhhccCCC-CccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcc
Q 003599          638 QDQADTGRVVGTFGYMSPEYAMEGRF-SEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL  716 (808)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  716 (808)
                         ......+|++.|.|||++.+.++ .+++|+||+|++||-|+.|..||+...    +             .++-++.+
T Consensus       209 ---~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~----l-------------k~Lr~rvl  268 (596)
T KOG0586|consen  209 ---LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN----L-------------KELRPRVL  268 (596)
T ss_pred             ---ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc----c-------------ccccchhe
Confidence               23344789999999999998876 789999999999999999999986322    1             11111111


Q ss_pred             cCC-cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          717 SES-SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       717 ~~~-~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                      ... ..+.-...+|-+++.++|-.+|.+|+++++|.+.
T Consensus       269 ~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  269 RGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             eeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence            100 1222345678899999999999999999998653

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-32  Score=287.41  Aligned_cols=244  Identities=20%  Similarity=0.224  Sum_probs=189.9

Q ss_pred             CcccccCceeEEEEEec-CCcEEEEEEeccccc---ccHHHHHHHHHHH-HhccCCceeeEeeEEEeCCeeEEEEEecCC
Q 003599          488 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG---QGLEEFMNEVMVI-SKLQHRNLVRLLGCCVEGEEKMLIYEYMPN  562 (808)
Q Consensus       488 ~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~~l-~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  562 (808)
                      +.||+|+||.||+|... +++.||+|.+++...   .....+..|..++ ...+|+|++++++++..++..++||||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            57999999999999875 588999999865421   2223445555544 455899999999999999999999999999


Q ss_pred             CCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCccc
Q 003599          563 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD  642 (808)
Q Consensus       563 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  642 (808)
                      ++|.+++..   ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||+++....      
T Consensus        82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------  149 (260)
T cd05611          82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------  149 (260)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence            999999853   346889999999999999999999988   99999999999999999999999999885432      


Q ss_pred             ccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCccc
Q 003599          643 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQ  722 (808)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  722 (808)
                      .....++..|+|||.+.+..++.++||||||+++|||++|..|+..........     ....+...  ....     ..
T Consensus       150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-----~~~~~~~~--~~~~-----~~  217 (260)
T cd05611         150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFD-----NILSRRIN--WPEE-----VK  217 (260)
T ss_pred             cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHH-----HHHhcccC--CCCc-----cc
Confidence            122457889999999988888999999999999999999999986433221111     11111000  0000     11


Q ss_pred             HHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHh
Q 003599          723 LDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN  755 (808)
Q Consensus       723 ~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~  755 (808)
                      ......+.+++.+|++.+|++||++.++.+.|.
T Consensus       218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~  250 (260)
T cd05611         218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS  250 (260)
T ss_pred             ccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence            123467889999999999999998877666553

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.2e-32  Score=297.21  Aligned_cols=263  Identities=21%  Similarity=0.321  Sum_probs=194.7

Q ss_pred             hcCCcccCcccccCceeEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHHhccCCceeeEeeEEEeCC------
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE------  551 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------  551 (808)
                      .++|.+.+.||+|+||.||+|+.. +++.||||++....  ......+.+|+.++++++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            378999999999999999999865 68999999986532  223457889999999999999999999987543      


Q ss_pred             eeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccc
Q 003599          552 EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA  631 (808)
Q Consensus       552 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla  631 (808)
                      ..++|+||+.. +|..++     ...+++..+..++.|+++||+|||+.+   ++||||||+||+++.++.+||+|||++
T Consensus        94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~  164 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA  164 (342)
T ss_pred             eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence            46899999964 676654     235888999999999999999999988   999999999999999999999999998


Q ss_pred             eecCCCCCcccccceeccCCccChhhhcc-CCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhh---------
Q 003599          632 KIFGGNQDQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWK---------  701 (808)
Q Consensus       632 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~---------  701 (808)
                      +.....     .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...............         
T Consensus       165 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  239 (342)
T cd07879         165 RHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV  239 (342)
T ss_pred             cCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            754221     122467889999999876 46889999999999999999999998653321111111000         


Q ss_pred             -hhccccchhccC--CcccCCccc---HHHHHHHHHHHHhcccCCcCCCCCHHHHHHH--Hhhc
Q 003599          702 -LWNENKILALVD--PFLSESSFQ---LDMIIRCIHVGLLCVQELVKDRPNMSTVVSM--LNSE  757 (808)
Q Consensus       702 -~~~~~~~~~~~d--~~l~~~~~~---~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~--L~~~  757 (808)
                       ...+......+.  +........   ......+.+++.+|++.||++||++++++..  ++..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~  303 (342)
T cd07879         240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF  303 (342)
T ss_pred             HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence             000000000000  000000000   1123567899999999999999999999854  5554

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=3.1e-32  Score=291.81  Aligned_cols=251  Identities=25%  Similarity=0.342  Sum_probs=195.9

Q ss_pred             CCcccCcccccCceeEEEEEe----cCCcEEEEEEecccc----cccHHHHHHHHHHHHhc-cCCceeeEeeEEEeCCee
Q 003599          483 NFQLSSKLGQGGFGPVYWGRL----KDGQEIAVKRLSKAS----GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEK  553 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~----~~~~~vAvK~l~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~  553 (808)
                      +|++.+.||+|+||.||+++.    .+|..||+|++....    ....+++.+|+.++.++ +|+||+++++.+..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            477889999999999999986    368899999987532    22346788999999999 599999999999999999


Q ss_pred             EEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeecccccee
Q 003599          554 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI  633 (808)
Q Consensus       554 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  633 (808)
                      ++||||+++++|.+++..   ...+++..+..++.|+++||.|||+.+   ++||||+|+|||++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            999999999999999853   346888899999999999999999988   99999999999999999999999999986


Q ss_pred             cCCCCCcccccceeccCCccChhhhccC--CCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhc
Q 003599          634 FGGNQDQADTGRVVGTFGYMSPEYAMEG--RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILAL  711 (808)
Q Consensus       634 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  711 (808)
                      ....... ......|+..|+|||.+...  .++.++||||||+++|||++|+.|+...................      
T Consensus       155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~------  227 (290)
T cd05613         155 FHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS------  227 (290)
T ss_pred             ccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc------
Confidence            5432211 12234688999999998753  46789999999999999999999986432222211111111110      


Q ss_pred             cCCcccCCcccHHHHHHHHHHHHhcccCCcCCCC-----CHHHHHH
Q 003599          712 VDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRP-----NMSTVVS  752 (808)
Q Consensus       712 ~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~ev~~  752 (808)
                       .     ...+......+.+++.+|++.+|++||     ++++++.
T Consensus       228 -~-----~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         228 -E-----PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             -C-----CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence             0     012223445778999999999999997     5666554

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5e-34  Score=329.28  Aligned_cols=255  Identities=27%  Similarity=0.362  Sum_probs=203.4

Q ss_pred             HHhcCCcccCcccccCceeEEEEEe-cCCcEEEEEEeccc--ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEE
Q 003599          479 TATNNFQLSSKLGQGGFGPVYWGRL-KDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML  555 (808)
Q Consensus       479 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  555 (808)
                      ..+-+++-...||.|.||.||-|.. .+|...|+|.+...  .........+|..++..|+|||+|+++|.-.+++..+|
T Consensus      1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred             cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence            3445777788999999999999985 46888999987643  23345677899999999999999999999999999999


Q ss_pred             EEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecC
Q 003599          556 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG  635 (808)
Q Consensus       556 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~  635 (808)
                      .||||++|+|.+.+..   ....++.....+..|++.|++|||+++   ||||||||.||+|+.+|.+|++|||.|..+.
T Consensus      1312 FMEyC~~GsLa~ll~~---gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEH---GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred             HHHHhccCcHHHHHHh---cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEec
Confidence            9999999999999853   334556666677899999999999999   9999999999999999999999999999886


Q ss_pred             CCCC--cccccceeccCCccChhhhccCC---CCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchh
Q 003599          636 GNQD--QADTGRVVGTFGYMSPEYAMEGR---FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILA  710 (808)
Q Consensus       636 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~---~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  710 (808)
                      +...  ........||+.|||||.+.+.+   ...++||||||||++||+||++|+...+.+-.+.=.    +..+.   
T Consensus      1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~----V~~gh--- 1458 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYH----VAAGH--- 1458 (1509)
T ss_pred             CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhH----HhccC---
Confidence            5531  12233468999999999997644   456899999999999999999999866654322111    11111   


Q ss_pred             ccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          711 LVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       711 ~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                             .+.++.....+-.+++.+||+.||++|-++.|+++.
T Consensus      1459 -------~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1459 -------KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             -------CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence                   122344456667889999999999999888877654

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=4.1e-32  Score=296.31  Aligned_cols=261  Identities=23%  Similarity=0.307  Sum_probs=193.4

Q ss_pred             Cccccc--CceeEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEecCC
Q 003599          488 SKLGQG--GFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPN  562 (808)
Q Consensus       488 ~~lG~G--~~g~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  562 (808)
                      +.||+|  +||+||+++.. +++.||+|++....  ....+.+.+|+.+++.++||||+++++++..++..++||||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            467777  89999999875 68999999986432  23356788999999999999999999999999999999999999


Q ss_pred             CCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCcc-
Q 003599          563 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA-  641 (808)
Q Consensus       563 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~-  641 (808)
                      ++|.+++.... ...+++..+..++.|++.||+|||+.+   ++||||||+|||++.++.++++||+.+.......... 
T Consensus        84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence            99999886532 235888999999999999999999988   9999999999999999999999998654332211110 


Q ss_pred             ----cccceeccCCccChhhhccC--CCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhh---------h---
Q 003599          642 ----DTGRVVGTFGYMSPEYAMEG--RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKL---------W---  703 (808)
Q Consensus       642 ----~~~~~~gt~~y~aPE~~~~~--~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~---------~---  703 (808)
                          ......++..|+|||++.+.  .++.++||||||+++|||++|+.|+................         .   
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE  239 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence                01112346679999998764  47899999999999999999999986543222211100000         0   


Q ss_pred             -----------c----ccc-----chhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          704 -----------N----ENK-----ILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       704 -----------~----~~~-----~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                                 .    +..     .....+..+. .+........+.+++.+|++.||++|||++++++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~  308 (328)
T cd08226         240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLR-TPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH  308 (328)
T ss_pred             hhhhccchhhhhcccccchhcccccccccccccc-chhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                       0    000     0001111111 11233456788999999999999999999999753

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-32  Score=316.44  Aligned_cols=268  Identities=21%  Similarity=0.299  Sum_probs=186.9

Q ss_pred             HhcCCcccCcccccCceeEEEEEecC--CcEEEEE------------------EecccccccHHHHHHHHHHHHhccCCc
Q 003599          480 ATNNFQLSSKLGQGGFGPVYWGRLKD--GQEIAVK------------------RLSKASGQGLEEFMNEVMVISKLQHRN  539 (808)
Q Consensus       480 ~~~~~~~~~~lG~G~~g~Vy~~~~~~--~~~vAvK------------------~l~~~~~~~~~~~~~E~~~l~~l~H~n  539 (808)
                      ..++|++.++||+|+||+||++..+.  +...++|                  .+. ........+.+|+.+|++++|||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence            45789999999999999999987542  2222222                  111 12223466889999999999999


Q ss_pred             eeeEeeEEEeCCeeEEEEEecCCCCchhhccCCCC--CCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEe
Q 003599          540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLK--KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL  617 (808)
Q Consensus       540 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl  617 (808)
                      |+++++++...+..++|+|++. ++|.+++.....  .......+...|+.||+.||.|||+.+   |+||||||+|||+
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl  300 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL  300 (501)
T ss_pred             cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence            9999999999999999999985 566666643211  122345667789999999999999988   9999999999999


Q ss_pred             CCCCCeeeeccccceecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCC-CCCCCCc--hh
Q 003599          618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKN-TSFFEDD--LT  694 (808)
Q Consensus       618 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p-~~~~~~~--~~  694 (808)
                      +.++.+||+|||+++.+...... ......||..|+|||.+.+..++.++|||||||++|||++|+.+ +......  ..
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~  379 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ  379 (501)
T ss_pred             CCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence            99999999999999876433221 12235789999999999999999999999999999999998754 3222111  11


Q ss_pred             hhhhhhhhh-ccc-------cchhccCCccc-CC--cc-----cHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          695 ILGYAWKLW-NEN-------KILALVDPFLS-ES--SF-----QLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       695 ~~~~~~~~~-~~~-------~~~~~~d~~l~-~~--~~-----~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                      +........ ...       .+.+.++.... ..  ..     .......+.+++.+||+.||.+|||+.|+++.
T Consensus       380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            111100000 000       00111100000 00  00     00112356778899999999999999999864

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=3.9e-32  Score=292.71  Aligned_cols=266  Identities=22%  Similarity=0.322  Sum_probs=197.9

Q ss_pred             HHhcCCcccCcccccCceeEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHHhccCCceeeEeeEEEeCC----
Q 003599          479 TATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE----  551 (808)
Q Consensus       479 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----  551 (808)
                      ...++|++.+.||+|+||.||+|..+ +++.||+|+++...  ......+.+|+.++++++||||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            35678999999999999999999986 58899999986532  233457788999999999999999999987654    


Q ss_pred             ------eeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeee
Q 003599          552 ------EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKI  625 (808)
Q Consensus       552 ------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl  625 (808)
                            ..++|+||+++ +|...+..  ....+++..+..++.||+.||+|||+.+   |+|+||||+||++++++.+||
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl  157 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL  157 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence                  78999999986 66666643  2346899999999999999999999998   999999999999999999999


Q ss_pred             eccccceecCCCCCcccccceeccCCccChhhhccC-CCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhc
Q 003599          626 SDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN  704 (808)
Q Consensus       626 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~  704 (808)
                      +|||++......... ......++..|+|||.+... .++.++||||||+++|||++|+.|+........+... .....
T Consensus       158 ~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~-~~~~~  235 (302)
T cd07864         158 ADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELI-SRLCG  235 (302)
T ss_pred             CcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-HHHhC
Confidence            999999866433221 11223467889999988653 5688999999999999999999988643322221111 11100


Q ss_pred             cc---cchhc--------cCCccc--CC--cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          705 EN---KILAL--------VDPFLS--ES--SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       705 ~~---~~~~~--------~d~~l~--~~--~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      ..   .....        .++...  ..  .........+.+++.+|++.+|.+||++++|++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             CCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            00   00000        000000  00  000112467889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2e-32  Score=294.25  Aligned_cols=252  Identities=25%  Similarity=0.399  Sum_probs=194.4

Q ss_pred             cCCcccCcccccCceeEEEEEecC-CcEEEEEEecccc-cccHHHHHHHHHHHHhcc-CCceeeEeeEEEeCCeeEEEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEKMLIYE  558 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E  558 (808)
                      ++|++.+.||+|+||.||+|+.++ ++.||||.++... .....++..|+.++.+.+ |+||+++++++.++...++|||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            568889999999999999999875 8999999987543 234456777888777775 9999999999999999999999


Q ss_pred             ecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhc-CCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCC
Q 003599          559 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD-SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  637 (808)
Q Consensus       559 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  637 (808)
                      |+. ++|.+++..  ....+++..+..++.|+++||+|||+. +   |+||||+|+||++++++.+||+|||++..+...
T Consensus        95 ~~~-~~l~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~  168 (296)
T cd06618          95 LMS-TCLDKLLKR--IQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS  168 (296)
T ss_pred             ccC-cCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence            985 477766643  234789999999999999999999974 5   999999999999999999999999998765332


Q ss_pred             CCcccccceeccCCccChhhhccCC----CCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccC
Q 003599          638 QDQADTGRVVGTFGYMSPEYAMEGR----FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVD  713 (808)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~~----~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  713 (808)
                      ...   ....++..|+|||.+....    ++.++||||||+++|||++|+.|+..........   .......      .
T Consensus       169 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~---~~~~~~~------~  236 (296)
T cd06618         169 KAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVL---TKILQEE------P  236 (296)
T ss_pred             Ccc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHH---HHHhcCC------C
Confidence            211   1235788999999986543    7889999999999999999999986432221111   1111110      0


Q ss_pred             CcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHH
Q 003599          714 PFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML  754 (808)
Q Consensus       714 ~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L  754 (808)
                      +.+.   .......++.+++.+|++.+|++||++.++++.-
T Consensus       237 ~~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~  274 (296)
T cd06618         237 PSLP---PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP  274 (296)
T ss_pred             CCCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence            1111   1112345788999999999999999999998653

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.98  E-value=2.7e-32  Score=290.72  Aligned_cols=260  Identities=22%  Similarity=0.331  Sum_probs=200.0

Q ss_pred             CcccCcccccCceeEEEEEec-CCcEEEEEEeccccc--ccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEec
Q 003599          484 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG--QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  560 (808)
Q Consensus       484 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  560 (808)
                      |++.+.||+|++|.||++... +++.+|+|++.....  .....+.+|+.++++++|+||+++++++..+...++||||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            567789999999999999875 688999999875432  24567889999999999999999999999999999999999


Q ss_pred             CCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCc
Q 003599          561 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  640 (808)
Q Consensus       561 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  640 (808)
                      ++ +|.+++..  ....+++..+..++.|+++||.|||+.+   |+|+||||+||+++.++.++|+|||.+........ 
T Consensus        81 ~~-~l~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~-  153 (283)
T cd05118          81 DT-DLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR-  153 (283)
T ss_pred             CC-CHHHHHHh--hcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-
Confidence            75 88887754  2357899999999999999999999988   99999999999999999999999999987754431 


Q ss_pred             ccccceeccCCccChhhhccC-CCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccc------cchh---
Q 003599          641 ADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNEN------KILA---  710 (808)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~------~~~~---  710 (808)
                       ......++..|+|||.+... .++.++|+||||+++|+|++|+.|+...+........ .......      ....   
T Consensus       154 -~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd05118         154 -PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKI-FRTLGTPDPEVWPKFTSLAR  231 (283)
T ss_pred             -cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HHHcCCCchHhcccchhhhh
Confidence             11224578899999998776 6899999999999999999999888654322111110 0000000      0000   


Q ss_pred             -----ccCCcc-cCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          711 -----LVDPFL-SESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       711 -----~~d~~l-~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                           ..+... ...........++.+++.+|++.+|.+||++++++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                 000000 000112234678899999999999999999999976

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.98  E-value=4.1e-33  Score=272.88  Aligned_cols=250  Identities=26%  Similarity=0.406  Sum_probs=196.5

Q ss_pred             CCcccCcccccCceeEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHHhcc-CCceeeEeeEEEeCCeeEEEEEe
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~  559 (808)
                      +.+.+..||+|.-|.|++.+.+ .|..+|||.+.+.. .++.++++..+.++.+-+ .|.||+.+|+|..+....+.||.
T Consensus        93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel  172 (391)
T KOG0983|consen   93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL  172 (391)
T ss_pred             HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence            3445678999999999999976 48899999998754 445567777888777665 89999999999999999999999


Q ss_pred             cCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCC
Q 003599          560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  639 (808)
Q Consensus       560 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  639 (808)
                      |. ..++.+|..  -.+++++.-+-++...+.+||.||..+.  +|+|||+||+|||+|+.|++||||||++-.+-....
T Consensus       173 Ms-~C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA  247 (391)
T KOG0983|consen  173 MS-TCAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA  247 (391)
T ss_pred             HH-HHHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc
Confidence            84 356666643  3446888888899999999999998765  699999999999999999999999999987644332


Q ss_pred             cccccceeccCCccChhhhc---cCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcc
Q 003599          640 QADTGRVVGTFGYMSPEYAM---EGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL  716 (808)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  716 (808)
                         .....|-+.|||||.+.   ..+|+.++||||||++|+||.||+.|+.....+-..+.   ..++      -..|.+
T Consensus       248 ---htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~lt---kvln------~ePP~L  315 (391)
T KOG0983|consen  248 ---HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLT---KVLN------EEPPLL  315 (391)
T ss_pred             ---cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHH---HHHh------cCCCCC
Confidence               23357899999999985   34688999999999999999999999986554433221   1111      112444


Q ss_pred             cCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          717 SESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       717 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      ....   .....+++++..||+.|+.+||...++++
T Consensus       316 ~~~~---gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  316 PGHM---GFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             Cccc---CcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            3321   14457889999999999999999988765

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.98  E-value=6.4e-33  Score=288.70  Aligned_cols=245  Identities=27%  Similarity=0.348  Sum_probs=201.9

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  557 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  557 (808)
                      +.|+.-++||+||||.||-++.+ .|+.+|.|++.+.   ...+....++|-.+|.+++.+.||.+-..++..+.+++|+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            45777789999999999999866 5889999988653   3445667789999999999999999999999999999999


Q ss_pred             EecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCC
Q 003599          558 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  637 (808)
Q Consensus       558 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  637 (808)
                      ..|.||+|.-||.+. ..+.+++....-++.+|+-||++||...   ||.|||||+|||||+.|+++|+|+|||..+...
T Consensus       265 tlMNGGDLkfHiyn~-g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g  340 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNH-GNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEG  340 (591)
T ss_pred             EeecCCceeEEeecc-CCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence            999999999999874 3467999999999999999999999998   999999999999999999999999999977544


Q ss_pred             CCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCccc
Q 003599          638 QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS  717 (808)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  717 (808)
                      +...   ..+||.+|||||++.++.|+...|.|||||+||||+.|+.||....+....          +    -+|.+..
T Consensus       341 ~~~~---~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~----------e----Evdrr~~  403 (591)
T KOG0986|consen  341 KPIR---GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR----------E----EVDRRTL  403 (591)
T ss_pred             Cccc---cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH----------H----HHHHHHh
Confidence            3322   248999999999999999999999999999999999999998643321110          0    1111111


Q ss_pred             C--CcccHHHHHHHHHHHHhcccCCcCCCCCH
Q 003599          718 E--SSFQLDMIIRCIHVGLLCVQELVKDRPNM  747 (808)
Q Consensus       718 ~--~~~~~~~~~~l~~li~~cl~~~P~~RPs~  747 (808)
                      .  ..++....++...|....|+.||++|..-
T Consensus       404 ~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc  435 (591)
T KOG0986|consen  404 EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC  435 (591)
T ss_pred             cchhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence            0  11445556778888889999999999743

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.98  E-value=5.4e-32  Score=293.38  Aligned_cols=262  Identities=19%  Similarity=0.230  Sum_probs=192.8

Q ss_pred             cCcccccCceeEEEEEecCCcEEEEEEeccc--ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEecCCCC
Q 003599          487 SSKLGQGGFGPVYWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRS  564 (808)
Q Consensus       487 ~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs  564 (808)
                      .+.+|.|+++.||+++. +++.||||++...  .....+.+.+|++++++++|+||+++++++.+.+..+++|||+++++
T Consensus         7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~   85 (314)
T cd08216           7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS   85 (314)
T ss_pred             hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence            34455555655665555 5899999998754  34456789999999999999999999999999999999999999999


Q ss_pred             chhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCc----
Q 003599          565 LDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ----  640 (808)
Q Consensus       565 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~----  640 (808)
                      |.+++... ....+++.....++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||.+.........    
T Consensus        86 l~~~l~~~-~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~  161 (314)
T cd08216          86 CEDLLKTH-FPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV  161 (314)
T ss_pred             HHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence            99998653 2345888899999999999999999988   999999999999999999999999988765322111    


Q ss_pred             -ccccceeccCCccChhhhcc--CCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhh----hccc-------
Q 003599          641 -ADTGRVVGTFGYMSPEYAME--GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKL----WNEN-------  706 (808)
Q Consensus       641 -~~~~~~~gt~~y~aPE~~~~--~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~----~~~~-------  706 (808)
                       .......++..|+|||.+..  ..++.++||||||+++|||++|+.||................    ....       
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
T cd08216         162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED  241 (314)
T ss_pred             ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcC
Confidence             11122356788999999865  357889999999999999999999987543322211110000    0000       


Q ss_pred             cchh----ccCCcc---cCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          707 KILA----LVDPFL---SESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       707 ~~~~----~~d~~l---~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                      ....    ..++..   ...........++.+++.+||+.+|++||+++++++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence            0000    000000   0001222345678899999999999999999998874

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.98  E-value=5.5e-32  Score=292.57  Aligned_cols=247  Identities=30%  Similarity=0.465  Sum_probs=195.0

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  557 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  557 (808)
                      +.|+..+.||+|+||.||+|+.. +++.+|+|.+...   .....+++.+|++++++++|+|++++++++......++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            34777789999999999999975 5788999998642   2233567889999999999999999999999999999999


Q ss_pred             EecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCC
Q 003599          558 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  637 (808)
Q Consensus       558 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  637 (808)
                      ||+. |+|.+++..  ....+++.++..++.|++.|+.|||+.+   ++||||+|+||+++.++.++|+|||++......
T Consensus        95 e~~~-~~l~~~~~~--~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  168 (308)
T cd06634          95 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (308)
T ss_pred             EccC-CCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence            9996 577776643  2345889999999999999999999988   999999999999999999999999998765321


Q ss_pred             CCcccccceeccCCccChhhhc---cCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCC
Q 003599          638 QDQADTGRVVGTFGYMSPEYAM---EGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDP  714 (808)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  714 (808)
                            ....++..|+|||.+.   ...++.++||||||+++|||++|+.|+.............     .+.     .+
T Consensus       169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~-----~~~-----~~  232 (308)
T cd06634         169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-----QNE-----SP  232 (308)
T ss_pred             ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHh-----hcC-----CC
Confidence                  1245788999999974   3567889999999999999999999875432211111110     000     01


Q ss_pred             cccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHH
Q 003599          715 FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML  754 (808)
Q Consensus       715 ~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L  754 (808)
                      ..    ........+.+++.+|++.+|++||++++|++.-
T Consensus       233 ~~----~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         233 AL----QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             Cc----CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence            11    1112345678999999999999999999998764

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.98  E-value=1.9e-32  Score=291.25  Aligned_cols=249  Identities=27%  Similarity=0.379  Sum_probs=202.7

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHHhcc-CCceeeEeeEEEeCCeeEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEKMLI  556 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV  556 (808)
                      ++|.+.+.||+|+||.||+++.. +++.||+|++...   .....+.+.+|+.++++++ |+||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46888999999999999999976 6899999998653   2234567889999999998 99999999999999999999


Q ss_pred             EEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCC
Q 003599          557 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  636 (808)
Q Consensus       557 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  636 (808)
                      ||++++++|.+++..   ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            999999999999854   347999999999999999999999988   99999999999999999999999999987643


Q ss_pred             CCCc------------------ccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhh
Q 003599          637 NQDQ------------------ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGY  698 (808)
Q Consensus       637 ~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~  698 (808)
                      ....                  .......++..|+|||.+....++.++||||||++++|+++|+.|+........... 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~-  233 (280)
T cd05581         155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK-  233 (280)
T ss_pred             ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH-
Confidence            3211                  122234578999999999888899999999999999999999999875442211111 


Q ss_pred             hhhhhccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCH----HHHHH
Q 003599          699 AWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNM----STVVS  752 (808)
Q Consensus       699 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~----~ev~~  752 (808)
                         ..         +..   ...+......+.+++.+|++.+|.+||++    +++++
T Consensus       234 ---~~---------~~~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         234 ---IL---------KLE---YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             ---HH---------hcC---CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence               00         000   01222335678899999999999999999    66654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.98  E-value=3.2e-32  Score=298.88  Aligned_cols=263  Identities=21%  Similarity=0.306  Sum_probs=194.6

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeC----------
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG----------  550 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~----------  550 (808)
                      .+|.+.+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            68999999999999999999875 5889999998766656677899999999999999999999776543          


Q ss_pred             ----CeeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeC-CCCCeee
Q 003599          551 ----EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD-EELNPKI  625 (808)
Q Consensus       551 ----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~-~~~~~kl  625 (808)
                          ...++||||++ ++|.+++.    ...+++.....++.||++||.|||+.+   ++||||||+||+++ +++.+||
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl  156 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI  156 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence                35789999997 58888773    346889999999999999999999988   99999999999997 4567899


Q ss_pred             eccccceecCCCCCcc-cccceeccCCccChhhhcc-CCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhh
Q 003599          626 SDFGMAKIFGGNQDQA-DTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLW  703 (808)
Q Consensus       626 ~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~  703 (808)
                      +|||+++......... ......++..|+|||.+.. ..++.++|||||||++|||++|+.||....+............
T Consensus       157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~  236 (342)
T cd07854         157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP  236 (342)
T ss_pred             CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence            9999998653221111 1122357889999998754 4578899999999999999999999864432211111110000


Q ss_pred             --cc---ccchhccCCc----ccCCc-----ccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          704 --NE---NKILALVDPF----LSESS-----FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       704 --~~---~~~~~~~d~~----l~~~~-----~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                        .+   ......+...    .....     .......++.+++.+|++.+|++||+++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence              00   0000000000    00000     01123456889999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.98  E-value=1.3e-31  Score=283.57  Aligned_cols=247  Identities=23%  Similarity=0.308  Sum_probs=191.1

Q ss_pred             HHHHHhcCCcccCcc--cccCceeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHHhc-cCCceeeEeeEEEeCC
Q 003599          476 ELATATNNFQLSSKL--GQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGE  551 (808)
Q Consensus       476 ~l~~~~~~~~~~~~l--G~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~  551 (808)
                      +.....++|.+.+.+  |+|+||.||+++.+ ++..+|+|.+........     |+.....+ +||||+++++.+...+
T Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~   82 (267)
T PHA03390          8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLK   82 (267)
T ss_pred             HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCC
Confidence            344445677777777  99999999999865 578899999865322111     22222222 7999999999999999


Q ss_pred             eeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCC-Ceeeecccc
Q 003599          552 EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL-NPKISDFGM  630 (808)
Q Consensus       552 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~-~~kl~DFGl  630 (808)
                      ..++||||+++++|.+++..   ...+++.++..++.|+++||.|||+.+   ++||||||+||+++.++ .++|+|||+
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~  156 (267)
T PHA03390         83 GHVLIMDYIKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGL  156 (267)
T ss_pred             eeEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence            99999999999999999854   237899999999999999999999988   99999999999999998 999999999


Q ss_pred             ceecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCch-hhhhhhhhhhccccch
Q 003599          631 AKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDL-TILGYAWKLWNENKIL  709 (808)
Q Consensus       631 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~-~~~~~~~~~~~~~~~~  709 (808)
                      ++......      ...++..|+|||.+....++.++||||||+++|||++|+.|+....+.. ....+....       
T Consensus       157 ~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------  223 (267)
T PHA03390        157 CKIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-------  223 (267)
T ss_pred             ceecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-------
Confidence            88653221      2357899999999998889999999999999999999999987433221 111111100       


Q ss_pred             hccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCC-HHHHHH
Q 003599          710 ALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPN-MSTVVS  752 (808)
Q Consensus       710 ~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-~~ev~~  752 (808)
                         ....   .........+.+++.+|++.+|.+||+ ++++++
T Consensus       224 ---~~~~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        224 ---QKKL---PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             ---cccC---CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence               0000   011234567889999999999999995 688764

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.98  E-value=5.7e-32  Score=288.44  Aligned_cols=262  Identities=26%  Similarity=0.343  Sum_probs=196.6

Q ss_pred             CcccCcccccCceeEEEEEec-CCcEEEEEEeccccc-ccHHHHHHHHHHHHhcc-CCceeeEeeEEEeCCeeEEEEEec
Q 003599          484 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG-QGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEKMLIYEYM  560 (808)
Q Consensus       484 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~  560 (808)
                      |++.+.||+|++|+||+|+.. +++.||||++..... .......+|+..+++++ |+||+++++++..++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            567899999999999999986 478899999865432 22334567999999999 999999999999999999999999


Q ss_pred             CCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCc
Q 003599          561 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  640 (808)
Q Consensus       561 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  640 (808)
                       +|+|.+++... ....+++.++..++.|++.+|.|||+.+   ++|+||+|+||+++.++.++|+|||+++....... 
T Consensus        81 -~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-  154 (283)
T cd07830          81 -EGNLYQLMKDR-KGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-  154 (283)
T ss_pred             -CCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence             88998888543 2347899999999999999999999988   99999999999999999999999999986543221 


Q ss_pred             ccccceeccCCccChhhhcc-CCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhh-------hhhccc-cchhc
Q 003599          641 ADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAW-------KLWNEN-KILAL  711 (808)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~-------~~~~~~-~~~~~  711 (808)
                        .....++..|+|||.+.. ..++.++|+||||++++||++|+.|+..............       ..+.++ .....
T Consensus       155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07830         155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK  232 (283)
T ss_pred             --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence              122457889999998754 4578999999999999999999988865443221110000       000000 00000


Q ss_pred             cCCcccCC------cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          712 VDPFLSES------SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       712 ~d~~l~~~------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                      .+..+...      .........+.+++.+|++.+|++||+++|++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            00000000      0001124678899999999999999999998753

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.98  E-value=8.4e-32  Score=295.65  Aligned_cols=262  Identities=20%  Similarity=0.313  Sum_probs=196.0

Q ss_pred             HHHhcCCcccCcccccCceeEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHHhccCCceeeEeeEEEeCC---
Q 003599          478 ATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE---  551 (808)
Q Consensus       478 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~---  551 (808)
                      ....++|++.+.||+|+||.||++... ++..||||++....  ....+.+.+|+.++++++||||+++++++..+.   
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07880          11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD   90 (343)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence            334678999999999999999999865 68999999986432  223457889999999999999999999987554   


Q ss_pred             ---eeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeecc
Q 003599          552 ---EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDF  628 (808)
Q Consensus       552 ---~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DF  628 (808)
                         ..++||||+ +++|.+++.    ...+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.++|+||
T Consensus        91 ~~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~df  162 (343)
T cd07880          91 RFHDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDF  162 (343)
T ss_pred             ccceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeec
Confidence               358999998 778988874    346899999999999999999999988   999999999999999999999999


Q ss_pred             ccceecCCCCCcccccceeccCCccChhhhcc-CCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhh-------
Q 003599          629 GMAKIFGGNQDQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAW-------  700 (808)
Q Consensus       629 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~-------  700 (808)
                      |+++.....     .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.|+..............       
T Consensus       163 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  237 (343)
T cd07880         163 GLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK  237 (343)
T ss_pred             ccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence            999865321     122457889999999876 4578999999999999999999999864332111111000       


Q ss_pred             ---hhhccccchhccC--CcccCC---cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          701 ---KLWNENKILALVD--PFLSES---SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       701 ---~~~~~~~~~~~~d--~~l~~~---~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                         ...........+.  +.....   .........+.+++.+|++.+|++||++.+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence               0000000000000  000000   011123346789999999999999999999984

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.98  E-value=4.7e-32  Score=293.14  Aligned_cols=263  Identities=25%  Similarity=0.336  Sum_probs=194.8

Q ss_pred             hcCCcccCcccccCceeEEEEEec-CCcEEEEEEeccccc--ccHHHHHHHHHHHHhccCCceeeEeeEEEeCC------
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG--QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE------  551 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------  551 (808)
                      .++|++.++||+|+||.||+|+.. +++.+|||++.....  .....+.+|++++++++||||+++++++.+..      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            478999999999999999999976 588999999865322  22356789999999999999999999875443      


Q ss_pred             --eeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccc
Q 003599          552 --EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFG  629 (808)
Q Consensus       552 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFG  629 (808)
                        ..++||||+.+ +|...+..  ....+++..+..++.|+++||+|||+.+   |+|+||||+||++++++.++|+|||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg  160 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG  160 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence              46899999965 67666643  2346999999999999999999999998   9999999999999999999999999


Q ss_pred             cceecCCCCCcc---------cccceeccCCccChhhhccC-CCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhh
Q 003599          630 MAKIFGGNQDQA---------DTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYA  699 (808)
Q Consensus       630 la~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~  699 (808)
                      +++.........         ......+++.|+|||.+.+. .++.++||||||+++|||++|+.|+....+....... 
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~-  239 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI-  239 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-
Confidence            998654322111         11224578889999987654 5789999999999999999999998644332211111 


Q ss_pred             hhhhcc---------ccchhc--------cCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          700 WKLWNE---------NKILAL--------VDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       700 ~~~~~~---------~~~~~~--------~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      ......         ..+...        ..+.+..  ........+.+++.+|++.+|++|||+.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEE--RFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHhCCCChhhchhhhhcccccccccCCCCCccHHH--HcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            000000         000000        0000000  00112357889999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.98  E-value=3.6e-32  Score=317.10  Aligned_cols=265  Identities=27%  Similarity=0.394  Sum_probs=210.3

Q ss_pred             HHHhcCCcccCcccccCceeEEEEEec----C----CcEEEEEEecccc-cccHHHHHHHHHHHHhc-cCCceeeEeeEE
Q 003599          478 ATATNNFQLSSKLGQGGFGPVYWGRLK----D----GQEIAVKRLSKAS-GQGLEEFMNEVMVISKL-QHRNLVRLLGCC  547 (808)
Q Consensus       478 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~----~----~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~  547 (808)
                      +...++..+.+.||+|.||.|++|...    .    ...||||.++... ..+.+.++.|+++|..+ +|+||+.++|+|
T Consensus       292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~  371 (609)
T KOG0200|consen  292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC  371 (609)
T ss_pred             eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence            333455566779999999999999753    1    4569999998653 34678899999999999 799999999999


Q ss_pred             EeCCeeEEEEEecCCCCchhhccCCC-----------CC--CcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCc
Q 003599          548 VEGEEKMLIYEYMPNRSLDALLFDPL-----------KK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASN  614 (808)
Q Consensus       548 ~~~~~~~lV~E~~~~gsL~~~l~~~~-----------~~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~N  614 (808)
                      ..+...++|+||+..|+|.++|....           ..  ..++..+.+.++.|||.||+||++..   ++||||.++|
T Consensus       372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRN  448 (609)
T KOG0200|consen  372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARN  448 (609)
T ss_pred             ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhh
Confidence            99999999999999999999997643           00  23889999999999999999999987   9999999999


Q ss_pred             eEeCCCCCeeeeccccceecCCCCCcccc-cceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCc
Q 003599          615 ILLDEELNPKISDFGMAKIFGGNQDQADT-GRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDD  692 (808)
Q Consensus       615 ILl~~~~~~kl~DFGla~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~  692 (808)
                      ||+.++..+||+|||++|........... ....-+..|||||.+....|+.|+|||||||+||||+| |..|++.....
T Consensus       449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~  528 (609)
T KOG0200|consen  449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT  528 (609)
T ss_pred             EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence            99999999999999999965443333211 11113556999999999999999999999999999999 66777643222


Q ss_pred             hhhhhhhhhhhccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhccc
Q 003599          693 LTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIR  759 (808)
Q Consensus       693 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~~  759 (808)
                      ..+..    ...+|...+          .+..+..++..+++.||+.+|++||++.++++.++..+.
T Consensus       529 ~~l~~----~l~~G~r~~----------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~  581 (609)
T KOG0200|consen  529 EELLE----FLKEGNRME----------QPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ  581 (609)
T ss_pred             HHHHH----HHhcCCCCC----------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence            22221    223332111          334456788899999999999999999999999988543

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.98  E-value=6.3e-32  Score=294.67  Aligned_cols=263  Identities=23%  Similarity=0.312  Sum_probs=197.8

Q ss_pred             HHHhcCCcccCcccccCceeEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHHhccCCceeeEeeEEEe-CCee
Q 003599          478 ATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVE-GEEK  553 (808)
Q Consensus       478 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~  553 (808)
                      ..++++|++.+.||+|+||.||++... +++.||||++.+.  .....+.+.+|+.++++++||||+++.+++.. +...
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   85 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI   85 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence            346789999999999999999999865 6899999988643  22345678899999999999999999999875 5678


Q ss_pred             EEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeecccccee
Q 003599          554 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI  633 (808)
Q Consensus       554 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  633 (808)
                      ++|+||+ +++|.+++.    ...+++.....++.|+++||.|||+.+   |+||||+|+||++++++.++|+|||+++.
T Consensus        86 ~lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~  157 (328)
T cd07856          86 YFVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI  157 (328)
T ss_pred             EEEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence            8999998 568888874    345788888899999999999999998   99999999999999999999999999875


Q ss_pred             cCCCCCcccccceeccCCccChhhhcc-CCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhh----------hh
Q 003599          634 FGGNQDQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAW----------KL  702 (808)
Q Consensus       634 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~----------~~  702 (808)
                      ....     .....++..|+|||.+.+ ..++.++||||||+++|||++|+.|+..............          ..
T Consensus       158 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (328)
T cd07856         158 QDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT  232 (328)
T ss_pred             cCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            4221     112456889999998766 5689999999999999999999999865432111110000          00


Q ss_pred             hccccchhccCCcccCCcccH-----HHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          703 WNENKILALVDPFLSESSFQL-----DMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       703 ~~~~~~~~~~d~~l~~~~~~~-----~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                      ...+...+.+.........+.     .....+.+++.+|++.+|++||++++++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            000111111110000000111     124678899999999999999999998765

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.98  E-value=1.6e-31  Score=284.52  Aligned_cols=242  Identities=26%  Similarity=0.288  Sum_probs=186.9

Q ss_pred             cccccCceeEEEEEec-CCcEEEEEEeccccc---ccHHHHHHHHHH---HHhccCCceeeEeeEEEeCCeeEEEEEecC
Q 003599          489 KLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG---QGLEEFMNEVMV---ISKLQHRNLVRLLGCCVEGEEKMLIYEYMP  561 (808)
Q Consensus       489 ~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~~---l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  561 (808)
                      .||+|+||.||++... +++.||+|.+.+...   .....+..|..+   ++...||||+++++++...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999875 588999999865321   222334455444   444579999999999999999999999999


Q ss_pred             CCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCcc
Q 003599          562 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA  641 (808)
Q Consensus       562 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  641 (808)
                      +++|..++..   ...+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||+++......   
T Consensus        81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---  151 (278)
T cd05606          81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---  151 (278)
T ss_pred             CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence            9999988843   357999999999999999999999988   9999999999999999999999999987553221   


Q ss_pred             cccceeccCCccChhhhccC-CCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCc
Q 003599          642 DTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS  720 (808)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  720 (808)
                       .....|+..|+|||.+..+ .++.++||||+|+++|||++|+.|+......... .... .      .....+.     
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~-~~~~-~------~~~~~~~-----  217 (278)
T cd05606         152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDR-M------TLTMAVE-----  217 (278)
T ss_pred             -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH-HHHH-H------hhccCCC-----
Confidence             1224689999999998754 5899999999999999999999998643221110 0000 0      0001111     


Q ss_pred             ccHHHHHHHHHHHHhcccCCcCCCC-----CHHHHHHH
Q 003599          721 FQLDMIIRCIHVGLLCVQELVKDRP-----NMSTVVSM  753 (808)
Q Consensus       721 ~~~~~~~~l~~li~~cl~~~P~~RP-----s~~ev~~~  753 (808)
                      .+.....++.+++.+|+..+|++||     ++.++++.
T Consensus       218 ~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         218 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence            1122346788999999999999999     99998753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.98  E-value=1.4e-31  Score=290.04  Aligned_cols=244  Identities=28%  Similarity=0.456  Sum_probs=191.8

Q ss_pred             CcccCcccccCceeEEEEEec-CCcEEEEEEeccccc---ccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEe
Q 003599          484 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       484 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  559 (808)
                      |...++||+|+||.||+|+.. +++.||+|++.....   ...+.+.+|++++++++|||++++++++.++...++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            556678999999999999875 588999999865322   2345788999999999999999999999999999999999


Q ss_pred             cCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCC
Q 003599          560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  639 (808)
Q Consensus       560 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  639 (808)
                      +. ++|.+++..  ....+++.++..++.||+.||.|||+.+   ++|+||+|+||+++.++.+||+|||++.....   
T Consensus       103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---  173 (313)
T cd06633         103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP---  173 (313)
T ss_pred             CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence            96 577776643  2346899999999999999999999988   99999999999999999999999999864321   


Q ss_pred             cccccceeccCCccChhhhc---cCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcc
Q 003599          640 QADTGRVVGTFGYMSPEYAM---EGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL  716 (808)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  716 (808)
                         .....|+..|+|||.+.   ...++.++||||||+++|||++|+.|+...........    .....      .+..
T Consensus       174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~----~~~~~------~~~~  240 (313)
T cd06633         174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH----IAQND------SPTL  240 (313)
T ss_pred             ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH----HHhcC------CCCC
Confidence               12346889999999974   45688899999999999999999998754322111111    10000      0111


Q ss_pred             cCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          717 SESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       717 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                      .    .......+.+++.+|++.+|.+||++.++++.
T Consensus       241 ~----~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         241 Q----SNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             C----ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1    11123457889999999999999999998854

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.98  E-value=7.5e-32  Score=296.28  Aligned_cols=268  Identities=22%  Similarity=0.292  Sum_probs=199.1

Q ss_pred             HHHHHHHhcCCcccCcccccCceeEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHHhccCCceeeEeeEEEeC
Q 003599          474 FEELATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG  550 (808)
Q Consensus       474 ~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~  550 (808)
                      ..++...+++|++.+.||+|+||.||++... +++.||+|++....  ....+.+.+|+.++++++||||+++++++...
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~   88 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   88 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence            3456667899999999999999999999864 68899999987532  22356788999999999999999999988643


Q ss_pred             ------CeeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCee
Q 003599          551 ------EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPK  624 (808)
Q Consensus       551 ------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~k  624 (808)
                            ...+++++++ +++|.+++.    ...+++..+..++.|+++||+|||+.+   |+||||||+||++++++.+|
T Consensus        89 ~~~~~~~~~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k  160 (345)
T cd07877          89 RSLEEFNDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK  160 (345)
T ss_pred             ccccccccEEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence                  3357778876 789988774    335899999999999999999999988   99999999999999999999


Q ss_pred             eeccccceecCCCCCcccccceeccCCccChhhhcc-CCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhh
Q 003599          625 ISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLW  703 (808)
Q Consensus       625 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~  703 (808)
                      |+|||+++.....     .....++..|+|||.+.+ ..++.++||||||+++|||++|+.|+........+........
T Consensus       161 l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  235 (345)
T cd07877         161 ILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG  235 (345)
T ss_pred             Eeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            9999998854321     122467889999998866 4678899999999999999999999864432221111110000


Q ss_pred             -ccccchhccC-----------CcccCCcc---cHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHH
Q 003599          704 -NENKILALVD-----------PFLSESSF---QLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML  754 (808)
Q Consensus       704 -~~~~~~~~~d-----------~~l~~~~~---~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L  754 (808)
                       ....+...+.           +......+   ......++.+++.+|++.+|.+||++.++++.=
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~  301 (345)
T cd07877         236 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA  301 (345)
T ss_pred             CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence             0000000000           00000000   001245678999999999999999999988653

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.98  E-value=1.2e-31  Score=292.91  Aligned_cols=264  Identities=22%  Similarity=0.301  Sum_probs=201.4

Q ss_pred             CCcccCcccccCceeEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHHhccCCceeeEeeEEEeCC-----eeE
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE-----EKM  554 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~  554 (808)
                      +|++.+.||+|++|.||+|+.. .++.||||++....  ....+.+.+|+.++++++|+||+++++++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5788899999999999999976 48999999987643  345678999999999999999999999988775     789


Q ss_pred             EEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceec
Q 003599          555 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF  634 (808)
Q Consensus       555 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~  634 (808)
                      +||||++ ++|.+++..   ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.++|+|||++...
T Consensus        81 lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          81 IVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             EEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence            9999997 488888853   337999999999999999999999998   999999999999999999999999999976


Q ss_pred             CCCCCc-ccccceeccCCccChhhhccC-CCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhh----------
Q 003599          635 GGNQDQ-ADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKL----------  702 (808)
Q Consensus       635 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~----------  702 (808)
                      ...... .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||................          
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  233 (330)
T cd07834         154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF  233 (330)
T ss_pred             cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence            543210 112234678899999999887 78999999999999999999999986543211110000000          


Q ss_pred             hccccchhccCCcccCCc-----ccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          703 WNENKILALVDPFLSESS-----FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       703 ~~~~~~~~~~d~~l~~~~-----~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                      .........+........     ........+.+++.+||+.+|++||+++++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            000000001000000000     111234678899999999999999999999875

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.98  E-value=3.1e-32  Score=270.15  Aligned_cols=302  Identities=20%  Similarity=0.224  Sum_probs=229.1

Q ss_pred             HhcCCccc-CcccccCceeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHHhc-cCCceeeEeeEEEe----CCe
Q 003599          480 ATNNFQLS-SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVE----GEE  552 (808)
Q Consensus       480 ~~~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~----~~~  552 (808)
                      .+++|++. ++||-|-.|.|-.+..+ .++.+|+|++...     ....+|+++.-+. .|||||.+++.+..    ...
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            45677664 57999999999988765 5888999998543     4456788887666 69999999998864    346


Q ss_pred             eEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCC---CCCeeeeccc
Q 003599          553 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE---ELNPKISDFG  629 (808)
Q Consensus       553 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~---~~~~kl~DFG  629 (808)
                      +++|||.|+||.|...+++. ....+++.+.-.|++||+.|+.|||+.+   |.||||||+|+|...   |-.+||+|||
T Consensus       134 LLiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             eEeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence            68899999999999988764 4567999999999999999999999998   999999999999964   5569999999


Q ss_pred             cceecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccch
Q 003599          630 MAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKIL  709 (808)
Q Consensus       630 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  709 (808)
                      +|+.-..   .......+-|+.|.|||++...+|+...|+||+||++|-|++|.+||........-.++-.. ...+ ..
T Consensus       210 FAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~r-I~~g-qy  284 (400)
T KOG0604|consen  210 FAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRR-IRTG-QY  284 (400)
T ss_pred             cccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhH-hhcc-Cc
Confidence            9986432   22333457899999999999999999999999999999999999998643321111111111 0011 11


Q ss_pred             hccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhcccCCCCCCCCCcccCCCCCCchhHHHHHHHHH
Q 003599          710 ALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPAFTERQGADDSESFKQIQQRIL  789 (808)
Q Consensus       710 ~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~~~~~~p~~p~~~~~~~~~~~~~~~~~~~~~~  789 (808)
                      ++.++..      ....+...++|+..|..+|.+|.|+.+++..== +......|..|....+...+..+.+..+|++|.
T Consensus       285 ~FP~pEW------s~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpw-i~~~~~vp~tpl~t~~~l~~a~e~w~dvqeem~  357 (400)
T KOG0604|consen  285 EFPEPEW------SCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPW-INQYEAVPQTPLSTSRMLKEAVEAWDDVQEEMT  357 (400)
T ss_pred             cCCChhH------hHHHHHHHHHHHHHhcCCchhheeHHHhhcCch-hcccccCCCCCchhhhhcchhhhhhHHHHHHHH
Confidence            1222111      245677789999999999999999999876421 113456788899989999999999999999987


Q ss_pred             HH--HHHHhhhhHhh
Q 003599          790 LM--ILLLHSQQAEI  802 (808)
Q Consensus       790 ~~--~~~~~~~~~~~  802 (808)
                      ..  .+.++++|.+|
T Consensus       358 ~~lA~mrv~~~~v~i  372 (400)
T KOG0604|consen  358 ETLATMRVDPLQVQI  372 (400)
T ss_pred             HHHHhcccCcceeEE
Confidence            53  23345555554

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.97  E-value=9.9e-32  Score=294.19  Aligned_cols=265  Identities=21%  Similarity=0.270  Sum_probs=196.1

Q ss_pred             cCCcc-cCcccccCceeEEEEEec-CCcEEEEEEeccccccc--------------HHHHHHHHHHHHhccCCceeeEee
Q 003599          482 NNFQL-SSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQG--------------LEEFMNEVMVISKLQHRNLVRLLG  545 (808)
Q Consensus       482 ~~~~~-~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~~~--------------~~~~~~E~~~l~~l~H~niv~l~g  545 (808)
                      ++|.. .+.||+|+||+||+|... +++.||||+++......              ...+.+|++++++++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            45653 467999999999999875 68999999986532211              125789999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeee
Q 003599          546 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKI  625 (808)
Q Consensus       546 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl  625 (808)
                      ++..++..++||||+. ++|.+++..   ...+++.....++.|++.||.|||+.+   ++|+||+|+||+++.++.++|
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl  160 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI  160 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence            9999999999999997 689888843   346889999999999999999999988   999999999999999999999


Q ss_pred             eccccceecCCCCC------------cccccceeccCCccChhhhccC-CCCccccEEehhHHHHHHHhCCCCCCCCCCc
Q 003599          626 SDFGMAKIFGGNQD------------QADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDD  692 (808)
Q Consensus       626 ~DFGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvil~elltG~~p~~~~~~~  692 (808)
                      +|||+++.......            ........++..|+|||.+.+. .++.++||||||+++|||++|+.|+....+.
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~  240 (335)
T PTZ00024        161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI  240 (335)
T ss_pred             CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            99999987641110            1111123467889999998764 4689999999999999999999998754432


Q ss_pred             hhhhhhhhhhhccccc---hh--------ccCCcccCC--cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHH
Q 003599          693 LTILGYAWKLWNENKI---LA--------LVDPFLSES--SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML  754 (808)
Q Consensus       693 ~~~~~~~~~~~~~~~~---~~--------~~d~~l~~~--~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L  754 (808)
                      ..+. ...........   ..        ...+.....  ........++.+++.+|++.+|++||++++++..-
T Consensus       241 ~~~~-~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~  314 (335)
T PTZ00024        241 DQLG-RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE  314 (335)
T ss_pred             HHHH-HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence            2111 11111100000   00        000000000  00112245688999999999999999999998743

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.97  E-value=1.4e-31  Score=292.58  Aligned_cols=263  Identities=21%  Similarity=0.260  Sum_probs=191.9

Q ss_pred             CCcccCcccccCceeEEEEEec-C--CcEEEEEEecccc--cccHHHHHHHHHHHHhc-cCCceeeEeeEEEeC----Ce
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLK-D--GQEIAVKRLSKAS--GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEG----EE  552 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~-~--~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~----~~  552 (808)
                      +|++.+.||+|+||.||+++.. .  +..||+|++....  ....+.+.+|+.+++++ +||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4778899999999999999975 3  6789999986532  22356788999999999 599999999976533    34


Q ss_pred             eEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccce
Q 003599          553 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK  632 (808)
Q Consensus       553 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~  632 (808)
                      .++++||+. ++|.+++..   ...+++..+..++.||+.||.|||+.+   ++||||||+|||++.++.+||+|||+++
T Consensus        81 ~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          81 LYLYEELME-ADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             EEEEEeccc-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence            678888885 688888743   456899999999999999999999988   9999999999999999999999999998


Q ss_pred             ecCCCCCc--ccccceeccCCccChhhhcc-CCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhh--------
Q 003599          633 IFGGNQDQ--ADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWK--------  701 (808)
Q Consensus       633 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~--------  701 (808)
                      ........  .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.|+........+......        
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET  233 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            66432211  11223568999999998765 46789999999999999999999988653321111100000        


Q ss_pred             --hhccccchhccC-----CcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          702 --LWNENKILALVD-----PFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       702 --~~~~~~~~~~~d-----~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                        ............     +..............+.+++.+|++.+|++||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence              000000000000     000000001112457889999999999999999999864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.97  E-value=8.2e-32  Score=283.56  Aligned_cols=249  Identities=26%  Similarity=0.344  Sum_probs=194.8

Q ss_pred             CCcccCcccccCceeEEEEEecC-CcEEEEEEeccc-----ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEE
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKA-----SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI  556 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vAvK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  556 (808)
                      +|.+.++||+|+||.||+++... +..+++|.++..     ......++..|+.++++++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            47888999999999999998753 444566655431     122345677899999999999999999999999999999


Q ss_pred             EEecCCCCchhhccCC-CCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecC
Q 003599          557 YEYMPNRSLDALLFDP-LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG  635 (808)
Q Consensus       557 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~  635 (808)
                      |||+++++|.+++... .....+++.++..++.|+++||.|||+.+   ++|+||+|+||+++. +.++|+|||+++...
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence            9999999999888642 23457999999999999999999999988   999999999999975 569999999998764


Q ss_pred             CCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCc
Q 003599          636 GNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPF  715 (808)
Q Consensus       636 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  715 (808)
                      ....  ......|+..|+|||.+....++.++|+||||+++|+|++|..|+.......    ...... .+     ..+.
T Consensus       157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~----~~~~~~-~~-----~~~~  224 (260)
T cd08222         157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS----VVLRIV-EG-----PTPS  224 (260)
T ss_pred             CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH----HHHHHH-cC-----CCCC
Confidence            3322  1223457889999999988888999999999999999999999885322111    111110 00     1111


Q ss_pred             ccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          716 LSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       716 l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                           .+.....++.+++.+|++.+|++||++.++++
T Consensus       225 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         225 -----LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             -----CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence                 22344567889999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=1.9e-31  Score=283.97  Aligned_cols=260  Identities=25%  Similarity=0.350  Sum_probs=198.0

Q ss_pred             CcccCcccccCceeEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEec
Q 003599          484 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  560 (808)
Q Consensus       484 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  560 (808)
                      |++.+.||+|++|.||+|+.. +++.+|+|.+....  ....+.+.+|+.++++++|+||+++++++.+....++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            566789999999999999976 48999999987653  334567889999999999999999999999999999999999


Q ss_pred             CCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCc
Q 003599          561 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  640 (808)
Q Consensus       561 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  640 (808)
                      + ++|.+++...  ...+++..+.+++.++++||+|||+.+   |+||||+|+||++++++.++|+|||+++....... 
T Consensus        81 ~-~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-  153 (282)
T cd07829          81 D-MDLKKYLDKR--PGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-  153 (282)
T ss_pred             C-cCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence            7 5899998642  246899999999999999999999998   99999999999999999999999999986543221 


Q ss_pred             ccccceeccCCccChhhhccC-CCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhc---cc------cc--
Q 003599          641 ADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN---EN------KI--  708 (808)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~---~~------~~--  708 (808)
                       ......++..|+|||.+... .++.++||||||+++|||++|+.|+........+.... ....   +.      ..  
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  231 (282)
T cd07829         154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIF-QILGTPTEESWPGVTKLPD  231 (282)
T ss_pred             -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-HHhCCCcHHHHHhhccccc
Confidence             11223457789999998776 78999999999999999999998885433221111100 0000   00      00  


Q ss_pred             -hhccCCcccCC--cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          709 -LALVDPFLSES--SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       709 -~~~~d~~l~~~--~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                       ...........  .........+.+++.+|++.+|++||++++|+.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             ccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence             00000000000  000112457899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.6e-31  Score=293.45  Aligned_cols=261  Identities=22%  Similarity=0.309  Sum_probs=196.9

Q ss_pred             HhcCCcccCcccccCceeEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCe----
Q 003599          480 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEE----  552 (808)
Q Consensus       480 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----  552 (808)
                      ..++|++.+.||+|++|.||+|+.. +++.||||++...  .....+.+.+|+.++++++|+||+++++++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            4578999999999999999999976 5789999998653  22344667889999999999999999998776554    


Q ss_pred             --eEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeecccc
Q 003599          553 --KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGM  630 (808)
Q Consensus       553 --~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGl  630 (808)
                        .++|+||+ +++|.+++..    ..+++..+..++.|+++||.|||+.+   |+||||||+||++++++.++|+|||+
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~  164 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL  164 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence              89999998 6699888843    46899999999999999999999988   99999999999999999999999999


Q ss_pred             ceecCCCCCcccccceeccCCccChhhhcc-CCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhh---------
Q 003599          631 AKIFGGNQDQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAW---------  700 (808)
Q Consensus       631 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~---------  700 (808)
                      +......     .....++..|+|||.+.. ..++.++||||||+++|||++|+.|+........+.....         
T Consensus       165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  239 (343)
T cd07851         165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL  239 (343)
T ss_pred             ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence            9865322     122457889999998865 3678999999999999999999999864332211111000         


Q ss_pred             -hhhccccchhccCCcc--cCCcc---cHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          701 -KLWNENKILALVDPFL--SESSF---QLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       701 -~~~~~~~~~~~~d~~l--~~~~~---~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                       ..+........+....  ....+   .......+.+++.+|++.+|++|||+.+|++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence             0000000000000000  00000   01125678899999999999999999998763

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.6e-32  Score=272.66  Aligned_cols=240  Identities=25%  Similarity=0.289  Sum_probs=199.1

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  557 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  557 (808)
                      ++|..+++||+|.||.|.+++-+ .++.+|+|++++.   ......+-+.|-++|+..+||.+..+...+...+.+++||
T Consensus       168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM  247 (516)
T KOG0690|consen  168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM  247 (516)
T ss_pred             chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence            67889999999999999999866 6899999999875   3344566678999999999999999999999999999999


Q ss_pred             EecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCC
Q 003599          558 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  637 (808)
Q Consensus       558 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  637 (808)
                      ||..||.|.-+|.+   ...+++....-+..+|..||.|||+.+   ||.||||.+|.|||.+|.+||+|||+++.-.  
T Consensus       248 eyanGGeLf~HLsr---er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I--  319 (516)
T KOG0690|consen  248 EYANGGELFFHLSR---ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI--  319 (516)
T ss_pred             EEccCceEeeehhh---hhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc--
Confidence            99999999988853   456788777888999999999999988   9999999999999999999999999998432  


Q ss_pred             CCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCccc
Q 003599          638 QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS  717 (808)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  717 (808)
                      .....+...+||+.|+|||++.+..|..+.|.|.+||++|||++|+.||...+.+..              .++|--.  
T Consensus       320 ~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kL--------------FeLIl~e--  383 (516)
T KOG0690|consen  320 KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKL--------------FELILME--  383 (516)
T ss_pred             cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHH--------------HHHHHhh--
Confidence            223445568999999999999999999999999999999999999999875443321              1111100  


Q ss_pred             CCcccHHHHHHHHHHHHhcccCCcCCCC
Q 003599          718 ESSFQLDMIIRCIHVGLLCVQELVKDRP  745 (808)
Q Consensus       718 ~~~~~~~~~~~l~~li~~cl~~~P~~RP  745 (808)
                      +-.++.....+...|....|..||.+|.
T Consensus       384 d~kFPr~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  384 DLKFPRTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             hccCCccCCHHHHHHHHHHhhcChHhhc
Confidence            0114444555667778888999999996

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=6.6e-32  Score=276.07  Aligned_cols=264  Identities=24%  Similarity=0.361  Sum_probs=214.8

Q ss_pred             HHHHHHhcCCcccCcccccCceeEEEEEec------CCcEEEEEEeccc-ccccHHHHHHHHHHHHhccCCceeeEeeEE
Q 003599          475 EELATATNNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCC  547 (808)
Q Consensus       475 ~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~  547 (808)
                      .++.....+++..-.+-+|.||.||+|.+.      +.+.|-||.++.. +.-....++.|...+..+.|||+..+.+.+
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~  356 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS  356 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence            344445567888889999999999999654      3456788887654 344567889999999999999999999998


Q ss_pred             EeC-CeeEEEEEecCCCCchhhcc-----CCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCC
Q 003599          548 VEG-EEKMLIYEYMPNRSLDALLF-----DPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL  621 (808)
Q Consensus       548 ~~~-~~~~lV~E~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~  621 (808)
                      ++. ...+++|.++.-|+|+.||.     +....+.++..+...++.|++.|++|||.++   +||.||.++|.+||+..
T Consensus       357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~L  433 (563)
T KOG1024|consen  357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQL  433 (563)
T ss_pred             eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhe
Confidence            764 56789999999999999998     5555567888899999999999999999998   99999999999999999


Q ss_pred             CeeeeccccceecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhh
Q 003599          622 NPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAW  700 (808)
Q Consensus       622 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~  700 (808)
                      ++||+|=.++|.+.+............+..||+||.+.+..|+.++|||||||+||||+| |+.|+...++. ..    .
T Consensus       434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf-Em----~  508 (563)
T KOG1024|consen  434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF-EM----E  508 (563)
T ss_pred             eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH-HH----H
Confidence            999999999998877666655555566889999999999999999999999999999998 77776432211 11    1


Q ss_pred             hhhccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhh
Q 003599          701 KLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS  756 (808)
Q Consensus       701 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~  756 (808)
                      .++.+|        .-..  .+.+++.++..++.-||...|++||+.+|++..|.+
T Consensus       509 ~ylkdG--------yRla--QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse  554 (563)
T KOG1024|consen  509 HYLKDG--------YRLA--QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE  554 (563)
T ss_pred             HHHhcc--------ceec--CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence            111111        1111  345577899999999999999999999999999865

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.7e-32  Score=281.05  Aligned_cols=259  Identities=27%  Similarity=0.349  Sum_probs=202.8

Q ss_pred             HHhcCCcccCcccccCceeEEEEEe-cCCcEEEEEEecccc-------cccHHHHHHHHHHHHhccCCceeeEeeEEE-e
Q 003599          479 TATNNFQLSSKLGQGGFGPVYWGRL-KDGQEIAVKRLSKAS-------GQGLEEFMNEVMVISKLQHRNLVRLLGCCV-E  549 (808)
Q Consensus       479 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~~~~-------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~-~  549 (808)
                      ...++|-++++||+|||+.||++.+ ...+.||||+-....       ....+...+|.++.+.|.||.||++++++. +
T Consensus       460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD  539 (775)
T KOG1151|consen  460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD  539 (775)
T ss_pred             chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence            3456788999999999999999974 567889999754321       122355678999999999999999999987 5


Q ss_pred             CCeeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCC---CCCeeee
Q 003599          550 GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE---ELNPKIS  626 (808)
Q Consensus       550 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~---~~~~kl~  626 (808)
                      .+.++-|+||++|.+|+-+|.   ....+++.+...|+.||..||.||.... +||||-||||.||||-+   -|.+||+
T Consensus       540 tdsFCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKIT  615 (775)
T KOG1151|consen  540 TDSFCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKIT  615 (775)
T ss_pred             cccceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEee
Confidence            567889999999999999994   4567999999999999999999999875 78999999999999954   5789999


Q ss_pred             ccccceecCCCCCcc-----cccceeccCCccChhhhccC----CCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhh
Q 003599          627 DFGMAKIFGGNQDQA-----DTGRVVGTFGYMSPEYAMEG----RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILG  697 (808)
Q Consensus       627 DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~----~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~  697 (808)
                      |||+++++..+....     .+....||..|++||.+.-+    +++.|.||||+|||+|..+.|++||......+.+++
T Consensus       616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILq  695 (775)
T KOG1151|consen  616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQ  695 (775)
T ss_pred             ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHh
Confidence            999999997665442     23446799999999998644    578899999999999999999999986555544443


Q ss_pred             hhhhhhccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHH
Q 003599          698 YAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVV  751 (808)
Q Consensus       698 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~  751 (808)
                      .       ..+...-+-.+   +..+....+...+|.+||++..++|-...++.
T Consensus       696 e-------NTIlkAtEVqF---P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  696 E-------NTILKATEVQF---PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             h-------hchhcceeccC---CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence            2       22221111111   12223445667899999999999998766654

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.97  E-value=4.2e-33  Score=272.05  Aligned_cols=252  Identities=25%  Similarity=0.332  Sum_probs=192.9

Q ss_pred             cCcccccCceeEEEEEec-CCcEEEEEEeccccc-ccHHHHHHHHHHHHhc-cCCceeeEeeEEEeCCeeEEEEEecCCC
Q 003599          487 SSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG-QGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEYMPNR  563 (808)
Q Consensus       487 ~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~g  563 (808)
                      +..||.|+||+|+|-..+ .|+.+|||+++.... .+.++++.|.+...+- +.||||+++|.+..++..++.||.|. .
T Consensus        69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~  147 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-I  147 (361)
T ss_pred             HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-h
Confidence            578999999999998876 699999999987543 5667888888876555 78999999999999999999999994 4


Q ss_pred             CchhhccC--CCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCcc
Q 003599          564 SLDALLFD--PLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA  641 (808)
Q Consensus       564 sL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  641 (808)
                      ||+.+-..  ..+...+++.-+-.|.....+||.||...-  .|+|||+||+||||+..|.+||||||++-.+-...   
T Consensus       148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si---  222 (361)
T KOG1006|consen  148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI---  222 (361)
T ss_pred             hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHHH---
Confidence            76654321  123456888888889999999999998765  59999999999999999999999999987553222   


Q ss_pred             cccceeccCCccChhhhccC--CCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCC
Q 003599          642 DTGRVVGTFGYMSPEYAMEG--RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSES  719 (808)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~~~--~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  719 (808)
                      ....-.|-..|||||.+...  .|+.++||||||++|||+.||+.|+...++...   ...... .+.     .|.+...
T Consensus       223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfe---ql~~Vv-~gd-----pp~l~~~  293 (361)
T KOG1006|consen  223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFE---QLCQVV-IGD-----PPILLFD  293 (361)
T ss_pred             HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHH---HHHHHH-cCC-----CCeecCc
Confidence            22235688999999998533  488999999999999999999999875543211   111111 110     1222222


Q ss_pred             cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          720 SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       720 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                      ....+....+.+++..|+.+|..+||+..++.++
T Consensus       294 ~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  294 KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            1223456788999999999999999999987654

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.97  E-value=9.3e-32  Score=267.79  Aligned_cols=203  Identities=26%  Similarity=0.414  Sum_probs=169.4

Q ss_pred             cCCcccCcccccCceeEEEEEec---C--CcEEEEEEeccccc--ccHHHHHHHHHHHHhccCCceeeEeeEEEe-CCee
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK---D--GQEIAVKRLSKASG--QGLEEFMNEVMVISKLQHRNLVRLLGCCVE-GEEK  553 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~---~--~~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~  553 (808)
                      ..|+....||+|.||.||+|.-+   +  ...+|+|+++....  .......+|+.+++.++||||+.+...+.. +...
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            56888999999999999999643   2  23799999976532  234567899999999999999999999887 7788


Q ss_pred             EEEEEecCCCCchhhccC--CCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCC----CCeeeec
Q 003599          554 MLIYEYMPNRSLDALLFD--PLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE----LNPKISD  627 (808)
Q Consensus       554 ~lV~E~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~----~~~kl~D  627 (808)
                      ++++||.+. +|...++.  ..+...++-..+..|+.||+.|+.|||++-   |+||||||.||||..+    |.+||+|
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence            999999977 77776643  233457888999999999999999999997   9999999999999877    9999999


Q ss_pred             cccceecCCCCC-cccccceeccCCccChhhhccCC-CCccccEEehhHHHHHHHhCCCCCCC
Q 003599          628 FGMAKIFGGNQD-QADTGRVVGTFGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGRKNTSF  688 (808)
Q Consensus       628 FGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DvwSlGvil~elltG~~p~~~  688 (808)
                      ||++|.+...-. ......++-|..|.|||.+.+.+ |+.+.|||+.|||+.||+|-++.|..
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g  242 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG  242 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence            999998865432 23455678899999999998764 89999999999999999998876643

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.97  E-value=9e-31  Score=273.64  Aligned_cols=236  Identities=29%  Similarity=0.360  Sum_probs=192.3

Q ss_pred             ccccCceeEEEEEec-CCcEEEEEEeccccc---ccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEecCCCCc
Q 003599          490 LGQGGFGPVYWGRLK-DGQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSL  565 (808)
Q Consensus       490 lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL  565 (808)
                      ||+|+||.||++... +++.+|+|.+.....   ...+.+.+|+.++++++|+||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999876 588999999876432   2456889999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCcccccc
Q 003599          566 DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR  645 (808)
Q Consensus       566 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~  645 (808)
                      .+++..   ...+++..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.++|+|||++........  ....
T Consensus        81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~  152 (250)
T cd05123          81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNT  152 (250)
T ss_pred             HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCC--cccC
Confidence            999854   236899999999999999999999987   99999999999999999999999999987643321  1223


Q ss_pred             eeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCcccHHH
Q 003599          646 VVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDM  725 (808)
Q Consensus       646 ~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  725 (808)
                      ..++..|+|||...+...+.++|+||||+++|||++|+.|+...+... ..   ....         ....   ..+...
T Consensus       153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~-~~---~~~~---------~~~~---~~~~~~  216 (250)
T cd05123         153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE-IY---EKIL---------KDPL---RFPEFL  216 (250)
T ss_pred             CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-HH---HHHh---------cCCC---CCCCCC
Confidence            567889999999988888999999999999999999999985433211 11   0000         0011   122223


Q ss_pred             HHHHHHHHHhcccCCcCCCCCHHH
Q 003599          726 IIRCIHVGLLCVQELVKDRPNMST  749 (808)
Q Consensus       726 ~~~l~~li~~cl~~~P~~RPs~~e  749 (808)
                      ...+.+++.+|+..+|++||++.+
T Consensus       217 ~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         217 SPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CHHHHHHHHHHhcCCHhhCCCccc
Confidence            567789999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.97  E-value=1.2e-30  Score=308.92  Aligned_cols=145  Identities=30%  Similarity=0.458  Sum_probs=130.9

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  557 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  557 (808)
                      ++|.+.++||+|+||.||+|... +++.||||+++...   ......+.+|+.+++.++||||+++++.+......++||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57899999999999999999976 68999999987532   223467889999999999999999999999999999999


Q ss_pred             EecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccce
Q 003599          558 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK  632 (808)
Q Consensus       558 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~  632 (808)
                      ||+.+++|.+++..   ...+++..+++|+.||+.||.|||..+   |+||||||+||||+.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999853   345788899999999999999999987   9999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=2.4e-31  Score=280.16  Aligned_cols=242  Identities=28%  Similarity=0.380  Sum_probs=194.9

Q ss_pred             cCcccccCceeEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEecCCC
Q 003599          487 SSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNR  563 (808)
Q Consensus       487 ~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  563 (808)
                      .+.||+|-||+||-|+.+ .|+.||||++.+.  ......++.+|+.+|++++||.||.+.-.|+..+..++|||.+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            578999999999999875 6999999999764  3445688999999999999999999999999999999999999665


Q ss_pred             CchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCC---CCeeeeccccceecCCCCCc
Q 003599          564 SLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE---LNPKISDFGMAKIFGGNQDQ  640 (808)
Q Consensus       564 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~---~~~kl~DFGla~~~~~~~~~  640 (808)
                      -|+-.|..  +.+++++....-++.||+.||.|||.++   |+|+||||+||||...   -++||||||.||+++.....
T Consensus       649 MLEMILSs--EkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR  723 (888)
T KOG4236|consen  649 MLEMILSS--EKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR  723 (888)
T ss_pred             HHHHHHHh--hcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence            55555533  5678999888899999999999999999   9999999999999644   46999999999998654332


Q ss_pred             ccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCc
Q 003599          641 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS  720 (808)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  720 (808)
                         ..++||+.|+|||++.+..|...-|+||.|||+|--++|-.||...++-.+.++-+.               ..-.+
T Consensus       724 ---rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAa---------------FMyPp  785 (888)
T KOG4236|consen  724 ---RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAA---------------FMYPP  785 (888)
T ss_pred             ---hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccc---------------cccCC
Confidence               237899999999999999999999999999999999999999864332111111111               11111


Q ss_pred             cc-HHHHHHHHHHHHhcccCCcCCCCCHHHHH
Q 003599          721 FQ-LDMIIRCIHVGLLCVQELVKDRPNMSTVV  751 (808)
Q Consensus       721 ~~-~~~~~~l~~li~~cl~~~P~~RPs~~ev~  751 (808)
                      .+ .+.....+++|...||..-++|-+.+.-+
T Consensus       786 ~PW~eis~~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  786 NPWSEISPEAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             CchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence            11 23455677888888888888888876643

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=6.4e-31  Score=262.55  Aligned_cols=286  Identities=22%  Similarity=0.295  Sum_probs=210.5

Q ss_pred             CHHHHHHHhcCCcccCcccccCceeEEEEE-ecCCcEEEEEEecccccccHHHHHHHHHHHHhcc-CCceeeEeeEEEeC
Q 003599          473 QFEELATATNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEG  550 (808)
Q Consensus       473 ~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~  550 (808)
                      .++++-+.+     .+.||+|+|+.|--++ +.+|.++|||++.+.......+..+|++++.+.+ |+||++++.+++++
T Consensus        74 ~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd  148 (463)
T KOG0607|consen   74 KFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD  148 (463)
T ss_pred             hHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence            355555554     3689999999999876 5689999999999887777889999999999995 99999999999999


Q ss_pred             CeeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCC---eeeec
Q 003599          551 EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELN---PKISD  627 (808)
Q Consensus       551 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~---~kl~D  627 (808)
                      ..+|||||.|.||.|..+++.   +..+++.+..++..+||.||.|||.++   |.||||||+|||-.....   +||+|
T Consensus       149 ~~FYLVfEKm~GGplLshI~~---~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCD  222 (463)
T KOG0607|consen  149 TRFYLVFEKMRGGPLLSHIQK---RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICD  222 (463)
T ss_pred             ceEEEEEecccCchHHHHHHH---hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeec
Confidence            999999999999999999964   567999999999999999999999999   999999999999965544   89999


Q ss_pred             cccceecCCCC-----CcccccceeccCCccChhhhc-----cCCCCccccEEehhHHHHHHHhCCCCCCCCCCch----
Q 003599          628 FGMAKIFGGNQ-----DQADTGRVVGTFGYMSPEYAM-----EGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDL----  693 (808)
Q Consensus       628 FGla~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~----  693 (808)
                      |.+..-.....     ........+|+..|||||+..     ...|+.++|.||||||||-|++|.+||...=...    
T Consensus       223 fDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWd  302 (463)
T KOG0607|consen  223 FDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWD  302 (463)
T ss_pred             cccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCcc
Confidence            99876432211     111222357899999999863     3458899999999999999999999986432111    


Q ss_pred             ---hhh---hhhhhhhccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH--HHhhcccCCCCCC
Q 003599          694 ---TIL---GYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS--MLNSEIRDLPYPK  765 (808)
Q Consensus       694 ---~~~---~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~--~L~~~~~~~~~p~  765 (808)
                         .-.   ........+| -.++.|...      .....+..+++...+..++.+|-++.+++.  ..+.. ...+.-+
T Consensus       303 rGe~Cr~CQ~~LFesIQEG-kYeFPdkdW------ahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~-~~ekalp  374 (463)
T KOG0607|consen  303 RGEVCRVCQNKLFESIQEG-KYEFPDKDW------AHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRC-APEKALP  374 (463)
T ss_pred             CCCccHHHHHHHHHHHhcc-CCcCChhhh------HHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccccc-chhccCC
Confidence               000   0000011111 111222111      234566678888888899999999999877  22222 1223334


Q ss_pred             CCCcccCCCCCC
Q 003599          766 EPAFTERQGADD  777 (808)
Q Consensus       766 ~p~~~~~~~~~~  777 (808)
                      .|....+.+...
T Consensus       375 tp~v~~r~~s~~  386 (463)
T KOG0607|consen  375 TPQVLQRNSSTM  386 (463)
T ss_pred             CCcccccCccch
Confidence            555555544444

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=7.4e-31  Score=286.52  Aligned_cols=239  Identities=23%  Similarity=0.299  Sum_probs=194.3

Q ss_pred             hcCCcccCcccccCceeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHHhc-cCCceeeEeeEEEeCCeeEEEEE
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYE  558 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E  558 (808)
                      ++.|.+...+|.|+|+.|-.+... +++..+||++.+...    +-.+|+.++... +||||+++.+.+.++.+.++|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            567888899999999999988865 578899999976522    234577666655 79999999999999999999999


Q ss_pred             ecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEe-CCCCCeeeeccccceecCCC
Q 003599          559 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL-DEELNPKISDFGMAKIFGGN  637 (808)
Q Consensus       559 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl-~~~~~~kl~DFGla~~~~~~  637 (808)
                      .+.++-|.+.+..   . +....++..|+.+|+.|+.|||.++   +|||||||+|||+ +..++++|+|||.++...+.
T Consensus       397 ~l~g~ell~ri~~---~-~~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~  469 (612)
T KOG0603|consen  397 LLDGGELLRRIRS---K-PEFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS  469 (612)
T ss_pred             hccccHHHHHHHh---c-chhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence            9999888766632   2 2222777789999999999999998   9999999999999 69999999999999866443


Q ss_pred             CCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCccc
Q 003599          638 QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS  717 (808)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  717 (808)
                           ....+-|..|.|||......+++++|+||||++||+|++|+.|+.....+..+..                 ++.
T Consensus       470 -----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~-----------------~i~  527 (612)
T KOG0603|consen  470 -----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHT-----------------RIQ  527 (612)
T ss_pred             -----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHH-----------------hhc
Confidence                 2224568999999999999999999999999999999999999875544422221                 112


Q ss_pred             CCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          718 ESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       718 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      ...++........+|+.+||+.||.+||+|.++..
T Consensus       528 ~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  528 MPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             CCccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence            22244556677889999999999999999999865

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=7.4e-31  Score=299.63  Aligned_cols=260  Identities=24%  Similarity=0.280  Sum_probs=207.7

Q ss_pred             HHHHHHhcCCcccCcccccCceeEEEEEec-CCcEEEEEEecc---cccccHHHHHHHHHHHHhccCCceeeEeeEEEeC
Q 003599          475 EELATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG  550 (808)
Q Consensus       475 ~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~  550 (808)
                      .++.-..++|.++++||+|+||.|..++.+ .++.+|+|++.+   .......-|..|-.+|..-+.+=|+.++..|.+.
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~  147 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE  147 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence            344555688999999999999999999986 578899999987   3345567788999999999999999999999999


Q ss_pred             CeeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeecccc
Q 003599          551 EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGM  630 (808)
Q Consensus       551 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGl  630 (808)
                      .++|+|||||+||+|-.++..   ..++++....-++..|.-||.-||+.|   +|||||||.|||||..|++||+|||.
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk---~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGs  221 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSK---FDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGS  221 (1317)
T ss_pred             cceEEEEecccCchHHHHHhh---cCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchh
Confidence            999999999999999999954   337888888889999999999999998   99999999999999999999999999


Q ss_pred             ceecCCCCCcccccceeccCCccChhhhc----c-CCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhcc
Q 003599          631 AKIFGGNQDQADTGRVVGTFGYMSPEYAM----E-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNE  705 (808)
Q Consensus       631 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~  705 (808)
                      +-.+..+.. ......+|||.|.+||++.    + +.|+..+|.||+||++|||+.|..||..    ..++.-..++.+.
T Consensus       222 Clkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa----dslveTY~KIm~h  296 (1317)
T KOG0612|consen  222 CLKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA----DSLVETYGKIMNH  296 (1317)
T ss_pred             HHhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH----HHHHHHHHHHhch
Confidence            887754432 2334468999999999984    3 5789999999999999999999999853    2233333333333


Q ss_pred             ccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCC---HHHHHHHH
Q 003599          706 NKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPN---MSTVVSML  754 (808)
Q Consensus       706 ~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs---~~ev~~~L  754 (808)
                      .....+.        ...+..++..+||.+.+. +|+.|..   .+++-..-
T Consensus       297 k~~l~FP--------~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~Hp  339 (1317)
T KOG0612|consen  297 KESLSFP--------DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHP  339 (1317)
T ss_pred             hhhcCCC--------cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCc
Confidence            2222221        113356677778876655 6778887   88876654

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=2.5e-30  Score=268.56  Aligned_cols=221  Identities=19%  Similarity=0.138  Sum_probs=176.5

Q ss_pred             cCceeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEecCCCCchhhccC
Q 003599          493 GGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD  571 (808)
Q Consensus       493 G~~g~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  571 (808)
                      |.+|.||+++.. +++.+|+|+++...     .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            889999999875 68899999996543     234556666667899999999999999999999999999999998854


Q ss_pred             CCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCcccccceeccCC
Q 003599          572 PLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFG  651 (808)
Q Consensus       572 ~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~  651 (808)
                         ...+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.++++|||.+.......     ....++..
T Consensus        79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~  147 (237)
T cd05576          79 ---FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENM  147 (237)
T ss_pred             ---hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcc
Confidence               345899999999999999999999988   9999999999999999999999999887553321     12345678


Q ss_pred             ccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCcccHHHHHHHHH
Q 003599          652 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIH  731 (808)
Q Consensus       652 y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~  731 (808)
                      |+|||.+....++.++||||+|+++|||++|+.|+.......               .......     .+......+.+
T Consensus       148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~---------------~~~~~~~-----~~~~~~~~~~~  207 (237)
T cd05576         148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI---------------NTHTTLN-----IPEWVSEEARS  207 (237)
T ss_pred             ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc---------------ccccccC-----CcccCCHHHHH
Confidence            999999988889999999999999999999997754221100               0000000     11223456788


Q ss_pred             HHHhcccCCcCCCCCHHH
Q 003599          732 VGLLCVQELVKDRPNMST  749 (808)
Q Consensus       732 li~~cl~~~P~~RPs~~e  749 (808)
                      ++.+|++.||++||++.+
T Consensus       208 li~~~l~~dp~~R~~~~~  225 (237)
T cd05576         208 LLQQLLQFNPTERLGAGV  225 (237)
T ss_pred             HHHHHccCCHHHhcCCCc
Confidence            999999999999999743

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=1.1e-29  Score=262.94  Aligned_cols=238  Identities=28%  Similarity=0.377  Sum_probs=193.6

Q ss_pred             CceeEEEEEecC-CcEEEEEEeccccccc-HHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEecCCCCchhhccC
Q 003599          494 GFGPVYWGRLKD-GQEIAVKRLSKASGQG-LEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD  571 (808)
Q Consensus       494 ~~g~Vy~~~~~~-~~~vAvK~l~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  571 (808)
                      +||.||+|+..+ ++.+|+|++....... .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            589999999874 8999999997655444 78999999999999999999999999999999999999999999999854


Q ss_pred             CCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCcccccceeccCC
Q 003599          572 PLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFG  651 (808)
Q Consensus       572 ~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~  651 (808)
                      .   ..+++..+..++.++++++.|||+.+   ++|+||+|+||++++++.++|+|||.+.......   ......++..
T Consensus        81 ~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~  151 (244)
T smart00220       81 R---GRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE  151 (244)
T ss_pred             c---cCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence            2   22889999999999999999999987   9999999999999999999999999998764432   2223567889


Q ss_pred             ccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCcccHHHHHHHHH
Q 003599          652 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIH  731 (808)
Q Consensus       652 y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~  731 (808)
                      |+|||.+....++.++||||||+++++|++|+.|+....+.........    .+        .............++.+
T Consensus       152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~----~~--------~~~~~~~~~~~~~~~~~  219 (244)
T smart00220      152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIG----KP--------KPPFPPPEWKISPEAKD  219 (244)
T ss_pred             CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh----cc--------CCCCccccccCCHHHHH
Confidence            9999999888899999999999999999999998865332222221111    00        00000000014467889


Q ss_pred             HHHhcccCCcCCCCCHHHHHH
Q 003599          732 VGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       732 li~~cl~~~P~~RPs~~ev~~  752 (808)
                      ++.+|+..+|++||++.++++
T Consensus       220 ~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      220 LIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHccCCchhccCHHHHhh
Confidence            999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=6.3e-30  Score=286.00  Aligned_cols=259  Identities=25%  Similarity=0.387  Sum_probs=210.7

Q ss_pred             HHHHHHHhcCCcccCcccccCceeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHHhc-cCCceeeEeeEEEe--
Q 003599          474 FEELATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVE--  549 (808)
Q Consensus       474 ~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~--  549 (808)
                      ++.+...++.|++.+.||.|.+|.||+++.. +++.+|+|++... ....++...|.++|+.. +|||++.++|++..  
T Consensus        11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~   89 (953)
T KOG0587|consen   11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD   89 (953)
T ss_pred             hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence            3444455678999999999999999999865 6888999988654 34456778899999988 69999999999873  


Q ss_pred             ---CCeeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeee
Q 003599          550 ---GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKIS  626 (808)
Q Consensus       550 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~  626 (808)
                         +++++||||||.+||.-+++.... ..++.|..+..|++.+++|+.+||...   ++|||||-.|||++.++.+||+
T Consensus        90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLv  165 (953)
T KOG0587|consen   90 PGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLV  165 (953)
T ss_pred             CCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEe
Confidence               678999999999999999997764 778999999999999999999999988   9999999999999999999999


Q ss_pred             ccccceecCCCCCcccccceeccCCccChhhhccC-----CCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhh
Q 003599          627 DFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG-----RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWK  701 (808)
Q Consensus       627 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~  701 (808)
                      |||++..+...  ........||+.|||||++...     .|+..+|+||||++..||.-|.+|+.....-..+.     
T Consensus       166 DFGvSaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF-----  238 (953)
T KOG0587|consen  166 DFGVSAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALF-----  238 (953)
T ss_pred             eeeeeeeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhc-----
Confidence            99999866432  2333346899999999998643     47788999999999999999999976443322221     


Q ss_pred             hhccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          702 LWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       702 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                           .+.....|.+.   .+..-.+++.++|..||.+|.++||++.++++
T Consensus       239 -----~IpRNPPPkLk---rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  239 -----LIPRNPPPKLK---RPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             -----cCCCCCCcccc---chhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence                 11122233343   34556788999999999999999999988765

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.96  E-value=5.6e-29  Score=287.58  Aligned_cols=261  Identities=20%  Similarity=0.240  Sum_probs=167.8

Q ss_pred             HhcCCcccCcccccCceeEEEEEecC-----CcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeE------EE
Q 003599          480 ATNNFQLSSKLGQGGFGPVYWGRLKD-----GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGC------CV  548 (808)
Q Consensus       480 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~------~~  548 (808)
                      ..++|.+.++||+|+||.||+|++.+     +..||||++.....  .+.+..|  .+.+..+.++..++..      +.
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            45789999999999999999999764     68999999864322  1222222  1222222222222211      24


Q ss_pred             eCCeeEEEEEecCCCCchhhccCCCCC-----------------CcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCC
Q 003599          549 EGEEKMLIYEYMPNRSLDALLFDPLKK-----------------ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLK  611 (808)
Q Consensus       549 ~~~~~~lV~E~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik  611 (808)
                      .+...++||||+.+++|.+++......                 .......+..++.||+.||+|||+.+   |+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence            567789999999999999988642110                 01112335578999999999999988   9999999


Q ss_pred             CCceEeCC-CCCeeeeccccceecCCCCCcccccceeccCCccChhhhccC----------------------CCCcccc
Q 003599          612 ASNILLDE-ELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG----------------------RFSEKSD  668 (808)
Q Consensus       612 p~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~k~D  668 (808)
                      |+|||++. ++.+||+|||+++.+...... ......+++.|+|||.+...                      .++.++|
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            99999986 689999999999865432221 12235789999999966322                      2344679


Q ss_pred             EEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccc----cchhccCCcccCC-----cccHHHHHHHHHHHHhcccC
Q 003599          669 VFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNEN----KILALVDPFLSES-----SFQLDMIIRCIHVGLLCVQE  739 (808)
Q Consensus       669 vwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~d~~l~~~-----~~~~~~~~~l~~li~~cl~~  739 (808)
                      ||||||+||||+++..+.+.     ....+.......+    .....+++.....     ...........+|+.+||+.
T Consensus       362 VwSlGviL~el~~~~~~~~~-----~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~  436 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDS-----NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF  436 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCch-----HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence            99999999999997655321     1111110000000    0011111110000     00000122345899999999


Q ss_pred             CcCCCCCHHHHHHH
Q 003599          740 LVKDRPNMSTVVSM  753 (808)
Q Consensus       740 ~P~~RPs~~ev~~~  753 (808)
                      ||++|||++++++.
T Consensus       437 dP~kR~ta~e~L~H  450 (566)
T PLN03225        437 KGRQRISAKAALAH  450 (566)
T ss_pred             CcccCCCHHHHhCC
Confidence            99999999999874

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.96  E-value=5.8e-30  Score=262.85  Aligned_cols=260  Identities=19%  Similarity=0.231  Sum_probs=201.1

Q ss_pred             hcCCcccCcccccCceeEEEEEecC-CcEEEEEEecccccccHHHHHHHHHHHHhcc-C-Cc----eeeEeeEEEeCCee
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-H-RN----LVRLLGCCVEGEEK  553 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-H-~n----iv~l~g~~~~~~~~  553 (808)
                      +++|.+...+|+|.||.|-...+.. +..||||+++.- ....+.-+-|+++|++|. + |+    +|++.+++...++.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            6789999999999999999998664 689999998643 334456678999999993 3 33    78888999999999


Q ss_pred             EEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCC--------------
Q 003599          554 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE--------------  619 (808)
Q Consensus       554 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~--------------  619 (808)
                      +||+|.+ |-|+.++|.+. +..+++..++..|+.|++++++|||+..   ++|-||||+|||+.+              
T Consensus       167 Civfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~  241 (415)
T KOG0671|consen  167 CIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVC  241 (415)
T ss_pred             EEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccc
Confidence            9999998 66899999653 4457889999999999999999999998   999999999999932              


Q ss_pred             ------CCCeeeeccccceecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCch
Q 003599          620 ------ELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDL  693 (808)
Q Consensus       620 ------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~  693 (808)
                            +..++|+|||.|+.-....     ...+.|..|.|||++.+...+.++||||+||||.|+.||...|...++.+
T Consensus       242 ~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E  316 (415)
T KOG0671|consen  242 FIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE  316 (415)
T ss_pred             eeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence                  3458999999998643222     34678999999999999999999999999999999999998887665433


Q ss_pred             hhhhhhhhhhc-----------------cccc-----------hhccCCccc---CCcccHHHHHHHHHHHHhcccCCcC
Q 003599          694 TILGYAWKLWN-----------------ENKI-----------LALVDPFLS---ESSFQLDMIIRCIHVGLLCVQELVK  742 (808)
Q Consensus       694 ~~~~~~~~~~~-----------------~~~~-----------~~~~d~~l~---~~~~~~~~~~~l~~li~~cl~~~P~  742 (808)
                      .+ .+....+.                 .+++           ....++...   --.....+..+|.+|+..+|..||.
T Consensus       317 HL-aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~  395 (415)
T KOG0671|consen  317 HL-AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA  395 (415)
T ss_pred             HH-HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence            22 22221111                 1100           011111000   0013345677899999999999999


Q ss_pred             CCCCHHHHHH
Q 003599          743 DRPNMSTVVS  752 (808)
Q Consensus       743 ~RPs~~ev~~  752 (808)
                      +|+|+.|++.
T Consensus       396 ~RiTl~EAL~  405 (415)
T KOG0671|consen  396 RRITLREALS  405 (415)
T ss_pred             ccccHHHHhc
Confidence            9999999875

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.4e-30  Score=267.45  Aligned_cols=241  Identities=26%  Similarity=0.347  Sum_probs=198.1

Q ss_pred             hcCCcccCcccccCceeEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHHhc-cCCceeeEeeEEEeCCeeEE
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKML  555 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l  555 (808)
                      ..+|..+.+||+|+||.|.+|.-+ ..+.+|||++++.   ...+.+--+.|-++|+.. +-|.++++..++..-+.+++
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF  427 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF  427 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence            346888999999999999999866 4567999999875   233445567788888877 56889999999999999999


Q ss_pred             EEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecC
Q 003599          556 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG  635 (808)
Q Consensus       556 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~  635 (808)
                      ||||+.+|+|--+++   +-+.+.+....-++.+||-||-+||+++   |+.||||..|||||.+|.+||+|||+++.- 
T Consensus       428 VMEyvnGGDLMyhiQ---Q~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn-  500 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHIQ---QVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN-  500 (683)
T ss_pred             EEEEecCchhhhHHH---HhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccc-
Confidence            999999999988885   3466788888899999999999999999   999999999999999999999999999842 


Q ss_pred             CCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCc
Q 003599          636 GNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPF  715 (808)
Q Consensus       636 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  715 (808)
                       -.....+...+||+.|+|||++...+|+...|.|||||+||||+.|++||+..+++......             .+..
T Consensus       501 -i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI-------------~ehn  566 (683)
T KOG0696|consen  501 -IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAI-------------MEHN  566 (683)
T ss_pred             -ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-------------HHcc
Confidence             22334556689999999999999999999999999999999999999999865443322111             1111


Q ss_pred             ccCCcccHHHHHHHHHHHHhcccCCcCCCC
Q 003599          716 LSESSFQLDMIIRCIHVGLLCVQELVKDRP  745 (808)
Q Consensus       716 l~~~~~~~~~~~~l~~li~~cl~~~P~~RP  745 (808)
                         -.++.....+...++...+...|.+|.
T Consensus       567 ---vsyPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  567 ---VSYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             ---CcCcccccHHHHHHHHHHhhcCCcccc
Confidence               125555667778888899999999995

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.96  E-value=2.6e-29  Score=283.09  Aligned_cols=260  Identities=20%  Similarity=0.289  Sum_probs=180.1

Q ss_pred             HhcCCcccCcccccCceeEEEEEe-----------------cCCcEEEEEEecccccccHHH--------------HHHH
Q 003599          480 ATNNFQLSSKLGQGGFGPVYWGRL-----------------KDGQEIAVKRLSKASGQGLEE--------------FMNE  528 (808)
Q Consensus       480 ~~~~~~~~~~lG~G~~g~Vy~~~~-----------------~~~~~vAvK~l~~~~~~~~~~--------------~~~E  528 (808)
                      ..++|.+.++||+|+||.||+|..                 .+++.||||++........++              +..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            367899999999999999999964                 235689999986543322333              3447


Q ss_pred             HHHHHhccCCce-----eeEeeEEEe--------CCeeEEEEEecCCCCchhhccCCCC---------------------
Q 003599          529 VMVISKLQHRNL-----VRLLGCCVE--------GEEKMLIYEYMPNRSLDALLFDPLK---------------------  574 (808)
Q Consensus       529 ~~~l~~l~H~ni-----v~l~g~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~---------------------  574 (808)
                      +.++.+++|.++     ++++++|..        ....+|||||+++++|.++++....                     
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777888877654     677787753        3567999999999999998864211                     


Q ss_pred             CCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCcccccceeccCCccC
Q 003599          575 KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS  654 (808)
Q Consensus       575 ~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~a  654 (808)
                      ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++........ ......+++.|+|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~a  378 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSP  378 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeC
Confidence            123567788899999999999999988   999999999999999999999999999765332211 1111235789999


Q ss_pred             hhhhccCCC----------------------CccccEEehhHHHHHHHhCCC-CCCCCCC-chhhhh-----hhhhhhcc
Q 003599          655 PEYAMEGRF----------------------SEKSDVFSFGVLLLEIVSGRK-NTSFFED-DLTILG-----YAWKLWNE  705 (808)
Q Consensus       655 PE~~~~~~~----------------------s~k~DvwSlGvil~elltG~~-p~~~~~~-~~~~~~-----~~~~~~~~  705 (808)
                      ||.+.....                      ..+.||||+||++|||++|.. |+..... ......     ..|.....
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~  458 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG  458 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence            998754321                      234799999999999999875 5432110 000000     00111111


Q ss_pred             ccchhccCCcccCCcccHHHHHHHHHHHHhcccCCc---CCCCCHHHHHH
Q 003599          706 NKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELV---KDRPNMSTVVS  752 (808)
Q Consensus       706 ~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P---~~RPs~~ev~~  752 (808)
                      ..    .+-.     ..........+++.+++..+|   .+|+|++|+++
T Consensus       459 ~~----~~~~-----~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        459 QK----YDFS-----LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             cC----CCcc-----cccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            10    0100     111234567788888998765   78999999876

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.96  E-value=8.9e-30  Score=234.79  Aligned_cols=262  Identities=21%  Similarity=0.297  Sum_probs=191.0

Q ss_pred             CCcccCcccccCceeEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEe
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  559 (808)
                      +|.-.++||+|.||+||+|+.. .++.||+|+++-..  +......++|+-+|+.++|+|||++++....+....+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            3555689999999999999976 47889999987542  22345678999999999999999999999999999999999


Q ss_pred             cCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCC
Q 003599          560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  639 (808)
Q Consensus       560 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  639 (808)
                      +. .+|..+...  -.+.++......++.|+++||.+.|+++   +.|||+||.|.||+.+|++|++|||++|.++-...
T Consensus        83 cd-qdlkkyfds--lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr  156 (292)
T KOG0662|consen   83 CD-QDLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR  156 (292)
T ss_pred             hh-HHHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence            95 477777643  3567888999999999999999999998   99999999999999999999999999998754321


Q ss_pred             cccccceeccCCccChhhhccCC-CCccccEEehhHHHHHHHhC-CCCCCCCCCchhhhhhhhhh--hcccc---chhcc
Q 003599          640 QADTGRVVGTFGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSG-RKNTSFFEDDLTILGYAWKL--WNENK---ILALV  712 (808)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DvwSlGvil~elltG-~~p~~~~~~~~~~~~~~~~~--~~~~~---~~~~~  712 (808)
                        -....+-|..|.+|.++.+.+ |+...|+||-|||+.|+..- ++.|+..+-...+....+..  ..+++   +..+.
T Consensus       157 --cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp  234 (292)
T KOG0662|consen  157 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP  234 (292)
T ss_pred             --eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC
Confidence              122245689999999998765 78999999999999999884 44455444333332222211  11111   11222


Q ss_pred             CCccc----CCc----ccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          713 DPFLS----ESS----FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       713 d~~l~----~~~----~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      |-..-    ...    .-.....+-.++....+.-+|.+|.++++.++
T Consensus       235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            21110    000    00111122345566666779999999887654

>PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity

Probab=99.96  E-value=9e-30  Score=229.75  Aligned_cols=111  Identities=46%  Similarity=0.768  Sum_probs=82.2

Q ss_pred             CceEEEEecCCCCCCCC--cceEEEecCCcEEEEcCCCcEEEee-ccccccccceEEEEecCCCEEEEecccCceEeccc
Q 003599           69 EKAVIWVANRDNPLKDS--SGIITISEDGNLVLVNGQKEVLWSS-NVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESF  145 (808)
Q Consensus        69 ~~t~vW~Anr~~p~~~~--~~~l~~~~~G~L~l~~~~~~~vWst-~~~~~~~~~~~a~LldsGNlVl~~~~~~~~lWqSF  145 (808)
                      ++|+||+|||+.|+.++  ..+|.|+.||+|+|.+++++++|++ ++.+....+..|+|+|+|||||+|. ++.++||||
T Consensus         1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~-~~~~lW~Sf   79 (114)
T PF01453_consen    1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDS-SGNVLWQSF   79 (114)
T ss_dssp             ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEET-TSEEEEEST
T ss_pred             CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEee-cceEEEeec
Confidence            47999999999999653  3789999999999999999999999 5554322578999999999999996 789999999


Q ss_pred             CCCccccCCCCcccccccCCCeeEEEEeccCCCCC
Q 003599          146 QEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPS  180 (808)
Q Consensus       146 d~PtDtllpg~~l~~~~~~g~~~~l~S~~s~~dps  180 (808)
                      ||||||+||||+|+.+..++....++||++.+|||
T Consensus        80 ~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps  114 (114)
T PF01453_consen   80 DYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS  114 (114)
T ss_dssp             TSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred             CCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence            99999999999999988887777899999999997

Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B ....

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=4.2e-30  Score=248.96  Aligned_cols=266  Identities=21%  Similarity=0.378  Sum_probs=194.8

Q ss_pred             CCcccCcccccCceeEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHHhccCCceeeEeeEEEe--------CC
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVE--------GE  551 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--------~~  551 (808)
                      .|.-..+||+|.||+||+|+.+ .|+.||+|+.--.  ...--...++|+++|..++|+|++.++..|..        ..
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~   97 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA   97 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence            4555679999999999999876 4778899875432  22223456799999999999999999988753        33


Q ss_pred             eeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccc
Q 003599          552 EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA  631 (808)
Q Consensus       552 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla  631 (808)
                      .+++|+.+++. +|..+|.+  ...+++..++.+++.++..||.|+|...   |+|||+||.|+||+.++.+||+|||++
T Consensus        98 t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGla  171 (376)
T KOG0669|consen   98 TFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLA  171 (376)
T ss_pred             eeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccc
Confidence            57999999976 78777754  3357899999999999999999999988   999999999999999999999999999


Q ss_pred             eecCCCCCc--ccccceeccCCccChhhhccC-CCCccccEEehhHHHHHHHhCCCCCCCCCCchhhh--hhh-------
Q 003599          632 KIFGGNQDQ--ADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTIL--GYA-------  699 (808)
Q Consensus       632 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~--~~~-------  699 (808)
                      |.+......  ......+-|..|.+||.+.+. .++++.|||.-|||+.||+||.+.+....+.+.+.  ...       
T Consensus       172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke  251 (376)
T KOG0669|consen  172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE  251 (376)
T ss_pred             cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence            877543322  223334569999999998754 68999999999999999999998776655443322  111       


Q ss_pred             -hhhhccccchhccCCc-ccCCccc--HHHH------HHHHHHHHhcccCCcCCCCCHHHHHHHH
Q 003599          700 -WKLWNENKILALVDPF-LSESSFQ--LDMI------IRCIHVGLLCVQELVKDRPNMSTVVSML  754 (808)
Q Consensus       700 -~~~~~~~~~~~~~d~~-l~~~~~~--~~~~------~~l~~li~~cl~~~P~~RPs~~ev~~~L  754 (808)
                       |....+-.+.+.++.. +....+.  .+.+      .+.++++.+++..||.+|+.+++++...
T Consensus       252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~  316 (376)
T KOG0669|consen  252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD  316 (376)
T ss_pred             cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence             1111111111112100 1111111  1111      2567889999999999999999987654

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.95  E-value=3.4e-29  Score=236.40  Aligned_cols=207  Identities=26%  Similarity=0.340  Sum_probs=169.7

Q ss_pred             HHhcCCcccCcccccCceeEEEEEec-CCcEEEEEEeccc-ccccHHHHHHHHHHHHhc-cCCceeeEeeEEEeCCeeEE
Q 003599          479 TATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA-SGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKML  555 (808)
Q Consensus       479 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l  555 (808)
                      ...+...-...||+|++|.|-+-++. +|+.+|+|++... ..+..++.+.|+.+..+- .+|.+|.++|.........+
T Consensus        43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwI  122 (282)
T KOG0984|consen   43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWI  122 (282)
T ss_pred             cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEE
Confidence            33455555789999999999888764 7999999999765 345566788888887665 79999999999998999999


Q ss_pred             EEEecCCCCchhhccC-CCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceec
Q 003599          556 IYEYMPNRSLDALLFD-PLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF  634 (808)
Q Consensus       556 V~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~  634 (808)
                      .||.|. .||+.+-.+ ..+...+++..+-+|+..+..||.|||++-  .++|||+||+||||+.+|++||||||++-.+
T Consensus       123 cME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L  199 (282)
T KOG0984|consen  123 CMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYL  199 (282)
T ss_pred             eHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceee
Confidence            999994 578776543 234567889999999999999999999875  5999999999999999999999999999876


Q ss_pred             CCCCCcccccceeccCCccChhhhcc----CCCCccccEEehhHHHHHHHhCCCCCCCCCC
Q 003599          635 GGNQDQADTGRVVGTFGYMSPEYAME----GRFSEKSDVFSFGVLLLEIVSGRKNTSFFED  691 (808)
Q Consensus       635 ~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~k~DvwSlGvil~elltG~~p~~~~~~  691 (808)
                      .+....   ....|-..|||||.+..    ..|+.|+||||||+++.||.+++.|++....
T Consensus       200 ~dSiAk---t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t  257 (282)
T KOG0984|consen  200 VDSIAK---TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT  257 (282)
T ss_pred             hhhhHH---HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence            443222   12457889999998853    3689999999999999999999999875544

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.95  E-value=6e-29  Score=276.98  Aligned_cols=245  Identities=27%  Similarity=0.376  Sum_probs=186.2

Q ss_pred             CcccCcccccCcee-EEEEEecCCcEEEEEEecccccccHHHHHHHHHHHHhc-cCCceeeEeeEEEeCCeeEEEEEecC
Q 003599          484 FQLSSKLGQGGFGP-VYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEYMP  561 (808)
Q Consensus       484 ~~~~~~lG~G~~g~-Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~  561 (808)
                      |.-.+.+|.|+-|+ ||+|... |+.||||++-..   ...-..+|+..|+.- +|||||++++.-.++...||..|.| 
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence            44456789999885 7999987 789999998432   234456899999988 6999999999999999999999999 


Q ss_pred             CCCchhhccCC-CCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCC-----CCCeeeeccccceecC
Q 003599          562 NRSLDALLFDP-LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE-----ELNPKISDFGMAKIFG  635 (808)
Q Consensus       562 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~-----~~~~kl~DFGla~~~~  635 (808)
                      ..+|++++... .......-.....+..|+++||++||+.+   ||||||||.||||+.     ...++|+|||+++.+.
T Consensus       586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            45999999763 11112222445678899999999999987   999999999999975     2569999999999987


Q ss_pred             CCCCc-ccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhC-CCCCCCCCCc-hhhhhhhhhhhccccchhcc
Q 003599          636 GNQDQ-ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG-RKNTSFFEDD-LTILGYAWKLWNENKILALV  712 (808)
Q Consensus       636 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG-~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~  712 (808)
                      ..... .......||-+|+|||.+....-+.+.||||+|||+|+.++| .+||...-+. .+++.       .......+
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~-------~~~~L~~L  735 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILT-------GNYTLVHL  735 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhc-------Cccceeee
Confidence            65433 334456799999999999998888899999999999999997 7888643221 11110       10000001


Q ss_pred             CCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          713 DPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       713 d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      .       ...+.  +..+||.+|++++|..||++.+|+.
T Consensus       736 ~-------~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  736 E-------PLPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             c-------cCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            0       01111  6678999999999999999999873

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=3.8e-30  Score=270.81  Aligned_cols=249  Identities=23%  Similarity=0.312  Sum_probs=204.0

Q ss_pred             cCCcccCcccccCceeEEEEEecCCc-EEEEEEeccc---ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLKDGQ-EIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  557 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~~~~-~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  557 (808)
                      .+++.+.-||-||||.|=+++.+... .+|+|++++.   .....++...|-.+|...+.|.||+++..+.+....|++|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            34556678999999999998876433 4888888764   3445678889999999999999999999999999999999


Q ss_pred             EecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCC
Q 003599          558 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  637 (808)
Q Consensus       558 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  637 (808)
                      |-|-||.|...|.   .++.++.....-++..+.+|++|||.++   ||.|||||+|.||+.+|-+||.|||+|+.+...
T Consensus       500 EaClGGElWTiLr---dRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g  573 (732)
T KOG0614|consen  500 EACLGGELWTILR---DRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG  573 (732)
T ss_pred             HhhcCchhhhhhh---hcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence            9999999999995   4567888888889999999999999998   999999999999999999999999999988644


Q ss_pred             CCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCccc
Q 003599          638 QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS  717 (808)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  717 (808)
                      .   .+-.++||+.|.|||++.+...+.+.|.||||+++|||++|.+||...+.-...-              +|-+.+.
T Consensus       574 ~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn--------------~ILkGid  636 (732)
T KOG0614|consen  574 R---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYN--------------LILKGID  636 (732)
T ss_pred             C---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHH--------------HHHhhhh
Confidence            3   3445899999999999999999999999999999999999999997544321111              1111111


Q ss_pred             CCcccHHHHHHHHHHHHhcccCCcCCCCC-----HHHHHHH
Q 003599          718 ESSFQLDMIIRCIHVGLLCVQELVKDRPN-----MSTVVSM  753 (808)
Q Consensus       718 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~ev~~~  753 (808)
                      .-.++........+++++.+..+|.+|..     ..+|-+.
T Consensus       637 ~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH  677 (732)
T KOG0614|consen  637 KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH  677 (732)
T ss_pred             hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence            11255556677788999999999999986     5555443

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=6e-28  Score=242.11  Aligned_cols=245  Identities=25%  Similarity=0.365  Sum_probs=198.3

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHHhc-cCCceeeEeeEEEeCCeeEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLI  556 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV  556 (808)
                      ++|.++.+||+|+|..|..++++ ..+.+|+|++++.   ..+.++-...|..+..+- +||.+|.+..++..+...++|
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv  329 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV  329 (593)
T ss_pred             ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence            57888999999999999999976 4678999998764   345566677788888776 799999999999999999999


Q ss_pred             EEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCC
Q 003599          557 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  636 (808)
Q Consensus       557 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  636 (808)
                      .||+++|+|--+++   +...+++....-+..+|.-||.|||+.+   |+.||||..|||||..|.+||+|+|+.+.-..
T Consensus       330 ieyv~ggdlmfhmq---rqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~  403 (593)
T KOG0695|consen  330 IEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG  403 (593)
T ss_pred             EEEecCcceeeehh---hhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCC
Confidence            99999999987775   3456888888889999999999999999   99999999999999999999999999985322


Q ss_pred             CCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCC---CchhhhhhhhhhhccccchhccC
Q 003599          637 NQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFE---DDLTILGYAWKLWNENKILALVD  713 (808)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~d  713 (808)
                        ....+..++||+.|.|||++.+..|....|.|+|||+++||+.|+.||+...   .+++-..+.....-        +
T Consensus       404 --~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvil--------e  473 (593)
T KOG0695|consen  404 --PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVIL--------E  473 (593)
T ss_pred             --CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHh--------h
Confidence              2334556899999999999999999999999999999999999999997543   22333333322221        2


Q ss_pred             CcccCCcccHHHHHHHHHHHHhcccCCcCCCC
Q 003599          714 PFLSESSFQLDMIIRCIHVGLLCVQELVKDRP  745 (808)
Q Consensus       714 ~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RP  745 (808)
                      ..+.   .+.....+...+.+.-|.+||.+|.
T Consensus       474 kqir---iprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  474 KQIR---IPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             hccc---ccceeehhhHHHHHHhhcCCcHHhc
Confidence            2221   2233345566778888999999985

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.95  E-value=1.1e-26  Score=234.33  Aligned_cols=210  Identities=37%  Similarity=0.602  Sum_probs=183.1

Q ss_pred             ccccCceeEEEEEecC-CcEEEEEEecccccc-cHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEecCCCCchh
Q 003599          490 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQ-GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDA  567 (808)
Q Consensus       490 lG~G~~g~Vy~~~~~~-~~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~  567 (808)
                      ||+|.+|.||++...+ ++.+++|++...... ..+.+.+|+..++.++|++|+++++++......++++|++++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999864 899999998754332 35789999999999999999999999999999999999999999999


Q ss_pred             hccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCC-CCCeeeeccccceecCCCCCcccccce
Q 003599          568 LLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE-ELNPKISDFGMAKIFGGNQDQADTGRV  646 (808)
Q Consensus       568 ~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~  646 (808)
                      ++...  ...+++..+..++.++++++.+||+.+   ++|+||+|.||+++. ++.++|+|||.+........  .....
T Consensus        81 ~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~  153 (215)
T cd00180          81 LLKEN--EGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI  153 (215)
T ss_pred             HHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence            98542  146889999999999999999999998   999999999999999 89999999999987643321  12224


Q ss_pred             eccCCccChhhhccC-CCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCcccHHH
Q 003599          647 VGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDM  725 (808)
Q Consensus       647 ~gt~~y~aPE~~~~~-~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  725 (808)
                      .+...|++||..... ..+.+.|+|++|+++++|                                              
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------  187 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------  187 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence            578899999999877 788999999999999999                                              


Q ss_pred             HHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          726 IIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       726 ~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                       ..+.+++..|++.+|++||++.++++.
T Consensus       188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 -PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             -HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence             466789999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.2e-28  Score=241.10  Aligned_cols=262  Identities=22%  Similarity=0.290  Sum_probs=193.4

Q ss_pred             cccCcccccCceeEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHHhccCCceeeEeeEEEeC-----CeeEEE
Q 003599          485 QLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG-----EEKMLI  556 (808)
Q Consensus       485 ~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~lV  556 (808)
                      +-.+.||.|+||.||...+. +|+.||+|++...  .-...+.+.+|+++|..++|.|++..++...-.     .+.|+|
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            34579999999999998865 7999999998643  223457899999999999999999888775432     346788


Q ss_pred             EEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCC
Q 003599          557 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  636 (808)
Q Consensus       557 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  636 (808)
                      .|.| ..+|...+-.   .+.++-..+.-++.||++||.|||+.+   |.||||||.|.|++.|-.+||+|||++|..+.
T Consensus       136 TELm-QSDLHKIIVS---PQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~  208 (449)
T KOG0664|consen  136 TELM-QSDLHKIIVS---PQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ  208 (449)
T ss_pred             HHHH-Hhhhhheecc---CCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence            8888 4588887743   457888889999999999999999998   99999999999999999999999999998765


Q ss_pred             CCCcccccceeccCCccChhhhccC-CCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhh-----------c
Q 003599          637 NQDQADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLW-----------N  704 (808)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~-----------~  704 (808)
                      ++....+. .+-|..|.|||++++. .|+.+.||||.|||+.||+..+..|.....-+.+ ++....+           -
T Consensus       209 d~~~hMTq-EVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL-~lItdLLGTPs~EaMr~AC  286 (449)
T KOG0664|consen  209 RDRLNMTH-EVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQL-QMIIDLLGTPSQEAMKYAC  286 (449)
T ss_pred             hhhhhhHH-HHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHH-HHHHHHhCCCcHHHHHHHh
Confidence            55444443 4568999999999876 4899999999999999999888766543321111 1111111           1


Q ss_pred             cccchhccCCcccCC--------cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHh
Q 003599          705 ENKILALVDPFLSES--------SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN  755 (808)
Q Consensus       705 ~~~~~~~~d~~l~~~--------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~  755 (808)
                      +|.-..++.......        ....+.-.+-..+..+++..+|++|.+..+.+..+.
T Consensus       287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~  345 (449)
T KOG0664|consen  287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY  345 (449)
T ss_pred             hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence            121111221111111        011122344566777889999999999888877663

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=3.3e-27  Score=253.98  Aligned_cols=203  Identities=25%  Similarity=0.368  Sum_probs=172.2

Q ss_pred             cCCcccCcccccCceeEEEEEe-cCCcEEEEEEeccc---ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRL-KDGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  557 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  557 (808)
                      .-|..++.||-|+||+|.+++- +....+|+|.+++.   ........+.|-.||+.-..+=||+|+..|.+.+.+|+||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            4577788999999999999864 44677999999875   3445667889999999999999999999999999999999


Q ss_pred             EecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCC
Q 003599          558 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  637 (808)
Q Consensus       558 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~  637 (808)
                      +|++||++-.+|.   +.+.+.+....-++.++..|+++.|..|   +|||||||.|||||.+|.+||+||||+.-+.-.
T Consensus       709 dYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT  782 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  782 (1034)
T ss_pred             eccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceec
Confidence            9999999999885   4566777777888999999999999988   999999999999999999999999998754100


Q ss_pred             --------CCcc--------------------------------cccceeccCCccChhhhccCCCCccccEEehhHHHH
Q 003599          638 --------QDQA--------------------------------DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL  677 (808)
Q Consensus       638 --------~~~~--------------------------------~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~  677 (808)
                              .+..                                .....+||+.|+|||++....++..+|.||.|||||
T Consensus       783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~  862 (1034)
T KOG0608|consen  783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY  862 (1034)
T ss_pred             cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence                    0000                                001246999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCC
Q 003599          678 EIVSGRKNTSFFE  690 (808)
Q Consensus       678 elltG~~p~~~~~  690 (808)
                      ||+.|+.||-...
T Consensus       863 em~~g~~pf~~~t  875 (1034)
T KOG0608|consen  863 EMLVGQPPFLADT  875 (1034)
T ss_pred             HHhhCCCCccCCC
Confidence            9999999986544

>cd00028 B_lectin Bulb-type mannose-specific lectin

Probab=99.94  E-value=2.6e-26  Score=209.25  Aligned_cols=115  Identities=43%  Similarity=0.734  Sum_probs=103.5

Q ss_pred             cccCCCCeEEeCCCeeEEEEecCCCCCceEEEEEeecCCCceEEEEecCCCCCCCCcceEEEecCCcEEEEcCCCcEEEe
Q 003599           30 QLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWS  109 (808)
Q Consensus        30 ~~l~~~~~l~S~~g~F~lgF~~~~~~~~~ylgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~G~L~l~~~~~~~vWs  109 (808)
                      ++|.++++|+|++|.|++|||.+......+.+|||++++ +++||.|||+.|. ...+.|.|+.||+|+|.|.+|.++|+
T Consensus         2 ~~l~~~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~-~~~vW~snt~~~~-~~~~~l~l~~dGnLvl~~~~g~~vW~   79 (116)
T cd00028           2 NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSS-RTVVWVANRDNPS-GSSCTLTLQSDGNLVIYDGSGTVVWS   79 (116)
T ss_pred             cCcCCCCEEEeCCCcEEEecccCCCCCCeEEEEEEeCCC-CeEEEECCCCCCC-CCCEEEEEecCCCeEEEcCCCcEEEE
Confidence            578999999999999999999987664479999999887 8999999999994 45688999999999999999999999


Q ss_pred             eccccccccceEEEEecCCCEEEEecccCceEecccCCC
Q 003599          110 SNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQEP  148 (808)
Q Consensus       110 t~~~~~~~~~~~a~LldsGNlVl~~~~~~~~lWqSFd~P  148 (808)
                      |++++ ..+..+|+|+|+|||||++. ++.++|||||||
T Consensus        80 S~~~~-~~~~~~~~L~ddGnlvl~~~-~~~~~W~Sf~~P  116 (116)
T cd00028          80 SNTTR-VNGNYVLVLLDDGNLVLYDS-DGNFLWQSFDYP  116 (116)
T ss_pred             ecccC-CCCceEEEEeCCCCEEEECC-CCCEEEcCCCCC
Confidence            99876 35677899999999999997 588999999999

The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses.

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.94  E-value=4.4e-27  Score=225.12  Aligned_cols=256  Identities=19%  Similarity=0.338  Sum_probs=194.2

Q ss_pred             hcCCcccCcccccCceeEEEEE-ecCCcEEEEEEecccccccHHHHHHHHHHHHhcc-CCceeeEeeEEEeC--CeeEEE
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEG--EEKMLI  556 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lV  556 (808)
                      .++|++.+++|+|-+++||.|. ..+++.++||.++.   ...+.+.+|+.+|+.|. ||||+++++...+.  ....||
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            4789999999999999999997 45688999999964   34577889999999997 99999999998764  456899


Q ss_pred             EEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCC-CCeeeeccccceecC
Q 003599          557 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE-LNPKISDFGMAKIFG  635 (808)
Q Consensus       557 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~-~~~kl~DFGla~~~~  635 (808)
                      +||+.+.+...+-      +.++...+...+.++++||.|+|+.|   |+|||+||.|++||.. ..++|+|+|+|.+..
T Consensus       114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH  184 (338)
T KOG0668|consen  114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  184 (338)
T ss_pred             hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence            9999998776544      34777788889999999999999998   9999999999999854 569999999999876


Q ss_pred             CCCCcccccceeccCCccChhhhccC-CCCccccEEehhHHHHHHHhCCCCCCCCCCch-hhhhhhhhhhccccchh---
Q 003599          636 GNQDQADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDL-TILGYAWKLWNENKILA---  710 (808)
Q Consensus       636 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwSlGvil~elltG~~p~~~~~~~~-~~~~~~~~~~~~~~~~~---  710 (808)
                      +..+..   ..+.+..|--||.+.+- .++..-|+|||||+|..|+-.+.||-...++. .++..+. .+.-..+..   
T Consensus       185 p~~eYn---VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIak-VLGt~el~~Yl~  260 (338)
T KOG0668|consen  185 PGKEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAK-VLGTDELYAYLN  260 (338)
T ss_pred             CCceee---eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHH-HhChHHHHHHHH
Confidence            554332   34567888999998654 47889999999999999999999986555432 3332222 221111111   


Q ss_pred             ----ccCCcccC--------C------cccHH-HHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          711 ----LVDPFLSE--------S------SFQLD-MIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       711 ----~~d~~l~~--------~------~~~~~-~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                          .+||....        .      +.... ...+.++++...|..|-.+|||++|...
T Consensus       261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence                12222111        0      00011 1357788899999999999999998654

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.93  E-value=3.8e-27  Score=256.01  Aligned_cols=253  Identities=23%  Similarity=0.339  Sum_probs=203.5

Q ss_pred             hcCCcccCcccccCceeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEe
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  559 (808)
                      .++|.+...+|+|.||.|||+++. .++..|+|.++-.......-..+|+-+++..+|||||.++|.+...+...++|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            468999999999999999999976 6889999999887777888888999999999999999999999999999999999


Q ss_pred             cCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCC
Q 003599          560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  639 (808)
Q Consensus       560 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  639 (808)
                      +.+|+|++.-+-   ..++++.++....++..+|++|||..+   -+|||||-.|||+++.|.+|++|||.+-.+.... 
T Consensus        94 cgggslQdiy~~---TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati-  166 (829)
T KOG0576|consen   94 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI-  166 (829)
T ss_pred             cCCCcccceeee---cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh-
Confidence            999999987653   467889999999999999999999998   7999999999999999999999999987654322 


Q ss_pred             cccccceeccCCccChhhhc---cCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcc
Q 003599          640 QADTGRVVGTFGYMSPEYAM---EGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL  716 (808)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  716 (808)
                       .....+.||+.|||||+..   .+.|..++|||++|+...|+-.-++|......-+.+.-+-         ....+|--
T Consensus       167 -~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmT---------kS~~qpp~  236 (829)
T KOG0576|consen  167 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMT---------KSGFQPPT  236 (829)
T ss_pred             -hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhh---------ccCCCCCc
Confidence             2233478999999999874   5668999999999999999988776643222211111111         11122211


Q ss_pred             cCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          717 SESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       717 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      .+  ....-.+.+.++++.|+..+|++||+++.+++
T Consensus       237 lk--Dk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  237 LK--DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             cc--CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            11  11223466788999999999999999987653

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.93  E-value=1.2e-25  Score=230.43  Aligned_cols=199  Identities=35%  Similarity=0.505  Sum_probs=172.4

Q ss_pred             CcccCcccccCceeEEEEEecC-CcEEEEEEecccccc-cHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEecC
Q 003599          484 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQ-GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMP  561 (808)
Q Consensus       484 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  561 (808)
                      |.+.+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++|+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4567899999999999999875 889999999765544 67889999999999999999999999999999999999999


Q ss_pred             CCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCcc
Q 003599          562 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA  641 (808)
Q Consensus       562 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  641 (808)
                      +++|.+++....  ..+++..+..++.+++.++.+||+.+   ++|+||+|.||+++.++.++|+|||.+......... 
T Consensus        81 ~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-  154 (225)
T smart00221       81 GGDLFDYLRKKG--GKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-  154 (225)
T ss_pred             CCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-
Confidence            999999986421  11889999999999999999999987   999999999999999999999999999876543211 


Q ss_pred             cccceeccCCccChhhh-ccCCCCccccEEehhHHHHHHHhCCCCCCC
Q 003599          642 DTGRVVGTFGYMSPEYA-MEGRFSEKSDVFSFGVLLLEIVSGRKNTSF  688 (808)
Q Consensus       642 ~~~~~~gt~~y~aPE~~-~~~~~s~k~DvwSlGvil~elltG~~p~~~  688 (808)
                      ......++..|++||.+ ....++.++|+|+||++++||++|+.||+.
T Consensus       155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            22235678899999998 666778899999999999999999999853

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.93  E-value=1.3e-26  Score=247.87  Aligned_cols=196  Identities=26%  Similarity=0.399  Sum_probs=166.2

Q ss_pred             cCCcccCcccccCceeEEEEEecC-CcEEEEEEecccc--------cccHHHHHHHHHHHHhcc---CCceeeEeeEEEe
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKAS--------GQGLEEFMNEVMVISKLQ---HRNLVRLLGCCVE  549 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vAvK~l~~~~--------~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~  549 (808)
                      .+|..++.+|+|+||.|+.+.++. ...|+||.+.+..        ....-..-.|+.+|..++   |+||+|++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            458999999999999999999875 5678899886642        111122345999999997   9999999999999


Q ss_pred             CCeeEEEEEec-CCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeecc
Q 003599          550 GEEKMLIYEYM-PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDF  628 (808)
Q Consensus       550 ~~~~~lV~E~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DF  628 (808)
                      ++..+|+||-. ++.+|.+++.   .++.+++.+..-|++|++.|+++||+.+   |||||||-+||+++.+|-+||+||
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE---~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf  714 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIE---FKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF  714 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhh---ccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence            99999999975 4667888884   3567999999999999999999999999   999999999999999999999999


Q ss_pred             ccceecCCCCCcccccceeccCCccChhhhccCCC-CccccEEehhHHHHHHHhCCCCCC
Q 003599          629 GMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRF-SEKSDVFSFGVLLLEIVSGRKNTS  687 (808)
Q Consensus       629 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DvwSlGvil~elltG~~p~~  687 (808)
                      |.+......    ....++||.+|.|||++.+.+| ...-|||++|++||-++....|+.
T Consensus       715 gsaa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  715 GSAAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             cchhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            998765332    2334789999999999998887 567899999999999998887763

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.93  E-value=3.3e-26  Score=230.08  Aligned_cols=296  Identities=19%  Similarity=0.211  Sum_probs=203.6

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHHhccCCceeeEeeEEEeC------Ce
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG------EE  552 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~  552 (808)
                      .+|.-++.+|.|.- .|-.+.+. .+++||+|++...  .....++..+|...+..++|+||++++.++.-.      .+
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            46777788999888 55555443 5899999988653  334567778999999999999999999998744      35


Q ss_pred             eEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccce
Q 003599          553 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK  632 (808)
Q Consensus       553 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~  632 (808)
                      .++|||+|. .+|...++.     .++-..+..|..|++.|+.|||+.+   |+||||||+||++..+..+||.|||+++
T Consensus        96 ~y~v~e~m~-~nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar  166 (369)
T KOG0665|consen   96 VYLVMELMD-ANLCQVILM-----ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR  166 (369)
T ss_pred             HHHHHHhhh-hHHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence            689999994 588887752     4677788899999999999999998   9999999999999999999999999998


Q ss_pred             ecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCc------------------hh
Q 003599          633 IFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDD------------------LT  694 (808)
Q Consensus       633 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~------------------~~  694 (808)
                      .-...   -.....+.|..|.|||++.+..+.+..||||+||++.||++|+..|.....-                  ..
T Consensus       167 ~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q  243 (369)
T KOG0665|consen  167 TEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ  243 (369)
T ss_pred             ccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence            64332   2334467899999999999888999999999999999999999877533210                  00


Q ss_pred             hhhhhhhhhcc-c-----cchhc-cCCcccCC-cccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhh-cc---cCCC
Q 003599          695 ILGYAWKLWNE-N-----KILAL-VDPFLSES-SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS-EI---RDLP  762 (808)
Q Consensus       695 ~~~~~~~~~~~-~-----~~~~~-~d~~l~~~-~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~-~~---~~~~  762 (808)
                      +...+...... .     ...+. .|...... ..+.-......+++.+||..+|++|-+.+++++.=-- ++   ++.+
T Consensus       244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~~ev~  323 (369)
T KOG0665|consen  244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDPDEVE  323 (369)
T ss_pred             hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeeccccccc
Confidence            00111111110 0     00000 11111000 0111123345678899999999999999999875311 11   2233


Q ss_pred             CCCCCCcccCCCCCCchhHHHHHHHHHHH
Q 003599          763 YPKEPAFTERQGADDSESFKQIQQRILLM  791 (808)
Q Consensus       763 ~p~~p~~~~~~~~~~~~~~~~~~~~~~~~  791 (808)
                      .|+.| ...+.....+.+..+..++|...
T Consensus       324 ap~pe-~~d~~~d~~~~t~~e~ke~If~e  351 (369)
T KOG0665|consen  324 APPPE-IYDKQLDEREHTIEEWKELIFKE  351 (369)
T ss_pred             CCCCc-hhhhhcccccCCHHHHHHHHHHH
Confidence            33333 22233444444455555555443

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.93  E-value=5.5e-26  Score=222.88  Aligned_cols=252  Identities=19%  Similarity=0.345  Sum_probs=186.5

Q ss_pred             hcCCcccCcccccCceeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHHhc-cCCceeeEeeE-EEeCCeeEEEE
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLVRLLGC-CVEGEEKMLIY  557 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~-~~~~~~~~lV~  557 (808)
                      .+.|.+.+.||+|.||.+.+++.+ +.+.+++|-+.+. ....++|.+|...--.| .|.||+.-++. +...+..++++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            356888999999999999999987 5778999988654 34578899998776666 68999987754 55667778899


Q ss_pred             EecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeC--CCCCeeeeccccceecC
Q 003599          558 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD--EELNPKISDFGMAKIFG  635 (808)
Q Consensus       558 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~--~~~~~kl~DFGla~~~~  635 (808)
                      ||++.|+|.+-+.    ...+.+.-..+++.|++.||.|||+++   +||||||.+||||-  +..++||||||+.+..+
T Consensus       102 E~aP~gdL~snv~----~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen  102 EFAPRGDLRSNVE----AAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             ccCccchhhhhcC----cccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence            9999999988773    345777888899999999999999998   99999999999993  44579999999998654


Q ss_pred             CCCCcccccceeccCCccChhhhccC-----CCCccccEEehhHHHHHHHhCCCCCCCCC-Cchhhhhhhhhhhccccch
Q 003599          636 GNQDQADTGRVVGTFGYMSPEYAMEG-----RFSEKSDVFSFGVLLLEIVSGRKNTSFFE-DDLTILGYAWKLWNENKIL  709 (808)
Q Consensus       636 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~k~DvwSlGvil~elltG~~p~~~~~-~~~~~~~~~~~~~~~~~~~  709 (808)
                      ..-..     ..-+..|.|||.....     ...+.+|||.||++++.++||+.|+.... .+...  |-+..|..+...
T Consensus       175 ~tV~~-----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y--~~~~~w~~rk~~  247 (378)
T KOG1345|consen  175 TTVKY-----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPY--WEWEQWLKRKNP  247 (378)
T ss_pred             ceehh-----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchH--HHHHHHhcccCc
Confidence            32222     2346789999987432     24678999999999999999999986321 12221  223334333333


Q ss_pred             hccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHH
Q 003599          710 ALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML  754 (808)
Q Consensus       710 ~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L  754 (808)
                      .+.+..-       -..+++.++.++-+..+|++|=...++.++.
T Consensus       248 ~~P~~F~-------~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r  285 (378)
T KOG1345|consen  248 ALPKKFN-------PFSEKALRLFKKSLTPRFKDRCKIWTAKKMR  285 (378)
T ss_pred             cCchhhc-------ccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence            2222111       1234667778888999999995555555444

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=3.2e-25  Score=233.70  Aligned_cols=131  Identities=27%  Similarity=0.430  Sum_probs=111.0

Q ss_pred             cCCcccCcccccCceeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHHhcc-----C---CceeeEeeEEEe---
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-----H---RNLVRLLGCCVE---  549 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-----H---~niv~l~g~~~~---  549 (808)
                      .+|.+.++||-|-|++||++.+. ..+.||+|+.+.. ..-.+.-+.|+++|++++     |   .+||++++.|..   
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            67999999999999999999865 5789999998543 334566788999999994     3   359999999974   


Q ss_pred             -CCeeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEe
Q 003599          550 -GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL  617 (808)
Q Consensus       550 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl  617 (808)
                       +.+.++|+|++ |.+|..+|... .-+.++...+.+|++||+.||.|||.++  +|||-||||+|||+
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence             56899999999 66887877543 4456889999999999999999999998  69999999999998

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.92  E-value=8.1e-26  Score=238.89  Aligned_cols=264  Identities=19%  Similarity=0.227  Sum_probs=202.5

Q ss_pred             HhcCCcccCcccccCceeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHHhcc------CCceeeEeeEEEeCCe
Q 003599          480 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ------HRNLVRLLGCCVEGEE  552 (808)
Q Consensus       480 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~------H~niv~l~g~~~~~~~  552 (808)
                      .-.+|.+....|+|-|++|.+|.+. .|+.||||+++.. +...+.=+.|+++|++|+      .-|.++++..|...++
T Consensus       430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH  508 (752)
T KOG0670|consen  430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH  508 (752)
T ss_pred             hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence            4467888899999999999999876 4889999999654 333455568999999995      3589999999999999


Q ss_pred             eEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCC-Ceeeeccccc
Q 003599          553 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL-NPKISDFGMA  631 (808)
Q Consensus       553 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~-~~kl~DFGla  631 (808)
                      +|||+|-+ ..+|.+.|......-.|....+..++.|+.-||..|...+   |+|.||||.||||++.. .+||||||.|
T Consensus       509 LClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA  584 (752)
T KOG0670|consen  509 LCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSA  584 (752)
T ss_pred             eEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCccc
Confidence            99999988 5689999977656667888999999999999999999888   99999999999999765 5899999999


Q ss_pred             eecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhh-------hhhhhc
Q 003599          632 KIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGY-------AWKLWN  704 (808)
Q Consensus       632 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~-------~~~~~~  704 (808)
                      .....+.-    ....-+.-|.|||++.+.+|+...|+||.||.||||.||+..|+...++.-+.-+       ...++.
T Consensus       585 ~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlR  660 (752)
T KOG0670|consen  585 SFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLR  660 (752)
T ss_pred             cccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhh
Confidence            86644322    1234467899999999999999999999999999999999988766543221100       011111


Q ss_pred             cc---------------------------cchhccCC------cccC----CcccHHHHHHHHHHHHhcccCCcCCCCCH
Q 003599          705 EN---------------------------KILALVDP------FLSE----SSFQLDMIIRCIHVGLLCVQELVKDRPNM  747 (808)
Q Consensus       705 ~~---------------------------~~~~~~d~------~l~~----~~~~~~~~~~l~~li~~cl~~~P~~RPs~  747 (808)
                      .+                           .++..+.|      .+.+    ..-....+..+.+|...|+..||++|.|.
T Consensus       661 KgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~  740 (752)
T KOG0670|consen  661 KGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITV  740 (752)
T ss_pred             hcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCH
Confidence            11                           11111222      1111    01223456788899999999999999999


Q ss_pred             HHHHH
Q 003599          748 STVVS  752 (808)
Q Consensus       748 ~ev~~  752 (808)
                      .+.++
T Consensus       741 nqAL~  745 (752)
T KOG0670|consen  741 NQALK  745 (752)
T ss_pred             HHHhc
Confidence            88764

>smart00108 B_lectin Bulb-type mannose-specific lectin

Probab=99.92  E-value=1.3e-24  Score=197.55  Aligned_cols=113  Identities=42%  Similarity=0.712  Sum_probs=100.9

Q ss_pred             cccCCCCeEEeCCCeeEEEEecCCCCCceEEEEEeecCCCceEEEEecCCCCCCCCcceEEEecCCcEEEEcCCCcEEEe
Q 003599           30 QLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWS  109 (808)
Q Consensus        30 ~~l~~~~~l~S~~g~F~lgF~~~~~~~~~ylgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~G~L~l~~~~~~~vWs  109 (808)
                      +.|.++++|+|++|.|++|||.+... ..+.+|||++.+ +++||.|||+.|+.+ ++.|.++.||+|+|.+.+|.++|+
T Consensus         2 ~~l~~~~~l~s~~~~f~~G~~~~~~q-~dgnlV~~~~~~-~~~vW~snt~~~~~~-~~~l~l~~dGnLvl~~~~g~~vW~   78 (114)
T smart00108        2 NTLSSGQTLVSGNSLFELGFFTLIMQ-NDYNLILYKSSS-RTVVWVANRDNPVSD-SCTLTLQSDGNLVLYDGDGRVVWS   78 (114)
T ss_pred             cccCCCCEEecCCCcEeeeccccCCC-CCEEEEEEECCC-CcEEEECCCCCCCCC-CEEEEEeCCCCEEEEeCCCCEEEE
Confidence            56889999999999999999998755 569999999987 899999999999865 478999999999999999999999


Q ss_pred             eccccccccceEEEEecCCCEEEEecccCceEecccCC
Q 003599          110 SNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQE  147 (808)
Q Consensus       110 t~~~~~~~~~~~a~LldsGNlVl~~~~~~~~lWqSFd~  147 (808)
                      |+++ ...+..+|+|+|+|||||++. .+.++||||||
T Consensus        79 S~t~-~~~~~~~~~L~ddGnlvl~~~-~~~~~W~Sf~~  114 (114)
T smart00108       79 SNTT-GANGNYVLVLLDDGNLVIYDS-DGNFLWQSFDY  114 (114)
T ss_pred             eccc-CCCCceEEEEeCCCCEEEECC-CCCEEeCCCCC
Confidence            9987 235677899999999999997 57899999997

>PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation

Probab=99.92  E-value=5.4e-25  Score=198.30  Aligned_cols=99  Identities=47%  Similarity=0.957  Sum_probs=91.1

Q ss_pred             EecCCCCCcccccccccceeeeeeEEeeeCC-----------CCceEEEEEcccceEEEEEeecCCCceEEEEEecccCC
Q 003599          206 WRSGPWNGQIFIGIPELKSVYLFRHNFTFGF-----------ANDWTFFALTAQGILEERIWIKWKDNWEVGFLNLRTEC  274 (808)
Q Consensus       206 w~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~l~~~G~l~~~~w~~~~~~W~~~~~~p~~~C  274 (808)
                      ||+|+|||..|+++|+|.....+.+.|+.+.           ...++|++||.+|+++++.|++..++|.+.|.+|.++|
T Consensus         1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~~~e~~~t~~~~~~s~~~r~~ld~~G~l~~~~w~~~~~~W~~~~~~p~d~C   80 (110)
T PF00954_consen    1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSNNEEVYYTYSLSNSSVLSRLVLDSDGQLQRYIWNESTQSWSVFWSAPKDQC   80 (110)
T ss_pred             CCccccCCeEECCcccccccceeEEEEEECCCeEEEEEecCCCceEEEEEEeeeeEEEEEEEecCCCcEEEEEEecccCC
Confidence            8999999999999999998778887777665           12389999999999999999999999999999999999


Q ss_pred             CCCCCCCCCccccCCCCCcccccCCCCcCC
Q 003599          275 DVYGKCGAFGICNSQEKPICSCLEGFEPKN  304 (808)
Q Consensus       275 d~~g~CG~~g~C~~~~~~~C~C~~Gf~~~~  304 (808)
                      |+|+.||+||+|+.+..|.|+||+||+|++
T Consensus        81 d~y~~CG~~g~C~~~~~~~C~Cl~GF~P~n  110 (110)
T PF00954_consen   81 DVYGFCGPNGICNSNNSPKCSCLPGFEPKN  110 (110)
T ss_pred             CCccccCCccEeCCCCCCceECCCCcCCCc
Confidence            999999999999988889999999999974

This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.92  E-value=8.8e-25  Score=228.06  Aligned_cols=266  Identities=21%  Similarity=0.358  Sum_probs=197.6

Q ss_pred             HHHHhcCCcccCcccccCceeEEEEEec----CCcEEEEEEecccccccHHHHHHHHHHHHhcc-CCceeeEeeEEEeCC
Q 003599          477 LATATNNFQLSSKLGQGGFGPVYWGRLK----DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGE  551 (808)
Q Consensus       477 l~~~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~  551 (808)
                      +....+.|..+++||+|.|++||++.+.    ..+.||+|.+...+.  .....+|++.|..+. |.||+++.+++..++
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            3445567899999999999999999864    367899999876543  366889999999994 999999999999999


Q ss_pred             eeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCC-CCCeeeecccc
Q 003599          552 EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE-ELNPKISDFGM  630 (808)
Q Consensus       552 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~-~~~~kl~DFGl  630 (808)
                      ...+|+||+++....++...      ++..++..+++.+.+||+++|..|   ||||||||+|+|.+. .+.-.|.|||+
T Consensus       109 ~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL  179 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL  179 (418)
T ss_pred             eeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence            99999999999998888743      668889999999999999999999   999999999999975 56689999999


Q ss_pred             ceecCCCC------------------------------------------CcccccceeccCCccChhhhcc-CCCCccc
Q 003599          631 AKIFGGNQ------------------------------------------DQADTGRVVGTFGYMSPEYAME-GRFSEKS  667 (808)
Q Consensus       631 a~~~~~~~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~  667 (808)
                      |......+                                          .........||++|.|||++.. ...+++.
T Consensus       180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai  259 (418)
T KOG1167|consen  180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI  259 (418)
T ss_pred             HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence            98321000                                          0001112459999999999864 5578999


Q ss_pred             cEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhc----------ccc--ch---------hc------cC-Cc----
Q 003599          668 DVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN----------ENK--IL---------AL------VD-PF----  715 (808)
Q Consensus       668 DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~----------~~~--~~---------~~------~d-~~----  715 (808)
                      ||||-|||++-+++++.||-...++...+......+.          .|.  +.         +.      ++ ..    
T Consensus       260 Diws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~  339 (418)
T KOG1167|consen  260 DIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS  339 (418)
T ss_pred             ceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence            9999999999999999998654433222111111110          111  00         00      00 00    


Q ss_pred             ----ccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          716 ----LSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       716 ----l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                          .............+.++..+|+..||.+|-|+++.++.
T Consensus       340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence                00111122234478899999999999999999997653

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.90  E-value=9.7e-25  Score=264.91  Aligned_cols=197  Identities=19%  Similarity=0.207  Sum_probs=140.0

Q ss_pred             hccC-CceeeEeeEE-------EeCCeeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcE
Q 003599          534 KLQH-RNLVRLLGCC-------VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI  605 (808)
Q Consensus       534 ~l~H-~niv~l~g~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i  605 (808)
                      .++| +||+++++++       .+....++++|++ +++|.++|..  ....+++.+++.++.||++||+|||+++   |
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---I  101 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHSQG---I  101 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            4556 6888888877       2334567788987 6699999964  2356999999999999999999999988   9


Q ss_pred             EeCCCCCCceEeCC-------------------CCCeeeeccccceecCCCCC--------------cccccceeccCCc
Q 003599          606 IHRDLKASNILLDE-------------------ELNPKISDFGMAKIFGGNQD--------------QADTGRVVGTFGY  652 (808)
Q Consensus       606 vH~Dikp~NILl~~-------------------~~~~kl~DFGla~~~~~~~~--------------~~~~~~~~gt~~y  652 (808)
                      +||||||+||||+.                   ++.+||+|||+++.......              ........||+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            99999999999954                   45567777777764321000              0001113578899


Q ss_pred             cChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCcccHHHHHHHHHH
Q 003599          653 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHV  732 (808)
Q Consensus       653 ~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l  732 (808)
                      ||||++.+..++.++|||||||+||||++|..|+.....  ......     .    ..+.+..      .....+...+
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~-----~----~~~~~~~------~~~~~~~~~~  244 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLR-----H----RVLPPQI------LLNWPKEASF  244 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHH-----H----hhcChhh------hhcCHHHHHH
Confidence            999999999999999999999999999998877532110  100000     0    0111111      1112345678


Q ss_pred             HHhcccCCcCCCCCHHHHHHH
Q 003599          733 GLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       733 i~~cl~~~P~~RPs~~ev~~~  753 (808)
                      +.+||+.+|.+||+|.||++.
T Consensus       245 ~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        245 CLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             HHHhCCCChhhCcChHHHhhc
Confidence            889999999999999999874

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.89  E-value=2.8e-23  Score=205.08  Aligned_cols=167  Identities=21%  Similarity=0.162  Sum_probs=125.6

Q ss_pred             CCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCccc
Q 003599          563 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD  642 (808)
Q Consensus       563 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  642 (808)
                      |+|.+++..  ....+++.++..|+.||++||.|||+.+         ||+|||++.++.+|+  ||+++......    
T Consensus         1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~----   63 (176)
T smart00750        1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ----   63 (176)
T ss_pred             CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence            688888854  2456999999999999999999999875         999999999999999  99998754321    


Q ss_pred             ccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCccc
Q 003599          643 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQ  722 (808)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  722 (808)
                         ..||+.|+|||.+.+..++.++|||||||++|||++|+.|+...................      .++..  ....
T Consensus        64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~------~~~~~--~~~~  132 (176)
T smart00750       64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPA------DDPRD--RSNL  132 (176)
T ss_pred             ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhcc------CCccc--cccH
Confidence               257899999999999999999999999999999999999985432211111111000000      00000  0011


Q ss_pred             HHHHH--HHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003599          723 LDMII--RCIHVGLLCVQELVKDRPNMSTVVSMLNSE  757 (808)
Q Consensus       723 ~~~~~--~l~~li~~cl~~~P~~RPs~~ev~~~L~~~  757 (808)
                      .....  ++.+++.+|++.+|++||++.++++.+...
T Consensus       133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence            22223  689999999999999999999999988654

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=1.8e-22  Score=218.55  Aligned_cols=176  Identities=19%  Similarity=0.217  Sum_probs=134.6

Q ss_pred             HHHhcCCcccCcccccCceeEEEEEec--CCcEEEEEEeccc-----ccccHHHHHHHHHHHHhccCCceee-EeeEEEe
Q 003599          478 ATATNNFQLSSKLGQGGFGPVYWGRLK--DGQEIAVKRLSKA-----SGQGLEEFMNEVMVISKLQHRNLVR-LLGCCVE  549 (808)
Q Consensus       478 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vAvK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~-l~g~~~~  549 (808)
                      ....++|.+.+.||+|+||+||+|..+  +++.||||++...     .....+.|.+|+++|++++|+|+++ ++..   
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---   90 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---   90 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence            344578999999999999999999875  4777899987533     1223567899999999999999985 4432   


Q ss_pred             CCeeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCC-CCCceEeCCCCCeeeecc
Q 003599          550 GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDL-KASNILLDEELNPKISDF  628 (808)
Q Consensus       550 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Di-kp~NILl~~~~~~kl~DF  628 (808)
                       ...++||||+++++|....    ...      ...++.++++||.|||+.+   |+|||| ||+|||++.++.+||+||
T Consensus        91 -~~~~LVmE~~~G~~L~~~~----~~~------~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDF  156 (365)
T PRK09188         91 -GKDGLVRGWTEGVPLHLAR----PHG------DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDF  156 (365)
T ss_pred             -CCcEEEEEccCCCCHHHhC----ccc------hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEEC
Confidence             4579999999999996321    111      1467889999999999988   999999 999999999999999999


Q ss_pred             ccceecCCCCCccc------ccceeccCCccChhhhccCC------CCccccEE
Q 003599          629 GMAKIFGGNQDQAD------TGRVVGTFGYMSPEYAMEGR------FSEKSDVF  670 (808)
Q Consensus       629 Gla~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~------~s~k~Dvw  670 (808)
                      |+++.+........      .....+++.|+|||.+...+      .+..+|-|
T Consensus       157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             ccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            99998754322111      12356888999999885432      23346666

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=1.5e-21  Score=211.93  Aligned_cols=263  Identities=22%  Similarity=0.286  Sum_probs=196.7

Q ss_pred             CCcccCcccccCceeEEEEEecCC--cEEEEEEecccccccHHHHHHHHHHHHhccC----CceeeEeeEE-EeCCeeEE
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLKDG--QEIAVKRLSKASGQGLEEFMNEVMVISKLQH----RNLVRLLGCC-VEGEEKML  555 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~~~--~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H----~niv~l~g~~-~~~~~~~l  555 (808)
                      +|.+.++||+|+||.||++...+.  ..+|+|............+..|..++..+.+    +++.++++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            799999999999999999997653  4789998766543333378889999999873    6899999888 47778899


Q ss_pred             EEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCC-----CCeeeecccc
Q 003599          556 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE-----LNPKISDFGM  630 (808)
Q Consensus       556 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~-----~~~kl~DFGl  630 (808)
                      ||+.+ |.+|.++..... .+.++..+.++|+.|++.+|++||+.+   ++||||||.|+++...     ..+.|.|||+
T Consensus        99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            99988 889999775433 578999999999999999999999998   9999999999999755     4699999999


Q ss_pred             ce--ecCCCCC----cc-c-ccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhh
Q 003599          631 AK--IFGGNQD----QA-D-TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKL  702 (808)
Q Consensus       631 a~--~~~~~~~----~~-~-~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~  702 (808)
                      ++  .+.....    .. . ....+||..|+++..+.+...+.+.|+||++.++.|++.|..|+..............  
T Consensus       174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~--  251 (322)
T KOG1164|consen  174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEK--  251 (322)
T ss_pred             CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHH--
Confidence            99  3322211    11 1 2235699999999999999999999999999999999999999865443222111110  


Q ss_pred             hccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhcccCC
Q 003599          703 WNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDL  761 (808)
Q Consensus       703 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~~~~  761 (808)
                         ........+ .  ....   ..++..+...+-..+..++|....+...|.......
T Consensus       252 ---~~~~~~~~~-~--~~~~---~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  252 ---DPRKLLTDR-F--GDLK---PEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             ---Hhhhhcccc-c--cCCC---hHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence               000011111 0  1112   234445555555589999999999999987765443

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.86  E-value=1.5e-22  Score=198.47  Aligned_cols=248  Identities=23%  Similarity=0.326  Sum_probs=188.6

Q ss_pred             ccCcccccCceeEEEEEecCCcEEEEEEeccc--ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEecCCC
Q 003599          486 LSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNR  563 (808)
Q Consensus       486 ~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g  563 (808)
                      +..+|.+...|+.|+|+++ |..+++|++...  .....++|.+|.-.|+-+.||||+.++|.|....+..+|..||+.|
T Consensus       194 l~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g  272 (448)
T KOG0195|consen  194 LITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG  272 (448)
T ss_pred             hhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence            3457888999999999998 456667776532  3344578999999999999999999999999999999999999999


Q ss_pred             CchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCcccc
Q 003599          564 SLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT  643 (808)
Q Consensus       564 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  643 (808)
                      +|...|++. ..-..+..+..+++.++|+|++|||+..+ -|.---|.+..|+||++.+++|+- +-+++.     ....
T Consensus       273 slynvlhe~-t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarism-ad~kfs-----fqe~  344 (448)
T KOG0195|consen  273 SLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISM-ADTKFS-----FQEV  344 (448)
T ss_pred             HHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheec-ccceee-----eecc
Confidence            999999874 34467888999999999999999999873 244456899999999999988752 111111     0111


Q ss_pred             cceeccCCccChhhhccCCCC---ccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCc
Q 003599          644 GRVVGTFGYMSPEYAMEGRFS---EKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS  720 (808)
Q Consensus       644 ~~~~gt~~y~aPE~~~~~~~s---~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  720 (808)
                       ...-.+.||+||.+...+-+   .++|+|||.++||||.|...||...+.-..-...+.    +     -+.     ..
T Consensus       345 -gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial----e-----glr-----v~  409 (448)
T KOG0195|consen  345 -GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL----E-----GLR-----VH  409 (448)
T ss_pred             -ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh----c-----ccc-----cc
Confidence             12346899999999766533   478999999999999999999975543222111111    1     111     11


Q ss_pred             ccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003599          721 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  757 (808)
Q Consensus       721 ~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~  757 (808)
                      .+......+.+++.-|...||.+||.+..|+-.|++.
T Consensus       410 ippgis~hm~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  410 IPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             CCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence            3344556788899999999999999999999999875

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.84  E-value=6e-20  Score=198.22  Aligned_cols=259  Identities=30%  Similarity=0.404  Sum_probs=197.4

Q ss_pred             CcccCcccccCceeEEEEEecCCcEEEEEEecccccc---cHHHHHHHHHHHHhccCC-ceeeEeeEEEeCCeeEEEEEe
Q 003599          484 FQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQ---GLEEFMNEVMVISKLQHR-NLVRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       484 ~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~---~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lV~E~  559 (808)
                      |.+.+.||.|+||.||++...  ..+++|.+......   ....|.+|+.+++.+.|+ +++++.+.+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            667789999999999999987  78999998765433   377899999999999988 799999999777778999999


Q ss_pred             cCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCC-CeeeeccccceecCCCC
Q 003599          560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL-NPKISDFGMAKIFGGNQ  638 (808)
Q Consensus       560 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~-~~kl~DFGla~~~~~~~  638 (808)
                      +.++++.+++........+.......++.|++.++.|+|..+   ++||||||+||+++..+ .++++|||+++......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999966643211136888899999999999999999998   99999999999999998 79999999998665433


Q ss_pred             Ccc----cccceeccCCccChhhhcc---CCCCccccEEehhHHHHHHHhCCCCCCCCCC---chhhhhhhhhhhccccc
Q 003599          639 DQA----DTGRVVGTFGYMSPEYAME---GRFSEKSDVFSFGVLLLEIVSGRKNTSFFED---DLTILGYAWKLWNENKI  708 (808)
Q Consensus       639 ~~~----~~~~~~gt~~y~aPE~~~~---~~~s~k~DvwSlGvil~elltG~~p~~~~~~---~~~~~~~~~~~~~~~~~  708 (808)
                      ...    ......|+..|+|||.+..   ...+...|+||+|++++++++|..|+.....   ..............   
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---  233 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP---  233 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc---
Confidence            221    2345689999999999987   5788999999999999999999999654432   11111111111100   


Q ss_pred             hhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          709 LALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       709 ~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                        ......... ........+.+++..++..+|..|.++.+....
T Consensus       234 --~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         234 --SLASPLSPS-NPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             --ccccccCcc-ccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence              000000000 001223567788889999999999998887664

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.83  E-value=7.9e-21  Score=183.89  Aligned_cols=261  Identities=20%  Similarity=0.300  Sum_probs=193.1

Q ss_pred             hcCCcccCcccccCceeEEEEE-ecCCcEEEEEEecccccccHHHHHHHHHHHHhccC-CceeeEeeEEEeCCeeEEEEE
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQH-RNLVRLLGCCVEGEEKMLIYE  558 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E  558 (808)
                      .++|.++++||+|+||.+|.|. ..+|.+||||.-+...  ...++.-|.++.+.|+| ..|..+..+..+...-.+||+
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            4689999999999999999997 5689999999875433  33567789999999976 789999999999999999999


Q ss_pred             ecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCC---CCeeeeccccceecC
Q 003599          559 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE---LNPKISDFGMAKIFG  635 (808)
Q Consensus       559 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~---~~~kl~DFGla~~~~  635 (808)
                      .+ |-+|+++..-  -...++..+++-++.|++.-++|+|.++   ++||||||+|+|..-+   ..+.++|||+++.+.
T Consensus        92 LL-GPsLEdLfnf--C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   92 LL-GPSLEDLFNF--CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             cc-CccHHHHHHH--HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence            98 7899887643  2456888999999999999999999998   9999999999999643   458999999999875


Q ss_pred             CCCCc-----ccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchh
Q 003599          636 GNQDQ-----ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILA  710 (808)
Q Consensus       636 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  710 (808)
                      +....     .......||..|.+--.+.+...+...|+=|+|.+|.++.-|..|+..........  -++...+.++.-
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~Q--KyEkI~EkK~s~  243 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQ--KYEKISEKKMST  243 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHH--HHHHHHHhhcCC
Confidence            43222     23334679999999888888888999999999999999999999987544221111  111111111111


Q ss_pred             ccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003599          711 LVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  757 (808)
Q Consensus       711 ~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~  757 (808)
                      .++ .+..     ..+.++.-.+.-|-..--++-|...-+.++..-+
T Consensus       244 ~ie-~LC~-----G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriL  284 (341)
T KOG1163|consen  244 PIE-VLCK-----GFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRIL  284 (341)
T ss_pred             CHH-HHhC-----CCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHH
Confidence            111 1111     1234555556667677777777655554444333

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.82  E-value=6.1e-20  Score=185.51  Aligned_cols=201  Identities=21%  Similarity=0.348  Sum_probs=170.1

Q ss_pred             cCCcccCcccccCceeEEEEEe-cCCcEEEEEEecccccccHHHHHHHHHHHHhcc-CCceeeEeeEEEeCCeeEEEEEe
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRL-KDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~  559 (808)
                      -+|.+.++||+|.||+++.|+. -++++||||.-...+  ...++..|.+..+.|. .++|..++.|-.++.+-.||+|.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            3689999999999999999984 468999999865433  3467788888888884 69999999999999999999999


Q ss_pred             cCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCC-----CCeeeeccccceec
Q 003599          560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE-----LNPKISDFGMAKIF  634 (808)
Q Consensus       560 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~-----~~~kl~DFGla~~~  634 (808)
                      + |-||+++..-  -...++..++..||.|++.-++|+|++.   +|.|||||+|+||...     ..+.|+|||+|+.+
T Consensus       106 L-GPSLEDLFD~--CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  106 L-GPSLEDLFDL--CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             h-CcCHHHHHHH--hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence            8 7788876532  3557999999999999999999999998   9999999999999643     34899999999987


Q ss_pred             CCCCCc-----ccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCC
Q 003599          635 GGNQDQ-----ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFE  690 (808)
Q Consensus       635 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~  690 (808)
                      .+....     .......||.+||+-..+.+.+.+...|+=|||-++++.+-|..|+....
T Consensus       180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK  240 (449)
T KOG1165|consen  180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK  240 (449)
T ss_pred             cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence            543322     23344679999999999999999999999999999999999999997544

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.82  E-value=3.3e-20  Score=186.89  Aligned_cols=172  Identities=13%  Similarity=0.171  Sum_probs=134.0

Q ss_pred             HhcCCcccCcccccCceeEEEEEecCCcEEEEEEecccccccHH---H------HHHHHHHHHhccCCceeeEeeEEEeC
Q 003599          480 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLE---E------FMNEVMVISKLQHRNLVRLLGCCVEG  550 (808)
Q Consensus       480 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~~~~---~------~~~E~~~l~~l~H~niv~l~g~~~~~  550 (808)
                      ..++|++.+.+|.|+||.||.... ++..+|||.++.......+   .      +.+|+..+.+++|++|..+..++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            357899999999999999999766 5778999999764333222   2      67899999999999999999886643


Q ss_pred             --------CeeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCC
Q 003599          551 --------EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELN  622 (808)
Q Consensus       551 --------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~  622 (808)
                              ...+|||||++|.+|.++..       ++.    ....+++.+|..+|+.+   ++||||||+||+++.++ 
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-  172 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-  172 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence                    35789999999999977631       221    34669999999999998   99999999999999988 


Q ss_pred             eeeeccccceecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh
Q 003599          623 PKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS  681 (808)
Q Consensus       623 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt  681 (808)
                      ++|+|||..+........              ..+.....+..++|+|+||+++..+..
T Consensus       173 i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        173 LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHHH
Confidence            999999988754211100              113444456679999999999876643

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.82  E-value=5.8e-20  Score=183.05  Aligned_cols=139  Identities=17%  Similarity=0.176  Sum_probs=108.9

Q ss_pred             cCcccccCceeEEEEEecCCcEEEEEEecccccc--c-------HHHH-----------------HHHHHHHHhccCCce
Q 003599          487 SSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQ--G-------LEEF-----------------MNEVMVISKLQHRNL  540 (808)
Q Consensus       487 ~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~--~-------~~~~-----------------~~E~~~l~~l~H~ni  540 (808)
                      ...||+|+||.||+|...+|+.||||+++.....  .       ...|                 ..|++.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4789999999999999888999999999754211  1       1122                 349999999988776


Q ss_pred             eeEeeEEEeCCeeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHh-HhcCCCcEEeCCCCCCceEeCC
Q 003599          541 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL-HRDSRLRIIHRDLKASNILLDE  619 (808)
Q Consensus       541 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yL-H~~~~~~ivH~Dikp~NILl~~  619 (808)
                      .....+..  ...+|||||++++++.....   ....++..+..+++.|++.+|.|| |+.+   |+||||||+|||++ 
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-  152 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-  152 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence            44333222  23489999999987765432   234688899999999999999999 6777   99999999999998 


Q ss_pred             CCCeeeeccccceec
Q 003599          620 ELNPKISDFGMAKIF  634 (808)
Q Consensus       620 ~~~~kl~DFGla~~~  634 (808)
                      ++.++|+|||++...
T Consensus       153 ~~~v~LiDFG~a~~~  167 (190)
T cd05147         153 DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CCcEEEEEccccccC
Confidence            478999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.81  E-value=9e-21  Score=218.61  Aligned_cols=254  Identities=22%  Similarity=0.281  Sum_probs=186.2

Q ss_pred             ccCcccccCceeEEEEEec-CCcEEEEEEeccc--ccccH----HHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEE
Q 003599          486 LSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGL----EEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  558 (808)
Q Consensus       486 ~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~--~~~~~----~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  558 (808)
                      ..+.+|.|.+|.|+..... .....+.|..+..  .....    ..+..|+-+-..++|+|++..+..+.+.....-+||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            3578999999988776533 3333444433210  11111    125567777788899999888887777666666699


Q ss_pred             ecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCC
Q 003599          559 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  638 (808)
Q Consensus       559 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  638 (808)
                      |+++ +|..++..   ...+...++..++.|++.|+.|||..+   |.|||||++|+++..++.+||+|||.+..+....
T Consensus       402 ~~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~  474 (601)
T KOG0590|consen  402 YCPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPW  474 (601)
T ss_pred             cccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence            9999 99998853   247888899999999999999999999   9999999999999999999999999998775544


Q ss_pred             Cc--ccccceeccCCccChhhhccCCCCc-cccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCc
Q 003599          639 DQ--ADTGRVVGTFGYMSPEYAMEGRFSE-KSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPF  715 (808)
Q Consensus       639 ~~--~~~~~~~gt~~y~aPE~~~~~~~s~-k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  715 (808)
                      +.  .......|+..|+|||.+...+|.+ ..||||.|+++..|++|+.|+.......+..   .    ......-..-.
T Consensus       475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~---~----~~~~~~~~~~~  547 (601)
T KOG0590|consen  475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF---K----TNNYSDQRNIF  547 (601)
T ss_pred             chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch---h----hhccccccccc
Confidence            43  4455578999999999999999866 5899999999999999999986543322211   0    00000000000


Q ss_pred             ccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          716 LSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       716 l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                      ..........+.+...++.++|+.+|.+|-++++|++.
T Consensus       548 ~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d  585 (601)
T KOG0590|consen  548 EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND  585 (601)
T ss_pred             cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence            01111334556788899999999999999999999763

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.80  E-value=4.7e-19  Score=177.10  Aligned_cols=140  Identities=21%  Similarity=0.251  Sum_probs=111.4

Q ss_pred             cCcccccCceeEEEEEecCCcEEEEEEecccccc--c------------------------HHHHHHHHHHHHhccCCce
Q 003599          487 SSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQ--G------------------------LEEFMNEVMVISKLQHRNL  540 (808)
Q Consensus       487 ~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~--~------------------------~~~~~~E~~~l~~l~H~ni  540 (808)
                      ...||+|++|.||+|+..+|+.||||+++.....  .                        ...+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            5789999999999999888999999998754211  0                        1223578999999999987


Q ss_pred             eeEeeEEEeCCeeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHh-cCCCcEEeCCCCCCceEeCC
Q 003599          541 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR-DSRLRIIHRDLKASNILLDE  619 (808)
Q Consensus       541 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~ivH~Dikp~NILl~~  619 (808)
                      .....+...  ..++||||++++++.....   ....++..+..+++.|++.++.+||+ .+   |+||||||+|||++ 
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence            544443332  3489999999886543321   23457788899999999999999999 77   99999999999999 


Q ss_pred             CCCeeeeccccceecC
Q 003599          620 ELNPKISDFGMAKIFG  635 (808)
Q Consensus       620 ~~~~kl~DFGla~~~~  635 (808)
                      ++.++|+|||+++...
T Consensus       153 ~~~~~liDFG~a~~~~  168 (190)
T cd05145         153 DGKPYIIDVSQAVELD  168 (190)
T ss_pred             CCCEEEEEcccceecC
Confidence            8899999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.79  E-value=4.3e-20  Score=211.37  Aligned_cols=248  Identities=19%  Similarity=0.210  Sum_probs=181.5

Q ss_pred             CCcccCcccccCceeEEEEEecCCcEEEEEEecccc-cccHHHHHHHHHHH--HhccCCceeeEeeEEEeCCeeEEEEEe
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKAS-GQGLEEFMNEVMVI--SKLQHRNLVRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~~l--~~l~H~niv~l~g~~~~~~~~~lV~E~  559 (808)
                      ++...+.||++.|=.|.+|+.++|. |+||++-+.. .-..+.|.++++-+  ..++|||.+++.-.-......|||-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            5777899999999999999999887 9999987654 34556666554444  455899999998887777778888888


Q ss_pred             cCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCC-C
Q 003599          560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN-Q  638 (808)
Q Consensus       560 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~-~  638 (808)
                      +.+ +|.+.|   ..++.+...+..-|+.|++.||...|..+   |+|||||.+||||+.-.-+.|+||...+...-. .
T Consensus       103 vkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD  175 (1431)
T KOG1240|consen  103 VKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED  175 (1431)
T ss_pred             Hhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence            855 777766   35567888888899999999999999998   999999999999999999999999987754321 1


Q ss_pred             Ccccccce----eccCCccChhhhccC-----------CCCccccEEehhHHHHHHHh-CCCCCCCCCCchhhhhhhhhh
Q 003599          639 DQADTGRV----VGTFGYMSPEYAMEG-----------RFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKL  702 (808)
Q Consensus       639 ~~~~~~~~----~gt~~y~aPE~~~~~-----------~~s~k~DvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~  702 (808)
                      +.....-+    ..-..|.|||.+...           ..+++.||||+||++.||++ |+++|...    .+..|-...
T Consensus       176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----QL~aYr~~~  251 (1431)
T KOG1240|consen  176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----QLLAYRSGN  251 (1431)
T ss_pred             CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----HHHhHhccC
Confidence            12211111    223479999988431           26788999999999999988 56766421    122111100


Q ss_pred             -hccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHH
Q 003599          703 -WNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML  754 (808)
Q Consensus       703 -~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L  754 (808)
                       ...+...+.++            ...+.++++.|++.||++|-++++.++.-
T Consensus       252 ~~~~e~~Le~Ie------------d~~~Rnlil~Mi~rdPs~RlSAedyL~~y  292 (1431)
T KOG1240|consen  252 ADDPEQLLEKIE------------DVSLRNLILSMIQRDPSKRLSAEDYLQKY  292 (1431)
T ss_pred             ccCHHHHHHhCc------------CccHHHHHHHHHccCchhccCHHHHHHhh
Confidence             00001111110            12567899999999999999999999874

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.78  E-value=5.1e-19  Score=194.70  Aligned_cols=214  Identities=25%  Similarity=0.385  Sum_probs=164.8

Q ss_pred             HHhccCCceeeEeeEEEeCCeeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCC
Q 003599          532 ISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLK  611 (808)
Q Consensus       532 l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik  611 (808)
                      |+.+.|.|+.+++|.+.++...++|.+|++.|+|.+.+..  ....+++.-...++++|++||+|||...  -..|+.++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence            4578999999999999999999999999999999999976  4567999999999999999999999865  23999999


Q ss_pred             CCceEeCCCCCeeeeccccceecCCCCCcccccceeccCCccChhhhccC-------CCCccccEEehhHHHHHHHhCCC
Q 003599          612 ASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG-------RFSEKSDVFSFGVLLLEIVSGRK  684 (808)
Q Consensus       612 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~s~k~DvwSlGvil~elltG~~  684 (808)
                      +.|.++|....+||+|||+.................-..-|.|||.+...       ..+.+.||||||++++|+++.+.
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            99999999999999999998876431111111122345679999998753       14678999999999999999999


Q ss_pred             CCCCCCCch---hhhhhhhhhhccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhhc
Q 003599          685 NTSFFEDDL---TILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  757 (808)
Q Consensus       685 p~~~~~~~~---~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~  757 (808)
                      ||+......   .+...+..     .....+.|.+...   .+...++..++..||..+|++||++++|-..++..
T Consensus       157 ~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~---~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~  224 (484)
T KOG1023|consen  157 PFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELL---NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI  224 (484)
T ss_pred             ccccccccCChHHHHHHHHh-----cCCCCcCcchhhh---hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence            997643222   22222111     1122233333211   13444789999999999999999999999999776

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.76  E-value=2.5e-18  Score=169.44  Aligned_cols=184  Identities=21%  Similarity=0.195  Sum_probs=139.4

Q ss_pred             cccCcccccCceeEEEEEecCCcEEEEEEecccccc----cHHHHHHHHHHHHhcc-CCceeeEeeEEEeCCeeEEEEEe
Q 003599          485 QLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQ----GLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       485 ~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~----~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~  559 (808)
                      .+...|++|+||+||.+.. .+.+++.+.+.....-    ....|.+|+++|++|+ |+++++++++    +..+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            3467899999999997766 5788888877554321    1225789999999995 5889999886    446999999


Q ss_pred             cCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCC-CCCceEeCCCCCeeeeccccceecCCCC
Q 003599          560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDL-KASNILLDEELNPKISDFGMAKIFGGNQ  638 (808)
Q Consensus       560 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Di-kp~NILl~~~~~~kl~DFGla~~~~~~~  638 (808)
                      +.|.+|...+.    .      ....++.|++++|.++|+.+   |+|||| ||+|||++.++.++|+|||++.......
T Consensus        80 I~G~~L~~~~~----~------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~  146 (218)
T PRK12274         80 LAGAAMYQRPP----R------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA  146 (218)
T ss_pred             ecCccHHhhhh----h------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence            99999865431    1      12357889999999999998   999999 7999999999999999999998654332


Q ss_pred             Cc----c--c-----ccceeccCCccChhhhccC-CCC-ccccEEehhHHHHHHHhCCCCC
Q 003599          639 DQ----A--D-----TGRVVGTFGYMSPEYAMEG-RFS-EKSDVFSFGVLLLEIVSGRKNT  686 (808)
Q Consensus       639 ~~----~--~-----~~~~~gt~~y~aPE~~~~~-~~s-~k~DvwSlGvil~elltG~~p~  686 (808)
                      ..    .  .     ......++.|++|+...-. ..+ ...+.++-|.-+|.++|++.+.
T Consensus       147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~  207 (218)
T PRK12274        147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH  207 (218)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence            11    0  0     0112368889999865433 333 4678889999999999998764

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.74  E-value=5.8e-18  Score=175.69  Aligned_cols=232  Identities=20%  Similarity=0.243  Sum_probs=151.7

Q ss_pred             CcccCcccccCceeEEEEEecC-CcEEEEEEeccc---ccccHHHHHHHHHHHHhccC----------CceeeEeeEEE-
Q 003599          484 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQH----------RNLVRLLGCCV-  548 (808)
Q Consensus       484 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H----------~niv~l~g~~~-  548 (808)
                      +...+.||.|+++.||.+++.+ ++++|||.+...   .....+++++|.-....+.+          -.++..++... 
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            4456789999999999999874 899999987643   33456778887766655432          22332222221 


Q ss_pred             --------eCC--------eeEEEEEecCCCCchhhccC----CCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeC
Q 003599          549 --------EGE--------EKMLIYEYMPNRSLDALLFD----PLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHR  608 (808)
Q Consensus       549 --------~~~--------~~~lV~E~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~  608 (808)
                              ...        ..+++|+-+ .++|..++..    ......+....++.+..|+++.+++||..+   ++|+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHg  169 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHG  169 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEES
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEec
Confidence                    111        236778877 5688777531    111234556667788899999999999999   9999


Q ss_pred             CCCCCceEeCCCCCeeeeccccceecCCCCCcccccceeccCCccChhhhcc--------CCCCccccEEehhHHHHHHH
Q 003599          609 DLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME--------GRFSEKSDVFSFGVLLLEIV  680 (808)
Q Consensus       609 Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~k~DvwSlGvil~ell  680 (808)
                      ||+|+|++++.+|.++|+||+.....+.....     ...+..|.+||....        -.++.+.|.|+||+++|.|+
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW  244 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW  244 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence            99999999999999999999988765321111     234578999997743        24788999999999999999


Q ss_pred             hCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCC
Q 003599          681 SGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDR  744 (808)
Q Consensus       681 tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~R  744 (808)
                      +|+.|+..........                 ..+.  .+. +.++.+..|+..+|+.+|++|
T Consensus       245 C~~lPf~~~~~~~~~~-----------------~~f~--~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  245 CGRLPFGLSSPEADPE-----------------WDFS--RCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HSS-STCCCGGGSTSG-----------------GGGT--TSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HccCCCCCCCcccccc-----------------ccch--hcC-CcCHHHHHHHHHHccCCcccC
Confidence            9999987543221100                 0111  134 778899999999999999998

>PRK10345 hypothetical protein; Provisional

Probab=99.73  E-value=2.1e-17  Score=166.21  Aligned_cols=136  Identities=22%  Similarity=0.274  Sum_probs=106.1

Q ss_pred             ccCcccccCceeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHHhc-----cCCceeeEeeEEEeCC---e-eEEE
Q 003599          486 LSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKL-----QHRNLVRLLGCCVEGE---E-KMLI  556 (808)
Q Consensus       486 ~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~g~~~~~~---~-~~lV  556 (808)
                      -.+.||+|+||.||. ...++.. +||++........+.+.+|+.+++++     .||||++++|++.++.   . ..+|
T Consensus         6 ~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I   83 (210)
T PRK10345          6 EQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI   83 (210)
T ss_pred             CcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence            357999999999996 3234444 79988765445567899999999999     5799999999998764   3 3378


Q ss_pred             EEe--cCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHH-HHhHhcCCCcEEeCCCCCCceEeCC----CCCeeeeccc
Q 003599          557 YEY--MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL-LYLHRDSRLRIIHRDLKASNILLDE----ELNPKISDFG  629 (808)
Q Consensus       557 ~E~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l-~yLH~~~~~~ivH~Dikp~NILl~~----~~~~kl~DFG  629 (808)
                      +||  +++++|.+++.+    ..+++.  ..++.+++.++ +|||+++   |+||||||+|||++.    +..++|+||+
T Consensus        84 ~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         84 ADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             ecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            999  668999999943    234444  35677888777 9999998   999999999999974    3479999955


Q ss_pred             cce
Q 003599          630 MAK  632 (808)
Q Consensus       630 la~  632 (808)
                      .++
T Consensus       155 G~~  157 (210)
T PRK10345        155 GES  157 (210)
T ss_pred             CCc
Confidence            443

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.70  E-value=2.8e-18  Score=188.41  Aligned_cols=225  Identities=25%  Similarity=0.289  Sum_probs=177.2

Q ss_pred             cccccCceeEEEEE----ecCCcEEEEEEecccccc--cHHHHHHHHHHHHhcc-CCceeeEeeEEEeCCeeEEEEEecC
Q 003599          489 KLGQGGFGPVYWGR----LKDGQEIAVKRLSKASGQ--GLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEKMLIYEYMP  561 (808)
Q Consensus       489 ~lG~G~~g~Vy~~~----~~~~~~vAvK~l~~~~~~--~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~  561 (808)
                      .+|+|.||.|++.+    .+.+..+|+|.+.+....  .......|..++..++ ||.+|++...+..+...++++++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37899999999654    234777899988764211  1225667888999997 9999999999999999999999999


Q ss_pred             CCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCcc
Q 003599          562 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA  641 (808)
Q Consensus       562 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  641 (808)
                      +|.|...+.   +...++..........++-+++++|+.+   |+|||+|++||+++.+|.+++.|||+++..-...   
T Consensus        81 gg~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~---  151 (612)
T KOG0603|consen   81 GGDLFTRLS---KEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK---  151 (612)
T ss_pred             cchhhhccc---cCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh---
Confidence            999988774   3456777777788889999999999998   9999999999999999999999999998643221   


Q ss_pred             cccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCcc
Q 003599          642 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSF  721 (808)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  721 (808)
                         ..+||..|||||++.  ......|.||||++.+||+||-.||..  +  ..             ..++...+   ..
T Consensus       152 ---~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~--~--~~-------------~~Il~~~~---~~  206 (612)
T KOG0603|consen  152 ---IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG--D--TM-------------KRILKAEL---EM  206 (612)
T ss_pred             ---hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch--H--HH-------------HHHhhhcc---CC
Confidence               127899999999998  557789999999999999999998853  0  00             01111111   25


Q ss_pred             cHHHHHHHHHHHHhcccCCcCCCCCH
Q 003599          722 QLDMIIRCIHVGLLCVQELVKDRPNM  747 (808)
Q Consensus       722 ~~~~~~~l~~li~~cl~~~P~~RPs~  747 (808)
                      +.+......+++..+...+|.+|-..
T Consensus       207 p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  207 PRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            55666777788888888889988755

>smart00090 RIO RIO-like kinase

Probab=99.69  E-value=1.8e-16  Score=163.42  Aligned_cols=144  Identities=17%  Similarity=0.192  Sum_probs=112.7

Q ss_pred             hcCCcccCcccccCceeEEEEE--ecCCcEEEEEEecccccc------------------------cHHHHHHHHHHHHh
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGR--LKDGQEIAVKRLSKASGQ------------------------GLEEFMNEVMVISK  534 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~--~~~~~~vAvK~l~~~~~~------------------------~~~~~~~E~~~l~~  534 (808)
                      ...|.+.+.||+|++|.||+|.  ..+|+.||||+++.....                        ....+..|+.++.+
T Consensus        27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~  106 (237)
T smart00090       27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR  106 (237)
T ss_pred             CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence            3458889999999999999998  567999999998753210                        01235689999999


Q ss_pred             ccCC--ceeeEeeEEEeCCeeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCC
Q 003599          535 LQHR--NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKA  612 (808)
Q Consensus       535 l~H~--niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp  612 (808)
                      +.+.  .+++++++    ...++||||+++.+|......   ...+...+...++.||+.++.+||+.+  .++||||||
T Consensus       107 L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp  177 (237)
T smart00090      107 LYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSE  177 (237)
T ss_pred             HHhcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCCh
Confidence            9753  34555543    235899999999888765422   234556667899999999999999886  499999999


Q ss_pred             CceEeCCCCCeeeeccccceec
Q 003599          613 SNILLDEELNPKISDFGMAKIF  634 (808)
Q Consensus       613 ~NILl~~~~~~kl~DFGla~~~  634 (808)
                      +||+++ ++.++|+|||.+...
T Consensus       178 ~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      178 YNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             hhEEEE-CCCEEEEEChhhhcc
Confidence            999999 889999999998754

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.69  E-value=9e-17  Score=188.71  Aligned_cols=197  Identities=22%  Similarity=0.265  Sum_probs=161.3

Q ss_pred             HHhcCCcccCcccccCceeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHHhcc---CCceeeEeeEEEeCCeeEE
Q 003599          479 TATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ---HRNLVRLLGCCVEGEEKML  555 (808)
Q Consensus       479 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~l  555 (808)
                      .-.+.|.|.+.||+|+||.||+|...+|+.||+|+-+....-   +|.--.+++.+|+   -+-|..+...+...+.-+|
T Consensus       695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l  771 (974)
T KOG1166|consen  695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVL  771 (974)
T ss_pred             ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence            344679999999999999999999888999999997655432   1222233444444   2445566666677788899


Q ss_pred             EEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeC-------CCCCeeeecc
Q 003599          556 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD-------EELNPKISDF  628 (808)
Q Consensus       556 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~-------~~~~~kl~DF  628 (808)
                      |+||.+.|+|.+++.   ..+.++|.-.+.++.|+++.++.||..+   |||+||||.|.||.       ++..++|+||
T Consensus       772 v~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf  845 (974)
T KOG1166|consen  772 VSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDF  845 (974)
T ss_pred             eeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEec
Confidence            999999999999996   4567999999999999999999999998   99999999999994       2445999999


Q ss_pred             ccceecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCC
Q 003599          629 GMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRK  684 (808)
Q Consensus       629 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~  684 (808)
                      |-+-.+..-.+.......++|-.+--+|...+.+.+..+|.|.|..+++-|+-|+.
T Consensus       846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             ccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            99886654444445555788999999999999999999999999999999999985

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.69  E-value=2.4e-16  Score=158.86  Aligned_cols=145  Identities=19%  Similarity=0.217  Sum_probs=113.9

Q ss_pred             HHHHHHhcCCcccCcccccCceeEEEEEecCCcEEEEEEecccccc----------------------cHHHHHHHHHHH
Q 003599          475 EELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQ----------------------GLEEFMNEVMVI  532 (808)
Q Consensus       475 ~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~----------------------~~~~~~~E~~~l  532 (808)
                      .++......|.+.+.||+|+||.||++...+|+.||||+++.....                      ....+..|..++
T Consensus         8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   87 (198)
T cd05144           8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL   87 (198)
T ss_pred             HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence            3444444458888999999999999999888999999987543210                      112366789999


Q ss_pred             HhccCCc--eeeEeeEEEeCCeeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCC
Q 003599          533 SKLQHRN--LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDL  610 (808)
Q Consensus       533 ~~l~H~n--iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Di  610 (808)
                      .++.|++  +++.++.    ...++||||+++++|......         .....++.++++++.++|+.+   ++||||
T Consensus        88 ~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl  151 (198)
T cd05144          88 KALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDL  151 (198)
T ss_pred             HHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCC
Confidence            9998874  4455442    455899999999999765421         345678999999999999987   999999


Q ss_pred             CCCceEeCCCCCeeeeccccceecC
Q 003599          611 KASNILLDEELNPKISDFGMAKIFG  635 (808)
Q Consensus       611 kp~NILl~~~~~~kl~DFGla~~~~  635 (808)
                      ||+||++++++.++|+|||++....
T Consensus       152 ~p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         152 SEFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             CcccEEEcCCCcEEEEECCccccCC
Confidence            9999999999999999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.68  E-value=1.9e-16  Score=161.15  Aligned_cols=134  Identities=22%  Similarity=0.317  Sum_probs=113.5

Q ss_pred             CcccccCceeEEEEEecCCcEEEEEEecccccc--------cHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEe
Q 003599          488 SKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQ--------GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       488 ~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  559 (808)
                      +.||+|++|.||+|.. .+..+++|+.......        ....+.+|+.++..++|++++....++......++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            6899999999999987 5778999986543211        124578899999999999988877777777888999999


Q ss_pred             cCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeecccccee
Q 003599          560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI  633 (808)
Q Consensus       560 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  633 (808)
                      +++++|.+++...      .. ++..++.+++.+|.+||+.+   ++|+|++|.|||++ ++.++|+|||+++.
T Consensus        81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999988431      11 78899999999999999998   99999999999999 78999999999874

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.65  E-value=5.5e-16  Score=156.30  Aligned_cols=130  Identities=23%  Similarity=0.366  Sum_probs=106.8

Q ss_pred             cccccCceeEEEEEecCCcEEEEEEeccccc--------ccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEec
Q 003599          489 KLGQGGFGPVYWGRLKDGQEIAVKRLSKASG--------QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  560 (808)
Q Consensus       489 ~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  560 (808)
                      .||+|++|.||+|.. ++..|++|.......        ...+++.+|++++..++|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999985 478899998654211        11356778999999999887666555666677789999999


Q ss_pred             CCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeecccccee
Q 003599          561 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI  633 (808)
Q Consensus       561 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  633 (808)
                      ++++|.+++...   ..       .++.+++++|.+||+.+   ++|+|++|+||+++ ++.++++|||+++.
T Consensus        80 ~g~~l~~~~~~~---~~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEG---ND-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhc---HH-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999999887431   10       78999999999999998   99999999999999 88999999999874

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.65  E-value=4.1e-16  Score=180.82  Aligned_cols=140  Identities=20%  Similarity=0.292  Sum_probs=114.0

Q ss_pred             HHHhcCCcccCcccccCceeEEEEEecCCcEEEEEE-ecccc-------cccHHHHHHHHHHHHhccCCceeeEeeEEEe
Q 003599          478 ATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKR-LSKAS-------GQGLEEFMNEVMVISKLQHRNLVRLLGCCVE  549 (808)
Q Consensus       478 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~-l~~~~-------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~  549 (808)
                      ......|...+.||+|+||+||+|.+.... +++|+ ..+..       ....+++.+|++++++++|++++....++..
T Consensus       329 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~  407 (535)
T PRK09605        329 EEVKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD  407 (535)
T ss_pred             cccccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe
Confidence            333455667899999999999999876443 44443 22211       1123568899999999999999988888887


Q ss_pred             CCeeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccc
Q 003599          550 GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFG  629 (808)
Q Consensus       550 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFG  629 (808)
                      ....++||||+++++|.+++.           ....++.+++++|.|||+.+   ++||||||+|||+ .++.++|+|||
T Consensus       408 ~~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFG  472 (535)
T PRK09605        408 PEEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFG  472 (535)
T ss_pred             CCCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCc
Confidence            778899999999999998873           35689999999999999998   9999999999999 67899999999


Q ss_pred             ccee
Q 003599          630 MAKI  633 (808)
Q Consensus       630 la~~  633 (808)
                      +++.
T Consensus       473 la~~  476 (535)
T PRK09605        473 LGKY  476 (535)
T ss_pred             cccc
Confidence            9975

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.63  E-value=5.9e-17  Score=174.83  Aligned_cols=124  Identities=29%  Similarity=0.464  Sum_probs=110.0

Q ss_pred             eeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccc
Q 003599          552 EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA  631 (808)
Q Consensus       552 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla  631 (808)
                      ..++.|+++...+|.+||..+......++...+.++.|++.|++|   ++   .+|+|+||.||+...+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence            468999999999999999876677788999999999999999999   55   999999999999999999999999999


Q ss_pred             eecCCCC----CcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHh
Q 003599          632 KIFGGNQ----DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS  681 (808)
Q Consensus       632 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~ellt  681 (808)
                      .......    .........||..||+||.+.+..|+.|+||||||+||+|+++
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            8765443    2233445689999999999999999999999999999999998

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.62  E-value=1.2e-15  Score=157.72  Aligned_cols=197  Identities=20%  Similarity=0.255  Sum_probs=136.6

Q ss_pred             cCCceeeEeeEEEe---------------------------CCeeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHH
Q 003599          536 QHRNLVRLLGCCVE---------------------------GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE  588 (808)
Q Consensus       536 ~H~niv~l~g~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~  588 (808)
                      +|||||++.++|.+                           ....|+||...+. +|.+++-.    ...+.....-|+.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~----~~~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT----RHRSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc----CCCchHHHHHHHH
Confidence            59999999988764                           2356888887744 88888843    3567777788999


Q ss_pred             HHHHHHHHhHhcCCCcEEeCCCCCCceEe--CCCC--CeeeeccccceecCCCCC----cccccceeccCCccChhhhcc
Q 003599          589 GISRGLLYLHRDSRLRIIHRDLKASNILL--DEEL--NPKISDFGMAKIFGGNQD----QADTGRVVGTFGYMSPEYAME  660 (808)
Q Consensus       589 ~ia~~l~yLH~~~~~~ivH~Dikp~NILl--~~~~--~~kl~DFGla~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~  660 (808)
                      |+++|+.|||+++   |.|||+|+.||||  |+++  .+.|+|||.+-.-....-    ....-..-|...-||||+...
T Consensus       349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta  425 (598)
T KOG4158|consen  349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA  425 (598)
T ss_pred             HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence            9999999999998   9999999999999  3333  478999998764322110    011111246778899998864


Q ss_pred             CC------CCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCcccHHHHHHHHHHHH
Q 003599          661 GR------FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGL  734 (808)
Q Consensus       661 ~~------~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~  734 (808)
                      .+      --.|+|.|+.|.+.||+++...||....+ ..+.        -....+.--|.     .+..+...+.+++.
T Consensus       426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe-m~L~--------~r~Yqe~qLPa-----lp~~vpp~~rqlV~  491 (598)
T KOG4158|consen  426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE-MLLD--------TRTYQESQLPA-----LPSRVPPVARQLVF  491 (598)
T ss_pred             CCCCceeeccchhhhhhhhhhHHHHhccCCcccccch-heec--------hhhhhhhhCCC-----CcccCChHHHHHHH
Confidence            32      13589999999999999999999854211 1110        01111111112     23334456778999


Q ss_pred             hcccCCcCCCCCHHHHHHHH
Q 003599          735 LCVQELVKDRPNMSTVVSML  754 (808)
Q Consensus       735 ~cl~~~P~~RPs~~ev~~~L  754 (808)
                      ..|+.||.+||+..-....|
T Consensus       492 ~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  492 DLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             HHhcCCccccCCccHHHhHH
Confidence            99999999999977655555

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.58  E-value=1.3e-14  Score=138.58  Aligned_cols=135  Identities=23%  Similarity=0.238  Sum_probs=115.9

Q ss_pred             ccCcccccCceeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHHhccC--CceeeEeeEEEeCCeeEEEEEecCCC
Q 003599          486 LSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQH--RNLVRLLGCCVEGEEKMLIYEYMPNR  563 (808)
Q Consensus       486 ~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~E~~~~g  563 (808)
                      +.+.||+|.++.||++...+ ..+++|.......  ...+.+|+..+..++|  .++++++++....+..+++|||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            45789999999999999865 7899999865433  5678999999999976  58999999988888899999999988


Q ss_pred             CchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeecccccee
Q 003599          564 SLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI  633 (808)
Q Consensus       564 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  633 (808)
                      .+..+          +......++.++++++++||.....+++|+|++|+||++++.+.++++|||.++.
T Consensus        79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            77543          4566778899999999999987555699999999999999989999999999874

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.58  E-value=8.9e-15  Score=145.89  Aligned_cols=136  Identities=21%  Similarity=0.275  Sum_probs=99.7

Q ss_pred             cCcccccCceeEEEEEecCCcEEEEEEecccccc--cHHHH----------------------HHHHHHHHhccCCc--e
Q 003599          487 SSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQ--GLEEF----------------------MNEVMVISKLQHRN--L  540 (808)
Q Consensus       487 ~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~--~~~~~----------------------~~E~~~l~~l~H~n--i  540 (808)
                      .+.||+|+||.||+|...+++.||||+++.....  ....+                      ..|...+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            5789999999999999888999999988653211  11111                      35666666665443  4


Q ss_pred             eeEeeEEEeCCeeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHh-cCCCcEEeCCCCCCceEeCC
Q 003599          541 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR-DSRLRIIHRDLKASNILLDE  619 (808)
Q Consensus       541 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~ivH~Dikp~NILl~~  619 (808)
                      .+.+++    ...++||||++++.+.......   .... .+...++.+++.++.++|. .+   |+|+||||+||+++ 
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~---~~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKD---VRLL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhh---hhhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence            555543    2468999999996543221110   0011 5678899999999999999 76   99999999999999 


Q ss_pred             CCCeeeeccccceec
Q 003599          620 ELNPKISDFGMAKIF  634 (808)
Q Consensus       620 ~~~~kl~DFGla~~~  634 (808)
                      ++.++|+|||.+...
T Consensus       150 ~~~~~liDfg~a~~~  164 (187)
T cd05119         150 DGKVYIIDVPQAVEI  164 (187)
T ss_pred             CCcEEEEECcccccc
Confidence            899999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions []

Probab=99.54  E-value=5.3e-15  Score=119.43  Aligned_cols=59  Identities=49%  Similarity=1.082  Sum_probs=52.4

Q ss_pred             CCCCeeEeecccCCCccccc--CccchHHHHHHHhhcCCceeeeec---CCeeEEEeeeeccccc
Q 003599          336 KEDGFSKLNKMKVPDFTEWT--SPATEDECREQCLKNCSCIAYAFD---GGIGCMVWRSINLIDI  395 (808)
Q Consensus       336 ~~~~f~~~~~~~~pd~~~~~--~~~s~~~C~~~Cl~nCsC~a~~~~---~~~~C~~w~~~~l~~~  395 (808)
                      .+|+|+++++|++|++....  ...++++|++.|++||||+||+|.   ++++|++|++ +|+|+
T Consensus         3 ~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~~~~~C~lW~~-~L~d~   66 (66)
T PF08276_consen    3 SGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLSGGGGCLLWYG-DLVDL   66 (66)
T ss_pred             CCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccCCCCEEEEEcC-EeecC
Confidence            57899999999999986665  345999999999999999999998   5789999999 98874

These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.54  E-value=4.5e-14  Score=145.89  Aligned_cols=134  Identities=22%  Similarity=0.321  Sum_probs=105.1

Q ss_pred             Cccc-ccCceeEEEEEecCCcEEEEEEecccc-------------cccHHHHHHHHHHHHhccCCce--eeEeeEEEeCC
Q 003599          488 SKLG-QGGFGPVYWGRLKDGQEIAVKRLSKAS-------------GQGLEEFMNEVMVISKLQHRNL--VRLLGCCVEGE  551 (808)
Q Consensus       488 ~~lG-~G~~g~Vy~~~~~~~~~vAvK~l~~~~-------------~~~~~~~~~E~~~l~~l~H~ni--v~l~g~~~~~~  551 (808)
                      ..|| .||.|+||++... +..++||++....             ......+.+|++++.+++|++|  ++.+++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            4687 8999999998876 6789999875311             1223567889999999998875  77777754432


Q ss_pred             e----eEEEEEecCC-CCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeee
Q 003599          552 E----KMLIYEYMPN-RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKIS  626 (808)
Q Consensus       552 ~----~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~  626 (808)
                      .    .++|||++++ .+|.+++..    ..++.    ..+.+|+++|.+||+.+   |+||||||+|||++.++.++|+
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~----~~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI  184 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQE----APLSE----EQWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI  184 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhc----CCCCH----HHHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence            2    3599999997 689888743    23333    24678999999999998   9999999999999999999999


Q ss_pred             cccccee
Q 003599          627 DFGMAKI  633 (808)
Q Consensus       627 DFGla~~  633 (808)
                      |||.++.
T Consensus       185 Dfg~~~~  191 (239)
T PRK01723        185 DFDRGEL  191 (239)
T ss_pred             ECCCccc
Confidence            9999875

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.53  E-value=3.4e-15  Score=171.79  Aligned_cols=209  Identities=21%  Similarity=0.242  Sum_probs=140.0

Q ss_pred             hcCCcccCcccccCceeEEEEEecC-CcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEe
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  559 (808)
                      ..+|..++.|..|+||.||..+++. .++.|+| +.+..-     +.+-  ++.....|.+|                  
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-----ilRn--ilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-----ILRN--ILTFAGNPFVV------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhc-ccccch-----hhhc--cccccCCccee------------------
Confidence            4678889999999999999998874 5678884 332210     0000  22222233332                  


Q ss_pred             cCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCC
Q 003599          560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  639 (808)
Q Consensus       560 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  639 (808)
                         |+-...+.   .-+.++.        +++.+++|||+.+   |+|||+||.|.+|..-|.+|+.|||+++.......
T Consensus       136 ---gDc~tllk---~~g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a  198 (1205)
T KOG0606|consen  136 ---GDCATLLK---NIGPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA  198 (1205)
T ss_pred             ---chhhhhcc---cCCCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence               22222231   1122222        2277999999988   99999999999999999999999999986422110


Q ss_pred             -------------cccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccc
Q 003599          640 -------------QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNEN  706 (808)
Q Consensus       640 -------------~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~  706 (808)
                                   +.....++||+.|.|||++....|....|.|++|+|+||.+-|+.||.....+..+-+.+....   
T Consensus       199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i---  275 (1205)
T KOG0606|consen  199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI---  275 (1205)
T ss_pred             chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc---
Confidence                         0112235899999999999999999999999999999999999999875544332222211110   


Q ss_pred             cchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCC
Q 003599          707 KILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRP  745 (808)
Q Consensus       707 ~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RP  745 (808)
                         +..+       .+.....+.+.++.+.|+.+|..|-
T Consensus       276 ---~wpE-------~dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  276 ---EWPE-------EDEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             ---cccc-------cCcCCCHHHHHHHHHHHHhChHhhc
Confidence               0111       1222345677888899999999996

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.48  E-value=1e-14  Score=168.71  Aligned_cols=254  Identities=22%  Similarity=0.258  Sum_probs=187.8

Q ss_pred             cCCcccCcccccCceeEEEEEecC--CcEEEEEEecccc--cccHHHHHHHHHHHHhcc-CCceeeEeeEEEeCCeeEEE
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLKD--GQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEKMLI  556 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~~--~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV  556 (808)
                      ..|.+.+.||+|.|+.|-......  ...+|+|.+....  ....+....|..+-..+. |+|++++++...+.+..+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            457778889999999998877643  4556777665443  223344445777777776 99999999999999999999


Q ss_pred             EEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhH-hcCCCcEEeCCCCCCceEeCCCC-Ceeeeccccceec
Q 003599          557 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH-RDSRLRIIHRDLKASNILLDEEL-NPKISDFGMAKIF  634 (808)
Q Consensus       557 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH-~~~~~~ivH~Dikp~NILl~~~~-~~kl~DFGla~~~  634 (808)
                      .+|..++++.+.+... .....+....-..+.|+..++.|+| ..+   +.|+||||+|.+++..+ ..+++|||+|..+
T Consensus       100 ~~~s~g~~~f~~i~~~-~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~  175 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHP-DSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY  175 (601)
T ss_pred             cCcccccccccccccC-CccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence            9999999998877321 1224555566778999999999999 777   99999999999999999 9999999999988


Q ss_pred             CC-CCCcccccceec-cCCccChhhhccC-CCCccccEEehhHHHHHHHhCCCCCCCCCCchhh-hhhhhhhhccccchh
Q 003599          635 GG-NQDQADTGRVVG-TFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTI-LGYAWKLWNENKILA  710 (808)
Q Consensus       635 ~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~  710 (808)
                      .. ...........| ++.|+|||..... ...+..|+||.|+++.-+++|..|+......... ..|            
T Consensus       176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~------------  243 (601)
T KOG0590|consen  176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSW------------  243 (601)
T ss_pred             cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceee------------
Confidence            76 444444555678 9999999998874 4577899999999999999999998654432211 111            


Q ss_pred             ccCCccc-CCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          711 LVDPFLS-ESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       711 ~~d~~l~-~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                       .+.... .............++..+++..+|..|.+.+++..
T Consensus       244 -~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  244 -KSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             -cccccccccCccccCChhhhhcccccccCCchhccccccccc
Confidence             111000 00011122344566777888899999998887643

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.46  E-value=3.7e-13  Score=151.07  Aligned_cols=141  Identities=24%  Similarity=0.278  Sum_probs=102.2

Q ss_pred             cCcccccCceeEEEEEecCCcEEEEEEeccccccc----------------------------------------HHHHH
Q 003599          487 SSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQG----------------------------------------LEEFM  526 (808)
Q Consensus       487 ~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~~----------------------------------------~~~~~  526 (808)
                      .+.||+|++|.||+|++++|+.||||+.+......                                        +-+|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            36799999999999999999999999986532110                                        01355


Q ss_pred             HHHHHHHhcc----CCceeeEeeEE-EeCCeeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHH-HHHHhHhc
Q 003599          527 NEVMVISKLQ----HRNLVRLLGCC-VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR-GLLYLHRD  600 (808)
Q Consensus       527 ~E~~~l~~l~----H~niv~l~g~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-~l~yLH~~  600 (808)
                      +|++.+.+++    |.+-+.+-..+ ......+|||||++|++|.++....  ....   .+.+++..+++ .+..+|..
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~--~~~~---~~~~ia~~~~~~~l~ql~~~  276 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALD--EAGL---DRKALAENLARSFLNQVLRD  276 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHH--hcCC---CHHHHHHHHHHHHHHHHHhC
Confidence            6777777663    32223332222 2345679999999999998876321  1111   34567777776 46788888


Q ss_pred             CCCcEEeCCCCCCceEeCCCCCeeeeccccceecC
Q 003599          601 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG  635 (808)
Q Consensus       601 ~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~  635 (808)
                      +   ++|+|+||.||++++++.++++|||++..+.
T Consensus       277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             C---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            7   9999999999999999999999999997653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins

Probab=99.44  E-value=1.1e-13  Score=115.27  Aligned_cols=68  Identities=25%  Similarity=0.369  Sum_probs=61.1

Q ss_pred             CCCCeeEeecccCCCcccccCccchHHHHHHHhh---cCCceeeeecC-CeeEEEeeeecc-ccccccCCCccceEEE
Q 003599          336 KEDGFSKLNKMKVPDFTEWTSPATEDECREQCLK---NCSCIAYAFDG-GIGCMVWRSINL-IDIQRLPFGGTDLYIR  408 (808)
Q Consensus       336 ~~~~f~~~~~~~~pd~~~~~~~~s~~~C~~~Cl~---nCsC~a~~~~~-~~~C~~w~~~~l-~~~~~~~~~~~~lylr  408 (808)
                      ..++|+++.+|++|++..    .+++||++.|++   ||||+||+|.. +.||.+|++ +| +|++++..++.++|+|
T Consensus         7 ~~g~fl~~~~~klpd~~~----~s~~eC~~~Cl~~~~nCsC~Aya~~~~~~gC~~W~~-~l~~d~~~~~~~g~~Ly~r   79 (80)
T cd00129           7 SAGTTLIKIALKIKTTKA----NTADECANRCEKNGLPFSCKAFVFAKARKQCLWFPF-NSMSGVRKEFSHGFDLYEN   79 (80)
T ss_pred             cCCeEEEeecccCCcccc----cCHHHHHHHHhcCCCCCCceeeeccCCCCCeEEecC-cchhhHHhccCCCceeEeE
Confidence            456799999999999874    589999999999   99999999973 568999999 99 9999988889999998

Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.32  E-value=1.2e-12  Score=133.15  Aligned_cols=205  Identities=20%  Similarity=0.228  Sum_probs=142.9

Q ss_pred             HHHHHHhccCCceeeEeeEEEeC-----CeeEEEEEecCCCCchhhccCCC-CCCcCChhhHHHHHHHHHHHHHHhHhcC
Q 003599          528 EVMVISKLQHRNLVRLLGCCVEG-----EEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLYLHRDS  601 (808)
Q Consensus       528 E~~~l~~l~H~niv~l~g~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~  601 (808)
                      -...|-++.|.|||+++.|+.+.     ....++.|||+.|+|..+|.+.. ....+......+++.||..||.|||+..
T Consensus       117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~  196 (458)
T KOG1266|consen  117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC
Confidence            34456667899999999998653     34678999999999999997632 2345777778899999999999999875


Q ss_pred             CCcEEeCCCCCCceEeCCCCCeeeeccccc--eecCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHH
Q 003599          602 RLRIIHRDLKASNILLDEELNPKISDFGMA--KIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEI  679 (808)
Q Consensus       602 ~~~ivH~Dikp~NILl~~~~~~kl~DFGla--~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~el  679 (808)
                       ++|+|+++.-+.|++..++-+||.--.-.  ...-............+-++|.|||+-.....+.++|||+||+..+||
T Consensus       197 -PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem  275 (458)
T KOG1266|consen  197 -PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM  275 (458)
T ss_pred             -CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence             78999999999999999999988532111  110011111222234577899999988777888899999999999999


Q ss_pred             HhCCCCCCCCCCchhhhhhhhhhhccccchhcc---CCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHH
Q 003599          680 VSGRKNTSFFEDDLTILGYAWKLWNENKILALV---DPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML  754 (808)
Q Consensus       680 ltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L  754 (808)
                      .-+..-....... ..        .+..+...+   ...+.            ..++..|++.+|..||+|++++...
T Consensus       276 ailEiq~tnseS~-~~--------~ee~ia~~i~~len~lq------------r~~i~kcl~~eP~~rp~ar~llfHp  332 (458)
T KOG1266|consen  276 AILEIQSTNSESK-VE--------VEENIANVIIGLENGLQ------------RGSITKCLEGEPNGRPDARLLLFHP  332 (458)
T ss_pred             HHheeccCCCcce-ee--------hhhhhhhheeeccCccc------------cCcCcccccCCCCCCcchhhhhcCc
Confidence            9887532211110 00        011111111   11111            2456799999999999999977644

>cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins

Probab=99.29  E-value=5e-12  Score=108.28  Aligned_cols=73  Identities=44%  Similarity=0.914  Sum_probs=61.3

Q ss_pred             CCCeeEeecccCCCcccccCccchHHHHHHHhhcCCceeeeecC-CeeEEEeeeeccccccccCCCccceEEEEe
Q 003599          337 EDGFSKLNKMKVPDFTEWTSPATEDECREQCLKNCSCIAYAFDG-GIGCMVWRSINLIDIQRLPFGGTDLYIRVA  410 (808)
Q Consensus       337 ~~~f~~~~~~~~pd~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~~-~~~C~~w~~~~l~~~~~~~~~~~~lylrv~  410 (808)
                      .++|+.+.++++|+........++++|++.|++||+|+||+|.+ +++|.+|.+ ++.+.+.....+.++||||+
T Consensus        11 ~~~f~~~~~~~~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~C~~~~~-~~~~~~~~~~~~~~~yiKv~   84 (84)
T cd01098          11 TDGFLKLPDVKLPDNASAITAISLEECREACLSNCSCTAYAYNNGSGGCLLWNG-LLNNLRSLSSGGGTLYLRLA   84 (84)
T ss_pred             CCEEEEeCCeeCCCchhhhccCCHHHHHHHHhcCCCcceeeecCCCCeEEEEec-eecceEeecCCCcEEEEEeC
Confidence            36899999999998865544459999999999999999999974 668999998 88887776656688999984

PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.29  E-value=1.6e-11  Score=120.11  Aligned_cols=131  Identities=22%  Similarity=0.149  Sum_probs=99.0

Q ss_pred             cCcccccCceeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHHhccCCcee-eEeeEEEeCCeeEEEEEecCCCCc
Q 003599          487 SSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV-RLLGCCVEGEEKMLIYEYMPNRSL  565 (808)
Q Consensus       487 ~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~E~~~~gsL  565 (808)
                      .+.|+.|.++.||+++.. +..+++|....... ....+..|+.+++.+.+.+++ +++.+.  ....++||||+++.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence            367899999999999876 77899998754432 234567899999999765544 455443  3346899999999888


Q ss_pred             hhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcC--CCcEEeCCCCCCceEeCCCCCeeeecccccee
Q 003599          566 DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS--RLRIIHRDLKASNILLDEELNPKISDFGMAKI  633 (808)
Q Consensus       566 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~--~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  633 (808)
                      ....           .....++.+++++|+.||..+  ...++|+|++|.||+++ ++.++++|||.+..
T Consensus        79 ~~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          79 LTED-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cccc-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            5430           112346789999999999886  23469999999999999 66899999998863

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.26  E-value=2.4e-11  Score=137.98  Aligned_cols=145  Identities=21%  Similarity=0.261  Sum_probs=95.8

Q ss_pred             CCcccCcccccCceeEEEEEecC-CcEEEEEEecccccc------------------------------c----H-----
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQ------------------------------G----L-----  522 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vAvK~l~~~~~~------------------------------~----~-----  522 (808)
                      .|.. +.||+|++|.||+|++++ |+.||||+++.....                              .    .     
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~  199 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD  199 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence            4665 789999999999999987 999999999753210                              0    0     


Q ss_pred             -HHHHHHHHHHHhcc----CCceeeEeeEEE-eCCeeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHH-HH
Q 003599          523 -EEFMNEVMVISKLQ----HRNLVRLLGCCV-EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRG-LL  595 (808)
Q Consensus       523 -~~~~~E~~~l~~l~----H~niv~l~g~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~-l~  595 (808)
                       -+|.+|+..+.+++    +.+.+.+-..+. .....+|||||++|+.+.++..-  .....+   +..++...++. +.
T Consensus       200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l--~~~g~d---~~~la~~~v~~~~~  274 (537)
T PRK04750        200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAAL--RAAGTD---MKLLAERGVEVFFT  274 (537)
T ss_pred             hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHH--HhcCCC---HHHHHHHHHHHHHH
Confidence             12455666666663    444344333332 25678999999999999764211  111111   22233333222 22


Q ss_pred             HhHhcCCCcEEeCCCCCCceEeCCCC----CeeeeccccceecCC
Q 003599          596 YLHRDSRLRIIHRDLKASNILLDEEL----NPKISDFGMAKIFGG  636 (808)
Q Consensus       596 yLH~~~~~~ivH~Dikp~NILl~~~~----~~kl~DFGla~~~~~  636 (808)
                      .++..+   ++|+|+||.||+++.++    .++++|||++..+..
T Consensus       275 Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        275 QVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            233455   99999999999999888    999999999987743

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.24  E-value=9.1e-12  Score=137.73  Aligned_cols=248  Identities=23%  Similarity=0.265  Sum_probs=176.7

Q ss_pred             CCcccCcccc--cCceeEEEEEe--c-CCcEEEEEEeccc--ccccHHHHHHHHHHHHhc-cCCceeeEeeEEEeCCeeE
Q 003599          483 NFQLSSKLGQ--GGFGPVYWGRL--K-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKM  554 (808)
Q Consensus       483 ~~~~~~~lG~--G~~g~Vy~~~~--~-~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~  554 (808)
                      .|.+.+.+|+  |.+|.||.+..  + ++..+|+|+-+..  .+.....=++|+....++ .|+|.++....++.++..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            4666789999  99999999987  3 5788999984432  223333345677777777 4999999999999999999


Q ss_pred             EEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHH----HHHHhHhcCCCcEEeCCCCCCceEeCCC-CCeeeeccc
Q 003599          555 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR----GLLYLHRDSRLRIIHRDLKASNILLDEE-LNPKISDFG  629 (808)
Q Consensus       555 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----~l~yLH~~~~~~ivH~Dikp~NILl~~~-~~~kl~DFG  629 (808)
                      +-.|++. .+|..+.+..  ...++......+..+..+    |+.++|...   ++|-|+||.||++..+ ...+++|||
T Consensus       195 iqtE~~~-~sl~~~~~~~--~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~  268 (524)
T KOG0601|consen  195 IQTELCG-ESLQSYCHTP--CNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFG  268 (524)
T ss_pred             eeecccc-chhHHhhhcc--cccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcc
Confidence            9999884 7888877653  233555666677777777    999999998   9999999999999999 889999999


Q ss_pred             cceecCCCCCccc---ccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccc
Q 003599          630 MAKIFGGNQDQAD---TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNEN  706 (808)
Q Consensus       630 la~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~  706 (808)
                      +...++.......   .....|...|++||.. .+.++.+.|+|++|.++.|..++-.........      .|...+..
T Consensus       269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------~W~~~r~~  341 (524)
T KOG0601|consen  269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNS------SWSQLRQG  341 (524)
T ss_pred             eeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCC------Cccccccc
Confidence            9998865542211   1223577889999965 556788999999999999999987654321100      11111111


Q ss_pred             cchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHH
Q 003599          707 KILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       707 ~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      -    +...     +......++..++.++++.+|..|++.+.+..
T Consensus       342 ~----ip~e-----~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  342 Y----IPLE-----FCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             c----Cchh-----hhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            0    1111     11112233444888999999999997776543

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.14  E-value=5.6e-10  Score=110.44  Aligned_cols=137  Identities=15%  Similarity=0.131  Sum_probs=99.8

Q ss_pred             cCcccccCceeEEEEEecC-------CcEEEEEEecccc------------c----------ccHHHHH----HHHHHHH
Q 003599          487 SSKLGQGGFGPVYWGRLKD-------GQEIAVKRLSKAS------------G----------QGLEEFM----NEVMVIS  533 (808)
Q Consensus       487 ~~~lG~G~~g~Vy~~~~~~-------~~~vAvK~l~~~~------------~----------~~~~~~~----~E~~~l~  533 (808)
                      ...||.|--+.||.|...+       +..+|||+.+...            +          ...+.+.    +|.+.|.
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3579999999999998653       4799999875311            0          0122333    7999999


Q ss_pred             hccC--CceeeEeeEEEeCCeeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHh-HhcCCCcEEeCCC
Q 003599          534 KLQH--RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL-HRDSRLRIIHRDL  610 (808)
Q Consensus       534 ~l~H--~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yL-H~~~~~~ivH~Di  610 (808)
                      ++..  -++++++++    ...+|||||+.+..+..-.   .+...++..+...+..+++.+|..| |+.+   ++|+||
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~---Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL  151 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPK---LKDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL  151 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchh---hhccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence            9953  566777765    5678999999765442211   1122344456677889999999999 7777   999999


Q ss_pred             CCCceEeCCCCCeeeeccccceec
Q 003599          611 KASNILLDEELNPKISDFGMAKIF  634 (808)
Q Consensus       611 kp~NILl~~~~~~kl~DFGla~~~  634 (808)
                      ++.|||++ ++.+.|+|||.+...
T Consensus       152 s~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         152 SEYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             CHHHEEEE-CCcEEEEECCCceeC
Confidence            99999997 468999999988754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.10  E-value=6.2e-10  Score=113.95  Aligned_cols=142  Identities=18%  Similarity=0.287  Sum_probs=111.6

Q ss_pred             CcccccCceeEEEEEecCCcEEEEEEeccccc-ccHHHHHHHHHHHHhccC--CceeeEeeEEEeCC---eeEEEEEecC
Q 003599          488 SKLGQGGFGPVYWGRLKDGQEIAVKRLSKASG-QGLEEFMNEVMVISKLQH--RNLVRLLGCCVEGE---EKMLIYEYMP  561 (808)
Q Consensus       488 ~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~---~~~lV~E~~~  561 (808)
                      +.|+.|..+.||+++..+|+.+++|....... .....+..|+++++.+++  .++.+++.+.....   ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            67899999999999987778999999765322 245678899999999976  44677887766542   5689999999


Q ss_pred             CCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcC----------------------------------------
Q 003599          562 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS----------------------------------------  601 (808)
Q Consensus       562 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~----------------------------------------  601 (808)
                      +.++...+..    ..++..++..++.+++++|..||+..                                        
T Consensus        84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9988776521    34677778888888888888888531                                        


Q ss_pred             -------------CCcEEeCCCCCCceEeCC--CCCeeeecccccee
Q 003599          602 -------------RLRIIHRDLKASNILLDE--ELNPKISDFGMAKI  633 (808)
Q Consensus       602 -------------~~~ivH~Dikp~NILl~~--~~~~kl~DFGla~~  633 (808)
                                   ...++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                         245899999999999998  66789999998763

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.05  E-value=6.6e-10  Score=124.05  Aligned_cols=166  Identities=19%  Similarity=0.247  Sum_probs=125.9

Q ss_pred             ecCCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEecCCCCchhhccCCCCCCcCChhh
Q 003599          503 LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRK  582 (808)
Q Consensus       503 ~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~  582 (808)
                      ..++.+|.|+..+.......+...+-++.|+.++||||++++...+.....|||+|.+.  -|..++.+      +....
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~  105 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEE  105 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHH
Confidence            34688999998876655445567788999999999999999999999999999999873  45545532      33455


Q ss_pred             HHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCcccccceeccCCccChhhhccCC
Q 003599          583 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGR  662 (808)
Q Consensus       583 ~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  662 (808)
                      ..-.+.||+.||.|||+.+  .++|++|.-..|+|++.|..||++|.++........  ......--..|..|+.+....
T Consensus       106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~  181 (690)
T KOG1243|consen  106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE  181 (690)
T ss_pred             HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc
Confidence            5667899999999999776  499999999999999999999999998875432221  011112233566776553222


Q ss_pred             CCccccEEehhHHHHHHHhC
Q 003599          663 FSEKSDVFSFGVLLLEIVSG  682 (808)
Q Consensus       663 ~s~k~DvwSlGvil~elltG  682 (808)
                        -..|.|-||++++|++.|
T Consensus       182 --~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 --WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             --cchhhhhHHHHHHHHhCc
Confidence              346999999999999999

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.02  E-value=2.3e-09  Score=102.22  Aligned_cols=131  Identities=23%  Similarity=0.335  Sum_probs=102.2

Q ss_pred             CcccccCceeEEEEEecCCcEEEEEEe-cccc--cc-----cHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEEEe
Q 003599          488 SKLGQGGFGPVYWGRLKDGQEIAVKRL-SKAS--GQ-----GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       488 ~~lG~G~~g~Vy~~~~~~~~~vAvK~l-~~~~--~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  559 (808)
                      ..+++|+-+.+|.+.+. |.++++|.- ++.-  ++     ..++-.+|+++|.+++--.|.-.+=+..+.+...|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            46889999999999775 445666642 2221  11     134567899999999876666666666778888999999


Q ss_pred             cCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeecccccee
Q 003599          560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI  633 (808)
Q Consensus       560 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  633 (808)
                      +++..|.+.+...          +..++..+-+-+.-||..+   |+|+||.++||++..+. +.++||||+..
T Consensus        81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999999888542          3567778888888999998   99999999999998765 99999999974

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.00  E-value=3.3e-10  Score=125.49  Aligned_cols=248  Identities=20%  Similarity=0.192  Sum_probs=175.8

Q ss_pred             HHhcCCcccCcccccCceeEEEEEec--CCcEEEEEEecccccccHHH--HHHHHHHHHhc-cCCceeeEeeEEEeCCee
Q 003599          479 TATNNFQLSSKLGQGGFGPVYWGRLK--DGQEIAVKRLSKASGQGLEE--FMNEVMVISKL-QHRNLVRLLGCCVEGEEK  553 (808)
Q Consensus       479 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vAvK~l~~~~~~~~~~--~~~E~~~l~~l-~H~niv~l~g~~~~~~~~  553 (808)
                      ....+|..+..||.|.|+.|++...+  ++..+++|.+.+.......+  -+.|+.+...+ .|.++++....+......
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~  341 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG  341 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence            34567889999999999999987644  57789999876543332222  23566666666 589999988888888888


Q ss_pred             EEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCC-CCeeeeccccce
Q 003599          554 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE-LNPKISDFGMAK  632 (808)
Q Consensus       554 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~-~~~kl~DFGla~  632 (808)
                      ++=-||++++++...+   .....++...++++..|++.++.++|+..   ++|+|+||+||++..+ +.-++.|||...
T Consensus       342 ~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t  415 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWT  415 (524)
T ss_pred             cCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccc
Confidence            8889999999987665   23456888889999999999999999887   9999999999999886 888999999986


Q ss_pred             ecCCCCCcccccceeccCCcc--ChhhhccCCCCccccEEehhHHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchh
Q 003599          633 IFGGNQDQADTGRVVGTFGYM--SPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILA  710 (808)
Q Consensus       633 ~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  710 (808)
                      .+.-..     .......+++  +|+......+-.+.|++|||.-+.|.+++............             +..
T Consensus       416 ~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~-------------i~~  477 (524)
T KOG0601|consen  416 RLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLT-------------IRS  477 (524)
T ss_pred             ccceec-----ccccccccccccchhhccccccccccccccccccccccccCcccCccccccee-------------eec
Confidence            421111     0112233334  55555666788999999999999999999754321111000             000


Q ss_pred             ccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHHHhh
Q 003599          711 LVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS  756 (808)
Q Consensus       711 ~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~  756 (808)
                      -.-+.     .+. ...++..+...+...++..||.+.++..+.+.
T Consensus       478 ~~~p~-----~~~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~  517 (524)
T KOG0601|consen  478 GDTPN-----LPG-LKLQLQVLLKVMINPDRKRRPSAVELSLHSEF  517 (524)
T ss_pred             ccccC-----CCc-hHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence            00011     111 12556667778888999999988887665543

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.99  E-value=2.7e-09  Score=101.08  Aligned_cols=143  Identities=22%  Similarity=0.309  Sum_probs=107.4

Q ss_pred             ccCcccccCceeEEEEEecCCcEEEEEE-eccc--c-----cccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeEEEE
Q 003599          486 LSSKLGQGGFGPVYWGRLKDGQEIAVKR-LSKA--S-----GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  557 (808)
Q Consensus       486 ~~~~lG~G~~g~Vy~~~~~~~~~vAvK~-l~~~--~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  557 (808)
                      ....|-+|+-+.|+++.+. |+...||. +.+.  .     .-...+.++|++.|.+++--.|.-..=++.+...-.|+|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            4678999999999999987 66666664 3332  1     113456788999999997666666555667777788999


Q ss_pred             EecCC-CCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCC---eeeecccccee
Q 003599          558 EYMPN-RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELN---PKISDFGMAKI  633 (808)
Q Consensus       558 E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~---~kl~DFGla~~  633 (808)
                      ||+++ .++.+++......+..+ .....++.+|-+.+.-||..+   |+|+||..+||+|..++.   +.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d-~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESED-EGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccc-hhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence            99977 47788876543333222 222678888999999999998   999999999999965543   58999999864

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.87  E-value=2e-08  Score=99.11  Aligned_cols=125  Identities=26%  Similarity=0.312  Sum_probs=84.5

Q ss_pred             eEEEEEecCCcEEEEEEecccc--------------c-------c-----cHHHHHHHHHHHHhccCC--ceeeEeeEEE
Q 003599          497 PVYWGRLKDGQEIAVKRLSKAS--------------G-------Q-----GLEEFMNEVMVISKLQHR--NLVRLLGCCV  548 (808)
Q Consensus       497 ~Vy~~~~~~~~~vAvK~l~~~~--------------~-------~-----~~~~~~~E~~~l~~l~H~--niv~l~g~~~  548 (808)
                      .||.|...+|..+|||..+...              .       .     ......+|.+.|.++..-  ++++++++  
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--   78 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--   78 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence            4899999999999999875321              0       0     123456799999999765  56777755  


Q ss_pred             eCCeeEEEEEecC--CCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHH-hHhcCCCcEEeCCCCCCceEeCCCCCeee
Q 003599          549 EGEEKMLIYEYMP--NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY-LHRDSRLRIIHRDLKASNILLDEELNPKI  625 (808)
Q Consensus       549 ~~~~~~lV~E~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~y-LH~~~~~~ivH~Dikp~NILl~~~~~~kl  625 (808)
                        ....|||||++  +..+..+...     .++......++.++++.+.. +|..+   |+|+||.+.|||++++ .+.|
T Consensus        79 --~~~~ivME~I~~~G~~~~~l~~~-----~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   79 --NRNVIVMEYIGEDGVPLPRLKDV-----DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             --ETTEEEEE--EETTEEGGCHHHC-----GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred             --eCCEEEEEecCCCccchhhHHhc-----cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence              24579999998  5555443311     22245567788888886666 46777   9999999999999988 9999


Q ss_pred             eccccceec
Q 003599          626 SDFGMAKIF  634 (808)
Q Consensus       626 ~DFGla~~~  634 (808)
                      +|||.+...
T Consensus       148 IDf~qav~~  156 (188)
T PF01163_consen  148 IDFGQAVDS  156 (188)
T ss_dssp             --GTTEEET
T ss_pred             EecCcceec
Confidence            999998754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.76  E-value=2.5e-09  Score=124.27  Aligned_cols=251  Identities=18%  Similarity=0.168  Sum_probs=167.1

Q ss_pred             HHhcCCcccCcccccCceeEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHHhccCCceeeEeeEEEeCCeeE
Q 003599          479 TATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKM  554 (808)
Q Consensus       479 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  554 (808)
                      ...+.+.+.+.+-+|.++.+..++-. .|...+.|.....   .....+....+-.++-..+||-+++...-+.-.....
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~  880 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP  880 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence            34567888889999999999977643 2323333332211   1222233333333333345566776665555677889


Q ss_pred             EEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceec
Q 003599          555 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF  634 (808)
Q Consensus       555 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~  634 (808)
                      |+++|..+++|...|+..   +..+..-....+..+..+++|||...   +.|+|++|.|+++..++..+++|||.....
T Consensus       881 L~~~~~~~~~~~Skl~~~---~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v  954 (1205)
T KOG0606|consen  881 LVGHYLNGGDLPSKLHNS---GCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV  954 (1205)
T ss_pred             hhhHHhccCCchhhhhcC---CCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence            999999999999888653   23444444455667788999999876   899999999999999999999999844432


Q ss_pred             CCC-------------------------CCc----ccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCC
Q 003599          635 GGN-------------------------QDQ----ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKN  685 (808)
Q Consensus       635 ~~~-------------------------~~~----~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p  685 (808)
                      +..                         ...    .......||+.|.+||...+......+|.|++|++++|.++|..|
T Consensus       955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen  955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred             ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence            100                         000    012235689999999999999999999999999999999999999


Q ss_pred             CCCCCCchhhhhhhhhhhccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHH
Q 003599          686 TSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMS  748 (808)
Q Consensus       686 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~  748 (808)
                      +.....++..-.             ++...+.-...+.+...+..+++...+..+|.+|-.|.
T Consensus      1035 ~na~tpq~~f~n-------------i~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETPQQIFEN-------------ILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCcchhhhhhc-------------cccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            875444332211             11111111112233445566777778888898887665

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.75  E-value=6.7e-08  Score=101.14  Aligned_cols=134  Identities=19%  Similarity=0.126  Sum_probs=97.7

Q ss_pred             ceeEEEEEecCCcEEEEEEeccccc-----------ccHHHHHHHHHHHHhccCCce--eeEeeEEEe-----CCeeEEE
Q 003599          495 FGPVYWGRLKDGQEIAVKRLSKASG-----------QGLEEFMNEVMVISKLQHRNL--VRLLGCCVE-----GEEKMLI  556 (808)
Q Consensus       495 ~g~Vy~~~~~~~~~vAvK~l~~~~~-----------~~~~~~~~E~~~l~~l~H~ni--v~l~g~~~~-----~~~~~lV  556 (808)
                      ...|++..+. |+.+.||.......           .....+.+|...+.++...+|  ++++++.+.     ....+||
T Consensus        35 ~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV  113 (268)
T PRK15123         35 GRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII  113 (268)
T ss_pred             CceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence            3346676664 77899997643221           111247899999999854443  445556543     2346899


Q ss_pred             EEecCCC-CchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCC-------CCCeeeecc
Q 003599          557 YEYMPNR-SLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE-------ELNPKISDF  628 (808)
Q Consensus       557 ~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~-------~~~~kl~DF  628 (808)
                      +|++++. +|.+++.+.. ....+...+..++.++++.+.-||..+   |+|+|++++|||++.       +..+.|+||
T Consensus       114 te~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl  189 (268)
T PRK15123        114 TEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDL  189 (268)
T ss_pred             EeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEEC
Confidence            9999986 8988874321 234455677789999999999999999   999999999999975       567999999


Q ss_pred             cccee
Q 003599          629 GMAKI  633 (808)
Q Consensus       629 Gla~~  633 (808)
                      +.++.
T Consensus       190 ~r~~~  194 (268)
T PRK15123        190 HRAQI  194 (268)
T ss_pred             Ccccc
Confidence            98863

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.75  E-value=8.5e-08  Score=104.10  Aligned_cols=169  Identities=22%  Similarity=0.344  Sum_probs=127.1

Q ss_pred             ceeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHHhccCCceeeEeeEEE----eCCeeEEEEEecCC-CCchhh
Q 003599          495 FGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV----EGEEKMLIYEYMPN-RSLDAL  568 (808)
Q Consensus       495 ~g~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~----~~~~~~lV~E~~~~-gsL~~~  568 (808)
                      -.+.|++... ||..|++|+++....+....-..-++.++++.|.|+|++...+.    .+...++||+|.++ ++|.+.
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            3577888754 89999999995544333333345678899999999999988876    34567899999885 466554


Q ss_pred             ccCC------------CCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCC
Q 003599          569 LFDP------------LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  636 (808)
Q Consensus       569 l~~~------------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~  636 (808)
                      -+..            ......++..++.++.|++.||.++|+.|   +.-+-|.|.+||++.+.+++|+..|+...+..
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            4432            12334777899999999999999999999   88899999999999999999999888766533


Q ss_pred             CCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCC
Q 003599          637 NQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKN  685 (808)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p  685 (808)
                      +..                |.+..   -.+-|.=.||.+++.|.||...
T Consensus       446 d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  446 DPT----------------EPLES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCC----------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            320                11111   2356788899999999999643

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.73  E-value=2.1e-07  Score=98.51  Aligned_cols=263  Identities=14%  Similarity=0.123  Sum_probs=156.8

Q ss_pred             ccCcccccCceeEEEE-EecCCcEEEEEEecccccccHHHHHHHHHHHHhc-cCCceeeEeeEE-------EeCCeeEEE
Q 003599          486 LSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLVRLLGCC-------VEGEEKMLI  556 (808)
Q Consensus       486 ~~~~lG~G~~g~Vy~~-~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~-------~~~~~~~lV  556 (808)
                      ....||+|+.+.+|-. ...   ..+.|+..........+   .+..|... .||-+-.-+.+=       ..+...-+.
T Consensus        15 ~gr~LgqGgea~ly~l~e~~---d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl   88 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEVR---DQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL   88 (637)
T ss_pred             CCccccCCccceeeecchhh---chhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence            4578999999999943 222   23557766544332222   22233333 455433211110       112224567


Q ss_pred             EEecCCCCchhhccC----CCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccce
Q 003599          557 YEYMPNRSLDALLFD----PLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK  632 (808)
Q Consensus       557 ~E~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~  632 (808)
                      |..+++.-=-..+.+    +..-...+|.-.++.++.+|.+.+-||..+   .+-+|+.++|+|+.+++.+.|.|-....
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence            777766532222222    223346889999999999999999999998   8899999999999999999999877655


Q ss_pred             ecCCCCCcccccceeccCCccChhhhc-----cCCCCccccEEehhHHHHHHHhC-CCCCCCCCCchhhhhhhhhhhccc
Q 003599          633 IFGGNQDQADTGRVVGTFGYMSPEYAM-----EGRFSEKSDVFSFGVLLLEIVSG-RKNTSFFEDDLTILGYAWKLWNEN  706 (808)
Q Consensus       633 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DvwSlGvil~elltG-~~p~~~~~~~~~~~~~~~~~~~~~  706 (808)
                      ...+.   ......+|...|.+||.-.     +-.-+...|.|.||+++++++.| ++|++..........-.......+
T Consensus       166 i~~ng---~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g  242 (637)
T COG4248         166 INANG---TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG  242 (637)
T ss_pred             eccCC---ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence            44222   2223357889999999754     23456789999999999999887 888864321100000000000011


Q ss_pred             cchhccCCcccC--C--cccH-HHHHHHHHHHHhcccC--CcCCCCCHHHHHHHHhhcccC
Q 003599          707 KILALVDPFLSE--S--SFQL-DMIIRCIHVGLLCVQE--LVKDRPNMSTVVSMLNSEIRD  760 (808)
Q Consensus       707 ~~~~~~d~~l~~--~--~~~~-~~~~~l~~li~~cl~~--~P~~RPs~~ev~~~L~~~~~~  760 (808)
                      .....-|.....  .  ..+. -....+..+..+|+..  ++.-||+++..+..|..+.+.
T Consensus       243 ~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~  303 (637)
T COG4248         243 RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ  303 (637)
T ss_pred             eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence            111111100000  0  0111 1234556677777765  366899999999998765433

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.68  E-value=1.4e-07  Score=95.56  Aligned_cols=134  Identities=22%  Similarity=0.249  Sum_probs=98.6

Q ss_pred             CcccCcccccCceeEEEEEecCCcEEEEEEecccc----------------------cccHHHHHHHHHHHHhccCC--c
Q 003599          484 FQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKAS----------------------GQGLEEFMNEVMVISKLQHR--N  539 (808)
Q Consensus       484 ~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~----------------------~~~~~~~~~E~~~l~~l~H~--n  539 (808)
                      ..+..+||-|--+.||.|...+|.++|||.-+...                      ........+|.+.|.+|.-.  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            44568999999999999999999999999643210                      00123346799999999755  7


Q ss_pred             eeeEeeEEEeCCeeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCC
Q 003599          540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE  619 (808)
Q Consensus       540 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~  619 (808)
                      +++.+++    +...+|||++++--|...-        ++....-.|+..|++-+..+-..|   |||+|+++-||++++
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~  237 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE  237 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence            8888776    5678999999886664321        233334445555555555544555   999999999999999


Q ss_pred             CCCeeeeccccce
Q 003599          620 ELNPKISDFGMAK  632 (808)
Q Consensus       620 ~~~~kl~DFGla~  632 (808)
                      +|.+.++||--+.
T Consensus       238 dg~~~vIDwPQ~v  250 (304)
T COG0478         238 DGDIVVIDWPQAV  250 (304)
T ss_pred             CCCEEEEeCcccc
Confidence            9999999997665

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.54  E-value=2.7e-07  Score=104.45  Aligned_cols=159  Identities=21%  Similarity=0.297  Sum_probs=107.1

Q ss_pred             CCCCcCHHHHHHHh------------cCCcccCcccccCceeEEEEEecCCcEEEEEEeccccccc--------------
Q 003599          468 DLPLFQFEELATAT------------NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQG--------------  521 (808)
Q Consensus       468 ~l~~f~~~~l~~~~------------~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~~--------------  521 (808)
                      ..|.|++++.....            ..|. .+.|+.++-|.||+|++++|+.||||+.+..-...              
T Consensus       100 ~vpp~~~~~~~~iie~eLG~~iee~F~eF~-~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~  178 (517)
T COG0661         100 RVPPFPFEEAERIIEEELGRPIEELFSEFE-PEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARL  178 (517)
T ss_pred             CCCCCCHHHHHHHHHHHhCCCHHHHHHHcC-CCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHH
Confidence            45777777654432            2243 36799999999999999999999999987532110              


Q ss_pred             --------------------------HHHHHHHHHHHHhcc-----CCceeeEeeEEEeCCeeEEEEEecCCCCchhhcc
Q 003599          522 --------------------------LEEFMNEVMVISKLQ-----HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLF  570 (808)
Q Consensus       522 --------------------------~~~~~~E~~~l~~l~-----H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  570 (808)
                                                +-++.+|+..+.+++     .+++.-..=|........|+|||++|-.+.+...
T Consensus       179 ~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~  258 (517)
T COG0661         179 IKRLPPGGRRLDLVEVVDEFEKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAA  258 (517)
T ss_pred             HHHcCCccccCChHHHHHHHHHHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHH
Confidence                                      112345666666663     3443332333344577899999999999988753


Q ss_pred             CCCCCCcCChhhHHHHHHHHHHHH-HHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecC
Q 003599          571 DPLKKERLDWRKRFNIIEGISRGL-LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG  635 (808)
Q Consensus       571 ~~~~~~~l~~~~~~~i~~~ia~~l-~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~  635 (808)
                      -  +...++   +..++..++++. ..+-..+   ++|.|.+|.||+++.++.+.+.|||+...+.
T Consensus       259 l--~~~g~d---~k~ia~~~~~~f~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         259 L--KSAGID---RKELAELLVRAFLRQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             H--HhcCCC---HHHHHHHHHHHHHHHHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence            2  112333   344555555542 2222234   9999999999999999999999999998764

>PRK09902 hypothetical protein; Provisional

Probab=98.52  E-value=1.3e-06  Score=86.74  Aligned_cols=139  Identities=16%  Similarity=0.152  Sum_probs=105.0

Q ss_pred             ccccCceeEEEEEecCCcEEEEEEeccc------ccccHHHHHHHHHHHHhccCC--ceeeEeeEEEeC----CeeEEEE
Q 003599          490 LGQGGFGPVYWGRLKDGQEIAVKRLSKA------SGQGLEEFMNEVMVISKLQHR--NLVRLLGCCVEG----EEKMLIY  557 (808)
Q Consensus       490 lG~G~~g~Vy~~~~~~~~~vAvK~l~~~------~~~~~~~~~~E~~~l~~l~H~--niv~l~g~~~~~----~~~~lV~  557 (808)
                      -|+||.+.|++.... |..+-+|+-...      .+.....|.+|...|.++...  .+++++.+....    -..+||+
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            467999999998776 447888876521      144678999999999999533  355555222221    2357999


Q ss_pred             EecCC-CCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCC--eeeecccccee
Q 003599          558 EYMPN-RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELN--PKISDFGMAKI  633 (808)
Q Consensus       558 E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~--~kl~DFGla~~  633 (808)
                      |-+.+ .+|.+++.+. ...+.+...+..++.++++.++-||+.+   +.|+|+.+.||+++.++.  ++++||.-++.
T Consensus       105 e~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            97753 5888887542 2335677788899999999999999998   999999999999986667  99999998774

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.50  E-value=5.8e-07  Score=90.91  Aligned_cols=108  Identities=23%  Similarity=0.246  Sum_probs=85.8

Q ss_pred             cHHHHHHHHHHHHhccC--CceeeEeeEEEeCC----eeEEEEEecCCC-CchhhccCCCCCCcCChhhHHHHHHHHHHH
Q 003599          521 GLEEFMNEVMVISKLQH--RNLVRLLGCCVEGE----EKMLIYEYMPNR-SLDALLFDPLKKERLDWRKRFNIIEGISRG  593 (808)
Q Consensus       521 ~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~----~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~  593 (808)
                      ......+|...+.++..  -..++.+++.+...    ..+||+|++++. +|.+++....   .++......++.++++.
T Consensus        54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~---~~~~~~~~~ll~~l~~~  130 (206)
T PF06293_consen   54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE---QLDPSQRRELLRALARL  130 (206)
T ss_pred             cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc---ccchhhHHHHHHHHHHH
Confidence            34567889998888854  34566777766532    348999999884 7998885421   25666778999999999


Q ss_pred             HHHhHhcCCCcEEeCCCCCCceEeCCCC---Ceeeeccccceec
Q 003599          594 LLYLHRDSRLRIIHRDLKASNILLDEEL---NPKISDFGMAKIF  634 (808)
Q Consensus       594 l~yLH~~~~~~ivH~Dikp~NILl~~~~---~~kl~DFGla~~~  634 (808)
                      ++-||..+   |+|+|+++.|||++.+.   .+.++||+-++..
T Consensus       131 i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  131 IAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            99999999   99999999999999887   8999999988753

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.43  E-value=9.1e-07  Score=99.75  Aligned_cols=158  Identities=18%  Similarity=0.277  Sum_probs=104.1

Q ss_pred             CCCCcCHHHHHHHhc------------CCcccCcccccCceeEEEEEecCCcEEEEEEeccccccc--------------
Q 003599          468 DLPLFQFEELATATN------------NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQG--------------  521 (808)
Q Consensus       468 ~l~~f~~~~l~~~~~------------~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~~--------------  521 (808)
                      ..|.++++|+....+            .|. .+.|+..+.|.||+|++++|+.||||+.+..-...              
T Consensus       136 ~~Pp~~~ee~~~i~e~ElG~~ie~if~~f~-~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~  214 (538)
T KOG1235|consen  136 QAPPFPWEEAFKIFEEELGAPIEDIFSEFD-EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKV  214 (538)
T ss_pred             cCCCCCHHHHHHHHHHHhCCCHHHHHHhcC-cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHH
Confidence            456677776654432            232 46899999999999999999999999876532111              


Q ss_pred             -----------------------HHHHHHHHHHHHhc----cCCc------eeeEeeEEEeCCeeEEEEEecCCCCchhh
Q 003599          522 -----------------------LEEFMNEVMVISKL----QHRN------LVRLLGCCVEGEEKMLIYEYMPNRSLDAL  568 (808)
Q Consensus       522 -----------------------~~~~~~E~~~l~~l----~H~n------iv~l~g~~~~~~~~~lV~E~~~~gsL~~~  568 (808)
                                             +=+|.+|++...++    .|-+      |++++-.  ....+.|+||||+|..+.+.
T Consensus       215 l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl  292 (538)
T KOG1235|consen  215 LQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDL  292 (538)
T ss_pred             HHHhCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCH
Confidence                                   12355666666555    3555      3333332  34578999999999988776


Q ss_pred             ccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCC----CCCeeeeccccceecC
Q 003599          569 LFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE----ELNPKISDFGMAKIFG  635 (808)
Q Consensus       569 l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~----~~~~kl~DFGla~~~~  635 (808)
                      ..-  ....++..   .|+..+.++.  +++.-..+++|+|-+|.||+++.    ++++.+.|||+.....
T Consensus       293 ~~i--~~~gi~~~---~i~~~l~~~~--~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  293 DAI--DKRGISPH---DILNKLVEAY--LEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             HHH--HHcCCCHH---HHHHHHHHHH--HHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            421  22334444   3444444432  22222234999999999999984    6789999999988653

>smart00473 PAN_AP divergent subfamily of APPLE domains

Probab=98.39  E-value=7.2e-07  Score=74.79  Aligned_cols=71  Identities=39%  Similarity=0.895  Sum_probs=55.5

Q ss_pred             CCCeeEeecccCCCccccc-CccchHHHHHHHhh-cCCceeeeecC-CeeEEEee-eeccccccccCCCccceEEE
Q 003599          337 EDGFSKLNKMKVPDFTEWT-SPATEDECREQCLK-NCSCIAYAFDG-GIGCMVWR-SINLIDIQRLPFGGTDLYIR  408 (808)
Q Consensus       337 ~~~f~~~~~~~~pd~~~~~-~~~s~~~C~~~Cl~-nCsC~a~~~~~-~~~C~~w~-~~~l~~~~~~~~~~~~lylr  408 (808)
                      ...|.+++++.+++..... ...++++|++.|++ +|+|.||.|.. +.+|.+|. + .+.+....+..+.++|.|
T Consensus         3 ~~~f~~~~~~~l~~~~~~~~~~~s~~~C~~~C~~~~~~C~s~~y~~~~~~C~l~~~~-~~~~~~~~~~~~~~~y~~   77 (78)
T smart00473        3 DDCFVRLPNTKLPGFSRIVISVASLEECASKCLNSNCSCRSFTYNNGTKGCLLWSES-SLGDARLFPSGGVDLYEK   77 (78)
T ss_pred             CceeEEecCccCCCCcceeEcCCCHHHHHHHhCCCCCceEEEEEcCCCCEEEEeeCC-ccccceecccCCceeEEe
Confidence            3569999999998665432 33499999999999 99999999984 67899999 6 777776555556667765

Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions.

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.39  E-value=1.6e-07  Score=105.69  Aligned_cols=153  Identities=20%  Similarity=0.347  Sum_probs=103.2

Q ss_pred             HHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccceecCCCCCc-------ccccceeccCCccChhhhc
Q 003599          587 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ-------ADTGRVVGTFGYMSPEYAM  659 (808)
Q Consensus       587 ~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~  659 (808)
                      +.+++.|+.|+|...  .+||++|.|++|.++.++..||+.|+.+.........       .......-...|.|||++.
T Consensus       105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            345568999999875  5999999999999999999999999988755431111       0011122456899999999


Q ss_pred             cCCCCccccEEehhHHHHHHHhCCCC-CCCCCCchhhhhhhhhhhccccchhccCCcccCCcccHHHHHHHHHHHHhccc
Q 003599          660 EGRFSEKSDVFSFGVLLLEIVSGRKN-TSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQ  738 (808)
Q Consensus       660 ~~~~s~k~DvwSlGvil~elltG~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~  738 (808)
                      ....+.++|+||+|+++|-+..|.++ +........   +..    ++   ...+...  ...+.+.+.++.+=+.+.+.
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~---~~~----~~---~~~~~~~--~~~s~~~p~el~~~l~k~l~  250 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS---YSF----SR---NLLNAGA--FGYSNNLPSELRESLKKLLN  250 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcch---hhh----hh---ccccccc--ccccccCcHHHHHHHHHHhc
Confidence            98889999999999999999955544 322211100   000    00   0011111  11334556677777888899


Q ss_pred             CCcCCCCCHHHHHHH
Q 003599          739 ELVKDRPNMSTVVSM  753 (808)
Q Consensus       739 ~~P~~RPs~~ev~~~  753 (808)
                      .++.-||++.++...
T Consensus       251 ~~~~~rp~~~~l~~~  265 (700)
T KOG2137|consen  251 GDSAVRPTLDLLLSI  265 (700)
T ss_pred             CCcccCcchhhhhcc
Confidence            999999987776543

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.36  E-value=4.6e-06  Score=85.53  Aligned_cols=132  Identities=16%  Similarity=0.188  Sum_probs=86.6

Q ss_pred             CcccccCceeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHHhccCCc--eeeEeeEEEeCCeeEEEEEecCCCC-
Q 003599          488 SKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN--LVRLLGCCVEGEEKMLIYEYMPNRS-  564 (808)
Q Consensus       488 ~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lV~E~~~~gs-  564 (808)
                      .+||+|..+.||+.   .+..+++|......  ......+|.++++.+..-+  +.+.+++....+...+|||+++|.. 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            58999999999984   24567888876533  3355688999999996544  4778888877778889999999863 


Q ss_pred             chhhccCCCCCCcCChhhHHHHHHHHHHHH---------------------------------------HHhHh-cCCCc
Q 003599          565 LDALLFDPLKKERLDWRKRFNIIEGISRGL---------------------------------------LYLHR-DSRLR  604 (808)
Q Consensus       565 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l---------------------------------------~yLH~-~~~~~  604 (808)
                      +...+..       +......++.++++.+                                       .+|.. .....
T Consensus        82 ~~~~~~~-------~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~  154 (226)
T TIGR02172        82 FSRIISD-------NPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST  154 (226)
T ss_pred             hhhhhcC-------CHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence            2211110       0011111111111111                                       12211 12235


Q ss_pred             EEeCCCCCCceEeCCCCCeeeeccccce
Q 003599          605 IIHRDLKASNILLDEELNPKISDFGMAK  632 (808)
Q Consensus       605 ivH~Dikp~NILl~~~~~~kl~DFGla~  632 (808)
                      ++|+|+.|.||++++++ +.|+||+.+.
T Consensus       155 ~~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       155 CLHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             eEecCCCCCcEEEcCCC-cEEEechhcC
Confidence            79999999999999988 9999999875

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>smart00108 B_lectin Bulb-type mannose-specific lectin

Probab=98.30  E-value=2.8e-06  Score=77.08  Aligned_cols=55  Identities=36%  Similarity=0.657  Sum_probs=44.4

Q ss_pred             EEEecCCcEEEEcCC-CcEEEeeccccccccceEEEEecCCCEEEEecccCceEecc
Q 003599           89 ITISEDGNLVLVNGQ-KEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWES  144 (808)
Q Consensus        89 l~~~~~G~L~l~~~~-~~~vWst~~~~~~~~~~~a~LldsGNlVl~~~~~~~~lWqS  144 (808)
                      +.+..||+||+.+.. +.++|++++.........+.|.++|||||++. ++.++|+|
T Consensus        24 ~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~-~g~~vW~S   79 (114)
T smart00108       24 LIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDG-DGRVVWSS   79 (114)
T ss_pred             cCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeC-CCCEEEEe
Confidence            445578999999865 58999999875444447899999999999987 57789998

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.23  E-value=1.5e-05  Score=80.33  Aligned_cols=154  Identities=19%  Similarity=0.232  Sum_probs=104.5

Q ss_pred             CcCHHHHHHHhcCCcccCcc---cccCceeEEEEEecCCcEEEEEEecccccc-------------------cHH-----
Q 003599          471 LFQFEELATATNNFQLSSKL---GQGGFGPVYWGRLKDGQEIAVKRLSKASGQ-------------------GLE-----  523 (808)
Q Consensus       471 ~f~~~~l~~~~~~~~~~~~l---G~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~-------------------~~~-----  523 (808)
                      ..+.+.+....++..+.+..   +.|--+.||+|...++..+|||+++.....                   ..+     
T Consensus        34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~  113 (268)
T COG1718          34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA  113 (268)
T ss_pred             hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence            34566666666776666654   456667899999888999999998643211                   111     


Q ss_pred             HHHHHHHHHHhcc--CCceeeEeeEEEeCCeeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcC
Q 003599          524 EFMNEVMVISKLQ--HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS  601 (808)
Q Consensus       524 ~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~  601 (808)
                      -..+|...|.++.  +-.+++.+++.    .-.|||||+....+   -....+.-.+...+...+..++++.+.-|-...
T Consensus       114 W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~---pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a  186 (268)
T COG1718         114 WARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGL---PAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEA  186 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCC---CCCCcccCCcCchhHHHHHHHHHHHHHHHHHhc
Confidence            1235788888874  45566666663    45899999965421   111112222333356677788888888887633


Q ss_pred             CCcEEeCCCCCCceEeCCCCCeeeeccccceec
Q 003599          602 RLRIIHRDLKASNILLDEELNPKISDFGMAKIF  634 (808)
Q Consensus       602 ~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~  634 (808)
                        ++||+||+.=|||+. ++.+.|+|||-+...
T Consensus       187 --~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~  216 (268)
T COG1718         187 --GLVHGDLSEYNILVH-DGEPYIIDVSQAVTI  216 (268)
T ss_pred             --CcccccchhhheEEE-CCeEEEEECcccccc
Confidence              399999999999999 889999999988744

>cd00028 B_lectin Bulb-type mannose-specific lectin

Probab=98.21  E-value=4.6e-06  Score=75.94  Aligned_cols=54  Identities=35%  Similarity=0.639  Sum_probs=43.4

Q ss_pred             EEec-CCcEEEEcCC-CcEEEeeccccccccceEEEEecCCCEEEEecccCceEecc
Q 003599           90 TISE-DGNLVLVNGQ-KEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWES  144 (808)
Q Consensus        90 ~~~~-~G~L~l~~~~-~~~vWst~~~~~~~~~~~a~LldsGNlVl~~~~~~~~lWqS  144 (808)
                      .... +|+||+.+.. ++++|++|+.........+.|.++|||||++. ++.++|+|
T Consensus        25 ~~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~-~g~~vW~S   80 (116)
T cd00028          25 IMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDG-SGTVVWSS   80 (116)
T ss_pred             CCCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcC-CCcEEEEe
Confidence            3444 8999998765 58999999875444667899999999999986 57789997

The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.20  E-value=1.5e-05  Score=79.43  Aligned_cols=137  Identities=16%  Similarity=0.203  Sum_probs=91.3

Q ss_pred             hcCCcccCcccccCceeEEEEEecCCcEEEEEEecccccccHHHHH---------HHHHHHHhccCCc---eeeEeeEEE
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFM---------NEVMVISKLQHRN---LVRLLGCCV  548 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~---------~E~~~l~~l~H~n---iv~l~g~~~  548 (808)
                      ..+|.+.+.+-......|.+-..+ |..+++|..+.......+.|+         +++..+.+++..+   +..++...+
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e  108 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE  108 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence            456777777777777677666655 688999988764433333332         3444444443322   222222222


Q ss_pred             -----eCCeeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCe
Q 003599          549 -----EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP  623 (808)
Q Consensus       549 -----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~  623 (808)
                           .....+++|||++|..|.++..       ++.    .++..+++++.-||+.|   ++|+|.+|.|+++++++ +
T Consensus       109 kk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-i  173 (229)
T PF06176_consen  109 KKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-I  173 (229)
T ss_pred             eeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-E
Confidence                 2345578999999988866541       221    35567888899999998   99999999999999655 9


Q ss_pred             eeecccccee
Q 003599          624 KISDFGMAKI  633 (808)
Q Consensus       624 kl~DFGla~~  633 (808)
                      +++||+..+.
T Consensus       174 ~iID~~~k~~  183 (229)
T PF06176_consen  174 RIIDTQGKRM  183 (229)
T ss_pred             EEEECccccc
Confidence            9999987764

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.11  E-value=1.4e-05  Score=82.23  Aligned_cols=144  Identities=24%  Similarity=0.226  Sum_probs=86.2

Q ss_pred             cCcccccCceeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHHhccCC--ceeeEeeEEEeC---CeeEEEEEecC
Q 003599          487 SSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHR--NLVRLLGCCVEG---EEKMLIYEYMP  561 (808)
Q Consensus       487 ~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~~~~~---~~~~lV~E~~~  561 (808)
                      ++.|+.|..+.||+....+ ..+++|.....  .....+.+|..+++.+...  .+.+++.+....   ...+++|++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            3578999999999999887 69999997554  4456778899999988533  356777655332   34689999999


Q ss_pred             CCCchh----------------hcc---CC-CCCCcCChhh---------HHHH------------HHHHHH-HHHHhHh
Q 003599          562 NRSLDA----------------LLF---DP-LKKERLDWRK---------RFNI------------IEGISR-GLLYLHR  599 (808)
Q Consensus       562 ~gsL~~----------------~l~---~~-~~~~~l~~~~---------~~~i------------~~~ia~-~l~yLH~  599 (808)
                      +..+..                .+.   .. .......+..         ....            ...+.+ .+..+++
T Consensus        79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (239)
T PF01636_consen   79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA  158 (239)
T ss_dssp             SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence            988877                110   10 0111111100         0000            111222 2333332


Q ss_pred             ----cCCCcEEeCCCCCCceEeC-CCCCeeeecccccee
Q 003599          600 ----DSRLRIIHRDLKASNILLD-EELNPKISDFGMAKI  633 (808)
Q Consensus       600 ----~~~~~ivH~Dikp~NILl~-~~~~~kl~DFGla~~  633 (808)
                          .....++|+|+.|.|||++ +++.+.|+||+.+..
T Consensus       159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence                2345699999999999999 666668999998753

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.08  E-value=3.7e-05  Score=80.00  Aligned_cols=141  Identities=16%  Similarity=0.136  Sum_probs=86.9

Q ss_pred             CcccccCc-eeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHHhcc-CCceeeEeeEEEeCCeeEEEEEecCCCCc
Q 003599          488 SKLGQGGF-GPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEKMLIYEYMPNRSL  565 (808)
Q Consensus       488 ~~lG~G~~-g~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gsL  565 (808)
                      +.|..|.. ..||+.... +..+.||+.....   .....+|+++++.+. +--+.+++++...++..++|||+++|.+|
T Consensus         4 ~~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l   79 (244)
T cd05150           4 ERVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA   79 (244)
T ss_pred             eecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence            34555555 688998765 4778888875432   345678999998884 44566788887766678999999999887


Q ss_pred             hhhcc-------------------CCCC-CCcCC--hhhHHHHHH--------------------HHHHHHHHhHh----
Q 003599          566 DALLF-------------------DPLK-KERLD--WRKRFNIIE--------------------GISRGLLYLHR----  599 (808)
Q Consensus       566 ~~~l~-------------------~~~~-~~~l~--~~~~~~i~~--------------------~ia~~l~yLH~----  599 (808)
                      .....                   .... ...+.  ...+.....                    .+.+.+..|-.    
T Consensus        80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  159 (244)
T cd05150          80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA  159 (244)
T ss_pred             hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence            64421                   0000 00000  000000000                    01111122211    


Q ss_pred             cCCCcEEeCCCCCCceEeCCCCCeeeeccccce
Q 003599          600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAK  632 (808)
Q Consensus       600 ~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~  632 (808)
                      ...+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus       160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             cCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            123458999999999999998778999999775

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.04  E-value=9.5e-07  Score=98.34  Aligned_cols=194  Identities=19%  Similarity=0.147  Sum_probs=141.1

Q ss_pred             HHHHHhcCCcccCcccccCceeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHHhccCCc-eeeEeeEEEeCCeeE
Q 003599          476 ELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN-LVRLLGCCVEGEEKM  554 (808)
Q Consensus       476 ~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~  554 (808)
                      .++..+.-+...+.+++++++.+||.+....+....+.+...     ....-++++|.+++||| .+..++-+..++...
T Consensus       236 ~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~  310 (829)
T KOG0576|consen  236 TLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLW  310 (829)
T ss_pred             cccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccc
Confidence            334444555556788999999999988654455556655432     44456899999999999 777777777778888


Q ss_pred             EEEEecCCC-CchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeecccccee
Q 003599          555 LIYEYMPNR-SLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI  633 (808)
Q Consensus       555 lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  633 (808)
                      ++++++..+ +-..-..  .....+...+...+.+.-++++++||+..   =+|+|    ||+..+ +..+..||+....
T Consensus       311 i~~~i~s~~rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~  380 (829)
T KOG0576|consen  311 IPMRICSTGRSSALEMT--VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQ  380 (829)
T ss_pred             hhhhhhcCCccccccCC--hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcc
Confidence            999999877 2211110  11123444455567777888999999875   58998    777766 6889999999886


Q ss_pred             cCCCCCcccccceeccCCccChhhhccCCCCccccEEehhHHHHHHHhCCCCCC
Q 003599          634 FGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTS  687 (808)
Q Consensus       634 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwSlGvil~elltG~~p~~  687 (808)
                      +.+..   ......+++.++|||......+..+-|+|++|+-..++.-|-+|..
T Consensus       381 L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  381 LTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             cCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            64432   2333578999999999999999999999999998888888877643

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.03  E-value=1.7e-05  Score=78.64  Aligned_cols=105  Identities=20%  Similarity=0.229  Sum_probs=84.2

Q ss_pred             HHHHHHHHhccC-CceeeEeeEEEeCCeeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCc
Q 003599          526 MNEVMVISKLQH-RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR  604 (808)
Q Consensus       526 ~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~  604 (808)
                      .+|..+|+.+++ +++++++|+|    ..++|.||...+++...-..-.+-...+|..|.+|+.++++.+.+|++.....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            358889999976 6999999998    35789999988766422100011224789999999999999999999866556


Q ss_pred             EEeCCCCCCceEeCCCCCeeeeccccceec
Q 003599          605 IIHRDLKASNILLDEELNPKISDFGMAKIF  634 (808)
Q Consensus       605 ivH~Dikp~NILl~~~~~~kl~DFGla~~~  634 (808)
                      +...|++|+|+-+++++++|++|...+...
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            888999999999999999999999877543

Proteins in this uncharacterised family are described as transmembrane proteins.

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.89  E-value=5.8e-05  Score=71.97  Aligned_cols=129  Identities=22%  Similarity=0.292  Sum_probs=90.6

Q ss_pred             cccCcccccCceeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHHhccCCcee-eEeeEEEeCCeeEEEEEecCCC
Q 003599          485 QLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV-RLLGCCVEGEEKMLIYEYMPNR  563 (808)
Q Consensus       485 ~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~E~~~~g  563 (808)
                      ...+.|++|.+|.||+|.+. |..+|+|+-+..+  ....+..|+++|..++-.++- +++.|-    ..++.|||+.|-
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~   97 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGR   97 (201)
T ss_pred             hhhhhhhcccccEEEEeecc-CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCc
Confidence            34578999999999999998 5689999876543  457889999999999877664 445442    234459999988


Q ss_pred             CchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCC-CCceEeCCCCCeeeecccccee
Q 003599          564 SLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLK-ASNILLDEELNPKISDFGMAKI  633 (808)
Q Consensus       564 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik-p~NILl~~~~~~kl~DFGla~~  633 (808)
                      .|.+.-..      .+-    +-+..+++.-.-|...+   |-|+.|. |..++|-.+..+.|+||..|+.
T Consensus        98 ~L~~~~~~------~~r----k~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          98 PLGKLEIG------GDR----KHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             chhhhhhc------ccH----HHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            88665421      011    22344555544455555   9999986 5555555555999999999873

>PLN02876 acyl-CoA dehydrogenase

Probab=97.82  E-value=0.00017  Score=88.24  Aligned_cols=79  Identities=19%  Similarity=0.394  Sum_probs=58.6

Q ss_pred             cCcccccCceeEEEEEecCC---cEEEEEEecccc-cccHHHHHHHHHHHHhcc-CCce--eeEeeEEEeC---CeeEEE
Q 003599          487 SSKLGQGGFGPVYWGRLKDG---QEIAVKRLSKAS-GQGLEEFMNEVMVISKLQ-HRNL--VRLLGCCVEG---EEKMLI  556 (808)
Q Consensus       487 ~~~lG~G~~g~Vy~~~~~~~---~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~-H~ni--v~l~g~~~~~---~~~~lV  556 (808)
                      .+.++.|.+..+|+....++   ..+++|+..... ......+.+|+++|+.+. |.++  ++++.+|.+.   ...++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            46789999999999887654   467778764322 123457889999999995 6665  7888888764   457899


Q ss_pred             EEecCCCCc
Q 003599          557 YEYMPNRSL  565 (808)
Q Consensus       557 ~E~~~~gsL  565 (808)
                      |||+++..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999998654

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.80  E-value=0.00015  Score=74.95  Aligned_cols=75  Identities=17%  Similarity=0.228  Sum_probs=48.4

Q ss_pred             cCcccccCce-eEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHHhccCC---ceeeEeeEEEeC---CeeEEEEEe
Q 003599          487 SSKLGQGGFG-PVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHR---NLVRLLGCCVEG---EEKMLIYEY  559 (808)
Q Consensus       487 ~~~lG~G~~g-~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~~~---~~~~lV~E~  559 (808)
                      ++.|+.||.. .||+.    +..+++|..+..  .....+.+|++++..+...   -+.++++.....   ...+++|++
T Consensus         2 ~~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~   75 (235)
T cd05155           2 IEPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW   75 (235)
T ss_pred             ceeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence            3567877777 48975    235777765432  2345788999999888532   344555443332   234789999


Q ss_pred             cCCCCchh
Q 003599          560 MPNRSLDA  567 (808)
Q Consensus       560 ~~~gsL~~  567 (808)
                      ++|.++.+
T Consensus        76 i~G~~l~~   83 (235)
T cd05155          76 LEGETATA   83 (235)
T ss_pred             ecCCCCCc
Confidence            99988753

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.78  E-value=0.00031  Score=69.98  Aligned_cols=128  Identities=20%  Similarity=0.237  Sum_probs=90.2

Q ss_pred             cCcccccCceeEEEEEecCCcEEEEEEecccc----------------cccHHHHHHHHHHHHhcc------CCceeeEe
Q 003599          487 SSKLGQGGFGPVYWGRLKDGQEIAVKRLSKAS----------------GQGLEEFMNEVMVISKLQ------HRNLVRLL  544 (808)
Q Consensus       487 ~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~----------------~~~~~~~~~E~~~l~~l~------H~niv~l~  544 (808)
                      ...||+|+.=.||.  +++.....||+.....                ....+++.+|+.-..++.      +.+|.+++
T Consensus         6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            46899999999994  4555667888886544                223566777777766665      88899999


Q ss_pred             eEEEeCCeeEEEEEecCCC------CchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeC
Q 003599          545 GCCVEGEEKMLIYEYMPNR------SLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD  618 (808)
Q Consensus       545 g~~~~~~~~~lV~E~~~~g------sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~  618 (808)
                      |+.......-+|+|.+.+.      +|.+++.    .+.++. ...+.+.   +-..||-+..   |+.+|++|+||++.
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~----~~~~~~-~~~~~L~---~f~~~l~~~~---Iv~~dl~~~NIv~~  152 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLK----EGGLTE-ELRQALD---EFKRYLLDHH---IVIRDLNPHNIVVQ  152 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHH----cCCccH-HHHHHHH---HHHHHHHHcC---CeecCCCcccEEEE
Confidence            9999999999999987532      4666663    334544 3333333   4445666665   99999999999995


Q ss_pred             CCC----Ceeeec
Q 003599          619 EEL----NPKISD  627 (808)
Q Consensus       619 ~~~----~~kl~D  627 (808)
                      ...    .+.|+|
T Consensus       153 ~~~~~~~~lvlID  165 (199)
T PF10707_consen  153 RRDSGEFRLVLID  165 (199)
T ss_pred             ecCCCceEEEEEe
Confidence            432    466776

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PRK10593 hypothetical protein; Provisional

Probab=97.77  E-value=0.00038  Score=74.59  Aligned_cols=76  Identities=11%  Similarity=0.047  Sum_probs=57.5

Q ss_pred             cCcccccCceeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHHhccC---CceeeEeeEEEeC---CeeEEEEEec
Q 003599          487 SSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQH---RNLVRLLGCCVEG---EEKMLIYEYM  560 (808)
Q Consensus       487 ~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~g~~~~~---~~~~lV~E~~  560 (808)
                      .+.||+|..+.||+....++ .+.+|..+.  ......|..|++.|+.+.-   ..++++++.+..+   +..+||||++
T Consensus        19 ~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i   95 (297)
T PRK10593         19 VECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL   95 (297)
T ss_pred             eeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence            46899999999999887666 466676432  1123688899999999853   4688899887643   5689999999


Q ss_pred             CCCCc
Q 003599          561 PNRSL  565 (808)
Q Consensus       561 ~~gsL  565 (808)
                      +++++
T Consensus        96 ~G~~~  100 (297)
T PRK10593         96 RGVSV  100 (297)
T ss_pred             CCEec
Confidence            98765

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.71  E-value=0.00036  Score=68.95  Aligned_cols=134  Identities=23%  Similarity=0.375  Sum_probs=95.0

Q ss_pred             CCCCcCHHHHHHHhcCCcccCcccccCc-eeEEEEEecCCcEEEEEEecc---cc--------c----------ccHHHH
Q 003599          468 DLPLFQFEELATATNNFQLSSKLGQGGF-GPVYWGRLKDGQEIAVKRLSK---AS--------G----------QGLEEF  525 (808)
Q Consensus       468 ~l~~f~~~~l~~~~~~~~~~~~lG~G~~-g~Vy~~~~~~~~~vAvK~l~~---~~--------~----------~~~~~~  525 (808)
                      .++.|+.     -+.+++.++.||.|.. |.||++++. |+.+|+|.++.   ..        .          .....|
T Consensus        28 KL~~F~~-----h~~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF  101 (207)
T PF13095_consen   28 KLEPFTH-----HGDDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPF  101 (207)
T ss_pred             CcCCcCC-----CCCcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChH
Confidence            4445655     2278889999999999 999999998 67999999332   00        0          112357


Q ss_pred             HHHHHHHHhcc---CCce--eeEeeEEEeC------------------CeeEEEEEecCCCCchhhccCCCCCCcCChhh
Q 003599          526 MNEVMVISKLQ---HRNL--VRLLGCCVEG------------------EEKMLIYEYMPNRSLDALLFDPLKKERLDWRK  582 (808)
Q Consensus       526 ~~E~~~l~~l~---H~ni--v~l~g~~~~~------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~  582 (808)
                      ..|.+...+|+   +.++  |+++||..-.                  ....||.||++...            .+    
T Consensus       102 ~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~----  165 (207)
T PF13095_consen  102 NCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PL----  165 (207)
T ss_pred             HHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------cc----
Confidence            88999988885   4566  9999997422                  12356777765422            11    


Q ss_pred             HHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCCCCCeeeeccccc
Q 003599          583 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA  631 (808)
Q Consensus       583 ~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla  631 (808)
                      ..+-+.+|.+-|..+|..+   |+-+|+++.|..     .-||+|||.+
T Consensus       166 ~~~~~~~~~~dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  166 QIRDIPQMLRDLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             chhHHHHHHHHHHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence            2234567777888899888   999999999986     4589999864

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.64  E-value=0.00033  Score=73.51  Aligned_cols=139  Identities=15%  Similarity=0.078  Sum_probs=80.0

Q ss_pred             cccccCceeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHHhccCCce-eeEeeEEEeCCeeEEEEEecCCCCchh
Q 003599          489 KLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL-VRLLGCCVEGEEKMLIYEYMPNRSLDA  567 (808)
Q Consensus       489 ~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~~~~gsL~~  567 (808)
                      .+..|-...+|+... +++.+++|..........-...+|.++++.+...++ .++++...    ..+||||++|..+..
T Consensus         3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL   77 (256)
T ss_pred             cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence            456677889998874 467888887654322211235779999998864333 34444432    368999999877643


Q ss_pred             h-----------------ccCCC-CCCcCChhhHH-HHHHH---------HHHHHHHhHhc-----CCCcEEeCCCCCCc
Q 003599          568 L-----------------LFDPL-KKERLDWRKRF-NIIEG---------ISRGLLYLHRD-----SRLRIIHRDLKASN  614 (808)
Q Consensus       568 ~-----------------l~~~~-~~~~l~~~~~~-~i~~~---------ia~~l~yLH~~-----~~~~ivH~Dikp~N  614 (808)
                      .                 ||... ...+++...+. ....+         +.+.+..+...     .+..++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence            2                 11110 01111211111 11111         11112222111     12358999999999


Q ss_pred             eEeCCCCCeeeecccccee
Q 003599          615 ILLDEELNPKISDFGMAKI  633 (808)
Q Consensus       615 ILl~~~~~~kl~DFGla~~  633 (808)
                      |++++++ +.|+||+.+..
T Consensus       158 il~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEEeCCC-CEEEeccccCc
Confidence            9999877 78999998763

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity

Probab=97.63  E-value=0.00076  Score=60.99  Aligned_cols=100  Identities=27%  Similarity=0.466  Sum_probs=64.7

Q ss_pred             CeEEeCCCeeEEEEecCCCCCceEEEEEeecCCCceEEEEe-cCCCCCCCCcceEEEecCCcEEEEcCCCcEEEeecccc
Q 003599           36 DAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVA-NRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSN  114 (808)
Q Consensus        36 ~~l~S~~g~F~lgF~~~~~~~~~ylgiw~~~~~~~t~vW~A-nr~~p~~~~~~~l~~~~~G~L~l~~~~~~~vWst~~~~  114 (808)
                      +.+.+.+|.+.|-|-..++     |-| |+.  ..+++|.. +...... ..+.+.|.+||||||.|..+.++|++... 
T Consensus        12 ~p~~~~s~~~~L~l~~dGn-----Lvl-~~~--~~~~iWss~~t~~~~~-~~~~~~L~~~GNlvl~d~~~~~lW~Sf~~-   81 (114)
T PF01453_consen   12 SPLTSSSGNYTLILQSDGN-----LVL-YDS--NGSVIWSSNNTSGRGN-SGCYLVLQDDGNLVLYDSSGNVLWQSFDY-   81 (114)
T ss_dssp             EEEEECETTEEEEEETTSE-----EEE-EET--TTEEEEE--S-TTSS--SSEEEEEETTSEEEEEETTSEEEEESTTS-
T ss_pred             cccccccccccceECCCCe-----EEE-EcC--CCCEEEEecccCCccc-cCeEEEEeCCCCEEEEeecceEEEeecCC-
Confidence            4455555888888865442     233 332  25679999 4343332 45789999999999999999999998432 


Q ss_pred             ccccceEEEEec--CCCEEEEecccCceEecccCCCc
Q 003599          115 LVNNSTSAQLLD--SGNLVLRDNINRAIVWESFQEPT  149 (808)
Q Consensus       115 ~~~~~~~a~Lld--sGNlVl~~~~~~~~lWqSFd~Pt  149 (808)
                        .+.+.+...+  .||++ ... ...+.|.|=+.|+
T Consensus        82 --ptdt~L~~q~l~~~~~~-~~~-~~~~sw~s~~dps  114 (114)
T PF01453_consen   82 --PTDTLLPGQKLGDGNVT-GKN-DSLTSWSSNTDPS  114 (114)
T ss_dssp             --SS-EEEEEET--TSEEE-EES-TSSEEEESS----
T ss_pred             --CccEEEeccCcccCCCc-ccc-ceEEeECCCCCCC
Confidence              2455677777  88998 553 4578899877663

Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B ....

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.58  E-value=0.00062  Score=70.34  Aligned_cols=74  Identities=18%  Similarity=0.262  Sum_probs=49.3

Q ss_pred             CcccccCceeEEEEEecC--CcEEEEEEecccccccHHHHHHHHHHHHhccCCc-eeeEeeEEEeCCeeEEEEEecCCCC
Q 003599          488 SKLGQGGFGPVYWGRLKD--GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN-LVRLLGCCVEGEEKMLIYEYMPNRS  564 (808)
Q Consensus       488 ~~lG~G~~g~Vy~~~~~~--~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~E~~~~gs  564 (808)
                      +.|..|-...+|+....+  +..+++|........ .-...+|+.++..+...+ .+++++...    ..+||||+++.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence            567788888999998764  678889977543221 122347888888885433 445554432    247999999987


Q ss_pred             ch
Q 003599          565 LD  566 (808)
Q Consensus       565 L~  566 (808)
                      +.
T Consensus        79 l~   80 (235)
T cd05157          79 LE   80 (235)
T ss_pred             CC
Confidence            63

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.53  E-value=0.00064  Score=72.95  Aligned_cols=142  Identities=17%  Similarity=0.181  Sum_probs=87.1

Q ss_pred             cCcccccCceeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHHhccCCc--eeeEeeE------EEeCCeeEEEEE
Q 003599          487 SSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN--LVRLLGC------CVEGEEKMLIYE  558 (808)
Q Consensus       487 ~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~------~~~~~~~~lV~E  558 (808)
                      .+.|..|....+|+....+ ..+++|+...   ........|++++..+++.+  +++++..      ....+..++|++
T Consensus        19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            4567778888999987654 4688898754   23456777888888885433  4455432      123445689999


Q ss_pred             ecCCCCchh----hc----------cCCC---CC-----CcCChhhHH----------HHHHHHHHHHHHhHh----cCC
Q 003599          559 YMPNRSLDA----LL----------FDPL---KK-----ERLDWRKRF----------NIIEGISRGLLYLHR----DSR  602 (808)
Q Consensus       559 ~~~~gsL~~----~l----------~~~~---~~-----~~l~~~~~~----------~i~~~ia~~l~yLH~----~~~  602 (808)
                      +++|..+..    ..          +...   ..     ....|....          .....+..++.++.+    ..+
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            999987643    00          1000   00     111221111          011223344455543    123


Q ss_pred             CcEEeCCCCCCceEeCCCCCeeeeccccce
Q 003599          603 LRIIHRDLKASNILLDEELNPKISDFGMAK  632 (808)
Q Consensus       603 ~~ivH~Dikp~NILl~~~~~~kl~DFGla~  632 (808)
                      ..++|+|+.|.|||++++..+.|+||+.+.
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            459999999999999998778999999875

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.52  E-value=0.0011  Score=73.34  Aligned_cols=76  Identities=14%  Similarity=0.194  Sum_probs=56.4

Q ss_pred             cCcccccCceeEEEEEecCC-cEEEEEEeccc------c-cccHHHHHHHHHHHHhcc---CCceeeEeeEEEeCCeeEE
Q 003599          487 SSKLGQGGFGPVYWGRLKDG-QEIAVKRLSKA------S-GQGLEEFMNEVMVISKLQ---HRNLVRLLGCCVEGEEKML  555 (808)
Q Consensus       487 ~~~lG~G~~g~Vy~~~~~~~-~~vAvK~l~~~------~-~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~l  555 (808)
                      .+.||.|.+..||++...+| +.|+||.-...      . +...+++..|.+.|..+.   -.++++++.+  +.+..++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            36899999999999999877 48999974321      1 234567888998888873   2457777777  3456789


Q ss_pred             EEEecCCCC
Q 003599          556 IYEYMPNRS  564 (808)
Q Consensus       556 V~E~~~~gs  564 (808)
                      |||++++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998643

>PRK05231 homoserine kinase; Provisional

Probab=97.43  E-value=0.0022  Score=69.68  Aligned_cols=141  Identities=16%  Similarity=0.213  Sum_probs=78.1

Q ss_pred             CcccccCceeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHHhccCCc--eeeEee------EEEeCCeeEEEEEe
Q 003599          488 SKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN--LVRLLG------CCVEGEEKMLIYEY  559 (808)
Q Consensus       488 ~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g------~~~~~~~~~lV~E~  559 (808)
                      +.|+.|....+|+....+| .+++|+...   ...+....|+.++..|...+  +.+++.      +....+..++++||
T Consensus        28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~  103 (319)
T PRK05231         28 KGIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF  103 (319)
T ss_pred             chhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence            4567777789999887655 688898752   12234445566666663222  333332      12234567899999


Q ss_pred             cCCCCchhh--------------ccCCCC--------CCcCCh-hhHHH------------HHHH-HHHHHHHhHhc---
Q 003599          560 MPNRSLDAL--------------LFDPLK--------KERLDW-RKRFN------------IIEG-ISRGLLYLHRD---  600 (808)
Q Consensus       560 ~~~gsL~~~--------------l~~~~~--------~~~l~~-~~~~~------------i~~~-ia~~l~yLH~~---  600 (808)
                      ++|..+...              ++....        ...+.| .+...            .+.+ +...+..+...   
T Consensus       104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  183 (319)
T PRK05231        104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP  183 (319)
T ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence            998764211              111000        001112 11111            1111 11122233211   


Q ss_pred             -CCCcEEeCCCCCCceEeCCCCCeeeeccccce
Q 003599          601 -SRLRIIHRDLKASNILLDEELNPKISDFGMAK  632 (808)
Q Consensus       601 -~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~  632 (808)
                       -+..++|+|++|.|||++.+...-|+||+.+.
T Consensus       184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence             23469999999999999977656899999875

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.35  E-value=0.0026  Score=68.62  Aligned_cols=143  Identities=17%  Similarity=0.188  Sum_probs=83.8

Q ss_pred             cCcccccCceeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHHhccCCc--eeeEeeEE------EeCCeeEEEEE
Q 003599          487 SSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN--LVRLLGCC------VEGEEKMLIYE  558 (808)
Q Consensus       487 ~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~------~~~~~~~lV~E  558 (808)
                      .+.++.|....+|+....++ .+++|+.....  ..++...|.+++..|...+  +++++...      ...+..++++|
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            45677777789999876655 57788765421  2345566777787774322  44444321      22456789999


Q ss_pred             ecCCCCchhh--------------ccCCCCC---------CcCChhhHH------------HHHHHHHHHHHHhHh----
Q 003599          559 YMPNRSLDAL--------------LFDPLKK---------ERLDWRKRF------------NIIEGISRGLLYLHR----  599 (808)
Q Consensus       559 ~~~~gsL~~~--------------l~~~~~~---------~~l~~~~~~------------~i~~~ia~~l~yLH~----  599 (808)
                      |++|..+...              ++.....         ..-.|....            .....+.+.++++..    
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            9998664311              1110000         001111110            011223344555543    


Q ss_pred             cCCCcEEeCCCCCCceEeCCCCCeeeeccccce
Q 003599          600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAK  632 (808)
Q Consensus       600 ~~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~  632 (808)
                      ..+..++|+|+++.||++++++.+.|+||+.+.
T Consensus       184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            223569999999999999998877899999874

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.11  E-value=0.0024  Score=68.69  Aligned_cols=140  Identities=26%  Similarity=0.349  Sum_probs=84.1

Q ss_pred             CcccccCceeEEEEEecC-------CcEEEEEEecccccccHHHHHHHHHHHHhccCCce-eeEeeEEEeCCeeEEEEEe
Q 003599          488 SKLGQGGFGPVYWGRLKD-------GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL-VRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       488 ~~lG~G~~g~Vy~~~~~~-------~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~  559 (808)
                      +.|..|-...+|+....+       ++.+++|+..... .......+|.+++..+...++ .++++++..    .+|+||
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence            456666677899888665       5789999875543 223455788888888854333 455555532    358999


Q ss_pred             cCCCCchhh-c----------------cCCCCCC------cCC--hhhHHH--------------------------HHH
Q 003599          560 MPNRSLDAL-L----------------FDPLKKE------RLD--WRKRFN--------------------------IIE  588 (808)
Q Consensus       560 ~~~gsL~~~-l----------------~~~~~~~------~l~--~~~~~~--------------------------i~~  588 (808)
                      ++|..+... +                |......      ..+  |..+.+                          +..
T Consensus        79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (302)
T cd05156          79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE  158 (302)
T ss_pred             eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence            998876432 1                1110000      000  111101                          111


Q ss_pred             HHHHHHHHhHh------cCCCcEEeCCCCCCceEeCCC----CCeeeeccccce
Q 003599          589 GISRGLLYLHR------DSRLRIIHRDLKASNILLDEE----LNPKISDFGMAK  632 (808)
Q Consensus       589 ~ia~~l~yLH~------~~~~~ivH~Dikp~NILl~~~----~~~kl~DFGla~  632 (808)
                      .+.+.+.+|..      ..+..++|+|+.|.|||++++    +.++++||..+.
T Consensus       159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            22223334432      244569999999999999985    889999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.09  E-value=0.0052  Score=65.56  Aligned_cols=138  Identities=17%  Similarity=0.238  Sum_probs=86.6

Q ss_pred             cCcccccCceeEEEEEecCCcEEEEEEecc--cccccHHHHHHHHHHHHhccC--CceeeEeeEEEeCC--eeEEEEEec
Q 003599          487 SSKLGQGGFGPVYWGRLKDGQEIAVKRLSK--ASGQGLEEFMNEVMVISKLQH--RNLVRLLGCCVEGE--EKMLIYEYM  560 (808)
Q Consensus       487 ~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~--~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~--~~~lV~E~~  560 (808)
                      .+.+..|-.-.+|..... ++.++++ ...  ..........+|..+|+.+.-  .-+.+.++.|.++.  ..+.||+|+
T Consensus        30 v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~v  107 (321)
T COG3173          30 VEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWV  107 (321)
T ss_pred             eeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEe
Confidence            344444444455655544 7778888 331  222334556678888888743  34556778887776  679999999


Q ss_pred             CCCCchhhccCCCCCCcCChhhHHHHH-HHHHHHHHHhHh----------------------------------------
Q 003599          561 PNRSLDALLFDPLKKERLDWRKRFNII-EGISRGLLYLHR----------------------------------------  599 (808)
Q Consensus       561 ~~gsL~~~l~~~~~~~~l~~~~~~~i~-~~ia~~l~yLH~----------------------------------------  599 (808)
                      ++..+.+.+....    ..    .+.+ ..+++.|+-||+                                        
T Consensus       108 eGe~~~~~~~~~~----~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~  179 (321)
T COG3173         108 EGEVVWSALPPES----LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPL  179 (321)
T ss_pred             cceeccCcCCccc----ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCch
Confidence            9865544332110    00    0111 234444444443                                        


Q ss_pred             ----------c-----CCCcEEeCCCCCCceEeCCCCCeeeeccccceec
Q 003599          600 ----------D-----SRLRIIHRDLKASNILLDEELNPKISDFGMAKIF  634 (808)
Q Consensus       600 ----------~-----~~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~~  634 (808)
                                +     ++..++|+|+++.||+++.+.-+-+.||+++..-
T Consensus       180 ~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         180 ADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             HHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence                      2     2356999999999999999988999999998754

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.89  E-value=0.0066  Score=64.36  Aligned_cols=73  Identities=18%  Similarity=0.242  Sum_probs=49.1

Q ss_pred             cCcccccCceeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHHhcc---CCceeeEeeEEEeCCeeEEEEEecCCC
Q 003599          487 SSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ---HRNLVRLLGCCVEGEEKMLIYEYMPNR  563 (808)
Q Consensus       487 ~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~E~~~~g  563 (808)
                      .+.|+.|....+|+.. .+++.+.||.-.   ......|..|.+-|+.|.   --.+++++++....+..+||+||++.+
T Consensus        22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~   97 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG   97 (288)
T ss_dssp             EEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred             eEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence            4678889999999988 567889999875   233467888988888883   455788999888878889999999877

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.77  E-value=0.012  Score=62.40  Aligned_cols=69  Identities=14%  Similarity=0.131  Sum_probs=41.0

Q ss_pred             cccCceeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHHhcc-C-C-ceeeEeeEEEeCCeeEEEEEecCCCCc
Q 003599          491 GQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-H-R-NLVRLLGCCVEGEEKMLIYEYMPNRSL  565 (808)
Q Consensus       491 G~G~~g~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-H-~-niv~l~g~~~~~~~~~lV~E~~~~gsL  565 (808)
                      ++|--..||.....+|..+++|.-+.  ........+|+++|+.+. | + -+.+++..    +...++|++++|..+
T Consensus        20 ~~g~~~~v~~i~~~~g~~~VlR~p~~--~~~~~~l~rE~~vL~~L~~~l~vpvP~~~~~----~~~~~~y~~i~G~p~   91 (276)
T cd05152          20 ESGLDFQVVFAKDTDGVPWVLRIPRR--PDVSERAAAEKRVLALVRKHLPVQVPDWRVH----TPELIAYPKLPGVPA   91 (276)
T ss_pred             CCcceeEEEEEEcCCCCeEEEEecCC--HHHHHHHHHHHHHHHHHHhcCCCCCCceeee----cCceEEEeccCCCcc
Confidence            44444556655555688999988643  223456788999999885 3 2 11222221    223567777777655

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=96.74  E-value=0.0046  Score=74.45  Aligned_cols=196  Identities=21%  Similarity=0.187  Sum_probs=133.3

Q ss_pred             HHHHHHHHHhccCCceeeEeeEEEeCCeeE----EEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhc
Q 003599          525 FMNEVMVISKLQHRNLVRLLGCCVEGEEKM----LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD  600 (808)
Q Consensus       525 ~~~E~~~l~~l~H~niv~l~g~~~~~~~~~----lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~  600 (808)
                      ..-|...+.++.|+|++.++.|..+....-    +..|+++.-++...+.   ....++....+.+..++.+|++|+|..
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q---~v~~i~~~~~r~~~~~~~~GL~~~h~~  305 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ---SVGSIPLETLRILHQKLLEGLAYLHSL  305 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh---hccccCHHHHHHHHHHHhhhHHHHHHh
Confidence            345777888899999999999987654333    3356777777777664   345678888888999999999999998


Q ss_pred             CCCcEEeCCCCCC---ceEeCCCCCeeee--ccccceecCCCCCcccccceeccCCccChhhhccCCCC--ccccEEehh
Q 003599          601 SRLRIIHRDLKAS---NILLDEELNPKIS--DFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFS--EKSDVFSFG  673 (808)
Q Consensus       601 ~~~~ivH~Dikp~---NILl~~~~~~kl~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s--~k~DvwSlG  673 (808)
                      .   ..|.-+..+   +--.+.++...++  ||+..+.+.......   ...-+..+.|||........  ...|+|.+|
T Consensus       306 ~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg  379 (1351)
T KOG1035|consen  306 S---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWCLG  379 (1351)
T ss_pred             c---cceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHHHH
Confidence            5   555555444   5555667777777  999887654322211   12335667788877655544  447999999


Q ss_pred             HHHHHHHhCCCCCCCCCCchhhhhhhhhhhccccchhccCCcccCCcccHHHHHHHHHHHHhcccCCcCCCCCHHHHHHH
Q 003599          674 VLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       674 vil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                      ..+..+..|..+.......                ..+++..     ..    ..+.....+|+..++++|+++.+++..
T Consensus       380 ll~~~~~~~~~i~~~~~~~----------------~~~l~~~-----~~----~~~~d~~~~~~~~~~~~Rl~~~~ll~~  434 (1351)
T KOG1035|consen  380 LLLLQLSQGEDISEKSAVP----------------VSLLDVL-----ST----SELLDALPKCLDEDSEERLSALELLTH  434 (1351)
T ss_pred             HHHhhhhhcCcccccccch----------------hhhhccc-----cc----hhhhhhhhhhcchhhhhccchhhhhhc
Confidence            9999999987653211100                0011100     11    144566678999999999999999887


Q ss_pred             H
Q 003599          754 L  754 (808)
Q Consensus       754 L  754 (808)
                      .
T Consensus       435 ~  435 (1351)
T KOG1035|consen  435 P  435 (1351)
T ss_pred             h
Confidence            6

>PLN02236 choline kinase

Probab=96.69  E-value=0.013  Score=64.28  Aligned_cols=141  Identities=21%  Similarity=0.277  Sum_probs=82.2

Q ss_pred             CcccccCceeEEEEEecC-----CcEEEEEEecccccccHHHHHHHHHHHHhccCCcee-eEeeEEEeCCeeEEEEEecC
Q 003599          488 SKLGQGGFGPVYWGRLKD-----GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV-RLLGCCVEGEEKMLIYEYMP  561 (808)
Q Consensus       488 ~~lG~G~~g~Vy~~~~~~-----~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~E~~~  561 (808)
                      +.|..|-.-.+|+....+     ++.|++|+.......... -.+|..+++.+..-++. ++++.+..+    .|+||++
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~  116 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH  116 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence            456567778899987542     367899987654333222 36789999888644443 555655332    5899998


Q ss_pred             CCCchhh-----------------ccCCC-CC-C-cCChhhHHHHHHH-----------------HHHHHHHh----Hh-
Q 003599          562 NRSLDAL-----------------LFDPL-KK-E-RLDWRKRFNIIEG-----------------ISRGLLYL----HR-  599 (808)
Q Consensus       562 ~gsL~~~-----------------l~~~~-~~-~-~l~~~~~~~i~~~-----------------ia~~l~yL----H~-  599 (808)
                      +.+|...                 +|... .. . ...+.+..++..+                 +...+..|    .. 
T Consensus       117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~  196 (344)
T PLN02236        117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD  196 (344)
T ss_pred             CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence            8776422                 11100 00 0 1112222222211                 11112222    21 


Q ss_pred             cCCCcEEeCCCCCCceEeCC-CCCeeeecccccee
Q 003599          600 DSRLRIIHRDLKASNILLDE-ELNPKISDFGMAKI  633 (808)
Q Consensus       600 ~~~~~ivH~Dikp~NILl~~-~~~~kl~DFGla~~  633 (808)
                      ..+..++|+|+++.|||+++ ++.+.++||..+..
T Consensus       197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            22346899999999999986 47899999998763

>cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins

Probab=96.45  E-value=0.0027  Score=52.40  Aligned_cols=32  Identities=19%  Similarity=0.712  Sum_probs=27.6

Q ss_pred             cchHHHHHHHhhcCCceeeeecC-CeeEEEeee
Q 003599          358 ATEDECREQCLKNCSCIAYAFDG-GIGCMVWRS  389 (808)
Q Consensus       358 ~s~~~C~~~Cl~nCsC~a~~~~~-~~~C~~w~~  389 (808)
                      .+.++|+..|+.+|+|.||.|.. ...|+++.+
T Consensus        25 ~s~~~Cq~~C~~~~~C~afT~~~~~~~C~lk~~   57 (73)
T cd01100          25 SSAEQCQAACTADPGCLAFTYNTKSKKCFLKSS   57 (73)
T ss_pred             CCHHHHHHHcCCCCCceEEEEECCCCeEEcccC
Confidence            38999999999999999999984 456988776

PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.36  E-value=0.011  Score=61.81  Aligned_cols=145  Identities=14%  Similarity=0.207  Sum_probs=98.2

Q ss_pred             cCHHHHHHHhcC---CcccCcccccCceeEEEEEecCCcEEEEEEeccc---------c--------ccc-----HHHHH
Q 003599          472 FQFEELATATNN---FQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKA---------S--------GQG-----LEEFM  526 (808)
Q Consensus       472 f~~~~l~~~~~~---~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~---------~--------~~~-----~~~~~  526 (808)
                      ++|..+....++   +.+.++||-|--+.||.+...+|++.++|.-+-.         .        ...     .-...
T Consensus        79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~  158 (465)
T KOG2268|consen   79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAAT  158 (465)
T ss_pred             chHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHH
Confidence            455555554443   6778899999999999999999999999853210         0        000     11234


Q ss_pred             HHHHHHHhccC--CceeeEeeEEEeCCeeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCc
Q 003599          527 NEVMVISKLQH--RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR  604 (808)
Q Consensus       527 ~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~  604 (808)
                      +|...|+.|..  --+++.+++    +..++|||++.+-.|...-+      ..+...   +...+..-|--|-.+|   
T Consensus       159 kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~------v~d~~~---ly~~lm~~Iv~la~~G---  222 (465)
T KOG2268|consen  159 KEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRH------VEDPPT---LYDDLMGLIVRLANHG---  222 (465)
T ss_pred             HHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeee------cCChHH---HHHHHHHHHHHHHHcC---
Confidence            68888888853  335566655    45689999998877754321      122222   3333444445555566   


Q ss_pred             EEeCCCCCCceEeCCCCCeeeeccccce
Q 003599          605 IIHRDLKASNILLDEELNPKISDFGMAK  632 (808)
Q Consensus       605 ivH~Dikp~NILl~~~~~~kl~DFGla~  632 (808)
                      +||+|..-=||+++++..++++||--..
T Consensus       223 lIHgDFNEFNimv~dd~~i~vIDFPQmv  250 (465)
T KOG2268|consen  223 LIHGDFNEFNIMVKDDDKIVVIDFPQMV  250 (465)
T ss_pred             ceecccchheeEEecCCCEEEeechHhh
Confidence            9999999999999999999999997543

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.29  E-value=0.042  Score=60.70  Aligned_cols=73  Identities=11%  Similarity=0.087  Sum_probs=51.3

Q ss_pred             cCcccccCceeEEEEEecCCcEEEEEEeccc----c---cccHHHHHHHHHHHHhcc---CCceeeEeeEEEeCCeeEEE
Q 003599          487 SSKLGQGGFGPVYWGRLKDGQEIAVKRLSKA----S---GQGLEEFMNEVMVISKLQ---HRNLVRLLGCCVEGEEKMLI  556 (808)
Q Consensus       487 ~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~----~---~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV  556 (808)
                      .+.||.|....||+.... +..++||.-...    .   +....+-..|++.|+.+.   ..++++++.++.  +..+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            468899999999998875 556889975421    1   113444455677776653   357888998876  456788


Q ss_pred             EEecCC
Q 003599          557 YEYMPN  562 (808)
Q Consensus       557 ~E~~~~  562 (808)
                      ||++++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999977

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.26  E-value=0.028  Score=60.92  Aligned_cols=74  Identities=15%  Similarity=0.185  Sum_probs=49.7

Q ss_pred             CcccccCceeEEEEEecCC-cEEEEEEecc-------cccccHHHHHHHHHHHHhcc--CC-ceeeEeeEEEeCCeeEEE
Q 003599          488 SKLGQGGFGPVYWGRLKDG-QEIAVKRLSK-------ASGQGLEEFMNEVMVISKLQ--HR-NLVRLLGCCVEGEEKMLI  556 (808)
Q Consensus       488 ~~lG~G~~g~Vy~~~~~~~-~~vAvK~l~~-------~~~~~~~~~~~E~~~l~~l~--H~-niv~l~g~~~~~~~~~lV  556 (808)
                      +.||-|....||++..++| +.|+||.-..       .-+-..++-.-|.+.|+...  -| .+++++.+  +.+...+|
T Consensus         1 ~EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~v   78 (370)
T TIGR01767         1 QEVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTV   78 (370)
T ss_pred             CcCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceeh
Confidence            3689999999999998754 5799996432       11334556667888887663  34 35555554  45566799


Q ss_pred             EEecCCC
Q 003599          557 YEYMPNR  563 (808)
Q Consensus       557 ~E~~~~g  563 (808)
                      ||+++..
T Consensus        79 MEdL~~~   85 (370)
T TIGR01767        79 MEDLSHH   85 (370)
T ss_pred             HhhCccc
Confidence            9998643

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.18  E-value=0.038  Score=59.03  Aligned_cols=140  Identities=20%  Similarity=0.244  Sum_probs=97.3

Q ss_pred             ccCcccccCceeEEEEEecCCcEEEEEEecccc-----c----cc-------------HH----HHHHHHHHHHhccCCc
Q 003599          486 LSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKAS-----G----QG-------------LE----EFMNEVMVISKLQHRN  539 (808)
Q Consensus       486 ~~~~lG~G~~g~Vy~~~~~~~~~vAvK~l~~~~-----~----~~-------------~~----~~~~E~~~l~~l~H~n  539 (808)
                      +...|..|--+.||.+.-.+|..+|||+++...     .    .+             .+    -...|++.|.+|+.-.
T Consensus       148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            445788899999999999999999999875320     0    00             01    1235888888887555


Q ss_pred             eeeEeeEEEeCCeeEEEEEecCCCCchhhccCCCCCCcCChhhHHHHHHHHHHHHHHhHhcCCCcEEeCCCCCCceEeCC
Q 003599          540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE  619 (808)
Q Consensus       540 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dikp~NILl~~  619 (808)
                      |.-.--...  ....|||+|+..   +.+-....+...++...+..+-.++++-|.-|.+.+  .+||.||+-=|+|+-+
T Consensus       228 IP~PePIlL--k~hVLVM~FlGr---dgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyhd  300 (520)
T KOG2270|consen  228 IPCPEPILL--KNHVLVMEFLGR---DGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYHD  300 (520)
T ss_pred             CCCCCceee--ecceEeeeeccC---CCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEEC
Confidence            432211111  234799999953   223333334556777788888889999999998888  5999999999999965


Q ss_pred             CCCeeeecccccee
Q 003599          620 ELNPKISDFGMAKI  633 (808)
Q Consensus       620 ~~~~kl~DFGla~~  633 (808)
                       |.+.|+|-+-+.-
T Consensus       301 -G~lyiIDVSQSVE  313 (520)
T KOG2270|consen  301 -GKLYIIDVSQSVE  313 (520)
T ss_pred             -CEEEEEEcccccc
Confidence             5889999887653

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.04  E-value=0.033  Score=60.67  Aligned_cols=141  Identities=18%  Similarity=0.281  Sum_probs=79.6

Q ss_pred             CcccccCceeEEEEEecC----CcEEEEEEecccccccHHHHHHHHHHHHhccCCce-eeEeeEEEeCCeeEEEEEecCC
Q 003599          488 SKLGQGGFGPVYWGRLKD----GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL-VRLLGCCVEGEEKMLIYEYMPN  562 (808)
Q Consensus       488 ~~lG~G~~g~Vy~~~~~~----~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~~~~  562 (808)
                      +.|..|=-..+|+....+    +..|++|+....... .-.-.+|..+++.+..-++ +++++++..+    +|.+|+++
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g   94 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINA   94 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcC
Confidence            455556677889887543    237889987654322 2223578889998865555 4566665322    58999987


Q ss_pred             CCchhh-------c----------cCCC-C-CC-cCChhhHHHHHHHH----------------------HHHHHHhH--
Q 003599          563 RSLDAL-------L----------FDPL-K-KE-RLDWRKRFNIIEGI----------------------SRGLLYLH--  598 (808)
Q Consensus       563 gsL~~~-------l----------~~~~-~-~~-~l~~~~~~~i~~~i----------------------a~~l~yLH--  598 (808)
                      ..|..-       +          |... . .. .--|....++..++                      .+-+..+.  
T Consensus        95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~  174 (330)
T PLN02421         95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI  174 (330)
T ss_pred             CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence            766321       1          1100 0 00 11122222222111                      11111111  


Q ss_pred             --h-cCCCcEEeCCCCCCceEeCC-CCCeeeecccccee
Q 003599          599 --R-DSRLRIIHRDLKASNILLDE-ELNPKISDFGMAKI  633 (808)
Q Consensus       599 --~-~~~~~ivH~Dikp~NILl~~-~~~~kl~DFGla~~  633 (808)
                        . ..+.-++|+|+.+.|||+++ ++.++++||..|-.
T Consensus       175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence              1 12234899999999999975 57899999998753

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=95.93  E-value=0.023  Score=57.61  Aligned_cols=123  Identities=20%  Similarity=0.260  Sum_probs=60.4

Q ss_pred             CcEEEEEEecccccccHHHHHHHHHHHHhccCCce-eeEeeEEEeCCeeEEEEEecCCCCchhh-ccC------------
Q 003599          506 GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL-VRLLGCCVEGEEKMLIYEYMPNRSLDAL-LFD------------  571 (808)
Q Consensus       506 ~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~~~~gsL~~~-l~~------------  571 (808)
                      ++.|+||+.... ....-.-..|..+++.+...++ .++++++..    ..|+||+++..|..- +.+            
T Consensus         2 ~~~~~~Ri~g~~-t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~   76 (211)
T PF01633_consen    2 PEKYLVRIPGEG-TENFIDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFIEGRTLSPEDFRNPEILKRIAKLLA   76 (211)
T ss_dssp             TSEEEEEEEESC-GCSHHHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred             CCEEEEEeCCCC-cccccCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEecccccChhhccChHHHHHHHHHHH
Confidence            467888887554 3344566789999998865444 556665433    257799977665331 110            


Q ss_pred             ------C--CCCCcCChhhHHHH----------------------HHHHHHHHHHhHh-----cCCCcEEeCCCCCCceE
Q 003599          572 ------P--LKKERLDWRKRFNI----------------------IEGISRGLLYLHR-----DSRLRIIHRDLKASNIL  616 (808)
Q Consensus       572 ------~--~~~~~l~~~~~~~i----------------------~~~ia~~l~yLH~-----~~~~~ivH~Dikp~NIL  616 (808)
                            .  .....--|....++                      ...+.+-+..+..     ..+..+.|+|+.|.|||
T Consensus        77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil  156 (211)
T PF01633_consen   77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL  156 (211)
T ss_dssp             HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred             HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence                  0  00000001111111                      0111111222111     11235899999999999


Q ss_pred             e-CCCCCeeeecccccee
Q 003599          617 L-DEELNPKISDFGMAKI  633 (808)
Q Consensus       617 l-~~~~~~kl~DFGla~~  633 (808)
                      + +.++.++++||..+..
T Consensus       157 ~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  157 INNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             ETSSSSCEEE--GTT-EE
T ss_pred             eccCCCeEEEecHHHHhh
Confidence            9 8899999999998864

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=95.69  E-value=0.1  Score=56.27  Aligned_cols=32  Identities=28%  Similarity=0.381  Sum_probs=28.5

Q ss_pred             CCcEEeCCCCCCceEeCCCCCeeeecccccee
Q 003599          602 RLRIIHRDLKASNILLDEELNPKISDFGMAKI  633 (808)
Q Consensus       602 ~~~ivH~Dikp~NILl~~~~~~kl~DFGla~~  633 (808)
                      +..++|+|+.++|||++.++.+.++||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            44699999999999999999999999998763

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	808
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-57
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-56
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-44
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-43
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		8e-38
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-37
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-37
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		5e-36
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-25
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		6e-25
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-24
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-24
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		4e-24
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		5e-24
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		5e-24
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		6e-24
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		6e-24
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		7e-24
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		7e-24
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		7e-24
3a4o_X	286	Lyn Kinase Domain Length = 286		8e-24
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		8e-24
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		9e-24
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-23
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-23
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-23
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-23
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-23
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-23
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-23
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-23
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-23
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-23
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-23
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-23
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-23
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-23
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-23
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-23
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		4e-23
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		4e-23
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		4e-23
2pl0_A	289	Lck Bound To Imatinib Length = 289		4e-23
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		5e-23
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		6e-23
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-23
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-22
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-22
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-22
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-22
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-22
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-22
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-22
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-22
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-22
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-22
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-22
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-22
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-22
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-22
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-22
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-22
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-22
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-22
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-22
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-22
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-22
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-22
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-22
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-22
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-22
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-22
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-22
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		4e-22
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		6e-22
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		6e-22
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		7e-22
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-21
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-21
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-21
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-21
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-21
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		3e-21
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-21
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		5e-21
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		6e-21
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		7e-21
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		7e-21
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-20
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-20
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-20
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		3e-20
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		5e-20
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		5e-20
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		5e-20
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		5e-20
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		6e-20
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		6e-20
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		7e-20
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		7e-20
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-19
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-19
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-19
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-19
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-19
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-19
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-19
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-19
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-19
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-19
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-19
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-19
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-19
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-19
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-19
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-19
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-19
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-19
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-19
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-19
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-19
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-19
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-19
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-19
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-19
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-19
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-19
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		3e-19
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-19
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-19
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-19
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-19
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		3e-19
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-19
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-19
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-19
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-19
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-19
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-19
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-19
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		3e-19
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		4e-19
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-19
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		4e-19
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-19
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		5e-19
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-19
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		5e-19
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-19
4h58_A	275	Braf In Complex With Compound 3 Length = 275		5e-19
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		5e-19
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		5e-19
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		5e-19
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		5e-19
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		5e-19
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		5e-19
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		5e-19
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-19
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		5e-19
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		5e-19
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-19
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		6e-19
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		6e-19
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		6e-19
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		6e-19
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		6e-19
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		6e-19
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		7e-19
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		7e-19
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		7e-19
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		7e-19
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		8e-19
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		9e-19
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-18
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-18
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-18
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-18
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-18
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-18
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-18
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-18
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-18
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-18
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-18
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-18
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-18
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-18
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-18
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-18
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-18
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-18
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-18
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-18
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-18
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		4e-18
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		4e-18
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		4e-18
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		5e-18
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		5e-18
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		5e-18
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-18
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-18
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		6e-18
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-18
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		6e-18
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		6e-18
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		6e-18
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		6e-18
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		7e-18
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		7e-18
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		7e-18
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		8e-18
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		8e-18
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		8e-18
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		8e-18
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		8e-18
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		8e-18
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		8e-18
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		8e-18
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		8e-18
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		9e-18
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		9e-18
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-17
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-17
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-17
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-17
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-17
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-17
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-17
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-17
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-17
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-17
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-17
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-17
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-17
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-17
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-17
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-17
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-17
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-17
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-17
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-17
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		4e-17
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		4e-17
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-17
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		5e-17
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		6e-17
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		6e-17
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-17
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		7e-17
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		7e-17
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		7e-17
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		7e-17
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		7e-17
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		8e-17
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		8e-17
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		8e-17
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		8e-17
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		8e-17
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		9e-17
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-16
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-16
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-16
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-16
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-16
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-16
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-16
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-16
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-16
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-16
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-16
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-16
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-16
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-16
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-16
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-16
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-16
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-16
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-16
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-16
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-16
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-16
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-16
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-16
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-16
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-16
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-16
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-16
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-16
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-16
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-16
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-16
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-16
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-16
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-16
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-16
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-16
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-16
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-16
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-16
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-16
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-16
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-16
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-16
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-16
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-16
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-16
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-16
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-16
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-16
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-16
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-16
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-16
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-16
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-16
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-16
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-16
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-16
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-16
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-16
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-16
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-16
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-16
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-16
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-16
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		4e-16
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		4e-16
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		4e-16
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-16
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-16
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-16
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		5e-16
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		5e-16
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		5e-16
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		5e-16
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-16
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		6e-16
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		6e-16
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		6e-16
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		6e-16
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		6e-16
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		6e-16
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		6e-16
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-16
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-16
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-16
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		7e-16
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		7e-16
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		7e-16
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-16
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		8e-16
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		8e-16
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-16
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		8e-16
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		8e-16
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		8e-16
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		8e-16
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		8e-16
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		8e-16
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		8e-16
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		8e-16
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		8e-16
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		8e-16
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		8e-16
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		8e-16
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		9e-16
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		9e-16
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		9e-16
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-16
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-15
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-15
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-15
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-15
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-15
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-15
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-15
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-15
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-15
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-15
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-15
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-15
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-15
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-15
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-15
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-15
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-15
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-15
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-15
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-15
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-15
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-15
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-15
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-15
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-15
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-15
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-15
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-15
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-15
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-15
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-15
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		4e-15
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-15
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-15
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		4e-15
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		4e-15
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-15
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-15
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-15
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-15
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-15
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		7e-15
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		7e-15
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		7e-15
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		8e-15
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		8e-15
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-15
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		9e-15
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		9e-15
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		9e-15
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-14
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-14
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-14
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-14
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-14
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-14
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-14
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-14
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-14
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-14
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-14
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-14
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-14
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-14
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-14
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-14
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-14
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-14
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-14
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-14
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-14
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-14
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-14
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-14
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-14
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-14
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-14
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-14
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-14
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-14
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-14
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-14
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-14
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-14
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-14
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-14
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-14
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-14
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-14
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-14
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-14
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-14
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		4e-14
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-14
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		5e-14
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		5e-14
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		5e-14
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		5e-14
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		5e-14
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		5e-14
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		5e-14
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		5e-14
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-14
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		5e-14
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-14
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-14
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		5e-14
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-14
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		5e-14
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		6e-14
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		6e-14
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-14
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-14
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		6e-14
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		6e-14
3a7f_A	303	Human Mst3 Kinase Length = 303		6e-14
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-14
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		6e-14
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		6e-14
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		6e-14
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-14
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		6e-14
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		6e-14
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-14
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-14
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		6e-14
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		6e-14
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		7e-14
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		7e-14
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		7e-14
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		7e-14
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		7e-14
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		7e-14
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		8e-14
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		8e-14
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		8e-14
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		8e-14
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		8e-14
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		8e-14
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-14
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		9e-14
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		9e-14
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-13
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-13
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-13
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-13
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-13
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-13
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-13
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-13
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-13
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-13
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-13
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-13
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-13
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-13
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-13
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-13
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-13
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-13
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-13
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-13
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-13
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-13
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-13
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-13
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-13
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-13
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-13
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-13
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-13
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-13
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-13
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-13
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-13
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		4e-13
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-13
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-13
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		4e-13
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-13
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-13
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-13
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		4e-13
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		5e-13
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-13
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		5e-13
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		5e-13
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		5e-13
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		5e-13
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		6e-13
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		6e-13
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		6e-13
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		6e-13
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		6e-13
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		6e-13
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		6e-13
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		6e-13
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		6e-13
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		6e-13
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		6e-13
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		6e-13
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		6e-13
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		6e-13
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		7e-13
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		7e-13
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		7e-13
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		7e-13
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		7e-13
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		7e-13
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		7e-13
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		7e-13
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		8e-13
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		8e-13
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		8e-13
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		8e-13
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		9e-13
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		9e-13
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		9e-13
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-12
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-12
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-12
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-12
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-12
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-12
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-12
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-12
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-12
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-12
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-12
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-12
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-12
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-12
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-12
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-12
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-12
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-12
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-12
3soa_A	444	Full-Length Human Camkii Length = 444		2e-12
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-12
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-12
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-12
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-12
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-12
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-12
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-12
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-12
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-12
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-12
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-12
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-12
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-12
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-12
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-12
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-12
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-12
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-12
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-12
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-12
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-12
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		4e-12
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		4e-12
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		4e-12
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-12
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		4e-12
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		4e-12
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		4e-12
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-12
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-12
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-12
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		4e-12
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		4e-12
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		5e-12
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		5e-12
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		5e-12
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		5e-12
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		5e-12
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		5e-12
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		5e-12
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		5e-12
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		6e-12
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		6e-12
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		6e-12
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		6e-12
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		6e-12
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		7e-12
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-12
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-12
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		8e-12
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-12
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		9e-12
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		9e-12
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-11
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-11
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-11
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-11
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-11
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-11
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-11
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-11
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-11
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-11
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-11
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-11
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-11
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-11
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-11
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-11
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-11
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-11
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-11
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-11
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-11
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-11
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-11
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-11
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-11
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-11
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-11
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-11
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-11
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-11
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-11
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-11
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-11
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-11
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-11
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-11
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-11
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-11
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		4e-11
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		4e-11
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		4e-11
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		4e-11
4exu_A	371	Mapk13, Inactive Form Length = 371		4e-11
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		4e-11
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		4e-11
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		5e-11
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-11
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		5e-11
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		5e-11
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		5e-11
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		5e-11
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		6e-11
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		6e-11
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		6e-11
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		6e-11
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-11
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		6e-11
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		6e-11
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-11
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		6e-11
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		6e-11
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-11
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-11
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		6e-11
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		6e-11
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		7e-11
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		7e-11
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		7e-11
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		7e-11
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		7e-11
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		8e-11
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		8e-11
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		8e-11
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-11
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		8e-11
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		9e-11
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		9e-11
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		9e-11
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		9e-11
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		9e-11
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-10
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-10
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-10
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-10
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-10
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-10
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-10
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-10
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-10
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-10
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-10
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-10
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-10
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-10
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-10
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-10
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-10
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-10
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-10
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-10
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-10
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-10
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-10
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-10
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-10
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-10
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-10
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-10
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-10
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-10
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-10
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-10
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		3e-10
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-10
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-10
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-10
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-10
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-10
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		3e-10
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		3e-10
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		3e-10
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		3e-10
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-10
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-10
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-10
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		5e-10
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		5e-10
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		5e-10
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		5e-10
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		5e-10
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		5e-10
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		5e-10
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		5e-10
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		5e-10
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		5e-10
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		6e-10
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		6e-10
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		6e-10
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		6e-10
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		6e-10
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		6e-10
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		6e-10
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		6e-10
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		7e-10
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		7e-10
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		7e-10
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		7e-10
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		9e-10
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		9e-10
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		9e-10
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		9e-10
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		9e-10
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		9e-10
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-09
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-09
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-09
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-09
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-09
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-09
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-09
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-09
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-09
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-09
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-09
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-09
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-09
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-09
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-09
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-09
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-09
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-09
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-09
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-09
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-09
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		3e-09
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		3e-09
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-09
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		4e-09
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		4e-09
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-09
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		4e-09
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		4e-09
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		4e-09
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-09
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-09
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-09
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		5e-09
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		5e-09
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		5e-09
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		5e-09
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		6e-09
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		6e-09
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		8e-09
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		9e-09
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-08
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-08
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-08
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-08
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-08
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-08
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-08
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-08
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-08
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-08
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-08
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-08
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-08
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-08
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-08
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-08
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-08
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-08
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-08
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-08
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-08
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-08
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-08
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-08
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-08
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-08
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		3e-08
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-08
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		3e-08
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-08
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-08
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-08
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-08
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-08
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		3e-08
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-08
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-08
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-08
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		4e-08
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		4e-08
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-08
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		4e-08
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		4e-08
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-08
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-08
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-08
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		4e-08
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		5e-08
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		5e-08
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		5e-08
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		5e-08
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		5e-08
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		5e-08
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		5e-08
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		5e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		5e-08
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-08
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		5e-08
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		6e-08
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		6e-08
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		6e-08
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-08
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		6e-08
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		6e-08
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		6e-08
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		6e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		6e-08
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		6e-08
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		6e-08
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		6e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		6e-08
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		7e-08
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		7e-08
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		7e-08
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		7e-08
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		7e-08
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		8e-08
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		8e-08
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		8e-08
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		9e-08
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		9e-08
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-07
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-07
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-07
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-07
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-07
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		2e-07
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-07
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-07
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-07
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-07
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-07
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-07
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-07
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-07
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-07
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-07
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-07
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-07
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-07
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		3e-07
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		3e-07
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		3e-07
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-07
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		3e-07
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		4e-07
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		4e-07
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		5e-07
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		5e-07
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		5e-07
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		5e-07
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		5e-07
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-07
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		5e-07
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		5e-07
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		6e-07
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		6e-07
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		6e-07
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		6e-07
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		6e-07
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		7e-07
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		7e-07
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		7e-07
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		7e-07
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		7e-07
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		7e-07
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		7e-07
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		8e-07
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-06
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-06
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-06
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-06
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-06

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  220 bits (561), Expect = 2e-57,   Method: Compositional matrix adjust.
 Identities = 130/300 (43%), Positives = 181/300 (60%), Gaps = 8/300 (2%)
Query: 464 VKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLE 523
           V L  L  F   EL  A++NF   + LG+GGFG VY GRL DG  +AVKRL +   QG E
Sbjct: 20  VHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGE 79
Query: 524 -EFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD-PLKKERLDWR 581
            +F  EV +IS   HRNL+RL G C+   E++L+Y YM N S+ + L + P  +  LDW 
Sbjct: 80  LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWP 139
Query: 582 KRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA 641
           KR  I  G +RGL YLH     +IIHRD+KA+NILLDEE    + DFG+AK+    +D  
Sbjct: 140 KRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-DYKDXH 198
Query: 642 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFF----EDDLTILG 697
               V GT G+++PEY   G+ SEK+DVF +GV+LLE+++G++         +DD+ +L 
Sbjct: 199 VXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 258
Query: 698 YAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE 757
           +   L  E K+ ALVD  L + +++ + + + I V LLC Q    +RP MS VV ML  +
Sbjct: 259 WVKGLLKEKKLEALVDVDL-QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 317

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  218 bits (554), Expect = 1e-56,   Method: Compositional matrix adjust.
 Identities = 129/300 (43%), Positives = 180/300 (60%), Gaps = 8/300 (2%)
Query: 464 VKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLE 523
           V L  L  F   EL  A++NF   + LG+GGFG VY GRL DG  +AVKRL +   QG E
Sbjct: 12  VHLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGE 71
Query: 524 -EFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD-PLKKERLDWR 581
            +F  EV +IS   HRNL+RL G C+   E++L+Y YM N S+ + L + P  +  LDW 
Sbjct: 72  LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWP 131
Query: 582 KRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA 641
           KR  I  G +RGL YLH     +IIHRD+KA+NILLDEE    + DFG+AK+    +D  
Sbjct: 132 KRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-DYKDXH 190
Query: 642 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFF----EDDLTILG 697
               V G  G+++PEY   G+ SEK+DVF +GV+LLE+++G++         +DD+ +L 
Sbjct: 191 VXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250
Query: 698 YAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE 757
           +   L  E K+ ALVD  L + +++ + + + I V LLC Q    +RP MS VV ML  +
Sbjct: 251 WVKGLLKEKKLEALVDVDL-QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  177 bits (448), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 117/295 (39%), Positives = 171/295 (57%), Gaps = 12/295 (4%)
Query: 469 LPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNE 528
           +PL   EE   ATNNF     +G G FG VY G L+DG ++A+KR +  S QG+EEF  E
Sbjct: 29  VPLVDLEE---ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETE 85
Query: 529 VMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLF-DPLKKERLDWRKRFNII 587
           +  +S  +H +LV L+G C E  E +LIY+YM N +L   L+   L    + W +R  I 
Sbjct: 86  IETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEIC 145
Query: 588 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVV 647
            G +RGL YLH  +   IIHRD+K+ NILLDE   PKI+DFG++K  G   DQ     VV
Sbjct: 146 IGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKK-GTELDQTHLXXVV 201
Query: 648 -GTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNT--SFFEDDLTILGYAWKLWN 704
            GT GY+ PEY ++GR +EKSDV+SFGV+L E++  R     S   + + +  +A +  N
Sbjct: 202 KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN 261
Query: 705 ENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIR 759
             ++  +VDP L++   + + + +     + C+    +DRP+M  V+  L   +R
Sbjct: 262 NGQLEQIVDPNLAD-KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  174 bits (440), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 116/295 (39%), Positives = 170/295 (57%), Gaps = 12/295 (4%)
Query: 469 LPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNE 528
           +PL   EE   ATNNF     +G G FG VY G L+DG ++A+KR +  S QG+EEF  E
Sbjct: 29  VPLVDLEE---ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETE 85
Query: 529 VMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLF-DPLKKERLDWRKRFNII 587
           +  +S  +H +LV L+G C E  E +LIY+YM N +L   L+   L    + W +R  I 
Sbjct: 86  IETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEIC 145
Query: 588 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVV 647
            G +RGL YLH  +   IIHRD+K+ NILLDE   PKI+DFG++K  G    Q     VV
Sbjct: 146 IGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKK-GTELGQTHLXXVV 201
Query: 648 -GTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNT--SFFEDDLTILGYAWKLWN 704
            GT GY+ PEY ++GR +EKSDV+SFGV+L E++  R     S   + + +  +A +  N
Sbjct: 202 KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN 261
Query: 705 ENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIR 759
             ++  +VDP L++   + + + +     + C+    +DRP+M  V+  L   +R
Sbjct: 262 NGQLEQIVDPNLAD-KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  155 bits (392), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 93/221 (42%), Positives = 127/221 (57%), Gaps = 15/221 (6%)
Query: 472 FQFEELATATNNFQL------SSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEE- 524
           F F EL   TNNF         +K+G+GGFG VY G + +   +AVK+L+       EE 
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 525 ---FMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWR 581
              F  E+ V++K QH NLV LLG   +G++  L+Y YMPN SL   L        L W 
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 582 KRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA 641
            R  I +G + G+ +LH +     IHRD+K++NILLDE    KISDFG+A+         
Sbjct: 134 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 642 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
              R+VGT  YM+PE A+ G  + KSD++SFGV+LLEI++G
Sbjct: 191 MXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG 230

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  155 bits (391), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 93/221 (42%), Positives = 127/221 (57%), Gaps = 15/221 (6%)
Query: 472 FQFEELATATNNFQL------SSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEE- 524
           F F EL   TNNF         +K+G+GGFG VY G + +   +AVK+L+       EE 
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 525 ---FMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWR 581
              F  E+ V++K QH NLV LLG   +G++  L+Y YMPN SL   L        L W 
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 582 KRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA 641
            R  I +G + G+ +LH +     IHRD+K++NILLDE    KISDFG+A+         
Sbjct: 134 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 642 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
              R+VGT  YM+PE A+ G  + KSD++SFGV+LLEI++G
Sbjct: 191 MXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG 230

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  154 bits (390), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 93/221 (42%), Positives = 127/221 (57%), Gaps = 15/221 (6%)
Query: 472 FQFEELATATNNFQL------SSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEE- 524
           F F EL   TNNF         +K+G+GGFG VY G + +   +AVK+L+       EE 
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 67
Query: 525 ---FMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWR 581
              F  E+ V++K QH NLV LLG   +G++  L+Y YMPN SL   L        L W 
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 127
Query: 582 KRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA 641
            R  I +G + G+ +LH +     IHRD+K++NILLDE    KISDFG+A+         
Sbjct: 128 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 184
Query: 642 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
              R+VGT  YM+PE A+ G  + KSD++SFGV+LLEI++G
Sbjct: 185 MXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG 224

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  149 bits (376), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 91/221 (41%), Positives = 123/221 (55%), Gaps = 15/221 (6%)
Query: 472 FQFEELATATNNFQL------SSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEE- 524
           F F EL   TNNF         +K G+GGFG VY G + +   +AVK+L+       EE 
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 64
Query: 525 ---FMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWR 581
              F  E+ V +K QH NLV LLG   +G++  L+Y Y PN SL   L        L W 
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWH 124
Query: 582 KRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA 641
            R  I +G + G+ +LH +     IHRD+K++NILLDE    KISDFG+A+         
Sbjct: 125 XRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 181
Query: 642 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
              R+VGT  Y +PE A+ G  + KSD++SFGV+LLEI++G
Sbjct: 182 XXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITG 221

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  113 bits (282), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 114/201 (56%), Gaps = 6/201 (2%)
Query: 483 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNL 540
           +  +  K+G G FG V+      G ++AVK L +     + + EF+ EV ++ +L+H N+
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 541 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 600
           V  +G   +     ++ EY+   SL  LL     +E+LD R+R ++   +++G+ YLH +
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-N 155
Query: 601 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
               I+HRDLK+ N+L+D++   K+ DFG++++         +    GT  +M+PE   +
Sbjct: 156 RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASX--FLXSKXAAGTPEWMAPEVLRD 213
Query: 661 GRFSEKSDVFSFGVLLLEIVS 681
              +EKSDV+SFGV+L E+ +
Sbjct: 214 EPSNEKSDVYSFGVILWELAT 234

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  112 bits (281), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 115/201 (57%), Gaps = 6/201 (2%)
Query: 483 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNL 540
           +  +  K+G G FG V+      G ++AVK L +     + + EF+ EV ++ +L+H N+
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 541 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 600
           V  +G   +     ++ EY+   SL  LL     +E+LD R+R ++   +++G+ YLH +
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-N 155
Query: 601 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
               I+HR+LK+ N+L+D++   K+ DFG++++       + +    GT  +M+PE   +
Sbjct: 156 RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA--AGTPEWMAPEVLRD 213
Query: 661 GRFSEKSDVFSFGVLLLEIVS 681
              +EKSDV+SFGV+L E+ +
Sbjct: 214 EPSNEKSDVYSFGVILWELAT 234

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  110 bits (274), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 73/203 (35%), Positives = 111/203 (54%), Gaps = 13/203 (6%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 541
            + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+ KL+H  LV
Sbjct: 8   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 66
Query: 542 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE---GISRGLLYLH 598
           +L     E E   ++ EYM   SL     D LK E   + +   +++    I+ G+ Y+ 
Sbjct: 67  QLYAVVSE-EPIXIVTEYMSKGSL----LDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 121
Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 658
           R   +  +HRDL+A+NIL+ E L  K++DFG+A++   N+  A  G       + +PE A
Sbjct: 122 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKF-PIKWTAPEAA 177
Query: 659 MEGRFSEKSDVFSFGVLLLEIVS 681
           + GRF+ KSDV+SFG+LL E+ +
Sbjct: 178 LYGRFTIKSDVWSFGILLTELTT 200

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  110 bits (274), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 111/202 (54%), Gaps = 13/202 (6%)
Query: 483 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 542
           + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+ KL+H  LV+
Sbjct: 185 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQ 243
Query: 543 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE---GISRGLLYLHR 599
           L     E E   ++ EYM   SL     D LK E   + +   +++    I+ G+ Y+ R
Sbjct: 244 LYAVVSE-EPIYIVTEYMSKGSL----LDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 298
Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 659
              +  +HRDL+A+NIL+ E L  K++DFG+A++   N+  A  G       + +PE A+
Sbjct: 299 ---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAAL 354
Query: 660 EGRFSEKSDVFSFGVLLLEIVS 681
            GRF+ KSDV+SFG+LL E+ +
Sbjct: 355 YGRFTIKSDVWSFGILLTELTT 376

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  110 bits (274), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 72/200 (36%), Positives = 109/200 (54%), Gaps = 7/200 (3%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 541
            + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+ KL+H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 542 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
           +L     E E   ++ EYM   SL   L   + K  L   +  ++   I+ G+ Y+ R  
Sbjct: 77  QLYAVVSE-EPIYIVIEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVER-- 132
Query: 602 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 661
            +  +HRDL+A+NIL+ E L  K++DFG+A++   N+  A  G       + +PE A+ G
Sbjct: 133 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKF-PIKWTAPEAALYG 190
Query: 662 RFSEKSDVFSFGVLLLEIVS 681
           RF+ KSDV+SFG+LL E+ +
Sbjct: 191 RFTIKSDVWSFGILLTELTT 210

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  110 bits (274), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 111/202 (54%), Gaps = 13/202 (6%)
Query: 483 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 542
           + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+ KL+H  LV+
Sbjct: 185 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQ 243
Query: 543 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE---GISRGLLYLHR 599
           L     E E   ++ EYM   SL     D LK E   + +   +++    I+ G+ Y+ R
Sbjct: 244 LYAVVSE-EPIYIVTEYMSKGSL----LDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 298
Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 659
              +  +HRDL+A+NIL+ E L  K++DFG+A++   N+  A  G       + +PE A+
Sbjct: 299 ---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAAL 354
Query: 660 EGRFSEKSDVFSFGVLLLEIVS 681
            GRF+ KSDV+SFG+LL E+ +
Sbjct: 355 YGRFTIKSDVWSFGILLTELTT 376

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  109 bits (273), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 111/202 (54%), Gaps = 13/202 (6%)
Query: 483 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 542
           + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+ KL+H  LV+
Sbjct: 268 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQ 326
Query: 543 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE---GISRGLLYLHR 599
           L     E E   ++ EYM   SL     D LK E   + +   +++    I+ G+ Y+ R
Sbjct: 327 LYAVVSE-EPIYIVTEYMSKGSL----LDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 381
Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 659
              +  +HRDL+A+NIL+ E L  K++DFG+A++   N+  A  G       + +PE A+
Sbjct: 382 ---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAAL 437
Query: 660 EGRFSEKSDVFSFGVLLLEIVS 681
            GRF+ KSDV+SFG+LL E+ +
Sbjct: 438 YGRFTIKSDVWSFGILLTELTT 459

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  109 bits (273), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 73/203 (35%), Positives = 111/203 (54%), Gaps = 13/203 (6%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 541
            + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+ KL+H  LV
Sbjct: 11  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 69
Query: 542 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE---GISRGLLYLH 598
           +L     E E   ++ EYM   SL     D LK E   + +   +++    I+ G+ Y+ 
Sbjct: 70  QLYAVVSE-EPIYIVTEYMSKGSL----LDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 124
Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 658
           R   +  +HRDL+A+NIL+ E L  K++DFG+A++   N+  A  G       + +PE A
Sbjct: 125 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAA 180
Query: 659 MEGRFSEKSDVFSFGVLLLEIVS 681
           + GRF+ KSDV+SFG+LL E+ +
Sbjct: 181 LYGRFTIKSDVWSFGILLTELTT 203

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score =  109 bits (272), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 72/200 (36%), Positives = 109/200 (54%), Gaps = 7/200 (3%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 541
            + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+ KL+H  LV
Sbjct: 7   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 65
Query: 542 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
           +L     E E   ++ EYM   SL   L   + K  L   +  ++   I+ G+ Y+ R  
Sbjct: 66  QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVER-- 121
Query: 602 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 661
            +  +HRDL+A+NIL+ E L  K++DFG+A++   N+  A  G       + +PE A+ G
Sbjct: 122 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 179
Query: 662 RFSEKSDVFSFGVLLLEIVS 681
           RF+ KSDV+SFG+LL E+ +
Sbjct: 180 RFTIKSDVWSFGILLTELTT 199

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score =  109 bits (272), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 72/200 (36%), Positives = 109/200 (54%), Gaps = 7/200 (3%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 541
            + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+ KL+H  LV
Sbjct: 9   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 67
Query: 542 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
           +L     E E   ++ EYM   SL   L   + K  L   +  ++   I+ G+ Y+ R  
Sbjct: 68  QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVER-- 123
Query: 602 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 661
            +  +HRDL+A+NIL+ E L  K++DFG+A++   N+  A  G       + +PE A+ G
Sbjct: 124 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 181
Query: 662 RFSEKSDVFSFGVLLLEIVS 681
           RF+ KSDV+SFG+LL E+ +
Sbjct: 182 RFTIKSDVWSFGILLTELTT 201

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  109 bits (272), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 111/202 (54%), Gaps = 13/202 (6%)
Query: 483 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 542
           + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+ KL+H  LV+
Sbjct: 185 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQ 243
Query: 543 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE---GISRGLLYLHR 599
           L     E E   ++ EYM   SL     D LK E   + +   +++    I+ G+ Y+ R
Sbjct: 244 LYAVVSE-EPIYIVGEYMSKGSL----LDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 298
Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 659
              +  +HRDL+A+NIL+ E L  K++DFG+A++   N+  A  G       + +PE A+
Sbjct: 299 ---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAAL 354
Query: 660 EGRFSEKSDVFSFGVLLLEIVS 681
            GRF+ KSDV+SFG+LL E+ +
Sbjct: 355 YGRFTIKSDVWSFGILLTELTT 376

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  109 bits (272), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 72/200 (36%), Positives = 109/200 (54%), Gaps = 7/200 (3%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 541
            + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+ KL+H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 542 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
           +L     E E   ++ EYM   SL   L   + K  L   +  ++   I+ G+ Y+ R  
Sbjct: 77  QLYAVVSE-EPIYIVIEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVER-- 132
Query: 602 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 661
            +  +HRDL+A+NIL+ E L  K++DFG+A++   N+  A  G       + +PE A+ G
Sbjct: 133 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 190
Query: 662 RFSEKSDVFSFGVLLLEIVS 681
           RF+ KSDV+SFG+LL E+ +
Sbjct: 191 RFTIKSDVWSFGILLTELTT 210

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score =  109 bits (272), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 89/282 (31%), Positives = 137/282 (48%), Gaps = 36/282 (12%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 541
            + +L  +LG G FG V+ G   +  ++AVK L K     ++ F+ E  ++  LQH  LV
Sbjct: 13  ESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLV 71
Query: 542 RLLGCCVEGEEKMLIYEYMPNRSL-DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 600
           RL       E   +I EYM   SL D L  D   K  L   K  +    I+ G+ Y+ R 
Sbjct: 72  RLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLP--KLIDFSAQIAEGMAYIERK 129
Query: 601 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
           +    IHRDL+A+N+L+ E L  KI+DFG+A++   N+  A  G       + +PE    
Sbjct: 130 N---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINF 185
Query: 661 GRFSEKSDVFSFGVLLLEIVS-------GRKNTSFFEDDLTILGYAWKLWNENKILALVD 713
           G F+ KSDV+SFG+LL EIV+       GR N     D +T L   +++           
Sbjct: 186 GCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNA----DVMTALSQGYRM----------- 230
Query: 714 PFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN 755
           P +     +L  I++      +C +E  ++RP    + S+L+
Sbjct: 231 PRVENCPDELYDIMK------MCWKEKAEERPTFDYLQSVLD 266

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score =  109 bits (272), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 72/200 (36%), Positives = 109/200 (54%), Gaps = 7/200 (3%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 541
            + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+ KL+H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 542 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
           +L     E E   ++ EYM   SL   L   + K  L   +  ++   I+ G+ Y+ R  
Sbjct: 77  QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVER-- 132
Query: 602 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 661
            +  +HRDL+A+NIL+ E L  K++DFG+A++   N+  A  G       + +PE A+ G
Sbjct: 133 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 190
Query: 662 RFSEKSDVFSFGVLLLEIVS 681
           RF+ KSDV+SFG+LL E+ +
Sbjct: 191 RFTIKSDVWSFGILLTELTT 210

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score =  108 bits (271), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 72/200 (36%), Positives = 109/200 (54%), Gaps = 7/200 (3%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 541
            + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+ KL+H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 542 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
           +L     E E   ++ EYM   SL   L   + K  L   +  ++   I+ G+ Y+ R  
Sbjct: 77  QLYAVVSE-EPIYIVCEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVER-- 132
Query: 602 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 661
            +  +HRDL+A+NIL+ E L  K++DFG+A++   N+  A  G       + +PE A+ G
Sbjct: 133 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 190
Query: 662 RFSEKSDVFSFGVLLLEIVS 681
           RF+ KSDV+SFG+LL E+ +
Sbjct: 191 RFTIKSDVWSFGILLTELTT 210

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score =  108 bits (271), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 73/203 (35%), Positives = 111/203 (54%), Gaps = 13/203 (6%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 541
            + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+ KL+H  LV
Sbjct: 15  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 73
Query: 542 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE---GISRGLLYLH 598
           +L     E E   ++ EYM   SL     D LK E   + +   +++    I+ G+ Y+ 
Sbjct: 74  QLYAVVSE-EPIYIVTEYMNKGSL----LDFLKGETGKYLRLPQLVDMSAQIASGMAYVE 128
Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 658
           R   +  +HRDL+A+NIL+ E L  K++DFG+A++   N+  A  G       + +PE A
Sbjct: 129 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAA 184
Query: 659 MEGRFSEKSDVFSFGVLLLEIVS 681
           + GRF+ KSDV+SFG+LL E+ +
Sbjct: 185 LYGRFTIKSDVWSFGILLTELTT 207

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score =  108 bits (270), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 93/326 (28%), Positives = 156/326 (47%), Gaps = 48/326 (14%)
Query: 472 FQFEELATATNNF---------QLSSKLGQGGFGPVYWGRLK-DGQE---IAVKRLSKA- 517
           F FE+   A   F         ++   +G G FG V  GRLK  G+    +A+K L    
Sbjct: 10  FTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGY 69
Query: 518 SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER 577
           + +   +F++E  ++ +  H N++ L G   + +  M+I EYM N SLDA L       R
Sbjct: 70  TDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRK--NDGR 127
Query: 578 LDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 637
               +   ++ GI  G+ YL   S +  +HRDL A NIL++  L  K+SDFGM+++   +
Sbjct: 128 FTVIQLVGMLRGIGSGMKYL---SDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDD 184
Query: 638 QDQADTGRVVGT-FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTIL 696
            + A T R       + +PE     +F+  SDV+S+G+++ E++S  +            
Sbjct: 185 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP---------- 234
Query: 697 GYAWKLWNENKILALVDPFLSESSFQLDMIIRC---IHVGLL-CVQELVKDRPNMSTVVS 752
              W + N++ I A+      E  ++L   + C   +H  +L C Q+   DRP    +V+
Sbjct: 235 --YWDMSNQDVIKAI------EEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVN 286
Query: 753 MLNSEIRDLPYPKEPAFTERQGADDS 778
           ML+  IR+      P   +R G++ S
Sbjct: 287 MLDKLIRN------PNSLKRTGSESS 306

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score =  108 bits (270), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 71/199 (35%), Positives = 108/199 (54%), Gaps = 7/199 (3%)
Query: 483 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 542
           + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+ KL+H  LV+
Sbjct: 186 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGNMSPEAFLQEAQVMKKLRHEKLVQ 244
Query: 543 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSR 602
           L     E E   ++ EYM   SL   L   + K  L   +  ++   I+ G+ Y+ R   
Sbjct: 245 LYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVER--- 299
Query: 603 LRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGR 662
           +  +HRDL+A+NIL+ E L  K++DFG+ ++   N+  A  G       + +PE A+ GR
Sbjct: 300 MNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKF-PIKWTAPEAALYGR 358
Query: 663 FSEKSDVFSFGVLLLEIVS 681
           F+ KSDV+SFG+LL E+ +
Sbjct: 359 FTIKSDVWSFGILLTELTT 377

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  108 bits (270), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 71/200 (35%), Positives = 109/200 (54%), Gaps = 7/200 (3%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 541
            + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+ K++H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKIRHEKLV 76
Query: 542 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
           +L     E E   ++ EYM   SL   L   + K  L   +  ++   I+ G+ Y+ R  
Sbjct: 77  QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVER-- 132
Query: 602 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 661
            +  +HRDL+A+NIL+ E L  K++DFG+A++   N+  A  G       + +PE A+ G
Sbjct: 133 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 190
Query: 662 RFSEKSDVFSFGVLLLEIVS 681
           RF+ KSDV+SFG+LL E+ +
Sbjct: 191 RFTIKSDVWSFGILLTELTT 210

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 72/200 (36%), Positives = 108/200 (54%), Gaps = 7/200 (3%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 541
            + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+ KL+H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 542 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
           +L     E E   ++ EYM   SL   L   + K  L   +  ++   I+ G+ Y+ R  
Sbjct: 77  QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVER-- 132
Query: 602 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 661
            +  +HRDL A+NIL+ E L  K++DFG+A++   N+  A  G       + +PE A+ G
Sbjct: 133 -MNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 190
Query: 662 RFSEKSDVFSFGVLLLEIVS 681
           RF+ KSDV+SFG+LL E+ +
Sbjct: 191 RFTIKSDVWSFGILLTELTT 210

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 73/203 (35%), Positives = 111/203 (54%), Gaps = 13/203 (6%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 541
            + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+ KL+H  LV
Sbjct: 15  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 73
Query: 542 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE---GISRGLLYLH 598
           +L     E E   ++ EYM   SL     D LK E   + +   +++    I+ G+ Y+ 
Sbjct: 74  QLYAVVSE-EPIYIVTEYMNKGSL----LDFLKGETGKYLRLPQLVDMSAQIASGMAYVE 128
Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 658
           R   +  +HRDL+A+NIL+ E L  K++DFG+A++   N+  A  G       + +PE A
Sbjct: 129 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKF-PIKWTAPEAA 184
Query: 659 MEGRFSEKSDVFSFGVLLLEIVS 681
           + GRF+ KSDV+SFG+LL E+ +
Sbjct: 185 LYGRFTIKSDVWSFGILLTELTT 207

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 72/203 (35%), Positives = 110/203 (54%), Gaps = 13/203 (6%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 541
            + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+ KL+H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 542 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE---GISRGLLYLH 598
           +L     E E   ++ EYM        L D LK E   + +   +++    I+ G+ Y+ 
Sbjct: 77  QLYAVVSE-EPIYIVMEYMSK----GCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 131
Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 658
           R   +  +HRDL+A+NIL+ E L  K++DFG+A++   N+  A  G       + +PE A
Sbjct: 132 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAA 187
Query: 659 MEGRFSEKSDVFSFGVLLLEIVS 681
           + GRF+ KSDV+SFG+LL E+ +
Sbjct: 188 LYGRFTIKSDVWSFGILLTELTT 210

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score =  108 bits (269), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 72/203 (35%), Positives = 110/203 (54%), Gaps = 13/203 (6%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 541
            + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+ KL+H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 542 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE---GISRGLLYLH 598
           +L     E E   ++ EYM        L D LK E   + +   +++    I+ G+ Y+ 
Sbjct: 77  QLYAVVSE-EPIYIVTEYMSK----GCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 131
Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 658
           R   +  +HRDL+A+NIL+ E L  K++DFG+A++   N+  A  G       + +PE A
Sbjct: 132 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAA 187
Query: 659 MEGRFSEKSDVFSFGVLLLEIVS 681
           + GRF+ KSDV+SFG+LL E+ +
Sbjct: 188 LYGRFTIKSDVWSFGILLTELTT 210

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  107 bits (268), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 72/207 (34%), Positives = 111/207 (53%), Gaps = 7/207 (3%)
Query: 475 EELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISK 534
           +E        +L  +LG G FG V+ G      ++AVK L + S    + F+ E  ++ +
Sbjct: 8   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQ 66
Query: 535 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 594
           LQH+ LVRL     + E   +I EYM N SL   L  P    +L   K  ++   I+ G+
Sbjct: 67  LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGM 124
Query: 595 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 654
            ++   +    IHRDL+A+NIL+ + L+ KI+DFG+A++   N+  A  G       + +
Sbjct: 125 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF-PIKWTA 180
Query: 655 PEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           PE    G F+ KSDV+SFG+LL EIV+
Sbjct: 181 PEAINYGTFTIKSDVWSFGILLTEIVT 207

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 72/207 (34%), Positives = 111/207 (53%), Gaps = 7/207 (3%)
Query: 475 EELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISK 534
           +E        +L  +LG G FG V+ G      ++AVK L + S    + F+ E  ++ +
Sbjct: 7   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQ 65
Query: 535 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 594
           LQH+ LVRL     + E   +I EYM N SL   L  P    +L   K  ++   I+ G+
Sbjct: 66  LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGM 123
Query: 595 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 654
            ++   +    IHRDL+A+NIL+ + L+ KI+DFG+A++   N+  A  G       + +
Sbjct: 124 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF-PIKWTA 179
Query: 655 PEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           PE    G F+ KSDV+SFG+LL EIV+
Sbjct: 180 PEAINYGTFTIKSDVWSFGILLTEIVT 206

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 72/207 (34%), Positives = 111/207 (53%), Gaps = 7/207 (3%)
Query: 475 EELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISK 534
           +E        +L  +LG G FG V+ G      ++AVK L + S    + F+ E  ++ +
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQ 64
Query: 535 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 594
           LQH+ LVRL     + E   +I EYM N SL   L  P    +L   K  ++   I+ G+
Sbjct: 65  LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGM 122
Query: 595 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 654
            ++   +    IHRDL+A+NIL+ + L+ KI+DFG+A++   N+  A  G       + +
Sbjct: 123 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF-PIKWTA 178
Query: 655 PEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           PE    G F+ KSDV+SFG+LL EIV+
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  107 bits (267), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 72/207 (34%), Positives = 111/207 (53%), Gaps = 7/207 (3%)
Query: 475 EELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISK 534
           +E        +L  +LG G FG V+ G      ++AVK L + S    + F+ E  ++ +
Sbjct: 12  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQ 70
Query: 535 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 594
           LQH+ LVRL     + E   +I EYM N SL   L  P    +L   K  ++   I+ G+
Sbjct: 71  LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGM 128
Query: 595 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 654
            ++   +    IHRDL+A+NIL+ + L+ KI+DFG+A++   N+  A  G       + +
Sbjct: 129 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF-PIKWTA 184
Query: 655 PEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           PE    G F+ KSDV+SFG+LL EIV+
Sbjct: 185 PEAINYGTFTIKSDVWSFGILLTEIVT 211

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  107 bits (267), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 72/207 (34%), Positives = 111/207 (53%), Gaps = 7/207 (3%)
Query: 475 EELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISK 534
           +E        +L  +LG G FG V+ G      ++AVK L + S    + F+ E  ++ +
Sbjct: 14  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQ 72
Query: 535 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 594
           LQH+ LVRL     + E   +I EYM N SL   L  P    +L   K  ++   I+ G+
Sbjct: 73  LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGM 130
Query: 595 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 654
            ++   +    IHRDL+A+NIL+ + L+ KI+DFG+A++   N+  A  G       + +
Sbjct: 131 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF-PIKWTA 186
Query: 655 PEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           PE    G F+ KSDV+SFG+LL EIV+
Sbjct: 187 PEAINYGTFTIKSDVWSFGILLTEIVT 213

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  107 bits (267), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 72/207 (34%), Positives = 111/207 (53%), Gaps = 7/207 (3%)
Query: 475 EELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISK 534
           +E        +L  +LG G FG V+ G      ++AVK L + S    + F+ E  ++ +
Sbjct: 15  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQ 73
Query: 535 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 594
           LQH+ LVRL     + E   +I EYM N SL   L  P    +L   K  ++   I+ G+
Sbjct: 74  LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGM 131
Query: 595 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 654
            ++   +    IHRDL+A+NIL+ + L+ KI+DFG+A++   N+  A  G       + +
Sbjct: 132 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF-PIKWTA 187
Query: 655 PEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           PE    G F+ KSDV+SFG+LL EIV+
Sbjct: 188 PEAINYGTFTIKSDVWSFGILLTEIVT 214

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  107 bits (266), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 72/207 (34%), Positives = 111/207 (53%), Gaps = 7/207 (3%)
Query: 475 EELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISK 534
           +E        +L  +LG G FG V+ G      ++AVK L + S    + F+ E  ++ +
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQ 64
Query: 535 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 594
           LQH+ LVRL     + E   +I EYM N SL   L  P    +L   K  ++   I+ G+
Sbjct: 65  LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGM 122
Query: 595 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 654
            ++   +    IHRDL+A+NIL+ + L+ KI+DFG+A++   N+  A  G       + +
Sbjct: 123 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF-PIKWTA 178
Query: 655 PEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           PE    G F+ KSDV+SFG+LL EIV+
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score =  107 bits (266), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 88/305 (28%), Positives = 150/305 (49%), Gaps = 39/305 (12%)
Query: 484 FQLSSKLGQGGFGPVYWGRLK-DGQE---IAVKRLSKA-SGQGLEEFMNEVMVISKLQHR 538
            ++   +G G FG V  GRLK  G+    +A+K L    + +   +F++E  ++ +  H 
Sbjct: 10  IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHP 69
Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           N++ L G   + +  M+I EYM N SLDA L       R    +   ++ GI  G+ YL 
Sbjct: 70  NIIHLEGVVTKCKPVMIITEYMENGSLDAFLRK--NDGRFTVIQLVGMLRGIGSGMKYL- 126
Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT-FGYMSPEY 657
             S +  +HRDL A NIL++  L  K+SDFGM+++   + + A T R       + +PE 
Sbjct: 127 --SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEA 184
Query: 658 AMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS 717
               +F+  SDV+S+G+++ E++S  +               W + N++ I A+      
Sbjct: 185 IAYRKFTSASDVWSYGIVMWEVMSYGERP------------YWDMSNQDVIKAI------ 226
Query: 718 ESSFQLDMIIRC---IHVGLL-CVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPAFTERQ 773
           E  ++L   + C   +H  +L C Q+   DRP    +V+ML+  IR+      P   +R 
Sbjct: 227 EEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKLIRN------PNSLKRT 280
Query: 774 GADDS 778
           G++ S
Sbjct: 281 GSESS 285

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  107 bits (266), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 72/207 (34%), Positives = 111/207 (53%), Gaps = 7/207 (3%)
Query: 475 EELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISK 534
           +E        +L  +LG G FG V+ G      ++AVK L + S    + F+ E  ++ +
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQ 64
Query: 535 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 594
           LQH+ LVRL     + E   +I EYM N SL   L  P    +L   K  ++   I+ G+
Sbjct: 65  LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGM 122
Query: 595 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 654
            ++   +    IHRDL+A+NIL+ + L+ KI+DFG+A++   N+  A  G       + +
Sbjct: 123 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF-PIKWTA 178
Query: 655 PEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           PE    G F+ KSDV+SFG+LL EIV+
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  106 bits (265), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 72/207 (34%), Positives = 111/207 (53%), Gaps = 7/207 (3%)
Query: 475 EELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISK 534
           +E        +L  +LG G FG V+ G      ++AVK L + S    + F+ E  ++ +
Sbjct: 12  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQ 70
Query: 535 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 594
           LQH+ LVRL     + E   +I EYM N SL   L  P    +L   K  ++   I+ G+
Sbjct: 71  LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGM 128
Query: 595 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 654
            ++   +    IHRDL+A+NIL+ + L+ KI+DFG+A++   N+  A  G       + +
Sbjct: 129 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF-PIKWTA 184
Query: 655 PEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           PE    G F+ KSDV+SFG+LL EIV+
Sbjct: 185 PEAINYGTFTIKSDVWSFGILLTEIVT 211

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  106 bits (265), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 72/207 (34%), Positives = 111/207 (53%), Gaps = 7/207 (3%)
Query: 475 EELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISK 534
           +E        +L  +LG G FG V+ G      ++AVK L + S    + F+ E  ++ +
Sbjct: 11  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQ 69
Query: 535 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 594
           LQH+ LVRL     + E   +I EYM N SL   L  P    +L   K  ++   I+ G+
Sbjct: 70  LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGM 127
Query: 595 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 654
            ++   +    IHRDL+A+NIL+ + L+ KI+DFG+A++   N+  A  G       + +
Sbjct: 128 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF-PIKWTA 183
Query: 655 PEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           PE    G F+ KSDV+SFG+LL EIV+
Sbjct: 184 PEAINYGTFTIKSDVWSFGILLTEIVT 210

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  106 bits (265), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 72/207 (34%), Positives = 111/207 (53%), Gaps = 7/207 (3%)
Query: 475 EELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISK 534
           +E        +L  +LG G FG V+ G      ++AVK L + S    + F+ E  ++ +
Sbjct: 16  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQ 74
Query: 535 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 594
           LQH+ LVRL     + E   +I EYM N SL   L  P    +L   K  ++   I+ G+
Sbjct: 75  LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGM 132
Query: 595 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 654
            ++   +    IHRDL+A+NIL+ + L+ KI+DFG+A++   N+  A  G       + +
Sbjct: 133 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF-PIKWTA 188
Query: 655 PEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           PE    G F+ KSDV+SFG+LL EIV+
Sbjct: 189 PEAINYGTFTIKSDVWSFGILLTEIVT 215

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score =  106 bits (265), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 88/305 (28%), Positives = 150/305 (49%), Gaps = 39/305 (12%)
Query: 484 FQLSSKLGQGGFGPVYWGRLK-DGQE---IAVKRLSKA-SGQGLEEFMNEVMVISKLQHR 538
            ++   +G G FG V  GRLK  G+    +A+K L    + +   +F++E  ++ +  H 
Sbjct: 16  IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHP 75
Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           N++ L G   + +  M+I EYM N SLDA L       R    +   ++ GI  G+ YL 
Sbjct: 76  NIIHLEGVVTKCKPVMIITEYMENGSLDAFLRK--NDGRFTVIQLVGMLRGIGSGMKYL- 132
Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT-FGYMSPEY 657
             S +  +HRDL A NIL++  L  K+SDFGM+++   + + A T R       + +PE 
Sbjct: 133 --SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEA 190
Query: 658 AMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS 717
               +F+  SDV+S+G+++ E++S  +               W + N++ I A+      
Sbjct: 191 IAYRKFTSASDVWSYGIVMWEVMSYGERP------------YWDMSNQDVIKAI------ 232
Query: 718 ESSFQLDMIIRC---IHVGLL-CVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPAFTERQ 773
           E  ++L   + C   +H  +L C Q+   DRP    +V+ML+  IR+      P   +R 
Sbjct: 233 EEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKLIRN------PNSLKRT 286
Query: 774 GADDS 778
           G++ S
Sbjct: 287 GSESS 291

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  106 bits (264), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 72/207 (34%), Positives = 111/207 (53%), Gaps = 7/207 (3%)
Query: 475 EELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISK 534
           +E        +L  +LG G FG V+ G      ++AVK L + S    + F+ E  ++ +
Sbjct: 1   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQ 59
Query: 535 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 594
           LQH+ LVRL     + E   +I EYM N SL   L  P    +L   K  ++   I+ G+
Sbjct: 60  LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGM 117
Query: 595 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 654
            ++   +    IHRDL+A+NIL+ + L+ KI+DFG+A++   N+  A  G       + +
Sbjct: 118 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF-PIKWTA 173
Query: 655 PEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           PE    G F+ KSDV+SFG+LL EIV+
Sbjct: 174 PEAINYGTFTIKSDVWSFGILLTEIVT 200

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score =  105 bits (263), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 85/300 (28%), Positives = 148/300 (49%), Gaps = 34/300 (11%)
Query: 471 LFQFEELATATNNFQLSSKLGQGGFGPVYWGRLK--DGQEIAVKRLSKASG---QGLEEF 525
           + +F +   ATN   +   +G G FG V  GRLK    +EI+V   +   G   +   +F
Sbjct: 35  VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 526 MNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 585
           + E  ++ +  H N++RL G   + +  M++ EYM N SLD+ L       +    +   
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK--HDAQFTVIQLVG 151
Query: 586 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 645
           ++ GI+ G+ YL   S +  +HRDL A NIL++  L  K+SDFG+A++   + + A T R
Sbjct: 152 MLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTR 208
Query: 646 VVGT-FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN 704
                  + SPE     +F+  SDV+S+G++L E++S  +               W++ N
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP------------YWEMSN 256
Query: 705 ENKILALVDPFLSESSFQLDMIIRC----IHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 760
           ++ I A+      +  ++L   + C      + L C Q+   +RP    +VS+L+  IR+
Sbjct: 257 QDVIKAV------DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score =  105 bits (262), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 87/281 (30%), Positives = 138/281 (49%), Gaps = 36/281 (12%)
Query: 483 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 542
           + +L  KLG G FG V+ G   +  ++AVK L K     ++ F+ E  ++  LQH  LVR
Sbjct: 13  SIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVR 71
Query: 543 LLGCCVEGEEKMLIYEYMPNRSL-DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
           L     + E   +I E+M   SL D L  D   K  L   K  +    I+ G+ Y+ R +
Sbjct: 72  LYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLP--KLIDFSAQIAEGMAYIERKN 129
Query: 602 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 661
               IHRDL+A+N+L+ E L  KI+DFG+A++   N+  A  G       + +PE    G
Sbjct: 130 ---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFG 185
Query: 662 RFSEKSDVFSFGVLLLEIVS-------GRKNTSFFEDDLTILGYAWKLWNENKILALVDP 714
            F+ KS+V+SFG+LL EIV+       GR N     D ++ L   +++           P
Sbjct: 186 CFTIKSNVWSFGILLYEIVTYGKIPYPGRTNA----DVMSALSQGYRM-----------P 230
Query: 715 FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN 755
            +     +L  I++      +C +E  ++RP    + S+L+
Sbjct: 231 RMENCPDELYDIMK------MCWKEKAEERPTFDYLQSVLD 265

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score =  105 bits (262), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 140/291 (48%), Gaps = 37/291 (12%)
Query: 481 TNNFQLSSKLGQGGFGPVYWGRLK-DGQE---IAVKRLSKA-SGQGLEEFMNEVMVISKL 535
            +   +   +G G  G V +GRL+  GQ    +A+K L    + +   +F++E  ++ + 
Sbjct: 48  ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF 107
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
            H N++RL G    G   M++ EYM N SLD  L       +    +   ++ G+  G+ 
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR--THDGQFTIMQLVGMLRGVGAGMR 165
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT---GRVVGTFGY 652
           YL   S L  +HRDL A N+L+D  L  K+SDFG++++   + D A T   G++     +
Sbjct: 166 YL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKI--PIRW 220
Query: 653 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALV 712
            +PE      FS  SDV+SFGV++ E+++  +               W + N + I ++ 
Sbjct: 221 TAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY------------WNMTNRDVISSV- 267
Query: 713 DPFLSESSFQLDMIIRCIH----VGLLCVQELVKDRPNMSTVVSMLNSEIR 759
                E  ++L   + C H    + L C  +    RP  S +VS+L++ IR
Sbjct: 268 -----EEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/199 (35%), Positives = 108/199 (54%), Gaps = 7/199 (3%)
Query: 483 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 542
           + QL  +LG G FG V+ G      ++A+K L K      E F+ E  ++ KL+H  LV+
Sbjct: 10  SLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTL-KPGTMSPESFLEEAQIMKKLKHDKLVQ 68
Query: 543 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSR 602
           L     E E   ++ EYM   SL   L D  +   L      ++   ++ G+ Y+ R   
Sbjct: 69  LYAVVSE-EPIYIVTEYMNKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIER--- 123
Query: 603 LRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGR 662
           +  IHRDL+++NIL+   L  KI+DFG+A++   N+  A  G       + +PE A+ GR
Sbjct: 124 MNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKF-PIKWTAPEAALYGR 182
Query: 663 FSEKSDVFSFGVLLLEIVS 681
           F+ KSDV+SFG+LL E+V+
Sbjct: 183 FTIKSDVWSFGILLTELVT 201

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 148/300 (49%), Gaps = 34/300 (11%)
Query: 471 LFQFEELATATNNFQLSSKLGQGGFGPVYWGRLK--DGQEIAVKRLSKASG---QGLEEF 525
           + +F +   ATN   +   +G G FG V  GRLK    +EI+V   +   G   +   +F
Sbjct: 35  VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 526 MNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 585
           + E  ++ +  H N++RL G   + +  M++ EYM N SLD+ L       +    +   
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK--HDAQFTVIQLVG 151
Query: 586 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 645
           ++ GI+ G+ YL   S +  +HRDL A NIL++  L  K+SDFG++++   + + A T R
Sbjct: 152 MLRGIASGMKYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208
Query: 646 VVGT-FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN 704
                  + SPE     +F+  SDV+S+G++L E++S  +               W++ N
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP------------YWEMSN 256
Query: 705 ENKILALVDPFLSESSFQLDMIIRC----IHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 760
           ++ I A+      +  ++L   + C      + L C Q+   +RP    +VS+L+  IR+
Sbjct: 257 QDVIKAV------DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 140/291 (48%), Gaps = 37/291 (12%)
Query: 481 TNNFQLSSKLGQGGFGPVYWGRLK-DGQE---IAVKRLSKA-SGQGLEEFMNEVMVISKL 535
            +   +   +G G  G V +GRL+  GQ    +A+K L    + +   +F++E  ++ + 
Sbjct: 48  ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF 107
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
            H N++RL G    G   M++ EYM N SLD  L       +    +   ++ G+  G+ 
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR--THDGQFTIMQLVGMLRGVGAGMR 165
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT---GRVVGTFGY 652
           YL   S L  +HRDL A N+L+D  L  K+SDFG++++   + D A T   G++     +
Sbjct: 166 YL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI--PIRW 220
Query: 653 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALV 712
            +PE      FS  SDV+SFGV++ E+++  +               W + N + I ++ 
Sbjct: 221 TAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY------------WNMTNRDVISSV- 267
Query: 713 DPFLSESSFQLDMIIRCIH----VGLLCVQELVKDRPNMSTVVSMLNSEIR 759
                E  ++L   + C H    + L C  +    RP  S +VS+L++ IR
Sbjct: 268 -----EEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 70/199 (35%), Positives = 109/199 (54%), Gaps = 7/199 (3%)
Query: 483 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 542
             +L  +LG G FG V+ G      ++AVK L + S    + F+ E  ++ +LQH+ LVR
Sbjct: 10  TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVR 68
Query: 543 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSR 602
           L     + E   +I EYM N SL   L  P    +L   K  ++   I+ G+ ++   + 
Sbjct: 69  LYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN- 125
Query: 603 LRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGR 662
              IHR+L+A+NIL+ + L+ KI+DFG+A++   N+  A  G       + +PE    G 
Sbjct: 126 --YIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF-PIKWTAPEAINYGT 182
Query: 663 FSEKSDVFSFGVLLLEIVS 681
           F+ KSDV+SFG+LL EIV+
Sbjct: 183 FTIKSDVWSFGILLTEIVT 201

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 148/300 (49%), Gaps = 34/300 (11%)
Query: 471 LFQFEELATATNNFQLSSKLGQGGFGPVYWGRLK--DGQEIAVKRLSKASG---QGLEEF 525
           + +F +   ATN   +   +G G FG V  GRLK    +EI+V   +   G   +   +F
Sbjct: 35  VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 526 MNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 585
           + E  ++ +  H N++RL G   + +  M++ EYM N SLD+ L       +    +   
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK--HDAQFTVIQLVG 151
Query: 586 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 645
           ++ GI+ G+ YL   S +  +HRDL A NIL++  L  K+SDFG++++   + + A T R
Sbjct: 152 MLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208
Query: 646 VVGT-FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN 704
                  + SPE     +F+  SDV+S+G++L E++S  +               W++ N
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP------------YWEMSN 256
Query: 705 ENKILALVDPFLSESSFQLDMIIRC----IHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 760
           ++ I A+      +  ++L   + C      + L C Q+   +RP    +VS+L+  IR+
Sbjct: 257 QDVIKAV------DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 148/300 (49%), Gaps = 34/300 (11%)
Query: 471 LFQFEELATATNNFQLSSKLGQGGFGPVYWGRLK--DGQEIAVKRLSKASG---QGLEEF 525
           + +F +   ATN   +   +G G FG V  GRLK    +EI+V   +   G   +   +F
Sbjct: 35  VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 526 MNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 585
           + E  ++ +  H N++RL G   + +  M++ EYM N SLD+ L       +    +   
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK--HDAQFTVIQLVG 151
Query: 586 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 645
           ++ GI+ G+ YL   S +  +HRDL A NIL++  L  K+SDFG++++   + + A T R
Sbjct: 152 MLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208
Query: 646 VVGT-FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN 704
                  + SPE     +F+  SDV+S+G++L E++S  +               W++ N
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP------------YWEMSN 256
Query: 705 ENKILALVDPFLSESSFQLDMIIRC----IHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 760
           ++ I A+      +  ++L   + C      + L C Q+   +RP    +VS+L+  IR+
Sbjct: 257 QDVIKAV------DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 75/217 (34%), Positives = 111/217 (51%), Gaps = 18/217 (8%)
Query: 473 QFEELATATNNFQLSSKLGQGGFGPVYWGR---LKD--GQEIAVKRLSKASGQGLEEFMN 527
           QFEE      + +   +LG+G FG V   R   L+D  G+ +AVK+L  ++ + L +F  
Sbjct: 5   QFEE-----RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 59
Query: 528 EVMVISKLQHRNLVRLLGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 585
           E+ ++  LQH N+V+  G C     +   LI EY+P  SL   L     KER+D  K   
Sbjct: 60  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQ 117
Query: 586 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 645
               I +G+ YL      R IHRDL   NIL++ E   KI DFG+ K+   +++      
Sbjct: 118 YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE 174
Query: 646 V-VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
                  + +PE   E +FS  SDV+SFGV+L E+ +
Sbjct: 175 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 148/300 (49%), Gaps = 34/300 (11%)
Query: 471 LFQFEELATATNNFQLSSKLGQGGFGPVYWGRLK--DGQEIAVKRLSKASG---QGLEEF 525
           + +F +   ATN   +   +G G FG V  GRLK    +EI+V   +   G   +   +F
Sbjct: 35  VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 526 MNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 585
           + E  ++ +  H N++RL G   + +  M++ EYM N SLD+ L       +    +   
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK--HDAQFTVIQLVG 151
Query: 586 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 645
           ++ GI+ G+ YL   S +  +HRDL A NIL++  L  K+SDFG++++   + + A T R
Sbjct: 152 MLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208
Query: 646 VVGT-FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN 704
                  + SPE     +F+  SDV+S+G++L E++S  +               W++ N
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP------------YWEMSN 256
Query: 705 ENKILALVDPFLSESSFQLDMIIRC----IHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 760
           ++ I A+      +  ++L   + C      + L C Q+   +RP    +VS+L+  IR+
Sbjct: 257 QDVIKAV------DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 75/217 (34%), Positives = 111/217 (51%), Gaps = 18/217 (8%)
Query: 473 QFEELATATNNFQLSSKLGQGGFGPVYWGR---LKD--GQEIAVKRLSKASGQGLEEFMN 527
           QFEE      + +   +LG+G FG V   R   L+D  G+ +AVK+L  ++ + L +F  
Sbjct: 10  QFEE-----RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 64
Query: 528 EVMVISKLQHRNLVRLLGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 585
           E+ ++  LQH N+V+  G C     +   LI EY+P  SL   L     KER+D  K   
Sbjct: 65  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQ 122
Query: 586 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 645
               I +G+ YL      R IHRDL   NIL++ E   KI DFG+ K+   +++      
Sbjct: 123 YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE 179
Query: 646 V-VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
                  + +PE   E +FS  SDV+SFGV+L E+ +
Sbjct: 180 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 75/217 (34%), Positives = 111/217 (51%), Gaps = 18/217 (8%)
Query: 473 QFEELATATNNFQLSSKLGQGGFGPVYWGR---LKD--GQEIAVKRLSKASGQGLEEFMN 527
           QFEE      + +   +LG+G FG V   R   L+D  G+ +AVK+L  ++ + L +F  
Sbjct: 37  QFEE-----RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 91
Query: 528 EVMVISKLQHRNLVRLLGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 585
           E+ ++  LQH N+V+  G C     +   LI EY+P  SL   L     KER+D  K   
Sbjct: 92  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQ 149
Query: 586 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 645
               I +G+ YL      R IHRDL   NIL++ E   KI DFG+ K+   +++      
Sbjct: 150 YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE 206
Query: 646 V-VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
                  + +PE   E +FS  SDV+SFGV+L E+ +
Sbjct: 207 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 75/217 (34%), Positives = 111/217 (51%), Gaps = 18/217 (8%)
Query: 473 QFEELATATNNFQLSSKLGQGGFGPVYWGR---LKD--GQEIAVKRLSKASGQGLEEFMN 527
           QFEE      + +   +LG+G FG V   R   L+D  G+ +AVK+L  ++ + L +F  
Sbjct: 12  QFEE-----RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 66
Query: 528 EVMVISKLQHRNLVRLLGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 585
           E+ ++  LQH N+V+  G C     +   LI EY+P  SL   L     KER+D  K   
Sbjct: 67  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQ 124
Query: 586 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 645
               I +G+ YL      R IHRDL   NIL++ E   KI DFG+ K+   +++      
Sbjct: 125 YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE 181
Query: 646 V-VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
                  + +PE   E +FS  SDV+SFGV+L E+ +
Sbjct: 182 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 148/300 (49%), Gaps = 34/300 (11%)
Query: 471 LFQFEELATATNNFQLSSKLGQGGFGPVYWGRLK--DGQEIAVKRLSKASG---QGLEEF 525
           + +F +   ATN   +   +G G FG V  GRLK    +EI+V   +   G   +   +F
Sbjct: 33  VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 91
Query: 526 MNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 585
           + E  ++ +  H N++RL G   + +  M++ EYM N SLD+ L       +    +   
Sbjct: 92  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK--HDAQFTVIQLVG 149
Query: 586 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 645
           ++ GI+ G+ YL   S +  +HRDL A NIL++  L  K+SDFG++++   + + A T R
Sbjct: 150 MLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 206
Query: 646 VVGT-FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN 704
                  + SPE     +F+  SDV+S+G++L E++S  +               W++ N
Sbjct: 207 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP------------YWEMSN 254
Query: 705 ENKILALVDPFLSESSFQLDMIIRC----IHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 760
           ++ I A+      +  ++L   + C      + L C Q+   +RP    +VS+L+  IR+
Sbjct: 255 QDVIKAV------DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 308

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 148/300 (49%), Gaps = 34/300 (11%)
Query: 471 LFQFEELATATNNFQLSSKLGQGGFGPVYWGRLK--DGQEIAVKRLSKASG---QGLEEF 525
           + +F +   ATN   +   +G G FG V  GRLK    +EI+V   +   G   +   +F
Sbjct: 35  VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 526 MNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 585
           + E  ++ +  H N++RL G   + +  M++ EYM N SLD+ L       +    +   
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK--HDAQFTVIQLVG 151
Query: 586 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 645
           ++ GI+ G+ YL   S +  +HRDL A NIL++  L  K+SDFG++++   + + A T R
Sbjct: 152 MLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208
Query: 646 VVGT-FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN 704
                  + SPE     +F+  SDV+S+G++L E++S  +               W++ N
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP------------YWEMSN 256
Query: 705 ENKILALVDPFLSESSFQLDMIIRC----IHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 760
           ++ I A+      +  ++L   + C      + L C Q+   +RP    +VS+L+  IR+
Sbjct: 257 QDVIKAV------DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 75/217 (34%), Positives = 111/217 (51%), Gaps = 18/217 (8%)
Query: 473 QFEELATATNNFQLSSKLGQGGFGPVYWGR---LKD--GQEIAVKRLSKASGQGLEEFMN 527
           QFEE      + +   +LG+G FG V   R   L+D  G+ +AVK+L  ++ + L +F  
Sbjct: 13  QFEE-----RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 67
Query: 528 EVMVISKLQHRNLVRLLGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 585
           E+ ++  LQH N+V+  G C     +   LI EY+P  SL   L     KER+D  K   
Sbjct: 68  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQ 125
Query: 586 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 645
               I +G+ YL      R IHRDL   NIL++ E   KI DFG+ K+   +++      
Sbjct: 126 YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE 182
Query: 646 V-VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
                  + +PE   E +FS  SDV+SFGV+L E+ +
Sbjct: 183 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 108/216 (50%), Gaps = 19/216 (8%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRL------KDGQEIAVKRLSKASGQGLEEFMNEVMVISKL 535
           +N  L  +LG+G FG V+          +D   +AVK L  AS    ++F  E  +++ L
Sbjct: 13  HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 72
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLD----------ALLFDPLKKERLDWRKRFN 585
           QH ++V+  G CVEG+  ++++EYM +  L+           L+ +      L   +  +
Sbjct: 73  QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLH 132
Query: 586 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 645
           I + I+ G++YL   +    +HRDL   N L+ E L  KI DFGM++           G 
Sbjct: 133 IAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGH 189
Query: 646 VVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
            +    +M PE  M  +F+ +SDV+S GV+L EI +
Sbjct: 190 TMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 225

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 75/217 (34%), Positives = 111/217 (51%), Gaps = 18/217 (8%)
Query: 473 QFEELATATNNFQLSSKLGQGGFGPVYWGR---LKD--GQEIAVKRLSKASGQGLEEFMN 527
           QFEE      + +   +LG+G FG V   R   L+D  G+ +AVK+L  ++ + L +F  
Sbjct: 11  QFEE-----RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 65
Query: 528 EVMVISKLQHRNLVRLLGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 585
           E+ ++  LQH N+V+  G C     +   LI EY+P  SL   L     KER+D  K   
Sbjct: 66  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQ 123
Query: 586 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 645
               I +G+ YL      R IHRDL   NIL++ E   KI DFG+ K+   +++      
Sbjct: 124 YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE 180
Query: 646 V-VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
                  + +PE   E +FS  SDV+SFGV+L E+ +
Sbjct: 181 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 148/300 (49%), Gaps = 34/300 (11%)
Query: 471 LFQFEELATATNNFQLSSKLGQGGFGPVYWGRLK--DGQEIAVKRLSKASG---QGLEEF 525
           + +F +   ATN   +   +G G FG V  GRLK    +EI+V   +   G   +   +F
Sbjct: 6   VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 64
Query: 526 MNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 585
           + E  ++ +  H N++RL G   + +  M++ EYM N SLD+ L       +    +   
Sbjct: 65  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK--HDAQFTVIQLVG 122
Query: 586 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 645
           ++ GI+ G+ YL   S +  +HRDL A NIL++  L  K+SDFG++++   + + A T R
Sbjct: 123 MLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 179
Query: 646 VVGT-FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN 704
                  + SPE     +F+  SDV+S+G++L E++S  +               W++ N
Sbjct: 180 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP------------YWEMSN 227
Query: 705 ENKILALVDPFLSESSFQLDMIIRC----IHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 760
           ++ I A+      +  ++L   + C      + L C Q+   +RP    +VS+L+  IR+
Sbjct: 228 QDVIKAV------DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 281

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 75/217 (34%), Positives = 111/217 (51%), Gaps = 18/217 (8%)
Query: 473 QFEELATATNNFQLSSKLGQGGFGPVYWGR---LKD--GQEIAVKRLSKASGQGLEEFMN 527
           QFEE      + +   +LG+G FG V   R   L+D  G+ +AVK+L  ++ + L +F  
Sbjct: 6   QFEE-----RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 60
Query: 528 EVMVISKLQHRNLVRLLGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 585
           E+ ++  LQH N+V+  G C     +   LI EY+P  SL   L     KER+D  K   
Sbjct: 61  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQ 118
Query: 586 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 645
               I +G+ YL      R IHRDL   NIL++ E   KI DFG+ K+   +++      
Sbjct: 119 YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE 175
Query: 646 V-VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
                  + +PE   E +FS  SDV+SFGV+L E+ +
Sbjct: 176 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 75/217 (34%), Positives = 111/217 (51%), Gaps = 18/217 (8%)
Query: 473 QFEELATATNNFQLSSKLGQGGFGPVYWGR---LKD--GQEIAVKRLSKASGQGLEEFMN 527
           QFEE      + +   +LG+G FG V   R   L+D  G+ +AVK+L  ++ + L +F  
Sbjct: 4   QFEE-----RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 58
Query: 528 EVMVISKLQHRNLVRLLGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 585
           E+ ++  LQH N+V+  G C     +   LI EY+P  SL   L     KER+D  K   
Sbjct: 59  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQ 116
Query: 586 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 645
               I +G+ YL      R IHRDL   NIL++ E   KI DFG+ K+   +++      
Sbjct: 117 YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE 173
Query: 646 V-VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
                  + +PE   E +FS  SDV+SFGV+L E+ +
Sbjct: 174 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 148/300 (49%), Gaps = 34/300 (11%)
Query: 471 LFQFEELATATNNFQLSSKLGQGGFGPVYWGRLK--DGQEIAVKRLSKASG---QGLEEF 525
           + +F +   ATN   +   +G G FG V  GRLK    +EI+V   +   G   +   +F
Sbjct: 23  VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 81
Query: 526 MNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 585
           + E  ++ +  H N++RL G   + +  M++ EYM N SLD+ L       +    +   
Sbjct: 82  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK--HDAQFTVIQLVG 139
Query: 586 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 645
           ++ GI+ G+ YL   S +  +HRDL A NIL++  L  K+SDFG++++   + + A T R
Sbjct: 140 MLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 196
Query: 646 VVGT-FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN 704
                  + SPE     +F+  SDV+S+G++L E++S  +               W++ N
Sbjct: 197 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP------------YWEMSN 244
Query: 705 ENKILALVDPFLSESSFQLDMIIRC----IHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 760
           ++ I A+      +  ++L   + C      + L C Q+   +RP    +VS+L+  IR+
Sbjct: 245 QDVIKAV------DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 298

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 75/217 (34%), Positives = 111/217 (51%), Gaps = 18/217 (8%)
Query: 473 QFEELATATNNFQLSSKLGQGGFGPVYWGR---LKD--GQEIAVKRLSKASGQGLEEFMN 527
           QFEE      + +   +LG+G FG V   R   L+D  G+ +AVK+L  ++ + L +F  
Sbjct: 6   QFEE-----RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 60
Query: 528 EVMVISKLQHRNLVRLLGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 585
           E+ ++  LQH N+V+  G C     +   LI EY+P  SL   L     KER+D  K   
Sbjct: 61  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQ 118
Query: 586 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 645
               I +G+ YL      R IHRDL   NIL++ E   KI DFG+ K+   +++      
Sbjct: 119 YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE 175
Query: 646 V-VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
                  + +PE   E +FS  SDV+SFGV+L E+ +
Sbjct: 176 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 75/217 (34%), Positives = 111/217 (51%), Gaps = 18/217 (8%)
Query: 473 QFEELATATNNFQLSSKLGQGGFGPVYWGR---LKD--GQEIAVKRLSKASGQGLEEFMN 527
           QFEE      + +   +LG+G FG V   R   L+D  G+ +AVK+L  ++ + L +F  
Sbjct: 9   QFEE-----RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 63
Query: 528 EVMVISKLQHRNLVRLLGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 585
           E+ ++  LQH N+V+  G C     +   LI EY+P  SL   L     KER+D  K   
Sbjct: 64  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQ 121
Query: 586 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 645
               I +G+ YL      R IHRDL   NIL++ E   KI DFG+ K+   +++      
Sbjct: 122 YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE 178
Query: 646 V-VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
                  + +PE   E +FS  SDV+SFGV+L E+ +
Sbjct: 179 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 75/219 (34%), Positives = 112/219 (51%), Gaps = 18/219 (8%)
Query: 471 LFQFEELATATNNFQLSSKLGQGGFGPVYWGR---LKD--GQEIAVKRLSKASGQGLEEF 525
           + QFEE      + +   +LG+G FG V   R   L+D  G+ +AVK+L  ++ + L +F
Sbjct: 22  MTQFEE-----RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF 76
Query: 526 MNEVMVISKLQHRNLVRLLGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKR 583
             E+ ++  LQH N+V+  G C     +   LI EY+P  SL   L     KER+D  K 
Sbjct: 77  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKL 134
Query: 584 FNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 643
                 I +G+ YL      R IHRDL   NIL++ E   KI DFG+ K+   +++    
Sbjct: 135 LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 191
Query: 644 GRV-VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
                    + +PE   E +FS  SDV+SFGV+L E+ +
Sbjct: 192 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 75/219 (34%), Positives = 112/219 (51%), Gaps = 18/219 (8%)
Query: 471 LFQFEELATATNNFQLSSKLGQGGFGPVYWGR---LKD--GQEIAVKRLSKASGQGLEEF 525
           + QFEE      + +   +LG+G FG V   R   L+D  G+ +AVK+L  ++ + L +F
Sbjct: 22  MTQFEE-----RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF 76
Query: 526 MNEVMVISKLQHRNLVRLLGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKR 583
             E+ ++  LQH N+V+  G C     +   LI EY+P  SL   L     KER+D  K 
Sbjct: 77  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKL 134
Query: 584 FNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 643
                 I +G+ YL      R IHRDL   NIL++ E   KI DFG+ K+   +++    
Sbjct: 135 LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 191
Query: 644 GRV-VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
                    + +PE   E +FS  SDV+SFGV+L E+ +
Sbjct: 192 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score =  103 bits (258), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 147/300 (49%), Gaps = 34/300 (11%)
Query: 471 LFQFEELATATNNFQLSSKLGQGGFGPVYWGRLK--DGQEIAVKRLSKASG---QGLEEF 525
           + +F +   ATN   +   +G G FG V  GRLK    +EI+V   +   G   +   +F
Sbjct: 35  VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 526 MNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 585
           + E  ++ +  H N++RL G   + +  M++ EYM N SLD+ L       +    +   
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK--HDAQFTVIQLVG 151
Query: 586 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 645
           ++ GI+ G+ YL   S +  +HRDL A NIL++  L  K+SDFG+ ++   + + A T R
Sbjct: 152 MLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR 208
Query: 646 VVGT-FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN 704
                  + SPE     +F+  SDV+S+G++L E++S  +               W++ N
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP------------YWEMSN 256
Query: 705 ENKILALVDPFLSESSFQLDMIIRC----IHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 760
           ++ I A+      +  ++L   + C      + L C Q+   +RP    +VS+L+  IR+
Sbjct: 257 QDVIKAV------DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score =  103 bits (257), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 77/218 (35%), Positives = 113/218 (51%), Gaps = 20/218 (9%)
Query: 473 QFEELATATNNFQLSSKLGQGGFGPVYWGR---LKD--GQEIAVKRLSKASGQGLEEFMN 527
           QFEE      + +   +LG+G FG V   R   L+D  G+ +AVK+L  ++ + L +F  
Sbjct: 6   QFEE-----RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 60
Query: 528 EVMVISKLQHRNLVRLLGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 585
           E+ ++  LQH N+V+  G C     +   LI EY+P  SL   L     KER+D  K   
Sbjct: 61  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQ 118
Query: 586 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD--QADT 643
               I +G+ YL      R IHRDL   NIL++ E   KI DFG+ K+   +++  +   
Sbjct: 119 YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKE 175
Query: 644 GRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
                 F Y +PE   E +FS  SDV+SFGV+L E+ +
Sbjct: 176 PGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score =  102 bits (255), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 74/217 (34%), Positives = 111/217 (51%), Gaps = 18/217 (8%)
Query: 473 QFEELATATNNFQLSSKLGQGGFGPVYWGR---LKD--GQEIAVKRLSKASGQGLEEFMN 527
           QFEE      + +   +LG+G FG V   R   L+D  G+ +AVK+L  ++ + L +F  
Sbjct: 9   QFEE-----RHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 63
Query: 528 EVMVISKLQHRNLVRLLGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 585
           E+ ++  LQH N+V+  G C     +   LI E++P  SL   L     KER+D  K   
Sbjct: 64  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYL--QKHKERIDHIKLLQ 121
Query: 586 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 645
               I +G+ YL      R IHRDL   NIL++ E   KI DFG+ K+   +++      
Sbjct: 122 YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE 178
Query: 646 V-VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
                  + +PE   E +FS  SDV+SFGV+L E+ +
Sbjct: 179 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score =  102 bits (255), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 74/217 (34%), Positives = 110/217 (50%), Gaps = 18/217 (8%)
Query: 473 QFEELATATNNFQLSSKLGQGGFGPVYWGR---LKD--GQEIAVKRLSKASGQGLEEFMN 527
           QFEE      + +   +LG+G FG V   R   L+D  G+ +AVK+L  ++ + L +F  
Sbjct: 9   QFEE-----RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 63
Query: 528 EVMVISKLQHRNLVRLLGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 585
           E+ ++  LQH N+V+  G C     +   LI EY+P  SL   L      ER+D  K   
Sbjct: 64  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QAHAERIDHIKLLQ 121
Query: 586 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 645
               I +G+ YL      R IHRDL   NIL++ E   KI DFG+ K+   +++      
Sbjct: 122 YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE 178
Query: 646 V-VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
                  + +PE   E +FS  SDV+SFGV+L E+ +
Sbjct: 179 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  102 bits (255), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 71/201 (35%), Positives = 109/201 (54%), Gaps = 11/201 (5%)
Query: 483 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 542
             +L  +LG G  G V+ G      ++AVK L + S    + F+ E  ++ +LQH+ LVR
Sbjct: 14  TLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVR 72
Query: 543 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSR 602
           L     + E   +I EYM N SL   L  P    +L   K  ++   I+ G+ ++   + 
Sbjct: 73  LYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN- 129
Query: 603 LRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMSPEYAME 660
              IHRDL+A+NIL+ + L+ KI+DFG+A++    +D   T R    F   + +PE    
Sbjct: 130 --YIHRDLRAANILVSDTLSCKIADFGLARLI---EDAEXTAREGAKFPIKWTAPEAINY 184
Query: 661 GRFSEKSDVFSFGVLLLEIVS 681
           G F+ KSDV+SFG+LL EIV+
Sbjct: 185 GTFTIKSDVWSFGILLTEIVT 205

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 74/217 (34%), Positives = 111/217 (51%), Gaps = 18/217 (8%)
Query: 473 QFEELATATNNFQLSSKLGQGGFGPVYWGR---LKD--GQEIAVKRLSKASGQGLEEFMN 527
           QFEE      + +   +LG+G FG V   R   L+D  G+ +AVK+L  ++ + L +F  
Sbjct: 7   QFEE-----RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 61
Query: 528 EVMVISKLQHRNLVRLLGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 585
           E+ ++  LQH N+V+  G C     +   LI EY+P  SL   L     KER+D  K   
Sbjct: 62  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQ 119
Query: 586 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 645
               I +G+ YL      R IHR+L   NIL++ E   KI DFG+ K+   +++      
Sbjct: 120 YTSQICKGMEYL---GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKE 176
Query: 646 V-VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
                  + +PE   E +FS  SDV+SFGV+L E+ +
Sbjct: 177 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/300 (27%), Positives = 147/300 (49%), Gaps = 34/300 (11%)
Query: 471 LFQFEELATATNNFQLSSKLGQGGFGPVYWGRLK--DGQEIAVKRLSKASG---QGLEEF 525
           + +F +   ATN   +   +G G FG V  GRLK    +EI+V   +   G   +   +F
Sbjct: 35  VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 526 MNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 585
           + E  ++ +  H N++RL G   + +  M++ E M N SLD+ L       +    +   
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRK--HDAQFTVIQLVG 151
Query: 586 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 645
           ++ GI+ G+ YL   S +  +HRDL A NIL++  L  K+SDFG++++   + + A T R
Sbjct: 152 MLRGIASGMKYL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208
Query: 646 VVGT-FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN 704
                  + SPE     +F+  SDV+S+G++L E++S  +               W++ N
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP------------YWEMSN 256
Query: 705 ENKILALVDPFLSESSFQLDMIIRC----IHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 760
           ++ I A+      +  ++L   + C      + L C Q+   +RP    +VS+L+  IR+
Sbjct: 257 QDVIKAV------DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/300 (27%), Positives = 147/300 (49%), Gaps = 34/300 (11%)
Query: 471 LFQFEELATATNNFQLSSKLGQGGFGPVYWGRLK--DGQEIAVKRLSKASG---QGLEEF 525
           + +F +   ATN   +   +G G FG V  GRLK    +EI+V   +   G   +   +F
Sbjct: 35  VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 526 MNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 585
           + E  ++ +  H N++RL G   + +  M++ E M N SLD+ L       +    +   
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRK--HDAQFTVIQLVG 151
Query: 586 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 645
           ++ GI+ G+ YL   S +  +HRDL A NIL++  L  K+SDFG++++   + + A T R
Sbjct: 152 MLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208
Query: 646 VVGT-FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN 704
                  + SPE     +F+  SDV+S+G++L E++S  +               W++ N
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP------------YWEMSN 256
Query: 705 ENKILALVDPFLSESSFQLDMIIRC----IHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 760
           ++ I A+      +  ++L   + C      + L C Q+   +RP    +VS+L+  IR+
Sbjct: 257 QDVIKAV------DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/300 (27%), Positives = 147/300 (49%), Gaps = 34/300 (11%)
Query: 471 LFQFEELATATNNFQLSSKLGQGGFGPVYWGRLK--DGQEIAVKRLSKASG---QGLEEF 525
           + +F +   ATN   +   +G G FG V  GRLK    +EI+V   +   G   +   +F
Sbjct: 6   VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 64
Query: 526 MNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 585
           + E  ++ +  H N++RL G   + +  M++ E M N SLD+ L       +    +   
Sbjct: 65  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRK--HDAQFTVIQLVG 122
Query: 586 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 645
           ++ GI+ G+ YL   S +  +HRDL A NIL++  L  K+SDFG++++   + + A T R
Sbjct: 123 MLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 179
Query: 646 VVGT-FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN 704
                  + SPE     +F+  SDV+S+G++L E++S  +               W++ N
Sbjct: 180 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP------------YWEMSN 227
Query: 705 ENKILALVDPFLSESSFQLDMIIRC----IHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 760
           ++ I A+      +  ++L   + C      + L C Q+   +RP    +VS+L+  IR+
Sbjct: 228 QDVIKAV------DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 281

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 135/279 (48%), Gaps = 30/279 (10%)
Query: 490 LGQGGFGPVYWGRLKDGQ-----EIAVKRLSKASGQGLE-EFMNEVMVISKLQHRNLVRL 543
           +G G FG VY G LK         +A+K L     +    +F+ E  ++ +  H N++RL
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 544 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 603
            G   + +  M+I EYM N +LD  L +  K       +   ++ GI+ G+ YL   + +
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYL---ANM 166
Query: 604 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT---GRVVGTFGYMSPEYAME 660
             +HRDL A NIL++  L  K+SDFG++++   + +   T   G++     + +PE    
Sbjct: 167 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI--PIRWTAPEAISY 224
Query: 661 GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS 720
            +F+  SDV+SFG+++ E+++  +               W+L N   + A+ D F   + 
Sbjct: 225 RKFTSASDVWSFGIVMWEVMTYGERP------------YWELSNHEVMKAINDGFRLPTP 272
Query: 721 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIR 759
             +D       + + C Q+    RP  + +VS+L+  IR
Sbjct: 273 --MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 139/279 (49%), Gaps = 29/279 (10%)
Query: 490 LGQGGFGPVYWGRLK-DGQE---IAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLL 544
           +G G FG V  GRLK  G+    +A+K L    + +   +F+ E  ++ +  H N++ L 
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLE 89
Query: 545 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKE--RLDWRKRFNIIEGISRGLLYLHRDSR 602
           G   + +  M++ EYM N SLD  L    KK   +    +   ++ GIS G+ YL   S 
Sbjct: 90  GVVTKSKPVMIVTEYMENGSLDTFL----KKNDGQFTVIQLVGMLRGISAGMKYL---SD 142
Query: 603 LRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT-FGYMSPEYAMEG 661
           +  +HRDL A NIL++  L  K+SDFG++++   + + A T R       + +PE     
Sbjct: 143 MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFR 202
Query: 662 RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSF 721
           +F+  SDV+S+G+++ E+VS  +               W++ N++ I A+ + +   S  
Sbjct: 203 KFTSASDVWSYGIVMWEVVSYGERPY------------WEMTNQDVIKAVEEGYRLPSP- 249
Query: 722 QLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 760
            +D       + L C Q+    RP    +V+ML+  IR+
Sbjct: 250 -MDCPAALYQLMLDCWQKERNSRPKFDEIVNMLDKLIRN 287

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 72/200 (36%), Positives = 107/200 (53%), Gaps = 9/200 (4%)
Query: 483 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 542
           + +L  KLG G FG V+        ++AVK + K     +E F+ E  V+  LQH  LV+
Sbjct: 16  SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVK 74
Query: 543 LLGCCVEGEEKMLIYEYMPNRSL-DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
           L    V  E   +I E+M   SL D L  D   K+ L   K  +    I+ G+ ++ + +
Sbjct: 75  L-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQRN 131
Query: 602 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 661
               IHRDL+A+NIL+   L  KI+DFG+A++   N+  A  G       + +PE    G
Sbjct: 132 ---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFG 187
Query: 662 RFSEKSDVFSFGVLLLEIVS 681
            F+ KSDV+SFG+LL+EIV+
Sbjct: 188 SFTIKSDVWSFGILLMEIVT 207

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score =  100 bits (248), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 21/214 (9%)
Query: 486 LSSKLGQGGFGPVYWGRL------KDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 539
           L  +LG+G FG V+          +D   +AVK L +AS    ++F  E  +++ LQH++
Sbjct: 22  LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 81
Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLF------------DPLKKERLDWRKRFNII 587
           +VR  G C EG   ++++EYM +  L+  L             + +    L   +   + 
Sbjct: 82  IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 141
Query: 588 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVV 647
             ++ G++YL   + L  +HRDL   N L+ + L  KI DFGM++           GR +
Sbjct: 142 SQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 198
Query: 648 GTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
               +M PE  +  +F+ +SDV+SFGV+L EI +
Sbjct: 199 LPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 232

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 99.8 bits (247), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 108/214 (50%), Gaps = 21/214 (9%)
Query: 486 LSSKLGQGGFGPVYWGRL------KDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 539
           L  +LG+G FG V+          +D   +AVK L +AS    ++F  E  +++ LQH++
Sbjct: 16  LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 75
Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSL---------DALLF---DPLKKERLDWRKRFNII 587
           +VR  G C EG   ++++EYM +  L         DA L    + +    L   +   + 
Sbjct: 76  IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 135
Query: 588 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVV 647
             ++ G++YL   + L  +HRDL   N L+ + L  KI DFGM++           GR +
Sbjct: 136 SQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 192
Query: 648 GTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
               +M PE  +  +F+ +SDV+SFGV+L EI +
Sbjct: 193 LPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 226

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 99.4 bits (246), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 107/211 (50%), Gaps = 21/211 (9%)
Query: 489 KLGQGGFGPVYWGRL------KDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 542
           +LG+G FG V+          +D   +AVK L +AS    ++F  E  +++ LQH+++VR
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 543 LLGCCVEGEEKMLIYEYMPNRSL---------DALLF---DPLKKERLDWRKRFNIIEGI 590
             G C EG   ++++EYM +  L         DA L    + +    L   +   +   +
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 591 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF 650
           + G++YL   + L  +HRDL   N L+ + L  KI DFGM++           GR +   
Sbjct: 168 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224
Query: 651 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
            +M PE  +  +F+ +SDV+SFGV+L EI +
Sbjct: 225 RWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 99.4 bits (246), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 72/200 (36%), Positives = 107/200 (53%), Gaps = 9/200 (4%)
Query: 483 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 542
           + +L  KLG G FG V+        ++AVK + K     +E F+ E  V+  LQH  LV+
Sbjct: 189 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVK 247
Query: 543 LLGCCVEGEEKMLIYEYMPNRSL-DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
           L    V  E   +I E+M   SL D L  D   K+ L   K  +    I+ G+ ++ + +
Sbjct: 248 L-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQRN 304
Query: 602 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 661
               IHRDL+A+NIL+   L  KI+DFG+A++   N+  A  G       + +PE    G
Sbjct: 305 ---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFG 360
Query: 662 RFSEKSDVFSFGVLLLEIVS 681
            F+ KSDV+SFG+LL+EIV+
Sbjct: 361 SFTIKSDVWSFGILLMEIVT 380

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 115/218 (52%), Gaps = 25/218 (11%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGRL-KDGQEIAVKRLSKASGQG-------LEEFMNEVMV 531
           A N  +   ++G+GGFG V+ GRL KD   +A+K L     +G        +EF  EV +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 532 ISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGIS 591
           +S L H N+V+L G         ++ E++P   L   L D  K   + W  +  ++  I+
Sbjct: 77  MSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIA 132
Query: 592 RGLLYLHRDSRLRIIHRDLKASNILLD--EELNP---KISDFGMAKIFGGNQDQADTGRV 646
            G+ Y+ ++    I+HRDL++ NI L   +E  P   K++DFG+++     Q       +
Sbjct: 133 LGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGL 186
Query: 647 VGTFGYMSPEY--AMEGRFSEKSDVFSFGVLLLEIVSG 682
           +G F +M+PE   A E  ++EK+D +SF ++L  I++G
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG 224

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 70/212 (33%), Positives = 105/212 (49%), Gaps = 18/212 (8%)
Query: 489 KLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV 548
           ++G G FG V+ G   +  ++A+K + +      E+F+ E  V+ KL H  LV+L G C+
Sbjct: 14  EIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 72
Query: 549 EGEEKMLIYEYMPNRSLDALLFDPLKKER--LDWRKRFNIIEGISRGLLYLHRDSRLRII 606
           E     L++E+M +  L     D L+ +R          +   +  G+ YL   S   +I
Sbjct: 73  EQAPICLVFEFMEHGCLS----DYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAS---VI 125
Query: 607 HRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEK 666
           HRDL A N L+ E    K+SDFGM +    +Q  + TG       + SPE     R+S K
Sbjct: 126 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSRYSSK 184
Query: 667 SDVFSFGVLLLEIVS-------GRKNTSFFED 691
           SDV+SFGVL+ E+ S        R N+   ED
Sbjct: 185 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVED 216

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/201 (34%), Positives = 103/201 (51%), Gaps = 7/201 (3%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 540
            +  +  KLG G +G VY G  K     +AVK L K     +EEF+ E  V+ +++H NL
Sbjct: 32  TDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 90
Query: 541 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 600
           V+LLG C       ++ EYMP  +L   L +   +E +       +   IS  + YL + 
Sbjct: 91  VQLLGVCTLEPPFYIVTEYMPYGNLLDYLRE-CNREEVTAVVLLYMATQISSAMEYLEKK 149
Query: 601 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
           +    IHRDL A N L+ E    K++DFG++++  G+   A  G       + +PE    
Sbjct: 150 N---FIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAY 205
Query: 661 GRFSEKSDVFSFGVLLLEIVS 681
             FS KSDV++FGVLL EI +
Sbjct: 206 NTFSIKSDVWAFGVLLWEIAT 226

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 114/218 (52%), Gaps = 25/218 (11%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGRL-KDGQEIAVKRLSKASGQG-------LEEFMNEVMV 531
           A N  +   ++G+GGFG V+ GRL KD   +A+K L     +G        +EF  EV +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 532 ISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGIS 591
           +S L H N+V+L G         ++ E++P   L   L D  K   + W  +  ++  I+
Sbjct: 77  MSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIA 132
Query: 592 RGLLYLHRDSRLRIIHRDLKASNILLD--EELNP---KISDFGMAKIFGGNQDQADTGRV 646
            G+ Y+ ++    I+HRDL++ NI L   +E  P   K++DFG ++     Q       +
Sbjct: 133 LGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ-----QSVHSVSGL 186
Query: 647 VGTFGYMSPEY--AMEGRFSEKSDVFSFGVLLLEIVSG 682
           +G F +M+PE   A E  ++EK+D +SF ++L  I++G
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG 224

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 104/212 (49%), Gaps = 18/212 (8%)
Query: 489 KLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV 548
           ++G G FG V+ G   +  ++A+K + +      E+F+ E  V+ KL H  LV+L G C+
Sbjct: 12  EIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 549 EGEEKMLIYEYMPNRSLDALLFDPLKKER--LDWRKRFNIIEGISRGLLYLHRDSRLRII 606
           E     L++E+M +  L     D L+ +R          +   +  G+ YL       +I
Sbjct: 71  EQAPICLVFEFMEHGCLS----DYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 123
Query: 607 HRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEK 666
           HRDL A N L+ E    K+SDFGM +    +Q  + TG       + SPE     R+S K
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSRYSSK 182
Query: 667 SDVFSFGVLLLEIVS-------GRKNTSFFED 691
           SDV+SFGVL+ E+ S        R N+   ED
Sbjct: 183 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVED 214

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 70/229 (30%), Positives = 114/229 (49%), Gaps = 25/229 (10%)
Query: 473 QFEELATATNNFQLSSKLGQGGFGPVYWGRL------KDGQEIAVKRLS-KASGQGLEEF 525
           + +E++ +   F    +LG+  FG VY G L      +  Q +A+K L  KA G   EEF
Sbjct: 19  KLKEISLSAVRFM--EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEF 76
Query: 526 MNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLF-------------DP 572
            +E M+ ++LQH N+V LLG   + +   +I+ Y  +  L   L              D 
Sbjct: 77  RHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDR 136
Query: 573 LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 632
             K  L+     +++  I+ G+ YL   S   ++H+DL   N+L+ ++LN KISD G+ +
Sbjct: 137 TVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR 193
Query: 633 IFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
                      G  +    +M+PE  M G+FS  SD++S+GV+L E+ S
Sbjct: 194 EVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 143/288 (49%), Gaps = 35/288 (12%)
Query: 485 QLSSKLGQGGFGPVYWGRLK-DGQE---IAVKRLSKA-SGQGLEEFMNEVMVISKLQHRN 539
           ++   +G G FG V  GRLK  G++   +A+K L    + +   EF++E  ++ + +H N
Sbjct: 19  KIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPN 78
Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 599
           ++RL G        M++ E+M N +LD+ L   L   +    +   ++ GI+ G+ YL  
Sbjct: 79  IIRLEGVVTNSMPVMILTEFMENGALDSFLR--LNDGQFTVIQLVGMLRGIASGMRYL-- 134
Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN-QDQADTGRVVGTFG--YMSPE 656
            + +  +HRDL A NIL++  L  K+SDFG+++    N  D  +T  + G     + +PE
Sbjct: 135 -AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPE 193
Query: 657 YAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL 716
                +F+  SD +S+G+++ E++      SF E         W + N++ I A+     
Sbjct: 194 AIAFRKFTSASDAWSYGIVMWEVM------SFGERPY------WDMSNQDVINAI----- 236
Query: 717 SESSFQLDMIIRC---IHVGLL-CVQELVKDRPNMSTVVSMLNSEIRD 760
            E  ++L     C   +H  +L C Q+    RP    VVS L+  IR+
Sbjct: 237 -EQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMIRN 283

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 104/212 (49%), Gaps = 18/212 (8%)
Query: 489 KLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV 548
           ++G G FG V+ G   +  ++A+K + +      E+F+ E  V+ KL H  LV+L G C+
Sbjct: 17  EIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 75
Query: 549 EGEEKMLIYEYMPNRSLDALLFDPLKKER--LDWRKRFNIIEGISRGLLYLHRDSRLRII 606
           E     L++E+M +  L     D L+ +R          +   +  G+ YL       +I
Sbjct: 76  EQAPICLVFEFMEHGCLS----DYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 128
Query: 607 HRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEK 666
           HRDL A N L+ E    K+SDFGM +    +Q  + TG       + SPE     R+S K
Sbjct: 129 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSRYSSK 187
Query: 667 SDVFSFGVLLLEIVS-------GRKNTSFFED 691
           SDV+SFGVL+ E+ S        R N+   ED
Sbjct: 188 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVED 219

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 70/229 (30%), Positives = 114/229 (49%), Gaps = 25/229 (10%)
Query: 473 QFEELATATNNFQLSSKLGQGGFGPVYWGRL------KDGQEIAVKRLS-KASGQGLEEF 525
           + +E++ +   F    +LG+  FG VY G L      +  Q +A+K L  KA G   EEF
Sbjct: 2   KLKEISLSAVRFM--EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEF 59
Query: 526 MNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLF-------------DP 572
            +E M+ ++LQH N+V LLG   + +   +I+ Y  +  L   L              D 
Sbjct: 60  RHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDR 119
Query: 573 LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 632
             K  L+     +++  I+ G+ YL   S   ++H+DL   N+L+ ++LN KISD G+ +
Sbjct: 120 TVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR 176
Query: 633 IFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
                      G  +    +M+PE  M G+FS  SD++S+GV+L E+ S
Sbjct: 177 EVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 104/212 (49%), Gaps = 18/212 (8%)
Query: 489 KLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV 548
           ++G G FG V+ G   +  ++A+K + +      E+F+ E  V+ KL H  LV+L G C+
Sbjct: 14  EIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 72
Query: 549 EGEEKMLIYEYMPNRSLDALLFDPLKKER--LDWRKRFNIIEGISRGLLYLHRDSRLRII 606
           E     L++E+M +  L     D L+ +R          +   +  G+ YL       +I
Sbjct: 73  EQAPICLVFEFMEHGCLS----DYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 125
Query: 607 HRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEK 666
           HRDL A N L+ E    K+SDFGM +    +Q  + TG       + SPE     R+S K
Sbjct: 126 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSRYSSK 184
Query: 667 SDVFSFGVLLLEIVS-------GRKNTSFFED 691
           SDV+SFGVL+ E+ S        R N+   ED
Sbjct: 185 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVED 216

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 108/222 (48%), Gaps = 22/222 (9%)
Query: 486 LSSKLGQGGFGPVYWGR------LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 539
           L  +LG+G FG V+          KD   +AVK L   +    ++F  E  +++ LQH +
Sbjct: 19  LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSL---------DALLF---DPLK-KERLDWRKRFNI 586
           +V+  G C +G+  ++++EYM +  L         DA++     P + K  L   +  +I
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 587 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV 646
              I+ G++YL   +    +HRDL   N L+   L  KI DFGM++           G  
Sbjct: 139 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195
Query: 647 VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSF 688
           +    +M PE  M  +F+ +SDV+SFGV+L EI +  K   F
Sbjct: 196 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF 237

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 114/218 (52%), Gaps = 25/218 (11%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGRL-KDGQEIAVKRLSKASGQG-------LEEFMNEVMV 531
           A N  +   ++G+GGFG V+ GRL KD   +A+K L     +G        +EF  EV +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 532 ISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGIS 591
           +S L H N+V+L G         ++ E++P   L   L D  K   + W  +  ++  I+
Sbjct: 77  MSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIA 132
Query: 592 RGLLYLHRDSRLRIIHRDLKASNILLD--EELNP---KISDFGMAKIFGGNQDQADTGRV 646
            G+ Y+ ++    I+HRDL++ NI L   +E  P   K++DF +++     Q       +
Sbjct: 133 LGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ-----QSVHSVSGL 186
Query: 647 VGTFGYMSPEY--AMEGRFSEKSDVFSFGVLLLEIVSG 682
           +G F +M+PE   A E  ++EK+D +SF ++L  I++G
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG 224

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 7/201 (3%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 540
            +  +  KLG G +G VY G  K     +AVK L K     +EEF+ E  V+ +++H NL
Sbjct: 18  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 76
Query: 541 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 600
           V+LLG C       +I E+M   +L   L +   ++ ++      +   IS  + YL + 
Sbjct: 77  VQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKK 135
Query: 601 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
           +    IHRDL A N L+ E    K++DFG++++  G+   A  G       + +PE    
Sbjct: 136 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF-PIKWTAPESLAY 191
Query: 661 GRFSEKSDVFSFGVLLLEIVS 681
            +FS KSDV++FGVLL EI +
Sbjct: 192 NKFSIKSDVWAFGVLLWEIAT 212

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 105/212 (49%), Gaps = 18/212 (8%)
Query: 489 KLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV 548
           ++G G FG V+ G   +  ++A+K + + S    ++F+ E  V+ KL H  LV+L G C+
Sbjct: 34  EIGSGQFGLVHLGYWLNKDKVAIKTIKEGS-MSEDDFIEEAEVMMKLSHPKLVQLYGVCL 92
Query: 549 EGEEKMLIYEYMPNRSLDALLFDPLKKER--LDWRKRFNIIEGISRGLLYLHRDSRLRII 606
           E     L++E+M +  L     D L+ +R          +   +  G+ YL       +I
Sbjct: 93  EQAPICLVFEFMEHGCLS----DYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 145
Query: 607 HRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEK 666
           HRDL A N L+ E    K+SDFGM +    +Q  + TG       + SPE     R+S K
Sbjct: 146 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSRYSSK 204
Query: 667 SDVFSFGVLLLEIVS-------GRKNTSFFED 691
           SDV+SFGVL+ E+ S        R N+   ED
Sbjct: 205 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVED 236

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 117/200 (58%), Gaps = 16/200 (8%)
Query: 490 LGQGGFGPVYWGR-LKDGQ----EIAVKRLSKASGQGLE-EFMNEVMVISKLQHRNLVRL 543
           LG G FG VY G  + +G+     +A+K L++ +G     EFM+E ++++ + H +LVRL
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 544 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 603
           LG C+    + L+ + MP+  L   + +   K+ +  +   N    I++G++YL      
Sbjct: 106 LGVCLSPTIQ-LVTQLMPHGCLLEYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEER--- 159
Query: 604 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYMSPEYAMEG 661
           R++HRDL A N+L+    + KI+DFG+A++  G++ +  AD G++     +M+ E     
Sbjct: 160 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM--PIKWMALECIHYR 217
Query: 662 RFSEKSDVFSFGVLLLEIVS 681
           +F+ +SDV+S+GV + E+++
Sbjct: 218 KFTHQSDVWSYGVTIWELMT 237

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 85/297 (28%), Positives = 130/297 (43%), Gaps = 41/297 (13%)
Query: 483 NFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASGQGLE-EFMNEVMVISKL 535
           N  L   LG G FG VY G++          ++AVK L +   +  E +F+ E ++ISKL
Sbjct: 46  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKL 105
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD----PLKKERLDWRKRFNIIEGIS 591
            H+N+VR +G  ++   + ++ E M    L + L +    P +   L      ++   I+
Sbjct: 106 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 165
Query: 592 RGLLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKIFGGNQDQADTGRVVG 648
            G  YL  +     IHRD+ A N LL         KI DFGMA+           G  + 
Sbjct: 166 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 222
Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGY-AWKLWNENK 707
              +M PE  MEG F+ K+D +SFGVLL EI S              LGY  +   +  +
Sbjct: 223 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--------------LGYMPYPSKSNQE 268
Query: 708 ILALVDPFLSESSFQLDMIIRC----IHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 760
           +L  V      S  ++D    C      +   C Q   +DRPN + ++  +    +D
Sbjct: 269 VLEFVT-----SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 320

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 85/297 (28%), Positives = 130/297 (43%), Gaps = 41/297 (13%)
Query: 483 NFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASGQGLE-EFMNEVMVISKL 535
           N  L   LG G FG VY G++          ++AVK L +   +  E +F+ E ++ISKL
Sbjct: 32  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKL 91
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD----PLKKERLDWRKRFNIIEGIS 591
            H+N+VR +G  ++   + ++ E M    L + L +    P +   L      ++   I+
Sbjct: 92  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 151
Query: 592 RGLLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKIFGGNQDQADTGRVVG 648
            G  YL  +     IHRD+ A N LL         KI DFGMA+           G  + 
Sbjct: 152 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 208
Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGY-AWKLWNENK 707
              +M PE  MEG F+ K+D +SFGVLL EI S              LGY  +   +  +
Sbjct: 209 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--------------LGYMPYPSKSNQE 254
Query: 708 ILALVDPFLSESSFQLDMIIRC----IHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 760
           +L  V      S  ++D    C      +   C Q   +DRPN + ++  +    +D
Sbjct: 255 VLEFVT-----SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 306

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 7/201 (3%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 540
            +  +  KLG G +G VY G  K     +AVK L K     +EEF+ E  V+ +++H NL
Sbjct: 18  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 76
Query: 541 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 600
           V+LLG C       +I E+M   +L   L +   ++ ++      +   IS  + YL + 
Sbjct: 77  VQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKK 135
Query: 601 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
           +    IHRDL A N L+ E    K++DFG++++  G+   A  G       + +PE    
Sbjct: 136 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAY 191
Query: 661 GRFSEKSDVFSFGVLLLEIVS 681
            +FS KSDV++FGVLL EI +
Sbjct: 192 NKFSIKSDVWAFGVLLWEIAT 212

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 88/314 (28%), Positives = 144/314 (45%), Gaps = 44/314 (14%)
Query: 475 EELATATNNFQLSSKLGQGGFGPVYWGR----LKDGQE--IAVKRLSKASGQGLE-EFMN 527
           +E   A     +S +LGQG FG VY G     +KD  E  +A+K +++A+      EF+N
Sbjct: 3   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 62
Query: 528 EVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD-------- 579
           E  V+ +    ++VRLLG   +G+  ++I E M    L + L   L+ E  +        
Sbjct: 63  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS-LRPEMENNPVLAPPS 121
Query: 580 WRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 639
             K   +   I+ G+ YL+ +   + +HRDL A N ++ E+   KI DFGM +       
Sbjct: 122 LSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDX 178
Query: 640 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYA 699
               G+ +    +MSPE   +G F+  SDV+SFGV+L EI              T+    
Sbjct: 179 XRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA-------------TLAEQP 225
Query: 700 WKLWNENKILALV--DPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE 757
           ++  +  ++L  V     L +     DM++  +    +C Q   K RP+   ++S +  E
Sbjct: 226 YQGLSNEQVLRFVMEGGLLDKPDNCPDMLLELMR---MCWQYNPKMRPSFLEIISSIKEE 282
Query: 758 IRDLPYPKEPAFTE 771
           +       EP F E
Sbjct: 283 M-------EPGFRE 289

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 117/200 (58%), Gaps = 16/200 (8%)
Query: 490 LGQGGFGPVYWGR-LKDGQ----EIAVKRLSKASGQGLE-EFMNEVMVISKLQHRNLVRL 543
           LG G FG VY G  + +G+     +A+K L++ +G     EFM+E ++++ + H +LVRL
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 544 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 603
           LG C+    + L+ + MP+  L   + +   K+ +  +   N    I++G++YL      
Sbjct: 83  LGVCLSPTIQ-LVTQLMPHGCLLEYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEER--- 136
Query: 604 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYMSPEYAMEG 661
           R++HRDL A N+L+    + KI+DFG+A++  G++ +  AD G++     +M+ E     
Sbjct: 137 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM--PIKWMALECIHYR 194
Query: 662 RFSEKSDVFSFGVLLLEIVS 681
           +F+ +SDV+S+GV + E+++
Sbjct: 195 KFTHQSDVWSYGVTIWELMT 214

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/201 (33%), Positives = 103/201 (51%), Gaps = 7/201 (3%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 540
            +  +  KLG G FG VY G  K     +AVK L K     +EEF+ E  V+ +++H NL
Sbjct: 11  TDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 69
Query: 541 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 600
           V+LLG C       +I E+M   +L   L +   ++ +       +   IS  + YL + 
Sbjct: 70  VQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKK 128
Query: 601 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
           +    IHRDL A N L+ E    K++DFG++++  G+   A  G       + +PE    
Sbjct: 129 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF-PIKWTAPESLAY 184
Query: 661 GRFSEKSDVFSFGVLLLEIVS 681
            +FS KSDV++FGVLL EI +
Sbjct: 185 NKFSIKSDVWAFGVLLWEIAT 205

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 108/213 (50%), Gaps = 7/213 (3%)
Query: 470 PLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNE 528
           P   +++      +  +  KLG G +G VY G  K     +AVK L K     +EEF+ E
Sbjct: 2   PSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKE 60
Query: 529 VMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE 588
             V+ +++H NLV+LLG C       +I E+M   +L   L +   ++ ++      +  
Sbjct: 61  AAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRE-CNRQEVNAVVLLYMAT 119
Query: 589 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 648
            IS  + YL + +    IHRDL A N L+ E    K++DFG++++  G+   A  G    
Sbjct: 120 QISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF- 175
Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
              + +PE     +FS KSDV++FGVLL EI +
Sbjct: 176 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 7/201 (3%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 540
            +  +  KLG G +G VY G  K     +AVK L K     +EEF+ E  V+ +++H NL
Sbjct: 18  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 76
Query: 541 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 600
           V+LLG C       +I E+M   +L   L +   ++ ++      +   IS  + YL + 
Sbjct: 77  VQLLGVCTREPPFYIIIEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKK 135
Query: 601 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
           +    IHRDL A N L+ E    K++DFG++++  G+   A  G       + +PE    
Sbjct: 136 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAY 191
Query: 661 GRFSEKSDVFSFGVLLLEIVS 681
            +FS KSDV++FGVLL EI +
Sbjct: 192 NKFSIKSDVWAFGVLLWEIAT 212

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 95.1 bits (235), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 140/288 (48%), Gaps = 35/288 (12%)
Query: 485 QLSSKLGQGGFGPVYWGRLK-DGQE---IAVKRLSKA-SGQGLEEFMNEVMVISKLQHRN 539
           ++   +G G FG V  GRLK  G++   +A+K L    + +   EF++E  ++ + +H N
Sbjct: 17  KIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPN 76
Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 599
           ++RL G        M++ E+M N +LD+ L   L   +    +   ++ GI+ G+ YL  
Sbjct: 77  IIRLEGVVTNSMPVMILTEFMENGALDSFLR--LNDGQFTVIQLVGMLRGIASGMRYL-- 132
Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG---TFGYMSPE 656
            + +  +HRDL A NIL++  L  K+SDFG+++    N         +G      + +PE
Sbjct: 133 -AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPE 191
Query: 657 YAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL 716
                +F+  SD +S+G+++ E++      SF E         W + N++ I A+     
Sbjct: 192 AIAFRKFTSASDAWSYGIVMWEVM------SFGERPY------WDMSNQDVINAI----- 234
Query: 717 SESSFQLDMIIRC---IHVGLL-CVQELVKDRPNMSTVVSMLNSEIRD 760
            E  ++L     C   +H  +L C Q+    RP    VVS L+  IR+
Sbjct: 235 -EQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMIRN 281

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 95.1 bits (235), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 7/201 (3%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 540
            +  +  KLG G +G VY G  K     +AVK L K     +EEF+ E  V+ +++H NL
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 75
Query: 541 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 600
           V+LLG C       +I E+M   +L   L +   ++ ++      +   IS  + YL + 
Sbjct: 76  VQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKK 134
Query: 601 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
           +    IHRDL A N L+ E    K++DFG++++  G+   A  G       + +PE    
Sbjct: 135 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAY 190
Query: 661 GRFSEKSDVFSFGVLLLEIVS 681
            +FS KSDV++FGVLL EI +
Sbjct: 191 NKFSIKSDVWAFGVLLWEIAT 211

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 143/289 (49%), Gaps = 37/289 (12%)
Query: 484 FQLSSKLGQGGFGPVYWGRLK-DGQE---IAVKRLSKA-SGQGLEEFMNEVMVISKLQHR 538
            ++   +G G FG V  GRLK  G+    +A+K L    + +   +F+ E  ++ +  H 
Sbjct: 45  IKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHP 104
Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           N+V L G    G+  M++ E+M N +LDA L       +    +   ++ GI+ G+ YL 
Sbjct: 105 NVVHLEGVVTRGKPVMIVIEFMENGALDAFLRK--HDGQFTVIQLVGMLRGIAAGMRYL- 161
Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT---GRVVGTFGYMSP 655
             + +  +HRDL A NIL++  L  K+SDFG++++   + +   T   G++     + +P
Sbjct: 162 --ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKI--PVRWTAP 217
Query: 656 EYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPF 715
           E     +F+  SDV+S+G+++ E++S  +               W + N++ I A+    
Sbjct: 218 EAIQYRKFTSASDVWSYGIVMWEVMSYGERPY------------WDMSNQDVIKAI---- 261
Query: 716 LSESSFQLDMIIRC---IHVGLL-CVQELVKDRPNMSTVVSMLNSEIRD 760
             E  ++L   + C   +H  +L C Q+   +RP    +V +L+  IR+
Sbjct: 262 --EEGYRLPAPMDCPAGLHQLMLDCWQKERAERPKFEQIVGILDKMIRN 308

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 107/211 (50%), Gaps = 21/211 (9%)
Query: 484 FQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKAS----GQGLEEFMNEVMVISKLQHRN 539
             L   +G GGFG VY      G E+AVK           Q +E    E  + + L+H N
Sbjct: 9   LTLEEIIGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 599
           ++ L G C++     L+ E+     L+ +L      +R+      N    I+RG+ YLH 
Sbjct: 68  IIALRGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHD 123
Query: 600 DSRLRIIHRDLKASNILLDEELNP--------KISDFGMAKIFGGNQDQADTGRVVGTFG 651
           ++ + IIHRDLK+SNIL+ +++          KI+DFG+A+ +      +      G + 
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMS----AAGAYA 179
Query: 652 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           +M+PE      FS+ SDV+S+GVLL E+++G
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTG 210

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 7/201 (3%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 540
            +  +  KLG G +G VY G  K     +AVK L K     +EEF+ E  V+ +++H NL
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 71
Query: 541 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 600
           V+LLG C       +I E+M   +L   L +   ++ ++      +   IS  + YL + 
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKK 130
Query: 601 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
           +    IHRDL A N L+ E    K++DFG++++  G+   A  G       + +PE    
Sbjct: 131 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAY 186
Query: 661 GRFSEKSDVFSFGVLLLEIVS 681
            +FS KSDV++FGVLL EI +
Sbjct: 187 NKFSIKSDVWAFGVLLWEIAT 207

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 112/215 (52%), Gaps = 20/215 (9%)
Query: 489 KLGQGGFGPVYWGR-LKDGQEIAVKRLS---KASGQGLEEFMNEVMVISKLQHRNLVRLL 544
           ++G G FG VY+ R +++ + +A+K++S   K S +  ++ + EV  + KL+H N ++  
Sbjct: 61  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120
Query: 545 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 604
           GC +      L+ EY    + D L    + K+ L   +   +  G  +GL YLH  +   
Sbjct: 121 GCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHSHN--- 174
Query: 605 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM---EG 661
           +IHRD+KA NILL E    K+ DFG A I       A     VGT  +M+PE  +   EG
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVILAMDEG 228
Query: 662 RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTIL 696
           ++  K DV+S G+  +E+   RK   F  + ++ L
Sbjct: 229 QYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSAL 262

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 103/212 (48%), Gaps = 18/212 (8%)
Query: 489 KLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV 548
           ++G G FG V+ G   +  ++A+K + +      E+F+ E  V+ KL H  LV+L G C+
Sbjct: 15  EIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 549 EGEEKMLIYEYMPNRSLDALLFDPLKKER--LDWRKRFNIIEGISRGLLYLHRDSRLRII 606
           E     L+ E+M +  L     D L+ +R          +   +  G+ YL       +I
Sbjct: 74  EQAPICLVTEFMEHGCLS----DYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 126
Query: 607 HRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEK 666
           HRDL A N L+ E    K+SDFGM +    +Q  + TG       + SPE     R+S K
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSRYSSK 185
Query: 667 SDVFSFGVLLLEIVS-------GRKNTSFFED 691
           SDV+SFGVL+ E+ S        R N+   ED
Sbjct: 186 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVED 217

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 7/201 (3%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 540
            +  +  KLG G +G VY G  K     +AVK L K     +EEF+ E  V+ +++H NL
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 71
Query: 541 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 600
           V+LLG C       +I E+M   +L   L +   ++ ++      +   IS  + YL + 
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKK 130
Query: 601 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
           +    IHRDL A N L+ E    K++DFG++++  G+   A  G       + +PE    
Sbjct: 131 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAY 186
Query: 661 GRFSEKSDVFSFGVLLLEIVS 681
            +FS KSDV++FGVLL EI +
Sbjct: 187 NKFSIKSDVWAFGVLLWEIAT 207

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 112/215 (52%), Gaps = 20/215 (9%)
Query: 489 KLGQGGFGPVYWGR-LKDGQEIAVKRLS---KASGQGLEEFMNEVMVISKLQHRNLVRLL 544
           ++G G FG VY+ R +++ + +A+K++S   K S +  ++ + EV  + KL+H N ++  
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 545 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 604
           GC +      L+ EY    + D L    + K+ L   +   +  G  +GL YLH  +   
Sbjct: 82  GCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHSHN--- 135
Query: 605 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM---EG 661
           +IHRD+KA NILL E    K+ DFG A I       A     VGT  +M+PE  +   EG
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVILAMDEG 189
Query: 662 RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTIL 696
           ++  K DV+S G+  +E+   RK   F  + ++ L
Sbjct: 190 QYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSAL 223

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 103/201 (51%), Gaps = 7/201 (3%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 540
            +  +  KLG G +G VY G  K     +AVK L K     +EEF+ E  V+ +++H NL
Sbjct: 11  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 69
Query: 541 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 600
           V+LLG C       +I E+M   +L   L +   ++ +       +   IS  + YL + 
Sbjct: 70  VQLLGVCTREPPFYIIIEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKK 128
Query: 601 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
           +    IHRDL A N L+ E    K++DFG++++  G+   A  G       + +PE    
Sbjct: 129 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF-PIKWTAPESLAY 184
Query: 661 GRFSEKSDVFSFGVLLLEIVS 681
            +FS KSDV++FGVLL EI +
Sbjct: 185 NKFSIKSDVWAFGVLLWEIAT 205

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 102/193 (52%), Gaps = 7/193 (3%)
Query: 489 KLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV 548
           +LG G FG V +G+ +   ++A+K + + S    +EF+ E  V+  L H  LV+L G C 
Sbjct: 31  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 549 EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHR 608
           +     +I EYM N  L   L +   + R   ++   + + +   + YL      + +HR
Sbjct: 90  KQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHR 144
Query: 609 DLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSD 668
           DL A N L++++   K+SDFG+++    +++ +  G       +  PE  M  +FS KSD
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKF-PVRWSPPEVLMYSKFSSKSD 203
Query: 669 VFSFGVLLLEIVS 681
           +++FGVL+ EI S
Sbjct: 204 IWAFGVLMWEIYS 216

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/222 (31%), Positives = 112/222 (50%), Gaps = 19/222 (8%)
Query: 475 EELATATNNFQLSSKLGQGGFGPVYWGR----LKDGQE--IAVKRLSKASGQGLE-EFMN 527
           +E   A     +S +LGQG FG VY G     +KD  E  +A+K +++A+      EF+N
Sbjct: 12  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 71
Query: 528 EVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD-------- 579
           E  V+ +    ++VRLLG   +G+  ++I E M    L + L   L+ E  +        
Sbjct: 72  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPS 130
Query: 580 WRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 639
             K   +   I+ G+ YL+ +   + +HRDL A N ++ E+   KI DFGM +       
Sbjct: 131 LSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDX 187
Query: 640 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
               G+ +    +MSPE   +G F+  SDV+SFGV+L EI +
Sbjct: 188 XRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 7/201 (3%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 540
            +  +  KLG G +G VY G  K     +AVK L K     +EEF+ E  V+ +++H NL
Sbjct: 18  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 76
Query: 541 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 600
           V+LLG C       +I E+M   +L   L +   ++ ++      +   IS  + YL + 
Sbjct: 77  VQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKK 135
Query: 601 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
           +    IHRDL A N L+ E    K++DFG++++  G+   A  G       + +PE    
Sbjct: 136 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAY 191
Query: 661 GRFSEKSDVFSFGVLLLEIVS 681
            +FS KSDV++FGVLL EI +
Sbjct: 192 NKFSIKSDVWAFGVLLWEIAT 212

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 84/297 (28%), Positives = 129/297 (43%), Gaps = 41/297 (13%)
Query: 483 NFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASGQGLE-EFMNEVMVISKL 535
           N  L   LG G FG VY G++          ++AVK L +   +  E +F+ E ++ISK 
Sbjct: 46  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 105
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD----PLKKERLDWRKRFNIIEGIS 591
            H+N+VR +G  ++   + ++ E M    L + L +    P +   L      ++   I+
Sbjct: 106 NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 165
Query: 592 RGLLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKIFGGNQDQADTGRVVG 648
            G  YL  +     IHRD+ A N LL         KI DFGMA+           G  + 
Sbjct: 166 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 222
Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGY-AWKLWNENK 707
              +M PE  MEG F+ K+D +SFGVLL EI S              LGY  +   +  +
Sbjct: 223 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--------------LGYMPYPSKSNQE 268
Query: 708 ILALVDPFLSESSFQLDMIIRC----IHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 760
           +L  V      S  ++D    C      +   C Q   +DRPN + ++  +    +D
Sbjct: 269 VLEFVT-----SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 320

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 7/201 (3%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 540
            +  +  KLG G +G VY G  K     +AVK L K     +EEF+ E  V+ +++H NL
Sbjct: 15  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 73
Query: 541 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 600
           V+LLG C       +I E+M   +L   L +   ++ ++      +   IS  + YL + 
Sbjct: 74  VQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKK 132
Query: 601 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
           +    IHRDL A N L+ E    K++DFG++++  G+   A  G       + +PE    
Sbjct: 133 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAY 188
Query: 661 GRFSEKSDVFSFGVLLLEIVS 681
            +FS KSDV++FGVLL EI +
Sbjct: 189 NKFSIKSDVWAFGVLLWEIAT 209

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 7/201 (3%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 540
            +  +  KLG G +G VY G  K     +AVK L K     +EEF+ E  V+ +++H NL
Sbjct: 15  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 73
Query: 541 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 600
           V+LLG C       +I E+M   +L   L +   ++ ++      +   IS  + YL + 
Sbjct: 74  VQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKK 132
Query: 601 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
           +    IHRDL A N L+ E    K++DFG++++  G+   A  G       + +PE    
Sbjct: 133 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAY 188
Query: 661 GRFSEKSDVFSFGVLLLEIVS 681
            +FS KSDV++FGVLL EI +
Sbjct: 189 NKFSIKSDVWAFGVLLWEIAT 209

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 129/298 (43%), Gaps = 41/298 (13%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASGQGLE-EFMNEVMVISK 534
            N  L   LG G FG VY G++          ++AVK L +   +  E +F+ E ++ISK
Sbjct: 22  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 81
Query: 535 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD----PLKKERLDWRKRFNIIEGI 590
             H+N+VR +G  ++   + ++ E M    L + L +    P +   L      ++   I
Sbjct: 82  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 141
Query: 591 SRGLLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKIFGGNQDQADTGRVV 647
           + G  YL  +     IHRD+ A N LL         KI DFGMA+           G  +
Sbjct: 142 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 198
Query: 648 GTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGY-AWKLWNEN 706
               +M PE  MEG F+ K+D +SFGVLL EI S              LGY  +   +  
Sbjct: 199 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--------------LGYMPYPSKSNQ 244
Query: 707 KILALVDPFLSESSFQLDMIIRC----IHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 760
           ++L  V      S  ++D    C      +   C Q   +DRPN + ++  +    +D
Sbjct: 245 EVLEFVT-----SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 297

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 90/333 (27%), Positives = 141/333 (42%), Gaps = 49/333 (14%)
Query: 455 KLSATNVNTVKLQDLPLFQFEELATATN--------NFQLSSKLGQGGFGPVYWGRLK-- 504
           KLS    +T+     P + F    ++ +        N  L   LG G FG VY G++   
Sbjct: 2   KLSKLRTSTIMTDYNPNYSFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGM 61
Query: 505 ----DGQEIAVKRLSKASGQGLE-EFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 559
                  ++AVK L +   +  E +F+ E ++ISK  H+N+VR +G  ++   + ++ E 
Sbjct: 62  PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLEL 121
Query: 560 MPNRSLDALLFD----PLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNI 615
           M    L + L +    P +   L      ++   I+ G  YL  +     IHRD+ A N 
Sbjct: 122 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNC 178
Query: 616 LLD---EELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSF 672
           LL         KI DFGMA+           G  +    +M PE  MEG F+ K+D +SF
Sbjct: 179 LLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSF 238
Query: 673 GVLLLEIVSGRKNTSFFEDDLTILGY-AWKLWNENKILALVDPFLSESSFQLDMIIRC-- 729
           GVLL EI S              LGY  +   +  ++L  V      S  ++D    C  
Sbjct: 239 GVLLWEIFS--------------LGYMPYPSKSNQEVLEFVT-----SGGRMDPPKNCPG 279
Query: 730 --IHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 760
               +   C Q   +DRPN + ++  +    +D
Sbjct: 280 PVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 312

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 7/201 (3%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 540
            +  +  KLG G +G VY G  K     +AVK L K     +EEF+ E  V+ +++H NL
Sbjct: 26  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 84
Query: 541 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 600
           V+LLG C       +I E+M   +L   L +   ++ ++      +   IS  + YL + 
Sbjct: 85  VQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKK 143
Query: 601 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
           +    IHRDL A N L+ E    K++DFG++++  G+   A  G       + +PE    
Sbjct: 144 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAY 199
Query: 661 GRFSEKSDVFSFGVLLLEIVS 681
            +FS KSDV++FGVLL EI +
Sbjct: 200 NKFSIKSDVWAFGVLLWEIAT 220

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 84/297 (28%), Positives = 129/297 (43%), Gaps = 41/297 (13%)
Query: 483 NFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASGQGLE-EFMNEVMVISKL 535
           N  L   LG G FG VY G++          ++AVK L +   +  E +F+ E ++ISK 
Sbjct: 31  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 90
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD----PLKKERLDWRKRFNIIEGIS 591
            H+N+VR +G  ++   + ++ E M    L + L +    P +   L      ++   I+
Sbjct: 91  NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150
Query: 592 RGLLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKIFGGNQDQADTGRVVG 648
            G  YL  +     IHRD+ A N LL         KI DFGMA+           G  + 
Sbjct: 151 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 207
Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGY-AWKLWNENK 707
              +M PE  MEG F+ K+D +SFGVLL EI S              LGY  +   +  +
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--------------LGYMPYPSKSNQE 253
Query: 708 ILALVDPFLSESSFQLDMIIRC----IHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 760
           +L  V      S  ++D    C      +   C Q   +DRPN + ++  +    +D
Sbjct: 254 VLEFVT-----SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 84/297 (28%), Positives = 129/297 (43%), Gaps = 41/297 (13%)
Query: 483 NFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASGQGLE-EFMNEVMVISKL 535
           N  L   LG G FG VY G++          ++AVK L +   +  E +F+ E ++ISK 
Sbjct: 32  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 91
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD----PLKKERLDWRKRFNIIEGIS 591
            H+N+VR +G  ++   + ++ E M    L + L +    P +   L      ++   I+
Sbjct: 92  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 151
Query: 592 RGLLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKIFGGNQDQADTGRVVG 648
            G  YL  +     IHRD+ A N LL         KI DFGMA+           G  + 
Sbjct: 152 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 208
Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGY-AWKLWNENK 707
              +M PE  MEG F+ K+D +SFGVLL EI S              LGY  +   +  +
Sbjct: 209 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--------------LGYMPYPSKSNQE 254
Query: 708 ILALVDPFLSESSFQLDMIIRC----IHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 760
           +L  V      S  ++D    C      +   C Q   +DRPN + ++  +    +D
Sbjct: 255 VLEFVT-----SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 306

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 84/297 (28%), Positives = 129/297 (43%), Gaps = 41/297 (13%)
Query: 483 NFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASGQGLE-EFMNEVMVISKL 535
           N  L   LG G FG VY G++          ++AVK L +   +  E +F+ E ++ISK 
Sbjct: 31  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 90
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD----PLKKERLDWRKRFNIIEGIS 591
            H+N+VR +G  ++   + ++ E M    L + L +    P +   L      ++   I+
Sbjct: 91  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150
Query: 592 RGLLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKIFGGNQDQADTGRVVG 648
            G  YL  +     IHRD+ A N LL         KI DFGMA+           G  + 
Sbjct: 151 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 207
Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGY-AWKLWNENK 707
              +M PE  MEG F+ K+D +SFGVLL EI S              LGY  +   +  +
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--------------LGYMPYPSKSNQE 253
Query: 708 ILALVDPFLSESSFQLDMIIRC----IHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 760
           +L  V      S  ++D    C      +   C Q   +DRPN + ++  +    +D
Sbjct: 254 VLEFVT-----SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 7/201 (3%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 540
            +  +  KLG G +G VY G  K     +AVK L K     +EEF+ E  V+ +++H NL
Sbjct: 14  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 72
Query: 541 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 600
           V+LLG C       +I E+M   +L   L +   ++ ++      +   IS  + YL + 
Sbjct: 73  VQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKK 131
Query: 601 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
           +    IHRDL A N L+ E    K++DFG++++  G+   A  G       + +PE    
Sbjct: 132 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKF-PIKWTAPESLAY 187
Query: 661 GRFSEKSDVFSFGVLLLEIVS 681
            +FS KSDV++FGVLL EI +
Sbjct: 188 NKFSIKSDVWAFGVLLWEIAT 208

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 7/201 (3%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 540
            +  +  KLG G +G VY G  K     +AVK L K     +EEF+ E  V+ +++H NL
Sbjct: 15  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 73
Query: 541 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 600
           V+LLG C       +I E+M   +L   L +   ++ ++      +   IS  + YL + 
Sbjct: 74  VQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKK 132
Query: 601 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
           +    IHRDL A N L+ E    K++DFG++++  G+   A  G       + +PE    
Sbjct: 133 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKF-PIKWTAPESLAY 188
Query: 661 GRFSEKSDVFSFGVLLLEIVS 681
            +FS KSDV++FGVLL EI +
Sbjct: 189 NKFSIKSDVWAFGVLLWEIAT 209

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 114/226 (50%), Gaps = 19/226 (8%)
Query: 471 LFQFEELATATNNFQLSSKLGQGGFGPVYWGR----LKDGQE--IAVKRLSKASGQGLE- 523
           +F  +E   A     +S +LGQG FG VY G     +KD  E  +A+K +++A+      
Sbjct: 5   VFVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 64
Query: 524 EFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD---- 579
           EF+NE  V+ +    ++VRLLG   +G+  ++I E M    L + L   L+ E  +    
Sbjct: 65  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVL 123
Query: 580 ----WRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 635
                 K   +   I+ G+ YL+ +   + +HRDL A N ++ E+   KI DFGM +   
Sbjct: 124 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 180
Query: 636 GNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
                   G+ +    +MSPE   +G F+  SDV+SFGV+L EI +
Sbjct: 181 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 103/201 (51%), Gaps = 7/201 (3%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 540
            +  +  KLG G +G VY G  K     +AVK L K     +EEF+ E  V+ +++H NL
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 71
Query: 541 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 600
           V+LLG C       +I E+M   +L   L +   ++ +       +   IS  + YL + 
Sbjct: 72  VQLLGVCTREPPFYIIIEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKK 130
Query: 601 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
           +    IHRDL A N L+ E    K++DFG++++  G+   A  G       + +PE    
Sbjct: 131 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAY 186
Query: 661 GRFSEKSDVFSFGVLLLEIVS 681
            +FS KSDV++FGVLL EI +
Sbjct: 187 NKFSIKSDVWAFGVLLWEIAT 207

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 103/201 (51%), Gaps = 7/201 (3%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 540
            +  +  KLG G +G VY G  K     +AVK L K     +EEF+ E  V+ +++H NL
Sbjct: 18  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 76
Query: 541 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 600
           V+LLG C       +I E+M   +L   L +   ++ +       +   IS  + YL + 
Sbjct: 77  VQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKK 135
Query: 601 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
           +    IHRDL A N L+ E    K++DFG++++  G+   A  G       + +PE    
Sbjct: 136 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAY 191
Query: 661 GRFSEKSDVFSFGVLLLEIVS 681
            +FS KSDV++FGVLL EI +
Sbjct: 192 NKFSIKSDVWAFGVLLWEIAT 212

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 103/201 (51%), Gaps = 7/201 (3%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 540
            +  +  KLG G +G VY G  K     +AVK L K     +EEF+ E  V+ +++H NL
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 71
Query: 541 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 600
           V+LLG C       +I E+M   +L   L +   ++ +       +   IS  + YL + 
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKK 130
Query: 601 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
           +    IHRDL A N L+ E    K++DFG++++  G+   A  G       + +PE    
Sbjct: 131 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAY 186
Query: 661 GRFSEKSDVFSFGVLLLEIVS 681
            +FS KSDV++FGVLL EI +
Sbjct: 187 NKFSIKSDVWAFGVLLWEIAT 207

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 103/201 (51%), Gaps = 7/201 (3%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 540
            +  +  KLG G +G VY G  K     +AVK L K     +EEF+ E  V+ +++H NL
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 71
Query: 541 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 600
           V+LLG C       +I E+M   +L   L +   ++ +       +   IS  + YL + 
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKK 130
Query: 601 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
           +    IHRDL A N L+ E    K++DFG++++  G+   A  G       + +PE    
Sbjct: 131 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAY 186
Query: 661 GRFSEKSDVFSFGVLLLEIVS 681
            +FS KSDV++FGVLL EI +
Sbjct: 187 NKFSIKSDVWAFGVLLWEIAT 207

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 84/297 (28%), Positives = 129/297 (43%), Gaps = 41/297 (13%)
Query: 483 NFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASGQGLE-EFMNEVMVISKL 535
           N  L   LG G FG VY G++          ++AVK L +   +  E +F+ E ++ISK 
Sbjct: 32  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 91
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD----PLKKERLDWRKRFNIIEGIS 591
            H+N+VR +G  ++   + ++ E M    L + L +    P +   L      ++   I+
Sbjct: 92  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 151
Query: 592 RGLLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKIFGGNQDQADTGRVVG 648
            G  YL  +     IHRD+ A N LL         KI DFGMA+           G  + 
Sbjct: 152 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAML 208
Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGY-AWKLWNENK 707
              +M PE  MEG F+ K+D +SFGVLL EI S              LGY  +   +  +
Sbjct: 209 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--------------LGYMPYPSKSNQE 254
Query: 708 ILALVDPFLSESSFQLDMIIRC----IHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 760
           +L  V      S  ++D    C      +   C Q   +DRPN + ++  +    +D
Sbjct: 255 VLEFVT-----SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 306

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 85/297 (28%), Positives = 129/297 (43%), Gaps = 41/297 (13%)
Query: 483 NFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKA-SGQGLEEFMNEVMVISKL 535
           N  L   LG G FG VY G++          ++AVK L +  S Q   +F+ E ++ISK 
Sbjct: 46  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKF 105
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD----PLKKERLDWRKRFNIIEGIS 591
            H+N+VR +G  ++   + ++ E M    L + L +    P +   L      ++   I+
Sbjct: 106 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 165
Query: 592 RGLLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKIFGGNQDQADTGRVVG 648
            G  YL  +     IHRD+ A N LL         KI DFGMA+           G  + 
Sbjct: 166 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 222
Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGY-AWKLWNENK 707
              +M PE  MEG F+ K+D +SFGVLL EI S              LGY  +   +  +
Sbjct: 223 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--------------LGYMPYPSKSNQE 268
Query: 708 ILALVDPFLSESSFQLDMIIRC----IHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 760
           +L  V      S  ++D    C      +   C Q   +DRPN + ++  +    +D
Sbjct: 269 VLEFVT-----SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 320

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 103/201 (51%), Gaps = 7/201 (3%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 540
            +  +  KLG G +G VY G  K     +AVK L K     +EEF+ E  V+ +++H NL
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 71
Query: 541 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 600
           V+LLG C       +I E+M   +L   L +   ++ +       +   IS  + YL + 
Sbjct: 72  VQLLGVCTREPPFYIIIEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKK 130
Query: 601 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
           +    IHRDL A N L+ E    K++DFG++++  G+   A  G       + +PE    
Sbjct: 131 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAY 186
Query: 661 GRFSEKSDVFSFGVLLLEIVS 681
            +FS KSDV++FGVLL EI +
Sbjct: 187 NKFSIKSDVWAFGVLLWEIAT 207

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 129/298 (43%), Gaps = 41/298 (13%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASGQGLE-EFMNEVMVISK 534
            N  L   LG G FG VY G++          ++AVK L +   +  E +F+ E ++ISK
Sbjct: 47  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 106
Query: 535 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD----PLKKERLDWRKRFNIIEGI 590
             H+N+VR +G  ++   + ++ E M    L + L +    P +   L      ++   I
Sbjct: 107 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 166
Query: 591 SRGLLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKIFGGNQDQADTGRVV 647
           + G  YL  +     IHRD+ A N LL         KI DFGMA+           G  +
Sbjct: 167 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 223
Query: 648 GTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGY-AWKLWNEN 706
               +M PE  MEG F+ K+D +SFGVLL EI S              LGY  +   +  
Sbjct: 224 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--------------LGYMPYPSKSNQ 269
Query: 707 KILALVDPFLSESSFQLDMIIRC----IHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 760
           ++L  V      S  ++D    C      +   C Q   +DRPN + ++  +    +D
Sbjct: 270 EVLEFVT-----SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 322

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/202 (33%), Positives = 106/202 (52%), Gaps = 16/202 (7%)
Query: 490 LGQGGFGPVYWGRL-----KDGQEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRL 543
           LG+G FG V   R        G+++AVK L   SG   + +   E+ ++  L H N+V+ 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 544 LGCCVE--GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
            G C E  G    LI E++P+ SL   L  P  K +++ +++      I +G+ YL   S
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYL--GS 132
Query: 602 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT--GRVVGTFGYMSPEYAM 659
           R + +HRDL A N+L++ E   KI DFG+ K    +++       R    F Y +PE  M
Sbjct: 133 R-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APECLM 190
Query: 660 EGRFSEKSDVFSFGVLLLEIVS 681
           + +F   SDV+SFGV L E+++
Sbjct: 191 QSKFYIASDVWSFGVTLHELLT 212

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 72/237 (30%), Positives = 115/237 (48%), Gaps = 17/237 (7%)
Query: 459 TNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGR----LKDGQE--IAVK 512
            +VN        ++  +E   A     +S +LGQG FG VY G     +KD  E  +A+K
Sbjct: 2   ASVNPEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIK 61
Query: 513 RLSKASGQGLE-EFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPN-------RS 564
            +++A+      EF+NE  V+ +    ++VRLLG   +G+  ++I E M         RS
Sbjct: 62  TVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS 121
Query: 565 LDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPK 624
           L   + +          K   +   I+ G+ YL+ +   + +HRDL A N ++ E+   K
Sbjct: 122 LRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK 178
Query: 625 ISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           I DFGM +           G+ +    +MSPE   +G F+  SDV+SFGV+L EI +
Sbjct: 179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 84/297 (28%), Positives = 129/297 (43%), Gaps = 41/297 (13%)
Query: 483 NFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASGQGLE-EFMNEVMVISKL 535
           N  L   LG G FG VY G++          ++AVK L +   +  E +F+ E ++ISK 
Sbjct: 72  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 131
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD----PLKKERLDWRKRFNIIEGIS 591
            H+N+VR +G  ++   + ++ E M    L + L +    P +   L      ++   I+
Sbjct: 132 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 191
Query: 592 RGLLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKIFGGNQDQADTGRVVG 648
            G  YL  +     IHRD+ A N LL         KI DFGMA+           G  + 
Sbjct: 192 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAML 248
Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGY-AWKLWNENK 707
              +M PE  MEG F+ K+D +SFGVLL EI S              LGY  +   +  +
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--------------LGYMPYPSKSNQE 294
Query: 708 ILALVDPFLSESSFQLDMIIRC----IHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 760
           +L  V      S  ++D    C      +   C Q   +DRPN + ++  +    +D
Sbjct: 295 VLEFVT-----SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 111/201 (55%), Gaps = 9/201 (4%)
Query: 486 LSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLG 545
           +  ++G G FG VY G+      + +  ++  + Q L+ F NEV V+ K +H N++  +G
Sbjct: 17  VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 76
Query: 546 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 605
              +  +  ++ ++    SL   L   + + + +  K  +I    ++G+ YLH  S   I
Sbjct: 77  YSTK-PQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---I 130
Query: 606 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA-MEGR-- 662
           IHRDLK++NI L E+L  KI DFG+A +           ++ G+  +M+PE   M+ +  
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 190
Query: 663 FSEKSDVFSFGVLLLEIVSGR 683
           +S +SDV++FG++L E+++G+
Sbjct: 191 YSFQSDVYAFGIVLYELMTGQ 211

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 90/333 (27%), Positives = 141/333 (42%), Gaps = 49/333 (14%)
Query: 455 KLSATNVNTVKLQDLPLFQFEELATATN--------NFQLSSKLGQGGFGPVYWGRLK-- 504
           KLS    +T+     P + F    ++ +        N  L   LG G FG VY G++   
Sbjct: 22  KLSKLRTSTIMTDYNPNYSFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGM 81
Query: 505 ----DGQEIAVKRLSKASGQGLE-EFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 559
                  ++AVK L +   +  E +F+ E ++ISK  H+N+VR +G  ++   + ++ E 
Sbjct: 82  PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLEL 141
Query: 560 MPNRSLDALLFD----PLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNI 615
           M    L + L +    P +   L      ++   I+ G  YL  +     IHRD+ A N 
Sbjct: 142 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNC 198
Query: 616 LLD---EELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSF 672
           LL         KI DFGMA+           G  +    +M PE  MEG F+ K+D +SF
Sbjct: 199 LLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSF 258
Query: 673 GVLLLEIVSGRKNTSFFEDDLTILGY-AWKLWNENKILALVDPFLSESSFQLDMIIRC-- 729
           GVLL EI S              LGY  +   +  ++L  V      S  ++D    C  
Sbjct: 259 GVLLWEIFS--------------LGYMPYPSKSNQEVLEFVT-----SGGRMDPPKNCPG 299
Query: 730 --IHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 760
               +   C Q   +DRPN + ++  +    +D
Sbjct: 300 PVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 332

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 111/201 (55%), Gaps = 9/201 (4%)
Query: 486 LSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLG 545
           +  ++G G FG VY G+      + +  ++  + Q L+ F NEV V+ K +H N++  +G
Sbjct: 12  VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 546 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 605
              +  +  ++ ++    SL   L   + + + +  K  +I    ++G+ YLH  S   I
Sbjct: 72  YSTK-PQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---I 125
Query: 606 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA-MEGR-- 662
           IHRDLK++NI L E+L  KI DFG+A +           ++ G+  +M+PE   M+ +  
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 663 FSEKSDVFSFGVLLLEIVSGR 683
           +S +SDV++FG++L E+++G+
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQ 206

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 68/202 (33%), Positives = 106/202 (52%), Gaps = 16/202 (7%)
Query: 490 LGQGGFGPVYWGRL-----KDGQEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRL 543
           LG+G FG V   R        G+++AVK L   SG   + +   E+ ++  L H N+V+ 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 544 LGCCVE--GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
            G C E  G    LI E++P+ SL   L  P  K +++ +++      I +G+ YL   S
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYL--GS 144
Query: 602 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT--GRVVGTFGYMSPEYAM 659
           R + +HRDL A N+L++ E   KI DFG+ K    +++       R    F Y +PE  M
Sbjct: 145 R-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APECLM 202
Query: 660 EGRFSEKSDVFSFGVLLLEIVS 681
           + +F   SDV+SFGV L E+++
Sbjct: 203 QSKFYIASDVWSFGVTLHELLT 224

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 102/198 (51%), Gaps = 7/198 (3%)
Query: 486 LSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLE-EFMNEVMVISKLQHRNLVRL 543
           L  ++G+G FG V+ GRL+ D   +AVK   +     L+ +F+ E  ++ +  H N+VRL
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 544 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 603
           +G C + +   ++ E +  +  D L F   +  RL  +    ++   + G+ YL      
Sbjct: 178 IGVCTQKQPIYIVMELV--QGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC-- 233
Query: 604 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRF 663
             IHRDL A N L+ E+   KISDFGM++        A  G       + +PE    GR+
Sbjct: 234 -CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRY 292
Query: 664 SEKSDVFSFGVLLLEIVS 681
           S +SDV+SFG+LL E  S
Sbjct: 293 SSESDVWSFGILLWETFS 310

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 73/238 (30%), Positives = 117/238 (49%), Gaps = 19/238 (7%)
Query: 459 TNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGR----LKDGQE--IAVK 512
            +VN        ++  +E   A     +S +LGQG FG VY G     +KD  E  +A+K
Sbjct: 2   ASVNPEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIK 61
Query: 513 RLSKASGQGLE-EFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD 571
            +++A+      EF+NE  V+ +    ++VRLLG   +G+  ++I E M    L + L  
Sbjct: 62  TVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS 121
Query: 572 PLKKERLD--------WRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP 623
            L+ E  +          K   +   I+ G+ YL+ +   + +HRDL A N ++ E+   
Sbjct: 122 -LRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV 177
Query: 624 KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           KI DFGM +           G+ +    +MSPE   +G F+  SDV+SFGV+L EI +
Sbjct: 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 70/221 (31%), Positives = 110/221 (49%), Gaps = 17/221 (7%)
Query: 475 EELATATNNFQLSSKLGQGGFGPVYWGR----LKDGQE--IAVKRLSKASGQGLE-EFMN 527
           +E   A     +S +LGQG FG VY G     +KD  E  +A+K +++A+      EF+N
Sbjct: 8   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 67
Query: 528 EVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPN-------RSLDALLFDPLKKERLDW 580
           E  V+ +    ++VRLLG   +G+  ++I E M         RSL   + +         
Sbjct: 68  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 127
Query: 581 RKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ 640
            K   +   I+ G+ YL+ +   + +HRDL A N ++ E+   KI DFGM +        
Sbjct: 128 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 184
Query: 641 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
              G+ +    +MSPE   +G F+  SDV+SFGV+L EI +
Sbjct: 185 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 110/201 (54%), Gaps = 9/201 (4%)
Query: 486 LSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLG 545
           +  ++G G FG VY G+      + +  ++  + Q L+ F NEV V+ K +H N++  +G
Sbjct: 12  VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 546 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 605
                 +  ++ ++    SL   L   + + + +  K  +I    ++G+ YLH  S   I
Sbjct: 72  YST-APQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---I 125
Query: 606 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA-MEGR-- 662
           IHRDLK++NI L E+L  KI DFG+A +           ++ G+  +M+PE   M+ +  
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 663 FSEKSDVFSFGVLLLEIVSGR 683
           +S +SDV++FG++L E+++G+
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQ 206

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 71/222 (31%), Positives = 112/222 (50%), Gaps = 19/222 (8%)
Query: 475 EELATATNNFQLSSKLGQGGFGPVYWGR----LKDGQE--IAVKRLSKASGQGLE-EFMN 527
           +E   A     +S +LGQG FG VY G     +KD  E  +A+K +++A+      EF+N
Sbjct: 11  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 70
Query: 528 EVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD-------- 579
           E  V+ +    ++VRLLG   +G+  ++I E M    L + L   L+ E  +        
Sbjct: 71  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPS 129
Query: 580 WRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 639
             K   +   I+ G+ YL+ +   + +HRDL A N ++ E+   KI DFGM +       
Sbjct: 130 LSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 186
Query: 640 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
               G+ +    +MSPE   +G F+  SDV+SFGV+L EI +
Sbjct: 187 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 71/222 (31%), Positives = 112/222 (50%), Gaps = 19/222 (8%)
Query: 475 EELATATNNFQLSSKLGQGGFGPVYWGR----LKDGQE--IAVKRLSKASGQGLE-EFMN 527
           +E   A     +S +LGQG FG VY G     +KD  E  +A+K +++A+      EF+N
Sbjct: 11  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 70
Query: 528 EVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD-------- 579
           E  V+ +    ++VRLLG   +G+  ++I E M    L + L   L+ E  +        
Sbjct: 71  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS-LRPEMENNPVLAPPS 129
Query: 580 WRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 639
             K   +   I+ G+ YL+ +   + +HRDL A N ++ E+   KI DFGM +       
Sbjct: 130 LSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 186
Query: 640 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
               G+ +    +MSPE   +G F+  SDV+SFGV+L EI +
Sbjct: 187 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 103/201 (51%), Gaps = 7/201 (3%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 540
            +  +  KLG G +G VY G  K     +AVK L K     +EEF+ E  V+ +++H NL
Sbjct: 11  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 69
Query: 541 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 600
           V+LLG C       +I E+M   +L   L +   ++ +       +   IS  + YL + 
Sbjct: 70  VQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKK 128
Query: 601 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
           +    IHRDL A N L+ E    K++DFG++++  G+   A  G       + +PE    
Sbjct: 129 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKF-PIKWTAPESLAY 184
Query: 661 GRFSEKSDVFSFGVLLLEIVS 681
            +FS KSDV++FGVLL EI +
Sbjct: 185 NKFSIKSDVWAFGVLLWEIAT 205

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 71/222 (31%), Positives = 112/222 (50%), Gaps = 19/222 (8%)
Query: 475 EELATATNNFQLSSKLGQGGFGPVYWGR----LKDGQE--IAVKRLSKASGQGLE-EFMN 527
           +E   A     +S +LGQG FG VY G     +KD  E  +A+K +++A+      EF+N
Sbjct: 12  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 71
Query: 528 EVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD-------- 579
           E  V+ +    ++VRLLG   +G+  ++I E M    L + L   L+ E  +        
Sbjct: 72  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPS 130
Query: 580 WRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 639
             K   +   I+ G+ YL+ +   + +HRDL A N ++ E+   KI DFGM +       
Sbjct: 131 LSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 187
Query: 640 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
               G+ +    +MSPE   +G F+  SDV+SFGV+L EI +
Sbjct: 188 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 111/201 (55%), Gaps = 9/201 (4%)
Query: 486 LSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLG 545
           +  ++G G FG VY G+      + +  ++  + Q L+ F NEV V+ K +H N++  +G
Sbjct: 14  VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 73
Query: 546 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 605
              +  +  ++ ++    SL   L   + + + +  K  +I    ++G+ YLH  S   I
Sbjct: 74  YSTK-PQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---I 127
Query: 606 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA-MEGR-- 662
           IHRDLK++NI L E+L  KI DFG+A +           ++ G+  +M+PE   M+ +  
Sbjct: 128 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 187
Query: 663 FSEKSDVFSFGVLLLEIVSGR 683
           +S +SDV++FG++L E+++G+
Sbjct: 188 YSFQSDVYAFGIVLYELMTGQ 208

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 129/298 (43%), Gaps = 41/298 (13%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASGQGLE-EFMNEVMVISK 534
            N  L   LG G FG VY G++          ++AVK L +   +  E +F+ E ++ISK
Sbjct: 48  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 107
Query: 535 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD----PLKKERLDWRKRFNIIEGI 590
             H+N+VR +G  ++   + ++ E M    L + L +    P +   L      ++   I
Sbjct: 108 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 167
Query: 591 SRGLLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKIFGGNQDQADTGRVV 647
           + G  YL  +     IHRD+ A N LL         KI DFGMA+           G  +
Sbjct: 168 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 224
Query: 648 GTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGY-AWKLWNEN 706
               +M PE  MEG F+ K+D +SFGVLL EI S              LGY  +   +  
Sbjct: 225 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--------------LGYMPYPSKSNQ 270
Query: 707 KILALVDPFLSESSFQLDMIIRC----IHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 760
           ++L  V      S  ++D    C      +   C Q   +DRPN + ++  +    +D
Sbjct: 271 EVLEFVT-----SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 323

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 93.2 bits (230), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 101/193 (52%), Gaps = 7/193 (3%)
Query: 489 KLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV 548
           +LG G FG V +G+ +   ++A+K + + S    +EF+ E  V+  L H  LV+L G C 
Sbjct: 15  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT 73
Query: 549 EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHR 608
           +     +I EYM N  L   L +   + R   ++   + + +   + YL      + +HR
Sbjct: 74  KQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHR 128
Query: 609 DLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSD 668
           DL A N L++++   K+SDFG+++    ++  +  G       +  PE  M  +FS KSD
Sbjct: 129 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYSKFSSKSD 187
Query: 669 VFSFGVLLLEIVS 681
           +++FGVL+ EI S
Sbjct: 188 IWAFGVLMWEIYS 200

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 101/193 (52%), Gaps = 7/193 (3%)
Query: 489 KLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV 548
           +LG G FG V +G+ +   ++A+K + + S    +EF+ E  V+  L H  LV+L G C 
Sbjct: 31  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 549 EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHR 608
           +     +I EYM N  L   L +   + R   ++   + + +   + YL      + +HR
Sbjct: 90  KQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHR 144
Query: 609 DLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSD 668
           DL A N L++++   K+SDFG+++    ++  +  G       +  PE  M  +FS KSD
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF-PVRWSPPEVLMYSKFSSKSD 203
Query: 669 VFSFGVLLLEIVS 681
           +++FGVL+ EI S
Sbjct: 204 IWAFGVLMWEIYS 216

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 71/222 (31%), Positives = 112/222 (50%), Gaps = 19/222 (8%)
Query: 475 EELATATNNFQLSSKLGQGGFGPVYWGR----LKDGQE--IAVKRLSKASGQGLE-EFMN 527
           +E   A     +S +LGQG FG VY G     +KD  E  +A+K +++A+      EF+N
Sbjct: 5   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 64
Query: 528 EVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD-------- 579
           E  V+ +    ++VRLLG   +G+  ++I E M    L + L   L+ E  +        
Sbjct: 65  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPS 123
Query: 580 WRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 639
             K   +   I+ G+ YL+ +   + +HRDL A N ++ E+   KI DFGM +       
Sbjct: 124 LSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 180
Query: 640 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
               G+ +    +MSPE   +G F+  SDV+SFGV+L EI +
Sbjct: 181 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 101/193 (52%), Gaps = 7/193 (3%)
Query: 489 KLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV 548
           +LG G FG V +G+ +   ++A+K + + S    +EF+ E  V+  L H  LV+L G C 
Sbjct: 16  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 549 EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHR 608
           +     +I EYM N  L   L +   + R   ++   + + +   + YL      + +HR
Sbjct: 75  KQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHR 129
Query: 609 DLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSD 668
           DL A N L++++   K+SDFG+++    ++  +  G       +  PE  M  +FS KSD
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYSKFSSKSD 188
Query: 669 VFSFGVLLLEIVS 681
           +++FGVL+ EI S
Sbjct: 189 IWAFGVLMWEIYS 201

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 111/201 (55%), Gaps = 9/201 (4%)
Query: 486 LSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLG 545
           +  ++G G FG VY G+      + +  ++  + Q L+ F NEV V+ K +H N++  +G
Sbjct: 17  VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 76
Query: 546 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 605
              +  +  ++ ++    SL   L   + + + +  K  +I    ++G+ YLH  S   I
Sbjct: 77  YSTK-PQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---I 130
Query: 606 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA-MEGR-- 662
           IHRDLK++NI L E+L  KI DFG+A +           ++ G+  +M+PE   M+ +  
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 190
Query: 663 FSEKSDVFSFGVLLLEIVSGR 683
           +S +SDV++FG++L E+++G+
Sbjct: 191 YSFQSDVYAFGIVLYELMTGQ 211

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 73/238 (30%), Positives = 117/238 (49%), Gaps = 19/238 (7%)
Query: 459 TNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGR----LKDGQE--IAVK 512
            +VN        ++  +E   A     +S +LGQG FG VY G     +KD  E  +A+K
Sbjct: 24  ASVNPEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIK 83
Query: 513 RLSKASGQGLE-EFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD 571
            +++A+      EF+NE  V+ +    ++VRLLG   +G+  ++I E M    L + L  
Sbjct: 84  TVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-R 142
Query: 572 PLKKERLD--------WRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP 623
            L+ E  +          K   +   I+ G+ YL+ +   + +HRDL A N ++ E+   
Sbjct: 143 SLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV 199
Query: 624 KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           KI DFGM +           G+ +    +MSPE   +G F+  SDV+SFGV+L EI +
Sbjct: 200 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 144/310 (46%), Gaps = 44/310 (14%)
Query: 472 FQFEELATATNNF---------QLSSKLGQGGFGPVYWGRLK-DGQE---IAVKRL-SKA 517
           F FE+   A   F         ++   +G G FG V  G LK  G+    +A+K L S  
Sbjct: 14  FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 73
Query: 518 SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER 577
           + +   +F++E  ++ +  H N++ L G   +    M+I E+M N SLD+ L       +
Sbjct: 74  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ--NDGQ 131
Query: 578 LDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 637
               +   ++ GI+ G+ YL   + +  +HRDL A NIL++  L  K+SDFG+++    +
Sbjct: 132 FTVIQLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 188
Query: 638 QDQADTGRVVG---TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLT 694
                    +G      + +PE     +F+  SDV+S+G+++ E++S  +          
Sbjct: 189 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP-------- 240
Query: 695 ILGYAWKLWNENKILALVDPFLSESSFQLDMIIRC---IHVGLL-CVQELVKDRPNMSTV 750
                W + N++ I A+      E  ++L   + C   +H  +L C Q+    RP    +
Sbjct: 241 ----YWDMTNQDVINAI------EQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQI 290
Query: 751 VSMLNSEIRD 760
           V+ L+  IR+
Sbjct: 291 VNTLDKMIRN 300

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 101/193 (52%), Gaps = 7/193 (3%)
Query: 489 KLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV 548
           +LG G FG V +G+ +   ++A+K + + S    +EF+ E  V+  L H  LV+L G C 
Sbjct: 11  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 549 EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHR 608
           +     +I EYM N  L   L +   + R   ++   + + +   + YL      + +HR
Sbjct: 70  KQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHR 124
Query: 609 DLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSD 668
           DL A N L++++   K+SDFG+++    ++  +  G       +  PE  M  +FS KSD
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYSKFSSKSD 183
Query: 669 VFSFGVLLLEIVS 681
           +++FGVL+ EI S
Sbjct: 184 IWAFGVLMWEIYS 196

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 101/193 (52%), Gaps = 7/193 (3%)
Query: 489 KLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV 548
           +LG G FG V +G+ +   ++A+K + + S    +EF+ E  V+  L H  LV+L G C 
Sbjct: 22  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT 80
Query: 549 EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHR 608
           +     +I EYM N  L   L +   + R   ++   + + +   + YL      + +HR
Sbjct: 81  KQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHR 135
Query: 609 DLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSD 668
           DL A N L++++   K+SDFG+++    ++  +  G       +  PE  M  +FS KSD
Sbjct: 136 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYSKFSSKSD 194
Query: 669 VFSFGVLLLEIVS 681
           +++FGVL+ EI S
Sbjct: 195 IWAFGVLMWEIYS 207

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 102/198 (51%), Gaps = 7/198 (3%)
Query: 486 LSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLE-EFMNEVMVISKLQHRNLVRL 543
           L  ++G+G FG V+ GRL+ D   +AVK   +     L+ +F+ E  ++ +  H N+VRL
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 544 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 603
           +G C + +   ++ E +  +  D L F   +  RL  +    ++   + G+ YL      
Sbjct: 178 IGVCTQKQPIYIVMELV--QGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC-- 233
Query: 604 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRF 663
             IHRDL A N L+ E+   KISDFGM++        A  G       + +PE    GR+
Sbjct: 234 -CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRY 292
Query: 664 SEKSDVFSFGVLLLEIVS 681
           S +SDV+SFG+LL E  S
Sbjct: 293 SSESDVWSFGILLWETFS 310

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 107/201 (53%), Gaps = 9/201 (4%)
Query: 486 LSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLG 545
           +  ++G G FG VY G+      + +  ++  + Q L+ F NEV V+ K +H N++  +G
Sbjct: 16  VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 75
Query: 546 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 605
              +  +  ++ ++    SL   L     + + + +K  +I    +RG+ YLH  S   I
Sbjct: 76  YSTK-PQLAIVTQWCEGSSLYHHLH--ASETKFEMKKLIDIARQTARGMDYLHAKS---I 129
Query: 606 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM---EGR 662
           IHRDLK++NI L E+   KI DFG+A +           ++ G+  +M+PE         
Sbjct: 130 IHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 189
Query: 663 FSEKSDVFSFGVLLLEIVSGR 683
           +S +SDV++FG++L E+++G+
Sbjct: 190 YSFQSDVYAFGIVLYELMTGQ 210

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 92.4 bits (228), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 111/201 (55%), Gaps = 9/201 (4%)
Query: 486 LSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLG 545
           +  ++G G FG VY G+      + +  ++  + Q L+ F NEV V+ K +H N++  +G
Sbjct: 39  VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 98
Query: 546 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 605
              +  +  ++ ++    SL   L   + + + +  K  +I    ++G+ YLH  S   I
Sbjct: 99  YSTK-PQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---I 152
Query: 606 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA-MEGR-- 662
           IHRDLK++NI L E+L  KI DFG+A +           ++ G+  +M+PE   M+ +  
Sbjct: 153 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 212
Query: 663 FSEKSDVFSFGVLLLEIVSGR 683
           +S +SDV++FG++L E+++G+
Sbjct: 213 YSFQSDVYAFGIVLYELMTGQ 233

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 101/193 (52%), Gaps = 7/193 (3%)
Query: 489 KLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV 548
           +LG G FG V +G+ +   ++A+K + + S    +EF+ E  V+  L H  LV+L G C 
Sbjct: 16  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 549 EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHR 608
           +     +I EYM N  L   L +   + R   ++   + + +   + YL      + +HR
Sbjct: 75  KQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHR 129
Query: 609 DLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSD 668
           DL A N L++++   K+SDFG+++    ++  +  G       +  PE  M  +FS KSD
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPV-RWSPPEVLMYSKFSSKSD 188
Query: 669 VFSFGVLLLEIVS 681
           +++FGVL+ EI S
Sbjct: 189 IWAFGVLMWEIYS 201

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 111/201 (55%), Gaps = 9/201 (4%)
Query: 486 LSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLG 545
           +  ++G G FG VY G+      + +  ++  + Q L+ F NEV V+ K +H N++  +G
Sbjct: 40  VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 99
Query: 546 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 605
              +  +  ++ ++    SL   L   + + + +  K  +I    ++G+ YLH  S   I
Sbjct: 100 YSTK-PQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---I 153
Query: 606 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA-MEGR-- 662
           IHRDLK++NI L E+L  KI DFG+A +           ++ G+  +M+PE   M+ +  
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 213
Query: 663 FSEKSDVFSFGVLLLEIVSGR 683
           +S +SDV++FG++L E+++G+
Sbjct: 214 YSFQSDVYAFGIVLYELMTGQ 234

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 110/204 (53%), Gaps = 17/204 (8%)
Query: 486 LSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLG 545
           LS+++G G FG VY G+      + + ++   + +  + F NEV V+ K +H N++  +G
Sbjct: 40  LSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMG 99
Query: 546 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 605
              + +   ++ ++    SL   L   +++ +    +  +I    ++G+ YLH  +   I
Sbjct: 100 YMTK-DNLAIVTQWCEGSSLYKHLH--VQETKFQMFQLIDIARQTAQGMDYLHAKN---I 153
Query: 606 IHRDLKASNILLDEELNPKISDFGMAKI----FGGNQDQADTGRVVGTFGYMSPEYAM-- 659
           IHRD+K++NI L E L  KI DFG+A +     G  Q +  TG V+    +M+PE     
Sbjct: 154 IHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVL----WMAPEVIRMQ 209
Query: 660 -EGRFSEKSDVFSFGVLLLEIVSG 682
               FS +SDV+S+G++L E+++G
Sbjct: 210 DNNPFSFQSDVYSYGIVLYELMTG 233

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 88/314 (28%), Positives = 143/314 (45%), Gaps = 44/314 (14%)
Query: 475 EELATATNNFQLSSKLGQGGFGPVYWGR----LKDGQE--IAVKRLSKASGQGLE-EFMN 527
           +E   A     +S +LGQG FG VY G     +KD  E  +A+K +++A+      EF+N
Sbjct: 5   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 64
Query: 528 EVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD-------- 579
           E  V+ +    ++VRLLG   +G+  ++I E M    L + L   L+ E  +        
Sbjct: 65  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS-LRPEMENNPVLAPPS 123
Query: 580 WRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 639
             K   +   I+ G+ YL+ +   + +HRDL A N  + E+   KI DFGM +       
Sbjct: 124 LSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDY 180
Query: 640 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYA 699
               G+ +    +MSPE   +G F+  SDV+SFGV+L EI              T+    
Sbjct: 181 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA-------------TLAEQP 227
Query: 700 WKLWNENKILALV--DPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE 757
           ++  +  ++L  V     L +     DM++  +    +C Q   K RP+   ++S +  E
Sbjct: 228 YQGLSNEQVLRFVMEGGLLDKPDNCPDMLLELMR---MCWQYNPKMRPSFLEIISSIKEE 284
Query: 758 IRDLPYPKEPAFTE 771
           +       EP F E
Sbjct: 285 M-------EPGFRE 291

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 103/200 (51%), Gaps = 7/200 (3%)
Query: 483 NFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 541
           +  +  KLG G +G VY G  K     +AVK L K     +EEF+ E  V+ +++H NLV
Sbjct: 221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLV 279
Query: 542 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
           +LLG C       +I E+M   +L   L +   ++ +       +   IS  + YL + +
Sbjct: 280 QLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKKN 338
Query: 602 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 661
               IHR+L A N L+ E    K++DFG++++  G+   A  G       + +PE     
Sbjct: 339 ---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYN 394
Query: 662 RFSEKSDVFSFGVLLLEIVS 681
           +FS KSDV++FGVLL EI +
Sbjct: 395 KFSIKSDVWAFGVLLWEIAT 414

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/202 (35%), Positives = 104/202 (51%), Gaps = 23/202 (11%)
Query: 483 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 542
           + +L  KLG G FG V+        ++AVK + K     +E F+ E  V+  LQH  LV+
Sbjct: 183 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVK 241
Query: 543 LLGCCVEGEEKMLIYEYMPNRSL-DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
           L    V  E   +I E+M   SL D L  D   K+ L   K  +    I+ G+ ++ + +
Sbjct: 242 L-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQRN 298
Query: 602 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMSPEYAM 659
               IHRDL+A+NIL+   L  KI+DFG+A             RV   F   + +PE   
Sbjct: 299 ---YIHRDLRAANILVSASLVCKIADFGLA-------------RVGAKFPIKWTAPEAIN 342
Query: 660 EGRFSEKSDVFSFGVLLLEIVS 681
            G F+ KSDV+SFG+LL+EIV+
Sbjct: 343 FGSFTIKSDVWSFGILLMEIVT 364

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 104/200 (52%), Gaps = 7/200 (3%)
Query: 483 NFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 541
           +  +  KLG G +G VY G  K     +AVK L K     +EEF+ E  V+ +++H NLV
Sbjct: 260 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLV 318
Query: 542 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
           +LLG C       +I E+M   +L   L +   ++ ++      +   IS  + YL + +
Sbjct: 319 QLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKKN 377
Query: 602 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 661
               IHR+L A N L+ E    K++DFG++++  G+   A  G       + +PE     
Sbjct: 378 ---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYN 433
Query: 662 RFSEKSDVFSFGVLLLEIVS 681
           +FS KSDV++FGVLL EI +
Sbjct: 434 KFSIKSDVWAFGVLLWEIAT 453

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 106/210 (50%), Gaps = 19/210 (9%)
Query: 490 LGQGGFG-PVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV 548
           LG+G FG  +     + G+ + +K L +   +    F+ EV V+  L+H N+++ +G   
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 549 EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHR 608
           + +    I EY+   +L  ++       +  W +R +  + I+ G+ YLH    + IIHR
Sbjct: 78  KDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHR 132
Query: 609 DLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR------------VVGTFGYMSPE 656
           DL + N L+ E  N  ++DFG+A++    + Q +  R            VVG   +M+PE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 657 YAMEGRFSEKSDVFSFGVLLLEIVSGRKNT 686
                 + EK DVFSFG++L EI+ GR N 
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEII-GRVNA 221

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/215 (34%), Positives = 110/215 (51%), Gaps = 33/215 (15%)
Query: 478 ATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRL-SKASGQGLEEFMNEVMVISKLQ 536
           A      +L   +G+G FG V  G  + G ++AVK + + A+ Q    F+ E  V+++L+
Sbjct: 189 ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLR 244
Query: 537 HRNLVRLLGCCVEGEEKM-LIYEYMPNRSL---------DALLFDPLKKERLDWRKRFNI 586
           H NLV+LLG  VE +  + ++ EYM   SL           L  D L K  LD  +    
Sbjct: 245 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 304
Query: 587 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV 646
           +EG +              +HRDL A N+L+ E+   K+SDFG+ K     Q   DTG++
Sbjct: 305 LEGNN-------------FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKL 348
Query: 647 VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
                + +PE   E +FS KSDV+SFG+LL EI S
Sbjct: 349 --PVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 381

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/215 (34%), Positives = 110/215 (51%), Gaps = 33/215 (15%)
Query: 478 ATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRL-SKASGQGLEEFMNEVMVISKLQ 536
           A      +L   +G+G FG V  G  + G ++AVK + + A+ Q    F+ E  V+++L+
Sbjct: 2   ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLR 57
Query: 537 HRNLVRLLGCCVEGEEKM-LIYEYMPNRSL---------DALLFDPLKKERLDWRKRFNI 586
           H NLV+LLG  VE +  + ++ EYM   SL           L  D L K  LD  +    
Sbjct: 58  HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 117
Query: 587 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV 646
           +EG +              +HRDL A N+L+ E+   K+SDFG+ K     Q   DTG++
Sbjct: 118 LEGNN-------------FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKL 161
Query: 647 VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
                + +PE   E +FS KSDV+SFG+LL EI S
Sbjct: 162 --PVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 194

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 75/215 (34%), Positives = 110/215 (51%), Gaps = 33/215 (15%)
Query: 478 ATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRL-SKASGQGLEEFMNEVMVISKLQ 536
           A      +L   +G+G FG V  G  + G ++AVK + + A+ Q    F+ E  V+++L+
Sbjct: 17  ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLR 72
Query: 537 HRNLVRLLGCCVEGEEKM-LIYEYMPNRSL---------DALLFDPLKKERLDWRKRFNI 586
           H NLV+LLG  VE +  + ++ EYM   SL           L  D L K  LD  +    
Sbjct: 73  HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 132
Query: 587 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV 646
           +EG +              +HRDL A N+L+ E+   K+SDFG+ K     Q   DTG++
Sbjct: 133 LEGNN-------------FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKL 176
Query: 647 VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
                + +PE   E +FS KSDV+SFG+LL EI S
Sbjct: 177 --PVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 209

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 115/205 (56%), Gaps = 17/205 (8%)
Query: 486 LSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLG 545
           +  ++G G FG VY G+      + +  ++  + Q L+ F NEV V+ K +H N++  +G
Sbjct: 12  VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 546 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 605
              +  +  ++ ++    SL   L   + + + +  K  +I    ++G+ YLH  S   I
Sbjct: 72  YSTK-PQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---I 125
Query: 606 IHRDLKASNILLDEELNPKISDFGMA----KIFGGNQDQADTGRVVGTFGYMSPEYA-ME 660
           IHRDLK++NI L E+L  KI DFG+A    +  G +Q +  +G ++    +M+PE   M+
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL----WMAPEVIRMQ 181
Query: 661 GR--FSEKSDVFSFGVLLLEIVSGR 683
            +  +S +SDV++FG++L E+++G+
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/209 (34%), Positives = 108/209 (51%), Gaps = 16/209 (7%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 535
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
           +H N++RL G   +     LI EY P   L  +  +  K  + D ++    I  ++  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 655
           Y H     R+IHRD+K  N+LL      KI+DFG + +   +  + D   + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTD---LCGTLDYLPP 175
Query: 656 EYAMEGRFS-EKSDVFSFGVLLLEIVSGR 683
           E  +EGR   EK D++S GVL  E + G+
Sbjct: 176 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/209 (34%), Positives = 108/209 (51%), Gaps = 16/209 (7%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 535
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
           +H N++RL G   +     LI EY P   L  +  +  K  + D ++    I  ++  L 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 655
           Y H     R+IHRD+K  N+LL      KI+DFG + +   +  + D   + GT  Y+ P
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTD---LCGTLDYLPP 176
Query: 656 EYAMEGRFS-EKSDVFSFGVLLLEIVSGR 683
           E  +EGR   EK D++S GVL  E + G+
Sbjct: 177 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/209 (34%), Positives = 108/209 (51%), Gaps = 16/209 (7%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 535
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
           +H N++RL G   +     LI EY P   L  +  +  K  + D ++    I  ++  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 655
           Y H     R+IHRD+K  N+LL      KI+DFG + +   +  + D   + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTD---LCGTLDYLPP 175
Query: 656 EYAMEGRFS-EKSDVFSFGVLLLEIVSGR 683
           E  +EGR   EK D++S GVL  E + G+
Sbjct: 176 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/209 (34%), Positives = 108/209 (51%), Gaps = 16/209 (7%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 535
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
           +H N++RL G   +     LI EY P   L  +  +  K  + D ++    I  ++  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 655
           Y H     R+IHRD+K  N+LL      KI+DFG + +   +  + D   + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTD---LCGTLDYLPP 180
Query: 656 EYAMEGRFS-EKSDVFSFGVLLLEIVSGR 683
           E  +EGR   EK D++S GVL  E + G+
Sbjct: 181 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 110/205 (53%), Gaps = 14/205 (6%)
Query: 489 KLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC 547
           K+G+G  G V   R K  G+++AVK +     Q  E   NEV+++   QH N+V +    
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 548 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 607
           + GEE  ++ E++   +L     D + + RL+  +   + E + + L YLH      +IH
Sbjct: 112 LVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHAQG---VIH 164
Query: 608 RDLKASNILLDEELNPKISDFGM-AKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEK 666
           RD+K+ +ILL  +   K+SDFG  A+I   ++D      +VGT  +M+PE      ++ +
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFGFCAQI---SKDVPKRKXLVGTPYWMAPEVISRSLYATE 221
Query: 667 SDVFSFGVLLLEIVSGRKNTSFFED 691
            D++S G++++E+V G     +F D
Sbjct: 222 VDIWSLGIMVIEMVDG--EPPYFSD 244

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 73/209 (34%), Positives = 107/209 (51%), Gaps = 16/209 (7%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 535
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
           +H N++RL G   +     LI EY P   L  +  +  K  + D ++    I  ++  L 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 655
           Y H     R+IHRD+K  N+LL      KI+DFG +        + DT  + GT  Y+ P
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDT--LCGTLDYLPP 176
Query: 656 EYAMEGRFS-EKSDVFSFGVLLLEIVSGR 683
           E  +EGR   EK D++S GVL  E + G+
Sbjct: 177 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 75/215 (34%), Positives = 109/215 (50%), Gaps = 33/215 (15%)
Query: 478 ATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRL-SKASGQGLEEFMNEVMVISKLQ 536
           A      +L   +G+G FG V  G  + G ++AVK + + A+ Q    F+ E  V+++L+
Sbjct: 8   ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLR 63
Query: 537 HRNLVRLLGCCVEGEEKM-LIYEYMPNRSL---------DALLFDPLKKERLDWRKRFNI 586
           H NLV+LLG  VE +  + ++ EYM   SL           L  D L K  LD  +    
Sbjct: 64  HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 123
Query: 587 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV 646
           +EG +              +HRDL A N+L+ E+   K+SDFG+ K     Q   DTG++
Sbjct: 124 LEGNN-------------FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKL 167
Query: 647 VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
                + +PE   E  FS KSDV+SFG+LL EI S
Sbjct: 168 --PVKWTAPEALREAAFSTKSDVWSFGILLWEIYS 200

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 122/231 (52%), Gaps = 16/231 (6%)
Query: 460 NVNTVKLQDLPLFQFEEL------ATATNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVK 512
           ++ TV+L++ P  Q ++L            F +  KLG+G +G VY    K+ GQ +A+K
Sbjct: 1   SLETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIK 60
Query: 513 RLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDP 572
           ++   S   L+E + E+ ++ +    ++V+  G   +  +  ++ EY    S+  ++   
Sbjct: 61  QVPVESD--LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIR-- 116
Query: 573 LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 632
           L+ + L   +   I++   +GL YLH    +R IHRD+KA NILL+ E + K++DFG+A 
Sbjct: 117 LRNKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAG 173
Query: 633 IFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
                   A    V+GT  +M+PE   E  ++  +D++S G+  +E+  G+
Sbjct: 174 QL--TDXMAKRNXVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 69/214 (32%), Positives = 111/214 (51%), Gaps = 22/214 (10%)
Query: 478 ATATNNFQLSSKLGQGGFGPVYWGRLKD---GQEIAVKRLSKASGQGLEE--FMNEVMVI 532
            T    + +   LG+G FG V   + KD    QE AVK ++KAS +  +    + EV ++
Sbjct: 18  GTFAERYNIVCMLGKGSFGEVL--KCKDRITQQEYAVKVINKASAKNKDTSTILREVELL 75
Query: 533 SKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGIS 591
            KL H N+++L     +     ++ E          LFD + K++R        II+ + 
Sbjct: 76  KKLDHPNIMKLFEILEDSSSFYIVGELYTG----GELFDEIIKRKRFSEHDAARIIKQVF 131
Query: 592 RGLLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKIFGGNQDQADTGRVVG 648
            G+ Y+H+ +   I+HRDLK  NILL+   ++ + KI DFG++  F  N    D    +G
Sbjct: 132 SGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR---IG 185
Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           T  Y++PE  + G + EK DV+S GV+L  ++SG
Sbjct: 186 TAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 69/214 (32%), Positives = 111/214 (51%), Gaps = 22/214 (10%)
Query: 478 ATATNNFQLSSKLGQGGFGPVYWGRLKD---GQEIAVKRLSKASGQGLEE--FMNEVMVI 532
            T    + +   LG+G FG V   + KD    QE AVK ++KAS +  +    + EV ++
Sbjct: 18  GTFAERYNIVCMLGKGSFGEVL--KCKDRITQQEYAVKVINKASAKNKDTSTILREVELL 75
Query: 533 SKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGIS 591
            KL H N+++L     +     ++ E          LFD + K++R        II+ + 
Sbjct: 76  KKLDHPNIMKLFEILEDSSSFYIVGELYTG----GELFDEIIKRKRFSEHDAARIIKQVF 131
Query: 592 RGLLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKIFGGNQDQADTGRVVG 648
            G+ Y+H+ +   I+HRDLK  NILL+   ++ + KI DFG++  F  N    D    +G
Sbjct: 132 SGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR---IG 185
Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           T  Y++PE  + G + EK DV+S GV+L  ++SG
Sbjct: 186 TAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 102/219 (46%), Gaps = 22/219 (10%)
Query: 482 NNFQLSSKLGQGGFGPVY------WGRLKDGQEIAVKRL-SKASGQGLEEFMNEVMVISK 534
           NN Q    LG G FG V        G+     ++AVK L S A     E  M+E+ ++S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 535 L-QHRNLVRLLGCCVEGEEKMLIYEY--------MPNRSLDALLFDP---LKKERLDWRK 582
           L QH N+V LLG C  G   ++I EY           R    L  DP   +    L  R 
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRD 165
Query: 583 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD 642
             +    +++G+ +L   +    IHRD+ A N+LL      KI DFG+A+    + +   
Sbjct: 166 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 643 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
            G       +M+PE   +  ++ +SDV+S+G+LL EI S
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 115/205 (56%), Gaps = 17/205 (8%)
Query: 486 LSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLG 545
           +  ++G G FG VY G+      + +  ++  + Q L+ F NEV V+ K +H N++  +G
Sbjct: 32  VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 91
Query: 546 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 605
              +  +  ++ ++    SL   L   + + + +  K  +I    ++G+ YLH  S   I
Sbjct: 92  YSTK-PQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---I 145
Query: 606 IHRDLKASNILLDEELNPKISDFGMA----KIFGGNQDQADTGRVVGTFGYMSPEYA-ME 660
           IHRDLK++NI L E+L  KI DFG+A    +  G +Q +  +G ++    +M+PE   M+
Sbjct: 146 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL----WMAPEVIRMQ 201
Query: 661 GR--FSEKSDVFSFGVLLLEIVSGR 683
            +  +S +SDV++FG++L E+++G+
Sbjct: 202 DKNPYSFQSDVYAFGIVLYELMTGQ 226

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 135/303 (44%), Gaps = 47/303 (15%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR------LKDGQEIAVKRL-SKASGQGLEEFMNEVMVISK 534
           NN +    +G+G FG V+  R       +    +AVK L  +AS     +F  E  ++++
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 535 LQHRNLVRLLGCCVEGEEKMLIYEYMPN-------RSLDALLFDPLKKERLDWRKRFN-- 585
             + N+V+LLG C  G+   L++EYM         RS+       L    L  R R +  
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 586 ------------IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK- 632
                       I   ++ G+ YL   S  + +HRDL   N L+ E +  KI+DFG+++ 
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRN 223
Query: 633 IFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDD 692
           I+  +  +AD    +    +M PE     R++ +SDV+++GV+L EI S      +    
Sbjct: 224 IYSADYYKADGNDAI-PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 282
Query: 693 LTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS 752
             ++ Y      +  ILA  +        +L  ++R      LC  +L  DRP+  ++  
Sbjct: 283 EEVIYYV----RDGNILACPE----NCPLELYNLMR------LCWSKLPADRPSFCSIHR 328
Query: 753 MLN 755
           +L 
Sbjct: 329 ILQ 331

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 535
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
           +H N++RL G   +     LI EY P   L  +  +  K  + D ++    I  ++  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 655
           Y H     R+IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPP 178
Query: 656 EYAMEGRFS-EKSDVFSFGVLLLEIVSGR 683
           E  +EGR   EK D++S GVL  E + G+
Sbjct: 179 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 110/205 (53%), Gaps = 17/205 (8%)
Query: 486 LSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLG 545
           +  ++G G FG VY G+      + +  ++  + Q L+ F NEV V+ K +H N++  +G
Sbjct: 28  VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 546 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 605
                 +  ++ ++    SL   L     + + + +K  +I    +RG+ YLH  S   I
Sbjct: 88  YST-APQLAIVTQWCEGSSLYHHLH--ASETKFEMKKLIDIARQTARGMDYLHAKS---I 141
Query: 606 IHRDLKASNILLDEELNPKISDFGMA----KIFGGNQDQADTGRVVGTFGYMSPEYAM-- 659
           IHRDLK++NI L E+   KI DFG+A    +  G +Q +  +G ++    +M+PE     
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL----WMAPEVIRMQ 197
Query: 660 -EGRFSEKSDVFSFGVLLLEIVSGR 683
               +S +SDV++FG++L E+++G+
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 535
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
           +H N++RL G   +     LI EY P   L  +  +  K  + D ++    I  ++  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 655
           Y H     R+IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTELCGTLDYLPP 175
Query: 656 EYAMEGRFS-EKSDVFSFGVLLLEIVSGR 683
           E  +EGR   EK D++S GVL  E + G+
Sbjct: 176 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 115/205 (56%), Gaps = 17/205 (8%)
Query: 486 LSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLG 545
           +  ++G G FG VY G+      + +  ++  + Q L+ F NEV V+ K +H N++  +G
Sbjct: 40  VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 99
Query: 546 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 605
              +  +  ++ ++    SL   L   + + + +  K  +I    ++G+ YLH  S   I
Sbjct: 100 YSTK-PQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---I 153
Query: 606 IHRDLKASNILLDEELNPKISDFGMA----KIFGGNQDQADTGRVVGTFGYMSPEYA-ME 660
           IHRDLK++NI L E+L  KI DFG+A    +  G +Q +  +G ++    +M+PE   M+
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL----WMAPEVIRMQ 209
Query: 661 GR--FSEKSDVFSFGVLLLEIVSGR 683
            +  +S +SDV++FG++L E+++G+
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 111/205 (54%), Gaps = 17/205 (8%)
Query: 486 LSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLG 545
           +  ++G G FG VY G+      + +  ++  + Q L+ F NEV V+ K +H N++  +G
Sbjct: 28  VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 546 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 605
              +  +  ++ ++    SL   L     + + + +K  +I    +RG+ YLH  S   I
Sbjct: 88  YSTK-PQLAIVTQWCEGSSLYHHLH--ASETKFEMKKLIDIARQTARGMDYLHAKS---I 141
Query: 606 IHRDLKASNILLDEELNPKISDFGMA----KIFGGNQDQADTGRVVGTFGYMSPEYAM-- 659
           IHRDLK++NI L E+   KI DFG+A    +  G +Q +  +G ++    +M+PE     
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL----WMAPEVIRMQ 197
Query: 660 -EGRFSEKSDVFSFGVLLLEIVSGR 683
               +S +SDV++FG++L E+++G+
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 535
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
           +H N++RL G   +     LI EY P   L  +  +  K  + D ++    I  ++  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 655
           Y H     R+IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPP 175
Query: 656 EYAMEGRFS-EKSDVFSFGVLLLEIVSGR 683
           E  +EGR   EK D++S GVL  E + G+
Sbjct: 176 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 101/215 (46%), Gaps = 18/215 (8%)
Query: 482 NNFQLSSKLGQGGFGPVY------WGRLKDGQEIAVKRL-SKASGQGLEEFMNEVMVISK 534
           NN Q    LG G FG V        G+     ++AVK L S A     E  M+E+ ++S 
Sbjct: 38  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 97
Query: 535 L-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-------FDPLKKERLDWRKRFNI 586
           L QH N+V LLG C  G   ++I EY     L   L        D      L+ R   + 
Sbjct: 98  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHF 157
Query: 587 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV 646
              +++G+ +L   +    IHRD+ A N+LL      KI DFG+A+    + +    G  
Sbjct: 158 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 214
Query: 647 VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
                +M+PE   +  ++ +SDV+S+G+LL EI S
Sbjct: 215 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 535
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
           +H N++RL G   +     LI EY P   L  +  +  K  + D ++    I  ++  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 655
           Y H     R+IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 175
Query: 656 EYAMEGRFS-EKSDVFSFGVLLLEIVSGR 683
           E  +EGR   EK D++S GVL  E + G+
Sbjct: 176 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 535
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
           +H N++RL G   +     LI EY P   L  +  +  K  + D ++    I  ++  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 655
           Y H     R+IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 178
Query: 656 EYAMEGRFS-EKSDVFSFGVLLLEIVSGR 683
           E  +EGR   EK D++S GVL  E + G+
Sbjct: 179 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 72/209 (34%), Positives = 108/209 (51%), Gaps = 16/209 (7%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 535
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
           +H N++RL G   +     LI EY P   L  +  +  K  + D ++    I  ++  L 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 148
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 655
           Y H     R+IHRD+K  N+LL      KI+DFG + +   +  + D   + GT  Y+ P
Sbjct: 149 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRDD---LCGTLDYLPP 201
Query: 656 EYAMEGRFS-EKSDVFSFGVLLLEIVSGR 683
           E  +EGR   EK D++S GVL  E + G+
Sbjct: 202 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 535
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
           +H N++RL G   +     LI EY P   L  +  +  K  + D ++    I  ++  L 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 655
           Y H     R+IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 125 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPP 177
Query: 656 EYAMEGRFS-EKSDVFSFGVLLLEIVSGR 683
           E  +EGR   EK D++S GVL  E + G+
Sbjct: 178 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 535
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
           +H N++RL G   +     LI EY P   L  +  +  K  + D ++    I  ++  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 655
           Y H     R+IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 180
Query: 656 EYAMEGRFS-EKSDVFSFGVLLLEIVSGR 683
           E  +EGR   EK D++S GVL  E + G+
Sbjct: 181 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 535
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
           +H N++RL G   +     LI EY P   L  +  +  K  + D ++    I  ++  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 655
           Y H     R+IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 180
Query: 656 EYAMEGR-FSEKSDVFSFGVLLLEIVSGR 683
           E  +EGR   EK D++S GVL  E + G+
Sbjct: 181 E-XIEGRXHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 535
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
           +H N++RL G   +     LI EY P   L  +  +  K  + D ++    I  ++  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 655
           Y H     R+IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTXLCGTLDYLPP 175
Query: 656 EYAMEGRFS-EKSDVFSFGVLLLEIVSGR 683
           E  +EGR   EK D++S GVL  E + G+
Sbjct: 176 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 111/226 (49%), Gaps = 19/226 (8%)
Query: 471 LFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKD------GQEIAVKRLSK-ASGQGLE 523
           +F  +E   +     L  +LGQG FG VY G  +D         +AVK +++ AS +   
Sbjct: 3   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 62
Query: 524 EFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD---- 579
           EF+NE  V+      ++VRLLG   +G+  +++ E M +  L + L   L+ E  +    
Sbjct: 63  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS-LRPEAENNPGR 121
Query: 580 ----WRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 635
                ++   +   I+ G+ YL+     + +HRDL A N ++  +   KI DFGM +   
Sbjct: 122 PPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIX 178
Query: 636 GNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
                   G+ +    +M+PE   +G F+  SD++SFGV+L EI S
Sbjct: 179 ETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 224

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 111/226 (49%), Gaps = 19/226 (8%)
Query: 471 LFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKD------GQEIAVKRLSK-ASGQGLE 523
           +F  +E   +     L  +LGQG FG VY G  +D         +AVK +++ AS +   
Sbjct: 6   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 65
Query: 524 EFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD---- 579
           EF+NE  V+      ++VRLLG   +G+  +++ E M +  L + L   L+ E  +    
Sbjct: 66  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS-LRPEAENNPGR 124
Query: 580 ----WRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 635
                ++   +   I+ G+ YL+     + +HRDL A N ++  +   KI DFGM +   
Sbjct: 125 PPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIX 181
Query: 636 GNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
                   G+ +    +M+PE   +G F+  SD++SFGV+L EI S
Sbjct: 182 ETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 535
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
           +H N++RL G   +     LI EY P   L  +  +  K  + D ++    I  ++  L 
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 126
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 655
           Y H     R+IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 127 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 179
Query: 656 EYAMEGRFS-EKSDVFSFGVLLLEIVSGR 683
           E  +EGR   EK D++S GVL  E + G+
Sbjct: 180 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 207

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 535
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
           +H N++RL G   +     LI EY P   L  +  +  K  + D ++    I  ++  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 655
           Y H     R+IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 178
Query: 656 EYAMEGRFS-EKSDVFSFGVLLLEIVSGR 683
           E  +EGR   EK D++S GVL  E + G+
Sbjct: 179 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 535
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
           +H N++RL G   +     LI EY P   L  +  +  K  + D ++    I  ++  L 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 148
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 655
           Y H     R+IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 149 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 201
Query: 656 EYAMEGRFS-EKSDVFSFGVLLLEIVSGR 683
           E  +EGR   EK D++S GVL  E + G+
Sbjct: 202 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 72/209 (34%), Positives = 108/209 (51%), Gaps = 16/209 (7%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 535
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
           +H N++RL G   +     LI EY P   L  +  +  K  + D ++    I  ++  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 655
           Y H     R+IHRD+K  N+LL      KI+DFG + +   +  + D   + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRDD---LCGTLDYLPP 178
Query: 656 EYAMEGRFS-EKSDVFSFGVLLLEIVSGR 683
           E  +EGR   EK D++S GVL  E + G+
Sbjct: 179 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 535
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
           +H N++RL G   +     LI EY P   L  +  +  K  + D ++    I  ++  L 
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 121
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 655
           Y H     R+IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 122 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 174
Query: 656 EYAMEGRFS-EKSDVFSFGVLLLEIVSGR 683
           E  +EGR   EK D++S GVL  E + G+
Sbjct: 175 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 202

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 535
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
           +H N++RL G   +     LI EY P   L  +  +  K  + D ++    I  ++  L 
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 139
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 655
           Y H     R+IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 140 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 192
Query: 656 EYAMEGRFS-EKSDVFSFGVLLLEIVSGR 683
           E  +EGR   EK D++S GVL  E + G+
Sbjct: 193 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 220

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 101/215 (46%), Gaps = 18/215 (8%)
Query: 482 NNFQLSSKLGQGGFGPVY------WGRLKDGQEIAVKRL-SKASGQGLEEFMNEVMVISK 534
           NN Q    LG G FG V        G+     ++AVK L S A     E  M+E+ ++S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 535 L-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-------FDPLKKERLDWRKRFNI 586
           L QH N+V LLG C  G   ++I EY     L   L        D      L+ R   + 
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHF 165
Query: 587 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV 646
              +++G+ +L   +    IHRD+ A N+LL      KI DFG+A+    + +    G  
Sbjct: 166 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 222
Query: 647 VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
                +M+PE   +  ++ +SDV+S+G+LL EI S
Sbjct: 223 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 535
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
           +H N++RL G   +     LI EY P   L  +  +  K  + D ++    I  ++  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 655
           Y H     R+IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPP 175
Query: 656 EYAMEGRFS-EKSDVFSFGVLLLEIVSGR 683
           E  +EGR   EK D++S GVL  E + G+
Sbjct: 176 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 535
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
           +H N++RL G   +     LI EY P   L  +  +  K  + D ++    I  ++  L 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 655
           Y H     R+IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSCHAPSSRRTTLSGTLDYLPP 176
Query: 656 EYAMEGRFS-EKSDVFSFGVLLLEIVSGR 683
           E  +EGR   EK D++S GVL  E + G+
Sbjct: 177 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 535
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
           +H N++RL G   +     LI EY P   L  +  +  K  + D ++    I  ++  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 655
           Y H     R+IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPP 178
Query: 656 EYAMEGRFS-EKSDVFSFGVLLLEIVSGR 683
           E  +EGR   EK D++S GVL  E + G+
Sbjct: 179 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 105/221 (47%), Gaps = 24/221 (10%)
Query: 482 NNFQLSSKLGQGGFGPVY------WGRLKDGQEIAVKRL-SKASGQGLEEFMNEVMVISK 534
           NN Q    LG G FG V        G+     ++AVK L S A     E  M+E+ ++S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 535 L-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----------FDPLK--KERLDW 580
           L QH N+V LLG C  G   ++I EY     L   L           ++P    +E+L  
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSS 165
Query: 581 RKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ 640
           R   +    +++G+ +L   +    IHRD+ A N+LL      KI DFG+A+    + + 
Sbjct: 166 RDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 222
Query: 641 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
              G       +M+PE   +  ++ +SDV+S+G+LL EI S
Sbjct: 223 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/209 (33%), Positives = 107/209 (51%), Gaps = 16/209 (7%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 535
           A  +F++   LG+G FG VY  R K+ + I A+K L KA  +  G+E +   EV + S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
           +H N++RL G   +     LI EY P   L  +  +  K  + D ++    I  ++  L 
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 655
           Y H     ++IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 123 YCHSK---KVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPP 175
Query: 656 EYAMEGRFS-EKSDVFSFGVLLLEIVSGR 683
           E  +EGR   EK D++S GVL  E + G+
Sbjct: 176 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/214 (32%), Positives = 111/214 (51%), Gaps = 22/214 (10%)
Query: 478 ATATNNFQLSSKLGQGGFGPVYWGRLKD---GQEIAVKRLSKASGQGLEE--FMNEVMVI 532
            T    + +   LG+G FG V   + KD    QE AVK ++KAS +  +    + EV ++
Sbjct: 18  GTFAERYNIVCMLGKGSFGEVL--KCKDRITQQEYAVKVINKASAKNKDTSTILREVELL 75
Query: 533 SKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGIS 591
            KL H N+++L     +     ++ E          LFD + K++R        II+ + 
Sbjct: 76  KKLDHPNIMKLFEILEDSSSFYIVGELYTG----GELFDEIIKRKRFSEHDAARIIKQVF 131
Query: 592 RGLLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKIFGGNQDQADTGRVVG 648
            G+ Y+H+ +   I+HRDLK  NILL+   ++ + KI DFG++  F  N    D    +G
Sbjct: 132 SGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR---IG 185
Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           T  Y++PE  + G + EK DV+S GV+L  ++SG
Sbjct: 186 TAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 535
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
           +H N++RL G   +     LI EY P   L  +  +  K  + D ++    I  ++  L 
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 119
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 655
           Y H     R+IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 120 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 172
Query: 656 EYAMEGRFS-EKSDVFSFGVLLLEIVSGR 683
           E  +EGR   EK D++S GVL  E + G+
Sbjct: 173 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 200

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 109/222 (49%), Gaps = 19/222 (8%)
Query: 475 EELATATNNFQLSSKLGQGGFGPVYWGRLKD------GQEIAVKRLSK-ASGQGLEEFMN 527
           +E   +     L  +LGQG FG VY G  +D         +AVK +++ AS +   EF+N
Sbjct: 10  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN 69
Query: 528 EVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD-------- 579
           E  V+      ++VRLLG   +G+  +++ E M +  L + L   L+ E  +        
Sbjct: 70  EASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS-LRPEAENNPGRPPPT 128
Query: 580 WRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 639
            ++   +   I+ G+ YL+     + +HRDL A N ++  +   KI DFGM +       
Sbjct: 129 LQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDX 185
Query: 640 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
               G+ +    +M+PE   +G F+  SD++SFGV+L EI S
Sbjct: 186 XRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/210 (33%), Positives = 107/210 (50%), Gaps = 18/210 (8%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 535
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKK-ERLDWRKRFNIIEGISRGL 594
           +H N++RL G   +     LI EY P       ++  L+K  + D ++    I  ++  L
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPR----GEVYKELQKLSKFDEQRTATYITELANAL 126
Query: 595 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 654
            Y H     R+IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ 
Sbjct: 127 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLP 179
Query: 655 PEYAMEGRFS-EKSDVFSFGVLLLEIVSGR 683
           PE  +EGR   EK D++S GVL  E + G+
Sbjct: 180 PE-MIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 101/219 (46%), Gaps = 22/219 (10%)
Query: 482 NNFQLSSKLGQGGFGPVY------WGRLKDGQEIAVKRL-SKASGQGLEEFMNEVMVISK 534
           NN Q    LG G FG V        G+     ++AVK L S A     E  M+E+ ++S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 535 L-QHRNLVRLLGCCVEGEEKMLIYEY--------MPNRSLDALLFDP---LKKERLDWRK 582
           L QH N+V LLG C  G   ++I EY           R    L  DP   +       R 
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 583 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD 642
             +    +++G+ +L   +    IHRD+ A N+LL      KI DFG+A+    + +   
Sbjct: 166 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 643 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
            G       +M+PE   +  ++ +SDV+S+G+LL EI S
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 62/196 (31%), Positives = 97/196 (49%), Gaps = 7/196 (3%)
Query: 486 LSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLG 545
           L  +LG G FG V  G+ K   ++AVK + + S    +EF  E   + KL H  LV+  G
Sbjct: 12  LLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYG 70
Query: 546 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 605
            C +     ++ EY+ N  L   L    K   L+  +   +   +  G+ +L      + 
Sbjct: 71  VCSKEYPIYIVTEYISNGCLLNYLRSHGKG--LEPSQLLEMCYDVCEGMAFLESH---QF 125
Query: 606 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSE 665
           IHRDL A N L+D +L  K+SDFGM +    +Q  +  G       + +PE     ++S 
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKF-PVKWSAPEVFHYFKYSS 184
Query: 666 KSDVFSFGVLLLEIVS 681
           KSDV++FG+L+ E+ S
Sbjct: 185 KSDVWAFGILMWEVFS 200

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 137/288 (47%), Gaps = 35/288 (12%)
Query: 485 QLSSKLGQGGFGPVYWGRLK-DGQE---IAVKRL-SKASGQGLEEFMNEVMVISKLQHRN 539
           ++   +G G FG V  G LK  G+    +A+K L S  + +   +F++E  ++ +  H N
Sbjct: 10  KIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPN 69
Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 599
           ++ L G   +    M+I E+M N SLD+ L       +    +   ++ GI+ G+ YL  
Sbjct: 70  VIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYL-- 125
Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG---TFGYMSPE 656
            + +  +HR L A NIL++  L  K+SDFG+++    +         +G      + +PE
Sbjct: 126 -ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE 184
Query: 657 YAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL 716
                +F+  SDV+S+G+++ E++S  +               W + N++ I A+     
Sbjct: 185 AIQYRKFTSASDVWSYGIVMWEVMSYGERP------------YWDMTNQDVINAI----- 227
Query: 717 SESSFQLDMIIRC---IHVGLL-CVQELVKDRPNMSTVVSMLNSEIRD 760
            E  ++L   + C   +H  +L C Q+    RP    +V+ L+  IR+
Sbjct: 228 -EQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 274

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/210 (33%), Positives = 107/210 (50%), Gaps = 18/210 (8%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 535
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKK-ERLDWRKRFNIIEGISRGL 594
           +H N++RL G   +     LI EY P       ++  L+K  + D ++    I  ++  L
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPR----GEVYKELQKLSKFDEQRTATYITELANAL 126
Query: 595 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 654
            Y H     R+IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ 
Sbjct: 127 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLXGTLDYLP 179
Query: 655 PEYAMEGRFS-EKSDVFSFGVLLLEIVSGR 683
           PE  +EGR   EK D++S GVL  E + G+
Sbjct: 180 PE-MIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/228 (32%), Positives = 108/228 (47%), Gaps = 31/228 (13%)
Query: 482 NNFQLSSKLGQGGFGPVY------WGRLKDGQEIAVKRL-SKASGQGLEEFMNEVMVISK 534
           NN Q    LG G FG V        G+     ++AVK L S A     E  M+E+ ++S 
Sbjct: 31  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 90
Query: 535 L-QHRNLVRLLGCCVEGEEKMLIYEY--------MPNRSLDALLF-------DP--LKKE 576
           L QH N+V LLG C  G   ++I EY           R  +A+L        DP  L KE
Sbjct: 91  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKE 150
Query: 577 R---LDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 633
               L+ R   +    +++G+ +L   +    IHRD+ A N+LL      KI DFG+A+ 
Sbjct: 151 DGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD 207
Query: 634 FGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
              + +    G       +M+PE   +  ++ +SDV+S+G+LL EI S
Sbjct: 208 IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 103/199 (51%), Gaps = 13/199 (6%)
Query: 489 KLGQGGFGPVYWG--RLKDGQ-EIAVKRLSKASGQG-LEEFMNEVMVISKLQHRNLVRLL 544
           +LG G FG V  G  R++  Q ++A+K L + + +   EE M E  ++ +L +  +VRL+
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 545 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 604
           G C + E  ML+ E      L   L    K+E +       ++  +S G+ YL   +   
Sbjct: 77  GVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN--- 130
Query: 605 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT--FGYMSPEYAMEGR 662
            +HRDL A N+LL      KISDFG++K  G + D   T R  G     + +PE     +
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD-DSYYTARSAGKWPLKWYAPECINFRK 189
Query: 663 FSEKSDVFSFGVLLLEIVS 681
           FS +SDV+S+GV + E +S
Sbjct: 190 FSSRSDVWSYGVTMWEALS 208

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 105/195 (53%), Gaps = 10/195 (5%)
Query: 489 KLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC 547
           K+GQG  G VY    +  GQE+A+++++       E  +NE++V+ + ++ N+V  L   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 548 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 607
           + G+E  ++ EY+   SL     D + +  +D  +   +     + L +LH +   ++IH
Sbjct: 87  LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 608 RDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKS 667
           RD+K+ NILL  + + K++DFG        Q +  T  +VGT  +M+PE      +  K 
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKV 197
Query: 668 DVFSFGVLLLEIVSG 682
           D++S G++ +E++ G
Sbjct: 198 DIWSLGIMAIEMIEG 212

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/209 (33%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 535
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
           +H N++RL G   +     LI EY P   L  +  +  K  + D ++    I  ++  L 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 655
           Y H     R+IHRD+K  N+LL      KI++FG    +  +   +    + GT  Y+ P
Sbjct: 125 YCHSK---RVIHRDIKPENLLLGSAGELKIANFG----WSVHAPSSRRTTLCGTLDYLPP 177
Query: 656 EYAMEGRFS-EKSDVFSFGVLLLEIVSGR 683
           E  +EGR   EK D++S GVL  E + G+
Sbjct: 178 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 111/226 (49%), Gaps = 19/226 (8%)
Query: 471 LFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKD------GQEIAVKRLSK-ASGQGLE 523
           +F  +E   +     L  +LGQG FG VY G  +D         +AVK +++ AS +   
Sbjct: 6   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 65
Query: 524 EFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD---- 579
           EF+NE  V+      ++VRLLG   +G+  +++ E M +  L + L   L+ E  +    
Sbjct: 66  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS-LRPEAENNPGR 124
Query: 580 ----WRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 635
                ++   +   I+ G+ YL+     + +HRDL A N ++  +   KI DFGM +   
Sbjct: 125 PPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIY 181
Query: 636 GNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
                   G+ +    +M+PE   +G F+  SD++SFGV+L EI S
Sbjct: 182 ETAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 111/226 (49%), Gaps = 19/226 (8%)
Query: 471 LFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKD------GQEIAVKRLSK-ASGQGLE 523
           +F  +E   +     L  +LGQG FG VY G  +D         +AVK +++ AS +   
Sbjct: 6   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 65
Query: 524 EFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD---- 579
           EF+NE  V+      ++VRLLG   +G+  +++ E M +  L + L   L+ E  +    
Sbjct: 66  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS-LRPEAENNPGR 124
Query: 580 ----WRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 635
                ++   +   I+ G+ YL+     + +HRDL A N ++  +   KI DFGM +   
Sbjct: 125 PPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIY 181
Query: 636 GNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
                   G+ +    +M+PE   +G F+  SD++SFGV+L EI S
Sbjct: 182 ETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/209 (33%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKL 535
           A  +F++   LG+G FG VY  R K  + I A+K L KA  +  G+E +   EV + S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
           +H N++RL G   +     LI EY P   L  +  +  K  + D ++    I  ++  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 655
           Y H     R+IHRD+K  N+LL      KI++FG    +  +   +    + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIANFG----WSVHAPSSRRTTLCGTLDYLPP 178
Query: 656 EYAMEGRFS-EKSDVFSFGVLLLEIVSGR 683
           E  +EGR   EK D++S GVL  E + G+
Sbjct: 179 E-MIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 108/200 (54%), Gaps = 13/200 (6%)
Query: 490 LGQGGFGPVYWGRL--KDGQEI--AVKRLSKASGQG-LEEFMNEVMVISKLQHRNLVRLL 544
           +G+G FG VY G L   DG++I  AVK L++ +  G + +F+ E +++    H N++ LL
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 545 GCCVEGE-EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 603
           G C+  E   +++  YM +  L   + +      +     F +   +++G+ YL   +  
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL---ASK 151
Query: 604 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMSPEYAMEG 661
           + +HRDL A N +LDE+   K++DFG+A+     +  +   +        +M+ E     
Sbjct: 152 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQ 211
Query: 662 RFSEKSDVFSFGVLLLEIVS 681
           +F+ KSDV+SFGVLL E+++
Sbjct: 212 KFTTKSDVWSFGVLLWELMT 231

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 108/196 (55%), Gaps = 12/196 (6%)
Query: 489 KLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC 547
           K+GQG  G VY    +  GQE+A+++++       E  +NE++V+ + ++ N+V  L   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 548 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 607
           + G+E  ++ EY+   SL     D + +  +D  +   +     + L +LH +   ++IH
Sbjct: 87  LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 608 RDLKASNILLDEELNPKISDFGM-AKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEK 666
           RD+K+ NILL  + + K++DFG  A+I     +Q+    +VGT  +M+PE      +  K
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSEMVGTPYWMAPEVVTRKAYGPK 196
Query: 667 SDVFSFGVLLLEIVSG 682
            D++S G++ +E++ G
Sbjct: 197 VDIWSLGIMAIEMIEG 212

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 108/196 (55%), Gaps = 12/196 (6%)
Query: 489 KLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC 547
           K+GQG  G VY    +  GQE+A+++++       E  +NE++V+ + ++ N+V  L   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 548 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 607
           + G+E  ++ EY+   SL     D + +  +D  +   +     + L +LH +   ++IH
Sbjct: 87  LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 608 RDLKASNILLDEELNPKISDFGM-AKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEK 666
           RD+K+ NILL  + + K++DFG  A+I     +Q+    +VGT  +M+PE      +  K
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSXMVGTPYWMAPEVVTRKAYGPK 196
Query: 667 SDVFSFGVLLLEIVSG 682
            D++S G++ +E++ G
Sbjct: 197 VDIWSLGIMAIEMIEG 212

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 108/196 (55%), Gaps = 12/196 (6%)
Query: 489 KLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC 547
           K+GQG  G VY    +  GQE+A+++++       E  +NE++V+ + ++ N+V  L   
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 87
Query: 548 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 607
           + G+E  ++ EY+   SL     D + +  +D  +   +     + L +LH +   ++IH
Sbjct: 88  LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 140
Query: 608 RDLKASNILLDEELNPKISDFGM-AKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEK 666
           RD+K+ NILL  + + K++DFG  A+I     +Q+    +VGT  +M+PE      +  K
Sbjct: 141 RDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSXMVGTPYWMAPEVVTRKAYGPK 197
Query: 667 SDVFSFGVLLLEIVSG 682
            D++S G++ +E++ G
Sbjct: 198 VDIWSLGIMAIEMIEG 213

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/199 (32%), Positives = 103/199 (51%), Gaps = 13/199 (6%)
Query: 489 KLGQGGFGPVYWG--RLKDGQ-EIAVKRLSKASGQG-LEEFMNEVMVISKLQHRNLVRLL 544
           +LG G FG V  G  R++  Q ++A+K L + + +   EE M E  ++ +L +  +VRL+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 545 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 604
           G C + E  ML+ E      L   L    K+E +       ++  +S G+ YL   +   
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN--- 456
Query: 605 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG--TFGYMSPEYAMEGR 662
            +HR+L A N+LL      KISDFG++K  G + D   T R  G     + +PE     +
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGAD-DSYYTARSAGKWPLKWYAPECINFRK 515
Query: 663 FSEKSDVFSFGVLLLEIVS 681
           FS +SDV+S+GV + E +S
Sbjct: 516 FSSRSDVWSYGVTMWEALS 534

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 99/210 (47%), Gaps = 20/210 (9%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 537
            +F+    LG+G F  V   R L   +E A+K L K        +     E  V+S+L H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----FDPLKKERLDWRKRFNIIEGISR 592
              V+L  C  + E+      Y  N  L   +     FD       +   RF   E +S 
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRFYTAEIVS- 148
Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 652
            L YLH      IIHRDLK  NILL+E+++ +I+DFG AK+      QA     VGT  Y
Sbjct: 149 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 205
Query: 653 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           +SPE   E    + SD+++ G ++ ++V+G
Sbjct: 206 VSPELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 70/207 (33%), Positives = 101/207 (48%), Gaps = 13/207 (6%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 537
           +NF+    LG+G FG V   R+K+ G   AVK L K        +E  M E  ++S  ++
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD-WRKRFNIIEGISRGLLY 596
              +  L CC +  +++       N     L+F   K  R D  R RF   E IS  L++
Sbjct: 83  HPFLTQLFCCFQTPDRLFFVMEFVNGG--DLMFHIQKSRRFDEARARFYAAEIIS-ALMF 139
Query: 597 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 656
           LH      II+RDLK  N+LLD E + K++DFGM K   G  +   T    GT  Y++PE
Sbjct: 140 LHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYIAPE 194
Query: 657 YAMEGRFSEKSDVFSFGVLLLEIVSGR 683
              E  +    D ++ GVLL E++ G 
Sbjct: 195 ILQEMLYGPAVDWWAMGVLLYEMLCGH 221

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 108/200 (54%), Gaps = 13/200 (6%)
Query: 490 LGQGGFGPVYWGRL--KDGQEI--AVKRLSKASGQG-LEEFMNEVMVISKLQHRNLVRLL 544
           +G+G FG VY G L   DG++I  AVK L++ +  G + +F+ E +++    H N++ LL
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 545 GCCVEGE-EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 603
           G C+  E   +++  YM +  L   + +      +     F +   +++G+ YL   +  
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL---ASK 151
Query: 604 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMSPEYAMEG 661
           + +HRDL A N +LDE+   K++DFG+A+     +  +   +        +M+ E     
Sbjct: 152 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 211
Query: 662 RFSEKSDVFSFGVLLLEIVS 681
           +F+ KSDV+SFGVLL E+++
Sbjct: 212 KFTTKSDVWSFGVLLWELMT 231

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 108/200 (54%), Gaps = 13/200 (6%)
Query: 490 LGQGGFGPVYWGRL--KDGQEI--AVKRLSKASGQG-LEEFMNEVMVISKLQHRNLVRLL 544
           +G+G FG VY G L   DG++I  AVK L++ +  G + +F+ E +++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 545 GCCVEGE-EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 603
           G C+  E   +++  YM +  L   + +      +     F +   +++G+ YL   +  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL---ASK 152
Query: 604 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMSPEYAMEG 661
           + +HRDL A N +LDE+   K++DFG+A+     +  +   +        +M+ E     
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 212
Query: 662 RFSEKSDVFSFGVLLLEIVS 681
           +F+ KSDV+SFGVLL E+++
Sbjct: 213 KFTTKSDVWSFGVLLWELMT 232

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 111/204 (54%), Gaps = 21/204 (10%)
Query: 490 LGQGGFGPVYWGRL--KDGQEI--AVKRLSKASGQG-LEEFMNEVMVISKLQHRNLVRLL 544
           +G+G FG VY G L   DG++I  AVK L++ +  G + +F+ E +++    H N++ LL
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 545 GCCVEGE-EKMLIYEYMPNRSLDALL----FDPLKKERLDWRKRFNIIEGISRGLLYLHR 599
           G C+  E   +++  YM +  L   +     +P  K+ + +  +      +++G+ YL  
Sbjct: 117 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKYL-- 168
Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMSPEY 657
            +  + +HRDL A N +LDE+   K++DFG+A+     +  +   +        +M+ E 
Sbjct: 169 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 227
Query: 658 AMEGRFSEKSDVFSFGVLLLEIVS 681
               +F+ KSDV+SFGVLL E+++
Sbjct: 228 LQTQKFTTKSDVWSFGVLLWELMT 251

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 111/204 (54%), Gaps = 21/204 (10%)
Query: 490 LGQGGFGPVYWGRL--KDGQEI--AVKRLSKASGQG-LEEFMNEVMVISKLQHRNLVRLL 544
           +G+G FG VY G L   DG++I  AVK L++ +  G + +F+ E +++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 545 GCCVEGE-EKMLIYEYMPNRSLDALL----FDPLKKERLDWRKRFNIIEGISRGLLYLHR 599
           G C+  E   +++  YM +  L   +     +P  K+ + +  +      +++G+ YL  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKYL-- 149
Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMSPEY 657
            +  + +HRDL A N +LDE+   K++DFG+A+     +  +   +        +M+ E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 208
Query: 658 AMEGRFSEKSDVFSFGVLLLEIVS 681
               +F+ KSDV+SFGVLL E+++
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 108/200 (54%), Gaps = 13/200 (6%)
Query: 490 LGQGGFGPVYWGRL--KDGQEI--AVKRLSKASGQG-LEEFMNEVMVISKLQHRNLVRLL 544
           +G+G FG VY G L   DG++I  AVK L++ +  G + +F+ E +++    H N++ LL
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 545 GCCVEGE-EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 603
           G C+  E   +++  YM +  L   + +      +     F +   +++G+ YL   +  
Sbjct: 90  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL---ASK 144
Query: 604 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMSPEYAMEG 661
           + +HRDL A N +LDE+   K++DFG+A+     +  +   +        +M+ E     
Sbjct: 145 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 204
Query: 662 RFSEKSDVFSFGVLLLEIVS 681
           +F+ KSDV+SFGVLL E+++
Sbjct: 205 KFTTKSDVWSFGVLLWELMT 224

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 108/200 (54%), Gaps = 13/200 (6%)
Query: 490 LGQGGFGPVYWGRL--KDGQEI--AVKRLSKASGQG-LEEFMNEVMVISKLQHRNLVRLL 544
           +G+G FG VY G L   DG++I  AVK L++ +  G + +F+ E +++    H N++ LL
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 545 GCCVEGE-EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 603
           G C+  E   +++  YM +  L   + +      +     F +   +++G+ YL   +  
Sbjct: 93  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL---ASK 147
Query: 604 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMSPEYAMEG 661
           + +HRDL A N +LDE+   K++DFG+A+     +  +   +        +M+ E     
Sbjct: 148 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 207
Query: 662 RFSEKSDVFSFGVLLLEIVS 681
           +F+ KSDV+SFGVLL E+++
Sbjct: 208 KFTTKSDVWSFGVLLWELMT 227

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 71/206 (34%), Positives = 103/206 (50%), Gaps = 16/206 (7%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKLQH 537
            +F +   LG+G FG VY  R +  + I A+K L K   +  G+E +   EV + S L+H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 597
            N++RL G   +     LI EY P   L  +  +  K  R D ++    I  ++  L Y 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSRFDEQRTATYITELANALSYC 128
Query: 598 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEY 657
           H     R+IHRD+K  N+LL      KI+DFG +        + DT  + GT  Y+ PE 
Sbjct: 129 HSK---RVIHRDIKPENLLLGSNGELKIADFGWS--VHAPSSRRDT--LCGTLDYLPPE- 180
Query: 658 AMEGRFS-EKSDVFSFGVLLLEIVSG 682
            +EGR   EK D++S GVL  E + G
Sbjct: 181 MIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 111/204 (54%), Gaps = 21/204 (10%)
Query: 490 LGQGGFGPVYWGRL--KDGQEI--AVKRLSKASGQG-LEEFMNEVMVISKLQHRNLVRLL 544
           +G+G FG VY G L   DG++I  AVK L++ +  G + +F+ E +++    H N++ LL
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 545 GCCVEGE-EKMLIYEYMPNRSLDALL----FDPLKKERLDWRKRFNIIEGISRGLLYLHR 599
           G C+  E   +++  YM +  L   +     +P  K+ + +  +      +++G+ YL  
Sbjct: 116 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKYL-- 167
Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMSPEY 657
            +  + +HRDL A N +LDE+   K++DFG+A+     +  +   +        +M+ E 
Sbjct: 168 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 226
Query: 658 AMEGRFSEKSDVFSFGVLLLEIVS 681
               +F+ KSDV+SFGVLL E+++
Sbjct: 227 LQTQKFTTKSDVWSFGVLLWELMT 250

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 111/204 (54%), Gaps = 21/204 (10%)
Query: 490 LGQGGFGPVYWGRL--KDGQEI--AVKRLSKASGQG-LEEFMNEVMVISKLQHRNLVRLL 544
           +G+G FG VY G L   DG++I  AVK L++ +  G + +F+ E +++    H N++ LL
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 545 GCCVEGE-EKMLIYEYMPNRSLDALL----FDPLKKERLDWRKRFNIIEGISRGLLYLHR 599
           G C+  E   +++  YM +  L   +     +P  K+ + +  +      +++G+ YL  
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKYL-- 147
Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMSPEY 657
            +  + +HRDL A N +LDE+   K++DFG+A+     +  +   +        +M+ E 
Sbjct: 148 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 206
Query: 658 AMEGRFSEKSDVFSFGVLLLEIVS 681
               +F+ KSDV+SFGVLL E+++
Sbjct: 207 LQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 108/200 (54%), Gaps = 13/200 (6%)
Query: 490 LGQGGFGPVYWGRL--KDGQEI--AVKRLSKASGQG-LEEFMNEVMVISKLQHRNLVRLL 544
           +G+G FG VY G L   DG++I  AVK L++ +  G + +F+ E +++    H N++ LL
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 545 GCCVEGE-EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 603
           G C+  E   +++  YM +  L   + +      +     F +   +++G+ YL   +  
Sbjct: 95  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL---ASK 149
Query: 604 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMSPEYAMEG 661
           + +HRDL A N +LDE+   K++DFG+A+     +  +   +        +M+ E     
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 209
Query: 662 RFSEKSDVFSFGVLLLEIVS 681
           +F+ KSDV+SFGVLL E+++
Sbjct: 210 KFTTKSDVWSFGVLLWELMT 229

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 106/211 (50%), Gaps = 19/211 (9%)
Query: 486 LSSKLGQGGFGPVYWGRLKD------GQEIAVKRLSK-ASGQGLEEFMNEVMVISKLQHR 538
           L  +LGQG FG VY G  +D         +AVK +++ AS +   EF+NE  V+      
Sbjct: 20  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 79
Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD--------WRKRFNIIEGI 590
           ++VRLLG   +G+  +++ E M +  L + L   L+ E  +         ++   +   I
Sbjct: 80  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS-LRPEAENNPGRPPPTLQEMIQMAAEI 138
Query: 591 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF 650
           + G+ YL+     + +HRDL A N ++  +   KI DFGM +           G+ +   
Sbjct: 139 ADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 195
Query: 651 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
            +M+PE   +G F+  SD++SFGV+L EI S
Sbjct: 196 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 226

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 103/205 (50%), Gaps = 11/205 (5%)
Query: 483 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHR 538
           +F++ + LG+G F  VY    +  G E+A+K + K +      ++   NEV +  +L+H 
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           +++ L     +     L+ E   N  ++  L + +K    +  + F  +  I  G+LYLH
Sbjct: 72  SILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHF--MHQIITGMLYLH 129
Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 658
                 I+HRDL  SN+LL   +N KI+DFG+A       ++  T  + GT  Y+SPE A
Sbjct: 130 SHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEIA 184
Query: 659 MEGRFSEKSDVFSFGVLLLEIVSGR 683
                  +SDV+S G +   ++ GR
Sbjct: 185 TRSAHGLESDVWSLGCMFYTLLIGR 209

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 108/209 (51%), Gaps = 19/209 (9%)
Query: 490 LGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV 548
           LG+G +G VY GR L +   IA+K + +   +  +    E+ +   L+H+N+V+ LG   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 549 EGEEKMLIYEYMPNRSLDALL---FDPLKKERLDWRKRFNI-IEGISRGLLYLHRDSRLR 604
           E     +  E +P  SL ALL   + PLK    D  +      + I  GL YLH +   +
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLK----DNEQTIGFYTKQILEGLKYLHDN---Q 142
Query: 605 IIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGR- 662
           I+HRD+K  N+L++      KISDFG +K   G     +T    GT  YM+PE   +G  
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGPR 200
Query: 663 -FSEKSDVFSFGVLLLEIVSGRKNTSFFE 690
            + + +D++S G  ++E+ +G+    F+E
Sbjct: 201 GYGKAADIWSLGCTIIEMATGK--PPFYE 227

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 105/195 (53%), Gaps = 10/195 (5%)
Query: 489 KLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC 547
           K+GQG  G VY    +  GQE+A+++++       E  +NE++V+ + ++ N+V  L   
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 87
Query: 548 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 607
           + G+E  ++ EY+   SL     D + +  +D  +   +     + L +LH +   ++IH
Sbjct: 88  LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 140
Query: 608 RDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKS 667
           R++K+ NILL  + + K++DFG        Q +  T  +VGT  +M+PE      +  K 
Sbjct: 141 RNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKV 198
Query: 668 DVFSFGVLLLEIVSG 682
           D++S G++ +E++ G
Sbjct: 199 DIWSLGIMAIEMIEG 213

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 114/205 (55%), Gaps = 23/205 (11%)
Query: 490 LGQGGFGPVYWGRL--KDGQEI--AVKRLSKASGQG-LEEFMNEVMVISKLQHRNLVRLL 544
           +G+G FG VY G L   DG++I  AVK L++ +  G + +F+ E +++    H N++ LL
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 545 GCCVEGE-EKMLIYEYMPNRSLDALL----FDPLKKERLDWRKRFNIIEGISRGLLYLHR 599
           G C+  E   +++  YM +  L   +     +P  K+ + +  +      +++G+ +L  
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKFL-- 147
Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAK-IFGGNQDQAD--TGRVVGTFGYMSPE 656
            +  + +HRDL A N +LDE+   K++DFG+A+ ++    D     TG  +    +M+ E
Sbjct: 148 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALE 205
Query: 657 YAMEGRFSEKSDVFSFGVLLLEIVS 681
                +F+ KSDV+SFGVLL E+++
Sbjct: 206 SLQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 109/222 (49%), Gaps = 19/222 (8%)
Query: 475 EELATATNNFQLSSKLGQGGFGPVYWGRLKD------GQEIAVKRLSK-ASGQGLEEFMN 527
           +E   +     L  +LGQG FG VY G  +D         +AVK +++ AS +   EF+N
Sbjct: 10  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN 69
Query: 528 EVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD-------- 579
           E  V+      ++VRLLG   +G+  +++ E M +  L + L   L+ E  +        
Sbjct: 70  EASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS-LRPEAENNPGRPPPT 128
Query: 580 WRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 639
            ++   +   I+ G+ YL+     + +HR+L A N ++  +   KI DFGM +       
Sbjct: 129 LQEMIQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDY 185
Query: 640 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
               G+ +    +M+PE   +G F+  SD++SFGV+L EI S
Sbjct: 186 YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 108/209 (51%), Gaps = 19/209 (9%)
Query: 490 LGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV 548
           LG+G +G VY GR L +   IA+K + +   +  +    E+ +   L+H+N+V+ LG   
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 549 EGEEKMLIYEYMPNRSLDALL---FDPLKKERLDWRKRFNI-IEGISRGLLYLHRDSRLR 604
           E     +  E +P  SL ALL   + PLK    D  +      + I  GL YLH +   +
Sbjct: 76  ENGFIKIFMEQVPGGSLSALLRSKWGPLK----DNEQTIGFYTKQILEGLKYLHDN---Q 128
Query: 605 IIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGR- 662
           I+HRD+K  N+L++      KISDFG +K   G     +T    GT  YM+PE   +G  
Sbjct: 129 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGPR 186
Query: 663 -FSEKSDVFSFGVLLLEIVSGRKNTSFFE 690
            + + +D++S G  ++E+ +G+    F+E
Sbjct: 187 GYGKAADIWSLGCTIIEMATGK--PPFYE 213

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 103/205 (50%), Gaps = 9/205 (4%)
Query: 481 TNNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLS-KASGQGLEEFMNEVMVISKLQHR 538
             ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ + + L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHE 65
Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           N+V+  G   EG  + L  EY     L   +   +     D ++ F+    +  G++YLH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH 122
Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 658
               + I HRD+K  N+LLDE  N KISDFG+A +F  N  +    ++ GT  Y++PE  
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 659 MEGRF-SEKSDVFSFGVLLLEIVSG 682
               F +E  DV+S G++L  +++G
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 112/219 (51%), Gaps = 17/219 (7%)
Query: 471 LFQFEELATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSK---ASGQGLEEFM 526
           +F     A  ++ ++    LG+G FG V   + K  GQE AVK +SK         E  +
Sbjct: 21  MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLL 80
Query: 527 NEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNI 586
            EV ++ +L H N+++L       E+K   Y      +   L  + + ++R        I
Sbjct: 81  REVQLLKQLDHPNIMKLYEFF---EDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI 137
Query: 587 IEGISRGLLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKIFGGNQDQADT 643
           I  +  G+ Y+H++   +I+HRDLK  N+LL+   ++ N +I DFG++  F  ++   D 
Sbjct: 138 IRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK 194
Query: 644 GRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
              +GT  Y++PE  + G + EK DV+S GV+L  ++SG
Sbjct: 195 ---IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 229

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 9/208 (4%)
Query: 478 ATATNNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLSKASGQGLEEFMNEVMVISK-L 535
           A    ++ L   LG+G +G V     +  +E +AVK +         E + + + I+K L
Sbjct: 1   APFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 60
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
            H N+V+  G   EG  + L  EY     L   +   +     D ++ F+    +  G++
Sbjct: 61  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVV 117
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 655
           YLH    + I HRD+K  N+LLDE  N KISDFG+A +F  N  +    ++ GT  Y++P
Sbjct: 118 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174
Query: 656 EYAMEGRF-SEKSDVFSFGVLLLEIVSG 682
           E      F +E  DV+S G++L  +++G
Sbjct: 175 ELLKRREFHAEPVDVWSCGIVLTAMLAG 202

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 9/205 (4%)
Query: 481 TNNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLS-KASGQGLEEFMNEVMVISKLQHR 538
             ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           N+V+  G   EG  + L  EY     L   +   +     D ++ F+    +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH 121
Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 658
               + I HRD+K  N+LLDE  N KISDFG+A +F  N  +    ++ GT  Y++PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 659 MEGRF-SEKSDVFSFGVLLLEIVSG 682
               F +E  DV+S G++L  +++G
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 102/206 (49%), Gaps = 16/206 (7%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQ--GLE-EFMNEVMVISKLQH 537
            +F +   LG+G FG VY  R +  + I A+K L K   +  G+E +   EV + S L+H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 597
            N++RL G   +     LI EY P   L  +  +  K  R D ++    I  ++  L Y 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSRFDEQRTATYITELANALSYC 128
Query: 598 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEY 657
           H     R+IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ PE 
Sbjct: 129 HSK---RVIHRDIKPENLLLGSNGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPE- 180
Query: 658 AMEGRFS-EKSDVFSFGVLLLEIVSG 682
            +EGR   EK D++S GVL  E + G
Sbjct: 181 MIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 109/222 (49%), Gaps = 19/222 (8%)
Query: 475 EELATATNNFQLSSKLGQGGFGPVYWGRLKD------GQEIAVKRLSK-ASGQGLEEFMN 527
           +E   +     L  +LGQG FG VY G  +D         +AVK +++ AS +   EF+N
Sbjct: 11  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN 70
Query: 528 EVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD-------- 579
           E  V+      ++VRLLG   +G+  +++ E M +  L + L   L+ E  +        
Sbjct: 71  EASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS-LRPEAENNPGRPPPT 129
Query: 580 WRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 639
            ++   +   I+ G+ YL+     + +HR+L A N ++  +   KI DFGM +       
Sbjct: 130 LQEMIQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDY 186
Query: 640 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
               G+ +    +M+PE   +G F+  SD++SFGV+L EI S
Sbjct: 187 YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 228

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 114/205 (55%), Gaps = 23/205 (11%)
Query: 490 LGQGGFGPVYWGRL--KDGQEI--AVKRLSKASGQG-LEEFMNEVMVISKLQHRNLVRLL 544
           +G+G FG VY G L   DG++I  AVK L++ +  G + +F+ E +++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 545 GCCVEGE-EKMLIYEYMPNRSLDALL----FDPLKKERLDWRKRFNIIEGISRGLLYLHR 599
           G C+  E   +++  YM +  L   +     +P  K+ + +  +      +++G+ +L  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKFL-- 149
Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAK-IFGGNQDQAD--TGRVVGTFGYMSPE 656
            +  + +HRDL A N +LDE+   K++DFG+A+ ++    D     TG  +    +M+ E
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALE 207
Query: 657 YAMEGRFSEKSDVFSFGVLLLEIVS 681
                +F+ KSDV+SFGVLL E+++
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 114/205 (55%), Gaps = 23/205 (11%)
Query: 490 LGQGGFGPVYWGRL--KDGQEI--AVKRLSKASGQG-LEEFMNEVMVISKLQHRNLVRLL 544
           +G+G FG VY G L   DG++I  AVK L++ +  G + +F+ E +++    H N++ LL
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 545 GCCVEGE-EKMLIYEYMPNRSLDALL----FDPLKKERLDWRKRFNIIEGISRGLLYLHR 599
           G C+  E   +++  YM +  L   +     +P  K+ + +  +      +++G+ +L  
Sbjct: 103 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKFL-- 154
Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAK-IFGGNQDQAD--TGRVVGTFGYMSPE 656
            +  + +HRDL A N +LDE+   K++DFG+A+ ++    D     TG  +    +M+ E
Sbjct: 155 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALE 212
Query: 657 YAMEGRFSEKSDVFSFGVLLLEIVS 681
                +F+ KSDV+SFGVLL E+++
Sbjct: 213 SLQTQKFTTKSDVWSFGVLLWELMT 237

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 9/205 (4%)
Query: 481 TNNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLS-KASGQGLEEFMNEVMVISKLQHR 538
             ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           N+V+  G   EG  + L  EY     L   +   +     D ++ F+    +  G++YLH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH 122
Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 658
               + I HRD+K  N+LLDE  N KISDFG+A +F  N  +    ++ GT  Y++PE  
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 659 MEGRF-SEKSDVFSFGVLLLEIVSG 682
               F +E  DV+S G++L  +++G
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 117/225 (52%), Gaps = 21/225 (9%)
Query: 473 QFEELATATNNFQLSSKLGQGGFGPVYWGRLK--DGQ--EIAVK--RLSKASGQGLEEFM 526
           + E++    N   L   LG+G FG V  G LK  DG   ++AVK  +L  +S + +EEF+
Sbjct: 25  KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFL 84
Query: 527 NEVMVISKLQHRNLVRLLGCCVEGEEK-----MLIYEYMPNRSLDA-LLFDPLKK--ERL 578
           +E   +    H N++RLLG C+E   +     M+I  +M    L   LL+  L+   + +
Sbjct: 85  SEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHI 144
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA-KIFGGN 637
             +     +  I+ G+ YL   S    +HRDL A N +L +++   ++DFG++ KI+ G 
Sbjct: 145 PLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSG- 200
Query: 638 QDQADTGRVVGT-FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
            D    GR+      +++ E   +  ++ KSDV++FGV + EI +
Sbjct: 201 -DYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 9/205 (4%)
Query: 481 TNNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLS-KASGQGLEEFMNEVMVISKLQHR 538
             ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           N+V+  G   EG  + L  EY     L   +   +     D ++ F+    +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH 121
Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 658
               + I HRD+K  N+LLDE  N KISDFG+A +F  N  +    ++ GT  Y++PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 659 MEGRF-SEKSDVFSFGVLLLEIVSG 682
               F +E  DV+S G++L  +++G
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 114/205 (55%), Gaps = 23/205 (11%)
Query: 490 LGQGGFGPVYWGRL--KDGQEI--AVKRLSKASGQG-LEEFMNEVMVISKLQHRNLVRLL 544
           +G+G FG VY G L   DG++I  AVK L++ +  G + +F+ E +++    H N++ LL
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 545 GCCVEGE-EKMLIYEYMPNRSLDALL----FDPLKKERLDWRKRFNIIEGISRGLLYLHR 599
           G C+  E   +++  YM +  L   +     +P  K+ + +  +      +++G+ +L  
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKFL-- 150
Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAK-IFGGNQDQAD--TGRVVGTFGYMSPE 656
            +  + +HRDL A N +LDE+   K++DFG+A+ ++    D     TG  +    +M+ E
Sbjct: 151 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALE 208
Query: 657 YAMEGRFSEKSDVFSFGVLLLEIVS 681
                +F+ KSDV+SFGVLL E+++
Sbjct: 209 SLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 114/205 (55%), Gaps = 23/205 (11%)
Query: 490 LGQGGFGPVYWGRL--KDGQEI--AVKRLSKASGQG-LEEFMNEVMVISKLQHRNLVRLL 544
           +G+G FG VY G L   DG++I  AVK L++ +  G + +F+ E +++    H N++ LL
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 545 GCCVEGE-EKMLIYEYMPNRSLDALL----FDPLKKERLDWRKRFNIIEGISRGLLYLHR 599
           G C+  E   +++  YM +  L   +     +P  K+ + +  +      +++G+ +L  
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKFL-- 208
Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAK-IFGGNQDQAD--TGRVVGTFGYMSPE 656
            +  + +HRDL A N +LDE+   K++DFG+A+ ++    D     TG  +    +M+ E
Sbjct: 209 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL-PVKWMALE 266
Query: 657 YAMEGRFSEKSDVFSFGVLLLEIVS 681
                +F+ KSDV+SFGVLL E+++
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMT 291

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 114/205 (55%), Gaps = 23/205 (11%)
Query: 490 LGQGGFGPVYWGRL--KDGQEI--AVKRLSKASGQG-LEEFMNEVMVISKLQHRNLVRLL 544
           +G+G FG VY G L   DG++I  AVK L++ +  G + +F+ E +++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 545 GCCVEGE-EKMLIYEYMPNRSLDALL----FDPLKKERLDWRKRFNIIEGISRGLLYLHR 599
           G C+  E   +++  YM +  L   +     +P  K+ + +  +      +++G+ +L  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKFL-- 149
Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAK-IFGGNQDQAD--TGRVVGTFGYMSPE 656
            +  + +HRDL A N +LDE+   K++DFG+A+ ++    D     TG  +    +M+ E
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALE 207
Query: 657 YAMEGRFSEKSDVFSFGVLLLEIVS 681
                +F+ KSDV+SFGVLL E+++
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 9/205 (4%)
Query: 481 TNNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLS-KASGQGLEEFMNEVMVISKLQHR 538
             ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           N+V+  G   EG  + L  EY     L   +   +     D ++ F+    +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH 121
Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 658
               + I HRD+K  N+LLDE  N KISDFG+A +F  N  +    ++ GT  Y++PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 659 MEGRF-SEKSDVFSFGVLLLEIVSG 682
               F +E  DV+S G++L  +++G
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 9/205 (4%)
Query: 481 TNNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLS-KASGQGLEEFMNEVMVISKLQHR 538
             ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           N+V+  G   EG  + L  EY     L   +   +     D ++ F+    +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH 121
Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 658
               + I HRD+K  N+LLDE  N KISDFG+A +F  N  +    ++ GT  Y++PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 659 MEGRF-SEKSDVFSFGVLLLEIVSG 682
               F +E  DV+S G++L  +++G
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 9/205 (4%)
Query: 481 TNNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLS-KASGQGLEEFMNEVMVISKLQHR 538
             ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           N+V+  G   EG  + L  EY     L   +   +     D ++ F+    +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH 121
Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 658
               + I HRD+K  N+LLDE  N KISDFG+A +F  N  +    ++ GT  Y++PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 659 MEGRF-SEKSDVFSFGVLLLEIVSG 682
               F +E  DV+S G++L  +++G
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 9/205 (4%)
Query: 481 TNNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLS-KASGQGLEEFMNEVMVISKLQHR 538
             ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           N+V+  G   EG  + L  EY     L   +   +     D ++ F+    +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH 121
Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 658
               + I HRD+K  N+LLDE  N KISDFG+A +F  N  +    ++ GT  Y++PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 659 MEGRF-SEKSDVFSFGVLLLEIVSG 682
               F +E  DV+S G++L  +++G
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 102/203 (50%), Gaps = 9/203 (4%)
Query: 483 NFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLS-KASGQGLEEFMNEVMVISKLQHRNL 540
           ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ +   L H N+
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 541 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 600
           V+  G   EG  + L  EY     L   +   +     D ++ F+ +     G++YLH  
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG- 122
Query: 601 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
             + I HRD+K  N+LLDE  N KISDFG+A +F  N  +    ++ GT  Y++PE    
Sbjct: 123 --IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 661 GRF-SEKSDVFSFGVLLLEIVSG 682
             F +E  DV+S G++L  +++G
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAG 203

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 9/205 (4%)
Query: 481 TNNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLS-KASGQGLEEFMNEVMVISKLQHR 538
             ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           N+V+  G   EG  + L  EY     L   +   +     D ++ F+    +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH 121
Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 658
               + I HRD+K  N+LLDE  N KISDFG+A +F  N  +    ++ GT  Y++PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 659 MEGRF-SEKSDVFSFGVLLLEIVSG 682
               F +E  DV+S G++L  +++G
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 116/208 (55%), Gaps = 16/208 (7%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 535
             F+    LG G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ 
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 653
           YL  D RL  +HRDL A N+L+    + KI+DFG+AK+ G  + +  A+ G+V     +M
Sbjct: 132 YLE-DRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 186
Query: 654 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 112/207 (54%), Gaps = 27/207 (13%)
Query: 490 LGQGGFGPVYWGRL--KDGQEI--AVKRLSKASGQG-LEEFMNEVMVISKLQHRNLVRLL 544
           +G+G FG VY G L   DG++I  AVK L++ +  G + +F+ E +++    H N++ LL
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 545 GCCVEGE-EKMLIYEYMPNRSLDALL----FDPLKKERLDWRKRFNIIEGISRGLLYLHR 599
           G C+  E   +++  YM +  L   +     +P  K+ + +  +      +++G+ +L  
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKFL-- 150
Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMA-----KIFGGNQDQADTGRVVGTFGYMS 654
            +  + +HRDL A N +LDE+   K++DFG+A     K F    ++      V    +M+
Sbjct: 151 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPV---KWMA 206
Query: 655 PEYAMEGRFSEKSDVFSFGVLLLEIVS 681
            E     +F+ KSDV+SFGVLL E+++
Sbjct: 207 LESLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 102/203 (50%), Gaps = 9/203 (4%)
Query: 483 NFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLS-KASGQGLEEFMNEVMVISKLQHRNL 540
           ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ +   L H N+
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 541 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 600
           V+  G   EG  + L  EY     L   +   +     D ++ F+ +     G++YLH  
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG- 123
Query: 601 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
             + I HRD+K  N+LLDE  N KISDFG+A +F  N  +    ++ GT  Y++PE    
Sbjct: 124 --IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 661 GRF-SEKSDVFSFGVLLLEIVSG 682
             F +E  DV+S G++L  +++G
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAG 204

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 116/208 (55%), Gaps = 16/208 (7%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 535
             F+    LG G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ +
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ 
Sbjct: 69  DNPHVCRLLGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 125
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 653
           YL  D RL  +HRDL A N+L+    + KI+DFG+AK+ G  + +  A+ G+V     +M
Sbjct: 126 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 180
Query: 654 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 181 ALESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 116/208 (55%), Gaps = 16/208 (7%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 535
             F+    LG G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ +
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ 
Sbjct: 76  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 132
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 653
           YL  D RL  +HRDL A N+L+    + KI+DFG+AK+ G  + +  A+ G+V     +M
Sbjct: 133 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 187
Query: 654 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 188 ALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 9/205 (4%)
Query: 481 TNNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLS-KASGQGLEEFMNEVMVISKLQHR 538
             ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           N+V+  G   EG  + L  EY     L   +   +     D ++ F+    +  G++YLH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH 122
Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 658
               + I HRD+K  N+LLDE  N KISDFG+A +F  N  +    ++ GT  Y++PE  
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 659 MEGRF-SEKSDVFSFGVLLLEIVSG 682
               F +E  DV+S G++L  +++G
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 15/206 (7%)
Query: 484 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRL---SKASGQGLEEFMNEVMVISKLQHRN 539
           +++  KLG GG   VY         ++A+K +    +   + L+ F  EV   S+L H+N
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALL--FDPLKKERLDWRKRFNIIEGISRGLLYL 597
           +V ++    E +   L+ EY+   +L   +    PL  +        N    I  G+ + 
Sbjct: 73  IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVD-----TAINFTNQILDGIKHA 127
Query: 598 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEY 657
           H    +RI+HRD+K  NIL+D     KI DFG+AK          T  V+GT  Y SPE 
Sbjct: 128 HD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS-LTQTNHVLGTVQYFSPEQ 183
Query: 658 AMEGRFSEKSDVFSFGVLLLEIVSGR 683
           A      E +D++S G++L E++ G 
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVGE 209

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 116/208 (55%), Gaps = 16/208 (7%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 535
             F+    LG G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ 
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 653
           YL  D RL  +HRDL A N+L+    + KI+DFG+AK+ G  + +  A+ G+V     +M
Sbjct: 132 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 186
Query: 654 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 116/208 (55%), Gaps = 16/208 (7%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 535
             F+    LG G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ +
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ 
Sbjct: 79  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 135
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 653
           YL  D RL  +HRDL A N+L+    + KI+DFG+AK+ G  + +  A+ G+V     +M
Sbjct: 136 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 190
Query: 654 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 191 ALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 9/205 (4%)
Query: 481 TNNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLS-KASGQGLEEFMNEVMVISKLQHR 538
             ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           N+V+  G   EG  + L  EY     L   +   +     D ++ F+    +  G++YLH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH 122
Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 658
               + I HRD+K  N+LLDE  N KISDFG+A +F  N  +    ++ GT  Y++PE  
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 659 MEGRF-SEKSDVFSFGVLLLEIVSG 682
               F +E  DV+S G++L  +++G
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 9/205 (4%)
Query: 481 TNNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLS-KASGQGLEEFMNEVMVISKLQHR 538
             ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           N+V+  G   EG  + L  EY     L   +   +     D ++ F+    +  G++YLH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH 122
Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 658
               + I HRD+K  N+LLDE  N KISDFG+A +F  N  +    ++ GT  Y++PE  
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 659 MEGRF-SEKSDVFSFGVLLLEIVSG 682
               F +E  DV+S G++L  +++G
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 9/205 (4%)
Query: 481 TNNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLS-KASGQGLEEFMNEVMVISKLQHR 538
             ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           N+V+  G   EG  + L  EY     L   +   +     D ++ F+    +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH 121
Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 658
               + I HRD+K  N+LLDE  N KISDFG+A +F  N  +    ++ GT  Y++PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 659 MEGRF-SEKSDVFSFGVLLLEIVSG 682
               F +E  DV+S G++L  +++G
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 9/205 (4%)
Query: 481 TNNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLS-KASGQGLEEFMNEVMVISKLQHR 538
             ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           N+V+  G   EG  + L  EY     L   +   +     D ++ F+    +  G++YLH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH 122
Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 658
               + I HRD+K  N+LLDE  N KISDFG+A +F  N  +    ++ GT  Y++PE  
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 659 MEGRF-SEKSDVFSFGVLLLEIVSG 682
               F +E  DV+S G++L  +++G
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 9/205 (4%)
Query: 481 TNNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLS-KASGQGLEEFMNEVMVISKLQHR 538
             ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           N+V+  G   EG  + L  EY     L   +   +     D ++ F+    +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH 121
Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 658
               + I HRD+K  N+LLDE  N KISDFG+A +F  N  +    ++ GT  Y++PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 659 MEGRF-SEKSDVFSFGVLLLEIVSG 682
               F +E  DV+S G++L  +++G
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/234 (30%), Positives = 116/234 (49%), Gaps = 47/234 (20%)
Query: 471 LFQFEELATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSK---ASGQGLEEFM 526
           +F     A  ++ ++    LG+G FG V   + K  GQE AVK +SK         E  +
Sbjct: 15  MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLL 74
Query: 527 NEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDAL---------LFDPLKKER 577
            EV ++ +L H N+++L             YE+  ++    L         LFD +    
Sbjct: 75  REVQLLKQLDHPNIMKL-------------YEFFEDKGYFYLVGEVYTGGELFDEIIS-- 119
Query: 578 LDWRKRFN------IIEGISRGLLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDF 628
              RKRF+      II  +  G+ Y+H++   +I+HRDLK  N+LL+   ++ N +I DF
Sbjct: 120 ---RKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDF 173
Query: 629 GMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           G++  F  ++   D    +GT  Y++PE  + G + EK DV+S GV+L  ++SG
Sbjct: 174 GLSTHFEASKKMKDK---IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 99/210 (47%), Gaps = 20/210 (9%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 537
            +F+    LG+G F  V   R L   +E A+K L K        +     E  V+S+L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----FDPLKKERLDWRKRFNIIEGISR 592
              V+L     + E+      Y  N  L   +     FD       +   RF   E +S 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFD-------ETCTRFYTAEIVS- 143
Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 652
            L YLH      IIHRDLK  NILL+E+++ +I+DFG AK+      QA     VGT  Y
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 200
Query: 653 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           +SPE   E   S+ SD+++ G ++ ++V+G
Sbjct: 201 VSPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 116/208 (55%), Gaps = 16/208 (7%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 535
             F+    LG G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ 
Sbjct: 78  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 134
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 653
           YL  D RL  +HRDL A N+L+    + KI+DFG+AK+ G  + +  A+ G+V     +M
Sbjct: 135 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 189
Query: 654 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 190 ALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 483 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRN 539
           N++L   +G+G F  V   R +  G+E+A+K + K   +   L++   EV ++  L H N
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 540 LVRLLGCCVEGEEKMLIYEYMPN-RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           +V+L       +   LI EY       D L+     KE+ + R +F     I   + Y H
Sbjct: 76  IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEK-EARSKFR---QIVSAVQYCH 131
Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF--GGNQDQADTGRVVGTFGYMSPE 656
           +    RI+HRDLKA N+LLD ++N KI+DFG +  F  GG  D        G   Y +PE
Sbjct: 132 QK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA-----FCGAPPYAAPE 183
Query: 657 YAMEGRFS-EKSDVFSFGVLLLEIVSG 682
                ++   + DV+S GV+L  +VSG
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 116/208 (55%), Gaps = 16/208 (7%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 535
             F+    LG G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ 
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 653
           YL  D RL  +HRDL A N+L+    + KI+DFG+AK+ G  + +  A+ G+V     +M
Sbjct: 132 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 186
Query: 654 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 116/208 (55%), Gaps = 16/208 (7%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 535
             F+    LG G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ +
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ 
Sbjct: 76  DNPHVCRLLGICLTSTVQ-LIMQLMPFGXL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 132
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 653
           YL  D RL  +HRDL A N+L+    + KI+DFG+AK+ G  + +  A+ G+V     +M
Sbjct: 133 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 187
Query: 654 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 188 ALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 116/208 (55%), Gaps = 16/208 (7%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 535
             F+    LG G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ +
Sbjct: 21  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 80
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ 
Sbjct: 81  DNPHVCRLLGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 137
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 653
           YL  D RL  +HRDL A N+L+    + KI+DFG+AK+ G  + +  A+ G+V     +M
Sbjct: 138 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 192
Query: 654 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 193 ALESILHRIYTHQSDVWSYGVTVWELMT 220

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 116/208 (55%), Gaps = 16/208 (7%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 535
             F+    LG G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ 
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 133
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 653
           YL  D RL  +HRDL A N+L+    + KI+DFG+AK+ G  + +  A+ G+V     +M
Sbjct: 134 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 188
Query: 654 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 9/205 (4%)
Query: 481 TNNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLS-KASGQGLEEFMNEVMVISKLQHR 538
             ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 65
Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           N+V+  G   EG  + L  EY     L   +   +     D ++ F+    +  G++YLH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH 122
Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 658
               + I HRD+K  N+LLDE  N KISDFG+A +F  N  +    ++ GT  Y++PE  
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 179
Query: 659 MEGRF-SEKSDVFSFGVLLLEIVSG 682
               F +E  DV+S G++L  +++G
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 116/208 (55%), Gaps = 16/208 (7%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 535
             F+    LG G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ 
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGXL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 653
           YL  D RL  +HRDL A N+L+    + KI+DFG+AK+ G  + +  A+ G+V     +M
Sbjct: 132 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 186
Query: 654 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 116/208 (55%), Gaps = 16/208 (7%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 535
             F+    LG G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ 
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 133
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 653
           YL  D RL  +HRDL A N+L+    + KI+DFG+AK+ G  + +  A+ G+V     +M
Sbjct: 134 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 188
Query: 654 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 116/208 (55%), Gaps = 16/208 (7%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 535
             F+    LG G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ 
Sbjct: 78  DNPHVCRLLGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 134
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 653
           YL  D RL  +HRDL A N+L+    + KI+DFG+AK+ G  + +  A+ G+V     +M
Sbjct: 135 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 189
Query: 654 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 190 ALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 116/208 (55%), Gaps = 16/208 (7%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 535
             F+    LG G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ +
Sbjct: 25  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 84
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ 
Sbjct: 85  DNPHVCRLLGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 141
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 653
           YL  D RL  +HRDL A N+L+    + KI+DFG+AK+ G  + +  A+ G+V     +M
Sbjct: 142 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 196
Query: 654 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 197 ALESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 116/208 (55%), Gaps = 16/208 (7%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 535
             F+    LG G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ 
Sbjct: 78  DNPHVCRLLGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 134
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 653
           YL  D RL  +HRDL A N+L+    + KI+DFG+AK+ G  + +  A+ G+V     +M
Sbjct: 135 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 189
Query: 654 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 190 ALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 108/220 (49%), Gaps = 26/220 (11%)
Query: 474 FEELATATNNFQLSSKLGQGGFGPVYWGRL-----KDGQEIAVKRLSKASGQGLEEFMNE 528
           FEE      + +  S+LG+G FG V   R        G  +AVK+L  +      +F  E
Sbjct: 4   FEE-----RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQRE 58
Query: 529 VMVISKLQHRNLVRLLGCCVEG--EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNI 586
           + ++  L    +V+  G        E  L+ EY+P+  L   L     + RLD  +    
Sbjct: 59  IQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQR--HRARLDASRLLLY 116
Query: 587 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV 646
              I +G+ YL   SR R +HRDL A NIL++ E + KI+DFG+AK+   ++D      V
Sbjct: 117 SSQICKGMEYL--GSR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXX----V 169
Query: 647 VGTFG-----YMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           V   G     + +PE   +  FS +SDV+SFGV+L E+ +
Sbjct: 170 VREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 105/207 (50%), Gaps = 19/207 (9%)
Query: 483 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRN 539
           N++L   +G+G F  V   R +  G+E+A+K + K   +   L++   EV ++  L H N
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 72
Query: 540 LVRLLGCCVEGEEKMLIYEYMPN-RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           +V+L       +   LI EY       D L+     KE+ + R +F     I   + Y H
Sbjct: 73  IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEK-EARSKFR---QIVSAVQYCH 128
Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF--GGNQDQADTGRVVGTFGYMSPE 656
           +    RI+HRDLKA N+LLD ++N KI+DFG +  F  GG  D        G+  Y +PE
Sbjct: 129 QK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDT-----FCGSPPYAAPE 180
Query: 657 YAMEGRFS-EKSDVFSFGVLLLEIVSG 682
                ++   + DV+S GV+L  +VSG
Sbjct: 181 LFQGKKYDGPEVDVWSLGVILYTLVSG 207

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 116/208 (55%), Gaps = 16/208 (7%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 535
             F+    LG G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ +
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ 
Sbjct: 82  DNPHVCRLLGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 138
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 653
           YL  D RL  +HRDL A N+L+    + KI+DFG+AK+ G  + +  A+ G+V     +M
Sbjct: 139 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 193
Query: 654 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 194 ALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 110/220 (50%), Gaps = 26/220 (11%)
Query: 474 FEELATATNNFQLSSKLGQGGFGPVYWGRL-----KDGQEIAVKRLSKASGQGLEEFMNE 528
           FEE      + +  S+LG+G FG V   R        G  +AVK+L  +      +F  E
Sbjct: 7   FEE-----RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQRE 61
Query: 529 VMVISKLQHRNLVRLLGCCV-EGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNI 586
           + ++  L    +V+  G     G + + L+ EY+P+  L   L     + RLD  +    
Sbjct: 62  IQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLY 119
Query: 587 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV 646
              I +G+ YL   SR R +HRDL A NIL++ E + KI+DFG+AK+   ++D      V
Sbjct: 120 SSQICKGMEYL--GSR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY----V 172
Query: 647 VGTFG-----YMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           V   G     + +PE   +  FS +SDV+SFGV+L E+ +
Sbjct: 173 VREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 110/220 (50%), Gaps = 26/220 (11%)
Query: 474 FEELATATNNFQLSSKLGQGGFGPVYWGRL-----KDGQEIAVKRLSKASGQGLEEFMNE 528
           FEE      + +  S+LG+G FG V   R        G  +AVK+L  +      +F  E
Sbjct: 20  FEE-----RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQRE 74
Query: 529 VMVISKLQHRNLVRLLGCCV-EGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNI 586
           + ++  L    +V+  G     G + + L+ EY+P+  L   L     + RLD  +    
Sbjct: 75  IQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLY 132
Query: 587 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV 646
              I +G+ YL   SR R +HRDL A NIL++ E + KI+DFG+AK+   ++D      V
Sbjct: 133 SSQICKGMEYL--GSR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY----V 185
Query: 647 VGTFG-----YMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           V   G     + +PE   +  FS +SDV+SFGV+L E+ +
Sbjct: 186 VREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/224 (31%), Positives = 110/224 (49%), Gaps = 36/224 (16%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLK-DG--QEIAVKRLSK-ASGQGLEEFMNEVMVISKL-Q 536
           N+ +    +G+G FG V   R+K DG   + A+KR+ + AS     +F  E+ V+ KL  
Sbjct: 15  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 74
Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER-----------------LD 579
           H N++ LLG C       L  EY P+ +L     D L+K R                 L 
Sbjct: 75  HPNIINLLGACEHRGYLYLAIEYAPHGNL----LDFLRKSRVLETDPAFAIANSTASTLS 130
Query: 580 WRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 639
            ++  +    ++RG+ YL   S+ + IHRDL A NIL+ E    KI+DFG+++       
Sbjct: 131 SQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQ 182
Query: 640 QADTGRVVGTFG--YMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           +    + +G     +M+ E      ++  SDV+S+GVLL EIVS
Sbjct: 183 EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 116/208 (55%), Gaps = 16/208 (7%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 535
             F+    LG G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ 
Sbjct: 78  DNPHVCRLLGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 134
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 653
           YL  D RL  +HRDL A N+L+    + KI+DFG+AK+ G  + +  A+ G+V     +M
Sbjct: 135 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 189
Query: 654 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 190 ALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 9/205 (4%)
Query: 481 TNNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLS-KASGQGLEEFMNEVMVISKLQHR 538
             ++ L   LG+G +G V     +  +E +AVK +  K +    E    E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           N+V+  G   EG  + L  EY     L   +   +     D ++ F+    +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH 121
Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 658
               + I HRD+K  N+LLDE  N KISDFG+A +F  N  +    ++ GT  Y++PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 659 MEGRF-SEKSDVFSFGVLLLEIVSG 682
               F +E  DV+S G++L  +++G
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 116/208 (55%), Gaps = 16/208 (7%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 535
             F+    LG G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ +
Sbjct: 40  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 99
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ 
Sbjct: 100 DNPHVCRLLGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 156
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 653
           YL  D RL  +HRDL A N+L+    + KI+DFG+AK+ G  + +  A+ G+V     +M
Sbjct: 157 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 211
Query: 654 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 212 ALESILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/224 (31%), Positives = 110/224 (49%), Gaps = 36/224 (16%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLK-DG--QEIAVKRLSK-ASGQGLEEFMNEVMVISKL-Q 536
           N+ +    +G+G FG V   R+K DG   + A+KR+ + AS     +F  E+ V+ KL  
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER-----------------LD 579
           H N++ LLG C       L  EY P+ +L     D L+K R                 L 
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNL----LDFLRKSRVLETDPAFAIANSTASTLS 140
Query: 580 WRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 639
            ++  +    ++RG+ YL   S+ + IHRDL A NIL+ E    KI+DFG+++       
Sbjct: 141 SQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQ 192
Query: 640 QADTGRVVGTFG--YMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           +    + +G     +M+ E      ++  SDV+S+GVLL EIVS
Sbjct: 193 EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 126/287 (43%), Gaps = 24/287 (8%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 541
              ++   +G+G FG V   + +  +++A+K++   S +  + F+ E+  +S++ H N+V
Sbjct: 9   KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIV 65
Query: 542 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
           +L G C+      L+ EY    SL  +L               +     S+G+ YLH   
Sbjct: 66  KLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 123
Query: 602 RLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
              +IHRDLK  N+LL       KI DFG A        Q       G+  +M+PE    
Sbjct: 124 PKALIHRDLKPPNLLLVAGGTVLKICDFGTA-----CDIQTHMTNNKGSAAWMAPEVFEG 178
Query: 661 GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS 720
             +SEK DVFS+G++L E+++ RK   F E         W + N  +      P +    
Sbjct: 179 SNYSEKCDVFSWGIILWEVITRRK--PFDEIGGPAFRIMWAVHNGTR-----PPLIKNLP 231
Query: 721 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEP 767
             ++ ++        C  +    RP+M  +V ++   +R  P   EP
Sbjct: 232 KPIESLM------TRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 272

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 110/220 (50%), Gaps = 26/220 (11%)
Query: 474 FEELATATNNFQLSSKLGQGGFGPVYWGRL-----KDGQEIAVKRLSKASGQGLEEFMNE 528
           FEE      + +  S+LG+G FG V   R        G  +AVK+L  +      +F  E
Sbjct: 8   FEE-----RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQRE 62
Query: 529 VMVISKLQHRNLVRLLGCCV-EGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNI 586
           + ++  L    +V+  G     G + + L+ EY+P+  L   L     + RLD  +    
Sbjct: 63  IQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLY 120
Query: 587 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV 646
              I +G+ YL   SR R +HRDL A NIL++ E + KI+DFG+AK+   ++D      V
Sbjct: 121 SSQICKGMEYL--GSR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY----V 173
Query: 647 VGTFG-----YMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           V   G     + +PE   +  FS +SDV+SFGV+L E+ +
Sbjct: 174 VREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 112/219 (51%), Gaps = 17/219 (7%)
Query: 471 LFQFEELATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSK---ASGQGLEEFM 526
           +F     A  ++ ++    LG+G FG V   + K  GQE AVK +SK         E  +
Sbjct: 38  MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLL 97
Query: 527 NEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNI 586
            EV ++ +L H N+++L       E+K   Y      +   L  + + ++R        I
Sbjct: 98  REVQLLKQLDHPNIMKLYEFF---EDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI 154
Query: 587 IEGISRGLLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKIFGGNQDQADT 643
           I  +  G+ Y+H++   +I+HRDLK  N+LL+   ++ N +I DFG++  F  ++   D 
Sbjct: 155 IRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK 211
Query: 644 GRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
              +GT  Y++PE  + G + EK DV+S GV+L  ++SG
Sbjct: 212 ---IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 246

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 112/219 (51%), Gaps = 17/219 (7%)
Query: 471 LFQFEELATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSK---ASGQGLEEFM 526
           +F     A  ++ ++    LG+G FG V   + K  GQE AVK +SK         E  +
Sbjct: 39  MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLL 98
Query: 527 NEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNI 586
            EV ++ +L H N+++L       E+K   Y      +   L  + + ++R        I
Sbjct: 99  REVQLLKQLDHPNIMKLYEFF---EDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI 155
Query: 587 IEGISRGLLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKIFGGNQDQADT 643
           I  +  G+ Y+H++   +I+HRDLK  N+LL+   ++ N +I DFG++  F  ++   D 
Sbjct: 156 IRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK 212
Query: 644 GRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
              +GT  Y++PE  + G + EK DV+S GV+L  ++SG
Sbjct: 213 ---IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 247

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 126/287 (43%), Gaps = 24/287 (8%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 541
              ++   +G+G FG V   + +  +++A+K++   S +  + F+ E+  +S++ H N+V
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIV 64
Query: 542 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
           +L G C+      L+ EY    SL  +L               +     S+G+ YLH   
Sbjct: 65  KLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 602 RLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
              +IHRDLK  N+LL       KI DFG A        Q       G+  +M+PE    
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTA-----CDIQTHMTNNKGSAAWMAPEVFEG 177
Query: 661 GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS 720
             +SEK DVFS+G++L E+++ RK   F E         W + N  +      P +    
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRK--PFDEIGGPAFRIMWAVHNGTR-----PPLIKNLP 230
Query: 721 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEP 767
             ++ ++        C  +    RP+M  +V ++   +R  P   EP
Sbjct: 231 KPIESLM------TRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 537
            +F+    LG+G F  V   R L   +E A+K L K        +     E  V+S+L H
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----FDPLKKERLDWRKRFNIIEGISR 592
              V+L     + E+      Y  N  L   +     FD       +   RF   E +S 
Sbjct: 70  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRFYTAEIVS- 121
Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 652
            L YLH      IIHRDLK  NILL+E+++ +I+DFG AK+      QA     VGT  Y
Sbjct: 122 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 178
Query: 653 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           +SPE   E    + SD+++ G ++ ++V+G
Sbjct: 179 VSPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 108/213 (50%), Gaps = 10/213 (4%)
Query: 477 LATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFM--NEVMVIS 533
           + +   ++++   +G G +G     R K DG+ +  K L   S    E+ M  +EV ++ 
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR 60
Query: 534 KLQHRNLVRLLGCCVEGEEKML--IYEYMPNRSLDALLFDPLK-KERLDWRKRFNIIEGI 590
           +L+H N+VR     ++     L  + EY     L +++    K ++ LD      ++  +
Sbjct: 61  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120
Query: 591 SRGLLYLHR--DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 648
           +  L   HR  D    ++HRDLK +N+ LD + N K+ DFG+A+I   N D +     VG
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKTFVG 178
Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           T  YMSPE      ++EKSD++S G LL E+ +
Sbjct: 179 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 109/205 (53%), Gaps = 21/205 (10%)
Query: 485 QLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRL 543
           ++  +LG G FG VY  + K+ G   A K +   S + LE+++ E+ +++   H  +V+L
Sbjct: 14  EIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKL 73
Query: 544 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL----YLHR 599
           LG      +  ++ E+ P  ++DA++ +      LD       I+ + R +L    +LH 
Sbjct: 74  LGAYYHDGKLWIMIEFCPGGAVDAIMLE------LDRGLTEPQIQVVCRQMLEALNFLHS 127
Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 659
               RIIHRDLKA N+L+  E + +++DFG++        + D+   +GT  +M+PE  M
Sbjct: 128 K---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVM 182
Query: 660 -----EGRFSEKSDVFSFGVLLLEI 679
                +  +  K+D++S G+ L+E+
Sbjct: 183 CETMKDTPYDYKADIWSLGITLIEM 207

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 108/213 (50%), Gaps = 10/213 (4%)
Query: 477 LATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFM--NEVMVIS 533
           + +   ++++   +G G +G     R K DG+ +  K L   S    E+ M  +EV ++ 
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR 60
Query: 534 KLQHRNLVRLLGCCVEGEEKML--IYEYMPNRSLDALLFDPLK-KERLDWRKRFNIIEGI 590
           +L+H N+VR     ++     L  + EY     L +++    K ++ LD      ++  +
Sbjct: 61  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120
Query: 591 SRGLLYLHR--DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 648
           +  L   HR  D    ++HRDLK +N+ LD + N K+ DFG+A+I   N D+      VG
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDEDFAKEFVG 178
Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           T  YMSPE      ++EKSD++S G LL E+ +
Sbjct: 179 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 108/213 (50%), Gaps = 10/213 (4%)
Query: 477 LATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFM--NEVMVIS 533
           + +   ++++   +G G +G     R K DG+ +  K L   S    E+ M  +EV ++ 
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR 60
Query: 534 KLQHRNLVRLLGCCVEGEEKML--IYEYMPNRSLDALLFDPLK-KERLDWRKRFNIIEGI 590
           +L+H N+VR     ++     L  + EY     L +++    K ++ LD      ++  +
Sbjct: 61  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120
Query: 591 SRGLLYLHR--DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 648
           +  L   HR  D    ++HRDLK +N+ LD + N K+ DFG+A+I   N D +     VG
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKAFVG 178
Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           T  YMSPE      ++EKSD++S G LL E+ +
Sbjct: 179 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 108/222 (48%), Gaps = 25/222 (11%)
Query: 482 NNFQLSSKLGQGGFGPVYWG------RLKDGQEIAVKRLSK-ASGQGLEEFMNEVMVISK 534
           +  +L   LG+G FG V         +    + +AVK L + A+       M+E+ ++  
Sbjct: 29  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 88
Query: 535 L-QHRNLVRLLGCCVE-GEEKMLIYEYMPNRSLDALL------FDPLKKERLDWRKRFNI 586
           +  H N+V LLG C + G   M+I E+    +L   L      F P K+   D  K F  
Sbjct: 89  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLT 148
Query: 587 IEG-------ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 639
           +E        +++G+ +L   +  + IHRDL A NILL E+   KI DFG+A+    + D
Sbjct: 149 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 205
Query: 640 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
               G       +M+PE   +  ++ +SDV+SFGVLL EI S
Sbjct: 206 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 537
            +F+    LG+G F  V   R L   +E A+K L K        +     E  V+S+L H
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----FDPLKKERLDWRKRFNIIEGISR 592
              V+L     + E+      Y  N  L   +     FD       +   RF   E +S 
Sbjct: 69  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRFYTAEIVS- 120
Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 652
            L YLH      IIHRDLK  NILL+E+++ +I+DFG AK+      QA     VGT  Y
Sbjct: 121 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 177
Query: 653 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           +SPE   E    + SD+++ G ++ ++V+G
Sbjct: 178 VSPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 537
            +F+    LG+G F  V   R L   +E A+K L K        +     E  V+S+L H
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----FDPLKKERLDWRKRFNIIEGISR 592
              V+L     + E+      Y  N  L   +     FD       +   RF   E +S 
Sbjct: 67  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRFYTAEIVS- 118
Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 652
            L YLH      IIHRDLK  NILL+E+++ +I+DFG AK+      QA     VGT  Y
Sbjct: 119 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 175
Query: 653 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           +SPE   E    + SD+++ G ++ ++V+G
Sbjct: 176 VSPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 537
            +F+    LG+G F  V   R L   +E A+K L K        +     E  V+S+L H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----FDPLKKERLDWRKRFNIIEGISR 592
              V+L     + E+      Y  N  L   +     FD       +   RF   E +S 
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRFYTAEIVS- 125
Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 652
            L YLH      IIHRDLK  NILL+E+++ +I+DFG AK+      QA     VGT  Y
Sbjct: 126 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 182
Query: 653 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           +SPE   E    + SD+++ G ++ ++V+G
Sbjct: 183 VSPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 537
            +F+    LG+G F  V   R L   +E A+K L K        +     E  V+S+L H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----FDPLKKERLDWRKRFNIIEGISR 592
              V+L     + E+      Y  N  L   +     FD       +   RF   E +S 
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRFYTAEIVS- 119
Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 652
            L YLH      IIHRDLK  NILL+E+++ +I+DFG AK+      QA     VGT  Y
Sbjct: 120 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 176
Query: 653 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           +SPE   E    + SD+++ G ++ ++V+G
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 115/208 (55%), Gaps = 16/208 (7%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 535
             F+    LG G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ +
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ 
Sbjct: 79  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 135
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 653
           YL  D RL  +HRDL A N+L+    + KI+DFG AK+ G  + +  A+ G+V     +M
Sbjct: 136 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV--PIKWM 190
Query: 654 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 191 ALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 115/208 (55%), Gaps = 16/208 (7%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 535
             F+    LG G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ +
Sbjct: 12  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 71
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I+ G+ 
Sbjct: 72  DNPHVCRLLGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAEGMN 128
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 653
           YL  D RL  +HRDL A N+L+    + KI+DFG+AK+ G  + +  A+ G+V     +M
Sbjct: 129 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 183
Query: 654 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 184 ALESILHRIYTHQSDVWSYGVTVWELMT 211

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 107/222 (48%), Gaps = 25/222 (11%)
Query: 482 NNFQLSSKLGQGGFGPVYWG------RLKDGQEIAVKRLSK-ASGQGLEEFMNEVMVISK 534
           +  +L   LG+G FG V         +    + +AVK L + A+       M+E+ ++  
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 535 L-QHRNLVRLLGCCVE-GEEKMLIYEYMPNRSLDALL------FDPLKKERLDWRKRFNI 586
           +  H N+V LLG C + G   M+I E+    +L   L      F P K    D  K F  
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 587 IEG-------ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 639
           +E        +++G+ +L   +  + IHRDL A NILL E+   KI DFG+A+    + D
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD 203
Query: 640 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
               G       +M+PE   +  ++ +SDV+SFGVLL EI S
Sbjct: 204 XVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 109/207 (52%), Gaps = 21/207 (10%)
Query: 485 QLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRL 543
           ++  +LG G FG VY  + K+ G   A K +   S + LE+++ E+ +++   H  +V+L
Sbjct: 22  EIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKL 81
Query: 544 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL----YLHR 599
           LG      +  ++ E+ P  ++DA++ +      LD       I+ + R +L    +LH 
Sbjct: 82  LGAYYHDGKLWIMIEFCPGGAVDAIMLE------LDRGLTEPQIQVVCRQMLEALNFLHS 135
Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 659
               RIIHRDLKA N+L+  E + +++DFG++        + D+   +GT  +M+PE  M
Sbjct: 136 K---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVM 190
Query: 660 -----EGRFSEKSDVFSFGVLLLEIVS 681
                +  +  K+D++S G+ L+E+  
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQ 217

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 537
            +F+    LG+G F  V   R L   +E A+K L K        +     E  V+S+L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----FDPLKKERLDWRKRFNIIEGISR 592
              V+L     + E+      Y  N  L   +     FD       +   RF   E +S 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRFYTAEIVS- 141
Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 652
            L YLH      IIHRDLK  NILL+E+++ +I+DFG AK+      QA     VGT  Y
Sbjct: 142 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 653 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           +SPE   E    + SD+++ G ++ ++V+G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 107/222 (48%), Gaps = 25/222 (11%)
Query: 482 NNFQLSSKLGQGGFGPVYWG------RLKDGQEIAVKRLSK-ASGQGLEEFMNEVMVISK 534
           +  +L   LG+G FG V         +    + +AVK L + A+       M+E+ ++  
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 77
Query: 535 L-QHRNLVRLLGCCVE-GEEKMLIYEYMPNRSLDALL------FDPLKKERLDWRKRFNI 586
           +  H N+V LLG C + G   M+I E+    +L   L      F P K    D  K F  
Sbjct: 78  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 137
Query: 587 IEG-------ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 639
           +E        +++G+ +L   +  + IHRDL A NILL E+   KI DFG+A+    + D
Sbjct: 138 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD 194
Query: 640 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
               G       +M+PE   +  ++ +SDV+SFGVLL EI S
Sbjct: 195 XVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 537
            +F+    LG+G F  V   R L   +E A+K L K        +     E  V+S+L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----FDPLKKERLDWRKRFNIIEGISR 592
              V+L     + E+      Y  N  L   +     FD       +   RF   E +S 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRFYTAEIVS- 141
Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 652
            L YLH      IIHRDLK  NILL+E+++ +I+DFG AK+      QA     VGT  Y
Sbjct: 142 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 653 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           +SPE   E    + SD+++ G ++ ++V+G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 115/208 (55%), Gaps = 16/208 (7%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 535
             F+    LG G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ 
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 653
           YL  D RL  +HRDL A N+L+    + KI+DFG AK+ G  + +  A+ G+V     +M
Sbjct: 132 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV--PIKWM 186
Query: 654 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 115/208 (55%), Gaps = 16/208 (7%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 535
             F+    LG G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ 
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 133
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 653
           YL  D RL  +HRDL A N+L+    + KI+DFG AK+ G  + +  A+ G+V     +M
Sbjct: 134 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV--PIKWM 188
Query: 654 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 537
            +F+    LG+G F  V   R L   +E A+K L K        +     E  V+S+L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----FDPLKKERLDWRKRFNIIEGISR 592
              V+L     + E+      Y  N  L   +     FD       +   RF   E +S 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRFYTAEIVS- 141
Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 652
            L YLH      IIHRDLK  NILL+E+++ +I+DFG AK+      QA     VGT  Y
Sbjct: 142 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQY 198
Query: 653 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           +SPE   E    + SD+++ G ++ ++V+G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 113/229 (49%), Gaps = 37/229 (16%)
Query: 481 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 539
            ++F+  + LGQG FG V   R   D +  A+K++ + + + L   ++EVM+++ L H+ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQY 63
Query: 540 LVRLLGC------------CVEGEEKMLI-YEYMPNRSL-DALLFDPLKKERLD-WRKRF 584
           +VR                 V+ +  + I  EY  NR+L D +  + L ++R + WR   
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFR 123
Query: 585 NIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD----- 639
            I+E +S    Y+H      IIHRDLK  NI +DE  N KI DFG+AK    + D     
Sbjct: 124 QILEALS----YIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 640 -------QADTGRVVGTFGYMSPEYA-MEGRFSEKSDVFSFGVLLLEIV 680
                    +    +GT  Y++ E     G ++EK D++S G++  E++
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 537
            +F+    LG+G F  V   R L   +E A+K L K        +     E  V+S+L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----FDPLKKERLDWRKRFNIIEGISR 592
              V+L     + E+      Y  N  L   +     FD       +   RF   E +S 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRFYTAEIVS- 143
Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 652
            L YLH      IIHRDLK  NILL+E+++ +I+DFG AK+      QA     VGT  Y
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 653 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           +SPE   E    + SD+++ G ++ ++V+G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 537
            +F+    LG+G F  V   R L   +E A+K L K        +     E  V+S+L H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----FDPLKKERLDWRKRFNIIEGISR 592
              V+L     + E+      Y  N  L   +     FD       +   RF   E +S 
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRFYTAEIVS- 140
Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 652
            L YLH      IIHRDLK  NILL+E+++ +I+DFG AK+      QA     VGT  Y
Sbjct: 141 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 197
Query: 653 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           +SPE   E    + SD+++ G ++ ++V+G
Sbjct: 198 VSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 107/222 (48%), Gaps = 25/222 (11%)
Query: 482 NNFQLSSKLGQGGFGPVYWG------RLKDGQEIAVKRLSK-ASGQGLEEFMNEVMVISK 534
           +  +L   LG+G FG V         +    + +AVK L + A+       M+E+ ++  
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 77
Query: 535 L-QHRNLVRLLGCCVE-GEEKMLIYEYMPNRSLDALL------FDPLKKERLDWRKRFNI 586
           +  H N+V LLG C + G   M+I E+    +L   L      F P K    D  K F  
Sbjct: 78  IGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 137
Query: 587 IEG-------ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 639
           +E        +++G+ +L   +  + IHRDL A NILL E+   KI DFG+A+    + D
Sbjct: 138 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD 194
Query: 640 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
               G       +M+PE   +  ++ +SDV+SFGVLL EI S
Sbjct: 195 XVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 93/314 (29%), Positives = 154/314 (49%), Gaps = 36/314 (11%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSK---ASGQGLEEFMNEVMVISKL 535
           +  +FQ+   LG G FG V+  R + +G+  A+K L K      + +E   +E +++S +
Sbjct: 4   SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 63
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL-DWRKRFNIIEGISRGL 594
            H  ++R+ G   + ++  +I +Y+    L +LL    K +R  +   +F   E +   L
Sbjct: 64  THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL---RKSQRFPNPVAKFYAAE-VCLAL 119
Query: 595 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 654
            YLH      II+RDLK  NILLD+  + KI+DFG AK          T  + GT  Y++
Sbjct: 120 EYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYXLCGTPDYIA 171
Query: 655 PEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDP 714
           PE      +++  D +SFG+L+ E+++G   T F++ + T+  Y   L  E +      P
Sbjct: 172 PEVVSTKPYNKSIDWWSFGILIYEMLAGY--TPFYDSN-TMKTYEKILNAELRF----PP 224
Query: 715 FLSESSFQL--DMIIRCIHVGLLCVQ---ELVKDRPNMSTVV--SMLNSEIRDLPYPKEP 767
           F +E    L   +I R +   L  +Q   E VK+ P    VV   +L+   R++  P EP
Sbjct: 225 FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLS---RNIETPYEP 281
Query: 768 AFTERQGADDSESF 781
               +QG  D+  F
Sbjct: 282 PI--QQGQGDTSQF 293

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 537
            +F+    LG+G F  V   R L   +E A+K L K        +     E  V+S+L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----FDPLKKERLDWRKRFNIIEGISR 592
              V+L     + E+      Y  N  L   +     FD       +   RF   E +S 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRFYTAEIVS- 143
Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 652
            L YLH      IIHRDLK  NILL+E+++ +I+DFG AK+      QA     VGT  Y
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 653 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           +SPE   E    + SD+++ G ++ ++V+G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 101/205 (49%), Gaps = 9/205 (4%)
Query: 481 TNNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLS-KASGQGLEEFMNEVMVISKLQHR 538
             ++ L   LG+G  G V     +  +E +AVK +  K +    E    E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           N+V+  G   EG  + L  EY     L   +   +     D ++ F+    +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH 121
Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 658
               + I HRD+K  N+LLDE  N KISDFG+A +F  N  +    ++ GT  Y++PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 659 MEGRF-SEKSDVFSFGVLLLEIVSG 682
               F +E  DV+S G++L  +++G
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 537
            +F+    LG+G F  V   R L   +E A+K L K        +     E  V+S+L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----FDPLKKERLDWRKRFNIIEGISR 592
              V+L     + E+      Y  N  L   +     FD       +   RF   E +S 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRFYTAEIVS- 143
Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 652
            L YLH      IIHRDLK  NILL+E+++ +I+DFG AK+      QA     VGT  Y
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 653 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           +SPE   E    + SD+++ G ++ ++V+G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 115/208 (55%), Gaps = 16/208 (7%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 535
             F+    LG G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ +
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ 
Sbjct: 82  DNPHVCRLLGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 138
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 653
           YL  D RL  +HRDL A N+L+    + KI+DFG AK+ G  + +  A+ G+V     +M
Sbjct: 139 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV--PIKWM 193
Query: 654 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 194 ALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 537
            +F+    LG+G F  V   R L   +E A+K L K        +     E  V+S+L H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----FDPLKKERLDWRKRFNIIEGISR 592
              V+L     + E+      Y  N  L   +     FD       +   RF   E +S 
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRFYTAEIVS- 144
Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 652
            L YLH      IIHRDLK  NILL+E+++ +I+DFG AK+      QA     VGT  Y
Sbjct: 145 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 201
Query: 653 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           +SPE   E    + SD+++ G ++ ++V+G
Sbjct: 202 VSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 107/222 (48%), Gaps = 25/222 (11%)
Query: 482 NNFQLSSKLGQGGFGPVYWG------RLKDGQEIAVKRLSK-ASGQGLEEFMNEVMVISK 534
           +  +L   LG+G FG V         +    + +AVK L + A+       M+E+ ++  
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 535 L-QHRNLVRLLGCCVE-GEEKMLIYEYMPNRSLDALL------FDPLKKERLDWRKRFNI 586
           +  H N+V LLG C + G   M+I E+    +L   L      F P K    D  K F  
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 587 IEG-------ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 639
           +E        +++G+ +L   +  + IHRDL A NILL E+   KI DFG+A+    + D
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 203
Query: 640 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
               G       +M+PE   +  ++ +SDV+SFGVLL EI S
Sbjct: 204 XVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 115/208 (55%), Gaps = 16/208 (7%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 535
             F+    LG G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ 
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 133
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 653
           YL  D RL  +HRDL A N+L+    + KI+DFG AK+ G  + +  A+ G+V     +M
Sbjct: 134 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV--PIKWM 188
Query: 654 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 537
            +F+    LG+G F  V   R L   +E A+K L K        +     E  V+S+L H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----FDPLKKERLDWRKRFNIIEGISR 592
              V+L     + E+      Y  N  L   +     FD       +   RF   E +S 
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRFYTAEIVS- 144
Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 652
            L YLH      IIHRDLK  NILL+E+++ +I+DFG AK+      QA     VGT  Y
Sbjct: 145 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 201
Query: 653 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           +SPE   E    + SD+++ G ++ ++V+G
Sbjct: 202 VSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 537
            +F+    LG+G F  V   R L   +E A+K L K        +     E  V+S+L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----FDPLKKERLDWRKRFNIIEGISR 592
              V+L     + E+      Y  N  L   +     FD       +   RF   E +S 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRFYTAEIVS- 143
Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 652
            L YLH      IIHRDLK  NILL+E+++ +I+DFG AK+      QA     VGT  Y
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 653 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           +SPE   E    + SD+++ G ++ ++V+G
Sbjct: 201 VSPELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 537
            +F+    LG+G F  V   R L   +E A+K L K        +     E  V+S+L H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----FDPLKKERLDWRKRFNIIEGISR 592
              V+L     + E+      Y  N  L   +     FD       +   RF   E +S 
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRFYTAEIVS- 146
Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 652
            L YLH      IIHRDLK  NILL+E+++ +I+DFG AK+      QA     VGT  Y
Sbjct: 147 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 203
Query: 653 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           +SPE   E    + SD+++ G ++ ++V+G
Sbjct: 204 VSPELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 537
            +F+    LG+G F  V   R L   +E A+K L K        +     E  V+S+L H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----FDPLKKERLDWRKRFNIIEGISR 592
              V+L     + E+      Y  N  L   +     FD       +   RF   E +S 
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRFYTAEIVS- 140
Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 652
            L YLH      IIHRDLK  NILL+E+++ +I+DFG AK+      QA     VGT  Y
Sbjct: 141 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 197
Query: 653 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           +SPE   E    + SD+++ G ++ ++V+G
Sbjct: 198 VSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 112/202 (55%), Gaps = 20/202 (9%)
Query: 490 LGQGGFGPVYWGR-LKDGQEI----AVKRLSK-ASGQGLEEFMNEVMVISKLQHRNLVRL 543
           LG G FG VY G  + DG+ +    A+K L +  S +  +E ++E  V++ +    + RL
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 544 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER--LDWRKRFNIIEGISRGLLYLHRDS 601
           LG C+    + L+ + MP       L D +++ R  L  +   N    I++G+ YL    
Sbjct: 85  LGICLTSTVQ-LVTQLMPY----GCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLED-- 137
Query: 602 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYMSPEYAM 659
            +R++HRDL A N+L+    + KI+DFG+A++   ++ +  AD G+V     +M+ E  +
Sbjct: 138 -VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV--PIKWMALESIL 194
Query: 660 EGRFSEKSDVFSFGVLLLEIVS 681
             RF+ +SDV+S+GV + E+++
Sbjct: 195 RRRFTHQSDVWSYGVTVWELMT 216

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 537
            +F+    LG+G F  V   R L   +E A+K L K        +     E  V+S+L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----FDPLKKERLDWRKRFNIIEGISR 592
              V+L     + E+      Y  N  L   +     FD       +   RF   E +S 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRFYTAEIVS- 143
Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 652
            L YLH      IIHRDLK  NILL+E+++ +I+DFG AK+      QA     VGT  Y
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 653 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           +SPE   E    + SD+++ G ++ ++V+G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 115/208 (55%), Gaps = 16/208 (7%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 535
             F+    LG G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ 
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 133
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 653
           YL  D RL  +HRDL A N+L+    + KI+DFG AK+ G  + +  A+ G+V     +M
Sbjct: 134 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV--PIKWM 188
Query: 654 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 107/222 (48%), Gaps = 25/222 (11%)
Query: 482 NNFQLSSKLGQGGFGPVYWG------RLKDGQEIAVKRLSK-ASGQGLEEFMNEVMVISK 534
           +  +L   LG+G FG V         +    + +AVK L + A+       M+E+ ++  
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 535 L-QHRNLVRLLGCCVE-GEEKMLIYEYMPNRSLDALL------FDPLKKERLDWRKRFNI 586
           +  H N+V LLG C + G   M+I E+    +L   L      F P K    D  K F  
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 587 IEG-------ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 639
           +E        +++G+ +L   +  + IHRDL A NILL E+   KI DFG+A+    + D
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 203
Query: 640 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
               G       +M+PE   +  ++ +SDV+SFGVLL EI S
Sbjct: 204 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 112/225 (49%), Gaps = 12/225 (5%)
Query: 483 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLS---KASGQGLEEFMNEVMVISKLQHR 538
           NF++  K+G+G F  VY    L DG  +A+K++        +   + + E+ ++ +L H 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL-DWRKRFNIIEGISRGLLYL 597
           N+++     +E  E  ++ E      L  ++    K++RL   R  +     +   L ++
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152
Query: 598 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEY 657
           H  SR R++HRD+K +N+ +      K+ D G+ + F      A +  +VGT  YMSPE 
Sbjct: 153 H--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPER 207
Query: 658 AMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKL 702
             E  ++ KSD++S G LL E+ + +  + F+ D + +     K+
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQ--SPFYGDKMNLYSLCKKI 250

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/222 (31%), Positives = 108/222 (48%), Gaps = 27/222 (12%)
Query: 482 NNFQLSSKLGQGGFGPVYWG------RLKDGQEIAVKRLSK-ASGQGLEEFMNEVMVISK 534
           +  +L   LG+G FG V         +    + +AVK L + A+       M+E+ ++  
Sbjct: 29  DRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIH 88
Query: 535 L-QHRNLVRLLGCCVE-GEEKMLIYEYMPNRSLDALL------FDPLKKERLDWRKRFNI 586
           +  H N+V LLG C + G   M+I E+    +L   L      F P K E  D  K F  
Sbjct: 89  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPE--DLYKDFLT 146
Query: 587 IEG-------ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 639
           +E        +++G+ +L   +  + IHRDL A NILL E+   KI DFG+A+    + D
Sbjct: 147 LEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD 203
Query: 640 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
               G       +M+PE   +  ++ +SDV+SFGVLL EI S
Sbjct: 204 XVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 107/222 (48%), Gaps = 25/222 (11%)
Query: 482 NNFQLSSKLGQGGFGPVYWG------RLKDGQEIAVKRLSK-ASGQGLEEFMNEVMVISK 534
           +  +L   LG+G FG V         +    + +AVK L + A+       M+E+ ++  
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 77
Query: 535 L-QHRNLVRLLGCCVE-GEEKMLIYEYMPNRSLDALL------FDPLKKERLDWRKRFNI 586
           +  H N+V LLG C + G   M+I E+    +L   L      F P K    D  K F  
Sbjct: 78  IGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 137
Query: 587 IEG-------ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 639
           +E        +++G+ +L   +  + IHRDL A NILL E+   KI DFG+A+    + D
Sbjct: 138 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 194
Query: 640 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
               G       +M+PE   +  ++ +SDV+SFGVLL EI S
Sbjct: 195 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 107/222 (48%), Gaps = 25/222 (11%)
Query: 482 NNFQLSSKLGQGGFGPVYWG------RLKDGQEIAVKRLSK-ASGQGLEEFMNEVMVISK 534
           +  +L   LG+G FG V         +    + +AVK L + A+       M+E+ ++  
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 77
Query: 535 L-QHRNLVRLLGCCVE-GEEKMLIYEYMPNRSLDALL------FDPLKKERLDWRKRFNI 586
           +  H N+V LLG C + G   M+I E+    +L   L      F P K    D  K F  
Sbjct: 78  IGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 137
Query: 587 IEG-------ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 639
           +E        +++G+ +L   +  + IHRDL A NILL E+   KI DFG+A+    + D
Sbjct: 138 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 194
Query: 640 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
               G       +M+PE   +  ++ +SDV+SFGVLL EI S
Sbjct: 195 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 108/212 (50%), Gaps = 17/212 (8%)
Query: 478 ATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSK---ASGQGLEEFMNEVMVIS 533
           A  ++ ++    LG+G FG V   + K  GQE AVK +SK         E  + EV ++ 
Sbjct: 22  AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 81
Query: 534 KLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRG 593
           +L H N+ +L       E+K   Y      +   L  + + ++R        II  +  G
Sbjct: 82  QLDHPNIXKLYEFF---EDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSG 138
Query: 594 LLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKIFGGNQDQADTGRVVGTF 650
           + Y H++   +I+HRDLK  N+LL+   ++ N +I DFG++  F  ++   D    +GT 
Sbjct: 139 ITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDK---IGTA 192
Query: 651 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
            Y++PE  + G + EK DV+S GV+L  ++SG
Sbjct: 193 YYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 107/209 (51%), Gaps = 21/209 (10%)
Query: 483 NFQLSSKLGQGGFGPVYWG-RLKDGQEIAVK-----RLSKASGQGLEEFMNEVMVISKLQ 536
           N+Q+   LG+G FG V        GQ++A+K      L+K+  QG  E   E+  +  L+
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 71
Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 596
           H ++++L       +E +++ EY  N   D ++    +++++  ++     + I   + Y
Sbjct: 72  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQIISAVEY 127
Query: 597 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 656
            HR    +I+HRDLK  N+LLDE LN KI+DFG++ I     D        G+  Y +PE
Sbjct: 128 CHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM---TDGNFLKTSCGSPNYAAPE 181
Query: 657 YAMEGRF--SEKSDVFSFGVLLLEIVSGR 683
             + G+     + DV+S GV+L  ++  R
Sbjct: 182 -VISGKLYAGPEVDVWSCGVILYVMLCRR 209

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 107/209 (51%), Gaps = 21/209 (10%)
Query: 483 NFQLSSKLGQGGFGPVYWG-RLKDGQEIAVK-----RLSKASGQGLEEFMNEVMVISKLQ 536
           N+Q+   LG+G FG V        GQ++A+K      L+K+  QG  E   E+  +  L+
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 66
Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 596
           H ++++L       +E +++ EY  N   D ++    +++++  ++     + I   + Y
Sbjct: 67  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQIISAVEY 122
Query: 597 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 656
            HR    +I+HRDLK  N+LLDE LN KI+DFG++ I     D        G+  Y +PE
Sbjct: 123 CHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM---TDGNFLKTSCGSPNYAAPE 176
Query: 657 YAMEGRF--SEKSDVFSFGVLLLEIVSGR 683
             + G+     + DV+S GV+L  ++  R
Sbjct: 177 -VISGKLYAGPEVDVWSCGVILYVMLCRR 204

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 107/209 (51%), Gaps = 21/209 (10%)
Query: 483 NFQLSSKLGQGGFGPVYWG-RLKDGQEIAVK-----RLSKASGQGLEEFMNEVMVISKLQ 536
           N+Q+   LG+G FG V        GQ++A+K      L+K+  QG  E   E+  +  L+
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 62
Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 596
           H ++++L       +E +++ EY  N   D ++    +++++  ++     + I   + Y
Sbjct: 63  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQIISAVEY 118
Query: 597 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 656
            HR    +I+HRDLK  N+LLDE LN KI+DFG++ I     D        G+  Y +PE
Sbjct: 119 CHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM---TDGNFLKTSCGSPNYAAPE 172
Query: 657 YAMEGRF--SEKSDVFSFGVLLLEIVSGR 683
             + G+     + DV+S GV+L  ++  R
Sbjct: 173 -VISGKLYAGPEVDVWSCGVILYVMLCRR 200

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/224 (31%), Positives = 110/224 (49%), Gaps = 36/224 (16%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLK-DG--QEIAVKRLSK-ASGQGLEEFMNEVMVISKL-Q 536
           N+ +    +G+G FG V   R+K DG   + A+KR+ + AS     +F  E+ V+ KL  
Sbjct: 22  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 81
Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER-----------------LD 579
           H N++ LLG C       L  EY P+ +L     D L+K R                 L 
Sbjct: 82  HPNIINLLGACEHRGYLYLAIEYAPHGNL----LDFLRKSRVLETDPAFAIANSTASTLS 137
Query: 580 WRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 639
            ++  +    ++RG+ YL   S+ + IHR+L A NIL+ E    KI+DFG+++       
Sbjct: 138 SQQLLHFAADVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSR-----GQ 189
Query: 640 QADTGRVVGTFG--YMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           +    + +G     +M+ E      ++  SDV+S+GVLL EIVS
Sbjct: 190 EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 115/208 (55%), Gaps = 16/208 (7%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 535
             F+    L  G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ +
Sbjct: 15  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ 
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 653
           YL  D RL  +HRDL A N+L+    + KI+DFG+AK+ G  + +  A+ G+V     +M
Sbjct: 132 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 186
Query: 654 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 107/209 (51%), Gaps = 21/209 (10%)
Query: 483 NFQLSSKLGQGGFGPVYWG-RLKDGQEIAVK-----RLSKASGQGLEEFMNEVMVISKLQ 536
           N+Q+   LG+G FG V        GQ++A+K      L+K+  QG  E   E+  +  L+
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 72
Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 596
           H ++++L       +E +++ EY  N   D ++    +++++  ++     + I   + Y
Sbjct: 73  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQIISAVEY 128
Query: 597 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 656
            HR    +I+HRDLK  N+LLDE LN KI+DFG++ I     D        G+  Y +PE
Sbjct: 129 CHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM---TDGNFLKTSCGSPNYAAPE 182
Query: 657 YAMEGRF--SEKSDVFSFGVLLLEIVSGR 683
             + G+     + DV+S GV+L  ++  R
Sbjct: 183 -VISGKLYAGPEVDVWSCGVILYVMLCRR 210

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 115/208 (55%), Gaps = 16/208 (7%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 535
             F+    L  G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ +
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ 
Sbjct: 82  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 138
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 653
           YL  D RL  +HRDL A N+L+    + KI+DFG+AK+ G  + +  A+ G+V     +M
Sbjct: 139 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 193
Query: 654 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 194 ALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 107/222 (48%), Gaps = 25/222 (11%)
Query: 482 NNFQLSSKLGQGGFGPVYWG------RLKDGQEIAVKRLSK-ASGQGLEEFMNEVMVISK 534
           +  +L   LG+G FG V         +    + +AVK L + A+       M+E+ ++  
Sbjct: 64  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 123
Query: 535 L-QHRNLVRLLGCCVE-GEEKMLIYEYMPNRSLDALL------FDPLKKERLDWRKRFNI 586
           +  H N+V LLG C + G   M+I E+    +L   L      F P K    D  K F  
Sbjct: 124 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 183
Query: 587 IEG-------ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 639
           +E        +++G+ +L   +  + IHRDL A NILL E+   KI DFG+A+    + D
Sbjct: 184 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 240
Query: 640 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
               G       +M+PE   +  ++ +SDV+SFGVLL EI S
Sbjct: 241 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 108/201 (53%), Gaps = 11/201 (5%)
Query: 489 KLGQGGFGPVYWG-RLKDGQEIAVKRLS-KASGQGLEEFMNEVMVISKLQHRNLVRLLGC 546
           ++G+G FG V+ G   +  Q +A+K +  + +   +E+   E+ V+S+     + +  G 
Sbjct: 30  RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYGS 89
Query: 547 CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRII 606
            ++G +  +I EY+   S      D L+    D  +   +++ I +GL YLH + +   I
Sbjct: 90  YLKGSKLWIIMEYLGGGSA----LDLLRAGPFDEFQIATMLKEILKGLDYLHSEKK---I 142
Query: 607 HRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEK 666
           HRD+KA+N+LL E+ + K++DFG+A      Q + +T   VGT  +M+PE   +  +  K
Sbjct: 143 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQQSAYDSK 200
Query: 667 SDVFSFGVLLLEIVSGRKNTS 687
           +D++S G+  +E+  G    S
Sbjct: 201 ADIWSLGITAIELAKGEPPNS 221

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 106/206 (51%), Gaps = 17/206 (8%)
Query: 483 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRN 539
           N++L   +G+G F  V   R +  G+E+AVK + K   +   L++   EV ++  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 540 LVRLLGCCVEGEEKMLIYEYMPN-RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           +V+L       +   L+ EY       D L+     KE+ + R +F     I   + Y H
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK-EARAKF---RQIVSAVQYCH 130
Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG-GNQDQADTGRVVGTFGYMSPEY 657
           +     I+HRDLKA N+LLD ++N KI+DFG +  F  GN  + DT    G+  Y +PE 
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN--KLDT--FCGSPPYAAPEL 183
Query: 658 AMEGRFS-EKSDVFSFGVLLLEIVSG 682
               ++   + DV+S GV+L  +VSG
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 106/206 (51%), Gaps = 17/206 (8%)
Query: 483 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRN 539
           N++L   +G+G F  V   R +  G+E+AVK + K   +   L++   EV ++  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 540 LVRLLGCCVEGEEKMLIYEYMPN-RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           +V+L       +   L+ EY       D L+     KE+ + R +F     I   + Y H
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK-EARAKFR---QIVSAVQYCH 130
Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG-GNQDQADTGRVVGTFGYMSPEY 657
           +     I+HRDLKA N+LLD ++N KI+DFG +  F  GN  + DT    G+  Y +PE 
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN--KLDT--FCGSPPYAAPEL 183
Query: 658 AMEGRFS-EKSDVFSFGVLLLEIVSG 682
               ++   + DV+S GV+L  +VSG
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 104/206 (50%), Gaps = 17/206 (8%)
Query: 483 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRN 539
           N++L   +G+G F  V   R +  G+E+AVK + K   +   L++   EV ++  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 540 LVRLLGCCVEGEEKMLIYEYMPN-RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           +V+L       +   L+ EY       D L+     KE+ + R +F     I   + Y H
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK-EARAKFR---QIVSAVQYCH 130
Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG-GNQDQADTGRVVGTFGYMSPEY 657
           +     I+HRDLKA N+LLD ++N KI+DFG +  F  GN+  A      G   Y +PE 
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDA----FCGAPPYAAPEL 183
Query: 658 AMEGRFS-EKSDVFSFGVLLLEIVSG 682
               ++   + DV+S GV+L  +VSG
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 115/208 (55%), Gaps = 16/208 (7%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 535
             F+    L  G FG VY G  + +G+++    A+K L +A S +  +E ++E  V++ +
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ 
Sbjct: 82  DNPHVCRLLGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 138
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 653
           YL  D RL  +HRDL A N+L+    + KI+DFG+AK+ G  + +  A+ G+V     +M
Sbjct: 139 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 193
Query: 654 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 194 ALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 106/206 (51%), Gaps = 17/206 (8%)
Query: 483 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRN 539
           N++L   +G+G F  V   R +  G+E+AVK + K   +   L++   EV ++  L H N
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 540 LVRLLGCCVEGEEKMLIYEYMPN-RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           +V+L       +   L+ EY       D L+     KE+ + R +F     I   + Y H
Sbjct: 76  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK-EARAKFR---QIVSAVQYCH 131
Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG-GNQDQADTGRVVGTFGYMSPEY 657
           +     I+HRDLKA N+LLD ++N KI+DFG +  F  GN  + DT    G+  Y +PE 
Sbjct: 132 QKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGN--KLDT--FCGSPPYAAPEL 184
Query: 658 AMEGRFS-EKSDVFSFGVLLLEIVSG 682
               ++   + DV+S GV+L  +VSG
Sbjct: 185 FQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/227 (30%), Positives = 107/227 (47%), Gaps = 31/227 (13%)
Query: 483 NFQLSSKLGQGGFGPVY----WGRLKDGQ--EIAVKRL-SKASGQGLEEFMNEVMVISKL 535
           N +    LG G FG V     +G  K G   ++AVK L  KA     E  M+E+ ++++L
Sbjct: 46  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 105
Query: 536 -QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKK-----------ERLDWRKR 583
             H N+V LLG C       LI+EY     L   L    +K           +RL+  + 
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 584 FNIIE---------GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 634
            N++           +++G+ +L   S    +HRDL A N+L+      KI DFG+A+  
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDI 222
Query: 635 GGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
             + +    G       +M+PE   EG ++ KSDV+S+G+LL EI S
Sbjct: 223 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 97/210 (46%), Gaps = 20/210 (9%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 537
            +F+    LG+G F      R L   +E A+K L K        +     E  V+S+L H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----FDPLKKERLDWRKRFNIIEGISR 592
              V+L     + E+      Y  N  L   +     FD       +   RF   E +S 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-------ETCTRFYTAEIVS- 141
Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 652
            L YLH      IIHRDLK  NILL+E+++ +I+DFG AK+      QA     VGT  Y
Sbjct: 142 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 653 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           +SPE   E    + SD+++ G ++ ++V+G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 115/208 (55%), Gaps = 16/208 (7%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKL 535
             F+    LG G FG VY G  + +G+++    A+  L +A S +  +E ++E  V++ +
Sbjct: 49  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASV 108
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
            + ++ RLLG C+    + LI + MP   L  L +    K+ +  +   N    I++G+ 
Sbjct: 109 DNPHVCRLLGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 165
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVGTFGYM 653
           YL  D RL  +HRDL A N+L+    + KI+DFG+AK+ G  + +  A+ G+V     +M
Sbjct: 166 YLE-DRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 220
Query: 654 SPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           + E  +   ++ +SDV+S+GV + E+++
Sbjct: 221 ALESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 106/206 (51%), Gaps = 17/206 (8%)
Query: 483 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRN 539
           N++L   +G+G F  V   R +  G+E+AVK + K   +   L++   EV ++  L H N
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 67
Query: 540 LVRLLGCCVEGEEKMLIYEYMPN-RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           +V+L       +   L+ EY       D L+     KE+ + R +F     I   + Y H
Sbjct: 68  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEK-EARAKFR---QIVSAVQYCH 123
Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG-GNQDQADTGRVVGTFGYMSPEY 657
           +     I+HRDLKA N+LLD ++N KI+DFG +  F  GN  + DT    G+  Y +PE 
Sbjct: 124 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN--KLDT--FCGSPPYAAPEL 176
Query: 658 AMEGRFS-EKSDVFSFGVLLLEIVSG 682
               ++   + DV+S GV+L  +VSG
Sbjct: 177 FQGKKYDGPEVDVWSLGVILYTLVSG 202

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 108/211 (51%), Gaps = 27/211 (12%)
Query: 489 KLGQGGFGPVYWGRLKDGQ-EIAVKRLSKAS-------------GQGLEEFMNEVMVISK 534
           KLG G +G V   + K+G  E A+K + K+               +  EE  NE+ ++  
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 535 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 594
           L H N+++L     + +   L+ E+     L   +   + + + D     NI++ I  G+
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI---INRHKFDECDAANIMKQILSGI 159
Query: 595 LYLHRDSRLRIIHRDLKASNILLDEE---LNPKISDFGMAKIFGGNQDQADTGRVVGTFG 651
            YLH+ +   I+HRD+K  NILL+ +   LN KI DFG++  F  +    D    +GT  
Sbjct: 160 CYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDR---LGTAY 213
Query: 652 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           Y++PE  ++ +++EK DV+S GV++  ++ G
Sbjct: 214 YIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 483 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRN 539
           N++L   +G+G F  V   R +  G+E+AV+ + K   +   L++   EV ++  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 540 LVRLLGCCVEGEEKMLIYEYMPN-RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           +V+L       +   L+ EY       D L+     KE+ + R +F     I   + Y H
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK-EARAKFR---QIVSAVQYCH 130
Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAK--IFGGNQDQADTGRVVGTFGYMSPE 656
           +     I+HRDLKA N+LLD ++N KI+DFG +    FG   D+       G+  Y +PE
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDE-----FCGSPPYAAPE 182
Query: 657 YAMEGRFS-EKSDVFSFGVLLLEIVSG 682
                ++   + DV+S GV+L  +VSG
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/202 (33%), Positives = 98/202 (48%), Gaps = 18/202 (8%)
Query: 490 LGQGGFGPVY---WGRLKDG--QEIAVKRLSKASGQGLEE-FMNEVMVISKLQHRNLVRL 543
           LG+G FG V    +    DG  + +AVK L +  G  L   +  E+ ++  L H ++V+ 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 544 LGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
            GCC +  EK   L+ EY+P  SL     D L +  +   +     + I  G+ YLH   
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLR----DYLPRHCVGLAQLLLFAQQICEGMAYLHAQ- 131
Query: 602 RLRIIHRDLKASNILLDEELNPKISDFGMAKIF--GGNQDQADTGRVVGTFGYMSPEYAM 659
               IHR L A N+LLD +   KI DFG+AK    G    +         F Y +PE   
Sbjct: 132 --HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLK 188
Query: 660 EGRFSEKSDVFSFGVLLLEIVS 681
           E +F   SDV+SFGV L E+++
Sbjct: 189 ECKFYYASDVWSFGVTLYELLT 210

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/202 (33%), Positives = 98/202 (48%), Gaps = 18/202 (8%)
Query: 490 LGQGGFGPVY---WGRLKDG--QEIAVKRLSKASGQGLEE-FMNEVMVISKLQHRNLVRL 543
           LG+G FG V    +    DG  + +AVK L +  G  L   +  E+ ++  L H ++V+ 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 544 LGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
            GCC +  EK   L+ EY+P  SL     D L +  +   +     + I  G+ YLH   
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLR----DYLPRHCVGLAQLLLFAQQICEGMAYLHAQ- 130
Query: 602 RLRIIHRDLKASNILLDEELNPKISDFGMAKIF--GGNQDQADTGRVVGTFGYMSPEYAM 659
               IHR L A N+LLD +   KI DFG+AK    G    +         F Y +PE   
Sbjct: 131 --HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLK 187
Query: 660 EGRFSEKSDVFSFGVLLLEIVS 681
           E +F   SDV+SFGV L E+++
Sbjct: 188 ECKFYYASDVWSFGVTLYELLT 209

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 106/206 (51%), Gaps = 17/206 (8%)
Query: 483 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRN 539
           N++L   +G+G F  V   R +  G+E+AV+ + K   +   L++   EV ++  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 540 LVRLLGCCVEGEEKMLIYEYMPN-RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           +V+L       +   L+ EY       D L+     KE+ + R +F     I   + Y H
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK-EARAKFR---QIVSAVQYCH 130
Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG-GNQDQADTGRVVGTFGYMSPEY 657
           +     I+HRDLKA N+LLD ++N KI+DFG +  F  GN  + DT    G+  Y +PE 
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN--KLDT--FCGSPPYAAPEL 183
Query: 658 AMEGRFS-EKSDVFSFGVLLLEIVSG 682
               ++   + DV+S GV+L  +VSG
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 119/234 (50%), Gaps = 18/234 (7%)
Query: 457 SATNVNTVKLQDLPLFQFEELATATNN---FQLSSKLGQGGFGPVYWGRLKDGQEIAV-K 512
           S  ++ T  L    + Q+E +    N    +++  +LG G FG VY  + K+   +A  K
Sbjct: 9   SGVDLGTENLYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAK 68
Query: 513 RLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDP 572
            +   S + LE++M E+ +++   H N+V+LL          ++ E+    ++DA++   
Sbjct: 69  VIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVM--- 125
Query: 573 LKKERLDWRKRFNII-EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 631
           L+ ER     +  ++ +     L YLH +   +IIHRDLKA NIL   + + K++DFG++
Sbjct: 126 LELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVS 182
Query: 632 KIFGGNQDQADTGRVVGTFGYMSPEYAM-----EGRFSEKSDVFSFGVLLLEIV 680
                   + D+   +GT  +M+PE  M     +  +  K+DV+S G+ L+E+ 
Sbjct: 183 AKNTRTIQRRDS--FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA 234

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 482 NNFQLSSKLGQGGFGPVYWG--------RLKDGQEIAVKRLSK-ASGQGLEEFMNEVMVI 532
           +   L   LG+G FG V           + K+   +AVK L   A+ + L + ++E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 533 SKL-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-------------FDPLKKERL 578
             + +H+N++ LLG C +     +I EY    +L   L              + + +E++
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQM 154
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
            ++   +    ++RG+ YL   +  + IHRDL A N+L+ E    KI+DFG+A+      
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 639 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
               T        +M+PE   +  ++ +SDV+SFGVL+ EI +
Sbjct: 212 XXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 482 NNFQLSSKLGQGGFGPVYWG--------RLKDGQEIAVKRLSK-ASGQGLEEFMNEVMVI 532
           +   L   LG+G FG V           + K+   +AVK L   A+ + L + ++E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 533 SKL-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-------------FDPLKKERL 578
             + +H+N++ LLG C +     +I EY    +L   L              + + +E++
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
            ++   +    ++RG+ YL   +  + IHRDL A N+L+ E    KI+DFG+A+      
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 639 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
               T        +M+PE   +  ++ +SDV+SFGVL+ EI +
Sbjct: 212 XXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 110/225 (48%), Gaps = 36/225 (16%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNE--VMVISKLQHRN 539
           +N +L   +G+G +G VY G L D + +AVK  S A+ Q    F+NE  +  +  ++H N
Sbjct: 13  DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQN---FINEKNIYRVPLMEHDN 68
Query: 540 LVRLL----GCCVEGE-EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 594
           + R +        +G  E +L+ EY PN SL   L         DW     +   ++RGL
Sbjct: 69  IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSCRLAHSVTRGL 124
Query: 595 LYLHRD------SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ----DQADTG 644
            YLH +       +  I HRDL + N+L+  +    ISDFG++    GN+     + D  
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184
Query: 645 RV--VGTFGYMSPEYAMEGRFS--------EKSDVFSFGVLLLEI 679
            +  VGT  YM+PE  +EG  +        ++ D+++ G++  EI
Sbjct: 185 AISEVGTIRYMAPE-VLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 109/223 (48%), Gaps = 26/223 (11%)
Query: 482 NNFQLSSKLGQGGFGPVYWG--------RLKDGQEIAVKRLSK-ASGQGLEEFMNEVMVI 532
           +   L   LG+G FG V           + K+   +AVK L   A+ + L + ++E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 533 SKL-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-------------FDPLKKERL 578
             + +H+N++ LLG C +     +I EY    +L   L              + + +E++
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
            ++   +    ++RG+ YL   +  + IHRDL A N+L+ E    KI+DFG+A+      
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 639 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
              +T        +M+PE   +  ++ +SDV+SFGVL+ EI +
Sbjct: 212 YYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 109/207 (52%), Gaps = 13/207 (6%)
Query: 484 FQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLS-KASGQGLEEFMNEVMVISKLQHRNLV 541
           F    ++G+G FG VY G     +E+ A+K +  + +   +E+   E+ V+S+     + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 542 RLLGCCVEGEEKMLIYEYMPNRS-LDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 600
           R  G  ++  +  +I EY+   S LD L   PL++  +       I+  I +GL YLH +
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIA-----TILREILKGLDYLHSE 135
Query: 601 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
              R IHRD+KA+N+LL E+ + K++DFG+A      Q + +    VGT  +M+PE   +
Sbjct: 136 ---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNX--FVGTPFWMAPEVIKQ 190
Query: 661 GRFSEKSDVFSFGVLLLEIVSGRKNTS 687
             +  K+D++S G+  +E+  G    S
Sbjct: 191 SAYDFKADIWSLGITAIELAKGEPPNS 217

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 106/222 (47%), Gaps = 26/222 (11%)
Query: 482 NNFQLSSKLGQGGFGPVYWG------RLKDGQEIAVKRLSK-ASGQGLEEFMNEVMVISK 534
           +   L   LG+G FG V         +    + +AVK L + A+       M+E+ ++  
Sbjct: 28  DRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 87
Query: 535 L-QHRNLVRLLGCCVE-GEEKMLIYEYMPNRSLDALL------FDPLKKERLDWRKRFNI 586
           +  H N+V LLG C + G   M+I E+    +L   L      F P K    D  K F  
Sbjct: 88  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPE-DLYKDFLT 146
Query: 587 IEG-------ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 639
           +E        +++G+ +L   +  + IHRDL A NILL E+   KI DFG+A+    + D
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD 203
Query: 640 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
               G       +M+PE   +  ++ +SDV+SFGVLL EI S
Sbjct: 204 XVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 119/234 (50%), Gaps = 18/234 (7%)
Query: 457 SATNVNTVKLQDLPLFQFEELATATNN---FQLSSKLGQGGFGPVYWGRLKDGQEIAV-K 512
           S  ++ T  L    + Q+E +    N    +++  +LG G FG VY  + K+   +A  K
Sbjct: 9   SGVDLGTENLYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAK 68
Query: 513 RLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDP 572
            +   S + LE++M E+ +++   H N+V+LL          ++ E+    ++DA++   
Sbjct: 69  VIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVM--- 125
Query: 573 LKKERLDWRKRFNII-EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 631
           L+ ER     +  ++ +     L YLH +   +IIHRDLKA NIL   + + K++DFG++
Sbjct: 126 LELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVS 182
Query: 632 KIFGGNQDQADTGRVVGTFGYMSPEYAM-----EGRFSEKSDVFSFGVLLLEIV 680
                   + D+   +GT  +M+PE  M     +  +  K+DV+S G+ L+E+ 
Sbjct: 183 AKNTRXIQRRDS--FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA 234

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 483 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRN 539
           N++L   +G+G F  V   R +  G+E+AVK + K   +   L++   EV +   L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPN 74
Query: 540 LVRLLGCCVEGEEKMLIYEYMPN-RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           +V+L       +   L+ EY       D L+     KE+ + R +F     I   + Y H
Sbjct: 75  IVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEK-EARAKFR---QIVSAVQYCH 130
Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG-GNQDQADTGRVVGTFGYMSPEY 657
           +     I+HRDLKA N+LLD + N KI+DFG +  F  GN+  A      G   Y +PE 
Sbjct: 131 QKF---IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDA----FCGAPPYAAPEL 183
Query: 658 AMEGRFS-EKSDVFSFGVLLLEIVSG 682
               ++   + DV+S GV+L  +VSG
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 110/219 (50%), Gaps = 26/219 (11%)
Query: 486 LSSKLGQGGFGPVYW----GRLKDG----QEIAVKRL-SKASGQGLEEFMNEVMVISKL- 535
           L   LG+G FG V      G  KD      ++AVK L S A+ + L + ++E+ ++  + 
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----------FDPLK--KERLDWRK 582
           +H+N++ LLG C +     +I EY    +L   L           F+P    +E+L  + 
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKD 151
Query: 583 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD 642
             +    ++RG+ YL   +  + IHRDL A N+L+ E+   KI+DFG+A+          
Sbjct: 152 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKK 208
Query: 643 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           T        +M+PE   +  ++ +SDV+SFGVLL EI +
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 482 NNFQLSSKLGQGGFGPVYWG--------RLKDGQEIAVKRLSK-ASGQGLEEFMNEVMVI 532
           +   L   LG+G FG V           + K+   +AVK L   A+ + L + ++E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 533 SKL-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-------------FDPLKKERL 578
             + +H+N++ LLG C +     +I EY    +L   L              + + +E++
Sbjct: 95  KMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
            ++   +    ++RG+ YL   +  + IHRDL A N+L+ E    KI+DFG+A+      
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 639 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
               T        +M+PE   +  ++ +SDV+SFGVL+ EI +
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 117/244 (47%), Gaps = 31/244 (12%)
Query: 461 VNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWG--------RLKDGQEIAVK 512
           V+  +L + P ++F       +   L   LG+G FG V           + K+   +AVK
Sbjct: 19  VSEYELPEDPKWEF-----PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK 73
Query: 513 RLSK-ASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL- 569
            L   A+ + L + ++E+ ++  + +H+N++ LLG C +     +I EY    +L   L 
Sbjct: 74  MLKDDATEEDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLR 133
Query: 570 ------------FDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
                        + + +E++ ++   +    ++RG+ YL   +  + IHRDL A N+L+
Sbjct: 134 ARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLV 190
Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
            E    KI+DFG+A+          T        +M+PE   +  ++ +SDV+SFGVL+ 
Sbjct: 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW 250
Query: 678 EIVS 681
           EI +
Sbjct: 251 EIFT 254

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 482 NNFQLSSKLGQGGFGPVYWG--------RLKDGQEIAVKRLSK-ASGQGLEEFMNEVMVI 532
           +   L   LG+G FG V           + K+   +AVK L   A+ + L + ++E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 533 SKL-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-------------FDPLKKERL 578
             + +H+N++ LLG C +     +I EY    +L   L              + + +E++
Sbjct: 95  KMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
            ++   +    ++RG+ YL   +  + IHRDL A N+L+ E    KI+DFG+A+      
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 639 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
               T        +M+PE   +  ++ +SDV+SFGVL+ EI +
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 118/234 (50%), Gaps = 18/234 (7%)
Query: 457 SATNVNTVKLQDLPLFQFEELATATNN---FQLSSKLGQGGFGPVYWGRLKDGQEIAV-K 512
           S  ++ T  L    + Q+E +    N    +++  +LG G FG VY  + K+   +A  K
Sbjct: 9   SGVDLGTENLYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAK 68
Query: 513 RLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDP 572
            +   S + LE++M E+ +++   H N+V+LL          ++ E+    ++DA++   
Sbjct: 69  VIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVM--- 125
Query: 573 LKKERLDWRKRFNII-EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 631
           L+ ER     +  ++ +     L YLH +   +IIHRDLKA NIL   + + K++DFG++
Sbjct: 126 LELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVS 182
Query: 632 KIFGGNQDQADTGRVVGTFGYMSPEYAM-----EGRFSEKSDVFSFGVLLLEIV 680
                   + D    +GT  +M+PE  M     +  +  K+DV+S G+ L+E+ 
Sbjct: 183 AKNTRXIQRRDX--FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA 234

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 114/213 (53%), Gaps = 11/213 (5%)
Query: 483 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLS-KASGQGLEEF-MNEVMVISKLQHRNL 540
            +Q   K+G+G +G VY  +   G+ +A+KR+   A  +G+    + E+ ++ +L H N+
Sbjct: 22  KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNI 81
Query: 541 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 600
           V L+          L++E+M  + L  +L D  K    D + +  + + + RG+ + H+ 
Sbjct: 82  VSLIDVIHSERCLTLVFEFM-EKDLKKVL-DENKTGLQDSQIKIYLYQ-LLRGVAHCHQH 138
Query: 601 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM- 659
              RI+HRDLK  N+L++ +   K++DFG+A+ FG    ++ T  VV T  Y +P+  M 
Sbjct: 139 ---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPV-RSYTHEVV-TLWYRAPDVLMG 193
Query: 660 EGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDD 692
             ++S   D++S G +  E+++G+       DD
Sbjct: 194 SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD 226

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 114/213 (53%), Gaps = 11/213 (5%)
Query: 483 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLS-KASGQGLEEF-MNEVMVISKLQHRNL 540
            +Q   K+G+G +G VY  +   G+ +A+KR+   A  +G+    + E+ ++ +L H N+
Sbjct: 22  KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNI 81
Query: 541 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 600
           V L+          L++E+M  + L  +L D  K    D + +  + + + RG+ + H+ 
Sbjct: 82  VSLIDVIHSERCLTLVFEFM-EKDLKKVL-DENKTGLQDSQIKIYLYQ-LLRGVAHCHQH 138
Query: 601 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM- 659
              RI+HRDLK  N+L++ +   K++DFG+A+ FG    ++ T  VV T  Y +P+  M 
Sbjct: 139 ---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPV-RSYTHEVV-TLWYRAPDVLMG 193
Query: 660 EGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDD 692
             ++S   D++S G +  E+++G+       DD
Sbjct: 194 SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD 226

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 98/202 (48%), Gaps = 18/202 (8%)
Query: 490 LGQGGFGPVY---WGRLKDG--QEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRL 543
           LG+G FG V    +    DG  + +AVK L    G Q    +  E+ ++  L H ++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 544 LGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
            GCC +  EK   L+ EY+P  SL     D L +  +   +     + I  G+ YLH   
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLR----DYLPRHSIGLAQLLLFAQQICEGMAYLHAQ- 136
Query: 602 RLRIIHRDLKASNILLDEELNPKISDFGMAKIF--GGNQDQADTGRVVGTFGYMSPEYAM 659
               IHR+L A N+LLD +   KI DFG+AK    G    +         F Y +PE   
Sbjct: 137 --HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLK 193
Query: 660 EGRFSEKSDVFSFGVLLLEIVS 681
           E +F   SDV+SFGV L E+++
Sbjct: 194 EYKFYYASDVWSFGVTLYELLT 215

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 98/202 (48%), Gaps = 18/202 (8%)
Query: 490 LGQGGFGPVY---WGRLKDG--QEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRL 543
           LG+G FG V    +    DG  + +AVK L    G Q    +  E+ ++  L H ++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 544 LGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
            GCC +  EK   L+ EY+P  SL     D L +  +   +     + I  G+ YLH   
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLR----DYLPRHSIGLAQLLLFAQQICEGMAYLHSQ- 136
Query: 602 RLRIIHRDLKASNILLDEELNPKISDFGMAKIF--GGNQDQADTGRVVGTFGYMSPEYAM 659
               IHR+L A N+LLD +   KI DFG+AK    G    +         F Y +PE   
Sbjct: 137 --HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLK 193
Query: 660 EGRFSEKSDVFSFGVLLLEIVS 681
           E +F   SDV+SFGV L E+++
Sbjct: 194 EYKFYYASDVWSFGVTLYELLT 215

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 112/229 (48%), Gaps = 37/229 (16%)
Query: 481 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 539
            ++F+  + LGQG FG V   R   D +  A+K++ + + + L   ++EVM+++ L H+ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQY 63
Query: 540 LVRLLGC------------CVEGEEKMLI-YEYMPNRSL-DALLFDPLKKERLD-WRKRF 584
           +VR                 V+ +  + I  EY  N +L D +  + L ++R + WR   
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 585 NIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD----- 639
            I+E +S    Y+H      IIHRDLK  NI +DE  N KI DFG+AK    + D     
Sbjct: 124 QILEALS----YIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 640 -------QADTGRVVGTFGYMSPEYA-MEGRFSEKSDVFSFGVLLLEIV 680
                    +    +GT  Y++ E     G ++EK D++S G++  E++
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 110/212 (51%), Gaps = 25/212 (11%)
Query: 483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRN 539
           NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 540 LVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEGISR 592
           +V+LL       +  L++E++     + +DA        PL K  L     F +++G+S 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQGLS- 117
Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 652
              + H     R++HRDLK  N+L++ E   K++DFG+A+ FG    +  T  VV T  Y
Sbjct: 118 ---FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVV-TLWY 169
Query: 653 MSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 683
            +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 482 NNFQLSSKLGQGGFGPVYWG--------RLKDGQEIAVKRLSK-ASGQGLEEFMNEVMVI 532
           +   L   LG+G FG V           + K+   +AVK L   A+ + L + ++E+ ++
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 533 SKL-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-------------FDPLKKERL 578
             + +H+N++ LLG C +     +I EY    +L   L              + + +E++
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
            ++   +    ++RG+ YL   +  + IHRDL A N+L+ E    KI+DFG+A+      
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257
Query: 639 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
               T        +M+PE   +  ++ +SDV+SFGVL+ EI +
Sbjct: 258 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 106/222 (47%), Gaps = 29/222 (13%)
Query: 482 NNFQLSSKLGQGGFGPVYWG------RLKDGQEIAVKRLSK-ASGQGLEEFMNEVMVISK 534
           +   L   LG+G FG V         +    + +AVK L + A+       M+E+ ++  
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 535 L-QHRNLVRLLGCCVE-GEEKMLIYEYMPNRSLDALL------FDPLKKERLDWRKRFNI 586
           +  H N+V LLG C + G   M+I E+    +L   L      F P K    D  K F  
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK----DLYKDFLT 142
Query: 587 IEG-------ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 639
           +E        +++G+ +L   +  + IHRDL A NILL E+   KI DFG+A+    + D
Sbjct: 143 LEHLICYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 199
Query: 640 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
               G       +M+PE   +  ++ +SDV+SFGVLL EI S
Sbjct: 200 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 110/212 (51%), Gaps = 14/212 (6%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLSKASGQ-GLEEFMNEVMVISKLQHRN 539
           ++++L   +G G    V        +E +A+KR++    Q  ++E + E+  +S+  H N
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRS-LDALLFDPLKKER----LDWRKRFNIIEGISRGL 594
           +V      V  +E  L+ + +   S LD +     K E     LD      I+  +  GL
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 595 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF--GGNQDQADTGRV-VGTFG 651
            YLH++ +   IHRD+KA NILL E+ + +I+DFG++     GG+  +    +  VGT  
Sbjct: 130 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 186
Query: 652 YMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSG 682
           +M+PE   + R +  K+D++SFG+  +E+ +G
Sbjct: 187 WMAPEVMEQVRGYDFKADIWSFGITAIELATG 218

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 102/200 (51%), Gaps = 16/200 (8%)
Query: 490 LGQGGFGPVYWGR-LKDGQEI----AVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRL 543
           LG G FG V+ G  + +G+ I     +K +   SG Q  +   + ++ I  L H ++VRL
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 98
Query: 544 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER--LDWRKRFNIIEGISRGLLYLHRDS 601
           LG C  G    L+ +Y+P  SL     D +++ R  L  +   N    I++G+ YL    
Sbjct: 99  LGLC-PGSSLQLVTQYLPLGSL----LDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG 153
Query: 602 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 661
              ++HR+L A N+LL      +++DFG+A +   +  Q           +M+ E    G
Sbjct: 154 ---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG 210
Query: 662 RFSEKSDVFSFGVLLLEIVS 681
           +++ +SDV+S+GV + E+++
Sbjct: 211 KYTHQSDVWSYGVTVWELMT 230

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 482 NNFQLSSKLGQGGFGPVYWG--------RLKDGQEIAVKRLSK-ASGQGLEEFMNEVMVI 532
           +   L   LG+G FG V           + K+   +AVK L   A+ + L + ++E+ ++
Sbjct: 22  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 81
Query: 533 SKL-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-------------FDPLKKERL 578
             + +H+N++ LLG C +     +I EY    +L   L              + + +E++
Sbjct: 82  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 141
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
            ++   +    ++RG+ YL   +  + IHRDL A N+L+ E    KI+DFG+A+      
Sbjct: 142 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNID 198
Query: 639 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
               T        +M+PE   +  ++ +SDV+SFGVL+ EI +
Sbjct: 199 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 103/196 (52%), Gaps = 12/196 (6%)
Query: 489 KLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC 547
           K+G+G  G V     K  G+++AVK++     Q  E   NEV+++    H N+V +    
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSY 111
Query: 548 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 607
           + G+E  ++ E++   +L     D +   R++  +   +   + R L YLH      +IH
Sbjct: 112 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 164
Query: 608 RDLKASNILLDEELNPKISDFGM-AKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEK 666
           RD+K+ +ILL  +   K+SDFG  A++   +++      +VGT  +M+PE      +  +
Sbjct: 165 RDIKSDSILLTSDGRIKLSDFGFCAQV---SKEVPKRKXLVGTPYWMAPEVISRLPYGTE 221
Query: 667 SDVFSFGVLLLEIVSG 682
            D++S G++++E++ G
Sbjct: 222 VDIWSLGIMVIEMIDG 237

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 482 NNFQLSSKLGQGGFGPVYWG--------RLKDGQEIAVKRLSK-ASGQGLEEFMNEVMVI 532
           +   L   LG+G FG V           + K+   +AVK L   A+ + L + ++E+ ++
Sbjct: 27  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 86
Query: 533 SKL-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-------------FDPLKKERL 578
             + +H+N++ LLG C +     +I EY    +L   L              + + +E++
Sbjct: 87  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 146
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
            ++   +    ++RG+ YL   +  + IHRDL A N+L+ E    KI+DFG+A+      
Sbjct: 147 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 203
Query: 639 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
               T        +M+PE   +  ++ +SDV+SFGVL+ EI +
Sbjct: 204 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 102/200 (51%), Gaps = 16/200 (8%)
Query: 490 LGQGGFGPVYWGR-LKDGQEI----AVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRL 543
           LG G FG V+ G  + +G+ I     +K +   SG Q  +   + ++ I  L H ++VRL
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 544 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER--LDWRKRFNIIEGISRGLLYLHRDS 601
           LG C  G    L+ +Y+P  SL     D +++ R  L  +   N    I++G+ YL    
Sbjct: 81  LGLC-PGSSLQLVTQYLPLGSL----LDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG 135
Query: 602 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 661
              ++HR+L A N+LL      +++DFG+A +   +  Q           +M+ E    G
Sbjct: 136 ---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG 192
Query: 662 RFSEKSDVFSFGVLLLEIVS 681
           +++ +SDV+S+GV + E+++
Sbjct: 193 KYTHQSDVWSYGVTVWELMT 212

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 115/215 (53%), Gaps = 20/215 (9%)
Query: 477 LATATNNFQLSSKLGQGGFGPVYWGR-LKDGQE-IAVKRLSKASGQ-GLE-EFMNEVMVI 532
           L  A   ++  +++G+G +G V+  R LK+G   +A+KR+   +G+ G+    + EV V+
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 533 SKLQ---HRNLVRLLGCCV----EGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRF 584
             L+   H N+VRL   C     + E K+ L++E++ ++ L   L D + +  +      
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIK 123
Query: 585 NIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG 644
           +++  + RGL +LH     R++HRDLK  NIL+      K++DFG+A+I+     Q    
Sbjct: 124 DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALT 177
Query: 645 RVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEI 679
            VV T  Y +PE  ++  ++   D++S G +  E+
Sbjct: 178 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 117/244 (47%), Gaps = 31/244 (12%)
Query: 461 VNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWG--------RLKDGQEIAVK 512
           V+  +L + P ++F       +   L   LG+G FG V           + K+   +AVK
Sbjct: 8   VSEYELPEDPKWEF-----PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVK 62
Query: 513 RLSK-ASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL- 569
            L   A+ + L + ++E+ ++  + +H+N++ LLG C +     +I EY    +L   L 
Sbjct: 63  MLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLR 122
Query: 570 ------------FDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
                        + + +E++ ++   +    ++RG+ YL   +  + IHRDL A N+L+
Sbjct: 123 ARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLV 179
Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
            E    KI+DFG+A+          T        +M+PE   +  ++ +SDV+SFGVL+ 
Sbjct: 180 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW 239
Query: 678 EIVS 681
           EI +
Sbjct: 240 EIFT 243

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 110/212 (51%), Gaps = 14/212 (6%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLSKASGQ-GLEEFMNEVMVISKLQHRN 539
           ++++L   +G G    V        +E +A+KR++    Q  ++E + E+  +S+  H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRS-LDALLFDPLKKER----LDWRKRFNIIEGISRGL 594
           +V      V  +E  L+ + +   S LD +     K E     LD      I+  +  GL
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 595 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF--GGNQDQADTGRV-VGTFG 651
            YLH++ +   IHRD+KA NILL E+ + +I+DFG++     GG+  +    +  VGT  
Sbjct: 135 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 652 YMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSG 682
           +M+PE   + R +  K+D++SFG+  +E+ +G
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATG 223

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 110/219 (50%), Gaps = 26/219 (11%)
Query: 486 LSSKLGQGGFGPVYW----GRLKDG----QEIAVKRL-SKASGQGLEEFMNEVMVISKL- 535
           L   LG+G FG V      G  KD      ++AVK L S A+ + L + ++E+ ++  + 
Sbjct: 17  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----------FDPLK--KERLDWRK 582
           +H+N++ LLG C +     +I EY    +L   L           ++P    +E+L  + 
Sbjct: 77  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKD 136
Query: 583 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD 642
             +    ++RG+ YL   +  + IHRDL A N+L+ E+   KI+DFG+A+          
Sbjct: 137 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 643 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           T        +M+PE   +  ++ +SDV+SFGVLL EI +
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 106/218 (48%), Gaps = 21/218 (9%)
Query: 482 NNFQLSSKLGQGGFGPVYWG------RLKDGQEIAVKRLSK-ASGQGLEEFMNEVMVISK 534
           +   L   LG+G FG V         +    + +AVK L + A+       M+E+ ++  
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 535 L-QHRNLVRLLGCCVE-GEEKMLIYEYMPNRSLDALL------FDPLKKERLDWRKRFNI 586
           +  H N+V LLG C + G   M+I E+    +L   L      F P K    D+    ++
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHL 146
Query: 587 IE---GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 643
           I     +++G+ +L   +  + IHRDL A NILL E+   KI DFG+A+    + D    
Sbjct: 147 IXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRK 203
Query: 644 GRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           G       +M+PE   +  ++ +SDV+SFGVLL EI S
Sbjct: 204 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 106/206 (51%), Gaps = 11/206 (5%)
Query: 484 FQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLS-KASGQGLEEFMNEVMVISKLQHRNLV 541
           F    K+G+G FG V+ G     Q++ A+K +  + +   +E+   E+ V+S+     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 542 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
           +  G  ++  +  +I EY+   S      D L+   LD  +   I+  I +GL YLH + 
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSA----LDLLEPGPLDETQIATILREILKGLDYLHSEK 124
Query: 602 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 661
           +   IHRD+KA+N+LL E    K++DFG+A      Q + +T   VGT  +M+PE   + 
Sbjct: 125 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 179
Query: 662 RFSEKSDVFSFGVLLLEIVSGRKNTS 687
            +  K+D++S G+  +E+  G    S
Sbjct: 180 AYDSKADIWSLGITAIELARGEPPHS 205

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 117/244 (47%), Gaps = 31/244 (12%)
Query: 461 VNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWG--------RLKDGQEIAVK 512
           V+  +L + P ++F       +   L   LG+G FG V           + K+   +AVK
Sbjct: 19  VSEYELPEDPKWEF-----PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK 73
Query: 513 RLSK-ASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL- 569
            L   A+ + L + ++E+ ++  + +H+N++ LLG C +     +I EY    +L   L 
Sbjct: 74  MLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLR 133
Query: 570 ------------FDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
                        + + +E++ ++   +    ++RG+ YL   +  + IHRDL A N+L+
Sbjct: 134 ARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLV 190
Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
            E    +I+DFG+A+          T        +M+PE   +  ++ +SDV+SFGVL+ 
Sbjct: 191 TENNVMRIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW 250
Query: 678 EIVS 681
           EI +
Sbjct: 251 EIFT 254

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 115/215 (53%), Gaps = 20/215 (9%)
Query: 477 LATATNNFQLSSKLGQGGFGPVYWGR-LKDGQE-IAVKRLSKASGQ-GLE-EFMNEVMVI 532
           L  A   ++  +++G+G +G V+  R LK+G   +A+KR+   +G+ G+    + EV V+
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 533 SKLQ---HRNLVRLLGCCV----EGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRF 584
             L+   H N+VRL   C     + E K+ L++E++ ++ L   L D + +  +      
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIK 123
Query: 585 NIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG 644
           +++  + RGL +LH     R++HRDLK  NIL+      K++DFG+A+I+     Q    
Sbjct: 124 DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALT 177
Query: 645 RVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEI 679
            VV T  Y +PE  ++  ++   D++S G +  E+
Sbjct: 178 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 110/219 (50%), Gaps = 26/219 (11%)
Query: 486 LSSKLGQGGFGPVYW----GRLKDG----QEIAVKRL-SKASGQGLEEFMNEVMVISKL- 535
           L   LG+G FG V      G  KD      ++AVK L S A+ + L + ++E+ ++  + 
Sbjct: 21  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 80
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----------FDPLK--KERLDWRK 582
           +H+N++ LLG C +     +I EY    +L   L           ++P    +E+L  + 
Sbjct: 81  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 140
Query: 583 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD 642
             +    ++RG+ YL   +  + IHRDL A N+L+ E+   KI+DFG+A+          
Sbjct: 141 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 197
Query: 643 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           T        +M+PE   +  ++ +SDV+SFGVLL EI +
Sbjct: 198 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 97/202 (48%), Gaps = 18/202 (8%)
Query: 490 LGQGGFGPVY---WGRLKDG--QEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRL 543
           LG+G FG V    +    DG  + +AVK L   +G Q    +  E+ ++  L H ++++ 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 544 LGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
            GCC +       L+ EY+P  SL     D L +  +   +     + I  G+ YLH   
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLR----DYLPRHSIGLAQLLLFAQQICEGMAYLHAQ- 153
Query: 602 RLRIIHRDLKASNILLDEELNPKISDFGMAKIF--GGNQDQADTGRVVGTFGYMSPEYAM 659
               IHRDL A N+LLD +   KI DFG+AK    G    +         F Y +PE   
Sbjct: 154 --HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWY-APECLK 210
Query: 660 EGRFSEKSDVFSFGVLLLEIVS 681
           E +F   SDV+SFGV L E+++
Sbjct: 211 EYKFYYASDVWSFGVTLYELLT 232

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 106/206 (51%), Gaps = 11/206 (5%)
Query: 484 FQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLS-KASGQGLEEFMNEVMVISKLQHRNLV 541
           F    K+G+G FG V+ G     Q++ A+K +  + +   +E+   E+ V+S+     + 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 542 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
           +  G  ++  +  +I EY+   S      D L+   LD  +   I+  I +GL YLH + 
Sbjct: 89  KYYGSYLKDTKLWIIMEYLGGGSA----LDLLEPGPLDETQIATILREILKGLDYLHSEK 144
Query: 602 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 661
           +   IHRD+KA+N+LL E    K++DFG+A      Q + +T   VGT  +M+PE   + 
Sbjct: 145 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 199
Query: 662 RFSEKSDVFSFGVLLLEIVSGRKNTS 687
            +  K+D++S G+  +E+  G    S
Sbjct: 200 AYDSKADIWSLGITAIELARGEPPHS 225

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 110/219 (50%), Gaps = 26/219 (11%)
Query: 486 LSSKLGQGGFGPVYW----GRLKDG----QEIAVKRL-SKASGQGLEEFMNEVMVISKL- 535
           L   LG+G FG V      G  KD      ++AVK L S A+ + L + ++E+ ++  + 
Sbjct: 25  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 84
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----------FDPLK--KERLDWRK 582
           +H+N++ LLG C +     +I EY    +L   L           ++P    +E+L  + 
Sbjct: 85  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 144
Query: 583 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD 642
             +    ++RG+ YL   +  + IHRDL A N+L+ E+   KI+DFG+A+          
Sbjct: 145 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 201
Query: 643 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           T        +M+PE   +  ++ +SDV+SFGVLL EI +
Sbjct: 202 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 110/212 (51%), Gaps = 25/212 (11%)
Query: 483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRN 539
           NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 540 LVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEGISR 592
           +V+LL       +  L++E++     + +DA        PL K  L     F +++G++ 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQGLA- 117
Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 652
              + H     R++HRDLK  N+L++ E   K++DFG+A+ FG    +  T  VV T  Y
Sbjct: 118 ---FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVV-TLWY 169
Query: 653 MSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 683
            +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 170 RAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 115/215 (53%), Gaps = 20/215 (9%)
Query: 477 LATATNNFQLSSKLGQGGFGPVYWGR-LKDGQE-IAVKRLSKASGQ-GLE-EFMNEVMVI 532
           L  A   ++  +++G+G +G V+  R LK+G   +A+KR+   +G+ G+    + EV V+
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 533 SKLQ---HRNLVRLLGCCV----EGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRF 584
             L+   H N+VRL   C     + E K+ L++E++ ++ L   L D + +  +      
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIK 123
Query: 585 NIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG 644
           +++  + RGL +LH     R++HRDLK  NIL+      K++DFG+A+I+     Q    
Sbjct: 124 DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALT 177
Query: 645 RVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEI 679
            VV T  Y +PE  ++  ++   D++S G +  E+
Sbjct: 178 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 110/219 (50%), Gaps = 26/219 (11%)
Query: 486 LSSKLGQGGFGPVYW----GRLKDG----QEIAVKRL-SKASGQGLEEFMNEVMVISKL- 535
           L   LG+G FG V      G  KD      ++AVK L S A+ + L + ++E+ ++  + 
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----------FDPLK--KERLDWRK 582
           +H+N++ LLG C +     +I EY    +L   L           ++P    +E+L  + 
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKD 151
Query: 583 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD 642
             +    ++RG+ YL   +  + IHRDL A N+L+ E+   KI+DFG+A+          
Sbjct: 152 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 208
Query: 643 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           T        +M+PE   +  ++ +SDV+SFGVLL EI +
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 110/219 (50%), Gaps = 26/219 (11%)
Query: 486 LSSKLGQGGFGPVYW----GRLKDG----QEIAVKRL-SKASGQGLEEFMNEVMVISKL- 535
           L   LG+G FG V      G  KD      ++AVK L S A+ + L + ++E+ ++  + 
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----------FDPLK--KERLDWRK 582
           +H+N++ LLG C +     +I EY    +L   L           ++P    +E+L  + 
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKD 151
Query: 583 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD 642
             +    ++RG+ YL   +  + IHRDL A N+L+ E+   KI+DFG+A+          
Sbjct: 152 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 208
Query: 643 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           T        +M+PE   +  ++ +SDV+SFGVLL EI +
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 105/203 (51%), Gaps = 19/203 (9%)
Query: 490 LGQGGFGPVYWGRLKDGQE----IAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRLL 544
           +G+G FG VY G   D  +     A+K LS+ +  Q +E F+ E +++  L H N++ L+
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 545 GCCV--EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSR 602
           G  +  EG   +L+  YM +  L   +  P +   +     F +   ++RG+ YL   + 
Sbjct: 89  GIMLPPEGLPHVLL-PYMCHGDLLQFIRSPQRNPTVKDLISFGL--QVARGMEYL---AE 142
Query: 603 LRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ----DQADTGRVVGTFGYMSPEYA 658
            + +HRDL A N +LDE    K++DFG+A+     +     Q    R+     + + E  
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL--PVKWTALESL 200
Query: 659 MEGRFSEKSDVFSFGVLLLEIVS 681
              RF+ KSDV+SFGVLL E+++
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLT 223

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 110/219 (50%), Gaps = 26/219 (11%)
Query: 486 LSSKLGQGGFGPVYW----GRLKDG----QEIAVKRL-SKASGQGLEEFMNEVMVISKL- 535
           L   LG+G FG V      G  KD      ++AVK L S A+ + L + ++E+ ++  + 
Sbjct: 24  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 83
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----------FDPLK--KERLDWRK 582
           +H+N++ LLG C +     +I EY    +L   L           ++P    +E+L  + 
Sbjct: 84  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 143
Query: 583 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD 642
             +    ++RG+ YL   +  + IHRDL A N+L+ E+   KI+DFG+A+          
Sbjct: 144 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 200
Query: 643 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           T        +M+PE   +  ++ +SDV+SFGVLL EI +
Sbjct: 201 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 110/219 (50%), Gaps = 26/219 (11%)
Query: 486 LSSKLGQGGFGPVYW----GRLKDG----QEIAVKRL-SKASGQGLEEFMNEVMVISKL- 535
           L   LG+G FG V      G  KD      ++AVK L S A+ + L + ++E+ ++  + 
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----------FDPLK--KERLDWRK 582
           +H+N++ LLG C +     +I EY    +L   L           ++P    +E+L  + 
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 151
Query: 583 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD 642
             +    ++RG+ YL   +  + IHRDL A N+L+ E+   KI+DFG+A+          
Sbjct: 152 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 208
Query: 643 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           T        +M+PE   +  ++ +SDV+SFGVLL EI +
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 109/217 (50%), Gaps = 21/217 (9%)
Query: 483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLE---EFMNEVMVISKLQHR 538
           ++ L   LG G FG V  G+ +  G ++AVK L++   + L+   +   E+  +   +H 
Sbjct: 17  HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLYL 597
           ++++L        +  ++ EY+        LFD + K  RLD ++   + + I  G+ Y 
Sbjct: 77  HIIKLYQVISTPSDIFMVMEYVSG----GELFDYICKNGRLDEKESRRLFQQILSGVDYC 132
Query: 598 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEY 657
           HR     ++HRDLK  N+LLD  +N KI+DFG++ +     D        G+  Y +PE 
Sbjct: 133 HRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS---DGEFLRXSCGSPNYAAPE- 185
Query: 658 AMEGRF--SEKSDVFSFGVLLLEIVSGRKNTSFFEDD 692
            + GR     + D++S GV+L  ++ G   T  F+DD
Sbjct: 186 VISGRLYAGPEVDIWSSGVILYALLCG---TLPFDDD 219

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 110/212 (51%), Gaps = 25/212 (11%)
Query: 483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRN 539
           NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 540 LVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEGISR 592
           +V+LL       +  L++E++     + +DA        PL K  L     F +++G++ 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQGLA- 117
Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 652
              + H     R++HRDLK  N+L++ E   K++DFG+A+ FG    +  T  VV T  Y
Sbjct: 118 ---FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVV-TLWY 169
Query: 653 MSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 683
            +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 110/212 (51%), Gaps = 25/212 (11%)
Query: 483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRN 539
           NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 540 LVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEGISR 592
           +V+LL       +  L++E++     + +DA        PL K  L     F +++G++ 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQGLA- 116
Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 652
              + H     R++HRDLK  N+L++ E   K++DFG+A+ FG    +  T  VV T  Y
Sbjct: 117 ---FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVV-TLWY 168
Query: 653 MSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 683
            +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 111/215 (51%), Gaps = 25/215 (11%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQ 536
           +  NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEG 589
           H N+V+LL       +  L++E++     + +DA        PL K  L     F +++G
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 116
Query: 590 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 649
           ++    + H     R++HRDLK  N+L++ E   K++DFG+A+ FG    +  T  VV T
Sbjct: 117 LA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVV-T 167
Query: 650 FGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 683
             Y +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 110/212 (51%), Gaps = 25/212 (11%)
Query: 483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRN 539
           NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 540 LVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEGISR 592
           +V+LL       +  L++E++     + +DA        PL K  L     F +++G++ 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQGLA- 116
Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 652
              + H     R++HRDLK  N+L++ E   K++DFG+A+ FG    +  T  VV T  Y
Sbjct: 117 ---FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVV-TLWY 168
Query: 653 MSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 683
            +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 107/225 (47%), Gaps = 26/225 (11%)
Query: 475 EELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLE-EFMNEVMVIS 533
           E L   +   QL     +G FG V+  +L + + +AVK       Q  + E+  EV  + 
Sbjct: 17  ENLYFQSMPLQLLEVKARGRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQNEY--EVYSLP 73
Query: 534 KLQHRNLVRLLGCCVEGE----EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEG 589
            ++H N+++ +G    G     +  LI  +    SL     D LK   + W +  +I E 
Sbjct: 74  GMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLS----DFLKANVVSWNELCHIAET 129
Query: 590 ISRGLLYLHRD-------SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD 642
           ++RGL YLH D        +  I HRD+K+ N+LL   L   I+DFG+A  F   +   D
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189
Query: 643 TGRVVGTFGYMSPEYAMEGRFSEKSDVF------SFGVLLLEIVS 681
           T   VGT  YM+PE  +EG  + + D F      + G++L E+ S
Sbjct: 190 THGQVGTRRYMAPE-VLEGAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 110/212 (51%), Gaps = 25/212 (11%)
Query: 483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRN 539
           NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L H N
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 70
Query: 540 LVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEGISR 592
           +V+LL       +  L++E++     + +DA        PL K  L     F +++G++ 
Sbjct: 71  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQGLA- 124
Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 652
              + H     R++HRDLK  N+L++ E   K++DFG+A+ FG    +  T  VV T  Y
Sbjct: 125 ---FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVV-TLWY 176
Query: 653 MSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 683
            +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 177 RAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 110/219 (50%), Gaps = 26/219 (11%)
Query: 486 LSSKLGQGGFGPVYW----GRLKDG----QEIAVKRL-SKASGQGLEEFMNEVMVISKL- 535
           L   LG+G FG V      G  KD      ++AVK L S A+ + L + ++E+ ++  + 
Sbjct: 73  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----------FDPLK--KERLDWRK 582
           +H+N++ LLG C +     +I EY    +L   L           ++P    +E+L  + 
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 583 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD 642
             +    ++RG+ YL   +  + IHRDL A N+L+ E+   KI+DFG+A+          
Sbjct: 193 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 249
Query: 643 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           T        +M+PE   +  ++ +SDV+SFGVLL EI +
Sbjct: 250 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 110/212 (51%), Gaps = 25/212 (11%)
Query: 483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRN 539
           NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 540 LVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEGISR 592
           +V+LL       +  L++E++     + +DA        PL K  L     F +++G++ 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQGLA- 117
Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 652
              + H     R++HRDLK  N+L++ E   K++DFG+A+ FG    +  T  VV T  Y
Sbjct: 118 ---FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVV-TLWY 169
Query: 653 MSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 683
            +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 110/213 (51%), Gaps = 25/213 (11%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHR 538
            NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 539 NLVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEGIS 591
           N+V+LL       +  L++E++     + +DA        PL K  L     F +++G++
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQGLA 124
Query: 592 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFG 651
               + H     R++HRDLK  N+L++ E   K++DFG+A+ FG    +  T  VV T  
Sbjct: 125 ----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVV-TLW 175
Query: 652 YMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 683
           Y +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 176 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 110/229 (48%), Gaps = 37/229 (16%)
Query: 481 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 539
            ++F+  + LGQG FG V   R   D +  A+K++ + + + L   ++EV +++ L H+ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVXLLASLNHQY 63
Query: 540 LVRLLGC------------CVEGEEKMLI-YEYMPNRSL-DALLFDPLKKERLD-WRKRF 584
           +VR                 V+ +  + I  EY  NR+L D +  + L ++R + WR   
Sbjct: 64  VVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFR 123
Query: 585 NIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD----- 639
            I+E +S    Y+H      IIHR+LK  NI +DE  N KI DFG+AK    + D     
Sbjct: 124 QILEALS----YIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 640 -------QADTGRVVGTFGYMSPEYA-MEGRFSEKSDVFSFGVLLLEIV 680
                    +    +GT  Y++ E     G ++EK D +S G++  E +
Sbjct: 177 SQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 110/212 (51%), Gaps = 25/212 (11%)
Query: 483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRN 539
           NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L H N
Sbjct: 8   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 67
Query: 540 LVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEGISR 592
           +V+LL       +  L++E++     + +DA        PL K  L     F +++G++ 
Sbjct: 68  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQGLA- 121
Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 652
              + H     R++HRDLK  N+L++ E   K++DFG+A+ FG    +  T  VV T  Y
Sbjct: 122 ---FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVV-TLWY 173
Query: 653 MSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 683
            +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 174 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 109/220 (49%), Gaps = 30/220 (13%)
Query: 479 TATNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEF-MNEVMVISKLQ 536
           ++++ F+   KLG G +  VY G  K  G  +A+K +   S +G     + E+ ++ +L+
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGIS----- 591
           H N+VRL        +  L++E+M N            K+ +D R   N   G+      
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMDNDL----------KKYMDSRTVGNTPRGLELNLVK 111
Query: 592 -------RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG 644
                  +GL + H +   +I+HRDLK  N+L+++    K+ DFG+A+ FG   +   + 
Sbjct: 112 YFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSE 168
Query: 645 RVVGTFGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 683
            V  T  Y +P+  M  R +S   D++S G +L E+++G+
Sbjct: 169 VV--TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 104/207 (50%), Gaps = 18/207 (8%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRL---SKASGQGLE-EFMNEVMVISKLQH 537
           ++F++   LG+G FG VY  R K    I   ++   S+   +G+E +   E+ + + L H
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKE-RLDWRKRFNIIEGISRGLLY 596
            N++RL     +     LI EY P       L+  L+K    D ++   I+E ++  L+Y
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPR----GELYKELQKSCTFDEQRTATIMEELADALMY 138
Query: 597 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 656
            H     ++IHRD+K  N+LL  +   KI+DFG    +  +        + GT  Y+ PE
Sbjct: 139 CHGK---KVIHRDIKPENLLLGLKGELKIADFG----WSVHAPSLRRKTMCGTLDYLPPE 191
Query: 657 YAMEGRF-SEKSDVFSFGVLLLEIVSG 682
             +EGR  +EK D++  GVL  E++ G
Sbjct: 192 -MIEGRMHNEKVDLWCIGVLCYELLVG 217

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 107/223 (47%), Gaps = 26/223 (11%)
Query: 482 NNFQLSSKLGQGGFGPVYWG--------RLKDGQEIAVKRLSK-ASGQGLEEFMNEVMVI 532
           +   L   LG+G FG V           + K+   +AVK L   A+ + L + ++E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 533 SKL-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-------------FDPLKKERL 578
             + +H+N++ LLG C +     +I  Y    +L   L              + + +E++
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
            ++   +    ++RG+ YL   +  + IHRDL A N+L+ E    KI+DFG+A+      
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 639 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
               T        +M+PE   +  ++ +SDV+SFGVL+ EI +
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 108/235 (45%), Gaps = 43/235 (18%)
Query: 490 LGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGC-- 546
           +G GGFG V+  + + DG+   ++R+   +    E+   EV  ++KL H N+V   GC  
Sbjct: 20  IGSGGFGQVFKAKHRIDGKTYVIRRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWD 75
Query: 547 -----CVEGEEKMLIYEYMP------NRSLDALLF---------------DPLKKERLDW 580
                    ++ +   +Y P      +RS    LF               +  + E+LD 
Sbjct: 76  GFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK 135
Query: 581 RKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ 640
                + E I++G+ Y+H     ++IHRDLK SNI L +    KI DFG+       ++ 
Sbjct: 136 VLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDFGLVTSL---KND 189
Query: 641 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIV----SGRKNTSFFED 691
               R  GT  YMSPE      + ++ D+++ G++L E++    +  + + FF D
Sbjct: 190 GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTD 244

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQ 536
           +  NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 596
           H N+V+LL       +  L++E++     D +    L    L   K +  +  + +GL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSY--LFQLLQGLAF 118
Query: 597 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 656
            H     R++HRDLK  N+L++ E   K++DFG+A+ FG           V T  Y +PE
Sbjct: 119 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAPE 173
Query: 657 YAMEGR-FSEKSDVFSFGVLLLEIVSGR 683
             +  + +S   D++S G +  E+V+ R
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 99/213 (46%), Gaps = 24/213 (11%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR--LKDGQ--EIAVKRLSK---ASGQGLEEFMNEVMVISK 534
            + +L  KLG G FG V  G      G+   +AVK L     +  + +++F+ EV  +  
Sbjct: 12  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 71
Query: 535 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER----LDWRKRFNIIEGI 590
           L HRNL+RL G  +    KM + E  P  SL     D L+K +    L    R+ +   +
Sbjct: 72  LDHRNLIRLYGVVLTPPMKM-VTELAPLGSL----LDRLRKHQGHFLLGTLSRYAV--QV 124
Query: 591 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVG 648
           + G+ YL      R IHRDL A N+LL      KI DFG+ +    N D       R V 
Sbjct: 125 AEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV- 180
Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
            F + +PE      FS  SD + FGV L E+ +
Sbjct: 181 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 118/252 (46%), Gaps = 36/252 (14%)
Query: 458 ATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPV-----YWGRLKDG-QEIAV 511
           + +V+  K+ + P ++F        N  L   LG+G FG V     +  + + G   +AV
Sbjct: 4   SLSVDAFKILEDPKWEF-----PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAV 58
Query: 512 KRLSK-ASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLF 570
           K L + AS   L + ++E  V+ ++ H ++++L G C +    +LI EY    SL   L 
Sbjct: 59  KMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLR 118
Query: 571 DPLK-------------KERLDWRKRFNIIEG--------ISRGLLYLHRDSRLRIIHRD 609
           +  K                LD      +  G        IS+G+ YL   + ++++HRD
Sbjct: 119 ESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRD 175
Query: 610 LKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDV 669
           L A NIL+ E    KISDFG+++            +      +M+ E   +  ++ +SDV
Sbjct: 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDV 235
Query: 670 FSFGVLLLEIVS 681
           +SFGVLL EIV+
Sbjct: 236 WSFGVLLWEIVT 247

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 102/203 (50%), Gaps = 24/203 (11%)
Query: 490 LGQGGFGPVYWGRLKDGQE-IAVKRLSKASGQGLEEFM-NEVMVISKLQHRNLVRLLGCC 547
           LG G F  V     K  Q+ +A+K ++K + +G E  M NE+ V+ K++H N+V L    
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 548 VEGEEKMLIYEYMPNRSL-DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRII 606
             G    LI + +    L D ++      ER   R  F +++ +     YLH    L I+
Sbjct: 86  ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVK----YLHD---LGIV 138
Query: 607 HRDLKASNIL---LDEELNPKISDFGMAKIFGGNQDQADTGRVV----GTFGYMSPEYAM 659
           HRDLK  N+L   LDE+    ISDFG++K+        D G V+    GT GY++PE   
Sbjct: 139 HRDLKPENLLYYSLDEDSKIMISDFGLSKM-------EDPGSVLSTACGTPGYVAPEVLA 191
Query: 660 EGRFSEKSDVFSFGVLLLEIVSG 682
           +  +S+  D +S GV+   ++ G
Sbjct: 192 QKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 104/212 (49%), Gaps = 30/212 (14%)
Query: 484 FQLSSKLGQGGFGPVYWGRLKDGQ-EIAVK--RLSKASGQGLEEFMNEVMVISKLQHRNL 540
           +Q   KLG G +G V   R K    E A+K  R +  S     + + EV V+  L H N+
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI 98
Query: 541 VRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERLDWRKRFN------IIEGISRG 593
           ++L     +     L+ E Y      D ++           R +FN      II+ +  G
Sbjct: 99  MKLYDFFEDKRNYYLVMECYKGGELFDEIIH----------RMKFNEVDAAVIIKQVLSG 148
Query: 594 LLYLHRDSRLRIIHRDLKASNILLDEELNP---KISDFGMAKIFGGNQDQADTGRVVGTF 650
           + YLH+ +   I+HRDLK  N+LL+ +      KI DFG++ +F   ++Q      +GT 
Sbjct: 149 VTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF---ENQKKMKERLGTA 202
Query: 651 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
            Y++PE  +  ++ EK DV+S GV+L  +++G
Sbjct: 203 YYIAPE-VLRKKYDEKCDVWSIGVILFILLAG 233

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 99/213 (46%), Gaps = 24/213 (11%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR--LKDGQ--EIAVKRLSK---ASGQGLEEFMNEVMVISK 534
            + +L  KLG G FG V  G      G+   +AVK L     +  + +++F+ EV  +  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 535 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER----LDWRKRFNIIEGI 590
           L HRNL+RL G  +    KM + E  P  SL     D L+K +    L    R+ +   +
Sbjct: 68  LDHRNLIRLYGVVLTPPMKM-VTELAPLGSL----LDRLRKHQGHFLLGTLSRYAV--QV 120
Query: 591 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA--DTGRVVG 648
           + G+ YL      R IHRDL A N+LL      KI DFG+ +    N D       R V 
Sbjct: 121 AEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV- 176
Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
            F + +PE      FS  SD + FGV L E+ +
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 102/203 (50%), Gaps = 24/203 (11%)
Query: 490 LGQGGFGPVYWGRLKDGQE-IAVKRLSKASGQGLEEFM-NEVMVISKLQHRNLVRLLGCC 547
           LG G F  V     K  Q+ +A+K ++K + +G E  M NE+ V+ K++H N+V L    
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 548 VEGEEKMLIYEYMPNRSL-DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRII 606
             G    LI + +    L D ++      ER   R  F +++ +     YLH    L I+
Sbjct: 86  ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVK----YLHD---LGIV 138
Query: 607 HRDLKASNIL---LDEELNPKISDFGMAKIFGGNQDQADTGRVV----GTFGYMSPEYAM 659
           HRDLK  N+L   LDE+    ISDFG++K+        D G V+    GT GY++PE   
Sbjct: 139 HRDLKPENLLYYSLDEDSKIMISDFGLSKM-------EDPGSVLSTACGTPGYVAPEVLA 191
Query: 660 EGRFSEKSDVFSFGVLLLEIVSG 682
           +  +S+  D +S GV+   ++ G
Sbjct: 192 QKPYSKAVDCWSIGVIAYILLCG 214

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 118/252 (46%), Gaps = 36/252 (14%)
Query: 458 ATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPV-----YWGRLKDG-QEIAV 511
           + +V+  K+ + P ++F        N  L   LG+G FG V     +  + + G   +AV
Sbjct: 4   SLSVDAFKILEDPKWEF-----PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAV 58
Query: 512 KRLSK-ASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLF 570
           K L + AS   L + ++E  V+ ++ H ++++L G C +    +LI EY    SL   L 
Sbjct: 59  KMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLR 118
Query: 571 DPLK-------------KERLDWRKRFNIIEG--------ISRGLLYLHRDSRLRIIHRD 609
           +  K                LD      +  G        IS+G+ YL   + ++++HRD
Sbjct: 119 ESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRD 175
Query: 610 LKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDV 669
           L A NIL+ E    KISDFG+++            +      +M+ E   +  ++ +SDV
Sbjct: 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDV 235
Query: 670 FSFGVLLLEIVS 681
           +SFGVLL EIV+
Sbjct: 236 WSFGVLLWEIVT 247

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 25/215 (11%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQ 536
           +  NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEG 589
           H N+V+LL       +  L++E++     + +DA        PL K  L     F +++G
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 115
Query: 590 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 649
           ++    + H     R++HRDLK  N+L++ E   K++DFG+A+ FG           V T
Sbjct: 116 LA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVT 166
Query: 650 FGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 683
             Y +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 102/203 (50%), Gaps = 24/203 (11%)
Query: 490 LGQGGFGPVYWGRLKDGQE-IAVKRLSKASGQGLEEFM-NEVMVISKLQHRNLVRLLGCC 547
           LG G F  V     K  Q+ +A+K ++K + +G E  M NE+ V+ K++H N+V L    
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 548 VEGEEKMLIYEYMPNRSL-DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRII 606
             G    LI + +    L D ++      ER   R  F +++ +     YLH    L I+
Sbjct: 86  ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVK----YLHD---LGIV 138
Query: 607 HRDLKASNIL---LDEELNPKISDFGMAKIFGGNQDQADTGRVV----GTFGYMSPEYAM 659
           HRDLK  N+L   LDE+    ISDFG++K+        D G V+    GT GY++PE   
Sbjct: 139 HRDLKPENLLYYSLDEDSKIMISDFGLSKM-------EDPGSVLSTACGTPGYVAPEVLA 191
Query: 660 EGRFSEKSDVFSFGVLLLEIVSG 682
           +  +S+  D +S GV+   ++ G
Sbjct: 192 QKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 103/209 (49%), Gaps = 24/209 (11%)
Query: 484 FQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLSKASGQGLEEFM-NEVMVISKLQHRNLV 541
           +     LG G F  V     K  Q+ +A+K ++K + +G E  M NE+ V+ K++H N+V
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 542 RLLGCCVEGEEKMLIYEYMPNRSL-DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 600
            L      G    LI + +    L D ++      ER   R  F +++ +     YLH  
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVK----YLHD- 134
Query: 601 SRLRIIHRDLKASNIL---LDEELNPKISDFGMAKIFGGNQDQADTGRVV----GTFGYM 653
             L I+HRDLK  N+L   LDE+    ISDFG++K+        D G V+    GT GY+
Sbjct: 135 --LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM-------EDPGSVLSTACGTPGYV 185
Query: 654 SPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           +PE   +  +S+  D +S GV+   ++ G
Sbjct: 186 APEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 107/223 (47%), Gaps = 26/223 (11%)
Query: 482 NNFQLSSKLGQGGFGPVYWG--------RLKDGQEIAVKRLSK-ASGQGLEEFMNEVMVI 532
           +   L   LG+G FG V           + K+   +AVK L   A+ + L + ++E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 533 SKL-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-------------FDPLKKERL 578
             + +H+N++ LLG C +     +I  Y    +L   L              + + +E++
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
            ++   +    ++RG+ YL   +  + IHRDL A N+L+ E    KI+DFG+A+      
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 639 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
               T        +M+PE   +  ++ +SDV+SFGVL+ EI +
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 25/215 (11%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQ 536
           +  NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEG 589
           H N+V+LL       +  L++E++     + +DA        PL K  L     F +++G
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 115
Query: 590 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 649
           ++    + H     R++HRDLK  N+L++ E   K++DFG+A+ FG           V T
Sbjct: 116 LA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVT 166
Query: 650 FGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 683
             Y +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 25/215 (11%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQ 536
           +  NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMP---NRSLDALLFD----PLKKERLDWRKRFNIIEG 589
           H N+V+LL       +  L++E++     + +DA        PL K  L     F +++G
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 116
Query: 590 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 649
           ++    + H     R++HRDLK  N+L++ E   K++DFG+A+ FG           V T
Sbjct: 117 LA----FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVT 167
Query: 650 FGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 683
             Y +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 25/215 (11%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQ 536
           +  NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMP---NRSLDALLFD----PLKKERLDWRKRFNIIEG 589
           H N+V+LL       +  L++E++     + +DA        PL K  L     F +++G
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 118
Query: 590 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 649
           ++    + H     R++HRDLK  N+L++ E   K++DFG+A+ FG           V T
Sbjct: 119 LA----FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVT 169
Query: 650 FGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 683
             Y +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 25/215 (11%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQ 536
           +  NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEG 589
           H N+V+LL       +  L++E++     + +DA        PL K  L     F +++G
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 115
Query: 590 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 649
           ++    + H     R++HRDLK  N+L++ E   K++DFG+A+ FG           V T
Sbjct: 116 LA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVT 166
Query: 650 FGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 683
             Y +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQ 536
           +  NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 596
           H N+V+LL       +  L++E++     D +    L    L   K +  +  + +GL +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSY--LFQLLQGLAF 120
Query: 597 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 656
            H     R++HRDLK  N+L++ E   K++DFG+A+ FG           V T  Y +PE
Sbjct: 121 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAPE 175
Query: 657 YAMEGR-FSEKSDVFSFGVLLLEIVSGR 683
             +  + +S   D++S G +  E+V+ R
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 25/215 (11%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQ 536
           +  NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEG 589
           H N+V+LL       +  L++E++     + +DA        PL K  L     F +++G
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 115
Query: 590 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 649
           ++    + H     R++HRDLK  N+L++ E   K++DFG+A+ FG           V T
Sbjct: 116 LA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVT 166
Query: 650 FGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 683
             Y +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 27/213 (12%)
Query: 483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRN 539
           NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 540 LVRLLGCCVEGEEKMLIYE--------YMPNRSLDALLFDPLKKERLDWRKRFNIIEGIS 591
           +V+LL       +  L++E        +M   +L  +   PL K  L     F +++G++
Sbjct: 63  IVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPL-PLIKSYL-----FQLLQGLA 116
Query: 592 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFG 651
               + H     R++HRDLK  N+L++ E   K++DFG+A+ FG    +  T  VV T  
Sbjct: 117 ----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVV-TLW 167
Query: 652 YMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 683
           Y +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 25/215 (11%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQ 536
           +  NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEG 589
           H N+V+LL       +  L++E++     + +DA        PL K  L     F +++G
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 116
Query: 590 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 649
           ++    + H     R++HRDLK  N+L++ E   K++DFG+A+ FG           V T
Sbjct: 117 LA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVT 167
Query: 650 FGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 683
             Y +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 105/206 (50%), Gaps = 11/206 (5%)
Query: 484 FQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLS-KASGQGLEEFMNEVMVISKLQHRNLV 541
           F    K+G+G FG V+ G     Q++ A+K +  + +   +E+   E+ V+S+     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 542 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
           +  G  ++  +  +I EY+   S      D L+   LD  +   I+  I +GL YLH + 
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSA----LDLLEPGPLDETQIATILREILKGLDYLHSEK 124
Query: 602 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 661
           +   IHRD+KA+N+LL E    K++DFG+A      Q + +    VGT  +M+PE   + 
Sbjct: 125 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNX--FVGTPFWMAPEVIKQS 179
Query: 662 RFSEKSDVFSFGVLLLEIVSGRKNTS 687
            +  K+D++S G+  +E+  G    S
Sbjct: 180 AYDSKADIWSLGITAIELARGEPPHS 205

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 25/215 (11%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQ 536
           +  NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEG 589
           H N+V+LL       +  L++E++     + +DA        PL K  L     F +++G
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 117
Query: 590 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 649
           ++    + H     R++HRDLK  N+L++ E   K++DFG+A+ FG           V T
Sbjct: 118 LA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVT 168
Query: 650 FGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 683
             Y +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 169 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 108/229 (47%), Gaps = 44/229 (19%)
Query: 490 LGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV 548
           +G GGFG V+  + + DG+   +KR+   +    E+   EV  ++KL H N+V   GC  
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCW- 73
Query: 549 EGEEKMLIYEYMP-------NRSLDALLF---------------DPLKKERLDWRKRFNI 586
           +G      ++Y P       +RS    LF               +  + E+LD      +
Sbjct: 74  DG------FDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127
Query: 587 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV 646
            E I++G+ Y+H     ++I+RDLK SNI L +    KI DFG+       ++     R 
Sbjct: 128 FEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGKRXRS 181
Query: 647 VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIV----SGRKNTSFFED 691
            GT  YMSPE      + ++ D+++ G++L E++    +  + + FF D
Sbjct: 182 KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTD 230

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 99/213 (46%), Gaps = 24/213 (11%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR--LKDGQ--EIAVKRLSK---ASGQGLEEFMNEVMVISK 534
            + +L  KLG G FG V  G      G+   +AVK L     +  + +++F+ EV  +  
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 535 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER----LDWRKRFNIIEGI 590
           L HRNL+RL G  +    KM + E  P  SL     D L+K +    L    R+ +   +
Sbjct: 78  LDHRNLIRLYGVVLTPPMKM-VTELAPLGSL----LDRLRKHQGHFLLGTLSRYAV--QV 130
Query: 591 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA--DTGRVVG 648
           + G+ YL      R IHRDL A N+LL      KI DFG+ +    N D       R V 
Sbjct: 131 AEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV- 186
Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
            F + +PE      FS  SD + FGV L E+ +
Sbjct: 187 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 105/206 (50%), Gaps = 11/206 (5%)
Query: 484 FQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLS-KASGQGLEEFMNEVMVISKLQHRNLV 541
           F    K+G+G FG V+ G     Q++ A+K +  + +   +E+   E+ V+S+     + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 542 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
           +  G  ++  +  +I EY+   S      D L+   LD  +   I+  I +GL YLH + 
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSA----LDLLEPGPLDETQIATILREILKGLDYLHSEK 139
Query: 602 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 661
           +   IHRD+KA+N+LL E    K++DFG+A      Q + +    VGT  +M+PE   + 
Sbjct: 140 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNX--FVGTPFWMAPEVIKQS 194
Query: 662 RFSEKSDVFSFGVLLLEIVSGRKNTS 687
            +  K+D++S G+  +E+  G    S
Sbjct: 195 AYDSKADIWSLGITAIELARGEPPHS 220

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 25/215 (11%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQ 536
           +  NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEG 589
           H N+V+LL       +  L++E++     + +DA        PL K  L     F +++G
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 118
Query: 590 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 649
           ++    + H     R++HRDLK  N+L++ E   K++DFG+A+ FG           V T
Sbjct: 119 LA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVT 169
Query: 650 FGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 683
             Y +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 25/215 (11%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQ 536
           +  NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEG 589
           H N+V+LL       +  L++E++     + +DA        PL K  L     F +++G
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 117
Query: 590 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 649
           ++    + H     R++HRDLK  N+L++ E   K++DFG+A+ FG           V T
Sbjct: 118 LA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVT 168
Query: 650 FGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 683
             Y +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 169 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 99/213 (46%), Gaps = 24/213 (11%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR--LKDGQ--EIAVKRLSK---ASGQGLEEFMNEVMVISK 534
            + +L  KLG G FG V  G      G+   +AVK L     +  + +++F+ EV  +  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 535 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER----LDWRKRFNIIEGI 590
           L HRNL+RL G  +    KM + E  P  SL     D L+K +    L    R+ +   +
Sbjct: 68  LDHRNLIRLYGVVLTPPMKM-VTELAPLGSL----LDRLRKHQGHFLLGTLSRYAV--QV 120
Query: 591 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVG 648
           + G+ YL      R IHRDL A N+LL      KI DFG+ +    N D       R V 
Sbjct: 121 AEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV- 176
Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
            F + +PE      FS  SD + FGV L E+ +
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 107/212 (50%), Gaps = 25/212 (11%)
Query: 483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRN 539
           NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 540 LVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEGISR 592
           +V+LL       +  L++E++     + +DA        PL K  L     F +++G++ 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQGLA- 116
Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 652
              + H     R++HRDLK  N+L++ E   K++DFG+A+ FG           V T  Y
Sbjct: 117 ---FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWY 168
Query: 653 MSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 683
            +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQ 536
           +  NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 596
           H N+V+LL       +  L++E++     D +    L    L   K +  +  + +GL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSY--LFQLLQGLAF 121
Query: 597 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 656
            H     R++HRDLK  N+L++ E   K++DFG+A+ FG           V T  Y +PE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAPE 176
Query: 657 YAMEGR-FSEKSDVFSFGVLLLEIVSGR 683
             +  + +S   D++S G +  E+V+ R
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 107/212 (50%), Gaps = 25/212 (11%)
Query: 483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRN 539
           NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 540 LVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEGISR 592
           +V+LL       +  L++E++     + +DA        PL K  L     F +++G++ 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQGLA- 116
Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 652
              + H     R++HRDLK  N+L++ E   K++DFG+A+ FG           V T  Y
Sbjct: 117 ---FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWY 168
Query: 653 MSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 683
            +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 99/213 (46%), Gaps = 24/213 (11%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR--LKDGQ--EIAVKRLSK---ASGQGLEEFMNEVMVISK 534
            + +L  KLG G FG V  G      G+   +AVK L     +  + +++F+ EV  +  
Sbjct: 12  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 71
Query: 535 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER----LDWRKRFNIIEGI 590
           L HRNL+RL G  +    KM + E  P  SL     D L+K +    L    R+ +   +
Sbjct: 72  LDHRNLIRLYGVVLTPPMKM-VTELAPLGSL----LDRLRKHQGHFLLGTLSRYAV--QV 124
Query: 591 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVG 648
           + G+ YL      R IHRDL A N+LL      KI DFG+ +    N D       R V 
Sbjct: 125 AEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV- 180
Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
            F + +PE      FS  SD + FGV L E+ +
Sbjct: 181 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 25/215 (11%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQ 536
           +  NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEG 589
           H N+V+LL       +  L++E++     + +DA        PL K  L     F +++G
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 117
Query: 590 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 649
           ++    + H     R++HRDLK  N+L++ E   K++DFG+A+ FG           V T
Sbjct: 118 LA----FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVT 168
Query: 650 FGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 683
             Y +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 169 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 25/215 (11%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQ 536
           +  NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEG 589
           H N+V+LL       +  L++E++     + +DA        PL K  L     F +++G
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 116
Query: 590 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 649
           ++    + H     R++HRDLK  N+L++ E   K++DFG+A+ FG           V T
Sbjct: 117 LA----FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVT 167
Query: 650 FGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 683
             Y +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 99/213 (46%), Gaps = 24/213 (11%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR--LKDGQ--EIAVKRLSK---ASGQGLEEFMNEVMVISK 534
            + +L  KLG G FG V  G      G+   +AVK L     +  + +++F+ EV  +  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 535 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER----LDWRKRFNIIEGI 590
           L HRNL+RL G  +    KM + E  P  SL     D L+K +    L    R+ +   +
Sbjct: 68  LDHRNLIRLYGVVLTPPMKM-VTELAPLGSL----LDRLRKHQGHFLLGTLSRYAV--QV 120
Query: 591 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVG 648
           + G+ YL      R IHRDL A N+LL      KI DFG+ +    N D       R V 
Sbjct: 121 AEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV- 176
Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
            F + +PE      FS  SD + FGV L E+ +
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 107/212 (50%), Gaps = 25/212 (11%)
Query: 483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRN 539
           NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L H N
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 540 LVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEGISR 592
           +V+LL       +  L++E++     + +DA        PL K  L     F +++G++ 
Sbjct: 65  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQGLA- 118
Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 652
              + H     R++HRDLK  N+L++ E   K++DFG+A+ FG           V T  Y
Sbjct: 119 ---FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWY 170
Query: 653 MSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 683
            +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 17/215 (7%)
Query: 476 ELATATNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSK---ASGQGLEEFMNEVMV 531
           ++     +F+L   LG+G FG V+    K   Q  A+K L K        +E  M E  V
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 71
Query: 532 ISKLQHRNLVRLLGCCVEGEEKML-IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGI 590
           +S       +  + C  + +E +  + EY+    L   ++      + D  +       I
Sbjct: 72  LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAEI 128
Query: 591 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK--IFGGNQDQADTGRVVG 648
             GL +LH      I++RDLK  NILLD++ + KI+DFGM K  + G     A T    G
Sbjct: 129 ILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG----DAKTNEFCG 181
Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           T  Y++PE  +  +++   D +SFGVLL E++ G+
Sbjct: 182 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 216

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 25/215 (11%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQ 536
           +  NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEG 589
           H N+V+LL       +  L++E++     + +DA        PL K  L     F +++G
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 118
Query: 590 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 649
           ++    + H     R++HRDLK  N+L++ E   K++DFG+A+ FG           V T
Sbjct: 119 LA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVT 169
Query: 650 FGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 683
             Y +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 25/215 (11%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQ 536
           +  NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L 
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEG 589
           H N+V+LL       +  L++E++     + +DA        PL K  L     F +++G
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 119
Query: 590 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 649
           ++    + H     R++HRDLK  N+L++ E   K++DFG+A+ FG           V T
Sbjct: 120 LA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVT 170
Query: 650 FGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 683
             Y +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 171 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 103/196 (52%), Gaps = 12/196 (6%)
Query: 489 KLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC 547
           K+G+G  G V    ++  G+ +AVK++     Q  E   NEV+++   QH N+V +    
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 548 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 607
           + G+E  ++ E++   +L     D +   R++  +   +   + + L  LH      +IH
Sbjct: 87  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 139
Query: 608 RDLKASNILLDEELNPKISDFGM-AKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEK 666
           RD+K+ +ILL  +   K+SDFG  A++   +++      +VGT  +M+PE      +  +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKXLVGTPYWMAPELISRLPYGPE 196
Query: 667 SDVFSFGVLLLEIVSG 682
            D++S G++++E+V G
Sbjct: 197 VDIWSLGIMVIEMVDG 212

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 99/213 (46%), Gaps = 24/213 (11%)
Query: 482 NNFQLSSKLGQGGFGPVYWGR--LKDGQ--EIAVKRLSK---ASGQGLEEFMNEVMVISK 534
            + +L  KLG G FG V  G      G+   +AVK L     +  + +++F+ EV  +  
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 535 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER----LDWRKRFNIIEGI 590
           L HRNL+RL G  +    KM + E  P  SL     D L+K +    L    R+ +   +
Sbjct: 78  LDHRNLIRLYGVVLTPPMKM-VTELAPLGSL----LDRLRKHQGHFLLGTLSRYAV--QV 130
Query: 591 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRVVG 648
           + G+ YL      R IHRDL A N+LL      KI DFG+ +    N D       R V 
Sbjct: 131 AEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV- 186
Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
            F + +PE      FS  SD + FGV L E+ +
Sbjct: 187 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 101/217 (46%), Gaps = 25/217 (11%)
Query: 483 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 542
           + QL     +G FG V+  +L +   +AVK       Q  +    E+     ++H NL++
Sbjct: 16  SLQLLEIKARGRFGCVWKAQLMN-DFVAVKIFPLQDKQSWQS-EREIFSTPGMKHENLLQ 73
Query: 543 LLGCCVEGE----EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
            +     G     E  LI  +    SL     D LK   + W +  ++ E +SRGL YLH
Sbjct: 74  FIAAEKRGSNLEVELWLITAFHDKGSLT----DYLKGNIITWNELCHVAETMSRGLSYLH 129
Query: 599 RD--------SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF 650
            D         +  I HRD K+ N+LL  +L   ++DFG+A  F   +   DT   VGT 
Sbjct: 130 EDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTR 189
Query: 651 GYMSPEYAMEGRFSEKSDVF------SFGVLLLEIVS 681
            YM+PE  +EG  + + D F      + G++L E+VS
Sbjct: 190 RYMAPE-VLEGAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 109/212 (51%), Gaps = 25/212 (11%)
Query: 483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRN 539
           NFQ   K+G+G +G VY  R K  G+ +A+   RL   +       + E+ ++ +L H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 540 LVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEGISR 592
           +V+LL       +  L++E++     + +DA        PL K  L     F +++G++ 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQGLA- 117
Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 652
              + H     R++HRDLK  N+L++ E   K++DFG+A+ FG    +  T  VV T  Y
Sbjct: 118 ---FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVV-TLWY 169
Query: 653 MSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 683
            +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 109/212 (51%), Gaps = 25/212 (11%)
Query: 483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRN 539
           NFQ   K+G+G +G VY  R K  G+ +A+   RL   +       + E+ ++ +L H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 540 LVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEGISR 592
           +V+LL       +  L++E++     + +DA        PL K  L     F +++G++ 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQGLA- 116
Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 652
              + H     R++HRDLK  N+L++ E   K++DFG+A+ FG    +  T  VV T  Y
Sbjct: 117 ---FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVV-TLWY 168
Query: 653 MSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 683
            +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 113/209 (54%), Gaps = 18/209 (8%)
Query: 482 NNFQLSSKLGQGGFGPVYW----GRLKDGQEIAVKRLSKASGQGLEEFMNEVM--VISKL 535
           ++F+L   LGQG FG V+      R   G   A+K L KA+ +  +    ++   +++ +
Sbjct: 28  SHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADV 87
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRG 593
            H  +V+L        +  LI +++  R  D  LF  L KE +  +   +F + E ++ G
Sbjct: 88  NHPFVVKLHYAFQTEGKLYLILDFL--RGGD--LFTRLSKEVMFTEEDVKFYLAE-LALG 142
Query: 594 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 653
           L +LH    L II+RDLK  NILLDEE + K++DFG++K    ++ +A +    GT  YM
Sbjct: 143 LDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYS--FCGTVEYM 197
Query: 654 SPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           +PE       S  +D +S+GVL+ E+++G
Sbjct: 198 APEVVNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 103/196 (52%), Gaps = 12/196 (6%)
Query: 489 KLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC 547
           K+G+G  G V    ++  G+ +AVK++     Q  E   NEV+++   QH N+V +    
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 90
Query: 548 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 607
           + G+E  ++ E++   +L     D +   R++  +   +   + + L  LH      +IH
Sbjct: 91  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 143
Query: 608 RDLKASNILLDEELNPKISDFGM-AKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEK 666
           RD+K+ +ILL  +   K+SDFG  A++   +++      +VGT  +M+PE      +  +
Sbjct: 144 RDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKXLVGTPYWMAPELISRLPYGPE 200
Query: 667 SDVFSFGVLLLEIVSG 682
            D++S G++++E+V G
Sbjct: 201 VDIWSLGIMVIEMVDG 216

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 15/211 (7%)
Query: 481 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLE---EFMNEVMVISKLQ 536
           ++ ++L   LG GG   V+  R L+D +++AVK L     +       F  E    + L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 537 HRNLVRLLGC----CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 592
           H  +V +          G    ++ EY+   +L  ++     +  +  ++   +I    +
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 127
Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA-DTGRVVGTFG 651
            L + H++    IIHRD+K +NIL+      K+ DFG+A+    + +    T  V+GT  
Sbjct: 128 ALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQ 184
Query: 652 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           Y+SPE A       +SDV+S G +L E+++G
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 103/196 (52%), Gaps = 12/196 (6%)
Query: 489 KLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC 547
           K+G+G  G V    ++  G+ +AVK++     Q  E   NEV+++   QH N+V +    
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 95
Query: 548 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 607
           + G+E  ++ E++   +L     D +   R++  +   +   + + L  LH      +IH
Sbjct: 96  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 148
Query: 608 RDLKASNILLDEELNPKISDFGM-AKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEK 666
           RD+K+ +ILL  +   K+SDFG  A++   +++      +VGT  +M+PE      +  +
Sbjct: 149 RDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKXLVGTPYWMAPELISRLPYGPE 205
Query: 667 SDVFSFGVLLLEIVSG 682
            D++S G++++E+V G
Sbjct: 206 VDIWSLGIMVIEMVDG 221

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 107/211 (50%), Gaps = 19/211 (9%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQ-GLE-EFMNEVMVISKLQ 536
           AT+ ++  +++G G +G VY  R    G  +A+K +   +G+ GL    + EV ++ +L+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 537 ---HRNLVRLLGCCVEGE-----EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE 588
              H N+VRL+  C         +  L++E++ ++ L   L D      L      +++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 589 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 648
              RGL +LH +    I+HRDLK  NIL+      K++DFG+A+I+     Q     VV 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY---QMALAPVVV 173
Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEI 679
           T  Y +PE  ++  ++   D++S G +  E+
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 103/196 (52%), Gaps = 12/196 (6%)
Query: 489 KLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC 547
           K+G+G  G V    ++  G+ +AVK++     Q  E   NEV+++   QH N+V +    
Sbjct: 38  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 97
Query: 548 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 607
           + G+E  ++ E++   +L     D +   R++  +   +   + + L  LH      +IH
Sbjct: 98  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 150
Query: 608 RDLKASNILLDEELNPKISDFGM-AKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEK 666
           RD+K+ +ILL  +   K+SDFG  A++   +++      +VGT  +M+PE      +  +
Sbjct: 151 RDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKXLVGTPYWMAPELISRLPYGPE 207
Query: 667 SDVFSFGVLLLEIVSG 682
            D++S G++++E+V G
Sbjct: 208 VDIWSLGIMVIEMVDG 223

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 117/252 (46%), Gaps = 36/252 (14%)
Query: 458 ATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPV-----YWGRLKDG-QEIAV 511
           + +V+  K+ + P ++F        N  L   LG+G FG V     +  + + G   +AV
Sbjct: 4   SLSVDAFKILEDPKWEF-----PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAV 58
Query: 512 KRLSK-ASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLF 570
           K L + AS   L + ++E  V+ ++ H ++++L G C +    +LI EY    SL   L 
Sbjct: 59  KMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLR 118
Query: 571 DPLK-------------KERLDWRKRFNIIEG--------ISRGLLYLHRDSRLRIIHRD 609
           +  K                LD      +  G        IS+G+ YL   + + ++HRD
Sbjct: 119 ESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMSLVHRD 175
Query: 610 LKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDV 669
           L A NIL+ E    KISDFG+++            +      +M+ E   +  ++ +SDV
Sbjct: 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDV 235
Query: 670 FSFGVLLLEIVS 681
           +SFGVLL EIV+
Sbjct: 236 WSFGVLLWEIVT 247

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 25/215 (11%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQ 536
           +  NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEG 589
           H N+V+LL       +  L++E++     + +DA        PL K  L     F +++G
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 118
Query: 590 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 649
           ++    + H     R++HRDLK  N+L++ E   K++DFG+A+ FG           V T
Sbjct: 119 LA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVT 169
Query: 650 FGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 683
             Y +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 111/214 (51%), Gaps = 22/214 (10%)
Query: 481 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKR-LSKASGQGLE-EFMNEVMVISKLQH 537
            + ++  +K+GQG FG V+  R  K GQ++A+K+ L +   +G     + E+ ++  L+H
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 538 RNLVRLLGCCVEGEEKM--------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEG 589
            N+V L+  C               L++++     L  LL + L K  L   KR  +++ 
Sbjct: 77  ENVVNLIEICRTKASPYNRCKASIYLVFDFC-EHDLAGLLSNVLVKFTLSEIKR--VMQM 133
Query: 590 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG---GNQDQADTGRV 646
           +  GL Y+HR+   +I+HRD+KA+N+L+  +   K++DFG+A+ F     +Q      RV
Sbjct: 134 LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRV 190
Query: 647 VGTFGYMSPEYAMEGR-FSEKSDVFSFGVLLLEI 679
           V T  Y  PE  +  R +    D++  G ++ E+
Sbjct: 191 V-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 15/211 (7%)
Query: 481 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLE---EFMNEVMVISKLQ 536
           ++ ++L   LG GG   V+  R L+D +++AVK L     +       F  E    + L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 537 HRNLVRLLGC----CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 592
           H  +V +          G    ++ EY+   +L  ++     +  +  ++   +I    +
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 127
Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ-ADTGRVVGTFG 651
            L + H++    IIHRD+K +NI++      K+ DFG+A+    + +    T  V+GT  
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 652 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           Y+SPE A       +SDV+S G +L E+++G
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 111/214 (51%), Gaps = 22/214 (10%)
Query: 481 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKR-LSKASGQGLE-EFMNEVMVISKLQH 537
            + ++  +K+GQG FG V+  R  K GQ++A+K+ L +   +G     + E+ ++  L+H
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 538 RNLVRLLGCCVEGEEKM--------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEG 589
            N+V L+  C               L++++     L  LL + L K  L   KR  +++ 
Sbjct: 77  ENVVNLIEICRTKASPYNRCKGSIYLVFDFC-EHDLAGLLSNVLVKFTLSEIKR--VMQM 133
Query: 590 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG---GNQDQADTGRV 646
           +  GL Y+HR+   +I+HRD+KA+N+L+  +   K++DFG+A+ F     +Q      RV
Sbjct: 134 LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRV 190
Query: 647 VGTFGYMSPEYAMEGR-FSEKSDVFSFGVLLLEI 679
           V T  Y  PE  +  R +    D++  G ++ E+
Sbjct: 191 V-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 111/214 (51%), Gaps = 22/214 (10%)
Query: 481 TNNFQLSSKLGQGGFGPVYWGRL-KDGQEIAVKR-LSKASGQGLE-EFMNEVMVISKLQH 537
            + ++  +K+GQG FG V+  R  K GQ++A+K+ L +   +G     + E+ ++  L+H
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 75
Query: 538 RNLVRLLGCCVEGEEKM--------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEG 589
            N+V L+  C               L++++     L  LL + L K  L   KR  +++ 
Sbjct: 76  ENVVNLIEICRTKASPYNRCKGSIYLVFDFC-EHDLAGLLSNVLVKFTLSEIKR--VMQM 132
Query: 590 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG---GNQDQADTGRV 646
           +  GL Y+HR+   +I+HRD+KA+N+L+  +   K++DFG+A+ F     +Q      RV
Sbjct: 133 LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRV 189
Query: 647 VGTFGYMSPEYAMEGR-FSEKSDVFSFGVLLLEI 679
           V T  Y  PE  +  R +    D++  G ++ E+
Sbjct: 190 V-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 222

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 111/214 (51%), Gaps = 22/214 (10%)
Query: 481 TNNFQLSSKLGQGGFGPVYWGRL-KDGQEIAVKR-LSKASGQGLE-EFMNEVMVISKLQH 537
            + ++  +K+GQG FG V+  R  K GQ++A+K+ L +   +G     + E+ ++  L+H
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 538 RNLVRLLGCCVEGEEKM--------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEG 589
            N+V L+  C               L++++     L  LL + L K  L   KR  +++ 
Sbjct: 77  ENVVNLIEICRTKASPYNRCKGSIYLVFDFC-EHDLAGLLSNVLVKFTLSEIKR--VMQM 133
Query: 590 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG---GNQDQADTGRV 646
           +  GL Y+HR+   +I+HRD+KA+N+L+  +   K++DFG+A+ F     +Q      RV
Sbjct: 134 LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRV 190
Query: 647 VGTFGYMSPEYAMEGR-FSEKSDVFSFGVLLLEI 679
           V T  Y  PE  +  R +    D++  G ++ E+
Sbjct: 191 V-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 15/211 (7%)
Query: 481 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLE---EFMNEVMVISKLQ 536
           ++ ++L   LG GG   V+  R L+D +++AVK L     +       F  E    + L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 537 HRNLVRLLGC----CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 592
           H  +V +          G    ++ EY+   +L  ++     +  +  ++   +I    +
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 127
Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ-ADTGRVVGTFG 651
            L + H++    IIHRD+K +NI++      K+ DFG+A+    + +    T  V+GT  
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 652 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           Y+SPE A       +SDV+S G +L E+++G
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 107/215 (49%), Gaps = 25/215 (11%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQ 536
           +  NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPN---RSLDALLFD----PLKKERLDWRKRFNIIEG 589
           H N+V+LL       +  L++E++       +DA        PL K  L     F +++G
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYL-----FQLLQG 118
Query: 590 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 649
           ++    + H     R++HRDLK  N+L++ E   K++DFG+A+ FG           V T
Sbjct: 119 LA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVT 169
Query: 650 FGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 683
             Y +PE  +  + +S   D++S G +  E+V+ R
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 103/220 (46%), Gaps = 37/220 (16%)
Query: 484 FQLSSKLGQGGFGPVY-WGRLKDGQEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLV 541
           +++  +LG GGFG V  W     G+++A+K+  +  S +  E +  E+ ++ KL H N+V
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 542 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN---------------I 586
                  +G +K+      PN   D  L      E  D RK  N               +
Sbjct: 76  SAREV-PDGLQKL-----APN---DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTL 126
Query: 587 IEGISRGLLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKIFGGNQDQAD- 642
           +  IS  L YLH +   RIIHRDLK  NI+L    + L  KI D G AK      DQ + 
Sbjct: 127 LSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL----DQGEL 179
Query: 643 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
               VGT  Y++PE   + +++   D +SFG L  E ++G
Sbjct: 180 CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 219

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 129/278 (46%), Gaps = 19/278 (6%)
Query: 489 KLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC 547
           K+G+G  G V    ++  G+ +AVK++     Q  E   NEV+++   QH N+V +    
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 217
Query: 548 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 607
           + G+E  ++ E++        L D +   R++  +   +   + + L  LH      +IH
Sbjct: 218 LVGDELWVVMEFLEG----GALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 270
Query: 608 RDLKASNILLDEELNPKISDFGM-AKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEK 666
           RD+K+ +ILL  +   K+SDFG  A++   +++      +VGT  +M+PE      +  +
Sbjct: 271 RDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKXLVGTPYWMAPELISRLPYGPE 327
Query: 667 SDVFSFGVLLLEIVSGRKNTSFFEDDLTIL-----GYAWKLWNENKILALVDPFLSESSF 721
            D++S G++++E+V G +   F E  L  +         +L N +K+   +  FL     
Sbjct: 328 VDIWSLGIMVIEMVDG-EPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLV 386
Query: 722 QLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIR 759
           + D   R     LL    L K  P  S V  M  +  R
Sbjct: 387 R-DPAQRATAAELLKHPFLAKAGPPASIVPLMRQNRTR 423

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 103/220 (46%), Gaps = 37/220 (16%)
Query: 484 FQLSSKLGQGGFGPVY-WGRLKDGQEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLV 541
           +++  +LG GGFG V  W     G+++A+K+  +  S +  E +  E+ ++ KL H N+V
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 542 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN---------------I 586
                  +G +K+      PN   D  L      E  D RK  N               +
Sbjct: 77  SAREV-PDGLQKL-----APN---DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTL 127
Query: 587 IEGISRGLLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKIFGGNQDQAD- 642
           +  IS  L YLH +   RIIHRDLK  NI+L    + L  KI D G AK      DQ + 
Sbjct: 128 LSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL----DQGEL 180
Query: 643 TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
               VGT  Y++PE   + +++   D +SFG L  E ++G
Sbjct: 181 CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 220

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 107/211 (50%), Gaps = 19/211 (9%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQ-GLE-EFMNEVMVISKLQ 536
           AT+ ++  +++G G +G VY  R    G  +A+K +   +G+ GL    + EV ++ +L+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 537 ---HRNLVRLLGCCVEGE-----EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE 588
              H N+VRL+  C         +  L++E++ ++ L   L D      L      +++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 589 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 648
              RGL +LH +    I+HRDLK  NIL+      K++DFG+A+I+     Q     VV 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY---QMALDPVVV 173
Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEI 679
           T  Y +PE  ++  ++   D++S G +  E+
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 100/205 (48%), Gaps = 16/205 (7%)
Query: 484 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFM-NEVMVISKLQHRNLV 541
           F+    LG G F  V     K  G+  AVK + K + +G E  + NE+ V+ K++H N+V
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 542 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN-IIEGISRGLLYLHRD 600
            L           L+ + +        LFD + ++     K  + +I  +   + YLHR 
Sbjct: 84  ALEDIYESPNHLYLVMQLVSG----GELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHR- 138
Query: 601 SRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEY 657
             + I+HRDLK  N+L    DEE    ISDFG++K+  G  D   T    GT GY++PE 
Sbjct: 139 --MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM-EGKGDVMSTA--CGTPGYVAPEV 193
Query: 658 AMEGRFSEKSDVFSFGVLLLEIVSG 682
             +  +S+  D +S GV+   ++ G
Sbjct: 194 LAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 103/196 (52%), Gaps = 12/196 (6%)
Query: 489 KLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC 547
           K+G+G  G V    ++  G+ +AVK++     Q  E   NEV+++   QH N+V +    
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 140
Query: 548 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 607
           + G+E  ++ E++   +L     D +   R++  +   +   + + L  LH      +IH
Sbjct: 141 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 193
Query: 608 RDLKASNILLDEELNPKISDFGM-AKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEK 666
           RD+K+ +ILL  +   K+SDFG  A++   +++      +VGT  +M+PE      +  +
Sbjct: 194 RDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKXLVGTPYWMAPELISRLPYGPE 250
Query: 667 SDVFSFGVLLLEIVSG 682
            D++S G++++E+V G
Sbjct: 251 VDIWSLGIMVIEMVDG 266

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 108/223 (48%), Gaps = 17/223 (7%)
Query: 470 PLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SGQGL 522
           P F  +ELA         +Q  S +G G +G V      K G  +AVK+LS+   S    
Sbjct: 2   PTFYRQELAKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA 61
Query: 523 EEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERLDWR 581
           +    E+ ++  ++H N++ LL             + Y+    + A L + +K  +L   
Sbjct: 62  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDD 121
Query: 582 KRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA 641
               +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + D  
Sbjct: 122 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDE 174
Query: 642 DTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
            TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 175 MTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 105/225 (46%), Gaps = 31/225 (13%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQ-GLEEFMNEVMVISKLQHRN 539
            +F+    LG+GGFG V+  + K D    A+KR+   + +   E+ M EV  ++KL+H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL-DW---------RKR---FNI 586
           +VR     +E      +    P   L  +     +KE L DW         R+R    +I
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYL-YIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 587 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA----- 641
              I+  + +LH      ++HRDLK SNI    +   K+ DFG+      ++++      
Sbjct: 124 FLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 642 ------DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIV 680
                  TG+V GT  YMSPE      +S K D+FS G++L E++
Sbjct: 181 MPAYARHTGQV-GTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 100/212 (47%), Gaps = 22/212 (10%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 541
              ++   +G+G FG VY GR      I +  + + +   L+ F  EVM   + +H N+V
Sbjct: 33  EQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVV 92
Query: 542 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
             +G C+      +I      R+L +++ D   K  LD  K   I + I +G+ YLH   
Sbjct: 93  LFMGACMSPPHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG 150
Query: 602 RLRIIHRDLKASNILLDEELNPK--ISDFGMAKIFGGNQ--DQADTGRVV-GTFGYMSPE 656
              I+H+DLK+ N+  D   N K  I+DFG+  I G  Q   + D  R+  G   +++PE
Sbjct: 151 ---ILHKDLKSKNVFYD---NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPE 204
Query: 657 YAMEGR---------FSEKSDVFSFGVLLLEI 679
              +           FS+ SDVF+ G +  E+
Sbjct: 205 IIRQLSPDTEEDKLPFSKHSDVFALGTIWYEL 236

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 467 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 519
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 62
Query: 520 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 578
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 175
Query: 639 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 176 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 17/215 (7%)
Query: 476 ELATATNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSK---ASGQGLEEFMNEVMV 531
           ++     +F L   LG+G FG V+    K   Q  A+K L K        +E  M E  V
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 70
Query: 532 ISKLQHRNLVRLLGCCVEGEEKML-IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGI 590
           +S       +  + C  + +E +  + EY+    L   ++      + D  +       I
Sbjct: 71  LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAEI 127
Query: 591 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK--IFGGNQDQADTGRVVG 648
             GL +LH      I++RDLK  NILLD++ + KI+DFGM K  + G     A T    G
Sbjct: 128 ILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG----DAKTNXFCG 180
Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           T  Y++PE  +  +++   D +SFGVLL E++ G+
Sbjct: 181 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 107/216 (49%), Gaps = 28/216 (12%)
Query: 484 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLV 541
           F+L   +G G +G VY GR +K GQ  A+K +   +G   EE   E+ ++ K   HRN+ 
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTGDEEEEIKQEINMLKKYSHHRNIA 84
Query: 542 RLLGCCVE------GEEKMLIYEYMPNRSLDALLFDP----LKKERLDWRKRFNIIEGIS 591
              G  ++       ++  L+ E+    S+  L+ +     LK+E + +     I   I 
Sbjct: 85  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY-----ICREIL 139
Query: 592 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFG 651
           RGL +LH+    ++IHRD+K  N+LL E    K+ DFG++        + +T   +GT  
Sbjct: 140 RGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPY 194
Query: 652 YMSPEYAM-----EGRFSEKSDVFSFGVLLLEIVSG 682
           +M+PE        +  +  KSD++S G+  +E+  G
Sbjct: 195 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 107/211 (50%), Gaps = 19/211 (9%)
Query: 480 ATNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQ-GLE-EFMNEVMVISKLQ 536
           AT+ ++  +++G G +G VY  R    G  +A+K +   +G+ GL    + EV ++ +L+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 537 ---HRNLVRLLGCCVEGE-----EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE 588
              H N+VRL+  C         +  L++E++ ++ L   L D      L      +++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 589 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 648
              RGL +LH +    I+HRDLK  NIL+      K++DFG+A+I+     Q     VV 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY---QMALFPVVV 173
Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEI 679
           T  Y +PE  ++  ++   D++S G +  E+
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 467 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 519
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 22  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 81
Query: 520 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 578
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 82  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 141
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 142 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 194
Query: 639 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 195 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 467 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 519
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 9   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 68
Query: 520 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 578
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 69  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 128
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 129 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 181
Query: 639 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 182 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 105/227 (46%), Gaps = 12/227 (5%)
Query: 476 ELATATNNFQLSSKLGQGGFGPVYWGRLKDGQ----EIAVKRLSK-ASGQGLEEFMNEVM 530
           +   A  +  L+  LG+G FG VY G   + +     +AVK   K  +    E+FM+E +
Sbjct: 2   QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAV 61
Query: 531 VISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGI 590
           ++  L H ++V+L+G  +E E   +I E  P   L   L     K  L           I
Sbjct: 62  IMKNLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQI 118
Query: 591 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF 650
            + + YL     +  +HRD+   NIL+      K+ DFG+++ +  ++D           
Sbjct: 119 CKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPI 174
Query: 651 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILG 697
            +MSPE     RF+  SDV+ F V + EI+S  K   F+ ++  ++G
Sbjct: 175 KWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIG 221

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 115/236 (48%), Gaps = 17/236 (7%)
Query: 457 SATNVNTVKLQDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAV 511
           SA    T+  ++ P F  +EL          +Q  S +G G +G V     +K G +IAV
Sbjct: 22  SAAAPFTMSHKERPTFYRQELNKTIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAV 81
Query: 512 KRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDAL 568
           K+LS+   S    +    E+ ++  ++H N++ LL             + Y+    + A 
Sbjct: 82  KKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGAD 141
Query: 569 LFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDF 628
           L + +K ++L       +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DF
Sbjct: 142 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF 198
Query: 629 GMAKIFGGNQDQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
           G+A+    + D   TG  V T  Y +PE  +    ++   D++S G ++ E+++GR
Sbjct: 199 GLAR----HTDDEMTG-YVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 107/222 (48%), Gaps = 21/222 (9%)
Query: 466 LQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRL--SKASGQGL 522
           L ++P  +F       ++F +   LG+G FG VY  R K  + I A+K L  S+   +G+
Sbjct: 4   LAEMPKRKF-----TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGV 58
Query: 523 E-EFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKE-RLDW 580
           E +   E+ + S L+H N++R+     + +   L+ E+ P       L+  L+K  R D 
Sbjct: 59  EHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPR----GELYKELQKHGRFDE 114
Query: 581 RKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ 640
           ++    +E ++  L Y H     ++IHRD+K  N+L+  +   KI+DFG    +  +   
Sbjct: 115 QRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFG----WSVHAPS 167
Query: 641 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
                + GT  Y+ PE        EK D++  GVL  E + G
Sbjct: 168 LRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 209

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 467 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 519
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 23  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 82
Query: 520 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 578
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 83  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 142
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 143 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 195
Query: 639 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 196 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 109/221 (49%), Gaps = 26/221 (11%)
Query: 476 ELATATNNFQLSSK------LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEE--FM 526
           +L T    FQ   K      +G+G +G V   R KD G+ +A+K+  ++    + +   M
Sbjct: 13  DLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAM 72
Query: 527 NEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDW----RK 582
            E+ ++ +L+H NLV LL  C + +   L++E++ +  LD L   P     LD+    + 
Sbjct: 73  REIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFP---NGLDYQVVQKY 129
Query: 583 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD 642
            F II GI  G  + H      IIHRD+K  NIL+ +    K+ DFG A+      +  D
Sbjct: 130 LFQIINGI--GFCHSH-----NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYD 182
Query: 643 TGRVVGTFGYMSPEYAM-EGRFSEKSDVFSFGVLLLEIVSG 682
               V T  Y +PE  + + ++ +  DV++ G L+ E+  G
Sbjct: 183 DE--VATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG 221

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 467 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 519
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LSK   S 
Sbjct: 15  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSI 74
Query: 520 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 578
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 75  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 134
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 135 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 187
Query: 639 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 188 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 107/222 (48%), Gaps = 21/222 (9%)
Query: 466 LQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRL--SKASGQGL 522
           L ++P  +F       ++F +   LG+G FG VY  R K  + I A+K L  S+   +G+
Sbjct: 3   LAEMPKRKF-----TIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGV 57
Query: 523 E-EFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKE-RLDW 580
           E +   E+ + S L+H N++R+     + +   L+ E+ P       L+  L+K  R D 
Sbjct: 58  EHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPR----GELYKELQKHGRFDE 113
Query: 581 RKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ 640
           ++    +E ++  L Y H     ++IHRD+K  N+L+  +   KI+DFG    +  +   
Sbjct: 114 QRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFG----WSVHAPS 166
Query: 641 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
                + GT  Y+ PE        EK D++  GVL  E + G
Sbjct: 167 LRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 467 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 519
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 520 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 578
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKL 122
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR----HT 175
Query: 639 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 176 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 105/227 (46%), Gaps = 12/227 (5%)
Query: 476 ELATATNNFQLSSKLGQGGFGPVYWGRLKDGQ----EIAVKRLSK-ASGQGLEEFMNEVM 530
           +   A  +  L+  LG+G FG VY G   + +     +AVK   K  +    E+FM+E +
Sbjct: 6   QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAV 65
Query: 531 VISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGI 590
           ++  L H ++V+L+G  +E E   +I E  P   L   L     K  L           I
Sbjct: 66  IMKNLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQI 122
Query: 591 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF 650
            + + YL     +  +HRD+   NIL+      K+ DFG+++ +  ++D           
Sbjct: 123 CKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPI 178
Query: 651 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILG 697
            +MSPE     RF+  SDV+ F V + EI+S  K   F+ ++  ++G
Sbjct: 179 KWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIG 225

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 101/210 (48%), Gaps = 37/210 (17%)
Query: 489 KLGQGGFGPVYWGRLKDGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGC 546
           K+G+G +G VY  +   G+  A+K  RL K         + E+ ++ +L+H N+V+L   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 547 CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEG-------------ISRG 593
               +  +L++E++                  D +K  ++ EG             +  G
Sbjct: 69  IHTKKRLVLVFEHLDQ----------------DLKKLLDVCEGGLESVTAKSFLLQLLNG 112
Query: 594 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 653
           + Y H     R++HRDLK  N+L++ E   KI+DFG+A+ FG    +  T  VV T  Y 
Sbjct: 113 IAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-THEVV-TLWYR 167
Query: 654 SPEYAM-EGRFSEKSDVFSFGVLLLEIVSG 682
           +P+  M   ++S   D++S G +  E+V+G
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 467 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 519
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 520 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 578
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 175
Query: 639 DQADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGR 683
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 176 DDEMTG-YVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 105/227 (46%), Gaps = 12/227 (5%)
Query: 476 ELATATNNFQLSSKLGQGGFGPVYWGRLKDGQ----EIAVKRLSK-ASGQGLEEFMNEVM 530
           +   A  +  L+  LG+G FG VY G   + +     +AVK   K  +    E+FM+E +
Sbjct: 18  QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAV 77
Query: 531 VISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGI 590
           ++  L H ++V+L+G  +E E   +I E  P   L   L     K  L           I
Sbjct: 78  IMKNLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQI 134
Query: 591 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF 650
            + + YL     +  +HRD+   NIL+      K+ DFG+++ +  ++D           
Sbjct: 135 CKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPI 190
Query: 651 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILG 697
            +MSPE     RF+  SDV+ F V + EI+S  K   F+ ++  ++G
Sbjct: 191 KWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIG 237

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 101/210 (48%), Gaps = 37/210 (17%)
Query: 489 KLGQGGFGPVYWGRLKDGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGC 546
           K+G+G +G VY  +   G+  A+K  RL K         + E+ ++ +L+H N+V+L   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 547 CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEG-------------ISRG 593
               +  +L++E++                  D +K  ++ EG             +  G
Sbjct: 69  IHTKKRLVLVFEHLDQ----------------DLKKLLDVCEGGLESVTAKSFLLQLLNG 112
Query: 594 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 653
           + Y H     R++HRDLK  N+L++ E   KI+DFG+A+ FG    +  T  VV T  Y 
Sbjct: 113 IAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-THEVV-TLWYR 167
Query: 654 SPEYAM-EGRFSEKSDVFSFGVLLLEIVSG 682
           +P+  M   ++S   D++S G +  E+V+G
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 467 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 519
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 520 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 578
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKL 122
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 175
Query: 639 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 176 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 105/216 (48%), Gaps = 15/216 (6%)
Query: 474 FEELATATNNFQLSSKLGQGGFGPV------YWGRLKDGQEIAVKRLSKASGQGLEEFMN 527
            E      N F+    LG+GGFG V        G++   +++  KR+ K  G+ +   +N
Sbjct: 176 LERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LN 233
Query: 528 EVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNII 587
           E  ++ K+  R +V L       +   L+   M    L   ++   +    + R  F   
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA 293
Query: 588 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVV 647
           E I  GL  LHR+   RI++RDLK  NILLD+  + +ISD G+A      + Q   GR V
Sbjct: 294 E-ICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGR-V 346
Query: 648 GTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           GT GYM+PE     R++   D ++ G LL E+++G+
Sbjct: 347 GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 115/230 (50%), Gaps = 42/230 (18%)
Query: 484 FQLSSKLGQGGFGPVYWGRL--KDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQ-HR 538
           ++L  KLG+G +G + W  +  + G+ +AVK++  A  +    +    E+M++++L  H 
Sbjct: 11  YELVKKLGKGAYG-IVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHE 69
Query: 539 NLVRLLGCCVEGEEK--MLIYEYMP---NRSLDALLFDPLKKERLDWRKRFNIIEGISRG 593
           N+V LL       ++   L+++YM    +  + A + +P+ K+         ++  + + 
Sbjct: 70  NIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQY--------VVYQLIKV 121
Query: 594 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG----------------- 636
           + YLH      ++HRD+K SNILL+ E + K++DFG+++ F                   
Sbjct: 122 IKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTE 178
Query: 637 --NQDQADTGRVVGTFGYMSPEYAM-EGRFSEKSDVFSFGVLLLEIVSGR 683
             + DQ      V T  Y +PE  +   ++++  D++S G +L EI+ G+
Sbjct: 179 NFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 467 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 519
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 520 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 578
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 175
Query: 639 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 176 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 467 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 519
           Q+ P F  +EL          +Q  + +G G +G V      K G  +AVK+LS+   S 
Sbjct: 13  QERPTFYRQELNKTIWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 72
Query: 520 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 578
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 73  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 132
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 133 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 185
Query: 639 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 186 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 467 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 519
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 520 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 578
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 175
Query: 639 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 176 DDEMTG-XVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 108/223 (48%), Gaps = 17/223 (7%)
Query: 470 PLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SGQGL 522
           P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S    
Sbjct: 2   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA 61
Query: 523 EEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERLDWR 581
           +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L   
Sbjct: 62  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 121
Query: 582 KRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA 641
               +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + D  
Sbjct: 122 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDE 174
Query: 642 DTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
            TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 175 MTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 467 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 519
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 8   QERPTFYRQELNKTIWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 67
Query: 520 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 578
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 68  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 127
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 128 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR----HT 180
Query: 639 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 181 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 467 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 519
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 520 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 578
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 175
Query: 639 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 176 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 105/216 (48%), Gaps = 15/216 (6%)
Query: 474 FEELATATNNFQLSSKLGQGGFGPV------YWGRLKDGQEIAVKRLSKASGQGLEEFMN 527
            E      N F+    LG+GGFG V        G++   +++  KR+ K  G+ +   +N
Sbjct: 176 LERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LN 233
Query: 528 EVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNII 587
           E  ++ K+  R +V L       +   L+   M    L   ++   +    + R  F   
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA 293
Query: 588 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVV 647
           E I  GL  LHR+   RI++RDLK  NILLD+  + +ISD G+A      + Q   GR V
Sbjct: 294 E-ICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGR-V 346
Query: 648 GTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           GT GYM+PE     R++   D ++ G LL E+++G+
Sbjct: 347 GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 467 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 519
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 8   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 67
Query: 520 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 578
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 68  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 127
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 128 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 180
Query: 639 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 181 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 467 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 519
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 2   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 61
Query: 520 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 578
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 62  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 121
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 122 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 174
Query: 639 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 175 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 467 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 519
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 5   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 64
Query: 520 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 578
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 65  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 124
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 125 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 177
Query: 639 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 178 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 101/210 (48%), Gaps = 37/210 (17%)
Query: 489 KLGQGGFGPVYWGRLKDGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGC 546
           K+G+G +G VY  +   G+  A+K  RL K         + E+ ++ +L+H N+V+L   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 547 CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEG-------------ISRG 593
               +  +L++E++                  D +K  ++ EG             +  G
Sbjct: 69  IHTKKRLVLVFEHLDQ----------------DLKKLLDVCEGGLESVTAKSFLLQLLNG 112
Query: 594 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 653
           + Y H     R++HRDLK  N+L++ E   KI+DFG+A+ FG    +  T  +V T  Y 
Sbjct: 113 IAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-THEIV-TLWYR 167
Query: 654 SPEYAM-EGRFSEKSDVFSFGVLLLEIVSG 682
           +P+  M   ++S   D++S G +  E+V+G
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 467 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 519
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 520 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 578
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 175
Query: 639 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 176 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 467 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 519
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 5   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 64
Query: 520 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 578
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 65  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 124
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 125 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 177
Query: 639 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 178 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 467 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 519
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 10  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 69
Query: 520 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 578
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 70  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 129
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 130 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 182
Query: 639 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 183 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 467 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 519
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 8   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 67
Query: 520 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 578
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 68  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 127
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 128 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 180
Query: 639 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 181 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 467 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 519
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 8   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 67
Query: 520 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 578
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 68  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 127
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 128 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR----HT 180
Query: 639 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 181 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 467 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 519
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 5   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 64
Query: 520 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 578
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 65  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 124
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 125 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 177
Query: 639 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 178 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 467 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 519
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 520 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 578
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 175
Query: 639 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 176 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 467 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 519
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 520 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 578
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 175
Query: 639 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 176 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 467 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 519
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 520 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 578
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 175
Query: 639 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 176 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 467 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 519
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 15  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 74
Query: 520 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 578
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 75  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 134
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 135 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 187
Query: 639 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 188 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 467 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 519
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 15  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 74
Query: 520 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 578
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 75  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 134
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 135 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 187
Query: 639 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 188 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 467 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 519
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 520 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 578
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 175
Query: 639 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 176 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 467 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 519
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 14  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 73
Query: 520 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 578
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 74  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 133
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 134 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 186
Query: 639 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 187 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 467 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 519
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 22  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 81
Query: 520 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 578
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 82  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 141
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 142 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 194
Query: 639 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 195 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 111/232 (47%), Gaps = 21/232 (9%)
Query: 473 QFEELATATNNFQLSSKLGQGGFGPVYWGRLK--DGQ--EIAVKRLSK--ASGQGLEEFM 526
           + E++      F L   LG+G FG V   +LK  DG   ++AVK L     +   +EEF+
Sbjct: 14  KLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFL 73
Query: 527 NEVMVISKLQHRNLVRLLGCCVEGEEK------MLIYEYMPNRSLDALLFDPLKKER--- 577
            E   + +  H ++ +L+G  +    K      M+I  +M +  L A L      E    
Sbjct: 74  REAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFN 133
Query: 578 LDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA-KIFGG 636
           L  +     +  I+ G+ YL   S    IHRDL A N +L E++   ++DFG++ KI+ G
Sbjct: 134 LPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSG 190
Query: 637 NQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSF 688
           +  +      +    +++ E   +  ++  SDV++FGV + EI++ R  T +
Sbjct: 191 DYYRQGCASKL-PVKWLALESLADNLYTVHSDVWAFGVTMWEIMT-RGQTPY 240

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 467 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 519
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 14  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 73
Query: 520 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 578
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 74  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 133
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 134 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR----HT 186
Query: 639 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 187 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 467 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 519
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 9   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 68
Query: 520 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 578
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 69  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 128
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 129 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 181
Query: 639 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 182 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 467 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 519
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 9   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 68
Query: 520 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 578
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 69  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 128
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 129 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 181
Query: 639 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 182 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 467 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 519
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 23  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 82
Query: 520 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 578
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 83  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 142
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 143 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 195
Query: 639 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 196 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 467 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 519
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 26  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 85
Query: 520 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 578
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 86  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 145
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 146 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 198
Query: 639 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 199 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 69/256 (26%), Positives = 113/256 (44%), Gaps = 32/256 (12%)
Query: 451 EVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVY----WGRLKD- 505
           +V+ +++  N   +    LP     E     N       LG G FG V     +G +K  
Sbjct: 10  KVVEEINGNNXVXIDPTQLPYDHKWEFPR--NRLSFGKTLGAGAFGKVVEATAYGLIKSD 67
Query: 506 -GQEIAVKRLSKASG-QGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEY--- 559
               +AVK L  ++     E  M+E+ V+S L  H N+V LLG C  G   ++I EY   
Sbjct: 68  AAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCY 127
Query: 560 --------------MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 605
                         + +++  A++ D      L+    F+    +++G+ +L   +    
Sbjct: 128 GDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSY--QVAKGMAFLASKN---C 182
Query: 606 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSE 665
           IHRDL A NILL      KI DFG+A+    + +    G       +M+PE      ++ 
Sbjct: 183 IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF 242
Query: 666 KSDVFSFGVLLLEIVS 681
           +SDV+S+G+ L E+ S
Sbjct: 243 ESDVWSYGIFLWELFS 258

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 109/226 (48%), Gaps = 17/226 (7%)
Query: 467 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 519
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 62
Query: 520 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 578
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 175
Query: 639 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
           D    G  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 176 DDEMAG-FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 109/226 (48%), Gaps = 17/226 (7%)
Query: 467 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 519
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 62
Query: 520 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 578
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 175
Query: 639 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
           D    G  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 176 DDEMAG-FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 119/267 (44%), Gaps = 32/267 (11%)
Query: 440 FLWRWIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVY 499
           +L + + + + +V+ +++  N   +    LP     E     N       LG G FG V 
Sbjct: 6   YLQKPMYEVQWKVVEEINGNNYVYIDPTQLPYDHKWEFPR--NRLSFGKTLGAGAFGKVV 63
Query: 500 ----WGRLKD--GQEIAVKRLSKASG-QGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGE 551
               +G +K      +AVK L  ++     E  M+E+ V+S L  H N+V LLG C  G 
Sbjct: 64  EATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 123
Query: 552 EKMLIYEY-----------------MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 594
             ++I EY                 + +++  A++ D      L+    F+    +++G+
Sbjct: 124 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSY--QVAKGM 181
Query: 595 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 654
            +L   +    IHRDL A NILL      KI DFG+A+    + +    G       +M+
Sbjct: 182 AFLASKN---CIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARLPVKWMA 238
Query: 655 PEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           PE      ++ +SDV+S+G+ L E+ S
Sbjct: 239 PESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 119/267 (44%), Gaps = 32/267 (11%)
Query: 440 FLWRWIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVY 499
           +L + + + + +V+ +++  N   +    LP     E     N       LG G FG V 
Sbjct: 1   YLQKPMYEVQWKVVEEINGNNYVYIDPTQLPYDHKWEFPR--NRLSFGKTLGAGAFGKVV 58
Query: 500 ----WGRLKD--GQEIAVKRLSKASG-QGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGE 551
               +G +K      +AVK L  ++     E  M+E+ V+S L  H N+V LLG C  G 
Sbjct: 59  EATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 118
Query: 552 EKMLIYEY-----------------MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 594
             ++I EY                 + +++  A++ D      L+    F+    +++G+
Sbjct: 119 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSY--QVAKGM 176
Query: 595 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 654
            +L   +    IHRDL A NILL      KI DFG+A+    + +    G       +M+
Sbjct: 177 AFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMA 233
Query: 655 PEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           PE      ++ +SDV+S+G+ L E+ S
Sbjct: 234 PESIFNCVYTFESDVWSYGIFLWELFS 260

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 467 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 519
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 5   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 64
Query: 520 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 578
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 65  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 124
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 125 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR----HT 177
Query: 639 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 178 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 113/209 (54%), Gaps = 18/209 (8%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDG----QEIAVKRLSKASGQGLEEFMNEVM--VISKL 535
           + F+L   LGQG FG V+  +   G    Q  A+K L KA+ +  +    ++   ++ ++
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRK--RFNIIEGISRG 593
            H  +V+L        +  LI +++  R  D  LF  L KE +   +  +F + E ++  
Sbjct: 84  NHPFIVKLHYAFQTEGKLYLILDFL--RGGD--LFTRLSKEVMFTEEDVKFYLAE-LALA 138
Query: 594 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 653
           L +LH    L II+RDLK  NILLDEE + K++DFG++K    ++ +A +    GT  YM
Sbjct: 139 LDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYM 193
Query: 654 SPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           +PE       ++ +D +SFGVL+ E+++G
Sbjct: 194 APEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 119/267 (44%), Gaps = 32/267 (11%)
Query: 440 FLWRWIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVY 499
           +L + + + + +V+ +++  N   +    LP     E     N       LG G FG V 
Sbjct: 6   YLQKPMYEVQWKVVEEINGNNYVYIDPTQLPYDHKWEFPR--NRLSFGKTLGAGAFGKVV 63
Query: 500 ----WGRLKD--GQEIAVKRLSKASG-QGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGE 551
               +G +K      +AVK L  ++     E  M+E+ V+S L  H N+V LLG C  G 
Sbjct: 64  EATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 123
Query: 552 EKMLIYEY-----------------MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 594
             ++I EY                 + +++  A++ D      L+    F+    +++G+
Sbjct: 124 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSY--QVAKGM 181
Query: 595 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 654
            +L   +    IHRDL A NILL      KI DFG+A+    + +    G       +M+
Sbjct: 182 AFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMA 238
Query: 655 PEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           PE      ++ +SDV+S+G+ L E+ S
Sbjct: 239 PESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 467 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 519
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 9   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 68
Query: 520 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 578
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 69  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 128
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 129 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR----HT 181
Query: 639 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 182 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 99/211 (46%), Gaps = 15/211 (7%)
Query: 481 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLE---EFMNEVMVISKLQ 536
           ++ ++L   LG GG   V+  R L+  +++AVK L     +       F  E    + L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 537 HRNLVRLLGC----CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 592
           H  +V +          G    ++ EY+   +L  ++     +  +  ++   +I    +
Sbjct: 71  HPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 127
Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ-ADTGRVVGTFG 651
            L + H++    IIHRD+K +NI++      K+ DFG+A+    + +    T  V+GT  
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 652 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           Y+SPE A       +SDV+S G +L E+++G
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 108/223 (48%), Gaps = 17/223 (7%)
Query: 470 PLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SGQGL 522
           P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S    
Sbjct: 4   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 63
Query: 523 EEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERLDWR 581
           +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L   
Sbjct: 64  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 123
Query: 582 KRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA 641
               +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + D  
Sbjct: 124 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDE 176
Query: 642 DTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
            TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 177 MTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 467 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 519
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 520 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 578
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI D+G+A+    + 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDYGLAR----HT 175
Query: 639 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 176 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 109/226 (48%), Gaps = 17/226 (7%)
Query: 467 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 519
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 23  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 82
Query: 520 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 578
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 83  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 142
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 143 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 195
Query: 639 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
           D    G  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 196 DDEMXG-XVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 98/225 (43%), Gaps = 30/225 (13%)
Query: 482 NNFQLSSKLGQGGFGPVY----WGRLKD--GQEIAVKRLSKASG-QGLEEFMNEVMVISK 534
           N       LG G FG V     +G +K      +AVK L  ++     E  M+E+ V+S 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 535 L-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEG---- 589
           L  H N+V LLG C  G   ++I EY      D L F   K++     K    I      
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYG--DLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 590 -------------ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 636
                        +++G+ +L   +    IHRDL A NILL      KI DFG+A+    
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKN 197
Query: 637 NQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           + +    G       +M+PE      ++ +SDV+S+G+ L E+ S
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 108/223 (48%), Gaps = 17/223 (7%)
Query: 470 PLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SGQGL 522
           P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S    
Sbjct: 2   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 61
Query: 523 EEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERLDWR 581
           +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L   
Sbjct: 62  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 121
Query: 582 KRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA 641
               +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + D  
Sbjct: 122 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDE 174
Query: 642 DTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
            TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 175 MTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 113/209 (54%), Gaps = 18/209 (8%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDG----QEIAVKRLSKASGQGLEEFMNEVM--VISKL 535
           + F+L   LGQG FG V+  +   G    Q  A+K L KA+ +  +    ++   ++ ++
Sbjct: 25  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 84
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRK--RFNIIEGISRG 593
            H  +V+L        +  LI +++  R  D  LF  L KE +   +  +F + E ++  
Sbjct: 85  NHPFIVKLHYAFQTEGKLYLILDFL--RGGD--LFTRLSKEVMFTEEDVKFYLAE-LALA 139
Query: 594 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 653
           L +LH    L II+RDLK  NILLDEE + K++DFG++K    ++ +A +    GT  YM
Sbjct: 140 LDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYM 194
Query: 654 SPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           +PE       ++ +D +SFGVL+ E+++G
Sbjct: 195 APEVVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 108/223 (48%), Gaps = 17/223 (7%)
Query: 470 PLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SGQGL 522
           P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S    
Sbjct: 3   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 62
Query: 523 EEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERLDWR 581
           +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L   
Sbjct: 63  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 122
Query: 582 KRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA 641
               +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + D  
Sbjct: 123 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDE 175
Query: 642 DTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
            TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 176 MTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 103/205 (50%), Gaps = 14/205 (6%)
Query: 484 FQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLS--KASGQGLEEFMNEVMVISKLQHRNL 540
           +QL  +LG+G F  V    ++  GQE A K ++  K S +  ++   E  +   L+H N+
Sbjct: 24  YQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNI 83
Query: 541 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 600
           VRL     E     LI++ +       L  D + +E        + I+ I   +L+ H+ 
Sbjct: 84  VRLHDSISEEGHHYLIFDLVTG---GELFEDIVAREYYSEADASHCIQQILEAVLHCHQ- 139
Query: 601 SRLRIIHRDLKASNILLDEELN---PKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEY 657
             + ++HRDLK  N+LL  +L     K++DFG+A    G Q QA  G   GT GY+SPE 
Sbjct: 140 --MGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-QAWFG-FAGTPGYLSPEV 195
Query: 658 AMEGRFSEKSDVFSFGVLLLEIVSG 682
             +  + +  D+++ GV+L  ++ G
Sbjct: 196 LRKDPYGKPVDLWACGVILYILLVG 220

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 108/223 (48%), Gaps = 17/223 (7%)
Query: 470 PLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SGQGL 522
           P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S    
Sbjct: 3   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 62
Query: 523 EEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERLDWR 581
           +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L   
Sbjct: 63  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 122
Query: 582 KRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA 641
               +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + D  
Sbjct: 123 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDE 175
Query: 642 DTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
            TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 176 MTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 15/208 (7%)
Query: 481 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLS--KASGQGLEEFMNEVMVISKLQH 537
           ++N+ +  +LG+G F  V     K  G E A K ++  K S +  ++   E  +  KLQH
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 597
            N+VRL     E     L+++ +    L     D + +E        + I+ I   + Y 
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILESIAYC 120
Query: 598 HRDSRLRIIHRDLKASNILLDEELN---PKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 654
           H +    I+HR+LK  N+LL  +      K++DFG+A     N  +A  G   GT GY+S
Sbjct: 121 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHG-FAGTPGYLS 174
Query: 655 PEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           PE   +  +S+  D+++ GV+L  ++ G
Sbjct: 175 PEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 107/216 (49%), Gaps = 19/216 (8%)
Query: 483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLE---EFMNEVMVISKLQHR 538
           ++ L   LG G FG V  G  +  G ++AVK L++   + L+   +   E+  +   +H 
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           ++++L        +  ++ EY+    L   +    + E ++ R+ F   + I   + Y H
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLF---QQILSAVDYCH 128
Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 658
           R     ++HRDLK  N+LLD  +N KI+DFG++ +    +   D+    G+  Y +PE  
Sbjct: 129 RHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDS---CGSPNYAAPE-V 181
Query: 659 MEGRF--SEKSDVFSFGVLLLEIVSGRKNTSFFEDD 692
           + GR     + D++S GV+L  ++ G   T  F+D+
Sbjct: 182 ISGRLYAGPEVDIWSCGVILYALLCG---TLPFDDE 214

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 15/208 (7%)
Query: 481 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLS--KASGQGLEEFMNEVMVISKLQH 537
           ++N+ +  +LG+G F  V     K  G E A K ++  K S +  ++   E  +  KLQH
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 597
            N+VRL     E     L+++ +    L     D + +E        + I+ I   + Y 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILESIAYC 121
Query: 598 HRDSRLRIIHRDLKASNILLDEELN---PKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 654
           H +    I+HR+LK  N+LL  +      K++DFG+A     N  +A  G   GT GY+S
Sbjct: 122 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHG-FAGTPGYLS 175
Query: 655 PEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           PE   +  +S+  D+++ GV+L  ++ G
Sbjct: 176 PEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 104/210 (49%), Gaps = 14/210 (6%)
Query: 479 TATNNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLS--KASGQGLEEFMNEVMVISKL 535
           + T+ +QL   +G+G F  V    +L  G E A K ++  K S +  ++   E  +   L
Sbjct: 1   SMTDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLL 60
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
           +H N+VRL     E     L+++ +       L  D + +E        + I+ I   +L
Sbjct: 61  KHSNIVRLHDSISEEGFHYLVFDLVTG---GELFEDIVAREYYSEADASHCIQQILEAVL 117
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELN---PKISDFGMAKIFGGNQDQADTGRVVGTFGY 652
           + H+   + ++HRDLK  N+LL  +      K++DFG+A    G+Q QA  G   GT GY
Sbjct: 118 HCHQ---MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQ-QAWFG-FAGTPGY 172
Query: 653 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           +SPE   +  + +  D+++ GV+L  ++ G
Sbjct: 173 LSPEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 103/211 (48%), Gaps = 20/211 (9%)
Query: 481 TNNFQLSSKLGQGGFGPVYWG-RLKDGQEIA-----VKRLSKASGQGLEEFMNEVMVISK 534
           T  +QL  +LG+G F  V    ++  GQE A      K+LS    Q LE    E  +   
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLE---REARICRL 66
Query: 535 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 594
           L+H N+VRL     E     LI++ +       L  D + +E        + I+ I   +
Sbjct: 67  LKHPNIVRLHDSISEEGHHYLIFDLVTG---GELFEDIVAREYYSEADASHCIQQILEAV 123
Query: 595 LYLHRDSRLRIIHRDLKASNILLDEELN---PKISDFGMAKIFGGNQDQADTGRVVGTFG 651
           L+ H+   + ++HR+LK  N+LL  +L     K++DFG+A    G Q QA  G   GT G
Sbjct: 124 LHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-QAWFG-FAGTPG 178
Query: 652 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           Y+SPE   +  + +  D+++ GV+L  ++ G
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 113/209 (54%), Gaps = 18/209 (8%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDG----QEIAVKRLSKASGQGLEEFMNEVM--VISKL 535
           + F+L   LGQG FG V+  +   G    Q  A+K L KA+ +  +    ++   ++ ++
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRK--RFNIIEGISRG 593
            H  +V+L        +  LI +++  R  D  LF  L KE +   +  +F + E ++  
Sbjct: 84  NHPFIVKLHYAFQTEGKLYLILDFL--RGGD--LFTRLSKEVMFTEEDVKFYLAE-LALA 138
Query: 594 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 653
           L +LH    L II+RDLK  NILLDEE + K++DFG++K    ++ +A +    GT  YM
Sbjct: 139 LDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYM 193
Query: 654 SPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           +PE       ++ +D +SFGVL+ E+++G
Sbjct: 194 APEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 15/208 (7%)
Query: 481 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLS--KASGQGLEEFMNEVMVISKLQH 537
           ++N+ +  +LG+G F  V     K  G E A K ++  K S +  ++   E  +  KLQH
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 597
            N+VRL     E     L+++ +    L     D + +E        + I+ I   + Y 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILESIAYC 121
Query: 598 HRDSRLRIIHRDLKASNILLDEELN---PKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 654
           H +    I+HR+LK  N+LL  +      K++DFG+A     N  +A  G   GT GY+S
Sbjct: 122 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHG-FAGTPGYLS 175
Query: 655 PEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           PE   +  +S+  D+++ GV+L  ++ G
Sbjct: 176 PEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 101/202 (50%), Gaps = 11/202 (5%)
Query: 488 SKLGQGGFGPVYWGRLKDGQ-EIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNLVRLLG 545
           S +G+G +G V        +  +A+K++S    Q   +  + E+ ++ + +H N++ +  
Sbjct: 49  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 108
Query: 546 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 605
                  + +   Y+    + A L+  LK + L        +  I RGL Y+H  +   +
Sbjct: 109 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 165
Query: 606 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG---RVVGTFGYMSPEYAMEGR 662
           +HRDLK SN+LL+   + KI DFG+A++   + D   TG     V T  Y +PE  +  +
Sbjct: 166 LHRDLKPSNLLLNTTXDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEIMLNSK 223
Query: 663 -FSEKSDVFSFGVLLLEIVSGR 683
            +++  D++S G +L E++S R
Sbjct: 224 GYTKSIDIWSVGCILAEMLSNR 245

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 109/226 (48%), Gaps = 17/226 (7%)
Query: 467 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 519
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 520 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 578
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKL 122
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+ +    + 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLCR----HT 175
Query: 639 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 176 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 107/223 (47%), Gaps = 17/223 (7%)
Query: 470 PLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SGQGL 522
           P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S    
Sbjct: 2   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA 61
Query: 523 EEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERLDWR 581
           +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L   
Sbjct: 62  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 121
Query: 582 KRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA 641
               +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + D  
Sbjct: 122 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDE 174
Query: 642 DTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
             G  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 175 MAG-FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 103/220 (46%), Gaps = 25/220 (11%)
Query: 479 TATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRL-SKASGQGLEEFMNEVMVISKLQH 537
           T     Q+  ++G+G +G V+ G+ + G+++AVK   +        E   E+     ++H
Sbjct: 34  TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRE--TEIYQTVLMRH 90
Query: 538 RNLVRLLGCCVEGE----EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRG 593
            N++  +   ++G     +  LI +Y  N SL    +D LK   LD +    +      G
Sbjct: 91  ENILGFIAADIKGTGSWTQLYLITDYHENGSL----YDYLKSTTLDAKSMLKLAYSSVSG 146
Query: 594 LLYLHRD-----SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT--GRV 646
           L +LH +      +  I HRDLK+ NIL+ +     I+D G+A  F  + ++ D      
Sbjct: 147 LCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR 206
Query: 647 VGTFGYMSPEYAMEG----RFSE--KSDVFSFGVLLLEIV 680
           VGT  YM PE   E      F     +D++SFG++L E+ 
Sbjct: 207 VGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 105/212 (49%), Gaps = 23/212 (10%)
Query: 481 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEE---FMNEVMVISKLQ 536
           ++ +Q   KLG G +G V   + K  G E A+K + K+S          ++EV V+ +L 
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 79
Query: 537 HRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
           H N+++L     +     L+ E Y      D ++     +++        I++ +  G  
Sbjct: 80  HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIIL----RQKFSEVDAAVIMKQVLSGTT 135
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNP---KISDFGMAKIF--GGNQDQADTGRVVGTF 650
           YLH+ +   I+HRDLK  N+LL+ +      KI DFG++  F  GG   +      +GT 
Sbjct: 136 YLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKER-----LGTA 187
Query: 651 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
            Y++PE  +  ++ EK DV+S GV+L  ++ G
Sbjct: 188 YYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 218

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 99/211 (46%), Gaps = 15/211 (7%)
Query: 481 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLE---EFMNEVMVISKLQ 536
           ++ ++L   LG GG   V+  R L+  +++AVK L     +       F  E    + L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 537 HRNLVRLLGC----CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 592
           H  +V +          G    ++ EY+   +L  ++     +  +  ++   +I    +
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 127
Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ-ADTGRVVGTFG 651
            L + H++    IIHRD+K +NI++      K+ DFG+A+    + +    T  V+GT  
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 652 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           Y+SPE A       +SDV+S G +L E+++G
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 109/226 (48%), Gaps = 17/226 (7%)
Query: 467 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 519
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 62
Query: 520 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 578
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DF +A+    + 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFYLAR----HT 175
Query: 639 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 176 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 100/203 (49%), Gaps = 23/203 (11%)
Query: 489 KLGQGGFG-PVYWGRLKDGQEIAVKRL--SKASGQGLEEFMNEVMVISKLQHRNLVRLLG 545
           K+G+G FG  +     +DG++  +K +  S+ S +  EE   EV V++ ++H N+V+   
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 546 CCVEGEEKMLIYEYMPNRSL-------DALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
              E     ++ +Y     L         +LF   + + LDW         I   L ++H
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQ--EDQILDW------FVQICLALKHVH 142
Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 658
                +I+HRD+K+ NI L ++   ++ DFG+A++     + A     +GT  Y+SPE  
Sbjct: 143 DR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEIC 197
Query: 659 MEGRFSEKSDVFSFGVLLLEIVS 681
               ++ KSD+++ G +L E+ +
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCT 220

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 108/226 (47%), Gaps = 17/226 (7%)
Query: 467 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 519
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 10  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 69
Query: 520 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 578
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 70  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 129
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+      
Sbjct: 130 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEM 186
Query: 639 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
               TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 187 ----TG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 103/203 (50%), Gaps = 13/203 (6%)
Query: 488 SKLGQGGFGPV--YWGRLKDGQEIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNLVRLL 544
           S +G+G +G V   +  L +   +A+K++S    Q   +  + E+ ++ + +H N++ + 
Sbjct: 33  SYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 545 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 604
                   + +   Y+    ++  L+  LK + L        +  I RGL Y+H  +   
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 148
Query: 605 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG---RVVGTFGYMSPEYAMEG 661
           ++HRDLK SN+LL+   + KI DFG+A++   + D   TG     V T  Y +PE  +  
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLARV--ADPDHDHTGFLXEXVATRWYRAPEIMLNS 206
Query: 662 R-FSEKSDVFSFGVLLLEIVSGR 683
           + +++  D++S G +L E++S R
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 103/203 (50%), Gaps = 13/203 (6%)
Query: 488 SKLGQGGFGPV--YWGRLKDGQEIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNLVRLL 544
           S +G+G +G V   +  L +   +A+K++S    Q   +  + E+ ++ + +H N++ + 
Sbjct: 34  SYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 92
Query: 545 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 604
                   + +   Y+    ++  L+  LK + L        +  I RGL Y+H  +   
Sbjct: 93  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 149
Query: 605 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG---RVVGTFGYMSPEYAMEG 661
           ++HRDLK SN+LL+   + KI DFG+A++   + D   TG     V T  Y +PE  +  
Sbjct: 150 VLHRDLKPSNLLLNTTCDLKICDFGLARV--ADPDHDHTGFLXEXVATRWYRAPEIMLNS 207
Query: 662 R-FSEKSDVFSFGVLLLEIVSGR 683
           + +++  D++S G +L E++S R
Sbjct: 208 KGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 108/226 (47%), Gaps = 17/226 (7%)
Query: 467 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 519
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 10  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 69
Query: 520 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 578
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 70  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 129
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+      
Sbjct: 130 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEM 186
Query: 639 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
               TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 187 ----TG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 103/203 (50%), Gaps = 13/203 (6%)
Query: 488 SKLGQGGFGPV--YWGRLKDGQEIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNLVRLL 544
           S +G+G +G V   +  L +   +A+K++S    Q   +  + E+ ++ + +H N++ + 
Sbjct: 34  SYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 92
Query: 545 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 604
                   + +   Y+    ++  L+  LK + L        +  I RGL Y+H  +   
Sbjct: 93  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 149
Query: 605 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG---RVVGTFGYMSPEYAMEG 661
           ++HRDLK SN+LL+   + KI DFG+A++   + D   TG     V T  Y +PE  +  
Sbjct: 150 VLHRDLKPSNLLLNTTCDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEIMLNS 207
Query: 662 R-FSEKSDVFSFGVLLLEIVSGR 683
           + +++  D++S G +L E++S R
Sbjct: 208 KGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 103/203 (50%), Gaps = 13/203 (6%)
Query: 488 SKLGQGGFGPV--YWGRLKDGQEIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNLVRLL 544
           S +G+G +G V   +  L +   +A+K++S    Q   +  + E+ ++ + +H N++ + 
Sbjct: 35  SYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 93
Query: 545 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 604
                   + +   Y+    ++  L+  LK + L        +  I RGL Y+H  +   
Sbjct: 94  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 150
Query: 605 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG---RVVGTFGYMSPEYAMEG 661
           ++HRDLK SN+LL+   + KI DFG+A++   + D   TG     V T  Y +PE  +  
Sbjct: 151 VLHRDLKPSNLLLNTTCDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEIMLNS 208
Query: 662 R-FSEKSDVFSFGVLLLEIVSGR 683
           + +++  D++S G +L E++S R
Sbjct: 209 KGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 103/203 (50%), Gaps = 13/203 (6%)
Query: 488 SKLGQGGFGPV--YWGRLKDGQEIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNLVRLL 544
           S +G+G +G V   +  L +   +A+K++S    Q   +  + E+ ++ + +H N++ + 
Sbjct: 26  SYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 84
Query: 545 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 604
                   + +   Y+    ++  L+  LK + L        +  I RGL Y+H  +   
Sbjct: 85  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 141
Query: 605 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG---RVVGTFGYMSPEYAMEG 661
           ++HRDLK SN+LL+   + KI DFG+A++   + D   TG     V T  Y +PE  +  
Sbjct: 142 VLHRDLKPSNLLLNTTCDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEIMLNS 199
Query: 662 R-FSEKSDVFSFGVLLLEIVSGR 683
           + +++  D++S G +L E++S R
Sbjct: 200 KGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 103/203 (50%), Gaps = 13/203 (6%)
Query: 488 SKLGQGGFGPV--YWGRLKDGQEIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNLVRLL 544
           S +G+G +G V   +  L +   +A+K++S    Q   +  + E+ ++ + +H N++ + 
Sbjct: 33  SYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 545 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 604
                   + +   Y+    ++  L+  LK + L        +  I RGL Y+H  +   
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 148
Query: 605 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG---RVVGTFGYMSPEYAMEG 661
           ++HRDLK SN+LL+   + KI DFG+A++   + D   TG     V T  Y +PE  +  
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 662 R-FSEKSDVFSFGVLLLEIVSGR 683
           + +++  D++S G +L E++S R
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 109/226 (48%), Gaps = 17/226 (7%)
Query: 467 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 519
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 26  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 85
Query: 520 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 578
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 86  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 145
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+    + 
Sbjct: 146 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HT 198
Query: 639 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
           D    G  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 199 DDEMXG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 108/226 (47%), Gaps = 17/226 (7%)
Query: 467 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 519
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 10  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 69
Query: 520 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 578
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 70  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 129
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+      
Sbjct: 130 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEM 186
Query: 639 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
               TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 187 ----TG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 103/203 (50%), Gaps = 13/203 (6%)
Query: 488 SKLGQGGFGPV--YWGRLKDGQEIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNLVRLL 544
           S +G+G +G V   +  L +   +A+K++S    Q   +  + E+ ++ + +H N++ + 
Sbjct: 27  SYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 85
Query: 545 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 604
                   + +   Y+    ++  L+  LK + L        +  I RGL Y+H  +   
Sbjct: 86  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 142
Query: 605 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG---RVVGTFGYMSPEYAMEG 661
           ++HRDLK SN+LL+   + KI DFG+A++   + D   TG     V T  Y +PE  +  
Sbjct: 143 VLHRDLKPSNLLLNTTCDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEIMLNS 200
Query: 662 R-FSEKSDVFSFGVLLLEIVSGR 683
           + +++  D++S G +L E++S R
Sbjct: 201 KGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 107/218 (49%), Gaps = 35/218 (16%)
Query: 481 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEE---FMNEVMVISKLQ 536
           ++ +Q   KLG G +G V   + K  G E A+K + K+S          ++EV V+ +L 
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 62
Query: 537 HRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERLDWRKRFN------IIEG 589
           H N+++L     +     L+ E Y      D ++           R++F+      I++ 
Sbjct: 63  HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIIL----------RQKFSEVDAAVIMKQ 112
Query: 590 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP---KISDFGMAKIF--GGNQDQADTG 644
           +  G  YLH+ +   I+HRDLK  N+LL+ +      KI DFG++  F  GG   +    
Sbjct: 113 VLSGTTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKER--- 166
Query: 645 RVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
             +GT  Y++PE  +  ++ EK DV+S GV+L  ++ G
Sbjct: 167 --LGTAYYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 201

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 99/211 (46%), Gaps = 15/211 (7%)
Query: 481 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLE---EFMNEVMVISKLQ 536
           ++ ++L   LG GG   V+  R L+  +++AVK L     +       F  E    + L 
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 537 HRNLVRLLGC----CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 592
           H  +V +          G    ++ EY+   +L  ++     +  +  ++   +I    +
Sbjct: 88  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 144
Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ-ADTGRVVGTFG 651
            L + H++    IIHRD+K +NI++      K+ DFG+A+    + +    T  V+GT  
Sbjct: 145 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 201
Query: 652 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           Y+SPE A       +SDV+S G +L E+++G
Sbjct: 202 YLSPEQARGDSVDARSDVYSLGCVLYEVLTG 232

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 103/203 (50%), Gaps = 13/203 (6%)
Query: 488 SKLGQGGFGPV--YWGRLKDGQEIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNLVRLL 544
           S +G+G +G V   +  L +   +A+K++S    Q   +  + E+ ++ + +H N++ + 
Sbjct: 27  SYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 85
Query: 545 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 604
                   + +   Y+    ++  L+  LK + L        +  I RGL Y+H  +   
Sbjct: 86  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 142
Query: 605 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG---RVVGTFGYMSPEYAMEG 661
           ++HRDLK SN+LL+   + KI DFG+A++   + D   TG     V T  Y +PE  +  
Sbjct: 143 VLHRDLKPSNLLLNTTCDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEIMLNS 200
Query: 662 R-FSEKSDVFSFGVLLLEIVSGR 683
           + +++  D++S G +L E++S R
Sbjct: 201 KGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 103/203 (50%), Gaps = 13/203 (6%)
Query: 488 SKLGQGGFGPV--YWGRLKDGQEIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNLVRLL 544
           S +G+G +G V   +  L +   +A+K++S    Q   +  + E+ ++ + +H N++ + 
Sbjct: 33  SYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 545 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 604
                   + +   Y+    ++  L+  LK + L        +  I RGL Y+H  +   
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 148
Query: 605 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG---RVVGTFGYMSPEYAMEG 661
           ++HRDLK SN+LL+   + KI DFG+A++   + D   TG     V T  Y +PE  +  
Sbjct: 149 VLHRDLKPSNLLLNTTXDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 662 R-FSEKSDVFSFGVLLLEIVSGR 683
           + +++  D++S G +L E++S R
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 110/246 (44%), Gaps = 18/246 (7%)
Query: 490 LGQGGFGPVYWGRLKDGQEIAVKRLSKAS----GQGLEEFMNEVMVISKLQHRNLVRLLG 545
           LG+GGF   +     D +E+   ++   S        E+   E+ +   L H+++V   G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 546 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 605
              + +   ++ E    RSL  L     +K   +   R+  +  I  G  YLHR+   R+
Sbjct: 89  FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLHRN---RV 142
Query: 606 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSE 665
           IHRDLK  N+ L+E+L  KI DFG+A     + ++  T  + GT  Y++PE   +   S 
Sbjct: 143 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSF 200
Query: 666 KSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPF---LSESSFQ 722
           + DV+S G ++  ++ G+     FE       Y     NE  I   ++P    L +   Q
Sbjct: 201 EVDVWSIGCIMYTLLVGKPP---FETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQ 257
Query: 723 LDMIIR 728
            D   R
Sbjct: 258 TDPTAR 263

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 101/202 (50%), Gaps = 11/202 (5%)
Query: 488 SKLGQGGFGPVYWGRLKDGQ-EIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNLVRLLG 545
           S +G+G +G V        +  +A+K++S    Q   +  + E+ ++ + +H N++ +  
Sbjct: 31  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 90
Query: 546 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 605
                  + +   Y+    ++  L+  LK + L        +  I RGL Y+H  +   +
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 147
Query: 606 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG---RVVGTFGYMSPEYAMEGR 662
           +HRDLK SN+LL+   + KI DFG+A++   + D   TG     V T  Y +PE  +  +
Sbjct: 148 LHRDLKPSNLLLNTTCDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEIMLNSK 205
Query: 663 -FSEKSDVFSFGVLLLEIVSGR 683
            +++  D++S G +L E++S R
Sbjct: 206 GYTKSIDIWSVGCILAEMLSNR 227

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 101/202 (50%), Gaps = 11/202 (5%)
Query: 488 SKLGQGGFGPVYWGRLKDGQ-EIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNLVRLLG 545
           S +G+G +G V        +  +A+K++S    Q   +  + E+ ++ + +H N++ +  
Sbjct: 29  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 546 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 605
                  + +   Y+    ++  L+  LK + L        +  I RGL Y+H  +   +
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 145
Query: 606 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG---RVVGTFGYMSPEYAMEGR 662
           +HRDLK SN+LL+   + KI DFG+A++   + D   TG     V T  Y +PE  +  +
Sbjct: 146 LHRDLKPSNLLLNTTCDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 663 -FSEKSDVFSFGVLLLEIVSGR 683
            +++  D++S G +L E++S R
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNR 225

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 103/203 (50%), Gaps = 13/203 (6%)
Query: 488 SKLGQGGFGPV--YWGRLKDGQEIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNLVRLL 544
           S +G+G +G V   +  L +   +A+K++S    Q   +  + E+ ++ + +H N++ + 
Sbjct: 33  SYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGIN 91
Query: 545 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 604
                   + +   Y+    ++  L+  LK + L        +  I RGL Y+H  +   
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 148
Query: 605 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG---RVVGTFGYMSPEYAMEG 661
           ++HRDLK SN+LL+   + KI DFG+A++   + D   TG     V T  Y +PE  +  
Sbjct: 149 VLHRDLKPSNLLLNTTXDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 662 R-FSEKSDVFSFGVLLLEIVSGR 683
           + +++  D++S G +L E++S R
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 15/208 (7%)
Query: 481 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLS--KASGQGLEEFMNEVMVISKLQH 537
           ++N+ +  +LG+G F  V     K  G E A K ++  K S +  ++   E  +  KLQH
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 597
            N+VRL     E     L+++ +       L  D + +E        + I+ I   + Y 
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTG---GELFEDIVAREFYSEADASHCIQQILESIAYC 144
Query: 598 HRDSRLRIIHRDLKASNILLDEELNP---KISDFGMAKIFGGNQDQADTGRVVGTFGYMS 654
           H +    I+HR+LK  N+LL  +      K++DFG+A     N  +A  G   GT GY+S
Sbjct: 145 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHG-FAGTPGYLS 198
Query: 655 PEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           PE   +  +S+  D+++ GV+L  ++ G
Sbjct: 199 PEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 110/246 (44%), Gaps = 18/246 (7%)
Query: 490 LGQGGFGPVYWGRLKDGQEIAVKRLSKAS----GQGLEEFMNEVMVISKLQHRNLVRLLG 545
           LG+GGF   +     D +E+   ++   S        E+   E+ +   L H+++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 546 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 605
              + +   ++ E    RSL  L     +K   +   R+  +  I  G  YLHR+   R+
Sbjct: 85  FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLHRN---RV 138
Query: 606 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSE 665
           IHRDLK  N+ L+E+L  KI DFG+A     + ++  T  + GT  Y++PE   +   S 
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSF 196
Query: 666 KSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPF---LSESSFQ 722
           + DV+S G ++  ++ G+     FE       Y     NE  I   ++P    L +   Q
Sbjct: 197 EVDVWSIGCIMYTLLVGKPP---FETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQ 253
Query: 723 LDMIIR 728
            D   R
Sbjct: 254 TDPTAR 259

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 107/209 (51%), Gaps = 23/209 (11%)
Query: 484 FQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGLEEFMN---EVMVISKLQHRN 539
           + +   LG+G FG V      K  Q++A+K +S+   +  +  M    E+  +  L+H +
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGLLYL 597
           +++L        + +++ EY      D ++    +K+R+  D  +RF   + I   + Y 
Sbjct: 71  IIKLYDVITTPTDIVMVIEYAGGELFDYIV----EKKRMTEDEGRRF--FQQIICAIEYC 124
Query: 598 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF-GGNQDQADTGRVVGTFGYMSPE 656
           HR    +I+HRDLK  N+LLD+ LN KI+DFG++ I   GN  +       G+  Y +PE
Sbjct: 125 HRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC----GSPNYAAPE 177
Query: 657 YAMEGRF--SEKSDVFSFGVLLLEIVSGR 683
             + G+     + DV+S G++L  ++ GR
Sbjct: 178 -VINGKLYAGPEVDVWSCGIVLYVMLVGR 205

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 110/246 (44%), Gaps = 18/246 (7%)
Query: 490 LGQGGFGPVYWGRLKDGQEIAVKRLSKAS----GQGLEEFMNEVMVISKLQHRNLVRLLG 545
           LG+GGF   +     D +E+   ++   S        E+   E+ +   L H+++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 546 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 605
              + +   ++ E    RSL  L     +K   +   R+  +  I  G  YLHR+   R+
Sbjct: 85  FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLHRN---RV 138
Query: 606 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSE 665
           IHRDLK  N+ L+E+L  KI DFG+A     + ++  T  + GT  Y++PE   +   S 
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSF 196
Query: 666 KSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPF---LSESSFQ 722
           + DV+S G ++  ++ G+     FE       Y     NE  I   ++P    L +   Q
Sbjct: 197 EVDVWSIGCIMYTLLVGKPP---FETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQ 253
Query: 723 LDMIIR 728
            D   R
Sbjct: 254 TDPTAR 259

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 101/202 (50%), Gaps = 11/202 (5%)
Query: 488 SKLGQGGFGPVYWGRLKDGQ-EIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNLVRLLG 545
           S +G+G +G V        +  +A+K++S    Q   +  + E+ ++ + +H N++ +  
Sbjct: 29  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 546 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 605
                  + +   Y+    ++  L+  LK + L        +  I RGL Y+H  +   +
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 145
Query: 606 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG---RVVGTFGYMSPEYAMEGR 662
           +HRDLK SN+LL+   + KI DFG+A++   + D   TG     V T  Y +PE  +  +
Sbjct: 146 LHRDLKPSNLLLNTTXDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 663 -FSEKSDVFSFGVLLLEIVSGR 683
            +++  D++S G +L E++S R
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNR 225

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 101/202 (50%), Gaps = 11/202 (5%)
Query: 488 SKLGQGGFGPVYWGRLKDGQ-EIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNLVRLLG 545
           S +G+G +G V        +  +A+K++S    Q   +  + E+ ++ + +H N++ +  
Sbjct: 29  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 546 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 605
                  + +   Y+    ++  L+  LK + L        +  I RGL Y+H  +   +
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 145
Query: 606 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG---RVVGTFGYMSPEYAMEGR 662
           +HRDLK SN+LL+   + KI DFG+A++   + D   TG     V T  Y +PE  +  +
Sbjct: 146 LHRDLKPSNLLLNTTXDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 663 -FSEKSDVFSFGVLLLEIVSGR 683
            +++  D++S G +L E++S R
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNR 225

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/165 (33%), Positives = 89/165 (53%), Gaps = 10/165 (6%)
Query: 522 LEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWR 581
           +E+   E+ ++ KL H N+V+L+    +  E  L Y      +   ++  P  K   + +
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL-YMVFELVNQGPVMEVPTLKPLSEDQ 138
Query: 582 KRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA 641
            RF   + + +G+ YLH     +IIHRD+K SN+L+ E+ + KI+DFG++  F G+   A
Sbjct: 139 ARF-YFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS--DA 192
Query: 642 DTGRVVGTFGYMSPEYAMEGR--FSEKS-DVFSFGVLLLEIVSGR 683
                VGT  +M+PE   E R  FS K+ DV++ GV L   V G+
Sbjct: 193 LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 101/202 (50%), Gaps = 11/202 (5%)
Query: 488 SKLGQGGFGPVYWGRLKDGQ-EIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNLVRLLG 545
           S +G+G +G V        +  +A+K++S    Q   +  + E+ ++ + +H N++ +  
Sbjct: 29  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 546 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 605
                  + +   Y+    ++  L+  LK + L        +  I RGL Y+H  +   +
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 145
Query: 606 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG---RVVGTFGYMSPEYAMEGR 662
           +HRDLK SN+LL+   + KI DFG+A++   + D   TG     V T  Y +PE  +  +
Sbjct: 146 LHRDLKPSNLLLNTTXDLKIXDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 663 -FSEKSDVFSFGVLLLEIVSGR 683
            +++  D++S G +L E++S R
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNR 225

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 101/202 (50%), Gaps = 11/202 (5%)
Query: 488 SKLGQGGFGPVYWGRLKDGQ-EIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNLVRLLG 545
           S +G+G +G V        +  +A+K++S    Q   +  + E+ ++ + +H N++ +  
Sbjct: 37  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 96
Query: 546 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 605
                  + +   Y+    ++  L+  LK + L        +  I RGL Y+H  +   +
Sbjct: 97  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 153
Query: 606 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG---RVVGTFGYMSPEYAMEGR 662
           +HRDLK SN+LL+   + KI DFG+A++   + D   TG     V T  Y +PE  +  +
Sbjct: 154 LHRDLKPSNLLLNTTCDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEIMLNSK 211
Query: 663 -FSEKSDVFSFGVLLLEIVSGR 683
            +++  D++S G +L E++S R
Sbjct: 212 GYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 101/202 (50%), Gaps = 11/202 (5%)
Query: 488 SKLGQGGFGPVYWGRLKDGQ-EIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNLVRLLG 545
           S +G+G +G V        +  +A+K++S    Q   +  + E+ ++ + +H N++ +  
Sbjct: 29  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 546 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 605
                  + +   Y+    ++  L+  LK + L        +  I RGL Y+H  +   +
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 145
Query: 606 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG---RVVGTFGYMSPEYAMEGR 662
           +HRDLK SN+LL+   + KI DFG+A++   + D   TG     V T  Y +PE  +  +
Sbjct: 146 LHRDLKPSNLLLNTTCDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 663 -FSEKSDVFSFGVLLLEIVSGR 683
            +++  D++S G +L E++S R
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNR 225

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 20/209 (9%)
Query: 484 FQLSSKLGQGGFGPVYWGR----LKDGQEIAVKRLSKA----SGQGLEEFMNEVMVISKL 535
           F+L   LG+GG+G V+  R       G+  A+K L KA    + +       E  ++ ++
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKR--FNIIEGISRG 593
           +H  +V L+     G +  LI EY+    L    F  L++E +       F + E IS  
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGEL----FMQLEREGIFMEDTACFYLAE-ISMA 133
Query: 594 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 653
           L +LH+     II+RDLK  NI+L+ + + K++DFG+ K      D   T    GT  YM
Sbjct: 134 LGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHTFCGTIEYM 188
Query: 654 SPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           +PE  M    +   D +S G L+ ++++G
Sbjct: 189 APEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 101/202 (50%), Gaps = 11/202 (5%)
Query: 488 SKLGQGGFGPVYWGRLKDGQ-EIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNLVRLLG 545
           S +G+G +G V        +  +A+K++S    Q   +  + E+ ++ + +H N++ +  
Sbjct: 49  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 108
Query: 546 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 605
                  + +   Y+    ++  L+  LK + L        +  I RGL Y+H  +   +
Sbjct: 109 IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 165
Query: 606 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG---RVVGTFGYMSPEYAMEGR 662
           +HRDLK SN+LL+   + KI DFG+A++   + D   TG     V T  Y +PE  +  +
Sbjct: 166 LHRDLKPSNLLLNTTCDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEIMLNSK 223
Query: 663 -FSEKSDVFSFGVLLLEIVSGR 683
            +++  D++S G +L E++S R
Sbjct: 224 GYTKSIDIWSVGCILAEMLSNR 245

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 109/226 (48%), Gaps = 17/226 (7%)
Query: 467 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 519
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 520 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 578
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI  FG+A+    + 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILGFGLAR----HT 175
Query: 639 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 176 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 106/216 (49%), Gaps = 22/216 (10%)
Query: 478 ATATNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFM-----NEVMV 531
           + AT+ ++  +++G G +G VY  R    G  +A+K +   +G G    +      EV +
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 532 ISKLQ---HRNLVRLLGCCVEGE-----EKMLIYEYMPNRSLDALLFDPLKKERLDWRKR 583
           + +L+   H N+VRL+  C         +  L++E++ ++ L   L D      L     
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETI 122
Query: 584 FNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 643
            +++    RGL +LH +    I+HRDLK  NIL+      K++DFG+A+I+     Q   
Sbjct: 123 KDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY---QMAL 176
Query: 644 GRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEI 679
             VV T  Y +PE  ++  ++   D++S G +  E+
Sbjct: 177 TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 212

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 103/203 (50%), Gaps = 13/203 (6%)
Query: 488 SKLGQGGFGPV--YWGRLKDGQEIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNLVRLL 544
           S +G+G +G V   +  L +   +A+K++S    Q   +  + E+ ++ + +H N++ + 
Sbjct: 33  SYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 545 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 604
                   + +   Y+    ++  L+  LK + L        +  I RGL Y+H  +   
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHSAN--- 148
Query: 605 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG---RVVGTFGYMSPEYAMEG 661
           ++HRDLK SN+LL+   + KI DFG+A++   + D   TG     V T  Y +PE  +  
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 662 R-FSEKSDVFSFGVLLLEIVSGR 683
           + +++  D++S G +L E++S R
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 109/226 (48%), Gaps = 17/226 (7%)
Query: 467 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 519
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 520 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 578
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI D G+A+    + 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDAGLAR----HT 175
Query: 639 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 176 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 20/209 (9%)
Query: 484 FQLSSKLGQGGFGPVYWGR----LKDGQEIAVKRLSKA----SGQGLEEFMNEVMVISKL 535
           F+L   LG+GG+G V+  R       G+  A+K L KA    + +       E  ++ ++
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKR--FNIIEGISRG 593
           +H  +V L+     G +  LI EY+    L    F  L++E +       F + E IS  
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGEL----FMQLEREGIFMEDTACFYLAE-ISMA 133
Query: 594 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 653
           L +LH+     II+RDLK  NI+L+ + + K++DFG+ K      D   T    GT  YM
Sbjct: 134 LGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHXFCGTIEYM 188
Query: 654 SPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           +PE  M    +   D +S G L+ ++++G
Sbjct: 189 APEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 104/208 (50%), Gaps = 20/208 (9%)
Query: 483 NFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEE--FMNEVMVISKLQHRN 539
            ++   K+G+G +G V+  R +D GQ +A+K+  ++    + +   + E+ ++ +L+H N
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPN 63
Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGIS----RGLL 595
           LV LL          L++EY  +  L  L       +R       ++++ I+    + + 
Sbjct: 64  LVNLLEVFRRKRRLHLVFEYCDHTVLHEL-------DRYQRGVPEHLVKSITWQTLQAVN 116
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 655
           + H+ +    IHRD+K  NIL+ +    K+ DFG A++  G  D  D    V T  Y SP
Sbjct: 117 FCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE--VATRWYRSP 171
Query: 656 EYAM-EGRFSEKSDVFSFGVLLLEIVSG 682
           E  + + ++    DV++ G +  E++SG
Sbjct: 172 ELLVGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 103/203 (50%), Gaps = 13/203 (6%)
Query: 488 SKLGQGGFGPV--YWGRLKDGQEIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNLVRLL 544
           S +G+G +G V   +  L +   +A++++S    Q   +  + E+ ++ + +H N++ + 
Sbjct: 33  SYIGEGAYGMVCSAYDNL-NKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 545 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 604
                   + +   Y+    ++  L+  LK + L        +  I RGL Y+H  +   
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 148
Query: 605 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG---RVVGTFGYMSPEYAMEG 661
           ++HRDLK SN+LL+   + KI DFG+A++   + D   TG     V T  Y +PE  +  
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 662 R-FSEKSDVFSFGVLLLEIVSGR 683
           + +++  D++S G +L E++S R
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 101/199 (50%), Gaps = 9/199 (4%)
Query: 490 LGQGGFGPV--YWGRLKDGQEIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNLVRLLGC 546
           +G+G +G V   +  ++  + +A+K++S    Q   +  + E+ ++ + +H N++ +   
Sbjct: 51  IGEGAYGMVSSAYDHVRKTR-VAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDI 109
Query: 547 CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRII 606
                 + +   Y+    ++  L+  LK ++L        +  I RGL Y+H  +   ++
Sbjct: 110 LRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSAN---VL 166
Query: 607 HRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD-TGRVVGTFGYMSPEYAMEGR-FS 664
           HRDLK SN+L++   + KI DFG+A+I     D        V T  Y +PE  +  + ++
Sbjct: 167 HRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKGYT 226
Query: 665 EKSDVFSFGVLLLEIVSGR 683
           +  D++S G +L E++S R
Sbjct: 227 KSIDIWSVGCILAEMLSNR 245

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 100/202 (49%), Gaps = 11/202 (5%)
Query: 488 SKLGQGGFGPVYWGRLKDGQ-EIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNLVRLLG 545
           S +G+G +G V        +  +A+K++S    Q   +  + E+ ++   +H N++ +  
Sbjct: 31  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGIND 90
Query: 546 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 605
                  + +   Y+    ++  L+  LK + L        +  I RGL Y+H  +   +
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 147
Query: 606 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG---RVVGTFGYMSPEYAMEGR 662
           +HRDLK SN+LL+   + KI DFG+A++   + D   TG     V T  Y +PE  +  +
Sbjct: 148 LHRDLKPSNLLLNTTCDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEIMLNSK 205
Query: 663 -FSEKSDVFSFGVLLLEIVSGR 683
            +++  D++S G +L E++S R
Sbjct: 206 GYTKSIDIWSVGCILAEMLSNR 227

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 109/226 (48%), Gaps = 17/226 (7%)
Query: 467 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 519
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 520 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 578
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI D G+A+    + 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDRGLAR----HT 175
Query: 639 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 176 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 106/216 (49%), Gaps = 19/216 (8%)
Query: 483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLE---EFMNEVMVISKLQHR 538
           ++ L   LG G FG V  G  +  G ++AVK L++   + L+   +   E+  +   +H 
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           ++++L        +  ++ EY+    L   +    + E ++ R+ F   + I   + Y H
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLF---QQILSAVDYCH 128
Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 658
           R     ++HRDLK  N+LLD  +N KI+DFG++ +    +    +    G+  Y +PE  
Sbjct: 129 RHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGSPNYAAPE-V 181
Query: 659 MEGRF--SEKSDVFSFGVLLLEIVSGRKNTSFFEDD 692
           + GR     + D++S GV+L  ++ G   T  F+D+
Sbjct: 182 ISGRLYAGPEVDIWSCGVILYALLCG---TLPFDDE 214

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 109/226 (48%), Gaps = 17/226 (7%)
Query: 467 QDLPLFQFEELATAT----NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SG 519
           Q+ P F  +EL          +Q  S +G G +G V      K G  +AVK+LS+   S 
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 520 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL 578
              +    E+ ++  ++H N++ LL             + Y+    + A L + +K ++L
Sbjct: 63  IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
                  +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI D G+A+    + 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDGGLAR----HT 175
Query: 639 DQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
           D   TG  V T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 176 DDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 106/218 (48%), Gaps = 17/218 (7%)
Query: 474 FEELATAT---NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLS--KASGQGLEEFMN 527
           F+ +AT T   +++QL  +LG+G F  V     K   QE A K ++  K S +  ++   
Sbjct: 20  FQXMATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLER 79
Query: 528 EVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNII 587
           E  +   L+H N+VRL     E     L+++ +       L  D + +E        + I
Sbjct: 80  EARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTG---GELFEDIVAREYYSEADASHCI 136
Query: 588 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELN---PKISDFGMAKIFGGNQDQADTG 644
             I   + ++H+     I+HRDLK  N+LL  +      K++DFG+A    G Q QA  G
Sbjct: 137 HQILESVNHIHQHD---IVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQ-QAWFG 192
Query: 645 RVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
              GT GY+SPE   +  + +  D+++ GV+L  ++ G
Sbjct: 193 -FAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 11/204 (5%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGL--EEFMNEVMVISKLQHRN 539
           ++F+  S+LG G  G V+    K    +  ++L     +     + + E+ V+ +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 599
           +V   G      E  +  E+M   SLD +L    K  R+  +    +   + +GL YL  
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 659
             + +I+HRD+K SNIL++     K+ DFG++    G    +     VGT  YMSPE   
Sbjct: 123 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 176
Query: 660 EGRFSEKSDVFSFGVLLLEIVSGR 683
              +S +SD++S G+ L+E+  GR
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 103/210 (49%), Gaps = 18/210 (8%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQH 537
           N+F +   +G+GGFG VY  R  D G+  A+K L K      QG    +NE +++S +  
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 538 RN--LVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 594
            +   +  +       +K+  I + M    L   L         D R  F   E I  GL
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMR--FYAAE-IILGL 305
Query: 595 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 654
            ++H  +R  +++RDLK +NILLDE  + +ISD G+A  F   +  A     VGT GYM+
Sbjct: 306 EHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMA 358
Query: 655 PEYAMEG-RFSEKSDVFSFGVLLLEIVSGR 683
           PE   +G  +   +D FS G +L +++ G 
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 103/210 (49%), Gaps = 18/210 (8%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQH 537
           N+F +   +G+GGFG VY  R  D G+  A+K L K      QG    +NE +++S +  
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 538 RN--LVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 594
            +   +  +       +K+  I + M    L   L         D R  F   E I  GL
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMR--FYAAE-IILGL 305
Query: 595 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 654
            ++H  +R  +++RDLK +NILLDE  + +ISD G+A  F   +  A     VGT GYM+
Sbjct: 306 EHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMA 358
Query: 655 PEYAMEG-RFSEKSDVFSFGVLLLEIVSGR 683
           PE   +G  +   +D FS G +L +++ G 
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 104/210 (49%), Gaps = 14/210 (6%)
Query: 479 TATNNFQLSSKLGQGGFGPVY-WGRLKDGQEIAVKRLS--KASGQGLEEFMNEVMVISKL 535
           + T+ +QL  +LG+G F  V    ++  GQE A K ++  K S +  ++   E  +   L
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLL 60
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
           +H N+VRL     E     L+++ +       L  D + +E        + I+ I   + 
Sbjct: 61  KHPNIVRLHDSISEEGFHYLVFDLVTG---GELFEDIVAREYYSEADASHCIQQILESVN 117
Query: 596 YLHRDSRLRIIHRDLKASNILLDEE---LNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 652
           + H +    I+HRDLK  N+LL  +      K++DFG+A    G+Q QA  G   GT GY
Sbjct: 118 HCHLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQ-QAWFG-FAGTPGY 172
Query: 653 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           +SPE   +  + +  D+++ GV+L  ++ G
Sbjct: 173 LSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 103/210 (49%), Gaps = 18/210 (8%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQH 537
           N+F +   +G+GGFG VY  R  D G+  A+K L K      QG    +NE +++S +  
Sbjct: 188 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 247
Query: 538 RN--LVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 594
            +   +  +       +K+  I + M    L   L         D R  F   E I  GL
Sbjct: 248 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMR--FYAAE-IILGL 304
Query: 595 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 654
            ++H  +R  +++RDLK +NILLDE  + +ISD G+A  F   +  A     VGT GYM+
Sbjct: 305 EHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMA 357
Query: 655 PEYAMEG-RFSEKSDVFSFGVLLLEIVSGR 683
           PE   +G  +   +D FS G +L +++ G 
Sbjct: 358 PEVLQKGVAYDSSADWFSLGCMLFKLLRGH 387

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 103/210 (49%), Gaps = 18/210 (8%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQH 537
           N+F +   +G+GGFG VY  R  D G+  A+K L K      QG    +NE +++S +  
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 538 RN--LVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 594
            +   +  +       +K+  I + M    L   L         D R  F   E I  GL
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMR--FYAAE-IILGL 305
Query: 595 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 654
            ++H  +R  +++RDLK +NILLDE  + +ISD G+A  F   +  A     VGT GYM+
Sbjct: 306 EHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMA 358
Query: 655 PEYAMEG-RFSEKSDVFSFGVLLLEIVSGR 683
           PE   +G  +   +D FS G +L +++ G 
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 11/204 (5%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGL--EEFMNEVMVISKLQHRN 539
           ++F+  S+LG G  G V+    K    +  ++L     +     + + E+ V+ +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 599
           +V   G      E  +  E+M   SLD +L    K  R+  +    +   + +GL YL  
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 659
             + +I+HRD+K SNIL++     K+ DFG++    G    +     VGT  YMSPE   
Sbjct: 123 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 176
Query: 660 EGRFSEKSDVFSFGVLLLEIVSGR 683
              +S +SD++S G+ L+E+  GR
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 104/210 (49%), Gaps = 14/210 (6%)
Query: 479 TATNNFQLSSKLGQGGFGPVY-WGRLKDGQEIAVKRLS--KASGQGLEEFMNEVMVISKL 535
           + T+ +QL  +LG+G F  V    ++  GQE A K ++  K S +  ++   E  +   L
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLL 60
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
           +H N+VRL     E     L+++ +       L  D + +E        + I+ I   + 
Sbjct: 61  KHPNIVRLHDSISEEGFHYLVFDLVTG---GELFEDIVAREYYSEADASHCIQQILESVN 117
Query: 596 YLHRDSRLRIIHRDLKASNILLDEE---LNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 652
           + H +    I+HRDLK  N+LL  +      K++DFG+A    G+Q QA  G   GT GY
Sbjct: 118 HCHLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQ-QAWFG-FAGTPGY 172
Query: 653 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           +SPE   +  + +  D+++ GV+L  ++ G
Sbjct: 173 LSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 105/212 (49%), Gaps = 18/212 (8%)
Query: 478 ATATNNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLS-KASGQGLE-EFMNEVMVISK 534
           AT+ + ++  +KLG+G +G VY        + +A+KR+  +   +G+    + EV ++ +
Sbjct: 30  ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKE 89
Query: 535 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 594
           LQHRN++ L           LI+EY  N     +  +P    R+     + +I G++   
Sbjct: 90  LQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVN--- 146
Query: 595 LYLHRDSRLRIIHRDLKASNILL---DEELNP--KISDFGMAKIFGGNQDQADTGRVVGT 649
            + H  SR R +HRDLK  N+LL   D    P  KI DFG+A+ FG    Q  T  ++ T
Sbjct: 147 -FCH--SR-RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF-THEII-T 200
Query: 650 FGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIV 680
             Y  PE  +  R +S   D++S   +  E++
Sbjct: 201 LWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 106/234 (45%), Gaps = 28/234 (11%)
Query: 455 KLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKR 513
           K  + N++ VKL D               F     LG+G FG V     K  +E+ A+K 
Sbjct: 7   KQPSNNLDRVKLTD---------------FNFLMVLGKGSFGKVMLADRKGTEELYAIKI 51
Query: 514 LSK---ASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALL 569
           L K        +E  M E  V++ L     +  L  C +  +++  + EY+    L   +
Sbjct: 52  LKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDL---M 108
Query: 570 FDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFG 629
           +   +  +    +       IS GL +LH+     II+RDLK  N++LD E + KI+DFG
Sbjct: 109 YHIQQVGKFKEPQAVFYAAEISIGLFFLHKRG---IIYRDLKLDNVMLDSEGHIKIADFG 165
Query: 630 MAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           M K      D   T    GT  Y++PE      + +  D +++GVLL E+++G+
Sbjct: 166 MCK--EHMMDGVTTREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 217

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 11/204 (5%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGL--EEFMNEVMVISKLQHRN 539
           ++F+  S+LG G  G V+    K    +  ++L     +     + + E+ V+ +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 599
           +V   G      E  +  E+M   SLD +L    K  R+  +    +   + +GL YL  
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 659
             + +I+HRD+K SNIL++     K+ DFG++    G    +     VGT  YMSPE   
Sbjct: 123 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 176
Query: 660 EGRFSEKSDVFSFGVLLLEIVSGR 683
              +S +SD++S G+ L+E+  GR
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 101/229 (44%), Gaps = 21/229 (9%)
Query: 479 TATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGL---EEFMNEVMVISKL 535
           T  +   L   +G+G +G V+ G  + G+ +AVK  S    +      E  N VM    L
Sbjct: 5   TVAHQITLLECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVM----L 59
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
           +H N++  +   +           + +      L+D L+   LD      I+  I+ GL 
Sbjct: 60  RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLA 119
Query: 596 YLH-----RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR--VVG 648
           +LH        +  I HRDLK+ NIL+ +     I+D G+A +   + +Q D G    VG
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVG 179
Query: 649 TFGYMSPEYAMEG------RFSEKSDVFSFGVLLLEIVSGRKNTSFFED 691
           T  YM+PE   E          ++ D+++FG++L E+     +    ED
Sbjct: 180 TKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 228

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 116/254 (45%), Gaps = 36/254 (14%)
Query: 444 WIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 503
           ++AK K + + K  +   NT  L      QFE + T          LG G FG V   + 
Sbjct: 11  FLAKAKEDFLKKWESPAQNTAHLD-----QFERIKT----------LGTGSFGRVMLVKH 55
Query: 504 KD-GQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 559
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 56  KETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 115
Query: 560 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
           +P   +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 116 VPGGEM----FSHLRRIGRFXEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 167
Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 168 DQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 222
Query: 678 EIVSGRKNTSFFED 691
           E+ +G     FF D
Sbjct: 223 EMAAGY--PPFFAD 234

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 11/204 (5%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGL--EEFMNEVMVISKLQHRN 539
           ++F+  S+LG G  G V+    K    +  ++L     +     + + E+ V+ +     
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 127
Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 599
           +V   G      E  +  E+M   SLD +L    K  R+  +    +   + +GL YL  
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLRE 184
Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 659
             + +I+HRD+K SNIL++     K+ DFG++    G    +     VGT  YMSPE   
Sbjct: 185 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 238
Query: 660 EGRFSEKSDVFSFGVLLLEIVSGR 683
              +S +SD++S G+ L+E+  GR
Sbjct: 239 GTHYSVQSDIWSMGLSLVEMAVGR 262

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 11/204 (5%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGL--EEFMNEVMVISKLQHRN 539
           ++F+  S+LG G  G V+    K    +  ++L     +     + + E+ V+ +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 599
           +V   G      E  +  E+M   SLD +L    K  R+  +    +   + +GL YL  
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 659
             + +I+HRD+K SNIL++     K+ DFG++    G    +     VGT  YMSPE   
Sbjct: 123 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 176
Query: 660 EGRFSEKSDVFSFGVLLLEIVSGR 683
              +S +SD++S G+ L+E+  GR
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 101/229 (44%), Gaps = 21/229 (9%)
Query: 479 TATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGL---EEFMNEVMVISKL 535
           T   +  L   +G+G +G V+ G  + G+ +AVK  S    +      E  N VM    L
Sbjct: 5   TVARDITLLECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVM----L 59
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
           +H N++  +   +           + +      L+D L+   LD      I+  I+ GL 
Sbjct: 60  RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLA 119
Query: 596 YLH-----RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR--VVG 648
           +LH        +  I HRDLK+ NIL+ +     I+D G+A +   + +Q D G    VG
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVG 179
Query: 649 TFGYMSPEYAMEG------RFSEKSDVFSFGVLLLEIVSGRKNTSFFED 691
           T  YM+PE   E          ++ D+++FG++L E+     +    ED
Sbjct: 180 TKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 228

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 11/204 (5%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGL--EEFMNEVMVISKLQHRN 539
           ++F+  S+LG G  G V+    K    +  ++L     +     + + E+ V+ +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 599
           +V   G      E  +  E+M   SLD +L    K  R+  +    +   + +GL YL  
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 659
             + +I+HRD+K SNIL++     K+ DFG++    G    +     VGT  YMSPE   
Sbjct: 123 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 176
Query: 660 EGRFSEKSDVFSFGVLLLEIVSGR 683
              +S +SD++S G+ L+E+  GR
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/275 (24%), Positives = 123/275 (44%), Gaps = 18/275 (6%)
Query: 450 AEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSK---LGQGGFGPVYWGRLKDG 506
           +  IAK SA     V  +  PL +  ++       +   +   LG+GGF   Y     D 
Sbjct: 7   SAAIAKPSAKPSAHVDPKSAPLKEIPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDT 66
Query: 507 QEIAVKRLSKAS----GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPN 562
           +E+   ++   S        E+   E+ +   L + ++V   G   + +   ++ E    
Sbjct: 67  KEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRR 126
Query: 563 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELN 622
           RSL  L     +K   +   R+ + + I +G+ YLH +   R+IHRDLK  N+ L+++++
Sbjct: 127 RSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---RVIHRDLKLGNLFLNDDMD 180
Query: 623 PKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
            KI DFG+A     + ++  T  + GT  Y++PE   +   S + D++S G +L  ++ G
Sbjct: 181 VKIGDFGLATKIEFDGERKKT--LCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVG 238
Query: 683 RKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS 717
           +     FE       Y     NE  +   ++P  S
Sbjct: 239 KPP---FETSCLKETYIRIKKNEYSVPRHINPVAS 270

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 100/202 (49%), Gaps = 11/202 (5%)
Query: 488 SKLGQGGFGPVYWGRLKDGQ-EIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNLVRLLG 545
           S +G+G +G V        +  +A+K++S    Q   +  + E+ ++   +H N++ +  
Sbjct: 31  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGIND 90
Query: 546 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 605
                  + +   Y+    ++  L+  LK + L        +  I RGL Y+H  +   +
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 147
Query: 606 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG---RVVGTFGYMSPEYAMEGR 662
           +HRDLK SN+LL+   + KI DFG+A++   + D   TG     V T  Y +PE  +  +
Sbjct: 148 LHRDLKPSNLLLNTTSDLKICDFGLARV--ADPDHDHTGFLTEYVATRWYRAPEIMLNSK 205
Query: 663 -FSEKSDVFSFGVLLLEIVSGR 683
            +++  D++S G +L E++S R
Sbjct: 206 GYTKSIDIWSVGCILAEMLSNR 227

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 100/200 (50%), Gaps = 15/200 (7%)
Query: 489 KLGQGGFGPVYWGRLKDGQEIAVKRL----SKASGQGL-EEFMNEVMVISKLQHRNLVRL 543
           +LG G FG V  G  +  + +    +    ++A+   L +E + E  V+ +L +  +VR+
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 544 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 603
           +G C E E  ML+ E      L+  L    +   +  +    ++  +S G+ YL   +  
Sbjct: 78  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 131
Query: 604 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMSPEYAMEG 661
             +HRDL A N+LL  +   KISDFG++K    +++     +  G +   + +PE     
Sbjct: 132 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXY-KAQTHGKWPVKWYAPECINYY 189
Query: 662 RFSEKSDVFSFGVLLLEIVS 681
           +FS KSDV+SFGVL+ E  S
Sbjct: 190 KFSSKSDVWSFGVLMWEAFS 209

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 100/200 (50%), Gaps = 15/200 (7%)
Query: 489 KLGQGGFGPVYWGRLKDGQEIAVKRL----SKASGQGL-EEFMNEVMVISKLQHRNLVRL 543
           +LG G FG V  G  +  + +    +    ++A+   L +E + E  V+ +L +  +VR+
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 93
Query: 544 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 603
           +G C E E  ML+ E      L+  L    +   +  +    ++  +S G+ YL   +  
Sbjct: 94  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 147
Query: 604 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMSPEYAMEG 661
             +HRDL A N+LL  +   KISDFG++K    +++     +  G +   + +PE     
Sbjct: 148 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY-KAQTHGKWPVKWYAPECINYY 205
Query: 662 RFSEKSDVFSFGVLLLEIVS 681
           +FS KSDV+SFGVL+ E  S
Sbjct: 206 KFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 100/200 (50%), Gaps = 15/200 (7%)
Query: 489 KLGQGGFGPVYWGRLKDGQEIAVKRL----SKASGQGL-EEFMNEVMVISKLQHRNLVRL 543
           +LG G FG V  G  +  + +    +    ++A+   L +E + E  V+ +L +  +VR+
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 93
Query: 544 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 603
           +G C E E  ML+ E      L+  L    +   +  +    ++  +S G+ YL   +  
Sbjct: 94  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 147
Query: 604 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMSPEYAMEG 661
             +HRDL A N+LL  +   KISDFG++K    +++     +  G +   + +PE     
Sbjct: 148 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY-KAQTHGKWPVKWYAPECINYY 205
Query: 662 RFSEKSDVFSFGVLLLEIVS 681
           +FS KSDV+SFGVL+ E  S
Sbjct: 206 KFSSKSDVWSFGVLMWEAFS 225

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 109/246 (44%), Gaps = 18/246 (7%)
Query: 490 LGQGGFGPVYWGRLKDGQEIAVKRLSKAS----GQGLEEFMNEVMVISKLQHRNLVRLLG 545
           LG+GGF   +     D +E+   ++   S        E+   E+ +   L H+++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 546 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 605
              + +   ++ E    RSL  L     +K   +   R+  +  I  G  YLHR+   R+
Sbjct: 109 FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLHRN---RV 162
Query: 606 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSE 665
           IHRDLK  N+ L+E+L  KI DFG+A     + ++     + GT  Y++PE   +   S 
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHSF 220
Query: 666 KSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPF---LSESSFQ 722
           + DV+S G ++  ++ G+     FE       Y     NE  I   ++P    L +   Q
Sbjct: 221 EVDVWSIGCIMYTLLVGKPP---FETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQ 277
Query: 723 LDMIIR 728
            D   R
Sbjct: 278 TDPTAR 283

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 100/200 (50%), Gaps = 15/200 (7%)
Query: 489 KLGQGGFGPVYWGRLKDGQEIAVKRL----SKASGQGL-EEFMNEVMVISKLQHRNLVRL 543
           +LG G FG V  G  +  + +    +    ++A+   L +E + E  V+ +L +  +VR+
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 544 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 603
           +G C E E  ML+ E      L+  L    +   +  +    ++  +S G+ YL   +  
Sbjct: 74  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 127
Query: 604 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMSPEYAMEG 661
             +HRDL A N+LL  +   KISDFG++K    +++     +  G +   + +PE     
Sbjct: 128 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY-KAQTHGKWPVKWYAPECINYY 185
Query: 662 RFSEKSDVFSFGVLLLEIVS 681
           +FS KSDV+SFGVL+ E  S
Sbjct: 186 KFSSKSDVWSFGVLMWEAFS 205

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 109/246 (44%), Gaps = 18/246 (7%)
Query: 490 LGQGGFGPVYWGRLKDGQEIAVKRLSKAS----GQGLEEFMNEVMVISKLQHRNLVRLLG 545
           LG+GGF   +     D +E+   ++   S        E+   E+ +   L H+++V   G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 546 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 605
              + +   ++ E    RSL  L     +K   +   R+  +  I  G  YLHR+   R+
Sbjct: 107 FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLHRN---RV 160
Query: 606 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSE 665
           IHRDLK  N+ L+E+L  KI DFG+A     + ++     + GT  Y++PE   +   S 
Sbjct: 161 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHSF 218
Query: 666 KSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPF---LSESSFQ 722
           + DV+S G ++  ++ G+     FE       Y     NE  I   ++P    L +   Q
Sbjct: 219 EVDVWSIGCIMYTLLVGKPP---FETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQ 275
Query: 723 LDMIIR 728
            D   R
Sbjct: 276 TDPTAR 281

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 100/200 (50%), Gaps = 15/200 (7%)
Query: 489 KLGQGGFGPVYWGRLKDGQEIAVKRL----SKASGQGL-EEFMNEVMVISKLQHRNLVRL 543
           +LG G FG V  G  +  + +    +    ++A+   L +E + E  V+ +L +  +VR+
Sbjct: 32  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 91
Query: 544 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 603
           +G C E E  ML+ E      L+  L    +   +  +    ++  +S G+ YL   +  
Sbjct: 92  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 145
Query: 604 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMSPEYAMEG 661
             +HRDL A N+LL  +   KISDFG++K    +++     +  G +   + +PE     
Sbjct: 146 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY-KAQTHGKWPVKWYAPECINYY 203
Query: 662 RFSEKSDVFSFGVLLLEIVS 681
           +FS KSDV+SFGVL+ E  S
Sbjct: 204 KFSSKSDVWSFGVLMWEAFS 223

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 104/229 (45%), Gaps = 15/229 (6%)
Query: 490 LGQGGFGPVYWGRLKDGQEIAVKRLSKAS----GQGLEEFMNEVMVISKLQHRNLVRLLG 545
           LG+GGF   +     D +E+   ++   S        E+   E+ +   L H+++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 546 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 605
              + +   ++ E    RSL  L     +K   +   R+  +  I  G  YLHR+   R+
Sbjct: 83  FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLHRN---RV 136
Query: 606 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSE 665
           IHRDLK  N+ L+E+L  KI DFG+A     + ++     + GT  Y++PE   +   S 
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHSF 194
Query: 666 KSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDP 714
           + DV+S G ++  ++ G+     FE       Y     NE  I   ++P
Sbjct: 195 EVDVWSIGCIMYTLLVGKPP---FETSCLKETYLRIKKNEYSIPKHINP 240

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 102/233 (43%), Gaps = 29/233 (12%)
Query: 479 TATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGL---EEFMNEVMVISKL 535
           T      L   +G+G +G V+ G  + G+ +AVK  S    +      E  N VM    L
Sbjct: 34  TVARQITLLECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVM----L 88
Query: 536 QHRNLVRLLGCCVEGEEKM----LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGIS 591
           +H N++  +   +          LI  Y    SL    +D L+   LD      I+  I+
Sbjct: 89  RHENILGFIASDMTSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIA 144
Query: 592 RGLLYLH-----RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR- 645
            GL +LH        +  I HRDLK+ NIL+ +     I+D G+A +   + +Q D G  
Sbjct: 145 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNN 204
Query: 646 -VVGTFGYMSPEYAMEG------RFSEKSDVFSFGVLLLEIVSGRKNTSFFED 691
             VGT  YM+PE   E          ++ D+++FG++L E+     +    ED
Sbjct: 205 PRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 257

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 100/200 (50%), Gaps = 15/200 (7%)
Query: 489 KLGQGGFGPVYWGRLKDGQEIAVKRL----SKASGQGL-EEFMNEVMVISKLQHRNLVRL 543
           +LG G FG V  G  +  + +    +    ++A+   L +E + E  V+ +L +  +VR+
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 544 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 603
           +G C E E  ML+ E      L+  L    +   +  +    ++  +S G+ YL   +  
Sbjct: 78  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 131
Query: 604 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMSPEYAMEG 661
             +HRDL A N+LL  +   KISDFG++K    +++     +  G +   + +PE     
Sbjct: 132 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY-KAQTHGKWPVKWYAPECINYY 189
Query: 662 RFSEKSDVFSFGVLLLEIVS 681
           +FS KSDV+SFGVL+ E  S
Sbjct: 190 KFSSKSDVWSFGVLMWEAFS 209

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 116/254 (45%), Gaps = 36/254 (14%)
Query: 444 WIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 503
           ++AK K + + K  +   NT  L      QFE + T          LG G FG V   + 
Sbjct: 11  FLAKAKEDFLKKWESPAQNTAHLD-----QFERIKT----------LGTGSFGRVMLVKH 55
Query: 504 KD-GQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 559
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 56  KETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 115
Query: 560 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
           +P       +F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 116 VPG----GEMFSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 167
Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 168 DQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 222
Query: 678 EIVSGRKNTSFFED 691
           E+ +G     FF D
Sbjct: 223 EMAAGY--PPFFAD 234

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 100/200 (50%), Gaps = 15/200 (7%)
Query: 489 KLGQGGFGPVYWGRLKDGQEIAVKRL----SKASGQGL-EEFMNEVMVISKLQHRNLVRL 543
           +LG G FG V  G  +  + +    +    ++A+   L +E + E  V+ +L +  +VR+
Sbjct: 12  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 71
Query: 544 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 603
           +G C E E  ML+ E      L+  L    +   +  +    ++  +S G+ YL   +  
Sbjct: 72  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 125
Query: 604 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMSPEYAMEG 661
             +HRDL A N+LL  +   KISDFG++K    +++     +  G +   + +PE     
Sbjct: 126 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY-KAQTHGKWPVKWYAPECINYY 183
Query: 662 RFSEKSDVFSFGVLLLEIVS 681
           +FS KSDV+SFGVL+ E  S
Sbjct: 184 KFSSKSDVWSFGVLMWEAFS 203

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 115/254 (45%), Gaps = 36/254 (14%)
Query: 444 WIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGR- 502
           ++AK K + + K      NT  L      QFE + T          +G G FG V   + 
Sbjct: 18  FLAKAKEDFLKKWENPAQNTAHLD-----QFERIKT----------IGTGSFGRVMLVKH 62
Query: 503 LKDGQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 559
           ++ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 63  METGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 560 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
           MP   +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 123 MPGGDM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 174
Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
           D++   K++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 175 DQQGYIKVADFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 678 EIVSGRKNTSFFED 691
           E+ +G     FF D
Sbjct: 230 EMAAGY--PPFFAD 241

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 83/161 (51%), Gaps = 10/161 (6%)
Query: 523 EEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRK 582
           +E + E  V+ +L +  +VR++G C E E  ML+ E      L+  L    +   +  + 
Sbjct: 416 DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKN 471
Query: 583 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD 642
              ++  +S G+ YL   +    +HRDL A N+LL  +   KISDFG++K    +++   
Sbjct: 472 IIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 528
Query: 643 TGRVVGTF--GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
             +  G +   + +PE     +FS KSDV+SFGVL+ E  S
Sbjct: 529 A-QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 83/161 (51%), Gaps = 10/161 (6%)
Query: 523 EEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRK 582
           +E + E  V+ +L +  +VR++G C E E  ML+ E      L+  L    +   +  + 
Sbjct: 415 DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKN 470
Query: 583 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD 642
              ++  +S G+ YL   +    +HRDL A N+LL  +   KISDFG++K    +++   
Sbjct: 471 IIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY- 526
Query: 643 TGRVVGTF--GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
             +  G +   + +PE     +FS KSDV+SFGVL+ E  S
Sbjct: 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 115/254 (45%), Gaps = 36/254 (14%)
Query: 444 WIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGR- 502
           ++AK K + + K      NT  L      QFE + T          +G G FG V   + 
Sbjct: 18  FLAKAKEDFLKKWENPAQNTAHLD-----QFERIKT----------IGTGSFGRVMLVKH 62
Query: 503 LKDGQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 559
           ++ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 63  METGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 560 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
           MP   +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 123 MPGGDM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 174
Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
           D++   K++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 175 DQQGYIKVADFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 678 EIVSGRKNTSFFED 691
           E+ +G     FF D
Sbjct: 230 EMAAGY--PPFFAD 241

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 11/204 (5%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGL--EEFMNEVMVISKLQHRN 539
           ++F+  S+LG G  G V+    K    +  ++L     +     + + E+ V+ +     
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 599
           +V   G      E  +  E+M   SLD +L    K  R+  +    +   + +GL YL  
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLRE 125
Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 659
             + +I+HRD+K SNIL++     K+ DFG++    G          VGT  YMSPE   
Sbjct: 126 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDEMANEFVGTRSYMSPERLQ 179
Query: 660 EGRFSEKSDVFSFGVLLLEIVSGR 683
              +S +SD++S G+ L+E+  GR
Sbjct: 180 GTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 100/200 (50%), Gaps = 15/200 (7%)
Query: 489 KLGQGGFGPVYWGRLKDGQEIAVKRL----SKASGQGL-EEFMNEVMVISKLQHRNLVRL 543
           +LG G FG V  G  +  + +    +    ++A+   L +E + E  V+ +L +  +VR+
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 544 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 603
           +G C E E  ML+ E      L+  L    +   +  +    ++  +S G+ YL   +  
Sbjct: 84  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 137
Query: 604 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMSPEYAMEG 661
             +HRDL A N+LL  +   KISDFG++K    +++     +  G +   + +PE     
Sbjct: 138 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY-KAQTHGKWPVKWYAPECINYY 195
Query: 662 RFSEKSDVFSFGVLLLEIVS 681
           +FS KSDV+SFGVL+ E  S
Sbjct: 196 KFSSKSDVWSFGVLMWEAFS 215

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 11/204 (5%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGL--EEFMNEVMVISKLQHRN 539
           ++F+  S+LG G  G V+    K    +  ++L     +     + + E+ V+ +     
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 599
           +V   G      E  +  E+M   SLD +L    K  R+  +    +   + +GL YL  
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLRE 149
Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 659
             + +I+HRD+K SNIL++     K+ DFG++    G    +     VGT  YMSPE   
Sbjct: 150 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 203
Query: 660 EGRFSEKSDVFSFGVLLLEIVSGR 683
              +S +SD++S G+ L+E+  GR
Sbjct: 204 GTHYSVQSDIWSMGLSLVEMAVGR 227

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 116/254 (45%), Gaps = 36/254 (14%)
Query: 444 WIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 503
           ++AK K + + K  +   NT  L      QFE + T          LG G FG V   + 
Sbjct: 19  FLAKAKEDFLKKWESPAQNTAHLD-----QFERIKT----------LGTGSFGRVMLVKH 63
Query: 504 KD-GQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 559
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 64  KETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 123
Query: 560 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
           +P   +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 124 VPGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 175
Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 176 DQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 230
Query: 678 EIVSGRKNTSFFED 691
           E+ +G     FF D
Sbjct: 231 EMAAGY--PPFFAD 242

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/277 (25%), Positives = 125/277 (45%), Gaps = 22/277 (7%)
Query: 450 AEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSK---LGQGGFGPVYWGRLKDG 506
           +  IAK SA     V  +  PL +  ++       +   +   LG+GGF   Y     D 
Sbjct: 7   SAAIAKPSAKPSAHVDPKSAPLKEIPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDT 66
Query: 507 QEIAVKRLSKAS----GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPN 562
           +E+   ++   S        E+   E+ +   L + ++V   G   + +   ++ E    
Sbjct: 67  KEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRR 126
Query: 563 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELN 622
           RSL  L     +K   +   R+ + + I +G+ YLH +   R+IHRDLK  N+ L+++++
Sbjct: 127 RSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---RVIHRDLKLGNLFLNDDMD 180
Query: 623 PKISDFGMA-KI-FGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIV 680
            KI DFG+A KI F G + +     + GT  Y++PE   +   S + D++S G +L  ++
Sbjct: 181 VKIGDFGLATKIEFDGERKKX----LCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLL 236
Query: 681 SGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS 717
            G+     FE       Y     NE  +   ++P  S
Sbjct: 237 VGKPP---FETSCLKETYIRIKKNEYSVPRHINPVAS 270

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 124/276 (44%), Gaps = 20/276 (7%)
Query: 450 AEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSK---LGQGGFGPVYWGRLKDG 506
           +  IAK SA     V  +  PL +  ++       +   +   LG+GGF   Y     D 
Sbjct: 7   SAAIAKPSAKPSAHVDPKSAPLKEIPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDT 66
Query: 507 QEIAVKRLSKAS----GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPN 562
           +E+   ++   S        E+   E+ +   L + ++V   G   + +   ++ E    
Sbjct: 67  KEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRR 126
Query: 563 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELN 622
           RSL  L     +K   +   R+ + + I +G+ YLH +   R+IHRDLK  N+ L+++++
Sbjct: 127 RSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---RVIHRDLKLGNLFLNDDMD 180
Query: 623 PKISDFGMA-KIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
            KI DFG+A KI    + + D   + GT  Y++PE   +   S + D++S G +L  ++ 
Sbjct: 181 VKIGDFGLATKIEFDGERKKD---LCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLV 237
Query: 682 GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS 717
           G+     FE       Y     NE  +   ++P  S
Sbjct: 238 GKPP---FETSCLKETYIRIKKNEYSVPRHINPVAS 270

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 116/254 (45%), Gaps = 36/254 (14%)
Query: 444 WIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 503
           ++AK K + + K  +   NT  L      QFE + T          LG G FG V   + 
Sbjct: 19  FLAKAKEDFLKKWESPAQNTAHLD-----QFERIKT----------LGTGSFGRVMLVKH 63
Query: 504 KD-GQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 559
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 64  KETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 123
Query: 560 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
           +P   +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 124 VPGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 175
Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 176 DQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 230
Query: 678 EIVSGRKNTSFFED 691
           E+ +G     FF D
Sbjct: 231 EMAAGY--PPFFAD 242

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 116/254 (45%), Gaps = 36/254 (14%)
Query: 444 WIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 503
           ++AK K + + K  +   NT  L      QFE + T          LG G FG V   + 
Sbjct: 19  FLAKAKEDFLKKWESPAQNTAHLD-----QFERIKT----------LGTGSFGRVMLVKH 63
Query: 504 KD-GQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 559
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 64  KETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 123
Query: 560 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
           +P   +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 124 VPGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 175
Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 176 DQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 230
Query: 678 EIVSGRKNTSFFED 691
           E+ +G     FF D
Sbjct: 231 EMAAGY--PPFFAD 242

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 115/254 (45%), Gaps = 36/254 (14%)
Query: 444 WIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 503
           ++AK K + + K  +   NT  L      QFE + T          LG G FG V   + 
Sbjct: 19  FLAKAKEDFLKKWESPAQNTAHLD-----QFERIKT----------LGTGSFGRVMLVKH 63
Query: 504 KD-GQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 559
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 64  KETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 123
Query: 560 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
            P   +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+++
Sbjct: 124 APGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLMI 175
Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
           D++   K++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 176 DQQGYIKVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 230
Query: 678 EIVSGRKNTSFFED 691
           E+ +G     FF D
Sbjct: 231 EMAAGY--PPFFAD 242

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 116/254 (45%), Gaps = 36/254 (14%)
Query: 444 WIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 503
           ++AK K + + K  +   NT  L      QFE + T          LG G FG V   + 
Sbjct: 39  FLAKAKEDFLKKWESPAQNTAHLD-----QFERIKT----------LGTGSFGRVMLVKH 83
Query: 504 KD-GQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 559
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 84  KETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 143
Query: 560 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
           +P   +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 144 VPGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 195
Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 196 DQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 250
Query: 678 EIVSGRKNTSFFED 691
           E+ +G     FF D
Sbjct: 251 EMAAGY--PPFFAD 262

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 11/204 (5%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGL--EEFMNEVMVISKLQHRN 539
           ++F+  S+LG G  G V+    K    +  ++L     +     + + E+ V+ +     
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 84
Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 599
           +V   G      E  +  E+M   SLD +L    K  R+  +    +   + +GL YL  
Sbjct: 85  IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLRE 141
Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 659
             + +I+HRD+K SNIL++     K+ DFG++    G    +     VGT  YMSPE   
Sbjct: 142 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 195
Query: 660 EGRFSEKSDVFSFGVLLLEIVSGR 683
              +S +SD++S G+ L+E+  GR
Sbjct: 196 GTHYSVQSDIWSMGLSLVEMAVGR 219

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 115/254 (45%), Gaps = 36/254 (14%)
Query: 444 WIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 503
           ++AK K + + K      NT  L      QFE + T          LG G FG V   + 
Sbjct: 18  FLAKAKEDFLKKWENPAQNTAHLD-----QFERIKT----------LGTGSFGRVMLVKH 62
Query: 504 KD-GQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 559
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 63  KETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEY 122
Query: 560 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
           +P   +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 123 VPGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 174
Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 175 DQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 678 EIVSGRKNTSFFED 691
           E+ +G     FF D
Sbjct: 230 EMAAGY--PPFFAD 241

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 115/254 (45%), Gaps = 36/254 (14%)
Query: 444 WIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 503
           ++AK K + + K      NT  L      QFE + T          LG G FG V   + 
Sbjct: 18  FLAKAKEDFLKKWENPAQNTAHLD-----QFERIKT----------LGTGSFGRVMLVKH 62
Query: 504 KD-GQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 559
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 63  KETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEY 122
Query: 560 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
           +P   +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 123 VPGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 174
Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 175 DQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 678 EIVSGRKNTSFFED 691
           E+ +G     FF D
Sbjct: 230 EMAAGY--PPFFAD 241

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 101/201 (50%), Gaps = 17/201 (8%)
Query: 490 LGQGGFGPV---YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLL 544
           +G G +G V   Y  RL+  Q++AVK+LS+   S         E+ ++  L+H N++ LL
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 545 GCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 603
                        E Y+    + A L + +K + L       ++  + RGL Y+H     
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHSAG-- 151
Query: 604 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME-GR 662
            IIHRDLK SN+ ++E+   +I DFG+A+      D+  TG  V T  Y +PE  +    
Sbjct: 152 -IIHRDLKPSNVAVNEDSELRILDFGLAR----QADEEMTG-YVATRWYRAPEIMLNWMH 205
Query: 663 FSEKSDVFSFGVLLLEIVSGR 683
           +++  D++S G ++ E++ G+
Sbjct: 206 YNQTVDIWSVGCIMAELLQGK 226

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 115/254 (45%), Gaps = 36/254 (14%)
Query: 444 WIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 503
           ++AK K + + K      NT  L      QFE + T          LG G FG V   + 
Sbjct: 18  FLAKAKEDFLKKWENPAQNTAHLD-----QFERIKT----------LGTGSFGRVMLVKH 62
Query: 504 KD-GQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 559
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 63  KETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEY 122
Query: 560 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
           +P   +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 123 VPGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 174
Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 175 DQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 678 EIVSGRKNTSFFED 691
           E+ +G     FF D
Sbjct: 230 EMAAGY--PPFFAD 241

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 105/205 (51%), Gaps = 22/205 (10%)
Query: 488 SKLGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGL--EEFMNEVMVISKLQHRNLVRLL 544
           + +G G +G V      + G+++A+K+LS+     +  +    E++++  +QH N++ LL
Sbjct: 48  THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 107
Query: 545 GCCVEGEEKMLIYEY---MP--NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 599
                       Y++   MP     L  ++     +E++ +     ++  + +GL Y+H 
Sbjct: 108 DVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQY-----LVYQMLKGLKYIHS 162
Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 659
                ++HRDLK  N+ ++E+   KI DFG+A+    + D   TG VV T  Y +PE  +
Sbjct: 163 AG---VVHRDLKPGNLAVNEDCELKILDFGLAR----HADAEMTGYVV-TRWYRAPEVIL 214
Query: 660 E-GRFSEKSDVFSFGVLLLEIVSGR 683
               +++  D++S G ++ E+++G+
Sbjct: 215 SWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 105/205 (51%), Gaps = 22/205 (10%)
Query: 488 SKLGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGL--EEFMNEVMVISKLQHRNLVRLL 544
           + +G G +G V      + G+++A+K+LS+     +  +    E++++  +QH N++ LL
Sbjct: 30  THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 89
Query: 545 GCCVEGEEKMLIYEY---MP--NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 599
                       Y++   MP     L  ++     +E++ +     ++  + +GL Y+H 
Sbjct: 90  DVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQY-----LVYQMLKGLKYIHS 144
Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 659
                ++HRDLK  N+ ++E+   KI DFG+A+    + D   TG VV T  Y +PE  +
Sbjct: 145 AG---VVHRDLKPGNLAVNEDCELKILDFGLAR----HADAEMTGYVV-TRWYRAPEVIL 196
Query: 660 E-GRFSEKSDVFSFGVLLLEIVSGR 683
               +++  D++S G ++ E+++G+
Sbjct: 197 SWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 101/201 (50%), Gaps = 17/201 (8%)
Query: 490 LGQGGFGPV---YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLL 544
           +G G +G V   Y  RL+  Q++AVK+LS+   S         E+ ++  L+H N++ LL
Sbjct: 28  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 545 GCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 603
                        E Y+    + A L + +K + L       ++  + RGL Y+H     
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAG-- 143
Query: 604 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME-GR 662
            IIHRDLK SN+ ++E+   +I DFG+A+      D+  TG  V T  Y +PE  +    
Sbjct: 144 -IIHRDLKPSNVAVNEDCELRILDFGLAR----QADEEMTG-YVATRWYRAPEIMLNWMH 197
Query: 663 FSEKSDVFSFGVLLLEIVSGR 683
           +++  D++S G ++ E++ G+
Sbjct: 198 YNQTVDIWSVGCIMAELLQGK 218

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 537
           N F+    LG+G FG V   + K  G+  A+K L K    +   +   + E  V+   +H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGLL 595
             L  L       +    + EY         LF  L +ER+  + R RF   E +S  L 
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANG----GELFFHLSRERVFSEDRARFYGAEIVS-ALD 262
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 655
           YLH  S   +++RDLK  N++LD++ + KI+DFG+ K   G +D A      GT  Y++P
Sbjct: 263 YLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAP 318
Query: 656 EYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           E   +  +    D +  GV++ E++ GR
Sbjct: 319 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 115/254 (45%), Gaps = 36/254 (14%)
Query: 444 WIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGR- 502
           ++AK K + + K      NT  L      QFE + T          LG G FG V   + 
Sbjct: 18  FLAKAKEDFLKKWENPAQNTAHLD-----QFERIKT----------LGTGSFGRVMLVKH 62
Query: 503 LKDGQEIAVKRLSKASGQGLEEF---MNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 559
           ++ G   A+K L K     L+E    +NE  ++  +    LV+L     +     ++ EY
Sbjct: 63  METGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 560 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
            P   +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+++
Sbjct: 123 APGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLMI 174
Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
           D++   K++DFG+AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 175 DQQGYIKVTDFGLAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 678 EIVSGRKNTSFFED 691
           E+ +G     FF D
Sbjct: 230 EMAAGY--PPFFAD 241

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 110/225 (48%), Gaps = 24/225 (10%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEI--AVKRLSKAS---GQGLEEFMNEVMVISK-L 535
           ++F     +G+G FG V   R K  +E+  AVK L K +    +  +  M+E  V+ K +
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHK-AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV 96
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER--LDWRKRFNIIEGISRG 593
           +H  LV L       ++   + +Y+    L    F  L++ER  L+ R RF   E I+  
Sbjct: 97  KHPFLVGLHFSFQTADKLYFVLDYINGGEL----FYHLQRERCFLEPRARFYAAE-IASA 151
Query: 594 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 653
           L YLH    L I++RDLK  NILLD + +  ++DFG+ K     +  + T    GT  Y+
Sbjct: 152 LGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPEYL 206
Query: 654 SPEYAMEGRFSEKSDVFSFGVLLLEIVSG-----RKNTSFFEDDL 693
           +PE   +  +    D +  G +L E++ G      +NT+   D++
Sbjct: 207 APEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI 251

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 537
           N F+    LG+G FG V   + K  G+  A+K L K    +   +   + E  V+   +H
Sbjct: 151 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 210
Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGLL 595
             L  L       +    + EY         LF  L +ER+  + R RF   E +S  L 
Sbjct: 211 PFLTALKYSFQTHDRLCFVMEYANG----GELFFHLSRERVFSEDRARFYGAEIVS-ALD 265
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 655
           YLH  S   +++RDLK  N++LD++ + KI+DFG+ K   G +D A      GT  Y++P
Sbjct: 266 YLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAP 321
Query: 656 EYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           E   +  +    D +  GV++ E++ GR
Sbjct: 322 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 349

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 490 LGQGGFGPVYWGRLKDGQEIAV----KRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLG 545
           LG+GGFG V+  ++K   ++       +      +G +  M E  +++K+  R +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 546 CCVEGEEKMLIYEYMPNRSLDALLF--DPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 603
                 +  L+   M    +   ++  D       + R  F   + +S GL +LH+ +  
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS-GLEHLHQRN-- 309
Query: 604 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRF 663
            II+RDLK  N+LLD++ N +ISD G+A      Q +  T    GT G+M+PE  +   +
Sbjct: 310 -IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGEEY 366
Query: 664 SEKSDVFSFGVLLLEIVSGR 683
               D F+ GV L E+++ R
Sbjct: 367 DFSVDYFALGVTLYEMIAAR 386

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 15/208 (7%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKAS----GQGLEEFMNEVMVISKLQH 537
            +F L   +G+G +  V   RLK    I   R+ K       + ++    E  V  +  +
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 538 RNLVRLLGCCVEGEEKML-IYEYMPNRSLDALLFDPLKKERL-DWRKRFNIIEGISRGLL 595
              +  L  C + E ++  + EY+    L   +F   ++ +L +   RF   E IS  L 
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAE-ISLALN 167
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 655
           YLH      II+RDLK  N+LLD E + K++D+GM K   G +    T    GT  Y++P
Sbjct: 168 YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAP 222
Query: 656 EYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           E      +    D ++ GVL+ E+++GR
Sbjct: 223 EILRGEDYGFSVDWWALGVLMFEMMAGR 250

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 99/209 (47%), Gaps = 18/209 (8%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVM---VISKLQH 537
           N+F     LG+G FG V   R K  G+  A+K L K      +E  + V    V+   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGLL 595
             L  L       +    + EY         LF  L +ER+  + R RF   E +S  L 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANG----GELFFHLSRERVFTEERARFYGAEIVS-ALE 119
Query: 596 YLH-RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 654
           YLH RD    +++RD+K  N++LD++ + KI+DFG+ K   G  D A      GT  Y++
Sbjct: 120 YLHSRD----VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLA 173
Query: 655 PEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           PE   +  +    D +  GV++ E++ GR
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 99/209 (47%), Gaps = 18/209 (8%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQH 537
           N+F     LG+G FG V   R K  G+  A+K L K    +   +   + E  V+   +H
Sbjct: 8   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 67
Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGLL 595
             L  L       +    + EY         LF  L +ER+  + R RF   E +S  L 
Sbjct: 68  PFLTALKYAFQTHDRLCFVMEYANG----GELFFHLSRERVFTEERARFYGAEIVS-ALE 122
Query: 596 YLH-RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 654
           YLH RD    +++RD+K  N++LD++ + KI+DFG+ K   G  D A      GT  Y++
Sbjct: 123 YLHSRD----VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLA 176
Query: 655 PEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           PE   +  +    D +  GV++ E++ GR
Sbjct: 177 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 537
           N F+    LG+G FG V   + K  G+  A+K L K    +   +   + E  V+   +H
Sbjct: 8   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 67
Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGLL 595
             L  L       +    + EY         LF  L +ER+  + R RF   E +S  L 
Sbjct: 68  PFLTALKYSFQTHDRLCFVMEYANG----GELFFHLSRERVFSEDRARFYGAEIVS-ALD 122
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 655
           YLH  S   +++RDLK  N++LD++ + KI+DFG+ K   G +D A      GT  Y++P
Sbjct: 123 YLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLAP 178
Query: 656 EYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           E   +  +    D +  GV++ E++ GR
Sbjct: 179 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 206

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 99/209 (47%), Gaps = 18/209 (8%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQH 537
           N+F     LG+G FG V   R K  G+  A+K L K    +   +   + E  V+   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGLL 595
             L  L       +    + EY     L    F  L +ER+  + R RF   E +S  L 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGEL----FFHLSRERVFTEERARFYGAEIVS-ALE 119
Query: 596 YLH-RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 654
           YLH RD    +++RD+K  N++LD++ + KI+DFG+ K   G  D A      GT  Y++
Sbjct: 120 YLHSRD----VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLA 173
Query: 655 PEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           PE   +  +    D +  GV++ E++ GR
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 115/254 (45%), Gaps = 36/254 (14%)
Query: 444 WIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGR- 502
           ++AK K + + K      NT  L      QFE + T          LG G FG V   + 
Sbjct: 19  FLAKAKEDFLKKWENPAQNTAHLD-----QFERIKT----------LGTGSFGRVMLVKH 63
Query: 503 LKDGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 559
           ++ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 64  METGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 123
Query: 560 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
           +P   +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 124 VPGGEM----FSHLRRIGRFXEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 175
Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 176 DQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 230
Query: 678 EIVSGRKNTSFFED 691
           E+ +G     FF D
Sbjct: 231 EMAAGY--PPFFAD 242

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 115/254 (45%), Gaps = 36/254 (14%)
Query: 444 WIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGR- 502
           ++AK K + + K      NT  L      QFE + T          LG G FG V   + 
Sbjct: 18  FLAKAKEDFLKKWENPAQNTAHLD-----QFERIKT----------LGTGSFGRVMLVKH 62
Query: 503 LKDGQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 559
           ++ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 63  METGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 560 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
           +P   +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 123 VPGGEM----FSHLRRIGRFXEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 174
Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 175 DQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 678 EIVSGRKNTSFFED 691
           E+ +G     FF D
Sbjct: 230 EMAAGY--PPFFAD 241

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 537
           N F+    LG+G FG V   + K  G+  A+K L K    +   +   + E  V+   +H
Sbjct: 10  NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 69
Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGLL 595
             L  L       +    + EY         LF  L +ER+  + R RF   E +S  L 
Sbjct: 70  PFLTALKYSFQTHDRLCFVMEYANG----GELFFHLSRERVFSEDRARFYGAEIVS-ALD 124
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 655
           YLH  S   +++RDLK  N++LD++ + KI+DFG+ K   G +D A      GT  Y++P
Sbjct: 125 YLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLAP 180
Query: 656 EYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           E   +  +    D +  GV++ E++ GR
Sbjct: 181 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 208

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 490 LGQGGFGPVYWGRLKDGQEIAV----KRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLG 545
           LG+GGFG V+  ++K   ++       +      +G +  M E  +++K+  R +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 546 CCVEGEEKMLIYEYMPNRSLDALLF--DPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 603
                 +  L+   M    +   ++  D       + R  F   + +S GL +LH+ +  
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS-GLEHLHQRN-- 309
Query: 604 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRF 663
            II+RDLK  N+LLD++ N +ISD G+A      Q +  T    GT G+M+PE  +   +
Sbjct: 310 -IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGEEY 366
Query: 664 SEKSDVFSFGVLLLEIVSGR 683
               D F+ GV L E+++ R
Sbjct: 367 DFSVDYFALGVTLYEMIAAR 386

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 99/209 (47%), Gaps = 18/209 (8%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQH 537
           N+F     LG+G FG V   R K  G+  A+K L K    +   +   + E  V+   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGLL 595
             L  L       +    + EY         LF  L +ER+  + R RF   E +S  L 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANG----GELFFHLSRERVFTEERARFYGAEIVS-ALE 119
Query: 596 YLH-RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 654
           YLH RD    +++RD+K  N++LD++ + KI+DFG+ K   G  D A      GT  Y++
Sbjct: 120 YLHSRD----VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLA 173
Query: 655 PEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           PE   +  +    D +  GV++ E++ GR
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 490 LGQGGFGPVYWGRLKDGQEIAV----KRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLG 545
           LG+GGFG V+  ++K   ++       +      +G +  M E  +++K+  R +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 546 CCVEGEEKMLIYEYMPNRSLDALLF--DPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 603
                 +  L+   M    +   ++  D       + R  F   + +S GL +LH+ +  
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS-GLEHLHQRN-- 309
Query: 604 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRF 663
            II+RDLK  N+LLD++ N +ISD G+A      Q +  T    GT G+M+PE  +   +
Sbjct: 310 -IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGEEY 366
Query: 664 SEKSDVFSFGVLLLEIVSGR 683
               D F+ GV L E+++ R
Sbjct: 367 DFSVDYFALGVTLYEMIAAR 386

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 115/254 (45%), Gaps = 36/254 (14%)
Query: 444 WIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGR- 502
           ++AK K + + K      NT  L      QFE + T          LG G FG V   + 
Sbjct: 18  FLAKAKEDFLKKWENPAQNTAHLD-----QFERIKT----------LGTGSFGRVMLVKH 62
Query: 503 LKDGQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 559
           ++ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 63  METGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 560 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
           +P   +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 123 VPGGEM----FSHLRRIGRFXEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 174
Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 175 DQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 678 EIVSGRKNTSFFED 691
           E+ +G     FF D
Sbjct: 230 EMAAGY--PPFFAD 241

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 490 LGQGGFGPVYWGRLKDGQEIAV----KRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLG 545
           LG+GGFG V+  ++K   ++       +      +G +  M E  +++K+  R +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 546 CCVEGEEKMLIYEYMPNRSLDALLF--DPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 603
                 +  L+   M    +   ++  D       + R  F   + +S GL +LH+ +  
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS-GLEHLHQRN-- 309
Query: 604 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRF 663
            II+RDLK  N+LLD++ N +ISD G+A      Q +  T    GT G+M+PE  +   +
Sbjct: 310 -IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGEEY 366
Query: 664 SEKSDVFSFGVLLLEIVSGR 683
               D F+ GV L E+++ R
Sbjct: 367 DFSVDYFALGVTLYEMIAAR 386

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 99/209 (47%), Gaps = 18/209 (8%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVM---VISKLQH 537
           N+F     LG+G FG V   R K  G+  A+K L K      +E  + V    V+   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGLL 595
             L  L       +    + EY         LF  L +ER+  + R RF   E +S  L 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANG----GELFFHLSRERVFTEERARFYGAEIVS-ALE 119
Query: 596 YLH-RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 654
           YLH RD    +++RD+K  N++LD++ + KI+DFG+ K   G  D A      GT  Y++
Sbjct: 120 YLHSRD----VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLA 173
Query: 655 PEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           PE   +  +    D +  GV++ E++ GR
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 537
           N F+    LG+G FG V   + K  G+  A+K L K    +   +   + E  V+   +H
Sbjct: 9   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 68
Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGLL 595
             L  L       +    + EY         LF  L +ER+  + R RF   E +S  L 
Sbjct: 69  PFLTALKYSFQTHDRLCFVMEYANG----GELFFHLSRERVFSEDRARFYGAEIVS-ALD 123
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 655
           YLH  S   +++RDLK  N++LD++ + KI+DFG+ K   G +D A      GT  Y++P
Sbjct: 124 YLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLAP 179
Query: 656 EYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           E   +  +    D +  GV++ E++ GR
Sbjct: 180 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 99/209 (47%), Gaps = 18/209 (8%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQH 537
           N+F     LG+G FG V   R K  G+  A+K L K    +   +   + E  V+   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGLL 595
             L  L       +    + EY         LF  L +ER+  + R RF   E +S  L 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANG----GELFFHLSRERVFTEERARFYGAEIVS-ALE 119
Query: 596 YLH-RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 654
           YLH RD    +++RD+K  N++LD++ + KI+DFG+ K   G  D A      GT  Y++
Sbjct: 120 YLHSRD----VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLA 173
Query: 655 PEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           PE   +  +    D +  GV++ E++ GR
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 104/198 (52%), Gaps = 15/198 (7%)
Query: 490 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN-----EVMVISKLQHRNLVRL 543
           LG+G F  VY  R K+  Q +A+K++        ++ +N     E+ ++ +L H N++ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 544 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 603
           L          L++++M    L+ ++ D          K + ++    +GL YLH+    
Sbjct: 78  LDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLM--TLQGLEYLHQHW-- 132
Query: 604 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGR- 662
            I+HRDLK +N+LLDE    K++DFG+AK F G+ ++A   +VV T  Y +PE     R 
Sbjct: 133 -ILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYXHQVV-TRWYRAPELLFGARM 189
Query: 663 FSEKSDVFSFGVLLLEIV 680
           +    D+++ G +L E++
Sbjct: 190 YGVGVDMWAVGCILAELL 207

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 114/254 (44%), Gaps = 36/254 (14%)
Query: 444 WIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGR- 502
           ++AK K + + K      NT  L      QFE + T          LG G FG V   + 
Sbjct: 18  FLAKAKEDFLKKWENPAQNTAHLD-----QFERIKT----------LGTGSFGRVMLVKH 62
Query: 503 LKDGQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 559
           ++ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 63  METGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 560 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
            P   +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+++
Sbjct: 123 APGGEM----FSHLRRIGRFXEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLMI 174
Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
           D++   K++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 175 DQQGYIKVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 678 EIVSGRKNTSFFED 691
           E+ +G     FF D
Sbjct: 230 EMAAGY--PPFFAD 241

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 99/209 (47%), Gaps = 18/209 (8%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQH 537
           N+F     LG+G FG V   R K  G+  A+K L K    +   +   + E  V+   +H
Sbjct: 10  NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 69
Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGLL 595
             L  L       +    + EY     L    F  L +ER+  + R RF   E +S  L 
Sbjct: 70  PFLTALKYAFQTHDRLCFVMEYANGGEL----FFHLSRERVFTEERARFYGAEIVS-ALE 124
Query: 596 YLH-RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 654
           YLH RD    +++RD+K  N++LD++ + KI+DFG+ K   G  D A      GT  Y++
Sbjct: 125 YLHSRD----VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLA 178
Query: 655 PEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           PE   +  +    D +  GV++ E++ GR
Sbjct: 179 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 95/198 (47%), Gaps = 16/198 (8%)
Query: 490 LGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV 548
           LG G F  V+  + +  G+  A+K + K+         NE+ V+ K++H N+V L     
Sbjct: 17  LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE 76
Query: 549 EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN-IIEGISRGLLYLHRDSRLRIIH 607
                 L+ + +    L    FD + +  +   K  + +I+ +   + YLH +    I+H
Sbjct: 77  STTHYYLVMQLVSGGEL----FDRILERGVYTEKDASLVIQQVLSAVKYLHENG---IVH 129
Query: 608 RDLKASNIL-LDEELNPKI--SDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFS 664
           RDLK  N+L L  E N KI  +DFG++K+    +         GT GY++PE   +  +S
Sbjct: 130 RDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMSTACGTPGYVAPEVLAQKPYS 185
Query: 665 EKSDVFSFGVLLLEIVSG 682
           +  D +S GV+   ++ G
Sbjct: 186 KAVDCWSIGVITYILLCG 203

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 71/254 (27%), Positives = 114/254 (44%), Gaps = 36/254 (14%)
Query: 444 WIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 503
           ++AK K + + K  +   NT  L      QFE + T          LG G FG V   + 
Sbjct: 19  FLAKAKEDFLKKWESPAQNTAHLD-----QFERIRT----------LGTGSFGRVMLVKH 63
Query: 504 KD-GQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 559
           K+ G   A+K L K      + +E  +NE  +   +    LV+L     +     ++ EY
Sbjct: 64  KETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEY 123
Query: 560 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
            P   +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 124 APGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 175
Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
           D++   K++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 176 DQQGYIKVADFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 230
Query: 678 EIVSGRKNTSFFED 691
           E+ +G     FF D
Sbjct: 231 EMAAGY--PPFFAD 242

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 115/254 (45%), Gaps = 36/254 (14%)
Query: 444 WIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGR- 502
           ++AK K + + K      NT  L      QFE + T          +G G FG V   + 
Sbjct: 18  FLAKAKEDFLKKWENPAQNTAHLD-----QFERIKT----------IGTGSFGRVMLVKH 62
Query: 503 LKDGQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 559
           ++ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 63  METGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 560 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
           +P   +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 123 VPGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 174
Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
           D++   K++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 175 DQQGYIKVADFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 678 EIVSGRKNTSFFED 691
           E+ +G     FF D
Sbjct: 230 EMAAGY--PPFFAD 241

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 115/254 (45%), Gaps = 36/254 (14%)
Query: 444 WIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGR- 502
           ++AK K + + K      NT  L      QFE + T          LG G FG V   + 
Sbjct: 4   FLAKAKEDFLKKWENPAQNTAHLD-----QFERIKT----------LGTGSFGRVMLVKH 48
Query: 503 LKDGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 559
           ++ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 49  METGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 108
Query: 560 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
           +P   +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 109 VPGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 160
Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 161 DQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 215
Query: 678 EIVSGRKNTSFFED 691
           E+ +G     FF D
Sbjct: 216 EMAAGY--PPFFAD 227

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 97/204 (47%), Gaps = 11/204 (5%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGL--EEFMNEVMVISKLQHRN 539
           ++F+  S+LG G  G V   + +    I  ++L     +     + + E+ V+ +     
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 75
Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 599
           +V   G      E  +  E+M   SLD +L +    +R+       +   + RGL YL  
Sbjct: 76  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLRE 132
Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 659
             + +I+HRD+K SNIL++     K+ DFG++    G    +     VGT  YM+PE   
Sbjct: 133 --KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMAPERLQ 186
Query: 660 EGRFSEKSDVFSFGVLLLEIVSGR 683
              +S +SD++S G+ L+E+  GR
Sbjct: 187 GTHYSVQSDIWSMGLSLVELAVGR 210

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 101/201 (50%), Gaps = 17/201 (8%)
Query: 490 LGQGGFGPV---YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLL 544
           +G G +G V   Y  RL+  Q++AVK+LS+   S         E+ ++  L+H N++ LL
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 545 GCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 603
                        E Y+    + A L + +K + L       ++  + RGL Y+H     
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAG-- 151
Query: 604 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME-GR 662
            IIHRDLK SN+ ++E+   +I DFG+A+      D+  TG  V T  Y +PE  +    
Sbjct: 152 -IIHRDLKPSNVAVNEDSELRILDFGLAR----QADEEMTG-YVATRWYRAPEIMLNWMH 205
Query: 663 FSEKSDVFSFGVLLLEIVSGR 683
           +++  D++S G ++ E++ G+
Sbjct: 206 YNQTVDIWSVGCIMAELLQGK 226

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 115/254 (45%), Gaps = 36/254 (14%)
Query: 444 WIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGR- 502
           ++AK K + + K      NT  L      QFE + T          LG G FG V   + 
Sbjct: 19  FLAKAKEDFLKKWENPAQNTAHLD-----QFERIKT----------LGTGSFGRVMLVKH 63
Query: 503 LKDGQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 559
           ++ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 64  METGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 123
Query: 560 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
           +P   +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 124 VPGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 175
Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 176 DQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 230
Query: 678 EIVSGRKNTSFFED 691
           E+ +G     FF D
Sbjct: 231 EMAAGY--PPFFAD 242

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 115/254 (45%), Gaps = 36/254 (14%)
Query: 444 WIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGR- 502
           ++AK K + + K      NT  L      QFE + T          LG G FG V   + 
Sbjct: 19  FLAKAKEDFLKKWENPAQNTAHLD-----QFERIKT----------LGTGSFGRVMLVKH 63
Query: 503 LKDGQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 559
           ++ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 64  METGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 123
Query: 560 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
           +P   +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 124 VPGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 175
Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 176 DQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 230
Query: 678 EIVSGRKNTSFFED 691
           E+ +G     FF D
Sbjct: 231 EMAAGY--PPFFAD 242

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 115/254 (45%), Gaps = 36/254 (14%)
Query: 444 WIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGR- 502
           ++AK K + + K      NT  L      QFE + T          LG G FG V   + 
Sbjct: 18  FLAKAKEDFLKKWENPAQNTAHLD-----QFERIKT----------LGTGSFGRVMLVKH 62
Query: 503 LKDGQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 559
           ++ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 63  METGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 560 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
           +P   +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 123 VPGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 174
Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 175 DQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 678 EIVSGRKNTSFFED 691
           E+ +G     FF D
Sbjct: 230 EMAAGY--PPFFAD 241

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 115/254 (45%), Gaps = 36/254 (14%)
Query: 444 WIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGR- 502
           ++AK K + + K      NT  L      QFE + T          LG G FG V   + 
Sbjct: 18  FLAKAKEDFLKKWENPAQNTAHLD-----QFERIKT----------LGTGSFGRVMLVKH 62
Query: 503 LKDGQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 559
           ++ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 63  METGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 560 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
           +P   +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 123 VPGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 174
Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 175 DQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 678 EIVSGRKNTSFFED 691
           E+ +G     FF D
Sbjct: 230 EMAAGY--PPFFAD 241

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 115/254 (45%), Gaps = 36/254 (14%)
Query: 444 WIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGR- 502
           ++AK K + + K      NT  L      QFE + T          LG G FG V   + 
Sbjct: 18  FLAKAKEDFLKKWENPAQNTAHLD-----QFERIKT----------LGTGSFGRVMLVKH 62
Query: 503 LKDGQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 559
           ++ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 63  METGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 560 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
           +P   +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 123 VPGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 174
Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 175 DQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 678 EIVSGRKNTSFFED 691
           E+ +G     FF D
Sbjct: 230 EMAAGY--PPFFAD 241

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 114/254 (44%), Gaps = 36/254 (14%)
Query: 444 WIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGR- 502
           ++AK K + + K      NT  L      QFE + T          LG G FG V   + 
Sbjct: 18  FLAKAKEDFLKKWENPAQNTAHLD-----QFERIKT----------LGTGSFGRVMLVKH 62
Query: 503 LKDGQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 559
           ++ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 63  METGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 560 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
            P   +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+++
Sbjct: 123 APGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLMI 174
Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
           D++   K++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 175 DQQGYIKVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 678 EIVSGRKNTSFFED 691
           E+ +G     FF D
Sbjct: 230 EMAAGY--PPFFAD 241

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/92 (43%), Positives = 53/92 (57%), Gaps = 3/92 (3%)
Query: 590 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 649
           ++RG+ +L   S  + IHRDL A NILL E    KI DFG+A+    N D    G     
Sbjct: 208 VARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 650 FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
             +M+PE   +  +S KSDV+S+GVLL EI S
Sbjct: 265 LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 115/254 (45%), Gaps = 36/254 (14%)
Query: 444 WIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGR- 502
           ++AK K + + K      NT  L      QFE + T          LG G FG V   + 
Sbjct: 18  FLAKAKEDFLKKWENPAQNTAHLD-----QFERIKT----------LGTGSFGRVMLVKH 62
Query: 503 LKDGQEIAVKRLSKASGQGLEEF---MNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 559
           ++ G   A+K L K     L+E    +NE  ++  +    LV+L     +     ++ EY
Sbjct: 63  METGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 560 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
            P   +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+++
Sbjct: 123 APGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLMI 174
Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
           D++   +++DFG+AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 175 DQQGYIQVTDFGLAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 678 EIVSGRKNTSFFED 691
           E+ +G     FF D
Sbjct: 230 EMAAGY--PPFFAD 241

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 106/227 (46%), Gaps = 20/227 (8%)
Query: 477 LATATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKAS--GQGLEEFMNEVMVIS 533
           L     ++ +   +G+G FG V   R K  Q++ A+K LSK     +    F  E   I 
Sbjct: 70  LQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIM 129
Query: 534 KLQHRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 592
              +   V  L C  + ++ + ++ EYMP   L  L+ +    E+  W K +      + 
Sbjct: 130 AFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK--WAKFYT-----AE 182
Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA-KIFGGNQDQADTGRVVGTFG 651
            +L L     + +IHRD+K  N+LLD+  + K++DFG   K+        DT   VGT  
Sbjct: 183 VVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTA--VGTPD 240
Query: 652 YMSPEY----AMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLT 694
           Y+SPE       +G +  + D +S GV L E++ G  +T F+ D L 
Sbjct: 241 YISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG--DTPFYADSLV 285

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 15/208 (7%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKAS----GQGLEEFMNEVMVISKLQH 537
            +F L   +G+G +  V   RLK    I   ++ K       + ++    E  V  +  +
Sbjct: 5   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 64
Query: 538 RNLVRLLGCCVEGEEKML-IYEYMPNRSLDALLFDPLKKERL-DWRKRFNIIEGISRGLL 595
              +  L  C + E ++  + EY+    L   +F   ++ +L +   RF   E IS  L 
Sbjct: 65  HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAE-ISLALN 120
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 655
           YLH      II+RDLK  N+LLD E + K++D+GM K   G +    T    GT  Y++P
Sbjct: 121 YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAP 175
Query: 656 EYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           E      +    D ++ GVL+ E+++GR
Sbjct: 176 EILRGEDYGFSVDWWALGVLMFEMMAGR 203

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 15/208 (7%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKAS----GQGLEEFMNEVMVISKLQH 537
            +F L   +G+G +  V   RLK    I   ++ K       + ++    E  V  +  +
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 538 RNLVRLLGCCVEGEEKML-IYEYMPNRSLDALLFDPLKKERL-DWRKRFNIIEGISRGLL 595
              +  L  C + E ++  + EY+    L   +F   ++ +L +   RF   E IS  L 
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAE-ISLALN 124
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 655
           YLH      II+RDLK  N+LLD E + K++D+GM K   G +    T    GT  Y++P
Sbjct: 125 YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAP 179
Query: 656 EYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           E      +    D ++ GVL+ E+++GR
Sbjct: 180 EILRGEDYGFSVDWWALGVLMFEMMAGR 207

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 15/208 (7%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKAS----GQGLEEFMNEVMVISKLQH 537
            +F L   +G+G +  V   RLK    I   ++ K       + ++    E  V  +  +
Sbjct: 20  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 79
Query: 538 RNLVRLLGCCVEGEEKML-IYEYMPNRSLDALLFDPLKKERL-DWRKRFNIIEGISRGLL 595
              +  L  C + E ++  + EY+    L   +F   ++ +L +   RF   E IS  L 
Sbjct: 80  HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAE-ISLALN 135
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 655
           YLH      II+RDLK  N+LLD E + K++D+GM K   G +    T    GT  Y++P
Sbjct: 136 YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAP 190
Query: 656 EYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           E      +    D ++ GVL+ E+++GR
Sbjct: 191 EILRGEDYGFSVDWWALGVLMFEMMAGR 218

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 116/254 (45%), Gaps = 36/254 (14%)
Query: 444 WIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 503
           ++AK K + + K    + NT +L      QF+ + T          LG G FG V   + 
Sbjct: 5   FLAKAKEDFLKKWETPSQNTAQLD-----QFDRIKT----------LGTGSFGRVMLVKH 49
Query: 504 KD-GQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 559
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 50  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 109
Query: 560 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
           +    +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 110 VAGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 161
Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
           DE+   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 162 DEQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 216
Query: 678 EIVSGRKNTSFFED 691
           E+ +G     FF D
Sbjct: 217 EMAAGY--PPFFAD 228

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 99/206 (48%), Gaps = 21/206 (10%)
Query: 484 FQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 542
           F++ S+LG+G    VY  + K  Q+  A+K L K   + +     E+ V+ +L H N+++
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI--VRTEIGVLLRLSHPNIIK 112
Query: 543 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLYLHRDS 601
           L        E  L+ E +    L    FD + +K     R   + ++ I   + YLH + 
Sbjct: 113 LKEIFETPTEISLVLELVTGGEL----FDRIVEKGYYSERDAADAVKQILEAVAYLHENG 168
Query: 602 RLRIIHRDLKASNILL-----DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 656
              I+HRDLK  N+L      D  L  KI+DFG++KI    + Q     V GT GY +PE
Sbjct: 169 ---IVHRDLKPENLLYATPAPDAPL--KIADFGLSKIV---EHQVLMKTVCGTPGYCAPE 220
Query: 657 YAMEGRFSEKSDVFSFGVLLLEIVSG 682
                 +  + D++S G++   ++ G
Sbjct: 221 ILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 14/203 (6%)
Query: 484 FQLSSKLGQGGFGPVYWGRLKDGQE----IAVKRLSKASGQGL-EEFMNEVMVISKLQHR 538
            +L   +G+G FG V+ G     +     +A+K     +   + E+F+ E + + +  H 
Sbjct: 12  IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 71
Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           ++V+L+G   E     +I E      L + L   ++K  LD          +S  L YL 
Sbjct: 72  HIVKLIGVITENP-VWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLE 128
Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF-GGNQDQADTGRVVGTFGYMSPEY 657
                R +HRD+ A N+L+      K+ DFG+++        +A  G++     +M+PE 
Sbjct: 129 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKL--PIKWMAPES 183
Query: 658 AMEGRFSEKSDVFSFGVLLLEIV 680
               RF+  SDV+ FGV + EI+
Sbjct: 184 INFRRFTSASDVWMFGVCMWEIL 206

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/214 (32%), Positives = 109/214 (50%), Gaps = 24/214 (11%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK-----RLSKAS-GQGLEEFMNEVMVISK 534
           +++++  +LG G F  V   R K  G+E A K     RLS +  G   EE   EV ++ +
Sbjct: 12  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 71
Query: 535 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRG 593
           ++H N++ L        + +LI E +        LFD L +KE L   +    ++ I  G
Sbjct: 72  IRHPNIITLHDIFENKTDVVLILELVSG----GELFDFLAEKESLTEDEATQFLKQILDG 127
Query: 594 LLYLHRDSRLRIIHRDLKASNI-LLDEEL-NPKIS--DFGMA-KIFGGNQDQADTGRVVG 648
           + YLH     RI H DLK  NI LLD+ + NP+I   DFG+A KI  GN+ +     + G
Sbjct: 128 VHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK----NIFG 180
Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           T  +++PE         ++D++S GV+   ++SG
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 110/218 (50%), Gaps = 24/218 (11%)
Query: 478 ATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK-----RLSKAS-GQGLEEFMNEVM 530
           +   +++++  +LG G F  V   R K  G+E A K     RLS +  G   EE   EV 
Sbjct: 1   SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 531 VISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEG 589
           ++ +++H N++ L        + +LI E +        LFD L +KE L   +    ++ 
Sbjct: 61  ILREIRHPNIITLHDIFENKTDVVLILELVSG----GELFDFLAEKESLTEDEATQFLKQ 116
Query: 590 ISRGLLYLHRDSRLRIIHRDLKASNI-LLDEEL-NPKIS--DFGMA-KIFGGNQDQADTG 644
           I  G+ YLH     RI H DLK  NI LLD+ + NP+I   DFG+A KI  GN+ +    
Sbjct: 117 ILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK---- 169
Query: 645 RVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
            + GT  +++PE         ++D++S GV+   ++SG
Sbjct: 170 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 14/203 (6%)
Query: 484 FQLSSKLGQGGFGPVYWGRLKDGQE----IAVKRLSKASGQGL-EEFMNEVMVISKLQHR 538
            +L   +G+G FG V+ G     +     +A+K     +   + E+F+ E + + +  H 
Sbjct: 9   IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 68
Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           ++V+L+G   E     +I E      L + L   ++K  LD          +S  L YL 
Sbjct: 69  HIVKLIGVITENP-VWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLE 125
Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF-GGNQDQADTGRVVGTFGYMSPEY 657
                R +HRD+ A N+L+      K+ DFG+++        +A  G++     +M+PE 
Sbjct: 126 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPES 180
Query: 658 AMEGRFSEKSDVFSFGVLLLEIV 680
               RF+  SDV+ FGV + EI+
Sbjct: 181 INFRRFTSASDVWMFGVCMWEIL 203

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 14/203 (6%)
Query: 484 FQLSSKLGQGGFGPVYWGRLKDGQE----IAVKRLSKASGQGL-EEFMNEVMVISKLQHR 538
            +L   +G+G FG V+ G     +     +A+K     +   + E+F+ E + + +  H 
Sbjct: 40  IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 99
Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           ++V+L+G   E     +I E      L + L   ++K  LD          +S  L YL 
Sbjct: 100 HIVKLIGVITENP-VWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLE 156
Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF-GGNQDQADTGRVVGTFGYMSPEY 657
                R +HRD+ A N+L+      K+ DFG+++        +A  G++     +M+PE 
Sbjct: 157 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPES 211
Query: 658 AMEGRFSEKSDVFSFGVLLLEIV 680
               RF+  SDV+ FGV + EI+
Sbjct: 212 INFRRFTSASDVWMFGVCMWEIL 234

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 14/203 (6%)
Query: 484 FQLSSKLGQGGFGPVYWGRLKDGQE----IAVKRLSKASGQGL-EEFMNEVMVISKLQHR 538
            +L   +G+G FG V+ G     +     +A+K     +   + E+F+ E + + +  H 
Sbjct: 12  IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 71
Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           ++V+L+G   E     +I E      L + L   ++K  LD          +S  L YL 
Sbjct: 72  HIVKLIGVITENP-VWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLE 128
Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF-GGNQDQADTGRVVGTFGYMSPEY 657
                R +HRD+ A N+L+      K+ DFG+++        +A  G++     +M+PE 
Sbjct: 129 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPES 183
Query: 658 AMEGRFSEKSDVFSFGVLLLEIV 680
               RF+  SDV+ FGV + EI+
Sbjct: 184 INFRRFTSASDVWMFGVCMWEIL 206

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 14/203 (6%)
Query: 484 FQLSSKLGQGGFGPVYWGRLKDGQE----IAVKRLSKASGQGL-EEFMNEVMVISKLQHR 538
            +L   +G+G FG V+ G     +     +A+K     +   + E+F+ E + + +  H 
Sbjct: 17  IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 76
Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           ++V+L+G   E     +I E      L + L   ++K  LD          +S  L YL 
Sbjct: 77  HIVKLIGVITENP-VWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLE 133
Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF-GGNQDQADTGRVVGTFGYMSPEY 657
                R +HRD+ A N+L+      K+ DFG+++        +A  G++     +M+PE 
Sbjct: 134 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPES 188
Query: 658 AMEGRFSEKSDVFSFGVLLLEIV 680
               RF+  SDV+ FGV + EI+
Sbjct: 189 INFRRFTSASDVWMFGVCMWEIL 211

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 116/254 (45%), Gaps = 36/254 (14%)
Query: 444 WIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 503
           ++AK K + + K    + NT +L      QF+ + T          LG G FG V   + 
Sbjct: 18  FLAKAKEDFLKKWETPSQNTAQLD-----QFDRIKT----------LGTGSFGRVMLVKH 62
Query: 504 KD-GQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 559
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 560 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
           +    +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 123 VAGGEM----FSHLRRIGRFXEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 174
Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 175 DQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 678 EIVSGRKNTSFFED 691
           E+ +G     FF D
Sbjct: 230 EMAAGY--PPFFAD 241

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 96/198 (48%), Gaps = 11/198 (5%)
Query: 489 KLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLE-EFMNEVMVISKLQHRNLVRLLGC 546
           KLG+G +  VY G+ K     +A+K +     +G     + EV ++  L+H N+V L   
Sbjct: 9   KLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 547 CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRII 606
               +   L++EY+ ++ L   L D      +   K F  +  + RGL Y HR    +++
Sbjct: 69  IHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLF--LFQLLRGLAYCHRQ---KVL 122
Query: 607 HRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM-EGRFSE 665
           HRDLK  N+L++E    K++DFG+A+         D   V  T  Y  P+  +    +S 
Sbjct: 123 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYRPPDILLGSTDYST 180
Query: 666 KSDVFSFGVLLLEIVSGR 683
           + D++  G +  E+ +GR
Sbjct: 181 QIDMWGVGCIFYEMATGR 198

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 14/203 (6%)
Query: 484 FQLSSKLGQGGFGPVYWGRLKDGQE----IAVKRLSKASGQGL-EEFMNEVMVISKLQHR 538
            +L   +G+G FG V+ G     +     +A+K     +   + E+F+ E + + +  H 
Sbjct: 12  IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 71
Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           ++V+L+G   E     +I E      L + L   ++K  LD          +S  L YL 
Sbjct: 72  HIVKLIGVITENP-VWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLE 128
Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF-GGNQDQADTGRVVGTFGYMSPEY 657
                R +HRD+ A N+L+      K+ DFG+++        +A  G++     +M+PE 
Sbjct: 129 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPES 183
Query: 658 AMEGRFSEKSDVFSFGVLLLEIV 680
               RF+  SDV+ FGV + EI+
Sbjct: 184 INFRRFTSASDVWMFGVCMWEIL 206

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 14/203 (6%)
Query: 484 FQLSSKLGQGGFGPVYWGRLKDGQE----IAVKRLSKASGQGL-EEFMNEVMVISKLQHR 538
            +L   +G+G FG V+ G     +     +A+K     +   + E+F+ E + + +  H 
Sbjct: 15  IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 74
Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           ++V+L+G   E     +I E      L + L   ++K  LD          +S  L YL 
Sbjct: 75  HIVKLIGVITENP-VWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLE 131
Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF-GGNQDQADTGRVVGTFGYMSPEY 657
                R +HRD+ A N+L+      K+ DFG+++        +A  G++     +M+PE 
Sbjct: 132 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPES 186
Query: 658 AMEGRFSEKSDVFSFGVLLLEIV 680
               RF+  SDV+ FGV + EI+
Sbjct: 187 INFRRFTSASDVWMFGVCMWEIL 209

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 113/254 (44%), Gaps = 36/254 (14%)
Query: 444 WIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGR- 502
           ++AK K + + K      NT  L      QFE + T          LG G FG V   + 
Sbjct: 19  FLAKAKEDFLKKWENPAQNTAHLD-----QFERIKT----------LGTGSFGRVMLVKH 63
Query: 503 LKDGQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 559
           ++ G   A+K L K      + +E  +NE  ++  +    L +L     +     ++ EY
Sbjct: 64  METGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEY 123
Query: 560 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
            P   +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+++
Sbjct: 124 APGGEM----FSHLRRIGRFXEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLMI 175
Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
           D++   K++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 176 DQQGYIKVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 230
Query: 678 EIVSGRKNTSFFED 691
           E+ +G     FF D
Sbjct: 231 EMAAGY--PPFFAD 242

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 14/203 (6%)
Query: 484 FQLSSKLGQGGFGPVYWGRLKDGQE----IAVKRLSKASGQGL-EEFMNEVMVISKLQHR 538
            +L   +G+G FG V+ G     +     +A+K     +   + E+F+ E + + +  H 
Sbjct: 14  IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 73
Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           ++V+L+G   E     +I E      L + L   ++K  LD          +S  L YL 
Sbjct: 74  HIVKLIGVITENP-VWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLE 130
Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF-GGNQDQADTGRVVGTFGYMSPEY 657
                R +HRD+ A N+L+      K+ DFG+++        +A  G++     +M+PE 
Sbjct: 131 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPES 185
Query: 658 AMEGRFSEKSDVFSFGVLLLEIV 680
               RF+  SDV+ FGV + EI+
Sbjct: 186 INFRRFTSASDVWMFGVCMWEIL 208

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 116/254 (45%), Gaps = 36/254 (14%)
Query: 444 WIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 503
           ++AK K + + K    + NT +L      QF+ + T          LG G FG V   + 
Sbjct: 18  FLAKAKEDFLKKWETPSQNTAQLD-----QFDRIKT----------LGTGSFGRVMLVKH 62
Query: 504 KD-GQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 559
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 560 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
           +    +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 123 VAGGEM----FSHLRRIGRFXEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 174
Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 175 DQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 678 EIVSGRKNTSFFED 691
           E+ +G     FF D
Sbjct: 230 EMAAGY--PPFFAD 241

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 109/233 (46%), Gaps = 17/233 (7%)
Query: 490 LGQGGFGPVYWGRLKDGQEIAVKRLSKAS----GQGLEEFMNEVMVISKLQHRNLVRLLG 545
           LG+GGF   Y     D +E+   ++   S        E+   E+ +   L + ++V   G
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 546 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 605
              + +   ++ E    RSL  L     +K   +   R+ + + I +G+ YLH +   R+
Sbjct: 94  FFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---RV 147
Query: 606 IHRDLKASNILLDEELNPKISDFGMA-KIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFS 664
           IHRDLK  N+ L+++++ KI DFG+A KI    + + D   + GT  Y++PE   +   S
Sbjct: 148 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKD---LCGTPNYIAPEVLCKKGHS 204
Query: 665 EKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS 717
            + D++S G +L  ++ G+     FE       Y     NE  +   ++P  S
Sbjct: 205 FEVDIWSLGCILYTLLVGKPP---FETSCLKETYIRIKKNEYSVPRHINPVAS 254

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 116/254 (45%), Gaps = 36/254 (14%)
Query: 444 WIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 503
           ++AK K + + K    + NT +L      QF+ + T          LG G FG V   + 
Sbjct: 18  FLAKAKEDFLKKWETPSQNTAQLD-----QFDRIKT----------LGTGSFGRVMLVKH 62
Query: 504 KD-GQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 559
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 560 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
           +    +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 123 VAGGEM----FSHLRRIGRFAEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 174
Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 175 DQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 678 EIVSGRKNTSFFED 691
           E+ +G     FF D
Sbjct: 230 EMAAGY--PPFFAD 241

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/255 (26%), Positives = 117/255 (45%), Gaps = 36/255 (14%)
Query: 444 WIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 503
           ++AK K + + K    + NT +L      QF+ + T          LG G FG V   + 
Sbjct: 18  FLAKAKEDFLKKWETPSQNTAQLD-----QFDRIKT----------LGTGSFGRVMLVKH 62
Query: 504 KD-GQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 559
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 560 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
           +    +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 123 VAGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 174
Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 175 DQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 678 EIVSGRKNTSFFEDD 692
           E+ +G     FF D+
Sbjct: 230 EMAAGY--PPFFADE 242

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 114/254 (44%), Gaps = 36/254 (14%)
Query: 444 WIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGR- 502
           ++AK K + + K      NT  L      QFE + T          LG G FG V   + 
Sbjct: 18  FLAKAKEDFLKKWENPAQNTAHLD-----QFERIKT----------LGTGSFGRVMLVKH 62
Query: 503 LKDGQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 559
           ++ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 63  METGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 560 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
            P   +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+++
Sbjct: 123 APGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLMI 174
Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 175 DQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 678 EIVSGRKNTSFFED 691
           E+ +G     FF D
Sbjct: 230 EMAAGY--PPFFAD 241

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 24/212 (11%)
Query: 484 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVK----RLSKASGQGL--EEFMNEVMVISKLQ 536
           +    +LG G F  V   R K  G + A K    R +K+S +G+  E+   EV ++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLL 595
           H N++ L        + +LI E +        LFD L +KE L   +    ++ I  G+ 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAG----GELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPK----ISDFGMA-KIFGGNQDQADTGRVVGTF 650
           YLH    L+I H DLK  NI+L +   PK    I DFG+A KI  GN+ +     + GT 
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTP 181
Query: 651 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
            +++PE         ++D++S GV+   ++SG
Sbjct: 182 AFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 116/254 (45%), Gaps = 36/254 (14%)
Query: 444 WIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 503
           ++AK K + + K    + NT +L      QF+ + T          LG G FG V   + 
Sbjct: 39  FLAKAKEDFLKKWETPSQNTAQLD-----QFDRIKT----------LGTGSFGRVMLVKH 83
Query: 504 KD-GQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 559
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 84  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 143
Query: 560 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
           +    +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 144 VAGGEM----FSHLRRIGRFXEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 195
Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 196 DQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 250
Query: 678 EIVSGRKNTSFFED 691
           E+ +G     FF D
Sbjct: 251 EMAAGY--PPFFAD 262

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 116/254 (45%), Gaps = 36/254 (14%)
Query: 444 WIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 503
           ++AK K + + K    + NT +L      QF+ + T          LG G FG V   + 
Sbjct: 18  FLAKAKEDFLKKWETPSQNTAQLD-----QFDRIKT----------LGTGSFGRVMLVKH 62
Query: 504 KD-GQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 559
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 560 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
           +    +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 123 VAGGEM----FSHLRRIGRFXEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 174
Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 175 DQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 678 EIVSGRKNTSFFED 691
           E+ +G     FF D
Sbjct: 230 EMAAGY--PPFFAD 241

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 116/254 (45%), Gaps = 36/254 (14%)
Query: 444 WIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 503
           ++AK K + + K    + NT +L      QF+ + T          LG G FG V   + 
Sbjct: 18  FLAKAKEDFLKKWETPSQNTAQLD-----QFDRIKT----------LGTGSFGRVMLVKH 62
Query: 504 KD-GQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 559
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 560 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
           +    +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 123 VAGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 174
Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 175 DQQGYIQVTDFGFAKRVKGR-----TWXLAGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 678 EIVSGRKNTSFFED 691
           E+ +G     FF D
Sbjct: 230 EMAAGY--PPFFAD 241

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 116/254 (45%), Gaps = 36/254 (14%)
Query: 444 WIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 503
           ++AK K + + K    + NT +L      QF+ + T          LG G FG V   + 
Sbjct: 13  FLAKAKEDFLKKWETPSQNTAQLD-----QFDRIKT----------LGTGSFGRVMLVKH 57
Query: 504 KD-GQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 559
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 58  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 117
Query: 560 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
           +    +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 118 VAGGEM----FSHLRRIGRFXEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 169
Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 170 DQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 224
Query: 678 EIVSGRKNTSFFED 691
           E+ +G     FF D
Sbjct: 225 EMAAGY--PPFFAD 236

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 112/218 (51%), Gaps = 24/218 (11%)
Query: 478 ATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSK----ASGQGL--EEFMNEVM 530
           +   +++++  +LG G F  V   R K  G+E A K + K    +S +G+  EE   EV 
Sbjct: 22  SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVN 81
Query: 531 VISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEG 589
           ++ +++H N++ L        + +LI E +        LFD L +KE L   +    ++ 
Sbjct: 82  ILREIRHPNIITLHDIFENKTDVVLILELVSG----GELFDFLAEKESLTEDEATQFLKQ 137
Query: 590 ISRGLLYLHRDSRLRIIHRDLKASNI-LLDEEL-NPKIS--DFGMA-KIFGGNQDQADTG 644
           I  G+ YLH     RI H DLK  NI LLD+ + NP+I   DFG+A KI  GN+ +    
Sbjct: 138 ILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK---- 190
Query: 645 RVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
            + GT  +++PE         ++D++S GV+   ++SG
Sbjct: 191 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 228

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 116/254 (45%), Gaps = 36/254 (14%)
Query: 444 WIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 503
           ++AK K + + K    + NT +L      QF+ + T          LG G FG V   + 
Sbjct: 18  FLAKAKEDFLKKWETPSQNTAQLD-----QFDRIKT----------LGTGSFGRVMLVKH 62
Query: 504 KD-GQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 559
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 560 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
           +    +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 123 VAGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 174
Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 175 DQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 678 EIVSGRKNTSFFED 691
           E+ +G     FF D
Sbjct: 230 EMAAGY--PPFFAD 241

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 14/203 (6%)
Query: 484 FQLSSKLGQGGFGPVYWGRLKDGQE----IAVKRLSKASGQGL-EEFMNEVMVISKLQHR 538
            +L   +G+G FG V+ G     +     +A+K     +   + E+F+ E + + +  H 
Sbjct: 12  IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 71
Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           ++V+L+G   E     +I E      L + L   ++K  LD          +S  L YL 
Sbjct: 72  HIVKLIGVITENP-VWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLE 128
Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF-GGNQDQADTGRVVGTFGYMSPEY 657
                R +HRD+ A N+L+      K+ DFG+++        +A  G++     +M+PE 
Sbjct: 129 SK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPES 183
Query: 658 AMEGRFSEKSDVFSFGVLLLEIV 680
               RF+  SDV+ FGV + EI+
Sbjct: 184 INFRRFTSASDVWMFGVCMWEIL 206

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/254 (24%), Positives = 117/254 (46%), Gaps = 28/254 (11%)
Query: 445 IAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLK 504
           +    A   A ++A N+  +K +      F+      + +++   +G G +G V   R +
Sbjct: 23  VKAEPAHTAASVAAKNLALLKARS-----FDVTFDVGDEYEIIETIGNGAYGVVSSARRR 77
Query: 505 -DGQEIAVKRLSKASG--QGLEEFMNEVMVISKLQHRNLVR----LLGCCVEGEEK--ML 555
             GQ++A+K++  A       +  + E+ ++   +H N++     L      GE K   +
Sbjct: 78  LTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYV 137
Query: 556 IYEYMPNRSLDALLF--DPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKAS 613
           + + M    L  ++    PL  E + +      +  + RGL Y+H     ++IHRDLK S
Sbjct: 138 VLDLM-ESDLHQIIHSSQPLTLEHVRY-----FLYQLLRGLKYMHS---AQVIHRDLKPS 188
Query: 614 NILLDEELNPKISDFGMAK--IFGGNQDQADTGRVVGTFGYMSPEYAME-GRFSEKSDVF 670
           N+L++E    KI DFGMA+       + Q      V T  Y +PE  +    +++  D++
Sbjct: 189 NLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLW 248
Query: 671 SFGVLLLEIVSGRK 684
           S G +  E+++ R+
Sbjct: 249 SVGCIFGEMLARRQ 262

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 113/254 (44%), Gaps = 36/254 (14%)
Query: 444 WIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGR- 502
           ++AK K + + K      NT  L      QFE + T          LG G FG V   + 
Sbjct: 19  FLAKAKEDFLKKWENPAQNTAHLD-----QFERIKT----------LGTGSFGRVMLVKH 63
Query: 503 LKDGQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 559
           ++ G   A+K L K      + +E  +NE  ++  +    L +L     +     ++ EY
Sbjct: 64  METGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEY 123
Query: 560 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
            P   +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+++
Sbjct: 124 APGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLMI 175
Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
           D++   K++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 176 DQQGYIKVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 230
Query: 678 EIVSGRKNTSFFED 691
           E+ +G     FF D
Sbjct: 231 EMAAGY--PPFFAD 242

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 99/212 (46%), Gaps = 18/212 (8%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEI----AVKRLSKAS----GQGLEEFMNEVMVIS 533
            NF+L   LG G +G V+  R   G +     A+K L KA+     +  E    E  V+ 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 534 KLQHRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 592
            ++    +  L    + E K+ LI +Y+    L   L    ++ER    +    +  I  
Sbjct: 114 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS---QRERFTEHEVQIYVGEIVL 170
Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 652
            L +LH+   L II+RD+K  NILLD   +  ++DFG++K F  ++ +       GT  Y
Sbjct: 171 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGTIEY 226
Query: 653 MSPEYAMEGRFSEKSDV--FSFGVLLLEIVSG 682
           M+P+    G       V  +S GVL+ E+++G
Sbjct: 227 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 113/254 (44%), Gaps = 36/254 (14%)
Query: 444 WIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGR- 502
           ++AK K + + K      NT  L      QFE + T          LG G FG V   + 
Sbjct: 19  FLAKAKEDFLKKWENPAQNTAHLD-----QFERIKT----------LGTGSFGRVMLVKH 63
Query: 503 LKDGQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 559
           ++ G   A+K L K      + +E  +NE  ++  +    L +L     +     ++ EY
Sbjct: 64  METGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEY 123
Query: 560 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
            P   +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+++
Sbjct: 124 APGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLMI 175
Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
           D++   K++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 176 DQQGYIKVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 230
Query: 678 EIVSGRKNTSFFED 691
           E+ +G     FF D
Sbjct: 231 EMAAGY--PPFFAD 242

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 116/254 (45%), Gaps = 36/254 (14%)
Query: 444 WIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 503
           ++AK K + + K    + NT +L      QF+ + T          LG G FG V   + 
Sbjct: 18  FLAKAKEDFLKKWETPSQNTAQLD-----QFDRIKT----------LGTGSFGRVMLVKH 62
Query: 504 KD-GQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 559
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 560 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
           +    +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 123 VAGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 174
Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 175 DQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 678 EIVSGRKNTSFFED 691
           E+ +G     FF D
Sbjct: 230 EMAAGY--PPFFAD 241

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 116/254 (45%), Gaps = 36/254 (14%)
Query: 444 WIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 503
           ++AK K + + K    + NT +L      QF+ + T          LG G FG V   + 
Sbjct: 19  FLAKAKEDFLKKWETPSQNTAQLD-----QFDRIKT----------LGTGSFGRVMLVKH 63
Query: 504 KD-GQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 559
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 64  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 123
Query: 560 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
           +    +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 124 VAGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 175
Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 176 DQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 230
Query: 678 EIVSGRKNTSFFED 691
           E+ +G     FF D
Sbjct: 231 EMAAGY--PPFFAD 242

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 116/254 (45%), Gaps = 36/254 (14%)
Query: 444 WIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 503
           ++AK K + + K    + NT +L      QF+ + T          LG G FG V   + 
Sbjct: 18  FLAKAKEDFLKKWETPSQNTAQLD-----QFDRIKT----------LGTGSFGRVMLVKH 62
Query: 504 KD-GQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 559
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 560 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
           +    +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 123 VAGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 174
Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 175 DQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 678 EIVSGRKNTSFFED 691
           E+ +G     FF D
Sbjct: 230 EMAAGY--PPFFAD 241

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 116/254 (45%), Gaps = 36/254 (14%)
Query: 444 WIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 503
           ++AK K + + K    + NT +L      QF+ + T          LG G FG V   + 
Sbjct: 18  FLAKAKEDFLKKWETPSQNTAQLD-----QFDRIKT----------LGTGSFGRVMLVKH 62
Query: 504 KD-GQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 559
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 560 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
           +    +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 123 VAGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 174
Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 175 DQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 678 EIVSGRKNTSFFED 691
           E+ +G     FF D
Sbjct: 230 EMAAGY--PPFFAD 241

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 116/254 (45%), Gaps = 36/254 (14%)
Query: 444 WIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 503
           ++AK K + + K    + NT +L      QF+ + T          LG G FG V   + 
Sbjct: 18  FLAKAKEDFLKKWETPSQNTAQLD-----QFDRIKT----------LGTGSFGRVMLVKH 62
Query: 504 KD-GQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 559
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 560 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
           +    +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 123 VAGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 174
Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 175 DQQGYIQVTDFGFAKRVKGR-----TWXLXGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 678 EIVSGRKNTSFFED 691
           E+ +G     FF D
Sbjct: 230 EMAAGY--PPFFAD 241

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 24/212 (11%)
Query: 484 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVK----RLSKASGQGL--EEFMNEVMVISKLQ 536
           +    +LG G F  V   R K  G + A K    R +K+S +G+  E+   EV ++ ++Q
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLL 595
           H N++ L        + +LI E +        LFD L +KE L   +    ++ I  G+ 
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAG----GELFDFLAEKESLTEEEATEFLKQILNGVY 127
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMA-KIFGGNQDQADTGRVVGTF 650
           YLH    L+I H DLK  NI+L +   P    KI DFG+A KI  GN+ +     + GT 
Sbjct: 128 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTP 180
Query: 651 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
            +++PE         ++D++S GV+   ++SG
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 490 LGQGGFGPV---YWGRLKDGQEIAVKRLSKASGQGL--EEFMNEVMVISKLQHRNLVRLL 544
           +G G +G V     GR   G ++A+K+L +     L  +    E+ ++  ++H N++ LL
Sbjct: 33  VGSGAYGAVCSAVDGRT--GAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 90
Query: 545 GCCVEGE---EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
                 E   +    Y  MP    D  L   +K E+L   +   ++  + +GL Y+H   
Sbjct: 91  DVFTPDETLDDFTDFYLVMPFMGTD--LGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG 148
Query: 602 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME- 660
              IIHRDLK  N+ ++E+   KI DFG+A+      D    G VV T  Y +PE  +  
Sbjct: 149 ---IIHRDLKPGNLAVNEDCELKILDFGLAR----QADSEMXGXVV-TRWYRAPEVILNW 200
Query: 661 GRFSEKSDVFSFGVLLLEIVSGR 683
            R+++  D++S G ++ E+++G+
Sbjct: 201 MRYTQTVDIWSVGCIMAEMITGK 223

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 24/212 (11%)
Query: 484 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVK----RLSKASGQGL--EEFMNEVMVISKLQ 536
           +    +LG G F  V   R K  G + A K    R +K+S +G+  E+   EV ++ ++Q
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLL 595
           H N++ L        + +LI E +        LFD L +KE L   +    ++ I  G+ 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAG----GELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMA-KIFGGNQDQADTGRVVGTF 650
           YLH    L+I H DLK  NI+L +   P    KI DFG+A KI  GN+ +     + GT 
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTP 181
Query: 651 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
            +++PE         ++D++S GV+   ++SG
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 24/212 (11%)
Query: 484 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVK----RLSKASGQGL--EEFMNEVMVISKLQ 536
           +    +LG G F  V   R K  G + A K    R +K+S +G+  E+   EV ++ ++Q
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLL 595
           H N++ L        + +LI E +        LFD L +KE L   +    ++ I  G+ 
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAG----GELFDFLAEKESLTEEEATEFLKQILNGVY 127
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMA-KIFGGNQDQADTGRVVGTF 650
           YLH    L+I H DLK  NI+L +   P    KI DFG+A KI  GN+ +     + GT 
Sbjct: 128 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTP 180
Query: 651 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
            +++PE         ++D++S GV+   ++SG
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 100/233 (42%), Gaps = 29/233 (12%)
Query: 479 TATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGL---EEFMNEVMVISKL 535
           T      L   +G+G +G V W  L  G+ +AVK  S    Q      E  N V+    L
Sbjct: 5   TVARQVALVECVGKGRYGEV-WRGLWHGESVAVKIFSSRDEQSWFRETEIYNTVL----L 59
Query: 536 QHRNLVRLLGCCVEGEEKM----LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGIS 591
           +H N++  +   +          LI  Y  + SL    +D L+++ L+      +    +
Sbjct: 60  RHDNILGFIASDMTSRNSSTQLWLITHYHEHGSL----YDFLQRQTLEPHLALRLAVSAA 115
Query: 592 RGLLYLHRD-----SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR- 645
            GL +LH +      +  I HRD K+ N+L+   L   I+D G+A +     D  D G  
Sbjct: 116 CGLAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNN 175
Query: 646 -VVGTFGYMSPEYAMEGRFSEK------SDVFSFGVLLLEIVSGRKNTSFFED 691
             VGT  YM+PE   E   ++       +D+++FG++L EI          ED
Sbjct: 176 PRVGTKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEIARRTIVNGIVED 228

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 24/212 (11%)
Query: 484 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVK----RLSKASGQGL--EEFMNEVMVISKLQ 536
           +    +LG G F  V   R K  G + A K    R +K+S +G+  E+   EV ++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLL 595
           H N++ L        + +LI E +        LFD L +KE L   +    ++ I  G+ 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAG----GELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMA-KIFGGNQDQADTGRVVGTF 650
           YLH    L+I H DLK  NI+L +   P    KI DFG+A KI  GN+ +     + GT 
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTP 181
Query: 651 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
            +++PE         ++D++S GV+   ++SG
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/254 (24%), Positives = 117/254 (46%), Gaps = 28/254 (11%)
Query: 445 IAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLK 504
           +    A   A ++A N+  +K +      F+      + +++   +G G +G V   R +
Sbjct: 22  VKAEPAHTAASVAAKNLALLKARS-----FDVTFDVGDEYEIIETIGNGAYGVVSSARRR 76
Query: 505 -DGQEIAVKRLSKASG--QGLEEFMNEVMVISKLQHRNLVR----LLGCCVEGEEK--ML 555
             GQ++A+K++  A       +  + E+ ++   +H N++     L      GE K   +
Sbjct: 77  LTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYV 136
Query: 556 IYEYMPNRSLDALLF--DPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKAS 613
           + + M    L  ++    PL  E + +      +  + RGL Y+H     ++IHRDLK S
Sbjct: 137 VLDLM-ESDLHQIIHSSQPLTLEHVRY-----FLYQLLRGLKYMHS---AQVIHRDLKPS 187
Query: 614 NILLDEELNPKISDFGMAKIF--GGNQDQADTGRVVGTFGYMSPEYAME-GRFSEKSDVF 670
           N+L++E    KI DFGMA+       + Q      V T  Y +PE  +    +++  D++
Sbjct: 188 NLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLW 247
Query: 671 SFGVLLLEIVSGRK 684
           S G +  E+++ R+
Sbjct: 248 SVGCIFGEMLARRQ 261

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 116/254 (45%), Gaps = 36/254 (14%)
Query: 444 WIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 503
           ++AK K + + K    + NT +L      QF+ + T          LG G FG V   + 
Sbjct: 39  FLAKAKEDFLKKWETPSQNTAQLD-----QFDRIKT----------LGTGSFGRVMLVKH 83
Query: 504 KD-GQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 559
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 84  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 143
Query: 560 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
           +    +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 144 VAGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 195
Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 196 DQQGYIQVTDFGFAKRVKGA-----TWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 250
Query: 678 EIVSGRKNTSFFED 691
           E+ +G     FF D
Sbjct: 251 EMAAGY--PPFFAD 262

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 24/212 (11%)
Query: 484 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVK----RLSKASGQGL--EEFMNEVMVISKLQ 536
           +    +LG G F  V   R K  G + A K    R +K+S +G+  E+   EV ++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLL 595
           H N++ L        + +LI E +        LFD L +KE L   +    ++ I  G+ 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAG----GELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMA-KIFGGNQDQADTGRVVGTF 650
           YLH    L+I H DLK  NI+L +   P    KI DFG+A KI  GN+ +     + GT 
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTP 181
Query: 651 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
            +++PE         ++D++S GV+   ++SG
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 24/221 (10%)
Query: 468 DLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLSKASGQGLEE-F 525
           DLP+         ++ ++L   +G G FG     R K   E +AVK + +  G+ ++E  
Sbjct: 11  DLPIMH------DSDRYELVKDIGAGNFGVARLMRDKQANELVAVKYIER--GEKIDENV 62
Query: 526 MNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF- 584
             E++    L+H N+VR     +      ++ EY     L   + +  +    + R  F 
Sbjct: 63  KREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ 122
Query: 585 NIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP--KISDFGMAKIFGGNQDQAD 642
            +I G+S    Y H    +++ HRDLK  N LLD    P  KI+DFG +K    +   + 
Sbjct: 123 QLISGVS----YAH---AMQVAHRDLKLENTLLDGSPAPRLKIADFGYSK---ASVLHSQ 172
Query: 643 TGRVVGTFGYMSPEYAMEGRFSEK-SDVFSFGVLLLEIVSG 682
               VGT  Y++PE  ++  +  K +DV+S GV L  ++ G
Sbjct: 173 PKSAVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 91/182 (50%), Gaps = 21/182 (11%)
Query: 508 EIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDA 567
           E AVK + K+     EE     +++   QH N++ L     +G+   L+ E M       
Sbjct: 54  EYAVKVIDKSKRDPSEEIE---ILLRYGQHPNIITLKDVYDDGKHVYLVTELMRG---GE 107
Query: 568 LLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNIL-LDEELNP--- 623
           LL   L+++    R+   ++  I + + YLH      ++HRDLK SNIL +DE  NP   
Sbjct: 108 LLDKILRQKFFSEREASFVLHTIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECL 164
Query: 624 KISDFGMAKIFGGNQDQADTGRVVG---TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIV 680
           +I DFG AK     Q +A+ G ++    T  +++PE      + E  D++S G+LL  ++
Sbjct: 165 RICDFGFAK-----QLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTML 219
Query: 681 SG 682
           +G
Sbjct: 220 AG 221

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 24/212 (11%)
Query: 484 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVK----RLSKASGQGL--EEFMNEVMVISKLQ 536
           +    +LG G F  V   R K  G + A K    R +K+S +G+  E+   EV ++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLL 595
           H N++ L        + +LI E +    L    FD L +KE L   +    ++ I  G+ 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGEL----FDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMA-KIFGGNQDQADTGRVVGTF 650
           YLH    L+I H DLK  NI+L +   P    KI DFG+A KI  GN+ +     + GT 
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTP 181
Query: 651 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
            +++PE         ++D++S GV+   ++SG
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 24/212 (11%)
Query: 484 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVK----RLSKASGQGL--EEFMNEVMVISKLQ 536
           +    +LG G F  V   R K  G + A K    R +K+S +G+  E+   EV ++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLL 595
           H N++ L        + +LI E +        LFD L +KE L   +    ++ I  G+ 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAG----GELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMA-KIFGGNQDQADTGRVVGTF 650
           YLH    L+I H DLK  NI+L +   P    KI DFG+A KI  GN+ +     + GT 
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTP 181
Query: 651 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
            +++PE         ++D++S GV+   ++SG
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 24/212 (11%)
Query: 484 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVK----RLSKASGQGL--EEFMNEVMVISKLQ 536
           +    +LG G F  V   R K  G + A K    R +K+S +G+  E+   EV ++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLL 595
           H N++ L        + +LI E +    L    FD L +KE L   +    ++ I  G+ 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGEL----FDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMA-KIFGGNQDQADTGRVVGTF 650
           YLH    L+I H DLK  NI+L +   P    KI DFG+A KI  GN+ +     + GT 
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTP 181
Query: 651 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
            +++PE         ++D++S GV+   ++SG
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 24/212 (11%)
Query: 484 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVK----RLSKASGQGL--EEFMNEVMVISKLQ 536
           +    +LG G F  V   R K  G + A K    R +K+S +G+  E+   EV ++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLL 595
           H N++ L        + +LI E +    L    FD L +KE L   +    ++ I  G+ 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGEL----FDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMA-KIFGGNQDQADTGRVVGTF 650
           YLH    L+I H DLK  NI+L +   P    KI DFG+A KI  GN+ +     + GT 
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTP 181
Query: 651 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
            +++PE         ++D++S GV+   ++SG
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 24/212 (11%)
Query: 484 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVK----RLSKASGQGL--EEFMNEVMVISKLQ 536
           +    +LG G F  V   R K  G + A K    R +K+S +G+  E+   EV ++ ++Q
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLL 595
           H N++ L        + +LI E +    L    FD L +KE L   +    ++ I  G+ 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGEL----FDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMA-KIFGGNQDQADTGRVVGTF 650
           YLH    L+I H DLK  NI+L +   P    KI DFG+A KI  GN+ +     + GT 
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTP 181
Query: 651 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
            +++PE         ++D++S GV+   ++SG
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 24/212 (11%)
Query: 484 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVK----RLSKASGQGL--EEFMNEVMVISKLQ 536
           +    +LG G F  V   R K  G + A K    R +K+S +G+  E+   EV ++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLL 595
           H N++ L        + +LI E +        LFD L +KE L   +    ++ I  G+ 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAG----GELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMA-KIFGGNQDQADTGRVVGTF 650
           YLH    L+I H DLK  NI+L +   P    KI DFG+A KI  GN+ +     + GT 
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTP 181
Query: 651 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
            +++PE         ++D++S GV+   ++SG
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 24/212 (11%)
Query: 484 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVK----RLSKASGQGL--EEFMNEVMVISKLQ 536
           +    +LG G F  V   R K  G + A K    R +K+S +G+  E+   EV ++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLL 595
           H N++ L        + +LI E +        LFD L +KE L   +    ++ I  G+ 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAG----GELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMA-KIFGGNQDQADTGRVVGTF 650
           YLH    L+I H DLK  NI+L +   P    KI DFG+A KI  GN+ +     + GT 
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTP 181
Query: 651 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
            +++PE         ++D++S GV+   ++SG
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 91/182 (50%), Gaps = 21/182 (11%)
Query: 508 EIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDA 567
           E AVK + K+     EE     +++   QH N++ L     +G+   L+ E M       
Sbjct: 54  EYAVKVIDKSKRDPSEEIE---ILLRYGQHPNIITLKDVYDDGKHVYLVTELMRG---GE 107
Query: 568 LLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNIL-LDEELNP--- 623
           LL   L+++    R+   ++  I + + YLH      ++HRDLK SNIL +DE  NP   
Sbjct: 108 LLDKILRQKFFSEREASFVLHTIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECL 164
Query: 624 KISDFGMAKIFGGNQDQADTGRVVG---TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIV 680
           +I DFG AK     Q +A+ G ++    T  +++PE      + E  D++S G+LL  ++
Sbjct: 165 RICDFGFAK-----QLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTML 219
Query: 681 SG 682
           +G
Sbjct: 220 AG 221

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 102/211 (48%), Gaps = 18/211 (8%)
Query: 480 ATNNFQLSSK---LGQGGFGPVY-WGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKL 535
           A N+F   SK   LG G FG V+       G ++A K +     +  EE  NE+ V+++L
Sbjct: 84  AVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL 143
Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNII--EGISRG 593
            H NL++L        + +L+ EY+        LFD +  E  +  +   I+  + I  G
Sbjct: 144 DHANLIQLYDAFESKNDIVLVMEYVDG----GELFDRIIDESYNLTELDTILFMKQICEG 199
Query: 594 LLYLHRDSRLRIIHRDLKASNILL--DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFG 651
           + ++H   ++ I+H DLK  NIL    +    KI DFG+A+ +   + +       GT  
Sbjct: 200 IRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY---KPREKLKVNFGTPE 253
Query: 652 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           +++PE       S  +D++S GV+   ++SG
Sbjct: 254 FLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 98/228 (42%), Gaps = 15/228 (6%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKD---GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHR 538
           +++ +  +LG G FG V+  R+ +   G   A K +        E    E+  +S L+H 
Sbjct: 157 DHYDIHEELGTGAFGVVH--RVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHP 214
Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
            LV L     +  E ++IYE+M    L   + D   K   D  +    +  + +GL ++H
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSED--EAVEYMRQVCKGLCHMH 272
Query: 599 RDSRLRIIHRDLKASNILLDEELNP--KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 656
            ++    +H DLK  NI+   + +   K+ DFG+       Q    T    GT  + +PE
Sbjct: 273 ENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT---TGTAEFAAPE 326
Query: 657 YAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN 704
            A        +D++S GVL   ++SG        DD T+       WN
Sbjct: 327 VAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN 374

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 116/254 (45%), Gaps = 36/254 (14%)
Query: 444 WIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 503
           ++AK K + + K    + NT +L      QF+ + T          LG G FG V   + 
Sbjct: 18  FLAKAKEDFLKKWETPSQNTAQLD-----QFDRIKT----------LGTGSFGRVMLVKH 62
Query: 504 KD-GQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 559
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 560 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
           +        +F  L++     +   RF   + I     YLH    L +I+RDLK  N+++
Sbjct: 123 VAG----GEMFSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLII 174
Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 175 DQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIIISKGYNKAVDWWALGVLIY 229
Query: 678 EIVSGRKNTSFFED 691
           E+ +G     FF D
Sbjct: 230 EMAAGY--PPFFAD 241

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 14/203 (6%)
Query: 484 FQLSSKLGQGGFGPVYWGRLKDGQE----IAVKRLSKASGQGL-EEFMNEVMVISKLQHR 538
            +L   +G+G FG V+ G     +     +A+K     +   + E+F+ E + + +  H 
Sbjct: 392 IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 451
Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           ++V+L+G   E     +I E      L + L   ++K  LD          +S  L YL 
Sbjct: 452 HIVKLIGVITENP-VWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLE 508
Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF-GGNQDQADTGRVVGTFGYMSPEY 657
                R +HRD+ A N+L+      K+ DFG+++        +A  G++     +M+PE 
Sbjct: 509 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPES 563
Query: 658 AMEGRFSEKSDVFSFGVLLLEIV 680
               RF+  SDV+ FGV + EI+
Sbjct: 564 INFRRFTSASDVWMFGVCMWEIL 586

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 116/254 (45%), Gaps = 36/254 (14%)
Query: 444 WIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 503
           ++AK K + + K    + NT +L      QF+ + T          LG G FG V   + 
Sbjct: 18  FLAKAKEDFLKKWETPSQNTAQLD-----QFDRIKT----------LGTGSFGRVMLVKH 62
Query: 504 KD-GQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 559
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 560 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
           +    +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 123 VAGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 174
Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 175 DQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 678 EIVSGRKNTSFFED 691
           ++ +G     FF D
Sbjct: 230 QMAAGY--PPFFAD 241

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 69/250 (27%), Positives = 116/250 (46%), Gaps = 22/250 (8%)
Query: 473 QFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEE---FMNE 528
           +  +L     ++++   +G+G FG V   R K  +++ A+K LSK       +   F  E
Sbjct: 60  KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 119
Query: 529 VMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE 588
             +++      +V+L     +     ++ EYMP   L  L+ +    E+  W  RF   E
Sbjct: 120 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK--W-ARFYTAE 176
Query: 589 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA-KIFGGNQDQADTGRVV 647
            +    L L     +  IHRD+K  N+LLD+  + K++DFG   K+      + DT   V
Sbjct: 177 VV----LALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA--V 230
Query: 648 GTFGYMSPEY----AMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLW 703
           GT  Y+SPE       +G +  + D +S GV L E++ G  +T F+ D  +++G   K+ 
Sbjct: 231 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG--DTPFYAD--SLVGTYSKIM 286
Query: 704 NENKILALVD 713
           N    L   D
Sbjct: 287 NHKNSLTFPD 296

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 103/211 (48%), Gaps = 22/211 (10%)
Query: 484 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVK----RLSKASGQGL--EEFMNEVMVISKLQ 536
           + +  +LG G F  V   R K  G E A K    R S+AS +G+  EE   EV ++ ++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLL 595
           H N++ L        + +LI E +        LFD L +KE L   +  + I+ I  G+ 
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSG----GELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMAKIFGGNQDQADTGRVVGTFG 651
           YLH     +I H DLK  NI+L ++  P    K+ DFG+A      +D  +   + GT  
Sbjct: 130 YLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPE 183
Query: 652 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           +++PE         ++D++S GV+   ++SG
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 69/250 (27%), Positives = 116/250 (46%), Gaps = 22/250 (8%)
Query: 473 QFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEE---FMNE 528
           +  +L     ++++   +G+G FG V   R K  +++ A+K LSK       +   F  E
Sbjct: 65  KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 124
Query: 529 VMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE 588
             +++      +V+L     +     ++ EYMP   L  L+ +    E+  W  RF   E
Sbjct: 125 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK--W-ARFYTAE 181
Query: 589 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA-KIFGGNQDQADTGRVV 647
            +    L L     +  IHRD+K  N+LLD+  + K++DFG   K+      + DT   V
Sbjct: 182 VV----LALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA--V 235
Query: 648 GTFGYMSPEY----AMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLW 703
           GT  Y+SPE       +G +  + D +S GV L E++ G  +T F+ D  +++G   K+ 
Sbjct: 236 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG--DTPFYAD--SLVGTYSKIM 291
Query: 704 NENKILALVD 713
           N    L   D
Sbjct: 292 NHKNSLTFPD 301

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 14/203 (6%)
Query: 484 FQLSSKLGQGGFGPVYWGRLKDGQE----IAVKRLSKASGQGL-EEFMNEVMVISKLQHR 538
            +L   +G+G FG V+ G     +     +A+K     +   + E+F+ E + + +  H 
Sbjct: 392 IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 451
Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           ++V+L+G   E     +I E      L + L   ++K  LD          +S  L YL 
Sbjct: 452 HIVKLIGVITENP-VWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLE 508
Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF-GGNQDQADTGRVVGTFGYMSPEY 657
                R +HRD+ A N+L+      K+ DFG+++        +A  G++     +M+PE 
Sbjct: 509 SK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPES 563
Query: 658 AMEGRFSEKSDVFSFGVLLLEIV 680
               RF+  SDV+ FGV + EI+
Sbjct: 564 INFRRFTSASDVWMFGVCMWEIL 586

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 103/211 (48%), Gaps = 22/211 (10%)
Query: 484 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVK----RLSKASGQGL--EEFMNEVMVISKLQ 536
           + +  +LG G F  V   R K  G E A K    R S+AS +G+  EE   EV ++ ++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLL 595
           H N++ L        + +LI E +        LFD L +KE L   +  + I+ I  G+ 
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSG----GELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMAKIFGGNQDQADTGRVVGTFG 651
           YLH     +I H DLK  NI+L ++  P    K+ DFG+A      +D  +   + GT  
Sbjct: 130 YLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPE 183
Query: 652 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           +++PE         ++D++S GV+   ++SG
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 24/212 (11%)
Query: 484 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVK----RLSKASGQGL--EEFMNEVMVISKLQ 536
           +    +LG G F  V   R K  G + A K    R +K+S +G+  E+   EV ++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLL 595
           H N++ L        + +LI E +        LFD L +KE L   +    ++ I  G+ 
Sbjct: 73  HPNVITLHEVYENKTDVILIGELVAG----GELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMA-KIFGGNQDQADTGRVVGTF 650
           YLH    L+I H DLK  NI+L +   P    KI DFG+A KI  GN+ +     + GT 
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTP 181
Query: 651 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
            +++PE         ++D++S GV+   ++SG
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 69/250 (27%), Positives = 116/250 (46%), Gaps = 22/250 (8%)
Query: 473 QFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEE---FMNE 528
           +  +L     ++++   +G+G FG V   R K  +++ A+K LSK       +   F  E
Sbjct: 65  KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 124
Query: 529 VMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE 588
             +++      +V+L     +     ++ EYMP   L  L+ +    E+  W  RF   E
Sbjct: 125 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK--W-ARFYTAE 181
Query: 589 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA-KIFGGNQDQADTGRVV 647
            +    L L     +  IHRD+K  N+LLD+  + K++DFG   K+      + DT   V
Sbjct: 182 VV----LALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA--V 235
Query: 648 GTFGYMSPEY----AMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLW 703
           GT  Y+SPE       +G +  + D +S GV L E++ G  +T F+ D  +++G   K+ 
Sbjct: 236 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG--DTPFYAD--SLVGTYSKIM 291
Query: 704 NENKILALVD 713
           N    L   D
Sbjct: 292 NHKNSLTFPD 301

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 114/254 (44%), Gaps = 36/254 (14%)
Query: 444 WIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGR- 502
           ++AK K + + K      NT  L      QFE + T          LG G FG V   + 
Sbjct: 18  FLAKAKEDFLKKWENPAQNTAHLD-----QFERIKT----------LGTGSFGRVMLVKH 62
Query: 503 LKDGQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 559
           ++ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 63  METGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 560 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
           +    +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 123 VAGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 174
Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
           D++   +++DFG AK   G      T  + GT  Y++PE  +   +++  D ++ GVL+ 
Sbjct: 175 DQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 678 EIVSGRKNTSFFED 691
           E+ +G     FF D
Sbjct: 230 EMAAGY--PPFFAD 241

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 103/212 (48%), Gaps = 26/212 (12%)
Query: 490 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRL----- 543
           LG GG G V+     D  + +A+K++     Q ++  + E+ +I +L H N+V++     
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 544 ---------LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 594
                    +G   E     ++ EYM     + L   PL    L+   R  + + + RGL
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPL----LEEHARLFMYQ-LLRGL 133
Query: 595 LYLHRDSRLRIIHRDLKASNILLD-EELNPKISDFGMAKIFGGN-QDQADTGRVVGTFGY 652
            Y+H  +   ++HRDLK +N+ ++ E+L  KI DFG+A+I   +   +      + T  Y
Sbjct: 134 KYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWY 190
Query: 653 MSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
            SP   +    +++  D+++ G +  E+++G+
Sbjct: 191 RSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 24/221 (10%)
Query: 468 DLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLSKASGQGLEEFM 526
           DLP+         ++ ++L   +G G FG     R K   E +AVK + +  G+ ++E +
Sbjct: 10  DLPIMH------DSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIER--GEKIDENV 61
Query: 527 N-EVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF- 584
             E++    L+H N+VR     +      ++ EY     L   + +  +    + R  F 
Sbjct: 62  KREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ 121
Query: 585 NIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP--KISDFGMAKIFGGNQDQAD 642
            +I G+S    Y H    +++ HRDLK  N LLD    P  KI DFG +K    +   + 
Sbjct: 122 QLISGVS----YCH---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQ 171
Query: 643 TGRVVGTFGYMSPEYAMEGRFSEK-SDVFSFGVLLLEIVSG 682
               VGT  Y++PE  ++  +  K +DV+S GV L  ++ G
Sbjct: 172 PKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 212

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 101/211 (47%), Gaps = 15/211 (7%)
Query: 479 TATNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQ-GLEEFMNEVMVISKLQ 536
           T  + F    KLG G FG V+    +  G E  +K ++K   Q  +E+   E+ V+  L 
Sbjct: 19  TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLD 78
Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPN-RSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
           H N++++     +     ++ E       L+ ++    + + L       +++ +   L 
Sbjct: 79  HPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALA 138
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMAKIFGGNQDQADTGRVVGTFG 651
           Y H      ++H+DLK  NIL  ++ +P    KI DFG+A++F  ++   +     GT  
Sbjct: 139 YFHSQ---HVVHKDLKPENILF-QDTSPHSPIKIIDFGLAELFKSDEHSTNAA---GTAL 191
Query: 652 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           YM+PE   +   + K D++S GV++  +++G
Sbjct: 192 YMAPE-VFKRDVTFKCDIWSAGVVMYFLLTG 221

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 103/233 (44%), Gaps = 45/233 (19%)
Query: 475 EELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKA----------------- 517
           +E     N++++   L QG F  +     KD +  A+K+  K+                 
Sbjct: 24  KEKDKYINDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKIS 82
Query: 518 SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSL------------ 565
                ++F NE+ +I+ +++   +   G     +E  +IYEYM N S+            
Sbjct: 83  IKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK 142
Query: 566 DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKI 625
           +   F P++  +        II+ +     Y+H +    I HRD+K SNIL+D+    K+
Sbjct: 143 NYTCFIPIQVIKC-------IIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKL 193
Query: 626 SDFGMAKIFGGNQDQADTGRVVGTFGYMSPE-YAMEGRFS-EKSDVFSFGVLL 676
           SDFG ++     + +       GT+ +M PE ++ E  ++  K D++S G+ L
Sbjct: 194 SDFGESEYMVDKKIKGSR----GTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 103/211 (48%), Gaps = 22/211 (10%)
Query: 484 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVK----RLSKASGQGL--EEFMNEVMVISKLQ 536
           + +  +LG G F  V   R K  G E A K    R S+AS +G+  EE   EV ++ ++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLL 595
           H N++ L        + +LI E +        LFD L +KE L   +  + I+ I  G+ 
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSG----GELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMAKIFGGNQDQADTGRVVGTFG 651
           YLH     +I H DLK  NI+L ++  P    K+ DFG+A      +D  +   + GT  
Sbjct: 130 YLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPE 183
Query: 652 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           +++PE         ++D++S GV+   ++SG
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 103/211 (48%), Gaps = 22/211 (10%)
Query: 484 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVK----RLSKASGQGL--EEFMNEVMVISKLQ 536
           + +  +LG G F  V   R K  G E A K    R S+AS +G+  EE   EV ++ ++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLL 595
           H N++ L        + +LI E +        LFD L +KE L   +  + I+ I  G+ 
Sbjct: 74  HPNIITLHDVYENRTDVVLILELVSG----GELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMAKIFGGNQDQADTGRVVGTFG 651
           YLH     +I H DLK  NI+L ++  P    K+ DFG+A      +D  +   + GT  
Sbjct: 130 YLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPE 183
Query: 652 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           +++PE         ++D++S GV+   ++SG
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 103/211 (48%), Gaps = 22/211 (10%)
Query: 484 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVK----RLSKASGQGL--EEFMNEVMVISKLQ 536
           + +  +LG G F  V   R K  G E A K    R S+AS +G+  EE   EV ++ ++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLL 595
           H N++ L        + +LI E +        LFD L +KE L   +  + I+ I  G+ 
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSG----GELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMAKIFGGNQDQADTGRVVGTFG 651
           YLH     +I H DLK  NI+L ++  P    K+ DFG+A      +D  +   + GT  
Sbjct: 130 YLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPE 183
Query: 652 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           +++PE         ++D++S GV+   ++SG
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 103/211 (48%), Gaps = 22/211 (10%)
Query: 484 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVK----RLSKASGQGL--EEFMNEVMVISKLQ 536
           + +  +LG G F  V   R K  G E A K    R S+AS +G+  EE   EV ++ ++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLL 595
           H N++ L        + +LI E +        LFD L +KE L   +  + I+ I  G+ 
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSG----GELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMAKIFGGNQDQADTGRVVGTFG 651
           YLH     +I H DLK  NI+L ++  P    K+ DFG+A      +D  +   + GT  
Sbjct: 130 YLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPE 183
Query: 652 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           +++PE         ++D++S GV+   ++SG
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 99/212 (46%), Gaps = 21/212 (9%)
Query: 484 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVK-----RLSKASGQGLEEFMNEVMVISKLQH 537
           ++L   +G+G F  V     ++ GQ+ AVK     + + + G   E+   E  +   L+H
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL-- 595
            ++V LL          +++E+M    L    F+ +K+    +     +     R +L  
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 596 --YLHRDSRLRIIHRDLKASNILLDEELNP---KISDFGMAKIFGGNQDQADTGRVVGTF 650
             Y H ++   IIHRD+K  N+LL  + N    K+ DFG+A I  G       GRV GT 
Sbjct: 143 LRYCHDNN---IIHRDVKPENVLLASKENSAPVKLGDFGVA-IQLGESGLVAGGRV-GTP 197
Query: 651 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
            +M+PE      + +  DV+  GV+L  ++SG
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 95/226 (42%), Gaps = 11/226 (4%)
Query: 482 NNFQLSSKLGQGGFGPVYW-GRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 540
           +++ +  +LG G FG V+       G   A K +        E    E+  +S L+H  L
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 541 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 600
           V L     +  E ++IYE+M    L   + D   K   D  +    +  + +GL ++H +
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSED--EAVEYMRQVCKGLCHMHEN 168
Query: 601 SRLRIIHRDLKASNILLDEELNP--KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 658
           +    +H DLK  NI+   + +   K+ DFG+       Q    T    GT  + +PE A
Sbjct: 169 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT---TGTAEFAAPEVA 222
Query: 659 MEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN 704
                   +D++S GVL   ++SG        DD T+       WN
Sbjct: 223 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN 268

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 115/254 (45%), Gaps = 36/254 (14%)
Query: 444 WIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 503
           ++AK K + + K    + NT +L      QF+ + T          LG G FG V   + 
Sbjct: 18  FLAKAKEDFLKKWETPSQNTAQLD-----QFDRIKT----------LGTGSFGRVMLVKH 62
Query: 504 KD-GQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 559
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 560 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
           +    +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 123 VAGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 174
Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
           D++   +++DFG AK   G      T  + GT  Y++P   +   +++  D ++ GVL+ 
Sbjct: 175 DQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPAIILSKGYNKAVDWWALGVLIY 229
Query: 678 EIVSGRKNTSFFED 691
           E+ +G     FF D
Sbjct: 230 EMAAGY--PPFFAD 241

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 107/215 (49%), Gaps = 22/215 (10%)
Query: 484 FQLSSKL-GQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HRNL 540
           ++L+S+L G+G +  V     L++G+E AVK + K +G        EV  + + Q ++N+
Sbjct: 14  YKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNI 73
Query: 541 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 600
           + L+    +     L++E +   S+ A +    K++  + R+   ++  ++  L +LH  
Sbjct: 74  LELIEFFEDDTRFYLVFEKLQGGSILAHI---QKQKHFNEREASRVVRDVAAALDFLHTK 130
Query: 601 SRLRIIHRDLKASNILLD--EELNP-KISDFGMAKIFGGNQD-----QADTGRVVGTFGY 652
               I HRDLK  NIL +  E+++P KI DF +      N         +     G+  Y
Sbjct: 131 G---IAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEY 187
Query: 653 MSPE----YAMEGRFSEK-SDVFSFGVLLLEIVSG 682
           M+PE    +  +  F +K  D++S GV+L  ++SG
Sbjct: 188 MAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 103/221 (46%), Gaps = 24/221 (10%)
Query: 468 DLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLSKASGQGLEEFM 526
           DLP+         ++ ++L   +G G FG     R K   E +AVK + +  G+ ++E +
Sbjct: 11  DLPIMH------DSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIER--GEKIDENV 62
Query: 527 N-EVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF- 584
             E++    L+H N+VR     +      ++ EY     L   + +  +    + R  F 
Sbjct: 63  KREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ 122
Query: 585 NIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP--KISDFGMAKIFGGNQDQAD 642
            +I G+S    Y H    +++ HRDLK  N LLD    P  KI  FG +K    +    D
Sbjct: 123 QLISGVS----YCH---AMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKD 175
Query: 643 TGRVVGTFGYMSPEYAMEGRFSEK-SDVFSFGVLLLEIVSG 682
           T   VGT  Y++PE  ++  +  K +DV+S GV L  ++ G
Sbjct: 176 T---VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 104/268 (38%), Gaps = 72/268 (26%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQ-GLEEFMNEVMVISKLQHRN 539
            +F+    +G+GGFG V+  + K D    A+KR+   + +   E+ M EV  ++KL+H  
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 540 LVRLLGCCVEGEEKMLIYEY-------------------MPNRSLDALLFDPL------- 573
           +VR     +E   +    E                    M   S+     DP        
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 574 ------------------KKERL-DWRKR------------FNIIEGISRGLLYLHRDSR 602
                             +KE L DW  R             +I   I+  + +LH    
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG- 184
Query: 603 LRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ----------ADTGRVVGTFGY 652
             ++HRDLK SNI    +   K+ DFG+      ++++          A     VGT  Y
Sbjct: 185 --LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLY 242
Query: 653 MSPEYAMEGRFSEKSDVFSFGVLLLEIV 680
           MSPE      +S K D+FS G++L E++
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 74/244 (30%), Positives = 113/244 (46%), Gaps = 31/244 (12%)
Query: 463 TVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQ---EIAVKRLSKASG 519
           T KL+ +     EE+  AT+      +LG+G FG V+  R++D Q   + AVK++     
Sbjct: 59  TEKLKPVDYEYREEVHWATHQL----RLGRGSFGEVH--RMEDKQTGFQCAVKKVR---- 108
Query: 520 QGLEEF-MNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER- 577
             LE F   E+M  + L    +V L G   EG    +  E +   SL  L+     KE+ 
Sbjct: 109 --LEVFRAEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLV-----KEQG 161
Query: 578 -LDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE-LNPKISDFGMAKIF- 634
            L   +    +     GL YLH  SR RI+H D+KA N+LL  +  +  + DFG A    
Sbjct: 162 CLPEDRALYYLGQALEGLEYLH--SR-RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQ 218
Query: 635 --GGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKN-TSFFED 691
             G  +D      + GT  +M+PE  +      K DV+S   ++L +++G    T FF  
Sbjct: 219 PDGLGKDLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRG 278
Query: 692 DLTI 695
            L +
Sbjct: 279 PLCL 282

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/90 (41%), Positives = 49/90 (54%), Gaps = 7/90 (7%)
Query: 598 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEY 657
           H    L+IIHRD+K SNILLD   N K+ DFG++   G   D     R  G   YM+PE 
Sbjct: 140 HLKENLKIIHRDIKPSNILLDRSGNIKLCDFGIS---GQLVDSIAKTRDAGCRPYMAPER 196
Query: 658 ----AMEGRFSEKSDVFSFGVLLLEIVSGR 683
               A    +  +SDV+S G+ L E+ +GR
Sbjct: 197 IDPSASRQGYDVRSDVWSLGITLYELATGR 226

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 93/207 (44%), Gaps = 13/207 (6%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSK---ASGQGLEEFMNEVMVISKLQH 537
            +F     LG+G FG V     K   E+ AVK L K        +E  M E  V++    
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79
Query: 538 RNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 596
              +  L  C +  +++  + EY+    L   ++   +  R            I+ GL +
Sbjct: 80  PPFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFKEPHAVFYAAEIAIGLFF 136
Query: 597 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 656
           L       II+RDLK  N++LD E + KI+DFGM K      D   T    GT  Y++PE
Sbjct: 137 LQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTPDYIAPE 191
Query: 657 YAMEGRFSEKSDVFSFGVLLLEIVSGR 683
                 + +  D ++FGVLL E+++G+
Sbjct: 192 IIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 22/221 (9%)
Query: 478 ATATNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASG-QGLEEFMNEVMVISKL 535
           +T+ + + LS  LGQG    V+ GR K  G   A+K  +  S  + ++  M E  V+ KL
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 536 QHRNLVRLLGCCVE--GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRG 593
            H+N+V+L     E     K+LI E+ P  SL  +L +P     L   +   ++  +  G
Sbjct: 65  NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 594 LLYLHRDSRLRIIHRDLKASNILL----DEELNPKISDFGMAKIFGGNQDQADTGRVVGT 649
           + +L  +    I+HR++K  NI+     D +   K++DFG A+     +D      + GT
Sbjct: 125 MNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL---EDDEQFVXLYGT 178
Query: 650 FGYMSPEYA--------MEGRFSEKSDVFSFGVLLLEIVSG 682
             Y+ P+           + ++    D++S GV      +G
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 101/210 (48%), Gaps = 22/210 (10%)
Query: 481 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 539
           T+ +++   +G G +        K    E AVK + K+     EE     +++   QH N
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIE---ILLRYGQHPN 77
Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 599
           ++ L     +G+   ++ E M       LL   L+++    R+   ++  I++ + YLH 
Sbjct: 78  IITLKDVYDDGKYVYVVTELMKG---GELLDKILRQKFFSEREASAVLFTITKTVEYLHA 134
Query: 600 DSRLRIIHRDLKASNIL-LDEELNP---KISDFGMAKIFGGNQDQADTGRVVG---TFGY 652
                ++HRDLK SNIL +DE  NP   +I DFG AK     Q +A+ G ++    T  +
Sbjct: 135 QG---VVHRDLKPSNILYVDESGNPESIRICDFGFAK-----QLRAENGLLMTPCYTANF 186
Query: 653 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           ++PE      +    D++S GVLL  +++G
Sbjct: 187 VAPEVLERQGYDAACDIWSLGVLLYTMLTG 216

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 94/207 (45%), Gaps = 13/207 (6%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSK---ASGQGLEEFMNEVMVISKLQH 537
            +F     LG+G FG V     K   E+ AVK L K        +E  M E  V++    
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 538 RNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 596
              +  L  C +  +++  + EY+   +   L++   +  R            I+ GL +
Sbjct: 401 PPFLTQLHSCFQTMDRLYFVMEYV---NGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFF 457
Query: 597 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 656
           L       II+RDLK  N++LD E + KI+DFGM K      D   T    GT  Y++PE
Sbjct: 458 LQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTPDYIAPE 512
Query: 657 YAMEGRFSEKSDVFSFGVLLLEIVSGR 683
                 + +  D ++FGVLL E+++G+
Sbjct: 513 IIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 102/208 (49%), Gaps = 17/208 (8%)
Query: 489 KLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLE-EFMNEVMVISKLQHRNLVRLLGCC 547
           K+G+G +G VY  + KDG++     L +  G G+      E+ ++ +L+H N++ L    
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 87
Query: 548 VEGEEKM--LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY-----LHRD 600
           +   ++   L+++Y  +     + F    K     +K   +  G+ + LLY     +H  
Sbjct: 88  LSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 601 SRLRIIHRDLKASNILL----DEELNPKISDFGMAKIFGGN-QDQADTGRVVGTFGYMSP 655
               ++HRDLK +NIL+     E    KI+D G A++F    +  AD   VV TF Y +P
Sbjct: 145 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 204
Query: 656 EYAMEGRFSEKS-DVFSFGVLLLEIVSG 682
           E  +  R   K+ D+++ G +  E+++ 
Sbjct: 205 ELLLGARHYTKAIDIWAIGCIFAELLTS 232

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 22/221 (9%)
Query: 478 ATATNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASG-QGLEEFMNEVMVISKL 535
           +T+ + + LS  LGQG    V+ GR K  G   A+K  +  S  + ++  M E  V+ KL
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 536 QHRNLVRLLGCCVE--GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRG 593
            H+N+V+L     E     K+LI E+ P  SL  +L +P     L   +   ++  +  G
Sbjct: 65  NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 594 LLYLHRDSRLRIIHRDLKASNILL----DEELNPKISDFGMAKIFGGNQDQADTGRVVGT 649
           + +L  +    I+HR++K  NI+     D +   K++DFG A+     +D      + GT
Sbjct: 125 MNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL---EDDEQFVSLYGT 178
Query: 650 FGYMSPEYA--------MEGRFSEKSDVFSFGVLLLEIVSG 682
             Y+ P+           + ++    D++S GV      +G
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 96/219 (43%), Gaps = 24/219 (10%)
Query: 481 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLE-EFMNEVMVISKLQHR 538
           +++FQL S LG+G +G V     K  G+ +A+K++            + E+ ++   +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 539 NLVRLLGCCVEGE-----EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRG 593
           N++ +             E  +I E M       +    L  + + +      I    R 
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY-----FIYQTLRA 124
Query: 594 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ--------DQADTGR 645
           +  LH  +   +IHRDLK SN+L++   + K+ DFG+A+I   +          Q+    
Sbjct: 125 VKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTE 181
Query: 646 VVGTFGYMSPEYAM-EGRFSEKSDVFSFGVLLLEIVSGR 683
            V T  Y +PE  +   ++S   DV+S G +L E+   R
Sbjct: 182 XVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 96/219 (43%), Gaps = 24/219 (10%)
Query: 481 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLE-EFMNEVMVISKLQHR 538
           +++FQL S LG+G +G V     K  G+ +A+K++            + E+ ++   +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 539 NLVRLLGCCVEGE-----EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRG 593
           N++ +             E  +I E M       +    L  + + +      I    R 
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY-----FIYQTLRA 124
Query: 594 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ--------DQADTGR 645
           +  LH  +   +IHRDLK SN+L++   + K+ DFG+A+I   +          Q+    
Sbjct: 125 VKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTE 181
Query: 646 VVGTFGYMSPEYAM-EGRFSEKSDVFSFGVLLLEIVSGR 683
            V T  Y +PE  +   ++S   DV+S G +L E+   R
Sbjct: 182 YVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 115/254 (45%), Gaps = 36/254 (14%)
Query: 444 WIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 503
           ++AK K + + K    + NT +L      QF+ + T          LG G FG V   + 
Sbjct: 18  FLAKAKEDFLKKWETPSQNTAQLD-----QFDRIKT----------LGTGSFGRVMLVKH 62
Query: 504 KD-GQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 559
           K+ G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 560 MPNRSLDALLFDPLKK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
           +    +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 123 VAGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 174
Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
           D++   +++DFG AK   G      T  + GT   ++PE  +   +++  D ++ GVL+ 
Sbjct: 175 DQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEALAPEIILSKGYNKAVDWWALGVLIY 229
Query: 678 EIVSGRKNTSFFED 691
           E+ +G     FF D
Sbjct: 230 EMAAGY--PPFFAD 241

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 36/92 (39%), Positives = 54/92 (58%), Gaps = 3/92 (3%)
Query: 590 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 649
           +++G+ +L   +  + IHRDL A NILL E+   KI DFG+A+    + D    G     
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 650 FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
             +M+PE   +  ++ +SDV+SFGVLL EI S
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 479 TATNNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKL 535
           T    +Q    +G G  G V        G  +AVK+LS+   +    +    E++++  +
Sbjct: 19  TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCV 78
Query: 536 QHRNLVRLLGCCV------EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEG 589
            H+N++ LL          E ++  L+ E M + +L  ++   L  ER+ +     ++  
Sbjct: 79  NHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIHMELDHERMSY-----LLYQ 132
Query: 590 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 649
           +  G+ +LH      IIHRDLK SNI++  +   KI DFG+A+    N     T  VV  
Sbjct: 133 MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMM--TPYVVTR 187
Query: 650 FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           + Y +PE  +   + E  D++S G ++ E+V G
Sbjct: 188 Y-YRAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 96/225 (42%), Gaps = 32/225 (14%)
Query: 468 DLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLSKASGQGLEEFM 526
           D+P+         ++ +     +G G FG     R K  +E +AVK + + +    E   
Sbjct: 12  DMPIMH------DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID-ENVQ 64
Query: 527 NEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN- 585
            E++    L+H N+VR     +      +I EY     L          ER+    RF+ 
Sbjct: 65  REIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGEL---------YERICNAGRFSE 115
Query: 586 -----IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP--KISDFGMAKIFGGNQ 638
                  + +  G+ Y H    ++I HRDLK  N LLD    P  KI DFG +K    + 
Sbjct: 116 DEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSV 169
Query: 639 DQADTGRVVGTFGYMSPEYAMEGRFSEK-SDVFSFGVLLLEIVSG 682
             +     VGT  Y++PE  +   +  K +DV+S GV L  ++ G
Sbjct: 170 LHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVG 214

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 36/92 (39%), Positives = 54/92 (58%), Gaps = 3/92 (3%)
Query: 590 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 649
           +++G+ +L   +  + IHRDL A NILL E+   KI DFG+A+    + D    G     
Sbjct: 207 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 650 FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
             +M+PE   +  ++ +SDV+SFGVLL EI S
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 36/92 (39%), Positives = 54/92 (58%), Gaps = 3/92 (3%)
Query: 590 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 649
           +++G+ +L   +  + IHRDL A NILL E+   KI DFG+A+    + D    G     
Sbjct: 200 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 650 FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
             +M+PE   +  ++ +SDV+SFGVLL EI S
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 36/92 (39%), Positives = 54/92 (58%), Gaps = 3/92 (3%)
Query: 590 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 649
           +++G+ +L   +  + IHRDL A NILL E+   KI DFG+A+    + D    G     
Sbjct: 209 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 650 FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
             +M+PE   +  ++ +SDV+SFGVLL EI S
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 104/212 (49%), Gaps = 19/212 (8%)
Query: 479 TATNNFQLSSKLGQGGFGPV---YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVIS 533
           T    +Q    +G G  G V   Y   L+  + +A+K+LS+   +    +    E++++ 
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 534 KLQHRNLVRLLGCCVEG---EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGI 590
            + H+N++ LL         EE   +Y  M    +DA L   ++ E LD  +   ++  +
Sbjct: 79  VVNHKNIIGLLNVFTPQKSLEEFQDVYIVM--ELMDANLSQVIQME-LDHERMSYLLYQM 135
Query: 591 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF 650
             G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +     T  VV  +
Sbjct: 136 LVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMM--TPYVVTRY 190
Query: 651 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
            Y +PE  +   + E  D++S GV++ E++ G
Sbjct: 191 -YRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 97/219 (44%), Gaps = 24/219 (10%)
Query: 481 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLE-EFMNEVMVISKLQHR 538
           +++FQL S LG+G +G V     K  G+ +A+K++            + E+ ++   +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 539 NLVRLLGCCVEGE-----EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRG 593
           N++ +             E  +I E M       +    L  + + +      I    R 
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY-----FIYQTLRA 124
Query: 594 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF--GGNQDQADTGR------ 645
           +  LH  +   +IHRDLK SN+L++   + K+ DFG+A+I       +   TG+      
Sbjct: 125 VKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181
Query: 646 VVGTFGYMSPEYAM-EGRFSEKSDVFSFGVLLLEIVSGR 683
            V T  Y +PE  +   ++S   DV+S G +L E+   R
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 474 FEELATATNNFQLSSK-LGQGGFGPVYWGRLKD-GQEIAVKRLSKAS-GQGLE-EFMNEV 529
           F+ +    N + L+SK LG+G F  V     K  GQE A K L K   GQ    E ++E+
Sbjct: 20  FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEI 79
Query: 530 MVISKLQH-RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE 588
            V+   +    ++ L        E +LI EY     + +L   P   E +       +I+
Sbjct: 80  AVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCL-PELAEMVSENDVIRLIK 138
Query: 589 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMAKIFGGNQDQADTG 644
            I  G+ YLH+++   I+H DLK  NILL   + P    KI DFGM++  G      +  
Sbjct: 139 QILEGVYYLHQNN---IVHLDLKPQNILLS-SIYPLGDIKIVDFGMSRKIG---HACELR 191
Query: 645 RVVGTFGYMSPEYAMEGRFSEKSDVFSFGVL 675
            ++GT  Y++PE       +  +D+++ G++
Sbjct: 192 EIMGTPEYLAPEILNYDPITTATDMWNIGII 222

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 95/219 (43%), Gaps = 20/219 (9%)
Query: 468 DLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMN 527
           DLP+         ++ ++L   +G G FG     R K   E+   +  +   +       
Sbjct: 11  DLPIMH------DSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKR 64
Query: 528 EVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF-NI 586
           E++    L+H N+VR     +      ++ EY     L   + +  +    + R  F  +
Sbjct: 65  EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL 124
Query: 587 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP--KISDFGMAKIFGGNQDQADTG 644
           I G+S    Y H    +++ HRDLK  N LLD    P  KI DFG +K    +   +   
Sbjct: 125 ISGVS----YCH---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPK 174
Query: 645 RVVGTFGYMSPEYAMEGRFSEK-SDVFSFGVLLLEIVSG 682
             VGT  Y++PE  ++  +  K +DV+S GV L  ++ G
Sbjct: 175 STVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 108/205 (52%), Gaps = 12/205 (5%)
Query: 484 FQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLS-KASGQGL-EEFMNEVMVISKLQHRNL 540
           ++   K+G+G +G V+  + ++  EI A+KR+      +G+    + E+ ++ +L+H+N+
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 541 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 600
           VRL       ++  L++E+  ++ L    FD    + LD     + +  + +GL + H  
Sbjct: 64  VRLHDVLHSDKKLTLVFEFC-DQDLKKY-FDSCNGD-LDPEIVKSFLFQLLKGLGFCH-- 118
Query: 601 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
           SR  ++HRDLK  N+L++     K++DFG+A+ FG    +  +  VV T  Y  P+    
Sbjct: 119 SR-NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-RCYSAEVV-TLWYRPPDVLFG 175
Query: 661 GR-FSEKSDVFSFGVLLLEIVSGRK 684
            + +S   D++S G +  E+ +  +
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAAR 200

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 104/212 (49%), Gaps = 19/212 (8%)
Query: 479 TATNNFQLSSKLGQGGFGPV---YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVIS 533
           T    +Q    +G G  G V   Y   L+  + +A+K+LS+   +    +    E++++ 
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVVAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 534 KLQHRNLVRLLGCCVEG---EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGI 590
            + H+N++ LL         EE   +Y  M    +DA L   ++ E LD  +   ++  +
Sbjct: 79  VVNHKNIIGLLNVFTPQKSLEEFQDVYIVM--ELMDANLSQVIQME-LDHERMSYLLYQM 135
Query: 591 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF 650
             G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +     T  VV  +
Sbjct: 136 LVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMM--TPYVVTRY 190
Query: 651 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
            Y +PE  +   + E  D++S GV++ E++ G
Sbjct: 191 -YRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 103/216 (47%), Gaps = 25/216 (11%)
Query: 479 TATNNFQLSSKLGQGGFGPV---YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVIS 533
           T    +Q    +G G  G V   Y   L   + +A+K+LS+   +    +    E++++ 
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 534 KLQHRNLVRLLGCCV------EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNII 587
            + H+N++ LL          E ++  L+ E M     DA L   ++ E LD  +   ++
Sbjct: 79  XVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLXQVIQME-LDHERMSYLL 132
Query: 588 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVV 647
             +  G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +     T  VV
Sbjct: 133 YQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMM--TPYVV 187
Query: 648 GTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
             + Y +PE  +   + E  D++S G ++ E+V  +
Sbjct: 188 TRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRL-KDGQEIAVKRLSKASGQGLEE--FMNEVMVISKLQHR 538
           N+ +   ++G G  G V+  R  K G  IAVK++ ++  +   +   M+  +V+      
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 539 NLVRLLGCCVEGEEKMLIYEYMPN--RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 596
            +V+  G  +   +  +  E M      L   +  P+  ER+  +    I+    + L Y
Sbjct: 85  YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIP-ERILGKMTVAIV----KALYY 139
Query: 597 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 656
           L    +  +IHRD+K SNILLDE    K+ DFG   I G   D     R  G   YM+PE
Sbjct: 140 LK--EKHGVIHRDVKPSNILLDERGQIKLCDFG---ISGRLVDDKAKDRSAGCAAYMAPE 194
Query: 657 Y-----AMEGRFSEKSDVFSFGVLLLEIVSGR 683
                   +  +  ++DV+S G+ L+E+ +G+
Sbjct: 195 RIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 24/221 (10%)
Query: 468 DLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLSKASGQGLEEFM 526
           DLP+         ++ ++L   +G G FG     R K   E +AVK + +  G+ ++E +
Sbjct: 11  DLPIMH------DSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIER--GEKIDENV 62
Query: 527 N-EVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF- 584
             E++    L+H N+VR     +      ++ EY     L   + +  +    + R  F 
Sbjct: 63  KREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ 122
Query: 585 NIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP--KISDFGMAKIFGGNQDQAD 642
            +I G+S    Y H    +++ HRDLK  N LLD    P  KI  FG +K    +   + 
Sbjct: 123 QLISGVS----YCH---AMQVCHRDLKLENTLLDGSPAPRLKICAFGYSK---SSVLHSQ 172
Query: 643 TGRVVGTFGYMSPEYAMEGRFSEK-SDVFSFGVLLLEIVSG 682
               VGT  Y++PE  ++  +  K +DV+S GV L  ++ G
Sbjct: 173 PKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 73/244 (29%), Positives = 112/244 (45%), Gaps = 31/244 (12%)
Query: 463 TVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQ---EIAVKRLSKASG 519
           T KL+ +     EE+  AT+      +LG+G FG V+  R++D Q   + AVK++     
Sbjct: 78  TEKLKPVDYEYREEVHWATHQL----RLGRGSFGEVH--RMEDKQTGFQCAVKKVR---- 127
Query: 520 QGLEEF-MNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER- 577
             LE F   E+M  + L    +V L G   EG    +  E +   SL  L+     KE+ 
Sbjct: 128 --LEVFRAEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLV-----KEQG 180
Query: 578 -LDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE-LNPKISDFGMAKIF- 634
            L   +    +     GL YLH  SR RI+H D+KA N+LL  +  +  + DFG A    
Sbjct: 181 CLPEDRALYYLGQALEGLEYLH--SR-RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQ 237
Query: 635 --GGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKN-TSFFED 691
             G  +       + GT  +M+PE  +      K DV+S   ++L +++G    T FF  
Sbjct: 238 PDGLGKSLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRG 297
Query: 692 DLTI 695
            L +
Sbjct: 298 PLCL 301

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 479 TATNNFQLSSKLGQGGFGPV--YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISK 534
           T    +Q    +G G  G V   +  + D + +A+K+LS+   +    +    E++++  
Sbjct: 14  TVLKRYQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKC 72
Query: 535 LQHRNLVRLLGCCV------EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE 588
           + H+N++ LL          E ++  L+ E M     DA L   ++ E LD  +   ++ 
Sbjct: 73  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLXQVIQME-LDHERMSYLLY 126
Query: 589 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 648
            +  G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +     T  VV 
Sbjct: 127 QMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMM--TPYVVT 181
Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
            + Y +PE  +   + E  D++S G ++ E+V  +
Sbjct: 182 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 479 TATNNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKL 535
           T    +Q    +G G  G V        G  +AVK+LS+   +    +    E++++  +
Sbjct: 21  TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCV 80
Query: 536 QHRNLVRLLGCCV------EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEG 589
            H+N++ LL          E ++  L+ E M + +L  ++   L  ER+ +     ++  
Sbjct: 81  NHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIHMELDHERMSY-----LLYQ 134
Query: 590 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 649
           +  G+ +LH      IIHRDLK SNI++  +   KI DFG+A+    N     T  VV  
Sbjct: 135 MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMM--TPYVVTR 189
Query: 650 FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           + Y +PE  +   ++   D++S G ++ E+V G
Sbjct: 190 Y-YRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 479 TATNNFQLSSKLGQGGFGPV--YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISK 534
           T    +Q    +G G  G V   +  + D + +A+K+LS+   +    +    E++++  
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKX 79
Query: 535 LQHRNLVRLLGCCV------EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE 588
           + H+N++ LL          E ++  L+ E M     DA L   ++ E LD  +   ++ 
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLXQVIQME-LDHERMSYLLY 133
Query: 589 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 648
            +  G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +     T  VV 
Sbjct: 134 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMM--TPYVVT 188
Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
            + Y +PE  +   + E  D++S G ++ E+V  +
Sbjct: 189 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 479 TATNNFQLSSKLGQGGFGPV--YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISK 534
           T    +Q    +G G  G V   +  + D + +A+K+LS+   +    +    E++++  
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKC 79
Query: 535 LQHRNLVRLLGCCV------EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE 588
           + H+N++ LL          E ++  L+ E M     DA L   ++ E LD  +   ++ 
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLXQVIQME-LDHERMSYLLY 133
Query: 589 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 648
            +  G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +     T  VV 
Sbjct: 134 QMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMM--TPYVVT 188
Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
            + Y +PE  +   + E  D++S G ++ E+V  +
Sbjct: 189 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 19/212 (8%)
Query: 479 TATNNFQLSSKLGQGGFGPV---YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVIS 533
           T    +Q    +G G  G V   Y   L+  + +A+K+LS+   +    +    E++++ 
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 534 KLQHRNLVRLLGCCVEG---EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGI 590
            + H+N++ LL         EE   +Y  M    +DA L   ++ E LD  +   ++  +
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVM--ELMDANLCQVIQME-LDHERMSYLLYQM 135
Query: 591 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF 650
             G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +     T  VV  +
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPEVVTRY 190
Query: 651 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
            Y +PE  +   + E  D++S G ++ E++ G
Sbjct: 191 -YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 110/234 (47%), Gaps = 41/234 (17%)
Query: 474 FEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVK--RLSKASGQGLEEFMNEVMV 531
           F+ ++     + +  ++G GG   V+    +  Q  A+K   L +A  Q L+ + NE+  
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 79
Query: 532 ISKLQHRN--LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD-W-RKRF--N 585
           ++KLQ  +  ++RL    +  +   ++ E   N  L++ L    KK+ +D W RK +  N
Sbjct: 80  LNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWL---KKKKSIDPWERKSYWKN 135
Query: 586 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 645
           ++E +       H   +  I+H DLK +N L+ + +  K+ DFG+A     NQ Q DT  
Sbjct: 136 MLEAV-------HTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDTTS 182
Query: 646 V-----VGTFGYMSPEYAMEGRFSEKS-----------DVFSFGVLLLEIVSGR 683
           V     VGT  YM PE   +   S ++           DV+S G +L  +  G+
Sbjct: 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 484 FQLSSKLGQGGFGPVYWGRLKDGQEI--AVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 541
           + L + +G+G +G V    ++ G  I  A K++ K   + ++ F  E+ ++  L H N++
Sbjct: 11  YTLENTIGRGSWGEVKIA-VQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 69
Query: 542 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKR--FNIIEGISRGLLYLHR 599
           RL     +  +  L+ E          LF+ +  +R+ +R+     I++ +   + Y H 
Sbjct: 70  RLYETFEDNTDIYLVMEL----CTGGELFERVVHKRV-FRESDAARIMKDVLSAVAYCH- 123
Query: 600 DSRLRIIHRDLKASNILL--DEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 656
             +L + HRDLK  N L   D   +P K+ DFG+A  F   +        VGT  Y+SP+
Sbjct: 124 --KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK---VGTPYYVSPQ 178
Query: 657 YAMEGRFSEKSDVFSFGVLLLEIVSG 682
             +EG +  + D +S GV++  ++ G
Sbjct: 179 -VLEGLYGPECDEWSAGVMMYVLLCG 203

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 479 TATNNFQLSSKLGQGGFGPV--YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISK 534
           T    +Q    +G G  G V   +  + D + +A+K+LS+   +    +    E++++  
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKX 79
Query: 535 LQHRNLVRLLGCCV------EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE 588
           + H+N++ LL          E ++  L+ E M     DA L   ++ E LD  +   ++ 
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQME-LDHERMSYLLY 133
Query: 589 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 648
            +  G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +     T  VV 
Sbjct: 134 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMM--TPYVVT 188
Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
            + Y +PE  +   + E  D++S G ++ E+V  +
Sbjct: 189 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 71/250 (28%), Positives = 113/250 (45%), Gaps = 46/250 (18%)
Query: 465 KLQDLPLFQFEELATATNNFQLSSK-LGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLE 523
           ++ ++P F+      +  N  +S K LG G  G V +     G+ +AVKR+       L 
Sbjct: 20  RIANIPNFE-----QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRM-------LI 67
Query: 524 EFMNEVMVISKL-----QHRNLVRLLGCCVEGEEKML-IYEYMPNRSLDALLFDP-LKKE 576
           +F +  ++  KL      H N++R    C E  ++ L I   + N +L  L+    +  E
Sbjct: 68  DFCDIALMEIKLLTESDDHPNVIRYY--CSETTDRFLYIALELCNLNLQDLVESKNVSDE 125
Query: 577 RLDWRKRFN---IIEGISRGLLYLHRDSRLRIIHRDLKASNILLD-------------EE 620
            L  +K +N   ++  I+ G+ +LH    L+IIHRDLK  NIL+              E 
Sbjct: 126 NLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAEN 182
Query: 621 LNPKISDFGMAKIFGGNQD--QADTGRVVGTFGYMSPEYAMEG---RFSEKSDVFSFGVL 675
           L   ISDFG+ K     Q   + +     GT G+ +PE   E    R +   D+FS G +
Sbjct: 183 LRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCV 242
Query: 676 LLEIVSGRKN 685
              I+S  K+
Sbjct: 243 FYYILSKGKH 252

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 71/250 (28%), Positives = 113/250 (45%), Gaps = 46/250 (18%)
Query: 465 KLQDLPLFQFEELATATNNFQLSSK-LGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLE 523
           ++ ++P F+      +  N  +S K LG G  G V +     G+ +AVKR+       L 
Sbjct: 20  RIANIPNFE-----QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRM-------LI 67
Query: 524 EFMNEVMVISKL-----QHRNLVRLLGCCVEGEEKML-IYEYMPNRSLDALLFDP-LKKE 576
           +F +  ++  KL      H N++R    C E  ++ L I   + N +L  L+    +  E
Sbjct: 68  DFCDIALMEIKLLTESDDHPNVIRYY--CSETTDRFLYIALELCNLNLQDLVESKNVSDE 125
Query: 577 RLDWRKRFN---IIEGISRGLLYLHRDSRLRIIHRDLKASNILLD-------------EE 620
            L  +K +N   ++  I+ G+ +LH    L+IIHRDLK  NIL+              E 
Sbjct: 126 NLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAEN 182
Query: 621 LNPKISDFGMAKIFGGNQD--QADTGRVVGTFGYMSPEYAMEG---RFSEKSDVFSFGVL 675
           L   ISDFG+ K     Q   + +     GT G+ +PE   E    R +   D+FS G +
Sbjct: 183 LRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCV 242
Query: 676 LLEIVSGRKN 685
              I+S  K+
Sbjct: 243 FYYILSKGKH 252

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 479 TATNNFQLSSKLGQGGFGPV--YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISK 534
           T    +Q    +G G  G V   +  + D + +A+K+LS+   +    +    E++++  
Sbjct: 59  TVLKRYQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKC 117
Query: 535 LQHRNLVRLLGCCV------EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE 588
           + H+N++ LL          E ++  L+ E M     DA L   ++ E LD  +   ++ 
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQME-LDHERMSYLLY 171
Query: 589 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 648
            +  G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +     T  VV 
Sbjct: 172 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVT 226
Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
            + Y +PE  +   + E  D++S G ++ E+V  +
Sbjct: 227 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 71/254 (27%), Positives = 113/254 (44%), Gaps = 50/254 (19%)
Query: 465 KLQDLPLFQFEELATATNNFQLSSK-LGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLE 523
           ++ ++P F+      +  N  +S K LG G  G V +     G+ +AVKR+       L 
Sbjct: 2   RIANIPNFE-----QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRM-------LI 49
Query: 524 EFMNEVMVISKL-----QHRNLVRLLGCCVEGEEKML-IYEYMPNRSLDALLFDP-LKKE 576
           +F +  ++  KL      H N++R    C E  ++ L I   + N +L  L+    +  E
Sbjct: 50  DFCDIALMEIKLLTESDDHPNVIRYY--CSETTDRFLYIALELCNLNLQDLVESKNVSDE 107
Query: 577 RLDWRKRFN---IIEGISRGLLYLHRDSRLRIIHRDLKASNILLD-------------EE 620
            L  +K +N   ++  I+ G+ +LH    L+IIHRDLK  NIL+              E 
Sbjct: 108 NLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAEN 164
Query: 621 LNPKISDFGMAKIFGGNQD--QADTGRVVGTFGYMSPEYAMEG-------RFSEKSDVFS 671
           L   ISDFG+ K     Q   + +     GT G+ +PE   E        R +   D+FS
Sbjct: 165 LRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFS 224
Query: 672 FGVLLLEIVSGRKN 685
            G +   I+S  K+
Sbjct: 225 MGCVFYYILSKGKH 238

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 103/218 (47%), Gaps = 20/218 (9%)
Query: 472 FQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEI--AVKRLSKASGQGLEEFMNEV 529
           FQ          + L + +G+G +G V    ++ G  I  A K++ K   + ++ F  E+
Sbjct: 16  FQGSTKGDINQYYTLENTIGRGSWGEVKIA-VQKGTRIRRAAKKIPKYFVEDVDRFKQEI 74
Query: 530 MVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKR--FNII 587
            ++  L H N++RL     +  +  L+ E          LF+ +  +R+ +R+     I+
Sbjct: 75  EIMKSLDHPNIIRLYETFEDNTDIYLVMEL----CTGGELFERVVHKRV-FRESDAARIM 129
Query: 588 EGISRGLLYLHRDSRLRIIHRDLKASNILL--DEELNP-KISDFGMAKIFGGNQDQADTG 644
           + +   + Y H   +L + HRDLK  N L   D   +P K+ DFG+A  F   +      
Sbjct: 130 KDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK- 185
Query: 645 RVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
             VGT  Y+SP+  +EG +  + D +S GV++  ++ G
Sbjct: 186 --VGTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 220

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 19/212 (8%)
Query: 479 TATNNFQLSSKLGQGGFGPV---YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVIS 533
           T    +Q    +G G  G V   Y   L+  + +A+K+LS+   +    +    E++++ 
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 534 KLQHRNLVRLLGCCVEG---EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGI 590
            + H+N++ LL         EE   +Y  M    +DA L   ++ E LD  +   ++  +
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVM--ELMDANLCQVIQME-LDHERMSYLLYQM 135
Query: 591 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF 650
             G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +     T  VV  +
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY 190
Query: 651 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
            Y +PE  +   + E  D++S G ++ E++ G
Sbjct: 191 -YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 19/212 (8%)
Query: 479 TATNNFQLSSKLGQGGFGPV---YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVIS 533
           T    +Q    +G G  G V   Y   L+  + +A+K+LS+   +    +    E++++ 
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 534 KLQHRNLVRLLGCCVEG---EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGI 590
            + H+N++ LL         EE   +Y  M    +DA L   ++ E LD  +   ++  +
Sbjct: 79  VVNHKNIIGLLNVFTPQKSLEEFQDVYIVM--ELMDANLSQVIQME-LDHERMSYLLYQM 135
Query: 591 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF 650
             G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +     T  VV  +
Sbjct: 136 LVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMM--TPYVVTRY 190
Query: 651 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
            Y +PE  +   + E  D++S G ++ E++ G
Sbjct: 191 -YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 100/210 (47%), Gaps = 16/210 (7%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEEFMN---EVMVISKLQH 537
           ++F++   +G+G FG V   +  D +++ A+K ++K       E  N   E+ ++  L+H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 597
             LV L     + E+  ++ + +    L   L     ++ + +++   +   I   ++ L
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL-----QQNVHFKEE-TVKLFICELVMAL 128
Query: 598 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEY 657
                 RIIHRD+K  NILLDE  +  I+DF +A +      +     + GT  YM+PE 
Sbjct: 129 DYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR---ETQITTMAGTKPYMAPEM 185
Query: 658 AMEGR---FSEKSDVFSFGVLLLEIVSGRK 684
               +   +S   D +S GV   E++ GR+
Sbjct: 186 FSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 19/212 (8%)
Query: 479 TATNNFQLSSKLGQGGFGPV---YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVIS 533
           T    +Q    +G G  G V   Y   L+  + +A+K+LS+   +    +    E++++ 
Sbjct: 22  TVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMK 79
Query: 534 KLQHRNLVRLLGCCVEG---EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGI 590
            + H+N++ LL         EE   +Y  M    +DA L   ++ E LD  +   ++  +
Sbjct: 80  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVM--ELMDANLCQVIQME-LDHERMSYLLYQM 136
Query: 591 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF 650
             G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +     T  VV  +
Sbjct: 137 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY 191
Query: 651 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
            Y +PE  +   + E  D++S G ++ E++ G
Sbjct: 192 -YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 479 TATNNFQLSSKLGQGGFGPV--YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISK 534
           T    +Q    +G G  G V   +  + D + +A+K+LS+   +    +    E++++  
Sbjct: 14  TVLKRYQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKC 72
Query: 535 LQHRNLVRLLGCCV------EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE 588
           + H+N++ LL          E ++  L+ E M     DA L   ++ E LD  +   ++ 
Sbjct: 73  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQME-LDHERMSYLLY 126
Query: 589 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 648
            +  G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +     T  VV 
Sbjct: 127 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVT 181
Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
            + Y +PE  +   + E  D++S G ++ E+V  +
Sbjct: 182 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 479 TATNNFQLSSKLGQGGFGPV--YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISK 534
           T    +Q    +G G  G V   +  + D + +A+K+LS+   +    +    E++++  
Sbjct: 15  TVLKRYQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKC 73
Query: 535 LQHRNLVRLLGCCV------EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE 588
           + H+N++ LL          E ++  L+ E M     DA L   ++ E LD  +   ++ 
Sbjct: 74  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQME-LDHERMSYLLY 127
Query: 589 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 648
            +  G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +     T  VV 
Sbjct: 128 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVT 182
Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
            + Y +PE  +   + E  D++S G ++ E+V  +
Sbjct: 183 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 479 TATNNFQLSSKLGQGGFGPV--YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISK 534
           T    +Q    +G G  G V   +  + D + +A+K+LS+   +    +    E++++  
Sbjct: 22  TVLKRYQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKC 80
Query: 535 LQHRNLVRLLGCCV------EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE 588
           + H+N++ LL          E ++  L+ E M     DA L   ++ E LD  +   ++ 
Sbjct: 81  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQME-LDHERMSYLLY 134
Query: 589 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 648
            +  G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +     T  VV 
Sbjct: 135 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVT 189
Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
            + Y +PE  +   + E  D++S G ++ E+V  +
Sbjct: 190 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 479 TATNNFQLSSKLGQGGFGPV--YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISK 534
           T    +Q    +G G  G V   +  + D + +A+K+LS+   +    +    E++++  
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKC 79
Query: 535 LQHRNLVRLLGCCV------EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE 588
           + H+N++ LL          E ++  L+ E M     DA L   ++ E LD  +   ++ 
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQME-LDHERMSYLLY 133
Query: 589 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 648
            +  G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +     T  VV 
Sbjct: 134 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVT 188
Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
            + Y +PE  +   + E  D++S G ++ E+V  +
Sbjct: 189 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 107/203 (52%), Gaps = 12/203 (5%)
Query: 484 FQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLS-KASGQGL-EEFMNEVMVISKLQHRNL 540
           ++   K+G+G +G V+  + ++  EI A+KR+      +G+    + E+ ++ +L+H+N+
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 541 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 600
           VRL       ++  L++E+  ++ L    FD    + LD     + +  + +GL + H  
Sbjct: 64  VRLHDVLHSDKKLTLVFEFC-DQDLKKY-FDSCNGD-LDPEIVKSFLFQLLKGLGFCH-- 118
Query: 601 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
           SR  ++HRDLK  N+L++     K+++FG+A+ FG    +  +  VV T  Y  P+    
Sbjct: 119 SR-NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCYSAEVV-TLWYRPPDVLFG 175
Query: 661 GR-FSEKSDVFSFGVLLLEIVSG 682
            + +S   D++S G +  E+ + 
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANA 198

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 479 TATNNFQLSSKLGQGGFGPV--YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISK 534
           T    +Q    +G G  G V   +  + D + +A+K+LS+   +    +    E++++  
Sbjct: 20  TVLKRYQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKC 78
Query: 535 LQHRNLVRLLGCCV------EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE 588
           + H+N++ LL          E ++  L+ E M     DA L   ++ E LD  +   ++ 
Sbjct: 79  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQME-LDHERMSYLLY 132
Query: 589 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 648
            +  G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +     T  VV 
Sbjct: 133 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVT 187
Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
            + Y +PE  +   + E  D++S G ++ E+V  +
Sbjct: 188 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 221

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 479 TATNNFQLSSKLGQGGFGPV--YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISK 534
           T    +Q    +G G  G V   +  + D + +A+K+LS+   +    +    E++++  
Sbjct: 15  TVLKRYQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKC 73
Query: 535 LQHRNLVRLLGCCV------EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE 588
           + H+N++ LL          E ++  L+ E M     DA L   ++ E LD  +   ++ 
Sbjct: 74  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQME-LDHERMSYLLY 127
Query: 589 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 648
            +  G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +     T  VV 
Sbjct: 128 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVT 182
Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
            + Y +PE  +   + E  D++S G ++ E+V  +
Sbjct: 183 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 479 TATNNFQLSSKLGQGGFGPV--YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISK 534
           T    +Q    +G G  G V   +  + D + +A+K+LS+   +    +    E++++  
Sbjct: 59  TVLKRYQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKC 117
Query: 535 LQHRNLVRLLGCCV------EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE 588
           + H+N++ LL          E ++  L+ E M     DA L   ++ E LD  +   ++ 
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQME-LDHERMSYLLY 171
Query: 589 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 648
            +  G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +     T  VV 
Sbjct: 172 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVT 226
Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
            + Y +PE  +   + E  D++S G ++ E+V  +
Sbjct: 227 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 101/234 (43%), Gaps = 33/234 (14%)
Query: 472 FQFEELATATNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVM 530
           FQ   +     ++    KLG+GGF  V     L DG   A+KR+     Q  EE   E  
Sbjct: 19  FQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREAD 78
Query: 531 VISKLQHRNLVRLLGCCVE----GEEKMLIYEYMPNRSL--------DALLFDPLKKERL 578
           +     H N++RL+  C+       E  L+  +    +L        D   F  L ++++
Sbjct: 79  MHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNF--LTEDQI 136
Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFG---MAKIFG 635
            W     ++ GI RGL  +H        HRDLK +NILL +E  P + D G    A I  
Sbjct: 137 LW-----LLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHV 188
Query: 636 GNQDQA----DTGRVVGTFGYMSPE-YAMEGR--FSEKSDVFSFGVLLLEIVSG 682
               QA    D      T  Y +PE ++++      E++DV+S G +L  ++ G
Sbjct: 189 EGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFG 242

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 103/216 (47%), Gaps = 25/216 (11%)
Query: 479 TATNNFQLSSKLGQGGFGPV---YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVIS 533
           T    +Q    +G G  G V   Y   L   + +A+K+LS+   +    +    E++++ 
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 534 KLQHRNLVRLLGCCV------EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNII 587
            + H+N++ LL          E ++  L+ E M     DA L   ++ E LD  +   ++
Sbjct: 79  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQME-LDHERMSYLL 132
Query: 588 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVV 647
             +  G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +     T  VV
Sbjct: 133 YQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVV 187
Query: 648 GTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
             + Y +PE  +   + E  D++S G ++ E+V  +
Sbjct: 188 TRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 103/234 (44%), Gaps = 40/234 (17%)
Query: 486 LSSKLGQGGFGPVYWGRLKD----GQ----EIAVKRLSKASGQGLEEFMNEVMVISKLQH 537
            +  LGQG F  ++ G  ++    GQ    E+ +K L KA     E F     ++SKL H
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 597
           ++LV   G CV G+E +L+ E++   SLD  L        + W  +  + + ++  + +L
Sbjct: 72  KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAAAMHFL 129
Query: 598 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF------- 650
             ++   +IH ++ A NILL  E + K  +    K+       +D G  +          
Sbjct: 130 EENT---LIHGNVCAKNILLIREEDRKTGNPPFIKL-------SDPGISITVLPKDILQE 179
Query: 651 --GYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSG----------RKNTSFFED 691
              ++ PE     +  +  +D +SFG  L EI SG          ++   F+ED
Sbjct: 180 RIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED 233

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 19/212 (8%)
Query: 479 TATNNFQLSSKLGQGGFGPV---YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVIS 533
           T    +Q    +G G  G V   Y   L+  + +A+K+LS+   +    +    E++++ 
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 534 KLQHRNLVRLLGCCVEG---EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGI 590
            + H+N++ LL         EE   +Y  M    +DA L   ++ E LD  +   ++  +
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVM--ELMDANLCQVIQME-LDHERMSYLLYQM 135
Query: 591 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF 650
             G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +     T  VV  +
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY 190
Query: 651 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
            Y +PE  +   + E  D++S G ++ E++ G
Sbjct: 191 -YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 19/212 (8%)
Query: 479 TATNNFQLSSKLGQGGFGPV---YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVIS 533
           T    +Q    +G G  G V   Y   L+  + +A+K+LS+   +    +    E++++ 
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 534 KLQHRNLVRLLGCCVEG---EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGI 590
            + H+N++ LL         EE   +Y  M    +DA L   ++ E LD  +   ++  +
Sbjct: 79  VVNHKNIIGLLNVFTPQKSLEEFQDVYIVM--ELMDANLSQVIQME-LDHERMSYLLYQM 135
Query: 591 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF 650
             G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +     T  VV  +
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMM--TPYVVTRY 190
Query: 651 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
            Y +PE  +   + E  D++S G ++ E++ G
Sbjct: 191 -YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 97/204 (47%), Gaps = 21/204 (10%)
Query: 490 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN-EVMVISKLQHRNLVRL-LGC 546
           +G G FG VY  +L D G+ +A+K++ +      + F N E+ ++ KL H N+VRL    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 547 CVEGEEKMLIY-----EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
              GE+K ++Y     +Y+P             K+ L        +  + R L Y+H   
Sbjct: 83  YSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 140
Query: 602 RLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
              I HRD+K  N+LLD +    K+ DFG AK     + + +   +   + Y +PE    
Sbjct: 141 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY-YRAPELIFG 196
Query: 661 GR-FSEKSDVFSFGVLLLEIVSGR 683
              ++   DV+S G +L E++ G+
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 479 TATNNFQLSSKLGQGGFGPV--YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISK 534
           T    +Q    +G G  G V   +  + D + +A+K+LS+   +    +    E++++  
Sbjct: 22  TVLKRYQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKC 80
Query: 535 LQHRNLVRLLGCCV------EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE 588
           + H+N++ LL          E ++  L+ E M     DA L   ++ E LD  +   ++ 
Sbjct: 81  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQME-LDHERMSYLLY 134
Query: 589 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 648
            +  G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +     T  VV 
Sbjct: 135 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVT 189
Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
            + Y +PE  +   + E  D++S G ++ E+V  +
Sbjct: 190 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 41/213 (19%)
Query: 489 KLGQGGFGPVYWGRLKDGQ------EIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 542
           ++G+G F  VY G   +        E+  ++L+K+  Q    F  E   +  LQH N+VR
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQ---RFKEEAEXLKGLQHPNIVR 89
Query: 543 LLGC---CVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE---------G 589
                   V+G++ + L+ E   + +L   L            KRF + +          
Sbjct: 90  FYDSWESTVKGKKCIVLVTELXTSGTLKTYL------------KRFKVXKIKVLRSWCRQ 137
Query: 590 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVG 648
           I +GL +LH  +   IIHRDLK  NI +       KI D G+A +   +  +A    V+G
Sbjct: 138 ILKGLQFLHTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIG 192
Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           T  + +PE   E ++ E  DV++FG   LE  +
Sbjct: 193 TPEFXAPE-XYEEKYDESVDVYAFGXCXLEXAT 224

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 71/254 (27%), Positives = 113/254 (44%), Gaps = 50/254 (19%)
Query: 465 KLQDLPLFQFEELATATNNFQLSSK-LGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLE 523
           ++ ++P F+      +  N  +S K LG G  G V +     G+ +AVKR+       L 
Sbjct: 2   RIANIPNFE-----QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRM-------LI 49
Query: 524 EFMNEVMVISKL-----QHRNLVRLLGCCVEGEEKML-IYEYMPNRSLDALLFDP-LKKE 576
           +F +  ++  KL      H N++R    C E  ++ L I   + N +L  L+    +  E
Sbjct: 50  DFCDIALMEIKLLTESDDHPNVIRYY--CSETTDRFLYIALELCNLNLQDLVESKNVSDE 107
Query: 577 RLDWRKRFN---IIEGISRGLLYLHRDSRLRIIHRDLKASNILLD-------------EE 620
            L  +K +N   ++  I+ G+ +LH    L+IIHRDLK  NIL+              E 
Sbjct: 108 NLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAEN 164
Query: 621 LNPKISDFGMAKIFGGNQD--QADTGRVVGTFGYMSPEYAMEG-------RFSEKSDVFS 671
           L   ISDFG+ K     Q   + +     GT G+ +PE   E        R +   D+FS
Sbjct: 165 LRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFS 224
Query: 672 FGVLLLEIVSGRKN 685
            G +   I+S  K+
Sbjct: 225 MGCVFYYILSKGKH 238

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 21/204 (10%)
Query: 490 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN-EVMVISKLQHRNLVRLLGCC 547
           +G G FG VY  +L D G+ +A+K++ +        F N E+ ++ KL H N+VRL    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKA-----FKNRELQIMRKLDHCNIVRLRYFF 82
Query: 548 VEGEEKM------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
               EK       L+ +Y+P             K+ L        +  + R L Y+H   
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 140
Query: 602 RLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
              I HRD+K  N+LLD +    K+ DFG AK     + + +   +   + Y +PE    
Sbjct: 141 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSXICSRY-YRAPELIFG 196
Query: 661 GR-FSEKSDVFSFGVLLLEIVSGR 683
              ++   DV+S G +L E++ G+
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 21/204 (10%)
Query: 490 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN-EVMVISKLQHRNLVRLLGCC 547
           +G G FG VY  +L D G+ +A+K++ +        F N E+ ++ KL H N+VRL    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKA-----FKNRELQIMRKLDHCNIVRLRYFF 82
Query: 548 VEGEEKM------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
               EK       L+ +Y+P             K+ L        +  + R L Y+H   
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 140
Query: 602 RLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
              I HRD+K  N+LLD +    K+ DFG AK     + + +   +   + Y +PE    
Sbjct: 141 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRY-YRAPELIFG 196
Query: 661 GR-FSEKSDVFSFGVLLLEIVSGR 683
              ++   DV+S G +L E++ G+
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 21/204 (10%)
Query: 490 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN-EVMVISKLQHRNLVRLLGCC 547
           +G G FG VY  +L D G+ +A+K++ +        F N E+ ++ KL H N+VRL    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKA-----FKNRELQIMRKLDHCNIVRLRYFF 82
Query: 548 VEGEEKM------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
               EK       L+ +Y+P             K+ L        +  + R L Y+H   
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 140
Query: 602 RLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
              I HRD+K  N+LLD +    K+ DFG AK     + + +   +   + Y +PE    
Sbjct: 141 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRY-YRAPELIFG 196
Query: 661 GR-FSEKSDVFSFGVLLLEIVSGR 683
              ++   DV+S G +L E++ G+
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 22/210 (10%)
Query: 481 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 539
           T+ +++   +G G +        K    E AVK + K+     EE     +++   QH N
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIE---ILLRYGQHPN 77
Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 599
           ++ L     +G+   ++ E         LL   L+++    R+   ++  I++ + YLH 
Sbjct: 78  IITLKDVYDDGKYVYVVTELXKG---GELLDKILRQKFFSEREASAVLFTITKTVEYLHA 134
Query: 600 DSRLRIIHRDLKASNIL-LDEELNP---KISDFGMAKIFGGNQDQADTGRVVG---TFGY 652
                ++HRDLK SNIL +DE  NP   +I DFG AK     Q +A+ G +     T  +
Sbjct: 135 QG---VVHRDLKPSNILYVDESGNPESIRICDFGFAK-----QLRAENGLLXTPCYTANF 186
Query: 653 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
           ++PE      +    D++S GVLL   ++G
Sbjct: 187 VAPEVLERQGYDAACDIWSLGVLLYTXLTG 216

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 19/212 (8%)
Query: 479 TATNNFQLSSKLGQGGFGPV---YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVIS 533
           T    +Q    +G G  G V   Y   L+  + +A+K+LS+   +    +    E++++ 
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 534 KLQHRNLVRLLGCCVEG---EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGI 590
            + H+N++ LL         EE   +Y  M    +DA L   ++ E LD  +   ++  +
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVM--ELMDANLSQVIQME-LDHERMSYLLYQM 135
Query: 591 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF 650
             G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +     T  VV  +
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMM--TPYVVTRY 190
Query: 651 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
            Y +PE  +   + E  D++S G ++ E++ G
Sbjct: 191 -YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 19/212 (8%)
Query: 479 TATNNFQLSSKLGQGGFGPV---YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVIS 533
           T    +Q    +G G  G V   Y   L+  + +A+K+LS+   +    +    E++++ 
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 534 KLQHRNLVRLLGCCVEG---EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGI 590
            + H+N++ LL         EE   +Y  M    +DA L   ++ E LD  +   ++  +
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVM--ELMDANLSQVIQME-LDHERMSYLLYQM 135
Query: 591 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF 650
             G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +     T  VV  +
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY 190
Query: 651 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
            Y +PE  +   + E  D++S G ++ E++ G
Sbjct: 191 -YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 101/212 (47%), Gaps = 19/212 (8%)
Query: 479 TATNNFQLSSKLGQGGFGPV---YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVIS 533
           T    +Q    +G G  G V   Y   L+  + +A+K+LS+   +    +    E++++ 
Sbjct: 23  TVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMK 80
Query: 534 KLQHRNLVRLLGCCVEG---EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGI 590
            + H+N++ LL         EE   +Y  M    +DA L   ++ E LD  +   ++  +
Sbjct: 81  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVM--ELMDANLCQVIQME-LDHERMSYLLYQM 137
Query: 591 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF 650
             G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +         V T 
Sbjct: 138 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVP---FVVTR 191
Query: 651 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
            Y +PE  +   + E  D++S G ++ E++ G
Sbjct: 192 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 120/261 (45%), Gaps = 37/261 (14%)
Query: 482 NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSK-----ASGQGLEEFMN---EVMVI 532
           + + +S  LG G  G V      K  +++A+K +SK      S +  +  +N   E+ ++
Sbjct: 16  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 75
Query: 533 SKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSL-DALLFDPLKKERLDWRKRFNIIEGIS 591
            KL H  ++++     + E+  ++ E M    L D ++ +   KE       + ++  + 
Sbjct: 76  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 134
Query: 592 RGLLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVVG 648
               YLH +    IIHRDLK  N+LL   +E+   KI+DFG +KI G   + +    + G
Sbjct: 135 ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRTLCG 184
Query: 649 TFGYMSPEYAME---GRFSEKSDVFSFGVLLLEIVSG------RKNTSFFEDDLTILGYA 699
           T  Y++PE  +      ++   D +S GV+L   +SG       +     +D +T   Y 
Sbjct: 185 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 244
Query: 700 W--KLWNE--NKILALVDPFL 716
           +  ++W E   K L LV   L
Sbjct: 245 FIPEVWAEVSEKALDLVKKLL 265

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 120/261 (45%), Gaps = 37/261 (14%)
Query: 482 NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSK-----ASGQGLEEFMN---EVMVI 532
           + + +S  LG G  G V      K  +++A+K +SK      S +  +  +N   E+ ++
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 533 SKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSL-DALLFDPLKKERLDWRKRFNIIEGIS 591
            KL H  ++++     + E+  ++ E M    L D ++ +   KE       + ++  + 
Sbjct: 70  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 592 RGLLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVVG 648
               YLH +    IIHRDLK  N+LL   +E+   KI+DFG +KI G   + +    + G
Sbjct: 129 ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRTLCG 178
Query: 649 TFGYMSPEYAME---GRFSEKSDVFSFGVLLLEIVSG------RKNTSFFEDDLTILGYA 699
           T  Y++PE  +      ++   D +S GV+L   +SG       +     +D +T   Y 
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 238
Query: 700 W--KLWNE--NKILALVDPFL 716
           +  ++W E   K L LV   L
Sbjct: 239 FIPEVWAEVSEKALDLVKKLL 259

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 120/261 (45%), Gaps = 37/261 (14%)
Query: 482 NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSK-----ASGQGLEEFMN---EVMVI 532
           + + +S  LG G  G V      K  +++A+K +SK      S +  +  +N   E+ ++
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 533 SKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSL-DALLFDPLKKERLDWRKRFNIIEGIS 591
            KL H  ++++     + E+  ++ E M    L D ++ +   KE       + ++  + 
Sbjct: 70  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 592 RGLLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVVG 648
               YLH +    IIHRDLK  N+LL   +E+   KI+DFG +KI G   + +    + G
Sbjct: 129 ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRTLCG 178
Query: 649 TFGYMSPEYAME---GRFSEKSDVFSFGVLLLEIVSG------RKNTSFFEDDLTILGYA 699
           T  Y++PE  +      ++   D +S GV+L   +SG       +     +D +T   Y 
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 238
Query: 700 W--KLWNE--NKILALVDPFL 716
           +  ++W E   K L LV   L
Sbjct: 239 FIPEVWAEVSEKALDLVKKLL 259

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 120/261 (45%), Gaps = 37/261 (14%)
Query: 482 NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSK-----ASGQGLEEFMN---EVMVI 532
           + + +S  LG G  G V      K  +++A+K +SK      S +  +  +N   E+ ++
Sbjct: 9   DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 68
Query: 533 SKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSL-DALLFDPLKKERLDWRKRFNIIEGIS 591
            KL H  ++++     + E+  ++ E M    L D ++ +   KE       + ++  + 
Sbjct: 69  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 127
Query: 592 RGLLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVVG 648
               YLH +    IIHRDLK  N+LL   +E+   KI+DFG +KI G   + +    + G
Sbjct: 128 ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRTLCG 177
Query: 649 TFGYMSPEYAME---GRFSEKSDVFSFGVLLLEIVSG------RKNTSFFEDDLTILGYA 699
           T  Y++PE  +      ++   D +S GV+L   +SG       +     +D +T   Y 
Sbjct: 178 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 237
Query: 700 W--KLWNE--NKILALVDPFL 716
           +  ++W E   K L LV   L
Sbjct: 238 FIPEVWAEVSEKALDLVKKLL 258

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 490 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN-EVMVISKLQHRNLVRLLGCC 547
           +G G FG VY  +L D G+ +A+K++ +      + F N E+ ++ KL H N+VRL    
Sbjct: 56  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 110
Query: 548 VEGEEKM------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
               EK       L+ +Y+P             K+ L        +  + R L Y+H   
Sbjct: 111 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 168
Query: 602 RLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
              I HRD+K  N+LLD +    K+ DFG AK     + + +   +   + Y +PE    
Sbjct: 169 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRY-YRAPELIFG 224
Query: 661 GR-FSEKSDVFSFGVLLLEIVSGR 683
              ++   DV+S G +L E++ G+
Sbjct: 225 ATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 120/261 (45%), Gaps = 37/261 (14%)
Query: 482 NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSK-----ASGQGLEEFMN---EVMVI 532
           + + +S  LG G  G V      K  +++A+K +SK      S +  +  +N   E+ ++
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 533 SKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSL-DALLFDPLKKERLDWRKRFNIIEGIS 591
            KL H  ++++     + E+  ++ E M    L D ++ +   KE       + ++  + 
Sbjct: 70  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 592 RGLLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVVG 648
               YLH +    IIHRDLK  N+LL   +E+   KI+DFG +KI G   + +    + G
Sbjct: 129 ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRTLCG 178
Query: 649 TFGYMSPEYAME---GRFSEKSDVFSFGVLLLEIVSG------RKNTSFFEDDLTILGYA 699
           T  Y++PE  +      ++   D +S GV+L   +SG       +     +D +T   Y 
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 238
Query: 700 W--KLWNE--NKILALVDPFL 716
           +  ++W E   K L LV   L
Sbjct: 239 FIPEVWAEVSEKALDLVKKLL 259

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 490 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN-EVMVISKLQHRNLVRLLGCC 547
           +G G FG VY  +L D G+ +A+K++ +      + F N E+ ++ KL H N+VRL    
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 116
Query: 548 VEGEEKM------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
               EK       L+ +Y+P             K+ L        +  + R L Y+H   
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 174
Query: 602 RLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
              I HRD+K  N+LLD +    K+ DFG AK     + + +   +   + Y +PE    
Sbjct: 175 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSXICSRY-YRAPELIFG 230
Query: 661 GR-FSEKSDVFSFGVLLLEIVSGR 683
              ++   DV+S G +L E++ G+
Sbjct: 231 ATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 490 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN-EVMVISKLQHRNLVRLLGCC 547
           +G G FG VY  +L D G+ +A+K++ +      + F N E+ ++ KL H N+VRL    
Sbjct: 36  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 90
Query: 548 VEGEEKM------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
               EK       L+ +Y+P             K+ L        +  + R L Y+H   
Sbjct: 91  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 148
Query: 602 RLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
              I HRD+K  N+LLD +    K+ DFG AK     + + +   +   + Y +PE    
Sbjct: 149 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY-YRAPELIFG 204
Query: 661 GR-FSEKSDVFSFGVLLLEIVSGR 683
              ++   DV+S G +L E++ G+
Sbjct: 205 ATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 490 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN-EVMVISKLQHRNLVRLLGCC 547
           +G G FG VY  +L D G+ +A+K++ +      + F N E+ ++ KL H N+VRL    
Sbjct: 33  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 87
Query: 548 VEGEEKM------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
               EK       L+ +Y+P             K+ L        +  + R L Y+H   
Sbjct: 88  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 145
Query: 602 RLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
              I HRD+K  N+LLD +    K+ DFG AK     + + +   +   + Y +PE    
Sbjct: 146 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRY-YRAPELIFG 201
Query: 661 GR-FSEKSDVFSFGVLLLEIVSGR 683
              ++   DV+S G +L E++ G+
Sbjct: 202 ATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 490 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN-EVMVISKLQHRNLVRLLGCC 547
           +G G FG VY  +L D G+ +A+K++ +      + F N E+ ++ KL H N+VRL    
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 116
Query: 548 VEGEEKM------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
               EK       L+ +Y+P             K+ L        +  + R L Y+H   
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 174
Query: 602 RLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
              I HRD+K  N+LLD +    K+ DFG AK     + + +   +   + Y +PE    
Sbjct: 175 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRY-YRAPELIFG 230
Query: 661 GR-FSEKSDVFSFGVLLLEIVSGR 683
              ++   DV+S G +L E++ G+
Sbjct: 231 ATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 490 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN-EVMVISKLQHRNLVRLLGCC 547
           +G G FG VY  +L D G+ +A+K++ +      + F N E+ ++ KL H N+VRL    
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 94
Query: 548 VEGEEKM------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
               EK       L+ +Y+P             K+ L        +  + R L Y+H   
Sbjct: 95  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 152
Query: 602 RLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
              I HRD+K  N+LLD +    K+ DFG AK     + + +   +   + Y +PE    
Sbjct: 153 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY-YRAPELIFG 208
Query: 661 GR-FSEKSDVFSFGVLLLEIVSGR 683
              ++   DV+S G +L E++ G+
Sbjct: 209 ATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 490 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN-EVMVISKLQHRNLVRLLGCC 547
           +G G FG VY  +L D G+ +A+K++ +      + F N E+ ++ KL H N+VRL    
Sbjct: 66  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 120
Query: 548 VEGEEKM------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
               EK       L+ +Y+P             K+ L        +  + R L Y+H   
Sbjct: 121 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 178
Query: 602 RLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
              I HRD+K  N+LLD +    K+ DFG AK     + + +   +   + Y +PE    
Sbjct: 179 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRY-YRAPELIFG 234
Query: 661 GR-FSEKSDVFSFGVLLLEIVSGR 683
              ++   DV+S G +L E++ G+
Sbjct: 235 ATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 490 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN-EVMVISKLQHRNLVRLLGCC 547
           +G G FG VY  +L D G+ +A+K++ +      + F N E+ ++ KL H N+VRL    
Sbjct: 47  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 101
Query: 548 VEGEEKM------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
               EK       L+ +Y+P             K+ L        +  + R L Y+H   
Sbjct: 102 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 159
Query: 602 RLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
              I HRD+K  N+LLD +    K+ DFG AK     + + +   +   + Y +PE    
Sbjct: 160 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY-YRAPELIFG 215
Query: 661 GR-FSEKSDVFSFGVLLLEIVSGR 683
              ++   DV+S G +L E++ G+
Sbjct: 216 ATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 87/169 (51%), Gaps = 20/169 (11%)
Query: 523 EEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDW 580
           E  + EV ++ K+  H N+++L           L+++ M    L    FD L +K  L  
Sbjct: 55  EATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSE 110
Query: 581 RKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ 640
           ++   I+  +   +  LH+   L I+HRDLK  NILLD+++N K++DFG    F    D 
Sbjct: 111 KETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFG----FSCQLDP 163
Query: 641 ADTGR-VVGTFGYMSPEY---AMEGR---FSEKSDVFSFGVLLLEIVSG 682
            +  R V GT  Y++PE    +M      + ++ D++S GV++  +++G
Sbjct: 164 GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 490 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN-EVMVISKLQHRNLVRLLGCC 547
           +G G FG VY  +L D G+ +A+K++ +      + F N E+ ++ KL H N+VRL    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 548 VEGEEKM------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
               EK       L+ +Y+P             K+ L        +  + R L Y+H   
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 140
Query: 602 RLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
              I HRD+K  N+LLD +    K+ DFG AK     + + +   +   + Y +PE    
Sbjct: 141 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY-YRAPELIFG 196
Query: 661 GR-FSEKSDVFSFGVLLLEIVSGR 683
              ++   DV+S G +L E++ G+
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 102/223 (45%), Gaps = 39/223 (17%)
Query: 484 FQLSSKLGQGGFGPVYWGRLKDGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRN-- 539
           + +  ++G GG   V+    +  Q  A+K   L +A  Q L+ + NE+  ++KLQ  +  
Sbjct: 14  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 73
Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDW-RKRF--NIIEGISRGLLY 596
           ++RL    +  +    IY  M   ++D   +   KK    W RK +  N++E +      
Sbjct: 74  IIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV------ 124
Query: 597 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV-----VGTFG 651
            H   +  I+H DLK +N L+ + +  K+ DFG+A     NQ Q DT  V     VGT  
Sbjct: 125 -HTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDTTSVVKDSQVGTVN 177
Query: 652 YMSPEYAMEGRFSEKS-----------DVFSFGVLLLEIVSGR 683
           YM PE   +   S ++           DV+S G +L  +  G+
Sbjct: 178 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 220

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 98/223 (43%), Gaps = 29/223 (13%)
Query: 478 ATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGL---EEFMNEVMVISK 534
           +T      L   +G+G FG V+ G+ + G+E+AVK  S    +      E    VM    
Sbjct: 5   STIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM---- 59
Query: 535 LQHRNLVRLLGCCVEGE----EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGI 590
           L+H N++  +    +      +  L+ +Y  + SL    FD L +  +       +    
Sbjct: 60  LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALST 115
Query: 591 SRGLLYLHRD-----SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG- 644
           + GL +LH +      +  I HRDLK+ NIL+ +     I+D G+A       D  D   
Sbjct: 116 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 175
Query: 645 -RVVGTFGYMSPEYAMEG----RFS--EKSDVFSFGVLLLEIV 680
              VGT  YM+PE   +      F   +++D+++ G++  EI 
Sbjct: 176 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 218

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 490 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN-EVMVISKLQHRNLVRLLGCC 547
           +G G FG VY  +L D G+ +A+K++ +      + F N E+ ++ KL H N+VRL    
Sbjct: 29  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 83
Query: 548 VEGEEKM------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
               EK       L+ +Y+P             K+ L        +  + R L Y+H   
Sbjct: 84  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 141
Query: 602 RLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
              I HRD+K  N+LLD +    K+ DFG AK     + + +   +   + Y +PE    
Sbjct: 142 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY-YRAPELIFG 197
Query: 661 GR-FSEKSDVFSFGVLLLEIVSGR 683
              ++   DV+S G +L E++ G+
Sbjct: 198 ATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 490 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN-EVMVISKLQHRNLVRLLGCC 547
           +G G FG VY  +L D G+ +A+K++ +      + F N E+ ++ KL H N+VRL    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 548 VEGEEKM------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
               EK       L+ +Y+P             K+ L        +  + R L Y+H   
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 140
Query: 602 RLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
              I HRD+K  N+LLD +    K+ DFG AK     + + +   +   + Y +PE    
Sbjct: 141 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY-YRAPELIFG 196
Query: 661 GR-FSEKSDVFSFGVLLLEIVSGR 683
              ++   DV+S G +L E++ G+
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 97/222 (43%), Gaps = 29/222 (13%)
Query: 479 TATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGL---EEFMNEVMVISKL 535
           T      L   +G+G FG V+ G+ + G+E+AVK  S    +      E    VM    L
Sbjct: 1   TIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM----L 55
Query: 536 QHRNLVRLLGCCVEGE----EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGIS 591
           +H N++  +    +      +  L+ +Y  + SL    FD L +  +       +    +
Sbjct: 56  RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTA 111
Query: 592 RGLLYLHRD-----SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG-- 644
            GL +LH +      +  I HRDLK+ NIL+ +     I+D G+A       D  D    
Sbjct: 112 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN 171
Query: 645 RVVGTFGYMSPEYAMEG----RFS--EKSDVFSFGVLLLEIV 680
             VGT  YM+PE   +      F   +++D+++ G++  EI 
Sbjct: 172 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 213

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 490 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN-EVMVISKLQHRNLVRLLGCC 547
           +G G FG VY  +L D G+ +A+K++ +      + F N E+ ++ KL H N+VRL    
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 94
Query: 548 VEGEEKM------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
               EK       L+ +Y+P             K+ L        +  + R L Y+H   
Sbjct: 95  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 152
Query: 602 RLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
              I HRD+K  N+LLD +    K+ DFG AK     + + +   +   + Y +PE    
Sbjct: 153 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY-YRAPELIFG 208
Query: 661 GR-FSEKSDVFSFGVLLLEIVSGR 683
              ++   DV+S G +L E++ G+
Sbjct: 209 ATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 490 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN-EVMVISKLQHRNLVRLLGCC 547
           +G G FG VY  +L D G+ +A+K++ +      + F N E+ ++ KL H N+VRL    
Sbjct: 64  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 118
Query: 548 VEGEEKM------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
               EK       L+ +Y+P             K+ L        +  + R L Y+H   
Sbjct: 119 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 176
Query: 602 RLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
              I HRD+K  N+LLD +    K+ DFG AK     + + +   +   + Y +PE    
Sbjct: 177 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRY-YRAPELIFG 232
Query: 661 GR-FSEKSDVFSFGVLLLEIVSGR 683
              ++   DV+S G +L E++ G+
Sbjct: 233 ATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 104/217 (47%), Gaps = 27/217 (12%)
Query: 482 NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSK-----ASGQGLEEFMN---EVMVI 532
           + + +S  LG G  G V      K  +++A++ +SK      S +  +  +N   E+ ++
Sbjct: 149 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 208
Query: 533 SKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSL-DALLFDPLKKERLDWRKRFNIIEGIS 591
            KL H  ++++     + E+  ++ E M    L D ++ +   KE       + ++  + 
Sbjct: 209 KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 267
Query: 592 RGLLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVVG 648
               YLH +    IIHRDLK  N+LL   +E+   KI+DFG +KI G   + +    + G
Sbjct: 268 ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRTLCG 317
Query: 649 TFGYMSPEYAME---GRFSEKSDVFSFGVLLLEIVSG 682
           T  Y++PE  +      ++   D +S GV+L   +SG
Sbjct: 318 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 354

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 21/204 (10%)
Query: 490 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN-EVMVISKLQHRNLVRLLGCC 547
           +G G FG VY  +L D G+ +A+K++ +      + F N E+ ++ KL H N+VRL    
Sbjct: 41  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 95
Query: 548 VEGEEKM------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
               EK       L+ +Y+P             K+ L        +  + R L Y+H   
Sbjct: 96  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 153
Query: 602 RLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
              I HRD+K  N+LLD +    K+ DFG AK     +        + +  Y +PE    
Sbjct: 154 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---YICSRYYRAPELIFG 209
Query: 661 GR-FSEKSDVFSFGVLLLEIVSGR 683
              ++   DV+S G +L E++ G+
Sbjct: 210 ATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 87/169 (51%), Gaps = 20/169 (11%)
Query: 523 EEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDW 580
           E  + EV ++ K+  H N+++L           L+++ M        LFD L +K  L  
Sbjct: 68  EATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKK----GELFDYLTEKVTLSE 123
Query: 581 RKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ 640
           ++   I+  +   +  LH+   L I+HRDLK  NILLD+++N K++DFG    F    D 
Sbjct: 124 KETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFG----FSCQLDP 176
Query: 641 ADTGR-VVGTFGYMSPEY---AMEGR---FSEKSDVFSFGVLLLEIVSG 682
            +  R V GT  Y++PE    +M      + ++ D++S GV++  +++G
Sbjct: 177 GEKLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 490 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN-EVMVISKLQHRNLVRLLGCC 547
           +G G FG VY  +L D G+ +A+K++ +      + F N E+ ++ KL H N+VRL    
Sbjct: 107 IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 161
Query: 548 VEGEEKM------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
               EK       L+ +Y+P             K+ L        +  + R L Y+H   
Sbjct: 162 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 219
Query: 602 RLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
              I HRD+K  N+LLD +    K+ DFG AK     + + +   +   + Y +PE    
Sbjct: 220 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRY-YRAPELIFG 275
Query: 661 GR-FSEKSDVFSFGVLLLEIVSGR 683
              ++   DV+S G +L E++ G+
Sbjct: 276 ATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 21/204 (10%)
Query: 490 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN-EVMVISKLQHRNLVRLLGCC 547
           +G G FG VY  +L D G+ +A+K++ +      + F N E+ ++ KL H N+VRL    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 548 VEGEEKM------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
               EK       L+ +Y+P             K+ L        +  + R L Y+H   
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 140
Query: 602 RLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
              I HRD+K  N+LLD +    K+ DFG AK     +        + +  Y +PE    
Sbjct: 141 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---YICSRYYRAPELIFG 196
Query: 661 GR-FSEKSDVFSFGVLLLEIVSGR 683
              ++   DV+S G +L E++ G+
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 490 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN-EVMVISKLQHRNLVRLLGCC 547
           +G G FG VY  +L D G+ +A+K++ +      + F N E+ ++ KL H N+VRL    
Sbjct: 32  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 86
Query: 548 VEGEEKM------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
               EK       L+ +Y+P             K+ L        +  + R L Y+H   
Sbjct: 87  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-- 144
Query: 602 RLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
              I HRD+K  N+LLD +    K+ DFG AK     + + +   +   + Y +PE    
Sbjct: 145 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSXICSRY-YRAPELIFG 200
Query: 661 GR-FSEKSDVFSFGVLLLEIVSGR 683
              ++   DV+S G +L E++ G+
Sbjct: 201 ATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 87/169 (51%), Gaps = 20/169 (11%)
Query: 523 EEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDW 580
           E  + EV ++ K+  H N+++L           L+++ M        LFD L +K  L  
Sbjct: 68  EATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKK----GELFDYLTEKVTLSE 123
Query: 581 RKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ 640
           ++   I+  +   +  LH+   L I+HRDLK  NILLD+++N K++DFG    F    D 
Sbjct: 124 KETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFG----FSCQLDP 176
Query: 641 ADTGR-VVGTFGYMSPEY---AMEGR---FSEKSDVFSFGVLLLEIVSG 682
            +  R V GT  Y++PE    +M      + ++ D++S GV++  +++G
Sbjct: 177 GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 104/217 (47%), Gaps = 27/217 (12%)
Query: 482 NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSK-----ASGQGLEEFMN---EVMVI 532
           + + +S  LG G  G V      K  +++A++ +SK      S +  +  +N   E+ ++
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 533 SKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSL-DALLFDPLKKERLDWRKRFNIIEGIS 591
            KL H  ++++     + E+  ++ E M    L D ++ +   KE       + ++  + 
Sbjct: 195 KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 253
Query: 592 RGLLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVVG 648
               YLH +    IIHRDLK  N+LL   +E+   KI+DFG +KI G   + +    + G
Sbjct: 254 ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRTLCG 303
Query: 649 TFGYMSPEYAME---GRFSEKSDVFSFGVLLLEIVSG 682
           T  Y++PE  +      ++   D +S GV+L   +SG
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 102/223 (45%), Gaps = 39/223 (17%)
Query: 484 FQLSSKLGQGGFGPVYWGRLKDGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRN-- 539
           + +  ++G GG   V+    +  Q  A+K   L +A  Q L+ + NE+  ++KLQ  +  
Sbjct: 10  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 69
Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDW-RKRF--NIIEGISRGLLY 596
           ++RL    +  +    IY  M   ++D   +   KK    W RK +  N++E +      
Sbjct: 70  IIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV------ 120
Query: 597 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV-----VGTFG 651
            H   +  I+H DLK +N L+ + +  K+ DFG+A     NQ Q DT  V     VGT  
Sbjct: 121 -HTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDTTSVVKDSQVGTVN 173
Query: 652 YMSPEYAMEGRFSEKS-----------DVFSFGVLLLEIVSGR 683
           YM PE   +   S ++           DV+S G +L  +  G+
Sbjct: 174 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 216

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 97/223 (43%), Gaps = 29/223 (13%)
Query: 478 ATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGL---EEFMNEVMVISK 534
            T      L   +G+G FG V+ G+ + G+E+AVK  S    +      E    VM    
Sbjct: 2   GTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM---- 56
Query: 535 LQHRNLVRLLGCCVEGE----EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGI 590
           L+H N++  +    +      +  L+ +Y  + SL    FD L +  +       +    
Sbjct: 57  LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALST 112
Query: 591 SRGLLYLHRD-----SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG- 644
           + GL +LH +      +  I HRDLK+ NIL+ +     I+D G+A       D  D   
Sbjct: 113 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 172
Query: 645 -RVVGTFGYMSPEYAMEG----RFS--EKSDVFSFGVLLLEIV 680
              VGT  YM+PE   +      F   +++D+++ G++  EI 
Sbjct: 173 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 215

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 102/223 (45%), Gaps = 39/223 (17%)
Query: 484 FQLSSKLGQGGFGPVYWGRLKDGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRN-- 539
           + +  ++G GG   V+    +  Q  A+K   L +A  Q L+ + NE+  ++KLQ  +  
Sbjct: 11  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 70
Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDW-RKRF--NIIEGISRGLLY 596
           ++RL    +  +    IY  M   ++D   +   KK    W RK +  N++E +      
Sbjct: 71  IIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV------ 121
Query: 597 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV-----VGTFG 651
            H   +  I+H DLK +N L+ + +  K+ DFG+A     NQ Q DT  V     VGT  
Sbjct: 122 -HTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDTTSVVKDSQVGTVN 174
Query: 652 YMSPEYAMEGRFSEKS-----------DVFSFGVLLLEIVSGR 683
           YM PE   +   S ++           DV+S G +L  +  G+
Sbjct: 175 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 97/222 (43%), Gaps = 29/222 (13%)
Query: 479 TATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGL---EEFMNEVMVISKL 535
           T      L   +G+G FG V+ G+ + G+E+AVK  S    +      E    VM    L
Sbjct: 39  TIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM----L 93
Query: 536 QHRNLVRLLGCCVEGE----EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGIS 591
           +H N++  +    +      +  L+ +Y  + SL    FD L +  +       +    +
Sbjct: 94  RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTA 149
Query: 592 RGLLYLHRD-----SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG-- 644
            GL +LH +      +  I HRDLK+ NIL+ +     I+D G+A       D  D    
Sbjct: 150 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN 209
Query: 645 RVVGTFGYMSPEYAMEG----RFS--EKSDVFSFGVLLLEIV 680
             VGT  YM+PE   +      F   +++D+++ G++  EI 
Sbjct: 210 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 97/222 (43%), Gaps = 29/222 (13%)
Query: 479 TATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGL---EEFMNEVMVISKL 535
           T      L   +G+G FG V+ G+ + G+E+AVK  S    +      E    VM    L
Sbjct: 26  TIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM----L 80
Query: 536 QHRNLVRLLGCCVEGE----EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGIS 591
           +H N++  +    +      +  L+ +Y  + SL    FD L +  +       +    +
Sbjct: 81  RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTA 136
Query: 592 RGLLYLHRD-----SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG-- 644
            GL +LH +      +  I HRDLK+ NIL+ +     I+D G+A       D  D    
Sbjct: 137 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN 196
Query: 645 RVVGTFGYMSPEYAMEG----RFS--EKSDVFSFGVLLLEIV 680
             VGT  YM+PE   +      F   +++D+++ G++  EI 
Sbjct: 197 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 238

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 102/223 (45%), Gaps = 39/223 (17%)
Query: 484 FQLSSKLGQGGFGPVYWGRLKDGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRN-- 539
           + +  ++G GG   V+    +  Q  A+K   L +A  Q L+ + NE+  ++KLQ  +  
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDW-RKRF--NIIEGISRGLLY 596
           ++RL    +  +    IY  M   ++D   +   KK    W RK +  N++E +      
Sbjct: 118 IIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV------ 168
Query: 597 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV-----VGTFG 651
            H   +  I+H DLK +N L+ + +  K+ DFG+A     NQ Q DT  V     VGT  
Sbjct: 169 -HTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDTTSVVKDSQVGTVN 221
Query: 652 YMSPEYAMEGRFSEKS-----------DVFSFGVLLLEIVSGR 683
           YM PE   +   S ++           DV+S G +L  +  G+
Sbjct: 222 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 109/234 (46%), Gaps = 41/234 (17%)
Query: 474 FEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVK--RLSKASGQGLEEFMNEVMV 531
           F+ ++     + +  ++G GG   V+    +  Q  A+K   L +A  Q L+ + NE+  
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 79
Query: 532 ISKLQHRN--LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD-W-RKRF--N 585
           ++KLQ  +  ++RL    +  +   ++ E   N  L++ L    KK+ +D W RK +  N
Sbjct: 80  LNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWL---KKKKSIDPWERKSYWKN 135
Query: 586 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 645
           ++E +       H   +  I+H DLK +N L+ + +  K+ DFG+A     NQ Q D   
Sbjct: 136 MLEAV-------HTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDXXX 182
Query: 646 V-----VGTFGYMSPEYAMEGRFSEKS-----------DVFSFGVLLLEIVSGR 683
           V     VGT  YM PE   +   S ++           DV+S G +L  +  G+
Sbjct: 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 103/213 (48%), Gaps = 19/213 (8%)
Query: 479 TATNNFQLSSKLGQGGFGPV---YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVIS 533
           T    +Q    +G G  G V   Y   L+  + +A+K+LS+   +    +    E++++ 
Sbjct: 15  TVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMK 72
Query: 534 KLQHRNLVRLLGCCVEG---EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGI 590
            + H+N++ LL         EE   +Y  M    +DA L   ++ E LD  +   ++  +
Sbjct: 73  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVM--ELMDANLCQVIQME-LDHERMSYLLYQM 129
Query: 591 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF 650
             G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +     T  VV  +
Sbjct: 130 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY 184
Query: 651 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
            Y +PE  +   + E  D++S G ++ E+V  +
Sbjct: 185 -YRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 490 LGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HRNLVRLLGCC 547
           LG+G    V     L   QE AVK + K  G        EV ++ + Q HRN++ L+   
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 548 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 607
            E +   L++E M   S+ + +    K+   +  +   +++ ++  L +LH      I H
Sbjct: 81  EEEDRFYLVFEKMRGGSILSHIH---KRRHFNELEASVVVQDVASALDFLHNKG---IAH 134
Query: 608 RDLKASNILLDE--ELNP-KISDFGMAKIFGGNQDQADTG-----RVVGTFGYMSPE--- 656
           RDLK  NIL +   +++P KI DFG+      N D +           G+  YM+PE   
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVE 194
Query: 657 -YAMEGR-FSEKSDVFSFGVLLLEIVSG 682
            ++ E   + ++ D++S GV+L  ++SG
Sbjct: 195 AFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 103/213 (48%), Gaps = 19/213 (8%)
Query: 479 TATNNFQLSSKLGQGGFGPV---YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVIS 533
           T    +Q    +G G  G V   Y   L+  + +A+K+LS+   +    +    E++++ 
Sbjct: 26  TVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMK 83
Query: 534 KLQHRNLVRLLGCCVEG---EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGI 590
            + H+N++ LL         EE   +Y  M    +DA L   ++ E LD  +   ++  +
Sbjct: 84  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVM--ELMDANLCQVIQME-LDHERMSYLLYQM 140
Query: 591 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF 650
             G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +     T  VV  +
Sbjct: 141 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY 195
Query: 651 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
            Y +PE  +   + E  D++S G ++ E+V  +
Sbjct: 196 -YRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 101/213 (47%), Gaps = 19/213 (8%)
Query: 479 TATNNFQLSSKLGQGGFGPV---YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVIS 533
           T    +Q    +G G  G V   Y   L+  + +A+K+LS+   +    +    E++++ 
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 534 KLQHRNLVRLLGCCVEG---EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGI 590
            + H+N++ LL         EE   +Y  M    +DA L   ++ E LD  +   ++  +
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVM--ELMDANLCQVIQME-LDHERMSYLLYQM 135
Query: 591 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF 650
             G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +         V T 
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPE---VVTR 189
Query: 651 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
            Y +PE  +   + E  D++S G ++ E+V  +
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 29/215 (13%)
Query: 486 LSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGL---EEFMNEVMVISKLQHRNLVR 542
           L   +G+G FG V+ G+ + G+E+AVK  S    +      E    VM    L+H N++ 
Sbjct: 7   LQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM----LRHENILG 61
Query: 543 LLGCCVEGE----EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
            +    +      +  L+ +Y  + SL    FD L +  +       +    + GL +LH
Sbjct: 62  FIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLH 117
Query: 599 RD-----SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG--RVVGTFG 651
            +      +  I HRDLK+ NIL+ +     I+D G+A       D  D      VGT  
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177
Query: 652 YMSPEYAMEG----RFS--EKSDVFSFGVLLLEIV 680
           YM+PE   +      F   +++D+++ G++  EI 
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 212

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 102/223 (45%), Gaps = 39/223 (17%)
Query: 484 FQLSSKLGQGGFGPVYWGRLKDGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRN-- 539
           + +  ++G GG   V+    +  Q  A+K   L +A  Q L+ + NE+  ++KLQ  +  
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDW-RKRF--NIIEGISRGLLY 596
           ++RL    +  +    IY  M   ++D   +   KK    W RK +  N++E +      
Sbjct: 118 IIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV------ 168
Query: 597 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV-----VGTFG 651
            H   +  I+H DLK +N L+ + +  K+ DFG+A     NQ Q DT  V     VGT  
Sbjct: 169 -HTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDTTSVVKDSQVGTVN 221
Query: 652 YMSPEYAMEGRFSEKS-----------DVFSFGVLLLEIVSGR 683
           YM PE   +   S ++           DV+S G +L  +  G+
Sbjct: 222 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/165 (23%), Positives = 86/165 (52%), Gaps = 13/165 (7%)
Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDG-QEIAVKRLSKASGQGLE--EFMNEVMVISKLQHR 538
           +N+++   +G+G +G VY    K+  + +A+K++++     ++    + E+ ++++L+  
Sbjct: 28  DNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 87
Query: 539 NLVRLLGCCVEGE----EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 594
            ++RL    +  +    +++ I   + +  L  L   P+    L  +    I+  +  G 
Sbjct: 88  YIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPI---FLTEQHVKTILYNLLLGE 144
Query: 595 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 639
            ++H      IIHRDLK +N LL+++ + KI DFG+A+    ++D
Sbjct: 145 KFIHESG---IIHRDLKPANCLLNQDCSVKICDFGLARTINSDKD 186

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 102/234 (43%), Gaps = 40/234 (17%)
Query: 486 LSSKLGQGGFGPVYWGRLKD----GQ----EIAVKRLSKASGQGLEEFMNEVMVISKLQH 537
            +  LGQG F  ++ G  ++    GQ    E+ +K L KA     E F     ++SKL H
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 597
           ++LV   G C  G+E +L+ E++   SLD  L        + W  +  + + ++  + +L
Sbjct: 72  KHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAWAMHFL 129
Query: 598 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF------- 650
             ++   +IH ++ A NILL  E + K  +    K+       +D G  +          
Sbjct: 130 EENT---LIHGNVCAKNILLIREEDRKTGNPPFIKL-------SDPGISITVLPKDILQE 179
Query: 651 --GYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSG----------RKNTSFFED 691
              ++ PE     +  +  +D +SFG  L EI SG          ++   F+ED
Sbjct: 180 RIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED 233

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 88/338 (26%), Positives = 139/338 (41%), Gaps = 60/338 (17%)
Query: 449 KAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWG-RLKDGQ 507
           K   +A L A   N   L    L   +E     + +Q+   LG GGFG VY G R+ D  
Sbjct: 6   KINSLAHLRAAPCN--DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL 63
Query: 508 EIAVKRLSKASGQGLEEFMN------EVMVISKLQH--RNLVRLLGCCVEGEEKMLIYEY 559
            +A+K + K       E  N      EV+++ K+      ++RLL      +  +LI E 
Sbjct: 64  PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE- 122
Query: 560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY-----LHRDSRLRIIHRDLKASN 614
            P    D  LFD +        +R  + E ++R   +     +       ++HRD+K  N
Sbjct: 123 RPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDEN 173
Query: 615 ILLDEELNP---KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKS-DVF 670
           IL+D  LN    K+ DFG   +    +D   T    GT  Y  PE+    R+  +S  V+
Sbjct: 174 ILID--LNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWIRYHRYHGRSAAVW 227
Query: 671 SFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCI 730
           S G+LL ++V G      FE D  I+G                    +  F+  +   C 
Sbjct: 228 SLGILLYDMVCGDIP---FEHDEEIIG-------------------GQVFFRQRVSXECQ 265
Query: 731 HVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPA 768
           H+   C+     DRP    + +  +  ++D+  P+E A
Sbjct: 266 HLIRWCLALRPSDRPTFEEIQN--HPWMQDVLLPQETA 301

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 97/212 (45%), Gaps = 21/212 (9%)
Query: 484 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVK-----RLSKASGQGLEEFMNEVMVISKLQH 537
           ++L   +G+G F  V     ++ GQ+ AVK     + + + G   E+   E  +   L+H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL-- 595
            ++V LL          +++E+M    L    F+ +K+    +     +     R +L  
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 596 --YLHRDSRLRIIHRDLKASNILLDEELNP---KISDFGMAKIFGGNQDQADTGRVVGTF 650
             Y H ++   IIHRD+K   +LL  + N    K+  FG+A I  G       GRV GT 
Sbjct: 143 LRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVA-IQLGESGLVAGGRV-GTP 197
Query: 651 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
            +M+PE      + +  DV+  GV+L  ++SG
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 88/338 (26%), Positives = 139/338 (41%), Gaps = 60/338 (17%)
Query: 449 KAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWG-RLKDGQ 507
           K   +A L A   N   L    L   +E     + +Q+   LG GGFG VY G R+ D  
Sbjct: 5   KINSLAHLRAAPCN--DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL 62
Query: 508 EIAVKRLSKASGQGLEEFMN------EVMVISKLQH--RNLVRLLGCCVEGEEKMLIYEY 559
            +A+K + K       E  N      EV+++ K+      ++RLL      +  +LI E 
Sbjct: 63  PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE- 121
Query: 560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY-----LHRDSRLRIIHRDLKASN 614
            P    D  LFD +        +R  + E ++R   +     +       ++HRD+K  N
Sbjct: 122 RPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDEN 172
Query: 615 ILLDEELNP---KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKS-DVF 670
           IL+D  LN    K+ DFG   +    +D   T    GT  Y  PE+    R+  +S  V+
Sbjct: 173 ILID--LNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWIRYHRYHGRSAAVW 226
Query: 671 SFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCI 730
           S G+LL ++V G      FE D  I+G                    +  F+  +   C 
Sbjct: 227 SLGILLYDMVCGDIP---FEHDEEIIG-------------------GQVFFRQRVSXECQ 264
Query: 731 HVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPA 768
           H+   C+     DRP    + +  +  ++D+  P+E A
Sbjct: 265 HLIRWCLALRPSDRPTFEEIQN--HPWMQDVLLPQETA 300

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 88/338 (26%), Positives = 139/338 (41%), Gaps = 60/338 (17%)
Query: 449 KAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWG-RLKDGQ 507
           K   +A L A   N   L    L   +E     + +Q+   LG GGFG VY G R+ D  
Sbjct: 6   KINSLAHLRAAPCN--DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL 63
Query: 508 EIAVKRLSKASGQGLEEFMN------EVMVISKLQH--RNLVRLLGCCVEGEEKMLIYEY 559
            +A+K + K       E  N      EV+++ K+      ++RLL      +  +LI E 
Sbjct: 64  PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE- 122
Query: 560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY-----LHRDSRLRIIHRDLKASN 614
            P    D  LFD +        +R  + E ++R   +     +       ++HRD+K  N
Sbjct: 123 RPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDEN 173
Query: 615 ILLDEELNP---KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKS-DVF 670
           IL+D  LN    K+ DFG   +    +D   T    GT  Y  PE+    R+  +S  V+
Sbjct: 174 ILID--LNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWIRYHRYHGRSAAVW 227
Query: 671 SFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCI 730
           S G+LL ++V G      FE D  I+G                    +  F+  +   C 
Sbjct: 228 SLGILLYDMVCGDIP---FEHDEEIIG-------------------GQVFFRQRVSXECQ 265
Query: 731 HVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPA 768
           H+   C+     DRP    + +  +  ++D+  P+E A
Sbjct: 266 HLIRWCLALRPSDRPTFEEIQN--HPWMQDVLLPQETA 301

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 97/212 (45%), Gaps = 21/212 (9%)
Query: 484 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVK-----RLSKASGQGLEEFMNEVMVISKLQH 537
           ++L   +G+G F  V     ++ GQ+ AVK     + + + G   E+   E  +   L+H
Sbjct: 28  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 87
Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL-- 595
            ++V LL          +++E+M    L    F+ +K+    +     +     R +L  
Sbjct: 88  PHIVELLETYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQILEA 144
Query: 596 --YLHRDSRLRIIHRDLKASNILLDEELNP---KISDFGMAKIFGGNQDQADTGRVVGTF 650
             Y H ++   IIHRD+K   +LL  + N    K+  FG+A I  G       GRV GT 
Sbjct: 145 LRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVA-IQLGESGLVAGGRV-GTP 199
Query: 651 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
            +M+PE      + +  DV+  GV+L  ++SG
Sbjct: 200 HFMAPEVVKREPYGKPVDVWGCGVILFILLSG 231

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 39/212 (18%)
Query: 490 LGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCV 548
           LG G  G + +  + D +++AVKR+        +    EV ++ +  +H N++R    C 
Sbjct: 32  LGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD---REVQLLRESDEHPNVIRYF--CT 86
Query: 549 EGEEKM----------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           E + +            + EY+  +    L  +P+            +++  + GL +LH
Sbjct: 87  EKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPI-----------TLLQQTTSGLAHLH 135
Query: 599 RDSRLRIIHRDLKASNILLDE-----ELNPKISDFGMAKIFG-GNQDQADTGRVVGTFGY 652
               L I+HRDLK  NIL+       ++   ISDFG+ K    G    +    V GT G+
Sbjct: 136 S---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
Query: 653 MSPEYAMEGRFSEKS---DVFSFGVLLLEIVS 681
           ++PE   E      +   D+FS G +   ++S
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 101/213 (47%), Gaps = 19/213 (8%)
Query: 479 TATNNFQLSSKLGQGGFGPV---YWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVIS 533
           T    +Q    +G G  G V   Y   L+  + +A+K+LS+   +    +    E++++ 
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 534 KLQHRNLVRLLGCCVEG---EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGI 590
            + H+N++ LL         EE   +Y  M    +DA L   ++ E LD  +   ++  +
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVM--ELMDANLCQVIQME-LDHERMSYLLYQM 135
Query: 591 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF 650
             G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +         V T 
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPE---VVTR 189
Query: 651 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
            Y +PE  +   + E  D++S G ++ E+V  +
Sbjct: 190 YYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 116/267 (43%), Gaps = 39/267 (14%)
Query: 449 KAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWG-RLKDGQ 507
           K   +A L A   N   L    L   +E     + +Q+   LG GGFG VY G R+ D  
Sbjct: 6   KINSLAHLRAAPCN--DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL 63
Query: 508 EIAVKRLSKASGQGLEEFMN------EVMVISKLQH--RNLVRLLGCCVEGEEKMLIYEY 559
            +A+K + K       E  N      EV+++ K+      ++RLL      +  +LI E 
Sbjct: 64  PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE- 122
Query: 560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY-----LHRDSRLRIIHRDLKASN 614
            P    D  LFD +        +R  + E ++R   +     +       ++HRD+K  N
Sbjct: 123 RPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDEN 173
Query: 615 ILLDEELNP---KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKS-DVF 670
           IL+D  LN    K+ DFG   +    +D   T    GT  Y  PE+    R+  +S  V+
Sbjct: 174 ILID--LNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWIRYHRYHGRSAAVW 227
Query: 671 SFGVLLLEIVSGRKNTSFFEDDLTILG 697
           S G+LL ++V G      FE D  I+G
Sbjct: 228 SLGILLYDMVCGDIP---FEHDEEIIG 251

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 87/338 (25%), Positives = 139/338 (41%), Gaps = 60/338 (17%)
Query: 449 KAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWG-RLKDGQ 507
           K   +A L A   N   L    L   +E     + +Q+   LG GGFG VY G R+ D  
Sbjct: 25  KINSLAHLRAAPCN--DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL 82
Query: 508 EIAVKRLSKASGQGLEEFMN------EVMVISKLQH--RNLVRLLGCCVEGEEKMLIYEY 559
            +A+K + K       E  N      EV+++ K+      ++RLL      +  +LI E 
Sbjct: 83  PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE- 141
Query: 560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY-----LHRDSRLRIIHRDLKASN 614
            P    D  LFD +        +R  + E ++R   +     +       ++HRD+K  N
Sbjct: 142 RPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDEN 192
Query: 615 ILLDEELNP---KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKS-DVF 670
           IL+D  LN    K+ DFG   +    +D   T    GT  Y  PE+    R+  +S  V+
Sbjct: 193 ILID--LNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWIRYHRYHGRSAAVW 246
Query: 671 SFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCI 730
           S G+LL ++V G  +  F  D+  I G  +                    F+  +   C 
Sbjct: 247 SLGILLYDMVCG--DIPFEHDEEIIRGQVF--------------------FRQRVSXECQ 284
Query: 731 HVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPA 768
           H+   C+     DRP    + +  +  ++D+  P+E A
Sbjct: 285 HLIRWCLALRPSDRPTFEEIQN--HPWMQDVLLPQETA 320

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 116/267 (43%), Gaps = 39/267 (14%)
Query: 449 KAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWG-RLKDGQ 507
           K   +A L A   N   L    L   +E     + +Q+   LG GGFG VY G R+ D  
Sbjct: 6   KINSLAHLRAAPCN--DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL 63
Query: 508 EIAVKRLSKASGQGLEEFMN------EVMVISKLQH--RNLVRLLGCCVEGEEKMLIYEY 559
            +A+K + K       E  N      EV+++ K+      ++RLL      +  +LI E 
Sbjct: 64  PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE- 122
Query: 560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY-----LHRDSRLRIIHRDLKASN 614
            P    D  LFD +        +R  + E ++R   +     +       ++HRD+K  N
Sbjct: 123 RPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDEN 173
Query: 615 ILLDEELNP---KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKS-DVF 670
           IL+D  LN    K+ DFG   +    +D   T    GT  Y  PE+    R+  +S  V+
Sbjct: 174 ILID--LNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWIRYHRYHGRSAAVW 227
Query: 671 SFGVLLLEIVSGRKNTSFFEDDLTILG 697
           S G+LL ++V G      FE D  I+G
Sbjct: 228 SLGILLYDMVCGDIP---FEHDEEIIG 251

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 116/267 (43%), Gaps = 39/267 (14%)
Query: 449 KAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWG-RLKDGQ 507
           K   +A L A   N   L    L   +E     + +Q+   LG GGFG VY G R+ D  
Sbjct: 5   KINSLAHLRAAPCN--DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL 62
Query: 508 EIAVKRLSKASGQGLEEFMN------EVMVISKLQH--RNLVRLLGCCVEGEEKMLIYEY 559
            +A+K + K       E  N      EV+++ K+      ++RLL      +  +LI E 
Sbjct: 63  PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE- 121
Query: 560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY-----LHRDSRLRIIHRDLKASN 614
            P    D  LFD +        +R  + E ++R   +     +       ++HRD+K  N
Sbjct: 122 RPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDEN 172
Query: 615 ILLDEELNP---KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKS-DVF 670
           IL+D  LN    K+ DFG   +    +D   T    GT  Y  PE+    R+  +S  V+
Sbjct: 173 ILID--LNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWIRYHRYHGRSAAVW 226
Query: 671 SFGVLLLEIVSGRKNTSFFEDDLTILG 697
           S G+LL ++V G      FE D  I+G
Sbjct: 227 SLGILLYDMVCGDIP---FEHDEEIIG 250

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 116/267 (43%), Gaps = 39/267 (14%)
Query: 449 KAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWG-RLKDGQ 507
           K   +A L A   N   L    L   +E     + +Q+   LG GGFG VY G R+ D  
Sbjct: 5   KINSLAHLRAAPCN--DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL 62
Query: 508 EIAVKRLSKASGQGLEEFMN------EVMVISKLQH--RNLVRLLGCCVEGEEKMLIYEY 559
            +A+K + K       E  N      EV+++ K+      ++RLL      +  +LI E 
Sbjct: 63  PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE- 121
Query: 560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY-----LHRDSRLRIIHRDLKASN 614
            P    D  LFD +        +R  + E ++R   +     +       ++HRD+K  N
Sbjct: 122 RPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDEN 172
Query: 615 ILLDEELNP---KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKS-DVF 670
           IL+D  LN    K+ DFG   +    +D   T    GT  Y  PE+    R+  +S  V+
Sbjct: 173 ILID--LNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWIRYHRYHGRSAAVW 226
Query: 671 SFGVLLLEIVSGRKNTSFFEDDLTILG 697
           S G+LL ++V G      FE D  I+G
Sbjct: 227 SLGILLYDMVCGDIP---FEHDEEIIG 250

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 87/338 (25%), Positives = 139/338 (41%), Gaps = 60/338 (17%)
Query: 449 KAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWG-RLKDGQ 507
           K   +A L A   N   L    L   +E     + +Q+   LG GGFG VY G R+ D  
Sbjct: 20  KINSLAHLRAAPCN--DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL 77
Query: 508 EIAVKRLSKASGQGLEEFMN------EVMVISKLQH--RNLVRLLGCCVEGEEKMLIYEY 559
            +A+K + K       E  N      EV+++ K+      ++RLL      +  +LI E 
Sbjct: 78  PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE- 136
Query: 560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY-----LHRDSRLRIIHRDLKASN 614
            P    D  LFD +        +R  + E ++R   +     +       ++HRD+K  N
Sbjct: 137 RPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDEN 187
Query: 615 ILLDEELNP---KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKS-DVF 670
           IL+D  LN    K+ DFG   +    +D   T    GT  Y  PE+    R+  +S  V+
Sbjct: 188 ILID--LNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWIRYHRYHGRSAAVW 241
Query: 671 SFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCI 730
           S G+LL ++V G  +  F  D+  I G  +                    F+  +   C 
Sbjct: 242 SLGILLYDMVCG--DIPFEHDEEIIRGQVF--------------------FRQRVSXECQ 279
Query: 731 HVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPA 768
           H+   C+     DRP    + +  +  ++D+  P+E A
Sbjct: 280 HLIRWCLALRPSDRPTFEEIQN--HPWMQDVLLPQETA 315

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 95/218 (43%), Gaps = 20/218 (9%)
Query: 476 ELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQG-----------LEE 524
           EL    + + +   +  G +G V  G   +G  +A+KR+      G            + 
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 525 FMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF 584
            + E+ +++   H N++ L    V  EE  +   Y+    +   L   +  +R+    + 
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQ- 134
Query: 585 NIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG 644
           +I   +   LL LH      ++HRDL   NILL +  +  I DF +A+     +D AD  
Sbjct: 135 HIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR-----EDTADAN 189
Query: 645 RV--VGTFGYMSPEYAMEGR-FSEKSDVFSFGVLLLEI 679
           +   V    Y +PE  M+ + F++  D++S G ++ E+
Sbjct: 190 KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEM 227

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 95/218 (43%), Gaps = 20/218 (9%)
Query: 476 ELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQG-----------LEE 524
           EL    + + +   +  G +G V  G   +G  +A+KR+      G            + 
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 525 FMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF 584
            + E+ +++   H N++ L    V  EE  +   Y+    +   L   +  +R+    + 
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQ- 134
Query: 585 NIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG 644
           +I   +   LL LH      ++HRDL   NILL +  +  I DF +A+     +D AD  
Sbjct: 135 HIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR-----EDTADAN 189
Query: 645 RV--VGTFGYMSPEYAMEGR-FSEKSDVFSFGVLLLEI 679
           +   V    Y +PE  M+ + F++  D++S G ++ E+
Sbjct: 190 KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEM 227

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 87/338 (25%), Positives = 139/338 (41%), Gaps = 60/338 (17%)
Query: 449 KAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWG-RLKDGQ 507
           K   +A L A   N   L    L   +E     + +Q+   LG GGFG VY G R+ D  
Sbjct: 5   KINSLAHLRAAPCN--DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL 62
Query: 508 EIAVKRLSKASGQGLEEFMN------EVMVISKLQH--RNLVRLLGCCVEGEEKMLIYEY 559
            +A+K + K       E  N      EV+++ K+      ++RLL      +  +LI E 
Sbjct: 63  PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE- 121
Query: 560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY-----LHRDSRLRIIHRDLKASN 614
            P    D  LFD +        +R  + E ++R   +     +       ++HRD+K  N
Sbjct: 122 RPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDEN 172
Query: 615 ILLDEELNP---KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKS-DVF 670
           IL+D  LN    K+ DFG   +    +D   T    GT  Y  PE+    R+  +S  V+
Sbjct: 173 ILID--LNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWIRYHRYHGRSAAVW 226
Query: 671 SFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCI 730
           S G+LL ++V G  +  F  D+  I G  +                    F+  +   C 
Sbjct: 227 SLGILLYDMVCG--DIPFEHDEEIIRGQVF--------------------FRQRVSSECQ 264
Query: 731 HVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPA 768
           H+   C+     DRP    + +  +  ++D+  P+E A
Sbjct: 265 HLIRWCLALRPSDRPTFEEIQN--HPWMQDVLLPQETA 300

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 87/338 (25%), Positives = 139/338 (41%), Gaps = 60/338 (17%)
Query: 449 KAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWG-RLKDGQ 507
           K   +A L A   N   L    L   +E     + +Q+   LG GGFG VY G R+ D  
Sbjct: 20  KINSLAHLRAAPCN--DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL 77
Query: 508 EIAVKRLSKASGQGLEEFMN------EVMVISKLQH--RNLVRLLGCCVEGEEKMLIYEY 559
            +A+K + K       E  N      EV+++ K+      ++RLL      +  +LI E 
Sbjct: 78  PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE- 136
Query: 560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY-----LHRDSRLRIIHRDLKASN 614
            P    D  LFD +        +R  + E ++R   +     +       ++HRD+K  N
Sbjct: 137 RPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDEN 187
Query: 615 ILLDEELNP---KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKS-DVF 670
           IL+D  LN    K+ DFG   +    +D   T    GT  Y  PE+    R+  +S  V+
Sbjct: 188 ILID--LNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWIRYHRYHGRSAAVW 241
Query: 671 SFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCI 730
           S G+LL ++V G  +  F  D+  I G  +                    F+  +   C 
Sbjct: 242 SLGILLYDMVCG--DIPFEHDEEIIRGQVF--------------------FRQRVSSECQ 279
Query: 731 HVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPA 768
           H+   C+     DRP    + +  +  ++D+  P+E A
Sbjct: 280 HLIRWCLALRPSDRPTFEEIQN--HPWMQDVLLPQETA 315

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 99/218 (45%), Gaps = 27/218 (12%)
Query: 489 KLGQGGFGPVYWGRLKDGQ---EIAVKRLSKASGQGLEEF-MNEVMVISKLQHRNLVRLL 544
           +LG+G FG V+  R+KD Q   + AVK++       LE F + E++  + L    +V L 
Sbjct: 79  RLGRGSFGEVH--RMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIVPLY 130
Query: 545 GCCVEGEEKMLIYEYMPNRSLDALL--FDPLKKERLDWRKRFNIIEGISRGLLYLHRDSR 602
           G   EG    +  E +   SL  L+     L ++R         +     GL YLH    
Sbjct: 131 GAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRA-----LYYLGQALEGLEYLHTR-- 183
Query: 603 LRIIHRDLKASNILLDEELN-PKISDFGMAKIF---GGNQDQADTGRVVGTFGYMSPEYA 658
            RI+H D+KA N+LL  + +   + DFG A      G  +       + GT  +M+PE  
Sbjct: 184 -RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 242
Query: 659 MEGRFSEKSDVFSFGVLLLEIVSGRKN-TSFFEDDLTI 695
           M      K D++S   ++L +++G    T +F   L +
Sbjct: 243 MGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL 280

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 108/234 (46%), Gaps = 23/234 (9%)
Query: 473 QFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEE---FMNE 528
           + +++     +F++   +G+G FG V   +LK+  ++ A+K L+K       E   F  E
Sbjct: 65  KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREE 124
Query: 529 VMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL--FDPLKKERLDWRKRFNI 586
             V+     + +  L     +     L+ +Y     L  LL  F+    E +    RF +
Sbjct: 125 RDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEM---ARFYL 181
Query: 587 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA-KIFGGNQDQADTGR 645
            E +    + +    +L  +HRD+K  NIL+D   + +++DFG   K+      Q+    
Sbjct: 182 AEMV----IAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA- 236
Query: 646 VVGTFGYMSPEY--AME---GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLT 694
            VGT  Y+SPE   AME   GR+  + D +S GV + E++ G   T F+ + L 
Sbjct: 237 -VGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE--TPFYAESLV 287

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 129/305 (42%), Gaps = 58/305 (19%)
Query: 482 NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGLEEFMN------EVMVISK 534
           + +Q+   LG GGFG VY G R+ D   +A+K + K       E  N      EV+++ K
Sbjct: 23  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 82
Query: 535 LQH--RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 592
           +      ++RLL      +  +LI E  P    D  LFD +        +R  + E ++R
Sbjct: 83  VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQD--LFDFIT-------ERGALQEELAR 132
Query: 593 GLLY-----LHRDSRLRIIHRDLKASNILLDEELNP---KISDFGMAKIFGGNQDQADTG 644
              +     +       ++HRD+K  NIL+D  LN    K+ DFG   +    +D   T 
Sbjct: 133 SFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSGALL---KDTVYTD 187
Query: 645 RVVGTFGYMSPEYAMEGRFSEKS-DVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLW 703
              GT  Y  PE+    R+  +S  V+S G+LL ++V G  +  F  D+  I G  +   
Sbjct: 188 -FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDEEIIRGQVF--- 241
Query: 704 NENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPY 763
                            F+  +   C H+   C+     DRP    + +  +  ++D+  
Sbjct: 242 -----------------FRQRVSXECQHLIRWCLALRPSDRPTFEEIQN--HPWMQDVLL 282
Query: 764 PKEPA 768
           P+E A
Sbjct: 283 PQETA 287

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 129/305 (42%), Gaps = 58/305 (19%)
Query: 482 NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGLEEFMN------EVMVISK 534
           + +Q+   LG GGFG VY G R+ D   +A+K + K       E  N      EV+++ K
Sbjct: 24  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 83
Query: 535 LQH--RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 592
           +      ++RLL      +  +LI E  P    D  LFD +        +R  + E ++R
Sbjct: 84  VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQD--LFDFIT-------ERGALQEELAR 133
Query: 593 GLLY-----LHRDSRLRIIHRDLKASNILLDEELNP---KISDFGMAKIFGGNQDQADTG 644
              +     +       ++HRD+K  NIL+D  LN    K+ DFG   +    +D   T 
Sbjct: 134 SFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSGALL---KDTVYTD 188
Query: 645 RVVGTFGYMSPEYAMEGRFSEKS-DVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLW 703
              GT  Y  PE+    R+  +S  V+S G+LL ++V G  +  F  D+  I G  +   
Sbjct: 189 -FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDEEIIRGQVF--- 242
Query: 704 NENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPY 763
                            F+  +   C H+   C+     DRP    + +  +  ++D+  
Sbjct: 243 -----------------FRQRVSXECQHLIRWCLALRPSDRPTFEEIQN--HPWMQDVLL 283
Query: 764 PKEPA 768
           P+E A
Sbjct: 284 PQETA 288

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 83/319 (26%), Positives = 134/319 (42%), Gaps = 61/319 (19%)
Query: 471 LFQ---FEELATATNNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGLEEFM 526
           LFQ    +E     + +Q+   LG GGFG VY G R+ D   +A+K + K       E  
Sbjct: 17  LFQGPHMKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELP 76
Query: 527 N------EVMVISKLQH--RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL 578
           N      EV+++ K+      ++RLL      +  +LI E  P    D  LFD +     
Sbjct: 77  NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQD--LFDFIT---- 129
Query: 579 DWRKRFNIIEGISRGLLY-----LHRDSRLRIIHRDLKASNILLDEELNP---KISDFGM 630
              +R  + E ++R   +     +       ++HRD+K  NIL+D  LN    K+ DFG 
Sbjct: 130 ---ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGS 184
Query: 631 AKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKS-DVFSFGVLLLEIVSGRKNTSFF 689
             +    +D   T    GT  Y  PE+    R+  +S  V+S G+LL ++V G  +  F 
Sbjct: 185 GALL---KDTVYTD-FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFE 238
Query: 690 EDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMST 749
            D+  I G  +                    F+  +   C H+   C+     DRP    
Sbjct: 239 HDEEIIRGQVF--------------------FRQRVSXECQHLIRWCLALRPSDRPTFEE 278
Query: 750 VVSMLNSEIRDLPYPKEPA 768
           + +  +  ++D+  P+E A
Sbjct: 279 IQN--HPWMQDVLLPQETA 295

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 79/302 (26%), Positives = 130/302 (43%), Gaps = 52/302 (17%)
Query: 482 NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGLEEFMN------EVMVISK 534
           + +Q+   LG GGFG VY G R+ D   +A+K + K       E  N      EV+++ K
Sbjct: 8   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 67
Query: 535 LQH--RNLVRLLGCCVEGEEKMLIYEYM-PNRSL-DALLFDPLKKERLDWRKRFNIIEGI 590
           +      ++RLL      +  +LI E M P + L D +      +E L     + ++E +
Sbjct: 68  VSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAV 127
Query: 591 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNP---KISDFGMAKIFGGNQDQADTGRVV 647
                + H      ++HRD+K  NIL+D  LN    K+ DFG   +    +D   T    
Sbjct: 128 R----HCH---NCGVLHRDIKDENILID--LNRGELKLIDFGSGALL---KDTVYTD-FD 174
Query: 648 GTFGYMSPEYAMEGRFSEKS-DVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNEN 706
           GT  Y  PE+    R+  +S  V+S G+LL ++V G  +  F  D+  I G  +      
Sbjct: 175 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDEEIIRGQVF------ 226
Query: 707 KILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKE 766
                         F+  +   C H+   C+     DRP    + +  +  ++D+  P+E
Sbjct: 227 --------------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN--HPWMQDVLLPQE 270
Query: 767 PA 768
            A
Sbjct: 271 TA 272

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 20/203 (9%)
Query: 490 LGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMN-EVMVISKLQHRNLVRLLGCCV 548
           +G G FG V+  +L +  E+A+K++ +      + F N E+ ++  ++H N+V L     
Sbjct: 48  IGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPNVVDLKAFFY 102
Query: 549 EGEEKM------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSR 602
              +K       L+ EY+P     A       K+ +        +  + R L Y+H    
Sbjct: 103 SNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---S 159
Query: 603 LRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 661
           + I HRD+K  N+LLD      K+ DFG AKI    +        + +  Y +PE     
Sbjct: 160 IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSX---ICSRYYRAPELIFGA 216
Query: 662 -RFSEKSDVFSFGVLLLEIVSGR 683
             ++   D++S G ++ E++ G+
Sbjct: 217 TNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 129/305 (42%), Gaps = 58/305 (19%)
Query: 482 NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGLEEFMN------EVMVISK 534
           + +Q+   LG GGFG VY G R+ D   +A+K + K       E  N      EV+++ K
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 535 LQH--RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 592
           +      ++RLL      +  +LI E  P    D  LFD +        +R  + E ++R
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQD--LFDFIT-------ERGALQEELAR 113
Query: 593 GLLY-----LHRDSRLRIIHRDLKASNILLDEELNP---KISDFGMAKIFGGNQDQADTG 644
              +     +       ++HRD+K  NIL+D  LN    K+ DFG   +    +D   T 
Sbjct: 114 SFFWQVLEAVRHCHNXGVLHRDIKDENILID--LNRGELKLIDFGSGALL---KDTVYTD 168
Query: 645 RVVGTFGYMSPEYAMEGRFSEKS-DVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLW 703
              GT  Y  PE+    R+  +S  V+S G+LL ++V G  +  F  D+  I G  +   
Sbjct: 169 -FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDEEIIRGQVF--- 222
Query: 704 NENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPY 763
                            F+  +   C H+   C+     DRP    + +  +  ++D+  
Sbjct: 223 -----------------FRQRVSXECQHLIRWCLALRPSDRPTFEEIQN--HPWMQDVLL 263
Query: 764 PKEPA 768
           P+E A
Sbjct: 264 PQETA 268

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 96/194 (49%), Gaps = 28/194 (14%)
Query: 506 GQEIAVKRLS----KASGQGLEEFMN----EVMVISKLQ-HRNLVRLLGCCVEGEEKMLI 556
           G E AVK +     + S + LEE       E  ++ ++  H +++ L+          L+
Sbjct: 119 GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV 178
Query: 557 YEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNI 615
           ++ M        LFD L +K  L  ++  +I+  +   + +LH ++   I+HRDLK  NI
Sbjct: 179 FDLMRK----GELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENI 231
Query: 616 LLDEELNPKISDFGMAKIFGGNQDQADTGR-VVGTFGYMSPEY------AMEGRFSEKSD 668
           LLD+ +  ++SDFG    F  + +  +  R + GT GY++PE            + ++ D
Sbjct: 232 LLDDNMQIRLSDFG----FSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVD 287
Query: 669 VFSFGVLLLEIVSG 682
           +++ GV+L  +++G
Sbjct: 288 LWACGVILFTLLAG 301

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 27/218 (12%)
Query: 489 KLGQGGFGPVYWGRLKDGQ---EIAVKRLSKASGQGLEEF-MNEVMVISKLQHRNLVRLL 544
           ++G+G FG V+  R+KD Q   + AVK++       LE F + E++  + L    +V L 
Sbjct: 65  RVGRGSFGEVH--RMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIVPLY 116
Query: 545 GCCVEGEEKMLIYEYMPNRSLDALL--FDPLKKERLDWRKRFNIIEGISRGLLYLHRDSR 602
           G   EG    +  E +   SL  L+     L ++R         +     GL YLH    
Sbjct: 117 GAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRA-----LYYLGQALEGLEYLHTR-- 169
Query: 603 LRIIHRDLKASNILLDEELN-PKISDFGMAKIF---GGNQDQADTGRVVGTFGYMSPEYA 658
            RI+H D+KA N+LL  + +   + DFG A      G  +       + GT  +M+PE  
Sbjct: 170 -RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 228
Query: 659 MEGRFSEKSDVFSFGVLLLEIVSGRKN-TSFFEDDLTI 695
           M      K D++S   ++L +++G    T +F   L +
Sbjct: 229 MGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL 266

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 101/223 (45%), Gaps = 39/223 (17%)
Query: 484 FQLSSKLGQGGFGPVYWGRLKDGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRN-- 539
           + +  ++G GG   V+    +  Q  A+K   L +A  Q L+ + NE+  ++KLQ  +  
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDW-RKRF--NIIEGISRGLLY 596
           ++RL    +  +    IY  M   ++D   +   KK    W RK +  N++E +      
Sbjct: 118 IIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV------ 168
Query: 597 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV-----VGTFG 651
            H   +  I+H DLK +N L+ + +  K+ DFG+A     NQ Q DT  V     VG   
Sbjct: 169 -HTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDTTSVVKDSQVGAVN 221
Query: 652 YMSPEYAMEGRFSEKS-----------DVFSFGVLLLEIVSGR 683
           YM PE   +   S ++           DV+S G +L  +  G+
Sbjct: 222 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 80/305 (26%), Positives = 129/305 (42%), Gaps = 58/305 (19%)
Query: 482 NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGLEEFMN------EVMVISK 534
           + +Q+   LG GGFG VY G R+ D   +A+K + K       E  N      EV+++ K
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 535 LQH--RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 592
           +      ++RLL      +  +LI E  P    D  LFD +        +R  + E ++R
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQD--LFDFIT-------ERGALQEELAR 113
Query: 593 GLLY-----LHRDSRLRIIHRDLKASNILLDEELNP---KISDFGMAKIFGGNQDQADTG 644
              +     +       ++HRD+K  NIL+D  LN    K+ DFG   +    +D   T 
Sbjct: 114 SFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSGALL---KDTVYTD 168
Query: 645 RVVGTFGYMSPEYAMEGRFSEKS-DVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLW 703
              GT  Y  PE+    R+  +S  V+S G+LL ++V G      FE D  I+G      
Sbjct: 169 -FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP---FEHDEEIIG------ 218
Query: 704 NENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPY 763
                         +  F+  +   C H+   C+     DRP    + +  +  ++D+  
Sbjct: 219 -------------GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN--HPWMQDVLL 263
Query: 764 PKEPA 768
           P+E A
Sbjct: 264 PQETA 268

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 129/305 (42%), Gaps = 58/305 (19%)
Query: 482 NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGLEEFMN------EVMVISK 534
           + +Q+   LG GGFG VY G R+ D   +A+K + K       E  N      EV+++ K
Sbjct: 24  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 83
Query: 535 LQH--RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 592
           +      ++RLL      +  +LI E  P    D  LFD +        +R  + E ++R
Sbjct: 84  VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQD--LFDFIT-------ERGALQEELAR 133
Query: 593 GLLY-----LHRDSRLRIIHRDLKASNILLDEELNP---KISDFGMAKIFGGNQDQADTG 644
              +     +       ++HRD+K  NIL+D  LN    K+ DFG   +    +D   T 
Sbjct: 134 SFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSGALL---KDTVYTD 188
Query: 645 RVVGTFGYMSPEYAMEGRFSEKS-DVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLW 703
              GT  Y  PE+    R+  +S  V+S G+LL ++V G  +  F  D+  I G  +   
Sbjct: 189 -FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDEEIIRGQVF--- 242
Query: 704 NENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPY 763
                            F+  +   C H+   C+     DRP    + +  +  ++D+  
Sbjct: 243 -----------------FRQRVSXECQHLIRWCLALRPXDRPTFEEIQN--HPWMQDVLL 283
Query: 764 PKEPA 768
           P+E A
Sbjct: 284 PQETA 288

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 129/305 (42%), Gaps = 58/305 (19%)
Query: 482 NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGLEEFMN------EVMVISK 534
           + +Q+   LG GGFG VY G R+ D   +A+K + K       E  N      EV+++ K
Sbjct: 23  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 82
Query: 535 LQH--RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 592
           +      ++RLL      +  +LI E  P    D  LFD +        +R  + E ++R
Sbjct: 83  VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQD--LFDFIT-------ERGALQEELAR 132
Query: 593 GLLY-----LHRDSRLRIIHRDLKASNILLDEELNP---KISDFGMAKIFGGNQDQADTG 644
              +     +       ++HRD+K  NIL+D  LN    K+ DFG   +    +D   T 
Sbjct: 133 SFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSGALL---KDTVYTD 187
Query: 645 RVVGTFGYMSPEYAMEGRFSEKS-DVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLW 703
              GT  Y  PE+    R+  +S  V+S G+LL ++V G  +  F  D+  I G  +   
Sbjct: 188 -FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDEEIIRGQVF--- 241
Query: 704 NENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPY 763
                            F+  +   C H+   C+     DRP    + +  +  ++D+  
Sbjct: 242 -----------------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN--HPWMQDVLL 282
Query: 764 PKEPA 768
           P+E A
Sbjct: 283 PQETA 287

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 21/208 (10%)
Query: 490 LGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HRNLVRLLGCC 547
           LG+G    V     L   QE AVK + K  G        EV ++ + Q HRN++ L+   
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 548 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 607
            E +   L++E M   S+ + +    K+   +  +   +++ ++  L +LH      I H
Sbjct: 81  EEEDRFYLVFEKMRGGSILSHIH---KRRHFNELEASVVVQDVASALDFLHNKG---IAH 134
Query: 608 RDLKASNILLDE--ELNP-KISDFGMAKIFGGNQDQADTG-----RVVGTFGYMSPE--- 656
           RDLK  NIL +   +++P KI DF +      N D +           G+  YM+PE   
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVE 194
Query: 657 -YAMEGR-FSEKSDVFSFGVLLLEIVSG 682
            ++ E   + ++ D++S GV+L  ++SG
Sbjct: 195 AFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 129/305 (42%), Gaps = 58/305 (19%)
Query: 482 NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGLEEFMN------EVMVISK 534
           + +Q+   LG GGFG VY G R+ D   +A+K + K       E  N      EV+++ K
Sbjct: 24  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 83
Query: 535 LQH--RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 592
           +      ++RLL      +  +LI E  P    D  LFD +        +R  + E ++R
Sbjct: 84  VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQD--LFDFIT-------ERGALQEELAR 133
Query: 593 GLLY-----LHRDSRLRIIHRDLKASNILLDEELNP---KISDFGMAKIFGGNQDQADTG 644
              +     +       ++HRD+K  NIL+D  LN    K+ DFG   +    +D   T 
Sbjct: 134 SFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSGALL---KDTVYTD 188
Query: 645 RVVGTFGYMSPEYAMEGRFSEKS-DVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLW 703
              GT  Y  PE+    R+  +S  V+S G+LL ++V G  +  F  D+  I G  +   
Sbjct: 189 -FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDEEIIRGQVF--- 242
Query: 704 NENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPY 763
                            F+  +   C H+   C+     DRP    + +  +  ++D+  
Sbjct: 243 -----------------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN--HPWMQDVLL 283
Query: 764 PKEPA 768
           P+E A
Sbjct: 284 PQETA 288

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 129/305 (42%), Gaps = 58/305 (19%)
Query: 482 NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGLEEFMN------EVMVISK 534
           + +Q+   LG GGFG VY G R+ D   +A+K + K       E  N      EV+++ K
Sbjct: 7   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 66
Query: 535 LQH--RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 592
           +      ++RLL      +  +LI E  P    D  LFD +        +R  + E ++R
Sbjct: 67  VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQD--LFDFIT-------ERGALQEELAR 116
Query: 593 GLLY-----LHRDSRLRIIHRDLKASNILLDEELNP---KISDFGMAKIFGGNQDQADTG 644
              +     +       ++HRD+K  NIL+D  LN    K+ DFG   +    +D   T 
Sbjct: 117 SFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSGALL---KDTVYTD 171
Query: 645 RVVGTFGYMSPEYAMEGRFSEKS-DVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLW 703
              GT  Y  PE+    R+  +S  V+S G+LL ++V G  +  F  D+  I G  +   
Sbjct: 172 -FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDEEIIRGQVF--- 225
Query: 704 NENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPY 763
                            F+  +   C H+   C+     DRP    + +  +  ++D+  
Sbjct: 226 -----------------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN--HPWMQDVLL 266
Query: 764 PKEPA 768
           P+E A
Sbjct: 267 PQETA 271

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 129/305 (42%), Gaps = 58/305 (19%)
Query: 482 NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGLEEFMN------EVMVISK 534
           + +Q+   LG GGFG VY G R+ D   +A+K + K       E  N      EV+++ K
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 535 LQH--RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 592
           +      ++RLL      +  +LI E  P    D  LFD +        +R  + E ++R
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQD--LFDFIT-------ERGALQEELAR 113
Query: 593 GLLY-----LHRDSRLRIIHRDLKASNILLDEELNP---KISDFGMAKIFGGNQDQADTG 644
              +     +       ++HRD+K  NIL+D  LN    K+ DFG   +    +D   T 
Sbjct: 114 SFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSGALL---KDTVYTD 168
Query: 645 RVVGTFGYMSPEYAMEGRFSEKS-DVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLW 703
              GT  Y  PE+    R+  +S  V+S G+LL ++V G  +  F  D+  I G  +   
Sbjct: 169 -FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDEEIIRGQVF--- 222
Query: 704 NENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPY 763
                            F+  +   C H+   C+     DRP    + +  +  ++D+  
Sbjct: 223 -----------------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN--HPWMQDVLL 263
Query: 764 PKEPA 768
           P+E A
Sbjct: 264 PQETA 268

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 80/313 (25%), Positives = 131/313 (41%), Gaps = 58/313 (18%)
Query: 474 FEELATATNNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGLEEFMN----- 527
            +E     + +Q+   LG GGFG VY G R+ D   +A+K + K       E  N     
Sbjct: 1   MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 528 -EVMVISKLQH--RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF 584
            EV+++ K+      ++RLL      +  +LI E  P    D  LFD +        +R 
Sbjct: 61  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQD--LFDFIT-------ERG 110
Query: 585 NIIEGISRGLLY-----LHRDSRLRIIHRDLKASNILLDEELNP---KISDFGMAKIFGG 636
            + E ++R   +     +       ++HRD+K  NIL+D  LN    K+ DFG   +   
Sbjct: 111 ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSGALL-- 166
Query: 637 NQDQADTGRVVGTFGYMSPEYAMEGRFSEKS-DVFSFGVLLLEIVSGRKNTSFFEDDLTI 695
            +D   T    GT  Y  PE+    R+  +S  V+S G+LL ++V G  +  F  D+  I
Sbjct: 167 -KDTVYTD-FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDEEII 222
Query: 696 LGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN 755
            G  +                    F+  +   C H+   C+     DRP    + +  +
Sbjct: 223 RGQVF--------------------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN--H 260
Query: 756 SEIRDLPYPKEPA 768
             ++D+  P+E A
Sbjct: 261 PWMQDVLLPQETA 273

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 129/305 (42%), Gaps = 58/305 (19%)
Query: 482 NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGLEEFMN------EVMVISK 534
           + +Q+   LG GGFG VY G R+ D   +A+K + K       E  N      EV+++ K
Sbjct: 9   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 68
Query: 535 LQH--RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 592
           +      ++RLL      +  +LI E  P    D  LFD +        +R  + E ++R
Sbjct: 69  VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQD--LFDFIT-------ERGALQEELAR 118
Query: 593 GLLY-----LHRDSRLRIIHRDLKASNILLDEELNP---KISDFGMAKIFGGNQDQADTG 644
              +     +       ++HRD+K  NIL+D  LN    K+ DFG   +    +D   T 
Sbjct: 119 SFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSGALL---KDTVYTD 173
Query: 645 RVVGTFGYMSPEYAMEGRFSEKS-DVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLW 703
              GT  Y  PE+    R+  +S  V+S G+LL ++V G  +  F  D+  I G  +   
Sbjct: 174 -FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDEEIIRGQVF--- 227
Query: 704 NENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPY 763
                            F+  +   C H+   C+     DRP    + +  +  ++D+  
Sbjct: 228 -----------------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN--HPWMQDVLL 268
Query: 764 PKEPA 768
           P+E A
Sbjct: 269 PQETA 273

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 27/218 (12%)
Query: 489 KLGQGGFGPVYWGRLKDGQ---EIAVKRLSKASGQGLEEF-MNEVMVISKLQHRNLVRLL 544
           ++G+G FG V+  R+KD Q   + AVK++       LE F + E++  + L    +V L 
Sbjct: 81  RVGRGSFGEVH--RMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIVPLY 132
Query: 545 GCCVEGEEKMLIYEYMPNRSLDALL--FDPLKKERLDWRKRFNIIEGISRGLLYLHRDSR 602
           G   EG    +  E +   SL  L+     L ++R         +     GL YLH    
Sbjct: 133 GAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRA-----LYYLGQALEGLEYLHTR-- 185
Query: 603 LRIIHRDLKASNILLDEELN-PKISDFGMAKIF---GGNQDQADTGRVVGTFGYMSPEYA 658
            RI+H D+KA N+LL  + +   + DFG A      G  +       + GT  +M+PE  
Sbjct: 186 -RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 244
Query: 659 MEGRFSEKSDVFSFGVLLLEIVSGRKN-TSFFEDDLTI 695
           M      K D++S   ++L +++G    T +F   L +
Sbjct: 245 MGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL 282

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 80/312 (25%), Positives = 131/312 (41%), Gaps = 58/312 (18%)
Query: 475 EELATATNNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGLEEFMN------ 527
           +E     + +Q+   LG GGFG VY G R+ D   +A+K + K       E  N      
Sbjct: 1   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 60
Query: 528 EVMVISKLQH--RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 585
           EV+++ K+      ++RLL      +  +LI E  P    D  LFD +        +R  
Sbjct: 61  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQD--LFDFIT-------ERGA 110
Query: 586 IIEGISRGLLY-----LHRDSRLRIIHRDLKASNILLDEELNP---KISDFGMAKIFGGN 637
           + E ++R   +     +       ++HRD+K  NIL+D  LN    K+ DFG   +    
Sbjct: 111 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSGALL--- 165
Query: 638 QDQADTGRVVGTFGYMSPEYAMEGRFSEKS-DVFSFGVLLLEIVSGRKNTSFFEDDLTIL 696
           +D   T    GT  Y  PE+    R+  +S  V+S G+LL ++V G  +  F  D+  I 
Sbjct: 166 KDTVYTD-FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDEEIIR 222
Query: 697 GYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS 756
           G  +                    F+  +   C H+   C+     DRP    + +  + 
Sbjct: 223 GQVF--------------------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN--HP 260
Query: 757 EIRDLPYPKEPA 768
            ++D+  P+E A
Sbjct: 261 WMQDVLLPQETA 272

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 80/313 (25%), Positives = 131/313 (41%), Gaps = 58/313 (18%)
Query: 474 FEELATATNNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGLEEFMN----- 527
            +E     + +Q+   LG GGFG VY G R+ D   +A+K + K       E  N     
Sbjct: 1   MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 528 -EVMVISKLQH--RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF 584
            EV+++ K+      ++RLL      +  +LI E  P    D  LFD +        +R 
Sbjct: 61  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQD--LFDFIT-------ERG 110
Query: 585 NIIEGISRGLLY-----LHRDSRLRIIHRDLKASNILLDEELNP---KISDFGMAKIFGG 636
            + E ++R   +     +       ++HRD+K  NIL+D  LN    K+ DFG   +   
Sbjct: 111 ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSGALL-- 166
Query: 637 NQDQADTGRVVGTFGYMSPEYAMEGRFSEKS-DVFSFGVLLLEIVSGRKNTSFFEDDLTI 695
            +D   T    GT  Y  PE+    R+  +S  V+S G+LL ++V G  +  F  D+  I
Sbjct: 167 -KDTVYTD-FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDEEII 222
Query: 696 LGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN 755
            G  +                    F+  +   C H+   C+     DRP    + +  +
Sbjct: 223 RGQVF--------------------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN--H 260
Query: 756 SEIRDLPYPKEPA 768
             ++D+  P+E A
Sbjct: 261 PWMQDVLLPQETA 273

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/241 (21%), Positives = 113/241 (46%), Gaps = 40/241 (16%)
Query: 472 FQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLSKASGQGLE--EFMNE 528
           FQ  +     +N+ +   +G+G +G VY    K+ ++ +A+K++++     ++    + E
Sbjct: 16  FQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILRE 75
Query: 529 VMVISKLQHRNLVRLLGCCVEGE----EKMLIYEYMPNRSLDALLFDP--LKKERLDWRK 582
           + ++++L+   ++RL    +  +    +++ I   + +  L  L   P  L +E +    
Sbjct: 76  ITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIK--- 132
Query: 583 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD--- 639
              I+  +  G  ++H      IIHRDLK +N LL+++ + K+ DFG+A+     +D   
Sbjct: 133 --TILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNI 187
Query: 640 ------------------QADTGRVVGTFGYMSPEYA-MEGRFSEKSDVFSFGVLLLEIV 680
                             +  T  VV T  Y +PE   ++  +++  D++S G +  E++
Sbjct: 188 VNDLEENEEPGPHNKNLKKQLTSHVV-TRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246
Query: 681 S 681
           +
Sbjct: 247 N 247

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 98/228 (42%), Gaps = 32/228 (14%)
Query: 466 LQDLPLFQFEELATATNNFQLSSKLGQGGFGPVY-WGRLKDGQEIAVKRLSKASGQGLEE 524
           ++D P +Q  +L            LG+G F         K  Q  AVK +SK      ++
Sbjct: 1   MKDSPFYQHYDLDLK------DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK 54
Query: 525 FMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF 584
            +  + +     H N+V+L     +     L+ E +    L          ER+  +K F
Sbjct: 55  EITALKLCEG--HPNIVKLHEVFHDQLHTFLVMELLNGGEL---------FERIKKKKHF 103
Query: 585 NIIEG--ISRGLL----YLHRDSRLRIIHRDLKASNILLDEE---LNPKISDFGMAKIFG 635
           +  E   I R L+    ++H    + ++HRDLK  N+L  +E   L  KI DFG A++  
Sbjct: 104 SETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP 160
Query: 636 GNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
            +     T     T  Y +PE   +  + E  D++S GV+L  ++SG+
Sbjct: 161 PDNQPLKTP--CFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQ 206

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 129/305 (42%), Gaps = 58/305 (19%)
Query: 482 NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGLEEFMN------EVMVISK 534
           + +Q+   LG GGFG VY G R+ D   +A+K + K       E  N      EV+++ K
Sbjct: 43  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 102
Query: 535 LQH--RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 592
           +      ++RLL      +  +LI E  P    D  LFD +        +R  + E ++R
Sbjct: 103 VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQD--LFDFIT-------ERGALQEELAR 152
Query: 593 GLLY-----LHRDSRLRIIHRDLKASNILLDEELNP---KISDFGMAKIFGGNQDQADTG 644
              +     +       ++HRD+K  NIL+D  LN    K+ DFG   +    +D   T 
Sbjct: 153 SFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSGALL---KDTVYTD 207
Query: 645 RVVGTFGYMSPEYAMEGRFSEKS-DVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLW 703
              GT  Y  PE+    R+  +S  V+S G+LL ++V G  +  F  D+  I G  +   
Sbjct: 208 -FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDEEIIRGQVF--- 261
Query: 704 NENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPY 763
                            F+  +   C H+   C+     DRP    + +  +  ++D+  
Sbjct: 262 -----------------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN--HPWMQDVLL 302
Query: 764 PKEPA 768
           P+E A
Sbjct: 303 PQETA 307

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 105/234 (44%), Gaps = 39/234 (16%)
Query: 483 NFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGLEEFMN------EVMVISKL 535
            ++L   LG+GGFG V+ G RL D  ++A+K + +    G     +      EV ++ K+
Sbjct: 32  EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 536 Q----HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDAL-LFDPLKKERLDWRKRFNIIEGI 590
                H  ++RLL      E  ML+ E    R L A  LFD + +       +  + EG 
Sbjct: 92  GAGGGHPGVIRLLDWFETQEGFMLVLE----RPLPAQDLFDYITE-------KGPLGEGP 140
Query: 591 SRGLL------YLHRDSRLRIIHRDLKASNILLDEELN-PKISDFGMAKIFGGNQDQADT 643
           SR           H  SR  ++HRD+K  NIL+D      K+ DFG   +     D+  T
Sbjct: 141 SRCFFGQVVAAIQHCHSR-GVVHRDIKDENILIDLRRGCAKLIDFGSGALL---HDEPYT 196
Query: 644 GRVVGTFGYMSPEYAMEGRFSE-KSDVFSFGVLLLEIVSGRKNTSFFEDDLTIL 696
               GT  Y  PE+    ++    + V+S G+LL ++V G      FE D  IL
Sbjct: 197 D-FDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP---FERDQEIL 246

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 108/238 (45%), Gaps = 24/238 (10%)
Query: 470 PLFQF-EELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEE--- 524
           P  Q  +E+     +F++   +G+G FG V   ++K+ + I A+K L+K       E   
Sbjct: 61  PFTQLVKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETAC 120
Query: 525 FMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL--FDPLKKERLDWRK 582
           F  E  V+     + +  L     +     L+ +Y     L  LL  F+    E +    
Sbjct: 121 FREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDM---A 177
Query: 583 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD-QA 641
           RF I E +    L +    +L  +HRD+K  N+LLD   + +++DFG       N D   
Sbjct: 178 RFYIGEMV----LAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFG--SCLKMNDDGTV 231
Query: 642 DTGRVVGTFGYMSPEY--AME---GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLT 694
            +   VGT  Y+SPE   AME   G++  + D +S GV + E++ G   T F+ + L 
Sbjct: 232 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE--TPFYAESLV 287

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 108/238 (45%), Gaps = 24/238 (10%)
Query: 470 PLFQF-EELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEE--- 524
           P  Q  +E+     +F++   +G+G FG V   ++K+ + I A+K L+K       E   
Sbjct: 77  PFTQLVKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETAC 136
Query: 525 FMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL--FDPLKKERLDWRK 582
           F  E  V+     + +  L     +     L+ +Y     L  LL  F+    E +    
Sbjct: 137 FREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDM---A 193
Query: 583 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD-QA 641
           RF I E +    L +    +L  +HRD+K  N+LLD   + +++DFG       N D   
Sbjct: 194 RFYIGEMV----LAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFG--SCLKMNDDGTV 247
Query: 642 DTGRVVGTFGYMSPEY--AME---GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLT 694
            +   VGT  Y+SPE   AME   G++  + D +S GV + E++ G   T F+ + L 
Sbjct: 248 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE--TPFYAESLV 303

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 102/220 (46%), Gaps = 23/220 (10%)
Query: 477 LATATNNFQLSS-------KLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEE---F 525
           ++    NF++ +       +LG+G +G V   R +  GQ +AVKR+ +A+    E+    
Sbjct: 39  ISIGNQNFEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQEQKRLL 97
Query: 526 MNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKK-ERLDWRKRF 584
           M+  + +  +     V   G      +  +  E M + SLD      + K + +      
Sbjct: 98  MDLDISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILG 156
Query: 585 NIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG 644
            I   I + L +LH  S+L +IHRD+K SN+L++     K+ DFG++   G   D     
Sbjct: 157 KIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS---GYLVDSVAKT 211
Query: 645 RVVGTFGYMSPEYA----MEGRFSEKSDVFSFGVLLLEIV 680
              G   YM+PE       +  +S KSD++S G+ ++E+ 
Sbjct: 212 IDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELA 251
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	808
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-148
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-147
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-126
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-91
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-75
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-62
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-60
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	9e-60
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-59
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-59
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-58
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-57
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	6e-57
3q4u_A	301	Activin receptor type-1; structural genomics conso	5e-53
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	8e-53
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-52
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	6e-51
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-49
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-49
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	8e-49
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-48
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	5e-48
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-47
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	5e-47
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	9e-47
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	9e-47
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-46
4aoj_A	329	High affinity nerve growth factor receptor; transf	7e-46
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-45
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-45
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-45
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-45
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-45
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-45
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-45
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-45
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	6e-45
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-44
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-44
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	5e-44
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	7e-44
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-43
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-43
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-43
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-43
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	4e-43
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-43
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-43
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	5e-43
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	5e-43
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	5e-43
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-42
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-42
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-42
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-42
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-42
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-42
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-42
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-42
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-42
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	8e-42
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-41
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-41
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-41
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-41
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-41
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	5e-41
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	6e-41
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	6e-41
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-40
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	4e-40
2a19_B	284	Interferon-induced, double-stranded RNA-activated	9e-40
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-39
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-39
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-39
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-39
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-39
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-38
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	6e-38
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-37
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	5e-37
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-36
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	4e-36
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	5e-36
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	7e-36
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-35
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-35
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	6e-35
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-34
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	5e-34
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-33
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-33
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-33
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-33
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-33
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	8e-33
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	8e-33
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	9e-33
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-32
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-32
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-32
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-32
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-32
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-32
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	9e-32
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-31
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-31
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-31
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-31
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	6e-31
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	7e-31
3fme_A	290	Dual specificity mitogen-activated protein kinase;	9e-31
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-30
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-30
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-30
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-30
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-30
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-30
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-30
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-30
3an0_A	340	Dual specificity mitogen-activated protein kinase;	9e-30
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-29
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-29
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	5e-29
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	7e-29
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	8e-29
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-28
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-28
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-28
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	4e-28
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	5e-28
2dyl_A	318	Dual specificity mitogen-activated protein kinase	5e-28
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-27
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-27
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-27
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-27
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-27
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-27
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	4e-27
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	4e-27
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	4e-27
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	4e-27
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-26
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-26
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-26
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-26
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-26
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-26
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-26
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-26
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	5e-26
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-25
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-25
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-25
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-25
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-25
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-25
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	5e-25
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	8e-25
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-24
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-24
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	6e-24
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-23
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-23
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	7e-23
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-22
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-22
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-22
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-22
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-22
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	4e-22
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	4e-22
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-22
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	5e-22
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	8e-22
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-21
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-21
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-21
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-21
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-21
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-21
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-21
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-21
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-21
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	5e-21
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	6e-21
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	8e-21
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	9e-21
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-20
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-20
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-20
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-20
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-20
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-20
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-20
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	4e-20
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	6e-20
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	7e-20
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	9e-20
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-19
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-19
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-19
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	7e-19
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-18
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-18
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	6e-18
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	7e-18
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	7e-18
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-12
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	9e-18
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-17
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	7e-17
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-16
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-16
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	4e-16
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-15
3rp9_A	458	Mitogen-activated protein kinase; structural genom	5e-15
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-14
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	6e-14
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	9e-14
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-13
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-12
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-12
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-11
3a0c_A	110	Mannose/sialic acid-binding lectin; beta-prism II,	3e-11
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	5e-11
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	5e-11
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-10
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-10
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-10
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-10
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	4e-10
1b2p_A	119	Protein (lectin); mannose-binding lectin, monocot,	8e-10
2dpf_A	115	Curculin; sweet taste, taste modifying, plant prot	1e-09
2dpf_A	115	Curculin; sweet taste, taste modifying, plant prot	1e-05
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-09
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	5e-09
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	6e-09
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	8e-09
1kj1_A	109	Lectin I, lecgna 1; BULB lectin, mannose, plant pr	1e-08
1kj1_A	109	Lectin I, lecgna 1; BULB lectin, mannose, plant pr	1e-08
3dzw_A	109	Agglutinin; lectin, mannobiose, mannose-alpha1, 3-	2e-08
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-08
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	6e-08
1xd5_A	112	Gastrodianin-1, antifungal protein GAFP-1; monocot	9e-08
3r0e_A	109	Lectin; carbohydrate binding, carbohydrate, sugar	2e-06
3r0e_A	109	Lectin; carbohydrate binding, carbohydrate, sugar	2e-04
3r0e_B	110	Lectin; carbohydrate binding, carbohydrate, sugar	4e-06
3r0e_B	110	Lectin; carbohydrate binding, carbohydrate, sugar	8e-06
1dlp_A	236	Lectin scafet precursor; two-domain lectin, beta p	5e-06
1dlp_A	236	Lectin scafet precursor; two-domain lectin, beta p	9e-06
1dlp_A	236	Lectin scafet precursor; two-domain lectin, beta p	1e-04
3m7h_A	276	Putidacin L1; monocot mannose-binding lectin, bact	2e-05
3m7h_A	276	Putidacin L1; monocot mannose-binding lectin, bact	2e-05
3m7h_A	276	Putidacin L1; monocot mannose-binding lectin, bact	1e-04
3mez_A	111	Mannose-specific lectin 3 chain 1; heterotetramer,	4e-05
3mez_B	113	Mannose-specific lectin 3 chain 2; heterotetramer,	8e-05

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  435 bits (1122), Expect = e-148
 Identities = 126/292 (43%), Positives = 177/292 (60%), Gaps = 8/292 (2%)

Query: 472 FQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLE-EFMNEVM 530
           F   EL  A++NF   + LG+GGFG VY GRL DG  +AVKRL +   QG E +F  EV 
Sbjct: 20  FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79

Query: 531 VISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLK-KERLDWRKRFNIIEG 589
           +IS   HRNL+RL G C+   E++L+Y YM N S+ + L +  + +  LDW KR  I  G
Sbjct: 80  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139

Query: 590 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 649
            +RGL YLH     +IIHRD+KA+NILLDEE    + DFG+AK+         T  V GT
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRGT 198

Query: 650 FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFF----EDDLTILGYAWKLWNE 705
            G+++PEY   G+ SEK+DVF +GV+LLE+++G++         +DD+ +L +   L  E
Sbjct: 199 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258

Query: 706 NKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE 757
            K+ ALVD  L + +++ + + + I V LLC Q    +RP MS VV ML  +
Sbjct: 259 KKLEALVDVDL-QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  434 bits (1118), Expect = e-147
 Identities = 102/300 (34%), Positives = 155/300 (51%), Gaps = 18/300 (6%)

Query: 468 DLPLFQFEELATATNNF------QLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSK----A 517
               F F EL   TNNF         +K+G+GGFG VY G + +   +AVK+L+      
Sbjct: 11  RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDIT 69

Query: 518 SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER 577
           + +  ++F  E+ V++K QH NLV LLG   +G++  L+Y YMPN SL   L        
Sbjct: 70  TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 129

Query: 578 LDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 637
           L W  R  I +G + G+ +LH +     IHRD+K++NILLDE    KISDFG+A+     
Sbjct: 130 LSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKF 186

Query: 638 QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILG 697
                T R+VGT  YM+PE  + G  + KSD++SFGV+LLEI++G        +   +L 
Sbjct: 187 AQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD 245

Query: 698 YAWKLWNENKIL-ALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS 756
              ++ +E K +   +D  +++       +     V   C+ E    RP++  V  +L  
Sbjct: 246 IKEEIEDEEKTIEDYIDKKMND--ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  379 bits (975), Expect = e-126
 Identities = 111/287 (38%), Positives = 163/287 (56%), Gaps = 9/287 (3%)

Query: 472 FQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMV 531
               +L  ATNNF     +G G FG VY G L+DG ++A+KR +  S QG+EEF  E+  
Sbjct: 29  VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88

Query: 532 ISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDP-LKKERLDWRKRFNIIEGI 590
           +S  +H +LV L+G C E  E +LIY+YM N +L   L+   L    + W +R  I  G 
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148

Query: 591 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF-GGNQDQADTGRVVGT 649
           +RGL YLH  +   IIHRD+K+ NILLDE   PKI+DFG++K     +Q    T  V GT
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST-VVKGT 204

Query: 650 FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRK--NTSFFEDDLTILGYAWKLWNENK 707
            GY+ PEY ++GR +EKSDV+SFGV+L E++  R     S   + + +  +A +  N  +
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264

Query: 708 ILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML 754
           +  +VDP L     + + + +     + C+    +DRP+M  V+  L
Sbjct: 265 LEQIVDPNL-ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  289 bits (742), Expect = 1e-91
 Identities = 72/309 (23%), Positives = 120/309 (38%), Gaps = 31/309 (10%)

Query: 472 FQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMV 531
              E L   +   QL     +G FG V+  +L   + +AVK       Q   +   EV  
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYEVYS 71

Query: 532 ISKLQHRNLVRLLGCCVEGE----EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNII 587
           +  ++H N+++ +G    G     +  LI  +    SL     D LK   + W +  +I 
Sbjct: 72  LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSL----SDFLKANVVSWNELCHIA 127

Query: 588 EGISRGLLYLHRD-------SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ 640
           E ++RGL YLH D        +  I HRD+K+ N+LL   L   I+DFG+A  F   +  
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187

Query: 641 ADTGRVVGTFGYMSPEYAMEG-----RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTI 695
            DT   VGT  YM+PE              + D+++ G++L E+ S         D+   
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM- 246

Query: 696 LGYAWKLWNENKILAL--------VDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNM 747
           L +  ++     +  +          P L +   +   +         C     + R + 
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306

Query: 748 STVVSMLNS 756
             V   +  
Sbjct: 307 GCVGERITQ 315

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  247 bits (631), Expect = 3e-75
 Identities = 72/336 (21%), Positives = 128/336 (38%), Gaps = 44/336 (13%)

Query: 472 FQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNE--V 529
               E +   +N +L   +G+G +G VY G L D + +AVK  S A+ Q    F+NE  +
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58

Query: 530 MVISKLQHRNLVRLLGCCVEGE-----EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF 584
             +  ++H N+ R +            E +L+ EY PN SL       L     DW    
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLX----KYLSLHTSDWVSSC 114

Query: 585 NIIEGISRGLLYLHRD------SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN- 637
            +   ++RGL YLH +       +  I HRDL + N+L+  +    ISDFG++    GN 
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174

Query: 638 -----QDQADTGRVVGTFGYMSPEYAME-------GRFSEKSDVFSFGVLLLEIVSGRKN 685
                ++       VGT  YM+PE               ++ D+++ G++  EI     +
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234

Query: 686 TSFFEDDLTI-LGYAWKLWNENKILALVDPFLSE-------SSFQLDMIIRCIHVGLL-- 735
               E      + +  ++ N      +      E        +++ + +        +  
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294

Query: 736 CVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPAFTE 771
           C  +  + R         +   +      K  + T 
Sbjct: 295 CWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTA 330

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  212 bits (541), Expect = 1e-62
 Identities = 78/319 (24%), Positives = 150/319 (47%), Gaps = 27/319 (8%)

Query: 457 SATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRL-- 514
                 T  L        +++     +  +  K+G G FG V+      G ++AVK L  
Sbjct: 12  DYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILME 70

Query: 515 SKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLK 574
                + + EF+ EV ++ +L+H N+V  +G   +     ++ EY+   SL  LL     
Sbjct: 71  QDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGA 130

Query: 575 KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 634
           +E+LD R+R ++   +++G+ YLH      I+HR+LK+ N+L+D++   K+ DFG++++ 
Sbjct: 131 REQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189

Query: 635 GGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLT 694
                 + +    GT  +M+PE   +   +EKSDV+SFGV+L E+ + ++    +  +L 
Sbjct: 190 ASTFLSSKSA--AGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ---PWG-NLN 243

Query: 695 ILGYAWKLWNENKILAL---VDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVV 751
                  +  + K L +   ++P ++       +I  C              RP+ +T++
Sbjct: 244 PAQVVAAVGFKCKRLEIPRNLNPQVA------AIIEGCWT-------NEPWKRPSFATIM 290

Query: 752 SMLNSEIRD-LPYPKEPAF 769
            +L   I+  +P P     
Sbjct: 291 DLLRPLIKSAVPPPNRSDL 309

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  206 bits (525), Expect = 2e-60
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 18/214 (8%)

Query: 484 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 542
                 LG+G FG       ++ G+ + +K L +   +    F+ EV V+  L+H N+++
Sbjct: 12  LIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLK 71

Query: 543 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSR 602
            +G   + +    I EY+   +L  ++       +  W +R +  + I+ G+ YLH    
Sbjct: 72  FIGVLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLH---S 126

Query: 603 LRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR------------VVGTF 650
           + IIHRDL + N L+ E  N  ++DFG+A++    + Q +  R            VVG  
Sbjct: 127 MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186

Query: 651 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRK 684
            +M+PE      + EK DVFSFG++L EI+    
Sbjct: 187 YWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVN 220

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  204 bits (520), Expect = 1e-59
 Identities = 73/290 (25%), Positives = 127/290 (43%), Gaps = 30/290 (10%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 541
              ++   +G+G FG V   + +  +++A+K++   S    + F+ E+  +S++ H N+V
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIV 64

Query: 542 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
           +L G C+      L+ EY    SL  +L               +     S+G+ YLH   
Sbjct: 65  KLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122

Query: 602 RLRIIHRDLKASNILLDEELN-PKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
              +IHRDLK  N+LL       KI DFG A     +     T    G+  +M+PE    
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNN-KGSAAWMAPEVFEG 177

Query: 661 GRFSEKSDVFSFGVLLLEIVSGRKNTSFFED-DLTILGYAWKLWNEN--KILALVDPFLS 717
             +SEK DVFS+G++L E+++ RK    F++         W + N     ++  +   + 
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRK---PFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIE 234

Query: 718 ESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEP 767
                  ++ RC         +    RP+M  +V ++   +R  P   EP
Sbjct: 235 S------LMTRCWS-------KDPSQRPSMEEIVKIMTHLMRYFPGADEP 271

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  201 bits (514), Expect = 3e-59
 Identities = 78/298 (26%), Positives = 129/298 (43%), Gaps = 48/298 (16%)

Query: 474 FEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRL----SKASGQGLEEFMNEV 529
           F EL        L   +G GGFG VY      G E+AVK       +   Q +E    E 
Sbjct: 6   FAEL-------TLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEA 57

Query: 530 MVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEG 589
            + + L+H N++ L G C++     L+ E+     L       L  +R+      N    
Sbjct: 58  KLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPL----NRVLSGKRIPPDILVNWAVQ 113

Query: 590 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP--------KISDFGMAKIFGGNQDQA 641
           I+RG+ YLH ++ + IIHRDLK+SNIL+ +++          KI+DFG+A+       + 
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE----WHRT 169

Query: 642 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWK 701
                 G + +M+PE      FS+ SDV+S+GVLL E+++G      F   +  L  A+ 
Sbjct: 170 TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEV---PFR-GIDGLAVAYG 225

Query: 702 LWNENK---ILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS 756
           +        I +      ++       ++        C       RP+ + ++  L +
Sbjct: 226 VAMNKLALPIPSTCPEPFAK-------LME------DCWNPDPHSRPSFTNILDQLTT 270

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  200 bits (511), Expect = 1e-58
 Identities = 69/287 (24%), Positives = 135/287 (47%), Gaps = 29/287 (10%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRN 539
               +  ++G G FG VY G+     ++AVK L+    + Q L+ F NEV V+ K +H N
Sbjct: 24  GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81

Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 599
           ++  +G      +  ++ ++    SL   L     + + + +K  +I    +RG+ YLH 
Sbjct: 82  ILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHA 138

Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE--- 656
                IIHRDLK++NI L E+   KI DFG+A             ++ G+  +M+PE   
Sbjct: 139 ---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195

Query: 657 YAMEGRFSEKSDVFSFGVLLLEIVSGR---KNTSFFEDDLTILGYAWKLWNENKILALVD 713
                 +S +SDV++FG++L E+++G+    N +  +  + ++G      + +K+ +   
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCP 255

Query: 714 PFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 760
             +        ++  C+        +   +RP+   +++ +    R+
Sbjct: 256 KRMK------RLMAECLK-------KKRDERPSFPRILAEIEELARE 289

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  197 bits (504), Expect = 1e-57
 Identities = 75/290 (25%), Positives = 132/290 (45%), Gaps = 37/290 (12%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQG-------LEEFMNEVMVIS 533
           N  +   ++G+GGFG V+ GRL  D   +A+K L     +G        +EF  EV ++S
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78

Query: 534 KLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRG 593
            L H N+V+L G         ++ E++P   L   L D  K   + W  +  ++  I+ G
Sbjct: 79  NLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALG 134

Query: 594 LLYLHRDSRLRIIHRDLKASNILLDE-----ELNPKISDFGMAKIFGGNQDQADTGRVVG 648
           + Y+  +    I+HRDL++ NI L        +  K++DFG+++             ++G
Sbjct: 135 IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVSGLLG 188

Query: 649 TFGYMSPE--YAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNEN 706
            F +M+PE   A E  ++EK+D +SF ++L  I++G      F+ + +     +      
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG---PFD-EYSYGKIKFINMIRE 244

Query: 707 KILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS 756
           + L        +   +L  +I       LC     K RP+ S +V  L+ 
Sbjct: 245 EGLRP--TIPEDCPPRLRNVIE------LCWSGDPKKRPHFSYIVKELSE 286

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  195 bits (497), Expect = 6e-57
 Identities = 62/286 (21%), Positives = 119/286 (41%), Gaps = 39/286 (13%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRL--SKASGQGLEEFMNEVMVISKLQHRN 539
                 +KL +   G ++ GR + G +I VK L     S +   +F  E   +    H N
Sbjct: 10  KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68

Query: 540 LVRLLGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 597
           ++ +LG C         LI  +MP  SL  +L +      +D  +       ++RG+ +L
Sbjct: 69  VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFL 127

Query: 598 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEY 657
           H    L I    L + ++++DE++  +IS   +   F        +   +    +++PE 
Sbjct: 128 HTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAWVAPE- 178

Query: 658 AMEGR----FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILAL-- 711
           A++ +        +D++SF VLL E+V+       F  DL+ +    K+  E     +  
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTREV---PFA-DLSNMEIGMKVALEGLRPTIPP 234

Query: 712 -VDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS 756
            + P +S+       +++      +C+ E    RP    +V +L  
Sbjct: 235 GISPHVSK-------LMK------ICMNEDPAKRPKFDMIVPILEK 267

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  185 bits (472), Expect = 5e-53
 Identities = 61/232 (26%), Positives = 102/232 (43%), Gaps = 27/232 (11%)

Query: 479 TATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNE--VMVISKLQ 536
           T   +  L   +G+G +G V+ G  + G+ +AVK  S    +  + +  E  +     L+
Sbjct: 5   TVARDITLLECVGKGRYGEVWRGSWQ-GENVAVKIFSS---RDEKSWFRETELYNTVMLR 60

Query: 537 HRNLVRLLGCCVEGEEK----MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 592
           H N++  +   +          LI  Y    SL    +D L+   LD      I+  I+ 
Sbjct: 61  HENILGFIASDMTSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIAS 116

Query: 593 GLLYLHRDSRLR-----IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR-- 645
           GL +LH +         I HRDLK+ NIL+ +     I+D G+A +   + +Q D G   
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNP 176

Query: 646 VVGTFGYMSPE------YAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFED 691
            VGT  YM+PE              ++ D+++FG++L E+     +    ED
Sbjct: 177 RVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 228

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  185 bits (472), Expect = 8e-53
 Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 29/224 (12%)

Query: 474 FEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRL--SKASGQGLEEFMNEVMV 531
           FE+L       ++   +G+G FG VY GR     E+A++ +   + +   L+ F  EVM 
Sbjct: 32  FEQL-------EIGELIGKGRFGQVYHGRWH--GEVAIRLIDIERDNEDQLKAFKREVMA 82

Query: 532 ISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGIS 591
             + +H N+V  +G C+      +I      R+L +++ D   K  LD  K   I + I 
Sbjct: 83  YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIV 140

Query: 592 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR---VVG 648
           +G+ YLH      I+H+DLK+ N+  D      I+DFG+  I G  Q      +     G
Sbjct: 141 KGMGYLH---AKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNG 196

Query: 649 TFGYMSPE---------YAMEGRFSEKSDVFSFGVLLLEIVSGR 683
              +++PE            +  FS+ SDVF+ G +  E+ +  
Sbjct: 197 WLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  180 bits (459), Expect = 6e-51
 Identities = 59/232 (25%), Positives = 102/232 (43%), Gaps = 27/232 (11%)

Query: 479 TATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNE--VMVISKLQ 536
           T     Q+  ++G+G +G V+ G+ + G+++AVK            +  E  +     ++
Sbjct: 34  TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFT---TEEASWFRETEIYQTVLMR 89

Query: 537 HRNLVRLLGCCVEGEEK----MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 592
           H N++  +   ++G        LI +Y  N SL    +D LK   LD +    +      
Sbjct: 90  HENILGFIAADIKGTGSWTQLYLITDYHENGSL----YDYLKSTTLDAKSMLKLAYSSVS 145

Query: 593 GLLYLHRDSRLR-----IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD--TGR 645
           GL +LH +         I HRDLK+ NIL+ +     I+D G+A  F  + ++ D     
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNT 205

Query: 646 VVGTFGYMSPE------YAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFED 691
            VGT  YM PE           +    +D++SFG++L E+     +    E+
Sbjct: 206 RVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE 257

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  177 bits (450), Expect = 1e-49
 Identities = 60/243 (24%), Positives = 102/243 (41%), Gaps = 32/243 (13%)

Query: 469 LPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNE 528
           LPL     +A       L   +G+G FG V+ G+ + G+E+AVK  S    +    +  E
Sbjct: 32  LPLLVQRTIA---RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSS---REERSWFRE 84

Query: 529 --VMVISKLQHRNLVRLLGCCVEGEEK----MLIYEYMPNRSLDALLFDPLKKERLDWRK 582
             +     L+H N++  +    +         L+ +Y  + SL    FD L +  +    
Sbjct: 85  AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEG 140

Query: 583 RFNIIEGISRGLLYLHRD-----SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 637
              +    + GL +LH +      +  I HRDLK+ NIL+ +     I+D G+A      
Sbjct: 141 MIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA 200

Query: 638 QDQADTGR--VVGTFGYMSPEYAMEG-------RFSEKSDVFSFGVLLLEIVSGRKNTSF 688
            D  D      VGT  YM+PE  ++           +++D+++ G++  EI         
Sbjct: 201 TDTIDIAPNHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 259

Query: 689 FED 691
            ED
Sbjct: 260 HED 262

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  175 bits (446), Expect = 3e-49
 Identities = 76/290 (26%), Positives = 124/290 (42%), Gaps = 28/290 (9%)

Query: 482 NNFQLSSKLGQGGFGPVY---WGRLKDGQEI--AVKRL-SKASGQGLEEFMNEVMVISKL 535
              +    LG+G FG V    +    DG     AVK L + A  Q    +  E+ ++  L
Sbjct: 31  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90

Query: 536 QHRNLVRLLGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRG 593
            H ++++  GCC +       L+ EY+P  SL     D L +  +   +     + I  G
Sbjct: 91  YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLR----DYLPRHSIGLAQLLLFAQQICEG 146

Query: 594 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD--QADTGRVVGTFG 651
           + YLH       IHRDL A N+LLD +   KI DFG+AK      +  +         F 
Sbjct: 147 MAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF- 202

Query: 652 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILA 710
           + +PE   E +F   SDV+SFGV L E+++    + S     L ++G A       ++  
Sbjct: 203 WYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262

Query: 711 LVDPFLSESSFQLDMIIRC---IH-VGLLCVQELVKDRPNMSTVVSMLNS 756
           L+     E   +L    +C   ++ +   C +     RP    ++ +L +
Sbjct: 263 LL-----ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKT 307

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  175 bits (447), Expect = 8e-49
 Identities = 62/204 (30%), Positives = 96/204 (47%), Gaps = 11/204 (5%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRL-SKASGQGLEEFMNEVMVISKLQHRN 539
            +  L  ++G+G FG V+ GRL+ D   +AVK            +F+ E  ++ +  H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173

Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 599
           +VRL+G C + +   ++ E +        L    +  RL  +    ++   + G+ YL  
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLE- 230

Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY--MSPEY 657
                 IHRDL A N L+ E+   KISDFGM++        A  G           +PE 
Sbjct: 231 --SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGL--RQVPVKWTAPEA 286

Query: 658 AMEGRFSEKSDVFSFGVLLLEIVS 681
              GR+S +SDV+SFG+LL E  S
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFS 310

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  173 bits (440), Expect = 2e-48
 Identities = 73/226 (32%), Positives = 114/226 (50%), Gaps = 16/226 (7%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRL-----KDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ 536
            + +   +LG+G FG V   R        G+ +AVK+L  ++ + L +F  E+ ++  LQ
Sbjct: 41  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100

Query: 537 HRNLVRLLGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 594
           H N+V+  G C     +   LI EY+P  SL   L     KER+D  K       I +G+
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 158

Query: 595 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD--QADTGRVVGTFGY 652
            YL      R IHRDL   NIL++ E   KI DFG+ K+   +++  +         F +
Sbjct: 159 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF-W 214

Query: 653 MSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILG 697
            +PE   E +FS  SDV+SFGV+L E+ +   K+ S   + + ++G
Sbjct: 215 YAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 260

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  171 bits (435), Expect = 5e-48
 Identities = 73/226 (32%), Positives = 114/226 (50%), Gaps = 16/226 (7%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLK-----DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ 536
            + +   +LG+G FG V   R        G+ +AVK+L  ++ + L +F  E+ ++  LQ
Sbjct: 10  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69

Query: 537 HRNLVRLLGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 594
           H N+V+  G C     +   LI EY+P  SL   L     KER+D  K       I +G+
Sbjct: 70  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 127

Query: 595 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD--QADTGRVVGTFGY 652
            YL      R IHRDL   NIL++ E   KI DFG+ K+   +++  +         F +
Sbjct: 128 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF-W 183

Query: 653 MSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILG 697
            +PE   E +FS  SDV+SFGV+L E+ +   K+ S   + + ++G
Sbjct: 184 YAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 229

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  171 bits (435), Expect = 1e-47
 Identities = 83/304 (27%), Positives = 138/304 (45%), Gaps = 25/304 (8%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLK-----DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ 536
            + +  S+LG+G FG V   R        G  +AVK+L  +      +F  E+ ++  L 
Sbjct: 23  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82

Query: 537 HRNLVRLLGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 594
              +V+  G       +   L+ EY+P+  L   L     + RLD  +       I +G+
Sbjct: 83  SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGM 140

Query: 595 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD--QADTGRVVGTFGY 652
            YL      R +HRDL A NIL++ E + KI+DFG+AK+   ++D            F +
Sbjct: 141 EYL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF-W 196

Query: 653 MSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILAL 711
            +PE   +  FS +SDV+SFGV+L E+ +   K+ S   + L ++G    +   +++L L
Sbjct: 197 YAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256

Query: 712 VDPFLSESSFQLDMIIRC---IH-VGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEP 767
           +     E   +L     C   +H +  LC     +DRP+ S +   L+         +  
Sbjct: 257 L-----EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETH 311

Query: 768 AFTE 771
           AFT 
Sbjct: 312 AFTA 315

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  168 bits (428), Expect = 5e-47
 Identities = 70/293 (23%), Positives = 133/293 (45%), Gaps = 26/293 (8%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLK-----DGQEIAVKRL-SKASGQGLEEFMNEVMVISKL 535
              +    LG+G FG V   R        G+++AVK L  ++ G  + +   E+ ++  L
Sbjct: 21  RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80

Query: 536 QHRNLVRLLGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRG 593
            H N+V+  G C E       LI E++P+ SL   L  P  K +++ +++      I +G
Sbjct: 81  YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKG 138

Query: 594 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD--QADTGRVVGTFG 651
           + YL      + +HRDL A N+L++ E   KI DFG+ K    +++       R    F 
Sbjct: 139 MDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF- 194

Query: 652 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILA 710
           + +PE  M+ +F   SDV+SFGV L E+++    ++S     L ++G         +++ 
Sbjct: 195 WYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254

Query: 711 LVDPFLSESSFQLDMIIRC---IH-VGLLCVQELVKDRPNMSTVVSMLNSEIR 759
            +     +   +L     C   ++ +   C +    +R +   ++    + ++
Sbjct: 255 TL-----KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  166 bits (424), Expect = 9e-47
 Identities = 63/206 (30%), Positives = 98/206 (47%), Gaps = 12/206 (5%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 541
               L  +LG G FG V  G+ K   ++AVK + K      +EF  E   + KL H  LV
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLV 66

Query: 542 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
           +  G C +     ++ EY+ N  L   L      + L+  +   +   +  G+ +L    
Sbjct: 67  KFYGVCSKEYPIYIVTEYISNGCLLNYLRS--HGKGLEPSQLLEMCYDVCEGMAFL---E 121

Query: 602 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY--MSPEYAM 659
             + IHRDL A N L+D +L  K+SDFGM +    +Q  +  G     F     +PE   
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVG---TKFPVKWSAPEVFH 178

Query: 660 EGRFSEKSDVFSFGVLLLEIVS-GRK 684
             ++S KSDV++FG+L+ E+ S G+ 
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFSLGKM 204

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  167 bits (425), Expect = 9e-47
 Identities = 60/202 (29%), Positives = 101/202 (50%), Gaps = 11/202 (5%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 541
            +     +LG G FG V +G+ +   ++A+K + K      +EF+ E  V+  L H  LV
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLV 82

Query: 542 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
           +L G C +     +I EYM N  L   L +   + R   ++   + + +   + YL    
Sbjct: 83  QLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYL---E 137

Query: 602 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY--MSPEYAM 659
             + +HRDL A N L++++   K+SDFG+++    ++  +  G     F      PE  M
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG---SKFPVRWSPPEVLM 194

Query: 660 EGRFSEKSDVFSFGVLLLEIVS 681
             +FS KSD+++FGVL+ EI S
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIYS 216

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  166 bits (422), Expect = 1e-46
 Identities = 65/206 (31%), Positives = 99/206 (48%), Gaps = 12/206 (5%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 541
           +      ++G G FG V+ G   +  ++A+K + +      E+F+ E  V+ KL H  LV
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 66

Query: 542 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
           +L G C+E     L+ E+M +  L   L    ++          +   +  G+ YL    
Sbjct: 67  QLYGVCLEQAPICLVTEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYL---E 121

Query: 602 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY--MSPEYAM 659
              +IHRDL A N L+ E    K+SDFGM +    +Q  + TG     F     SPE   
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG---TKFPVKWASPEVFS 178

Query: 660 EGRFSEKSDVFSFGVLLLEIVS-GRK 684
             R+S KSDV+SFGVL+ E+ S G+ 
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFSEGKI 204

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  166 bits (422), Expect = 7e-46
 Identities = 63/231 (27%), Positives = 106/231 (45%), Gaps = 47/231 (20%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQE------IAVKRLSKASGQGLEEFMNEVMVISKL 535
            +  L  +LG+G FG V+     +         +AVK L +AS    ++F  E  +++ L
Sbjct: 41  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100

Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL------------FDPLKKERLDWRKR 583
           QH+++VR  G C EG   ++++EYM +  L+  L             + +    L   + 
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160

Query: 584 FNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 643
             +   ++ G++YL   + L  +HRDL   N L+ + L  KI DFGM+            
Sbjct: 161 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMS------------ 205

Query: 644 GRVVGTFGY-------------MSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
            R + +  Y             M PE  +  +F+ +SDV+SFGV+L EI +
Sbjct: 206 -RDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  164 bits (418), Expect = 1e-45
 Identities = 63/232 (27%), Positives = 102/232 (43%), Gaps = 48/232 (20%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDG------QEIAVKRLSKASGQGLEEFMNEVMVISKL 535
            +  L  +LG+G FG V+     +         +AVK L   +    ++F  E  +++ L
Sbjct: 15  RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74

Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-------------FDPLKKERLDWRK 582
           QH ++V+  G C +G+  ++++EYM +  L+  L                  K  L   +
Sbjct: 75  QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134

Query: 583 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD 642
             +I   I+ G++YL   +    +HRDL   N L+   L  KI DFGM+           
Sbjct: 135 MLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMS----------- 180

Query: 643 TGRVVGTFGY-------------MSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
             R V +  Y             M PE  M  +F+ +SDV+SFGV+L EI +
Sbjct: 181 --RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  164 bits (417), Expect = 1e-45
 Identities = 68/203 (33%), Positives = 102/203 (50%), Gaps = 11/203 (5%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDG-QEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 540
            +  +  KLG G +G VY G  K     +AVK L K     +EEF+ E  V+ +++H NL
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 71

Query: 541 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 600
           V+LLG C       +I E+M   +L   L +   ++ +       +   IS  + YL   
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL--- 127

Query: 601 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY--MSPEYA 658
            +   IHRDL A N L+ E    K++DFG++++  G+   A  G     F     +PE  
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG---AKFPIKWTAPESL 184

Query: 659 MEGRFSEKSDVFSFGVLLLEIVS 681
              +FS KSDV++FGVLL EI +
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIAT 207

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  169 bits (429), Expect = 1e-45
 Identities = 68/202 (33%), Positives = 103/202 (50%), Gaps = 11/202 (5%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 541
            + +L  KLG G FG V+        ++AVK + K     +E F+ E  V+  LQH  LV
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV 246

Query: 542 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
           +L     + E   +I E+M   SL   L    +  +    K  +    I+ G+ ++    
Sbjct: 247 KLHAVVTK-EPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFI---E 301

Query: 602 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY--MSPEYAM 659
           +   IHRDL+A+NIL+   L  KI+DFG+A++   N+  A  G     F     +PE   
Sbjct: 302 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG---AKFPIKWTAPEAIN 358

Query: 660 EGRFSEKSDVFSFGVLLLEIVS 681
            G F+ KSDV+SFG+LL+EIV+
Sbjct: 359 FGSFTIKSDVWSFGILLMEIVT 380

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  169 bits (431), Expect = 1e-45
 Identities = 66/201 (32%), Positives = 102/201 (50%), Gaps = 7/201 (3%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 540
            +  +  KLG G +G VY G  K     +AVK L K     +EEF+ E  V+ +++H NL
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 278

Query: 541 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 600
           V+LLG C       +I E+M   +L   L +   ++ +       +   IS  + YL   
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL--- 334

Query: 601 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
            +   IHR+L A N L+ E    K++DFG++++  G+   A  G       + +PE    
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAY 393

Query: 661 GRFSEKSDVFSFGVLLLEIVS 681
            +FS KSDV++FGVLL EI +
Sbjct: 394 NKFSIKSDVWAFGVLLWEIAT 414

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  165 bits (419), Expect = 2e-45
 Identities = 63/212 (29%), Positives = 110/212 (51%), Gaps = 17/212 (8%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQE-----IAVKRLSK-ASGQGLEEFMNEVMVISKL 535
             F+    LG G FG VY G      E     +A+K L +  S +  +E ++E  V++ +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74

Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
            + ++ RLLG C+      LI + MP   L   + +   K+ +  +   N    I++G+ 
Sbjct: 75  DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMN 131

Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD--QADTGRVVGTFGYM 653
           YL      R++HRDL A N+L+    + KI+DFG+AK+ G  +    A+ G+V     +M
Sbjct: 132 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 186

Query: 654 SPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRK 684
           + E  +   ++ +SDV+S+GV + E+++ G K
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  164 bits (418), Expect = 2e-45
 Identities = 64/211 (30%), Positives = 109/211 (51%), Gaps = 14/211 (6%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLK--DGQEI--AVKRL-SKASGQGLEEFMNEVMVISKLQ 536
           +   +   +G G  G V +GRL+    +++  A+K L +  + +   +F++E  ++ +  
Sbjct: 49  SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108

Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 596
           H N++RL G    G   M++ EYM N SLD  L       +    +   ++ G+  G+ Y
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRY 166

Query: 597 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY--MS 654
           L   S L  +HRDL A N+L+D  L  K+SDFG++++   + D A T    G       +
Sbjct: 167 L---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYT-TTGGKIPIRWTA 222

Query: 655 PEYAMEGRFSEKSDVFSFGVLLLEIVS-GRK 684
           PE      FS  SDV+SFGV++ E+++ G +
Sbjct: 223 PEAIAFRTFSSASDVWSFGVVMWEVLAYGER 253

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  163 bits (414), Expect = 3e-45
 Identities = 72/202 (35%), Positives = 107/202 (52%), Gaps = 11/202 (5%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 541
              +L  +LG G FG V+ G      ++AVK L K      + F+ E  ++ +LQH+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71

Query: 542 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
           RL     + E   +I EYM N SL   L  P    +L   K  ++   I+ G+ ++    
Sbjct: 72  RLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFI---E 126

Query: 602 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY--MSPEYAM 659
               IHRDL+A+NIL+ + L+ KI+DFG+A++    +D   T R    F     +PE   
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAIN 183

Query: 660 EGRFSEKSDVFSFGVLLLEIVS 681
            G F+ KSDV+SFG+LL EIV+
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVT 205

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  163 bits (414), Expect = 3e-45
 Identities = 69/233 (29%), Positives = 106/233 (45%), Gaps = 49/233 (21%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDG------QEIAVKRLSK-ASGQGLEEFMNEVMVISK 534
           +  +   +LG+  FG VY G L         Q +A+K L   A G   EEF +E M+ ++
Sbjct: 9   SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR 68

Query: 535 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-------------FDPLKKERLDWR 581
           LQH N+V LLG   + +   +I+ Y  +  L   L              D   K  L+  
Sbjct: 69  LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128

Query: 582 KRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA 641
              +++  I+ G+ YL   S   ++H+DL   N+L+ ++LN KISD G+           
Sbjct: 129 DFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLF---------- 175

Query: 642 DTGRVVGTFGY-------------MSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
              R V    Y             M+PE  M G+FS  SD++S+GV+L E+ S
Sbjct: 176 ---REVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  164 bits (416), Expect = 6e-45
 Identities = 61/212 (28%), Positives = 107/212 (50%), Gaps = 15/212 (7%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQE-----IAVKRLSK-ASGQGLEEFMNEVMVISKL 535
           +       +G G FG VY G LK         +A+K L    + +   +F+ E  ++ + 
Sbjct: 44  SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103

Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
            H N++RL G   + +  M+I EYM N +LD  L +  K       +   ++ GI+ G+ 
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMK 161

Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY--M 653
           YL   + +  +HRDL A NIL++  L  K+SDFG++++   + + A      G       
Sbjct: 162 YL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE-ATYTTSGGKIPIRWT 217

Query: 654 SPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRK 684
           +PE     +F+  SDV+SFG+++ E+++ G +
Sbjct: 218 APEAISYRKFTSASDVWSFGIVMWEVMTYGER 249

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  163 bits (414), Expect = 2e-44
 Identities = 67/211 (31%), Positives = 110/211 (52%), Gaps = 14/211 (6%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLK--DGQEI--AVKRLSK-ASGQGLEEFMNEVMVISKLQ 536
            N  +   +G G FG V  GRLK    +EI  A+K L    + +   +F+ E  ++ +  
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104

Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 596
           H N++RL G   + +  M++ EYM N SLD+ L       +    +   ++ GI+ G+ Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKY 162

Query: 597 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY--MS 654
           L   S +  +HRDL A NIL++  L  K+SDFG+ ++   + + A T    G       S
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYT-TRGGKIPIRWTS 218

Query: 655 PEYAMEGRFSEKSDVFSFGVLLLEIVS-GRK 684
           PE     +F+  SDV+S+G++L E++S G +
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  165 bits (419), Expect = 3e-44
 Identities = 65/203 (32%), Positives = 96/203 (47%), Gaps = 17/203 (8%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 541
              +L   +G+G FG V  G  + G ++AVK +   +    + F+ E  V+++L+H NLV
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 249

Query: 542 RLLGCCVEGEEK-MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 600
           +LLG  VE +    ++ EYM   SL   L     +  L           +   + YL   
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL--- 305

Query: 601 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY--MSPEYA 658
                +HRDL A N+L+ E+   K+SDFG+ K               G       +PE  
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDT---GKLPVKWTAPEAL 358

Query: 659 MEGRFSEKSDVFSFGVLLLEIVS 681
            E +FS KSDV+SFG+LL EI S
Sbjct: 359 REKKFSTKSDVWSFGILLWEIYS 381

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  159 bits (404), Expect = 5e-44
 Identities = 67/207 (32%), Positives = 98/207 (47%), Gaps = 18/207 (8%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 541
              +L   +G+G FG V  G  + G ++AVK +   +    + F+ E  V+++L+H NLV
Sbjct: 21  KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLV 77

Query: 542 RLLGCCVEGEEK-MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 600
           +LLG  VE +    ++ EYM   SL   L     +  L           +   + YL   
Sbjct: 78  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL--- 133

Query: 601 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY--MSPEYA 658
                +HRDL A N+L+ E+   K+SDFG+ K               G       +PE  
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDT---GKLPVKWTAPEAL 186

Query: 659 MEGRFSEKSDVFSFGVLLLEIVS-GRK 684
            E +FS KSDV+SFG+LL EI S GR 
Sbjct: 187 REKKFSTKSDVWSFGILLWEIYSFGRV 213

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  160 bits (407), Expect = 7e-44
 Identities = 68/227 (29%), Positives = 103/227 (45%), Gaps = 43/227 (18%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQE------IAVKRLSK-ASGQGLEEFMNEVMVISK 534
               +S +LGQG FG VY G  K   +      +A+K +++ AS +   EF+NE  V+ +
Sbjct: 25  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84

Query: 535 LQHRNLVRLLGCCVEGEEKMLIYEYMPN-------RSLDALLFDPLKKERLDWRKRFNII 587
               ++VRLLG   +G+  ++I E M         RSL   + +          K   + 
Sbjct: 85  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144

Query: 588 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVV 647
             I+ G+ YL   +  + +HRDL A N ++ E+   KI DFGM              R +
Sbjct: 145 GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMT-------------RDI 188

Query: 648 GTFGY-------------MSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
               Y             MSPE   +G F+  SDV+SFGV+L EI +
Sbjct: 189 YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  159 bits (404), Expect = 1e-43
 Identities = 58/209 (27%), Positives = 101/209 (48%), Gaps = 21/209 (10%)

Query: 485 QLSSKLGQGGFGPVYWGRLKDG----QEIAVKRLSK-ASGQGLEEFMNEVMVISKLQHRN 539
             +  +G+G FG VY G L D        AVK L++      + +F+ E +++    H N
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87

Query: 540 LVRLLGCCVEGEEK-MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           ++ LLG C+  E   +++  YM +  L   + +         +        +++G+ YL 
Sbjct: 88  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYL- 144

Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFG------Y 652
             +  + +HRDL A N +LDE+   K++DFG+A+         +   V    G      +
Sbjct: 145 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM----YDKEYYSVHNKTGAKLPVKW 198

Query: 653 MSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           M+ E     +F+ KSDV+SFGVLL E+++
Sbjct: 199 MALESLQTQKFTTKSDVWSFGVLLWELMT 227

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  158 bits (403), Expect = 1e-43
 Identities = 62/213 (29%), Positives = 92/213 (43%), Gaps = 17/213 (7%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLK--DGQEI--AVKRL---SKASGQGLEEFMNEVMVISK 534
            + +L  KLG G FG V  G      G+ +  AVK L     +  + +++F+ EV  +  
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77

Query: 535 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 594
           L HRNL+RL G  +      ++ E  P  SL   L     +              ++ G+
Sbjct: 78  LDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGM 134

Query: 595 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY-- 652
            YL      R IHRDL A N+LL      KI DFG+ +    N D     +      +  
Sbjct: 135 GYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY-VMQEHRKVPFAW 190

Query: 653 MSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRK 684
            +PE      FS  SD + FGV L E+ + G++
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  158 bits (402), Expect = 2e-43
 Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 13/205 (6%)

Query: 485 QLSSKLGQGGFGPVYWGRLKDGQE----IAVKRLSK-ASGQGLEEFMNEVMVISKLQHRN 539
                +G+G FG VY G   D  +     A+K LS+    Q +E F+ E +++  L H N
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83

Query: 540 LVRLLGCCVEGEE-KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           ++ L+G  +  E    ++  YM +  L   +  P  +     +   +    ++RG+ YL 
Sbjct: 84  VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYL- 140

Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMSPE 656
             +  + +HRDL A N +LDE    K++DFG+A+     +  +            + + E
Sbjct: 141 --AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE 198

Query: 657 YAMEGRFSEKSDVFSFGVLLLEIVS 681
                RF+ KSDV+SFGVLL E+++
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLT 223

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  164 bits (416), Expect = 3e-43
 Identities = 71/200 (35%), Positives = 108/200 (54%), Gaps = 7/200 (3%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 541
            + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+ KL+H  LV
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 325

Query: 542 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
           +L     E E   ++ EYM   SL   L      + L   +  ++   I+ G+ Y+    
Sbjct: 326 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---E 380

Query: 602 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 661
           R+  +HRDL+A+NIL+ E L  K++DFG+A++   N+  A  G       + +PE A+ G
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 439

Query: 662 RFSEKSDVFSFGVLLLEIVS 681
           RF+ KSDV+SFG+LL E+ +
Sbjct: 440 RFTIKSDVWSFGILLTELTT 459

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  161 bits (410), Expect = 4e-43
 Identities = 71/200 (35%), Positives = 108/200 (54%), Gaps = 7/200 (3%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 541
            + +L  KLGQG FG V+ G       +A+K L K      E F+ E  V+ KL+H  LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 242

Query: 542 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
           +L     E E   ++ EYM   SL   L      + L   +  ++   I+ G+ Y+    
Sbjct: 243 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---E 297

Query: 602 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 661
           R+  +HRDL+A+NIL+ E L  K++DFG+A++   N+  A  G       + +PE A+ G
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 356

Query: 662 RFSEKSDVFSFGVLLLEIVS 681
           RF+ KSDV+SFG+LL E+ +
Sbjct: 357 RFTIKSDVWSFGILLTELTT 376

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  158 bits (401), Expect = 4e-43
 Identities = 58/227 (25%), Positives = 100/227 (44%), Gaps = 43/227 (18%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQE----IAVKRLSK--ASGQGLEEFMNEVMVISKL 535
           N   L   LG+G FG V  G LK        +AVK +    +S + +EEF++E   +   
Sbjct: 34  NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93

Query: 536 QHRNLVRLLGCCVEGE-----EKMLIYEYMPNRSLDALL---FDPLKKERLDWRKRFNII 587
            H N++RLLG C+E       + M+I  +M    L   L         + +  +     +
Sbjct: 94  SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153

Query: 588 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVV 647
             I+ G+ YL   S    +HRDL A N +L +++   ++DFG++             + +
Sbjct: 154 VDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLS-------------KKI 197

Query: 648 GTFGY-------------MSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
            +  Y             ++ E   +  ++ KSDV++FGV + EI +
Sbjct: 198 YSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  158 bits (402), Expect = 4e-43
 Identities = 63/212 (29%), Positives = 109/212 (51%), Gaps = 17/212 (8%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQE-----IAVKRL-SKASGQGLEEFMNEVMVISKL 535
             F+    LG G FG VY G      E     +A+K L    S +  +E ++E  V++ +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74

Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
            + ++ RLLG C+      LI + MP   L   + +   K+ +  +   N    I++G+ 
Sbjct: 75  DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMN 131

Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD--QADTGRVVGTFGYM 653
           YL      R++HRDL A N+L+    + KI+DFG+AK+ G  +    A+ G+V     +M
Sbjct: 132 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 186

Query: 654 SPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRK 684
           + E  +   ++ +SDV+S+GV + E+++ G K
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  157 bits (398), Expect = 5e-43
 Identities = 66/203 (32%), Positives = 102/203 (50%), Gaps = 14/203 (6%)

Query: 489 KLGQGGFGPVYWGRLKDGQE---IAVKRLSK-ASGQGLEEFMNEVMVISKLQHRNLVRLL 544
           +LG G FG V  G  +  ++   +A+K L +       EE M E  ++ +L +  +VRL+
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76

Query: 545 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 604
           G C + E  ML+ E      L   L    K+E +       ++  +S G+ YL       
Sbjct: 77  GVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYL---EEKN 130

Query: 605 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMSPEYAMEGR 662
            +HRDL A N+LL      KISDFG++K  G + D   T R  G +   + +PE     +
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD-DSYYTARSAGKWPLKWYAPECINFRK 189

Query: 663 FSEKSDVFSFGVLLLEIVS-GRK 684
           FS +SDV+S+GV + E +S G+K
Sbjct: 190 FSSRSDVWSYGVTMWEALSYGQK 212

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  158 bits (401), Expect = 5e-43
 Identities = 72/219 (32%), Positives = 101/219 (46%), Gaps = 27/219 (12%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDG------QEIAVKRLSK-ASGQGLEEFMNEVMVISK 534
            N  L   LG G FG VY G++          ++AVK L +  S Q   +F+ E ++ISK
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89

Query: 535 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL----FDPLKKERLDWRKRFNIIEGI 590
             H+N+VR +G  ++   + ++ E M    L + L      P +   L      ++   I
Sbjct: 90  FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149

Query: 591 SRGLLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKIFGGNQDQADTGRVV 647
           + G  YL        IHRD+ A N LL         KI DFGMA+    +  +A   R  
Sbjct: 150 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYR-K 201

Query: 648 GTFGY-----MSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           G         M PE  MEG F+ K+D +SFGVLL EI S
Sbjct: 202 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  157 bits (398), Expect = 5e-43
 Identities = 57/228 (25%), Positives = 95/228 (41%), Gaps = 43/228 (18%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKD--------GQEIAVKRLSKASGQGLEEFMNEVMVIS 533
            +   +  LGQG F  ++ G  ++          E+ +K L KA     E F     ++S
Sbjct: 8   EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67

Query: 534 KLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRG 593
           KL H++LV   G CV G+E +L+ E++   SLD  L     K  ++   +  + + ++  
Sbjct: 68  KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAA 125

Query: 594 LLYLHRDSRLRIIHRDLKASNILLDEELNP--------KISDFGMAKIFGGNQDQADTGR 645
           + +L       +IH ++ A NILL  E +         K+SD G++              
Sbjct: 126 MHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS-------------I 169

Query: 646 VVGTFGY-------MSPEYAMEGR-FSEKSDVFSFGVLLLEIVS-GRK 684
            V            + PE     +  +  +D +SFG  L EI S G K
Sbjct: 170 TVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  157 bits (400), Expect = 1e-42
 Identities = 67/270 (24%), Positives = 113/270 (41%), Gaps = 41/270 (15%)

Query: 445 IAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLK 504
           +    +E++      N    ++  L   +   L    NN +    +G+G FG V+  R  
Sbjct: 10  LTTLPSELLLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAP 69

Query: 505 DG------QEIAVKRL-SKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 557
                     +AVK L  +AS     +F  E  ++++  + N+V+LLG C  G+   L++
Sbjct: 70  GLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLF 129

Query: 558 EYMPNRSLDALL---------------------FDPLKKERLDWRKRFNIIEGISRGLLY 596
           EYM    L+  L                             L   ++  I   ++ G+ Y
Sbjct: 130 EYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAY 189

Query: 597 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY---- 652
           L   S  + +HRDL   N L+ E +  KI+DFG+++    N   AD  +           
Sbjct: 190 L---SERKFVHRDLATRNCLVGENMVVKIADFGLSR----NIYSADYYK-ADGNDAIPIR 241

Query: 653 -MSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
            M PE     R++ +SDV+++GV+L EI S
Sbjct: 242 WMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  157 bits (399), Expect = 1e-42
 Identities = 70/223 (31%), Positives = 103/223 (46%), Gaps = 34/223 (15%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQE---IAVKRL-SKASGQGLEEFMNEVMVISKL-Q 536
           N+ +    +G+G FG V   R+K        A+KR+   AS     +F  E+ V+ KL  
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84

Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-------FDPLKKERLDWRKRFNIIE- 588
           H N++ LLG C       L  EY P+ +L   L        DP            +  + 
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144

Query: 589 -----GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 643
                 ++RG+ YL   S+ + IHRDL A NIL+ E    KI+DFG+++     Q+    
Sbjct: 145 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVY-- 195

Query: 644 GRVVGTFG-----YMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
             V  T G     +M+ E      ++  SDV+S+GVLL EIVS
Sbjct: 196 --VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  157 bits (398), Expect = 1e-42
 Identities = 59/249 (23%), Positives = 107/249 (42%), Gaps = 44/249 (17%)

Query: 461 VNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDG----QEIAVKRLSK 516
           ++++ + D    + E++      F L   LG+G FG V   +LK       ++AVK L  
Sbjct: 2   LDSLGISDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKA 61

Query: 517 --ASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEK------MLIYEYMPNRSLDAL 568
              +   +EEF+ E   + +  H ++ +L+G  +    K      M+I  +M +  L A 
Sbjct: 62  DIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAF 121

Query: 569 LFD---PLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKI 625
           L           L  +     +  I+ G+ YL   S    IHRDL A N +L E++   +
Sbjct: 122 LLASRIGENPFNLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCV 178

Query: 626 SDFGMAKIFGGNQDQADTGRVVGTFGY-------------MSPEYAMEGRFSEKSDVFSF 672
           +DFG++             R + +  Y             ++ E   +  ++  SDV++F
Sbjct: 179 ADFGLS-------------RKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAF 225

Query: 673 GVLLLEIVS 681
           GV + EI++
Sbjct: 226 GVTMWEIMT 234

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  155 bits (394), Expect = 1e-42
 Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 17/211 (8%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLK--DGQEI--AVKRLSK-ASGQGLEEFMNEVMVISKLQ 536
            +  L+  LG+G FG VY G      G++I  AVK   K  +    E+FM+E +++  L 
Sbjct: 12  EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71

Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 596
           H ++V+L+G   E E   +I E  P   L   L     K  L           I + + Y
Sbjct: 72  HPHIVKLIGII-EEEPTWIIMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAY 128

Query: 597 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMS 654
           L     +  +HRD+   NIL+      K+ DFG+++     +D+      V      +MS
Sbjct: 129 L---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYI---EDEDYYKASVTRLPIKWMS 182

Query: 655 PEYAMEGRFSEKSDVFSFGVLLLEIVS-GRK 684
           PE     RF+  SDV+ F V + EI+S G++
Sbjct: 183 PESINFRRFTTASDVWMFAVCMWEILSFGKQ 213

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  155 bits (394), Expect = 2e-42
 Identities = 65/206 (31%), Positives = 102/206 (49%), Gaps = 20/206 (9%)

Query: 489 KLGQGGFGPVYWGRLKDG---QEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRL 543
           +LG G FG V  G  +     + +AVK L          +E + E  V+ +L +  +VR+
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 544 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 603
           +G C E E  ML+ E      L+  L    +   +  +    ++  +S G+ YL      
Sbjct: 84  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL---EES 136

Query: 604 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD--QADTGRVVGTF--GYMSPEYAM 659
             +HRDL A N+LL  +   KISDFG++K    +++  +A T    G +   + +PE   
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH---GKWPVKWYAPECIN 193

Query: 660 EGRFSEKSDVFSFGVLLLEIVS-GRK 684
             +FS KSDV+SFGVL+ E  S G+K
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQK 219

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  157 bits (400), Expect = 2e-42
 Identities = 56/209 (26%), Positives = 101/209 (48%), Gaps = 21/209 (10%)

Query: 485 QLSSKLGQGGFGPVYWGRLKDG----QEIAVKRLSK-ASGQGLEEFMNEVMVISKLQHRN 539
             +  +G+G FG VY G L D        AVK L++      + +F+ E +++    H N
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151

Query: 540 LVRLLGCCVEGEEK-MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           ++ LLG C+  E   +++  YM +  L   + +         +        +++G+ +L 
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFL- 208

Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAK-IFGGNQDQADTGRVVGTFG-----Y 652
             +  + +HRDL A N +LDE+   K++DFG+A+ ++    D                 +
Sbjct: 209 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTG----AKLPVKW 262

Query: 653 MSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           M+ E     +F+ KSDV+SFGVLL E+++
Sbjct: 263 MALESLQTQKFTTKSDVWSFGVLLWELMT 291

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  157 bits (399), Expect = 2e-42
 Identities = 72/219 (32%), Positives = 101/219 (46%), Gaps = 27/219 (12%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDG------QEIAVKRLSK-ASGQGLEEFMNEVMVISK 534
            N  L   LG G FG VY G++          ++AVK L +  S Q   +F+ E ++ISK
Sbjct: 71  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130

Query: 535 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL----FDPLKKERLDWRKRFNIIEGI 590
             H+N+VR +G  ++   + ++ E M    L + L      P +   L      ++   I
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190

Query: 591 SRGLLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKIFGGNQDQADTGRVV 647
           + G  YL        IHRD+ A N LL         KI DFGMA+    +  +A   R  
Sbjct: 191 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYR-K 242

Query: 648 GTFGY-----MSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           G         M PE  MEG F+ K+D +SFGVLL EI S
Sbjct: 243 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  156 bits (396), Expect = 2e-42
 Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 17/212 (8%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQE-----IAVKRLSKASG-QGLEEFMNEVMVISKL 535
              +    LG G FG V+ G      E     + +K +   SG Q  +   + ++ I  L
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72

Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
            H ++VRLLG C  G    L+ +Y+P  SL   +     +  L  +   N    I++G+ 
Sbjct: 73  DHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMY 129

Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD--QADTGRVVGTFGYM 653
           YL       ++HR+L A N+LL      +++DFG+A +   +         +      +M
Sbjct: 130 YL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKT--PIKWM 184

Query: 654 SPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRK 684
           + E    G+++ +SDV+S+GV + E+++ G +
Sbjct: 185 ALESIHFGKYTHQSDVWSYGVTVWELMTFGAE 216

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  154 bits (391), Expect = 4e-42
 Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 17/211 (8%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLK--DGQEI--AVKRLSK-ASGQGLEEFMNEVMVISKLQ 536
              +L   +G+G FG V+ G     +   +  A+K      S    E+F+ E + + +  
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74

Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 596
           H ++V+L+G   E     +I E      L + L    +K  LD          +S  L Y
Sbjct: 75  HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAY 131

Query: 597 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMS 654
           L      R +HRD+ A N+L+      K+ DFG+++     +D        G     +M+
Sbjct: 132 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMA 185

Query: 655 PEYAMEGRFSEKSDVFSFGVLLLEIVS-GRK 684
           PE     RF+  SDV+ FGV + EI+  G K
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEILMHGVK 216

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  155 bits (393), Expect = 8e-42
 Identities = 60/236 (25%), Positives = 105/236 (44%), Gaps = 52/236 (22%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKD--------GQEIAVKRL-SKASGQGLEEFMNEVMVI 532
           +   L   LG+G FG V                  +AVK L   A+ + L + ++E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94

Query: 533 SKL-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-------------FDPLKKERL 578
             + +H+N++ LLG C +     +I EY    +L   L              + + +E++
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154

Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
            ++   +    ++RG+ YL   +  + IHRDL A N+L+ E    KI+DFG+A       
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLA------- 204

Query: 639 DQADTGRVVGTFGY-------------MSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
                 R +    Y             M+PE   +  ++ +SDV+SFGVL+ EI +
Sbjct: 205 ------RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  155 bits (394), Expect = 1e-41
 Identities = 60/236 (25%), Positives = 105/236 (44%), Gaps = 52/236 (22%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKD--------GQEIAVKRL-SKASGQGLEEFMNEVMVI 532
           +   L   LG+G FG V                  +AVK L   A+ + L + ++E+ ++
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140

Query: 533 SKL-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-------------FDPLKKERL 578
             + +H+N++ LLG C +     +I EY    +L   L              + + +E++
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200

Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
            ++   +    ++RG+ YL   +  + IHRDL A N+L+ E    KI+DFG+A       
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLA------- 250

Query: 639 DQADTGRVVGTFGY-------------MSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
                 R +    Y             M+PE   +  ++ +SDV+SFGVL+ EI +
Sbjct: 251 ------RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  153 bits (390), Expect = 2e-41
 Identities = 65/220 (29%), Positives = 97/220 (44%), Gaps = 24/220 (10%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQE------IAVKRL-SKASGQGLEEFMNEVMVISK 534
           NN Q    LG G FG V         +      +AVK L S A     E  M+E+ ++S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105

Query: 535 L-QHRNLVRLLGCCVEGEEKMLIYEYMPN-----------RSLDALLFDPLKKERLDWRK 582
           L QH N+V LLG C  G   ++I EY              R L+      +       R 
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165

Query: 583 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA-KIFGGNQDQA 641
             +    +++G+ +L   +    IHRD+ A N+LL      KI DFG+A  I   +    
Sbjct: 166 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222

Query: 642 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
                +    +M+PE   +  ++ +SDV+S+G+LL EI S
Sbjct: 223 KGNARL-PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  154 bits (390), Expect = 2e-41
 Identities = 50/205 (24%), Positives = 99/205 (48%), Gaps = 9/205 (4%)

Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHR 538
             +    K+G+G FG     +  +DG++  +K   +S+ S +  EE   EV V++ ++H 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           N+V+      E     ++ +Y     L   + +  K       +  +    I   L ++H
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVH 142

Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 658
                +I+HRD+K+ NI L ++   ++ DFG+A++     + A     +GT  Y+SPE  
Sbjct: 143 DR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEIC 197

Query: 659 MEGRFSEKSDVFSFGVLLLEIVSGR 683
               ++ KSD+++ G +L E+ + +
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLK 222

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  153 bits (388), Expect = 2e-41
 Identities = 63/241 (26%), Positives = 97/241 (40%), Gaps = 57/241 (23%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDG------QEIAVKRL-SKASGQGLEEFMNEVMVISK 534
            N  L   LG+G FG V                +AVK L   AS   L + ++E  V+ +
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82

Query: 535 LQHRNLVRLLGCCVEGEEKMLIYEYMPN-------RSLDALLFDPLKKERLDWRKRFNII 587
           + H ++++L G C +    +LI EY          R    +    L           +  
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142

Query: 588 EG--------------ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 633
           +               IS+G+ YL   + ++++HRDL A NIL+ E    KISDFG++  
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLS-- 197

Query: 634 FGGNQDQADTGRVVGTFGY-------------MSPEYAMEGRFSEKSDVFSFGVLLLEIV 680
                      R V                  M+ E   +  ++ +SDV+SFGVLL EIV
Sbjct: 198 -----------RDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246

Query: 681 S 681
           +
Sbjct: 247 T 247

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  152 bits (386), Expect = 3e-41
 Identities = 69/316 (21%), Positives = 122/316 (38%), Gaps = 48/316 (15%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLS-KASGQGLEEFMNEVMVISKLQHRN 539
            +F+    LG+GGFG V+  + K D    A+KR+         E+ M EV  ++KL+H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 540 LVRLLGCCVEGEE---------KMLIY---EYMPNRSLDALLFDPLKKERLDWRKRFNII 587
           +VR     +E            K+ +Y   +     +L   +      E  +     +I 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124

Query: 588 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV- 646
             I+  + +LH      ++HRDLK SNI    +   K+ DFG+      ++++       
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181

Query: 647 ---------VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILG 697
                    VGT  YMSPE      +S K D+FS G++L E++       F      +  
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL-----YPFSTQMERVR- 235

Query: 698 YAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE 757
                    K      P  ++      ++++     +L       +RP    +   + + 
Sbjct: 236 -TLTDVRNLKF----PPLFTQKYPCEYVMVQ----DMLSPSP--MERPEAINI---IENA 281

Query: 758 -IRDLPYPKEPAFTER 772
              DL +P +    +R
Sbjct: 282 VFEDLDFPGKTVLRQR 297

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  152 bits (385), Expect = 5e-41
 Identities = 52/212 (24%), Positives = 98/212 (46%), Gaps = 20/212 (9%)

Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRL---SKASGQGLEEFMNEVMVISKLQH 537
            NF++  K+G+G F  VY    L DG  +A+K++        +   + + E+ ++ +L H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF------NIIEGIS 591
            N+++     +E  E  ++ E      L  ++     K     ++             + 
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMI-----KHFKKQKRLIPERTVWKYFVQLC 146

Query: 592 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFG 651
             L ++H     R++HRD+K +N+ +      K+ D G+ + F      A +  +VGT  
Sbjct: 147 SALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPY 201

Query: 652 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           YMSPE   E  ++ KSD++S G LL E+ + +
Sbjct: 202 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQ 233

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  152 bits (385), Expect = 6e-41
 Identities = 63/236 (26%), Positives = 89/236 (37%), Gaps = 52/236 (22%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQE------IAVKRL-SKASGQGLEEFMNEVMVISK 534
           N       LG G FG V         +      +AVK L   A     E  M+E+ V+S 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 535 L-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL---------------FDPLKKERL 578
           L  H N+V LLG C  G   ++I EY     L   L                    +  L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
           D     +    +++G+ +L   +    IHRDL A NILL      KI DFG+A       
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLA------- 192

Query: 639 DQADTGRVVGTFGY-------------MSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
                 R +                  M+PE      ++ +SDV+S+G+ L E+ S
Sbjct: 193 ------RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  158 bits (401), Expect = 6e-41
 Identities = 65/203 (32%), Positives = 99/203 (48%), Gaps = 14/203 (6%)

Query: 489 KLGQGGFGPVYWGRLKDGQE---IAVKRL-SKASGQGLEEFMNEVMVISKLQHRNLVRLL 544
           +LG G FG V  G  +  ++   +A+K L         EE M E  ++ +L +  +VRL+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402

Query: 545 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 604
           G C + E  ML+ E      L   L    K+E +       ++  +S G+ YL       
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYL---EEKN 456

Query: 605 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY--MSPEYAMEGR 662
            +HR+L A N+LL      KISDFG++K   G  D   T R  G +     +PE     +
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKAL-GADDSYYTARSAGKWPLKWYAPECINFRK 515

Query: 663 FSEKSDVFSFGVLLLEIVS-GRK 684
           FS +SDV+S+GV + E +S G+K
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQK 538

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  152 bits (386), Expect = 2e-40
 Identities = 62/236 (26%), Positives = 105/236 (44%), Gaps = 52/236 (22%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKD--------GQEIAVKRL-SKASGQGLEEFMNEVMVI 532
           +   L   LG+G FG V                 ++AVK L S A+ + L + ++E+ ++
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128

Query: 533 SKL-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSL-------------DALLFDPLKKERL 578
             + +H+N++ LLG C +     +I EY    +L              +       +E+L
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188

Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
             +   +    ++RG+ YL   +  + IHRDL A N+L+ E+   KI+DFG+A       
Sbjct: 189 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLA------- 238

Query: 639 DQADTGRVVGTFGY-------------MSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
                 R +    Y             M+PE   +  ++ +SDV+SFGVLL EI +
Sbjct: 239 ------RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  149 bits (379), Expect = 4e-40
 Identities = 65/235 (27%), Positives = 98/235 (41%), Gaps = 51/235 (21%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKD------GQEIAVKRL-SKASGQGLEEFMNEVMVISK 534
           +  +L   LG+G FG V              + +AVK L   A+       M+E+ ++  
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86

Query: 535 L-QHRNLVRLLGCC-VEGEEKMLIYEYMPNRSLDALL-------------FDPLKKERLD 579
           +  H N+V LLG C   G   M+I E+    +L   L              + L K+ L 
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146

Query: 580 WRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 639
                     +++G+ +L   +  + IHRDL A NILL E+   KI DFG+A        
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLA-------- 195

Query: 640 QADTGRVVGTFGY-------------MSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
                R +                  M+PE   +  ++ +SDV+SFGVLL EI S
Sbjct: 196 -----RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  147 bits (373), Expect = 9e-40
 Identities = 59/231 (25%), Positives = 104/231 (45%), Gaps = 30/231 (12%)

Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 540
            +F+    +G GGFG V+  +   DG+   +KR+   +    E+   EV  ++KL H N+
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66

Query: 541 VRLLGCCVEGEEKM----------------LIYEYMPNRSLDALLFDPLKKERLDWRKRF 584
           V   GC    +                   +  E+    +L+  + +  + E+LD     
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLAL 125

Query: 585 NIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG 644
            + E I++G+ Y+H     ++I+RDLK SNI L +    KI DFG+      +  +    
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRT--- 179

Query: 645 RVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTI 695
           R  GT  YMSPE      + ++ D+++ G++L E++      + FE     
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD--TAFETSKFF 228

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  154 bits (391), Expect = 2e-39
 Identities = 55/207 (26%), Positives = 91/207 (43%), Gaps = 16/207 (7%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLK--DGQEI--AVKRL-SKASGQGLEEFMNEVMVISKLQ 536
              +L   +G+G FG V+ G     +   +  A+K   +  S    E+F+ E + + +  
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449

Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 596
           H ++V+L+G   E     +I E      L + L    +K  LD          +S  L Y
Sbjct: 450 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAY 506

Query: 597 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF--GYMS 654
           L      R +HRD+ A N+L+      K+ DFG+++     +D        G     +M+
Sbjct: 507 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMA 560

Query: 655 PEYAMEGRFSEKSDVFSFGVLLLEIVS 681
           PE     RF+  SDV+ FGV + EI+ 
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILM 587

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  146 bits (370), Expect = 2e-39
 Identities = 67/286 (23%), Positives = 122/286 (42%), Gaps = 37/286 (12%)

Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHR 538
            ++++   +G G +G     R   DG+ +  K       +    +  ++EV ++ +L+H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 539 NLVRLLGCCVEGEEKML--IYEYMPNRSLDALLFDPLKKERLDWRKRF------NIIEGI 590
           N+VR     ++     L  + EY     L +++      +    R+         ++  +
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI-----TKGTKERQYLDEEFVLRVMTQL 120

Query: 591 SRGLLYLH--RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 648
           +  L   H   D    ++HRDLK +N+ LD + N K+ DFG+A+I   +   A T   VG
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVG 178

Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKI 708
           T  YMSPE      ++EKSD++S G LL E+ +      F       L          KI
Sbjct: 179 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP--PFTAFSQKELA--------GKI 228

Query: 709 LALVDPFLSES-SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM 753
                  +    S +L+ II      +L +++    RP++  ++  
Sbjct: 229 REGKFRRIPYRYSDELNEIIT----RMLNLKD--YHRPSVEEILEN 268

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  147 bits (374), Expect = 3e-39
 Identities = 63/241 (26%), Positives = 96/241 (39%), Gaps = 57/241 (23%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQE------IAVKRL-SKASGQGLEEFMNEVMVISK 534
            N +    LG G FG V         +      +AVK L  KA     E  M+E+ ++++
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104

Query: 535 L-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSL--------DALLFDPLKKERLDWRKRFN 585
           L  H N+V LLG C       LI+EY     L        +    D ++ E     +   
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164

Query: 586 IIEG------------ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 633
            +              +++G+ +L        +HRDL A N+L+      KI DFG+A  
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLA-- 219

Query: 634 FGGNQDQADTGRVVGTFGY-------------MSPEYAMEGRFSEKSDVFSFGVLLLEIV 680
                      R + +                M+PE   EG ++ KSDV+S+G+LL EI 
Sbjct: 220 -----------RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 268

Query: 681 S 681
           S
Sbjct: 269 S 269

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  146 bits (371), Expect = 3e-39
 Identities = 64/231 (27%), Positives = 107/231 (46%), Gaps = 37/231 (16%)

Query: 481 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 539
            ++F+  + LGQG FG V   R   D +  A+K++     + L   ++EVM+++ L H+ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63

Query: 540 LVRLLGCCVEG----------EEKMLIY---EYMPNRSLDALLFDPLKKERLDWRKRF-- 584
           +VR     +E           ++K  ++   EY  N +L    +D +  E L+ ++    
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL----YDLIHSENLNQQRDEYW 119

Query: 585 NIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG 644
            +   I   L Y+H      IIHRDLK  NI +DE  N KI DFG+AK    + D     
Sbjct: 120 RLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176

Query: 645 R------------VVGTFGYMSPE-YAMEGRFSEKSDVFSFGVLLLEIVSG 682
                         +GT  Y++ E     G ++EK D++S G++  E++  
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  146 bits (370), Expect = 3e-39
 Identities = 62/199 (31%), Positives = 104/199 (52%), Gaps = 11/199 (5%)

Query: 490 LGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV 548
           LG+G +G VY GR L +   IA+K + +   +  +    E+ +   L+H+N+V+ LG   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89

Query: 549 EGEEKMLIY-EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 607
           E    + I+ E +P  SL ALL       + + +      + I  GL YLH +   +I+H
Sbjct: 90  E-NGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 145

Query: 608 RDLKASNILLDEEL-NPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGR--FS 664
           RD+K  N+L++      KISDFG +K   G     +T    GT  YM+PE   +G   + 
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGPRGYG 203

Query: 665 EKSDVFSFGVLLLEIVSGR 683
           + +D++S G  ++E+ +G+
Sbjct: 204 KAADIWSLGCTIIEMATGK 222

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  144 bits (366), Expect = 2e-38
 Identities = 68/309 (22%), Positives = 119/309 (38%), Gaps = 50/309 (16%)

Query: 483 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 541
           ++    KLG+GGF  V     L DG   A+KR+     Q  EE   E  +     H N++
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89

Query: 542 RLLGCCVEGEEKM----LIYEYMPNRSLDALLFDPLKKERLDWRKRF------NIIEGIS 591
           RL+  C+          L+  +    +L    ++ +++   D            ++ GI 
Sbjct: 90  RLVAYCLRERGAKHEAWLLLPFFKRGTL----WNEIER-LKDKGNFLTEDQILWLLLGIC 144

Query: 592 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVV---- 647
           RGL  +H        HRDLK +NILL +E  P + D G       + + +     +    
Sbjct: 145 RGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWA 201

Query: 648 ---GTFGYMSPE------YAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGY 698
               T  Y +PE      + +     E++DV+S G +L  ++ G     +          
Sbjct: 202 AQRCTISYRAPELFSVQSHCVID---ERTDVWSLGCVLYAMMFGE--GPYDMVFQKGDSV 256

Query: 699 AWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEI 758
           A  + N+  I     P     S  L  ++      ++ V      RP++  ++S L   +
Sbjct: 257 ALAVQNQLSI-----PQSPRHSSALWQLLN----SMMTVD--PHQRPHIPLLLSQL-EAL 304

Query: 759 RDLPYPKEP 767
           +  P P + 
Sbjct: 305 QP-PAPGQH 312

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  142 bits (360), Expect = 6e-38
 Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 17/203 (8%)

Query: 489 KLGQGGFGPVYWGR-LKDGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRNLVRLLG 545
           ++G+G F  VY G   +   E+A    +  K +    + F  E  ++  LQH N+VR   
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 546 CCVEGEEKM----LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
                 +      L+ E M + +L   L    + + +  +   +    I +GL +LH   
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLH-TR 148

Query: 602 RLRIIHRDLKASNILLDEEL-NPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
              IIHRDLK  NI +     + KI D G+A +   +  +A    V+GT  +M+PE   E
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPEFMAPEMYEE 204

Query: 661 GRFSEKSDVFSFGVLLLEIVSGR 683
             + E  DV++FG+ +LE+ +  
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSE 226

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  141 bits (357), Expect = 2e-37
 Identities = 57/208 (27%), Positives = 86/208 (41%), Gaps = 18/208 (8%)

Query: 483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKL-QHR 538
           +FQ  S+LG G +G V+  R K DG+  AVKR        +     + EV    K+ QH 
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117

Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKE--RLDWRKRFNIIEGISRGLLY 596
             VRL     EG    L  E          L    +     L   + +  +      L +
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-----GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAH 172

Query: 597 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 656
           LH      ++H D+K +NI L      K+ DFG+     G     +     G   YM+PE
Sbjct: 173 LHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL-GTAGAGEV--QEGDPRYMAPE 226

Query: 657 YAMEGRFSEKSDVFSFGVLLLEIVSGRK 684
             ++G +   +DVFS G+ +LE+    +
Sbjct: 227 -LLQGSYGTAADVFSLGLTILEVACNME 253

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  140 bits (355), Expect = 5e-37
 Identities = 56/225 (24%), Positives = 102/225 (45%), Gaps = 23/225 (10%)

Query: 474 FEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKR--LSKASGQGLEEFMNEVMV 531
           F+ ++     + +  ++G GG   V+    +  Q  A+K   L +A  Q L+ + NE+  
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 79

Query: 532 ISKLQHRNL--VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEG 589
           ++KLQ  +   +RL    +  +   ++ E   N  L++ L    KK+ +D  +R +  + 
Sbjct: 80  LNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL---KKKKSIDPWERKSYWKN 135

Query: 590 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 649
           +   +  +H+     I+H DLK +N L+ +    K+ DFG+A     +         VGT
Sbjct: 136 MLEAVHTIHQ---HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGT 191

Query: 650 FGYMSPE-----------YAMEGRFSEKSDVFSFGVLLLEIVSGR 683
             YM PE              + + S KSDV+S G +L  +  G+
Sbjct: 192 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  138 bits (350), Expect = 4e-36
 Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 22/211 (10%)

Query: 481 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEF-MNEVMVISKLQHR 538
            +      ++G+G FG V+  +  + G + AVK++       LE F + E++  + L   
Sbjct: 57  VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSP 110

Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALL--FDPLKKERLDWRKRFNIIEGISRGLLY 596
            +V L G   EG    +  E +   SL  L+     L ++R         +     GL Y
Sbjct: 111 RIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRAL-----YYLGQALEGLEY 165

Query: 597 LHRDSRLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGR---VVGTFGY 652
           LH     RI+H D+KA N+LL  + +   + DFG A     +           + GT  +
Sbjct: 166 LHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETH 222

Query: 653 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           M+PE  M      K D++S   ++L +++G 
Sbjct: 223 MAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  139 bits (353), Expect = 4e-36
 Identities = 54/217 (24%), Positives = 97/217 (44%), Gaps = 23/217 (10%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKR--LSKASGQGLEEFMNEVMVISKLQHRN 539
             + +  ++G GG   V+    +  Q  A+K   L +A  Q L+ + NE+  ++KLQ  +
Sbjct: 56  RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115

Query: 540 L--VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 597
              +RL    +  +   ++ E   N  L++ L    KK+ +D  +R +  + +   +  +
Sbjct: 116 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTI 171

Query: 598 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE- 656
           H+     I+H DLK +N L+ +    K+ DFG+A     +         VG   YM PE 
Sbjct: 172 HQ---HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEA 227

Query: 657 ----------YAMEGRFSEKSDVFSFGVLLLEIVSGR 683
                        + + S KSDV+S G +L  +  G+
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  138 bits (350), Expect = 5e-36
 Identities = 54/217 (24%), Positives = 98/217 (45%), Gaps = 23/217 (10%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSK--ASGQGLEEFMNEVMVISKLQHRN 539
             + +  ++G GG   V+    +  Q  A+K ++   A  Q L+ + NE+  ++KLQ  +
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68

Query: 540 L--VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 597
              +RL    +  +   ++ E   N  L++ L    KK+ +D  +R +  + +   +  +
Sbjct: 69  DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTI 124

Query: 598 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE- 656
           H+     I+H DLK +N L+ +    K+ DFG+A     +         VGT  YM PE 
Sbjct: 125 HQ---HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180

Query: 657 ----------YAMEGRFSEKSDVFSFGVLLLEIVSGR 683
                        + + S KSDV+S G +L  +  G+
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  136 bits (345), Expect = 7e-36
 Identities = 56/200 (28%), Positives = 106/200 (53%), Gaps = 10/200 (5%)

Query: 484 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 542
           +    K+GQG  G VY    +  GQE+A+++++       E  +NE++V+ + ++ N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 543 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSR 602
            L   + G+E  ++ EY+   SL     D + +  +D  +   +     + L +LH +  
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN-- 135

Query: 603 LRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGR 662
            ++IHRD+K+ NILL  + + K++DFG        Q +  T  +VGT  +M+PE      
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKA 192

Query: 663 FSEKSDVFSFGVLLLEIVSG 682
           +  K D++S G++ +E++ G
Sbjct: 193 YGPKVDIWSLGIMAIEMIEG 212

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  135 bits (343), Expect = 2e-35
 Identities = 57/200 (28%), Positives = 103/200 (51%), Gaps = 10/200 (5%)

Query: 484 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 542
                K+G+G  G V   R    G+++AVK +     Q  E   NEV+++   QH N+V 
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 543 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSR 602
           +    + GEE  ++ E++   +L     D + + RL+  +   + E + + L YLH    
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHAQ-- 160

Query: 603 LRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGR 662
             +IHRD+K+ +ILL  +   K+SDFG       +  +  +  +VGT  +M+PE      
Sbjct: 161 -GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRSL 217

Query: 663 FSEKSDVFSFGVLLLEIVSG 682
           ++ + D++S G++++E+V G
Sbjct: 218 YATEVDIWSLGIMVIEMVDG 237

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  138 bits (349), Expect = 3e-35
 Identities = 60/265 (22%), Positives = 108/265 (40%), Gaps = 34/265 (12%)

Query: 483 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLV 541
           +F     LG G  G + +  + D +++AVKR+        +    EV ++ +  +H N++
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD---REVQLLRESDEHPNVI 81

Query: 542 RLLGCCVEGEEKMLIY---EYMPNRSLDALLFDPL--KKERLDWRKRFNIIEGISRGLLY 596
           R    C E +++   Y   E        A L + +  K       +   +++  + GL +
Sbjct: 82  RYF--CTE-KDRQFQYIAIELCA-----ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAH 133

Query: 597 LHRDSRLRIIHRDLKASNILLDE-----ELNPKISDFGMAKIFGGNQD-QADTGRVVGTF 650
           LH    L I+HRDLK  NIL+       ++   ISDFG+ K     +   +    V GT 
Sbjct: 134 LH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTE 190

Query: 651 GYMSPEY---AMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENK 707
           G+++PE      +   +   D+FS G +   ++S   +   F   L              
Sbjct: 191 GWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH--PFGKSLQRQANILL---GAC 245

Query: 708 ILALVDPFLSESSFQLDMIIRCIHV 732
            L  + P   E     ++I + I +
Sbjct: 246 SLDCLHPEKHEDVIARELIEKMIAM 270

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  134 bits (339), Expect = 6e-35
 Identities = 59/201 (29%), Positives = 104/201 (51%), Gaps = 11/201 (5%)

Query: 484 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQG-LEEFMNEVMVISKLQHRNLV 541
           F    K+G+G FG V+ G   +  + +A+K +     +  +E+   E+ V+S+     + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 542 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
           +  G  ++  +  +I EY+   S      D L+   LD  +   I+  I +GL YLH + 
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLHSE- 138

Query: 602 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 661
             + IHRD+KA+N+LL E    K++DFG+A      Q + +T   VGT  +M+PE   + 
Sbjct: 139 --KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 194

Query: 662 RFSEKSDVFSFGVLLLEIVSG 682
            +  K+D++S G+  +E+  G
Sbjct: 195 AYDSKADIWSLGITAIELARG 215

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  133 bits (337), Expect = 1e-34
 Identities = 56/222 (25%), Positives = 98/222 (44%), Gaps = 24/222 (10%)

Query: 479 TATNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQ 536
           T+ + + LS  LGQG    V+ GR K  G   A+K  +  S  + ++  M E  V+ KL 
Sbjct: 6   TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65

Query: 537 HRNLVRLLGCCVEGEEKMLIY---EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRG 593
           H+N+V+L     E           E+ P  SL  +L +P     L   +   ++  +  G
Sbjct: 66  HKNIVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124

Query: 594 LLYLHRDSRLRIIHRDLKASNILL----DEELNPKISDFGMAKIFGGNQDQADTGRVVGT 649
           + +L       I+HR++K  NI+     D +   K++DFG A+    ++ Q  +  + GT
Sbjct: 125 MNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVS--LYGT 178

Query: 650 FGYMSPE--------YAMEGRFSEKSDVFSFGVLLLEIVSGR 683
             Y+ P+           + ++    D++S GV      +G 
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  134 bits (338), Expect = 5e-34
 Identities = 56/222 (25%), Positives = 98/222 (44%), Gaps = 24/222 (10%)

Query: 479 TATNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQ 536
           T+ + + LS  LGQG    V+ GR K  G   A+K  +  S  + ++  M E  V+ KL 
Sbjct: 6   TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65

Query: 537 HRNLVRLLGCCVEGEEKMLIY---EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRG 593
           H+N+V+L     E           E+ P  SL  +L +P     L   +   ++  +  G
Sbjct: 66  HKNIVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124

Query: 594 LLYLHRDSRLRIIHRDLKASNILL----DEELNPKISDFGMAKIFGGNQDQADTGRVVGT 649
           + +L       I+HR++K  NI+     D +   K++DFG A+    ++ Q  +  + GT
Sbjct: 125 MNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVS--LYGT 178

Query: 650 FGYMSPE--------YAMEGRFSEKSDVFSFGVLLLEIVSGR 683
             Y+ P+           + ++    D++S GV      +G 
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  130 bits (329), Expect = 1e-33
 Identities = 54/205 (26%), Positives = 104/205 (50%), Gaps = 13/205 (6%)

Query: 484 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 542
           +++  +LG G FG VY  +  + G   A K +   S + LE+++ E+ +++   H  +V+
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 543 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSR 602
           LLG      +  ++ E+ P  ++DA++        L   +   +   +   L +LH    
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAVDAIM--LELDRGLTEPQIQVVCRQMLEALNFLHSK-- 136

Query: 603 LRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE-----Y 657
            RIIHRDLKA N+L+  E + +++DFG++        + D+   +GT  +M+PE      
Sbjct: 137 -RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMCET 193

Query: 658 AMEGRFSEKSDVFSFGVLLLEIVSG 682
             +  +  K+D++S G+ L+E+   
Sbjct: 194 MKDTPYDYKADIWSLGITLIEMAQI 218

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  129 bits (327), Expect = 1e-33
 Identities = 64/216 (29%), Positives = 102/216 (47%), Gaps = 31/216 (14%)

Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKAS--GQGLEE-FMNEVMVISKLQH 537
            +F++ + LG+G F  VY    +  G E+A+K + K +    G+ +   NEV +  +L+H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70

Query: 538 RNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFN------IIEGI 590
            +++ L     E    + L+ E   N  +       LK       K F+       +  I
Sbjct: 71  PSILELYNY-FEDSNYVYLVLEMCHNGEM----NRYLKNRV----KPFSENEARHFMHQI 121

Query: 591 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR---VV 647
             G+LYLH      I+HRDL  SN+LL   +N KI+DFG+A      Q +    +   + 
Sbjct: 122 ITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLA-----TQLKMPHEKHYTLC 173

Query: 648 GTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           GT  Y+SPE A       +SDV+S G +   ++ GR
Sbjct: 174 GTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  130 bits (329), Expect = 2e-33
 Identities = 64/230 (27%), Positives = 121/230 (52%), Gaps = 16/230 (6%)

Query: 460 NVNTVKLQDLPLFQFEELATATNN------FQLSSKLGQGGFGPVYWGR-LKDGQEIAVK 512
           ++ TV+L++ P  Q ++L   +        F +  KLG+G +G VY     + GQ +A+K
Sbjct: 1   SLETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIK 60

Query: 513 RLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDP 572
           ++       L+E + E+ ++ +    ++V+  G   +  +  ++ EY    S+  ++   
Sbjct: 61  QVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII--R 116

Query: 573 LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 632
           L+ + L   +   I++   +GL YLH     R IHRD+KA NILL+ E + K++DFG+A 
Sbjct: 117 LRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAG 173

Query: 633 IFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSG 682
                  + +T  V+GT  +M+PE   E  ++  +D++S G+  +E+  G
Sbjct: 174 QLTDTMAKRNT--VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEG 221

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  130 bits (330), Expect = 2e-33
 Identities = 58/215 (26%), Positives = 94/215 (43%), Gaps = 32/215 (14%)

Query: 483 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKAS--GQGLEE-FMNEVMVISKLQHR 538
            +     LG+GGF   +        +  A K + K+        E    E+ +   L H+
Sbjct: 42  RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 101

Query: 539 NLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFN------IIEGIS 591
           ++V   G   E  + + ++ E    RSL     +  K+     RK          +  I 
Sbjct: 102 HVVGFHGF-FEDNDFVFVVLELCRRRSL----LELHKR-----RKALTEPEARYYLRQIV 151

Query: 592 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR---VVG 648
            G  YLHR    R+IHRDLK  N+ L+E+L  KI DFG+A      + + D  R   + G
Sbjct: 152 LGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERKKVLCG 203

Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           T  Y++PE   +   S + DV+S G ++  ++ G+
Sbjct: 204 TPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  129 bits (326), Expect = 2e-33
 Identities = 58/215 (26%), Positives = 94/215 (43%), Gaps = 32/215 (14%)

Query: 483 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKAS--GQGLEE-FMNEVMVISKLQHR 538
            +     LG+GGF   +        +  A K + K+        E    E+ +   L H+
Sbjct: 16  RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75

Query: 539 NLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFN------IIEGIS 591
           ++V   G   E  + + ++ E    RSL     +  K+     RK          +  I 
Sbjct: 76  HVVGFHGF-FEDNDFVFVVLELCRRRSL----LELHKR-----RKALTEPEARYYLRQIV 125

Query: 592 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR---VVG 648
            G  YLHR    R+IHRDLK  N+ L+E+L  KI DFG+A      + + D  R   + G
Sbjct: 126 LGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERKKVLCG 177

Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           T  Y++PE   +   S + DV+S G ++  ++ G+
Sbjct: 178 TPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  134 bits (339), Expect = 8e-33
 Identities = 42/209 (20%), Positives = 85/209 (40%), Gaps = 26/209 (12%)

Query: 484 FQLSSKLGQGGFGPVYWG---RLKDGQEIAVKRLSKASGQGLEE-FMNEVMVISKLQHRN 539
           +++   +  GG G +Y      + +G+ + +K L  +     +   M E   ++++ H +
Sbjct: 82  YEVKGCIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPS 140

Query: 540 LVRLL--GCCVEGEEKMLIY---EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 594
           +V++       +     + Y   EY+  +SL          ++L   +    +  I   L
Sbjct: 141 IVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK-----GQKLPVAEAIAYLLEILPAL 195

Query: 595 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 654
            YLH    + +++ DLK  NI+L EE   K+ D G              G + GT G+ +
Sbjct: 196 SYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN------SFGYLYGTPGFQA 245

Query: 655 PEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           PE       +  +D+++ G  L  +    
Sbjct: 246 PEIV-RTGPTVATDIYTVGRTLAALTLDL 273

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  127 bits (321), Expect = 8e-33
 Identities = 66/207 (31%), Positives = 100/207 (48%), Gaps = 16/207 (7%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKA--SGQGLEE-FMNEVMVISKLQH 537
            +F++   LG+G FG VY  R K     +A+K L KA     G+E     EV + S L+H
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKE-RLDWRKRFNIIEGISRGLLY 596
            N++RL G   +     LI EY P  ++    +  L+K  + D ++    I  ++  L Y
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSY 124

Query: 597 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 656
            H     R+IHRD+K  N+LL      KI+DFG +     +  +     + GT  Y+ PE
Sbjct: 125 CHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTD--LCGTLDYLPPE 177

Query: 657 YAMEGRFSEKSDVFSFGVLLLEIVSGR 683
                   EK D++S GVL  E + G+
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  132 bits (333), Expect = 9e-33
 Identities = 64/215 (29%), Positives = 104/215 (48%), Gaps = 28/215 (13%)

Query: 481 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQH 537
           +  +Q   KLG G +G V   R K    E A+K + K   S     + + EV V+  L H
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95

Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN------IIEGIS 591
            N+++L     +     L+ E          LFD      +  R +FN      II+ + 
Sbjct: 96  PNIMKLYDFFEDKRNYYLVMECYKGGE----LFD-----EIIHRMKFNEVDAAVIIKQVL 146

Query: 592 RGLLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVVG 648
            G+ YLH   +  I+HRDLK  N+LL   +++   KI DFG++ +F   +   +    +G
Sbjct: 147 SGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKE---RLG 200

Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           T  Y++PE  +  ++ EK DV+S GV+L  +++G 
Sbjct: 201 TAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGY 234

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  128 bits (324), Expect = 1e-32
 Identities = 71/312 (22%), Positives = 118/312 (37%), Gaps = 48/312 (15%)

Query: 483 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HRNL 540
             ++   L +GGF  VY  + +  G+E A+KRL     +     + EV  + KL  H N+
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88

Query: 541 VRLLGCCVEGEEKM-------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRG 593
           V+       G+E+        L+   +    L   L     +  L       I     R 
Sbjct: 89  VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148

Query: 594 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR-------- 645
           + ++HR  +  IIHRDLK  N+LL  +   K+ DFG A       D + + +        
Sbjct: 149 VQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207

Query: 646 --VVGTFGYMSPE-YAMEGRF--SEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAW 700
                T  Y +PE   +   F   EK D+++ G +L  +         FED         
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFR---QHPFEDG-------- 256

Query: 701 KLWNENKIL--ALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN--S 756
               + +I+      P           +IR        +Q   ++R +++ VV  L   +
Sbjct: 257 ---AKLRIVNGKYSIPPHDTQYTVFHSLIRA------MLQVNPEERLSIAEVVHQLQEIA 307

Query: 757 EIRDLPYPKEPA 768
             R++  PK P 
Sbjct: 308 AARNVN-PKSPI 318

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  127 bits (321), Expect = 1e-32
 Identities = 62/207 (29%), Positives = 94/207 (45%), Gaps = 17/207 (8%)

Query: 484 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVK--RLSKASGQG-LEEFMNEVMVISKLQHRN 539
           +++  KLG GG   VY         ++A+K   +     +  L+ F  EV   S+L H+N
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72

Query: 540 LVRLLGCCVEGEEKMLIY---EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 596
           +V ++      EE    Y   EY+   +L   +        L      N    I  G+ +
Sbjct: 73  IVSMI---DVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKH 126

Query: 597 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 656
            H    +RI+HRD+K  NIL+D     KI DFG+AK          T  V+GT  Y SPE
Sbjct: 127 AHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS-LTQTNHVLGTVQYFSPE 182

Query: 657 YAMEGRFSEKSDVFSFGVLLLEIVSGR 683
            A      E +D++S G++L E++ G 
Sbjct: 183 QAKGEATDECTDIYSIGIVLYEMLVGE 209

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  129 bits (325), Expect = 1e-32
 Identities = 64/233 (27%), Positives = 106/233 (45%), Gaps = 21/233 (9%)

Query: 453 IAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAV 511
             +L A      K+ +L    FE++          S+LG G  G V+    K  G  +A 
Sbjct: 14  RKRLEAFLTQKQKVGELKDDDFEKI----------SELGAGNGGVVFKVSHKPSGLVMAR 63

Query: 512 KRLS-KASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLF 570
           K +  +       + + E+ V+ +     +V   G      E  +  E+M   SLD +L 
Sbjct: 64  KLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL- 122

Query: 571 DPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGM 630
              K  R+  +    +   + +GL YL    + +I+HRD+K SNIL++     K+ DFG+
Sbjct: 123 --KKAGRIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGV 178

Query: 631 AKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           +         A++   VGT  YMSPE      +S +SD++S G+ L+E+  GR
Sbjct: 179 SGQL--IDSMANS--FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  131 bits (331), Expect = 1e-32
 Identities = 68/216 (31%), Positives = 109/216 (50%), Gaps = 29/216 (13%)

Query: 481 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQ 536
           ++ ++    LG+G FG V   + K  GQE AVK +SK         E  + EV ++ +L 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84

Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN------IIEGI 590
           H N+++L     +     L+ E          LFD      +  RKRF+      II  +
Sbjct: 85  HPNIMKLYEFFEDKGYFYLVGEVYTGGE----LFD-----EIISRKRFSEVDAARIIRQV 135

Query: 591 SRGLLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVV 647
             G+ Y+H   + +I+HRDLK  N+LL    ++ N +I DFG++  F  ++   D    +
Sbjct: 136 LSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD---KI 189

Query: 648 GTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           GT  Y++PE  + G + EK DV+S GV+L  ++SG 
Sbjct: 190 GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGC 224

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  126 bits (318), Expect = 2e-32
 Identities = 54/234 (23%), Positives = 83/234 (35%), Gaps = 46/234 (19%)

Query: 481 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKR--LSKASGQGLEEFMNEVMVISKL-Q 536
           T  F    K+G G FG V+      DG   A+KR     A     +  + EV   + L Q
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 537 HRNLVRLLGCCVEGEEKMLIY-EYMPNRSLDALLFDPLKKERLDWRKRF------NIIEG 589
           H ++VR      E +  MLI  EY    SL   +      E       F      +++  
Sbjct: 70  HSHVVRYFSAWAEDD-HMLIQNEYCNGGSLADAI-----SENYRIMSYFKEAELKDLLLQ 123

Query: 590 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP-------------------KISDFGM 630
           + RGL Y+H      ++H D+K SNI +     P                   KI D G 
Sbjct: 124 VGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 180

Query: 631 AKIFGGNQDQADTGRVVGTFGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 683
                  Q +       G   +++ E   E      K+D+F+  + ++      
Sbjct: 181 VTRISSPQVE------EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  132 bits (334), Expect = 3e-32
 Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 19/213 (8%)

Query: 483 NFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEE-FMNEVMVISKLQHRNL 540
            +++  +LG GGFG V     +D G+++A+K+  +       E +  E+ ++ KL H N+
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74

Query: 541 VRLLGCCVEGEEKM-------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRG 593
           V       +G +K+       L  EY     L   L        L       ++  IS  
Sbjct: 75  VSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133

Query: 594 LLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKIFGGNQDQADTGRVVGTF 650
           L YLH     RIIHRDLK  NI+L    + L  KI D G AK     +        VGT 
Sbjct: 134 LRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE-LCTE--FVGTL 187

Query: 651 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
            Y++PE   + +++   D +SFG L  E ++G 
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  129 bits (325), Expect = 9e-32
 Identities = 67/215 (31%), Positives = 107/215 (49%), Gaps = 28/215 (13%)

Query: 481 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQH 537
              + +   LG+G FG V   + +   QE AVK ++KA    +     + EV ++ KL H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN------IIEGIS 591
            N+++L     +     ++ E          LFD      +  RKRF+      II+ + 
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGE----LFD-----EIIKRKRFSEHDAARIIKQVF 131

Query: 592 RGLLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVVG 648
            G+ Y+H   +  I+HRDLK  NILL   +++ + KI DFG++  F  N    D    +G
Sbjct: 132 SGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD---RIG 185

Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           T  Y++PE  + G + EK DV+S GV+L  ++SG 
Sbjct: 186 TAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGT 219

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  124 bits (313), Expect = 1e-31
 Identities = 55/214 (25%), Positives = 107/214 (50%), Gaps = 16/214 (7%)

Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLS-KASGQGLEEFMNEVMVISKLQHRN 539
           ++++L   +G G    V         +++A+KR++ +     ++E + E+  +S+  H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN------IIEGISRG 593
           +V      V  +E  L+ + +   S+  ++   +  +        +      I+  +  G
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDII-KHIVAKGEHKSGVLDESTIATILREVLEG 133

Query: 594 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGM-AKIFGGNQDQADTGR--VVGTF 650
           L YLH++     IHRD+KA NILL E+ + +I+DFG+ A +  G     +  R   VGT 
Sbjct: 134 LEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190

Query: 651 GYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 683
            +M+PE   + R +  K+D++SFG+  +E+ +G 
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  123 bits (312), Expect = 2e-31
 Identities = 52/205 (25%), Positives = 93/205 (45%), Gaps = 19/205 (9%)

Query: 481 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQG-LEEFMNEVMVISKLQHR 538
            + F    KLG G FG V+    +  G E  +K ++K   Q  +E+   E+ V+  L H 
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80

Query: 539 NLVRLLGCCVEGEEKMLIY---EYMPNRSL-DALLFDPLKKERLDWRKRFNIIEGISRGL 594
           N++++       E+   +Y   E      L + ++    + + L       +++ +   L
Sbjct: 81  NIIKIFEVF---EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNAL 137

Query: 595 LYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFG 651
            Y H      ++H+DLK  NIL          KI DFG+A++F  ++   +     GT  
Sbjct: 138 AYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN---AAGTAL 191

Query: 652 YMSPEYAMEGRFSEKSDVFSFGVLL 676
           YM+PE   +   + K D++S GV++
Sbjct: 192 YMAPE-VFKRDVTFKCDIWSAGVVM 215

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  123 bits (311), Expect = 2e-31
 Identities = 53/209 (25%), Positives = 91/209 (43%), Gaps = 32/209 (15%)

Query: 481 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 539
              + L + +G+G +G V     K      A K++ K   + ++ F  E+ ++  L H N
Sbjct: 8   NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67

Query: 540 LVRLLGCCVEGEEKMLIY---EYMPNRSLDALLFDPLKKERLDWRKRFN------IIEGI 590
           ++RL       E+   IY   E          LF+     R+  ++ F       I++ +
Sbjct: 68  IIRLYETF---EDNTDIYLVMELCTGGE----LFE-----RVVHKRVFRESDAARIMKDV 115

Query: 591 SRGLLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVV 647
              + Y H   +L + HRDLK  N L      +   K+ DFG+A  F   +        V
Sbjct: 116 LSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT---KV 169

Query: 648 GTFGYMSPEYAMEGRFSEKSDVFSFGVLL 676
           GT  Y+SP+  +EG +  + D +S GV++
Sbjct: 170 GTPYYVSPQ-VLEGLYGPECDEWSAGVMM 197

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  123 bits (312), Expect = 3e-31
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 17/210 (8%)

Query: 484 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVK--RLSKASGQG-LEEFMNEVMVISKLQHRN 539
           ++L   LG GG   V+  R L+D +++AVK  R   A        F  E    + L H  
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73

Query: 540 LVRLL--GCCVEGEEKMLIY---EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 594
           +V +   G   E     L Y   EY+   +L  ++     +  +  ++   +I    + L
Sbjct: 74  IVAVYDTGE-AETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQAL 129

Query: 595 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK-IFGGNQDQADTGRVVGTFGYM 653
            + H+     IIHRD+K +NI++      K+ DFG+A+ I         T  V+GT  Y+
Sbjct: 130 NFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186

Query: 654 SPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           SPE A       +SDV+S G +L E+++G 
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  123 bits (311), Expect = 6e-31
 Identities = 54/244 (22%), Positives = 98/244 (40%), Gaps = 46/244 (18%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKA-----------------SGQGLEE 524
           N++++   L QG F  +     KD +  A+K+  K+                      ++
Sbjct: 31  NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89

Query: 525 FMNEVMVISKLQHRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPL-KKERLDWRK 582
           F NE+ +I+ +++   +   G  +   +++ +IYEYM N S+             LD   
Sbjct: 90  FKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSI----LKFDEYFFVLDKNY 144

Query: 583 RFNIIEGISR--------GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 634
              I   + +           Y+H  +   I HRD+K SNIL+D+    K+SDFG ++  
Sbjct: 145 TCFIPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYM 202

Query: 635 GGNQDQADTGRVVGTFGYMSPEYAMEGRFS---EKSDVFSFGVLLLEIVSGRKNTSFFED 691
                +       GT+ +M PE       S    K D++S G+ L  +         F  
Sbjct: 203 VDK--KIKG--SRGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNV---VPFSL 254

Query: 692 DLTI 695
            +++
Sbjct: 255 KISL 258

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  121 bits (307), Expect = 7e-31
 Identities = 65/208 (31%), Positives = 103/208 (49%), Gaps = 28/208 (13%)

Query: 481 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQH 537
              + +   LG+G FG V   + +   QE AVK ++KA    +     + EV ++ KL H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN------IIEGIS 591
            N+++L     +     ++ E          LFD      +  RKRF+      II+ + 
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGE----LFD-----EIIKRKRFSEHDAARIIKQVF 131

Query: 592 RGLLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVVG 648
            G+ Y+H   +  I+HRDLK  NILL   +++ + KI DFG++  F  N    D    +G
Sbjct: 132 SGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD---RIG 185

Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLL 676
           T  Y++PE  + G + EK DV+S GV+L
Sbjct: 186 TAYYIAPE-VLRGTYDEKCDVWSAGVIL 212

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  121 bits (306), Expect = 9e-31
 Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 24/215 (11%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRL-SKASGQGLEEFMNEVMVISKL-QHR 538
           ++ +   +LG+G +G V   R    GQ +AVKR+ +  + Q  +  + ++ +  +     
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66

Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN------IIEGISR 592
             V   G      +  +  E M + SLD        K+ +D  +         I   I +
Sbjct: 67  FTVTFYGALFREGDVWICMELM-DTSLDKFY-----KQVIDKGQTIPEDILGKIAVSIVK 120

Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 652
            L +LH  S+L +IHRD+K SN+L++     K+ DFG++   G   D        G   Y
Sbjct: 121 ALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS---GYLVDDVAKDIDAGCKPY 175

Query: 653 MSPE----YAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           M+PE       +  +S KSD++S G+ ++E+   R
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  125 bits (317), Expect = 1e-30
 Identities = 62/226 (27%), Positives = 108/226 (47%), Gaps = 39/226 (17%)

Query: 481 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA-------------SGQGLEEFM 526
             ++    KLG G +G V   + K    E A+K + K+               +  EE  
Sbjct: 35  GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94

Query: 527 NEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN- 585
           NE+ ++  L H N+++L     + +   L+ E+     L    F+     ++  R +F+ 
Sbjct: 95  NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----FE-----QIINRHKFDE 145

Query: 586 -----IIEGISRGLLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGN 637
                I++ I  G+ YLH+     I+HRD+K  NILL   +  LN KI DFG++  F  +
Sbjct: 146 CDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD 202

Query: 638 QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
               D    +GT  Y++PE  ++ +++EK DV+S GV++  ++ G 
Sbjct: 203 YKLRD---RLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGY 244

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  122 bits (309), Expect = 1e-30
 Identities = 65/206 (31%), Positives = 105/206 (50%), Gaps = 19/206 (9%)

Query: 484 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLS---KASGQGLEEFMNEVMVISKLQHRN 539
           F    ++G G FG VY+ R +++ + +A+K++S   K S +  ++ + EV  + KL+H N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 599
            ++  GC +      L+ EY    + D L    + K+ L   +   +  G  +GL YLH 
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLHS 172

Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE--- 656
                +IHRD+KA NILL E    K+ DFG A         A++   VGT  +M+PE   
Sbjct: 173 H---NMIHRDVKAGNILLSEPGLVKLGDFGSA----SIMAPANS--FVGTPYWMAPEVIL 223

Query: 657 YAMEGRFSEKSDVFSFGVLLLEIVSG 682
              EG++  K DV+S G+  +E+   
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELAER 249

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  122 bits (307), Expect = 1e-30
 Identities = 59/241 (24%), Positives = 101/241 (41%), Gaps = 28/241 (11%)

Query: 456 LSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRL 514
           +S  +   +K+     + F        + +   ++G+G +G V     K  GQ +AVKR+
Sbjct: 1   MSIESSGKLKISPEQHWDFT-----AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI 55

Query: 515 -SKASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDP 572
            S    +  ++ + ++ V+ +      +V+  G      +  +  E M + S D      
Sbjct: 56  RSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFY--- 111

Query: 573 LKKERLDWRKRFN------IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKIS 626
            K                 I     + L +L     L+IIHRD+K SNILLD   N K+ 
Sbjct: 112 -KYVYSVLDDVIPEEILGKITLATVKALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLC 168

Query: 627 DFGMAKIFGGNQDQADTGRVVGTFGYMSPE----YAMEGRFSEKSDVFSFGVLLLEIVSG 682
           DFG++     +  +       G   YM+PE     A    +  +SDV+S G+ L E+ +G
Sbjct: 169 DFGISGQLVDSIAKTRD---AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATG 225

Query: 683 R 683
           R
Sbjct: 226 R 226

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  123 bits (309), Expect = 2e-30
 Identities = 43/215 (20%), Positives = 85/215 (39%), Gaps = 16/215 (7%)

Query: 481 TNNFQLSSKLGQG--GFGPVYWGR-LKDGQEIAVKR--LSKASGQGLEEFMNEVMVISKL 535
              ++L + +G+G      V   R    G+ + V+R  L   S + +     E+ V    
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
            H N+V      +   E  ++  +M   S   L+      + ++      I++G+ + L 
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLI-CTHFMDGMNELAIAYILQGVLKALD 142

Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT-----GRVVGTF 650
           Y+H       +HR +KAS+IL+  +    +S          +  +           V   
Sbjct: 143 YIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199

Query: 651 GYMSPEYAMEGR--FSEKSDVFSFGVLLLEIVSGR 683
            ++SPE   +    +  KSD++S G+   E+ +G 
Sbjct: 200 PWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  124 bits (312), Expect = 2e-30
 Identities = 57/235 (24%), Positives = 91/235 (38%), Gaps = 48/235 (20%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNL 540
           N       LG G  G V +     G+ +AVKR+        +  + E+ ++++   H N+
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNV 71

Query: 541 VRLLGCCVEGEEKMLIY---EYMPNRSLDALLFD--------PLKKERLDWRKRFNIIEG 589
           +R    C E      +Y   E       +  L D            +        +++  
Sbjct: 72  IRYY--CSE-TTDRFLYIALELC-----NLNLQDLVESKNVSDENLKLQKEYNPISLLRQ 123

Query: 590 ISRGLLYLHRDSRLRIIHRDLKASNILLD-------------EELNPKISDFGMAKIFGG 636
           I+ G+ +LH    L+IIHRDLK  NIL+              E L   ISDFG+ K    
Sbjct: 124 IASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180

Query: 637 NQD--QADTGRVVGTFGYMSPE-------YAMEGRFSEKSDVFSFGVLLLEIVSG 682
            Q   + +     GT G+ +PE          + R +   D+FS G +   I+S 
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  122 bits (307), Expect = 3e-30
 Identities = 27/253 (10%), Positives = 60/253 (23%), Gaps = 45/253 (17%)

Query: 467 QDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSK---ASGQGL 522
           Q+        L+      +L   L  G    V+  R  +  ++ A+K  +     S   L
Sbjct: 47  QNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSEL 106

Query: 523 EEFMNEVMVISKLQHRNLVRLLGCC----------VEGEEKM----------------LI 556
           E         ++L   +                  V+ +                   L+
Sbjct: 107 ERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLL 166

Query: 557 YEYMP---NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKAS 613
                         L F  + +          +   + R    L       ++H      
Sbjct: 167 MPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPD 223

Query: 614 NILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGR---FSEKSDVF 670
           N+ +  +    + D       G        G         +P   +      F+   + +
Sbjct: 224 NLFIMPDGRLMLGDVSALWKVG------TRGPASSVPVTYAPREFLNASTATFTHALNAW 277

Query: 671 SFGVLLLEIVSGR 683
             G+ +  +    
Sbjct: 278 QLGLSIYRVWCLF 290

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  120 bits (302), Expect = 3e-30
 Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 22/210 (10%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKA--SGQGLEE-FMNEVMVISKLQH 537
           ++F +   LG+G FG VY  R K     +A+K L K+    +G+E     E+ + S L+H
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73

Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKE-RLDWRKRFNIIEGISRGLLY 596
            N++R+     + +   L+ E+ P   L    +  L+K  R D ++    +E ++  L Y
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSATFMEELADALHY 129

Query: 597 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR---VVGTFGYM 653
            H     ++IHRD+K  N+L+  +   KI+DFG +         A + R   + GT  Y+
Sbjct: 130 CHE---RKVIHRDIKPENLLMGYKGELKIADFGWSV-------HAPSLRRRTMCGTLDYL 179

Query: 654 SPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
            PE        EK D++  GVL  E + G 
Sbjct: 180 PPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  120 bits (304), Expect = 3e-30
 Identities = 50/207 (24%), Positives = 87/207 (42%), Gaps = 17/207 (8%)

Query: 484 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK--ASGQG-LEEFMNEVMVISKLQHRN 539
           ++L   +G+GG G VY        + +A+K +S+  +S          E     +LQ  +
Sbjct: 36  YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPH 95

Query: 540 LVRLLGCCVEGEEKMLIY---EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 596
           +V +      GE    +Y     +    L A+L    ++  L   +   I+  I   L  
Sbjct: 96  VVPIHD---FGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDA 149

Query: 597 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 656
            H        HRD+K  NIL+  +    + DFG+A      +     G  VGT  YM+PE
Sbjct: 150 AHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEK-LTQLGNTVGTLYYMAPE 205

Query: 657 YAMEGRFSEKSDVFSFGVLLLEIVSGR 683
              E   + ++D+++   +L E ++G 
Sbjct: 206 RFSESHATYRADIYALTCVLYECLTGS 232

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  119 bits (299), Expect = 2e-29
 Identities = 57/263 (21%), Positives = 88/263 (33%), Gaps = 66/263 (25%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLS-KASGQGLEEFMNEVMVISKLQHRN 539
            +F+    +G+GGFG V+  + K D    A+KR+         E+ M EV  ++KL+H  
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNII------------ 587
           +VR     +E   +    E       D     PL            I             
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125

Query: 588 ---------------EGISRGLLYLHRDSRL---------------------------RI 605
                          +   +  L    + R                             +
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185

Query: 606 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG----------RVVGTFGYMSP 655
           +HRDLK SNI    +   K+ DFG+      ++++                VGT  YMSP
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245

Query: 656 EYAMEGRFSEKSDVFSFGVLLLE 678
           E      +S K D+FS G++L E
Sbjct: 246 EQIHGNNYSHKVDIFSLGLILFE 268

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  118 bits (297), Expect = 2e-29
 Identities = 53/206 (25%), Positives = 88/206 (42%), Gaps = 26/206 (12%)

Query: 481 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 539
              F     LG G F  V+  + +  G+  A+K + K+         NE+ V+ K++H N
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67

Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF------NIIEGISRG 593
           +V L           L+ + +        LFD     R+  R  +       +I+ +   
Sbjct: 68  IVTLEDIYESTTHYYLVMQLVSGGE----LFD-----RILERGVYTEKDASLVIQQVLSA 118

Query: 594 LLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVVGTF 650
           + YLH      I+HRDLK  N+L    +E     I+DFG++K+              GT 
Sbjct: 119 VKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI----MSTACGTP 171

Query: 651 GYMSPEYAMEGRFSEKSDVFSFGVLL 676
           GY++PE   +  +S+  D +S GV+ 
Sbjct: 172 GYVAPEVLAQKPYSKAVDCWSIGVIT 197

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  121 bits (305), Expect = 5e-29
 Identities = 60/209 (28%), Positives = 103/209 (49%), Gaps = 14/209 (6%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKA---SGQGLEEFMNEVMVISKLQH 537
           + F     LG+GGFG V+  ++K   ++ A K+L+K      +G +  M E  +++K+  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244

Query: 538 RNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGL 594
           R +V L     E +  + L+   M    +   +++  +      + R  F   + I  GL
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ-IVSGL 302

Query: 595 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 654
            +LH+     II+RDLK  N+LLD++ N +ISD G+A      Q +       GT G+M+
Sbjct: 303 EHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG--YAGTPGFMA 357

Query: 655 PEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           PE  +   +    D F+ GV L E+++ R
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  116 bits (292), Expect = 7e-29
 Identities = 56/214 (26%), Positives = 96/214 (44%), Gaps = 28/214 (13%)

Query: 481 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGL---------EEFMNEVM 530
             N++    LG+G    V     K   +E AVK +    G            E  + EV 
Sbjct: 16  YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75

Query: 531 VISKL-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIE 588
           ++ K+  H N+++L           L+++ M    L    FD L +K  L  ++   I+ 
Sbjct: 76  ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEKETRKIMR 131

Query: 589 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 648
            +   +  LH+   L I+HRDLK  NILLD+++N K++DFG +      +   +   V G
Sbjct: 132 ALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE---VCG 185

Query: 649 TFGYMSPE------YAMEGRFSEKSDVFSFGVLL 676
           T  Y++PE            + ++ D++S GV++
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  117 bits (294), Expect = 8e-29
 Identities = 64/234 (27%), Positives = 103/234 (44%), Gaps = 20/234 (8%)

Query: 462 NTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQ 520
           +    + L       L      F+L   +G G +G VY GR +K GQ  A+K +   +G 
Sbjct: 4   SDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGD 62

Query: 521 GLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKM------LIYEYMPNRSLDALLFDPL 573
             EE   E+ ++ K   HRN+    G  ++           L+ E+    S+  L+    
Sbjct: 63  EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI-KNT 121

Query: 574 KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 633
           K   L       I   I RGL +LH+    ++IHRD+K  N+LL E    K+ DFG++  
Sbjct: 122 KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 178

Query: 634 FGGNQDQADTGRVVGTFGYMSPEYAMEGRFSE-----KSDVFSFGVLLLEIVSG 682
                 + +T   +GT  +M+PE        +     KSD++S G+  +E+  G
Sbjct: 179 LDRTVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  118 bits (297), Expect = 1e-28
 Identities = 33/233 (14%), Positives = 64/233 (27%), Gaps = 43/233 (18%)

Query: 490 LGQGGFGPVYWGR-LKDGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH-------- 537
           LGQ            + G+   V             +++   EV+ +  L+         
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 538 --------RNLVRLLGCC-----VEGEEKMLIYEY---MPNRS------LDALLFDPLKK 575
                    +LV+             E  M +       P          + LL      
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 576 ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 635
           + L    R  +   + R L  LH      ++H  L+  +I+LD+     ++ F      G
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262

Query: 636 GNQDQADTGRVVGTFGYMSPE-----YAMEGRFSEKSDVFSFGVLLLEIVSGR 683
            +   +  GR        +              +   D ++ G+ +  I    
Sbjct: 263 ASA-VSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  114 bits (289), Expect = 2e-28
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 17/203 (8%)

Query: 481 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQH 537
           ++N+ +  +LG+G F  V     K  G E A K ++    S +  ++   E  +  KLQH
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64

Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLY 596
            N+VRL     E     L+++ +        LF+ +  +E        + I+ I   + Y
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQQILESIAY 120

Query: 597 LHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 653
            H      I+HR+LK  N+LL    +    K++DFG+A     ++         GT GY+
Sbjct: 121 CH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG---FAGTPGYL 174

Query: 654 SPEYAMEGRFSEKSDVFSFGVLL 676
           SPE   +  +S+  D+++ GV+L
Sbjct: 175 SPEVLKKDPYSKPVDIWACGVIL 197

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  115 bits (290), Expect = 2e-28
 Identities = 65/217 (29%), Positives = 96/217 (44%), Gaps = 16/217 (7%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKAS---GQGLEEFMNEVMVISKLQH 537
            +F+    LG+G F  V   R        A+K L K        +     E  V+S+L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89

Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER--LDWRKRFNIIEGISRGLL 595
              V+L     + E+      Y  N  L       ++K     +   RF   E I   L 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGEL----LKYIRKIGSFDETCTRFYTAE-IVSALE 144

Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 655
           YLH      IIHRDLK  NILL+E+++ +I+DFG AK+      QA     VGT  Y+SP
Sbjct: 145 YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 201

Query: 656 EYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDD 692
           E   E    + SD+++ G ++ ++V+G     F   +
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAGL--PPFRAGN 236

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  115 bits (291), Expect = 4e-28
 Identities = 52/248 (20%), Positives = 101/248 (40%), Gaps = 27/248 (10%)

Query: 446 AKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKD 505
           AK+  +   K +          +  L  +         +     +G+G    V     + 
Sbjct: 58  AKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRA 117

Query: 506 -GQEIAVKRLSKASGQG--------LEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKML 555
            G E AVK +   + +          E    E  ++ ++  H +++ L+          L
Sbjct: 118 TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFL 177

Query: 556 IYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASN 614
           +++ M    L    FD L +K  L  ++  +I+  +   + +LH      I+HRDLK  N
Sbjct: 178 VFDLMRKGEL----FDYLTEKVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPEN 230

Query: 615 ILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE------YAMEGRFSEKSD 668
           ILLD+ +  ++SDFG +      +   +   + GT GY++PE            + ++ D
Sbjct: 231 ILLDDNMQIRLSDFGFSCHLEPGEKLRE---LCGTPGYLAPEILKCSMDETHPGYGKEVD 287

Query: 669 VFSFGVLL 676
           +++ GV+L
Sbjct: 288 LWACGVIL 295

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  115 bits (291), Expect = 5e-28
 Identities = 45/201 (22%), Positives = 85/201 (42%), Gaps = 15/201 (7%)

Query: 481 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 539
            + + +  +LG G FG V+    K  G+    K ++           NE+ ++++L H  
Sbjct: 50  YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109

Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL--KKERLDWRKRFNIIEGISRGLLYL 597
           L+ L     +  E +LI E++        LFD +  +  ++   +  N +     GL ++
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGE----LFDRIAAEDYKMSEAEVINYMRQACEGLKHM 165

Query: 598 HRDSRLRIIHRDLKASNILL--DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 655
           H      I+H D+K  NI+    +  + KI DFG+A     ++          T  + +P
Sbjct: 166 H---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV---TTATAEFAAP 219

Query: 656 EYAMEGRFSEKSDVFSFGVLL 676
           E          +D+++ GVL 
Sbjct: 220 EIVDREPVGFYTDMWAIGVLG 240

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  114 bits (287), Expect = 5e-28
 Identities = 53/210 (25%), Positives = 95/210 (45%), Gaps = 16/210 (7%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRL-SKASGQGLEEFMNEVMVISKL-QHR 538
           N+ +   ++G G  G V+  R +  G  IAVK++    + +  +  + ++ V+ K     
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84

Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
            +V+  G  +   +  +  E M     +        +  +  R    +   I + L YL 
Sbjct: 85  YIVQCFGTFITNTDVFIAMELM-GTCAE--KLKKRMQGPIPERILGKMTVAIVKALYYLK 141

Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE-- 656
              +  +IHRD+K SNILLDE    K+ DFG++   G   D     R  G   YM+PE  
Sbjct: 142 --EKHGVIHRDVKPSNILLDERGQIKLCDFGIS---GRLVDDKAKDRSAGCAAYMAPERI 196

Query: 657 ---YAMEGRFSEKSDVFSFGVLLLEIVSGR 683
                 +  +  ++DV+S G+ L+E+ +G+
Sbjct: 197 DPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  113 bits (286), Expect = 2e-27
 Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 25/208 (12%)

Query: 484 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVK-----RLSKASGQGLEEFMNEVMVISKLQH 537
           ++L   +G+G F  V     ++ GQ+ AVK     + + + G   E+   E  +   L+H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85

Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF------NIIEGIS 591
            ++V LL          +++E+M      A L   +  +R D    +      + +  I 
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDG----ADLCFEI-VKRADAGFVYSEAVASHYMRQIL 140

Query: 592 RGLLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVVG 648
             L Y H      IIHRD+K   +LL   +     K+  FG+A   G +   A     VG
Sbjct: 141 EALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RVG 195

Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLL 676
           T  +M+PE      + +  DV+  GV+L
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVIL 223

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  113 bits (285), Expect = 2e-27
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 17/203 (8%)

Query: 481 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQH 537
           ++N+ +  +LG+G F  V     K  G E A K ++    S +  ++   E  +  KLQH
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87

Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLY 596
            N+VRL     E     L+++ +    L    F+ +  +E        + I+ I   + Y
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILESIAY 143

Query: 597 LHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 653
            H      I+HR+LK  N+LL    +    K++DFG+A     ++         GT GY+
Sbjct: 144 CHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG---FAGTPGYL 197

Query: 654 SPEYAMEGRFSEKSDVFSFGVLL 676
           SPE   +  +S+  D+++ GV+L
Sbjct: 198 SPEVLKKDPYSKPVDIWACGVIL 220

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  116 bits (293), Expect = 2e-27
 Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 21/211 (9%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKA---SGQGLEEFMNEVMVISKLQH 537
           N F+    LG+GGFG V   +++   ++ A K+L K      +G    +NE  ++ K+  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243

Query: 538 RNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDW----RKRFNIIEGISR 592
           R +V L     E ++ + L+   M    L       +           R  F   E I  
Sbjct: 244 RFVVSL-AYAYETKDALCLVLTLMNGGDL----KFHIYHMGQAGFPEARAVFYAAE-ICC 297

Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 652
           GL  LHR    RI++RDLK  NILLD+  + +ISD G+A      Q        VGT GY
Sbjct: 298 GLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGY 351

Query: 653 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           M+PE     R++   D ++ G LL E+++G+
Sbjct: 352 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  111 bits (280), Expect = 3e-27
 Identities = 63/239 (26%), Positives = 103/239 (43%), Gaps = 51/239 (21%)

Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK-------------------ASGQG 521
           N + L  ++G+G +G V       D    A+K LSK                    +  G
Sbjct: 13  NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72

Query: 522 LEEFMN-------EVMVISKLQHRNLVRLLGCCVEGEEKMLIY---EYMPNRSLDALLFD 571
             +          E+ ++ KL H N+V+L+   ++   +  +Y   E +    +     +
Sbjct: 73  CIQPRGPIEQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPV----ME 127

Query: 572 PLKKERLD---WRKRFN-IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISD 627
               + L     R  F  +I+GI     YLH     +IIHRD+K SN+L+ E+ + KI+D
Sbjct: 128 VPTLKPLSEDQARFYFQDLIKGIE----YLHY---QKIIHRDIKPSNLLVGEDGHIKIAD 180

Query: 628 FGMAKIFGGNQDQADTGRVVGTFGYMSPE--YAMEGRFS-EKSDVFSFGVLLLEIVSGR 683
           FG++  F G+         VGT  +M+PE        FS +  DV++ GV L   V G+
Sbjct: 181 FGVSNEFKGSDALLSN--TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  111 bits (281), Expect = 3e-27
 Identities = 54/212 (25%), Positives = 90/212 (42%), Gaps = 27/212 (12%)

Query: 481 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEE--------FMNEVMV 531
            + + +S  LG G  G V     +   +++A+K +SK                   E+ +
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 532 ISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGI 590
           + KL H  ++++     + E+  ++ E M    L    FD +   +RL           +
Sbjct: 69  LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQM 123

Query: 591 SRGLLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVV 647
              + YLH      IIHRDLK  N+LL   +E+   KI+DFG +KI G          + 
Sbjct: 124 LLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT---LC 177

Query: 648 GTFGYMSPE---YAMEGRFSEKSDVFSFGVLL 676
           GT  Y++PE         ++   D +S GV+L
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  112 bits (282), Expect = 3e-27
 Identities = 51/252 (20%), Positives = 85/252 (33%), Gaps = 52/252 (20%)

Query: 481 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVK-----RLSKASGQGLEEFMNEVMVISK 534
              + L   +GQG +G V            A+K     ++ + + + +E    EV ++ K
Sbjct: 25  QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84

Query: 535 LQHRNLVRLLGCCVEGEEKMLIYEYM-------------------------------PNR 563
           L H N+ RL     + +   L+ E                                    
Sbjct: 85  LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144

Query: 564 SLDALLFDPLKKERLDWRKRFN------IIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
             +  +   +   R              I+  I   L YLH      I HRD+K  N L 
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLF 201

Query: 618 --DEELNPKISDFGMAKIFGGNQ--DQADTGRVVGTFGYMSPE--YAMEGRFSEKSDVFS 671
             ++    K+ DFG++K F      +        GT  +++PE        +  K D +S
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261

Query: 672 FGVLLLEIVSGR 683
            GVLL  ++ G 
Sbjct: 262 AGVLLHLLLMGA 273

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  113 bits (284), Expect = 4e-27
 Identities = 52/199 (26%), Positives = 91/199 (45%), Gaps = 15/199 (7%)

Query: 483 NFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 541
               +  LG G FG V+       G ++A K +     +  EE  NE+ V+++L H NL+
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149

Query: 542 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL--KKERLDWRKRFNIIEGISRGLLYLHR 599
           +L        + +L+ EY+        LFD +  +   L        ++ I  G+ ++H 
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGE----LFDRIIDESYNLTELDTILFMKQICEGIRHMH- 204

Query: 600 DSRLRIIHRDLKASNILL-DEELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEY 657
             ++ I+H DLK  NIL  + +    KI DFG+A+ +   +         GT  +++PE 
Sbjct: 205 --QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV---NFGTPEFLAPEV 259

Query: 658 AMEGRFSEKSDVFSFGVLL 676
                 S  +D++S GV+ 
Sbjct: 260 VNYDFVSFPTDMWSVGVIA 278

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  116 bits (293), Expect = 4e-27
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 24/213 (11%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKA---SGQGLEEFMNEVMV---ISK 534
           N+F +   +G+GGFG VY  R  D  ++ A+K L K      QG    +NE ++   +S 
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248

Query: 535 LQHRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGIS 591
                +V +        +K+  I + M    L       L +  +  +   RF   E I 
Sbjct: 249 GDCPFIVCM-SYAFHTPDKLSFILDLMNGGDL----HYHLSQHGVFSEADMRFYAAE-II 302

Query: 592 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFG 651
            GL ++H      +++RDLK +NILLDE  + +ISD G+A  F   +        VGT G
Sbjct: 303 LGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHG 355

Query: 652 YMSPEYAMEGRFSEKS-DVFSFGVLLLEIVSGR 683
           YM+PE   +G   + S D FS G +L +++ G 
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  113 bits (283), Expect = 4e-27
 Identities = 31/226 (13%), Positives = 62/226 (27%), Gaps = 30/226 (13%)

Query: 481 TNNFQLSSKLGQGGFGPVYWGRLKD------GQEIAVKRLSKASGQGLEEFMNEVMVISK 534
           +    +   LG+G F  VY     D       Q+  +K    A+          +  +  
Sbjct: 64  SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123

Query: 535 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN------IIE 588
                 ++     +     +L+ E     +    L + +   +    K            
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGT----LLNAINLYKNTPEKVMPQGLVISFAM 179

Query: 589 GISRGLLYLHRDSRLRIIHRDLKASNILL-----------DEELNPKISDFGMAKIFGGN 637
            +   +  +H      IIH D+K  N +L           D      + D G +      
Sbjct: 180 RMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLF 236

Query: 638 QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
                      T G+   E      ++ + D F     +  ++ G 
Sbjct: 237 PKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  116 bits (291), Expect = 4e-27
 Identities = 48/201 (23%), Positives = 83/201 (41%), Gaps = 15/201 (7%)

Query: 481 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 539
            +++ +  +LG G FG V+    +  G   A K +        E    E+  +S L+H  
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215

Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL--KKERLDWRKRFNIIEGISRGLLYL 597
           LV L     +  E ++IYE+M        LF+ +  +  ++   +    +  + +GL ++
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGE----LFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 271

Query: 598 HRDSRLRIIHRDLKASNILL--DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 655
           H       +H DLK  NI+         K+ DFG+       Q         GT  + +P
Sbjct: 272 H---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEFAAP 325

Query: 656 EYAMEGRFSEKSDVFSFGVLL 676
           E A        +D++S GVL 
Sbjct: 326 EVAEGKPVGYYTDMWSVGVLS 346

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  110 bits (277), Expect = 1e-26
 Identities = 57/224 (25%), Positives = 93/224 (41%), Gaps = 27/224 (12%)

Query: 483 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKAS----GQGLEEFMNEVMVISKLQH 537
            + +   LG+G +G V      +     AVK L K        G      E+ ++ +L+H
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65

Query: 538 RNLVRLLGCCVEGEEKMLIY---EYMPNRSLDALLFDPLKKERL---DWRKRFN-IIEGI 590
           +N+++L+   +  EEK  +Y   EY      +  + D + ++R         F  +I+G+
Sbjct: 66  KNVIQLVDV-LYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGL 122

Query: 591 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF 650
                YLH      I+H+D+K  N+LL      KIS  G+A+               G+ 
Sbjct: 123 E----YLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSP 175

Query: 651 GYMSPEYAMEGRFSE--KSDVFSFGVLLLEIVSGRKNTSFFEDD 692
            +  PE A         K D++S GV L  I +G      FE D
Sbjct: 176 AFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP---FEGD 216

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  112 bits (282), Expect = 1e-26
 Identities = 53/212 (25%), Positives = 90/212 (42%), Gaps = 27/212 (12%)

Query: 481 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEE--------FMNEVMV 531
            + + +S  LG G  G V     +   +++A++ +SK                   E+ +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193

Query: 532 ISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGI 590
           + KL H  ++++     + E+  ++ E M    L    FD +   +RL           +
Sbjct: 194 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQM 248

Query: 591 SRGLLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVV 647
              + YLH      IIHRDLK  N+LL   +E+   KI+DFG +KI G          + 
Sbjct: 249 LLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT---LC 302

Query: 648 GTFGYMSPE---YAMEGRFSEKSDVFSFGVLL 676
           GT  Y++PE         ++   D +S GV+L
Sbjct: 303 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  111 bits (278), Expect = 2e-26
 Identities = 31/239 (12%), Positives = 66/239 (27%), Gaps = 54/239 (22%)

Query: 490 LGQGGFGPVYWGR-LKDGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQ--------- 536
           LGQ            + G+   V             +++   EV+ +  L+         
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 537 ----------------HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-----KK 575
                            + ++R+     +       + Y   +S      + L       
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200

Query: 576 ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 635
           + L    R  +   + R L  LH      ++H  L+  +I+LD+     ++ F      G
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257

Query: 636 GNQDQADTGRVVGTFGYMSPEY-----------AMEGRFSEKSDVFSFGVLLLEIVSGR 683
                        + G+  PE                  +   D ++ G+++  I    
Sbjct: 258 ARVV------SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  112 bits (282), Expect = 2e-26
 Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 26/208 (12%)

Query: 481 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEE--FMNEVMVISKLQH 537
           T  +QL  +LG+G F  V        GQE A   ++       +      E  +   L+H
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69

Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF------NIIEGIS 591
            N+VRL     E     LI++ +    L    F+      +  R+ +      + I+ I 
Sbjct: 70  PNIVRLHDSISEEGHHYLIFDLVTGGEL----FE-----DIVAREYYSEADASHCIQQIL 120

Query: 592 RGLLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVVG 648
             +L+ H+   + ++HR+LK  N+LL    +    K++DFG+A    G Q         G
Sbjct: 121 EAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAG 175

Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLL 676
           T GY+SPE   +  + +  D+++ GV+L
Sbjct: 176 TPGYLSPEVLRKDPYGKPVDLWACGVIL 203

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  108 bits (273), Expect = 2e-26
 Identities = 58/208 (27%), Positives = 97/208 (46%), Gaps = 22/208 (10%)

Query: 481 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKA------SGQGLEEFMNEVMVIS 533
            +++++  +LG G F  V   R K  G+E A K + K        G   EE   EV ++ 
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 534 KLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISR 592
           +++H N++ L        + +LI E +        LFD L +KE L   +    ++ I  
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGGE----LFDFLAEKESLTEDEATQFLKQILD 119

Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMAKIFGGNQDQADTGRVVG 648
           G+ YLH     RI H DLK  NI+L ++  P    K+ DFG+A       +  +   + G
Sbjct: 120 GVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN---IFG 173

Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLL 676
           T  +++PE         ++D++S GV+ 
Sbjct: 174 TPEFVAPEIVNYEPLGLEADMWSIGVIT 201

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  109 bits (275), Expect = 2e-26
 Identities = 54/208 (25%), Positives = 86/208 (41%), Gaps = 33/208 (15%)

Query: 490 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HRNLVRLLGCC 547
           LG+G    V         QE AVK + K  G        EV ++ + Q HRN++ L+   
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80

Query: 548 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN------IIEGISRGLLYLHRDS 601
            E +   L++E M   S+            +  R+ FN      +++ ++  L +LH   
Sbjct: 81  EEEDRFYLVFEKMRGGSI----LS-----HIHKRRHFNELEASVVVQDVASALDFLHN-- 129

Query: 602 RLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGR-----VVGTFGYM 653
              I HRDLK  NIL    ++    KI DF +      N D +           G+  YM
Sbjct: 130 -KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188

Query: 654 SPE-----YAMEGRFSEKSDVFSFGVLL 676
           +PE           + ++ D++S GV+L
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLGVIL 216

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  109 bits (274), Expect = 3e-26
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 22/208 (10%)

Query: 481 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKA------SGQGLEEFMNEVMVIS 533
            + + +  +LG G F  V   R K  G E A K + K        G   EE   EV ++ 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 534 KLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISR 592
           ++ H N++ L        + +LI E +        LFD L +KE L   +  + I+ I  
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEATSFIKQILD 126

Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMAKIFGGNQDQADTGRVVG 648
           G+ YLH     +I H DLK  NI+L ++  P    K+ DFG+A       +  +   + G
Sbjct: 127 GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFG 180

Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLL 676
           T  +++PE         ++D++S GV+ 
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  110 bits (276), Expect = 4e-26
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 22/208 (10%)

Query: 481 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKAS------GQGLEEFMNEVMVIS 533
            + + +  +LG G F  V   R K  G E A K + K        G   EE   EV ++ 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 534 KLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISR 592
           ++ H N++ L        + +LI E +        LFD L +KE L   +  + I+ I  
Sbjct: 71  QVLHPNIITLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEATSFIKQILD 126

Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMAKIFGGNQDQADTGRVVG 648
           G+ YLH     +I H DLK  NI+L ++  P    K+ DFG+A       +  +   + G
Sbjct: 127 GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFG 180

Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLL 676
           T  +++PE         ++D++S GV+ 
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  109 bits (274), Expect = 5e-26
 Identities = 54/206 (26%), Positives = 93/206 (45%), Gaps = 27/206 (13%)

Query: 481 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 539
           ++ F++ S+LG+G    VY  + K   +  A+K L K   +  +    E+ V+ +L H N
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPN 109

Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF------NIIEGISRG 593
           +++L        E  L+ E +    L    FD     R+  +  +      + ++ I   
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGEL----FD-----RIVEKGYYSERDAADAVKQILEA 160

Query: 594 LLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVVGTF 650
           + YLH      I+HRDLK  N+L      +   KI+DFG++KI            V GT 
Sbjct: 161 VAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT---VCGTP 214

Query: 651 GYMSPEYAMEGRFSEKSDVFSFGVLL 676
           GY +PE      +  + D++S G++ 
Sbjct: 215 GYCAPEILRGCAYGPEVDMWSVGIIT 240

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  107 bits (270), Expect = 1e-25
 Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 22/208 (10%)

Query: 481 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKA------SGQGLEEFMNEVMVIS 533
            + +    +LG G F  V   R K  G + A K + K        G   E+   EV ++ 
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69

Query: 534 KLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISR 592
           ++QH N++ L        + +LI E +        LFD L +KE L   +    ++ I  
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGE----LFDFLAEKESLTEEEATEFLKQILN 125

Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMAKIFGGNQDQADTGRVVG 648
           G+ YLH    L+I H DLK  NI+L +   P    KI DFG+A       +  +   + G
Sbjct: 126 GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFG 179

Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLL 676
           T  +++PE         ++D++S GV+ 
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVIT 207

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  106 bits (268), Expect = 2e-25
 Identities = 70/217 (32%), Positives = 111/217 (51%), Gaps = 37/217 (17%)

Query: 483 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRN 539
           N++L   +G+G F  V   R +  G+E+A+K + K   +   L++   EV ++  L H N
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75

Query: 540 LVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPL-KKERL---DWRKRFN-IIEGISRG 593
           +V+L    +E E+ + LI EY     +    FD L    R+   + R +F  I+  +   
Sbjct: 76  IVKLFEV-IETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEARSKFRQIVSAVQ-- 128

Query: 594 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF-GY 652
             Y H+    RI+HRDLKA N+LLD ++N KI+DFG +  F         G  +  F G 
Sbjct: 129 --YCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEF-------TVGGKLDAFCG- 175

Query: 653 MSPEYA----MEGRFSE--KSDVFSFGVLLLEIVSGR 683
            +P YA     +G+  +  + DV+S GV+L  +VSG 
Sbjct: 176 -APPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS 211

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  106 bits (268), Expect = 2e-25
 Identities = 41/201 (20%), Positives = 82/201 (40%), Gaps = 16/201 (7%)

Query: 481 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 539
              + ++  LG+G FG V+        +    K +    G        E+ +++  +HRN
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRN 62

Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL--KKERLDWRKRFNIIEGISRGLLYL 597
           ++ L       EE ++I+E++        +F+ +      L+ R+  + +  +   L +L
Sbjct: 63  ILHLHESFESMEELVMIFEFISGLD----IFERINTSAFELNEREIVSYVHQVCEALQFL 118

Query: 598 HRDSRLRIIHRDLKASNILLDEELNP--KISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 655
           H      I H D++  NI+     +   KI +FG A+      +      +     Y +P
Sbjct: 119 H---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAP 172

Query: 656 EYAMEGRFSEKSDVFSFGVLL 676
           E       S  +D++S G L+
Sbjct: 173 EVHQHDVVSTATDMWSLGTLV 193

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  105 bits (264), Expect = 3e-25
 Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 35/217 (16%)

Query: 483 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEE-FMNEVMVISKLQHRNL 540
           ++ L   LG+G +G V         + +AVK +         E    E+ +   L H N+
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67

Query: 541 VRLLGCCVEGEEKMLIY---EYMPNRSLDALLFDPL-KKERL---DWRKRFN-IIEGISR 592
           V+  G      E  + Y   EY     L    FD +     +   D ++ F+ ++ G+  
Sbjct: 68  VKFYGHR---REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV- 119

Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 652
              YLH    + I HRD+K  N+LLDE  N KISDFG+A +F  N  +    ++ GT  Y
Sbjct: 120 ---YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173

Query: 653 MSPE------YAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           ++PE      +      +E  DV+S G++L  +++G 
Sbjct: 174 VAPELLKRREFH-----AEPVDVWSCGIVLTAMLAGE 205

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  106 bits (267), Expect = 3e-25
 Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 32/218 (14%)

Query: 483 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN------EVMVISKL 535
            +Q+   LG GGFG VY G  + D   +A+K + K       E  N      EV+++ K+
Sbjct: 44  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103

Query: 536 QHR--NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLD---WRKRFN-IIE 588
                 ++RLL      +  +LI E  P    D  LFD + ++  L     R  F  ++E
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGALQEELARSFFWQVLE 160

Query: 589 GISRGLLYLHRDSRLRIIHRDLKASNILLDEE-LNPKISDFGMAKIFGGNQDQA-DTGRV 646
            +     + H      ++HRD+K  NIL+D      K+ DFG   +    +D        
Sbjct: 161 AVR----HCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD--F 208

Query: 647 VGTFGYMSPEYAMEGRFS-EKSDVFSFGVLLLEIVSGR 683
            GT  Y  PE+    R+    + V+S G+LL ++V G 
Sbjct: 209 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  106 bits (268), Expect = 3e-25
 Identities = 58/227 (25%), Positives = 96/227 (42%), Gaps = 28/227 (12%)

Query: 461 VNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASG 519
           + TV +  +           T+ +++   +G G +        K    E AVK + K+  
Sbjct: 1   MQTVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR 60

Query: 520 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD 579
              EE   E++ +   QH N++ L     +G+   ++ E M    L     D     ++ 
Sbjct: 61  DPTEE--IEIL-LRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL----LD-----KIL 108

Query: 580 WRKRFN------IIEGISRGLLYLHRDSRLRIIHRDLKASNILL-DEELNP---KISDFG 629
            +K F+      ++  I++ + YLH      ++HRDLK SNIL  DE  NP   +I DFG
Sbjct: 109 RQKFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFG 165

Query: 630 MAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLL 676
            AK          T     T  +++PE      +    D++S GVLL
Sbjct: 166 FAKQLRAENGLLMT--PCYTANFVAPEVLERQGYDAACDIWSLGVLL 210

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  105 bits (265), Expect = 5e-25
 Identities = 53/217 (24%), Positives = 89/217 (41%), Gaps = 30/217 (13%)

Query: 483 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKA--------SGQGLEEFMNEVMVIS 533
            +   S LG G FG V+     +  +E+ VK + K             L +   E+ ++S
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84

Query: 534 KLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLD---WRKRFN-IIE 588
           +++H N++++L      E +      M        LF  + +  RLD       F  ++ 
Sbjct: 85  RVEHANIIKVLDIF---ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVS 141

Query: 589 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 648
            +     YL       IIHRD+K  NI++ E+   K+ DFG A      +    T    G
Sbjct: 142 AVG----YLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK-LFYT--FCG 191

Query: 649 TFGYMSPEYAMEGRFSE--KSDVFSFGVLLLEIVSGR 683
           T  Y +PE  + G      + +++S GV L  +V   
Sbjct: 192 TIEYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEE 227

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  105 bits (263), Expect = 8e-25
 Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 35/217 (16%)

Query: 483 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEE-FMNEVMVISKLQHRNL 540
           ++ L   LG+G +G V         + +AVK +         E    E+ +   L H N+
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67

Query: 541 VRLLGCCVEGEEKMLIY---EYMPNRSLDALLFDPL-KKERL---DWRKRFN-IIEGISR 592
           V+  G      E  + Y   EY     L    FD +     +   D ++ F+ ++ G+  
Sbjct: 68  VKFYGHR---REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV- 119

Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 652
              YLH    + I HRD+K  N+LLDE  N KISDFG+A +F  N  +    ++ GT  Y
Sbjct: 120 ---YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173

Query: 653 MSPE------YAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           ++PE      +      +E  DV+S G++L  +++G 
Sbjct: 174 VAPELLKRREFH-----AEPVDVWSCGIVLTAMLAGE 205

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  104 bits (262), Expect = 1e-24
 Identities = 50/199 (25%), Positives = 84/199 (42%), Gaps = 28/199 (14%)

Query: 489 KLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HRNLVRLLGC 546
            LG+G F        K   Q  AVK +SK           E+  +   + H N+V+L   
Sbjct: 18  PLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEV 74

Query: 547 CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN------IIEGISRGLLYLHRD 600
             +     L+ E +    L    F+     R+  +K F+      I+  +   + ++H  
Sbjct: 75  FHDQLHTFLVMELLNGGEL----FE-----RIKKKKHFSETEASYIMRKLVSAVSHMHD- 124

Query: 601 SRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEY 657
             + ++HRDLK  N+L    ++ L  KI DFG A++   +     T     T  Y +PE 
Sbjct: 125 --VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYAAPEL 180

Query: 658 AMEGRFSEKSDVFSFGVLL 676
             +  + E  D++S GV+L
Sbjct: 181 LNQNGYDESCDLWSLGVIL 199

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  103 bits (258), Expect = 3e-24
 Identities = 66/234 (28%), Positives = 101/234 (43%), Gaps = 39/234 (16%)

Query: 483 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN------EV----MV 531
            ++L   LG+GGFG V+ G  L D  ++A+K + +    G     +      EV     V
Sbjct: 32  EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91

Query: 532 ISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLD---WRKRFN-I 586
            +   H  ++RLL      E  ML+ E  P  + D  LFD + +K  L     R  F  +
Sbjct: 92  GAGGGHPGVIRLLDWFETQEGFMLVLER-PLPAQD--LFDYITEKGPLGEGPSRCFFGQV 148

Query: 587 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQA-DTG 644
           +  I     + H      ++HRD+K  NIL+D      K+ DFG   +     D+     
Sbjct: 149 VAAIQ----HCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALL---HDEPYTD- 197

Query: 645 RVVGTFGYMSPEYAMEGRFS-EKSDVFSFGVLLLEIVSGRKNTSF-FEDDLTIL 696
              GT  Y  PE+    ++    + V+S G+LL ++V G       FE D  IL
Sbjct: 198 -FDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD----IPFERDQEIL 246

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  103 bits (259), Expect = 6e-24
 Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 22/212 (10%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEEF---MNEVMVISKLQH 537
           ++F++   +G+G FG V   +  D +++ A+K ++K       E      E+ ++  L+H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74

Query: 538 RNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGL 594
             LV L     + EE M ++ + +    L       L++     +   +  I E +   L
Sbjct: 75  PFLVNLW-YSFQDEEDMFMVVDLLLGGDL----RYHLQQNVHFKEETVKLFICE-LVMAL 128

Query: 595 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 654
            YL      RIIHRD+K  NILLDE  +  I+DF +A +      Q  T  + GT  YM+
Sbjct: 129 DYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-TQITT--MAGTKPYMA 182

Query: 655 PE--YAMEGRFSEKS-DVFSFGVLLLEIVSGR 683
           PE   + +G     + D +S GV   E++ GR
Sbjct: 183 PEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  101 bits (254), Expect = 2e-23
 Identities = 57/207 (27%), Positives = 91/207 (43%), Gaps = 21/207 (10%)

Query: 481 TNNFQLSSK-LGQGGFGPVYWGRLKD-GQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQ 536
            N + L+SK LG+G F  V     K  GQE A K L K         E ++E+ V+   +
Sbjct: 27  NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAK 86

Query: 537 HR-NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDW---RKRFNIIEGISR 592
               ++ L        E +LI EY     +    F     E  +         +I+ I  
Sbjct: 87  SCPRVINLHEVYENTSEIILILEYAAGGEI----FSLCLPELAEMVSENDVIRLIKQILE 142

Query: 593 GLLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVVGT 649
           G+ YLH+     I+H DLK  NILL       + KI DFGM++  G   +  +   ++GT
Sbjct: 143 GVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE---IMGT 196

Query: 650 FGYMSPEYAMEGRFSEKSDVFSFGVLL 676
             Y++PE       +  +D+++ G++ 
Sbjct: 197 PEYLAPEILNYDPITTATDMWNIGIIA 223

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  102 bits (256), Expect = 3e-23
 Identities = 62/264 (23%), Positives = 107/264 (40%), Gaps = 28/264 (10%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEE---FMNEVMVISKLQH 537
            ++++   +G+G FG V   R K  +++ A+K LSK       +   F  E  +++    
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128

Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD-WRKRFNIIEGISRGLLY 596
             +V+L     +     ++ EYMP   L     + +    +     RF   E +   L  
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYMPGGDL----VNLMSNYDVPEKWARFYTAEVVL-ALDA 183

Query: 597 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 656
           +H    +  IHRD+K  N+LLD+  + K++DFG                 VGT  Y+SPE
Sbjct: 184 IHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE-GMVRCDTAVGTPDYISPE 239

Query: 657 ----YAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALV 712
                  +G +  + D +S GV L E++ G   T F+ D L    Y       +KI+   
Sbjct: 240 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGD--TPFYADSLVGT-Y-------SKIMNHK 289

Query: 713 DPFLSESSFQLDMIIRCIHVGLLC 736
           +         +    + +    L 
Sbjct: 290 NSLTFPDDNDISKEAKNLICAFLT 313

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  100 bits (250), Expect = 7e-23
 Identities = 65/255 (25%), Positives = 113/255 (44%), Gaps = 36/255 (14%)

Query: 444 WIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRL 503
           ++AK K + + K    + NT +L       F+ + T          LG G FG V   + 
Sbjct: 18  FLAKAKEDFLKKWETPSQNTAQLDQ-----FDRIKT----------LGTGSFGRVMLVKH 62

Query: 504 KDGQEI-AVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 559
           K+     A+K L K      + +E  +NE  ++  +    LV+L     +     ++ EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122

Query: 560 MPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 617
           +    +    F  L++     +   RF   + I     YLH    L +I+RDLK  N+L+
Sbjct: 123 VAGGEM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLI 174

Query: 618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLL 677
           D++   +++DFG AK   G      T  + GT   ++PE  +   +++  D ++ GVL+ 
Sbjct: 175 DQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIY 229

Query: 678 EIVSGRKNTSFFEDD 692
           E+ +G     FF D 
Sbjct: 230 EMAAGY--PPFFADQ 242

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 99.9 bits (249), Expect = 2e-22
 Identities = 52/216 (24%), Positives = 102/216 (47%), Gaps = 25/216 (11%)

Query: 486 LSSKLGQGGFGPVYWGRLKD---GQEIAVKRLSKASGQGLE-EFMNEVMVISKLQHRNLV 541
              K+G+G +G VY  + KD    ++ A+K++      G+      E+ ++ +L+H N++
Sbjct: 25  EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEG---TGISMSACREIALLRELKHPNVI 81

Query: 542 RLLGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFN------IIEGISRG 593
            L    +   ++   L+++Y     L  ++      +      +        ++  I  G
Sbjct: 82  SLQKVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 140

Query: 594 LLYLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMAKIFGG-NQDQADTGRVVG 648
           + YLH +    ++HRDLK +NIL+  E       KI+D G A++F    +  AD   VV 
Sbjct: 141 IHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197

Query: 649 TFGYMSPEYAMEGRF-SEKSDVFSFGVLLLEIVSGR 683
           TF Y +PE  +  R  ++  D+++ G +  E+++  
Sbjct: 198 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 99.8 bits (249), Expect = 2e-22
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 17/209 (8%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEEF---MNEVMVISKLQH 537
           N F+    LG+G FG V   + K      A+K L K      +E    + E  V+   +H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207

Query: 538 RNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGL 594
             L  L     +  +++  + EY     L    F  L +ER+  + R RF   E +S  L
Sbjct: 208 PFLTALK-YSFQTHDRLCFVMEYANGGEL----FFHLSRERVFSEDRARFYGAEIVS-AL 261

Query: 595 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 654
            YLH  S   +++RDLK  N++LD++ + KI+DFG+ K    +     T    GT  Y++
Sbjct: 262 DYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLA 317

Query: 655 PEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           PE   +  +    D +  GV++ E++ GR
Sbjct: 318 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 96.9 bits (242), Expect = 2e-22
 Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 38/218 (17%)

Query: 483 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHR 538
           ++ L   LG G FG V  G     G ++AVK L++    S   + +   E+  +   +H 
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71

Query: 539 NLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPL-KKERL---DWRKRFN-IIEGISR 592
           ++++L    +       ++ EY+    L    FD + K  R+   + R+ F  I+  +  
Sbjct: 72  HIIKLYQV-ISTPTDFFMVMEYVSGGEL----FDYICKHGRVEEMEARRLFQQILSAVD- 125

Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF-G 651
              Y HR     ++HRDLK  N+LLD  +N KI+DFG++ +          G  + T  G
Sbjct: 126 ---YCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMM-------SDGEFLRTSCG 172

Query: 652 YMSPEYA----MEGRFSE--KSDVFSFGVLLLEIVSGR 683
             SP YA    + GR     + D++S GV+L  ++ G 
Sbjct: 173 --SPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGT 208

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 97.6 bits (244), Expect = 2e-22
 Identities = 56/211 (26%), Positives = 106/211 (50%), Gaps = 23/211 (10%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEF--------MNEVMVIS 533
             +Q   K+G+G +G VY  +   G+ +A+KR+       L+          + E+ ++ 
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLK 74

Query: 534 KLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRG 593
           +L H N+V L+          L++E+M    L  +L +     +    K +  +  + RG
Sbjct: 75  ELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIY--LYQLLRG 131

Query: 594 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 653
           + + H+    RI+HRDLK  N+L++ +   K++DFG+A+ F G   ++ T  VV T  Y 
Sbjct: 132 VAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV-TLWYR 186

Query: 654 SPEYAMEGRF-SEKSDVFSFGVLLLEIVSGR 683
           +P+  M  +  S   D++S G +  E+++G+
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 96.7 bits (241), Expect = 3e-22
 Identities = 23/207 (11%), Positives = 59/207 (28%), Gaps = 47/207 (22%)

Query: 484 FQLSSKLGQGGFGPVYWGRLKD---GQEIAVKRL---SKASGQGLEEFMNEVMVISKLQH 537
           ++L    G       +     D    +++A+  +          L+E ++  + +S++  
Sbjct: 33  YRLLIFHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDK 90

Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 597
             + R+L         +++ E++   SL  +                  ++ ++      
Sbjct: 91  PGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAA 145

Query: 598 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVV-GTFGYMSPE 656
           HR     +       S + +                       +  G VV      M   
Sbjct: 146 HRAG---VALSIDHPSRVRV-----------------------SIDGDVVLAYPATMPDA 179

Query: 657 YAMEGRFSEKSDVFSFGVLLLEIVSGR 683
                  + + D+   G  L  ++  R
Sbjct: 180 -------NPQDDIRGIGASLYALLVNR 199

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 99.0 bits (247), Expect = 4e-22
 Identities = 55/224 (24%), Positives = 98/224 (43%), Gaps = 21/224 (9%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKA---SGQGLEEFMNEVMVISKLQH 537
           ++F++   +G+G F  V   ++K   ++ A+K ++K        +  F  E  V+     
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120

Query: 538 RNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 596
           R + +L     + E  + L+ EY     L  LL    ++   +   RF + E +   +  
Sbjct: 121 RWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAE-MARFYLAEIVM-AIDS 177

Query: 597 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 656
           +HR   L  +HRD+K  NILLD   + +++DFG       +     +   VGT  Y+SPE
Sbjct: 178 VHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT-VRSLVAVGTPDYLSPE 233

Query: 657 -------YAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDL 693
                      G +  + D ++ GV   E+  G+  T F+ D  
Sbjct: 234 ILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ--TPFYADST 275

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 96.4 bits (241), Expect = 4e-22
 Identities = 57/211 (27%), Positives = 102/211 (48%), Gaps = 23/211 (10%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEF--------MNEVMVIS 533
             +    K+G+G +G VY  +   G+  A+K++       LE+         + E+ ++ 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILK 55

Query: 534 KLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRG 593
           +L+H N+V+L       +  +L++E++    L  LL            K F  +  +  G
Sbjct: 56  ELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSF--LLQLLNG 112

Query: 594 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 653
           + Y H     R++HRDLK  N+L++ E   KI+DFG+A+ F G   +  T  +V T  Y 
Sbjct: 113 IAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV-TLWYR 167

Query: 654 SPEYAMEGRF-SEKSDVFSFGVLLLEIVSGR 683
           +P+  M  +  S   D++S G +  E+V+G 
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 97.7 bits (244), Expect = 4e-22
 Identities = 62/221 (28%), Positives = 111/221 (50%), Gaps = 30/221 (13%)

Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVK--RLSKASGQGLEEF----MNEVMVISK 534
           + ++  +K+GQG FG V+  R  K GQ++A+K   +        E F    + E+ ++  
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK----EGFPITALREIKILQL 72

Query: 535 LQHRNLVRLLGCCVEGEEKM--------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNI 586
           L+H N+V L+  C               L++++  +  L  LL + L K  L   KR   
Sbjct: 73  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRV-- 129

Query: 587 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD---T 643
           ++ +  GL Y+HR+   +I+HRD+KA+N+L+  +   K++DFG+A+ F   ++      T
Sbjct: 130 MQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 186

Query: 644 GRVVGTFGYMSPEYAM-EGRFSEKSDVFSFGVLLLEIVSGR 683
            RVV T  Y  PE  + E  +    D++  G ++ E+ +  
Sbjct: 187 NRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 98.7 bits (246), Expect = 5e-22
 Identities = 58/224 (25%), Positives = 102/224 (45%), Gaps = 23/224 (10%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEE---FMNEVMVISKLQH 537
            +F++   +G+G FG V   +LK+  ++ A+K L+K       E   F  E  V+     
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133

Query: 538 RNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGL 594
           + +  L     + +  + L+ +Y     L  LL    K E    +   RF + E +   +
Sbjct: 134 KWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLL---SKFEDRLPEEMARFYLAEMVI-AI 188

Query: 595 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 654
             +H+   L  +HRD+K  NIL+D   + +++DFG       +     +   VGT  Y+S
Sbjct: 189 DSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYIS 244

Query: 655 PE-----YAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDL 693
           PE        +GR+  + D +S GV + E++ G   T F+ + L
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE--TPFYAESL 286

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 96.9 bits (242), Expect = 8e-22
 Identities = 59/209 (28%), Positives = 103/209 (49%), Gaps = 15/209 (7%)

Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN-----EVMVISKL 535
             ++    LG+G F  VY  R     Q +A+K++        ++ +N     E+ ++ +L
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69

Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
            H N++ LL          L++++M    L+ ++ D          K +  +    +GL 
Sbjct: 70  SHPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAY--MLMTLQGLE 126

Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 655
           YLH+     I+HRDLK +N+LLDE    K++DFG+AK F G+ ++A T +VV T  Y +P
Sbjct: 127 YLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQVV-TRWYRAP 181

Query: 656 EYAMEGRF-SEKSDVFSFGVLLLEIVSGR 683
           E     R      D+++ G +L E++   
Sbjct: 182 ELLFGARMYGVGVDMWAVGCILAELLLRV 210

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 95.7 bits (239), Expect = 1e-21
 Identities = 65/217 (29%), Positives = 110/217 (50%), Gaps = 21/217 (9%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEEF---MNEVMVISKLQH 537
            +FQ+   LG G FG V+  R +      A+K L K     L++     +E +++S + H
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65

Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGLL 595
             ++R+ G   + ++  +I +Y+    L    F  L+K +   +   +F   E +   L 
Sbjct: 66  PFIIRMWGTFQDAQQIFMIMDYIEGGEL----FSLLRKSQRFPNPVAKFYAAE-VCLALE 120

Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 655
           YLH      II+RDLK  NILLD+  + KI+DFG AK      D   T  + GT  Y++P
Sbjct: 121 YLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP---DVTYT--LCGTPDYIAP 172

Query: 656 EYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDD 692
           E      +++  D +SFG+L+ E+++G   T F++ +
Sbjct: 173 EVVSTKPYNKSIDWWSFGILIYEMLAGY--TPFYDSN 207

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 94.9 bits (237), Expect = 1e-21
 Identities = 47/213 (22%), Positives = 99/213 (46%), Gaps = 24/213 (11%)

Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEF--------MNEVMVI 532
             ++   K+G+G +G V+  +  +  + +A+KR+       L++         + E+ ++
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLL 55

Query: 533 SKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 592
            +L+H+N+VRL       ++  L++E+     L             +  K F  +  + +
Sbjct: 56  KELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSF--LFQLLK 112

Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 652
           GL + H      ++HRDLK  N+L++     K+++FG+A+ F G   +  +  VV T  Y
Sbjct: 113 GLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV-TLWY 167

Query: 653 MSPEYAMEGRF-SEKSDVFSFGVLLLEIVSGRK 684
             P+     +  S   D++S G +  E+ +  +
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 95.8 bits (239), Expect = 1e-21
 Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 39/218 (17%)

Query: 483 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHR 538
            + +   LG+G FG V      K  Q++A+K +S+              E+  +  L+H 
Sbjct: 10  PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69

Query: 539 NLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPL-KKERL---DWRKRFN-IIEGISR 592
           ++++L    +     + ++ EY         LFD + +K+R+   + R+ F  II  I  
Sbjct: 70  HIIKLYDV-ITTPTDIVMVIEYAGGE-----LFDYIVEKKRMTEDEGRRFFQQIICAIE- 122

Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF-G 651
              Y HR    +I+HRDLK  N+LLD+ LN KI+DFG++ I          G  + T  G
Sbjct: 123 ---YCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIM-------TDGNFLKTSCG 169

Query: 652 YMSPEYA----MEGRFSE--KSDVFSFGVLLLEIVSGR 683
             SP YA    + G+     + DV+S G++L  ++ GR
Sbjct: 170 --SPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 97.9 bits (244), Expect = 1e-21
 Identities = 62/218 (28%), Positives = 104/218 (47%), Gaps = 38/218 (17%)

Query: 483 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHR 538
           ++ L   LG G FG V  G+    G ++AVK L++    S   + +   E+  +   +H 
Sbjct: 17  HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76

Query: 539 NLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPL-KKERL---DWRKRFN-IIEGISR 592
           ++++L    +     + ++ EY+    L    FD + K  RL   + R+ F  I+ G+  
Sbjct: 77  HIIKLYQV-ISTPSDIFMVMEYVSGGEL----FDYICKNGRLDEKESRRLFQQILSGVD- 130

Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF-G 651
              Y HR     ++HRDLK  N+LLD  +N KI+DFG++ +          G  + T  G
Sbjct: 131 ---YCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMM-------SDGEFLRTSCG 177

Query: 652 YMSPEYA----MEGRFSE--KSDVFSFGVLLLEIVSGR 683
             SP YA    + GR     + D++S GV+L  ++ G 
Sbjct: 178 --SPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGT 213

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 95.3 bits (238), Expect = 2e-21
 Identities = 64/226 (28%), Positives = 107/226 (47%), Gaps = 42/226 (18%)

Query: 479 TATNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVK--RLSKASGQGLEEFMN-----EVM 530
           ++++ F+   KLG G +  VY G     G  +A+K  +L        EE        E+ 
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS------EEGTPSTAIREIS 55

Query: 531 VISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGI 590
           ++ +L+H N+VRL        +  L++E+M     D      LKK  +D R   N   G+
Sbjct: 56  LMKELKHENIVRLYDVIHTENKLTLVFEFM---DND------LKKY-MDSRTVGNTPRGL 105

Query: 591 S------------RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
                        +GL + H +   +I+HRDLK  N+L+++    K+ DFG+A+ F G  
Sbjct: 106 ELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIP 161

Query: 639 DQADTGRVVGTFGYMSPEYAMEGRF-SEKSDVFSFGVLLLEIVSGR 683
               +  VV T  Y +P+  M  R  S   D++S G +L E+++G+
Sbjct: 162 VNTFSSEVV-TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 95.0 bits (237), Expect = 2e-21
 Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 18/209 (8%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEEF---MNEVMVISKLQH 537
           N+F     LG+G FG V   R K      A+K L K      +E    + E  V+   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 538 RNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGL 594
             L  L     +  +++  + EY     L    F  L +ER+  + R RF   E I   L
Sbjct: 65  PFLTALK-YAFQTHDRLCFVMEYANGGEL----FFHLSRERVFTEERARFYGAE-IVSAL 118

Query: 595 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 654
            YLH      +++RD+K  N++LD++ + KI+DFG+ K    +     T    GT  Y++
Sbjct: 119 EYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLA 173

Query: 655 PEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           PE   +  +    D +  GV++ E++ GR
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 94.6 bits (236), Expect = 3e-21
 Identities = 57/211 (27%), Positives = 98/211 (46%), Gaps = 23/211 (10%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEE-------FMNEVMVIS 533
             +    KLG+G +  VY G+ K     +A+K +       LE         + EV ++ 
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR------LEHEEGAPCTAIREVSLLK 55

Query: 534 KLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRG 593
            L+H N+V L       +   L++EY+ ++ L   L D      +   K F  +  + RG
Sbjct: 56  DLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLF--LFQLLRG 112

Query: 594 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 653
           L Y HR    +++HRDLK  N+L++E    K++DFG+A+       +     VV T  Y 
Sbjct: 113 LAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV-TLWYR 167

Query: 654 SPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 683
            P+  +    +S + D++  G +  E+ +GR
Sbjct: 168 PPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 96.0 bits (239), Expect = 3e-21
 Identities = 44/203 (21%), Positives = 78/203 (38%), Gaps = 27/203 (13%)

Query: 486 LSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HRNLVRL 543
            S  LG G  G V     K   ++ A+K L         +   EV +  +     ++VR+
Sbjct: 66  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRI 120

Query: 544 LGCCVEGEEKM----LIYEYMPNRSLDALLFDPLKKERLDW---RKRFNIIEGISRGLLY 596
           +              ++ E +    L    F  ++         R+   I++ I   + Y
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTEREASEIMKSIGEAIQY 176

Query: 597 LHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 653
           LH    + I HRD+K  N+L          K++DFG AK    +           T  Y+
Sbjct: 177 LHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT---PCYTPYYV 230

Query: 654 SPEYAMEGRFSEKSDVFSFGVLL 676
           +PE     ++ +  D++S GV++
Sbjct: 231 APEVLGPEKYDKSCDMWSLGVIM 253

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 93.9 bits (234), Expect = 6e-21
 Identities = 51/212 (24%), Positives = 88/212 (41%), Gaps = 35/212 (16%)

Query: 481 TNNFQLSSK-LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-H 537
           T+++QLS + LG G  G V     +  GQ+ A+K L  +      +   EV    +    
Sbjct: 27  TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGG 81

Query: 538 RNLVRLLGCCVEGEEKM----LIYEYMPNRSLDALLFDPLKKERLDWRKRFN------II 587
            ++V +L              +I E M    L    F  +++      + F       I+
Sbjct: 82  PHIVCILDVYENMHHGKRCLLIIMECMEGGEL----FSRIQERG---DQAFTEREAAEIM 134

Query: 588 EGISRGLLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTG 644
             I   + +LH      I HRD+K  N+L    +++   K++DFG AK    N  Q    
Sbjct: 135 RDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ---- 187

Query: 645 RVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLL 676
               T  Y++PE     ++ +  D++S GV++
Sbjct: 188 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 94.3 bits (235), Expect = 8e-21
 Identities = 51/222 (22%), Positives = 97/222 (43%), Gaps = 40/222 (18%)

Query: 481 TNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMN-EVMVISKLQHRN 539
              +     +G G FG V+  +L +  E+A+K++ +      + F N E+ ++  ++H N
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPN 93

Query: 540 LVRLLGCCVEGEEKM------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEG---- 589
           +V L        +K       L+ EY+P         + + +    + K    +      
Sbjct: 94  VVDLKAFFYSNGDKKDEVFLNLVLEYVP---------ETVYRASRHYAKLKQTMPMLLIK 144

Query: 590 -----ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADT 643
                + R L Y+H    + I HRD+K  N+LLD      K+ DFG AKI      + + 
Sbjct: 145 LYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNV 199

Query: 644 GRVVGTFGYMSPEYAMEG--RFSEKSDVFSFGVLLLEIVSGR 683
             +  +  Y +PE  + G   ++   D++S G ++ E++ G+
Sbjct: 200 SYIC-SRYYRAPE-LIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 93.4 bits (233), Expect = 9e-21
 Identities = 62/213 (29%), Positives = 104/213 (48%), Gaps = 22/213 (10%)

Query: 482 NNFQLSSKLGQGGFGPVYWGR---LKDGQEI-AVKRLSKAS----GQGLEEFMNEVMVIS 533
             F+L   LG+GG+G V+  R     +  +I A+K L KA      +       E  ++ 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76

Query: 534 KLQHRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGI 590
           +++H  +V L+    +   K+ LI EY+    L    F  L++E +  +    F + E I
Sbjct: 77  EVKHPFIVDLI-YAFQTGGKLYLILEYLSGGEL----FMQLEREGIFMEDTACFYLAE-I 130

Query: 591 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTF 650
           S  L +LH+     II+RDLK  NI+L+ + + K++DFG+ K    +     T    GT 
Sbjct: 131 SMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTI 185

Query: 651 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
            YM+PE  M    +   D +S G L+ ++++G 
Sbjct: 186 EYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 93.0 bits (232), Expect = 1e-20
 Identities = 67/211 (31%), Positives = 114/211 (54%), Gaps = 20/211 (9%)

Query: 482 NNFQLSSKLGQGGFGPVYWGR---LKDGQEI-AVKRLSKAS--GQGLEEFMNEVMVISKL 535
           + F+L   LGQG FG V+  +     D +++ A+K L KA+   +       E  ++ ++
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83

Query: 536 QHRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISR 592
            H  +V+L     + E K+ LI +++    L    F  L KE +  +   +F + E ++ 
Sbjct: 84  NHPFIVKLH-YAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAE-LAL 137

Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 652
            L +LH    L II+RDLK  NILLDEE + K++DFG++K    ++ +A +    GT  Y
Sbjct: 138 ALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEY 192

Query: 653 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           M+PE       ++ +D +SFGVL+ E+++G 
Sbjct: 193 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 92.6 bits (231), Expect = 1e-20
 Identities = 59/218 (27%), Positives = 104/218 (47%), Gaps = 22/218 (10%)

Query: 480 ATNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLS-KASGQGLEEF----MNEVMVIS 533
           AT+ ++  +++G G +G VY  R    G  +A+K +     G G        + EV ++ 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66

Query: 534 KLQ---HRNLVRLLGCCVEGEEK-----MLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 585
           +L+   H N+VRL+  C            L++E++ ++ L   L D      L      +
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKD 124

Query: 586 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 645
           ++    RGL +LH +    I+HRDLK  NIL+      K++DFG+A+I+        T  
Sbjct: 125 LMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL--TPV 179

Query: 646 VVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           VV T  Y +PE  ++  ++   D++S G +  E+   +
Sbjct: 180 VV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 93.1 bits (232), Expect = 1e-20
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 20/210 (9%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVK--RLSKASGQGLEEF----MNEVMVISK 534
             ++    +G+G +G V   R KD G+ +A+K    S       +      M E+ ++ +
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD----KMVKKIAMREIKLLKQ 80

Query: 535 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 594
           L+H NLV LL  C + +   L++E++ + ++   L        LD++     +  I  G+
Sbjct: 81  LRHENLVNLLEVCKKKKRWYLVFEFV-DHTILDDLEL--FPNGLDYQVVQKYLFQIINGI 137

Query: 595 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 654
            + H      IIHRD+K  NIL+ +    K+ DFG A+       +     V  T  Y +
Sbjct: 138 GFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYDDEVA-TRWYRA 192

Query: 655 PEYAMEGRFSEKS-DVFSFGVLLLEIVSGR 683
           PE  +      K+ DV++ G L+ E+  G 
Sbjct: 193 PELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 93.2 bits (232), Expect = 1e-20
 Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 36/216 (16%)

Query: 483 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN-EVMVISKLQHRNL 540
            +     +G G FG     R     + +AVK + +  G  ++E +  E++    L+H N+
Sbjct: 21  RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNI 78

Query: 541 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERL---DWRKRFN-IIEGISRGLL 595
           VR     +      +I EY     L    ++ +    R    + R  F  ++ G+S    
Sbjct: 79  VRFKEVILTPTHLAIIMEYASGGEL----YERICNAGRFSEDEARFFFQQLLSGVS---- 130

Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNP--KISDFGMAKIFGGNQDQADTGRVVGTFGYM 653
           Y H    ++I HRDLK  N LLD    P  KI DFG +K    +  Q  +   VGT  Y+
Sbjct: 131 YCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS--TVGTPAYI 184

Query: 654 SPE------YAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           +PE      Y   G+    +DV+S GV L  ++ G 
Sbjct: 185 APEVLLRQEYD--GK---IADVWSCGVTLYVMLVGA 215

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 92.7 bits (231), Expect = 2e-20
 Identities = 58/223 (26%), Positives = 94/223 (42%), Gaps = 42/223 (18%)

Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEF--------MNEVMVI 532
           + ++  +KLG+G +G VY        + +A+KR+       LE          + EV ++
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLL 87

Query: 533 SKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGIS- 591
            +LQHRN++ L           LI+EY      D      LKK  +D     ++    S 
Sbjct: 88  KELQHRNIIELKSVIHHNHRLHLIFEYA---END------LKK-YMDKNPDVSMRVIKSF 137

Query: 592 -----RGLLYLHRDSRLRIIHRDLKASNILLDEELNP-----KISDFGMAKIFGGNQDQA 641
                 G+ + H     R +HRDLK  N+LL           KI DFG+A+ F G   + 
Sbjct: 138 LYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQ 193

Query: 642 DTGRVVGTFGYMSPEYAM-EGRFSEKSDVFSFGVLLLEIVSGR 683
            T  ++ T  Y  PE  +    +S   D++S   +  E++   
Sbjct: 194 FTHEII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 92.2 bits (230), Expect = 2e-20
 Identities = 51/206 (24%), Positives = 95/206 (46%), Gaps = 12/206 (5%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN--EVMVISKLQHR 538
             ++   K+G+G +G V+  R +D GQ +A+K+  ++    + + +   E+ ++ +L+H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62

Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           NLV LL          L++EY  + ++   L     +  +      +I     + + + H
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYC-DHTVLHELDR--YQRGVPEHLVKSITWQTLQAVNFCH 119

Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 658
           +      IHRD+K  NIL+ +    K+ DFG A++  G         V  T  Y SPE  
Sbjct: 120 KH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTG-PSDYYDDEVA-TRWYRSPELL 174

Query: 659 MEGRF-SEKSDVFSFGVLLLEIVSGR 683
           +         DV++ G +  E++SG 
Sbjct: 175 VGDTQYGPPVDVWAIGCVFAELLSGV 200

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 94.0 bits (234), Expect = 2e-20
 Identities = 56/223 (25%), Positives = 101/223 (45%), Gaps = 41/223 (18%)

Query: 481 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN-EVMVISKLQHR 538
             ++  +  +G G FG VY  +L D G+ +A+K++ +      + F N E+ ++ KL H 
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHC 107

Query: 539 NLVRLLGCCVEGEEKM------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEG--- 589
           N+VRL        EK       L+ +Y+P         + + +    + +    +     
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP---------ETVYRVARHYSRAKQTLPVIYV 158

Query: 590 ------ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQAD 642
                 + R L Y+H      I HRD+K  N+LLD +    K+ DFG AK     + + +
Sbjct: 159 KLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPN 213

Query: 643 TGRVVGTFGYMSPEYAMEG--RFSEKSDVFSFGVLLLEIVSGR 683
              +  +  Y +PE  + G   ++   DV+S G +L E++ G+
Sbjct: 214 VSYIC-SRYYRAPE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 91.9 bits (229), Expect = 4e-20
 Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 19/210 (9%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEEF---MNEVMVISK-LQ 536
           ++F     +G+G FG V   R K  +   AVK L K +    +E    M+E  V+ K ++
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97

Query: 537 HRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKER--LDWRKRFNIIEGISRG 593
           H  LV L     +  +K+  + +Y+    L    F  L++ER  L+ R RF   E I+  
Sbjct: 98  HPFLVGLH-FSFQTADKLYFVLDYINGGEL----FYHLQRERCFLEPRARFYAAE-IASA 151

Query: 594 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 653
           L YLH    L I++RDLK  NILLD + +  ++DFG+ K    +     T    GT  Y+
Sbjct: 152 LGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST--FCGTPEYL 206

Query: 654 SPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           +PE   +  +    D +  G +L E++ G 
Sbjct: 207 APEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 91.1 bits (227), Expect = 6e-20
 Identities = 63/210 (30%), Positives = 98/210 (46%), Gaps = 19/210 (9%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKA---SGQGLEEFMNEVMVISK-LQ 536
            +F L   +G+G +  V   RLK    I A+K + K      + ++    E  V  +   
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68

Query: 537 HRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKER--LDWRKRFNIIEGISRG 593
           H  LV L   C + E ++  + EY+    L       ++++R   +   RF   E IS  
Sbjct: 69  HPFLVGLH-SCFQTESRLFFVIEYVNGGDL----MFHMQRQRKLPEEHARFYSAE-ISLA 122

Query: 594 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 653
           L YLH      II+RDLK  N+LLD E + K++D+GM K      D   T    GT  Y+
Sbjct: 123 LNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNYI 177

Query: 654 SPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           +PE      +    D ++ GVL+ E+++GR
Sbjct: 178 APEILRGEDYGFSVDWWALGVLMFEMMAGR 207

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 91.1 bits (227), Expect = 7e-20
 Identities = 68/210 (32%), Positives = 103/210 (49%), Gaps = 19/210 (9%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKA---SGQGLEEFMNEVMVISK-LQ 536
           +NF+    LG+G FG V   R+K+  ++ AVK L K        +E  M E  ++S    
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82

Query: 537 HRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKER--LDWRKRFNIIEGISRG 593
           H  L +L  CC +  +++  + E++    L       ++K R   + R RF   E I   
Sbjct: 83  HPFLTQLF-CCFQTPDRLFFVMEFVNGGDL----MFHIQKSRRFDEARARFYAAE-IISA 136

Query: 594 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 653
           L++LH      II+RDLK  N+LLD E + K++DFGM K    N     T    GT  Y+
Sbjct: 137 LMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT--FCGTPDYI 191

Query: 654 SPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           +PE   E  +    D ++ GVLL E++ G 
Sbjct: 192 APEILQEMLYGPAVDWWAMGVLLYEMLCGH 221

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 90.7 bits (226), Expect = 9e-20
 Identities = 64/210 (30%), Positives = 100/210 (47%), Gaps = 19/210 (9%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEEF---MNEVMVISK-LQ 536
            +F L   LG+G FG V+    K   +  A+K L K      ++    M E  V+S   +
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76

Query: 537 HRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKER--LDWRKRFNIIEGISRG 593
           H  L  +  C  + +E +  + EY+    L       ++        R  F   E I  G
Sbjct: 77  HPFLTHMF-CTFQTKENLFFVMEYLNGGDL----MYHIQSCHKFDLSRATFYAAE-IILG 130

Query: 594 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 653
           L +LH      I++RDLK  NILLD++ + KI+DFGM K       + +T    GT  Y+
Sbjct: 131 LQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYI 185

Query: 654 SPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           +PE  +  +++   D +SFGVLL E++ G+
Sbjct: 186 APEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 90.9 bits (226), Expect = 1e-19
 Identities = 62/210 (29%), Positives = 98/210 (46%), Gaps = 19/210 (9%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKA---SGQGLEEFMNEVMVISK-LQ 536
            +F L   +G+G +  V   RLK    I A++ + K      + ++    E  V  +   
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111

Query: 537 HRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRG 593
           H  LV L   C + E ++  + EY+    L       ++++R   +   RF   E IS  
Sbjct: 112 HPFLVGLH-SCFQTESRLFFVIEYVNGGDL----MFHMQRQRKLPEEHARFYSAE-ISLA 165

Query: 594 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 653
           L YLH      II+RDLK  N+LLD E + K++D+GM K      D   T    GT  Y+
Sbjct: 166 LNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNYI 220

Query: 654 SPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           +PE      +    D ++ GVL+ E+++GR
Sbjct: 221 APEILRGEDYGFSVDWWALGVLMFEMMAGR 250

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 92.8 bits (230), Expect = 1e-19
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 19/210 (9%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKA---SGQGLEEFMNEVMVISK-LQ 536
            +F     LG+G FG V     K   E+ AVK L K        +E  M E  V++   +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400

Query: 537 HRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKER--LDWRKRFNIIEGISRG 593
              L +L   C +  +++  + EY+    L       +++     +    F   E I+ G
Sbjct: 401 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDL----MYHIQQVGRFKEPHAVFYAAE-IAIG 454

Query: 594 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 653
           L +L       II+RDLK  N++LD E + KI+DFGM K    +     T    GT  Y+
Sbjct: 455 LFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTPDYI 509

Query: 654 SPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           +PE      + +  D ++FGVLL E+++G+
Sbjct: 510 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 89.6 bits (223), Expect = 2e-19
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 19/210 (9%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKA---SGQGLEEFMNEVMVISK-LQ 536
            +F     LG+G FG V     K   E+ AVK L K        +E  M E  V++   +
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79

Query: 537 HRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRG 593
              L +L   C +  +++  + EY+    L       +++     +    F   E I+ G
Sbjct: 80  PPFLTQLH-SCFQTMDRLYFVMEYVNGGDL----MYHIQQVGRFKEPHAVFYAAE-IAIG 133

Query: 594 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 653
           L +L       II+RDLK  N++LD E + KI+DFGM K    +     T    GT  Y+
Sbjct: 134 LFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTPDYI 188

Query: 654 SPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           +PE      + +  D ++FGVLL E+++G+
Sbjct: 189 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 87.6 bits (218), Expect = 7e-19
 Identities = 57/220 (25%), Positives = 105/220 (47%), Gaps = 32/220 (14%)

Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI-AVKRLSKASGQGLEEFMN--------EVMV 531
             ++  +++G+G +G V+  R LK+G    A+KR+       ++            EV V
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR------VQTGEEGMPLSTIREVAV 64

Query: 532 ISKLQ---HRNLVRLLGCCVEGEEK-----MLIYEYMPNRSLDALLFDPLKKERLDWRKR 583
           +  L+   H N+VRL   C            L++E++ ++ L   L D + +  +     
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETI 122

Query: 584 FNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 643
            +++  + RGL +LH     R++HRDLK  NIL+      K++DFG+A+I+        T
Sbjct: 123 KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--T 177

Query: 644 GRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
             VV T  Y +PE  ++  ++   D++S G +  E+   +
Sbjct: 178 SVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 87.1 bits (216), Expect = 2e-18
 Identities = 57/219 (26%), Positives = 99/219 (45%), Gaps = 35/219 (15%)

Query: 481 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN---------EVM 530
              +Q    +G G  G V         + +A+K+LS+        F N         E++
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-------FQNQTHAKRAYRELV 76

Query: 531 VISKLQHRNLVRLL------GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF 584
           ++  + H+N++ LL          E ++  ++ E M     DA L   ++ E    R  +
Sbjct: 77  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHERMSY 131

Query: 585 NIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG 644
            ++  +  G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +     T 
Sbjct: 132 -LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TP 185

Query: 645 RVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
            VV T  Y +PE  +   + E  D++S G ++ E++ G 
Sbjct: 186 YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 87.2 bits (216), Expect = 4e-18
 Identities = 58/219 (26%), Positives = 98/219 (44%), Gaps = 35/219 (15%)

Query: 481 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN---------EVM 530
              +Q    +G G  G V         + +A+K+LS+        F N         E++
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-------FQNQTHAKRAYRELV 113

Query: 531 VISKLQHRNLVRLL------GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF 584
           ++  + H+N++ LL          E ++  L+ E M     DA L   ++ E    R  +
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSY 168

Query: 585 NIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG 644
            + + +  G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G       T 
Sbjct: 169 LLYQ-MLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTP 222

Query: 645 RVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
            VV T  Y +PE  +   + E  D++S G ++ E+V  +
Sbjct: 223 YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 85.4 bits (212), Expect = 6e-18
 Identities = 49/223 (21%), Positives = 89/223 (39%), Gaps = 32/223 (14%)

Query: 481 TNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEE--FMN---------EV 529
            + + +   +  G +G V  G   +G  +A+KR+      G       +         E+
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 530 MVISKLQHRNLVRLLGC-CVEGEEKM----LIYEYMPNRSLDALLFDPLKKERL---DWR 581
            +++   H N++ L        E  M    L+ E M        L   +  +R+      
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-----RTDLAQVIHDQRIVISPQH 135

Query: 582 KRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA 641
            ++  +  I  GL  LH      ++HRDL   NILL +  +  I DF +A+      D  
Sbjct: 136 IQY-FMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAR--EDTADAN 189

Query: 642 DTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
            T  V     Y +PE  M+   F++  D++S G ++ E+ + +
Sbjct: 190 KTHYVT-HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 85.0 bits (211), Expect = 7e-18
 Identities = 64/217 (29%), Positives = 101/217 (46%), Gaps = 26/217 (11%)

Query: 482 NNFQLSSKLGQGGFGPVYWGR---LKDGQEI-AVKRLSKAS----GQGLEEFMNEVMVIS 533
            NF+L   LG G +G V+  R     D  ++ A+K L KA+     +  E    E  V+ 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113

Query: 534 KLQHRN-LVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEG 589
            ++    LV L     + E K+ LI +Y+    L    F  L +     +   +  + E 
Sbjct: 114 HIRQSPFLVTLH-YAFQTETKLHLILDYINGGEL----FTHLSQRERFTEHEVQIYVGE- 167

Query: 590 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF-GGNQDQADTGRVVG 648
           I   L +LH+   L II+RD+K  NILLD   +  ++DFG++K F     ++A      G
Sbjct: 168 IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD--FCG 222

Query: 649 TFGYMSPEYAMEGRFSEKSDV--FSFGVLLLEIVSGR 683
           T  YM+P+    G       V  +S GVL+ E+++G 
Sbjct: 223 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 85.0 bits (210), Expect = 7e-18
 Identities = 36/92 (39%), Positives = 54/92 (58%), Gaps = 3/92 (3%)

Query: 590 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 649
           +++G+ +L   +  + IHRDL A NILL E+   KI DFG+A+    + D    G     
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258

Query: 650 FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS 681
             +M+PE   +  ++ +SDV+SFGVLL EI S
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 68.0 bits (166), Expect = 3e-12
 Identities = 37/168 (22%), Positives = 62/168 (36%), Gaps = 19/168 (11%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKD------GQEIAVKRL-SKASGQGLEEFMNEVMVISK 534
           +  +L   LG+G FG V              + +AVK L   A+       M+E+ ++  
Sbjct: 22  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81

Query: 535 L-QHRNLVRLLGCC-VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 592
           +  H N+V LLG C   G   M+I E+    +L   L            KR   +   ++
Sbjct: 82  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTK 131

Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ 640
           G  +      +  I  DLK     +    +   S F   K     +++
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 84.7 bits (210), Expect = 9e-18
 Identities = 50/220 (22%), Positives = 104/220 (47%), Gaps = 38/220 (17%)

Query: 481 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN---------EVM 530
              +   + +G G +G V      + G+++A+K+LS+        F +         E++
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP-------FQSEIFAKRAYRELL 75

Query: 531 VISKLQHRNLVRLL------GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF 584
           ++  +QH N++ LL             +  L+  +M        L   +  +  + + ++
Sbjct: 76  LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMGLKFSEEKIQY 130

Query: 585 NIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG 644
            ++  + +GL Y+H      ++HRDLK  N+ ++E+   KI DFG+A+      D   TG
Sbjct: 131 -LVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARH----ADAEMTG 182

Query: 645 RVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
            VV T  Y +PE  +    +++  D++S G ++ E+++G+
Sbjct: 183 YVV-TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 83.5 bits (207), Expect = 3e-17
 Identities = 53/223 (23%), Positives = 96/223 (43%), Gaps = 35/223 (15%)

Query: 481 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 539
            + FQ+    GQG FG V  G+ K  G  +A+K++ +       E    +  ++ L H N
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLHHPN 80

Query: 540 LVRLLGC-CVEGEEKM------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEG--- 589
           +V+L       GE         ++ EY+P         D L +   ++ +R         
Sbjct: 81  IVQLQSYFYTLGERDRRDIYLNVVMEYVP---------DTLHRCCRNYYRRQVAPPPILI 131

Query: 590 ------ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQAD 642
                 + R +  LH  S + + HRD+K  N+L++E     K+ DFG AK    +  + +
Sbjct: 132 KVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL--SPSEPN 188

Query: 643 TGRVVGTFGYMSPEYAMEG--RFSEKSDVFSFGVLLLEIVSGR 683
              +   + Y +PE  + G   ++   D++S G +  E++ G 
Sbjct: 189 VAYICSRY-YRAPEL-IFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 81.5 bits (202), Expect = 7e-17
 Identities = 48/210 (22%), Positives = 101/210 (48%), Gaps = 21/210 (10%)

Query: 481 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HR 538
            +++QL  KLG+G +  V+    + + +++ VK L     +   +   E+ ++  L+   
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGP 91

Query: 539 NLVRLLGCCVEGEEKM--LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 596
           N++ L     +   +   L++E++ N     L +  L    +    RF + E I + L Y
Sbjct: 92  NIITLADIVKDPVSRTPALVFEHVNNTDFKQL-YQTLTDYDI----RFYMYE-ILKALDY 145

Query: 597 LHRDSRLRIIHRDLKASNILLDEEL-NPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 655
            H  S   I+HRD+K  N+++D E    ++ D+G+A+    +  Q    RV  +  +  P
Sbjct: 146 CH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVRVA-SRYFKGP 199

Query: 656 EYAMEGRFSEKS-DVFSFGVLLLEIVSGRK 684
           E  ++ +  + S D++S G +L  ++  ++
Sbjct: 200 ELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 80.8 bits (200), Expect = 2e-16
 Identities = 55/222 (24%), Positives = 103/222 (46%), Gaps = 37/222 (16%)

Query: 481 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN---------EVM 530
              +   S +G+G +G V       +   +A+K++S         F +         E+ 
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIK 77

Query: 531 VISKLQHRNLVRLLGCCV-EGEEKM----LIYEYMPNRSLDALLFDPLKKERL-DWRKRF 584
           ++ + +H N++ +         E+M    ++ + M     +  L+  LK + L +    +
Sbjct: 78  ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICY 132

Query: 585 NIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD-- 642
             +  I RGL Y+H  S   ++HRDLK SN+LL+   + KI DFG+A++   + D     
Sbjct: 133 -FLYQILRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 188

Query: 643 TGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
           T  V  T  Y +PE  +    +++  D++S G +L E++S R
Sbjct: 189 TEYVA-TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 80.8 bits (200), Expect = 2e-16
 Identities = 56/221 (25%), Positives = 106/221 (47%), Gaps = 39/221 (17%)

Query: 481 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN---------EVM 530
              ++    +G G +G V      + G ++A+K+L +        F +         E+ 
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-------FQSELFAKRAYRELR 76

Query: 531 VISKLQHRNLVRLL------GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL-DWRKR 583
           ++  ++H N++ LL          +  +  L+  +M        L   +K E+L + R +
Sbjct: 77  LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-----GTDLGKLMKHEKLGEDRIQ 131

Query: 584 FNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 643
           F ++  + +GL Y+H      IIHRDLK  N+ ++E+   KI DFG+A+      D   T
Sbjct: 132 F-LVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ----ADSEMT 183

Query: 644 GRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
           G VV T  Y +PE  +   R+++  D++S G ++ E+++G+
Sbjct: 184 GYVV-TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 79.2 bits (196), Expect = 4e-16
 Identities = 52/232 (22%), Positives = 102/232 (43%), Gaps = 48/232 (20%)

Query: 481 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN---------EVM 530
            + +     LG GG G V+        + +A+K++            +         E+ 
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIK 60

Query: 531 VISKLQHRNLVRLL--------------GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKE 576
           +I +L H N+V++               G   E     ++ EYM     +  L + L++ 
Sbjct: 61  IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLEQG 115

Query: 577 RL-DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD-EELNPKISDFGMAKIF 634
            L +   R   +  + RGL Y+H  +   ++HRDLK +N+ ++ E+L  KI DFG+A+I 
Sbjct: 116 PLLEEHARL-FMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIM 171

Query: 635 GGNQDQAD--TGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
             +       +  +V T  Y SP   +    +++  D+++ G +  E+++G+
Sbjct: 172 DPHYSHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 78.5 bits (194), Expect = 1e-15
 Identities = 64/221 (28%), Positives = 105/221 (47%), Gaps = 39/221 (17%)

Query: 481 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN---------EVM 530
              +Q  S +G G +G V      K G  +AVK+LS+        F +         E+ 
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------FQSIIHAKRTYRELR 80

Query: 531 VISKLQHRNLVRLL------GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL-DWRKR 583
           ++  ++H N++ LL          E  +  L+   M      A L + +K ++L D   +
Sbjct: 81  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDDHVQ 135

Query: 584 FNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 643
           F +I  I RGL Y+H      IIHRDLK SN+ ++E+   KI DFG+A+          T
Sbjct: 136 F-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH----TADEMT 187

Query: 644 GRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
           G V  T  Y +PE  +    +++  D++S G ++ E+++GR
Sbjct: 188 GYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 77.2 bits (190), Expect = 5e-15
 Identities = 35/203 (17%), Positives = 85/203 (41%), Gaps = 33/203 (16%)

Query: 481 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN---------EVM 530
            + +++   +G G +G V       + + +A+K++ +        F +         E+ 
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-------FEDLIDCKRILREIA 104

Query: 531 VISKLQHRNLVRLLG-CCVEGEEKM----LIYEYMPNRSLDALL--FDPLKKERLDWRKR 583
           ++++L H ++V++L     +  EK     ++ E         L      L +       +
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRTPVYLTELH----IK 159

Query: 584 FNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 643
             ++  +  G+ Y+H  S   I+HRDLK +N L++++ + K+ DFG+A+     ++    
Sbjct: 160 T-LLYNLLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQ 215

Query: 644 GRVVGTFGYMSPEYAMEGRFSEK 666
             +      M+       +  ++
Sbjct: 216 LPISPREDDMNLVTFPHTKNLKR 238

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 74.4 bits (183), Expect = 3e-14
 Identities = 45/247 (18%), Positives = 91/247 (36%), Gaps = 53/247 (21%)

Query: 479 TATNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN-EVMVISKLQ 536
           T++  + L   LG G FG V      + G+  A+K++ +        + N E+ ++  L 
Sbjct: 4   TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-----RYKNRELDIMKVLD 58

Query: 537 HRNLVRLLGC----CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN------- 585
           H N+++L+        E  +     +            +   K  +    +         
Sbjct: 59  HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118

Query: 586 --------IIEGIS-------------------RGLLYLHRDSRLRIIHRDLKASNILLD 618
                   +++                      R + ++H    L I HRD+K  N+L++
Sbjct: 119 YVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVN 175

Query: 619 EELNP-KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGR-FSEKSDVFSFGVLL 676
            + N  K+ DFG AK       +     +   F Y +PE  +    ++   D++S G + 
Sbjct: 176 SKDNTLKLCDFGSAKKL--IPSEPSVAYICSRF-YRAPELMLGATEYTPSIDLWSIGCVF 232

Query: 677 LEIVSGR 683
            E++ G+
Sbjct: 233 GELILGK 239

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 73.0 bits (180), Expect = 6e-14
 Identities = 55/229 (24%), Positives = 96/229 (41%), Gaps = 44/229 (19%)

Query: 481 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN---------EVM 530
           +++FQL S LG+G +G V        G+ +A+K++          F           E+ 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIK 61

Query: 531 VISKLQHRNLVRLLGC-CVEGEEKM----LIYEYMPNRSLDALLFDPLKKERL-DWRKRF 584
           ++   +H N++ +      +  E      +I E M        L   +  + L D   ++
Sbjct: 62  ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-----QTDLHRVISTQMLSDDHIQY 116

Query: 585 NIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD-- 642
             I    R +  LH  +   +IHRDLK SN+L++   + K+ DFG+A+I   +       
Sbjct: 117 -FIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP 172

Query: 643 -------TGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGR 683
                     V  T  Y +PE  +   ++S   DV+S G +L E+   R
Sbjct: 173 TGQQSGMVEFVA-TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 71.9 bits (177), Expect = 9e-14
 Identities = 42/203 (20%), Positives = 75/203 (36%), Gaps = 48/203 (23%)

Query: 486 LSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLVRL 543
            S  LG G  G V     K   ++ A+K L         +   EV +  +  Q  ++VR+
Sbjct: 22  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRI 76

Query: 544 LGCC---VEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDW---RKRFNIIEGISRGLLY 596
           +        G + + ++ E +        LF  ++         R+   I++ I   + Y
Sbjct: 77  VDVYENLYAGRKCLLIVMECLD----GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 132

Query: 597 LHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYM 653
           LH    + I HRD+K  N+L          K++DFG AK                     
Sbjct: 133 LHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET------------------- 170

Query: 654 SPEYAMEGRFSEKSDVFSFGVLL 676
                   ++ +  D++S GV++
Sbjct: 171 -----TGEKYDKSCDMWSLGVIM 188

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 73.2 bits (180), Expect = 1e-13
 Identities = 40/211 (18%), Positives = 87/211 (41%), Gaps = 33/211 (15%)

Query: 472 FQFEELATATNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN--- 527
           FQ  +     +N+ +   +G+G +G VY        + +A+K++++        F +   
Sbjct: 16  FQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-------FEDLID 68

Query: 528 ------EVMVISKLQHRNLVRLLGCCV-EGEEKM----LIYEYMPNRSLDALL--FDPLK 574
                 E+ ++++L+   ++RL    + +   K     ++ E      L  L      L 
Sbjct: 69  CKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLT 127

Query: 575 KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 634
           +E      +  I+  +  G  ++H      IIHRDLK +N LL+++ + K+ DFG+A+  
Sbjct: 128 EEH----IKT-ILYNLLLGENFIH--ES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179

Query: 635 GGNQDQADTGRVVGTFGYMSPEYAMEGRFSE 665
              +D      +            ++ + + 
Sbjct: 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTS 210

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 68.9 bits (169), Expect = 2e-12
 Identities = 47/190 (24%), Positives = 92/190 (48%), Gaps = 30/190 (15%)

Query: 481 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN---------EVM 530
              ++L  KLG+G +G V+     + G+ +AVK++  A       F N         E+M
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQRTFREIM 60

Query: 531 VISKLQ-HRNLVRLLGCCV--EGEEKMLIYEYMPNRSLDALLFDPLKKERL-DWRKRFNI 586
           ++++L  H N+V LL         +  L+++YM     +  L   ++   L    K++ +
Sbjct: 61  ILTELSGHENIVNLLNVLRADNDRDVYLVFDYM-----ETDLHAVIRANILEPVHKQY-V 114

Query: 587 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV 646
           +  + + + YLH  S   ++HRD+K SNILL+ E + K++DFG+++ F   +   +   +
Sbjct: 115 VYQLIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPL 171

Query: 647 VGTFGYMSPE 656
                  + +
Sbjct: 172 SINENTENFD 181

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 69.0 bits (169), Expect = 2e-12
 Identities = 50/228 (21%), Positives = 98/228 (42%), Gaps = 44/228 (19%)

Query: 484 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ------ 536
           + L  KLG G F  V+  + + +   +A+K + +      E   +E+ ++ ++       
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTK 79

Query: 537 -----HRNLVRLLGC-CVEGEEKM---LIYEYMPNRSLDALLFDPLKKERLDWRKRFNI- 586
                  ++++LL     +G   +   +++E      L   L   +KK      +   + 
Sbjct: 80  EDSMGANHILKLLDHFNHKGPNGVHVVMVFE-----VLGENLLALIKKYEH---RGIPLI 131

Query: 587 -IEGISR----GLLYLHRDSRLRIIHRDLKASNILLDEELNP------KISDFGMAKIFG 635
            ++ IS+    GL Y+HR  R  IIH D+K  N+L++   +P      KI+D G A  + 
Sbjct: 132 YVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-CWY 188

Query: 636 GNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
                      + T  Y SPE  +   +   +D++S   L+ E+++G 
Sbjct: 189 DEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 66.1 bits (160), Expect = 1e-11
 Identities = 35/199 (17%), Positives = 67/199 (33%), Gaps = 46/199 (23%)

Query: 480 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRL--------SKASGQGLEEFMNEVMV 531
            T   Q   K+G+G FG V+         +A+K +        + +  +  EE + E+++
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIAD-HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 532 ISKLQ---------HRNLVRLLGC-CVEG---EEKMLIYEYM----------PNRSLDAL 568
             +L              + L    CV+G      +  +++           P+   D  
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 569 LF------------DPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNIL 616
           LF            + ++ +        +I+  ++  L        LR  HRDL   N+L
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVL 194

Query: 617 LDEELNPKISDFGMAKIFG 635
           L +    K+      K   
Sbjct: 195 LKKTSLKKLHYTLNGKSST 213

>3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110

 Score = 60.2 bits (146), Expect = 3e-11
 Identities = 22/121 (18%), Positives = 46/121 (38%), Gaps = 17/121 (14%)

Query: 24  SSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLK 83
           +S++S   +      L  G +++L      +       + YD       +W +N      
Sbjct: 2   NSLSSPNSLF-TGHSLEVGPSYRLIMQGDCNF------VLYD---SGKPVWASNTGG--L 49

Query: 84  DSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWE 143
            S   +T+  +GNLV+ +    V+W +  +    +     L    N+V+       +VW 
Sbjct: 50  GSGCRLTLHNNGNLVIYDQSNRVIWQTKTNG-KEDHYVLVLQQDRNVVIYGP----VVWA 104

Query: 144 S 144
           +
Sbjct: 105 T 105

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 65.0 bits (158), Expect = 5e-11
 Identities = 53/221 (23%), Positives = 93/221 (42%), Gaps = 36/221 (16%)

Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLS-KASGQGLEEFMNEVMVISKLQHRN 539
           N F+L  K+G G FG +Y G  ++  +E+A+K  + K     L     E  +   LQ   
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLL---YESKIYRILQGGT 63

Query: 540 LV-RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNI-------IEGIS 591
            +  +    VEG+  +L+ + +   SL+  LF+          ++ ++        + I+
Sbjct: 64  GIPNVRWFGVEGDYNVLVMDLL-GPSLED-LFNFCS-------RKLSLKTVLMLADQMIN 114

Query: 592 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPK---ISDFGMAKIFGGNQDQA-----DT 643
           R + ++H  S    +HRD+K  N L+          I DFG+AK +            + 
Sbjct: 115 R-VEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 170

Query: 644 GRVVGTFGYMSPEYAMEGRF-SEKSDVFSFGVLLLEIVSGR 683
             + GT  Y S      G   S + D+ S G +L+  + G 
Sbjct: 171 KNLTGTARYASV-NTHLGIEQSRRDDLESLGYVLMYFLRGS 210

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 64.3 bits (157), Expect = 5e-11
 Identities = 49/224 (21%), Positives = 85/224 (37%), Gaps = 42/224 (18%)

Query: 481 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVK------RLSKASGQGLEEFMNEVMVIS 533
            + +++ S +G+G FG V       + + +A+K           +         EV ++ 
Sbjct: 53  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA-------QIEVRLLE 105

Query: 534 KLQHR------NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNI- 586
            +          +V L    +      L++E      L   L+D L+       +  ++ 
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE-----MLSYNLYDLLRNTN---FRGVSLN 157

Query: 587 -IEGISR----GLLYLHRDSRLRIIHRDLKASNILLDEELNP--KISDFGMAKIFGGNQD 639
                ++     LL+L     L IIH DLK  NILL        KI DFG +        
Sbjct: 158 LTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ----LG 212

Query: 640 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           Q     +   F Y SPE  +   +    D++S G +L+E+ +G 
Sbjct: 213 QRIYQYIQSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 62.4 bits (152), Expect = 1e-10
 Identities = 55/221 (24%), Positives = 92/221 (41%), Gaps = 36/221 (16%)

Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLS-KASGQGLEEFMNEVMVISKLQH-R 538
           N ++L  K+G G FG +Y G  +  G+E+A+K    K     L     E  +   +Q   
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLH---IESKIYKMMQGGV 65

Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNI-------IEGIS 591
            +  +  C  EG+  +++ E +   SL+  LF+          ++F++        + IS
Sbjct: 66  GIPTIRWCGAEGDYNVMVMELL-GPSLED-LFNFCS-------RKFSLKTVLLLADQMIS 116

Query: 592 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPK---ISDFGMAKIF----GGNQDQADTG 644
           R + Y+H  +    IHRD+K  N L+          I DFG+AK +              
Sbjct: 117 R-IEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 172

Query: 645 R-VVGTFGYMSPEYAMEGRF-SEKSDVFSFGVLLLEIVSGR 683
           + + GT  Y S      G   S + D+ S G +L+    G 
Sbjct: 173 KNLTGTARYASI-NTHLGIEQSRRDDLESLGYVLMYFNLGS 212

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 62.8 bits (153), Expect = 1e-10
 Identities = 53/227 (23%), Positives = 94/227 (41%), Gaps = 46/227 (20%)

Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLS-KASGQGLEEFMNEVMVISKLQH-R 538
            NF++  K+G G FG +  G+ L   + +A+K    K+    L     E     +L    
Sbjct: 9   PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQL---HLEYRFYKQLGSGD 65

Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNI-------IEGIS 591
            + ++      G+   ++ E +   SL+  LFD          + F++       I+ IS
Sbjct: 66  GIPQVYYFGPCGKYNAMVLELL-GPSLED-LFDLCD-------RTFSLKTVLMIAIQLIS 116

Query: 592 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPK-----ISDFGMAKIFGGNQDQADTGR- 645
           R + Y+H  +   +I+RD+K  N L+    N       I DF +AK +    D  +T + 
Sbjct: 117 R-MEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY---ID-PETKKH 168

Query: 646 --------VVGTFGYMSPEYAMEGRF-SEKSDVFSFGVLLLEIVSGR 683
                   + GT  YMS      G+  S + D+ + G + +  + G 
Sbjct: 169 IPYREHKSLTGTARYMSI-NTHLGKEQSRRDDLEALGHMFMYFLRGS 214

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 63.2 bits (154), Expect = 1e-10
 Identities = 51/229 (22%), Positives = 96/229 (41%), Gaps = 60/229 (26%)

Query: 484 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVK------RLSKASGQGLEEFMNEVMVISKLQ 536
           +++   +G+G FG V      K  Q +A+K      R  + +         E+ ++  L+
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA-------AEEIRILEHLR 151

Query: 537 HR------NLVRLLGC-------CVEGEEKMLIYEYM-PNRSLDALLFDPLKKERLDWRK 582
            +      N++ +L         C       + +E +  N      L++ +KK +    +
Sbjct: 152 KQDKDNTMNVIHMLENFTFRNHIC-------MTFELLSMN------LYELIKKNKF---Q 195

Query: 583 RFNI--IEGISR----GLLYLHRDSRLRIIHRDLKASNILLDEELNP--KISDFGMAKIF 634
            F++  +   +      L  LH+    RIIH DLK  NILL ++     K+ DFG +   
Sbjct: 196 GFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY- 251

Query: 635 GGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
              + Q     +   F Y +PE  +  R+    D++S G +L E+++G 
Sbjct: 252 ---EHQRVYTYIQSRF-YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 62.2 bits (151), Expect = 3e-10
 Identities = 54/273 (19%), Positives = 99/273 (36%), Gaps = 88/273 (32%)

Query: 481 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ--- 536
              + +  KLG G F  V+    ++  + +A+K + K++    E  ++E+ ++  ++   
Sbjct: 36  NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSD 94

Query: 537 -----HRNLVRLLGC-CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN----- 585
                   +V+LL    + G           N +   ++F+ L    L W  + N     
Sbjct: 95  PNDPNREMVVQLLDDFKISG----------VNGTHICMVFEVLGHHLLKWIIKSNYQGLP 144

Query: 586 ------IIEGISRGLLYLHRDSRLRIIHRDLKASNILL---------------------- 617
                 II+ + +GL YLH  ++ RIIH D+K  NILL                      
Sbjct: 145 LPCVKKIIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGA 202

Query: 618 ---------------------------DEELNPKISDFGMAKIFGGNQDQADTGRVVGTF 650
                                       E+L  KI+D G A  +       D    + T 
Sbjct: 203 PPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNA-CWVHKHFTED----IQTR 257

Query: 651 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
            Y S E  +   ++  +D++S   +  E+ +G 
Sbjct: 258 QYRSLEVLIGSGYNTPADIWSTACMAFELATGD 290

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 60.8 bits (148), Expect = 4e-10
 Identities = 44/223 (19%), Positives = 93/223 (41%), Gaps = 38/223 (17%)

Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLS-KASGQGLEEFMNEVMVISKLQH-R 538
            ++++  ++G+G FG ++ G  L + Q++A+K    ++    L    +E      L    
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLR---DEYRTYKLLAGCT 66

Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNI-------IEGIS 591
            +  +     EG   +L+ + +   SL+  L D          ++F++        + ++
Sbjct: 67  GIPNVYYFGQEGLHNVLVIDLLG-PSLED-LLDLCG-------RKFSVKTVAMAAKQMLA 117

Query: 592 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPK-----ISDFGMAKIFGGNQDQA----- 641
           R +  +H  S   +++RD+K  N L+    +       + DFGM K +     +      
Sbjct: 118 R-VQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYR 173

Query: 642 DTGRVVGTFGYMSPEYAMEGRF-SEKSDVFSFGVLLLEIVSGR 683
           +   + GT  YMS      GR  S + D+ + G + +  + G 
Sbjct: 174 EKKNLSGTARYMSI-NTHLGREQSRRDDLEALGHVFMYFLRGS 215

>1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119

 Score = 56.1 bits (135), Expect = 8e-10
 Identities = 23/127 (18%), Positives = 40/127 (31%), Gaps = 17/127 (13%)

Query: 23  DSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMG-----IWYDMPSEKAVIWVAN 77
           ++ I S Q   +   IL    +  L            M      + YD       IW  N
Sbjct: 1   NNIIFSKQPDDNHPQILHATES--LEILFGTHVYRFIMQTDCNLVLYD---NNNPIWATN 55

Query: 78  RDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNIN 137
                  +     +  DG LV++  +   +W S V+          L    N+V+  +  
Sbjct: 56  TGG--LGNGCRAVLQPDGVLVVITNENVTVWQSPVAG-KAGHYVLVLQPDRNVVIYGD-- 110

Query: 138 RAIVWES 144
              +W +
Sbjct: 111 --ALWAT 115

>2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115

 Score = 55.3 bits (133), Expect = 1e-09
 Identities = 27/123 (21%), Positives = 45/123 (36%), Gaps = 18/123 (14%)

Query: 22  IDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNP 81
           +D+ + S Q +   D  L  G  + L   N  +       + Y        IW +N D  
Sbjct: 1   MDNVLLSGQTLH-ADHSLQAG-AYTLTIQNKCNL------VKYQ---NGRQIWASNTDR- 48

Query: 82  LKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIV 141
            + S   +T+  DGNLV+ +     +W S      N   +  L   G  V+       ++
Sbjct: 49  -RGSGCRLTLLSDGNLVIYDHNNNDVWGSACWG-DNGKYALVLQKDGRFVIYGP----VL 102

Query: 142 WES 144
           W  
Sbjct: 103 WSL 105

>2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115

 Score = 44.1 bits (104), Expect = 1e-05
 Identities = 18/76 (23%), Positives = 32/76 (42%), Gaps = 2/76 (2%)

Query: 77  NRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNI 136
           + D+ L+  +  +TI    NLV     +  +W+SN     +      LL  GNLV+ D+ 
Sbjct: 12  HADHSLQAGAYTLTIQNKCNLVKYQNGR-QIWASNTDRRGSGCR-LTLLSDGNLVIYDHN 69

Query: 137 NRAIVWESFQEPTDSF 152
           N  +   +       +
Sbjct: 70  NNDVWGSACWGDNGKY 85

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 32/214 (14%), Positives = 66/214 (30%), Gaps = 60/214 (28%)

Query: 482 NNFQLSSKLGQGGFGPVYWGR---------LKDGQEIAVKRLSKASGQGLEEFMNEVMVI 532
             ++L S   +   G +Y                Q+ ++K L    G+   E        
Sbjct: 42  RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100

Query: 533 SKLQHRNLVRLLGC------------CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDW 580
             LQ     +L                 + + + L+   +  RSL + L        +  
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSAL-------DVSP 152

Query: 581 RKRFNI-------IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKI--SDFGMA 631
           +   +           +   L +LH +     +H ++ A NI +D E   ++  + +G A
Sbjct: 153 KHVLSERSVLQVACRLLDA-LEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFA 208

Query: 632 KIFGGNQDQADTGRVV-----------GTFGYMS 654
             +        +G+ V           G   ++S
Sbjct: 209 FRY------CPSGKHVAYVEGSRSPHEGDLEFIS 236

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 58.1 bits (141), Expect = 5e-09
 Identities = 48/248 (19%), Positives = 88/248 (35%), Gaps = 76/248 (30%)

Query: 481 TNNFQLSSKLGQGGFGPVY--WGRLKDGQEIAVK------RLSKASGQGLEEFMNEVMVI 532
              +++   LG+G FG V       +   ++A+K      +  +A+         E+ V+
Sbjct: 18  QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA-------RLEINVL 70

Query: 533 SKLQHR------NLVRLLGC-------CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD 579
            K++ +        V +          C       + +E      L    F+ LK+    
Sbjct: 71  KKIKEKDKENKFLCVLMSDWFNFHGHMC-------IAFE-----LLGKNTFEFLKENN-- 116

Query: 580 WRKRFNI--IEGISRGLL----YLHRDSRLRIIHRDLKASNILLDEELNP---------- 623
             + + +  +  ++  L     +LH     ++ H DLK  NIL                 
Sbjct: 117 -FQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCE 172

Query: 624 ---------KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGV 674
                    +++DFG A  F    D      +V T  Y  PE  +E  +++  DV+S G 
Sbjct: 173 EKSVKNTSIRVADFGSA-TF----DHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGC 227

Query: 675 LLLEIVSG 682
           +L E   G
Sbjct: 228 ILFEYYRG 235

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 57.5 bits (139), Expect = 6e-09
 Identities = 43/238 (18%), Positives = 91/238 (38%), Gaps = 50/238 (21%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEI------AVKRLSKASGQ-----------GLEE 524
             +++   +GQGGFG +Y   +   + +       VK     +G               E
Sbjct: 35  AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94

Query: 525 FMNEVMVISKLQHRNLVRLLGCCVEGEEK----MLIYEYMPNRSLDALLFDPLKKERLDW 580
            + + +   KL++  + +  G  +  +       +I +      L  + ++   K     
Sbjct: 95  QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKI-YEANAK----- 147

Query: 581 RKRFNI-------IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKI--SDFGMA 631
             RF+        +  +   L Y+H       +H D+KASN+LL+ +   ++   D+G+A
Sbjct: 148 --RFSRKTVLQLSLRILDI-LEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLA 201

Query: 632 KIF---GGNQD--QADTGRVVGTFGYMSPEYAMEGRF-SEKSDVFSFGVLLLEIVSGR 683
             +   G ++           GT  + S + A  G   S + D+   G  +++ ++G 
Sbjct: 202 YRYCPEGVHKAYAADPKRCHDGTIEFTSID-AHNGVAPSRRGDLEILGYCMIQWLTGH 258

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 57.4 bits (139), Expect = 8e-09
 Identities = 39/206 (18%), Positives = 73/206 (35%), Gaps = 47/206 (22%)

Query: 482 NNFQLSSKLGQGGFGPVYWG-RLKDGQEIA---VKRLSKASGQGLEEF-----MNEVMVI 532
           N + L  K+G GGFG +Y        ++ A   VK   + +G    E      + +   I
Sbjct: 37  NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCI 96

Query: 533 SKLQHRNLVRLLG----------CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRK 582
            K   R  +  LG                 + ++ E +    L  +              
Sbjct: 97  KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKI---------SGQNG 146

Query: 583 RFNI-------IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKI--SDFGMAKI 633
            F         I  +   L Y+H +     +H D+KA+N+LL  +   ++  +D+G++  
Sbjct: 147 TFKKSTVLQLGIRMLDV-LEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYR 202

Query: 634 F---GGNQD--QADTGRVVGTFGYMS 654
           +   G ++   +       GT  + S
Sbjct: 203 YCPNGNHKQYQENPRKGHNGTIEFTS 228

>1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109

 Score = 52.5 bits (126), Expect = 1e-08
 Identities = 16/74 (21%), Positives = 31/74 (41%), Gaps = 6/74 (8%)

Query: 72  VIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLV 131
            +W +N     K       +  DGN V+ + +   LW+S+     N +    L + GN+V
Sbjct: 39  SVWASNTGILGKKGC-KAVLQSDGNFVVYDAEGRSLWASHSVR-GNGNYVLVLQEDGNVV 96

Query: 132 LRDNINRAIVWESF 145
           +  +     +W + 
Sbjct: 97  IYGS----DIWSTG 106

>1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109

 Score = 52.5 bits (126), Expect = 1e-08
 Identities = 20/68 (29%), Positives = 27/68 (39%), Gaps = 2/68 (2%)

Query: 77  NRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNI 136
                L        + ED NLVL +     +W+SN   L      A L   GN V+ D  
Sbjct: 11  YAGQSLDVEPYHFIMQEDCNLVLYDHST-SVWASNTGILGKKGCKAVLQSDGNFVVYDAE 69

Query: 137 NRAIVWES 144
            R+ +W S
Sbjct: 70  GRS-LWAS 76

>3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109

 Score = 51.8 bits (124), Expect = 2e-08
 Identities = 25/122 (20%), Positives = 45/122 (36%), Gaps = 18/122 (14%)

Query: 23  DSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPL 82
           D+ + S + +  P   L+NG  +        +       + YD       IW  N     
Sbjct: 1   DNILYSGETLS-PGEFLNNG-RYVFIMQEDCNL------VLYD---VDKPIWATNTGG-- 47

Query: 83  KDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVW 142
            D    +++  DGNLV+ + +   +W+SN     N +    L    N+V+         W
Sbjct: 48  LDRRCHLSMQSDGNLVVYSPRNNPIWASNTGG-ENGNYVCVLQKDRNVVIYGT----ARW 102

Query: 143 ES 144
            +
Sbjct: 103 AT 104

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 55.0 bits (133), Expect = 4e-08
 Identities = 52/248 (20%), Positives = 90/248 (36%), Gaps = 76/248 (30%)

Query: 481 TNNFQLSSKLGQGGFGPVY--WGRLKDGQEIAVK------RLSKASGQGLEEFMNEVMVI 532
           +  +++   LG+G FG V         G+ +AVK      R  +A+        +E+ V+
Sbjct: 13  SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA-------RSEIQVL 65

Query: 533 SKLQHR------NLVRLLGC-------CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD 579
             L           V++L         C       +++E      L    +D +K+    
Sbjct: 66  EHLNTTDPNSTFRCVQMLEWFEHHGHIC-------IVFE-----LLGLSTYDFIKENG-- 111

Query: 580 WRKRFNI--IEGISRGLL----YLHRDSRLRIIHRDLKASNILLDEELNP---------- 623
               F +  I  ++  +     +LH     ++ H DLK  NIL  +              
Sbjct: 112 -FLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167

Query: 624 ---------KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGV 674
                    K+ DFG A  +    D      +V T  Y +PE  +   +S+  DV+S G 
Sbjct: 168 ERTLINPDIKVVDFGSA-TY----DDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGC 222

Query: 675 LLLEIVSG 682
           +L+E   G
Sbjct: 223 ILIEYYLG 230

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 54.6 bits (132), Expect = 6e-08
 Identities = 54/247 (21%), Positives = 92/247 (37%), Gaps = 70/247 (28%)

Query: 481 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVK------RLSKASGQGLEEFMNEVMVIS 533
            N F +  K+G G FG V   + + + +  AVK      + ++++         E  ++ 
Sbjct: 34  NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA-------KIEADILK 86

Query: 534 KLQHR-----NLVRLLGC-------CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWR 581
           K+Q+      N+V+  G        C       LI+E      L   L++ + +      
Sbjct: 87  KIQNDDINNNNIVKYHGKFMYYDHMC-------LIFE-----PLGPSLYEIITRNN---Y 131

Query: 582 KRFNI--IEGISRGLL----YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 635
             F+I  I+     +L    YL +   + + H DLK  NILLD+    K          G
Sbjct: 132 NGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDG 188

Query: 636 GNQDQADTGRV---VGTFG-----------------YMSPEYAMEGRFSEKSDVFSFGVL 675
                  T      +  FG                 Y +PE  +   +   SD++SFG +
Sbjct: 189 KKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCV 248

Query: 676 LLEIVSG 682
           L E+ +G
Sbjct: 249 LAELYTG 255

>1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112

 Score = 50.3 bits (120), Expect = 9e-08
 Identities = 28/119 (23%), Positives = 50/119 (42%), Gaps = 16/119 (13%)

Query: 26  ITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDS 85
           + S   +      L+ G  +     N  +       + YD       +W +  +   K S
Sbjct: 4   LNSGHQLD-TGGSLAEG-GYLFIIQNDCNL------VLYD---NNRAVWASGTNG--KAS 50

Query: 86  SGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWES 144
             ++ +  DGNLV+ +G +  +W+SN +   N +    L    N+V+ DN N AI W +
Sbjct: 51  GCVLKMQNDGNLVIYSGSR-AIWASNTNR-QNGNYYLILQRDRNVVIYDNSNNAI-WAT 106

>3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109

 Score = 46.4 bits (110), Expect = 2e-06
 Identities = 19/82 (23%), Positives = 34/82 (41%), Gaps = 12/82 (14%)

Query: 74  WVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLR 133
           W +N  N        +T+++ G LV+ NG    +W S   + V  + +A +   G LV+ 
Sbjct: 40  WQSNTAN--NGRDCKLTLTDYGELVIKNGDGSTVWKSGAQS-VKGNYAAVVHPDGRLVVF 96

Query: 134 DNINRAIVWESFQEPTDSFLPG 155
                  V+       D ++ G
Sbjct: 97  GP----SVF-----KIDPWVRG 109

>3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109

 Score = 40.6 bits (95), Expect = 2e-04
 Identities = 21/68 (30%), Positives = 32/68 (47%), Gaps = 6/68 (8%)

Query: 77  NRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNI 136
           + +  LK+    + + +D NLVL NG     W SN +N         L D G LV+++  
Sbjct: 13  DTEGHLKNGDFDLVMQDDCNLVLYNGN----WQSNTANN-GRDCKLTLTDYGELVIKNGD 67

Query: 137 NRAIVWES 144
               VW+S
Sbjct: 68  GST-VWKS 74

>3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110

 Score = 45.6 bits (108), Expect = 4e-06
 Identities = 17/68 (25%), Positives = 28/68 (41%), Gaps = 4/68 (5%)

Query: 77  NRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNI 136
             D  L   +  + +  D NLVL     +  W SN      +    +L   G L+++D+ 
Sbjct: 16  YGDGRLTAKNHQLVMQGDCNLVLYG--GKYGWQSNTHGNGEHCF-LRLNHKGELIIKDDD 72

Query: 137 NRAIVWES 144
            + I W S
Sbjct: 73  FKTI-WSS 79

>3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110

 Score = 44.5 bits (105), Expect = 8e-06
 Identities = 17/110 (15%), Positives = 38/110 (34%), Gaps = 15/110 (13%)

Query: 23  DSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPL 82
           ++ + S Q++     + +   N +L      +       + Y         W +N     
Sbjct: 6   NNLLFSGQVLYGDGRLTA--KNHQLVMQGDCNL------VLYGG----KYGWQSNTHG-- 51

Query: 83  KDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVL 132
                 + ++  G L++ +   + +WSS  S+         L D G  V+
Sbjct: 52  NGEHCFLRLNHKGELIIKDDDFKTIWSSR-SSSKQGEYVLILQDDGFGVI 100

>1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236

 Score = 47.6 bits (112), Expect = 5e-06
 Identities = 18/142 (12%), Positives = 40/142 (28%), Gaps = 8/142 (5%)

Query: 71  AVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNL 130
             +W +N       +     +  DG LV++  Q  + WSS        +    L     +
Sbjct: 45  VRVWASNTAGA---TGCRAVLQSDGLLVILTAQNTIRWSSGTKG-SIGNYVLVLQPDRTV 100

Query: 131 VLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGSFSAGLIH 190
                I    +W+S      S +   +      + +          +  S       L  
Sbjct: 101 T----IYGPGLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLHATQSLQLSPYRLSM 156

Query: 191 QNIPEIFVWNVSRPYWRSGPWN 212
           +    + +++     W +    
Sbjct: 157 ETDCNLVLFDRDDRVWSTNTAG 178

>1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236

 Score = 46.8 bits (110), Expect = 9e-06
 Identities = 30/153 (19%), Positives = 47/153 (30%), Gaps = 10/153 (6%)

Query: 62  IWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTS 121
           I + +  E +     +    L+ SS   T+  D NLVL +     +W+SN +        
Sbjct: 3   ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDSDV-RVWASNTAG--ATGCR 59

Query: 122 AQLLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPST 181
           A L   G LV+       I W S          G +  + Q             L D  T
Sbjct: 60  AVLQSDGLLVILTA-QNTIRWSS----GTKGSIGNYVLVLQPDRTVT--IYGPGLWDSGT 112

Query: 182 GSFSAGLIHQNIPEIFVWNVSRPYWRSGPWNGQ 214
            +  + ++  N   I                 Q
Sbjct: 113 SNKGSVVVANNGNSILYSTQGNDNHPQTLHATQ 145

>1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236

 Score = 43.4 bits (101), Expect = 1e-04
 Identities = 11/75 (14%), Positives = 23/75 (30%), Gaps = 7/75 (9%)

Query: 70  KAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGN 129
              +W  N          ++    +G + ++  Q   +W+S  S          L    N
Sbjct: 168 DDRVWSTNTAGKGTGCRAVLQ--PNGRMDVLTNQNIAVWTSGNSRSAGRYV-FVLQPDRN 224

Query: 130 LVLRDNINRAIVWES 144
           L +        +W +
Sbjct: 225 LAIYGG----ALWTT 235

>3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276

 Score = 46.6 bits (109), Expect = 2e-05
 Identities = 29/144 (20%), Positives = 46/144 (31%), Gaps = 17/144 (11%)

Query: 35  PDAILSNGSNFKLGFFNPADSPYRYMGIWYDM---PSEKAVIWVANRDNPLKDSSGIITI 91
              +L+ GS    G    A +         ++       A  W A         +     
Sbjct: 145 DSLLLAPGSELVQGVVYGAGASKLVFQGDGNLVAYGPNGAATWNAGTQGK---GAVRAVF 201

Query: 92  SEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQEPTDS 151
             DGNLV+      VLW S+     + S   +L  +G++ + D      VW  F      
Sbjct: 202 QGDGNLVVYGAGNAVLWHSHTGG--HASAVLRLQANGSIAILDE---KPVWARF-----G 251

Query: 152 FLPGMHHG-IDQRTGKKVQLTSWK 174
           F P   H        K + + +W 
Sbjct: 252 FQPTYRHIRKINPDQKPIDIWTWH 275

>3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276

 Score = 46.2 bits (108), Expect = 2e-05
 Identities = 20/123 (16%), Positives = 36/123 (29%), Gaps = 5/123 (4%)

Query: 24  SSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAV--IWVANRDNP 81
           S+ TS+        +L +  N  L       +    + +         +       +   
Sbjct: 101 STFTSNDQWNRTHLVLQDDGNIVLVDSLALWNGTPAIPLVPGAIDSLLLAPGSELVQGVV 160

Query: 82  LKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIV 141
               +  +    DGNLV         W++        +  A     GNLV+    N  + 
Sbjct: 161 YGAGASKLVFQGDGNLVAYGPNGAATWNAGTQG--KGAVRAVFQGDGNLVVYGAGNAVL- 217

Query: 142 WES 144
           W S
Sbjct: 218 WHS 220

>3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276

 Score = 43.9 bits (102), Expect = 1e-04
 Identities = 30/202 (14%), Positives = 62/202 (30%), Gaps = 18/202 (8%)

Query: 15  CLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSP--YRYMGIWYDMPSEKAV 72
            + F     S + + Q +     +LS    FKL      +         +W     +   
Sbjct: 6   RIPFNGVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDGNLVIQDNGATVWVANEQQPFS 65

Query: 73  IWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVL 132
             +  R+         +         L +  +  +W ++ S   +N       +  +LVL
Sbjct: 66  STIPLRNKK-----APLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQW----NRTHLVL 116

Query: 133 RDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSL-SDPSTGSFSAGLIHQ 191
           +D+ N  +V           +P +   ID        L     L      G+ ++ L+ Q
Sbjct: 117 QDDGNIVLVDSLALWNGTPAIPLVPGAIDSL-----LLAPGSELVQGVVYGAGASKLVFQ 171

Query: 192 NIPEIFVWNVS-RPYWRSGPWN 212
               +  +  +    W +G   
Sbjct: 172 GDGNLVAYGPNGAATWNAGTQG 193

>3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111

 Score = 42.9 bits (101), Expect = 4e-05
 Identities = 17/68 (25%), Positives = 25/68 (36%), Gaps = 3/68 (4%)

Query: 77  NRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNI 136
           + DN L   S    +  D NLVL N      + SN         + +L + G L +    
Sbjct: 12  HTDNQLSYESAAFVMQGDCNLVLYNEA--GGFQSNTHGR-GVDCTLRLNNRGQLEIHSAN 68

Query: 137 NRAIVWES 144
           +   VW  
Sbjct: 69  SNTPVWVY 76

>3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113

 Score = 41.7 bits (98), Expect = 8e-05
 Identities = 11/77 (14%), Positives = 26/77 (33%), Gaps = 7/77 (9%)

Query: 68  SEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDS 127
           S+  ++W +      +     + +   G L + + +   ++ SN            L  +
Sbjct: 42  SKTNIVWESGTSG--RGQHCFMRLGHSGELDITDDRLNTVFVSNTVG-QEGDYVLILQIN 98

Query: 128 GNLVLRDNINRAIVWES 144
           G  V+        VW +
Sbjct: 99  GQAVVYGP----AVWST 111

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

No hit with probability above 80.00

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	808
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	5e-74
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-66
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	5e-65
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	4e-64
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	8e-64
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-63
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-63
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	5e-63
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	5e-63
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	6e-62
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	7e-62
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-60
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-59
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-59
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	6e-59
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	7e-59
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	8e-59
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-58
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-58
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	5e-58
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-57
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-57
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	5e-57
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	9e-57
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-56
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-56
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-55
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	9e-55
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-53
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-51
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	5e-51
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-50
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-50
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-48
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-47
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-46
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-46
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-44
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-44
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-44
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-44
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	9e-44
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	9e-44
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-43
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-43
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	7e-42
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-41
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	7e-41
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-40
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	6e-40
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	6e-40
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-39
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-38
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-38
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-37
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-36
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	9e-36
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	6e-33
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-32
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-31
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	4e-31
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	9e-28
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	5e-23
d1kj1a_	109	b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium	4e-18
d1dlpa2	120	b.78.1.1 (A:116-235) Fetuin-binding protein Scafet	7e-16
d1dlpa2	120	b.78.1.1 (A:116-235) Fetuin-binding protein Scafet	3e-04
d1dlpa1	115	b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p	5e-15
d1jpca_	108	b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan	1e-10
d1xd5a_	112	b.78.1.1 (A:) Gastrodianin (antifungal protein) {G	1e-09
d1b2pa_	119	b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill	1e-09
d1b2pa_	119	b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill	7e-05

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  240 bits (613), Expect = 5e-74
 Identities = 66/284 (23%), Positives = 130/284 (45%), Gaps = 19/284 (6%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 541
               +  ++G G FG VY G+      + +  ++  + Q L+ F NEV V+ K +H N++
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67

Query: 542 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
             +G      +  ++ ++    SL   L     + + +  K  +I    ++G+ YLH  S
Sbjct: 68  LFMGYS-TAPQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS 124

Query: 602 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM-- 659
              IIHRDLK++NI L E+L  KI DFG+A +           ++ G+  +M+PE     
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181

Query: 660 -EGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSE 718
            +  +S +SDV++FG++L E+++G+        ++        +     +   +    S 
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPY----SNINNRDQIIFMVGRGYLSPDLSKVRSN 237

Query: 719 SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLP 762
               +  ++        C+++   +RP    +++ +    R LP
Sbjct: 238 CPKAMKRLMA------ECLKKKRDERPLFPQILASIELLARSLP 275

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  220 bits (562), Expect = 1e-66
 Identities = 81/273 (29%), Positives = 130/273 (47%), Gaps = 21/273 (7%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 541
              +L  +LG G FG V+ G      ++AVK L + S    + F+ E  ++ +LQH+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71

Query: 542 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
           RL     + E   +I EYM N SL   L  P    +L   K  ++   I+ G+ ++   +
Sbjct: 72  RLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN 129

Query: 602 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 661
               IHRDL+A+NIL+ + L+ KI+DFG+A++   N+  A  G       + +PE    G
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG-AKFPIKWTAPEAINYG 185

Query: 662 RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSF 721
            F+ KSDV+SFG+LL EIV+  +       +  ++    +       +   D    E   
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI----QNLERGYRMVRPDNCPEE--- 238

Query: 722 QLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML 754
                     +  LC +E  +DRP    + S+L
Sbjct: 239 -------LYQLMRLCWKERPEDRPTFDYLRSVL 264

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (549), Expect = 5e-65
 Identities = 72/279 (25%), Positives = 118/279 (42%), Gaps = 22/279 (7%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 541
           +      ++G G FG V+ G   +  ++A+K + +      E+F+ E  V+ KL H  LV
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLV 63

Query: 542 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
           +L G C+E     L++E+M +  L   L    ++          +   +  G+ YL    
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLE--- 118

Query: 602 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 661
              +IHRDL A N L+ E    K+SDFGM +    +Q    +        + SPE     
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFS 177

Query: 662 RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSF 721
           R+S KSDV+SFGVL+ E+ S  K       +  ++           I      +      
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV---------EDISTGFRLYKPR--- 225

Query: 722 QLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 760
                     +   C +E  +DRP  S ++  L +EI +
Sbjct: 226 --LASTHVYQIMNHCWKERPEDRPAFSRLLRQL-AEIAE 261

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (542), Expect = 4e-64
 Identities = 66/273 (24%), Positives = 121/273 (44%), Gaps = 21/273 (7%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 541
            +     +LG G FG V +G+ +   ++A+K + + S    +EF+ E  V+  L H  LV
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62

Query: 542 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
           +L G C +     +I EYM N  L   L +   + R   ++   + + +   + YL    
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK- 119

Query: 602 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 661
             + +HRDL A N L++++   K+SDFG+++    ++  +  G       +  PE  M  
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG-SKFPVRWSPPEVLMYS 176

Query: 662 RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSF 721
           +FS KSD+++FGVL+ EI S  K               ++ +  ++    +   L     
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGK-------------MPYERFTNSETAEHIAQGL-RLYR 222

Query: 722 QLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML 754
                 +   +   C  E   +RP    ++S +
Sbjct: 223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (544), Expect = 8e-64
 Identities = 63/302 (20%), Positives = 113/302 (37%), Gaps = 30/302 (9%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 541
               L   +G+G FG V+ G+ + G+E+AVK  S    +       E+     L+H N++
Sbjct: 3   RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERS-WFREAEIYQTVMLRHENIL 60

Query: 542 RLLGCCVEGEEK----MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 597
             +    +         L+ +Y  + S    LFD L +  +       +    + GL +L
Sbjct: 61  GFIAADNKDNGTWTQLWLVSDYHEHGS----LFDYLNRYTVTVEGMIKLALSTASGLAHL 116

Query: 598 HRD-----SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD--TGRVVGTF 650
           H +      +  I HRDLK+ NIL+ +     I+D G+A       D  D      VGT 
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176

Query: 651 GYMSPEYAME------GRFSEKSDVFSFGVLLLEIVSGRKNTSFFED------DLTILGY 698
            YM+PE   +          +++D+++ G++  EI          ED      DL     
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236

Query: 699 AWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEI 758
           + +   +      + P +       + +     +   C       R     +   L S++
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL-SQL 295

Query: 759 RD 760
             
Sbjct: 296 SQ 297

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  213 bits (542), Expect = 1e-63
 Identities = 75/300 (25%), Positives = 131/300 (43%), Gaps = 21/300 (7%)

Query: 468 DLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFM 526
           D     +++      +  +  KLG G +G VY G  K     +AVK L + + + +EEF+
Sbjct: 3   DPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFL 61

Query: 527 NEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNI 586
            E  V+ +++H NLV+LLG C       +I E+M   +L   L +   ++ +       +
Sbjct: 62  KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYM 120

Query: 587 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV 646
              IS  + YL    +   IHRDL A N L+ E    K++DFG++++  G+   A  G  
Sbjct: 121 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-A 176

Query: 647 VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNEN 706
                + +PE     +FS KSDV++FGVLL EI +     S +              + +
Sbjct: 177 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM--SPYPG-----------IDLS 223

Query: 707 KILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKE 766
           ++  L++              +   +   C Q    DRP+ + +     +  ++     E
Sbjct: 224 QVYELLEKDY-RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDE 282

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  212 bits (540), Expect = 3e-63
 Identities = 71/306 (23%), Positives = 131/306 (42%), Gaps = 36/306 (11%)

Query: 472 FQFEELATATNNF---------QLSSKLGQGGFGPVYWGRLK----DGQEIAVKRLSKA- 517
           F FE+   A   F         ++   +G G FG V  G LK        +A+K L    
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 518 SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER 577
           + +   +F++E  ++ +  H N++ L G   +    M+I E+M N SLD+ L       +
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ--NDGQ 124

Query: 578 LDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 637
               +   ++ GI+ G+ YL     +  +HRDL A NIL++  L  K+SDFG+++    +
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 638 QDQADTGRVVG---TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLT 694
                    +G      + +PE     +F+  SDV+S+G+++ E++S  +          
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE---------- 231

Query: 695 ILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML 754
                +       ++  ++         +D       + L C Q+    RP    +V+ L
Sbjct: 232 ---RPYWDMTNQDVINAIEQDY-RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287

Query: 755 NSEIRD 760
           +  IR+
Sbjct: 288 DKMIRN 293

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (541), Expect = 5e-63
 Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 11/206 (5%)

Query: 480 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGL-EEFMNEVMVISKLQH 537
             ++F+  S+LG G  G V+    K  G  +A K +       +  + + E+ V+ +   
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63

Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 597
             +V   G      E  +  E+M   SLD +L    K  R+  +    +   + +GL YL
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYL 120

Query: 598 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEY 657
               + +I+HRD+K SNIL++     K+ DFG++     +         VGT  YMSPE 
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPER 174

Query: 658 AMEGRFSEKSDVFSFGVLLLEIVSGR 683
                +S +SD++S G+ L+E+  GR
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGR 200

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (537), Expect = 5e-63
 Identities = 76/287 (26%), Positives = 128/287 (44%), Gaps = 21/287 (7%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 541
            + +L  KLGQG FG V+ G       +A+K L   +    E F+ E  V+ KL+H  LV
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75

Query: 542 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
           +L       E   ++ EYM   SL   L      + L   +  ++   I+ G+ Y+ R  
Sbjct: 76  QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVER-- 131

Query: 602 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEG 661
            +  +HRDL+A+NIL+ E L  K++DFG+A++   N+  A  G       + +PE A+ G
Sbjct: 132 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYG 189

Query: 662 RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSF 721
           RF+ KSDV+SFG+LL E+ +  +    +                 ++L  V+        
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRV--PYPG-----------MVNREVLDQVERGY-RMPC 235

Query: 722 QLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPA 768
             +       +   C ++  ++RP    + + L           +P 
Sbjct: 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (530), Expect = 6e-62
 Identities = 74/306 (24%), Positives = 128/306 (41%), Gaps = 36/306 (11%)

Query: 475 EELATATNNFQLSS-KLGQGGFGPVYWGRLK---DGQEIAVKRLSKASGQG-LEEFMNEV 529
           ++L    +N  ++  +LG G FG V  G  +      ++A+K L + + +   EE M E 
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60

Query: 530 MVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEG 589
            ++ +L +  +VRL+G C + E  ML+ E      L   L    K+E +       ++  
Sbjct: 61  QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQ 117

Query: 590 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD-TGRVVG 648
           +S G+ YL        +HRDL A N+LL      KISDFG++K  G +            
Sbjct: 118 VSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174

Query: 649 TFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKI 708
              + +PE     +FS +SDV+S+GV + E +S  +               +K     ++
Sbjct: 175 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ-------------KPYKKMKGPEV 221

Query: 709 LALVD-----PFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPY 763
           +A ++         E   +L  ++        C     +DRP+  TV   + +    L  
Sbjct: 222 MAFIEQGKRMECPPECPPELYALMS------DCWIYKWEDRPDFLTVEQRMRACYYSLAS 275

Query: 764 PKEPAF 769
             E   
Sbjct: 276 KVEGHH 281

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  208 bits (530), Expect = 7e-62
 Identities = 71/310 (22%), Positives = 125/310 (40%), Gaps = 45/310 (14%)

Query: 473 QFEELATATNNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSK-ASGQGLEEF 525
           +   L    NN +    +G+G FG V+  R            +AVK L + AS     +F
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 526 MNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD-------------- 571
             E  ++++  + N+V+LLG C  G+   L++EYM    L+  L                
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123

Query: 572 -------PLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPK 624
                        L   ++  I   ++ G+ YL      + +HRDL   N L+ E +  K
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVK 180

Query: 625 ISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRK 684
           I+DFG+++           G       +M PE     R++ +SDV+++GV+L EI S   
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240

Query: 685 NTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDR 744
              +      ++        +  ILA  +          +  +   ++  LC  +L  DR
Sbjct: 241 QPYYGMAHEEVI----YYVRDGNILACPE----------NCPLELYNLMRLCWSKLPADR 286

Query: 745 PNMSTVVSML 754
           P+  ++  +L
Sbjct: 287 PSFCSIHRIL 296

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (518), Expect = 1e-60
 Identities = 72/274 (26%), Positives = 113/274 (41%), Gaps = 27/274 (9%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 541
              +L   +G+G FG V  G  + G ++AVK +   +    + F+ E  V+++L+H NLV
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63

Query: 542 RLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 600
           +LLG  VE +  + ++ EYM   SL   L     +  L           +   + YL  +
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGN 122

Query: 601 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAME 660
                +HRDL A N+L+ E+   K+SDFG+ K     QD            + +PE   E
Sbjct: 123 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEALRE 174

Query: 661 GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS 720
            +FS KSDV+SFG+LL EI S  +          ++        +   +   D       
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV----PRVEKGYKMDAPDGCPPA-- 228

Query: 721 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML 754
                      V   C       RP+   +   L
Sbjct: 229 --------VYEVMKNCWHLDAAMRPSFLQLREQL 254

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (515), Expect = 1e-59
 Identities = 70/302 (23%), Positives = 109/302 (36%), Gaps = 39/302 (12%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASGQG-LEEFMNEVMVISK 534
           N       LG G FG V                +AVK L  ++     E  M+E+ V+S 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 535 L-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKE---------------RL 578
           L  H N+V LLG C  G   ++I EY     L   L                       L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
           D     +    +++G+ +L        IHRDL A NILL      KI DFG+A+    + 
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 639 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGY 698
           +    G       +M+PE      ++ +SDV+S+G+ L E+ S   +        +    
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF-- 257

Query: 699 AWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEI 758
            +K+  E   + L                    +   C       RP    +V ++  +I
Sbjct: 258 -YKMIKEGFRM-LSPEHAPA---------EMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306

Query: 759 RD 760
            +
Sbjct: 307 SE 308

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 2e-59
 Identities = 66/286 (23%), Positives = 121/286 (42%), Gaps = 27/286 (9%)

Query: 485 QLSSKLGQGGFGPVYWGRLKD----GQEIAVKRLSKASGQG-LEEFMNEVMVISKLQHRN 539
             +  +G+G FG VY G L D        AVK L++ +  G + +F+ E +++    H N
Sbjct: 30  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89

Query: 540 LVRLLGCCVEGEEK-MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           ++ LLG C+  E   +++  YM +  L   + +      +     F +          + 
Sbjct: 90  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK-----GMK 144

Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR--VVGTFGYMSPE 656
             +  + +HRDL A N +LDE+   K++DFG+A+     +  +   +        +M+ E
Sbjct: 145 FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204

Query: 657 YAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL 716
                +F+ KSDV+SFGVLL E+++          D+        L    ++  L   + 
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAP---PYPDVNTFDITVYLLQGRRL--LQPEYC 259

Query: 717 SESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLP 762
            +             V L C     + RP+ S +VS +++      
Sbjct: 260 PDP---------LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 296

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (512), Expect = 6e-59
 Identities = 71/305 (23%), Positives = 117/305 (38%), Gaps = 44/305 (14%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKD------GQEIAVKRLSKASGQG-LEEFMNEVMVISK 534
            N +    LG G FG V               ++AVK L + +     E  M+E+ ++++
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 535 L-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKK------------------ 575
           L  H N+V LLG C       LI+EY     L   L    +K                  
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 576 --ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 633
               L +         +++G+ +L        +HRDL A N+L+      KI DFG+A+ 
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 634 FGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDL 693
              + +    G       +M+PE   EG ++ KSDV+S+G+LL EI S   N       +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN---PYPGI 270

Query: 694 TILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM 753
            +    +KL      +     + +E             +   C     + RP+   + S 
Sbjct: 271 PVDANFYKLIQNGFKMDQ-PFYATE---------EIYIIMQSCWAFDSRKRPSFPNLTSF 320

Query: 754 LNSEI 758
           L  ++
Sbjct: 321 LGCQL 325

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 7e-59
 Identities = 69/289 (23%), Positives = 117/289 (40%), Gaps = 30/289 (10%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRN 539
            ++ L   LG+G +G V     +   + +AVK +         E    E+ +   L H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 599
           +V+  G   EG  + L  EY     L   +        +           +  G++YLH 
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG 121

Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 659
              + I HRD+K  N+LLDE  N KISDFG+A +F  N  +    ++ GT  Y++PE   
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178

Query: 660 EGRF-SEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSE 718
              F +E  DV+S G++L  +++G        D        +  W E K    ++P+   
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE----YSDWKEKKT--YLNPWKKI 232

Query: 719 SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEP 767
            S  L ++ + +             R  +         +I+   +  +P
Sbjct: 233 DSAPLALLHKILVEN-------PSARITI--------PDIKKDRWYNKP 266

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  200 bits (510), Expect = 8e-59
 Identities = 85/324 (26%), Positives = 143/324 (44%), Gaps = 38/324 (11%)

Query: 484 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQG---LEEFMNEVMVISKLQHRN 539
           F    ++G G FG VY+ R +++ + +A+K++S +  Q     ++ + EV  + KL+H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 599
            ++  GC +      L+ EY    + D L    + K+ L   +   +  G  +GL YLH 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLH- 132

Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 659
                +IHRD+KA NILL E    K+ DFG A I       A     VGT  +M+PE  +
Sbjct: 133 --SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPEVIL 184

Query: 660 ---EGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL 716
              EG++  K DV+S G+  +E+   +     F  +     Y      +N+  AL     
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERK--PPLFNMNAMSALYHIA---QNESPALQSGHW 239

Query: 717 SESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPAFTERQGAD 776
           SE     + +  C+       Q++ +DRP    ++   +  +     P       ++  D
Sbjct: 240 SEYF--RNFVDSCL-------QKIPQDRPTSEVLLK--HRFVLRERPPTVIMDLIQRTKD 288

Query: 777 DSESFKQIQQRILLMILLLHSQQA 800
                  +Q R +  IL    Q+A
Sbjct: 289 AVRELDNLQYRKMKKIL---FQEA 309

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 2e-58
 Identities = 76/291 (26%), Positives = 132/291 (45%), Gaps = 26/291 (8%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQE-----IAVKRLSKASGQG-LEEFMNEVMVISKL 535
           +       +G G FG VY G LK         +A+K L     +    +F+ E  ++ + 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
            H N++RL G   + +  M+I EYM N +LD  L +  K       +   ++ GI+ G+ 
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMK 124

Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT-GRVVGTFGYMS 654
           YL     +  +HRDL A NIL++  L  K+SDFG++++   + +   T         + +
Sbjct: 125 YLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181

Query: 655 PEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDP 714
           PE     +F+  SDV+SFG+++ E+++  +               W+L N   + A+ D 
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGER------------PYWELSNHEVMKAINDG 229

Query: 715 FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPK 765
           F       +D       + + C Q+    RP  + +VS+L+  IR     K
Sbjct: 230 FRLP--TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLK 278

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (502), Expect = 4e-58
 Identities = 69/279 (24%), Positives = 119/279 (42%), Gaps = 27/279 (9%)

Query: 489 KLGQGGFGPVYWGRLKD---GQEIAVKRLSKASGQG--LEEFMNEVMVISKLQHRNLVRL 543
           +LG G FG V  G  +     + +AVK L   +      +E + E  V+ +L +  +VR+
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73

Query: 544 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 603
           +G C E E  ML+ E      L+  L    +   +  +    ++  +S G+ YL      
Sbjct: 74  IGIC-EAESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEES--- 126

Query: 604 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG-RVVGTFGYMSPEYAMEGR 662
             +HRDL A N+LL  +   KISDFG++K    +++             + +PE     +
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186

Query: 663 FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQ 722
           FS KSDV+SFGVL+ E  S  +               ++    +++ A+++         
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQ-------------KPYRGMKGSEVTAMLEKGERM-GCP 232

Query: 723 LDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDL 761
                    +  LC    V++RP  + V   L +   D+
Sbjct: 233 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 5e-58
 Identities = 80/302 (26%), Positives = 132/302 (43%), Gaps = 33/302 (10%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSK-ASGQGLEEFMNEVMVISK 534
               +S +LGQG FG VY G  K          +A+K +++ AS +   EF+NE  V+ +
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 535 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLF-------DPLKKERLDWRKRFNII 587
               ++VRLLG   +G+  ++I E M    L + L        +          K   + 
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 588 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVV 647
             I+ G+ YL+ +   + +HRDL A N ++ E+   KI DFGM +           G+ +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 648 GTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENK 707
               +MSPE   +G F+  SDV+SFGV+L EI +  +       +  +L    +   E  
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL----RFVMEGG 252

Query: 708 ILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEP 767
           +L   D                  +  +C Q   K RP+   ++S +  E+   P  +E 
Sbjct: 253 LLDKPDNCPDM----------LFELMRMCWQYNPKMRPSFLEIISSIKEEME--PGFREV 300

Query: 768 AF 769
           +F
Sbjct: 301 SF 302

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 1e-57
 Identities = 57/209 (27%), Positives = 105/209 (50%), Gaps = 13/209 (6%)

Query: 481 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 539
            + +++  +LG G FG VY  + K+     A K +   S + LE++M E+ +++   H N
Sbjct: 11  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70

Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 599
           +V+LL          ++ E+    ++DA++ +   +  L   +   + +     L YLH 
Sbjct: 71  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLH- 127

Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 659
               +IIHRDLKA NIL   + + K++DFG++        + D+   +GT  +M+PE  M
Sbjct: 128 --DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVM 183

Query: 660 -----EGRFSEKSDVFSFGVLLLEIVSGR 683
                +  +  K+DV+S G+ L+E+    
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIE 212

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 2e-57
 Identities = 69/277 (24%), Positives = 121/277 (43%), Gaps = 25/277 (9%)

Query: 483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRN 539
           ++++   +G G +G     R K DG+ +  K L   S      +  ++EV ++ +L+H N
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 540 LVRLLGCCVEGEEKML--IYEYMPNRSLDALLFDPLK-KERLDWRKRFNIIEGISRGLLY 596
           +VR     ++     L  + EY     L +++    K ++ LD      ++  ++  L  
Sbjct: 65  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124

Query: 597 LHR--DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 654
            HR  D    ++HRDLK +N+ LD + N K+ DFG+A+I   +   A     VGT  YMS
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYMS 182

Query: 655 PEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDP 714
           PE      ++EKSD++S G LL E+ +      F       L    +     +I      
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALM--PPFTAFSQKELAGKIREGKFRRIPYRYSD 240

Query: 715 FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVV 751
            L       ++I R +             RP++  ++
Sbjct: 241 EL------NEIITRML-------NLKDYHRPSVEEIL 264

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 5e-57
 Identities = 64/277 (23%), Positives = 117/277 (42%), Gaps = 30/277 (10%)

Query: 484 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSK--ASGQGLEEFMNEVMVISKLQHRNL 540
            +   ++G+G F  VY G   +   E+A   L     +    + F  E  ++  LQH N+
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70

Query: 541 VRLLGCCVEGEEK----MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 596
           VR         +     +L+ E M + +L   L    + + +  +   +    I +GL +
Sbjct: 71  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQF 127

Query: 597 LHRDSRLRIIHRDLKASNILLDEELN-PKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 655
           LH  +   IIHRDLK  NI +       KI D G+A +   +        V+GT  +M+P
Sbjct: 128 LHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAP 182

Query: 656 EYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPF 715
           E   E ++ E  DV++FG+ +LE+ +      + E             N  +I   V   
Sbjct: 183 EM-YEEKYDESVDVYAFGMCMLEMATSEYP--YSEC-----------QNAAQIYRRVTSG 228

Query: 716 LSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS 752
           +  +SF    I     +   C+++   +R ++  +++
Sbjct: 229 VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 9e-57
 Identities = 75/281 (26%), Positives = 109/281 (38%), Gaps = 27/281 (9%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLK----DGQEIAVKRLSK---ASGQGLEEFMNEVMVISK 534
            + +L  KLG G FG V  G           +AVK L     +  + +++F+ EV  +  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 535 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 594
           L HRNL+RL G  +    KM + E  P  SL   L     +              ++ G+
Sbjct: 68  LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGM 124

Query: 595 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD-TGRVVGTFGYM 653
            YL      R IHRDL A N+LL      KI DFG+ +    N D           F + 
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181

Query: 654 SPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVD 713
           +PE      FS  SD + FGV L E+ +  +      +   IL    K+  E + L   +
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL---HKIDKEGERLPRPE 238

Query: 714 PFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSML 754
                     D      +V + C     +DRP    +   L
Sbjct: 239 ----------DCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (495), Expect = 1e-56
 Identities = 69/303 (22%), Positives = 126/303 (41%), Gaps = 26/303 (8%)

Query: 484 FQLSSKLGQGGFGPVYWGRLKDGQE-----IAVKRLSKA-SGQGLEEFMNEVMVISKLQH 537
           F+    LG G FG VY G      E     +A+K L +A S +  +E ++E  V++ + +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 597
            ++ RLLG C+      LI + MP   L  L +    K+ +  +   N    I++G+ YL
Sbjct: 71  PHVCRLLGICLTSTV-QLITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127

Query: 598 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEY 657
                 R++HRDL A N+L+    + KI+DFG+AK+ G  + +           +M+ E 
Sbjct: 128 ED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184

Query: 658 AMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS 717
            +   ++ +SDV+S+GV + E+++                  +     ++I ++++    
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGS-------------KPYDGIPASEISSILEKGER 231

Query: 718 ESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPAFTERQGADD 777
                    I    + + C       RP    ++   +   RD          ER     
Sbjct: 232 LPQPP-ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPS 290

Query: 778 SES 780
              
Sbjct: 291 PTD 293

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 2e-56
 Identities = 75/299 (25%), Positives = 124/299 (41%), Gaps = 38/299 (12%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDG---QEIAVKRLSK-ASGQGLEEFMNEVMVISKL-Q 536
           N+ +    +G+G FG V   R+K      + A+KR+ + AS     +F  E+ V+ KL  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-------------FDPLKKERLDWRKR 583
           H N++ LLG C       L  EY P+ +L   L                     L  ++ 
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 584 FNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 643
            +    ++RG+ YL +    + IHRDL A NIL+ E    KI+DFG+++   G +     
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 183

Query: 644 GRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLW 703
                   +M+ E      ++  SDV+S+GVLL EIVS           +T      KL 
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT---PYCGMTCAELYEKLP 240

Query: 704 NENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLP 762
              ++              L+       +   C +E   +RP+ + ++  LN  + +  
Sbjct: 241 QGYRL-----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 2e-55
 Identities = 73/275 (26%), Positives = 114/275 (41%), Gaps = 30/275 (10%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQH 537
            +F++   LG+G FG VY  R K     +A+K L KA         +   EV + S L+H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 597
            N++RL G   +     LI EY P  ++   L    K  + D ++    I  ++  L Y 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYC 122

Query: 598 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEY 657
           H     R+IHRD+K  N+LL      KI+DFG +     ++       + GT  Y+ PE 
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEM 175

Query: 658 AMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS 717
                  EK D++S GVL  E + G+     FE +     Y        +I  +   F  
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGK---PPFEANTYQETY-------KRISRVEFTFPD 225

Query: 718 ESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS 752
             +     +I         ++     RP +  V+ 
Sbjct: 226 FVTEGARDLISR------LLKHNPSQRPMLREVLE 254

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 9e-55
 Identities = 56/204 (27%), Positives = 105/204 (51%), Gaps = 10/204 (4%)

Query: 481 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 539
              +    K+GQG  G VY    +  GQE+A+++++       E  +NE++V+ + ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 599
           +V  L   + G+E  ++ EY+   S    L D + +  +D  +   +     + L +LH 
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGS----LTDVVTETCMDEGQIAAVCRECLQALEFLH- 133

Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 659
               ++IHRD+K+ NILL  + + K++DFG        Q +  T  +VGT  +M+PE   
Sbjct: 134 --SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVT 189

Query: 660 EGRFSEKSDVFSFGVLLLEIVSGR 683
              +  K D++S G++ +E++ G 
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGE 213

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 3e-53
 Identities = 76/297 (25%), Positives = 117/297 (39%), Gaps = 38/297 (12%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASGQG-LEEFMNEVMVISK 534
           +  +L   LG+G FG V              + +AVK L + +        M+E+ ++  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 535 -LQHRNLVRLLGCCVE-GEEKMLIYEYMPNRSLDALLF-------------DPLKKERLD 579
              H N+V LLG C + G   M+I E+    +L   L              + L K+ L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 580 WRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 639
                     +++G+ +L      + IHRDL A NILL E+   KI DFG+A+    + D
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 640 QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYA 699
               G       +M+PE   +  ++ +SDV+SFGVLL EI S   +       + I    
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS---PYPGVKIDEEF 246

Query: 700 WKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS 756
            +   E   +   D    E               L C       RP  S +V  L +
Sbjct: 247 CRRLKEGTRMRAPDYTTPE----------MYQTMLDCWHGEPSQRPTFSELVEHLGN 293

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 1e-51
 Identities = 59/284 (20%), Positives = 112/284 (39%), Gaps = 26/284 (9%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKD----GQEIAVKRLSKASGQGL-EEFMNEVMVISKLQ 536
              +L   +G+G FG V+ G           +A+K     +   + E+F+ E + + +  
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 596
           H ++V+L+G   E     +I E      L + L    +K  LD          +S  L Y
Sbjct: 67  HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAY 123

Query: 597 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 656
           L      R +HRD+ A N+L+      K+ DFG+++    +       +      +M+PE
Sbjct: 124 LES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK-ASKGKLPIKWMAPE 179

Query: 657 YAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL 716
                RF+  SDV+ FGV + EI+           +  ++    ++ N  ++     P  
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---GRIENGERL-----PMP 231

Query: 717 SESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRD 760
                 L  ++        C       RP  + + + L++ + +
Sbjct: 232 PNCPPTLYSLMTK------CWAYDPSRRPRFTELKAQLSTILEE 269

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 5e-51
 Identities = 70/255 (27%), Positives = 110/255 (43%), Gaps = 21/255 (8%)

Query: 483 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHR 538
           +F+    LG+G F  V   R L   +E A+K L K        +     E  V+S+L H 
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
             V+L     + E+      Y  N  L   +    K    D          I   L YLH
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLH 125

Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 658
                 IIHRDLK  NILL+E+++ +I+DFG AK+      QA     VGT  Y+SPE  
Sbjct: 126 G---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182

Query: 659 MEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSE 718
            E    + SD+++ G ++ ++V+G     F   +  ++          KI+ L   F  +
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGL--PPFRAGNEYLI--------FQKIIKLEYDFPEK 232

Query: 719 SSFQL-DMIIRCIHV 732
              +  D++ + + +
Sbjct: 233 FFPKARDLVEKLLVL 247

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 1e-50
 Identities = 71/297 (23%), Positives = 123/297 (41%), Gaps = 40/297 (13%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLK--------DGQEIAVKRLSK-ASGQGLEEFMNEVMVI 532
           +   L   LG+G FG V                 ++AVK L   A+ + L + ++E+ ++
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 533 SKL-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLF-------------DPLKKERL 578
             + +H+N++ LLG C +     +I EY    +L   L                  +E+L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 579 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 638
             +   +    ++RG+ YL      + IHRDL A N+L+ E+   KI+DFG+A+      
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 639 DQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGY 698
               T        +M+PE   +  ++ +SDV+SFGVLL EI +    + +    +  L  
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG-SPYPGVPVEEL-- 246

Query: 699 AWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLN 755
            +KL  E   +       +E             +   C   +   RP    +V  L+
Sbjct: 247 -FKLLKEGHRMDKPSNCTNE----------LYMMMRDCWHAVPSQRPTFKQLVEDLD 292

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  178 bits (452), Expect = 3e-50
 Identities = 49/205 (23%), Positives = 87/205 (42%), Gaps = 11/205 (5%)

Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 540
           +++ +  +LG G FG V+       G   A K +        E    E+  +S L+H  L
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 541 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 600
           V L     +  E ++IYE+M    L   + D  +  ++   +    +  + +GL ++H  
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMH-- 141

Query: 601 SRLRIIHRDLKASNILLDEELNP--KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 658
                +H DLK  NI+   + +   K+ DFG+         +       GT  + +PE A
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVA 197

Query: 659 MEGRFSEKSDVFSFGVLLLEIVSGR 683
                   +D++S GVL   ++SG 
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGL 222

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  173 bits (439), Expect = 2e-48
 Identities = 44/205 (21%), Positives = 86/205 (41%), Gaps = 11/205 (5%)

Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 540
           + + +  +LG G FG V+       G+    K ++           NE+ ++++L H  L
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 541 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 600
           + L     +  E +LI E++    L   +    +  ++   +  N +     GL ++H  
Sbjct: 89  INLHDAFEDKYEMVLILEFLSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMH-- 144

Query: 601 SRLRIIHRDLKASNILLDEELNP--KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 658
               I+H D+K  NI+ + +     KI DFG+A     ++          T  + +PE  
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIV 200

Query: 659 MEGRFSEKSDVFSFGVLLLEIVSGR 683
                   +D+++ GVL   ++SG 
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGL 225

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (430), Expect = 2e-47
 Identities = 60/285 (21%), Positives = 119/285 (41%), Gaps = 21/285 (7%)

Query: 481 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQG-LEEFMNEVMVISKLQHR 538
              +   S +G+G +G V       +   +A+K++S    Q   +  + E+ ++ + +H 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           N++ +         + +   Y+    + A L+  LK + L        +  I RGL Y+H
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126

Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT-GRVVGTFGYMSPEY 657
                 ++HRDLK SN+LL+   + KI DFG+A++   + D        V T  Y +PE 
Sbjct: 127 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183

Query: 658 AMEGR-FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL 716
            +  + +++  D++S G +L E++S R                +   +    L  +   L
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNR--------------PIFPGKHYLDQLNHILGIL 229

Query: 717 SESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDL 761
              S +    I  +      +    K++   + +    +S+  DL
Sbjct: 230 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDL 274

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  165 bits (418), Expect = 2e-46
 Identities = 58/261 (22%), Positives = 111/261 (42%), Gaps = 20/261 (7%)

Query: 481 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQG---LEEFMNEVMVISKLQ 536
           ++ ++L   LG GG   V+  R L+  +++AVK L     +       F  E    + L 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 537 HRNLVRLLGCCVE----GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 592
           H  +V +          G    ++ EY+   +L  ++     +  +  ++   +I    +
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 122

Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD-TGRVVGTFG 651
            L + H+     IIHRD+K +NI++      K+ DFG+A+    + +    T  V+GT  
Sbjct: 123 ALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179

Query: 652 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILAL 711
           Y+SPE A       +SDV+S G +L E+++G      F  D  +      +  +    + 
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE---PPFTGDSPVSVAYQHVREDPIPPSA 236

Query: 712 VDPFLSESSFQLDMIIRCIHV 732
               LS       ++++ +  
Sbjct: 237 RHEGLSADL--DAVVLKALAK 255

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  166 bits (420), Expect = 3e-46
 Identities = 57/207 (27%), Positives = 100/207 (48%), Gaps = 15/207 (7%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 537
            +FQ+   LG G FG V+  R + +G+  A+K L K      + +E   +E +++S + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 597
             ++R+ G   + ++  +I +Y+    L +LL    +      +     +       L L
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLAL 117

Query: 598 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEY 657
                  II+RDLK  NILLD+  + KI+DFG AK             + GT  Y++PE 
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY-----TLCGTPDYIAPEV 172

Query: 658 AMEGRFSEKSDVFSFGVLLLEIVSGRK 684
                +++  D +SFG+L+ E+++G  
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYT 199

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  160 bits (406), Expect = 1e-44
 Identities = 52/298 (17%), Positives = 105/298 (35%), Gaps = 26/298 (8%)

Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 540
           N ++L  K+G G FG +Y G  +  G+E+A+K     +     +   E  +   +Q    
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64

Query: 541 VRLLG-CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 599
           +  +  C  EG+  +++ E +     D          +   +    + + +   + Y+H 
Sbjct: 65  IPTIRWCGAEGDYNVMVMELLGPSLED---LFNFCSRKFSLKTVLLLADQMISRIEYIHS 121

Query: 600 DSRLRIIHRDLKASNIL---LDEELNPKISDFGMAKIFGGNQDQAD-----TGRVVGTFG 651
                 IHRD+K  N L     +     I DFG+AK +   +            + GT  
Sbjct: 122 ---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178

Query: 652 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILAL 711
           Y S    +    S + D+ S G +L+    G     +           ++  +E K+   
Sbjct: 179 YASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP--WQGLKAATKRQKYERISEKKMSTP 236

Query: 712 VDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPAF 769
           ++        +    +        C      D+P+ S +  +  +      +  +  F
Sbjct: 237 IEVLCKGYPSEFATYLNF------CRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVF 288

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  162 bits (412), Expect = 1e-44
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 18/210 (8%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQ- 536
           N+F +   +G+GGFG VY  R  D G+  A+K L K      QG    +NE +++S +  
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 537 --HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 594
                +V +       ++   I + M    L   L    +               I  GL
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120

Query: 595 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 654
            ++H      +++RDLK +NILLDE  + +ISD G+A  F   +        VGT GYM+
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMA 173

Query: 655 PEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 683
           PE   +G  +   +D FS G +L +++ G 
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGH 203

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  160 bits (406), Expect = 2e-44
 Identities = 57/254 (22%), Positives = 103/254 (40%), Gaps = 13/254 (5%)

Query: 481 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEE-FMNEVMVISKLQHR 538
            + +     LG G F  V      +  + +A+K ++K + +G E    NE+ V+ K++H 
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67

Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           N+V L      G    LI + +    L   +   ++K     R    +I  +   + YLH
Sbjct: 68  NIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKYLH 124

Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 658
               +    +        LDE+    ISDFG++K+              GT GY++PE  
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVL 181

Query: 659 MEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSE 718
            +  +S+  D +S GV+   ++ G      F D+     +   L  E +  +     +S+
Sbjct: 182 AQKPYSKAVDCWSIGVIAYILLCGY---PPFYDENDAKLFEQILKAEYEFDSPYWDDISD 238

Query: 719 SSFQLDMIIRCIHV 732
           S+   D I   +  
Sbjct: 239 SA--KDFIRHLMEK 250

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 3e-44
 Identities = 48/253 (18%), Positives = 98/253 (38%), Gaps = 17/253 (6%)

Query: 483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 541
            + ++  LG+G FG V+        +    K + K  G        E+ +++  +HRN++
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNIL 64

Query: 542 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 601
            L       EE ++I+E++    +   +        L+ R+  + +  +   L +LH   
Sbjct: 65  HLHESFESMEELVMIFEFISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLH--- 119

Query: 602 RLRIIHRDLKASNILLDEELNP--KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 659
              I H D++  NI+     +   KI +FG A+         +   +     Y +PE   
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQ 176

Query: 660 EGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSES 719
               S  +D++S G L+  ++SG    + F  +         +  E          +S  
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGI---NPFLAETNQQIIENIMNAEYTFDEEAFKEISIE 233

Query: 720 SFQLDMIIRCIHV 732
           +  +D + R +  
Sbjct: 234 A--MDFVDRLLVK 244

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  158 bits (399), Expect = 9e-44
 Identities = 42/299 (14%), Positives = 102/299 (34%), Gaps = 26/299 (8%)

Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 540
            ++++  ++G+G FG ++ G  L + Q++A+K   + S     +  +E      L     
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62

Query: 541 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 600
           +  +    +     ++   +   SL+ LL       +   +      + +   +  +H  
Sbjct: 63  IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHE- 119

Query: 601 SRLRIIHRDLKASNILLDEELNP-----KISDFGMAKIF-----GGNQDQADTGRVVGTF 650
               +++RD+K  N L+    +       + DFGM K +       +    +   + GT 
Sbjct: 120 --KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177

Query: 651 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILA 710
            YMS    +    S + D+ + G + +  + G       +       Y  +   E K   
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY--ERIGEKKQST 235

Query: 711 LVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPAF 769
            +    +    +    +                 P+   +  + +  +  L   ++  F
Sbjct: 236 PLRELCAGFPEEFYKYMHY------ARNLAFDATPDYDYLQGLFSKVLERLNTTEDENF 288

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 9e-44
 Identities = 63/207 (30%), Positives = 95/207 (45%), Gaps = 13/207 (6%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSK---ASGQGLEEFMNEVMVISK-LQ 536
            +F L   LG+G FG V+    K   Q  A+K L K        +E  M E  V+S   +
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 537 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 596
           H  L  +       E    + EY+    L   +       + D  +       I  GL +
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQF 118

Query: 597 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 656
           LH      I++RDLK  NILLD++ + KI+DFGM K       + +T    GT  Y++PE
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPE 173

Query: 657 YAMEGRFSEKSDVFSFGVLLLEIVSGR 683
             +  +++   D +SFGVLL E++ G+
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQ 200

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 2e-43
 Identities = 63/335 (18%), Positives = 137/335 (40%), Gaps = 35/335 (10%)

Query: 482 NNFQLSSK-LGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHR 538
           ++++++S+ LG G  G V      +  ++ A+K L         +   EV +  +  Q  
Sbjct: 11  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCP 65

Query: 539 NLVRLLGCC----VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 594
           ++VR++          +  +++ E +    L + + D    +    R+   I++ I   +
Sbjct: 66  HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAI 124

Query: 595 LYLHRDSRLRIIHRDLKASNILLDEELNP---KISDFGMAKIFGGNQDQADTGRVVGTFG 651
            YLH    + I HRD+K  N+L   +      K++DFG AK    +           T  
Sbjct: 125 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPY 178

Query: 652 YMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILAL 711
           Y++PE     ++ +  D++S GV++  ++ G     F+ +    +    K          
Sbjct: 179 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY--PPFYSNHGLAISPGMKTRIRMGQYEF 236

Query: 712 VDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE--IRDLPYPKEPAF 769
            +P  SE S ++ M+IR        ++     R  ++     +N    ++    P+ P  
Sbjct: 237 PNPEWSEVSEEVKMLIRN------LLKTEPTQRMTITEF---MNHPWIMQSTKVPQTPLH 287

Query: 770 TERQGADDSESFKQIQQRILLMILLLHSQQAEIRR 804
           T R   +D E ++ +++ +   +  +     +I+ 
Sbjct: 288 TSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKI 322

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  156 bits (395), Expect = 3e-43
 Identities = 60/267 (22%), Positives = 111/267 (41%), Gaps = 31/267 (11%)

Query: 483 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGL---------EEFMNEVMVI 532
           N++    LG+G    V         +E AVK +    G            E  + EV ++
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 533 SKLQ-HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGIS 591
            K+  H N+++L           L+++ M    L   L    +K  L  ++   I+  + 
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALL 120

Query: 592 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFG 651
             +  LH+   L I+HRDLK  NILLD+++N K++DFG +      +       V GT  
Sbjct: 121 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPS 174

Query: 652 YMSPEYAMEGR------FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNE 705
           Y++PE            + ++ D++S GV++  +++G      F     +L     +   
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS---PPFWHRKQMLMLRMIMSGN 231

Query: 706 NKILALVDPFLSESSFQLDMIIRCIHV 732
            +  +      S++    D++ R + V
Sbjct: 232 YQFGSPEWDDYSDTV--KDLVSRFLVV 256

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (386), Expect = 7e-42
 Identities = 66/309 (21%), Positives = 127/309 (41%), Gaps = 31/309 (10%)

Query: 480 ATNNFQLSSKLGQGGFGPVYWGRLK--DGQEIAVKRLSKASGQG--LEEFMNEVMVISKL 535
           A   ++  +++G+G +G V+  R     G+ +A+KR+   +G+       + EV V+  L
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 536 ---QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLD---ALLFDPLKKERLDWRKRFNIIEG 589
              +H N+VRL   C            +    +D       D + +  +      +++  
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 590 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 649
           + RGL +LH     R++HRDLK  NIL+      K++DFG+A+I+           VV T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVT 178

Query: 650 FGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR------KNTSFFEDDLTILGYAWKLW 703
             Y +PE  ++  ++   D++S G +  E+   +       +       L ++G   +  
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238

Query: 704 NENKILALVDPFLSESSFQLDMIIRCIHVGLL-----CVQELVKDRPNMSTVVSMLNSE- 757
               +      F S+S+  ++  +  I          C+      R +  +    L+   
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA---LSHPY 295

Query: 758 IRDLPYPKE 766
            +DL   KE
Sbjct: 296 FQDLERCKE 304

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  150 bits (380), Expect = 3e-41
 Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 11/205 (5%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRN 539
             +    K+G+G +G VY  +   G+  A+K  RL K         + E+ ++ +L+H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 599
           +V+L       +  +L++E++       L      +  L+     + +  +  G+ Y H 
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCH- 117

Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAM 659
               R++HRDLK  N+L++ E   KI+DFG+A+ FG    +      + T  Y +P+  M
Sbjct: 118 --DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH--EIVTLWYRAPDVLM 173

Query: 660 -EGRFSEKSDVFSFGVLLLEIVSGR 683
              ++S   D++S G +  E+V+G 
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGT 198

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 7e-41
 Identities = 68/299 (22%), Positives = 112/299 (37%), Gaps = 46/299 (15%)

Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEE------FMNEVMVISK 534
           + +Q+   LG GGFG VY G  + D   +A+K + K       E         EV+++ K
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 535 LQ--HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 592
           +      ++RLL      +  +LI E               ++  L      +    +  
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT--ERGALQEELARSFFWQVLE 121

Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEE-LNPKISDFGMAKIFGGNQDQADTGRVVGTFG 651
            + + H      ++HRD+K  NIL+D      K+ DFG   +              GT  
Sbjct: 122 AVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRV 174

Query: 652 YMSPEYAMEGRF-SEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILA 710
           Y  PE+    R+    + V+S G+LL ++V G      FE D              +I+ 
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD---IPFEHD-------------EEIIR 218

Query: 711 LVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE-IRDLPYPKEPA 768
               F    S +   +IR       C+     DRP    +    N   ++D+  P+E A
Sbjct: 219 GQVFFRQRVSSECQHLIRW------CLALRPSDRPTFEEI---QNHPWMQDVLLPQETA 268

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 2e-40
 Identities = 52/209 (24%), Positives = 90/209 (43%), Gaps = 17/209 (8%)

Query: 483 NFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 541
           ++  +  +G G FG VY  +L D G+ +A+K++ +           E+ ++ KL H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIV 76

Query: 542 RLLGCCVEGEEKM------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
           RL        EK       L+ +Y+P             K+ L        +  + R L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136

Query: 596 YLHRDSRLRIIHRDLKASNILLDEE-LNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMS 654
           Y+H      I HRD+K  N+LLD +    K+ DFG AK     + + +   +   +    
Sbjct: 137 YIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRAP 191

Query: 655 PEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
                   ++   DV+S G +L E++ G+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 6e-40
 Identities = 69/303 (22%), Positives = 110/303 (36%), Gaps = 37/303 (12%)

Query: 489 KLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEE-----FMNEVMVISKLQHRNLVR 542
            LG+G F  VY  R K   Q +A+K++        ++      + E+ ++ +L H N++ 
Sbjct: 5   FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64

Query: 543 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSR 602
           LL          L++++M                 L        +    +GL YLH+   
Sbjct: 65  LLDAFGHKSNISLVFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH-- 119

Query: 603 LRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGR 662
             I+HRDLK +N+LLDE    K++DFG+AK FG           V T  Y +PE     R
Sbjct: 120 -WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTHQVVTRWYRAPELLFGAR 176

Query: 663 -FSEKSDVFSFGVLLLEIVSGRKNTSFFEDD----------LTILGYAWKLWNENKILAL 711
            +    D+++ G +L E++       F   D           T+     + W +   L  
Sbjct: 177 MYGVGVDMWAVGCILAELLLRV---PFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233

Query: 712 VDPFLSESSFQLDMIIRCIHVGLL-----CVQELVKDRPNMSTVVSMLNSE-IRDLPYPK 765
              F S     L  I       LL             R   +     L  +   + P P 
Sbjct: 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA---LKMKYFSNRPGPT 290

Query: 766 EPA 768
              
Sbjct: 291 PGC 293

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 6e-40
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 11/205 (5%)

Query: 483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRN 539
           NFQ   K+G+G +G VY  R K  G+ +A+K  RL   +       + E+ ++ +L H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 540 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 599
           +V+LL       +  L++E++          D      +      + +  + +GL + H 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120

Query: 600 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE-YA 658
               R++HRDLK  N+L++ E   K++DFG+A+ FG           V T  Y +PE   
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--EVVTLWYRAPEILL 175

Query: 659 MEGRFSEKSDVFSFGVLLLEIVSGR 683
               +S   D++S G +  E+V+ R
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 2e-39
 Identities = 57/213 (26%), Positives = 93/213 (43%), Gaps = 20/213 (9%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS------GQGLEEFMNEVMVISK 534
           + +    +LG G F  V   R K  G + A K + K        G   E+   EV ++ +
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 535 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 594
           +QH N++ L        + +LI E +       L     +KE L   +    ++ I  G+
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAG---GELFDFLAEKESLTEEEATEFLKQILNGV 126

Query: 595 LYLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMAKIFGGNQDQADTGRVVGTF 650
            YLH    L+I H DLK  NI+L +   P    KI DFG+A          +   + GT 
Sbjct: 127 YYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTP 180

Query: 651 GYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
            +++PE         ++D++S GV+   ++SG 
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 213

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 1e-38
 Identities = 49/216 (22%), Positives = 102/216 (47%), Gaps = 20/216 (9%)

Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQG--LEEFMNEVMVISKLQHR 538
           + ++  +K+GQG FG V+  R  K GQ++A+K++   + +       + E+ ++  L+H 
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 539 NLVRLLGCCVEGEEKM--------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGI 590
           N+V L+  C               L++++  +     L    +K    + ++   ++   
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML--- 126

Query: 591 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR--VVG 648
              L  L+   R +I+HRD+KA+N+L+  +   K++DFG+A+ F   ++         V 
Sbjct: 127 ---LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183

Query: 649 TFGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGR 683
           T  Y  PE  +  R +    D++  G ++ E+ +  
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 219

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 2e-38
 Identities = 55/206 (26%), Positives = 89/206 (43%), Gaps = 12/206 (5%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQH 537
           N+F     LG+G FG V   R K  G+  A+K L K    +   +   + E  V+   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 538 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 597
             L  L       +    + EY     L   L    ++      +       I   L YL
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYL 121

Query: 598 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEY 657
           H      +++RD+K  N++LD++ + KI+DFG+ K   G  D A      GT  Y++PE 
Sbjct: 122 HS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGTPEYLAPEV 176

Query: 658 AMEGRFSEKSDVFSFGVLLLEIVSGR 683
             +  +    D +  GV++ E++ GR
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGR 202

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  141 bits (356), Expect = 2e-37
 Identities = 65/294 (22%), Positives = 117/294 (39%), Gaps = 39/294 (13%)

Query: 443 RWIAKRKAEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGR 502
            ++AK K + + K    + NT +L               + F     LG G FG V   +
Sbjct: 17  EFLAKAKEDFLKKWETPSQNTAQL---------------DQFDRIKTLGTGSFGRVMLVK 61

Query: 503 -LKDGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE 558
             + G   A+K L K      + +E  +NE  ++  +    LV+L     +     ++ E
Sbjct: 62  HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121

Query: 559 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD 618
           Y+    + + L    +  R            I     YLH    L +I+RDLK  N+L+D
Sbjct: 122 YVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLID 175

Query: 619 EELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLE 678
           ++   +++DFG AK   G         + GT   ++PE  +   +++  D ++ GVL+ E
Sbjct: 176 QQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSKGYNKAVDWWALGVLIYE 230

Query: 679 IVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHV 732
           + +G      F  D  I  Y   +  + +  +     L       D++   + V
Sbjct: 231 MAAGY---PPFFADQPIQIYEKIVSGKVRFPSHFSSDLK------DLLRNLLQV 275

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 2e-36
 Identities = 49/206 (23%), Positives = 96/206 (46%), Gaps = 11/206 (5%)

Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK--ASGQGLEEFMNEVMVISKLQHR 538
             ++    +G G +G V      + G ++A+K+L +   S    +    E+ ++  ++H 
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77

Query: 539 NLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 597
           N++ LL      E      + Y+    +   L   +K E+L   +   ++  + +GL Y+
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137

Query: 598 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEY 657
           H      IIHRDLK  N+ ++E+   KI DFG+A+          TG VV  +       
Sbjct: 138 H---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM----TGYVVTRWYRAPEVI 190

Query: 658 AMEGRFSEKSDVFSFGVLLLEIVSGR 683
               R+++  D++S G ++ E+++G+
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGK 216

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (339), Expect = 9e-36
 Identities = 42/206 (20%), Positives = 93/206 (45%), Gaps = 10/206 (4%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHR 538
             ++   K+G+G +G V+  + +   + +A+KR+             + E+ ++ +L+H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 539 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 598
           N+VRL       ++  L++E+          +       LD     + +  + +GL + H
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKK---YFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118

Query: 599 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYA 658
                 ++HRDLK  N+L++     K+++FG+A+ FG    +  +  VV  +        
Sbjct: 119 S---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYSAEVVTLWYRPPDVLF 174

Query: 659 MEGRFSEKSDVFSFGVLLLEIVSGRK 684
               +S   D++S G +  E+ +  +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGR 200

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  128 bits (321), Expect = 6e-33
 Identities = 42/208 (20%), Positives = 95/208 (45%), Gaps = 21/208 (10%)

Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HRN 539
           +++QL  KLG+G +  V+    + + +++ VK L        ++   E+ ++  L+   N
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPN 91

Query: 540 LVRLLGCCVEGEEKM--LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 597
           ++ L     +   +   L++E++ N     L       + L        +  I + L Y 
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYC 145

Query: 598 HRDSRLRIIHRDLKASNILLDEE-LNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 656
           H    + I+HRD+K  N+++D E    ++ D+G+A+ +   Q+       V +  +  PE
Sbjct: 146 H---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPE 199

Query: 657 YAMEGR-FSEKSDVFSFGVLLLEIVSGR 683
             ++ + +    D++S G +L  ++  +
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRK 227

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 2e-32
 Identities = 71/263 (26%), Positives = 113/263 (42%), Gaps = 25/263 (9%)

Query: 482 NNFQLSSKLGQGGFGPVYWGRL----KDGQEIAVKRLSKAS----GQGLEEFMNEVMVIS 533
            NF+L   LG G +G V+  R       G+  A+K L KA+     +  E    E  V+ 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 534 KLQHR-NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 592
            ++    LV L        +  LI +Y+    L   L    ++ER    +    +  I  
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS---QRERFTEHEVQIYVGEIVL 140

Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 652
            L +LH+   L II+RD+K  NILLD   +  ++DFG++K F  ++ +       GT  Y
Sbjct: 141 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEY 196

Query: 653 MSPEYAMEGR--FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILA 710
           M+P+    G     +  D +S GVL+ E+++G   + F  D               +IL 
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA--SPFTVDGEKNSQAEIS----RRILK 250

Query: 711 LVDPFLSESSFQL-DMIIRCIHV 732
              P+  E S    D+I R +  
Sbjct: 251 SEPPYPQEMSALAKDLIQRLLMK 273

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 2e-31
 Identities = 51/211 (24%), Positives = 94/211 (44%), Gaps = 21/211 (9%)

Query: 482 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHR 538
             +Q    +G G  G V         + +A+K+LS+   +    +    E++++  + H+
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 539 NLVRLLGCCV------EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 592
           N++ LL          E ++  L+ E M       +      +  LD  +   ++  +  
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QMELDHERMSYLLYQMLC 130

Query: 593 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGY 652
           G+ +LH      IIHRDLK SNI++  +   KI DFG+A+  G +         V T  Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYY 184

Query: 653 MSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
            +PE  +   + E  D++S G ++ E+V  +
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (308), Expect = 4e-31
 Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 11/207 (5%)

Query: 481 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQH 537
              +Q  S +G G +G V      K G  +AVK+LS+   S    +    E+ ++  ++H
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76

Query: 538 RNLVRLLGCCVEGEEKMLI-YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 596
            N++ LL               Y+    + A L + +K ++L       +I  I RGL Y
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136

Query: 597 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPE 656
           +H      IIHRDLK SN+ ++E+   KI DFG+A+      D   TG V   +      
Sbjct: 137 IH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT----DDEMTGYVATRWYRAPEI 189

Query: 657 YAMEGRFSEKSDVFSFGVLLLEIVSGR 683
                 +++  D++S G ++ E+++GR
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGR 216

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  113 bits (283), Expect = 9e-28
 Identities = 42/217 (19%), Positives = 85/217 (39%), Gaps = 22/217 (10%)

Query: 484 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 542
           + L  KLG G F  V+  + + +   +A+K +        E   +E+ ++ ++   +  +
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTK 73

Query: 543 LLGCCVEGEEKMLIY---------------EYMPNRSLDALLFDPLKKERLDWRKRFNII 587
                     K+L +               E +    L  +     +   L + K+  I 
Sbjct: 74  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ--IS 131

Query: 588 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEE-LNPKISDFGMAKIFGGNQDQADTGRV 646
           + +  GL Y+HR  R  IIH D+K  N+L++       +    +A +             
Sbjct: 132 KQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 189

Query: 647 VGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR 683
           + T  Y SPE  +   +   +D++S   L+ E+++G 
Sbjct: 190 IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 95.2 bits (236), Expect = 5e-23
 Identities = 36/203 (17%), Positives = 67/203 (33%), Gaps = 25/203 (12%)

Query: 486 LSSKLGQGGFGPVYWGRLKDGQEIAVK--RLSKASGQ--------GLEEFMNEVMVISKL 535
           +   +G+G    V+    +   E  VK  ++   S +        G   F    +  ++ 
Sbjct: 4   IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63

Query: 536 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 595
           + R L +L G  V       +Y +  N  L  L+                +++ I   + 
Sbjct: 64  EFRALQKLQGLAV-----PKVYAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVA 117

Query: 596 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSP 655
             +      I+H DL   N+L+ EE    I DF  +   G    +    R V        
Sbjct: 118 KFYHR---GIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWREILERDVRNIITY-- 171

Query: 656 EYAMEGRFSEKSDVFSFGVLLLE 678
                  +  + D+ S    +L+
Sbjct: 172 ---FSRTYRTEKDINSAIDRILQ 191

>d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Garlic (Allium sativum) [TaxId: 4682]

 Score = 78.1 bits (192), Expect = 4e-18
 Identities = 18/107 (16%), Positives = 40/107 (37%), Gaps = 10/107 (9%)

Query: 39  LSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLV 98
           L  G +  +  ++        + ++         +W +N     K       +  DGN V
Sbjct: 10  LYAGQSLDVEPYHFIMQEDCNLVLYDH----STSVWASNTGILGKKGCKA-VLQSDGNFV 64

Query: 99  LVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESF 145
           + + +   LW+S+     N +    L + GN+V+  +     +W + 
Sbjct: 65  VYDAEGRSLWASHSVR-GNGNYVLVLQEDGNVVIYGS----DIWSTG 106

>d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 72.3 bits (177), Expect = 7e-16
 Identities = 18/84 (21%), Positives = 29/84 (34%), Gaps = 3/84 (3%)

Query: 62  IWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTS 121
           I Y            +    L+ S   +++  D NLVL +    V  ++           
Sbjct: 12  ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDRDDRVWSTNTAGK--GTGCR 69

Query: 122 AQLLDSGNLVLRDNINRAIVWESF 145
           A L  +G + +  N N   VW S 
Sbjct: 70  AVLQPNGRMDVLTNQNI-AVWTSG 92

>d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 38.8 bits (90), Expect = 3e-04
 Identities = 20/108 (18%), Positives = 38/108 (35%), Gaps = 10/108 (9%)

Query: 87  GIITISEDGNLVLVNGQKE--VLWSSNVSN-LVNNSTSAQLLDSGNLVLRDNINRAIVWE 143
           G + ++ +GN +L + Q       + + +  L  +     +    NLVL D  +R     
Sbjct: 1   GSVVVANNGNSILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDRDDRVWSTN 60

Query: 144 SFQEPTDSFLPGMHHG---IDQRTGKKVQLTSWKSLSDPSTGSFSAGL 188
           +  + T        +G   +       V    W S +  S G +   L
Sbjct: 61  TAGKGTGCRAVLQPNGRMDVLTNQNIAV----WTSGNSRSAGRYVFVL 104

>d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 69.6 bits (170), Expect = 5e-15
 Identities = 24/84 (28%), Positives = 34/84 (40%), Gaps = 4/84 (4%)

Query: 62  IWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTS 121
           I + +  E +     +    L+ SS   T+  D NLVL +    V W+SN +        
Sbjct: 3   ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDSDVRV-WASNTAG--ATGCR 59

Query: 122 AQLLDSGNLVLRDNINRAIVWESF 145
           A L   G LV+    N  I W S 
Sbjct: 60  AVLQSDGLLVILTAQNT-IRWSSG 82

>d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Snowdrop (Galanthus nivalis) [TaxId: 4670]

 Score = 56.9 bits (137), Expect = 1e-10
 Identities = 20/111 (18%), Positives = 35/111 (31%), Gaps = 17/111 (15%)

Query: 35  PDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISED 94
               L+ G +F        +     +             W  N        S  +++  D
Sbjct: 12  TGEFLNYG-SFVFIMQEDCNLVLYDVDKPI---------WATNTGGL--SRSCFLSMQTD 59

Query: 95  GNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESF 145
           GNLV+ N   + +W+SN     N +    L    N+V+         W + 
Sbjct: 60  GNLVVYNPSNKPIWASNTGG-QNGNYVCILQKDRNVVIYGT----DRWATG 105

>d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Gastrodianin (antifungal protein)
species: Gastrodia elata [TaxId: 91201]

 Score = 54.4 bits (130), Expect = 1e-09
 Identities = 23/116 (19%), Positives = 44/116 (37%), Gaps = 15/116 (12%)

Query: 35  PDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISED 94
               L+ G  +     N  +       + YD       +W +  +        ++ +  D
Sbjct: 12  TGGSLAEG-GYLFIIQNDCNL------VLYDN---NRAVWASGTNGKASGC--VLKMQND 59

Query: 95  GNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQEPTD 150
           GNLV+ +G + +    + +N  N +    L    N+V+ DN N AI W +     +
Sbjct: 60  GNLVIYSGSRAIWA--SNTNRQNGNYYLILQRDRNVVIYDNSNNAI-WATHTNVGN 112

>d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 54.6 bits (131), Expect = 1e-09
 Identities = 13/73 (17%), Positives = 23/73 (31%), Gaps = 7/73 (9%)

Query: 72  VIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLV 131
            IW  N             +  DG LV++  +   +W S             L    N+V
Sbjct: 50  PIWATNTGGLGNGC--RAVLQPDGVLVVITNENVTVWQSP-VAGKAGHYVLVLQPDRNVV 106

Query: 132 LRDNINRAIVWES 144
           +  +     +W +
Sbjct: 107 IYGD----ALWAT 115

>d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 40.8 bits (95), Expect = 7e-05
 Identities = 18/52 (34%), Positives = 24/52 (46%), Gaps = 3/52 (5%)

Query: 93  EDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWES 144
            D NLVL +     +W++N   L N    A L   G LV+  N     VW+S
Sbjct: 38  TDCNLVLYDNNN-PIWATNTGGLGNGCR-AVLQPDGVLVVITN-ENVTVWQS 86

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	808
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.82
d1xd5a_	112	Gastrodianin (antifungal protein) {Gastrodia elata	99.74
d1jpca_	108	Lectin (agglutinin) {Snowdrop (Galanthus nivalis)	99.71
d1kj1a_	109	Lectin (agglutinin) {Garlic (Allium sativum) [TaxI	99.7
d1dlpa2	120	Fetuin-binding protein Scafet precursor {Bluebell	99.57
d1dlpa1	115	Fetuin-binding protein Scafet precursor {Bluebell	99.4
d1b2pa_	119	Lectin (agglutinin) {Bluebell (Scilla campanulata)	99.4
d1dlpa1	115	Fetuin-binding protein Scafet precursor {Bluebell	99.07
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.85
d1dlpa2	120	Fetuin-binding protein Scafet precursor {Bluebell	98.77
d1kj1a_	109	Lectin (agglutinin) {Garlic (Allium sativum) [TaxI	98.67
d1b2pa_	119	Lectin (agglutinin) {Bluebell (Scilla campanulata)	98.64
d1jpca_	108	Lectin (agglutinin) {Snowdrop (Galanthus nivalis)	98.54
d1xd5a_	112	Gastrodianin (antifungal protein) {Gastrodia elata	98.3
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.28
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.85
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.45
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.42
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.21
d2qj2a1	91	Hepatocyte growth factor {Human (Homo sapiens) [Ta	81.39

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=366.70  Aligned_cols=264  Identities=28%  Similarity=0.468  Sum_probs=213.7

Q ss_pred             HCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEECCC--CCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEE
Q ss_conf             4287546853336963189899339969999991444--62048999999999982368724568538971883489998
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  558 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  558 (808)
                      .++|.+.+.||+|+||.||+|+.+  ..||||+++..  .....+.|.+|+.++++++||||++++|++.+ ...++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             CCCEEEEEEEEECCCCEEEEEEEC--CEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEEEEEE
T ss_conf             451899889830788589999999--989999997346998999999999999984799878645679715-58999996


Q ss_pred             ECCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEECCCCC
Q ss_conf             26899900010388988767924289899999988798672399847807779896674799980331136610038999
Q 003599          559 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  638 (808)
Q Consensus       559 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  638 (808)
                      |+++|+|.+++..  ....+++..++.++.|+|+||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        84 y~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~  158 (276)
T d1uwha_          84 WCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS  158 (276)
T ss_dssp             CCCEEEHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred             CCCCCCHHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCHHHEEECCCCCEEECCCCCEEECCCCC
T ss_conf             5899888999852--3578999999999999999988875099---9516147899798189978875002213335567


Q ss_pred             CCCCCCCEECCCCCCCHHHHCC---CCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCHHCCCCC
Q ss_conf             8654331002578659111026---9878545478326878998748989887778212555655541023210102775
Q 003599          639 DQADTGRVVGTFGYMSPEYAME---GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPF  715 (808)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~  715 (808)
                      .........||+.|+|||++..   ..++.++||||||+++|||+||+.||........+......    +    ...+.
T Consensus       159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~----~----~~~p~  230 (276)
T d1uwha_         159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR----G----YLSPD  230 (276)
T ss_dssp             -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHH----T----SCCCC
T ss_pred             CCCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHC----C----CCCCC
T ss_conf             763125665574317999995056899995315163599999999788998998969999999965----8----88986


Q ss_pred             CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCCC
Q ss_conf             55786518999999999976543786889999899999810235899
Q 003599          716 LSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLP  762 (808)
Q Consensus       716 l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~~~~~  762 (808)
                      +..  ...+.+.++.+++.+||+.+|++||||++|++.|+.+.+.+|
T Consensus       231 ~~~--~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P  275 (276)
T d1uwha_         231 LSK--VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP  275 (276)
T ss_dssp             GGG--SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             CHH--CCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCCC
T ss_conf             000--365554999999999758897689299999999999997098

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=366.63  Aligned_cols=256  Identities=27%  Similarity=0.405  Sum_probs=210.7

Q ss_pred             CCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEECC
Q ss_conf             28754685333696318989933996999999144462048999999999982368724568538971883489998268
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMP  561 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  561 (808)
                      ++|++.+.||+|+||.||+|.+.++..||||+++.. ....++|.+|+.++++++||||++++|++...+..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHCEEEEEEEECCCEEEEEEEECCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEEECC
T ss_conf             995888898208882999999889999999998788-6768999999999996689975653524315993379998369


Q ss_pred             CCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEECCCCCCCC
Q ss_conf             99900010388988767924289899999988798672399847807779896674799980331136610038999865
Q 003599          562 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA  641 (808)
Q Consensus       562 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  641 (808)
                      +|+|.+++..  ....+++..++.++.|+|+||.|||+.+   |+||||||+|||+++++.+||+|||+++.........
T Consensus        84 ~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~  158 (263)
T d1sm2a_          84 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  158 (263)
T ss_dssp             TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             CCCHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHHCCC---EEECCCCHHHEEECCCCCEEECCCCHHEECCCCCCEE
T ss_conf             9918997520--1347889999999999999877653164---3104431532666688776865532100236887335


Q ss_pred             CCCCEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCHHCCCCCCCCCCC
Q ss_conf             43310025786591110269878545478326878998748989887778212555655541023210102775557865
Q 003599          642 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESSF  721 (808)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~  721 (808)
                       .....||..|+|||++.+..++.++||||||+++|||+|++.|+..............    .+.  ...        .
T Consensus       159 -~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~----~~~--~~~--------~  223 (263)
T d1sm2a_         159 -STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS----TGF--RLY--------K  223 (263)
T ss_dssp             -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHH----HTC--CCC--------C
T ss_pred             -ECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHH----HCC--CCC--------C
T ss_conf             -0430017666785786079998403321059999999878988877899999999998----068--889--------9


Q ss_pred             CHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCC
Q ss_conf             1899999999997654378688999989999981023
Q 003599          722 QLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEI  758 (808)
Q Consensus       722 ~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~  758 (808)
                      +.....++.+++.+||+.+|++||+|++|++.|+++.
T Consensus       224 p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~  260 (263)
T d1sm2a_         224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA  260 (263)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf             5436799999999976579768919999999999998

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=368.87  Aligned_cols=261  Identities=27%  Similarity=0.390  Sum_probs=214.7

Q ss_pred             HHHCCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf             98428754685333696318989933-99699999914446204899999999998236872456853897188348999
Q 003599          479 TATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  557 (808)
Q Consensus       479 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  557 (808)
                      ...++|.+.+.||+|+||.||+|.+. +++.||||+++... ...++|.+|+.++++++||||++++|++.+++..++||
T Consensus        14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~   92 (287)
T d1opja_          14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   92 (287)
T ss_dssp             CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             ECHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHCCCCCEECCCCCEEECCEEEEEE
T ss_conf             45799398659820888089999999999699999977761-03999999999998679998826775274578547876


Q ss_pred             EECCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEECCCC
Q ss_conf             82689990001038898876792428989999998879867239984780777989667479998033113661003899
Q 003599          558 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  637 (808)
Q Consensus       558 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  637 (808)
                      ||+++|+|..++... ....+++..+..++.|+++||.|||+++   |+||||||+|||+++++.+||+|||+++.....
T Consensus        93 E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~  168 (287)
T d1opja_          93 EFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  168 (287)
T ss_dssp             ECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred             ECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCEEECCCC
T ss_conf             314676067775303-5541579999999999999788898789---305760457689989992898324454653788


Q ss_pred             CCCCCCCCEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCHHCCCCCCC
Q ss_conf             98654331002578659111026987854547832687899874898988777821255565554102321010277555
Q 003599          638 QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS  717 (808)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~  717 (808)
                      ... ......|+..|+|||++.+..++.++||||||+++|||++|+.|+....+...+....    ..+.     .+   
T Consensus       169 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i----~~~~-----~~---  235 (287)
T d1opja_         169 TYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL----EKDY-----RM---  235 (287)
T ss_dssp             SSE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH----HTTC-----CC---
T ss_pred             CCE-EECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH----HCCC-----CC---
T ss_conf             722-1035566546669278727999810430217899999986799887742599999998----5588-----88---


Q ss_pred             CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf             786518999999999976543786889999899999810235
Q 003599          718 ESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIR  759 (808)
Q Consensus       718 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~~  759 (808)
                        ..+...+.++.+++.+||+.||++||||++|++.|+.+.+
T Consensus       236 --~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         236 --ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             --CCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf             --8874330999999999757797689399999999999987

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=369.05  Aligned_cols=259  Identities=26%  Similarity=0.451  Sum_probs=210.1

Q ss_pred             CCCCCCCCCCCCCCEEEEEEEECC-C---CEEEEEEECCC-CCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEE
Q ss_conf             287546853336963189899339-9---69999991444-620489999999999823687245685389718834899
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLKD-G---QEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI  556 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  556 (808)
                      ++|++.+.||+|+||.||+|.++. +   ..||||.+... .....+.|.+|+.++++++||||++++|++.+.+..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             HHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEE
T ss_conf             04278569802788299999995799788999999978445989999999999999857998886189999628877999


Q ss_pred             EEECCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEECCC
Q ss_conf             98268999000103889887679242898999999887986723998478077798966747999803311366100389
Q 003599          557 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  636 (808)
Q Consensus       557 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  636 (808)
                      |||+++|+|.+++..  ..+.+++.+++.++.|+|+||.|||+.+   ++||||||+||||+.++.+||+|||+++....
T Consensus       106 ~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             EECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEECCCCCCEEEECC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCCEECCC
T ss_conf             972279853002104--5679999999999999999889885279---83576150448988999199888443157567


Q ss_pred             CCCCCC---CCCEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCHHHHHHHHHHHCCCCCHHCC
Q ss_conf             998654---331002578659111026987854547832687899874-8989887778212555655541023210102
Q 003599          637 NQDQAD---TGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALV  712 (808)
Q Consensus       637 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  712 (808)
                      ......   .....||+.|+|||.+.++.++.++||||||+++|||+| |+.||....... +...    ...+.     
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~-~~~~----i~~~~-----  250 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD-VINA----IEQDY-----  250 (299)
T ss_dssp             ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHHH----HHTTC-----
T ss_pred             CCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHH-HHHH----HHCCC-----
T ss_conf             7776536502566688300387888369978612144535789999867999999999999-9999----97378-----


Q ss_pred             CCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf             775557865189999999999765437868899998999998102358
Q 003599          713 DPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRD  760 (808)
Q Consensus       713 d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~~~  760 (808)
                        ..   +.+.+.+.++.+++.+||+.+|++||+|.+|++.|++++++
T Consensus       251 --~~---~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         251 --RL---PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             --CC---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             --CC---CCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf             --89---99742269999999997587976892999999999998418

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=364.66  Aligned_cols=257  Identities=30%  Similarity=0.459  Sum_probs=209.4

Q ss_pred             HCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEEC
Q ss_conf             42875468533369631898993399699999914446204899999999998236872456853897188348999826
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  560 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  560 (808)
                      .++|++.+.||+|+||.||+|.++++..||||+++... ...+.|.+|+.++++++||||++++|++.+ +..++||||+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEECC-CCEEEEEEEC
T ss_conf             89938867981079828999999999999999986476-888999999999986799988578731045-9769999957


Q ss_pred             CCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEECCCCCCC
Q ss_conf             89990001038898876792428989999998879867239984780777989667479998033113661003899986
Q 003599          561 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  640 (808)
Q Consensus       561 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  640 (808)
                      ++|+|.+++... ....+++..+++++.||++||.|||+.+   |+||||||+||||++++.+||+|||+++........
T Consensus        90 ~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~  165 (272)
T d1qpca_          90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT  165 (272)
T ss_dssp             TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred             CCCCHHHHHHHC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEEECCCCEEECCCCCEEECCCCCCC
T ss_conf             898288887514-7898878899999999999999997489---546756422515620244042341014773588644


Q ss_pred             CCCCCEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCHHCCCCCCCCCC
Q ss_conf             54331002578659111026987854547832687899874898988777821255565554102321010277555786
Q 003599          641 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS  720 (808)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~  720 (808)
                      . .....|++.|+|||++..+.++.++||||||+++|||+||+.|+.............    ..+     ..+.     
T Consensus       166 ~-~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i----~~~-----~~~~-----  230 (272)
T d1qpca_         166 A-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL----ERG-----YRMV-----  230 (272)
T ss_dssp             C-CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH----HTT-----CCCC-----
T ss_pred             C-CCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH----HHC-----CCCC-----
T ss_conf             2-035677444458289837999824564525799999996898888888999999999----706-----8888-----


Q ss_pred             CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCC
Q ss_conf             51899999999997654378688999989999981023
Q 003599          721 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEI  758 (808)
Q Consensus       721 ~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~  758 (808)
                      .+...+.++.+++.+|++.+|++||||++|+++|+...
T Consensus       231 ~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f  268 (272)
T d1qpca_         231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF  268 (272)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf             96557199999999975889768939999999861132

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=363.16  Aligned_cols=259  Identities=27%  Similarity=0.390  Sum_probs=212.6

Q ss_pred             HCCCCCCCCCCCCCCEEEEEEEECC-C-----CEEEEEEECCC-CCCCHHHHHHHHHHHHHC-CCCCEEEEEEEEEECCE
Q ss_conf             4287546853336963189899339-9-----69999991444-620489999999999823-68724568538971883
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLKD-G-----QEIAVKRLSKA-SGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEE  552 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~-----~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~  552 (808)
                      .++|.+.+.||+|+||.||+|+... +     ..||+|.+... .......+.+|+.++.++ +||||+++++++.+.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCE
T ss_conf             89939701983078819999998578855420499999966335878999999999999971589968687788862995


Q ss_pred             EEEEEEECCCCCCHHHCCCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCC
Q ss_conf             4899982689990001038898--------------------87679242898999999887986723998478077798
Q 003599          553 KMLIYEYMPNRSLDALLFDPLK--------------------KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKA  612 (808)
Q Consensus       553 ~~lV~E~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp  612 (808)
                      .++||||+++|+|.+++.....                    ...+++..++.++.|+++||.|||+.+   |+||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred             EEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCH
T ss_conf             899997279995999998625777510221000012220012577899999999999999999997399---05052703


Q ss_pred             CCEEECCCCCEEEECCCCCEECCCCCCCCCCCCEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCC
Q ss_conf             966747999803311366100389998654331002578659111026987854547832687899874-8989887778
Q 003599          613 SNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFED  691 (808)
Q Consensus       613 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~  691 (808)
                      +|||++.++.+||+|||+++...............||+.|+|||++.++.++.++|||||||++|||+| |+.||.....
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             HCCCCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCCCCCCH
T ss_conf             21443459828985142222045778615623435787657838872799996330300039999998389999999898


Q ss_pred             CHHHHHHHHHHHCCCCCHHCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHH
Q ss_conf             21255565554102321010277555786518999999999976543786889999899999810
Q 003599          692 DLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS  756 (808)
Q Consensus       692 ~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~  756 (808)
                      ...+....    ..+.     .+     +.+...+.++.+|+.+||+.+|++|||++||+++|.-
T Consensus       273 ~~~~~~~~----~~~~-----~~-----~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  323 (325)
T d1rjba_         273 DANFYKLI----QNGF-----KM-----DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC  323 (325)
T ss_dssp             SHHHHHHH----HTTC-----CC-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHHHH----HCCC-----CC-----CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf             99999998----5699-----89-----9887678999999999758896689399999999748

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=357.35  Aligned_cols=249  Identities=24%  Similarity=0.375  Sum_probs=208.6

Q ss_pred             CCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEEC
Q ss_conf             28754685333696318989933-99699999914446204899999999998236872456853897188348999826
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  560 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  560 (808)
                      ++|++.++||+|+||.||+|... +++.||||++........+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             CCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEEC
T ss_conf             05388789812858299999998999899999984301727999999999998679998805857798899989999703


Q ss_pred             CCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEECCCCCCC
Q ss_conf             89990001038898876792428989999998879867239984780777989667479998033113661003899986
Q 003599          561 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  640 (808)
Q Consensus       561 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  640 (808)
                      ++|+|.+++.    ...+++.++..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+......
T Consensus       100 ~gg~L~~~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~  172 (293)
T d1yhwa1         100 AGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  172 (293)
T ss_dssp             TTCBHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred             CCCCHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCCC
T ss_conf             7980898864----159999999999999999999999879---722677688868878996864251564132136664


Q ss_pred             CCCCCEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCHHCCCCCCCCCC
Q ss_conf             54331002578659111026987854547832687899874898988777821255565554102321010277555786
Q 003599          641 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS  720 (808)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~  720 (808)
                        .....||+.|+|||++.+..++.++||||+||++|||+||+.||........+..    ....+      .+.+   .
T Consensus       173 --~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~----~~~~~------~~~~---~  237 (293)
T d1yhwa1         173 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL----IATNG------TPEL---Q  237 (293)
T ss_dssp             --BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HHHHC------SCCC---S
T ss_pred             --CCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHHHHHH----HHHCC------CCCC---C
T ss_conf             --4444447773682664479988012031372999998048899899799999999----98579------9988---8


Q ss_pred             CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             51899999999997654378688999989999
Q 003599          721 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       721 ~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      .+.....++.+++.+|++.||++||+++|+++
T Consensus       238 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             85537999999999986699668909999964

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=361.19  Aligned_cols=266  Identities=28%  Similarity=0.416  Sum_probs=215.7

Q ss_pred             HCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEEC
Q ss_conf             42875468533369631898993399699999914446204899999999998236872456853897188348999826
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  560 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  560 (808)
                      .++|++.+.||+|+||.||+|+++++..||||++... ....+.|.+|+.++++++|+||++++|++.+ +..++||||+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~   93 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   93 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             HHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCEEEEEEEC
T ss_conf             7997984699307980999999999999999998804-4888999999999986666788689999823-9759999944


Q ss_pred             CCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEECCCCCCC
Q ss_conf             89990001038898876792428989999998879867239984780777989667479998033113661003899986
Q 003599          561 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  640 (808)
Q Consensus       561 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  640 (808)
                      ++|+|..++... ....++|.+++.++.||+.||+|||+.+   ++||||||+|||++.++.+||+|||+++........
T Consensus        94 ~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~  169 (285)
T d1fmka3          94 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  169 (285)
T ss_dssp             TTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             CCCCHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHHHH---EECCCCCCEEEEECCCCCEEECCCCHHHHCCCCCCE
T ss_conf             799435420000-3553059999999999999999875411---433531230799989992998442555425688733


Q ss_pred             CCCCCEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCHHCCCCCCCCCC
Q ss_conf             54331002578659111026987854547832687899874898988777821255565554102321010277555786
Q 003599          641 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS  720 (808)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~  720 (808)
                       ......|+..|+|||++..+.++.++||||||+++|||+||+.|+..............    .+.     .+     +
T Consensus       170 -~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~----~~~-----~~-----~  234 (285)
T d1fmka3         170 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE----RGY-----RM-----P  234 (285)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH----TTC-----CC-----C
T ss_pred             -EECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCCHHHHHHHHH----HCC-----CC-----C
T ss_conf             -52454556654580898379989177413235899999868999998888999999998----268-----99-----9


Q ss_pred             CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCC
Q ss_conf             51899999999997654378688999989999981023589999999
Q 003599          721 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEP  767 (808)
Q Consensus       721 ~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~~~~~~~~~p  767 (808)
                      .+....+++.+++.+||+.+|++||+|++|+++|+......+.+..|
T Consensus       235 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~p  281 (285)
T d1fmka3         235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP  281 (285)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCC
T ss_pred             CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCCCCCCCCC
T ss_conf             98323799999999975669758919999999876662389999999

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=357.71  Aligned_cols=253  Identities=25%  Similarity=0.340  Sum_probs=207.3

Q ss_pred             HCCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEE
Q ss_conf             428754685333696318989933-99699999914446-2048999999999982368724568538971883489998
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  558 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  558 (808)
                      .++|++.+.||+|+||.||+|+.. +++.||||++.... .+..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEE
T ss_conf             74608998972174809999999999979999998456641279999999999985799888469654046743679886


Q ss_pred             ECCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEECCCCC
Q ss_conf             26899900010388988767924289899999988798672399847807779896674799980331136610038999
Q 003599          559 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  638 (808)
Q Consensus       559 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  638 (808)
                      |+++|+|.+++.   ....+++.++..++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++......
T Consensus        84 y~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~  157 (271)
T d1nvra_          84 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  157 (271)
T ss_dssp             CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             CCCCCCHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEECCCHHHEEECCCC
T ss_conf             458980899975---3799999999999999999999999759---8357546899788789987983231422404688


Q ss_pred             CCCCCCCEECCCCCCCHHHHCCCCC-CCCCCEEEHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCHHCCCCCCC
Q ss_conf             8654331002578659111026987-854547832687899874898988777821255565554102321010277555
Q 003599          639 DQADTGRVVGTFGYMSPEYAMEGRF-SEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS  717 (808)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~  717 (808)
                      .........||+.|+|||++.+..+ +.++||||+|+++|||+||+.||....+........    .....        .
T Consensus       158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~----~~~~~--------~  225 (271)
T d1nvra_         158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW----KEKKT--------Y  225 (271)
T ss_dssp             EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHH----HTTCT--------T
T ss_pred             CCCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHH----HCCCC--------C
T ss_conf             65311132557474287286189999971016173799999982997888898599999998----63888--------7


Q ss_pred             CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             78651899999999997654378688999989999
Q 003599          718 ESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       718 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      .. .......++.+++.+|++.||++|||++|+++
T Consensus       226 ~~-~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         226 LN-PWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             ST-TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CC-CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             88-64469999999999976799668909999961

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=357.01  Aligned_cols=259  Identities=27%  Similarity=0.455  Sum_probs=210.2

Q ss_pred             CCCCCCCCCCCCCCEEEEEEEECCC-----CEEEEEEECCCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEE
Q ss_conf             2875468533369631898993399-----6999999144462-048999999999982368724568538971883489
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLKDG-----QEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML  555 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~~~-----~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  555 (808)
                      +.|++.+.||+|+||.||+|.++..     ..||||++..... ....+|.+|+.++++++||||++++|++.+....++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEE
T ss_conf             99686159811779099999996899878799999998844596899999999999985689878323677833880389


Q ss_pred             EEEECCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEECC
Q ss_conf             99826899900010388988767924289899999988798672399847807779896674799980331136610038
Q 003599          556 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG  635 (808)
Q Consensus       556 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  635 (808)
                      ||||+.+|++.+++..  ....+++.++++++.|++.|+.|||+.+   |+||||||+||||+.++.+||+|||+++...
T Consensus        87 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          87 ITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             EEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEECCCCCCHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHCCCCC---CCCCCCCCCEEEECCCCEEEECCCCHHHCCC
T ss_conf             9972135740222102--3454208999999999998541212123---4257656442788899849984551030035


Q ss_pred             CCCCCC-CCCCEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCHHCCCC
Q ss_conf             999865-4331002578659111026987854547832687899874898988777821255565554102321010277
Q 003599          636 GNQDQA-DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDP  714 (808)
Q Consensus       636 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~  714 (808)
                      ...... ......||+.|+|||++.++.++.++||||||+++|||++++.|+........+...    ..++.     .+
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~----i~~~~-----~~  232 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA----INDGF-----RL  232 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH----HHTTC-----CC
T ss_pred             CCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHH----HHCCC-----CC
T ss_conf             7876526742677773434888870499997355634489899999679886556899999999----86357-----89


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf             555786518999999999976543786889999899999810235
Q 003599          715 FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIR  759 (808)
Q Consensus       715 ~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~~  759 (808)
                           +.+.+.+.++.+|+.+||+.+|++||+|.+|+++|+++++
T Consensus       233 -----~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~  272 (283)
T d1mqba_         233 -----PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  272 (283)
T ss_dssp             -----CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             -----CCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf             -----9850457999999999776797689399999999999866

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=0  Score=352.78  Aligned_cols=253  Identities=22%  Similarity=0.289  Sum_probs=209.2

Q ss_pred             HCCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEE
Q ss_conf             428754685333696318989933-9969999991444620489999999999823687245685389718834899982
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  559 (808)
                      .++|.+.+.||+|+||.||+|+.. +++.||||++........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf             65758988984076819999998899989999998452431699999999999867997999299999989999999985


Q ss_pred             CCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC--CCCCEEEECCCCCEECCCC
Q ss_conf             68999000103889887679242898999999887986723998478077798966747--9998033113661003899
Q 003599          560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD--EELNPKISDFGMAKIFGGN  637 (808)
Q Consensus       560 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~Dfgla~~~~~~  637 (808)
                      +++|+|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++  .++.+||+|||+++.+...
T Consensus       105 ~~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~  179 (350)
T d1koaa2         105 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  179 (350)
T ss_dssp             CCSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHH--HCCCCCHHHHHHHHHHHHHHHHHHHHCC---CEEEEECHHHEEECCCCCCEEEEEECCHHEECCCC
T ss_conf             799889999976--2378999999999999999999997569---76000154673641688986999545210442565


Q ss_pred             CCCCCCCCEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCHHCCCCCCC
Q ss_conf             98654331002578659111026987854547832687899874898988777821255565554102321010277555
Q 003599          638 QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS  717 (808)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~  717 (808)
                      ..   .....||+.|+|||++.+..++.++|||||||++|||++|+.||........+...    ....       ....
T Consensus       180 ~~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i----~~~~-------~~~~  245 (350)
T d1koaa2         180 QS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV----KSCD-------WNMD  245 (350)
T ss_dssp             SC---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----HHTC-------CCSC
T ss_pred             CC---CCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH----HHCC-------CCCC
T ss_conf             43---20006862421889975899872676554659999998598998997999999999----8478-------8989


Q ss_pred             CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf             786518999999999976543786889999899999
Q 003599          718 ESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       718 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                       .........++.+++.+||+.||++|||++|+++.
T Consensus       246 -~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         246 -DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             -CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             -CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             -42235899999999999756896679089998629

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=353.76  Aligned_cols=253  Identities=26%  Similarity=0.442  Sum_probs=212.0

Q ss_pred             CCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEECC
Q ss_conf             28754685333696318989933996999999144462048999999999982368724568538971883489998268
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMP  561 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  561 (808)
                      ++|++.++||+|+||.||+|+.+++..||||+++... ...++|.+|+.++++++||||++++|++.+.+..++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEECCC
T ss_conf             9979968982078839999998899899999987475-778999999999996689860158899850781699997048


Q ss_pred             CCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEECCCCCCCC
Q ss_conf             99900010388988767924289899999988798672399847807779896674799980331136610038999865
Q 003599          562 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA  641 (808)
Q Consensus       562 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  641 (808)
                      +|+|..++..  ....+++..+.+++.|+++||.|||+.+   |+||||||+|||+++++.+||+|||+++........ 
T Consensus        83 ~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-  156 (258)
T d1k2pa_          83 NGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-  156 (258)
T ss_dssp             TEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-
T ss_pred             CCCHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCEEEEECCCCCEEECCCHHHEECCCCCCE-
T ss_conf             9938886410--2467768999999999999999875468---434665413588769984798861442023578722-


Q ss_pred             CCCCEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCHHHHHHHHHHHCCCCCHHCCCCCCCCCC
Q ss_conf             4331002578659111026987854547832687899874-898988777821255565554102321010277555786
Q 003599          642 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS  720 (808)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~  720 (808)
                      ......||..|+|||.+.+..++.++||||||+++|||+| |+.||..........     ....+..  ..        
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~-----~i~~~~~--~~--------  221 (258)
T d1k2pa_         157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE-----HIAQGLR--LY--------  221 (258)
T ss_dssp             CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHH-----HHHTTCC--CC--------
T ss_pred             EECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCHHHHHH-----HHHHCCC--CC--------
T ss_conf             52465788775780786379988521033643246739755999988999999999-----9980797--89--------


Q ss_pred             CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHH
Q ss_conf             518999999999976543786889999899999810
Q 003599          721 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNS  756 (808)
Q Consensus       721 ~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~  756 (808)
                      .+...+.++.+++.+||+.+|++|||+++|++.|..
T Consensus       222 ~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf             965465999999999766897689399999987418

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=354.65  Aligned_cols=257  Identities=27%  Similarity=0.437  Sum_probs=208.1

Q ss_pred             CCCCCCC-CCCCCCCEEEEEEEEC---CCCEEEEEEECCCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEE
Q ss_conf             2875468-5333696318989933---99699999914446-20489999999999823687245685389718834899
Q 003599          482 NNFQLSS-KLGQGGFGPVYWGRLK---DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI  556 (808)
Q Consensus       482 ~~~~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  556 (808)
                      +++.+.+ +||+|+||.||+|.++   ++..||||+++... ....++|.+|++++++++||||++++|++.. +..++|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             CCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CEEEEE
T ss_conf             4718878487306080999999960897689999998820397899999999999986799888068656036-807999


Q ss_pred             EEECCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEECCC
Q ss_conf             98268999000103889887679242898999999887986723998478077798966747999803311366100389
Q 003599          557 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  636 (808)
Q Consensus       557 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  636 (808)
                      |||+++|+|.+++..  ....+++..+.+++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus        87 mE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  161 (285)
T d1u59a_          87 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA  161 (285)
T ss_dssp             EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEECCCCCHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEECCCCCEEECCCHHHHCCCC
T ss_conf             980789968997521--2569999999999999999878998688---10576764660454688542033134211554


Q ss_pred             CCCC-CCCCCEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCHHHHHHHHHHHCCCCCHHCCCC
Q ss_conf             9986-54331002578659111026987854547832687899874-898988777821255565554102321010277
Q 003599          637 NQDQ-ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDP  714 (808)
Q Consensus       637 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~  714 (808)
                      .... .......||+.|+|||++..+.++.++||||||+++|||+| |+.||......... .    ....+...     
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~-~----~i~~~~~~-----  231 (285)
T d1u59a_         162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM-A----FIEQGKRM-----  231 (285)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH-H----HHHTTCCC-----
T ss_pred             CCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCHHHHH-H----HHHCCCCC-----
T ss_conf             3432113562113743358688727999954123220178999993899999997999999-9----99818999-----


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf             555786518999999999976543786889999899999810235
Q 003599          715 FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIR  759 (808)
Q Consensus       715 ~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~~  759 (808)
                           ..+...+.++.+|+.+||+.+|++||+|.+|++.|+....
T Consensus       232 -----~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~  271 (285)
T d1u59a_         232 -----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  271 (285)
T ss_dssp             -----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf             -----9997678999999999757797689099999999999999

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=355.64  Aligned_cols=251  Identities=25%  Similarity=0.375  Sum_probs=206.8

Q ss_pred             CCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEEC
Q ss_conf             28754685333696318989933-99699999914446204899999999998236872456853897188348999826
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  560 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  560 (808)
                      +.|++.+.||+|+||.||+|+.. ++..||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECC
T ss_conf             37598479930778199999999999399999987289999999999999998679999884988980099589999627


Q ss_pred             CCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEECCCCCCC
Q ss_conf             89990001038898876792428989999998879867239984780777989667479998033113661003899986
Q 003599          561 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  640 (808)
Q Consensus       561 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  640 (808)
                      ++|+|.+++.+  ....+++.++..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++......  
T Consensus        92 ~~g~L~~~~~~--~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--  164 (288)
T d2jfla1          92 AGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--  164 (288)
T ss_dssp             TTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--
T ss_pred             CCCCHHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEECCHHHEEECCCCCEEEEECHHHHCCCCCC--
T ss_conf             99818899986--2899999999999999999999999889---8871407003148789998997161230357786--


Q ss_pred             CCCCCEECCCCCCCHHHHC-----CCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCHHCCCCC
Q ss_conf             5433100257865911102-----69878545478326878998748989887778212555655541023210102775
Q 003599          641 ADTGRVVGTFGYMSPEYAM-----EGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPF  715 (808)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~  715 (808)
                      .......||+.|+|||++.     ...++.++|||||||++|||+||+.||........+...    ... .     .+.
T Consensus       165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i----~~~-~-----~~~  234 (288)
T d2jfla1         165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI----AKS-E-----PPT  234 (288)
T ss_dssp             HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH----HHS-C-----CCC
T ss_pred             CCCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH----HCC-C-----CCC
T ss_conf             410010256264799998320257888880665787899999982088999998999999999----707-9-----987


Q ss_pred             CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             5578651899999999997654378688999989999
Q 003599          716 LSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       716 l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      +.   .+.....++.+++.+||+.||++|||++|+++
T Consensus       235 ~~---~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         235 LA---QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             CS---SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CC---CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             77---65669999999999976699668919999962

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=0  Score=348.75  Aligned_cols=253  Identities=21%  Similarity=0.249  Sum_probs=208.6

Q ss_pred             HCCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEE
Q ss_conf             428754685333696318989933-9969999991444620489999999999823687245685389718834899982
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  559 (808)
                      .++|++.+.||+|+||.||+|+.. +++.||||++........+.+.+|+.++++++||||+++++++.+....++||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf             40359989993177829999999899979999998872646799999999999867997989199999989999999982


Q ss_pred             CCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC--CCCCEEEECCCCCEECCCC
Q ss_conf             68999000103889887679242898999999887986723998478077798966747--9998033113661003899
Q 003599          560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD--EELNPKISDFGMAKIFGGN  637 (808)
Q Consensus       560 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~Dfgla~~~~~~  637 (808)
                      +++|+|.+++..  ....+++.++..++.||+.||.|||+.+   |+||||||+|||++  .++.+||+|||+++.+...
T Consensus       108 ~~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~  182 (352)
T d1koba_         108 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  182 (352)
T ss_dssp             CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCCHHHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCCCCCCCCCCEEEEEECCCCEECCCC
T ss_conf             899808888986--3899899999999999999999999779---26513144553113467884899525630343788


Q ss_pred             CCCCCCCCEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCHHCCCCCCC
Q ss_conf             98654331002578659111026987854547832687899874898988777821255565554102321010277555
Q 003599          638 QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS  717 (808)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~  717 (808)
                      ..   .....|++.|+|||++.+..++.++||||+||++|||+||+.||........+..    ... .      +....
T Consensus       183 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~----i~~-~------~~~~~  248 (352)
T d1koba_         183 EI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQN----VKR-C------DWEFD  248 (352)
T ss_dssp             SC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH----HHH-C------CCCCC
T ss_pred             CC---EEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHH----HHH-C------CCCCC
T ss_conf             72---0100476453489997479989763338989999999968899899799999999----984-7------88989


Q ss_pred             CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf             786518999999999976543786889999899999
Q 003599          718 ESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       718 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                      .. .......++.+++.+||+.||.+|||++|+++.
T Consensus       249 ~~-~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         249 ED-AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             SS-TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CC-CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             30-024799999999999756996689189999609

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=354.88  Aligned_cols=258  Identities=25%  Similarity=0.331  Sum_probs=205.7

Q ss_pred             HCCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEE
Q ss_conf             428754685333696318989933-99699999914446-2048999999999982368724568538971883489998
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  558 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  558 (808)
                      .++|++.++||+|+||.||+|+.. +++.||+|+++... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEE
T ss_conf             56888978971277809999999899969999998754097899999999999986799999949999998999999997


Q ss_pred             ECCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCCCEEECCCCCCCEEECCCCCEEEECCCCCEECCCC
Q ss_conf             268999000103889887679242898999999887986723-9984780777989667479998033113661003899
Q 003599          559 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD-SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  637 (808)
Q Consensus       559 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  637 (808)
                      |+++|+|.+++.+   .+.+++..+..++.|++.||.|||+. +   |+||||||+|||++.++.+||+|||+|+.....
T Consensus        85 y~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  158 (322)
T d1s9ja_          85 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  158 (322)
T ss_dssp             CCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             CCCCCCHHHHHHH---CCCCCHHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEECCCCCEEEEECCCCCCCCCC
T ss_conf             6799868998742---4999999999999999999999998599---971445779946878998999548776256788


Q ss_pred             CCCCCCCCEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCC-----------
Q ss_conf             986543310025786591110269878545478326878998748989887778212555655541023-----------
Q 003599          638 QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNEN-----------  706 (808)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~-----------  706 (808)
                          ......||+.|+|||++.+..++.++||||+||++|||++|+.||...+................           
T Consensus       159 ----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (322)
T d1s9ja_         159 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  234 (322)
T ss_dssp             ----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred             ----CCCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCC
T ss_conf             ----6211137714119468758998948889989999999998889989988789999998875177545774212333


Q ss_pred             --------------CCHHC-------CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             --------------21010-------27755578651899999999997654378688999989999
Q 003599          707 --------------KILAL-------VDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       707 --------------~~~~~-------id~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                                    ...+.       ..+.+..    .....++.+++.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPS----GVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             -----------CCCCHHHHHHHHHTSCCCCCCB----TTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCC----CCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf             221111222354134778876650268766764----448999999999986899467908999960

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=355.40  Aligned_cols=263  Identities=26%  Similarity=0.449  Sum_probs=213.2

Q ss_pred             HHHHHCCCCCCCCCCCCCCEEEEEEEEC------CCCEEEEEEECCCCCC-CHHHHHHHHHHHHHCCCCCEEEEEEEEEE
Q ss_conf             9998428754685333696318989933------9969999991444620-48999999999982368724568538971
Q 003599          477 LATATNNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASGQ-GLEEFMNEVMVISKLQHRNLVRLLGCCVE  549 (808)
Q Consensus       477 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~  549 (808)
                      ++...++|++.+.||+|+||.||+|+.+      +++.||||++...... ..++|.+|+.++++++||||+++++++..
T Consensus         8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~   87 (301)
T d1lufa_           8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV   87 (301)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             CCCCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEEEECC
T ss_conf             13898893886798207883999999888765778829999998821085799999999999996689976552466605


Q ss_pred             CCEEEEEEEECCCCCCHHHCCCCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEC
Q ss_conf             883489998268999000103889---------------------88767924289899999988798672399847807
Q 003599          550 GEEKMLIYEYMPNRSLDALLFDPL---------------------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHR  608 (808)
Q Consensus       550 ~~~~~lV~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~  608 (808)
                      ....++|||++++|+|.+++....                     ....+++..++.++.|++.||+|||+.+   ++||
T Consensus        88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHr  164 (301)
T d1lufa_          88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR  164 (301)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred             CCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCC---EEEE
T ss_conf             9803899981589929999985275542100001110012103467889899999999999999855413578---6854


Q ss_pred             CCCCCCEEECCCCCEEEECCCCCEECCCCCCCCCCCCEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCC-CCC
Q ss_conf             7798966747999803311366100389998654331002578659111026987854547832687899874898-988
Q 003599          609 DLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRK-NTS  687 (808)
Q Consensus       609 Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~-p~~  687 (808)
                      ||||+|||++.++.+||+|||+++...............|++.|+|||.+.+..++.++||||||+++|||++|.. |+.
T Consensus       165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~  244 (301)
T d1lufa_         165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY  244 (301)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             EECCCCEEECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCCCCCC
T ss_conf             88401168989992898331442113677641115777767676798997268898056302523629999806899999


Q ss_pred             CCCCCHHHHHHHHHHHCCCCCHHCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHC
Q ss_conf             7778212555655541023210102775557865189999999999765437868899998999998102
Q 003599          688 FFEDDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  757 (808)
Q Consensus       688 ~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~  757 (808)
                      ...+.. +...    ..++...          ..+...+.++.+|+.+||+.+|++||||.||+++|+++
T Consensus       245 ~~~~~e-~~~~----v~~~~~~----------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i  299 (301)
T d1lufa_         245 GMAHEE-VIYY----VRDGNIL----------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM  299 (301)
T ss_dssp             TSCHHH-HHHH----HHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             CCCHHH-HHHH----HHCCCCC----------CCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             989999-9999----9739978----------88732529999999997488965793999999999984

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=351.86  Aligned_cols=245  Identities=27%  Similarity=0.373  Sum_probs=205.4

Q ss_pred             CCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCC---CCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf             28754685333696318989933-9969999991444---6204899999999998236872456853897188348999
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  557 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  557 (808)
                      ++|++.+.||+|+||.||+++.+ +++.||+|++.+.   .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf             37699889851778589999998999499999981688567689999999999998568888885999999899989998


Q ss_pred             EECCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEECCCC
Q ss_conf             82689990001038898876792428989999998879867239984780777989667479998033113661003899
Q 003599          558 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  637 (808)
Q Consensus       558 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  637 (808)
                      ||+++|+|.+++..   ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        86 Ey~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          86 EYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred             EECCCCCHHHHHHH---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECCCCCEECCCCCEEECCCCEEEECCCC
T ss_conf             50479858988750---489999999999999999999999889---465220234414668998711555633544888


Q ss_pred             CCCCCCCCEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCHHCCCCCCC
Q ss_conf             98654331002578659111026987854547832687899874898988777821255565554102321010277555
Q 003599          638 QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS  717 (808)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~  717 (808)
                      .    .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........    .. ..      +..  
T Consensus       160 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~----i~-~~------~~~--  222 (263)
T d2j4za1         160 R----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR----IS-RV------EFT--  222 (263)
T ss_dssp             C----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH----HH-TT------CCC--
T ss_pred             C----CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH----HH-CC------CCC--
T ss_conf             5----2355788763499997589989314404675999998329999888999999999----97-18------999--


Q ss_pred             CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             78651899999999997654378688999989999
Q 003599          718 ESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       718 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                         .+.....++.+++.+|++.||++|||++|+++
T Consensus       223 ---~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         223 ---FPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             ---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             ---98668999999999976479768909999971

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=351.52  Aligned_cols=249  Identities=27%  Similarity=0.342  Sum_probs=208.3

Q ss_pred             CCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCC---CCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf             28754685333696318989933-9969999991444---6204899999999998236872456853897188348999
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  557 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  557 (808)
                      ++|++.+.||+|+||.||+|+.. +++.||||++.+.   .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf             87789889850879099999998999799999986577557778999999999998768888617999999899889999


Q ss_pred             EECCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEECCCC
Q ss_conf             82689990001038898876792428989999998879867239984780777989667479998033113661003899
Q 003599          558 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  637 (808)
Q Consensus       558 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  637 (808)
                      ||+++|+|.+++.   ..+.+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++.+...
T Consensus        88 Ey~~gg~L~~~~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          88 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             ECCCCCCHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHCCCC---EECCCCCCCCCCCCCCCEEEECCCCCCEECCCC
T ss_conf             7048987777653---1599999999999999999997621650---884767741236688853886032102422567


Q ss_pred             CCCCCCCCEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCHHCCCCCCC
Q ss_conf             98654331002578659111026987854547832687899874898988777821255565554102321010277555
Q 003599          638 QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS  717 (808)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~  717 (808)
                      ..........||+.|+|||++.+..++.++||||+||++|||++|+.||...+......    ... ...      ..  
T Consensus       162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~----~i~-~~~------~~--  228 (288)
T d1uu3a_         162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ----KII-KLE------YD--  228 (288)
T ss_dssp             --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHH-TTC------CC--
T ss_pred             CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCHHHHHH----HHH-CCC------CC--
T ss_conf             76433355567755258440026898966623045699999803889989959999999----997-189------99--


Q ss_pred             CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             78651899999999997654378688999989999
Q 003599          718 ESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       718 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                         ++.....++.+++.+||+.||++|||++|++.
T Consensus       229 ---~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         229 ---FPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             ---CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             ---CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHCC
T ss_conf             ---98547999999999985579768919789737

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=349.78  Aligned_cols=249  Identities=27%  Similarity=0.404  Sum_probs=202.1

Q ss_pred             CCCCCCCCEEEEEEEECC---CCEEEEEEECCCC--CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEECCC
Q ss_conf             853336963189899339---9699999914446--20489999999999823687245685389718834899982689
Q 003599          488 SKLGQGGFGPVYWGRLKD---GQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPN  562 (808)
Q Consensus       488 ~~lG~G~~g~Vy~~~~~~---~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  562 (808)
                      ++||+|+||.||+|.++.   ++.||||+++...  ....++|.+|+.++++++||||++++|+|.. +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC-CCEEEEEECCCC
T ss_conf             7834587829999998169738599999988010898999999999999986799898527777505-977999974788


Q ss_pred             CCCHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEECCCCCCCC-
Q ss_conf             9900010388988767924289899999988798672399847807779896674799980331136610038999865-
Q 003599          563 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA-  641 (808)
Q Consensus       563 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~-  641 (808)
                      |+|.+++..   ...+++..+++++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.+....... 
T Consensus        92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~  165 (277)
T d1xbba_          92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  165 (277)
T ss_dssp             EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred             CCHHHHHHH---CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCCCC
T ss_conf             968999752---257899999999999999976687479---55677761131023567512341345331343234432


Q ss_pred             CCCCEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCHHHHHHHHHHHCCCCCHHCCCCCCCCCC
Q ss_conf             4331002578659111026987854547832687899874-898988777821255565554102321010277555786
Q 003599          642 DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSESS  720 (808)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~  720 (808)
                      ......||+.|+|||.+.+..++.++||||||+++|||+| |+.||....... +..    ....+..       .   .
T Consensus       166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~-~~~----~i~~~~~-------~---~  230 (277)
T d1xbba_         166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-VTA----MLEKGER-------M---G  230 (277)
T ss_dssp             C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-HHH----HHHTTCC-------C---C
T ss_pred             CCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCHHH-HHH----HHHCCCC-------C---C
T ss_conf             24456778420391665379998434430340313289658999999989999-999----9982899-------9---9


Q ss_pred             CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCC
Q ss_conf             51899999999997654378688999989999981023
Q 003599          721 FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEI  758 (808)
Q Consensus       721 ~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~  758 (808)
                      .+...+.++.+|+.+||+.+|++||++++|+++|+...
T Consensus       231 ~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~  268 (277)
T d1xbba_         231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  268 (277)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCHH
T ss_conf             98656799999999975889768909899999852887

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=353.09  Aligned_cols=255  Identities=25%  Similarity=0.358  Sum_probs=205.6

Q ss_pred             HCCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCC--CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEE--CCEEEE
Q ss_conf             428754685333696318989933-99699999914446--2048999999999982368724568538971--883489
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVE--GEEKML  555 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~l  555 (808)
                      .++|++.+.||+|+||.||+++.. +++.||+|.+....  ....+.+.+|++++++++||||+++++++.+  ....++
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             CHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
T ss_conf             33379967983088919999999999979999998746579799999999999999778999824899999178998999


Q ss_pred             EEEECCCCCCHHHCCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCEEECCCCCCCEEECCCCCEEEECCCCCE
Q ss_conf             99826899900010388-98876792428989999998879867239--9847807779896674799980331136610
Q 003599          556 IYEYMPNRSLDALLFDP-LKKERLDWRKRFNIIEGISRGLLYLHRDS--RLRIIHRDLKASNILLDEELNPKISDFGMAK  632 (808)
Q Consensus       556 V~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  632 (808)
                      ||||+++|+|.+++... .....+++..++.++.|++.||.|||+.+  ..+|+||||||+|||++.++.+||+|||+++
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCEE
T ss_conf             99568999389999851545789999999999999999999999716778878858676542574788857980010003


Q ss_pred             ECCCCCCCCCCCCEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCHHCC
Q ss_conf             03899986543310025786591110269878545478326878998748989887778212555655541023210102
Q 003599          633 IFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALV  712 (808)
Q Consensus       633 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  712 (808)
                      .+......  .....||+.|+|||++.+..++.++||||||+++|||+||+.||...+......     ....+...   
T Consensus       163 ~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~-----~i~~~~~~---  232 (269)
T d2java1         163 ILNHDTSF--AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG-----KIREGKFR---  232 (269)
T ss_dssp             HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-----HHHHTCCC---
T ss_pred             ECCCCCCC--CCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHH-----HHHCCCCC---
T ss_conf             22457775--566778823279999839999938988752789999801889989989999999-----99718998---


Q ss_pred             CCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             7755578651899999999997654378688999989999
Q 003599          713 DPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       713 d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                        .     .+.....++.+++.+||+.||++||+++|+++
T Consensus       233 --~-----~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         233 --R-----IPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             --C-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --C-----CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf             --8-----97435999999999976799557918999972

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=346.39  Aligned_cols=258  Identities=26%  Similarity=0.440  Sum_probs=209.6

Q ss_pred             CCCCCCCCCCCCCCEEEEEEEEC-CCC----EEEEEEECCC-CCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEE
Q ss_conf             28754685333696318989933-996----9999991444-62048999999999982368724568538971883489
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQ----EIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML  555 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  555 (808)
                      ++|++.+.||+|+||.||+|... +++    .||+|+++.. .....++|.+|+.++++++||||++++|+|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-CEEE
T ss_conf             999783198208992999999958998898999999965134979999999999999867998881589999619-8369


Q ss_pred             EEEECCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEECC
Q ss_conf             99826899900010388988767924289899999988798672399847807779896674799980331136610038
Q 003599          556 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG  635 (808)
Q Consensus       556 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  635 (808)
                      ++|++.+|+|.+++..  ....+++..+++++.|||+||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             EEEECCCCCCCCCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCHHHCCEECCCCCEEEECCCCCEECC
T ss_conf             9984268740101113--3457999999999999999999998769---5047621203116799875860255222335


Q ss_pred             CCCCCCCCCCEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCHHHHHHHHHHHCCCCCHHCCCC
Q ss_conf             9998654331002578659111026987854547832687899874-898988777821255565554102321010277
Q 003599          636 GNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDP  714 (808)
Q Consensus       636 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~  714 (808)
                      ............||..|+|||.+.++.++.++||||||+++|||+| |+.||....... +..    ....+.       
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~-~~~----~i~~~~-------  230 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISS----ILEKGE-------  230 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG-HHH----HHHHTC-------
T ss_pred             CCCCCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-HHH----HHHCCC-------
T ss_conf             44453223651058644670887469998356544079999999977999999999899-999----997599-------


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf             5557865189999999999765437868899998999998102358
Q 003599          715 FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRD  760 (808)
Q Consensus       715 ~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~~~  760 (808)
                      ++   +.+...+.++.+++.+|++.+|++||++.+|++.|+...++
T Consensus       231 ~~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~  273 (317)
T d1xkka_         231 RL---PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  273 (317)
T ss_dssp             CC---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             CC---CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf             89---99855689999999984789934691999999999998758

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=345.04  Aligned_cols=265  Identities=27%  Similarity=0.374  Sum_probs=212.1

Q ss_pred             CCCCCCCCCCCCCCEEEEEEEECC-CC--EEEEEEECCC-CCCCHHHHHHHHHHHHHC-CCCCEEEEEEEEEECCEEEEE
Q ss_conf             287546853336963189899339-96--9999991444-620489999999999823-687245685389718834899
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLKD-GQ--EIAVKRLSKA-SGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLI  556 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV  556 (808)
                      ++|++.++||+|+||.||+|.+++ +.  .||||++... .....+.|.+|++++.++ +||||++++|++.+.+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
T ss_conf             99688779820788289999998999699999999782338579999999999998622899883678888418736999


Q ss_pred             EEECCCCCCHHHCCCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCE
Q ss_conf             9826899900010388-------------988767924289899999988798672399847807779896674799980
Q 003599          557 YEYMPNRSLDALLFDP-------------LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP  623 (808)
Q Consensus       557 ~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  623 (808)
                      |||+++|+|.++++..             .....+++..+.+++.|||+||.|||+.+   ++||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCC---CCCCCCCCCEEEECCCCCE
T ss_conf             9802898699998640355555123101234578999999999999999987663089---5455505204898688763


Q ss_pred             EEECCCCCEECCCCCCCCCCCCEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCC-CCCCCCCCHHHHHHHHHH
Q ss_conf             3311366100389998654331002578659111026987854547832687899874898-988777821255565554
Q 003599          624 KISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRK-NTSFFEDDLTILGYAWKL  702 (808)
Q Consensus       624 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~-p~~~~~~~~~~~~~~~~~  702 (808)
                      ||+|||+++......   ......||..|+|||.+..+.++.++||||||+++|||++|.. |+.... ...+....   
T Consensus       167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~-~~~~~~~i---  239 (309)
T d1fvra_         167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-CAELYEKL---  239 (309)
T ss_dssp             EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-HHHHHHHG---
T ss_pred             EECCCCCCCCCCCCC---CCCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCCC-HHHHHHHH---
T ss_conf             874344322444223---45530137755553875269999622153138899999836899999999-99999999---


Q ss_pred             HCCCCCHHCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCC
Q ss_conf             10232101027755578651899999999997654378688999989999981023589999999
Q 003599          703 WNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEP  767 (808)
Q Consensus       703 ~~~~~~~~~id~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~~~~~~~~~p  767 (808)
                       ..+.     .+.     .+...+.++.+++.+||+.+|++||+|++|++.|++++++.+....+
T Consensus       240 -~~~~-----~~~-----~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~~~~~~  293 (309)
T d1fvra_         240 -PQGY-----RLE-----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNT  293 (309)
T ss_dssp             -GGTC-----CCC-----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSBCC
T ss_pred             -HHCC-----CCC-----CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCCCCCCCC
T ss_conf             -8268-----888-----87667899999999976789668949999999999998618677897

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=346.65  Aligned_cols=253  Identities=23%  Similarity=0.288  Sum_probs=206.0

Q ss_pred             HHCCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf             8428754685333696318989933-99699999914446-204899999999998236872456853897188348999
Q 003599          480 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  557 (808)
Q Consensus       480 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  557 (808)
                      ..+.|++.+.||+|+||.||+++.. +++.||||++.... ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm   86 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM   86 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf             76666998899406583999999999998999999815773128999999999998679989991989999899888988


Q ss_pred             EECCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC---CCCCEEEECCCCCEEC
Q ss_conf             8268999000103889887679242898999999887986723998478077798966747---9998033113661003
Q 003599          558 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKIF  634 (808)
Q Consensus       558 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfgla~~~  634 (808)
                      ||+++|+|.+++..   .+.+++..+..++.|++.||.|||+.+   |+||||||+|||+.   +++.+||+|||+++..
T Consensus        87 E~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~  160 (307)
T d1a06a_          87 QLVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME  160 (307)
T ss_dssp             CCCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred             ECCCCCCHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHCE---EEEEEECCCCEEECCCCCCCEEEEECCCEEEEC
T ss_conf             52689848886530---367887899999999999987524130---556870463001104688824998315435872


Q ss_pred             CCCCCCCCCCCEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCHHCCCC
Q ss_conf             89998654331002578659111026987854547832687899874898988777821255565554102321010277
Q 003599          635 GGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDP  714 (808)
Q Consensus       635 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~  714 (808)
                      ....   ......||+.|+|||++.+..++.++|||||||++|||++|+.||..........    ......       .
T Consensus       161 ~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~----~i~~~~-------~  226 (307)
T d1a06a_         161 DPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFE----QILKAE-------Y  226 (307)
T ss_dssp             ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH----HHHTTC-------C
T ss_pred             CCCC---EEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH----HHHCCC-------C
T ss_conf             5897---0440032842259188737999807873451599999985979999989999999----986168-------7


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf             555786518999999999976543786889999899999
Q 003599          715 FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       715 ~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                      ... .+...+...++.+++.+|++.||++|||++|+++.
T Consensus       227 ~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         227 EFD-SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             CCC-TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             CCC-CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             778-76666789999999999760897579189998629

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=347.11  Aligned_cols=268  Identities=27%  Similarity=0.341  Sum_probs=212.2

Q ss_pred             HHHHHHHHCCCCCCCCCCCCCCEEEEEEEEC------CCCEEEEEEECCCC-CCCHHHHHHHHHHHHHC-CCCCEEEEEE
Q ss_conf             8899998428754685333696318989933------99699999914446-20489999999999823-6872456853
Q 003599          474 FEELATATNNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKL-QHRNLVRLLG  545 (808)
Q Consensus       474 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g  545 (808)
                      ...++...++|.+.++||+|+||.||+|...      .++.||||+++... ....+.+.+|...+.++ +|+||+.+++
T Consensus         5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~   84 (299)
T d1ywna1           5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG   84 (299)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             CCCCCCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEEE
T ss_conf             82526167997984498416783999999867775557839999998600171789999999999886149984997411


Q ss_pred             EEEEC-CEEEEEEEECCCCCCHHHCCCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCC
Q ss_conf             89718-83489998268999000103889-------------88767924289899999988798672399847807779
Q 003599          546 CCVEG-EEKMLIYEYMPNRSLDALLFDPL-------------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLK  611 (808)
Q Consensus       546 ~~~~~-~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk  611 (808)
                      ++.+. ...++||||+++|+|.+++....             ....+++.++..++.||++||.|||+.+   |+|||||
T Consensus        85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlK  161 (299)
T d1ywna1          85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLA  161 (299)
T ss_dssp             EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCC
T ss_pred             EECCCCCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCC
T ss_conf             5404797579999845899299999853666665322202332146899999999999999999887379---7178677


Q ss_pred             CCCEEECCCCCEEEECCCCCEECCCCCCCCCCCCEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCC-CCCCCCC
Q ss_conf             896674799980331136610038999865433100257865911102698785454783268789987489-8988777
Q 003599          612 ASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR-KNTSFFE  690 (808)
Q Consensus       612 p~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~-~p~~~~~  690 (808)
                      |+|||+++++.+||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||+||. .||....
T Consensus       162 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~  241 (299)
T d1ywna1         162 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  241 (299)
T ss_dssp             GGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             CCCEEECCCCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCC
T ss_conf             31065779982898457520011356652224751667210203686468899663221367899999868899998999


Q ss_pred             CCHHHHHHHHHHHCCCCCHHCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCC
Q ss_conf             82125556555410232101027755578651899999999997654378688999989999981023
Q 003599          691 DDLTILGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEI  758 (808)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~  758 (808)
                      ....+...    ...+..     +.     .+...+.++.+++.+||+.||++|||++||+++|++++
T Consensus       242 ~~~~~~~~----~~~~~~-----~~-----~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il  295 (299)
T d1ywna1         242 IDEEFCRR----LKEGTR-----MR-----APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  295 (299)
T ss_dssp             CSHHHHHH----HHHTCC-----CC-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHH----HHCCCC-----CC-----CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf             89999999----963898-----88-----88657899999999976779667919999999997998

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=342.08  Aligned_cols=256  Identities=25%  Similarity=0.402  Sum_probs=205.7

Q ss_pred             CCCCCCCCCEEEEEEEECCC----CEEEEEEECCC-CCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCEEEEEEEEC
Q ss_conf             68533369631898993399----69999991444-62048999999999982368724568538971-88348999826
Q 003599          487 SSKLGQGGFGPVYWGRLKDG----QEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVE-GEEKMLIYEYM  560 (808)
Q Consensus       487 ~~~lG~G~~g~Vy~~~~~~~----~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lV~E~~  560 (808)
                      .++||+|+||+||+|++.++    ..||||+++.. .....++|.+|++++++++||||++++|++.+ ....++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             CEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEEE
T ss_conf             66981368809999999779987999999998843697899999999999986789998678678980699438999874


Q ss_pred             CCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEECCCCCCC
Q ss_conf             89990001038898876792428989999998879867239984780777989667479998033113661003899986
Q 003599          561 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  640 (808)
Q Consensus       561 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  640 (808)
                      ++|+|.+++..  ....+++..+++++.|+++||.|||+.+   |+||||||+|||+++++.+||+|||+++........
T Consensus       112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             ECCCHHHHHCC--CCCCCHHHHHHHHHHHHHHHHHHHCCCC---CCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCCCC
T ss_conf             06741442101--3454048999999999887652003367---625776687576779998899106523225566555


Q ss_pred             C--CCCCEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCHHCCCCCCCC
Q ss_conf             5--43310025786591110269878545478326878998748989887778212555655541023210102775557
Q 003599          641 A--DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSE  718 (808)
Q Consensus       641 ~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~  718 (808)
                      .  ......||..|+|||.+..+.++.++||||||+++|||+||+.|+.............    ..+..     +.   
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i----~~g~~-----~~---  254 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL----LQGRR-----LL---  254 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHH----HTTCC-----CC---
T ss_pred             CCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH----HCCCC-----CC---
T ss_conf             3100256555645567688743799974574661999999997899998889999999999----80898-----89---


Q ss_pred             CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCC
Q ss_conf             8651899999999997654378688999989999981023589
Q 003599          719 SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDL  761 (808)
Q Consensus       719 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~~~~  761 (808)
                        .+.....++.+++.+||+.||++||+|.||++.|+++....
T Consensus       255 --~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~  295 (311)
T d1r0pa_         255 --QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  295 (311)
T ss_dssp             --CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             --CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHH
T ss_conf             --96447599999999976889768939999999999999752

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=343.00  Aligned_cols=247  Identities=26%  Similarity=0.389  Sum_probs=196.7

Q ss_pred             CCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCC--CCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEE----CCEEEEE
Q ss_conf             754685333696318989933-9969999991444--62048999999999982368724568538971----8834899
Q 003599          484 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVE----GEEKMLI  556 (808)
Q Consensus       484 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lV  556 (808)
                      |++.++||+|+||.||+|... ++..||+|++...  .....+.+.+|++++++++||||+++++++..    ....++|
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEE
T ss_conf             88516970082849999999999959999998512279899999999999998579998506999984033458889999


Q ss_pred             EEECCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC-CCCCEEEECCCCCEECC
Q ss_conf             98268999000103889887679242898999999887986723998478077798966747-99980331136610038
Q 003599          557 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD-EELNPKISDFGMAKIFG  635 (808)
Q Consensus       557 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgla~~~~  635 (808)
                      |||+++|+|.+++..   ...+++..+..++.||++||.|||+++ .+|+||||||+|||++ +++.+||+|||+++...
T Consensus        91 mE~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          91 TELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EECCCCCCHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEECCCCHHHCEEECCCCCEEEEECCCCEECC
T ss_conf             957898948999751---355469999999999999999999789-9799687674351166799988980057654236


Q ss_pred             CCCCCCCCCCEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCHHCCCCC
Q ss_conf             99986543310025786591110269878545478326878998748989887778212555655541023210102775
Q 003599          636 GNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPF  715 (808)
Q Consensus       636 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~  715 (808)
                      ..    ......||+.|+|||++.+ .++.++|||||||++|||++|+.||....+...+....    ..+     ..+.
T Consensus       167 ~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i----~~~-----~~~~  232 (270)
T d1t4ha_         167 AS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV----TSG-----VKPA  232 (270)
T ss_dssp             TT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHH----TTT-----CCCG
T ss_pred             CC----CCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH----HCC-----CCCC
T ss_conf             87----6677553813008988478-99986711007999999987889998765599999999----738-----9986


Q ss_pred             CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             5578651899999999997654378688999989999
Q 003599          716 LSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       716 l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                          ..+.....++.+++.+|++.||++|||++|+++
T Consensus       233 ----~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         233 ----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             ----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ----CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             ----567557899999999976379758929999967

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=347.69  Aligned_cols=245  Identities=28%  Similarity=0.460  Sum_probs=200.5

Q ss_pred             CCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCC---CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf             28754685333696318989933-99699999914446---204899999999998236872456853897188348999
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  557 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  557 (808)
                      +.|+..+.||+|+||.||+|+.. +++.||||++....   ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf             85676279701888099999998999399999984444358899999999999999778999823899999899889999


Q ss_pred             EECCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEECCCC
Q ss_conf             82689990001038898876792428989999998879867239984780777989667479998033113661003899
Q 003599          558 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  637 (808)
Q Consensus       558 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  637 (808)
                      ||+++|+|..++.   ....+++.++..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        95 E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~  168 (309)
T d1u5ra_          95 EYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (309)
T ss_dssp             ECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             EECCCCCHHHHHH---HCCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCCCEEEECCCCCEEEEECCCCCCCCCC
T ss_conf             8069994578997---3799999999999999999999998689---766678842179879997898443653346778


Q ss_pred             CCCCCCCCEECCCCCCCHHHHCC---CCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCHHCCCC
Q ss_conf             98654331002578659111026---987854547832687899874898988777821255565554102321010277
Q 003599          638 QDQADTGRVVGTFGYMSPEYAME---GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDP  714 (808)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~  714 (808)
                            ....||+.|+|||++.+   +.++.++|||||||++|||++|+.||........+..    ....      ..+
T Consensus       169 ------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~----i~~~------~~~  232 (309)
T d1u5ra_         169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH----IAQN------ESP  232 (309)
T ss_dssp             ------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HHHS------CCC
T ss_pred             ------CCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH----HHHC------CCC
T ss_conf             ------731347663688998346788867214545589999999878899999799999999----9828------999


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             55578651899999999997654378688999989999
Q 003599          715 FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       715 ~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      .+..    .....++.+++.+||+.||++|||++|+++
T Consensus       233 ~~~~----~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         233 ALQS----GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             CCSC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCC----CCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf             8887----888999999999977379657918999971

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=344.10  Aligned_cols=264  Identities=26%  Similarity=0.373  Sum_probs=214.0

Q ss_pred             HHCCCCCCCCCCCCCCEEEEEEEEC------CCCEEEEEEECCCC-CCCHHHHHHHHHHHHHC-CCCCEEEEEEEEEECC
Q ss_conf             8428754685333696318989933------99699999914446-20489999999999823-6872456853897188
Q 003599          480 ATNNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGE  551 (808)
Q Consensus       480 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~  551 (808)
                      ..++|++.+.||+|+||.||+|++.      .+..||||+++... .....+|.+|+.++.++ +||||++++|++.+..
T Consensus        21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~  100 (311)
T d1t46a_          21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (311)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECC
T ss_conf             78996985498206882999999806644778869999998742487799999999999876269998878998983199


Q ss_pred             EEEEEEEECCCCCCHHHCCCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEE
Q ss_conf             3489998268999000103889---------------8876792428989999998879867239984780777989667
Q 003599          552 EKMLIYEYMPNRSLDALLFDPL---------------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNIL  616 (808)
Q Consensus       552 ~~~lV~E~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIl  616 (808)
                      ..++||||+++|+|.++++...               ....+++..+.+++.||++||+|||.++   ++||||||+|||
T Consensus       101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl  177 (311)
T d1t46a_         101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL  177 (311)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred             EEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCCC
T ss_conf             78999973799879999985356654444453322233458899999999999999999887579---266624102100


Q ss_pred             ECCCCCEEEECCCCCEECCCCCCCCCCCCEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCC-CCCCCCCHHH
Q ss_conf             479998033113661003899986543310025786591110269878545478326878998748989-8877782125
Q 003599          617 LDEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKN-TSFFEDDLTI  695 (808)
Q Consensus       617 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p-~~~~~~~~~~  695 (808)
                      ++.++.+||+|||+++...............||+.|+|||.+..+.++.++||||||+++|||+|++.| +........+
T Consensus       178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~  257 (311)
T d1t46a_         178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF  257 (311)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred             CCCCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHH
T ss_conf             00257521023401023367886158620135968767788617999974001025899999985899887789989999


Q ss_pred             HHHHHHHHCCCCCHHCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf             55655541023210102775557865189999999999765437868899998999998102358
Q 003599          696 LGYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRD  760 (808)
Q Consensus       696 ~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~~~  760 (808)
                      ...    ...+.     .+.     .+...+.++.+|+.+||+.+|++||+|++|+++|++.+.+
T Consensus       258 ~~~----i~~~~-----~~~-----~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         258 YKM----IKEGF-----RML-----SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             HHH----HHHTC-----CCC-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHH----HHCCC-----CCC-----CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf             999----86689-----889-----8543659999999997577965792999999999876534

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=338.99  Aligned_cols=251  Identities=24%  Similarity=0.290  Sum_probs=205.2

Q ss_pred             HCCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCC------CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEE
Q ss_conf             428754685333696318989933-99699999914446------20489999999999823687245685389718834
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS------GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEK  553 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~  553 (808)
                      .++|++.+.||+|+||.||+|+.. +++.||||++.+..      ....+.+.+|+.++++++||||+++++++.+....
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEE
T ss_conf             56779827981178959999999999989999998756632134068999999999999867998999388999979989


Q ss_pred             EEEEEECCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC----CEEEECCC
Q ss_conf             89998268999000103889887679242898999999887986723998478077798966747999----80331136
Q 003599          554 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL----NPKISDFG  629 (808)
Q Consensus       554 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Dfg  629 (808)
                      ++||||+++|+|.+++..   .+.+++..+..++.|++.||.|||+.+   |+||||||+|||++.++    .+||+|||
T Consensus        89 ~iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          89 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEECCCCCCCCCHHCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCEEEEECCCCCCCCEEECCHH
T ss_conf             999986778643100103---564215578999999999987666254---22113330127982589866646964334


Q ss_pred             CCEECCCCCCCCCCCCEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCH
Q ss_conf             61003899986543310025786591110269878545478326878998748989887778212555655541023210
Q 003599          630 MAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKIL  709 (808)
Q Consensus       630 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  709 (808)
                      +++.......   .....|++.|+|||++.+..++.++||||+|+++|||++|+.||............    . ...  
T Consensus       163 ~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i----~-~~~--  232 (293)
T d1jksa_         163 LAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV----S-AVN--  232 (293)
T ss_dssp             TCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----H-TTC--
T ss_pred             HHHHCCCCCC---CCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHH----H-HCC--
T ss_conf             4210577763---12247777430999981899997665221409999997088998899999999999----8-168--


Q ss_pred             HCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             1027755578651899999999997654378688999989999
Q 003599          710 ALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       710 ~~id~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                          .... ..........+.+++.+||+.||++|||++|+++
T Consensus       233 ----~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         233 ----YEFE-DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             ----CCCC-HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ----CCCC-CHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             ----8887-0104788999999999986389668919999961

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=340.38  Aligned_cols=248  Identities=23%  Similarity=0.271  Sum_probs=206.1

Q ss_pred             HCCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCC---CCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEE
Q ss_conf             428754685333696318989933-9969999991444---620489999999999823687245685389718834899
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI  556 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  556 (808)
                      .++|.+.+.||+|+||.||+++.+ +++.||+|++++.   .....+.+.+|+.+|++++||||+++++++.+.+..++|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf             47428988983176849999999899989999998156544979999999999999867999887787640356421110


Q ss_pred             EEECCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEECCC
Q ss_conf             98268999000103889887679242898999999887986723998478077798966747999803311366100389
Q 003599          557 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  636 (808)
Q Consensus       557 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  636 (808)
                      |||+++|+|..++..   ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        84 ~ey~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~  157 (337)
T d1o6la_          84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EECCCCCCHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEEEECCCCCCCCC
T ss_conf             003579860555532---567759999999999965211343159---62246477784765899888820565200356


Q ss_pred             CCCCCCCCCEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCHHCCCCCC
Q ss_conf             99865433100257865911102698785454783268789987489898877782125556555410232101027755
Q 003599          637 NQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL  716 (808)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l  716 (808)
                      ...  ......||+.|+|||++.+..++.++||||+||++|||++|+.||...+.......    .. .+.      .. 
T Consensus       158 ~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~----i~-~~~------~~-  223 (337)
T d1o6la_         158 DGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL----IL-MEE------IR-  223 (337)
T ss_dssp             TTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HH-HCC------CC-
T ss_pred             CCC--CCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCHHHHHHH----HH-CCC------CC-
T ss_conf             786--20551008899666650489888333102230678899878999999699999999----85-289------98-


Q ss_pred             CCCCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH
Q ss_conf             578651899999999997654378688999-----989999
Q 003599          717 SESSFQLDMIIRCIHVGLLCVQELVKDRPN-----MSTVVS  752 (808)
Q Consensus       717 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~ev~~  752 (808)
                          ++.....++.+++.+||+.||++||+     ++++++
T Consensus       224 ----~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         224 ----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ----CCCCCCHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHC
T ss_conf             ----9866899999999866638934422565234999972

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=341.43  Aligned_cols=270  Identities=21%  Similarity=0.283  Sum_probs=203.9

Q ss_pred             HCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHH--HHHHHHHCCCCCEEEEEEEEEECC----EEE
Q ss_conf             42875468533369631898993399699999914446204899999--999998236872456853897188----348
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMN--EVMVISKLQHRNLVRLLGCCVEGE----EKM  554 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~--E~~~l~~l~h~niv~l~g~~~~~~----~~~  554 (808)
                      .++|.+.+.||+|+||.||+|++. ++.||||+++...   .+.+..  |+..+.+++||||+++++++.+..    ..+
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~   77 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW   77 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             CCEEEEEEEEEECCCEEEEEEEEC-CEEEEEEEECCCC---HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEE
T ss_conf             868999889820788199999999-9899999987200---467999999999962799868326889983798604899


Q ss_pred             EEEEECCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-----CCCCEEECCCCCCCEEECCCCCEEEECCC
Q ss_conf             9998268999000103889887679242898999999887986723-----99847807779896674799980331136
Q 003599          555 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD-----SRLRIIHRDLKASNILLDEELNPKISDFG  629 (808)
Q Consensus       555 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-----~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  629 (808)
                      +||||+++|+|.+++.+    ..++|..+++++.|+|.||.|||..     ...+|+||||||+||||+.++.+||+|||
T Consensus        78 lv~Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG  153 (303)
T d1vjya_          78 LVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  153 (303)
T ss_dssp             EEEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEECCCCCCHHHHHHC----CCCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEECC
T ss_conf             99964669898999865----89998999999999999999988766520468986615317313578688776887638


Q ss_pred             CCEECCCCCCCC--CCCCEECCCCCCCHHHHCCCC------CCCCCCEEEHHHHHHHHHHCCCCCCCCCCCHHH-HH---
Q ss_conf             610038999865--433100257865911102698------785454783268789987489898877782125-55---
Q 003599          630 MAKIFGGNQDQA--DTGRVVGTFGYMSPEYAMEGR------FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTI-LG---  697 (808)
Q Consensus       630 la~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~-~~---  697 (808)
                      +++.........  ......||+.|+|||++....      ++.++||||||+++|||+||..|+......... ..   
T Consensus       154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~  233 (303)
T d1vjya_         154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  233 (303)
T ss_dssp             TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred             CCCCCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHCCC
T ss_conf             66234677762001355250354767822105654546777675012201599999996289988766311241012255


Q ss_pred             --HHHHHHCCCCCHHCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCC
Q ss_conf             --6555410232101027755578651899999999997654378688999989999981023
Q 003599          698 --YAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEI  758 (808)
Q Consensus       698 --~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~  758 (808)
                        ...............+|.+.......+.+..+.+++.+||+.||++|||+.||+++|+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~  296 (303)
T d1vjya_         234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             SSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf             643099999987502468887765577689999999999976069858959999999999888

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=341.02  Aligned_cols=261  Identities=29%  Similarity=0.430  Sum_probs=211.3

Q ss_pred             HCCCCCCCCCCCCCCEEEEEEEEC------CCCEEEEEEECCCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEE
Q ss_conf             428754685333696318989933------99699999914446-20489999999999823687245685389718834
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEK  553 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~  553 (808)
                      .++|.+.+.||+|+||.||+|.+.      .+..||||+++... ......|.+|+.++++++||||++++|++......
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCE
T ss_conf             89918835982078818999998786447789689999987012868999999999999976999884125478428810


Q ss_pred             EEEEEECCCCCCHHHCCCC-------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEE
Q ss_conf             8999826899900010388-------988767924289899999988798672399847807779896674799980331
Q 003599          554 MLIYEYMPNRSLDALLFDP-------LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKIS  626 (808)
Q Consensus       554 ~lV~E~~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  626 (808)
                      ++||||+++|+|.+++...       .....+++..+.+++.|+|+||.|||..+   |+||||||+|||+++++++||+
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred             EEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECEECCCCEEECCCCEEEEE
T ss_conf             6777604899889998750332113444688799999999999999999876479---6543286775403599649994


Q ss_pred             CCCCCEECCCCCCCCCCCCEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCC-CCCCCCCCCHHHHHHHHHHHCC
Q ss_conf             136610038999865433100257865911102698785454783268789987489-8988777821255565554102
Q 003599          627 DFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGR-KNTSFFEDDLTILGYAWKLWNE  705 (808)
Q Consensus       627 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~-~p~~~~~~~~~~~~~~~~~~~~  705 (808)
                      |||+++...............|++.|+|||.+.+..++.++||||||+++|||+||+ .|+........ ...    ...
T Consensus       176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~-~~~----i~~  250 (308)
T d1p4oa_         176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV-LRF----VME  250 (308)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH-HHH----HHT
T ss_pred             ECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHH-HHH----HHH
T ss_conf             245420235776303134023163237888873699883334443789999999689999999899999-999----980


Q ss_pred             CCCHHCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf             321010277555786518999999999976543786889999899999810235
Q 003599          706 NKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIR  759 (808)
Q Consensus       706 ~~~~~~id~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~~  759 (808)
                      +....          .+...+..+.+++.+||+.+|++||||++|+++|++.++
T Consensus       251 ~~~~~----------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         251 GGLLD----------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             TCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             CCCCC----------CCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCC
T ss_conf             88888----------863353999999999757796589399999999787617

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=339.38  Aligned_cols=261  Identities=26%  Similarity=0.400  Sum_probs=213.2

Q ss_pred             HCCCCCCCCCCCCCCEEEEEEEECC--------CCEEEEEEECCCCC-CCHHHHHHHHHHHHHC-CCCCEEEEEEEEEEC
Q ss_conf             4287546853336963189899339--------96999999144462-0489999999999823-687245685389718
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLKD--------GQEIAVKRLSKASG-QGLEEFMNEVMVISKL-QHRNLVRLLGCCVEG  550 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~  550 (808)
                      .++|.+.+.||+|+||.||+|+...        +..||||+++.... ....++.+|...+.++ +||||+++++++.+.
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCCC
T ss_conf             89969700985167828999998578755566754999999881128688999999999999813999697346522018


Q ss_pred             CEEEEEEEECCCCCCHHHCCCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEE
Q ss_conf             83489998268999000103889-------------88767924289899999988798672399847807779896674
Q 003599          551 EEKMLIYEYMPNRSLDALLFDPL-------------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL  617 (808)
Q Consensus       551 ~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll  617 (808)
                      ...++||||+++|+|.+++....             ....+++.++++++.|++.||.|||+.+   |+||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             CEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECCCCEEE
T ss_conf             8689999736999099999860677643222334574346799999999999999998766379---7863022102245


Q ss_pred             CCCCCEEEECCCCCEECCCCCCCCCCCCEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCHHHH
Q ss_conf             7999803311366100389998654331002578659111026987854547832687899874-898988777821255
Q 003599          618 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTIL  696 (808)
Q Consensus       618 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~  696 (808)
                      +.++.+||+|||+++...............+++.|+|||.+.++.++.++||||||+++|||++ |..||...... .+.
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~-~~~  247 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-ELF  247 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-HHH
T ss_pred             CCCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCHH-HHH
T ss_conf             4789767622111011355555431466788846632667517988825554775888887401798989999999-999


Q ss_pred             HHHHHHHCCCCCHHCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf             565554102321010277555786518999999999976543786889999899999810235
Q 003599          697 GYAWKLWNENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIR  759 (808)
Q Consensus       697 ~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~~  759 (808)
                          .....+..     +.     .+...+.++.+++.+|++.+|.+|||+.||+++|++++.
T Consensus       248 ----~~i~~~~~-----~~-----~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         248 ----KLLKEGHR-----MD-----KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             ----HHHHTTCC-----CC-----CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----HHHHCCCC-----CC-----CCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf             ----99972888-----89-----874352999999999766797679399999999988860

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=0  Score=336.03  Aligned_cols=245  Identities=28%  Similarity=0.363  Sum_probs=203.9

Q ss_pred             CCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCC---CCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf             28754685333696318989933-9969999991444---6204899999999998236872456853897188348999
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  557 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  557 (808)
                      ++|++.+.||+|+||.||+++.+ +++.||||++++.   .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEEE
T ss_conf             47088889720768089999998999799999984577548899999999999998636967533035685288005676


Q ss_pred             EECCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEECCCC
Q ss_conf             82689990001038898876792428989999998879867239984780777989667479998033113661003899
Q 003599          558 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  637 (808)
Q Consensus       558 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  637 (808)
                      ||+++|+|..++.   ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        84 E~~~gg~l~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          84 DYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             CCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             EECCCCCCCCCCC---CCCCCCCCHHHHHHHHHHHHHHHHCCCC---EECCCCCCHHEEECCCCCEEEECCCCCEEECCC
T ss_conf             5037863223432---2221110079999999987655412476---770556810503868998898317521671245


Q ss_pred             CCCCCCCCEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCHHCCCCCCC
Q ss_conf             98654331002578659111026987854547832687899874898988777821255565554102321010277555
Q 003599          638 QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS  717 (808)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~  717 (808)
                           .....||+.|+|||++.+..++.++||||+||++|||+||+.||...+......    .... +.      .   
T Consensus       158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~----~i~~-~~------~---  218 (316)
T d1fota_         158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE----KILN-AE------L---  218 (316)
T ss_dssp             -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH----HHHH-CC------C---
T ss_pred             -----CCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCHHHHHH----HHHC-CC------C---
T ss_conf             -----643457634359999838999804304653336899975989999969999999----9970-89------8---


Q ss_pred             CCCCCHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHHH
Q ss_conf             7865189999999999765437868899-----99899999
Q 003599          718 ESSFQLDMIIRCIHVGLLCVQELVKDRP-----NMSTVVSM  753 (808)
Q Consensus       718 ~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~ev~~~  753 (808)
                        ..+.....++.+++.+|++.+|.+||     +++++++.
T Consensus       219 --~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         219 --RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             --CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             --CCCCCCCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHCC
T ss_conf             --899778999999999995449976664310219999819

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=335.10  Aligned_cols=253  Identities=19%  Similarity=0.220  Sum_probs=198.9

Q ss_pred             HCCCCCCC-CCCCCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHC-CCCCEEEEEEEEEE----CCEE
Q ss_conf             42875468-5333696318989933-9969999991444620489999999999823-68724568538971----8834
Q 003599          481 TNNFQLSS-KLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVE----GEEK  553 (808)
Q Consensus       481 ~~~~~~~~-~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~----~~~~  553 (808)
                      .++|.+.. .||+|+||.||+|+.. +++.||||+++.     ...+.+|+.++.++ +||||+++++++.+    ....
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECC-----CHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCEE
T ss_conf             14879810796545486999999889998999999897-----4779999999998669999782989995034689789


Q ss_pred             EEEEEECCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC---CCCEEEECCCC
Q ss_conf             899982689990001038898876792428989999998879867239984780777989667479---99803311366
Q 003599          554 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE---ELNPKISDFGM  630 (808)
Q Consensus       554 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfgl  630 (808)
                      ++||||+++|+|.+++... ....+++.++..++.|++.||.|||+.+   |+||||||+|||++.   .+.+||+|||+
T Consensus        85 ~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~  160 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  160 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEECCCCCCHHHHHHHC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCE
T ss_conf             9999778998499999862-7877579999999999999999999769---86444100220113555566311354551


Q ss_pred             CEECCCCCCCCCCCCEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCHH
Q ss_conf             10038999865433100257865911102698785454783268789987489898877782125556555410232101
Q 003599          631 AKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILA  710 (808)
Q Consensus       631 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  710 (808)
                      ++.......   .....||+.|+|||++.+..++.++|||||||++|||+||+.||.................       
T Consensus       161 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~-------  230 (335)
T d2ozaa1         161 AKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR-------  230 (335)
T ss_dssp             CEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCC-------
T ss_pred             EEECCCCCC---CCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHH-------
T ss_conf             233368886---4322677563792777489888888887645167788658899889887788999999985-------


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf             0277555786518999999999976543786889999899999
Q 003599          711 LVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       711 ~id~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                      ....... .........++.+++.+|++.||++||+++|+++.
T Consensus       231 ~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         231 MGQYEFP-NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             SCSSSCC-TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCCCCCC-CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             3888889-85434699999999999756996579099999709

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=0  Score=336.16  Aligned_cols=248  Identities=25%  Similarity=0.293  Sum_probs=197.5

Q ss_pred             CCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCC---CCCHHHHHHH---HHHHHHCCCCCEEEEEEEEEECCEEE
Q ss_conf             28754685333696318989933-99699999914446---2048999999---99998236872456853897188348
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNE---VMVISKLQHRNLVRLLGCCVEGEEKM  554 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E---~~~l~~l~h~niv~l~g~~~~~~~~~  554 (808)
                      ++|.+.+.||+|+||.||+|+.. +++.||||++.+..   ......+.+|   +.+++.++||||+++++++.+.+..+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEE
T ss_conf             76851018842889099999999999799999984587542667999999999999985089985889999999899889


Q ss_pred             EEEEECCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEEC
Q ss_conf             99982689990001038898876792428989999998879867239984780777989667479998033113661003
Q 003599          555 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF  634 (808)
Q Consensus       555 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  634 (808)
                      +||||+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+
T Consensus        84 ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             EEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EEEEECCCCCHHHHHHH---CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCEEECCCEEEECCCCCEEEEEECEEEEC
T ss_conf             99991489838999873---255327899999999999999999779---622044422167858896798220102333


Q ss_pred             CCCCCCCCCCCEECCCCCCCHHHHCC-CCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCHHCCC
Q ss_conf             89998654331002578659111026-98785454783268789987489898877782125556555410232101027
Q 003599          635 GGNQDQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVD  713 (808)
Q Consensus       635 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id  713 (808)
                      ....    .....||+.|+|||++.. ..++.++|||||||++|||+||+.||.......... ....         ...
T Consensus       158 ~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~~~~---------~~~  223 (364)
T d1omwa3         158 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRM---------TLT  223 (364)
T ss_dssp             SSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH-HHHH---------SSS
T ss_pred             CCCC----CCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHH-HHHH---------CCC
T ss_conf             7886----4331134554216876038999844104677899999985999888899899999-9986---------046


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH
Q ss_conf             755578651899999999997654378688999-----989999
Q 003599          714 PFLSESSFQLDMIIRCIHVGLLCVQELVKDRPN-----MSTVVS  752 (808)
Q Consensus       714 ~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~ev~~  752 (808)
                      ...   ..+.....++.+++.+||+.||++||+     ++++++
T Consensus       224 ~~~---~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         224 MAV---ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             CCC---CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             CCC---CCCCCCCHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHC
T ss_conf             888---78877899999999998566988808874357999974

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=340.93  Aligned_cols=257  Identities=23%  Similarity=0.335  Sum_probs=208.3

Q ss_pred             HCCCCCCCCCCCCCCEEEEEEEECC----CCEEEEEEECCCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEE
Q ss_conf             4287546853336963189899339----9699999914446-2048999999999982368724568538971883489
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLKD----GQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML  555 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  555 (808)
                      .++|.+.+.||+|+||.||+|++..    +..||||.++... ....+.|.+|+.++++++||||++++|++. .+..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCEEEE
T ss_conf             8996987799307882999999936996449999999365668799999999999998689999856988995-374799


Q ss_pred             EEEECCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEECC
Q ss_conf             99826899900010388988767924289899999988798672399847807779896674799980331136610038
Q 003599          556 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG  635 (808)
Q Consensus       556 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  635 (808)
                      ||||+++|+|..++..  ....+++..++.++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||+++...
T Consensus        85 v~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~  159 (273)
T d1mp8a_          85 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME  159 (273)
T ss_dssp             EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEEECCCCCHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHCCCC---EECCCCCHHHEEECCCCCEEECCCHHHEECC
T ss_conf             9984069807765422--4789999999999999987752302267---4414102655320678967876503421336


Q ss_pred             CCCCCCCCCCEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCHHHHHHHHHHHCCCCCHHCCCC
Q ss_conf             9998654331002578659111026987854547832687899874-898988777821255565554102321010277
Q 003599          636 GNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDP  714 (808)
Q Consensus       636 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~  714 (808)
                      ..... ......||+.|+|||.+....++.++||||||+++|||+| |++|+.......... .    ...+...     
T Consensus       160 ~~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~-~----i~~~~~~-----  228 (273)
T d1mp8a_         160 DSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG-R----IENGERL-----  228 (273)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH-H----HHTTCCC-----
T ss_pred             CCCCE-ECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHH-H----HHCCCCC-----
T ss_conf             77623-30540058310326675169988745244424789999826999988899999999-9----9818999-----


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf             555786518999999999976543786889999899999810235
Q 003599          715 FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIR  759 (808)
Q Consensus       715 ~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~~  759 (808)
                           +.+...+.++.+++.+||+.||++|||+++|++.|+.+.+
T Consensus       229 -----~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  268 (273)
T d1mp8a_         229 -----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  268 (273)
T ss_dssp             -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf             -----8987779999999999768797689299999999999977

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=341.55  Aligned_cols=249  Identities=29%  Similarity=0.399  Sum_probs=204.2

Q ss_pred             CCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEEC-CEEEEEEEEC
Q ss_conf             287546853336963189899339969999991444620489999999999823687245685389718-8348999826
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG-EEKMLIYEYM  560 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~~lV~E~~  560 (808)
                      ++|++.+.||+|+||.||+|+++ +..||||+++..  ...+.|.+|++++++++||||++++|++.+. +..++||||+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~   83 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   83 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             HHEEEEEEEECCCCEEEEEEEEC-CEEEEEEEECCH--HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEECC
T ss_conf             99488579820798089999999-909999998857--779999999999986789898549878872389289999636


Q ss_pred             CCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEECCCCCCC
Q ss_conf             89990001038898876792428989999998879867239984780777989667479998033113661003899986
Q 003599          561 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  640 (808)
Q Consensus       561 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  640 (808)
                      ++|+|.+++... ....+++..+++++.||+.||.|||+.+   ++||||||+|||++.++.+||+|||+++......  
T Consensus        84 ~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~--  157 (262)
T d1byga_          84 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  157 (262)
T ss_dssp             TTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CCCCHHHHHHHC-CCCCCCHHHHHHHHHHHHHHCCCCCCCC---EECCCCCHHHHEECCCCCEEECCCCCCEECCCCC--
T ss_conf             999899998745-7888899999999999985232113376---5536665676014689977632456003447877--


Q ss_pred             CCCCCEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCHHHHHHHHHHHCCCCCHHCCCCCCCCC
Q ss_conf             54331002578659111026987854547832687899874-89898877782125556555410232101027755578
Q 003599          641 ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLSES  719 (808)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~  719 (808)
                         ....++..|+|||++.++.++.++||||||+++|||+| |+.|+...... .+....    ..+     ..+.    
T Consensus       158 ---~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~-~~~~~i----~~~-----~~~~----  220 (262)
T d1byga_         158 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-DVVPRV----EKG-----YKMD----  220 (262)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-GHHHHH----TTT-----CCCC----
T ss_pred             ---CCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHH-HHHHHH----HCC-----CCCC----
T ss_conf             ---65566646778178727988858877757999999997899999999999-999999----808-----9999----


Q ss_pred             CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHC
Q ss_conf             65189999999999765437868899998999998102
Q 003599          720 SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  757 (808)
Q Consensus       720 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~  757 (808)
                       .+.....++.+++.+|++.||++||||.+|+++|+.+
T Consensus       221 -~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i  257 (262)
T d1byga_         221 -APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  257 (262)
T ss_dssp             -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             -9765799999999997566976893999999999999

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=335.48  Aligned_cols=244  Identities=23%  Similarity=0.283  Sum_probs=204.3

Q ss_pred             CCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCC---CCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf             28754685333696318989933-9969999991444---6204899999999998236872456853897188348999
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY  557 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  557 (808)
                      ++|++.+.||+|+||.||+++.+ +++.||||++.+.   .....+.+.+|+.++++++||||+++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCC
T ss_conf             37089889611768089999998999899999982677458899999999999999748772740344443222223222


Q ss_pred             EECCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEECCCC
Q ss_conf             82689990001038898876792428989999998879867239984780777989667479998033113661003899
Q 003599          558 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN  637 (808)
Q Consensus       558 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  637 (808)
                      ||+.+|+|..++..   .+.+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       121 e~~~~g~l~~~l~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             CCCCCCCHHHHHHH---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHCCCCCCCCEEEEECEEEEECCCC
T ss_conf             23346622666751---589899999999999999899998599---861767999936077897886101033322566


Q ss_pred             CCCCCCCCEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCHHCCCCCCC
Q ss_conf             98654331002578659111026987854547832687899874898988777821255565554102321010277555
Q 003599          638 QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS  717 (808)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~  717 (808)
                           .....||+.|+|||++.+..++.++|||||||++|||+||+.||..........    .... +.      +.  
T Consensus       195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~----~i~~-~~------~~--  256 (350)
T d1rdqe_         195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE----KIVS-GK------VR--  256 (350)
T ss_dssp             -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHH-CC------CC--
T ss_pred             -----CCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHH----HHHC-CC------CC--
T ss_conf             -----643367635678899717998853311450078999975889989959999999----9861-79------88--


Q ss_pred             CCCCCHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHH
Q ss_conf             7865189999999999765437868899-----9989999
Q 003599          718 ESSFQLDMIIRCIHVGLLCVQELVKDRP-----NMSTVVS  752 (808)
Q Consensus       718 ~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~ev~~  752 (808)
                         .+.....++.+++.+||+.||.+|+     +++++++
T Consensus       257 ---~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         257 ---FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ---CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ---CCCCCCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHC
T ss_conf             ---9766899999999998340998606553454999971

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=340.20  Aligned_cols=256  Identities=28%  Similarity=0.392  Sum_probs=206.9

Q ss_pred             CCCCCCCCCCCCCCEEEEEEEECC--C--CEEEEEEECCC---CCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEE
Q ss_conf             287546853336963189899339--9--69999991444---6204899999999998236872456853897188348
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLKD--G--QEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKM  554 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~~--~--~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~  554 (808)
                      ++|++.+.||+|+||.||+|+...  +  ..||||++.+.   ..+..++|.+|+.++++++||||++++|++.+ ...+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCHH
T ss_conf             891997898038883999999988999079999999983555798999999999999986899998789877740-1001


Q ss_pred             EEEEECCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEEC
Q ss_conf             99982689990001038898876792428989999998879867239984780777989667479998033113661003
Q 003599          555 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF  634 (808)
Q Consensus       555 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  634 (808)
                      +||||+++|++.+.+..  +...+++..++.++.|+|+||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        87 lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             EEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEEECCCCHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECHHHHCCCCCCCEEECCCHHHHHC
T ss_conf             14654238612544421--2689999999999999999998752178---752056688815655654332561155530


Q ss_pred             CCCCCCC-CCCCEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCHHHHHHHHHHHCCCCCHHCC
Q ss_conf             8999865-4331002578659111026987854547832687899874-8989887778212555655541023210102
Q 003599          635 GGNQDQA-DTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVS-GRKNTSFFEDDLTILGYAWKLWNENKILALV  712 (808)
Q Consensus       635 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  712 (808)
                      ....... ......|+..|+|||.+.+..++.++||||||+++|||+| |+.||..........    .....+..    
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~----~i~~~~~~----  233 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH----KIDKEGER----  233 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH----HHHTSCCC----
T ss_pred             CCCCCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH----HHHHCCCC----
T ss_conf             3588752654763257310799998379999421566148999999968999999969999999----99847999----


Q ss_pred             CCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHC
Q ss_conf             775557865189999999999765437868899998999998102
Q 003599          713 DPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSE  757 (808)
Q Consensus       713 d~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~  757 (808)
                       +     +.+...+..+.+++.+||+.+|++||||.+|+++|.+.
T Consensus       234 -~-----~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         234 -L-----PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             -C-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -C-----CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHC
T ss_conf             -9-----98544539999999997688966792999999999964

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=332.15  Aligned_cols=251  Identities=19%  Similarity=0.258  Sum_probs=204.4

Q ss_pred             HCCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEE
Q ss_conf             428754685333696318989933-9969999991444620489999999999823687245685389718834899982
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  559 (808)
                      -++|.+.+.||+|+||.||+|... +++.||+|.++... .....+.+|+.+|++++||||+++++++.+.+..++||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEC
T ss_conf             010588789831778399999998999699999975786-6599999999999857997989098999889988999953


Q ss_pred             CCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC--CCCEEEECCCCCEECCCC
Q ss_conf             689990001038898876792428989999998879867239984780777989667479--998033113661003899
Q 003599          560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE--ELNPKISDFGMAKIFGGN  637 (808)
Q Consensus       560 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfgla~~~~~~  637 (808)
                      +++|+|.+++..  ....+++.++..++.||+.||.|||+.+   |+||||||+|||++.  ...+||+|||+++.....
T Consensus        83 ~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~  157 (321)
T d1tkia_          83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEECCCCCEEEEECCCCHHHCCCCC
T ss_conf             899808899875--3899999999999999999999998769---97513554443443788518997644111003467


Q ss_pred             CCCCCCCCEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCHHCCCCCCC
Q ss_conf             98654331002578659111026987854547832687899874898988777821255565554102321010277555
Q 003599          638 QDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFLS  717 (808)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~  717 (808)
                      .   ......+++.|+|||...+..++.++||||+||++|||++|+.||...........    .....       ....
T Consensus       158 ~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~----i~~~~-------~~~~  223 (321)
T d1tkia_         158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIEN----IMNAE-------YTFD  223 (321)
T ss_dssp             C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH----HHHTC-------CCCC
T ss_pred             C---CCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCHHHHHHH----HHHCC-------CCCC
T ss_conf             7---53212233222340210487778401130279999999828999999899999999----98389-------9988


Q ss_pred             CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             78651899999999997654378688999989999
Q 003599          718 ESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       718 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      . ........++.+++.+|++.||++||+++|+++
T Consensus       224 ~-~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         224 E-EAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             H-HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             H-HHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             0-223678999999999986699668909999963

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=0  Score=332.86  Aligned_cols=259  Identities=23%  Similarity=0.321  Sum_probs=209.1

Q ss_pred             HCCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCC---CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECC----E
Q ss_conf             428754685333696318989933-99699999914446---204899999999998236872456853897188----3
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE----E  552 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~  552 (808)
                      .++|.+.+.||+|+||.||+|+.. +++.||||+++...   ....+.+.+|+.++++++||||+++++++....    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCE
T ss_conf             62069868996089929999999999989999998556646989999999999999856999887311435432688766


Q ss_pred             EEEEEEECCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCE
Q ss_conf             48999826899900010388988767924289899999988798672399847807779896674799980331136610
Q 003599          553 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK  632 (808)
Q Consensus       553 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  632 (808)
                      .++||||+++|+|..++..   .+.+++.++..++.||+.||.|||+.+   |+||||||+|||++.++..+++|||.+.
T Consensus        86 ~~lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEEEEECCCCCEEHHHHCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCEEEHHHHHH
T ss_conf             9999977889871011203---589999999999999999999998579---5276346755665754320100344432


Q ss_pred             ECCCCCC-CCCCCCEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCHHC
Q ss_conf             0389998-654331002578659111026987854547832687899874898988777821255565554102321010
Q 003599          633 IFGGNQD-QADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILAL  711 (808)
Q Consensus       633 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  711 (808)
                      ....... ........||+.|+|||++.+..++.++||||||+++|||+||+.||..........    ........   
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~----~~~~~~~~---  232 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY----QHVREDPI---  232 (277)
T ss_dssp             ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH----HHHHCCCC---
T ss_pred             HHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCHHHHHH----HHHHCCCC---
T ss_conf             21235443333464257624369999839999966320265289999976979989969999999----99846999---


Q ss_pred             CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCC-CHHHHHHHHHHC
Q ss_conf             2775557865189999999999765437868899-998999998102
Q 003599          712 VDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRP-NMSTVVSMLNSE  757 (808)
Q Consensus       712 id~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RP-s~~ev~~~L~~~  757 (808)
                       .+..    .....+.++.+++.+|++.||++|| +++++.+.|.++
T Consensus       233 -~~~~----~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~  274 (277)
T d1o6ya_         233 -PPSA----RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  274 (277)
T ss_dssp             -CGGG----TSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             -CCCH----HCCCCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHHH
T ss_conf             -9710----03478999999999986679767773999999999997

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-44  Score=323.34  Aligned_cols=274  Identities=22%  Similarity=0.204  Sum_probs=202.7

Q ss_pred             CCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCCCC-----CHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEEC
Q ss_conf             685333696318989933-9969999991444620-----4899999999998236872456853897188348999826
Q 003599          487 SSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQ-----GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM  560 (808)
Q Consensus       487 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  560 (808)
                      .++||+|+||+||+|+.. +++.||||+++.....     ..+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             CEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHHH
T ss_conf             63851272829999999999969999998420212456799999999999998679999868985422587402204553


Q ss_pred             CCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEECCCCCCC
Q ss_conf             89990001038898876792428989999998879867239984780777989667479998033113661003899986
Q 003599          561 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ  640 (808)
Q Consensus       561 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  640 (808)
                      .++++.....   ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++........
T Consensus        83 ~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~  156 (299)
T d1ua2a_          83 ETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA  156 (299)
T ss_dssp             SEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred             CCHHHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             4507765541---2667789999999999999998863163---550357762588537784114657610005787554


Q ss_pred             CCCCCEECCCCCCCHHHHCCC-CCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCC---CH------H
Q ss_conf             543310025786591110269-8785454783268789987489898877782125556555410232---10------1
Q 003599          641 ADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENK---IL------A  710 (808)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~------~  710 (808)
                        .....||+.|+|||.+... .++.++||||+||++|||+||+.||....+...+..... ......   ..      .
T Consensus       157 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~-~~~~~~~~~~~~~~~~~~  233 (299)
T d1ua2a_         157 --YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFE-TLGTPTEEQWPDMCSLPD  233 (299)
T ss_dssp             --CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-HHCCCCTTTSSSTTSSTT
T ss_pred             --CCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHHHHHHHHH-HCCCCCHHHCCCHHCCCH
T ss_conf             --33020473336399972677888056436304289999859699999999999999998-518997254521000213


Q ss_pred             CCC-CCCCCCC---CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf             027-7555786---518999999999976543786889999899999810235899999997534
Q 003599          711 LVD-PFLSESS---FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPAFTE  771 (808)
Q Consensus       711 ~id-~~l~~~~---~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~~~~~~~~~p~~~~  771 (808)
                      ... ......+   .......++.+++.+|++.||++|||++|+++.  .-+++.+.|..+...|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H--p~f~~~p~p~~~~~~p  296 (299)
T d1ua2a_         234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM--KYFSNRPGPTPGCQLP  296 (299)
T ss_dssp             CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS--GGGTSSSCCCCSSSSC
T ss_pred             HHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC--HHHCCCCCCCCCCCCC
T ss_conf             44303478988678565689999999999763894569089999679--9657899998988899

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=334.09  Aligned_cols=247  Identities=27%  Similarity=0.383  Sum_probs=202.7

Q ss_pred             CCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCC---CCCCHHHHHHHHHHHH-HCCCCCEEEEEEEEEECCEEEEE
Q ss_conf             28754685333696318989933-9969999991444---6204899999999998-23687245685389718834899
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVIS-KLQHRNLVRLLGCCVEGEEKMLI  556 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~-~l~h~niv~l~g~~~~~~~~~lV  556 (808)
                      ++|.+.+.||+|+||+||+|+.. +++.||||++++.   .....+.+..|..++. .++||||+++++++.+++..++|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEE
T ss_conf             97188658940878289999999999899999980555338489999999999999847999687898897049831677


Q ss_pred             EEECCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEECCC
Q ss_conf             98268999000103889887679242898999999887986723998478077798966747999803311366100389
Q 003599          557 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG  636 (808)
Q Consensus       557 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  636 (808)
                      |||+++|+|.+++..   ...+++.++..++.||+.||.|||+++   ++||||||+|||+++++.+||+|||+++....
T Consensus        82 mEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          82 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEECCCCCHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCEEECCCCCEECCCCCHHHHCCC
T ss_conf             750379808998640---478999999999999999999998689---34034765404444899630155530232356


Q ss_pred             CCCCCCCCCEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCHHCCCCCC
Q ss_conf             99865433100257865911102698785454783268789987489898877782125556555410232101027755
Q 003599          637 NQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILALVDPFL  716 (808)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l  716 (808)
                      ...  ......||+.|+|||++.+..++.++||||+||++|||+||+.||..........    ... .+      .+. 
T Consensus       156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~----~i~-~~------~~~-  221 (320)
T d1xjda_         156 GDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH----SIR-MD------NPF-  221 (320)
T ss_dssp             TTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHH-HC------CCC-
T ss_pred             CCC--CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH----HHH-CC------CCC-
T ss_conf             653--3454578777689999827998832320112278989873889999989999999----997-18------998-


Q ss_pred             CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHH-HHHH
Q ss_conf             57865189999999999765437868899998-9999
Q 003599          717 SESSFQLDMIIRCIHVGLLCVQELVKDRPNMS-TVVS  752 (808)
Q Consensus       717 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~-ev~~  752 (808)
                          .+.....++.+++.+|++.||++||+++ ++++
T Consensus       222 ----~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         222 ----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             ----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ----CCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHH
T ss_conf             ----975679999999999654489878388999980

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=4.2e-45  Score=326.59  Aligned_cols=250  Identities=23%  Similarity=0.306  Sum_probs=203.2

Q ss_pred             CCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCCCC---------CHHHHHHHHHHHHHCC-CCCEEEEEEEEEEC
Q ss_conf             28754685333696318989933-9969999991444620---------4899999999998236-87245685389718
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQ---------GLEEFMNEVMVISKLQ-HRNLVRLLGCCVEG  550 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~---------~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~  550 (808)
                      ++|++.+.||+|+||.||+++.. +++.||||++.+....         ..+.+.+|+.++++++ ||||+++++++.+.
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             CCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCC
T ss_conf             63888528841768499999999999899999996244641147888999999999999999850799747997621467


Q ss_pred             CEEEEEEEECCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCC
Q ss_conf             83489998268999000103889887679242898999999887986723998478077798966747999803311366
Q 003599          551 EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGM  630 (808)
Q Consensus       551 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  630 (808)
                      +..++||||+++|+|.+++..   .+.+++.++..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             CCEEEEEECCCCCHHHHHHHH---CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCHH
T ss_conf             605999976898668999986---599999999999999999999998759---94323462548986899838712403


Q ss_pred             CEECCCCCCCCCCCCEECCCCCCCHHHHCC------CCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHC
Q ss_conf             100389998654331002578659111026------98785454783268789987489898877782125556555410
Q 003599          631 AKIFGGNQDQADTGRVVGTFGYMSPEYAME------GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN  704 (808)
Q Consensus       631 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~  704 (808)
                      ++.+.....   .....||..|+|||++..      ..++.++||||+|+++|||++|+.||....+.....    ... 
T Consensus       157 a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~----~i~-  228 (277)
T d1phka_         157 SCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR----MIM-  228 (277)
T ss_dssp             CEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHH-
T ss_pred             EEECCCCCC---EEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCHHHHHH----HHH-
T ss_conf             167268872---134524678889888605344567889923318565602310322888988999999999----998-


Q ss_pred             CCCCHHCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             232101027755578651899999999997654378688999989999
Q 003599          705 ENKILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       705 ~~~~~~~id~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      .+..    .  .. .........++.+++.+|++.+|++||+++||++
T Consensus       229 ~~~~----~--~~-~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         229 SGNY----Q--FG-SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HTCC----C--CC-TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HCCC----C--CC-CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             1898----8--89-8543468999999999976589668919999973

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-45  Score=324.53  Aligned_cols=265  Identities=21%  Similarity=0.307  Sum_probs=202.0

Q ss_pred             CCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCC--CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEE
Q ss_conf             28754685333696318989933-99699999914446--2048999999999982368724568538971883489998
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  558 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  558 (808)
                      ++|++.+.||+|+||.||+|+.. +++.||||+++...  ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf             99776517723768099999999999799999980222575899999999999986799838874453322432037886


Q ss_pred             ECCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEECCCCC
Q ss_conf             26899900010388988767924289899999988798672399847807779896674799980331136610038999
Q 003599          559 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  638 (808)
Q Consensus       559 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  638 (808)
                      |+.++.+......  ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||.++......
T Consensus        82 ~~~~~~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~  156 (298)
T d1gz8a_          82 FLHQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  156 (298)
T ss_dssp             CCSEEHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred             ECCCCHHHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCCHHEEECCCCCCEECCCCCCEECCCCC
T ss_conf             2377445554420--2568888999999999999999865288---9921357114011346762103578613436886


Q ss_pred             CCCCCCCEECCCCCCCHHHHCCCC-CCCCCCEEEHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCC-C----CCHHC-
Q ss_conf             865433100257865911102698-7854547832687899874898988777821255565554102-3----21010-
Q 003599          639 DQADTGRVVGTFGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNE-N----KILAL-  711 (808)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~-~----~~~~~-  711 (808)
                      ..  .....|++.|+|||.+.... ++.++||||+|+++|+|++|+.||...++...+.......... .    ..... 
T Consensus       157 ~~--~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  234 (298)
T d1gz8a_         157 RT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP  234 (298)
T ss_dssp             BC--TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             CC--CEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCCCCCC
T ss_conf             41--0010365215411221366577742210333313427966879989889999999999832898333144422242


Q ss_pred             -CCCC---CCCCC---CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf             -2775---55786---518999999999976543786889999899999
Q 003599          712 -VDPF---LSESS---FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       712 -id~~---l~~~~---~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                       ....   .....   .......++.+++.+|++.||++|||++|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             1243454322220444166789999999999763995579189999678

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.2e-44  Score=321.20  Aligned_cols=263  Identities=21%  Similarity=0.309  Sum_probs=204.5

Q ss_pred             CCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEECCCC--CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEE
Q ss_conf             2875468533369631898993399699999914446--20489999999999823687245685389718834899982
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  559 (808)
                      ++|.+.++||+|+||+||+|+.++++.||||++....  ....+.+.+|+.++++++||||+++++++...+..++++|+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEEE
T ss_conf             99634318722778189999968999999999812326858999999999999867998687660120467731589974


Q ss_pred             CCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEECCCCCC
Q ss_conf             68999000103889887679242898999999887986723998478077798966747999803311366100389998
Q 003599          560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD  639 (808)
Q Consensus       560 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  639 (808)
                      +.++.+..+..   ....+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||.+........
T Consensus        82 ~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~  155 (286)
T d1ob3a_          82 LDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (286)
T ss_dssp             CSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             EHHHHHHHHHH---HCCCCCHHHHHHHHHHHHHHHHHHCCCC---EEECCCCCCEEEECCCCCEEECCCCCCEECCCCCC
T ss_conf             00456789986---0477514456899999999999860574---88267877505686899787323664301146765


Q ss_pred             CCCCCCEECCCCCCCHHHHCCC-CCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHH-------CC----CC
Q ss_conf             6543310025786591110269-878545478326878998748989887778212555655541-------02----32
Q 003599          640 QADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLW-------NE----NK  707 (808)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~-------~~----~~  707 (808)
                      .  .....+++.|+|||.+... .++.++||||+|+++|||++|+.||....+...+........       ..    ..
T Consensus       156 ~--~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  233 (286)
T d1ob3a_         156 K--YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK  233 (286)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             C--CCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf             4--10102431101378871788888410021117589999779799898898999999998638997110421233322


Q ss_pred             CHHCCCCC--CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             10102775--5578651899999999997654378688999989999
Q 003599          708 ILALVDPF--LSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       708 ~~~~id~~--l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                      ........  .............+.+++.+|++.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             14333335676466651258999999999986689668909999856

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-44  Score=320.56  Aligned_cols=266  Identities=20%  Similarity=0.263  Sum_probs=199.0

Q ss_pred             HCCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECC----EEE
Q ss_conf             428754685333696318989933-99699999914446-204899999999998236872456853897188----348
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE----EKM  554 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~  554 (808)
                      .++|++.++||+|+||+||+|... +++.||||++.+.. ....+.+++|+.+|++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEE
T ss_conf             89859978994064809999999999949999998031095899999999999997689898858889950564554149


Q ss_pred             EEEEECCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEEC
Q ss_conf             99982689990001038898876792428989999998879867239984780777989667479998033113661003
Q 003599          555 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF  634 (808)
Q Consensus       555 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  634 (808)
                      ++++++.+|+|.+++.    ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++...
T Consensus        87 ~l~~~~~~g~L~~~l~----~~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          87 YLVTHLMGADLYKLLK----TQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             EEEEECCCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEECCCCHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCEEEC
T ss_conf             9999625986566440----589999999999999999999999789---867778764378879997787545705650


Q ss_pred             CCCCCC-CCCCCEECCCCCCCHHHHCC-CCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCC------
Q ss_conf             899986-54331002578659111026-9878545478326878998748989887778212555655541023------
Q 003599          635 GGNQDQ-ADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNEN------  706 (808)
Q Consensus       635 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~------  706 (808)
                      ...... .......|++.|+|||.+.. ..++.++||||+|+++|||++|+.||....................      
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (345)
T d1pmea_         160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC  239 (345)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred             CCCCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHH
T ss_conf             47776410101102652000387860478887410100467013377669799788888999998765206997566423


Q ss_pred             ----CCHH--CCCCCCCCCC---CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf             ----2101--0277555786---518999999999976543786889999899999
Q 003599          707 ----KILA--LVDPFLSESS---FQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       707 ----~~~~--~id~~l~~~~---~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                          ....  ...+.....+   .......++.+++.+|++.||.+||+++|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             43322220244677557787778378999999999999764895679089998619

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-43  Score=314.76  Aligned_cols=263  Identities=22%  Similarity=0.317  Sum_probs=201.2

Q ss_pred             HCCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCC--CCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECC------
Q ss_conf             428754685333696318989933-9969999991444--6204899999999998236872456853897188------
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE------  551 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------  551 (808)
                      .++|++.++||+|+||.||+|... +++.||||+++..  .....+.+.+|+.+|++++||||+++++++...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCC
T ss_conf             77189988980177819999999999989999998522259699999999999998668987547999863576555541


Q ss_pred             EEEEEEEECCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCC
Q ss_conf             34899982689990001038898876792428989999998879867239984780777989667479998033113661
Q 003599          552 EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA  631 (808)
Q Consensus       552 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  631 (808)
                      ..++||||+ +.+|..+.    +...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+|++|||++
T Consensus        97 ~~~lv~e~~-~~~l~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a  168 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLM----KHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  168 (346)
T ss_dssp             CCEEEEECC-SEEHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEEECC-CCCHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCHHHCCCCCCCCCCCCCCE
T ss_conf             599998405-52189998----7402269999999999999999987378---764566851111210012211343102


Q ss_pred             EECCCCCCCCCCCCEECCCCCCCHHHHCCC-CCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCC-----
Q ss_conf             003899986543310025786591110269-87854547832687899874898988777821255565554102-----
Q 003599          632 KIFGGNQDQADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNE-----  705 (808)
Q Consensus       632 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~-----  705 (808)
                      +......     ....|++.|+|||.+.+. .++.++||||+||++|||++|+.||...+....+..........     
T Consensus       169 ~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  243 (346)
T d1cm8a_         169 RQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV  243 (346)
T ss_dssp             EECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             ECCCCCC-----CCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCHHHH
T ss_conf             2068763-----10245533358899817878996501030038999999786998889768999999850378848888


Q ss_pred             -----C---CCHHCCCCCCCCC---CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HHHC
Q ss_conf             -----3---2101027755578---6518999999999976543786889999899999--8102
Q 003599          706 -----N---KILALVDPFLSES---SFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM--LNSE  757 (808)
Q Consensus       706 -----~---~~~~~id~~l~~~---~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~--L~~~  757 (808)
                           .   .....+ +.....   .........+.+++.+||+.||++|||++|+++.  ++.+
T Consensus       244 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~  307 (346)
T d1cm8a_         244 QRLQSDEAKNYMKGL-PELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  307 (346)
T ss_dssp             HTCSCHHHHHHHHHS-CCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             HHHCCHHHHHHHCCC-CCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf             653000344331157-8666556677556899999999999772995579299999639623758

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-44  Score=318.07  Aligned_cols=265  Identities=22%  Similarity=0.289  Sum_probs=197.1

Q ss_pred             HCCCCCCCCCCCCCCEEEEEEEEC-C-CCEEEEEEECCCC--CCCHHHHHHHHHHHHHC---CCCCEEEEEEEEEE----
Q ss_conf             428754685333696318989933-9-9699999914446--20489999999999823---68724568538971----
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLK-D-GQEIAVKRLSKAS--GQGLEEFMNEVMVISKL---QHRNLVRLLGCCVE----  549 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~----  549 (808)
                      .++|++.++||+|+||.||+|+.. + ++.||||+++...  ......+.+|+.+++.+   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             CCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCC
T ss_conf             58979888992155869999999888998999999802324516799999999999987425898802366322146666


Q ss_pred             -CCEEEEEEEECCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECC
Q ss_conf             -8834899982689990001038898876792428989999998879867239984780777989667479998033113
Q 003599          550 -GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDF  628 (808)
Q Consensus       550 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  628 (808)
                       ....++++|+++++.+......  ....+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred             CCCEEEEEEEECCCCCHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCEEEECCCCCEEECCH
T ss_conf             67469999974058714444430--3789998999999999999999997588---983579862789858997542100


Q ss_pred             CCCEECCCCCCCCCCCCEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCC--
Q ss_conf             661003899986543310025786591110269878545478326878998748989887778212555655541023--
Q 003599          629 GMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNEN--  706 (808)
Q Consensus       629 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~--  706 (808)
                      |+++.....   .......||+.|+|||++.+..++.++||||+||++|||++|+.||....+...+...........  
T Consensus       161 g~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  237 (305)
T d1blxa_         161 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE  237 (305)
T ss_dssp             CSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             HHHHHHCCC---CCCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHH
T ss_conf             010110023---45777654851148310017988811100032899999987879989989899999999840799611


Q ss_pred             ------CCHH-CCCCC--CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf             ------2101-02775--55786518999999999976543786889999899999
Q 003599          707 ------KILA-LVDPF--LSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       707 ------~~~~-~id~~--l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                            .... .....  .............+.+++.+|++.||++|||++|+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             05321111033302234564544044589999999999874896679189999669

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-43  Score=315.67  Aligned_cols=261  Identities=22%  Similarity=0.257  Sum_probs=193.5

Q ss_pred             CCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEEC------CEEEE
Q ss_conf             8754685333696318989933-9969999991444620489999999999823687245685389718------83489
Q 003599          483 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG------EEKML  555 (808)
Q Consensus       483 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~l  555 (808)
                      +|...++||+|+||+||+|+.. +++.||||++.....    ...+|+.++++++|+||+++++++...      ...++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH----HHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEE
T ss_conf             76751698217683999999999997999999881606----89999999986689898738789974476577318999


Q ss_pred             EEEECCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CEEEECCCCCEEC
Q ss_conf             998268999000103889887679242898999999887986723998478077798966747999-8033113661003
Q 003599          556 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL-NPKISDFGMAKIF  634 (808)
Q Consensus       556 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~  634 (808)
                      ||||++++.+............+++.++..++.|++.||+|||+++   |+||||||+|||++.++ .+||+|||+++.+
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEEECCCCCEEEECCCCHHHC
T ss_conf             9841688607888863103689999999999999999999998668---7645788603787358971167336605440


Q ss_pred             CCCCCCCCCCCEECCCCCCCHHHHCC-CCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHH-------HCC-
Q ss_conf             89998654331002578659111026-987854547832687899874898988777821255565554-------102-
Q 003599          635 GGNQDQADTGRVVGTFGYMSPEYAME-GRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKL-------WNE-  705 (808)
Q Consensus       635 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~-------~~~-  705 (808)
                      ......   ....|+..|+|||.+.. ..++.++||||+||++|||++|+.||........+.......       +.. 
T Consensus       174 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~  250 (350)
T d1q5ka_         174 VRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM  250 (350)
T ss_dssp             CTTSCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred             CCCCCC---CCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHHHHHHHHHHHCCCHHHHHHHH
T ss_conf             477653---20025555568277640468882100024652778550287998987999999999997489817765430


Q ss_pred             -CCCHHCCCCCCCC----CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf             -3210102775557----86518999999999976543786889999899999
Q 003599          706 -NKILALVDPFLSE----SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       706 -~~~~~~id~~l~~----~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                       .......-+....    .........++.+++.+||+.||++|||++|+++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  303 (350)
T d1q5ka_         251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  303 (350)
T ss_dssp             CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             62101103554456744443156899999999999765895579299999669

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-42  Score=307.42  Aligned_cols=267  Identities=18%  Similarity=0.273  Sum_probs=200.9

Q ss_pred             HCCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCC--CCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEE--------
Q ss_conf             428754685333696318989933-9969999991444--62048999999999982368724568538971--------
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVE--------  549 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--------  549 (808)
                      .++|++.++||+|+||+||+|+.. +++.||||++...  .......+.+|+.+|++++|+|++++++.+..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCC
T ss_conf             27988999972274829999999899979999998422246378999999999999835999660676540246544445


Q ss_pred             CCEEEEEEEECCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCC
Q ss_conf             88348999826899900010388988767924289899999988798672399847807779896674799980331136
Q 003599          550 GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFG  629 (808)
Q Consensus       550 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  629 (808)
                      ....++|||++.++.+.....   ....++...+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg  162 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG  162 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred             CCEEEEEEECCCCCCCCHHHH---CCCCCCCHHHHHHHHHHHHHHHHHCCCC---EEECCCCCHHEEECCCCCEEEEECC
T ss_conf             763899985357874101222---0344330899999999999998852299---8856767222036689968763135


Q ss_pred             CCEECCCCCCC--CCCCCEECCCCCCCHHHHCCC-CCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHC--
Q ss_conf             61003899986--543310025786591110269-8785454783268789987489898877782125556555410--
Q 003599          630 MAKIFGGNQDQ--ADTGRVVGTFGYMSPEYAMEG-RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWN--  704 (808)
Q Consensus       630 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~--  704 (808)
                      +++.+......  .......||+.|+|||.+.+. .++.++||||+|+++|||++|+.||....+...+.........  
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  242 (318)
T d3blha1         163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  242 (318)
T ss_dssp             TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             EEEECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHHHHHHHHHHCCCCC
T ss_conf             00223554443211356602497874289970799989178700678646617448799899899999999998418998


Q ss_pred             --------CCCCHHCCCCCCCCCCCCH------HHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf             --------2321010277555786518------999999999976543786889999899999
Q 003599          705 --------ENKILALVDPFLSESSFQL------DMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       705 --------~~~~~~~id~~l~~~~~~~------~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                              .......+...........      .....+.+++.+||+.||++|||++|+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             255344320344433201334455503340444599899999999873896589099999749

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=7.4e-43  Score=310.65  Aligned_cols=275  Identities=16%  Similarity=0.224  Sum_probs=213.2

Q ss_pred             HCCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCC-CCEEEEEEEEEECCEEEEEEE
Q ss_conf             428754685333696318989933-996999999144462048999999999982368-724568538971883489998
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQH-RNLVRLLGCCVEGEEKMLIYE  558 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lV~E  558 (808)
                      .++|.+.+.||+|+||.||+|+.. +++.||||.+.....  ...+.+|++.+..++| +|++.+++++.++...++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC--CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEE
T ss_conf             9806997998417882999999988997999999750258--29999999999996489998779999601881179999


Q ss_pred             ECCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC-----CCCEEEECCCCCEE
Q ss_conf             2689990001038898876792428989999998879867239984780777989667479-----99803311366100
Q 003599          559 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE-----ELNPKISDFGMAKI  633 (808)
Q Consensus       559 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~Dfgla~~  633 (808)
                      ++ +++|.+++..  ....++...+..++.|++.||.|||+.+   |+||||||+|||++.     .+.+||+|||+++.
T Consensus        82 ~~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          82 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             EC-CCCHHHHHHH--HCCCHHHHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCCEEECCCCCCCCCCEEECCCCEEEE
T ss_conf             64-8887999975--2031106899999999999999999779---6626677131523475434479568723660577


Q ss_pred             CCCCCCC-----CCCCCEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCC
Q ss_conf             3899986-----54331002578659111026987854547832687899874898988777821255565554102321
Q 003599          634 FGGNQDQ-----ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKI  708 (808)
Q Consensus       634 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  708 (808)
                      +......     .......||+.|+|||.+.+..++.++||||||+++|||+||+.||..............  ..+...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~--i~~~~~  233 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER--IGEKKQ  233 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH--HHHHHH
T ss_pred             CCCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH--HHHCCC
T ss_conf             146766541110246762775102679896488888699989831999999869876788530219999999--970567


Q ss_pred             HHCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf             010277555786518999999999976543786889999899999810235899999997534
Q 003599          709 LALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLPYPKEPAFTE  771 (808)
Q Consensus       709 ~~~id~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~~~~~~~~~p~~~~  771 (808)
                        ......    .....+.++.+++..|+..+|++||+++.+.+.|++.++.........+.|
T Consensus       234 --~~~~~~----l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~Dw  290 (293)
T d1csna_         234 --STPLRE----LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDW  290 (293)
T ss_dssp             --HSCHHH----HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGG
T ss_pred             --CCCHHH----HCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCC
T ss_conf             --999589----657998999999999843993008599999999999999759999999898

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.6e-43  Score=310.58  Aligned_cols=265  Identities=20%  Similarity=0.300  Sum_probs=201.6

Q ss_pred             CCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCC-EEEEEEEEEECCEEEEEEEE
Q ss_conf             28754685333696318989933-99699999914446204899999999998236872-45685389718834899982
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN-LVRLLGCCVEGEEKMLIYEY  559 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~lV~E~  559 (808)
                      ++|++.+.||+|+||.||+|+.. +++.||||.+.....  ..++..|++++++++|+| |+.+.++..+....++|||+
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCC--CHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEEEE
T ss_conf             889996898507880999999988998999999721005--888999999999703899601799999519877899987


Q ss_pred             CCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC---CCCCEEEECCCCCEECCC
Q ss_conf             68999000103889887679242898999999887986723998478077798966747---999803311366100389
Q 003599          560 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKIFGG  636 (808)
Q Consensus       560 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfgla~~~~~  636 (808)
                      + +++|...+..  ....+++..+..++.|++.||+|||+++   |+||||||+|||++   .+..+||+|||+++.+..
T Consensus        85 ~-~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          85 L-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             C-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             C-CCCHHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCHHHCCCCCCCCCCEEEEECCCCCEECCC
T ss_conf             3-8713332443--0688768999999999999999999799---44266787660643357776156504675134255


Q ss_pred             CCCC-----CCCCCEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCHHC
Q ss_conf             9986-----54331002578659111026987854547832687899874898988777821255565554102321010
Q 003599          637 NQDQ-----ADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILAL  711 (808)
Q Consensus       637 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  711 (808)
                      ....     .......||+.|+|||.+.+..++.++||||||+++|||+||+.||...............  ..... ..
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~--~~~~~-~~  235 (299)
T d1ckia_         159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI--SEKKM-ST  235 (299)
T ss_dssp             TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHH--HHHHH-HS
T ss_pred             CCCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHH--HCCCC-CC
T ss_conf             4455410001357767873532999991899898321886177899998498766553057799999985--23567-89


Q ss_pred             CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCCC
Q ss_conf             277555786518999999999976543786889999899999810235899
Q 003599          712 VDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSMLNSEIRDLP  762 (808)
Q Consensus       712 id~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~L~~~~~~~~  762 (808)
                      ..+.     .....+.++.+++..|++.+|++||+++++.+.|+..+....
T Consensus       236 ~~~~-----~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~  281 (299)
T d1ckia_         236 PIEV-----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  281 (299)
T ss_dssp             CHHH-----HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             CHHH-----HCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHCC
T ss_conf             8357-----534788999999999843995579199999999999999769

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-44  Score=319.43  Aligned_cols=240  Identities=25%  Similarity=0.394  Sum_probs=193.6

Q ss_pred             HCCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCCC------CCHHHHHHHHHHHHHCC--CCCEEEEEEEEEECC
Q ss_conf             428754685333696318989933-996999999144462------04899999999998236--872456853897188
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG------QGLEEFMNEVMVISKLQ--HRNLVRLLGCCVEGE  551 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~  551 (808)
                      .++|++.+.||+|+||.||+|+.. +++.||||++.+...      ....++.+|+.++++++  ||||+++++++.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECC
T ss_conf             88379967984087839999999999979999998568844334556799999999999974358988127999983099


Q ss_pred             EEEEEEEECCC-CCCHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC-CCCEEEECCC
Q ss_conf             34899982689-990001038898876792428989999998879867239984780777989667479-9980331136
Q 003599          552 EKMLIYEYMPN-RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE-ELNPKISDFG  629 (808)
Q Consensus       552 ~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg  629 (808)
                      ..++|||++.+ +++.+++.   ....+++.++..++.|+++||.|||+.+   |+||||||+|||++. ++.+||+|||
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG  156 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG  156 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             EEEEEEEECCCCCHHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEEECCCCEEEECCCC
T ss_conf             68999983368622899986---1589999999999999999999998779---75566761114774478848977546


Q ss_pred             CCEECCCCCCCCCCCCEECCCCCCCHHHHCCCCC-CCCCCEEEHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCC
Q ss_conf             6100389998654331002578659111026987-854547832687899874898988777821255565554102321
Q 003599          630 MAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRF-SEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKI  708 (808)
Q Consensus       630 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  708 (808)
                      +++......    .....||+.|+|||++.+..+ +.++||||+||++|||++|+.||....   ...       . .. 
T Consensus       157 ~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~i~-------~-~~-  220 (273)
T d1xwsa_         157 SGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---EII-------R-GQ-  220 (273)
T ss_dssp             TCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---HHH-------H-CC-
T ss_pred             CCEECCCCC----CCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCH---HHH-------H-CC-
T ss_conf             535324445----5665658774799998489978865332554034536756889988736---776-------1-54-


Q ss_pred             HHCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             01027755578651899999999997654378688999989999
Q 003599          709 LALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       709 ~~~id~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                           ..     .+...+.++.+++.+|++.||++|||++|+++
T Consensus       221 -----~~-----~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         221 -----VF-----FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             -----CC-----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----CC-----CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             -----47-----78779999999999976089758939999853

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.1e-41  Score=302.64  Aligned_cols=256  Identities=19%  Similarity=0.272  Sum_probs=196.8

Q ss_pred             CCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCC-CCCEEEEEEEEEEC--CEEEEEE
Q ss_conf             28754685333696318989933-99699999914446204899999999998236-87245685389718--8348999
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEG--EEKMLIY  557 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~--~~~~lV~  557 (808)
                      ++|++.++||+|+||+||+|+.. +++.||||+++..   ..+++.+|+.+|.+++ ||||+++++++...  ...++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEEEE
T ss_conf             6718978983174819999998899979999998889---9999999999998515799876799999816877126888


Q ss_pred             EECCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CEEEECCCCCEECCC
Q ss_conf             8268999000103889887679242898999999887986723998478077798966747999-803311366100389
Q 003599          558 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL-NPKISDFGMAKIFGG  636 (808)
Q Consensus       558 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~~  636 (808)
                      ||+++++|..+.      ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++ .+||+|||+++....
T Consensus       112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             EECCCCCHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEECCCCCEEEECCCCCCEECCC
T ss_conf             631798589974------68999999999999999998876433---443456441237748998366415654266468


Q ss_pred             CCCCCCCCCEECCCCCCCHHHHCCCC-CCCCCCEEEHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCC----------
Q ss_conf             99865433100257865911102698-7854547832687899874898988777821255565554102----------
Q 003599          637 NQDQADTGRVVGTFGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNE----------  705 (808)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~----------  705 (808)
                      ...   .....+|..|+|||.+.+.. ++.++||||+|+++|||++|+.||....+..............          
T Consensus       183 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  259 (328)
T d3bqca1         183 GQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY  259 (328)
T ss_dssp             TCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred             CCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHHHHHHC
T ss_conf             874---44322486424761026888888452323354555876048899988760189999999987884155555422


Q ss_pred             -----CCCHHCCCC-------CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             -----321010277-------55578651899999999997654378688999989999
Q 003599          706 -----NKILALVDP-------FLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       706 -----~~~~~~id~-------~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                           .........       .............++.+++.+|++.||++|||++|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             54447430000033343311211552112448999999999986699568908999964

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-42  Score=305.71  Aligned_cols=263  Identities=19%  Similarity=0.265  Sum_probs=205.1

Q ss_pred             CCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCC--CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEE
Q ss_conf             28754685333696318989933-99699999914446--2048999999999982368724568538971883489998
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE  558 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  558 (808)
                      ++|++.++||+|+||+||+|+.. +++.||||+++...  ....+.+.+|+.++++++||||+++++++.+....++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf             99786269712868199999999999699999980321786899999999999985675788821354444431158863


Q ss_pred             ECCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEECCCCC
Q ss_conf             26899900010388988767924289899999988798672399847807779896674799980331136610038999
Q 003599          559 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ  638 (808)
Q Consensus       559 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  638 (808)
                      ++.+++|..++.   ..+.+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||.++......
T Consensus        82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             ECCCCCCCCCCC---CCCCCCHHHHHHHHHHHHHHHHHHHCCC---EEEECCCCCCCCCCCCCCEEEEECCHHHCCCCCC
T ss_conf             023322211212---3565403678999999999987743399---8600146761211337826652046011046887


Q ss_pred             CCCCCCCEECCCCCCCHHHHCCCC-CCCCCCEEEHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCC-----------
Q ss_conf             865433100257865911102698-78545478326878998748989887778212555655541023-----------
Q 003599          639 DQADTGRVVGTFGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNEN-----------  706 (808)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~-----------  706 (808)
                      ...  ....++..|+|||.+.... ++.++||||+|+++|||++|+.|+....+...............           
T Consensus       156 ~~~--~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (292)
T d1unla_         156 RCY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             SCC--CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred             CCC--EEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHHC
T ss_conf             510--010344310146675069888804440265418899851899998899999999999861189973551344322


Q ss_pred             ---CCHHCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             ---2101027755578651899999999997654378688999989999
Q 003599          707 ---KILALVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVS  752 (808)
Q Consensus       707 ---~~~~~id~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~  752 (808)
                         ......................+.+++.+|++.||.+|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             2113344454431043306568999999999986499668909999964

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-42  Score=304.60  Aligned_cols=260  Identities=22%  Similarity=0.224  Sum_probs=200.2

Q ss_pred             CCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCC--CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEE------CCE
Q ss_conf             28754685333696318989933-99699999914446--2048999999999982368724568538971------883
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVE------GEE  552 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------~~~  552 (808)
                      ++|++.++||+|+||+||+|.+. +++.||||++....  ......+.+|+.++++++||||+++++++..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCCE
T ss_conf             77599889621758599999999999899999988233697999999999999986489876489989702564345762


Q ss_pred             EEEEEEECCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCE
Q ss_conf             48999826899900010388988767924289899999988798672399847807779896674799980331136610
Q 003599          553 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK  632 (808)
Q Consensus       553 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  632 (808)
                      .++||||+.++.+. .+.     ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+|++|||+++
T Consensus        97 ~~iv~Ey~~~~l~~-~~~-----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1          97 VYLVMELMDANLCQ-VIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             EEEEEECCSEEHHH-HHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             EEEEEECCCHHHHH-HHH-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCEEEECHHHHH
T ss_conf             69998414467787-650-----38999999999999999998865221---1245677632113654431320102321


Q ss_pred             ECCCCCCCCCCCCEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCHHHHHHHHH-------HHC-
Q ss_conf             038999865433100257865911102698785454783268789987489898877782125556555-------410-
Q 003599          633 IFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWK-------LWN-  704 (808)
Q Consensus       633 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~~~~-------~~~-  704 (808)
                      ......   ......+|..|+|||.+.+..++.++||||+||++|||++|+.||...++..........       .+. 
T Consensus       168 ~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~  244 (355)
T d2b1pa1         168 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  244 (355)
T ss_dssp             ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             CCCCCC---CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHH
T ss_conf             146665---53322146555581331477778774333566257898659899888977889999997205898799987


Q ss_pred             ---------CC-------CCHHCCCCCCCC--CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf             ---------23-------210102775557--86518999999999976543786889999899999
Q 003599          705 ---------EN-------KILALVDPFLSE--SSFQLDMIIRCIHVGLLCVQELVKDRPNMSTVVSM  753 (808)
Q Consensus       705 ---------~~-------~~~~~id~~l~~--~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~~  753 (808)
                               ..       ............  .........++.+++.+|++.||++|||++|+++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             6566777764175435666421264333543210133379999999999876994579089999669

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-42  Score=307.50  Aligned_cols=252  Identities=25%  Similarity=0.345  Sum_probs=201.8

Q ss_pred             CCCCCCCCCCCCCCEEEEEEEEC----CCCEEEEEEECCCC----CCCHHHHHHHHHHHHHCCC-CCEEEEEEEEEECCE
Q ss_conf             28754685333696318989933----99699999914446----2048999999999982368-724568538971883
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK----DGQEIAVKRLSKAS----GQGLEEFMNEVMVISKLQH-RNLVRLLGCCVEGEE  552 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~  552 (808)
                      ++|++.+.||+|+||.||+|...    +++.||||.+.+..    ....+.+.+|+.++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             HCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCC
T ss_conf             02599989832878399999987658879489999983677210168999999999999864679839996200024873


Q ss_pred             EEEEEEECCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCE
Q ss_conf             48999826899900010388988767924289899999988798672399847807779896674799980331136610
Q 003599          553 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK  632 (808)
Q Consensus       553 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  632 (808)
                      .++||||+.+|+|..++..   ...+.......++.|++.|+.|||+.+   ++||||||+|||++.++.+||+|||+++
T Consensus       104 ~~~v~e~~~~~~L~~~i~~---~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             EEEEEECCCCCHHHHHHHH---CCCCCHHHHHHHHHHHHHHHHHHHCCC---EEECCCCCCCEEECCCCCEEEEECCCHH
T ss_conf             0012312341179999873---045437888888999999998851499---8965477320124699988874132022


Q ss_pred             ECCCCCCCCCCCCEECCCCCCCHHHHCCC--CCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCHH
Q ss_conf             03899986543310025786591110269--8785454783268789987489898877782125556555410232101
Q 003599          633 IFGGNQDQADTGRVVGTFGYMSPEYAMEG--RFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNENKILA  710 (808)
Q Consensus       633 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  710 (808)
                      .+...... ......|++.|+|||.+...  .++.++||||+||+||||++|+.||...................     
T Consensus       178 ~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~-----  251 (322)
T d1vzoa_         178 EFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-----  251 (322)
T ss_dssp             ECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC-----
T ss_pred             HHCCCCCC-CCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCC-----
T ss_conf             20344443-221222333331068760577688713251777799999976899988887777999999833568-----


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH
Q ss_conf             027755578651899999999997654378688999-----989999
Q 003599          711 LVDPFLSESSFQLDMIIRCIHVGLLCVQELVKDRPN-----MSTVVS  752 (808)
Q Consensus       711 ~id~~l~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~ev~~  752 (808)
                        .+.     .+.....++.+++.+|++.||++||+     ++|+++
T Consensus       252 --~~~-----~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         252 --EPP-----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             --CCC-----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             --CCC-----CCCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHC
T ss_conf             --998-----8654799999999997445898819997450999974

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-42  Score=304.30  Aligned_cols=265  Identities=21%  Similarity=0.277  Sum_probs=200.1

Q ss_pred             HCCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCC--CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEEC-----CE
Q ss_conf             428754685333696318989933-99699999914446--20489999999999823687245685389718-----83
Q 003599          481 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG-----EE  552 (808)
Q Consensus       481 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~  552 (808)
                      .++|++.++||+|+||+||+|+.. +++.||||++++..  ....+.+.+|+.++++++|+|++++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCC
T ss_conf             98718888983178839999999999979999998820028689999999999998668987425999996346456686


Q ss_pred             EEEEEEECCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCE
Q ss_conf             48999826899900010388988767924289899999988798672399847807779896674799980331136610
Q 003599          553 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK  632 (808)
Q Consensus       553 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  632 (808)
                      .+++++++.+|+|.+++.    ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+|++|||++.
T Consensus        97 ~~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR  169 (348)
T ss_dssp             CCEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred             EEEEEEEECCCCHHHHCC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCCCCCCCHHC
T ss_conf             499999625886232002----245309999999999999999997388---7651667763345543220013210001


Q ss_pred             ECCCCCCCCCCCCEECCCCCCCHHHHCCCC-CCCCCCEEEHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCC------
Q ss_conf             038999865433100257865911102698-7854547832687899874898988777821255565554102------
Q 003599          633 IFGGNQDQADTGRVVGTFGYMSPEYAMEGR-FSEKSDVFSFGVLLLEIVSGRKNTSFFEDDLTILGYAWKLWNE------  705 (808)
Q Consensus       633 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~------  705 (808)
                      ....     ......|+..|+|||...+.. ++.++||||+|+++|+|++|+.||...+...............      
T Consensus       170 ~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~  244 (348)
T d2gfsa1         170 HTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK  244 (348)
T ss_dssp             CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             CCCC-----CCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHH
T ss_conf             2575-----44443454355583553377567855124320589999976889978898899999999730799757732


Q ss_pred             ----CCCHHCCC--CCCCCCCC---CHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHHC
Q ss_conf             ----32101027--75557865---1899999999997654378688999989999--98102
Q 003599          706 ----NKILALVD--PFLSESSF---QLDMIIRCIHVGLLCVQELVKDRPNMSTVVS--MLNSE  757 (808)
Q Consensus       706 ----~~~~~~id--~~l~~~~~---~~~~~~~l~~li~~cl~~~P~~RPs~~ev~~--~L~~~  757 (808)
                          ........  +.......   ......++.+++.+|++.||++|||++|+++  .+.+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~  307 (348)
T d2gfsa1         245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  307 (348)
T ss_dssp             TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             HCCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf             001024454443035578755566267899999999999775883459389998559954879

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.1e-37  Score=272.92  Aligned_cols=280  Identities=19%  Similarity=0.242  Sum_probs=199.1

Q ss_pred             CCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCC-----------CCCEEEEEEEEEE
Q ss_conf             28754685333696318989933-99699999914446204899999999998236-----------8724568538971
Q 003599          482 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-----------HRNLVRLLGCCVE  549 (808)
Q Consensus       482 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~g~~~~  549 (808)
                      .+|++.++||+|+||.||+|+.. +++.||||+++... ...+.+.+|+.+++.++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCC-CCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEEE
T ss_conf             85799899750778189999999999799999983431-33689999999999840145555542276764789987631


Q ss_pred             C--CEEEEEEEECCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCEEECCCCCCCEEECCCCC----
Q ss_conf             8--8348999826899900010388988767924289899999988798672-39984780777989667479998----
Q 003599          550 G--EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR-DSRLRIIHRDLKASNILLDEELN----  622 (808)
Q Consensus       550 ~--~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~----  622 (808)
                      .  ...++++++...+..............+++..+..++.|++.|+.|||+ .+   |+||||||+|||++.++.    
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred             CCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEEECCCCCCCC
T ss_conf             2565202343200035420000012234678689999999999999888764058---6465677057056305765644


Q ss_pred             --EEEECCCCCEECCCCCCCCCCCCEECCCCCCCHHHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCH------H
Q ss_conf             --03311366100389998654331002578659111026987854547832687899874898988777821------2
Q 003599          623 --PKISDFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLLLEIVSGRKNTSFFEDDL------T  694 (808)
Q Consensus       623 --~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~------~  694 (808)
                        ++++|||.+.......     ....|++.|+|||.+....++.++||||+|++++||++|+.||.......      .
T Consensus       169 ~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~  243 (362)
T d1q8ya_         169 IQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  243 (362)
T ss_dssp             EEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             CEEEEEECCCCCCCCCCC-----CCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHHH
T ss_conf             305675314421234454-----223665210571321466777643201237899999878899898755432102689


Q ss_pred             HHHHHHH-------HHCC----------CCCHHCCCCCC---------CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHH
Q ss_conf             5556555-------4102----------32101027755---------57865189999999999765437868899998
Q 003599          695 ILGYAWK-------LWNE----------NKILALVDPFL---------SESSFQLDMIIRCIHVGLLCVQELVKDRPNMS  748 (808)
Q Consensus       695 ~~~~~~~-------~~~~----------~~~~~~id~~l---------~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~  748 (808)
                      +......       ....          ......+....         ...........++.+++.+|++.||.+|||++
T Consensus       244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~  323 (362)
T d1q8ya_         244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  323 (362)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHH
T ss_conf             99999983799878862453220001320122024323577644421000156743589999999998779945790899


Q ss_pred             HHHHH--HHHC--CCCCCCCCCCCCC
Q ss_conf             99999--8102--3589999999753
Q 003599          749 TVVSM--LNSE--IRDLPYPKEPAFT  770 (808)
Q Consensus       749 ev~~~--L~~~--~~~~~~~~~p~~~  770 (808)
                      |+++.  +++.  .++.+.|..|...
T Consensus       324 e~L~Hp~f~~~~~~~~~~~p~~~~~~  349 (362)
T d1q8ya_         324 GLVNHPWLKDTLGMEEIRVPDRELYG  349 (362)
T ss_dssp             HHHTCGGGTTCTTCTTCCCTTSCTTC
T ss_pred             HHHCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             99669340789874447799866678

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.82  E-value=8e-21  Score=158.20  Aligned_cols=169  Identities=18%  Similarity=0.170  Sum_probs=119.5

Q ss_pred             CCCCCCCCCCCEEEEEEEECCCCEEEEEEECCCCC------------------CCHHHHHHHHHHHHHCCCCCEEEEEEE
Q ss_conf             54685333696318989933996999999144462------------------048999999999982368724568538
Q 003599          485 QLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASG------------------QGLEEFMNEVMVISKLQHRNLVRLLGC  546 (808)
Q Consensus       485 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~g~  546 (808)
                      .+.++||+|+||.||+|...+++.||||+++....                  .......+|...+.++.|.+++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             HHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEE
T ss_conf             22778024856599999979999999999860443466655656300088899999977899999998169991449986


Q ss_pred             EEECCEEEEEEEECCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEE
Q ss_conf             97188348999826899900010388988767924289899999988798672399847807779896674799980331
Q 003599          547 CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKIS  626 (808)
Q Consensus       547 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  626 (808)
                      .    ..+++||++++..+..          ++......++.|+++++.|||+.+   ++||||||+|||++++ .++|+
T Consensus        83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~li  144 (191)
T d1zara2          83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWII  144 (191)
T ss_dssp             E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEEC
T ss_pred             C----CCEEEEEEECCCCCCC----------HHHHHHHHHHHHHHHHHHHHHHCC---EEECCCCHHHEEEECC-CEEEE
T ss_conf             2----8889999504565420----------015789999999999999982688---8983689036114289-89998


Q ss_pred             CCCCCEECCCCCCCCCCCCEECCCCCCCHHHHCCCCCCCCCCEEEHHHHH
Q ss_conf             13661003899986543310025786591110269878545478326878
Q 003599          627 DFGMAKIFGGNQDQADTGRVVGTFGYMSPEYAMEGRFSEKSDVFSFGVLL  676 (808)
Q Consensus       627 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil  676 (808)
                      |||++.............+   ... .-.+. ....|+.++|+||..--+
T Consensus       145 DFG~a~~~~~~~~~~~l~r---d~~-~~~~~-f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         145 DFPQSVEVGEEGWREILER---DVR-NIITY-FSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CCTTCEETTSTTHHHHHHH---HHH-HHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred             ECCCCCCCCCCCCHHHHHH---HHH-HHHHH-HCCCCCCCCCHHHHHHHH
T ss_conf             7788430899870999987---799-99999-757899844689999987

>d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Gastrodianin (antifungal protein)
species: Gastrodia elata [TaxId: 91201]

Probab=99.74  E-value=1.9e-17  Score=134.88  Aligned_cols=112  Identities=17%  Similarity=0.419  Sum_probs=91.7

Q ss_pred             CCCCCCCCCCCCCCEEEECCCEEEEEEECCCCCCCEEEEEEEECCCCCEEEEEECCCCCCCCCCCEEEEECCCCEEEECC
Q ss_conf             36545886457999398389923898755899996399999505999528999459998778965499932875899739
Q 003599           23 DSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNG  102 (808)
Q Consensus        23 ~~~l~~~~~l~~~~~l~S~~g~F~~gF~~~~~~~~~~~~iw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~G~L~l~~~  102 (808)
                      +|+|.|||.|..++.|+  +|.|.|.|...++     |.++.    ..++||.||++.|..  .+.|.|+.+|+|+|.++
T Consensus         1 tDtL~~gq~L~~g~~l~--~g~~~l~~q~DGN-----Lvly~----~~~~vW~s~~~~~~~--~~~l~l~~dGnLvl~~~   67 (112)
T d1xd5a_           1 SDRLNSGHQLDTGGSLA--EGGYLFIIQNDCN-----LVLYD----NNRAVWASGTNGKAS--GCVLKMQNDGNLVIYSG   67 (112)
T ss_dssp             CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEEEE----TTEEEEECCCTTSCS--SEEEEECTTSCEEEEET
T ss_pred             CCEECCCCEECCCCEEE--ECCEEEEECCCCC-----EEEEC----CCCEEEECCCCCCCC--CCEEEEECCCCEEEEEC
T ss_conf             98906999955999998--7879999817998-----89873----983899846734788--85799961534999934


Q ss_pred             CCCEEEEECCCCCCCCCEEEEEECCCCEEEEECCCCCEEECCCCCCCC
Q ss_conf             971799630235645633899903888799935567157333477756
Q 003599          103 QKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQEPTD  150 (808)
Q Consensus       103 ~~~~vWst~~~~~~~~~~~a~LldsGNlVl~~~~~~~~~WqSFd~PTD  150 (808)
                      + ..+|++++... .+..+|+|+|+|||||++. +++++|||+.+|++
T Consensus        68 ~-~~~w~s~t~~~-~~~~~l~L~ddGNlvly~~-~~~~~W~S~t~~~n  112 (112)
T d1xd5a_          68 S-RAIWASNTNRQ-NGNYYLILQRDRNVVIYDN-SNNAIWATHTNVGN  112 (112)
T ss_dssp             T-EEEEECCCCCS-CCCCEEEECTTSCEEEECT-TSCEEEECCCCCCC
T ss_pred             C-CEEEEEEECCC-CCCEEEEECCCCCEEEECC-CCCEEECCCCCCCC
T ss_conf             8-74999830368-8725999967899999989-99679618885698

>d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Snowdrop (Galanthus nivalis) [TaxId: 4670]

Probab=99.71  E-value=9.3e-17  Score=130.09  Aligned_cols=107  Identities=20%  Similarity=0.330  Sum_probs=90.2

Q ss_pred             CCCCCCCCCCCCCCEEEECCCEEEEEEECCCCCCCEEEEEEEECCCCCEEEEEECCCCCCCCCCCEEEEECCCCEEEECC
Q ss_conf             36545886457999398389923898755899996399999505999528999459998778965499932875899739
Q 003599           23 DSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNG  102 (808)
Q Consensus        23 ~~~l~~~~~l~~~~~l~S~~g~F~~gF~~~~~~~~~~~~iw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~G~L~l~~~  102 (808)
                      +|+|.+||.|..++.|.  +|.|.|.|...++     |.|+.    ..++||.||++.|.  +.+.|.+..+|+|+|.++
T Consensus         1 ~~~L~~g~~L~~G~~l~--ng~~~l~~q~DGN-----Lvly~----~~~~vW~s~~~~~~--~~~~l~l~~~Gnlvl~~~   67 (108)
T d1jpca_           1 DNILYSGETLSTGEFLN--YGSFVFIMQEDCN-----LVLYD----VDKPIWATNTGGLS--RSCFLSMQTDGNLVVYNP   67 (108)
T ss_dssp             CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEEEE----TTEEEEECCCTTSC--SSCEEEECTTSCEEEECT
T ss_pred             CCCCCCCCEECCCCEEE--CCCEEEEECCCCE-----EEEEE----CCCEEEEECCCCCC--CCCEEEEECCCEEEEECC
T ss_conf             99956997726999897--2888999878980-----99970----99021570788998--754799812603999779


Q ss_pred             CCCEEEEECCCCCCCCCEEEEEECCCCEEEEECCCCCEEECCCCC
Q ss_conf             971799630235645633899903888799935567157333477
Q 003599          103 QKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQE  147 (808)
Q Consensus       103 ~~~~vWst~~~~~~~~~~~a~LldsGNlVl~~~~~~~~~WqSFd~  147 (808)
                      ++.++|+|++... ....+|+|+|+|||||++.    .+||||+|
T Consensus        68 ~g~~vWsS~t~~~-~~~~~l~L~ddGNlVly~~----~~W~S~t~  107 (108)
T d1jpca_          68 SNKPIWASNTGGQ-NGNYVCILQKDRNVVIYGT----DRWATGTH  107 (108)
T ss_dssp             TCCEEEECCCCCS-CSCEEEEECTTSCEEEEEC----CCCCCCCC
T ss_pred             CCCCEEECCCCCC-CCCEEEEECCCCCEEEECC----CCCCCCCC
T ss_conf             8551277045588-8767999968889999699----84568888

>d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Garlic (Allium sativum) [TaxId: 4682]

Probab=99.70  E-value=1.9e-16  Score=128.02  Aligned_cols=107  Identities=18%  Similarity=0.326  Sum_probs=89.1

Q ss_pred             CCCCCCCCCCCCCEEEECCCEEEEEEECCCCCCCEEEEEEEECCCCCEEEEEECCCCCCCCCCCEEEEECCCCEEEECCC
Q ss_conf             65458864579993983899238987558999963999995059995289994599987789654999328758997399
Q 003599           24 SSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQ  103 (808)
Q Consensus        24 ~~l~~~~~l~~~~~l~S~~g~F~~gF~~~~~~~~~~~~iw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~G~L~l~~~~  103 (808)
                      |+|.+|+.|..++.|.  +|.|.|+|...++     |.+ |.   ..++||+||++.|+.. .+.|.|+.+|+|+|.+++
T Consensus         2 ~~L~~g~~L~~g~~l~--~g~~~l~~q~dgn-----Lvl-~~---~~~~vW~ant~~~~~~-~~~l~l~~dGnLvl~~~~   69 (109)
T d1kj1a_           2 NLLTNGEGLYAGQSLD--VEPYHFIMQEDCN-----LVL-YD---HSTSVWASNTGILGKK-GCKAVLQSDGNFVVYDAE   69 (109)
T ss_dssp             CEEETTCEEETTCEEE--ETTEEEEECTTSC-----EEE-EE---TTEEEEECCCCCTTCC-CCEEEECTTSCEEEECSS
T ss_pred             CCCCCCCEEECCCEEE--ECCEEEEECCCCE-----EEE-EE---CCEEEEEECCCCCCCE-EEEEEECCCCEEEEEECC
T ss_conf             8925999882899898--3788999448986-----999-86---9989998378998751-079999379609999089


Q ss_pred             CCEEEEECCCCCCCCCEEEEEECCCCEEEEECCCCCEEECCCCC
Q ss_conf             71799630235645633899903888799935567157333477
Q 003599          104 KEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQE  147 (808)
Q Consensus       104 ~~~vWst~~~~~~~~~~~a~LldsGNlVl~~~~~~~~~WqSFd~  147 (808)
                      +.++|+|+++.. .+..+|.|+|+|||||+++    .+|||+-|
T Consensus        70 g~~vW~s~t~~~-~~~~~l~L~ddGNlvly~~----~~W~S~t~  108 (109)
T d1kj1a_          70 GRSLWASHSVRG-NGNYVLVLQEDGNVVIYGS----DIWSTGTY  108 (109)
T ss_dssp             SCEEEECCCCCC-SSCCEEEECTTSCEEEECC----EEEECCCC
T ss_pred             CCEEEEEEEECC-CCCEEEEEECCCCEEEECC----CEECCCCC
T ss_conf             867999730889-9977999947975999799----87217985

>d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.57  E-value=4.6e-15  Score=118.36  Aligned_cols=109  Identities=21%  Similarity=0.325  Sum_probs=87.6

Q ss_pred             EEEEECCCCCEEEEEECCCCCCCCCCCEEEEECCCCEEEECCCCCEEEEECCCCCCCCCEEEEEECCCCEEEEECCCCCE
Q ss_conf             99950599952899945999877896549993287589973997179963023564563389990388879993556715
Q 003599           61 GIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAI  140 (808)
Q Consensus        61 ~iw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~G~L~l~~~~~~~vWst~~~~~~~~~~~a~LldsGNlVl~~~~~~~~  140 (808)
                      .|||.++++++.+|++|++.|+.....+|.+..||+|+|.++ +.++|++++.+. .....|.|+++|||||+|. ++++
T Consensus        11 ~il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~-~~~~~~~l~~~GnLvl~d~-~~~~   87 (120)
T d1dlpa2          11 SILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGK-GTGCRAVLQPNGRMDVLTN-QNIA   87 (120)
T ss_dssp             EECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCSS-CSSCEEEEETTTEEEEEET-TTEE
T ss_pred             EEEECCCCCCCCCCEECCCCEEECCCEEEEECCCCCEEEECC-CCEEEEECCCCC-CCCEEEEEECCEEEEEECC-CCCE
T ss_conf             699828988885628839972174887999968983899649-968999752247-7747999907764999929-9988


Q ss_pred             EECCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEECCCCCEEEEECCCEEEEE
Q ss_conf             7333477756557898423212589703798704689999831485110367760698528800881
Q 003599          141 VWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGSFSAGLIHQNIPEIFVWNVSRPYWR  207 (808)
Q Consensus       141 ~WqSFd~PTDtllpg~~l~~~~~~~~~~~l~s~~s~~dps~G~f~~~~~~~~~~~~~~~~~~~~y~~  207 (808)
                      +||||.                               +.+.|.|.+.++++|..  ++|.  .++|.
T Consensus        88 lW~S~t-------------------------------~~~~~~~~l~Lq~DGnl--vlY~--~~~W~  119 (120)
T d1dlpa2          88 VWTSGN-------------------------------SRSAGRYVFVLQPDRNL--AIYG--GALWT  119 (120)
T ss_dssp             EEECCC-------------------------------CCSSSCCEEEECSSSCE--EEEC--CCCCB
T ss_pred             EEEECC-------------------------------CCCCCCEEEEECCCCCE--EEEC--CCCCC
T ss_conf             998199-------------------------------99998489998889869--9968--97434

>d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.40  E-value=1.1e-13  Score=108.97  Aligned_cols=111  Identities=25%  Similarity=0.356  Sum_probs=87.5

Q ss_pred             EEEEECCCCCEEEEEECCCCCCCCCCCEEEEECCCCEEEECCCCCEEEEECCCCCCCCCEEEEEECCCCEEEEECCCCCE
Q ss_conf             99950599952899945999877896549993287589973997179963023564563389990388879993556715
Q 003599           61 GIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAI  140 (808)
Q Consensus        61 ~iw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~G~L~l~~~~~~~vWst~~~~~~~~~~~a~LldsGNlVl~~~~~~~~  140 (808)
                      .|||...++.+..|+.+.+.++.....+|.+..||||||.++ +.++|++++.+  ..+..+.|+++|||||++. ++++
T Consensus         2 ~~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~~-~~~vW~s~t~~--~~~~~l~l~~dGNLvl~d~-~~~~   77 (115)
T d1dlpa1           2 NILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDS-DVRVWASNTAG--ATGCRAVLQSDGLLVILTA-QNTI   77 (115)
T ss_dssp             CCCBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEES-SSEEECCCCCS--CSCCBCCBCSSSCBCCBCT-TTCC
T ss_pred             CEEEECCCCCCCCCEECCCCCEECCCEEEEECCCCEEEEECC-CEEEEECCCCC--CCCEEEEEECCCCEEEECC-CCCE
T ss_conf             677864789988212469981775988999979983999819-90689711689--9756899944678999905-8978


Q ss_pred             EECCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEECCCCCEEEEECCCEEEEECCC
Q ss_conf             7333477756557898423212589703798704689999831485110367760698528800881299
Q 003599          141 VWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGSFSAGLIHQNIPEIFVWNVSRPYWRSGP  210 (808)
Q Consensus       141 ~WqSFd~PTDtllpg~~l~~~~~~~~~~~l~s~~s~~dps~G~f~~~~~~~~~~~~~~~~~~~~y~~~~~  210 (808)
                      +|||+.                               +.+.|.|.+.++++|..  +++.  .++|.++.
T Consensus        78 vWsS~t-------------------------------~~~~g~y~l~Lq~DGNl--vlY~--~~~Wssgt  112 (115)
T d1dlpa1          78 RWSSGT-------------------------------KGSIGNYVLVLQPDRTV--TIYG--PGLWDSGT  112 (115)
T ss_dssp             SCCCCC-------------------------------CCCSSCCEEEECSSSCE--EEEC--SEEEECSC
T ss_pred             EEECCC-------------------------------CCCCCCEEEEECCCCCE--EEEC--CCEECCCC
T ss_conf             998188-------------------------------89999789999899869--9968--97643889

>d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.40  E-value=4e-12  Score=98.05  Aligned_cols=105  Identities=17%  Similarity=0.340  Sum_probs=81.8

Q ss_pred             CCCCCCCCCCCCCCEEEECCCEEEEEEECCCCCCCEEEEEEEECCCCCEEEEEECCCCCCCCCCCEEEEECCCCEEEECC
Q ss_conf             36545886457999398389923898755899996399999505999528999459998778965499932875899739
Q 003599           23 DSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNG  102 (808)
Q Consensus        23 ~~~l~~~~~l~~~~~l~S~~g~F~~gF~~~~~~~~~~~~iw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~G~L~l~~~  102 (808)
                      ..+|.++|+|    ...+..|.|.|.|...++     |.+ |.   ..++||.||+..+..  .+.|.|..+|+|+|.|+
T Consensus        14 ~~~l~~~q~l----~~~~~~~~y~l~mQ~DGN-----LVL-y~---~~~~vWssnt~~~~~--~~~l~l~~dGnLvL~d~   78 (119)
T d1b2pa_          14 PQILHATESL----EILFGTHVYRFIMQTDCN-----LVL-YD---NNNPIWATNTGGLGN--GCRAVLQPDGVLVVITN   78 (119)
T ss_dssp             CCEEETTCEE----EEEETTEEEEEEECTTSC-----EEE-EE---TTEEEEECCCTTSCS--SCEEEECTTSCEEEECT
T ss_pred             CCEEECCCEE----EEECCCCEEEEEECCCCC-----EEE-EE---CCEEEEEECCCCCCC--CEEEEEEECCCEEEECC
T ss_conf             8888289758----870478538999889982-----999-97---996799946788774--16999983777999899


Q ss_pred             CCCEEEEECCCCCCCCCEEEEEECCCCEEEEECCCCCEEECCCCC
Q ss_conf             971799630235645633899903888799935567157333477
Q 003599          103 QKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQE  147 (808)
Q Consensus       103 ~~~~vWst~~~~~~~~~~~a~LldsGNlVl~~~~~~~~~WqSFd~  147 (808)
                      ++.++|++++.+. .+..+|+|+|+|||||++.    .+|||..+
T Consensus        79 ~g~~vWsS~t~~~-~~~~~l~Lq~DGNlvlYg~----~~W~S~T~  118 (119)
T d1b2pa_          79 ENVTVWQSPVAGK-AGHYVLVLQPDRNVVIYGD----ALWATQTV  118 (119)
T ss_dssp             TCCEEEECSCCCC-SSCEEEEECTTSCEEEEES----EEEECCCC
T ss_pred             CCCEEEECCCCCC-CCCEEEEECCCCCEEEECC----CEECCCCC
T ss_conf             9857997887699-8865999969988999799----88416974

>d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.07  E-value=1.1e-10  Score=88.11  Aligned_cols=109  Identities=17%  Similarity=0.306  Sum_probs=78.6

Q ss_pred             HHHHHHHHHCCCCCCCCCCCCCCCEEEECCCEEEEEEECCCCCCCEEEEEEEECCCCCEEEEEECCCCCCCCCCCEEEEE
Q ss_conf             75222221013654588645799939838992389875589999639999950599952899945999877896549993
Q 003599           13 CFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITIS   92 (808)
Q Consensus        13 ~~~~~~~~~~~~~l~~~~~l~~~~~l~S~~g~F~~gF~~~~~~~~~~~~iw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~   92 (808)
                      +|++++..      +..|+|..++.|.  +|.|.|.|...++     |.++.    ...+||.+|...+   ..+++.|.
T Consensus         4 ~~~~~~~~------~~~~tl~~~~~l~--~g~~~l~~q~DGN-----LvL~~----~~~~vW~s~t~~~---~~~~l~l~   63 (115)
T d1dlpa1           4 LFGLSHEG------SHPQTLHAAQSLE--LSSFRFTMQSDCN-----LVLFD----SDVRVWASNTAGA---TGCRAVLQ   63 (115)
T ss_dssp             CBCSSSSS------CSCSCCCTTCEEC--STTEEEEECTTSC-----EEEEE----SSSEEECCCCCSC---SCCBCCBC
T ss_pred             EEECCCCC------CCCCEECCCCCEE--CCCEEEEECCCCE-----EEEEC----CCEEEEECCCCCC---CCEEEEEE
T ss_conf             78647899------8821246998177--5988999979983-----99981----9906897116899---75689994


Q ss_pred             CCCCEEEECCCCCEEEEECCCCCCCCCEEEEEECCCCEEEEECCCCCEEECCCC
Q ss_conf             287589973997179963023564563389990388879993556715733347
Q 003599           93 EDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQ  146 (808)
Q Consensus        93 ~~G~L~l~~~~~~~vWst~~~~~~~~~~~a~LldsGNlVl~~~~~~~~~WqSFd  146 (808)
                      .+|+|||.+.++.++|++++... .+...++|+++|||||++.    .+|+|-.
T Consensus        64 ~dGNLvl~d~~~~~vWsS~t~~~-~g~y~l~Lq~DGNlvlY~~----~~Wssgt  112 (115)
T d1dlpa1          64 SDGLLVILTAQNTIRWSSGTKGS-IGNYVLVLQPDRTVTIYGP----GLWDSGT  112 (115)
T ss_dssp             SSSCBCCBCTTTCCSCCCCCCCC-SSCCEEEECSSSCEEEECS----EEEECSC
T ss_pred             CCCCEEEECCCCCEEEECCCCCC-CCCEEEEECCCCCEEEECC----CEECCCC
T ss_conf             46789999058978998188899-9978999989986999689----7643889

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.85  E-value=6.2e-08  Score=69.07  Aligned_cols=150  Identities=15%  Similarity=0.060  Sum_probs=105.3

Q ss_pred             HHHHHHHCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCC-CCCEEEEEEEEEECCEE
Q ss_conf             89999842875468533369631898993399699999914446204899999999998236-87245685389718834
Q 003599          475 EELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEK  553 (808)
Q Consensus       475 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~  553 (808)
                      .++....+.|+..+..+.+....||+.... ++.+.+|+...........+.+|...+..+. +--+.+++.+...++..
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHHHHHHCEEEEECCCCCCCCCEEEEEEC-CCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCE
T ss_conf             999975135279976789987718999908-9869999848876532556999999999876069987289997508964


Q ss_pred             EEEEEECCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--------------------------------
Q ss_conf             899982689990001038898876792428989999998879867239--------------------------------
Q 003599          554 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS--------------------------------  601 (808)
Q Consensus       554 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--------------------------------  601 (808)
                      ++||+++++.++......        ......++.++++.++.||+..                                
T Consensus        86 ~lv~~~l~G~~~~~~~~~--------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN  157 (263)
T ss_dssp             EEEEECCSSEEHHHHTTT--------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred             EEEEEECCCCCCCCCCCC--------CCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHC
T ss_conf             999986043343543344--------026999999899999998556842143576446565557789987765555430


Q ss_pred             ------------------------CCCEEECCCCCCCEEECCCCCEEEECCCCCEE
Q ss_conf             ------------------------98478077798966747999803311366100
Q 003599          602 ------------------------RLRIIHRDLKASNILLDEELNPKISDFGMAKI  633 (808)
Q Consensus       602 ------------------------~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  633 (808)
                                              ...++|+|+.|.|||++++..+.|+||+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             CCCCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf             33232005799999999844986781789860047642364996599960231441

>d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=98.77  E-value=1.8e-08  Score=72.76  Aligned_cols=99  Identities=15%  Similarity=0.306  Sum_probs=70.5

Q ss_pred             CCCCCCCCCEEEECCCEEEEEEECCCCCCCEEEEEEEECCCCCEEEEEECCCCCCCCCCCEEEEECCCCEEEECCCCCEE
Q ss_conf             88645799939838992389875589999639999950599952899945999877896549993287589973997179
Q 003599           28 SSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVL  107 (808)
Q Consensus        28 ~~~~l~~~~~l~S~~g~F~~gF~~~~~~~~~~~~iw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~G~L~l~~~~~~~v  107 (808)
                      +.+.|..++.|.  .|.|.|.|-..++     |.++.    ...+||.+|-.  ..+..+.+.|..+|+|||.|.++.++
T Consensus        22 ~~~~l~~~q~l~--~g~y~L~~q~DGN-----LvL~~----~~~~vW~s~t~--~~~~~~~~~l~~~GnLvl~d~~~~~l   88 (120)
T d1dlpa2          22 HPQTLHATQSLQ--LSPYRLSMETDCN-----LVLFD----RDDRVWSTNTA--GKGTGCRAVLQPNGRMDVLTNQNIAV   88 (120)
T ss_dssp             CCCEECSSCCCB--CSSCEEEEETTTE-----EEEEB----TTBCCSCCCCC--SSCSSCEEEEETTTEEEEEETTTEEE
T ss_pred             CCCEECCCCEEE--CCCEEEEECCCCC-----EEEEC----CCCEEEEECCC--CCCCCEEEEEECCEEEEEECCCCCEE
T ss_conf             562883997217--4887999968983-----89964----99689997522--47774799990776499992999889


Q ss_pred             EEECCCCCCCCCEEEEEECCCCEEEEECCCCCEEECC
Q ss_conf             9630235645633899903888799935567157333
Q 003599          108 WSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWES  144 (808)
Q Consensus       108 Wst~~~~~~~~~~~a~LldsGNlVl~~~~~~~~~WqS  144 (808)
                      |+|++... .+..++.|.++|||||++.    .+|.|
T Consensus        89 W~S~t~~~-~~~~~l~Lq~DGnlvlY~~----~~W~t  120 (120)
T d1dlpa2          89 WTSGNSRS-AGRYVFVLQPDRNLAIYGG----ALWTT  120 (120)
T ss_dssp             EECCCCCS-SSCCEEEECSSSCEEEECC----CCCBC
T ss_pred             EEECCCCC-CCCEEEEECCCCCEEEECC----CCCCC
T ss_conf             98199999-9848999888986999689----74349

>d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Garlic (Allium sativum) [TaxId: 4682]

Probab=98.67  E-value=1.8e-07  Score=65.89  Aligned_cols=88  Identities=25%  Similarity=0.427  Sum_probs=64.5

Q ss_pred             CCEEEEECCCCEEEECCCCCEEEEECCCCCCCCCEEEEEECCCCEEEEECCCCCEEECCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             65499932875899739971799630235645633899903888799935567157333477756557898423212589
Q 003599           86 SGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTG  165 (808)
Q Consensus        86 ~~~l~~~~~G~L~l~~~~~~~vWst~~~~~~~~~~~a~LldsGNlVl~~~~~~~~~WqSFd~PTDtllpg~~l~~~~~~~  165 (808)
                      .-.|.+..||+|||... +.++|++++.........+.|.++|||||+++ +++++|+|--                   
T Consensus        20 ~~~l~~q~dgnLvl~~~-~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~-~g~~vW~s~t-------------------   78 (109)
T d1kj1a_          20 PYHFIMQEDCNLVLYDH-STSVWASNTGILGKKGCKAVLQSDGNFVVYDA-EGRSLWASHS-------------------   78 (109)
T ss_dssp             TEEEEECTTSCEEEEET-TEEEEECCCCCTTCCCCEEEECTTSCEEEECS-SSCEEEECCC-------------------
T ss_pred             CEEEEECCCCEEEEEEC-CEEEEEECCCCCCCEEEEEEECCCCEEEEEEC-CCCEEEEEEE-------------------
T ss_conf             88999448986999869-98999837899875107999937960999908-9867999730-------------------


Q ss_pred             CEEEEEEECCCCCCCCCEEEEEEECCCCCEEEEECCCEEEEECCC
Q ss_conf             703798704689999831485110367760698528800881299
Q 003599          166 KKVQLTSWKSLSDPSTGSFSAGLIHQNIPEIFVWNVSRPYWRSGP  210 (808)
Q Consensus       166 ~~~~l~s~~s~~dps~G~f~~~~~~~~~~~~~~~~~~~~y~~~~~  210 (808)
                                  ..+.|.|.+.++++|..  ++++  .+.|.++.
T Consensus        79 ------------~~~~~~~~l~L~ddGNl--vly~--~~~W~S~t  107 (109)
T d1kj1a_          79 ------------VRGNGNYVLVLQEDGNV--VIYG--SDIWSTGT  107 (109)
T ss_dssp             ------------CCCSSCCEEEECTTSCE--EEEC--CEEEECCC
T ss_pred             ------------ECCCCCEEEEEECCCCE--EEEC--CCEECCCC
T ss_conf             ------------88999779999479759--9979--98721798

>d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=98.64  E-value=2e-07  Score=65.48  Aligned_cols=85  Identities=25%  Similarity=0.438  Sum_probs=63.1

Q ss_pred             EEEEECCCCEEEECCCCCEEEEECCCCCCCCCEEEEEECCCCEEEEECCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCE
Q ss_conf             49993287589973997179963023564563389990388879993556715733347775655789842321258970
Q 003599           88 IITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKK  167 (808)
Q Consensus        88 ~l~~~~~G~L~l~~~~~~~vWst~~~~~~~~~~~a~LldsGNlVl~~~~~~~~~WqSFd~PTDtllpg~~l~~~~~~~~~  167 (808)
                      .|.+..||||||.++ +.++|++++.+. .....+.|.++|||||+|. +++++|+|.-                     
T Consensus        33 ~l~mQ~DGNLVLy~~-~~~vWssnt~~~-~~~~~l~l~~dGnLvL~d~-~g~~vWsS~t---------------------   88 (119)
T d1b2pa_          33 RFIMQTDCNLVLYDN-NNPIWATNTGGL-GNGCRAVLQPDGVLVVITN-ENVTVWQSPV---------------------   88 (119)
T ss_dssp             EEEECTTSCEEEEET-TEEEEECCCTTS-CSSCEEEECTTSCEEEECT-TCCEEEECSC---------------------
T ss_pred             EEEECCCCCEEEEEC-CEEEEEECCCCC-CCCEEEEEEECCCEEEECC-CCCEEEECCC---------------------
T ss_conf             999889982999979-967999467887-7416999983777999899-9857997887---------------------


Q ss_pred             EEEEEECCCCCCCCCEEEEEEECCCCCEEEEECCCEEEEECCC
Q ss_conf             3798704689999831485110367760698528800881299
Q 003599          168 VQLTSWKSLSDPSTGSFSAGLIHQNIPEIFVWNVSRPYWRSGP  210 (808)
Q Consensus       168 ~~l~s~~s~~dps~G~f~~~~~~~~~~~~~~~~~~~~y~~~~~  210 (808)
                                .-+.|.|.+.++++|..  +++.  .+.|.++.
T Consensus        89 ----------~~~~~~~~l~Lq~DGNl--vlYg--~~~W~S~T  117 (119)
T d1b2pa_          89 ----------AGKAGHYVLVLQPDRNV--VIYG--DALWATQT  117 (119)
T ss_dssp             ----------CCCSSCEEEEECTTSCE--EEEE--SEEEECCC
T ss_pred             ----------CCCCCCEEEEECCCCCE--EEEC--CCEECCCC
T ss_conf             ----------69988659999699889--9979--98841697

>d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Snowdrop (Galanthus nivalis) [TaxId: 4670]

Probab=98.54  E-value=3.7e-07  Score=63.69  Aligned_cols=86  Identities=23%  Similarity=0.456  Sum_probs=61.3

Q ss_pred             CEEEEECCCCEEEECCCCCEEEEECCCCCCCCCEEEEEECCCCEEEEECCCCCEEECCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             54999328758997399717996302356456338999038887999355671573334777565578984232125897
Q 003599           87 GIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGK  166 (808)
Q Consensus        87 ~~l~~~~~G~L~l~~~~~~~vWst~~~~~~~~~~~a~LldsGNlVl~~~~~~~~~WqSFd~PTDtllpg~~l~~~~~~~~  166 (808)
                      -+|.+..||||||.++ +.+||++++.+. .....+.|.++|||||++. +++++|+|=     |               
T Consensus        21 ~~l~~q~DGNLvly~~-~~~vW~s~~~~~-~~~~~l~l~~~Gnlvl~~~-~g~~vWsS~-----t---------------   77 (108)
T d1jpca_          21 FVFIMQEDCNLVLYDV-DKPIWATNTGGL-SRSCFLSMQTDGNLVVYNP-SNKPIWASN-----T---------------   77 (108)
T ss_dssp             EEEEECTTSCEEEEET-TEEEEECCCTTS-CSSCEEEECTTSCEEEECT-TCCEEEECC-----C---------------
T ss_pred             EEEEECCCCEEEEEEC-CCEEEEECCCCC-CCCCEEEEECCCEEEEECC-CCCCEEECC-----C---------------
T ss_conf             8999878980999709-902157078899-8754799812603999779-855127704-----5---------------


Q ss_pred             EEEEEEECCCCCCCCCEEEEEEECCCCCEEEEECCCEEEEECCC
Q ss_conf             03798704689999831485110367760698528800881299
Q 003599          167 KVQLTSWKSLSDPSTGSFSAGLIHQNIPEIFVWNVSRPYWRSGP  210 (808)
Q Consensus       167 ~~~l~s~~s~~dps~G~f~~~~~~~~~~~~~~~~~~~~y~~~~~  210 (808)
                                 ..+.+.|.+.++++|..  +++.  .+.|.++.
T Consensus        78 -----------~~~~~~~~l~L~ddGNl--Vly~--~~~W~S~t  106 (108)
T d1jpca_          78 -----------GGQNGNYVCILQKDRNV--VIYG--TDRWATGT  106 (108)
T ss_dssp             -----------CCSCSCEEEEECTTSCE--EEEE--CCCCCCCC
T ss_pred             -----------CCCCCCEEEEECCCCCE--EEEC--CCCCCCCC
T ss_conf             -----------58887679999688899--9969--98456888

>d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Gastrodianin (antifungal protein)
species: Gastrodia elata [TaxId: 91201]

Probab=98.30  E-value=7.3e-06  Score=54.74  Aligned_cols=88  Identities=19%  Similarity=0.426  Sum_probs=58.8

Q ss_pred             CCEEEEECCCCEEEECCCCCEEEEECCCCCCCCCEEEEEECCCCEEEEECCCCCEEECCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             65499932875899739971799630235645633899903888799935567157333477756557898423212589
Q 003599           86 SGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTG  165 (808)
Q Consensus        86 ~~~l~~~~~G~L~l~~~~~~~vWst~~~~~~~~~~~a~LldsGNlVl~~~~~~~~~WqSFd~PTDtllpg~~l~~~~~~~  165 (808)
                      .-.|.|..||||||.+. +.+||++++.+. ...+.+.|..+|||||++.  ++.+|.|=                    
T Consensus        20 ~~~l~~q~DGNLvly~~-~~~vW~s~~~~~-~~~~~l~l~~dGnLvl~~~--~~~~w~s~--------------------   75 (112)
T d1xd5a_          20 GYLFIIQNDCNLVLYDN-NRAVWASGTNGK-ASGCVLKMQNDGNLVIYSG--SRAIWASN--------------------   75 (112)
T ss_dssp             TEEEEECTTSCEEEEET-TEEEEECCCTTS-CSSEEEEECTTSCEEEEET--TEEEEECC--------------------
T ss_pred             CEEEEECCCCCEEEECC-CCEEEECCCCCC-CCCCEEEEECCCCEEEEEC--CCEEEEEE--------------------
T ss_conf             79999817998898739-838998467347-8885799961534999934--87499983--------------------


Q ss_pred             CEEEEEEECCCCCCCCCEEEEEEECCCCCEEEEECC-CEEEEECCC
Q ss_conf             703798704689999831485110367760698528-800881299
Q 003599          166 KKVQLTSWKSLSDPSTGSFSAGLIHQNIPEIFVWNV-SRPYWRSGP  210 (808)
Q Consensus       166 ~~~~l~s~~s~~dps~G~f~~~~~~~~~~~~~~~~~-~~~y~~~~~  210 (808)
                                 ..-..+.+.+.++.+|..  ++++. ..+.|.++.
T Consensus        76 -----------t~~~~~~~~l~L~ddGNl--vly~~~~~~~W~S~t  108 (112)
T d1xd5a_          76 -----------TNRQNGNYYLILQRDRNV--VIYDNSNNAIWATHT  108 (112)
T ss_dssp             -----------CCCSCCCCEEEECTTSCE--EEECTTSCEEEECCC
T ss_pred             -----------ECCCCCCEEEEECCCCCE--EEECCCCCEEECCCC
T ss_conf             -----------036887259999678999--999899967961888

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.28  E-value=7.1e-06  Score=54.79  Aligned_cols=131  Identities=18%  Similarity=0.170  Sum_probs=86.2

Q ss_pred             CCCCCCC-EEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCC--CCCEEEEEEEEEECCEEEEEEEECCCCCC
Q ss_conf             5333696-31898993399699999914446204899999999998236--87245685389718834899982689990
Q 003599          489 KLGQGGF-GPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ--HRNLVRLLGCCVEGEEKMLIYEYMPNRSL  565 (808)
Q Consensus       489 ~lG~G~~-g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~~~lV~E~~~~gsL  565 (808)
                      .+..|.. ..||+....++..+.+|......   ...+..|...++.+.  .-.+.+++++..+.+..++||+++++.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             ECCCCCCCCEEEEEEECCCCEEEEEECCCCC---HHHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEECCCC
T ss_conf             7678654775899993898789999589667---7689999999999986599988613222456615999874413554


Q ss_pred             HHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---------------------------------------------
Q ss_conf             00103889887679242898999999887986723---------------------------------------------
Q 003599          566 DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD---------------------------------------------  600 (808)
Q Consensus       566 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~---------------------------------------------  600 (808)
                      .....        .   ...++.++++.+..||..                                             
T Consensus        94 ~~~~~--------~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (255)
T d1nd4a_          94 LSSHL--------A---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF  162 (255)
T ss_dssp             TTSCC--------C---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred             CCCCC--------C---HHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHH
T ss_conf             32212--------6---899999999999987368854488755412468899999987541101134011213799999


Q ss_pred             ----------CCCCEEECCCCCCCEEECCCCCEEEECCCCCEE
Q ss_conf             ----------998478077798966747999803311366100
Q 003599          601 ----------SRLRIIHRDLKASNILLDEELNPKISDFGMAKI  633 (808)
Q Consensus       601 ----------~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  633 (808)
                                .+..++|+|+.|.|||++++..+.|+||+.+..
T Consensus       163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf             9998718765795678678887635773796589998533265

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.85  E-value=0.00012  Score=46.42  Aligned_cols=77  Identities=12%  Similarity=0.176  Sum_probs=50.7

Q ss_pred             CCCCCCCCCEEEEEEEECC-CCEEEEEEECCC-------CCCCHHHHHHHHHHHHHCC-C--CCEEEEEEEEEECCEEEE
Q ss_conf             6853336963189899339-969999991444-------6204899999999998236-8--724568538971883489
Q 003599          487 SSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKA-------SGQGLEEFMNEVMVISKLQ-H--RNLVRLLGCCVEGEEKML  555 (808)
Q Consensus       487 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~l~~~-------~~~~~~~~~~E~~~l~~l~-h--~niv~l~g~~~~~~~~~l  555 (808)
                      .+.||.|....||+....+ ++.+++|.-...       ......+...|.+.+..+. +  ..+++++.+  +.+..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEE--CCCCCEE
T ss_conf             99807985276899995799848999617713034677788877899999999998650579885528998--5988779


Q ss_pred             EEEECCCCCC
Q ss_conf             9982689990
Q 003599          556 IYEYMPNRSL  565 (808)
Q Consensus       556 V~E~~~~gsL  565 (808)
                      |||++++..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEECCCCCCC
T ss_conf             8713577653

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.45  E-value=0.00031  Score=43.50  Aligned_cols=136  Identities=14%  Similarity=0.118  Sum_probs=72.9

Q ss_pred             CEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCE--EEEE-----EEEEECCEEEEEEEECCCCCCHH
Q ss_conf             6318989933996999999144462048999999999982368724--5685-----38971883489998268999000
Q 003599          495 FGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL--VRLL-----GCCVEGEEKMLIYEYMPNRSLDA  567 (808)
Q Consensus       495 ~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~-----g~~~~~~~~~lV~E~~~~gsL~~  567 (808)
                      --.||+....+|..+++|..+.. ....+++..|...+..|...++  +..+     .....+...+.++++++|..+..
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~  113 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA  113 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred             CCEEEEEECCCCCEEEEEEECCC-CCCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCCCCC
T ss_conf             20269998389997999984787-78899999999999999855998787520689805665347999986527768899


Q ss_pred             H------------------CCC--CCCCCCCC-------------------HHHHHHHHHHHHHHHHHHH----HCCCCC
Q ss_conf             1------------------038--89887679-------------------2428989999998879867----239984
Q 003599          568 L------------------LFD--PLKKERLD-------------------WRKRFNIIEGISRGLLYLH----RDSRLR  604 (808)
Q Consensus       568 ~------------------l~~--~~~~~~l~-------------------~~~~~~i~~~ia~~l~~LH----~~~~~~  604 (808)
                      .                  ...  .......+                   ...+-.+...+.+.+..+.    ...+..
T Consensus       114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~  193 (325)
T d1zyla1         114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL  193 (325)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred             CCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCE
T ss_conf             99999999899999988630357865567789788766568999874769988989999999999999998454568712


Q ss_pred             EEECCCCCCCEEECCCCCEEEECCCCCEE
Q ss_conf             78077798966747999803311366100
Q 003599          605 IIHRDLKASNILLDEELNPKISDFGMAKI  633 (808)
Q Consensus       605 ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  633 (808)
                      ++|+|+.+.|||++++  ..++||+-+..
T Consensus       194 liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         194 RLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             EECCCCCCCCEEEECC--CEEEECHHCCC
T ss_conf             0247888042878389--35886520146

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.42  E-value=0.0018  Score=38.20  Aligned_cols=74  Identities=18%  Similarity=0.274  Sum_probs=47.6

Q ss_pred             CCCCCCCCCEEEEEEEECC--------CCEEEEEEECCCCCCCHHHHHHHHHHHHHCC-CCCEEEEEEEEEECCEEEEEE
Q ss_conf             6853336963189899339--------9699999914446204899999999998236-872456853897188348999
Q 003599          487 SSKLGQGGFGPVYWGRLKD--------GQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEKMLIY  557 (808)
Q Consensus       487 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~  557 (808)
                      .+.|+.|-.-.+|+....+        ...|.+++...  ........+|..+++.+. +.-.+++++++..    .+|+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCC--CCHHHHHHHHHHHHHHHHHCCCCCEEEEECCC----CEEE
T ss_conf             99917853343489996887754457898179996599--61165899999999999757999808998189----5699


Q ss_pred             EECCCCCCH
Q ss_conf             826899900
Q 003599          558 EYMPNRSLD  566 (808)
Q Consensus       558 E~~~~gsL~  566 (808)
                      ||+++.++.
T Consensus       121 efi~g~~l~  129 (395)
T d1nw1a_         121 EYIPSRPLS  129 (395)
T ss_dssp             CCCCEEECC
T ss_pred             EEECCCCCC
T ss_conf             973455488

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.21  E-value=0.03  Score=29.70  Aligned_cols=158  Identities=13%  Similarity=0.045  Sum_probs=77.6

Q ss_pred             CCHHHHHHHHCCCCCCCCCC-----CCCCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCE--EEEE
Q ss_conf             28889999842875468533-----3696318989933996999999144462048999999999982368724--5685
Q 003599          472 FQFEELATATNNFQLSSKLG-----QGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL--VRLL  544 (808)
Q Consensus       472 ~~~~~~~~~~~~~~~~~~lG-----~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~  544 (808)
                      .+.+++.....+|.+.+...     .|---+.|+....++ .+++|+......  .++...|...+..+...++  ...+
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHHCCCCCCEEEECCCCCCCCCEEEEEECCC-CEEEEECCCCCC--HHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf             8999999999867999856852378885267389997897-289998078999--8899999999875430255545564


Q ss_pred             E------EEEECCEEEEEEEECCCCCCHHHCC-----------------CCCCCC---------------------CCCH
Q ss_conf             3------8971883489998268999000103-----------------889887---------------------6792
Q 003599          545 G------CCVEGEEKMLIYEYMPNRSLDALLF-----------------DPLKKE---------------------RLDW  580 (808)
Q Consensus       545 g------~~~~~~~~~lV~E~~~~gsL~~~l~-----------------~~~~~~---------------------~l~~  580 (808)
                      .      ..........++.+..+........                 ......                     ....
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             EECCCCCCEEEECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCC
T ss_conf             10489762134125502453114655333204678888899876454443202453101110120024567777653114


Q ss_pred             HHHHHHHHHHHHHHHHHH-HCCCCCEEECCCCCCCEEECCCCCEEEECCCCCE
Q ss_conf             428989999998879867-2399847807779896674799980331136610
Q 003599          581 RKRFNIIEGISRGLLYLH-RDSRLRIIHRDLKASNILLDEELNPKISDFGMAK  632 (808)
Q Consensus       581 ~~~~~i~~~ia~~l~~LH-~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  632 (808)
                      ......+..+...+...+ ..-+.+++|+|+.+.||+++.+...-+.||+.+.
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCC
T ss_conf             12799999998764204855454503337863656402045412674222123

>d2qj2a1 g.10.1.1 (A:36-126) Hepatocyte growth factor {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Hairpin loop containing domain-like
superfamily: Hairpin loop containing domain-like
family: Hairpin loop containing domain
domain: Hepatocyte growth factor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=81.39  E-value=1.1  Score=19.02  Aligned_cols=32  Identities=31%  Similarity=0.769  Sum_probs=24.6

Q ss_pred             CCHHHHHHHHHHC----CCCEEEEECCCEEEEEEEE
Q ss_conf             3467899997202----8811244128804899552
Q 003599          358 ATEDECREQCLKN----CSCIAYAFDGGIGCMVWRS  389 (808)
Q Consensus       358 ~s~~~C~~~C~~~----CsC~a~~~~~~~gc~~w~~  389 (808)
                      .|.++|...|+++    =.|.+|.|+...+.|++..
T Consensus        30 ~s~eeCA~rC~~~~~~~f~CrSF~y~~~~~~C~Ls~   65 (91)
T d2qj2a1          30 NTADQCANRCTRNKGLPFTCKAFVFDKARKQCLWFP   65 (91)
T ss_dssp             SCHHHHHHHHHTTTTCSSCCCEEEEETTTTEEEEES
T ss_pred             CCHHHHHHHHHCCCCCCCEEEEEEEECCCCEEEECC
T ss_conf             899999999872679870677689877898278726